Citrus Sinensis ID: 001034
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1182 | 2.2.26 [Sep-21-2011] | |||||||
| Q54BC9 | 915 | Probable serine/threonine | yes | no | 0.266 | 0.344 | 0.373 | 6e-59 | |
| Q09690 | 1087 | Dual specificity protein | yes | no | 0.268 | 0.291 | 0.382 | 5e-58 | |
| Q9NR20 | 520 | Dual specificity tyrosine | yes | no | 0.269 | 0.613 | 0.377 | 1e-55 | |
| Q09815 | 836 | Serine/threonine-protein | no | no | 0.252 | 0.356 | 0.368 | 2e-55 | |
| Q9V3D5 | 722 | Dual specificity tyrosine | yes | no | 0.267 | 0.437 | 0.365 | 7e-54 | |
| P83102 | 828 | Putative dual specificity | no | no | 0.256 | 0.365 | 0.378 | 2e-53 | |
| Q9P6P3 | 534 | Serine/threonine-protein | no | no | 0.250 | 0.554 | 0.370 | 6e-53 | |
| Q9XTF3 | 817 | Dual specificity tyrosine | yes | no | 0.273 | 0.395 | 0.358 | 1e-52 | |
| A8WJR8 | 815 | Dual specificity tyrosine | N/A | no | 0.273 | 0.396 | 0.358 | 1e-52 | |
| Q8BI55 | 632 | Dual specificity tyrosine | yes | no | 0.280 | 0.525 | 0.366 | 2e-52 |
| >sp|Q54BC9|DYRK2_DICDI Probable serine/threonine-protein kinase dyrk2 OS=Dictyostelium discoideum GN=dyrk2 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 230 bits (586), Expect = 6e-59, Method: Compositional matrix adjust.
Identities = 126/337 (37%), Positives = 190/337 (56%), Gaps = 22/337 (6%)
Query: 852 GFEEDKN-FHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD 910
G++ D + VV IA R+ + LG +F + ++ +D TG V +KI++N K F +
Sbjct: 585 GYDNDIGEYKVVERDHIAYRFEIVSILGQGSFCQVVKGYDYKTGEMVALKILRNQKRFHN 644
Query: 911 QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE 970
Q+L EIK+L+Y+ +DP ++ L +YFY+R HL++ ELL NLY+F K N G
Sbjct: 645 QALTEIKILEYLKTNDPNSTASIVHLNNYFYFRNHLILTFELLSMNLYDFLKVNHFQG-- 702
Query: 971 VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030
+ + ++ Q L +L+FL +IH DLKPENIL+KS ++ +K+ID GSSCFE +
Sbjct: 703 --YNLNLVRRFGAQILTSLRFLSKRNIIHADLKPENILLKSPTKSGIKLIDFGSSCFENE 760
Query: 1031 HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090
+ +Y+QSR YR+PEVILG YDK IDIWSLGCIL E+ TG LF LA ++ +
Sbjct: 761 QIFTYIQSRFYRSPEVILGTKYDKSIDIWSLGCILVEIFTGVPLFPGSDEPEQLACIMEV 820
Query: 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYE--------RNQETNRLEYLIPKKTSLRHRLPMG 1142
+G + ++ T+ + +E +N T L Y I K S + + G
Sbjct: 821 LGAPPKSVIDNS-------TRKDIFFEDDGTPKPVKNSTTGEL-YTIGTK-SFKDSIRSG 871
Query: 1143 DQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
D+ F +F+ L+ P +R +A LKH W+ P
Sbjct: 872 DEDFDNFILDCLKWEPSQRITAEQGLKHDWIIKVIAP 908
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|Q09690|POM1_SCHPO Dual specificity protein kinase pom1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pom1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 227 bits (578), Expect = 5e-58, Method: Compositional matrix adjust.
Identities = 124/324 (38%), Positives = 192/324 (59%), Gaps = 7/324 (2%)
Query: 852 GFEEDK-NFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD 910
GF++++ ++ VVL IA RY V ++LG +F + ++ D TG V +KII+N K F
Sbjct: 679 GFDDERGDYKVVLGDHIAYRYEVVDFLGKGSFGQVLRCIDYETGKLVALKIIRNKKRFHM 738
Query: 911 QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE 970
Q+L E K+L+ + + DP D+Y +++ D+FY+R+HL + ELL NLYE K N G
Sbjct: 739 QALVETKILQKIREWDPLDEYCMVQYTDHFYFRDHLCVATELLGKNLYELIKSNGFKGLP 798
Query: 971 VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030
+ ++SIT Q ++ L L+ +IHCDLKPENIL+ + +VKVID GSSCFE +
Sbjct: 799 IVV----IKSITRQLIQCLTLLNEKHVIHCDLKPENILLCHPFKSQVKVIDFGSSCFEGE 854
Query: 1031 HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090
+ +Y+QSR YR+PEVILG+ Y ID+WSLGCI+AE+ TG LF ++ LA ++ I
Sbjct: 855 CVYTYIQSRFYRSPEVILGMGYGTPIDVWSLGCIIAEMYTGFPLFPGENEQEQLACIMEI 914
Query: 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFV 1150
GP + ++ K +F + R +++ P SL L D F+ F+
Sbjct: 915 FGPPDHSLIDKCSRKKVFFDSSGK--PRPFVSSKGVSRRPFSKSLHQVLQCKDVSFLSFI 972
Query: 1151 AHLLEINPKKRPSASDALKHPWLS 1174
+ L+ +P +R + A +H +L+
Sbjct: 973 SDCLKWDPDERMTPQQAAQHDFLT 996
|
Involved in localization of polarized growth and cytokinesis. May interact with both the actin and microtubule cytoskeleton. Requires tea1 for localization to the cell ends but not to the cell center. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9NR20|DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 219 bits (558), Expect = 1e-55, Method: Compositional matrix adjust.
Identities = 123/326 (37%), Positives = 180/326 (55%), Gaps = 7/326 (2%)
Query: 849 NRTGFEEDKNFHV-VLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD 907
++T F+++ F++ VL+ IA RY V E +G +F + + D V +KII+N K
Sbjct: 81 SKTSFDDEHGFYLKVLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKR 140
Query: 908 FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRES 967
F Q+L E+K+L+ + K D + Y+++ + D+FY+R H I ELL NLYE K N
Sbjct: 141 FHQQALMELKILEALRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQ 200
Query: 968 GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027
G F++ ++ T+ L+ LQ L +IHCDLKPENI++ + VKVID GSSC+
Sbjct: 201 G----FSLSIVRRFTLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCY 256
Query: 1028 ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
E + +Y+QSR YR+PEVILG YD ID+WSLGCI AEL TG LF ++ LA +
Sbjct: 257 EHQKVYTYIQSRFYRSPEVILGHPYDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACI 316
Query: 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFI 1147
+ ++G G + +F + +N NR + P L L D F+
Sbjct: 317 MEVLGLPPAGFIQTASRRQTFFDSKG--FPKNITNNRGKKRYPDSKDLTMVLKTYDTSFL 374
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWL 1173
DF+ L P R + ALKH W+
Sbjct: 375 DFLRRCLVWEPSLRMTPDQALKHAWI 400
|
Possible non-essential role in spermiogenesis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q09815|PPK5_SCHPO Serine/threonine-protein kinase ppk5 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (555), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 112/304 (36%), Positives = 174/304 (57%), Gaps = 6/304 (1%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
RY + + +G +F + ++ D G V +K+IKN + F Q+L E+ +LK + + DP D
Sbjct: 517 RYEIIDTVGKGSFGQVLKCIDHKRGQVVAIKVIKNRQKFHGQTLVEVGILKRLCEADPAD 576
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
K +++R +F +R HL IV ELL +NL++ + N G + ++S +Q L+AL
Sbjct: 577 KNNVIRYLSHFDFRGHLCIVTELLGSNLFDVIRENNYKG----LPLIVVKSFALQGLQAL 632
Query: 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILG 1049
+ L G +IHCDLKPEN+L+ + +K+ID GSSCF + + +Y+QSR YRAPE+ILG
Sbjct: 633 RLLQGQNIIHCDLKPENLLLSHPLKARIKLIDFGSSCFYNEKVYTYLQSRFYRAPEIILG 692
Query: 1050 LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYF 1109
L Y K+IDIWS GCILAEL TG LF + L ++ ++GP ++ + YF
Sbjct: 693 LEYGKEIDIWSFGCILAELFTGVPLFPGGNETEQLGYIMEVLGPPPMALIRNSTRSKAYF 752
Query: 1110 TKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169
+ NRL L+P + L F+DF++ L+ +PK R + AL+
Sbjct: 753 DSEGKPHPITDSHNRL--LVPSTRTFSQLLNTKQASFLDFLSKCLKWDPKDRITVDSALQ 810
Query: 1170 HPWL 1173
H ++
Sbjct: 811 HEFI 814
|
Has a role in meiosis. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9V3D5|DYRK2_DROME Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Drosophila melanogaster GN=smi35A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 7e-54, Method: Compositional matrix adjust.
Identities = 118/323 (36%), Positives = 183/323 (56%), Gaps = 7/323 (2%)
Query: 852 GFEEDK-NFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD 910
G+++D N+ ++ + IA RY + E +G +F + I+A D T V +KII+N K F +
Sbjct: 178 GYDDDNGNYKIIEHDHIAFRYEILEVIGKGSFGQVIRALDHKTNTHVAIKIIRNKKRFLN 237
Query: 911 QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE 970
Q++ E+ +L + + D ++++ + DY Y+R+HL I EL+ NLYE K N +G
Sbjct: 238 QAVVELNILDELREKDADGSHNVIHMLDYTYFRKHLCITFELMSLNLYELIKKNNYNG-- 295
Query: 971 VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030
F+M ++ ++ L+ L+ +IHCDLKPENIL+K +KVID GSSC+
Sbjct: 296 --FSMSLIRRFCNSIVKCLRLLYKENIIHCDLKPENILLKQRGSSSIKVIDFGSSCYVDR 353
Query: 1031 HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090
+ +Y+QSR YR+PEVILGL Y ID+WSLGCILAEL TG LF ++ LA ++ +
Sbjct: 354 KIYTYIQSRFYRSPEVILGLQYGTAIDMWSLGCILAELYTGFPLFPGENEVEQLACIMEV 413
Query: 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFV 1150
+G + +++ R +F R + P SL H L D+ FIDF+
Sbjct: 414 LGLPPKVLISVARRRRLFFDSRDA--PRCITNTKGRKRSPGSKSLAHILHCQDRYFIDFL 471
Query: 1151 AHLLEINPKKRPSASDALKHPWL 1173
LE +P +R + +A H +L
Sbjct: 472 QRCLEWDPAERMTPDEAAHHEFL 494
|
In vitro; can phosphorylate exogenous substrates on Ser and Thr residues. May have a physiological role in development being involved in cellular growth and differentiation. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P83102|DYRK3_DROME Putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog OS=Drosophila melanogaster GN=Dyrk3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 122/322 (37%), Positives = 183/322 (56%), Gaps = 19/322 (5%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD 926
+A RY + + +G +F + I+A+D T V +KI++N K F Q+ +EI++L ++ +HD
Sbjct: 272 VAYRYEMLKIIGKGSFGQVIKAYDHKTHEHVALKIVRNEKRFHRQAQEEIRILHHLRRHD 331
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+ +++ ++DYF +R H I ELL NLYE K N G + S+ +QCL
Sbjct: 332 KYNTMNIIHMFDYFTFRNHTCITFELLSINLYELIKKNGFKGFSLQLVRKFAHSL-LQCL 390
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEV 1046
+AL + +IHCD+KPEN+L+K R +KVID GSSCFE + +Y+QSR YRAPEV
Sbjct: 391 DAL---YKNDIIHCDMKPENVLLKQQGRSGIKVIDFGSSCFENQRIYTYIQSRFYRAPEV 447
Query: 1047 ILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA------ 1100
ILG Y + ID+WSLGCILAEL +G+ LF ++ + LA +I ++G + +LA
Sbjct: 448 ILGGKYGRAIDMWSLGCILAELLSGHALFPGENESDQLACIIEVLGMPNKNILASSKRSK 507
Query: 1101 -----KGRDTY---KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLP-MGDQGFIDFVA 1151
KG Y + + ++ Q + P SL L D F++F+
Sbjct: 508 SFFSPKGYPRYCTVRTMSDGMVVLIGGQSRRGKQRGPPCSKSLSKALDGCKDPLFLNFIR 567
Query: 1152 HLLEINPKKRPSASDALKHPWL 1173
LE + KR + S+ALKHPWL
Sbjct: 568 GCLEWDADKRLTPSEALKHPWL 589
|
Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9P6P3|PPK15_SCHPO Serine/threonine-protein kinase ppk15 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (534), Expect = 6e-53, Method: Compositional matrix adjust.
Identities = 126/340 (37%), Positives = 177/340 (52%), Gaps = 44/340 (12%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVN-KHDPG 928
+Y + + LG F + + DL T V +K+IKN F++Q + E+ +L+ +N K+DP
Sbjct: 129 KYLILDTLGHGTFGQVARCQDLKTQQIVAIKVIKNKPAFYNQCVMEVSILELLNNKYDPE 188
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988
DK HL+RLYD F ++ HL +V ELL NLYE K N+ G + ++S Q L
Sbjct: 189 DKRHLIRLYDQFMHKNHLCLVFELLSINLYELIKQNQFRG----LHLSLVRSFATQLLSC 244
Query: 989 LQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVIL 1048
L +IHCDLKPENIL++ S VKVID GS+C E + +Y+QSR YR+PEVIL
Sbjct: 245 TSLLKQARIIHCDLKPENILLQDLSSPIVKVIDFGSACHERQTVYTYIQSRFYRSPEVIL 304
Query: 1049 GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKY 1108
GL Y+ ID+WSLGCILAEL G LF +S L R++ ++G ML G+++ KY
Sbjct: 305 GLHYNCGIDMWSLGCILAELFLGLPLFPGNSEYNQLCRIVDMLGNPPTWMLEMGKNSKKY 364
Query: 1109 FTKNHMLYERNQETNRLEYL--------------------------------IPKKTSLR 1136
+ + + E +E PK T
Sbjct: 365 YNSGFVNGRKTYELKSIEQFSIENNKTEQPGKQYFGEKTLDAIVLNYPRRKTTPKLTPEE 424
Query: 1137 H--RLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174
H RL FIDF+ LE+NP KR + A HP+++
Sbjct: 425 HEERL-----CFIDFIKQFLELNPLKRWTPDQAKNHPFIT 459
|
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XTF3|MBK2_CAEEL Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2 OS=Caenorhabditis elegans GN=mbk-2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (532), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 125/349 (35%), Positives = 191/349 (54%), Gaps = 26/349 (7%)
Query: 844 IVHRKNRTGFE-EDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII 902
++ N G++ E+ ++ +V++ IA RY V + +G +F + I+A D V +K++
Sbjct: 433 VIGGANNGGYDDENGSYQLVVHDHIAYRYEVLKVIGKGSFGQVIKAFDHKYQQYVALKLV 492
Query: 903 KNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHK 962
+N K F Q+ +EI++L ++ + D ++++ + DYF +R H I ELL NLYE K
Sbjct: 493 RNEKRFHRQADEEIRILDHLRRQDSDGTHNIIHMLDYFNFRNHKCITFELLSINLYELIK 552
Query: 963 FNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022
N+ G F++ ++ L L L LIHCDLKPEN+L+K R +KVID
Sbjct: 553 RNKFQG----FSLMLVRKFAYSMLLCLDLLQKNRLIHCDLKPENVLLKQQGRSGIKVIDF 608
Query: 1023 GSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082
GSSCF+ + +Y+QSR YRAPEVILG Y ID+WSLGCILAEL TG L +
Sbjct: 609 GSSCFDDQRIYTYIQSRFYRAPEVILGTKYGMPIDMWSLGCILAELLTGYPLLPGEDEND 668
Query: 1083 LLARVIGIIG--PIEQGMLAKGRDTY-------KYFTKNHM----LYERNQETNRLEYLI 1129
LA +I ++G P + AK T+ +Y T M + + R +
Sbjct: 669 QLALIIELLGMPPPKSLETAKRARTFITSKGYPRYCTATSMPDGSVVLAGARSKRGKMRG 728
Query: 1130 PKK-----TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
P T+L++ MGD+ F+DF+ L+ +P+ R + + ALKH WL
Sbjct: 729 PPASRSWSTALKN---MGDELFVDFLKRCLDWDPETRMTPAQALKHKWL 774
|
Required for oocyte-to-zygote transition in which it phosphorylates oocyte proteins, including mei-1, oma-1, oma-2, mex-5, and mex-6, modifying their activity and/or stability following meiosis. Functions in both spindle positioning and in the posterior localization of cytoplasmic determinants, including pie-1, pos-1, and pgl-1, in early embryos. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|A8WJR8|MBK2_CAEBR Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2 OS=Caenorhabditis briggsae GN=mbk-2 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 209 bits (532), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 125/349 (35%), Positives = 192/349 (55%), Gaps = 26/349 (7%)
Query: 844 IVHRKNRTGFE-EDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII 902
++ N G++ E+ ++ +V++ IA RY V + +G +F + I+A D V +K++
Sbjct: 432 VIGGANNGGYDDENGSYQLVVHDHIAYRYEVLKVIGKGSFGQVIKAFDHKYQQYVALKLV 491
Query: 903 KNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHK 962
+N K F Q+ +EI++L ++ + D ++++ + DYF +R H I ELL NLYE K
Sbjct: 492 RNEKRFHRQADEEIRILDHLRRQDSDGTHNIIHMLDYFNFRNHKCITFELLSINLYELIK 551
Query: 963 FNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022
N+ G F++ ++ L L L LIHCDLKPEN+L+K R +KVID
Sbjct: 552 RNKFQG----FSLMLVRKFAYSMLLCLDLLQKNRLIHCDLKPENVLLKQQGRSGIKVIDF 607
Query: 1023 GSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082
GSSCF+ + +Y+QSR YRAPEVILG Y ID+WSLGCILAEL TG L +
Sbjct: 608 GSSCFDDQRIYTYIQSRFYRAPEVILGTKYGMPIDMWSLGCILAELLTGYPLLPGEDEND 667
Query: 1083 LLARVIGIIG--PIEQGMLAKGRDTY-------KYFTKNHM----LYERNQETNRLEYLI 1129
LA +I ++G P + AK T+ +Y T M + + R +
Sbjct: 668 QLALIIELLGMPPPKSLETAKRARTFITSKGYPRYCTATSMPDGSVVLAGARSKRGKMRG 727
Query: 1130 PKK-----TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
P + T+L++ MGD+ F+DF+ L+ +P+ R + + ALKH WL
Sbjct: 728 PPESRSWSTALKN---MGDELFVDFLKRCLDWDPETRMTPAQALKHKWL 773
|
Required for oocyte-to-zygote transition in which it phosphorylates oocyte proteins, including mei-1, oma-1, oma-2, mex-5, and mex-6, modifying their activity and/or stability following meiosis. Functions in both spindle positioning and in the posterior localization of cytoplasmic determinants, including pie-1, pos-1, and pgl-1, in early embryos. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus GN=Dyrk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 208 bits (530), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 126/344 (36%), Positives = 184/344 (53%), Gaps = 12/344 (3%)
Query: 837 FETFNLKIVHRK-NRTGFE-EDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTG 894
E L +V K ++T F+ E ++ VL+ IA RY V E +G +F + + D
Sbjct: 183 LEAKKLNVVPEKFSKTSFDDEHGSYMKVLHDHIAYRYEVLEMIGKGSFGQVAKCLDHKNN 242
Query: 895 MDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLK 954
V +KII+N K F Q+L E+K+L+ + + D + ++++ + D+FY+R HL I ELL
Sbjct: 243 ELVALKIIRNKKRFHHQALVELKILEALRRKDKDNNHNVVHMKDFFYFRNHLCITFELLG 302
Query: 955 ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014
NLYE K N G F + ++ T L+ L L+ +IHCDLKPENI++ +
Sbjct: 303 INLYELMKNNSFHG----FNLSIVRRFTFSILKCLHMLYVEKIIHCDLKPENIVLYQRGQ 358
Query: 1015 CEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVL 1074
VKVID GSSC+E + +Y+QSR YR+PEVILG Y+ ID+WSLGCI+AEL TG L
Sbjct: 359 VTVKVIDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPL 418
Query: 1075 FQNDSPATLLARVIGIIG--PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK 1132
F ++ LA ++ ++G P A R +F + +N NR P
Sbjct: 419 FPGENEVEQLACIMEVLGLPPAHFTQTASRRQV--FFDSKGL--PKNINNNRGGKRYPDS 474
Query: 1133 TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176
L + D F+DF+ L P R + ALKH W+ P
Sbjct: 475 KDLTMVVKTYDSSFLDFLRRCLVWEPSLRMTPEQALKHAWIHEP 518
|
Possible non-essential role in spermiogenesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1182 | ||||||
| 374095601 | 1187 | putative ATP-binding protein [Camellia s | 0.993 | 0.989 | 0.775 | 0.0 | |
| 224120412 | 1158 | predicted protein [Populus trichocarpa] | 0.967 | 0.987 | 0.772 | 0.0 | |
| 224125922 | 1151 | predicted protein [Populus trichocarpa] | 0.959 | 0.985 | 0.758 | 0.0 | |
| 449506699 | 1187 | PREDICTED: uncharacterized LOC101208935 | 0.993 | 0.989 | 0.748 | 0.0 | |
| 449439201 | 1187 | PREDICTED: uncharacterized protein LOC10 | 0.993 | 0.989 | 0.748 | 0.0 | |
| 359472752 | 1142 | PREDICTED: uncharacterized protein LOC10 | 0.949 | 0.982 | 0.755 | 0.0 | |
| 255573523 | 1102 | ATP binding protein, putative [Ricinus c | 0.919 | 0.986 | 0.774 | 0.0 | |
| 356560083 | 1179 | PREDICTED: uncharacterized protein LOC10 | 0.985 | 0.988 | 0.729 | 0.0 | |
| 356531104 | 1149 | PREDICTED: uncharacterized protein LOC10 | 0.961 | 0.989 | 0.726 | 0.0 | |
| 356511238 | 1099 | PREDICTED: uncharacterized protein LOC10 | 0.918 | 0.988 | 0.690 | 0.0 |
| >gi|374095601|gb|AEY85028.1| putative ATP-binding protein [Camellia sinensis] | Back alignment and taxonomy information |
|---|
Score = 1847 bits (4784), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 927/1195 (77%), Positives = 1035/1195 (86%), Gaps = 21/1195 (1%)
Query: 1 MEDTGTVDVILEFLKRNHFTRAEAALRSELSNCPDLNGFLQKLNLEEKDTTEVVQEENVG 60
M ++ +VDVILEFL+RN FTRAEAA RSEL+N PDLNGFL+KL ++E+ ++++EEN G
Sbjct: 1 MAESSSVDVILEFLRRNKFTRAEAAFRSELNNRPDLNGFLEKLTIKEE-LGKLLEEENRG 59
Query: 61 KLASKNQGSSSRNSGEVSNELIVKEIECGIGRNGSESKWRNTASTGERNKPNEASGTSKD 120
K ++NQG+S++N+GEVS ELIV EIE G GRNGSESKW+N+AS GERNK NE GTS
Sbjct: 60 KATTENQGTSNQNTGEVSKELIVMEIEHGSGRNGSESKWKNSASVGERNKLNEPIGTS-G 118
Query: 121 RNFTFSKGSEDTVLDLYSWNCNSNNGPSDPYRND---SIHNFSELQTLEQSRYCTTEIPG 177
+NFTFSKG EDTVLDLYSWN N NGP D YRND + +N SE Q QS++ E+
Sbjct: 119 KNFTFSKGLEDTVLDLYSWNFNPGNGPVDRYRNDHSINTNNLSEFQVTGQSKFHLAEVSD 178
Query: 178 VGKVKLRPRDSDSSEEILFSGEKKTSWLESTSKSNAESKYEKIQASEPKVVDKQLKTGST 237
GK ++ S EE ++GE +TSWL STSK++AESK E+ QASE K +D+ K
Sbjct: 179 AGKANVK-----SGEEKSYAGEMRTSWLGSTSKASAESKNERNQASELKELDQLHKASGA 233
Query: 238 CSKETFTDNPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYDIGTGSDKKEGKRKT 297
S++ F DNPWSR+ EP +S+SELWKDCSVKTVFPFS D STS++ D+KEGKR+
Sbjct: 234 PSRDNFVDNPWSRSNEPTNSASELWKDCSVKTVFPFSKPDASTSFECAAIGDQKEGKRRA 293
Query: 298 DAADVRASIKQQVDEVGRALYLGKSQGNSEQKNIS-VGFPLVADNPREEFPRLPPVKLKS 356
+ +D+RA+IK+QVDEVGRAL+ GK+Q +SEQKN+S + FP + +EE PRLPPVKLKS
Sbjct: 294 EISDIRAAIKEQVDEVGRALFFGKTQESSEQKNVSSLSFPHAYEIQKEELPRLPPVKLKS 353
Query: 357 EDKPLNINWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLSVS 416
EDK L++NWEEKF+RD G+KL ++N+ LIGSYLDVPVGQEI S+GGKR GGGSWLSVS
Sbjct: 354 EDKELSVNWEEKFDRDGPGSKLTPADNTFLIGSYLDVPVGQEISSAGGKRAGGGSWLSVS 413
Query: 417 QGIAEDTSDLVSGFATIGDGLSESVDYPHEYWDSDEYDDDDDVGYMRQPIEDEAWFLAHE 476
QGIAEDTSDLVSGFATIGDGLSESVDYP+EYWDSDEYDDDDDVGYMRQPIEDE WFLAHE
Sbjct: 414 QGIAEDTSDLVSGFATIGDGLSESVDYPNEYWDSDEYDDDDDVGYMRQPIEDETWFLAHE 473
Query: 477 IDYPSDNEKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVTTSDD 536
IDYPSDNEKGTGHGSVPDPQ RGP KDEDDDQSFAEEDSYFSGE+YF+ KNV PVT DD
Sbjct: 474 IDYPSDNEKGTGHGSVPDPQERGPAKDEDDDQSFAEEDSYFSGERYFESKNVNPVTALDD 533
Query: 537 PIGLTVSEMYERTD-NDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVV 595
PIGL+++EMY RTD NDL+ QYDGQLMDEEELNLMRAEPVWQGFVTQTNE IMLG GKV
Sbjct: 534 PIGLSMTEMYGRTDENDLIAQYDGQLMDEEELNLMRAEPVWQGFVTQTNEFIMLGAGKVQ 593
Query: 596 SERGRPRLDDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFHDHDV 655
+E GRPRLDDICMDDDQHGSVRSIGVGINSDAA+MGSEVR+SL+GGSSEGDLEYF DHD+
Sbjct: 594 NECGRPRLDDICMDDDQHGSVRSIGVGINSDAADMGSEVRESLVGGSSEGDLEYFQDHDI 653
Query: 656 GIGGSRFSHHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFSFPPP 715
GI GSR S H SD+KY++R ++DK + +K +S+KY++GNDKG Q KN TDGGFSFPPP
Sbjct: 654 GISGSRHSVHLSDRKYVERSNRDKKRTNKHDSDKYVMGNDKGAGKQEKNHTDGGFSFPPP 713
Query: 716 LRDGQLVQKGSSKSLWSNNCDPVISDETDDPLKALMGADDMLATWRQKSTDSS-----RD 770
RDGQLVQ GSSKSLWSN C+ VI DE D L +GADDMLA WR+KS+DSS RD
Sbjct: 714 -RDGQLVQTGSSKSLWSNKCNAVIGDELDGCLNTEIGADDMLAQWRRKSSDSSPVKSSRD 772
Query: 771 ENNANAVRSANSSPSTLSNY---EREHVKREEAEKISGMREEDPGASLEDEEAAAVQEQV 827
ENNANAV S NSSPST+S+Y E++H K+EE E+ + REED GASLEDEEA AVQEQV
Sbjct: 773 ENNANAVVSENSSPSTISDYRYAEKDHDKKEEDERAACTREEDFGASLEDEEAVAVQEQV 832
Query: 828 RQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ 887
+QIK QEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ
Sbjct: 833 KQIKVQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ 892
Query: 888 AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947
AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLK VNKHDPGDKYH+LRLYDYFYYREHLL
Sbjct: 893 AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKLVNKHDPGDKYHILRLYDYFYYREHLL 952
Query: 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007
IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI
Sbjct: 953 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1012
Query: 1008 LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAE 1067
LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL YDKKIDIWSLGCILAE
Sbjct: 1013 LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDIWSLGCILAE 1072
Query: 1068 LCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEY 1127
LCTGNVLFQNDSPATLLARVIGII PI+Q MLAKGRDTYKYFTKNHMLYERNQ+TNRLEY
Sbjct: 1073 LCTGNVLFQNDSPATLLARVIGIISPIDQDMLAKGRDTYKYFTKNHMLYERNQDTNRLEY 1132
Query: 1128 LIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
LIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS+ALKHPWL++PYEPIS+
Sbjct: 1133 LIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASEALKHPWLAYPYEPISS 1187
|
Source: Camellia sinensis Species: Camellia sinensis Genus: Camellia Family: Theaceae Order: Ericales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120412|ref|XP_002318323.1| predicted protein [Populus trichocarpa] gi|222858996|gb|EEE96543.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1818 bits (4708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 925/1197 (77%), Positives = 1025/1197 (85%), Gaps = 54/1197 (4%)
Query: 1 MEDTGTVDVILEFLKRNHFTRAEAALRSELSNCPDLNGFLQKLNLEEKDTTEVVQEENVG 60
M +T +VDVIL+FL+RN FTRAEAALRSELS PDL GFLQKL LE+ D +VV+EEN G
Sbjct: 1 MAETSSVDVILDFLRRNRFTRAEAALRSELSKRPDLKGFLQKLTLEDNDLGKVVEEENGG 60
Query: 61 KLASKNQGSSSRNSGEVSNELIVKEIECGIGRNGSESKWRNTASTGERNKPNEASGTSKD 120
KLAS GS S+NSGE+S ELIVKEIECG+ RNG ESKWRN+AS GER N
Sbjct: 61 KLASHTPGSGSQNSGEISKELIVKEIECGVDRNGPESKWRNSASVGERGSKNNEP----- 115
Query: 121 RNFTFSKGSEDTVLDLYSWNCNSNNGPSDPYRND---SIHNFSELQTLEQSRYCTTEIPG 177
S+DT+LDLYSWN N +NGPS+PY+ND S NFS
Sbjct: 116 ------IDSDDTLLDLYSWNFNPSNGPSNPYKNDVGTSTSNFSARA-------------- 155
Query: 178 VGKVKLRPRDSDSSEEILFSGEKKTSWL--ESTSKSNAESKYEKIQASEPKVVDKQLKTG 235
++ S EEI+F GE K+ WL ST N ESKY KIQA+E K +D++L+
Sbjct: 156 ---------NAKSGEEIIFPGENKSPWLGNNSTINVNVESKYNKIQANELKELDRELRPT 206
Query: 236 STCSKETFTDNPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYDIGTGSDKKEGKR 295
S DNPWS+NEEP SSSS+LWKD SVKTVFPF GDV TSY I + SDK++GK+
Sbjct: 207 VAFS----ADNPWSKNEEPTSSSSDLWKDYSVKTVFPFPKGDVLTSYGITSSSDKRDGKK 262
Query: 296 KTDAADVRASIKQQVDEVGRALYLGKSQGNSEQKNIS-VGFPLVADNPREEFPRLPPVKL 354
K D +DVRA+IK+QVDEVGR L++GKSQG++EQ N+S +GF L +D P+EE+PRLPPVKL
Sbjct: 263 KADTSDVRAAIKEQVDEVGRTLFIGKSQGSTEQNNLSGLGFSLASDIPKEEYPRLPPVKL 322
Query: 355 KSEDKPLNINWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLS 414
KSEDKPL INW+EKFERD +K++S++NS LIGSYLDVPVGQEI+SSGGKR GGSWLS
Sbjct: 323 KSEDKPL-INWQEKFERDGPSSKVISADNSYLIGSYLDVPVGQEINSSGGKRIAGGSWLS 381
Query: 415 VSQGIAEDTSDLVSGFATIGDGLSESVDYPHEYWDSDEYDDDDDVGYMRQPIEDEAWFLA 474
VSQGIAEDTSDLVSGFAT+GDGLSES+DYP+EYWDSDEYDDDDDVGYMRQPIEDEAWFLA
Sbjct: 382 VSQGIAEDTSDLVSGFATVGDGLSESIDYPNEYWDSDEYDDDDDVGYMRQPIEDEAWFLA 441
Query: 475 HEIDYPSDNEKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVTTS 534
HE+DYPSDNEKGTGHGSVPDPQ R PTKDEDDDQSFAEEDSYFSGEQ FQ KNVEPVT S
Sbjct: 442 HEVDYPSDNEKGTGHGSVPDPQDRVPTKDEDDDQSFAEEDSYFSGEQLFQEKNVEPVTAS 501
Query: 535 DDPIGLTVSEMYERTD-NDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGK 593
DDPIGL+V+EMY RT+ +DL+ QYDGQLMDEEELNLMRAEPVWQGFVTQTNELIM+GDGK
Sbjct: 502 DDPIGLSVAEMYGRTNESDLIAQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMIGDGK 561
Query: 594 VVSERGRPRLDDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFHDH 653
V+ E GRPRLDDICMDDDQHGSVRSIGVGINSDAA++GSE+R+SL+GGSSEGDLEYFHDH
Sbjct: 562 VLDECGRPRLDDICMDDDQHGSVRSIGVGINSDAADIGSEIRESLVGGSSEGDLEYFHDH 621
Query: 654 DVGIGGSRFSHHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFSFP 713
DVG+GGSR SHH+S+KKY+D++++DK K+ K +S+KY+VG+D+ Q KN TDGGFSFP
Sbjct: 622 DVGVGGSRSSHHDSEKKYVDKQNRDKKKLDKYDSSKYVVGSDRDVRAQGKNHTDGGFSFP 681
Query: 714 PPLRDGQLVQKGSSKSLWSNNCDPVISDETDDPLKALMGADDMLATWRQKSTDSS----- 768
PPLR QL QKGSSKSLWSNNC+ S+ET+D L ALMG DDM TW++KS+DSS
Sbjct: 682 PPLRGEQLPQKGSSKSLWSNNCNVAASEETNDHLNALMGPDDMHGTWQRKSSDSSTVKSS 741
Query: 769 RDENNANAVRSANSSPSTLSNY---EREHVKREEAEKISGMREEDPGASLEDEEAAAVQE 825
RDENN NAV SANSSPS+LSNY E E +E+ EKI +REEDPGAS EDEEAAAVQE
Sbjct: 742 RDENNMNAVGSANSSPSSLSNYGYAEPECAMKEQDEKIGSVREEDPGASFEDEEAAAVQE 801
Query: 826 QVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKA 885
QVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKA
Sbjct: 802 QVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKA 861
Query: 886 IQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945
IQAHDLHTG+DVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP DKYH+LRLYDYFYYREH
Sbjct: 862 IQAHDLHTGIDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHILRLYDYFYYREH 921
Query: 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005
LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSIT QCLEALQFLHGLGLIHCDLKPE
Sbjct: 922 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITTQCLEALQFLHGLGLIHCDLKPE 981
Query: 1006 NILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
NILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL YDKKID+WSLGCIL
Sbjct: 982 NILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGCIL 1041
Query: 1066 AELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRL 1125
AELCTGNVLFQNDSPATLLARVIGIIGPI+Q MLAKGRDTYKYFTKNHMLYERNQ+T+RL
Sbjct: 1042 AELCTGNVLFQNDSPATLLARVIGIIGPIDQNMLAKGRDTYKYFTKNHMLYERNQDTSRL 1101
Query: 1126 EYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
EYLIPKKTSLRHRLPMGDQGFIDFV+HLLE+NPKKRPSAS+ALKHPWLS+PYEPISA
Sbjct: 1102 EYLIPKKTSLRHRLPMGDQGFIDFVSHLLEVNPKKRPSASEALKHPWLSYPYEPISA 1158
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125922|ref|XP_002329750.1| predicted protein [Populus trichocarpa] gi|222870658|gb|EEF07789.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1777 bits (4603), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 909/1199 (75%), Positives = 1017/1199 (84%), Gaps = 65/1199 (5%)
Query: 1 MEDTGTVDVILEFLKRNHFTRAEAALRSELSNCPDLNGFLQKLNLEEKDTTEVVQEENVG 60
ME+T +VDVIL+FLK+N FTRAEAALRSEL N PDLNGFLQKL LE+K++ +VV+EEN G
Sbjct: 1 MEETSSVDVILDFLKKNRFTRAEAALRSELGNLPDLNGFLQKLALEDKNSGKVVEEENGG 60
Query: 61 KLASKNQGSSSRNSGEVSNELIVKEIECGIGRNGSESKWRNTASTGERN-KPNEASGTSK 119
KL QGS ++S E+S ELIVKEIECG+ RNG+ESKW+N+AS GER K NEA
Sbjct: 61 KLTCHPQGSGPQHSAEISKELIVKEIECGVDRNGTESKWKNSASAGERGGKNNEAID--- 117
Query: 120 DRNFTFSKGSEDTVLDLYSWNCNSNNGPSDPYRND---SIHNFSELQTLEQSRYCTTEIP 176
SEDTVL LYSWN N +NGPS+PY+ND S NFS
Sbjct: 118 ---------SEDTVLGLYSWNFNPSNGPSNPYKNDVGTSTSNFS---------------- 152
Query: 177 GVGKVKLRPRDSDSSEEILFSGEKKTSWL--ESTSKSNAESKYEKIQASEPKVVDKQLKT 234
+ K + S EE + +GEKK+SWL +STS +NAESKY KI+ +E K +D QLKT
Sbjct: 153 --ARAKAK-----SGEEFILTGEKKSSWLGSKSTSDANAESKYNKIETNELKELDWQLKT 205
Query: 235 GSTCSKETFTDNPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYD-IGTGSDKKEG 293
S NPWS+NEEP +SSS+LWKDCSVKTVFPF G+ TSYD T SDK++G
Sbjct: 206 TVAFS----AGNPWSQNEEPANSSSDLWKDCSVKTVFPFPKGEALTSYDDTITNSDKRDG 261
Query: 294 KRKTDAADVRASIKQQVDEVGRALYLGKSQGNSEQKNIS-VGFPLVADNPREEFPRLPPV 352
K+K +D+RA+IK+QVDEVGR L+ GKSQ ++EQKN+S +GF LV+D P+EEFPRLPPV
Sbjct: 262 KKKAGTSDLRAAIKEQVDEVGRTLFFGKSQESTEQKNLSGLGFSLVSDIPKEEFPRLPPV 321
Query: 353 KLKSEDKPLNINWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSW 412
KLKSEDKP +INW+E FERD +K++S++NS LIGSYLDVPVGQEI+SSGGKR GGSW
Sbjct: 322 KLKSEDKP-SINWQETFERDGPSSKVISADNSYLIGSYLDVPVGQEINSSGGKRIAGGSW 380
Query: 413 LSVSQGIAEDTSDLVSGFATIGDGLSESVDYPHEYWDSDEYDDDDDVGYMRQPIEDEAWF 472
LSVSQGIAED SDLVSGFAT+GDGLSES+DY +EYWDSDEYDDDDDVGYMRQPIEDEAWF
Sbjct: 381 LSVSQGIAEDASDLVSGFATVGDGLSESIDYQNEYWDSDEYDDDDDVGYMRQPIEDEAWF 440
Query: 473 LAHEIDYPSDNEKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVT 532
LAHEIDYPSDNEKG GHGSVPDPQ R PTKDEDDDQSFAEEDSYFSGEQ FQ K VEPVT
Sbjct: 441 LAHEIDYPSDNEKGAGHGSVPDPQDRVPTKDEDDDQSFAEEDSYFSGEQIFQAKTVEPVT 500
Query: 533 TSDDPIGLTVSEMYERTD-NDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGD 591
SDDPIGL+V+EMY + +DL+ QYDGQLMDEEEL+LMRAEPVWQGFVTQTNELIM+GD
Sbjct: 501 ASDDPIGLSVTEMYGTNNGSDLISQYDGQLMDEEELSLMRAEPVWQGFVTQTNELIMIGD 560
Query: 592 GKVVSERGRPRLDDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFH 651
GKV++E GRP+LDDICMDDDQHGSVRSIGVGINSDAA++GSE+R+SL+ GSSEGD+EYF
Sbjct: 561 GKVLNECGRPQLDDICMDDDQHGSVRSIGVGINSDAADIGSEIRESLVVGSSEGDVEYFR 620
Query: 652 DHDVGIGGSRFSHHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFS 711
DHD G+GGSR SHH SDKKY+D++++DK K+ NKY+VG+D+ Q ++ DGGFS
Sbjct: 621 DHDTGVGGSRSSHHVSDKKYVDKQNRDKKKL-----NKYVVGSDQDMHAQGRSHADGGFS 675
Query: 712 FPPPLRDGQLVQKGSSKSLWSNNCDPVISDETDDPLKALMGADDMLATWRQKSTDSS--- 768
FPPPLR+ QL+Q GSSKSLWS+NC+ V+S+ET+D L AL G DD TW++KS DSS
Sbjct: 676 FPPPLRNEQLLQAGSSKSLWSDNCNAVVSEETNDHLNALTGPDD---TWQRKSCDSSTVK 732
Query: 769 --RDENNANAVRSANSSPSTLSNY---EREHVKREEAEKISGMREEDPGASLEDEEAAAV 823
RDENN NAVRSANSSPS+LSNY E EH +E EKI G+REEDP ASLEDEEAAAV
Sbjct: 733 SSRDENNTNAVRSANSSPSSLSNYGYTEPEHAIKERDEKIGGVREEDPVASLEDEEAAAV 792
Query: 824 QEQVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFS 883
QEQVRQIK QEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFS
Sbjct: 793 QEQVRQIKVQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFS 852
Query: 884 KAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943
KAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD DKYH+LRLYDYFYYR
Sbjct: 853 KAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDHADKYHILRLYDYFYYR 912
Query: 944 EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK 1003
EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSIT QCLEALQFLHGLGLIHCDLK
Sbjct: 913 EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITTQCLEALQFLHGLGLIHCDLK 972
Query: 1004 PENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGC 1063
PENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILG YDKKID+WSLGC
Sbjct: 973 PENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGHPYDKKIDVWSLGC 1032
Query: 1064 ILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETN 1123
ILAELCTGNVLFQNDSPATLLARVIGIIGPI+Q MLAKGRDTYKYF+KNHMLYERNQ+T+
Sbjct: 1033 ILAELCTGNVLFQNDSPATLLARVIGIIGPIDQSMLAKGRDTYKYFSKNHMLYERNQDTS 1092
Query: 1124 RLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
RLEYLIPKKTSLRHRLPMGDQGFIDFV+HLLE+NPKKRPSAS+ALKHPWLS+PYEPISA
Sbjct: 1093 RLEYLIPKKTSLRHRLPMGDQGFIDFVSHLLEVNPKKRPSASEALKHPWLSYPYEPISA 1151
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449506699|ref|XP_004162822.1| PREDICTED: uncharacterized LOC101208935 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1763 bits (4565), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 895/1195 (74%), Positives = 1006/1195 (84%), Gaps = 21/1195 (1%)
Query: 1 MEDTGTVDVILEFLKRNHFTRAEAALRSELSNCPDLNGFLQKLNLEEKDTTEVVQEENVG 60
M DT ++DVILEFLKRN FTRAEAALRSEL+N PDLNG L+KL LEEK + ++ EN
Sbjct: 1 MVDTNSIDVILEFLKRNQFTRAEAALRSELNNHPDLNGLLKKLTLEEKGLGDTLEVENGD 60
Query: 61 KLASKNQGSSSRNSGEVSNELIVKEIECGIGRNGSESKWRNTASTGERNKPNEASGTSKD 120
K + S + + +VS ELIVKEIECG GRNG+ESKW+N + GER+K N+A GTS D
Sbjct: 61 KPMVETGLSGPQVNLDVSKELIVKEIECGSGRNGAESKWKNDYTFGERSKSNDAVGTS-D 119
Query: 121 RNFTFSKGSEDTVLDLYSWNCNSNNGPSDPYRNDSI---HNFSELQTLEQSRYCTTEIPG 177
RNFTFS+GSEDTVLDLYSW S+NG +ND + ++F ELQ E+SRY T E+
Sbjct: 120 RNFTFSQGSEDTVLDLYSWKVKSSNGLVAVTQNDGVKDANSFPELQVSEKSRYHTGEVSE 179
Query: 178 VGKVKLRPRDSDSSEEILFSGEKKTSWLESTSKSNAESKYEKIQASEPKVVDKQLKTGST 237
K + + E ++ S EK+ W + S +N E+KY+ Q SEPK +D+Q+K S
Sbjct: 180 SRKANFK-----TGESVISSSEKRDLWHGNASTANVETKYDVSQKSEPKELDQQVKATSA 234
Query: 238 CSKETFTDNPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYDIGTGSDKKEGKRKT 297
KE D W + ++ SSSS+L DCSVKTVFPFS GDVS SYD GSDK + +RK
Sbjct: 235 YMKENTADLSWYKGKD--SSSSDLLMDCSVKTVFPFSKGDVSNSYDSTIGSDKSDARRKA 292
Query: 298 DAADVRASIKQQVDEVGRALYLGKSQGNSEQKNI-SVGFPLVADNPREEFPRLPPVKLKS 356
+ D+RA+IK+QVDEVGRALY G+SQ +++K + ++ LVA++ +EE PRLPPVKLKS
Sbjct: 293 EVNDIRATIKEQVDEVGRALYFGRSQDTADKKTLGNLSLALVAESQKEELPRLPPVKLKS 352
Query: 357 EDKPLNINWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLSVS 416
EDKPL+++W+E FERD K S ++SLLIGSYLDVPVGQEI S+GGKR GGSWLSVS
Sbjct: 353 EDKPLSLSWKENFERDGQIAKFTSIDSSLLIGSYLDVPVGQEISSAGGKRNTGGSWLSVS 412
Query: 417 QGIAEDTSDLVSGFATIGDGLSESVDYPHEYWDSDEYDDDDDVGYMRQPIEDEAWFLAHE 476
QGIAEDTSDLVSGFAT+GDGLSES+DYP+EYWDSDEYDDDDDVGYMRQPIEDE WFLAHE
Sbjct: 413 QGIAEDTSDLVSGFATVGDGLSESLDYPNEYWDSDEYDDDDDVGYMRQPIEDETWFLAHE 472
Query: 477 IDYPSDNEKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVTTSDD 536
IDYPSDNEKGTGHGSVPD Q R TK EDDDQSFAEEDSYFSGEQYFQ K+++PVTTS+D
Sbjct: 473 IDYPSDNEKGTGHGSVPDMQDRAQTKCEDDDQSFAEEDSYFSGEQYFQSKHIQPVTTSED 532
Query: 537 PIGLTVSEMYERTD-NDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVV 595
P+GLTV+EMY RT+ NDLM QYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVV
Sbjct: 533 PMGLTVTEMYGRTNENDLMAQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVV 592
Query: 596 SERGRPRLDDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFHDHDV 655
+E + RLDDIC+DDDQHGSVRSIGVGINSD A++GSEVR+SL+GGSSEGDLEYFHDH+V
Sbjct: 593 NESRKSRLDDICVDDDQHGSVRSIGVGINSDVADIGSEVRESLVGGSSEGDLEYFHDHEV 652
Query: 656 GIGGSRFSHHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFSFPPP 715
GIGGSRF +++SDKKY+DR +KDK SKQ+ NK + ND C Q +N +DGGFSFPPP
Sbjct: 653 GIGGSRFPYNDSDKKYLDRLNKDKKSSSKQQPNKQVSRNDTSTCLQKQNPSDGGFSFPPP 712
Query: 716 LRDGQLVQKGSSKSLWSNNCDPVISDETDDPLKALMGAD-DMLATWRQKSTDSSRD---- 770
LRD QLVQ SSKSLWSNN + VI+DE D L ALM ++ DMLA+W K +DSS D
Sbjct: 713 LRDRQLVQACSSKSLWSNNSNRVINDENDASLNALMQSNNDMLASWGPKDSDSSPDNSLG 772
Query: 771 -ENNANAVRSANSSPSTLSNYE--REHVKREEAEKISGMREEDPGASLEDEEAAAVQEQV 827
ENNANAVRS +SSPS LSNY+ K E +KIS +REEDP ASLEDEEAAAVQEQV
Sbjct: 773 DENNANAVRSGSSSPSMLSNYQYTERAPKMENDDKISSVREEDPVASLEDEEAAAVQEQV 832
Query: 828 RQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ 887
RQI++QEEEFE+FNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ
Sbjct: 833 RQIRSQEEEFESFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ 892
Query: 888 AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947
AHDLHTGMDVC+KIIKNNKDFFDQSLDEIKLLKYVNKHDP DKYH+LRLYDYFYYREHLL
Sbjct: 893 AHDLHTGMDVCIKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHILRLYDYFYYREHLL 952
Query: 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007
IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL LIHCDLKPENI
Sbjct: 953 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLDLIHCDLKPENI 1012
Query: 1008 LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAE 1067
LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL YDKKIDIWSLGCILAE
Sbjct: 1013 LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDIWSLGCILAE 1072
Query: 1068 LCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEY 1127
LCTGNVLFQNDSPATLLARVIGII PI+Q MLAKGRDTYKYFTKNHMLYERNQE+NRLEY
Sbjct: 1073 LCTGNVLFQNDSPATLLARVIGIISPIDQSMLAKGRDTYKYFTKNHMLYERNQESNRLEY 1132
Query: 1128 LIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
LIPKKTSLRHRLPMGDQGFIDFV+HLLEINPKKRPSAS+ALKHPWLS+PYEPIS+
Sbjct: 1133 LIPKKTSLRHRLPMGDQGFIDFVSHLLEINPKKRPSASEALKHPWLSYPYEPISS 1187
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439201|ref|XP_004137375.1| PREDICTED: uncharacterized protein LOC101208935 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1760 bits (4558), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 895/1195 (74%), Positives = 1005/1195 (84%), Gaps = 21/1195 (1%)
Query: 1 MEDTGTVDVILEFLKRNHFTRAEAALRSELSNCPDLNGFLQKLNLEEKDTTEVVQEENVG 60
M DT ++DVILEFLKRN FTRAEAALRSEL+N PDLNG L+KL LEEK + ++ EN
Sbjct: 1 MVDTNSIDVILEFLKRNQFTRAEAALRSELNNHPDLNGLLKKLTLEEKGLGDTLEVENGD 60
Query: 61 KLASKNQGSSSRNSGEVSNELIVKEIECGIGRNGSESKWRNTASTGERNKPNEASGTSKD 120
K + S + + +VS ELIVKEIECG GRNG+ESKW+N + GER+K N+A GTS D
Sbjct: 61 KPMVETGLSGPQVNLDVSKELIVKEIECGSGRNGAESKWKNDYTFGERSKSNDAVGTS-D 119
Query: 121 RNFTFSKGSEDTVLDLYSWNCNSNNGPSDPYRNDSI---HNFSELQTLEQSRYCTTEIPG 177
RNFTFS+GSEDTVLDLYSW S+NG +ND + ++F ELQ E+SRY T E+
Sbjct: 120 RNFTFSQGSEDTVLDLYSWKVKSSNGLVAVTQNDGVKDANSFPELQVSEKSRYHTGEVSE 179
Query: 178 VGKVKLRPRDSDSSEEILFSGEKKTSWLESTSKSNAESKYEKIQASEPKVVDKQLKTGST 237
K + + E ++ S EK+ W + S +N E+KY+ Q SEPK +D+Q+K S
Sbjct: 180 SRKANFK-----TGESVISSSEKRDLWHGNASTANVETKYDVSQKSEPKELDQQVKATSA 234
Query: 238 CSKETFTDNPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYDIGTGSDKKEGKRKT 297
KE D W + ++ SSSS+L DCSVKTVFPFS GDVS SYD GSDK + +RK
Sbjct: 235 YMKENTADLSWYKGKD--SSSSDLLMDCSVKTVFPFSKGDVSNSYDSTIGSDKSDARRKA 292
Query: 298 DAADVRASIKQQVDEVGRALYLGKSQGNSEQKNI-SVGFPLVADNPREEFPRLPPVKLKS 356
+ D+RA+IK+QVDEVGRALY G+SQ +++K + ++ LVA++ +EE PRLPPVKLKS
Sbjct: 293 EVNDIRATIKEQVDEVGRALYFGRSQDTADKKTLGNLSLALVAESQKEELPRLPPVKLKS 352
Query: 357 EDKPLNINWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLSVS 416
EDKPL+++W+E FERD K S ++SLLIGSYLDVPVGQEI S+GGKR GGSWLSVS
Sbjct: 353 EDKPLSLSWKENFERDGQIAKFTSIDSSLLIGSYLDVPVGQEISSAGGKRNTGGSWLSVS 412
Query: 417 QGIAEDTSDLVSGFATIGDGLSESVDYPHEYWDSDEYDDDDDVGYMRQPIEDEAWFLAHE 476
QGIAEDTSDLVSGFAT+GDGLSES+DYP+EYWDSDEYDDDDDVGYMRQPIEDE WFLAHE
Sbjct: 413 QGIAEDTSDLVSGFATVGDGLSESLDYPNEYWDSDEYDDDDDVGYMRQPIEDETWFLAHE 472
Query: 477 IDYPSDNEKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVTTSDD 536
IDYPSDNEKGTGHGSVPD Q R TK EDDDQSFAEEDSYFSGEQYFQ K+++PVTTS+D
Sbjct: 473 IDYPSDNEKGTGHGSVPDMQDRAQTKCEDDDQSFAEEDSYFSGEQYFQSKHIQPVTTSED 532
Query: 537 PIGLTVSEMYERTD-NDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVV 595
P+GLTV+EMY RT+ NDLM QYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVV
Sbjct: 533 PMGLTVTEMYGRTNENDLMAQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVV 592
Query: 596 SERGRPRLDDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFHDHDV 655
+E + RLDDIC+DDDQHGSVRSIGVGINSD A++GSEVR+SL+GGSSEGDLEYFHDH+V
Sbjct: 593 NESRKSRLDDICVDDDQHGSVRSIGVGINSDVADIGSEVRESLVGGSSEGDLEYFHDHEV 652
Query: 656 GIGGSRFSHHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFSFPPP 715
GIGGSRF +++SDKKY+DR +KDK SKQ+ NK ND C Q +N +DGGFSFPPP
Sbjct: 653 GIGGSRFPYNDSDKKYLDRLNKDKKSSSKQQPNKQASRNDTSTCLQKQNPSDGGFSFPPP 712
Query: 716 LRDGQLVQKGSSKSLWSNNCDPVISDETDDPLKALMGAD-DMLATWRQKSTDSSRD---- 770
LRD QLVQ SSKSLWSNN + VI+DE D L ALM ++ DMLA+W K +DSS D
Sbjct: 713 LRDRQLVQACSSKSLWSNNSNRVINDENDASLNALMQSNNDMLASWGPKDSDSSPDNSLG 772
Query: 771 -ENNANAVRSANSSPSTLSNYE--REHVKREEAEKISGMREEDPGASLEDEEAAAVQEQV 827
ENNANAVRS +SSPS LSNY+ K E +KIS +REEDP ASLEDEEAAAVQEQV
Sbjct: 773 DENNANAVRSGSSSPSMLSNYQYTERAPKIENDDKISSVREEDPVASLEDEEAAAVQEQV 832
Query: 828 RQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ 887
RQI++QEEEFE+FNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ
Sbjct: 833 RQIRSQEEEFESFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ 892
Query: 888 AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947
AHDLHTGMDVC+KIIKNNKDFFDQSLDEIKLLKYVNKHDP DKYH+LRLYDYFYYREHLL
Sbjct: 893 AHDLHTGMDVCIKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHILRLYDYFYYREHLL 952
Query: 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007
IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL LIHCDLKPENI
Sbjct: 953 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLDLIHCDLKPENI 1012
Query: 1008 LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAE 1067
LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL YDKKIDIWSLGCILAE
Sbjct: 1013 LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDIWSLGCILAE 1072
Query: 1068 LCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEY 1127
LCTGNVLFQNDSPATLLARVIGII PI+Q MLAKGRDTYKYFTKNHMLYERNQE+NRLEY
Sbjct: 1073 LCTGNVLFQNDSPATLLARVIGIISPIDQSMLAKGRDTYKYFTKNHMLYERNQESNRLEY 1132
Query: 1128 LIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
LIPKKTSLRHRLPMGDQGFIDFV+HLLEINPKKRPSAS+ALKHPWLS+PYEPIS+
Sbjct: 1133 LIPKKTSLRHRLPMGDQGFIDFVSHLLEINPKKRPSASEALKHPWLSYPYEPISS 1187
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472752|ref|XP_002276420.2| PREDICTED: uncharacterized protein LOC100255903 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1758 bits (4554), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 904/1197 (75%), Positives = 996/1197 (83%), Gaps = 75/1197 (6%)
Query: 3 DTGTVDVILEFLKRNHFTRAEAALRSELSNCPDLNGFLQKLNLEEK-DTTEVVQEENVGK 61
D+ +VDVIL+FL+RN FTRAEAALRSEL N PDLNGFLQKL LEEK D+ V E
Sbjct: 4 DSSSVDVILDFLRRNRFTRAEAALRSELGNRPDLNGFLQKLTLEEKADSGNVAGVEAANG 63
Query: 62 LASKNQGSSSRNSGEVSNELIVKEIECGIGRNGSESKWRNTASTGERNKP--NEASGTSK 119
S+ QGS S+ +IVKEIECG ERNKP +A+
Sbjct: 64 DGSQAQGSGSKEL------VIVKEIECG-----------------ERNKPPSGDATNMRS 100
Query: 120 DRNFTFSKGSEDTVLDLYSWNCNSNNGPSDPYRNDSIHNFSELQTLEQSRYCTTEIPGVG 179
++NF FSKGSEDTVLDLY+W N+ DPYRN+ + G+
Sbjct: 101 EKNFAFSKGSEDTVLDLYTWKFNA-----DPYRNEGGSS------------------GLS 137
Query: 180 KVKLRPRDSDSSEE-ILFSGEKKTSWLESTSKSNAES-KYEKIQASEPKVVDKQLKTGST 237
D+ S EE I FSGEK+ SW+ S+S+ E+ KY++ K +D++LK+ ++
Sbjct: 138 DAVASKADAKSGEEEIGFSGEKRGSWVGSSSEVTTETNKYDR------KELDQKLKSSNS 191
Query: 238 C--SKETFTDNPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYDIGTGSDKKEGKR 295
SK F DNPWS EP SSS+ WK+CS+KTVFPFS GDVSTSYD GS+KK+GKR
Sbjct: 192 ILYSKGNFADNPWS---EPMHSSSDQWKNCSIKTVFPFSKGDVSTSYDNAAGSEKKDGKR 248
Query: 296 KTDAADVRASIKQQVDEVGRALYLGKSQGNSEQKNIS-VGFPLVADNPREEFPRLPPVKL 354
K + +RA+IK+QVDEVGRALY GKSQG+SE K IS + FPLV + +EE PRLPPVKL
Sbjct: 249 KAEMGGIRAAIKEQVDEVGRALYFGKSQGSSELKTISSLNFPLVLECQKEELPRLPPVKL 308
Query: 355 KSEDKPLNINWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLS 414
KSE+KPLNI+WEEKFE + G+K+ +N+ LIGSYLDVP+GQEI+SSGGKRT GGSWLS
Sbjct: 309 KSEEKPLNISWEEKFEHEGPGSKIAGVDNAFLIGSYLDVPIGQEINSSGGKRTAGGSWLS 368
Query: 415 VSQGIAEDTSDLVSGFATIGDGLSESVDYPHEYWDSDEYDDDDDVGYMRQPIEDEAWFLA 474
VSQGIAEDTSDLVSGFAT+GDGLSES+DYP+EYWDSDEYDDDDDVGYMRQPIEDE WFLA
Sbjct: 369 VSQGIAEDTSDLVSGFATVGDGLSESIDYPNEYWDSDEYDDDDDVGYMRQPIEDETWFLA 428
Query: 475 HEIDYPSDNEKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVTTS 534
HEIDYPSDNEKGTGHGSVPDPQ RGPTKDEDDDQSFAEEDSYFSGEQYF K+V PV+ S
Sbjct: 429 HEIDYPSDNEKGTGHGSVPDPQERGPTKDEDDDQSFAEEDSYFSGEQYFPAKHVAPVSAS 488
Query: 535 DDPIGLTVSEMYERTD-NDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGK 593
DDPIGL+V+EMY RT+ NDL+ QYDGQLMDEEELNLMRAEPVWQGFVTQTNELIML DGK
Sbjct: 489 DDPIGLSVTEMYGRTEENDLIAQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLRDGK 548
Query: 594 VVSERGRPRLDDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFHDH 653
V+++ GRPRLDD CMDDDQHGSVRSIGVGINSDAA++GSEVR+SL+GGSSEGDLEYFHD
Sbjct: 549 VMNDCGRPRLDDNCMDDDQHGSVRSIGVGINSDAADIGSEVRESLVGGSSEGDLEYFHDQ 608
Query: 654 DVGIGGSRFSHHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFSFP 713
D+G SR SH ESDKKY DR + K + S +S+KY++GNDKG CTQVKN DGGFSFP
Sbjct: 609 DIG---SRHSHQESDKKYNDRSKRVKKRTSTHDSDKYVMGNDKGVCTQVKNHPDGGFSFP 665
Query: 714 PPLRDGQLVQKGSSKSLWSNNCDPVISDETDDPLKALMGADDMLATWRQKSTDSSR---- 769
PPLRDGQLVQ SSKSLWSNNC+ SDETDD L ALM DMLA+WR+KS+DSS
Sbjct: 666 PPLRDGQLVQASSSKSLWSNNCNAPTSDETDDCLNALMRNADMLASWRRKSSDSSPVKSS 725
Query: 770 -DENNANAVRSANSSPSTLSNY---EREHVKREEAEKISGMREEDPGASLEDEEAAAVQE 825
DENNANAVRS NSSPSTLSNY ER HVK+EE EK G REEDPG SLEDEEAAAVQE
Sbjct: 726 KDENNANAVRSENSSPSTLSNYGYNERGHVKKEEDEKTGGAREEDPGVSLEDEEAAAVQE 785
Query: 826 QVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKA 885
QVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKA
Sbjct: 786 QVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKA 845
Query: 886 IQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945
IQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLK+VNK+DP DKYH+LRLYDYFYYREH
Sbjct: 846 IQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKFVNKNDPADKYHILRLYDYFYYREH 905
Query: 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005
LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE
Sbjct: 906 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 965
Query: 1006 NILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
NILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL YDKKID+WSLGCIL
Sbjct: 966 NILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGCIL 1025
Query: 1066 AELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRL 1125
AELCTGNVLFQNDSPATLLARVIGIIG I+QGMLAKGRDTYKYFTKNHMLYERNQ+TNRL
Sbjct: 1026 AELCTGNVLFQNDSPATLLARVIGIIGSIDQGMLAKGRDTYKYFTKNHMLYERNQDTNRL 1085
Query: 1126 EYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
EYLIPKKTSLRHRLPMGDQGFIDFV+H+LEINPKKRPSAS+ALKHPWLS+PYEPIS+
Sbjct: 1086 EYLIPKKTSLRHRLPMGDQGFIDFVSHMLEINPKKRPSASEALKHPWLSYPYEPISS 1142
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255573523|ref|XP_002527686.1| ATP binding protein, putative [Ricinus communis] gi|223532917|gb|EEF34685.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1720 bits (4454), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 877/1133 (77%), Positives = 957/1133 (84%), Gaps = 46/1133 (4%)
Query: 1 MEDTGTVDVILEFLKRNHFTRAEAALRSELSNCPDLNGFLQKLNLEEKDTTEVVQEENVG 60
M DTG+VDVIL+FLKRN FTRAEAALRSELSN PDLNGFL KL LE+KD+ +++EEN
Sbjct: 1 MADTGSVDVILDFLKRNRFTRAEAALRSELSNRPDLNGFLSKLTLEDKDSGNILEEENGS 60
Query: 61 KLASKNQGSSSRNSGEVSNELIVKEIECGIGRNGSESKWRNTASTGE-RNKPNEASGTSK 119
K S N+G SRNS EVSNELIVKEIECG GRNGSESKWRN+A G+ KPNEA +
Sbjct: 61 KPRSDNRGLYSRNSCEVSNELIVKEIECGTGRNGSESKWRNSALVGDWSGKPNEAVAAND 120
Query: 120 DRNFTFSKGSEDTVLDLYSWNCNSNNG-PSDPYRNDSIHNFSELQTLEQSRYCTTEIPGV 178
SED +LDLYSWN NS NG SDPYRND G
Sbjct: 121 ---------SEDNLLDLYSWNFNSRNGHSSDPYRNDGG-------------------TGN 152
Query: 179 GKVKLRPRDS-DSSEEILFSGEKKTSWLESTSKSNAESKYEKIQASEPKVVDKQLKTGST 237
G R + S EE +FS E+++ WL TS + ESK+E+IQ SE +D+QLKT T
Sbjct: 153 GTDSFSCRSTAKSGEEAIFSSEQRSLWLGGTSTAKIESKHERIQTSEAIELDQQLKTTIT 212
Query: 238 CSKETFTDNPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYDIGTGSDKKEGKRKT 297
S DN WSR+E P SS++ WKDCSVKT+FPF GDVSTSYD G+G DK+EGK+KT
Sbjct: 213 YS----ADNTWSRSEGPTSSAAP-WKDCSVKTIFPFPKGDVSTSYDTGSGLDKREGKKKT 267
Query: 298 DAADVRASIKQQVDEVGRALYLGKSQGNSEQKNIS-VGFPLVADNPREEFPRLPPVKLKS 356
D DVR +IK+QVDEVGRALY GKSQGN EQKN + + F L +DNP+EEFPRLPPVKLKS
Sbjct: 268 DMGDVRVAIKEQVDEVGRALYFGKSQGNLEQKNSAGLSFSLASDNPKEEFPRLPPVKLKS 327
Query: 357 EDKPLNINWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLSVS 416
EDKPLN+NW+EKFERD G K S++N+ LIGSYLDVP+GQEI+SSGGKR GGSWLSVS
Sbjct: 328 EDKPLNVNWQEKFERDGPGGKHSSADNTFLIGSYLDVPIGQEINSSGGKRVAGGSWLSVS 387
Query: 417 QGIAEDTSDLVSGFATIGDGLSESVDYPHEYWDSDEYDDDDDVGYMRQPIEDEAWFLAHE 476
QGIAEDTSDLVSGFATIGDGLSES+DYP+EYWDSDEYDDDDDVGYMRQPIEDEAWFLAHE
Sbjct: 388 QGIAEDTSDLVSGFATIGDGLSESIDYPNEYWDSDEYDDDDDVGYMRQPIEDEAWFLAHE 447
Query: 477 IDYPSDNEKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVTTSDD 536
IDYPSDNEKGT HGSVPDPQ RGPTKDEDDDQSFAEEDSYFSGEQYFQ K VEP+T S+D
Sbjct: 448 IDYPSDNEKGTVHGSVPDPQERGPTKDEDDDQSFAEEDSYFSGEQYFQSKAVEPITASED 507
Query: 537 PIGLTVSEMYERTD-NDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVV 595
PIGL+V+EMY R+D NDL+ QYDGQLMDEEELNLMR+EPVWQGFVTQTNELIMLGDGK +
Sbjct: 508 PIGLSVTEMYRRSDENDLIAQYDGQLMDEEELNLMRSEPVWQGFVTQTNELIMLGDGKAL 567
Query: 596 SERGRPRLDDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFHDHDV 655
++ GRPRLDDIC+DDDQHGSVRSIGVGINSDAA+ GSE+R+SL+GGSSEGD+EYFH+HDV
Sbjct: 568 NDSGRPRLDDICVDDDQHGSVRSIGVGINSDAADFGSEIRESLVGGSSEGDIEYFHEHDV 627
Query: 656 GIGGSRFSHHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFSFPPP 715
GIGGSR S E+DKKY+DR+++DK +ISKQ+ N Y+ NDK + VK+ DGGFSFPPP
Sbjct: 628 GIGGSRPSLQETDKKYVDRQNRDKKRISKQDPNIYVAVNDKVASSLVKDNRDGGFSFPPP 687
Query: 716 LRDGQLVQKGSSKSLWSNNCDPVISDETDDPLKALMGADDMLATWRQKSTDSS-----RD 770
LRDGQLV GSSKSLWSNN +I ETD + A +G D MLA WRQKS+DSS RD
Sbjct: 688 LRDGQLVPAGSSKSLWSNNTKTIIGLETDGRMNASVGTDGMLAAWRQKSSDSSTVKSSRD 747
Query: 771 ENNANAVRSANSSPSTLSNY---EREHVKREEAEKISGMREEDPGASLEDEEAAAVQEQV 827
ENNANAVRS SSPSTLSNY E+EH K+EE EKI REEDPGASLEDEEAAAVQEQV
Sbjct: 748 ENNANAVRSGASSPSTLSNYCYAEQEHAKKEENEKIGSAREEDPGASLEDEEAAAVQEQV 807
Query: 828 RQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ 887
RQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ
Sbjct: 808 RQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ 867
Query: 888 AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947
AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP DKYH+LRLYDYFYYREHLL
Sbjct: 868 AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHILRLYDYFYYREHLL 927
Query: 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007
IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI
Sbjct: 928 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 987
Query: 1008 LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAE 1067
LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL YDKKIDIWSLGCILAE
Sbjct: 988 LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDIWSLGCILAE 1047
Query: 1068 LCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQ 1120
LCTGNVLFQNDSPATLLARVIGIIGPI+Q MLAKGRDTYKYFTKNHM+YERNQ
Sbjct: 1048 LCTGNVLFQNDSPATLLARVIGIIGPIDQVMLAKGRDTYKYFTKNHMVYERNQ 1100
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356560083|ref|XP_003548325.1| PREDICTED: uncharacterized protein LOC100786225 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1711 bits (4430), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 873/1196 (72%), Positives = 993/1196 (83%), Gaps = 31/1196 (2%)
Query: 1 MEDTGTVDVILEFLKRNHFTRAEAALRSELSNCPDLNGFLQKLNLEEKDTTEVVQEENVG 60
M DT +V+VIL+FLKRN FTRAEAALRSELSNC DLNGFLQKL L+EK+ + +Q + G
Sbjct: 1 MADTNSVEVILDFLKRNRFTRAEAALRSELSNCSDLNGFLQKLTLDEKNLHDGLQNDK-G 59
Query: 61 KLASKNQGSSSRNSGEVSNELIVKEIECGIG-RNGSESKWRNTASTGERNKPNEASGTSK 119
K +NQG SR+S EVS ELIVKEIECG G N +ESKW+ A TGERNK NE TS
Sbjct: 60 KPVVENQGLDSRDSVEVSKELIVKEIECGTGTSNAAESKWKIVAPTGERNKSNEVVETS- 118
Query: 120 DRNFTFSKGSEDTVLDLYSWNCNSNNGPSDPYRNDS---IHNFSELQTLEQSRYCTTEIP 176
D+NFTFSK SED+VLD+YSW N++NGP + Y+ND +N + +QS+Y T+E
Sbjct: 119 DKNFTFSKSSEDSVLDMYSWKFNASNGPVELYQNDGGSRPNNALKAPVSQQSKYQTSEAL 178
Query: 177 GVGKVKLRPRDSDSSEEILFSGEKKTSWLESTSKSNAESKYEKIQASEPKVVDKQLKTGS 236
++ S EE EK + W+ S+ K++ E KY+ +Q+ EP+ +D+Q K +
Sbjct: 179 DATNSNVK-----SKEENNVPAEKTSLWIGSSGKASTEPKYDLMQSKEPRELDRQFKFNA 233
Query: 237 TCSKETFTDNPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYDIGTGSDKKEGKRK 296
+ KE TDN SR +E +SS++ WKDCSVKTVFPFS GD+STSY+ T SD+KE KR+
Sbjct: 234 SSLKENLTDNVLSRTDENVNSSTDPWKDCSVKTVFPFSKGDMSTSYNGSTYSDRKEEKRR 293
Query: 297 TDAADVRASIKQQVDEVGRALYLGKSQGNSEQKNISVGFPLVADNPREEFPRLPPVKLKS 356
+ +DVRASIK+QVDEVGRALYLGK QG+S+ S+ FPL +N +EEFPRLPPVK+KS
Sbjct: 294 AENSDVRASIKEQVDEVGRALYLGKLQGSSD----SLSFPLAPENQKEEFPRLPPVKIKS 349
Query: 357 EDKPLNINWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLSVS 416
EDKPL NW EKFE D KL ++N+LLIGSYLDVP+GQEI ++G ++ GGSWLSVS
Sbjct: 350 EDKPLTFNWGEKFECDGLSVKLAGADNTLLIGSYLDVPIGQEIKTTGVRKAVGGSWLSVS 409
Query: 417 QGIAEDTSDLVSGFATIGDGLSESVDYPHEYWDSDEYDDDDDVGYMRQPIEDEAWFLAHE 476
QGIAEDTSDLVSGFATIGDGLSESVDYP+EYWDSDEYDDD+DVGY RQPIEDEAWFLAHE
Sbjct: 410 QGIAEDTSDLVSGFATIGDGLSESVDYPNEYWDSDEYDDDEDVGYTRQPIEDEAWFLAHE 469
Query: 477 IDYPSDNEKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVTTSDD 536
IDYPSDNEKGTGHGSVPDPQ RGP KDE+DDQSFAEEDSYFSGEQY KNVEPVT SDD
Sbjct: 470 IDYPSDNEKGTGHGSVPDPQERGPAKDEEDDQSFAEEDSYFSGEQYILPKNVEPVTASDD 529
Query: 537 PIGLTVSEMYERTD-NDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVV 595
PIGLTV+EMY RT+ +D+M Q+D QLMD EELNLM EPV QGFVT N+LIMLGDGKV+
Sbjct: 530 PIGLTVTEMYGRTNGDDVMAQFDRQLMDVEELNLMHMEPVRQGFVTHKNDLIMLGDGKVL 589
Query: 596 SERGRPRLDDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFHDHDV 655
+ R R++D M+DDQHGSVRSIGVGINSDAA++GSEV SL+GGSSEGDLEYF DHD
Sbjct: 590 NHSARSRIED--MEDDQHGSVRSIGVGINSDAADIGSEVHGSLVGGSSEGDLEYFRDHDT 647
Query: 656 GI-GGSRFSHHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFSFPP 714
GS+ SHH+ DK I++ K+ K ESNKY++ +DK C+Q+K TDG FSFP
Sbjct: 648 TTHSGSKHSHHDLDKNSINKSFKNNKKKDNTESNKYVIDSDKDACSQIKTHTDGNFSFPQ 707
Query: 715 PLRDGQLVQKGSSKSLWSNNCDPVISDETDDPLKALMGADDMLATWRQKSTDSS-----R 769
LRD Q++ GSSK+LWS+NC+ E DD + A +G+DDML++W++KS+DSS R
Sbjct: 708 SLRDSQMIHAGSSKTLWSSNCNV----EADDCMNAFVGSDDMLSSWKRKSSDSSPVKSSR 763
Query: 770 DENNANAVRSANSSPSTLSNY---EREHVKREEAEKISGMREEDPGASLEDEEAAAVQEQ 826
DENNA VRS NSSP+T+SNY + E VK E+ EK+S +RE+D GASLEDEEAAAVQEQ
Sbjct: 764 DENNAIVVRSRNSSPTTVSNYGYTDGELVKLEKDEKVSIVREDDIGASLEDEEAAAVQEQ 823
Query: 827 VRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAI 886
V QIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSV+AGRYHVTEYLGSAAFSKAI
Sbjct: 824 VMQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVLAGRYHVTEYLGSAAFSKAI 883
Query: 887 QAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946
QAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP DKYHLLRLYDYFYYREHL
Sbjct: 884 QAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPSDKYHLLRLYDYFYYREHL 943
Query: 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPEN 1006
LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH LGLIHCDLKPEN
Sbjct: 944 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHSLGLIHCDLKPEN 1003
Query: 1007 ILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILA 1066
ILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL YDKKIDIWSLGCILA
Sbjct: 1004 ILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDIWSLGCILA 1063
Query: 1067 ELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLE 1126
ELCTGNVLFQNDSPATLLARVIGIIGPI+QG+LAK RDTYKYFTKNHMLYERNQE+NRLE
Sbjct: 1064 ELCTGNVLFQNDSPATLLARVIGIIGPIDQGLLAKARDTYKYFTKNHMLYERNQESNRLE 1123
Query: 1127 YLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
YLIPKKTSLR+RLPMGDQGFIDFVAHLLE+NPKKRPSAS+ALKHPWLS+PYEPIS+
Sbjct: 1124 YLIPKKTSLRYRLPMGDQGFIDFVAHLLEVNPKKRPSASEALKHPWLSYPYEPISS 1179
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531104|ref|XP_003534118.1| PREDICTED: uncharacterized protein LOC100798608 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1695 bits (4389), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 867/1194 (72%), Positives = 976/1194 (81%), Gaps = 57/1194 (4%)
Query: 1 MEDTGTVDVILEFLKRNHFTRAEAALRSELSNCPDLNGFLQKLNLEEKDTTEVVQEENVG 60
M DT +V+VIL+FLKRN FTRAEAALRSELSNC D+NGFLQKL L+EKD +Q + G
Sbjct: 1 MADTNSVEVILDFLKRNRFTRAEAALRSELSNCSDVNGFLQKLTLDEKDLHGGLQNDK-G 59
Query: 61 KLASKNQGSSSRNSGEVSNELIVKEIECGIGRNGSESKWRNTASTGERNKPNEASGTSKD 120
K +NQG SR+S EVS ELIVKEIECG G+N SESKW+ A TGE NK NE GTS D
Sbjct: 60 KPVVENQGLDSRDSVEVSKELIVKEIECGTGKNASESKWKTVAPTGESNKSNEVVGTS-D 118
Query: 121 RNFTFSKGSEDTVLDLYSWNCNSNNGPSDPYRNDS---IHNFSELQTLEQSRYCTTEIPG 177
+NFTFSK SED+VLDLYSW N++NGP +PY+ND +N + +QS+Y T+E
Sbjct: 119 KNFTFSKSSEDSVLDLYSWKFNASNGPVEPYQNDGGSRPNNDLKAPVSQQSKYQTSE--- 175
Query: 178 VGKVKLRPRDSDSSEEILFSGEKKTSWLESTSKSNAESKYEKIQASEPKVVDKQLKTGST 237
+ R+ S EE EK +SWL ++ K++ E KY+ +Q+ EP+ +D+Q K ++
Sbjct: 176 --ALDATNRNVKSREENNVPAEKTSSWLGNSGKASTEPKYDLMQSKEPREIDRQFKFNAS 233
Query: 238 CSKETFTDNPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYDIGTGSDKKEGKRKT 297
KE TDN SR +E +SS+ELWKDCSVKTVFPFS GD+STSY+ T SD+KE KR+
Sbjct: 234 SLKENLTDNVLSRTDENVNSSTELWKDCSVKTVFPFSKGDMSTSYNGSTYSDRKEEKRRA 293
Query: 298 DAADVRASIKQQVDEVGRALYLGKSQGNSEQKNISVGFPLVADNPREEFPRLPPVKLKSE 357
+ +DVRAS+K+QVDEVGRALYLGK QG+S S+ FPL +N +EEFPRLPPVK+KSE
Sbjct: 294 ENSDVRASVKEQVDEVGRALYLGKLQGSSG----SLSFPLAPENQKEEFPRLPPVKIKSE 349
Query: 358 DKPLNINWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLSVSQ 417
DKP NW EKFE D KL ++N+LLIGSYLDVP+GQEI ++G ++ GGSWLSVS
Sbjct: 350 DKPFTFNWGEKFECDGLAVKLAGADNTLLIGSYLDVPIGQEIKNTGVRKAIGGSWLSVSH 409
Query: 418 GIAEDTSDLVSGFATIGDGLSESVDYPHEYWDSDEYDDDDDVGYMRQPIEDEAWFLAHEI 477
GI EDTSDLVSGFATIGDGL ESVDYP+EYWDSDEYDDD+DVGY RQPIEDEAWFLAHEI
Sbjct: 410 GITEDTSDLVSGFATIGDGLCESVDYPNEYWDSDEYDDDEDVGYTRQPIEDEAWFLAHEI 469
Query: 478 DYPSDNEKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVTTSDDP 537
DYPSDNEKGTGHGSVPDPQ RGP KDE+DDQSFAEEDSYFSGEQY KNVEPVT SDDP
Sbjct: 470 DYPSDNEKGTGHGSVPDPQERGPAKDEEDDQSFAEEDSYFSGEQYILPKNVEPVTASDDP 529
Query: 538 IGLTVSEMYERTD-NDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVVS 596
IGLT++EMY RT+ ND+M QYD QLMD EELNLM EPV QGFVT N+LIM+GDGKV++
Sbjct: 530 IGLTITEMYGRTNGNDVMPQYDRQLMDVEELNLMHMEPVRQGFVTHKNDLIMMGDGKVLN 589
Query: 597 ERGRPRLDDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFHDHDVG 656
R R++D M+DDQHGSVRSIGVGINSDAA++GSEV SL+GGSSEGDLEYF DHD
Sbjct: 590 HSARSRIED--MEDDQHGSVRSIGVGINSDAADIGSEVHGSLVGGSSEGDLEYFRDHDTT 647
Query: 657 IGGSRFSHHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFSFPPPL 716
S DKN +DK C+Q+K TDG FSFP L
Sbjct: 648 T-----------------HSLDKN------------SSDKDACSQIKAHTDGNFSFPQSL 678
Query: 717 RDGQLVQKGSSKSLWSNNCDPVISDETDDPLKALMGADDMLATWRQKSTDSS-----RDE 771
RD Q++ GSSK+LWS+NC+ +E DD + A +G+DDML +W++KS+DSS RDE
Sbjct: 679 RDSQMIHAGSSKTLWSSNCN---VEEADDCINAFVGSDDMLTSWKRKSSDSSPVKSSRDE 735
Query: 772 NNANAVRSANSSPSTLSNY---EREHVKREEAEKISGMREEDPGASLEDEEAAAVQEQVR 828
NNA AVRS NSSP+T+SNY + E VK E+ EK+S +RE+D GASLEDEEAAAVQEQVR
Sbjct: 736 NNAIAVRSRNSSPTTVSNYGYTDGELVKLEKDEKVSIVREDDLGASLEDEEAAAVQEQVR 795
Query: 829 QIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQA 888
QIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSV+AGRYHVTEYLGSAAFSKAIQA
Sbjct: 796 QIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVLAGRYHVTEYLGSAAFSKAIQA 855
Query: 889 HDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948
HDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP DKYHLLRLYDYFYYREHLLI
Sbjct: 856 HDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPSDKYHLLRLYDYFYYREHLLI 915
Query: 949 VCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008
VCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH LGLIHCDLKPENIL
Sbjct: 916 VCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHSLGLIHCDLKPENIL 975
Query: 1009 VKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAEL 1068
VKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL YDKKIDIWSLGCILAEL
Sbjct: 976 VKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDIWSLGCILAEL 1035
Query: 1069 CTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYL 1128
CTGNVLFQNDSPATLLARVIGIIGPI+QG+LAKGRDTYKYFTKNHMLYERNQE+NRLEYL
Sbjct: 1036 CTGNVLFQNDSPATLLARVIGIIGPIDQGLLAKGRDTYKYFTKNHMLYERNQESNRLEYL 1095
Query: 1129 IPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
IPKKTSLRHRLPMGDQGFIDFVAHLLE+N KKRPSAS+ALKHPWLS+PYEPIS+
Sbjct: 1096 IPKKTSLRHRLPMGDQGFIDFVAHLLEVNSKKRPSASEALKHPWLSYPYEPISS 1149
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511238|ref|XP_003524334.1| PREDICTED: uncharacterized protein LOC100797095 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1544 bits (3998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 820/1187 (69%), Positives = 923/1187 (77%), Gaps = 101/1187 (8%)
Query: 6 TVDVILEFLKRNHFTRAEAALRSELSNCPDLNGFLQKLNLEEKDTTEVVQEENVGKLASK 65
+VDVIL+FL+RN FTRAEAAL +E++N PDLN Q L
Sbjct: 4 SVDVILDFLRRNRFTRAEAALLTEINNLPDLNANPQGL---------------------- 41
Query: 66 NQGSSSRNSGEVSNELIVKEIECGIGRNGSESKWRNTASTGERNKPNEASGTSKDRNFTF 125
ELIVKEIECG NG+ +A + F
Sbjct: 42 --------------ELIVKEIECG---NGNAHLQATSAPS-----------------ILF 67
Query: 126 SKGSEDTVLDLYSWNCNSNNGPSDPYRNDSIHNFSELQTLEQSRYCTTEIPGVGKVKLRP 185
S SE+ L YS N N + P P + + + S+ + E V
Sbjct: 68 SNTSEEDFL--YSRNFNPSTVPVKPSVSQTNEAVDVIAANTNSKSWSVEENAV------- 118
Query: 186 RDSDSSEEILFSGEKKTSWLESTSKSNAESKYEKIQASEPKVVDKQLKTGSTCSKETFTD 245
+ W S+SK++ +Q+ +P +D+QLK + K FTD
Sbjct: 119 ----------------SMWPASSSKTSV------VQSKQPMELDRQLKFNTPSLKVNFTD 156
Query: 246 NPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYDIGTGSDKKEGKRKTDAADVR-A 304
PWSR ++ +SSS+ KDCSVKT+FPFS GD+S+S+ T SDKKE K+K + +D R +
Sbjct: 157 YPWSRTDDNMNSSSDSAKDCSVKTIFPFSKGDMSSSFGAVTYSDKKEEKKKVEISDTRTS 216
Query: 305 SIKQQVDEVGRALYLGKSQGNSEQKNI-SVGFPLVADNPREEFPRLPPVKLKSEDKPLNI 363
SIK+QV E+GR +YL K+ G+SEQK I S+ FPL+ +N +EEFP LPPVKLKS+DKPL +
Sbjct: 217 SIKEQVGELGRPIYLVKTPGSSEQKIIGSLSFPLLPENQKEEFPSLPPVKLKSDDKPLVV 276
Query: 364 NWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLSVSQGIAEDT 423
NWEEKFERD +KL ++++LLIGSYLDVP+GQEI+ SG +R GGSWLSVSQGIAEDT
Sbjct: 277 NWEEKFERDGPTSKLPGADSTLLIGSYLDVPIGQEINPSGMRRATGGSWLSVSQGIAEDT 336
Query: 424 SDLVSGFATIGDGLSESVDYPHEYWDSDEYDDDDDVGYMRQPIEDEAWFLAHEIDYPSDN 483
SDLVSGFAT+GDGLSES+DYP+EYWDSDEYDDD+DVGYMRQPIEDEAWFLAHEIDYPSDN
Sbjct: 337 SDLVSGFATVGDGLSESIDYPNEYWDSDEYDDDEDVGYMRQPIEDEAWFLAHEIDYPSDN 396
Query: 484 EKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVTTSDDPIGLTVS 543
EKGTGHGSVPDPQ RGP KDEDDDQSFAEEDSYFSGE+Y Q NV PVTT+DDPIG+T++
Sbjct: 397 EKGTGHGSVPDPQERGPAKDEDDDQSFAEEDSYFSGERYLQENNVVPVTTTDDPIGVTLT 456
Query: 544 EMYERTDNDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVVSERGRPRL 603
E DNDLM QYDGQLMDEEELNLM AEPVW+GFV QTNELIMLGDG+V+++ R RL
Sbjct: 457 EYGRTNDNDLMAQYDGQLMDEEELNLMCAEPVWRGFVPQTNELIMLGDGRVLNDNLRSRL 516
Query: 604 DDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFHDHDVGIGGSRFS 663
+DI MDDDQHGSVRSIGVGINSDAA++GSEVR+SL+GGSSEGDLEYFHD D G+GGSR S
Sbjct: 517 EDINMDDDQHGSVRSIGVGINSDAADIGSEVRESLVGGSSEGDLEYFHDRDAGLGGSRHS 576
Query: 664 HHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFSFPPPLRDGQLVQ 723
HH+ DKK KS K ESNKY++G DK Q+K DG FSFP L+DGQ++Q
Sbjct: 577 HHDLDKK-STNKSNKNKNNEKSESNKYVIGCDKDAPLQMKTHGDGNFSFPLSLKDGQMIQ 635
Query: 724 KGSSKSLWSNNCDPVISDETDDPLKALMGADDMLATWRQKSTDSS-----RDENNANAVR 778
++KSLWSNN + +D+ DD L A++ DDMLA WR+KS+DSS RDENNAN VR
Sbjct: 636 ASTNKSLWSNNGN---ADDADDCLSAIVETDDMLALWRRKSSDSSPVKSSRDENNANFVR 692
Query: 779 SANSSPSTLSNY---EREHVKREEAEKISGMREEDPGASLEDEEAAAVQEQVRQIKAQEE 835
S NSSP+T+SNY EREHVK EE EK RE+D GASLEDEE AAVQEQVRQIKAQEE
Sbjct: 693 STNSSPTTVSNYGYSEREHVKVEEDEKTGIAREDDLGASLEDEEVAAVQEQVRQIKAQEE 752
Query: 836 EFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGM 895
EFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGM
Sbjct: 753 EFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGM 812
Query: 896 DVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA 955
DVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP DKYH+LRLYDYFYYREHLLIVCELLKA
Sbjct: 813 DVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHILRLYDYFYYREHLLIVCELLKA 872
Query: 956 NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC 1015
NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH LGLIHCDLKPENILVKSYSRC
Sbjct: 873 NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHSLGLIHCDLKPENILVKSYSRC 932
Query: 1016 EVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLF 1075
EVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL YDKKIDIWSLGCILAELCTGNVLF
Sbjct: 933 EVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDIWSLGCILAELCTGNVLF 992
Query: 1076 QNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSL 1135
QNDSPATLLARVIGII PI+Q MLAKGRDTYKYFTKNHMLYERNQETNRLEYL+PKKTSL
Sbjct: 993 QNDSPATLLARVIGIIDPIDQSMLAKGRDTYKYFTKNHMLYERNQETNRLEYLVPKKTSL 1052
Query: 1136 RHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
RHRLPMGDQGFIDFVAHLLE+NPKKRPSAS+ALKHPWLS+PYEPIS+
Sbjct: 1053 RHRLPMGDQGFIDFVAHLLEVNPKKRPSASEALKHPWLSYPYEPISS 1099
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1182 | ||||||
| TAIR|locus:2206840 | 1169 | AT1G73460 [Arabidopsis thalian | 0.974 | 0.985 | 0.624 | 0.0 | |
| TAIR|locus:2206855 | 1152 | AT1G73450 [Arabidopsis thalian | 0.823 | 0.844 | 0.665 | 0.0 | |
| TAIR|locus:2089774 | 1138 | AT3G17750 [Arabidopsis thalian | 0.410 | 0.426 | 0.759 | 0.0 | |
| TAIR|locus:2047741 | 570 | AT2G40120 [Arabidopsis thalian | 0.288 | 0.598 | 0.689 | 1e-143 | |
| DICTYBASE|DDB_G0293750 | 915 | dyrk2 "protein kinase, CMGC gr | 0.267 | 0.345 | 0.382 | 3.9e-58 | |
| UNIPROTKB|F5H6L9 | 545 | DYRK4 "Dual-specificity tyrosi | 0.268 | 0.581 | 0.384 | 5.1e-54 | |
| FB|FBgn0016930 | 722 | smi35A "smell impaired 35A" [D | 0.267 | 0.437 | 0.365 | 5.6e-54 | |
| RGD|1306800 | 633 | Dyrk4 "dual-specificity tyrosi | 0.278 | 0.519 | 0.364 | 1.1e-53 | |
| UNIPROTKB|D4A0W8 | 597 | Dyrk4 "Protein Dyrk4" [Rattus | 0.278 | 0.551 | 0.364 | 7.8e-53 | |
| ZFIN|ZDB-GENE-091015-3 | 634 | dyrk4 "dual-specificity tyrosi | 0.267 | 0.498 | 0.372 | 1e-52 |
| TAIR|locus:2206840 AT1G73460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3682 (1301.2 bits), Expect = 0., P = 0.
Identities = 749/1199 (62%), Positives = 883/1199 (73%)
Query: 1 MEDTGTVDVILEFLKRNHFTRAEAALRSELSNCPDLNGFLQKLNLEEKDTTEVVQEENVG 60
M D +VD ILEFL+ N F++AE ALR+EL+N D+NGFLQKL LE+KD+ E +
Sbjct: 1 MTDQSSVDGILEFLRNNRFSQAEEALRNELNNRSDINGFLQKLKLEDKDSNEKAAGNELR 60
Query: 61 KLASKNQGSSSRNSGEVSNELIVKEIECGIGRNGSESKWRNTASTGERNKPNEASGTSKD 120
+ S SR+S EVS ELIVKE++CG NGS KW N A+ +K S +
Sbjct: 61 R-------SGSRDS-EVSKELIVKEVDCGTSTNGSVIKWENGATADNPSKKEPV--VSSE 110
Query: 121 RNFTFSKGSEDTVL--DLYSWNCNSNNGPSDPYRN---DSIHNFSELQTLEQSRYCTTEI 175
+FTFSK S D D +S+ S NG +P RN S + +L EQSR+
Sbjct: 111 MSFTFSKNSGDAAAPPDAHSYKFTSRNGTVEPSRNIDDSSSSSLVDLYAFEQSRH--GNF 168
Query: 176 PGVGKVKLRPRDSDSSEEILFSGEKKTSWLESTSKSNAESKYEKIQASEPKVVDKQLKTG 235
+ K K+ ++ E+I+F G K TSW ++SK N+ SK + EP + + ++
Sbjct: 169 ADIDK-KI----VETGEDIVFFGNKSTSWSGNSSKGNSGSKIK-----EPNEIHRLVENS 218
Query: 236 STCSKETFTDNPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYDIGTGSDKKEGKR 295
+++ + R+E+ +S+ W++CSVKT+F S GD S SY++ + SDK+EGK+
Sbjct: 219 G--KHDSYKGSILLRSEDVVDTSAN-WRECSVKTLFQSSRGDASNSYNLVSSSDKREGKK 275
Query: 296 KTDAADVRASIKQQVDEVGRALYLGKSQGNSEQKNIS-VGFPLVADNPREEFPRLPPVKL 354
K D +DVR +IK+Q EV RAL+ GKSQ + KNIS +GFPLV D +EEFPRLPPVKL
Sbjct: 276 KADISDVRVAIKEQESEVARALFFGKSQSTFDDKNISSLGFPLVYDTRKEEFPRLPPVKL 335
Query: 355 KSEDKPLNINWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLS 414
KSED PL+++ EEKFERD SG +L++ E++LLIGSYLDVP+GQEI SSGGK++ GG+WLS
Sbjct: 336 KSEDNPLSLHCEEKFERDGSGPRLINDEDALLIGSYLDVPIGQEISSSGGKKSTGGNWLS 395
Query: 415 VSQGIAEDTSDLVSGFATIGDGLSESVDYPHEYWXXXXXXXXXXVGYMRQPIEDEAWFLA 474
VSQGIAED SDLVSGFATIGDGLSESVDY +EYW +GY+RQPIEDE WFLA
Sbjct: 396 VSQGIAEDASDLVSGFATIGDGLSESVDYRNEYWDSDEYEDDDDIGYVRQPIEDEPWFLA 455
Query: 475 HEIDYPSDNEKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVTTS 534
HEIDYPSD+EKGT GS PD R KD DD QS+AEE SY SGEQY Q K+ EP+++
Sbjct: 456 HEIDYPSDHEKGTTRGS-PDHHERDANKDADD-QSYAEEASYISGEQYLQSKDAEPISSE 513
Query: 535 DDPIGLTVSEMYERTD-NDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGK 593
+D LTVSE+Y + NDL+ QYDG LMDEE L+ MR EPVWQGFV Q+NEL+MLGD K
Sbjct: 514 NDR-RLTVSEIYPASKKNDLLAQYDGHLMDEELLSSMRDEPVWQGFVAQSNELLMLGDKK 572
Query: 594 VVSERGRPRLDDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFHDH 653
++ + DD+ ++DDQH SVRSIGVGINSDAA+ GSEVRDSL GGSSEGD EY DH
Sbjct: 573 GINVHRKSHRDDVYVEDDQHDSVRSIGVGINSDAADFGSEVRDSLAGGSSEGDFEYSRDH 632
Query: 654 DVGIGGSRFS--HHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFS 711
D SRF + ESDKK+ID +K+K + SK + YI ND VK TDGGFS
Sbjct: 633 DPV--ASRFKQLYSESDKKHIDAPNKNKQQASKNDGPDYIADNDSSGSFHVKIQTDGGFS 690
Query: 712 FPPPLRDGQLVQKGSSKSLWSNNCDPVISDETDDPLKALMGADDMLATWRQKSTDSSRDE 771
F +DGQ + SSKSLWS N + V D + L A DDM+ATWR+KS+DSS
Sbjct: 691 FGSSQKDGQSMHAESSKSLWSGNHETVTRDRNTERLSASTAMDDMVATWRRKSSDSSSSH 750
Query: 772 XX-----XXXXXXXXXXXXTLSNY---EREHVKREEAEKISGMREEDPGASLEDXXXXXX 823
+LSNY ER+H +E+ S E+D +L+D
Sbjct: 751 SSVKDNNATSIKSLNSSPSSLSNYACEERKHADKEDDRNDSSEIEDDNATALDDEEAVAV 810
Query: 824 XXXXRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFS 883
RQIKAQEEEFETF+LKIVHRKNRTGFEE+KNF+VVLNSVIAGRYHVTEYLGSAAFS
Sbjct: 811 QEQVRQIKAQEEEFETFDLKIVHRKNRTGFEEEKNFNVVLNSVIAGRYHVTEYLGSAAFS 870
Query: 884 KAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943
KAIQAHDL TGMDVC+KIIKNNKDFFDQSLDEIKLLKYVNKHDP DKYHLLRLYDYFYYR
Sbjct: 871 KAIQAHDLQTGMDVCIKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHLLRLYDYFYYR 930
Query: 944 EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK 1003
EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE+LQFLHGLGLIHCDLK
Sbjct: 931 EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLESLQFLHGLGLIHCDLK 990
Query: 1004 PENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGC 1063
PENILVKSYSRCE+KVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL YDKKID+WSLGC
Sbjct: 991 PENILVKSYSRCEIKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGC 1050
Query: 1064 ILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETN 1123
ILAELCTGNVLFQNDSPA+LLARV+GI+G + ML KGRD++KYFTKN MLYERNQE+N
Sbjct: 1051 ILAELCTGNVLFQNDSPASLLARVMGIVGSFDNEMLTKGRDSHKYFTKNRMLYERNQESN 1110
Query: 1124 RLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
RLEYLIPK+TSLRHRLPMGDQGF DFVAHLLEINPKKRPSA++ALKHPWLS+PYEPISA
Sbjct: 1111 RLEYLIPKRTSLRHRLPMGDQGFTDFVAHLLEINPKKRPSAAEALKHPWLSYPYEPISA 1169
|
|
| TAIR|locus:2206855 AT1G73450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3315 (1172.0 bits), Expect = 0., Sum P(2) = 0.
Identities = 670/1007 (66%), Positives = 771/1007 (76%)
Query: 188 SDSSEEILFSGEKKTSW-LESTSKSNAESKYEK-IQASEPKVVDKQLKTGSTCSK-ETFT 244
+D ++I+ +GE + +ST S SK + +P +D QL G K +++
Sbjct: 168 ADIDKKIVETGEDIVFFGNKSTLLSGNSSKGNSGSKIKKPNEID-QL--GEIFGKHDSYK 224
Query: 245 DNPWSRNEEPGSSSSELWKDCSVKTVFPFSMGDVSTSYDIGTGSDKKEGKRKTDAADVRA 304
+ R E+ +SE WK+ SVKT+F S GD S SY++ + SDK+EGK+K + +DVR
Sbjct: 225 GSVLLRTEDV-IDTSENWKERSVKTLFQSSRGDASNSYNLVSSSDKREGKKKAEISDVRV 283
Query: 305 SIKQQVDEVGRALYLGKSQGNSEQKNIS-VGFPLVADNPREEFPRLPPVKLKSEDKPLNI 363
+IK+Q EV RAL+ GKSQ + KNIS +GFPLV D +EEFPRLPPVKLKSED PL++
Sbjct: 284 AIKEQESEVARALFFGKSQSTFDDKNISSLGFPLVFDTRKEEFPRLPPVKLKSEDNPLSL 343
Query: 364 NWEEKFERDVSGTKLLSSENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLSVSQGIAEDT 423
+ EEKFERD SG +L++ + +LLIGSYLDVP+GQEI SSGGK++GGG+WLSVSQGIA
Sbjct: 344 HCEEKFERDGSGPRLINDDEALLIGSYLDVPIGQEISSSGGKKSGGGNWLSVSQGIA--- 400
Query: 424 SDLVSGFATIGDGLSESVDYPHEYWXXXXXXXXXXVGYMRQPIEDEAWFLAHEIDYPSDN 483
DLVSGFATIGDGLSESVDY +EYW +GY+RQPIEDE WFLAHEIDYPSD+
Sbjct: 401 -DLVSGFATIGDGLSESVDYRNEYWDSDEYEDDGDIGYVRQPIEDETWFLAHEIDYPSDH 459
Query: 484 EKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYFSGEQYFQGKNVEPVTTSDDPIGLTVS 543
EKGT GS PD R KDEDD QS+AE++SY SGE+Y Q K+ EP+++ +D LTVS
Sbjct: 460 EKGTTRGS-PDHHDRDANKDEDD-QSYAEDESYLSGERYLQSKDAEPISSENDR-RLTVS 516
Query: 544 EMYERTD-NDLMDQYDGQLMDEEELNLMRAEPVWQGFVTQTNELIMLGDGKVVSERGRPR 602
E+Y NDL+ QYDGQLMDE+ LN MR EPVWQGFV Q+NEL+MLGD K ++ +
Sbjct: 517 EIYPACKKNDLLAQYDGQLMDEDLLNSMRTEPVWQGFVAQSNELVMLGDKKGINVHRKSH 576
Query: 603 LDDICMDDDQHGSVRSIGVGINSDAAEMGSEVRDSLLGGSSEGDLEYFHDHDVGIGGSRF 662
LDD+ ++DDQH SVRSIGVGINSDAA+ GSEVRDSL GGSSEGD EY DHD SRF
Sbjct: 577 LDDVYVEDDQHDSVRSIGVGINSDAADFGSEVRDSLAGGSSEGDFEYSRDHDPV--ASRF 634
Query: 663 S--HHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFSFPPPLRDGQ 720
+ ESDKK+ID ++K+K K SK ND G VK TDG FSF +DGQ
Sbjct: 635 KQLYSESDKKHIDGQNKNKQKASK---------NDSGGSFHVKIQTDGDFSFGSSQKDGQ 685
Query: 721 LVQKGSSKSLWSNNCDPVISDETDDPLKALMGADDMLATWRQKSTDSSRD-----EXXXX 775
L+ SSKSLWS N + V D + L A DDM+ATWRQKS+DSS E
Sbjct: 686 LMHAESSKSLWSGNRETVTRDRNTELLSASTATDDMVATWRQKSSDSSSSRSSVKENNAT 745
Query: 776 XXXXXXXXXXTLSNYEREHVKREEAEKISGMREEDPGASLEDXXXXXXXXXXRQIKAQEE 835
+LSNY R K E E S RE+ +L+D RQIKAQEE
Sbjct: 746 SIKSVNSSPSSLSNYARGERKHAEKENDSSEREDGHATALDDEEAVAVQEQVRQIKAQEE 805
Query: 836 EFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGM 895
EFETF+LKIVHRKNRTGFEE+KNF+VVLNSVIAGRYHVTEYLGSAAFSKAIQAHDL TGM
Sbjct: 806 EFETFDLKIVHRKNRTGFEEEKNFNVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLQTGM 865
Query: 896 DVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA 955
DVC+KIIKNNKDFFDQSLDEIKLLKYVNKHDP DKYHLLRLYDYFYYREHLLIVCELLKA
Sbjct: 866 DVCIKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHLLRLYDYFYYREHLLIVCELLKA 925
Query: 956 NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC 1015
NLYEFHKFNRESGGEVYFTMPRLQSITIQCLE+LQFLHGLGLIHCDLKPENILVKSYSRC
Sbjct: 926 NLYEFHKFNRESGGEVYFTMPRLQSITIQCLESLQFLHGLGLIHCDLKPENILVKSYSRC 985
Query: 1016 EVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLF 1075
E+KVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL YDKKID+WSLGCILAELCTGNVLF
Sbjct: 986 EIKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGCILAELCTGNVLF 1045
Query: 1076 QNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSL 1135
QNDSPA+LLARV+GI+G + ML KGRD++KYFTKN MLYERNQE+NRLEYLIPK+TSL
Sbjct: 1046 QNDSPASLLARVMGIVGSFDNEMLTKGRDSHKYFTKNRMLYERNQESNRLEYLIPKRTSL 1105
Query: 1136 RHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
RHRLPMGDQGF DFVAHLLEINPKKRPSA++ALKHPWLS+PYEPISA
Sbjct: 1106 RHRLPMGDQGFTDFVAHLLEINPKKRPSAAEALKHPWLSYPYEPISA 1152
|
|
| TAIR|locus:2089774 AT3G17750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1940 (688.0 bits), Expect = 0., Sum P(2) = 0.
Identities = 376/495 (75%), Positives = 412/495 (83%)
Query: 696 KGKCTQVKNLTDGGFSFPPPLRDGQLVQKGSSKSLWSNNCDPVISDETDDPLKALMGADD 755
KG +KN DGGFSFP P+ D Q Q S+ WSN+CD V+ +E+D+P K L+ +D
Sbjct: 646 KGASMLLKNFADGGFSFPSPVADRQKSQDDSANPEWSNHCDAVVRNESDEP-KGLIQSDS 704
Query: 756 ML--ATWRQKSTDSSR------DEXXXXXXXXXXXXXXTLSNYEREHVKREEAEKISGMR 807
M+ +T R + S R DE S+ REH K E+ E+ S
Sbjct: 705 MIVSSTKRCSGSSSERNLRDMDDEKVASSRNSSPSALSHSSDTGREH-KEEDEEETSHGP 763
Query: 808 EEDPGASLEDXXXXXXXXXXRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVI 867
EEDPG S ED RQI+AQE++FETFNLKIVHRKNRTGFEEDKNFHVVLNSVI
Sbjct: 764 EEDPGTSFEDEDAIVVQEQVRQIQAQEQDFETFNLKIVHRKNRTGFEEDKNFHVVLNSVI 823
Query: 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP 927
AGRYHVTE+LGSAAFSKAIQAHDLHTG+DVCVKIIKNNKDFFDQSLDEIKLLKYVN+HDP
Sbjct: 824 AGRYHVTEHLGSAAFSKAIQAHDLHTGIDVCVKIIKNNKDFFDQSLDEIKLLKYVNQHDP 883
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
DKYHLLRLYDYFY+REHLLIVCELLKANLYEF KFNRESGGEVYFTMPRLQSITIQCLE
Sbjct: 884 ADKYHLLRLYDYFYFREHLLIVCELLKANLYEFQKFNRESGGEVYFTMPRLQSITIQCLE 943
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVI 1047
AL FLHGLGLIHCDLKPENIL+KSYSRCE+KVIDLGSSCFETDHLCSYVQSRSYRAPEVI
Sbjct: 944 ALNFLHGLGLIHCDLKPENILIKSYSRCEIKVIDLGSSCFETDHLCSYVQSRSYRAPEVI 1003
Query: 1048 LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYK 1107
LGL YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG I+Q MLAKGRDT K
Sbjct: 1004 LGLPYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGSIDQEMLAKGRDTCK 1063
Query: 1108 YFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167
YFTKNH+LYERNQE+N LEYLIPKK+SLR RLPMGDQGFIDFVA+LL+++PKKRPSA +A
Sbjct: 1064 YFTKNHLLYERNQESNNLEYLIPKKSSLRRRLPMGDQGFIDFVAYLLQVDPKKRPSAFEA 1123
Query: 1168 LKHPWLSHPYEPISA 1182
LKHPWL++PYEPISA
Sbjct: 1124 LKHPWLTYPYEPISA 1138
|
|
| TAIR|locus:2047741 AT2G40120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1324 (471.1 bits), Expect = 1.0e-143, Sum P(3) = 1.0e-143
Identities = 235/341 (68%), Positives = 295/341 (86%)
Query: 834 EEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHT 893
E+E+E FNL+I+H KNRTGFEE+K+ +V+N+VI GRY++TEY+GSAAFSK +QA DLH
Sbjct: 224 EDEYEVFNLRIIHWKNRTGFEENKDLPIVINTVIGGRYYITEYIGSAAFSKVVQAQDLHN 283
Query: 894 GMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL 953
G+DVC+KIIKN+KDFFDQSLDEIKLLK+VNKHDP D++H+LRLYDYFY++EHL IVCELL
Sbjct: 284 GVDVCLKIIKNDKDFFDQSLDEIKLLKHVNKHDPADEHHILRLYDYFYHQEHLFIVCELL 343
Query: 954 KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013
+ANLYEF KFN+ESGGE YF + RLQ IT QCL+AL FLHGLG+IHCDLKPENIL+KSY
Sbjct: 344 RANLYEFQKFNQESGGEPYFNLSRLQVITRQCLDALVFLHGLGIIHCDLKPENILIKSYK 403
Query: 1014 RCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNV 1073
RC VK+IDLGSSCF +D+LC YVQSRSYRAPEVILGL YD+KID+WSLGCILAELC+G V
Sbjct: 404 RCAVKIIDLGSSCFRSDNLCLYVQSRSYRAPEVILGLPYDEKIDLWSLGCILAELCSGEV 463
Query: 1074 LFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT 1133
LF N++ A +LAR++ ++GPIE ML KG++T+KYFTK + LY N+E+N +EY+I +++
Sbjct: 464 LFPNEAVAMILARIVAVLGPIETEMLEKGQETHKYFTKEYDLYHLNEESNEIEYIITEES 523
Query: 1134 SLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174
SL +L + D+ F+DFV LL+INP +RP+A +AL HPWLS
Sbjct: 524 SLEEQLQVSDELFLDFVRTLLDINPLRRPTALEALNHPWLS 564
|
|
| DICTYBASE|DDB_G0293750 dyrk2 "protein kinase, CMGC group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 3.9e-58, Sum P(3) = 3.9e-58
Identities = 124/324 (38%), Positives = 187/324 (57%)
Query: 852 GFEED-KNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD 910
G++ D + VV IA R+ + LG +F + ++ +D TG V +KI++N K F +
Sbjct: 585 GYDNDIGEYKVVERDHIAYRFEIVSILGQGSFCQVVKGYDYKTGEMVALKILRNQKRFHN 644
Query: 911 QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE 970
Q+L EIK+L+Y+ +DP ++ L +YFY+R HL++ ELL NLY+F K N G
Sbjct: 645 QALTEIKILEYLKTNDPNSTASIVHLNNYFYFRNHLILTFELLSMNLYDFLKVNHFQG-- 702
Query: 971 VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030
+ + ++ Q L +L+FL +IH DLKPENIL+KS ++ +K+ID GSSCFE +
Sbjct: 703 --YNLNLVRRFGAQILTSLRFLSKRNIIHADLKPENILLKSPTKSGIKLIDFGSSCFENE 760
Query: 1031 HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090
+ +Y+QSR YR+PEVILG YDK IDIWSLGCIL E+ TG LF LA ++ +
Sbjct: 761 QIFTYIQSRFYRSPEVILGTKYDKSIDIWSLGCILVEIFTGVPLFPGSDEPEQLACIMEV 820
Query: 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYE-RNQETNRLEYLIPKKTSLRHRLPMGDQGFIDF 1149
+G + ++ +F + +N T L Y I K S + + GD+ F +F
Sbjct: 821 LGAPPKSVIDNSTRKDIFFEDDGTPKPVKNSTTGEL-YTIGTK-SFKDSIRSGDEDFDNF 878
Query: 1150 VAHLLEINPKKRPSASDALKHPWL 1173
+ L+ P +R +A LKH W+
Sbjct: 879 ILDCLKWEPSQRITAEQGLKHDWI 902
|
|
| UNIPROTKB|F5H6L9 DYRK4 "Dual-specificity tyrosine-phosphorylation-regulated kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 5.1e-54, Sum P(2) = 5.1e-54
Identities = 126/328 (38%), Positives = 185/328 (56%)
Query: 849 NRTGFEEDKNFHV-VLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD 907
++T F+++ F++ VL+ IA RY V E +G +F + + D V +KII+N K
Sbjct: 196 SKTSFDDEHGFYLKVLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKR 255
Query: 908 FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRES 967
F Q+L E+K+L+ + K D + Y+++ + D+FY+R H I ELL NLYE K N
Sbjct: 256 FHQQALMELKILEALRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQ 315
Query: 968 GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027
G F++ ++ T+ L+ LQ L +IHCDLKPENI++ + VKVID GSSC+
Sbjct: 316 G----FSLSIVRRFTLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCY 371
Query: 1028 ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
E + +Y+QSR YR+PEVILG YD ID+WSLGCI AEL TG LF ++ LA +
Sbjct: 372 EHQKVYTYIQSRFYRSPEVILGHPYDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACI 431
Query: 1088 IGIIGPIEQGML--AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQG 1145
+ ++G G + A R T+ + +K + +N NR + P L L D
Sbjct: 432 MEVLGLPPAGFIQTASRRQTF-FDSKG---FPKNITNNRGKKRYPDSKDLTMVLKTYDTS 487
Query: 1146 FIDFVAHLLEINPKKRPSASDALKHPWL 1173
F+DF+ L P R + ALKH W+
Sbjct: 488 FLDFLRRCLVWEPSLRMTPDQALKHAWI 515
|
|
| FB|FBgn0016930 smi35A "smell impaired 35A" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 5.6e-54, Sum P(2) = 5.6e-54
Identities = 118/323 (36%), Positives = 183/323 (56%)
Query: 852 GFEEDK-NFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD 910
G+++D N+ ++ + IA RY + E +G +F + I+A D T V +KII+N K F +
Sbjct: 178 GYDDDNGNYKIIEHDHIAFRYEILEVIGKGSFGQVIRALDHKTNTHVAIKIIRNKKRFLN 237
Query: 911 QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE 970
Q++ E+ +L + + D ++++ + DY Y+R+HL I EL+ NLYE K N +G
Sbjct: 238 QAVVELNILDELREKDADGSHNVIHMLDYTYFRKHLCITFELMSLNLYELIKKNNYNG-- 295
Query: 971 VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030
F+M ++ ++ L+ L+ +IHCDLKPENIL+K +KVID GSSC+
Sbjct: 296 --FSMSLIRRFCNSIVKCLRLLYKENIIHCDLKPENILLKQRGSSSIKVIDFGSSCYVDR 353
Query: 1031 HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090
+ +Y+QSR YR+PEVILGL Y ID+WSLGCILAEL TG LF ++ LA ++ +
Sbjct: 354 KIYTYIQSRFYRSPEVILGLQYGTAIDMWSLGCILAELYTGFPLFPGENEVEQLACIMEV 413
Query: 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFV 1150
+G + +++ R +F R + P SL H L D+ FIDF+
Sbjct: 414 LGLPPKVLISVARRRRLFFDSRDA--PRCITNTKGRKRSPGSKSLAHILHCQDRYFIDFL 471
Query: 1151 AHLLEINPKKRPSASDALKHPWL 1173
LE +P +R + +A H +L
Sbjct: 472 QRCLEWDPAERMTPDEAAHHEFL 494
|
|
| RGD|1306800 Dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 1.1e-53, Sum P(2) = 1.1e-53
Identities = 123/337 (36%), Positives = 187/337 (55%)
Query: 842 LKIVHRK-NRTGFEEDKNFHV-VLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCV 899
L +V K ++T F+++ +V VL+ IA RY V + +G +F + + D V +
Sbjct: 189 LNVVPEKFSKTSFDDEHGSYVKVLHDHIAYRYEVLDMIGKGSFGQVAKCLDHKNNELVAL 248
Query: 900 KIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYE 959
KII+N K F Q+L E+K+L+ + + D + ++++ + D+FY+R HL I ELL NLYE
Sbjct: 249 KIIRNKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYE 308
Query: 960 FHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019
K N G F++ ++ T+ L+ LQ L+ +IHCDLKPENI++ + VKV
Sbjct: 309 LMKNNSFQG----FSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKV 364
Query: 1020 IDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
ID GSSC+E + +Y+QSR YR+PEVILG Y+ ID+WSLGCI+AEL TG LF ++
Sbjct: 365 IDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGEN 424
Query: 1080 PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRL 1139
LA ++ ++G ++ +F + +N NR E P L +
Sbjct: 425 EVEQLACIMEVLGLPPTHLIQTATRRQIFFDSKGL--PKNITNNRGEKRYPNSKDLPMVV 482
Query: 1140 PMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176
D F+DF+ L P R + ALKH W+ P
Sbjct: 483 KTYDSSFLDFLRRCLVWEPSLRMTPDQALKHAWIHEP 519
|
|
| UNIPROTKB|D4A0W8 Dyrk4 "Protein Dyrk4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 7.8e-53, Sum P(2) = 7.8e-53
Identities = 123/337 (36%), Positives = 187/337 (55%)
Query: 842 LKIVHRK-NRTGFEEDKNFHV-VLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCV 899
L +V K ++T F+++ +V VL+ IA RY V + +G +F + + D V +
Sbjct: 153 LNVVPEKFSKTSFDDEHGSYVKVLHDHIAYRYEVLDMIGKGSFGQVAKCLDHKNNELVAL 212
Query: 900 KIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYE 959
KII+N K F Q+L E+K+L+ + + D + ++++ + D+FY+R HL I ELL NLYE
Sbjct: 213 KIIRNKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYE 272
Query: 960 FHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019
K N G F++ ++ T+ L+ LQ L+ +IHCDLKPENI++ + VKV
Sbjct: 273 LMKNNSFQG----FSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKV 328
Query: 1020 IDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
ID GSSC+E + +Y+QSR YR+PEVILG Y+ ID+WSLGCI+AEL TG LF ++
Sbjct: 329 IDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGEN 388
Query: 1080 PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRL 1139
LA ++ ++G ++ +F + +N NR E P L +
Sbjct: 389 EVEQLACIMEVLGLPPTHLIQTATRRQIFFDSKGL--PKNITNNRGEKRYPNSKDLPMVV 446
Query: 1140 PMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176
D F+DF+ L P R + ALKH W+ P
Sbjct: 447 KTYDSSFLDFLRRCLVWEPSLRMTPDQALKHAWIHEP 483
|
|
| ZFIN|ZDB-GENE-091015-3 dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 1.0e-52, Sum P(2) = 1.0e-52
Identities = 121/325 (37%), Positives = 184/325 (56%)
Query: 852 GFEEDKNFHV-VLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD 910
G++++ ++ VL+ I RY V E +G +F + ++ D T V +KII+N K F
Sbjct: 192 GYDDEHGSYLKVLHDHIGYRYEVLEVIGKGSFGQVLKCLDHKTNETVAIKIIRNKKRFHH 251
Query: 911 QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE 970
Q+L E+K+L V + D + ++++ + +YFY+R HL I ELL ANLYE K N G
Sbjct: 252 QALVELKILDAVRRRDRDNCHNVIHMKEYFYFRNHLCISFELLGANLYELIKKNNFQG-- 309
Query: 971 VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030
F++ ++ L+ LQ LH +IHCDLKPENIL+ + +KV+D GSSC+E
Sbjct: 310 --FSLGLIRRFAHSLLKCLQMLHKEKIIHCDLKPENILLSQRGQGNIKVVDFGSSCYEQQ 367
Query: 1031 HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090
+ +Y+QSR YR+PEVILG Y ID+WSLGCILAEL TG LF +S +A ++ I
Sbjct: 368 RVYTYIQSRFYRSPEVILGHPYSMAIDMWSLGCILAELYTGYPLFPGESEVEQIACIMEI 427
Query: 1091 IG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDF 1149
+G P + R + +K + RN ++ + P L L D F+DF
Sbjct: 428 MGLPPNDFVQTASRRRLFFDSKGN---PRNITNSKGKKRRPSSKDLASVLKTNDPLFLDF 484
Query: 1150 VAHLLEINPKKRPSASDALKHPWLS 1174
+ L +P KR + +A++H W++
Sbjct: 485 IQRCLVWDPTKRMTPDEAMQHEWIT 509
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1182 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-64 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-57 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-52 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-46 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-46 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-42 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-42 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-39 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-38 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-38 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-37 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-37 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-37 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-36 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-36 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-35 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-34 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-33 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-33 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-31 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-30 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-30 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-30 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-29 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-29 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-28 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-28 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-28 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-28 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-27 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-27 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-27 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-26 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-26 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-26 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-25 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-23 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-23 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-22 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-22 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-21 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-19 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-19 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-16 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 8e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 0.001 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.001 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.003 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 0.004 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 4e-64
Identities = 93/308 (30%), Positives = 134/308 (43%), Gaps = 59/308 (19%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPG 928
Y + E LG +F K A D TG V +K+IK K ++ L EIK+LK + H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK-HP-- 57
Query: 929 DKYHLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
+++RLYD F + L +V E +L++ K + + Q L
Sbjct: 58 ---NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQILS 108
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF--ETDHLCSYVQSRSYRAPE 1045
AL++LH G++H DLKPENIL+ VK+ D G + + L ++V + Y APE
Sbjct: 109 ALEYLHSKGIVHRDLKPENILLDE--DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166
Query: 1046 VILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105
V+LG Y K +DIWSLG IL EL TG F D L + IG
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG---------------- 210
Query: 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165
PK + + D + LL +P+KR +A
Sbjct: 211 -----------------------KPKPPFPPPEWDISPE-AKDLIRKLLVKDPEKRLTAE 246
Query: 1166 DALKHPWL 1173
+AL+HP+
Sbjct: 247 EALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 3e-57
Identities = 91/310 (29%), Positives = 136/310 (43%), Gaps = 57/310 (18%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHDP 927
Y + LGS +F +A TG V VKI+K + EI++L+ ++ H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-HP- 58
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
+++RL D F ++HL +V E + + G + + I +Q L
Sbjct: 59 ----NIVRLIDAFEDKDHLYLVMEYC--EGGDLFDYLSRGGP---LSEDEAKKIALQILR 109
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH---LCSYVQSRSYRAP 1044
L++LH G+IH DLKPENIL+ VK+ D G + L ++V + Y AP
Sbjct: 110 GLEYLHSNGIIHRDLKPENILLDE--NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
Query: 1045 EVIL-GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103
EV+L G Y K+D+WSLG IL EL TG F ++ L + I+GP
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPP--------- 218
Query: 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163
LE+ PK +S G + D + L +P KRP+
Sbjct: 219 ---------------------LEFDEPKWSS-------GSEEAKDLIKKCLNKDPSKRPT 250
Query: 1164 ASDALKHPWL 1173
A + L+HPW
Sbjct: 251 AEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 2e-52
Identities = 103/329 (31%), Positives = 154/329 (46%), Gaps = 50/329 (15%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYVN 923
RY + + +GS A+ A D TG V +K I N FD +D EIKLL+++
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRHL- 56
Query: 924 KHDPGDKYHLLRLYDYFYYR-----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRL 978
+H+ +++ L D + IV EL++ +L++ K S + T +
Sbjct: 57 RHE-----NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIK----SPQPL--TDDHI 105
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG------SSCFETDHL 1032
Q Q L L++LH +IH DLKP NILV S C++K+ D G E L
Sbjct: 106 QYFLYQILRGLKYLHSANVIHRDLKPSNILVNS--NCDLKICDFGLARGVDPDEDEKGFL 163
Query: 1033 CSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091
YV +R YRAPE++L S Y K IDIWS+GCI AEL T LF L ++ ++
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL 223
Query: 1092 G-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFV 1150
G P E+ + + + + K+ K L P ID +
Sbjct: 224 GTPSEEDLKFITSEKARNYLKSLPKKP--------------KKPLSKLFPGASPEAIDLL 269
Query: 1151 AHLLEINPKKRPSASDALKHPWLSHPYEP 1179
+L +PKKR +A +AL HP+L+ ++P
Sbjct: 270 EKMLVFDPKKRITADEALAHPYLAQLHDP 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 103/320 (32%), Positives = 155/320 (48%), Gaps = 54/320 (16%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQ--SLDEIKLLKYVNKHDPG 928
Y V + LG F A + TG V +K +K +++ +L E+K L+ +N+H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHP-- 58
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988
++++L + F + L V E ++ NLY+ K +R+ F+ ++SI Q L+
Sbjct: 59 ---NIVKLKEVFRENDELYFVFEYMEGNLYQLMK-DRKGK---PFSESVIRSIIYQILQG 111
Query: 989 LQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG------SSCFETDHLCSYVQSRSYR 1042
L +H G H DLKPEN+LV VK+ D G S TD YV +R YR
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD----YVSTRWYR 165
Query: 1043 APEVIL-GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQ---- 1096
APE++L SY +DIW+LGCI+AEL T LF S L ++ ++G P +Q
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225
Query: 1097 GM-LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK--TSLRHRLPMGDQGFIDFVAHL 1153
G LA ++L + P+ TSL +P ID + +
Sbjct: 226 GYKLA----------------------SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDM 263
Query: 1154 LEINPKKRPSASDALKHPWL 1173
L +PKKRP+AS AL+HP+
Sbjct: 264 LRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 4e-46
Identities = 89/314 (28%), Positives = 136/314 (43%), Gaps = 43/314 (13%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---FFDQSLDEIKLLKYVNKHDP 927
Y E LG + +A D TG V +K I+ + + +L EI LLK + H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HP- 58
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
++++L D + L +V E +L ++ + ++SI Q L
Sbjct: 59 ----NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGP-----LSPNLIKSIMYQLLR 109
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRAP 1044
L + H ++H DLKP+NIL+ +K+ D G + V + YRAP
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINR--DGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAP 167
Query: 1045 EVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQ---GML 1099
E++LG Y +DIWS+GCI AE+ TG LF DS L ++ I+G P E+ G+
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV- 226
Query: 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159
+ + L LP D ID ++ +L+ NP
Sbjct: 227 ----TKLPDYKPT--------------FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPA 268
Query: 1160 KRPSASDALKHPWL 1173
KR SA +ALKHP+
Sbjct: 269 KRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 6e-46
Identities = 89/314 (28%), Positives = 139/314 (44%), Gaps = 42/314 (13%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHDP 927
Y +G + +A D TG V +K IK ++ +L EIKLLK +N H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HP- 58
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
++++L D F ++ L +V E + +LY+ K + ++S Q L+
Sbjct: 59 ----NIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-----LPESLIKSYLYQLLQ 109
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS-CFETDH--LCSYVQSRSYRAP 1044
L F H G++H DLKPEN+L+ + +K+ D G + F + YV +R YRAP
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINT--EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAP 167
Query: 1045 EVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQ---GML 1099
E++LG Y +DIWS+GCI AEL + LF S L ++ +G P +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227
Query: 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159
+ R+ F K L P +D ++ +L +P
Sbjct: 228 SLARNYKFSFPK------------------KAGMPLPKLFPNASPQALDLLSQMLHYDPH 269
Query: 1160 KRPSASDALKHPWL 1173
KR +A AL HP+
Sbjct: 270 KRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 74/199 (37%), Positives = 104/199 (52%), Gaps = 19/199 (9%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLL 934
LG F A D TG V +KIIK ++ ++ L EI++LK +N +++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP------NIV 54
Query: 935 RLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH 993
+LY F HL +V E + +L + K N + + I +Q LE L++LH
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG-----KLSEDEILRILLQILEGLEYLH 109
Query: 994 GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH---LCSYVQSRSYRAPEVILGL 1050
G+IH DLKPENIL+ S + VK+ D G S T L + V + +Y APEV+LG
Sbjct: 110 SNGIIHRDLKPENILLDSDNGK-VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 1051 -SYDKKIDIWSLGCILAEL 1068
Y +K DIWSLG IL EL
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 87/318 (27%), Positives = 149/318 (46%), Gaps = 43/318 (13%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKH 925
+Y V +G A+ ++ + TG V +K K +++D +L E+K+L+ + +H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RH 59
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPR--LQSITI 983
+ +++ L + F + L +V E ++ L E GG +P ++S
Sbjct: 60 E-----NIVNLKEAFRRKGRLYLVFEYVERTLLEL--LEASPGG-----LPPDAVRSYIW 107
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG----SSCFETDHLCSYVQSR 1039
Q L+A+ + H +IH D+KPENILV +K+ D G L YV +R
Sbjct: 108 QLLQAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRARPASPLTDYVATR 165
Query: 1040 SYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098
YRAPE+++G +Y K +D+W++GCI+AEL G LF DS L + +GP+
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL---- 221
Query: 1099 LAKGRDTYKYFTKNHM-LYERNQETNRLEYL-IPKKTSLRHRLP-MGDQGFIDFVAHLLE 1155
+H L+ N + + + SL R P +DF+ L
Sbjct: 222 -----------PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLR 270
Query: 1156 INPKKRPSASDALKHPWL 1173
++PK+R + + L+HP+
Sbjct: 271 MDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 7e-39
Identities = 88/317 (27%), Positives = 147/317 (46%), Gaps = 46/317 (14%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFD-QSLDEIKLLKYVNKHDP 927
Y +G + + +A + TG V +K I+ N K+ F ++ EIKLL+ + H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HP- 58
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLY---EF--HKFNR-ESGGEVYFTMPRLQSI 981
+++RL + IV K ++Y E+ H EV FT +++
Sbjct: 59 ----NIVRLKE---------IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY 105
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCSY---VQ 1037
Q LE LQ+LH G++H D+K NIL+ + +K+ D G + + + Y V
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILIN--NDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 1038 SRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIE 1095
+ YR PE++LG Y ++D+WS+GCILAEL G +FQ + L ++ + G P +
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
+ G +F + + R + +H + D +D + LL
Sbjct: 224 ENW--PGVSKLPWFE----NLKPKKPYKRRL-----REFFKHLI---DPSALDLLDKLLT 269
Query: 1156 INPKKRPSASDALKHPW 1172
++PKKR SA AL+H +
Sbjct: 270 LDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 4e-38
Identities = 91/318 (28%), Positives = 155/318 (48%), Gaps = 44/318 (13%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD-----QSLDEIKLLKYVNK 924
RY +GS A+ + A D TG V +K K ++ F ++ E++LLK+++
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMD- 72
Query: 925 HDPGDKYHLLRLYDYFYYREHL------LIVCELLKANLYEFHKFNRESGGEVYFTMPRL 978
H+ +++ L D F L +V L+ A+L K + S + F
Sbjct: 73 HE-----NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF----- 122
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQS 1038
+ Q L L+++H G+IH DLKP NI V CE+K++D G + D + YV +
Sbjct: 123 --LVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCELKILDFGLARHTDDEMTGYVAT 178
Query: 1039 RSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQ 1096
R YRAPE++L + Y++ +DIWS+GCI+AEL TG LF L R++ ++G P E+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238
Query: 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156
+ ++ + + ++ K + + ID + +L +
Sbjct: 239 LLQKISSESARNYIQS--------------LPQMPKKDFKEVFSGANPLAIDLLEKMLVL 284
Query: 1157 NPKKRPSASDALKHPWLS 1174
+P KR +A++AL HP+L+
Sbjct: 285 DPDKRITAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 5e-38
Identities = 87/311 (27%), Positives = 150/311 (48%), Gaps = 39/311 (12%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQ--SLDEIKLLKYVNKHDPG 928
Y + +G FS+ ++A TG +K +K + +Q +L EI+ L+ ++ H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHP-- 58
Query: 929 DKYHLLRLYDYFYYREH--LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
++LRL + + R+ L +V EL+ NLYE K + R++S Q L
Sbjct: 59 ---NILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKR-----PLPEKRVKSYMYQLL 110
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC--FETDHLCSYVQSRSYRAP 1044
++L +H G+ H D+KPENIL+K +K+ D GS + Y+ +R YRAP
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD---ILKLADFGSCRGIYSKPPYTEYISTRWYRAP 167
Query: 1045 EVIL-GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103
E +L Y K+DIW++GC+ E+ + LF + +A++ ++G
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG----------- 216
Query: 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKK--TSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161
T + + ++ +++ + Y P K T LR LP +D + LL +P +R
Sbjct: 217 ------TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDER 270
Query: 1162 PSASDALKHPW 1172
+A AL+HP+
Sbjct: 271 ITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 80/312 (25%), Positives = 141/312 (45%), Gaps = 35/312 (11%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFF---DQSLDEIKLLKYVNKHD 926
RY + +G A +A D TG V +K + + +Q+L EIK L+ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHP 59
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
++++L D F + ++V E + ++L E + +++S L
Sbjct: 60 -----YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERP-----LPEAQVKSYMRMLL 109
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCSY---VQSRSYR 1042
+ + ++H G++H DLKP N+L+ + +K+ D G + F + Y V +R YR
Sbjct: 110 KGVAYMHANGIMHRDLKPANLLISA--DGVLKIADFGLARLFSEEEPRLYSHQVATRWYR 167
Query: 1043 APEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101
APE++ G YD +D+W++GCI AEL G+ LF ++ LA V +G +
Sbjct: 168 APELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGT----PNEE 223
Query: 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161
+ + + LE + P + +D + LL +P KR
Sbjct: 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDAS----------PEALDLLKGLLVYDPSKR 273
Query: 1162 PSASDALKHPWL 1173
SA++AL+HP+
Sbjct: 274 LSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 4e-37
Identities = 89/316 (28%), Positives = 144/316 (45%), Gaps = 41/316 (12%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN-----KDFFDQS-LDEIKLLKYVN 923
RY + LG ++ +A D TG V +K IK KD + + L EIKLL+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL- 59
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
KH +++ L D F ++ ++ +V E ++ +L + K + T ++S +
Sbjct: 60 KHP-----NIIGLLDVFGHKSNINLVFEFMETDLEKVIKDK-----SIVLTPADIKSYML 109
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRS 1040
L L++LH ++H DLKP N+L+ S +K+ D G + + V +R
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIAS--DGVLKLADFGLARSFGSPNRKMTHQVVTRW 167
Query: 1041 YRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGM 1098
YRAPE++ G Y +D+WS+GCI AEL DS L ++ +G P E
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE--- 224
Query: 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINP 1158
+ + T Y +E+ T L+ P +D + LL +NP
Sbjct: 225 -----ENWPGVTS-LPDY--------VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270
Query: 1159 KKRPSASDALKHPWLS 1174
KR +A AL+HP+ S
Sbjct: 271 NKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 144 bits (362), Expect = 5e-37
Identities = 82/325 (25%), Positives = 129/325 (39%), Gaps = 58/325 (17%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHD 926
Y + LG +F + A D V +K++ + ++ L EI++L +N
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
++++LYD+F L +V E + ++ G + + I Q L
Sbjct: 59 -----NIVKLYDFFQDEGSLYLVMEYVDGG--SLEDLLKKIGRKGPLSESEALFILAQIL 111
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH---------LCSYVQ 1037
AL++LH G+IH D+KPENIL+ VK+ID G + D + V
Sbjct: 112 SALEYLHSKGIIHRDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 1038 SRSYRAPEVILGLS---YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094
+ Y APEV+LGLS DIWSLG L EL TG F+ + ++ ++ + II
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII--- 227
Query: 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLL 1154
T L + + + D + LL
Sbjct: 228 -----------------------LELPTPSLASPLSPSNP-----ELISKAASDLLKKLL 259
Query: 1155 EINPKKRPSASDALKHPWLSHPYEP 1179
+PK R S+S L H L+H
Sbjct: 260 AKDPKNRLSSSSDLSHDLLAHLKLK 284
|
Length = 384 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 6e-37
Identities = 102/343 (29%), Positives = 148/343 (43%), Gaps = 83/343 (24%)
Query: 867 IAGRYHVTEYLGSAAFS---KAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIK 917
I +Y + + LG A+ KAI D T V +K I D F + D EI
Sbjct: 5 ILRKYEILQKLGKGAYGIVWKAI---DRRTKEVVALKKIF---DAFRNATDAQRTFREIM 58
Query: 918 LLKYVNKHDPGDKYHLLRLYD----------Y--FYYRE---HLLIVCELLKAN-LYEFH 961
L+ + H ++++L + Y F Y E H +I +AN L + H
Sbjct: 59 FLQELGDHP-----NIVKLLNVIKAENDKDIYLVFEYMETDLHAVI-----RANILEDVH 108
Query: 962 KFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021
K + I Q L+AL+++H +IH DLKP NIL+ S C VK+ D
Sbjct: 109 K----------------RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLAD 150
Query: 1022 LG--------SSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGN 1072
G E L YV +R YRAPE++LG Y K +D+WS+GCIL E+ G
Sbjct: 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
Query: 1073 VLFQNDSPATLLARVIGIIG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK 1131
LF S L ++I +IG P + + + F ML
Sbjct: 211 PLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP----FAAT-MLDSLPS---------RP 256
Query: 1132 KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174
+ L LP +D + LL NP KR +A +AL+HP+++
Sbjct: 257 RKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-36
Identities = 92/327 (28%), Positives = 148/327 (45%), Gaps = 42/327 (12%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNK 924
+ RY Y+G A+ A TG+ V +K I ++ F ++L EIK+L+
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH 62
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV-YFTMPRLQSITI 983
+ ++R + + + + IV EL++ +LY+ K S + YF
Sbjct: 63 ENIIGILDIIRPPSFESFND-VYIVQELMETDLYKLIKTQHLSNDHIQYFLY-------- 113
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDH---LCSYVQ 1037
Q L L+++H ++H DLKP N+L+ + C++K+ D G + E DH L YV
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 1038 SRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096
+R YRAPE++L Y K IDIWS+GCILAE+ + LF L ++G++G
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG---- 227
Query: 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYL--IP--KKTSLRHRLPMGDQGFIDFVAH 1152
T + Y+ +P K P D +D +
Sbjct: 228 -------------TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDK 274
Query: 1153 LLEINPKKRPSASDALKHPWLSHPYEP 1179
+L NP KR + +AL HP+L ++P
Sbjct: 275 MLTFNPHKRITVEEALAHPYLEQYHDP 301
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 95/319 (29%), Positives = 152/319 (47%), Gaps = 48/319 (15%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQS-LDEIKLLKYVNKHD- 926
Y +G A+ +A DL+TG V +K ++ +++ S L EI LLK + +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 927 PGDKYHLLRLYDYFY----YRE-HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSI 981
P +++RL D + RE L +V E + +L + + G ++ +
Sbjct: 61 P----NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG----LPPETIKDL 112
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS---CFETDHLCSYVQS 1038
Q L + FLH ++H DLKP+NILV S +VK+ D G + FE L S V +
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTS--DGQVKIADFGLARIYSFEMA-LTSVVVT 169
Query: 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQG 1097
YRAPEV+L SY +D+WS+GCI AEL LF+ S A L ++ +IG P E+
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 1098 ---MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLL 1154
++ R ++ +T K+ + + ++G +D + +L
Sbjct: 230 WPRNVSLPRSSFPSYTP-----------------RSFKSFVPE---ICEEG-LDLLKKML 268
Query: 1155 EINPKKRPSASDALKHPWL 1173
NP KR SA +AL+HP+
Sbjct: 269 TFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 86/310 (27%), Positives = 131/310 (42%), Gaps = 74/310 (23%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFFDQSLDEIKLLKYVNKHDPGDKYHL 933
E +G F + +A TG +V +K+IK +K+ ++ ++EI++LK ++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHP------NI 59
Query: 934 LRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY---------FTMPRLQSITIQ 984
++ Y + ++ L IV E SGG + T ++ + +
Sbjct: 60 VKYYGSYLKKDELWIVMEFC-------------SGGSLKDLLKSTNQTLTESQIAYVCKE 106
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC--SYVQSRSYR 1042
L+ L++LH G+IH D+K NIL+ S EVK+ID G S +D + V + +
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLTS--DGEVKLIDFGLSAQLSDTKARNTMVGTPYWM 164
Query: 1043 APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
APEVI G YD K DIWSLG EL G + P L + I GP
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-IATNGP--------- 214
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
P+K S F DF+ L+ NP+KRP
Sbjct: 215 ----------------------PGLRNPEKWSDE---------FKDFLKKCLQKNPEKRP 243
Query: 1163 SASDALKHPW 1172
+A LKHP+
Sbjct: 244 TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 6e-35
Identities = 96/330 (29%), Positives = 151/330 (45%), Gaps = 47/330 (14%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN---NKDFFDQSLDEIKLLKYVN 923
I RY + +G AF A D TG +V +K I ++ E+KLLK++
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL- 66
Query: 924 KHDPGDKYHLLRLYDYFYY-REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSIT 982
+H+ +++ L D F E + V ELL +L H+ E F +Q
Sbjct: 67 RHE-----NIISLSDIFISPLEDIYFVTELLGTDL---HRLLTSRPLEKQF----IQYFL 114
Query: 983 IQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR 1042
Q L L+++H G++H DLKP NIL+ C++K+ D G + + + YV +R YR
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINE--NCDLKICDFGLARIQDPQMTGYVSTRYYR 172
Query: 1043 APEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101
APE++L YD ++DIWS GCI AE+ G LF + + ++G
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG--------- 223
Query: 1102 GRDTYKYFTKNHMLYERNQETNRLEYL--IPK--KTSLRHRLPMGDQGFIDFVAHLLEIN 1157
T + N L ++ +PK + D ID + +L +
Sbjct: 224 --------TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFD 275
Query: 1158 PKKRPSASDALKHPWLSHPY-----EPISA 1182
P+KR SA++AL HP+L+ PY EP++
Sbjct: 276 PQKRISAAEALAHPYLA-PYHDPTDEPVAE 304
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 96/328 (29%), Positives = 154/328 (46%), Gaps = 45/328 (13%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMD--VCVKIIKN---NKDFFDQSLDEIKLLKYVNK 924
RY + + LG A+ A + T + V +K I N K ++L E+KLL++
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 925 HDPGDKYHLLRLYD-----YFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQ 979
H ++ LYD + E L + EL++A+L H+ R T Q
Sbjct: 61 HK-----NITCLYDMDIVFPGNFNE-LYLYEELMEADL---HQIIRSG---QPLTDAHFQ 108
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC-------FETDHL 1032
S Q L L+++H ++H DLKP N+LV + CE+K+ D G + +
Sbjct: 109 SFIYQILCGLKYIHSANVLHRDLKPGNLLVNA--DCELKICDFGLARGFSENPGENAGFM 166
Query: 1033 CSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091
YV +R YRAPE++L SY K ID+WS+GCILAEL +F+ L +++ ++
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226
Query: 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVA 1151
G ++ L+ + + Y R+ IPKK P + +D +
Sbjct: 227 GTPDEETLS------RIGSPKAQNYIRSLPN------IPKK-PFESIFPNANPLALDLLE 273
Query: 1152 HLLEINPKKRPSASDALKHPWLSHPYEP 1179
LL +P KR S +AL+HP+L+ ++P
Sbjct: 274 KLLAFDPTKRISVEEALEHPYLAIWHDP 301
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 98/332 (29%), Positives = 163/332 (49%), Gaps = 42/332 (12%)
Query: 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQ-----SLDEIKLLK 920
+ RY + +GS A A+D TG +V +K K ++ F + + E+ L+K
Sbjct: 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMK 70
Query: 921 YVNKHDPGDKYHLLRLYDYFYYR------EHLLIVCELLKANLYEFHKFNRESGGEVYFT 974
VN + ++ L + F + + + +V EL+ ANL + + E
Sbjct: 71 LVNHKN------IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQV--IQMDLDHE---- 118
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG------SSCFE 1028
R+ + Q L ++ LH G+IH DLKP NI+VKS C +K++D G +S
Sbjct: 119 --RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMM 174
Query: 1029 TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
T YV +R YRAPEVILG+ Y + +DIWS+GCI+ E+ G VLF ++I
Sbjct: 175 TP----YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230
Query: 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYE-RNQETNRLEYLIPKKTSLRHRLPMGDQGFI 1147
+G +++ + T + + +N Y + E + L P + ++L
Sbjct: 231 EQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR-- 288
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
D ++ +L I+P+KR S DAL+HP+++ Y+P
Sbjct: 289 DLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 1e-33
Identities = 85/321 (26%), Positives = 129/321 (40%), Gaps = 78/321 (24%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVK---IIKNNKDFFDQSLDEIKLLKYVNKHD 926
+ E LG +F A D TG + VK + ++++ + EI++L + +H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59
Query: 927 PGDKYHLLRLYDYFYYRE--HLLIVCEL-----LKANLYEFHKFNRESGGEVYFTMPRLQ 979
+++R Y E L I E L + L +F K P ++
Sbjct: 60 -----NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP----------EPVIR 104
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSR 1039
T Q LE L +LH G++H D+K NILV S VK+ D G + + + +
Sbjct: 105 KYTRQILEGLAYLHSNGIVHRDIKGANILVD--SDGVVKLADFGCA-KRLGDIETGEGTG 161
Query: 1040 SYR------APEVILGLSYDKKIDIWSLGCILAELCTGN-VLFQNDSPATLLARVIGIIG 1092
S R APEVI G Y + DIWSLGC + E+ TG + +P L + IG G
Sbjct: 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK-IGSSG 220
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
+ IP+ S + DF+
Sbjct: 221 EPPE--------------------------------IPEHLS---------EEAKDFLRK 239
Query: 1153 LLEINPKKRPSASDALKHPWL 1173
L +PKKRP+A + L+HP+L
Sbjct: 240 CLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 102/344 (29%), Positives = 164/344 (47%), Gaps = 33/344 (9%)
Query: 854 EEDKNFHVVLNS----VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNK 906
EED F+ V + + RY + +GS A A D G++V VK + N+
Sbjct: 2 EEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ 61
Query: 907 DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR------EHLLIVCELLKANLYEF 960
++ E+ LLK VN + ++ L + F + + + +V EL+ ANL +
Sbjct: 62 THAKRAYRELVLLKCVNHKN------IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV 115
Query: 961 HKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020
+ R+ + Q L ++ LH G+IH DLKP NI+VKS C +K++
Sbjct: 116 IHMELDH--------ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKIL 165
Query: 1021 DLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078
D G + + + YV +R YRAPEVILG+ Y + +DIWS+GCI+ EL G+V+FQ
Sbjct: 166 DFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225
Query: 1079 SPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHR 1138
+VI +G + + + T + + +N Y I S R +
Sbjct: 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDK 285
Query: 1139 LPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
L D ++ +L I+P KR S +AL+HP+++ Y+P A
Sbjct: 286 LKTSQAR--DLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEA 327
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 75/309 (24%), Positives = 132/309 (42%), Gaps = 60/309 (19%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII---KNNKDFFDQSLDEIKLLKYVNKHD 926
+Y + + +G +F K G +K I ++ + +L+E+K+LK +N H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HP 59
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
++++ Y+ F + L IV E +L + K ++ G+ F ++ +Q
Sbjct: 60 -----NIIKYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGK-PFPEEQILDWFVQL 112
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFE--TDHLCSYVQSRSYR 1042
AL++LH ++H D+KP+NI + S VK+ D G S D + V + Y
Sbjct: 113 CLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVDLAKTVVGTPYYL 170
Query: 1043 APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
+PE+ Y+ K DIWSLGC+L ELCT F+ ++ L +++ G
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYPP------ 222
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
IP + S + V+ LL+ +P++RP
Sbjct: 223 --------------------------IPSQYS---------SELRNLVSSLLQKDPEERP 247
Query: 1163 SASDALKHP 1171
S + L+ P
Sbjct: 248 SIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 91/331 (27%), Positives = 153/331 (46%), Gaps = 52/331 (15%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD------QSLDEIKLLKYVN 923
RY E +GS A+ A D +G V +K I + FD ++L E+K+L++
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA---FDVPTLAKRTLRELKILRHF- 61
Query: 924 KHDPGDKYHLLRLYDYFYYRE----HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQ 979
KHD +++ + D + +V +L++++L H T ++
Sbjct: 62 KHD-----NIIAIRDILRPPGADFKDVYVVMDLMESDL---HHIIHSDQP---LTEEHIR 110
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG----SSCFETDH---L 1032
Q L L+++H +IH DLKP N+LV CE+++ D G S T+H +
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE--DCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 1033 CSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091
YV +R YRAPE++L L Y ID+WS+GCI AE+ LF + L ++ ++
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228
Query: 1092 G-PIEQGMLAKGRD-TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDF 1149
G P E+ + G D KY R Q + PK +D
Sbjct: 229 GSPSEEVLNRIGSDRVRKYIQN----LPRKQPVP-WSKIFPKA----------SPEALDL 273
Query: 1150 VAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180
++ +L+ +P++R + AL+HP+L+ ++P
Sbjct: 274 LSQMLQFDPEERITVEQALQHPFLAQYHDPD 304
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 92/323 (28%), Positives = 149/323 (46%), Gaps = 51/323 (15%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYVN 923
RY + E +G ++ A D HTG V +K I D F+ D EIKLL+ +
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN---DVFEHVSDATRILREIKLLRLLR 57
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
D + H++ +++ + +V EL++++L++ K N + E + Q
Sbjct: 58 HPDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDDLTPEHH------QFFLY 110
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG----------SSCFETDHLC 1033
Q L AL+++H + H DLKP+NIL + C++K+ D G ++ F TD
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFWTD--- 165
Query: 1034 SYVQSRSYRAPEVILGL--SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091
YV +R YRAPE+ Y IDIWS+GCI AE+ TG LF + L + ++
Sbjct: 166 -YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224
Query: 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNR-LEYLIPKK-TSLRHRLPMGDQGFIDF 1149
G +++ RN++ R L + K+ + P D +
Sbjct: 225 GTPSPETISR---------------VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRL 269
Query: 1150 VAHLLEINPKKRPSASDALKHPW 1172
+ LL +PK RP+A +AL P+
Sbjct: 270 LERLLAFDPKDRPTAEEALADPY 292
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-30
Identities = 76/315 (24%), Positives = 126/315 (40%), Gaps = 72/315 (22%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDK 930
Y E +G A + +A D TG +V +K ++ K + ++EI ++K KH
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMK-DCKHP---- 75
Query: 931 YHLLRLYDYFYYREHLLIVCELLKAN----LYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+++ YD + + L +V E + + + V P++ + + L
Sbjct: 76 -NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--------FVRMNEPQIAYVCREVL 126
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS------ 1040
+ L++LH +IH D+K +NIL+ VK+ D G F L R+
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSK--DGSVKLADFG---FAA-QLTKEKSKRNSVVGTP 180
Query: 1041 -YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099
+ APEVI Y K+DIWSLG + E+ G + + P L +
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI------------ 228
Query: 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159
+ L+ P+K S F DF+ L +P+
Sbjct: 229 ------------------TTKGIPPLKN--PEKWS---------PEFKDFLNKCLVKDPE 259
Query: 1160 KRPSASDALKHPWLS 1174
KRPSA + L+HP+L
Sbjct: 260 KRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 93/319 (29%), Positives = 144/319 (45%), Gaps = 45/319 (14%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---FFDQSLDEIKLLKYVNKHDP 927
Y E +G + K +A D +TG V +K + D +L EI LL+ ++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS-ESI 61
Query: 928 GDKYHLLRLYDYFYYREH-----LLIVCELLKANLYEFHKFNRESGGEVYFTMPR--LQS 980
+++RL D + E L +V E L ++L +F N G +P ++S
Sbjct: 62 ----YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGR---PLPAKTIKS 114
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY---VQ 1037
Q L+ + H G++H DLKP+N+LV +K+ DLG + + SY +
Sbjct: 115 FMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL-LKIADLGLGRAFSIPVKSYTHEIV 173
Query: 1038 SRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIE 1095
+ YRAPEV+LG + Y +DIWS+GCI AE+ LF DS L + ++G P E
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233
Query: 1096 QGM--LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153
Q ++K RD + E+ K L +P +D + +
Sbjct: 234 QVWPGVSKLRDWH-------------------EFPQWKPQDLSRAVPDLSPEGLDLLQKM 274
Query: 1154 LEINPKKRPSASDALKHPW 1172
L +P KR SA AL HP+
Sbjct: 275 LRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-30
Identities = 99/327 (30%), Positives = 157/327 (48%), Gaps = 52/327 (15%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSL-------DEIKLLKYV 922
RY +GS A+ A+D V VK K ++ F QSL E++LLK++
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPF--QSLIHARRTYRELRLLKHM 71
Query: 923 NKHDPGDKYHLLRLYDYFY-------YREHLLIVCELLKANLYEFHKFNRESGGEVYFTM 975
KH+ +++ L D F + E + +V L+ A+L K + S V F
Sbjct: 72 -KHE-----NVIGLLDVFTPATSIENFNE-VYLVTNLMGADLNNIVKCQKLSDEHVQF-- 122
Query: 976 PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY 1035
+ Q L L+++H G+IH DLKP N+ V CE++++D G + D + Y
Sbjct: 123 -----LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DCELRILDFGLARQADDEMTGY 175
Query: 1036 VQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094
V +R YRAPE++L + Y++ +DIWS+GCI+AEL G LF + L R++ ++G
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235
Query: 1095 EQGMLAK--GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
+L K KY + + Q+ K R P+ ID +
Sbjct: 236 SPEVLKKISSEHARKYIQS--LPHMPQQDL---------KKIFRGANPLA----IDLLEK 280
Query: 1153 LLEINPKKRPSASDALKHPWLSHPYEP 1179
+L ++ KR SAS+AL HP+ S ++P
Sbjct: 281 MLVLDSDKRISASEALAHPYFSQYHDP 307
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 86/304 (28%), Positives = 144/304 (47%), Gaps = 32/304 (10%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHDPGDKYH 932
E LG ++ + + TG V +K I + + S + EI L+K + KH+ +
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHE-----N 59
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
++RL+D + L++V E + +L ++ + G ++S T Q L+ + F
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGA---LDPNTVKSFTYQLLKGIAFC 116
Query: 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRAPEVILG 1049
H ++H DLKP+N+L+ R E+K+ D G + + + V + YRAP+V+LG
Sbjct: 117 HENRVLHRDLKPQNLLINK--RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 1050 -LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKY 1108
+Y IDIWS+GCI+AE+ TG LF + L ++ I+G + +Y
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 1109 FTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168
+ + L+ P D ID + LL++NP+ R SA DAL
Sbjct: 235 ---------------KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279
Query: 1169 KHPW 1172
+HPW
Sbjct: 280 QHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 92/336 (27%), Positives = 152/336 (45%), Gaps = 70/336 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHD 926
RY + +GS A+ A D TG V +K + ++ F ++ E++LLK++ KH+
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHE 74
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMP---------- 976
+++ L D F +L FH F Y MP
Sbjct: 75 -----NVIGLLDVFTPDL-----------SLDRFHDF--------YLVMPFMGTDLGKLM 110
Query: 977 --------RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028
R+Q + Q L+ L+++H G+IH DLKP N+ V CE+K++D G +
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE--DCELKILDFGLARQT 168
Query: 1029 TDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
+ YV +R YRAPEVIL + Y + +DIWS+GCI+AE+ TG LF+ L +
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228
Query: 1088 IGIIGPIEQGMLAK--GRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGD 1143
+ + G + + K D Y K +P+ K R LP +
Sbjct: 229 MKVTGTPSKEFVQKLQSEDAKNYVKK-----------------LPRFRKKDFRSLLPNAN 271
Query: 1144 QGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
++ + +L ++ + R +A++AL HP+ ++P
Sbjct: 272 PLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 97/352 (27%), Positives = 161/352 (45%), Gaps = 49/352 (13%)
Query: 854 EEDKNFHVV----LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNK 906
+ D NF+ V + RY + +GS A A+D +V +K + N+
Sbjct: 5 KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ 64
Query: 907 DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRE 966
++ E+ L+K VN + ++ + + IV EL+ ANL + + +
Sbjct: 65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 124
Query: 967 SGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG--S 1024
R+ + Q L ++ LH G+IH DLKP NI+VKS C +K++D G
Sbjct: 125 H--------ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLAR 174
Query: 1025 SCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLL 1084
+ + + YV +R YRAPEVILG+ Y + +DIWS+GCI+ E+ G VLF
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNH--------------MLYERNQETNRLEYLIP 1130
+VI +G + K + T + + +N +L+ + E N+L
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL----- 289
Query: 1131 KKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
K + R D ++ +L I+ KR S +AL+HP+++ Y+P A
Sbjct: 290 KASQAR-----------DLLSKMLVIDASKRISVDEALQHPYINVWYDPSEA 330
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 90/339 (26%), Positives = 145/339 (42%), Gaps = 45/339 (13%)
Query: 764 STDSSRDENNANAVRSANSSPSTLSNYEREHVKREEAEKISGMREEDPGASLEDEEAAAV 823
+ S N+ + ++ + ++ R KR+ S + E AA
Sbjct: 25 NALSGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATS-----TDSGRTKSHEGAAT 79
Query: 824 QEQVRQIKAQEEEFETFNLK-----IVHRKNRTGFEEDKNFHVVLNSVI---AGRYHVTE 875
+Q E K + ++R E+ +F+VVL I R+ +
Sbjct: 80 TKQATTTPTTNVEVAPPPKKKKVTYALPNQSR----EEGHFYVVLGEDIDVSTQRFKILS 135
Query: 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLR 935
LG F K ++A D VKI++N + + EI+ ++ V + DP D++ L++
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 936 LYDYFYYRE-HLLIVCELLKANLYEF---HKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
+ YF H+ IV L ++ H F+ L I Q AL +
Sbjct: 196 IQRYFQNETGHMCIVMPKYGPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDY 246
Query: 992 LHG-LGLIHCDLKPENILVKSYSR--------------CEVKVIDLGSSCFETDHLCSYV 1036
H L L+H DLKPENIL+++ C V++ DLG C E + V
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIV 306
Query: 1037 QSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLF 1075
+R YR+PEV+LGL + D+WS+GCI+ EL TG +L+
Sbjct: 307 STRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-28
Identities = 79/278 (28%), Positives = 126/278 (45%), Gaps = 50/278 (17%)
Query: 913 LDEIKLLKYVNKHDPGDKYHLLRLYDYFY-----YREHLLIVCELLKANLYEFHKFNRES 967
E+K+L + KHD ++L D E + +V EL++++L HK
Sbjct: 47 FRELKMLCFF-KHD-----NVLSALDILQPPHIDPFEEIYVVTELMQSDL---HK----- 92
Query: 968 GGEVYFTMPRLQS-----ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022
+ + L S Q L L++LH G++H D+KP N+LV S C +K+ D
Sbjct: 93 ---IIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS--NCVLKICDF 147
Query: 1023 GSSCFE----TDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQN 1077
G + E + H+ V ++ YRAPE+++G Y +DIWS+GCI AEL +LFQ
Sbjct: 148 GLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207
Query: 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLY--ERNQETNRLEYLIPKKTSL 1135
SP L + ++G + + + H+L + L L +
Sbjct: 208 QSPIQQLDLITDLLGTPSLEAMRSACEG----ARAHILRGPHKPPSLPVLYTL---SSQA 260
Query: 1136 RHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
H + + +L +P KR SA+DAL HP+L
Sbjct: 261 THEA-------VHLLCRMLVFDPDKRISAADALAHPYL 291
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-28
Identities = 93/335 (27%), Positives = 156/335 (46%), Gaps = 57/335 (17%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHD 926
RY + +GS A A+D +V +K + N+ ++ E+ L+K VN +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 927 PGDKYHLLRLYDYFYYREHL------LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQS 980
++ L + F ++ L +V EL+ ANL + + + R+
Sbjct: 78 ------IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDH--------ERMSY 123
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG--SSCFETDHLCSYVQS 1038
+ Q L ++ LH G+IH DLKP NI+VKS C +K++D G + + + YV +
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098
R YRAPEVILG+ Y + +DIWS+GCI+ E+ +LF +VI +G
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 1099 LAKGRDTYKYFTKNH--------------MLYERNQETNRLEYLIPKKTSLRHRLPMGDQ 1144
+ K + T + + +N L+ + E N+L K + R
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL-----KASQAR-------- 288
Query: 1145 GFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
D ++ +L I+P KR S +AL+HP+++ Y+P
Sbjct: 289 ---DLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 90/322 (27%), Positives = 151/322 (46%), Gaps = 42/322 (13%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF-----FDQSLDEIKLLKYVNK 924
RY +GS A+ A D TG+ V VK K ++ F ++ E++LLK++ K
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHM-K 74
Query: 925 HDPGDKYHLLRLYDYFYYREHL------LIVCELLKANLYEFHKFNRESGGEVYFTMPRL 978
H+ +++ L D F L +V L+ A+L K + + V F
Sbjct: 75 HE-----NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----- 124
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQS 1038
+ Q L L+++H +IH DLKP N+ V CE+K++D G + D + YV +
Sbjct: 125 --LIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELKILDFGLARHTDDEMTGYVAT 180
Query: 1039 RSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
R YRAPE++L + Y++ +DIWS+GCI+AEL TG LF L ++ ++G
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240
Query: 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157
+L K +N++ L + PK + +D + +L ++
Sbjct: 241 LLKK---ISSESARNYI--------QSLTQM-PKMNFANVFIGANPLA-VDLLEKMLVLD 287
Query: 1158 PKKRPSASDALKHPWLSHPYEP 1179
KR +A+ AL H + + ++P
Sbjct: 288 SDKRITAAQALAHAYFAQYHDP 309
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 88/316 (27%), Positives = 147/316 (46%), Gaps = 45/316 (14%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII---KNNKDFFDQSLDEIKLLKYVNKHD 926
+Y +G ++ ++ TG V +K +++K ++ EI++LK + +H+
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHE 60
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+L+ L + F ++ L +V E + L + K+ +G R++ Q
Sbjct: 61 -----NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY--PNG----LDESRVRKYLFQI 109
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF-------ETDHLCSYVQS 1038
L ++F H +IH D+KPENILV S S VK+ D G + TD YV +
Sbjct: 110 LRGIEFCHSHNIIHRDIKPENILV-SQSGV-VKLCDFGFARTLAAPGEVYTD----YVAT 163
Query: 1039 RSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
R YRAPE+++G Y + +DIW++GC++ E+ TG LF DS L +I +G
Sbjct: 164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG----N 219
Query: 1098 MLAKGRDTYKYFTKNHMLYE-RNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156
++ + ++ F KN + R E +E L R P +D L I
Sbjct: 220 LIPRHQEI---FQKNPLFAGMRLPEVKEIE-------PLEKRFPKLSGLVLDLAKQCLRI 269
Query: 1157 NPKKRPSASDALKHPW 1172
+P RPS+S L H +
Sbjct: 270 DPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 86/339 (25%), Positives = 135/339 (39%), Gaps = 71/339 (20%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVK--IIKNNKDFFD-QSLDEIKLLKYVNKH 925
Y + LG F + +A + TG V +K ++ N KD F +L EIK+LK + H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-H 66
Query: 926 -----------DPGDKYHLLR--LYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY 972
+ DK R +Y Y +H L LL+ V
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDL--SGLLENP-------------SVK 111
Query: 973 FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG--------- 1023
T +++ +Q LE + +LH ++H D+K NIL+ + +K+ D G
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG--ILKIADFGLARPYDGPP 169
Query: 1024 -----SSCFETDHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQN 1077
T + V +R YR PE++LG Y +DIW +GC+ AE+ T + Q
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229
Query: 1078 DSPATLLARVIGIIGPIEQGMLAKGRD----TYKYFTKNHMLYERNQETNRLEYLIPKKT 1133
S L + + G + R + N+ LE
Sbjct: 230 KSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNY--------PRTLE------E 275
Query: 1134 SLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172
P G +D ++ LL ++P KR +ASDAL+HP+
Sbjct: 276 RFGKLGPEG----LDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 973 FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS---CFET 1029
F ++ + +Q L + LH ++H DLK N+L+ + R +K+ D G +
Sbjct: 103 FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN--RGILKICDFGLAREYGSPL 160
Query: 1030 DHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
V + YRAPE++LG Y ID+WS+GCI AEL T LF S L ++
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220
Query: 1089 GIIG-PIEQ---GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLP---M 1141
++G P E+ G K T Y + LR + P +
Sbjct: 221 KLLGTPTEKIWPGF--SELPGAKKKTFTKYPYNQ----------------LRKKFPALSL 262
Query: 1142 GDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172
D GF D + LL +P KR SA DALKHP+
Sbjct: 263 SDNGF-DLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 57/324 (17%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYVNKHD---- 926
+G A+ A + T V +K I N FD +D EIKLL+++ H+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIAN---AFDNRIDAKRTLREIKLLRHL-DHENVIA 68
Query: 927 ------PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQS 980
P + +Y IV EL+ +L++ + ++ + Q
Sbjct: 69 IKDIMPPPHREAFNDVY----------IVYELMDTDLHQIIRSSQT------LSDDHCQY 112
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQ 1037
Q L L+++H ++H DLKP N+L+ + C++K+ D G ++ + D + YV
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARTTSEKGDFMTEYVV 170
Query: 1038 SRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIE 1095
+R YRAPE++L S Y ID+WS+GCI AEL LF L + ++G P E
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
+ + + + + ++ R S P + ID + +L
Sbjct: 231 EDLGFIRNEKARRYIRSLPYTPR--------------QSFARLFPHANPLAIDLLEKMLV 276
Query: 1156 INPKKRPSASDALKHPWLSHPYEP 1179
+P KR + +AL HP+L+ ++P
Sbjct: 277 FDPSKRITVEEALAHPYLASLHDP 300
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 92/330 (27%), Positives = 146/330 (44%), Gaps = 71/330 (21%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHD 926
RY + +GS A+ A D TG V +K + ++ F ++ E+ LLK++ +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMP---------- 976
++ L D F + EF F Y MP
Sbjct: 76 ------VIGLLDVF-----------TSAVSGDEFQDF--------YLVMPYMQTDLQKIM 110
Query: 977 -------RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029
++Q + Q L L+++H G+IH DLKP N+ V CE+K++D G +
Sbjct: 111 GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE--DCELKILDFGLARHAD 168
Query: 1030 DHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQND---SPATLLA 1085
+ YV +R YRAPEVIL + Y++ +DIWS+GCI+AE+ TG LF+ T +
Sbjct: 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228
Query: 1086 RVIGIIGP-IEQGMLAKGRDTY-KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD 1143
+V G+ GP Q + K +Y K K P+K P
Sbjct: 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPK-----------------YPRK-DFSTLFPKAS 270
Query: 1144 QGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
+D + +LE++ KR +A++AL+HP+
Sbjct: 271 PQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 90/342 (26%), Positives = 148/342 (43%), Gaps = 68/342 (19%)
Query: 867 IAGRY-HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQS------------- 912
I+ RY +LG + K +A+D TG V +K +K + D +
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65
Query: 913 --LDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE 970
L E+K++ + KH+ +++ L D + + + +V +++ ++L + +R+
Sbjct: 66 TTLRELKIMNEI-KHE-----NIMGLVDVYVEGDFINLVMDIMASDLKKV--VDRK---- 113
Query: 971 VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFET 1029
+ T +++ I +Q L L LH +H DL P NI + S K+ D G + +
Sbjct: 114 IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG--ICKIADFGLARRYGY 171
Query: 1030 DHL---CS---YVQSRS----------YRAPEVILGLS-YDKKIDIWSLGCILAELCTGN 1072
S +Q R YRAPE+++G Y +D+WS+GCI AEL TG
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
Query: 1073 VLFQNDSPATLLARVIGIIG-PIEQGM-LAKGRDTYKYFTKNHMLYERNQETNRLEYLIP 1130
LF ++ L R+ ++G P E AK Y FT
Sbjct: 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR------------------ 273
Query: 1131 KKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172
K L+ P ID + LL++NP +R SA +ALKH +
Sbjct: 274 KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315
|
Length = 335 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 79/335 (23%), Positives = 128/335 (38%), Gaps = 91/335 (27%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKI------IKNNKDFFDQSLDEIKLLKYVNK 924
+ + +G +FS + A + T + +KI IK K E ++L +N
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV--KYVKIEKEVLTRLNG 60
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
H PG +++LY F E+L V E A E ++ R+ G + +
Sbjct: 61 H-PG----IIKLYYTFQDEENLYFVLEY--APNGELLQYIRKYGS---LDEKCTRFYAAE 110
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC----------- 1033
L AL++LH G+IH DLKPENIL+ +K+ D G++ +
Sbjct: 111 ILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 1034 ------------SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA 1081
S+V + Y +PE++ K D+W+LGCI+ ++ TG F
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF------ 222
Query: 1082 TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPM 1141
R + +Y T Q+ +LEY P
Sbjct: 223 ---------------------RGSNEYLTF--------QKILKLEYSFPPNF-------- 245
Query: 1142 GDQGFIDFVAHLLEINPKKRPSAS---DALK-HPW 1172
D + LL ++P+ R + D LK HP+
Sbjct: 246 -PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 973 FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFET-- 1029
F+ +++ + +Q L LQ+LH +IH DLK N+L+ + +K+ D G + +
Sbjct: 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD--KGCLKIADFGLARTYGLPA 162
Query: 1030 DHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
+ V + YRAPE++LG +Y ID+W++GCILAEL L S L +I
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222
Query: 1089 GIIG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFI 1147
++G P E + G K + Q N +L+H+ P + +
Sbjct: 223 QLLGTPNES--IWPGFSDLPLVGKFTL---PKQPYN----------NLKHKFPWLSEAGL 267
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS---HPYEP 1179
+ LL +PKKR +A +AL+ + P EP
Sbjct: 268 RLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEP 302
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 85/307 (27%), Positives = 140/307 (45%), Gaps = 38/307 (12%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---FFDQSLDEIKLLKYVNKHDPGDKY 931
E +G + +A + TG V +K I+ + + ++ EI LLK +N +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN----- 60
Query: 932 HLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
+++L D + L +V E L +L +F + SG +P ++S Q L+ L F
Sbjct: 61 -IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSG----IPLPLIKSYLFQLLQGLAF 115
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY---VQSRSYRAPEVIL 1048
H ++H DLKP+N+L+ + +K+ D G + + +Y V + YRAPE++L
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173
Query: 1049 GLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYK 1107
G Y +DIWSLGCI AE+ T LF DS L R+ +G
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG--------------- 218
Query: 1108 YFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165
T + +++ + PK + +P D+ D ++ +L +P KR SA
Sbjct: 219 --TPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK 276
Query: 1166 DALKHPW 1172
AL HP+
Sbjct: 277 AALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 77/315 (24%), Positives = 116/315 (36%), Gaps = 72/315 (22%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD---EIKLLKYVNKHD 926
Y + + +G AF + +L TG V +K I K + EI LLK +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP- 59
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCEL-----LKANLYEFHKFNRESGGEVYFTMPRLQSI 981
++++ + L I+ E L+ + +F F ES VY
Sbjct: 60 -----NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLVAVYVY------- 106
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCSY--VQS 1038
Q L+ L +LH G+IH D+K NIL VK+ D G ++ V +
Sbjct: 107 --QVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDASVVGT 162
Query: 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098
+ APEVI DIWSLGC + EL TGN + + +P L R++
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV---------- 212
Query: 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINP 1158
+P+ S DF+ + +P
Sbjct: 213 ------------------------QDDHPPLPEGIS---------PELKDFLMQCFQKDP 239
Query: 1159 KKRPSASDALKHPWL 1173
RP+A LKHPW+
Sbjct: 240 NLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 91/321 (28%), Positives = 148/321 (46%), Gaps = 56/321 (17%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQ-----SLDEIKLLKYVNK 924
+Y E +G + +A + T V +K ++ + D D+ +L EI LLK + K
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKEL-K 57
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
H +++RLYD + + L +V E +L K+ G++ ++S Q
Sbjct: 58 HK-----NIVRLYDVLHSDKKLTLVFEYCDQDL---KKYFDSCNGDI--DPEIVKSFMFQ 107
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--------CFETDHLCSYV 1036
L+ L F H ++H DLKP+N+L+ E+K+ D G + C+ + V
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLIN--KNGELKLADFGLARAFGIPVRCYSAE-----V 160
Query: 1037 QSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIG-P 1093
+ YR P+V+ G Y ID+WS GCI AEL G LF + L R+ ++G P
Sbjct: 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220
Query: 1094 IEQGM--LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVA 1151
E+ ++K D YK + + P TSL + +P + D +
Sbjct: 221 TEESWPGVSKLPD-YKPYP-----------------MYPATTSLVNVVPKLNSTGRDLLQ 262
Query: 1152 HLLEINPKKRPSASDALKHPW 1172
+LL NP +R SA +AL+HP+
Sbjct: 263 NLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 85/321 (26%), Positives = 131/321 (40%), Gaps = 74/321 (23%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHD 926
R+ +G F K A +L TG + VK I+ N+ + DE+K+L+ + H
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HP 59
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+L++ Y +RE + I E L E + R V ++ T+Q
Sbjct: 60 -----NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV------IRVYTLQL 108
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEV-KVIDLGSS---------CFETDHLCSY 1035
LE L +LH G++H D+KP NI + V K+ D G + E + S
Sbjct: 109 LEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGE--EVQSL 163
Query: 1036 VQSRSYRAPEVILGLSYDKK---IDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092
+ +Y APEVI G DIWSLGC++ E+ TG P + L I+
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR------PWSELDNEFQIMF 217
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
+ G K + L + +G DF+
Sbjct: 218 HVGAGH---------------------------------KPPIPDSLQLSPEG-KDFLDR 243
Query: 1153 LLEINPKKRPSASDALKHPWL 1173
LE +PKKRP+AS+ L+HP++
Sbjct: 244 CLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 55/209 (26%), Positives = 81/209 (38%), Gaps = 60/209 (28%)
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF-----------ET 1029
+ + AL++LH G+IH DLKP+NIL+ S +K+ D G S +
Sbjct: 98 YIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDE 155
Query: 1030 DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI- 1088
V + Y APEVILG + K +D WSLGCIL E G F ++P + ++
Sbjct: 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN 215
Query: 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFID 1148
G I E ++ E ID
Sbjct: 216 GKIEWPEDVEVSD------------------------EA-------------------ID 232
Query: 1149 FVAHLLEINPKKRP---SASDALKHPWLS 1174
++ LL +P+KR S + HP+
Sbjct: 233 LISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 90/316 (28%), Positives = 144/316 (45%), Gaps = 46/316 (14%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQ-----SLDEIKLLKYVNKH 925
Y E +G + +A D TG V +K I+ + D+ ++ EI LLK +N H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELN-H 57
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+++RL D + L +V E L +L K +S P ++S Q
Sbjct: 58 P-----NIVRLLDVVHSENKLYLVFEFLDLDL----KKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCSY---VQSRSY 1041
L+ + + H ++H DLKP+N+L+ +K+ D G + F + +Y V + Y
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDR--EGALKLADFGLARAFGVP-VRTYTHEVVTLWY 165
Query: 1042 RAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGML 1099
RAPE++LG Y +DIWS+GCI AE+ LF DS L R+ +G P E +
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDED--V 223
Query: 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEIN 1157
G + + + T PK + L +P D+ +D ++ +L +
Sbjct: 224 WPGVTSLPDY----------KPT------FPKWARQDLSKVVPNLDEDGLDLLSKMLVYD 267
Query: 1158 PKKRPSASDALKHPWL 1173
P KR SA AL+HP+
Sbjct: 268 PAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 4e-23
Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 44/231 (19%)
Query: 877 LGSAAFSKAIQAHDLHTG----MDVCVK--IIKNNKDFFDQSLDEIKLLKYVNKHDPGDK 930
LG +F K + TG M V K IIK + + +L E +L +N
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE--VEHTLTERNILSRIN------- 51
Query: 931 YH--LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC--- 985
H +++L+ F E L +V E GGE++ + + + +
Sbjct: 52 -HPFIVKLHYAFQTEEKLYLVLEYA-------------PGGELFSHLSKEGRFSEERARF 97
Query: 986 -----LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS---CFETDHLCSYVQ 1037
+ AL++LH LG+I+ DLKPENIL+ + +K+ D G + E ++
Sbjct: 98 YAAEIVLALEYLHSLGIIYRDLKPENILLDA--DGHIKLTDFGLAKELSSEGSRTNTFCG 155
Query: 1038 SRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
+ Y APEV+LG Y K +D WSLG +L E+ TG F + + +++
Sbjct: 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 88/348 (25%), Positives = 157/348 (45%), Gaps = 43/348 (12%)
Query: 846 HRKNRTGF-EEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN 904
H N +E+K +N Y + +G+ +F +A + T V +K +
Sbjct: 42 HNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101
Query: 905 NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY---YREH-----LLIVCELLKAN 956
+ + ++ L +K L ++N ++ L DY+Y ++++ L +V E +
Sbjct: 102 DPQYKNRELLIMKNLNHIN---------IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT 152
Query: 957 LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016
++++ K + + + +L S Q AL ++H + H DLKP+N+L+ +
Sbjct: 153 VHKYMKHYARNNHALPLFLVKLYSY--QLCRALAYIHSKFICHRDLKPQNLLIDPNTHT- 209
Query: 1017 VKVIDLGSS--CFETDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNV 1073
+K+ D GS+ SY+ SR YRAPE++LG + Y ID+WSLGCI+AE+ G
Sbjct: 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
Query: 1074 LFQNDSPATLLARVIGIIG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK 1132
+F S L R+I ++G P E + E N +++ K
Sbjct: 270 IFSGQSSVDQLVRIIQVLGTPTEDQL-----------------KEMNPNYADIKFPDVKP 312
Query: 1133 TSLRHRLPMGD-QGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
L+ P G I+F++ L+ P KR + +AL P+ +P
Sbjct: 313 KDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360
|
Length = 440 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 88/315 (27%), Positives = 140/315 (44%), Gaps = 38/315 (12%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQS-LDEIKLLKYVNKHD 926
+Y +G A+ +A D H+G V +K ++ N+D S + E+ LLK + D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 927 PGDKYHLLRLYDYFYY----RE-HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSI 981
+ ++RL D RE + +V E + +L + G ++ +
Sbjct: 61 HPN---IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG----LPAETIKDL 113
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH--LCSYVQSR 1039
Q L L FLH ++H DLKPENILV S +VK+ D G + + L V +
Sbjct: 114 MRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLADFGLARIYSCQMALTPVVVTL 171
Query: 1040 SYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGM 1098
YRAPEV+L +Y +D+WS+GCI AE+ LF +S A L ++ +IG P E
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD- 230
Query: 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINP 1158
+ R+ R + ++ +P ++ + +L NP
Sbjct: 231 -----------------WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNP 273
Query: 1159 KKRPSASDALKHPWL 1173
KR SA AL+HP+
Sbjct: 274 HKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 94/340 (27%), Positives = 147/340 (43%), Gaps = 62/340 (18%)
Query: 870 RYHVTEYLGSAAFSKAIQAH--DLHTGMDVCVKIIKNNKDFFD---QS-LDEIKLLKYVN 923
+Y + +G + + +A + G + +K K +K+ + QS EI LL+ +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL- 59
Query: 924 KH-----------DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY 972
KH + DK +Y F Y EH +L++ KF+R++ V
Sbjct: 60 KHENVVSLVEVFLEHADK----SVYLLFDYAEH----------DLWQIIKFHRQAKR-VS 104
Query: 973 FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS--YSRCEVKVIDLGSSCFETD 1030
++S+ Q L + +LH ++H DLKP NILV R VK+ DLG +
Sbjct: 105 IPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
Query: 1031 HLCSY------VQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLF---QNDSP 1080
L V + YRAPE++LG Y K IDIW++GCI AEL T +F +
Sbjct: 165 PLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK 224
Query: 1081 ATL------LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLE--YLIPKK 1132
+ L R+ ++G + + +Y T + +N L KK
Sbjct: 225 KSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK 284
Query: 1133 TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172
QGF D + LLE +P KR +A +AL+HP+
Sbjct: 285 PD--------SQGF-DLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 78/308 (25%), Positives = 127/308 (41%), Gaps = 61/308 (19%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDK 930
+ + E LG ++ +A TG V +K++ +D + EI +LK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII-KEISILKQC-DSP---- 58
Query: 931 YHLLRLYDYFYYREHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
++++ Y ++ L IV E A + + K ++ T + +I Q L+ L
Sbjct: 59 -YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT-----LTEEEIAAILYQTLKGL 112
Query: 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---SYVQSRSYRAPEV 1046
++LH IH D+K NIL+ + K+ D G S TD + + + + + APEV
Sbjct: 113 EYLHSNKKIHRDIKAGNILLNE--EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 1047 ILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106
I + Y+ K DIWSLG I IE +A+G+
Sbjct: 171 IQEIGYNNKADIWSLG----------------------------ITAIE---MAEGKP-- 197
Query: 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMG-DQGFIDFVAHLLEINPKKRPSAS 1165
Y + M R ++IP K P F DFV L +P++RPSA
Sbjct: 198 PYSDIHPM---------RAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAI 248
Query: 1166 DALKHPWL 1173
L+HP++
Sbjct: 249 QLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 95/340 (27%), Positives = 152/340 (44%), Gaps = 74/340 (21%)
Query: 869 GRYHVTEY-----LGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFD-QSLDEIKLLK 920
G+ V ++ +G + + +A D TG V +K ++ N K+ F ++ EIK+L+
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR 61
Query: 921 YVN-------------KHDPGD-KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRE 966
+N K D D K Y F Y +H L+ LL++ L
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLM--GLLESGL--------- 110
Query: 967 SGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SS 1025
V+F+ ++S Q LE L + H +H D+K NIL+ + + ++K+ D G +
Sbjct: 111 ----VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN--KGQIKLADFGLAR 164
Query: 1026 CFETDHLCSY---VQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPA 1081
+ ++ Y V + YR PE++LG Y ID+WS GCIL EL T +FQ +
Sbjct: 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224
Query: 1082 T---LLARVIGIIGPIEQGMLAKGRDTYK--YFTKNHMLYERNQETNRL--EY-LIPKKT 1133
L++R+ G P A D K YF + + + Q RL E+ IP
Sbjct: 225 AQLELISRLCGSPCP------AVWPDVIKLPYF---NTMKPKKQYRRRLREEFSFIPTPA 275
Query: 1134 SLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
+D + H+L ++P KR +A +AL PWL
Sbjct: 276 -------------LDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 78/316 (24%), Positives = 124/316 (39%), Gaps = 75/316 (23%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLL-KYVNK---- 924
+ + E +G +F + +A D T V +K+I +++ DEI+ + + +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQC 56
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLK----ANLYEFHKFNRESGGEVYFTMPRLQS 980
P ++ + Y F L I+ E +L + K + +
Sbjct: 57 RSP----YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY----------IAF 102
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---SYVQ 1037
I + L L++LH G IH D+K NIL+ +VK+ D G S T + ++V
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEG--DVKLADFGVSGQLTSTMSKRNTFVG 160
Query: 1038 SRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
+ + APEVI YD+K DIWSLG EL G + P RV+
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----MRVL--------- 207
Query: 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157
+LIPK + F DFV+ L +
Sbjct: 208 -----------------------------FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKD 238
Query: 1158 PKKRPSASDALKHPWL 1173
PK+RPSA + LKH ++
Sbjct: 239 PKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 40/270 (14%)
Query: 912 SLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV 971
+L EI++LK + KH +L+ L + F + L +V E + ++ + G
Sbjct: 47 ALREIRMLKQL-KHP-----NLVNLIEVFRRKRKLHLVFEYCDHTV--LNELEKNPRG-- 96
Query: 972 YFTMPRLQ--SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029
+P I Q L+A+ F H IH D+KPENIL+ ++K+ D G + T
Sbjct: 97 ---VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILT 151
Query: 1030 ---DHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT--- 1082
D YV +R YRAPE+++G Y +D+W++GC+ AEL TG L+ S
Sbjct: 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
Query: 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMG 1142
L+ + +G + P Q + + T ++F + +E LE P +S
Sbjct: 212 LIRKTLGDLIPRHQQIFS----TNQFFKGLSIPEPETREP--LESKFPNISSPA------ 259
Query: 1143 DQGFIDFVAHLLEINPKKRPSASDALKHPW 1172
+ F+ L+++P +R S + L+HP+
Sbjct: 260 ----LSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 79/309 (25%), Positives = 121/309 (39%), Gaps = 70/309 (22%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLL 934
LG + + TG +K I +++F Q L E+K L+ +++
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP------YVV 62
Query: 935 RLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH 993
+ Y FY + IV E + +L + K + P L I Q L+ L +LH
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK------IPEPVLAYIARQILKGLDYLH 116
Query: 994 G-LGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFE-TDHLC-SYVQSRSYRAPEVILG 1049
+IH D+KP N+L+ S EVK+ D G S E T C ++V + +Y +PE I G
Sbjct: 117 TKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 1050 LSYDKKIDIWSLGCILAELCTGNVLFQND---SPATLLARVIG--IIGPIEQGMLAKGRD 1104
SY DIWSLG L E G F S L+ + + + RD
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
F++ L+ +PKKRPSA
Sbjct: 235 --------------------------------------------FISACLQKDPKKRPSA 250
Query: 1165 SDALKHPWL 1173
++ L+HP++
Sbjct: 251 AELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 78/311 (25%), Positives = 147/311 (47%), Gaps = 36/311 (11%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN---NKDFFDQSLDEIKLLKYVNKHD 926
++ V +G A+ ++ T V +K K+ N++ + +L E+K+L+ + + +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMP--RLQSITIQ 984
++ L + F R L +V E ++ N+ E + E+ +P +++S Q
Sbjct: 62 ------IVELKEAFRRRGKLYLVFEYVEKNMLELLE-------EMPNGVPPEKVRSYIYQ 108
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD----HLCSYVQSRS 1040
++A+ + H ++H D+KPEN+L+ +K+ D G + ++ + YV +R
Sbjct: 109 LIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANYTEYVATRW 166
Query: 1041 YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100
YR+PE++LG Y K +D+WS+GCIL EL G LF +S L + ++GP+
Sbjct: 167 YRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA---- 222
Query: 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160
+ K F N + R + ++ R L + +D + +LL++NP
Sbjct: 223 ---EQMKLFYSNPRFHGL-----RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTD 274
Query: 1161 RPSASDALKHP 1171
R L HP
Sbjct: 275 RYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 79/342 (23%), Positives = 140/342 (40%), Gaps = 56/342 (16%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVK-IIKNNKDFFDQSLDEIKLLKYVNKH 925
+ RY LG + A D V VK I+ + +L EIK+++ ++ H
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-H 61
Query: 926 DPGDKYHLLRLYDYFYYREH--------------LLIVCELLKANLYEFHKFNRESGGEV 971
D +++++Y+ + IV E ++ +L + S
Sbjct: 62 D-----NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA 116
Query: 972 YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---- 1027
RL Q L L+++H ++H DLKP N+ + + +K+ D G +
Sbjct: 117 -----RL--FMYQLLRGLKYIHSANVLHRDLKPANVFINT-EDLVLKIGDFGLARIVDPH 168
Query: 1028 --ETDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLL 1084
+L + ++ YR+P ++L + Y K ID+W+ GCI AE+ TG LF +
Sbjct: 169 YSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228
Query: 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQ 1144
++ + + + + + F +N R LR LP +
Sbjct: 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPR--------------RPLRDLLPGVNP 274
Query: 1145 GFIDFVAHLLEINPKKRPSASDALKHPWLSHPY-----EPIS 1181
+DF+ +L NP R +A +AL HP++S Y EP+S
Sbjct: 275 EALDFLEQILTFNPMDRLTAEEALMHPYMS-CYSCPFDEPVS 315
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 70/319 (21%), Positives = 121/319 (37%), Gaps = 81/319 (25%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNK----DFFDQSLDEIKLLKYVNKHDP 927
+ LG+ AFS QA D+ TG + VK + N + + EI+L+ +N H
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HP- 63
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTM----PRLQSITI 983
H++R+ H + E + +GG V + +++ I
Sbjct: 64 ----HIIRMLGATCEDSHFNLFVEWM-------------AGGSVSHLLSKYGAFKEAVII 106
Query: 984 ----QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC------ 1033
Q L L +LH +IH D+K N+L+ S + +++ D G++
Sbjct: 107 NYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQ 165
Query: 1034 -SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092
+ + ++ APEV+ G Y + D+WS+GC++ E+ T + + + LA + I
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS 225
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
IP+ S G D
Sbjct: 226 ATTAPS------------------------------IPEHLS---------PGLRDVTLR 246
Query: 1153 LLEINPKKRPSASDALKHP 1171
LE+ P+ RP + + LKHP
Sbjct: 247 CLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 85/309 (27%), Positives = 134/309 (43%), Gaps = 66/309 (21%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKN-NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLR 935
LG AF K +A + TG K+I+ +++ + + EI++L N ++++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHP------YIVK 73
Query: 936 LYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL 995
L FY+ L I+ E + + G T P++Q I Q LEALQ+LH +
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSM 129
Query: 996 GLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---SYVQSRSYRAPEVIL---- 1048
+IH DLK N+L+ ++K+ D G S L S++ + + APEV++
Sbjct: 130 KIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 1049 -GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLL--ARVIGIIGPIEQGMLAKGRDT 1105
YD K DIWSLG L E+ Q + P L RV+ I E L++
Sbjct: 188 KDTPYDYKADIWSLGITLIEMA------QIEPPHHELNPMRVLLKIAKSEPPTLSQ---- 237
Query: 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165
P K S+ F DF+ L+ +P+ RPSA+
Sbjct: 238 ------------------------PSKWSME---------FRDFLKTALDKHPETRPSAA 264
Query: 1166 DALKHPWLS 1174
L+HP++S
Sbjct: 265 QLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 76/265 (28%), Positives = 117/265 (44%), Gaps = 34/265 (12%)
Query: 915 EIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFT 974
EI LLK + +H +++ L D L ++ E L +L K+ Y
Sbjct: 49 EISLLKEL-QHP-----NIVCLQDVLMQESRLYLIFEFLSMDL---KKYLDSLPKGQYMD 99
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCS 1034
++S Q L+ + F H ++H DLKP+N+L+ ++ +K+ D G + +
Sbjct: 100 AELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID--NKGVIKLADFGLARAFGIPVRV 157
Query: 1035 Y---VQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090
Y V + YRAPEV+LG Y +DIWS+G I AE+ T LF DS L R+ I
Sbjct: 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRI 217
Query: 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFID 1148
+G T ++ + PK K SLR + D+ +D
Sbjct: 218 LG-----------------TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLD 260
Query: 1149 FVAHLLEINPKKRPSASDALKHPWL 1173
+ +L +P KR SA AL HP+
Sbjct: 261 LLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 75/309 (24%), Positives = 119/309 (38%), Gaps = 62/309 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKH 925
+ V + LG ++ + L +K + + K+ D +++EI++L VN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED-AVNEIRILASVNHP 59
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
+++ + F L IV E +L + R+ ++ + I IQ
Sbjct: 60 ------NIISYKEAFLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKL-IPEQEIWRIFIQ 111
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQ--SRSYR 1042
L LQ LH ++H DLK NIL+ + VK+ DLG S ++ + Q + Y
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILL--VANDLVKIGDLGISKVLKKNM-AKTQIGTPHYM 168
Query: 1043 APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
APEV G Y K DIWSLGC+L E+ T F+ S L +V
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
+ IP S Q +F+ +L++ PK RP
Sbjct: 216 ----GKYPP-----------------IPPIYS---------QDLQNFIRSMLQVKPKLRP 245
Query: 1163 SASDALKHP 1171
+ L P
Sbjct: 246 NCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 29/227 (12%)
Query: 875 EYLGSAAFSKAIQAH----DLHTGMDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHDPG 928
+ LG AF + + ++V VK +K + L E ++++ + H
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHP-- 61
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
++++L E L IV E ++ +L + + NR ++ L S +Q
Sbjct: 62 ---NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIAR 113
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS----YR- 1042
+++L IH DL N LV VK+ D G S D Y + R R
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVG--ENLVVKISDFGLSRDLYDD--DYYRKRGGKLPIRW 169
Query: 1043 -APEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARV 1087
APE + + K D+WS G +L E+ T G + S +L +
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL 216
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 84/290 (28%), Positives = 124/290 (42%), Gaps = 63/290 (21%)
Query: 893 TGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950
TG + VK I+ N+ Q L E+ +L + P +++ Y FY + I
Sbjct: 25 TGKIMAVKTIRLEINEAIQKQILRELDILH--KCNSP----YIVGFYGAFYNNGDISICM 78
Query: 951 ELLKA-NLYEFHKFNRESGGEVYFTMPR--LQSITIQCLEALQFLH-GLGLIHCDLKPEN 1006
E + +L + K EV +P L I + L+ L +LH +IH D+KP N
Sbjct: 79 EYMDGGSLDKILK-------EVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131
Query: 1007 ILVKSYSRCEVKVIDLGSSCFETDHLC-SYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
ILV S R ++K+ D G S + L ++V + SY APE I G Y K DIWSLG L
Sbjct: 132 ILVNS--RGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSL 189
Query: 1066 AELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRL 1125
EL TG + ++ G E L
Sbjct: 190 IELATGRFPYPPEN--------DPPDGIFEL----------------------------L 213
Query: 1126 EYLIPKKTSLRHRLPMG--DQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
+Y++ + RLP G F DFV L +P++RPS + L+HP++
Sbjct: 214 QYIVNEPPP---RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-19
Identities = 86/317 (27%), Positives = 138/317 (43%), Gaps = 43/317 (13%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMD-VCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPG 928
+Y +G A+ K +A DL G V +K ++ L I+ + + +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 929 DKYHLLRLYDYFYY----RE-HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
+ +++RL+D RE L +V E + +L + E G ++ +
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMF 117
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS---CFETDHLCSYVQSRS 1040
Q L L FLH ++H DLKP+NILV S ++K+ D G + F+ L S V +
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQM-ALTSVVVTLW 174
Query: 1041 YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGML 1099
YRAPEV+L SY +D+WS+GCI AE+ LF+ S L +++ +IG P E+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW- 233
Query: 1100 AKGRDTYKYFTKNHMLYERNQETNR----LEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
+ R ++ +E + + + G D + L
Sbjct: 234 -----------PRDVALPRQAFHSKSAQPIEKFVTD---------IDELG-KDLLLKCLT 272
Query: 1156 INPKKRPSASDALKHPW 1172
NP KR SA AL HP+
Sbjct: 273 FNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 61/262 (23%), Positives = 98/262 (37%), Gaps = 80/262 (30%)
Query: 933 LLRLYDYFYYREHLLIVCELLKAN-----LYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
+++LY F ++++ ++ E L + F+ + + +
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTA----------RFYIACVVL 104
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS------- 1040
A ++LH G+I+ DLKPEN+L+ S VK++D G + ++S
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFA--------KKLKSGQKTWTFCG 154
Query: 1041 ---YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
Y APE+IL YD +D WSLG +L EL TG F D
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED------------------- 195
Query: 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157
D N +L + +LE+ P D+ D + LL N
Sbjct: 196 ------DEDPMEIYNDIL----KGNGKLEF--PNYI---------DKAAKDLIKQLLRRN 234
Query: 1158 PKKR-----PSASDALKHPWLS 1174
P++R D KH W +
Sbjct: 235 PEERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 8e-19
Identities = 80/322 (24%), Positives = 140/322 (43%), Gaps = 57/322 (17%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHD 926
+Y E +G + +A D T + +K I+ ++ ++ EI LLK + +H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHG 61
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFH----KFNRESGGEVYFTMPRL-QSI 981
+++RL D + + L +V E L +L + F + PRL ++
Sbjct: 62 -----NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN---------PRLIKTY 107
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCF--ETDHLCSYVQS 1038
Q L + + H ++H DLKP+N+L+ +K+ D G + F V +
Sbjct: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPVRTFTHEVVT 166
Query: 1039 RSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
YRAPE++LG Y +DIWS+GCI AE+ LF DS L ++ I+G +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226
Query: 1098 M------LAKGRDTY-KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFV 1150
L + + K+ K+ L ++P + G +D +
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKD------------LATVVPT---------LEPAG-VDLL 264
Query: 1151 AHLLEINPKKRPSASDALKHPW 1172
+ +L ++P KR +A AL+H +
Sbjct: 265 SKMLRLDPSKRITARAALEHEY 286
|
Length = 294 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 28/227 (12%)
Query: 875 EYLGSAAFSKAIQAH----DLHTGMDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHDPG 928
+ LG AF + + ++V VK +K + L E ++++ + H
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHP-- 61
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
++++L E L+IV E + +L + R++ + ++ L S +Q
Sbjct: 62 ---NIVKLLGVCTEEEPLMIVMEYMPGGDL---LDYLRKNRPKE-LSLSDLLSFALQIAR 114
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS----YR- 1042
+++L IH DL N LV VK+ D G S D Y + + R
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVG--ENLVVKISDFGLSRDLYDD--DYYKVKGGKLPIRW 170
Query: 1043 -APEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARV 1087
APE + + K D+WS G +L E+ T G + S A +L +
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 76/312 (24%), Positives = 121/312 (38%), Gaps = 60/312 (19%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPG 928
Y + E +G A + A L V +K I K D+ E++ + N H
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN-HP-- 59
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
++++ Y F + L +V L +L + K + GG + ++ + L+
Sbjct: 60 ---NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG---LDEAIIATVLKEVLK 113
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCS------YVQSRS 1040
L++LH G IH D+K NIL+ VK+ D G S+ + +V +
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 1041 YRAPEVI-LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099
+ APEV+ YD K DIWS G EL TG + P +L + P L
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP----SL 227
Query: 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159
G D YK ++K+ F ++ L+ +P
Sbjct: 228 ETGAD-YKKYSKS---------------------------------FRKMISLCLQKDPS 253
Query: 1160 KRPSASDALKHP 1171
KRP+A + LKH
Sbjct: 254 KRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 77/310 (24%), Positives = 125/310 (40%), Gaps = 60/310 (19%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFFDQSLDEIKLLKYVNKHDPG 928
Y + + +GS + +A D+ TG V +K+IK D F+ EI +LK H
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR-HP-- 60
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
+++ + + R+ L IV E +L + ++ R E ++ + + L+
Sbjct: 61 ---NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE-----LQIAYVCRETLK 112
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---SYVQSRSYRAP 1044
L +LH G IH D+K NIL+ +VK+ D G S T + S++ + + AP
Sbjct: 113 GLAYLHETGKIHRDIKGANILLTEDG--DVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170
Query: 1045 EVILGLS---YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101
EV YD K DIW+LG EL + P R + +I
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP----MRALFLI---------- 216
Query: 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161
+ + P K + + F DF+ L +PKKR
Sbjct: 217 SKSNFP----------------------PPKLKDKEKW---SPVFHDFIKKCLTKDPKKR 251
Query: 1162 PSASDALKHP 1171
P+A+ L+HP
Sbjct: 252 PTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 77/318 (24%), Positives = 121/318 (38%), Gaps = 89/318 (27%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD-----QSLD-EIKLLKYVNKHDPGDK 930
LG AF + +D+ TG ++ VK + + D + +L+ EI+LLK + +H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHE---- 64
Query: 931 YHLLRLYDYF---YYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQ 979
R+ Y+ E L I E + GG V T +
Sbjct: 65 ----RIVQYYGCLRDDETLSIFMEYM-------------PGGSVKDQLKAYGALTETVTR 107
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS------CFETDHLC 1033
T Q LE +++LH ++H D+K NIL S VK+ D G+S C +
Sbjct: 108 KYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICSSGTGMK 165
Query: 1034 SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093
S + + +PEVI G Y +K D+WS+GC + E+ T + + ++
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA----- 220
Query: 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153
Q TN +P S R +F+
Sbjct: 221 -------------------------TQPTN---PQLPSHVSPDAR---------NFLRRT 243
Query: 1154 LEINPKKRPSASDALKHP 1171
N KKRPSA + L+H
Sbjct: 244 FVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 72/267 (26%), Positives = 124/267 (46%), Gaps = 33/267 (12%)
Query: 912 SLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV 971
++ E+ LLK + KH +++ L+D + + L +V E L +L ++ + G +
Sbjct: 51 AIREVSLLKDL-KHA-----NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD---DCGNSI 101
Query: 972 YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFE 1028
M ++ Q L L + H ++H DLKP+N+L+ R E+K+ D G +
Sbjct: 102 N--MHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIP 157
Query: 1029 TDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
T + V + YR P+++LG + Y +ID+W +GCI E+ TG LF + L +
Sbjct: 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
Query: 1088 IGIIG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGF 1146
I+G P E+ T+ N N R + L + P D
Sbjct: 218 FRILGTPTEE--------TWPGILSNEEFKSYNYPKYRAD-------CLHNHAPRLDSDG 262
Query: 1147 IDFVAHLLEINPKKRPSASDALKHPWL 1173
+ ++ LL+ +KR SA +A+KHP+
Sbjct: 263 AELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 77/299 (25%), Positives = 118/299 (39%), Gaps = 77/299 (25%)
Query: 888 AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYH---LLRLYDYFYYRE 944
A D TG V VK + D Q E+ + V D Y ++ +Y + +
Sbjct: 38 ATDKSTGRQVAVKKM----DLRKQQRRELLFNEVVIMRD----YQHPNIVEMYSSYLVGD 89
Query: 945 HLLIVCELLKANLYEFHKFNRESGG-------EVYFTMPRLQSITIQCLEALQFLHGLGL 997
L +V E L+ GG ++ ++ + L+AL FLH G+
Sbjct: 90 ELWVVMEFLE-------------GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 998 IHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRAPEVILGLSYDK 1054
IH D+K ++IL+ S R VK+ D G E S V + + APEVI L Y
Sbjct: 137 IHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194
Query: 1055 KIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHM 1114
++DIWSLG ++ E+ G + N+ P + R+ RD KN
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI---------------RDNLPPKLKN-- 237
Query: 1115 LYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
K S R R F+ +L +P +R +A++ L HP+L
Sbjct: 238 ---------------LHKVSPRLR---------SFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-17
Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 32/248 (12%)
Query: 871 YHVTEYLGSAAFS-----------------KAIQAHDLHTGMDVCVKIIKNNKDFFDQSL 913
Y V E+LGS AF K I H+ G K + +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFG-----KDKRERDKSIGDIV 56
Query: 914 DEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVY 972
E+ ++K +H +++R Y F + L IV +L++ A L E +E
Sbjct: 57 SEVTIIKEQLRHP-----NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR-- 109
Query: 973 FTMPRLQSITIQCLEALQFLHGLG-LIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH 1031
FT R+ +I +Q + AL++LH ++H DL P NI++ + + L
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169
Query: 1032 LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI-GI 1090
L S V + Y PE++ Y +K D+W+ GCIL ++CT F + + +L +++ +
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229
Query: 1091 IGPIEQGM 1098
P+ +GM
Sbjct: 230 YEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 86/319 (26%), Positives = 126/319 (39%), Gaps = 86/319 (26%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLR 935
LG AF K +A TG+ KII+ +++ + + EI +L KH +++
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHP-----NIVG 66
Query: 936 LYDYFYYREHLLIVCELLKANLYEFHKFNRESGG---------EVYFTMPRLQSITIQCL 986
LY+ ++Y L I+ E GG E T P+++ + Q L
Sbjct: 67 LYEAYFYENKLWILIEFC-------------DGGALDSIMLELERGLTEPQIRYVCRQML 113
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL---CSYVQSRSYRA 1043
EAL FLH +IH DLK NIL+ +VK+ D G S L +++ + + A
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLTLDG--DVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171
Query: 1044 PEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098
PEV+ YD K DIWSLG I IE
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLG----------------------------ITLIE--- 200
Query: 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYL--IPKKTSLRHRLPMG-DQGFIDFVAHLLE 1155
LA+ + E N + L I K P F DF+ L
Sbjct: 201 LAQMEPP-------------HHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLV 247
Query: 1156 INPKKRPSASDALKHPWLS 1174
+P RP+A++ LKHP++S
Sbjct: 248 KDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-17
Identities = 74/269 (27%), Positives = 125/269 (46%), Gaps = 37/269 (13%)
Query: 912 SLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV 971
++ E+ LLK + KH +++ L+D + L +V E L ++L ++ ++ G +
Sbjct: 50 AIREVSLLKNL-KHA-----NIVTLHDIIHTERCLTLVFEYLDSDLKQY----LDNCGNL 99
Query: 972 YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFE 1028
+M ++ Q L L + H ++H DLKP+N+L+ + E+K+ D G +
Sbjct: 100 -MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE--KGELKLADFGLARAKSVP 156
Query: 1029 TDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
T + V + YR P+V+LG + Y ID+W +GCIL E+ TG +F + L +
Sbjct: 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
Query: 1088 IGIIG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIP--KKTSLRHRLPMGDQ 1144
++G P E +T+ T N YL P + L + P D
Sbjct: 217 FRLLGTPTE--------ETWPGITSNEEFR---------SYLFPQYRAQPLINHAPRLDT 259
Query: 1145 GFIDFVAHLLEINPKKRPSASDALKHPWL 1173
ID ++ LL K R SA AL+H +
Sbjct: 260 DGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 62/214 (28%), Positives = 86/214 (40%), Gaps = 63/214 (29%)
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS 1040
I + L AL+++H +G+IH D+K NILV + VK+ D G + Q+ S
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAA-------LLNQNSS 156
Query: 1041 YR----------APEVIL-GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089
R APEVI G YD K DIWSLG + E+ TGN P +
Sbjct: 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN------PPYS------- 203
Query: 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDF 1149
+ + R LIPK R + +F
Sbjct: 204 -----------------------------DVDAFRAMMLIPKSKPPRLEDNGYSKLLREF 234
Query: 1150 VAHLLEINPKKRPSASDALKHPWL-SHPYEPISA 1182
VA L+ PK+R SA + LK W+ +H P+S
Sbjct: 235 VAACLDEEPKERLSAEELLKSKWIKAHSKTPVSI 268
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 81/316 (25%), Positives = 137/316 (43%), Gaps = 46/316 (14%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKII--KNNKDFFD-QSLDEIKLLKYVNKHDPGDKYHL 933
+G F + +A T V +K + +N K+ F +L EIK+L+ + KH+ ++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHE-----NV 73
Query: 934 LRLYD--------YFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+ L + Y Y+ +V E + +L S V FT+ ++ +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGL-----LSNKNVKFTLSEIKKVMKML 128
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEV-KVIDLG----SSCFETDHLCSY---VQ 1037
L L ++H ++H D+K NIL+ ++ + K+ D G S + Y V
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 1038 SRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096
+ YR PE++LG Y ID+W GCI+AE+ T + + Q ++ L + + G I
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245
Query: 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156
+ G D + F K M + Q+ E L P D +D + LL +
Sbjct: 246 EVWP-GVDKLELFKK--MELPQGQKRKVKERLKPYVK---------DPHALDLIDKLLVL 293
Query: 1157 NPKKRPSASDALKHPW 1172
+P KR A AL H +
Sbjct: 294 DPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 54/236 (22%), Positives = 91/236 (38%), Gaps = 50/236 (21%)
Query: 877 LGSAAFSKAIQAH----DLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHD 926
LG AF + + T V VK +K ++F L+E ++K ++ H
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMKKLS-HP 61
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+++RL E L IV E + +L +F + + E T+ L + +Q
Sbjct: 62 -----NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-----LTLKDLLQMALQI 111
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSY---- 1041
+ +++L +H DL N LV + VK+ D G L + Y
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTE-NLV-VKISDFG--------LSRDIYEDDYYRKR 161
Query: 1042 ---------RAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARV 1087
APE + + K D+WS G +L E+ T G + S +L +
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217
|
Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 53/232 (22%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHD 926
+ + LG+ +F + + +G +KI+ K + L+E ++L+ +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR--- 59
Query: 927 PGDKYH--LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMP 976
H L+ LY F +L +V E + GGE++ F P
Sbjct: 60 -----HPFLVNLYGSFQDDSNLYLVMEYV-------------PGGELFSHLRKSGRFPEP 101
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYV 1036
+ Q + AL++LH L +++ DLKPEN+L+ S +K+ D G V
Sbjct: 102 VARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFG--------FAKRV 151
Query: 1037 QSRS--------YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080
+ R+ Y APE+IL Y K +D W+LG ++ E+ G F +D+P
Sbjct: 152 KGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-16
Identities = 90/324 (27%), Positives = 141/324 (43%), Gaps = 54/324 (16%)
Query: 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD----FFDQSLDEIKLLKYVN 923
A Y E LG +++ + G V +K+I + F ++ E LLK +
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPF--TAIREASLLKGL- 60
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
KH +++ L+D + +E L V E + +L ++ + GG ++ RL
Sbjct: 61 KHA-----NIVLLHDIIHTKETLTFVFEYMHTDLAQY--MIQHPGG-LHPYNVRL--FMF 110
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRS 1040
Q L L ++HG ++H DLKP+N+L+ E+K+ D G + + S V +
Sbjct: 111 QLLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQTYSSEVVTLW 168
Query: 1041 YRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQ--NDSPATLLA--RVIGIIGPIE 1095
YR P+V+LG + Y +DIW GCI E+ G F +D L V+G+ P E
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGV--PTE 226
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLR------HRLPMGDQGFIDF 1149
DT+ +K L E +L K LR R P + D
Sbjct: 227 --------DTWPGVSK---LPNYKPEW----FLPCKPQQLRVVWKRLSRPPKAE----DL 267
Query: 1150 VAHLLEINPKKRPSASDALKHPWL 1173
+ +L + PK R SA DAL HP+
Sbjct: 268 ASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 81/317 (25%), Positives = 141/317 (44%), Gaps = 46/317 (14%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD----FFDQSLDEIKLLKYVNKHD 926
Y + LG +++ + TG V +K I+ + F ++ E LLK + KH
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDL-KHA 63
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+++ L+D + ++ L +V E L +L ++ + GG +M ++ Q L
Sbjct: 64 -----NIVTLHDIIHTKKTLTLVFEYLDTDLKQY--MDDCGGG---LSMHNVRLFLFQLL 113
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRA 1043
L + H ++H DLKP+N+L+ R E+K+ D G + + + V + YR
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISE--RGELKLADFGLARAKSVPSKTYSNEVVTLWYRP 171
Query: 1044 PEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPAT----LLARVIGIIGPIEQGM 1098
P+V+LG + Y +D+W +GCI E+ TG LF + + RV+G P E
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT--PTE--- 226
Query: 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQ--GFIDFVAHLLEI 1156
+T+ + N E + L + P D+ + L+
Sbjct: 227 -----ETWPGVSSN---PEFKPYSFPF----YPPRPLINHAPRLDRIPHGEELALKFLQY 274
Query: 1157 NPKKRPSASDALKHPWL 1173
PKKR SA++A+KHP+
Sbjct: 275 EPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 76/330 (23%), Positives = 128/330 (38%), Gaps = 83/330 (25%)
Query: 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP 927
G + + E +G + K +A TG V +KI+ +D ++ +E +L+ + H
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP- 63
Query: 928 GDKYHLLRLYDYFYYREH------LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQS 980
++ Y F + L +V EL ++ + K R+ G + +
Sbjct: 64 ----NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL--KEEWIAY 117
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS 1040
I + L L +LH +IH D+K +NIL+ + EVK++D G + + + S
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFG--------VSAQLDSTL 167
Query: 1041 YR-----------APEVI-----LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLL 1084
R APEVI SYD + D+WSLG
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG---------------------- 205
Query: 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMG-D 1143
I IE LA G+ H + R + IP+ + P
Sbjct: 206 ------ITAIE---LADGKPP---LCDMHPM--------RALFKIPRNPPPTLKSPENWS 245
Query: 1144 QGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
+ F DF++ L N ++RP + L+HP++
Sbjct: 246 KKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 75/309 (24%), Positives = 121/309 (39%), Gaps = 66/309 (21%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVC----VKIIKNNKDFFD---QSLDEIKLLKYVNKHDP 927
E LGS +F + +L G D V + + + + Q EI LL + +H
Sbjct: 6 ELLGSGSFGSVYEGLNLDDG-DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHP- 62
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
++++ ++L I EL+ K ++ G F P ++ T Q L
Sbjct: 63 ----NIVQYLGTEREEDNLYIFLELVPGG--SLAKLLKKYGS---FPEPVIRLYTRQILL 113
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCSYVQSRSYRAPE 1045
L++LH +H D+K NILV + VK+ D G + E S+ S + APE
Sbjct: 114 GLEYLHDRNTVHRDIKGANILVD--TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171
Query: 1046 VILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104
VI Y DIWSLGC + E+ TG + + ++ GR
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI--------------GR- 216
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
+K IP S + DF+ L+ +P RP+A
Sbjct: 217 -----SKELP-------------PIPDHLSDEAK---------DFILKCLQRDPSLRPTA 249
Query: 1165 SDALKHPWL 1173
++ L+HP++
Sbjct: 250 AELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNK 924
G + + + +G FS +A L G V +K ++ + L EI LLK ++
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD- 60
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITI 983
H ++++ F L IV EL A +L K ++ + +
Sbjct: 61 HP-----NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK--RLIPERTIWKYFV 113
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRS 1040
Q AL+ +H ++H D+KP N+ + + VK+ DLG F +T S V +
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 1041 YRAPEVILGLSYDKKIDIWSLGCILAEL 1068
Y +PE I Y+ K DIWSLGC+L E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-15
Identities = 74/263 (28%), Positives = 125/263 (47%), Gaps = 43/263 (16%)
Query: 935 RLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG 994
+++ F Y EH L ++ +FH+ ++ + V ++S+ Q L+ + +LH
Sbjct: 74 KVWLLFDYAEHDL-------WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 995 LGLIHCDLKPENILV--KSYSRCEVKVIDLG------SSCFETDHLCSYVQSRSYRAPEV 1046
++H DLKP NILV + R VK+ D+G S L V + YRAPE+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 1047 ILGLS-YDKKIDIWSLGCILAELCTGNVLF---QNDSPAT------LLARVIGIIG-PIE 1095
+LG Y K IDIW++GCI AEL T +F Q D + L R+ ++G P +
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPAD 246
Query: 1096 QGMLAKGRDTYKYFTKNHML---YERNQETN--RLEYLIPKKTSLRHRLPMGDQGFIDFV 1150
K + K ++ L + RN TN ++Y+ +H++ + F +
Sbjct: 247 -----KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM------EKHKVKPDSKAF-HLL 294
Query: 1151 AHLLEINPKKRPSASDALKHPWL 1173
LL ++P KR ++ A++ P+
Sbjct: 295 QKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-15
Identities = 71/266 (26%), Positives = 126/266 (47%), Gaps = 31/266 (11%)
Query: 912 SLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV 971
++ E+ LLK + KH +++ L+D + + L +V E L +L ++ + G +
Sbjct: 51 AIREVSLLKDL-KHA-----NIVTLHDIVHTDKSLTLVFEYLDKDLKQY----MDDCGNI 100
Query: 972 YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFE 1028
+M ++ Q L L + H ++H DLKP+N+L+ R E+K+ D G +
Sbjct: 101 -MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLARAKSVP 157
Query: 1029 TDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
T + V + YR P+V+LG S Y +ID+W +GCI E+ +G LF + L +
Sbjct: 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
Query: 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFI 1147
++G + +T+ + N + + N +Y K L + P D I
Sbjct: 218 FRLLGTPTE-------ETWPGISSN----DEFKNYNFPKY---KPQPLINHAPRLDTEGI 263
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWL 1173
+ + L+ KKR SA +A+KH +
Sbjct: 264 ELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 54/200 (27%), Positives = 81/200 (40%), Gaps = 53/200 (26%)
Query: 980 SITIQCLEALQFLHGLG-----LIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLC 1033
I Q L AL H ++H DLKP NI + + VK+ D G + D
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL-DANNN-VKLGDFGLAKILGHDSSF 166
Query: 1034 --SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091
+YV + Y +PE + +SYD+K DIWSLGC++ ELC + F + L
Sbjct: 167 AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL-------A 219
Query: 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVA 1151
I++G R Y+Y + E N + +
Sbjct: 220 SKIKEGKFR--RIPYRY----------SSELNEV------------------------IK 243
Query: 1152 HLLEINPKKRPSASDALKHP 1171
+L ++P KRPS + L+ P
Sbjct: 244 SMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 26/212 (12%)
Query: 875 EYLGSAAFSKAIQAHDLHTG----MDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHDPG 928
+ LG AF + + L +V VK +K + ++ L E +++K + H
Sbjct: 1 KKLGEGAFGEVYKGK-LKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HP-- 56
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKA-NLYEF---HKFNRESGGEVYFTMPRLQSITIQ 984
+++RL E L +V E ++ +L ++ + S + ++ L S IQ
Sbjct: 57 ---NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR-- 1042
+ +++L +H DL N LV VK+ D G S + Y + +
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGE--DLVVKISDFGLS-RDVYDDDYYRKKTGGKLP 170
Query: 1043 ----APEVILGLSYDKKIDIWSLGCILAELCT 1070
APE + + K D+WS G +L E+ T
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 82/306 (26%), Positives = 129/306 (42%), Gaps = 63/306 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD--QSLDEIKLLKYVNKHDP 927
+Y+V +G +F +A+ +++ +K I+ K S E LL + KH
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHP- 58
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+++ + F HL IV E +L + K R G+++ LQ CL
Sbjct: 59 ----NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR---GKLFPEDTILQWFVQMCL 111
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD---HLCSYVQSRSYRA 1043
+Q +H ++H D+K +NI + +VK+ D GS+ T + C+YV + Y
Sbjct: 112 -GVQHIHEKRVLHRDIKSKNIFLTQ--NGKVKLGDFGSARLLTSPGAYACTYVGTPYYVP 168
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI-GIIGPIEQGMLAKG 1102
PE+ + Y+ K DIWSLGCIL ELCT FQ +S L+ +V G P+
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL-------- 220
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
+H YE L LI + + + NP+ RP
Sbjct: 221 --------PSHYSYE-------LRSLIKQ---------------------MFKRNPRSRP 244
Query: 1163 SASDAL 1168
SA+ L
Sbjct: 245 SATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKN-NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLR 935
LG AF K +A + TG+ K+I +++ + + EI +L D ++++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC------DHPNIVK 66
Query: 936 LYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL 995
L D FYY +L I+ E + E T P+++ + Q LEAL +LH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHEN 122
Query: 996 GLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---SYVQSRSYRAPEVILGLS- 1051
+IH DLK NIL ++K+ D G S T + S++ + + APEV++ +
Sbjct: 123 KIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 1052 ----YDKKIDIWSLGCILAEL 1068
YD K D+WSLG L E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 44/209 (21%)
Query: 970 EVYFTMPR--LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027
+VY +P L I + ++ L +L L ++H D+KP N+LV + R +VK+ D G S
Sbjct: 87 DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT--RGQVKLCDFGVSTQ 144
Query: 1028 ETDHLC-SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLAR 1086
+ + +YV + +Y APE I G Y D+WSLG E
Sbjct: 145 LVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFME------------------- 185
Query: 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD--Q 1144
LA GR Y KN Q L+ ++ + LP+G +
Sbjct: 186 ------------LALGRFPYPQIQKNQGSLMPLQ---LLQCIVDEDPP---VLPVGQFSE 227
Query: 1145 GFIDFVAHLLEINPKKRPSASDALKHPWL 1173
F+ F+ + PK+RP+ + + HP++
Sbjct: 228 KFVHFITQCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 41/98 (41%), Positives = 52/98 (53%), Gaps = 2/98 (2%)
Query: 983 IQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR 1042
+ EA+ LH LG IH DLKPEN L+ + +K+ D G S + S V S Y
Sbjct: 108 AEMFEAVDALHELGYIHRDLKPENFLIDASG--HIKLTDFGLSKGIVTYANSVVGSPDYM 165
Query: 1043 APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080
APEV+ G YD +D WSLGC+L E G F +P
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 978 LQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC-SY 1035
L I+I L L +L ++H D+KP NILV S R E+K+ D G S D + S+
Sbjct: 101 LGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSF 158
Query: 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095
V +RSY +PE + G Y + DIWSLG L E+ G L A + G
Sbjct: 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA----MFGRPV 214
Query: 1096 QGMLAKGRDTYKYF-----TKNHMLYERNQETNRLEYLIPKKTSLRHRLPMG--DQGFID 1148
AK + ++E L+Y++ + +LP G F D
Sbjct: 215 SEGEAKESHRPVSGHPPDSPRPMAIFE------LLDYIVNEPPP---KLPSGAFSDEFQD 265
Query: 1149 FVAHLLEINPKKRPSASDALKHPWL 1173
FV L+ NPK+R + KHP++
Sbjct: 266 FVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 68/268 (25%), Positives = 106/268 (39%), Gaps = 59/268 (22%)
Query: 910 DQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESG 968
+L+EI +L + H +++ Y++F LLI E LY+ K R+ G
Sbjct: 44 RDALNEIVILSLLQ-HP-----NIIAYYNHFMDDNTLLIEMEYANGGTLYD--KIVRQKG 95
Query: 969 GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF- 1027
F + Q + A+ ++H G++H D+K NI + +K+ D G S
Sbjct: 96 --QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKIL 151
Query: 1028 --ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLA 1085
E + V + Y +PE+ G+ Y+ K DIW+LGC+L EL T F +P L
Sbjct: 152 GSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-- 209
Query: 1086 RVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQG 1145
V+ I+ QG Y
Sbjct: 210 -VVKIV----QGNYTPVVSVYS------------------------------------SE 228
Query: 1146 FIDFVAHLLEINPKKRPSASDALKHPWL 1173
I V LL+ +P+KRP+A + L P L
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-14
Identities = 77/260 (29%), Positives = 120/260 (46%), Gaps = 37/260 (14%)
Query: 935 RLYDYFYYREHLLIVCELLKANLYEFHKFNRES-GGEVYFTMPR--LQSITIQCLEALQF 991
+++ F Y EH +L+ KF+R S + +PR ++S+ Q L+ + +
Sbjct: 74 KVWLLFDYAEH----------DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 992 LHGLGLIHCDLKPENILV--KSYSRCEVKVIDLG------SSCFETDHLCSYVQSRSYRA 1043
LH ++H DLKP NILV + R VK+ D+G S L V + YRA
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 1044 PEVILGLS-YDKKIDIWSLGCILAELCTGNVLF---QNDSPAT------LLARVIGIIGP 1093
PE++LG Y K IDIW++GCI AEL T +F Q D + L R+ ++G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
Query: 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153
R +Y T + R N LI K +H++ + F+ + L
Sbjct: 244 PADKDWEDIRKMPEYPTLQKD-FRRTTYAN--SSLI--KYMEKHKVKPDSKVFL-LLQKL 297
Query: 1154 LEINPKKRPSASDALKHPWL 1173
L ++P KR ++ AL+ P+
Sbjct: 298 LTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-14
Identities = 82/317 (25%), Positives = 134/317 (42%), Gaps = 77/317 (24%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSL--DEIKLLKYVNKHDP 927
+Y E +G A A D+ TG +V +K + N + + L +EI +++ NKH
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRE-NKHP- 76
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGG-------EVYFTMPRLQS 980
+++ D + + L +V E L +GG E ++ +
Sbjct: 77 ----NIVNYLDSYLVGDELWVVMEYL-------------AGGSLTDVVTETCMDEGQIAA 119
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQ 1037
+ +CL+AL+FLH +IH D+K +NIL+ VK+ D G E + V
Sbjct: 120 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVG 177
Query: 1038 SRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
+ + APEV+ +Y K+DIWSLG + E+ G + N++P R + +I
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYLIA----- 228
Query: 1098 MLAKGRDTYKYFTKNHMLYERNQETN-RLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156
TN E P+K S F DF+ LE+
Sbjct: 229 ------------------------TNGTPELQNPEKLSA---------IFRDFLNRCLEM 255
Query: 1157 NPKKRPSASDALKHPWL 1173
+ +KR SA + L+HP+L
Sbjct: 256 DVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 7/139 (5%)
Query: 940 FYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIH 999
F ++ L +V L+ ++H +N GE F R Q + L+ LH +++
Sbjct: 62 FETKDDLCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 1000 CDLKPENILVKSYSRCEVKVIDLGSSC--FETDHLCSYVQSRSYRAPEVILGLSYDKKID 1057
DLKPEN+L+ + ++ DLG + + + Y APEV+ G YD +D
Sbjct: 119 RDLKPENVLLDDHGNV--RISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 1058 IWSLGCILAELCTGNVLFQ 1076
++LGC L E+ G F+
Sbjct: 177 WFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 24/237 (10%)
Query: 871 YHVTEYLGSAAFS---KAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP 927
+ + +G +F K ++ D + + K N+ ++++DE ++L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL----- 56
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQ--SITIQ 984
D +++R Y+ F + L IV E +L++ K R +P Q IQ
Sbjct: 57 -DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR------PLPEDQVWRFFIQ 109
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRSY 1041
L L LH ++H D+K N+ + +Y VK+ DLG + T+ + V + Y
Sbjct: 110 ILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 1042 RAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI-GIIGPIEQG 1097
+PE+ Y++K D+W+LG +L E CTG F ++ L+ ++I G+ P+ Q
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM 224
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 73/261 (27%), Positives = 112/261 (42%), Gaps = 69/261 (26%)
Query: 934 LRLYDYFY--------YREHLLIVC-ELLKANLYEFHKFNRESGGEVYFTMPR--LQSIT 982
+R D Y +RE + +C E++ +L +F+K + G T+P L I
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKG----LTIPEDILGKIA 109
Query: 983 IQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQ--SR 1039
+ ++AL++LH L +IH D+KP N+L+ +VK+ D G S + D + + +
Sbjct: 110 VSIVKALEYLHSKLSVIHRDVKPSNVLINR--NGQVKLCDFGISGYLVDSVAKTIDAGCK 167
Query: 1040 SYRAPEVILG----LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095
Y APE I YD K D+WSLG + EL TG F DS T P +
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKT----------PFQ 215
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMG--DQGFIDFVAHL 1153
Q L + +E + P+ LP F DFV
Sbjct: 216 Q------------------LKQVVEEPS------PQ-------LPAEKFSPEFQDFVNKC 244
Query: 1154 LEINPKKRPSASDALKHPWLS 1174
L+ N K+RP+ + L+HP+
Sbjct: 245 LKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 49/208 (23%)
Query: 973 FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL 1032
F ++ T Q LE L +LH G++H DLK +N+LV + C K+ D G S ++D +
Sbjct: 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC--KISDFGIS-KKSDDI 161
Query: 1033 CSYVQSRSYR------APEVI--LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLL 1084
Q+ S + APEVI Y K+DIWSLGC++ E+ G + ++
Sbjct: 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE------ 215
Query: 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQ 1144
I + +K K R IP S
Sbjct: 216 -EAIAAM--------------FKLGNK------------RSAPPIPPDVS-----MNLSP 243
Query: 1145 GFIDFVAHLLEINPKKRPSASDALKHPW 1172
+DF+ INP RP+A + L+HP+
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 69/315 (21%), Positives = 128/315 (40%), Gaps = 66/315 (20%)
Query: 870 RYHVTEYLGSAAF--------SKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKY 921
RY + + LG +F KA+ L ++ V + N+ Q+ E +LL
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV--QANQEAQLLSK 58
Query: 922 VNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSI 981
+ D +++ + F R+ I+ E + + + G+ + ++
Sbjct: 59 L------DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT-LSENQVCEW 111
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQS 1038
IQ L + ++H ++H DLK +NI +K+ +K+ D G S D ++ +
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL---LKIGDFGVSRLLMGSCDLATTFTGT 168
Query: 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098
Y +PE + YD K DIWSLGCIL E+C F+ L+ V+ I+ +G
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG---QNFLSVVLRIV----EGP 221
Query: 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINP 1158
+TY +++ N + + +L +P
Sbjct: 222 TPSLPETY------------SRQLNSI------------------------MQSMLNKDP 245
Query: 1159 KKRPSASDALKHPWL 1173
RPSA++ L++P++
Sbjct: 246 SLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 81/308 (26%), Positives = 118/308 (38%), Gaps = 66/308 (21%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSL-DEIKLLKYVNKHDPGDKYHLLR 935
LG + A DL T + + +K I + Q L +EI L Y+ KH ++++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHR-----NIVQ 69
Query: 936 LYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL 995
I E + R G + + T Q LE L++LH
Sbjct: 70 YLGSDSENGFFKIFMEQVPGG--SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 996 GLIHCDLKPENILVKSYSRCEVKVIDLGSS--------CFETDHLCSYVQSRSYRAPEVI 1047
++H D+K +N+LV +YS VK+ D G+S C ET + + Y APEVI
Sbjct: 128 QIVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINPCTET-----FTGTLQYMAPEVI 181
Query: 1048 -LGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105
G Y DIWSLGC + E+ TG F +G + M G
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIE-------------LGEPQAAMFKVG--- 225
Query: 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165
K H IP+ S + +F+ E +P KR SA
Sbjct: 226 ---MFKIHP-------------EIPESLSAEAK---------NFILRCFEPDPDKRASAH 260
Query: 1166 DALKHPWL 1173
D L+ P+L
Sbjct: 261 DLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 54/210 (25%)
Query: 973 FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDH 1031
F +++ Q L+ L +LH G+IH D+K NILV + + +K+ D G S E +
Sbjct: 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN--KGGIKISDFGISKKLEANS 160
Query: 1032 LC--------SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
L S S + APEV+ SY +K DIWSLGC++ E+ TG F + +
Sbjct: 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA 220
Query: 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD 1143
+ ++ P IP S
Sbjct: 221 IFKIGENASPE----------------------------------IPSNISSEAI----- 241
Query: 1144 QGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
DF+ EI+ KRP+A++ LKHP+L
Sbjct: 242 ----DFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 76/317 (23%), Positives = 135/317 (42%), Gaps = 38/317 (11%)
Query: 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD--QSLDEIKLLKYVNKH 925
A Y E LG +++ + G V +K+I+ ++ ++ E LLK + KH
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KH 62
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+++ L+D + +E L +V E + +L ++ ++ GG ++ Q
Sbjct: 63 A-----NIVLLHDIIHTKETLTLVFEYVHTDLCQY--MDKHPGG---LHPENVKLFLFQL 112
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYR 1042
L L ++H ++H DLKP+N+L+ E+K+ D G + + + V + YR
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYSNEVVTLWYR 170
Query: 1043 APEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQN-DSPATLLARVIGIIGPIEQGMLA 1100
P+V+LG + Y +D+W +GCI E+ G F L R+ ++G +
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230
Query: 1101 KGRDTYKYFTKNHMLYERN---QETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157
+ + LY Q N+L Y+ + D + LL+
Sbjct: 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAE---------------DLASKLLQCF 275
Query: 1158 PKKRPSASDALKHPWLS 1174
PK R SA AL H + S
Sbjct: 276 PKNRLSAQAALSHEYFS 292
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD----EIKLLKYVNKHDPGDKYH 932
LG +F K A T +K +K + D ++ E ++L +H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP-----F 57
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
L LY F +E+L V E L FH + F +PR + + LQFL
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFL 112
Query: 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET----DHLCSYVQSRSYRAPEVIL 1048
H G+++ DLK +NIL+ + +K+ D G C E C++ + Y APE++L
Sbjct: 113 HSKGIVYRDLKLDNILLDTDG--HIKIADFGM-CKENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 1049 GLSYDKKIDIWSLGCILAELCTGNVLFQ 1076
G Y+ +D WS G +L E+ G F
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 71/296 (23%)
Query: 888 AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYH---LLRLYDYFYYRE 944
A + HTG V VK D Q E+ + V D YH ++ +Y+ + +
Sbjct: 41 ATEKHTGKQVAVK----KMDLRKQQRRELLFNEVVIMRD----YHHENVVDMYNSYLVGD 92
Query: 945 HLLIVCELLKA----NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHC 1000
L +V E L+ ++ + N E ++ ++ + L AL +LH G+IH
Sbjct: 93 ELWVVMEFLEGGALTDIVTHTRMNEE----------QIATVCLSVLRALSYLHNQGVIHR 142
Query: 1001 DLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRAPEVILGLSYDKKID 1057
D+K ++IL+ S R +K+ D G E S V + + APEVI L Y ++D
Sbjct: 143 DIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 1058 IWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYE 1117
IWSLG ++ E+ G + N+ P + R+ RD
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---------------RDN------------ 233
Query: 1118 RNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
+P + H++ +GF+D +L P +R +A + L+HP+L
Sbjct: 234 -----------LPPRVKDSHKVSSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 9/107 (8%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCS-YVQSRSYRAPEV 1046
++ LH G+IH D+KPEN+L+ +K+ D G S +V + Y APE
Sbjct: 109 GVEDLHQRGIIHRDIKPENLLIDQ--TGHLKLTDFGLS--RNGLENKKFVGTPDYLAPET 164
Query: 1047 ILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP----ATLLARVIG 1089
ILG+ DK D WSLGC++ E G F ++P +L+R I
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN 211
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 81/319 (25%), Positives = 123/319 (38%), Gaps = 81/319 (25%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKII----KNNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
+G +F A D+ T V +K + K + + + + E++ L+ + + +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE--- 79
Query: 933 LLRLYDYFYYREH----LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988
Y Y REH ++ C +++ E HK + EV + +I L+
Sbjct: 80 ----YKGCYLREHTAWLVMEYCLGSASDILEVHK---KPLQEV-----EIAAICHGALQG 127
Query: 989 LQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVIL 1048
L +LH IH D+K NIL+ VK+ D GS+ S+V + + APEVIL
Sbjct: 128 LAYLHSHERIHRDIKAGNILLTEPG--TVKLADFGSASL-VSPANSFVGTPYWMAPEVIL 184
Query: 1049 GL---SYDKKIDIWSLG--CI-LAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
+ YD K+D+WSLG CI LAE P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAE---------RKPP---------------------- 213
Query: 1103 RDTYKYFTKNHM--LYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160
F N M LY Q N L S F +FV L+ P+
Sbjct: 214 -----LFNMNAMSALYHIAQ--NDSPTLSSNDWS---------DYFRNFVDSCLQKIPQD 257
Query: 1161 RPSASDALKHPWLSHPYEP 1179
RPS+ + LKH ++ P
Sbjct: 258 RPSSEELLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 54/191 (28%), Positives = 77/191 (40%), Gaps = 35/191 (18%)
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCS-YVQSRSYRAP 1044
L+ L +LH +IH D+KP NIL+ + +VK+ D G S + L + + Y AP
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTR--KGQVKLCDFGVSGELVNSLAGTFTGTSFYMAP 172
Query: 1045 EVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104
E I G Y D+WSLG L E+ F + L GPIE
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL--------GPIEL-------- 216
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
+ Y N L+ + F DF+ LE +P +RP+
Sbjct: 217 ---------LSYIVNMPNPELKDEPGNGIKW-------SEEFKDFIKQCLEKDPTRRPTP 260
Query: 1165 SDALKHPWLSH 1175
D L+HPW+
Sbjct: 261 WDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-13
Identities = 44/129 (34%), Positives = 60/129 (46%), Gaps = 28/129 (21%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC--------------------- 1026
AL++LH G++H DLKP+N+L+ S +K+ D G S
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 1027 FETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLAR 1086
F +C + Y APEVIL Y K +D W++G IL E G V F D+P L +
Sbjct: 171 FLDKQVCG---TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227
Query: 1087 VIG--IIGP 1093
VI I P
Sbjct: 228 VISDDIEWP 236
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 78/308 (25%), Positives = 130/308 (42%), Gaps = 59/308 (19%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQ-SLDEIKLLKYVNKHDPG 928
+Y E +G A A D+ TG +V +K I K + ++EI ++K + +P
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK--NP- 76
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988
+++ D F + L +V E L + E ++ ++ +CL+A
Sbjct: 77 ---NIVNFLDSFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQIAAVCRECLQA 127
Query: 989 LQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRSYRAPE 1045
L+FLH +IH D+K +N+L+ VK+ D G E + V + + APE
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 1046 VILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105
V+ +Y K+DIWSLG + E+ G + N++P L + P Q
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN-------- 237
Query: 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165
P+K S P+ F DF+ LE++ +KR SA
Sbjct: 238 ------------------------PEKLS-----PI----FRDFLNRCLEMDVEKRGSAK 264
Query: 1166 DALKHPWL 1173
+ L+HP+L
Sbjct: 265 ELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 13/205 (6%)
Query: 877 LGSAAFSKAIQAHDLHTG-MDVCVKIIKN---NKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG F + +TG M C K+ K K +L E ++L+ VN
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS------PF 54
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
++ L F + HL +V L+ ++H +N GE M R+ + Q + L
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHL 111
Query: 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSY 1052
H + +++ D+KPEN+L+ C + + L + + + Y APE++ Y
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 1053 DKKIDIWSLGCILAELCTGNVLFQN 1077
+D +++GC + E+ G F++
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 49/191 (25%), Positives = 69/191 (36%), Gaps = 49/191 (25%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC-FETDHLC-SYVQSRSYRAPE 1045
AL++LH G+IH D+KP+NIL+ + V + D + D L S + Y APE
Sbjct: 112 ALEYLHSKGIIHRDIKPDNILLDE--QGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE 169
Query: 1046 VILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105
V+ Y +D WSLG E G ++ S +Q
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----------IRDQ--------- 209
Query: 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD-QGFIDFVAHLLEINPKKRPS- 1163
QET + Y P ID + LLE +P+KR
Sbjct: 210 ----------IRAKQETADVLY------------PATWSTEAIDAINKLLERDPQKRLGD 247
Query: 1164 -ASDALKHPWL 1173
D HP+
Sbjct: 248 NLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 75/313 (23%), Positives = 123/313 (39%), Gaps = 65/313 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQ---SLDEIKLLKYVNKHD 926
RY + + +G +F K A +K I K + S E+ LL + KH
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHP 59
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+++ + F L IV E + NR+ G V F+ ++ S +Q
Sbjct: 60 -----NIVTFFASFQENGRLFIVMEYCDGGDL-MKRINRQRG--VLFSEDQILSWFVQIS 111
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-----SSCFETDHLCSYVQSRSY 1041
L+ +H ++H D+K +NI + K+ D G + E + C V + Y
Sbjct: 112 LGLKHIHDRKILHRDIKSQNIFLSKNGMV-AKLGDFGIARQLNDSMELAYTC--VGTPYY 168
Query: 1042 RAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI-GIIGPIEQGMLA 1100
+PE+ Y+ K DIWSLGC+L ELCT F+ ++ L+ ++ G PI
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN--- 225
Query: 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160
+ R+ L LI + L +++P+
Sbjct: 226 ---------------FSRD-----LRSLISQ---------------------LFKVSPRD 244
Query: 1161 RPSASDALKHPWL 1173
RPS + LK P+L
Sbjct: 245 RPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 11/214 (5%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936
LG +F K + A G VK +K + D ++ + K V + + L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF-LTHL 61
Query: 937 YDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG 996
Y F +EHL V E L FH ++ G F + R + + LQFLH G
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHI--QDKG---RFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 997 LIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRAPEVILGLSYD 1053
+I+ DLK +N+++ +K+ D G + F + ++ + Y APE++ GL Y
Sbjct: 117 IIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 1054 KKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
+D WS G +L E+ G F D L +
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-12
Identities = 38/127 (29%), Positives = 50/127 (39%), Gaps = 36/127 (28%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRC-EVKVIDLGSS--------------------- 1025
AL +H LG IH D+KP+NIL+ +K+ D G
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 1026 -----CFETDHL------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVL 1074
DH S V + Y APEV+ G Y + D WSLG IL E+ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 1075 FQNDSPA 1081
F +D+
Sbjct: 230 FYSDTLQ 236
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG +F K + A T VK++K D + ++ E ++L KH
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHP-----F 57
Query: 933 LLRLYDYFYYREHLLIVCELLKAN--LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQ 990
L +L+ F ++ L V E + ++ + R F PR + + + LQ
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-------FDEPRARFYAAEIVLGLQ 110
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE-------TDHLCSYVQSRSYRA 1043
FLH G+I+ DLK +N+L+ S K+ D G C E T C + Y A
Sbjct: 111 FLHERGIIYRDLKLDNVLLDSEGHI--KIADFGM-CKEGILGGVTTSTFCG---TPDYIA 164
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
PE++ Y +D W+LG +L E+ G F+ D L
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 62/255 (24%), Positives = 110/255 (43%), Gaps = 60/255 (23%)
Query: 932 HLLRLYDYFYYREHLLIVCELLKA----NLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
+++ +Y+ + + L +V E L+ ++ + N E ++ ++ + L+
Sbjct: 78 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----------QIAAVCLAVLK 127
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRAP 1044
AL LH G+IH D+K ++IL+ R VK+ D G E S V + + AP
Sbjct: 128 ALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
Query: 1045 EVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104
E+I L Y ++DIWSLG ++ E+ G + N+ P + + RD
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---------------RD 230
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
+P K H++ +GF+D LL +P +R +A
Sbjct: 231 N-----------------------LPPKLKNLHKVSPSLKGFLD---RLLVRDPAQRATA 264
Query: 1165 SDALKHPWLSHPYEP 1179
++ LKHP+L+ P
Sbjct: 265 AELLKHPFLAKAGPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 33/176 (18%)
Query: 963 FNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022
F R S EV FT ++ + AL LH LG+I+ DLKPENIL+ +K+ D
Sbjct: 86 FTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDF 142
Query: 1023 GSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQ 1076
G S DH C V+ Y APEV+ + + D WS G ++ E+ TG++ FQ
Sbjct: 143 GLSKESIDHEKKAYSFCGTVE---YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
Query: 1077 ----NDSPATLLARVIGI---IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRL 1125
++ +L +G+ + P Q +L L++RN NRL
Sbjct: 200 GKDRKETMTMILKAKLGMPQFLSPEAQSLL-------------RALFKRN-PANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-12
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKN----NKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
+G +F K +Q T +K I+ ++ +L E +L VN P
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN--CP----F 54
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
++ L F E L +V + FH RE F + R + T + L AL+ L
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGEL-FHHLQREG----RFDLSRARFYTAELLCALENL 109
Query: 993 HGLGLIHCDLKPENILVK---SYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILG 1049
H +I+ DLKPENIL+ + C+ + L + D ++ + Y APE++LG
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPEYLAPELLLG 167
Query: 1050 LSYDKKIDIWSLGCILAELCTG 1071
Y K +D W+LG +L E+ TG
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 64/223 (28%), Positives = 93/223 (41%), Gaps = 55/223 (24%)
Query: 961 HKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020
H + RE +FT ++ + + AL LH LG+I+ D+K ENIL+ S V +
Sbjct: 95 HLYQRE-----HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLT 147
Query: 1021 DLG-SSCF---ETDHLCSYVQSRSYRAPEVILGLS--YDKKIDIWSLGCILAELCTGNVL 1074
D G S F E + S+ + Y APEVI G S +DK +D WSLG + EL TG
Sbjct: 148 DFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA-- 205
Query: 1075 FQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTS 1134
SP T+ E+N ++ ++ K
Sbjct: 206 ----SPFTVDG-------------------------------EQNSQSEISRRILKSKPP 230
Query: 1135 LRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177
+ DF+ LLE +PKKR A+ A +HP+
Sbjct: 231 FPKTM---SAEARDFIQKLLEKDPKKRLGANGA--DEIKNHPF 268
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-12
Identities = 71/290 (24%), Positives = 119/290 (41%), Gaps = 59/290 (20%)
Query: 888 AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947
A + H+G V VK++ D Q E+ + V D +++ +Y + E L
Sbjct: 40 AREKHSGRQVAVKMM----DLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELW 94
Query: 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007
++ E L+ + + ++ ++ L+AL +LH G+IH D+K ++I
Sbjct: 95 VLMEFLQGGALT------DIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSI 148
Query: 1008 LVKSYSRCEVKVIDLGSSCFETDHLC----SYVQSRSYRAPEVILGLSYDKKIDIWSLGC 1063
L+ R VK+ D G C + S V + + APEVI Y ++DIWSLG
Sbjct: 149 LLTLDGR--VKLSDFGF-CAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGI 205
Query: 1064 ILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETN 1123
++ E+ G + +DSP + R+ RD+ KN
Sbjct: 206 MVIEMVDGEPPYFSDSPVQAMKRL---------------RDSPPPKLKNA---------- 240
Query: 1124 RLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
K S R DF+ +L P++R +A + L HP+L
Sbjct: 241 -------HKISPVLR---------DFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 53/184 (28%), Positives = 82/184 (44%), Gaps = 25/184 (13%)
Query: 896 DVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951
V VK +K + + F L E +++K + +HD L++LY E + IV E
Sbjct: 32 KVAVKTLKPGTMSPEAF----LQEAQIMKKL-RHD-----KLVQLYAVCSEEEPIYIVTE 81
Query: 952 LL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVK 1010
+ K +L +F K SG +P+L + Q E + +L IH DL NILV
Sbjct: 82 YMSKGSLLDFLK----SGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG 137
Query: 1011 SYSRCEVKVIDLG-SSCFETDHLCSYVQSR---SYRAPEVILGLSYDKKIDIWSLGCILA 1066
C K+ D G + E D + ++ + APE + K D+WS G +L
Sbjct: 138 ENLVC--KIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLT 195
Query: 1067 ELCT 1070
E+ T
Sbjct: 196 EIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 67/268 (25%), Positives = 104/268 (38%), Gaps = 77/268 (28%)
Query: 932 HLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPR--LQSITIQCLEAL 989
++++ Y YF + I EL+ L + K + +P L +T+ ++AL
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTCLDKLLK-------RIQGPIPEDILGKMTVAIVKAL 127
Query: 990 QFL---HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS-----Y 1041
+L HG+ IH D+KP NIL+ + VK+ D G S D S ++RS Y
Sbjct: 128 HYLKEKHGV--IHRDVKPSNILLDA--SGNVKLCDFGISGRLVD---SKAKTRSAGCAAY 180
Query: 1042 RAPEVI----LGLSYDKKIDIWSLGCILAELCTGNVLFQN-DSPATLLARVIGIIGPIEQ 1096
APE I YD + D+WSLG L EL TG ++N + +L +++ P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP--- 237
Query: 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD---QGFIDFVAHL 1153
LP + F FV
Sbjct: 238 -----------------------------------------SLPPNEGFSPDFCSFVDLC 256
Query: 1154 LEINPKKRPSASDALKHPWLSHPYEPIS 1181
L + +KRP + L+HP++ YE
Sbjct: 257 LTKDHRKRPKYRELLQHPFIRR-YETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 18/232 (7%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII---KNNKDFFDQSLDEIKLLKYVNKHD 926
+Y +G AF V +K I + KD + +E ++LK +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL--SH 58
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
P +++ Y+ F + L+IV E L E+ + S + +Q
Sbjct: 59 P----NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS----LLDEDTILHFFVQI 110
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY--VQSRSYRA 1043
L AL +H ++H DLK +NIL+ + + VK+ D G S + +Y V + Y +
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKH-KMVVKIGDFGISKILSSKSKAYTVVGTPCYIS 169
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS-PATLLARVIGIIGPI 1094
PE+ G Y++K DIW+LGC+L EL + F+ + PA +L + G PI
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG +F K + A +G VK++K + D + ++ E ++L H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP-----F 57
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFH--KFNRESGGEVYFTMPRLQSITIQCLEALQ 990
L +LY F + L V E + FH K R F R + + AL
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-------FDEARARFYAAEITSALM 110
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRAPEVI 1047
FLH G+I+ DLK +N+L+ C K+ D G F ++ + Y APE++
Sbjct: 111 FLHDKGIIYRDLKLDNVLLDHEGHC--KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 1048 LGLSYDKKIDIWSLGCILAELCTGNVLFQ 1076
+ Y +D W++G +L E+ G+ F+
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-11
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 975 MPRLQSITIQ--CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL 1032
+P Q+ITIQ LEAL +LHG G+IH D+K ENI + + D G++C H
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE--NAVLGDFGAACKLDAHP 239
Query: 1033 CS-----YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLF---QNDSPATLL 1084
+ + + +PE++ Y K DIWS G +L E+ NV Q S ++ L
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299
Query: 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQ 1144
II ++ L ++ K+ +++ R Y IP ++ + M +
Sbjct: 300 R---SIIRCMQVHPLEFPQNGSTNLCKH---FKQYAIVLRPPYTIPPVIR-KYGMHMDVE 352
Query: 1145 GFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
I A +L + + RPSA D L P + EPI+
Sbjct: 353 YLI---AKMLTFDQEFRPSAQDILSLPLFTK--EPINL 385
|
Length = 392 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 9e-11
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYVNKHDPGDK 930
LG AF + +D+ TG ++ K ++ + + + S + EI+LLK +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 931 YHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQ 990
Y LR + L I E + K ++ G + ++ R T Q LE +
Sbjct: 70 YGCLRDRA----EKTLTIFMEYMPGGSV---KDQLKAYGALTESVTR--KYTRQILEGMS 120
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS------CFETDHLCSYVQSRSYRAP 1044
+LH ++H D+K NIL S VK+ D G+S C + S + + +P
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 1045 EVILGLSYDKKIDIWSLGCILAELCT 1070
EVI G Y +K D+WSLGC + E+ T
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 29/203 (14%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKII----KNNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
+G +F A D+ T V +K + K + + + + E+K L+ + + +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE--- 89
Query: 933 LLRLYDYFYYREH----LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988
Y Y REH ++ C ++L E HK + EV + +IT L+
Sbjct: 90 ----YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ---EV-----EIAAITHGALQG 137
Query: 989 LQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVIL 1048
L +LH +IH D+K NIL+ +VK+ D GS+ + S+V + + APEVIL
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASIASP-ANSFVGTPYWMAPEVIL 194
Query: 1049 GL---SYDKKIDIWSLGCILAEL 1068
+ YD K+D+WSLG EL
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVI 1047
A ++LH +I+ DLKPEN+L+ + + VKV D G + D + + Y APEVI
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLLDN--KGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVI 187
Query: 1048 LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080
+ K +D W++G +L E G F +D+P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 74/307 (24%), Positives = 123/307 (40%), Gaps = 57/307 (18%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
+Y E +G A A D+ TG +V +K + + + + L+ NK+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNP--- 76
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
+++ D + + L +V E L + E ++ ++ +CL+AL
Sbjct: 77 --NIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQAL 128
Query: 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRSYRAPEV 1046
FLH +IH D+K +NIL+ VK+ D G E + V + + APEV
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
Query: 1047 ILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106
+ +Y K+DIWSLG + E+ G + N++P L +I G E
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTPEL---------- 235
Query: 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASD 1166
Q RL + F DF+ LE++ +R SA +
Sbjct: 236 -------------QNPERLSAV-----------------FRDFLNRCLEMDVDRRGSAKE 265
Query: 1167 ALKHPWL 1173
L+HP+L
Sbjct: 266 LLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 31/225 (13%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG +F K + A T +K++K + D D ++ E ++L KH
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP-----F 57
Query: 933 LLRLYDYFYYREHLLIVCELLKAN--LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQ 990
L L+ F ++ L V E + +++ + + F PR + + AL
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-------FDEPRSRFYAAEVTLALM 110
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE-------TDHLCSYVQSRSYRA 1043
FLH G+I+ DLK +NIL+ + C K+ D G C E T C + Y A
Sbjct: 111 FLHRHGVIYRDLKLDNILLDAEGHC--KLADFG-MCKEGILNGVTTTTFCG---TPDYIA 164
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
PE++ L Y +D W+LG ++ E+ G F+ D+ L ++
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG +F K + A T +K +K + D + ++ E ++L +H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP-----F 57
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
L L+ F +EHL V E L FH + SG F R + + + LQFL
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSG---RFDEARARFYAAEIICGLQFL 112
Query: 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE-------TDHLCSYVQSRSYRAPE 1045
H G+I+ DLK +N+L+ +K+ D G C E C + Y APE
Sbjct: 113 HKKGIIYRDLKLDNVLLDKDGH--IKIADFGM-CKENMNGEGKASTFCG---TPDYIAPE 166
Query: 1046 VILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078
++ G Y++ +D WS G +L E+ G F +
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 45/205 (21%)
Query: 899 VKIIKNNKDFFDQSLDEIKLLKYVNKHD-PGDKYHLLRLYDYFYY--REHLLIVCELLKA 955
KIIK K+F + E V H D + ++LY Y + H+LI+ +
Sbjct: 46 QKIIKA-KNF---NAIEP----MV--HQLMKDNPNFIKLY-YSVTTLKGHVLIMDYIKDG 94
Query: 956 NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR- 1014
+L++ K + ++ I Q +EAL LH +IH D+K EN+L Y R
Sbjct: 95 DLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL---YDRA 145
Query: 1015 -CEVKVIDLGSSCFETDHLCSYVQSRS-------YRAPEVILGLSYDKKIDIWSLGCILA 1066
+ + D G LC + + S Y +PE I G +YD D W++G +
Sbjct: 146 KDRIYLCDYG--------LCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTY 197
Query: 1067 ELCTGNVLFQND-----SPATLLAR 1086
EL TG F+ D +LL R
Sbjct: 198 ELLTGKHPFKEDEDEELDLESLLKR 222
|
Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 72/280 (25%), Positives = 114/280 (40%), Gaps = 51/280 (18%)
Query: 912 SLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV 971
+L E LL+ VN H ++R+ D +V ++LY + + S
Sbjct: 104 TLIEAMLLQNVN-HP-----SVIRMKDTLVSGAITCMVLPHYSSDLYTY--LTKRSR--- 152
Query: 972 YFTMPRLQSITI--QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029
+P Q++ I Q LE L++LH +IH D+K ENI + +V + DLG++ F
Sbjct: 153 --PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD--QVCIGDLGAAQFPV 208
Query: 1030 DH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL- 1083
L V++ APEV+ Y+ K DIWS G +L E+ D P+T
Sbjct: 209 VAPAFLGLAGTVET---NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265
Query: 1084 ---------LARVIGIIG--PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK 1132
L ++I + P E RD + + Y + Y
Sbjct: 266 EYVKSCHSHLLKIISTLKVHPEE-----FPRDPGSRLVRGFIEYASLERQPYTRY----P 316
Query: 1133 TSLRHRLPMGDQGFIDFVAH-LLEINPKKRPSASDALKHP 1171
R LP+ + F+ H +L + RPSA + L +P
Sbjct: 317 CFQRVNLPIDGE----FLVHKMLTFDAAMRPSAEEILNYP 352
|
Length = 357 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 15/117 (12%)
Query: 967 SGGEVYFTM--------PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018
+GGE++F + PR + + AL +LH + +++ DLKPENIL+ S V
Sbjct: 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG--HVV 136
Query: 1019 VIDLGSSCFE----TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
+ D G C E +D ++ + Y APEVI YD +D W LG +L E+ G
Sbjct: 137 LTDFG-LCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-10
Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 978 LQSITIQCLEALQFL-HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC-SY 1035
L ++I L L +L ++H D+KP NILV S R E+K+ D G S D + S+
Sbjct: 105 LGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSF 162
Query: 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
V +RSY +PE + G Y + DIWS+G L EL G
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 38/106 (35%), Positives = 55/106 (51%), Gaps = 7/106 (6%)
Query: 970 EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE- 1028
E F PR + + AL +LH L +I+ DLKPENIL+ S+ V + D G C E
Sbjct: 90 ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD--SQGHVVLTDFG-LCKEG 146
Query: 1029 ---TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
+ ++ + Y APEV+ YD+ +D W LG +L E+ G
Sbjct: 147 IEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYVNK 924
+ + + LG AF + +D TG ++ VK ++ + + + S + EI+LLK +
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
Y LR L I E + K +S G + + R T Q
Sbjct: 64 ERIVQYYGCLRDPM----ERTLSIFMEHMPGGSI---KDQLKSYGALTENVTR--KYTRQ 114
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS------CFETDHLCSYVQS 1038
LE + +LH ++H D+K NIL S VK+ D G+S C + S +
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVG--NVKLGDFGASKRLQTICLSGTGMKSVTGT 172
Query: 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
+ +PEVI G Y +K DIWS+GC + E+ T
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 877 LGSAAFSKAIQAHDLHTG-MDVCVKI----IKNNKDFFDQSLDEIKLLKYVNKHDPGDKY 931
LG F + TG M C ++ IK K +L+E ++L+ VN
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGE-SMALNEKQILEKVNSQ------ 60
Query: 932 HLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
++ L + ++ L +V ++ +FH +N + G F R + L L+
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FEEERALFYAAEILCGLED 117
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLS 1051
LH ++ DLKPENIL+ Y + + L E + + V + Y APEV+
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR 177
Query: 1052 YDKKIDIWSLGCILAELCTGNVLFQ 1076
Y D W LGC++ E+ G F+
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 34/115 (29%), Positives = 60/115 (52%), Gaps = 4/115 (3%)
Query: 974 TMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC 1033
+ + I C AL++LH +++ DLKPENIL+ +K+ D G + D
Sbjct: 101 STGLFYASEIVC--ALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRDRTW 156
Query: 1034 SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
+ + Y APEVI ++K +D W+LG ++ E+ G F +D+P + +++
Sbjct: 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-09
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
+++L F Y + ++ K +LY + R + + +I L A+Q+L
Sbjct: 145 IIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRN------IAICDILAIERSVLRAIQYL 198
Query: 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSY--------RAP 1044
H +IH D+K ENI + +V + D G++CF D ++ Y AP
Sbjct: 199 HENRIIHRDIKAENIFINHPG--DVCLGDFGAACFPVD----INANKYYGWAGTIATNAP 252
Query: 1045 EVILGLSYDKKIDIWSLGCILAELCTG-NVLFQND 1078
E++ Y +DIWS G +L E+ T + LF+ D
Sbjct: 253 ELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 44/142 (30%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
L+ L+ F E L V + + FH RE F PR + + A+ +L
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGELFFH-LQRER----CFLEPRARFYAAEVASAIGYL 112
Query: 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRAPEVILG 1049
H L +I+ DLKPENIL+ S+ V + D G + ++ + Y APEV+
Sbjct: 113 HSLNIIYRDLKPENILLD--SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 1050 LSYDKKIDIWSLGCILAELCTG 1071
YD+ +D W LG +L E+ G
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 41/123 (33%), Positives = 63/123 (51%), Gaps = 27/123 (21%)
Query: 967 SGGEVYFTMPR------------LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014
SGGE++ + R L I++ AL+ LH G+I+ DLKPENIL+ +
Sbjct: 83 SGGELFMHLEREGIFMEDTACFYLSEISL----ALEHLHQQGIIYRDLKPENILLDAQG- 137
Query: 1015 CEVKVIDLG---SSCFE---TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAEL 1068
VK+ D G S E T C ++ Y APE+++ + K +D WSLG ++ ++
Sbjct: 138 -HVKLTDFGLCKESIHEGTVTHTFCGTIE---YMAPEILMRSGHGKAVDWWSLGALMYDM 193
Query: 1069 CTG 1071
TG
Sbjct: 194 LTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 967 SGGEVY--------FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018
+GGE++ F +Q + + + AL+ LH LG+I+ D+K ENIL+ S V
Sbjct: 88 NGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVV 145
Query: 1019 VIDLGSS----CFETDHLCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGN 1072
+ D G S E + S+ + Y AP+++ G +DK +D WS+G ++ EL TG
Sbjct: 146 LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGA 205
Query: 1073 VLFQND----SPATLLARVIGIIGPIEQGMLAKGRD 1104
F D S A + R++ P Q M A +D
Sbjct: 206 SPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD 241
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 4/96 (4%)
Query: 978 LQSITIQCLEALQFL-HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC-SY 1035
L ++I ++ L +L ++H D+KP NILV S R E+K+ D G S D + S+
Sbjct: 105 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSF 162
Query: 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
V +RSY +PE + G Y + DIWS+G L E+ G
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
+Y E +G A A D+ TG +V ++ + + + + L+ NK+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP--- 77
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
+++ D + + L +V E L + E ++ ++ +CL+AL
Sbjct: 78 --NIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQAL 129
Query: 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRSYRAPEV 1046
+FLH +IH D+K +NIL+ VK+ D G E + V + + APEV
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 1047 ILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080
+ +Y K+DIWSLG + E+ G + N++P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936
LG+ F + + + V VK +K L+E L+K + +HD L+RL
Sbjct: 14 LGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHD-----KLVRL 66
Query: 937 YDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL 995
Y E + I+ E + K +L +F K + GG+V +P+L + Q E + ++
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLK--SDEGGKV--LLPKLIDFSAQIAEGMAYIERK 122
Query: 996 GLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCSYVQSR---SYRAPEVILGLS 1051
IH DL+ N+LV C K+ D G + E + + ++ + APE I S
Sbjct: 123 NYIHRDLRAANVLVSESLMC--KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 1052 YDKKIDIWSLGCILAELCT 1070
+ K D+WS G +L E+ T
Sbjct: 181 FTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 877 LGSAAFSKAIQAHDLHTG-MDVCVKI----IKNNKDFFDQSLDEIKLLKYVNKHDPGDKY 931
LG F + TG M C K+ IK K +L+E ++L+ VN
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE-SMALNEKQILEKVNSR------ 60
Query: 932 HLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
++ L + ++ L +V L+ +FH ++ GE F R + L+
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLED 117
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLS 1051
LH +++ DLKPENIL+ + + + L E + V + Y APEV+
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 177
Query: 1052 YDKKIDIWSLGCILAELCTGNVLFQ 1076
Y D W+LGC+L E+ G FQ
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 981 ITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC-SYVQS 1038
I + +E L +L+ ++H D+KP NILV S R ++K+ D G S + + ++V +
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS--RGQIKLCDFGVSGELINSIADTFVGT 165
Query: 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLF 1075
+Y +PE I G Y K D+WSLG + EL G F
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 71/228 (31%), Positives = 106/228 (46%), Gaps = 42/228 (18%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKII----KNNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
+G +F A + HT V VK + K + + + E+K L+ + KH +Y
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYK 87
Query: 933 LLRLYDYFYYREH----LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988
Y +EH ++ C ++L E HK + EV + +IT L+
Sbjct: 88 GC------YLKEHTAWLVMEYCLGSASDLLEVHKKPLQ---EV-----EIAAITHGALQG 133
Query: 989 LQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVIL 1048
L +LH +IH D+K NIL+ +VK+ D GS+ + S+V + + APEVIL
Sbjct: 134 LAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASKSSP-ANSFVGTPYWMAPEVIL 190
Query: 1049 GL---SYDKKIDIWSLG--CI-LAE----LCTGNVL------FQNDSP 1080
+ YD K+D+WSLG CI LAE L N + QNDSP
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 78/318 (24%), Positives = 124/318 (38%), Gaps = 88/318 (27%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIK-LLKYVNKHDPGDKYHL 933
E +G +F + + D T V +KII +++ DEI+ + + + D ++
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 934 LRLYDYFYYREHLLIVCE---------LLKANLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
R Y + L I+ E LLK E E Y + +I +
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLE----------ETY-----IATILRE 109
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---SYVQSRSY 1041
L+ L +LH IH D+K N+L+ + +VK+ D G + TD ++V + +
Sbjct: 110 ILKGLDYLHSERKIHRDIKAANVLLSE--QGDVKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 1042 RAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101
APEVI +YD K DIWSLG EL G + P +L
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL----------------- 210
Query: 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQG-----FIDFVAHLLEI 1156
+LIPK + P +G F +FV L
Sbjct: 211 -------------------------FLIPKNS------PPTLEGQYSKPFKEFVEACLNK 239
Query: 1157 NPKKRPSASDALKHPWLS 1174
+P+ RP+A + LKH +++
Sbjct: 240 DPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 38/134 (28%), Positives = 61/134 (45%), Gaps = 3/134 (2%)
Query: 943 REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDL 1002
++ L +V L+ +FH +N + G F R + L+ LH +++ DL
Sbjct: 72 KDALCLVLTLMNGGDLKFHIYNMGNPG---FDEERAVFYAAEITCGLEDLHRERIVYRDL 128
Query: 1003 KPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLG 1062
KPENIL+ Y + + L E + + V + Y APEV+ Y D W LG
Sbjct: 129 KPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLG 188
Query: 1063 CILAELCTGNVLFQ 1076
C++ E+ G F+
Sbjct: 189 CLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 65/227 (28%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD--------QSLDEIKLLKYV 922
+ + + +G FS+ +A L G+ V +K ++ FD + EI LLK +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ----IFDLMDAKARADCIKEIDLLKQL 59
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELLKAN-----LYEFHKFNR---ESGGEVYFT 974
N + +++ Y F L IV EL A + F K R E YF
Sbjct: 60 NHPN------VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF- 112
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDH 1031
+Q AL+ +H ++H D+KP N+ + + VK+ DLG F +T
Sbjct: 113 --------VQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTA 162
Query: 1032 LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078
S V + Y +PE I Y+ K DIWSLGC+L E+ F D
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 54/177 (30%), Positives = 78/177 (44%), Gaps = 28/177 (15%)
Query: 913 LDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKAN-----LYEFHKFNR-- 965
+ EI LLK +N + +++ D F L IV EL A + F K R
Sbjct: 50 VKEIDLLKQLNHPN------VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103
Query: 966 -ESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024
E YF +Q A++ +H ++H D+KP N+ + + VK+ DLG
Sbjct: 104 PERTVWKYF---------VQLCSAVEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGL 152
Query: 1025 SCF---ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078
F +T S V + Y +PE I Y+ K DIWSLGC+L E+ F D
Sbjct: 153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-09
Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 26/159 (16%)
Query: 967 SGGEV--------YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018
SGGE+ F+ ++ + + + AL+ LH LG+++ D+K ENIL+ S V
Sbjct: 88 SGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG--HVV 145
Query: 1019 VIDLGSS----CFETDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNV 1073
+ D G S E + S+ + Y APE+I G + K +D WSLG ++ EL TG
Sbjct: 146 LTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205
Query: 1074 LF----QNDSPATLLARVI-------GIIGPIEQGMLAK 1101
F + ++ + + R++ IGP Q +L K
Sbjct: 206 PFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHK 244
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 22/220 (10%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG F K I + TG +KI++ KD ++ E ++L+ N P
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ--NTRHP----F 56
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
L L F + L V E FH +RE FT R + + + AL++L
Sbjct: 57 LTALKYAFQTHDRLCFVMEYANGGELFFH-LSRER----VFTEERARFYGAEIVSALEYL 111
Query: 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE--TDH--LCSYVQSRSYRAPEVIL 1048
H +++ D+K EN+++ +K+ D G C E +D + ++ + Y APEV+
Sbjct: 112 HSRDVVYRDIKLENLMLDKDG--HIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLE 168
Query: 1049 GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
Y + +D W LG ++ E+ G + F N L ++
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 9/114 (7%)
Query: 967 SGGEVYFTM--------PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018
+GGE+++ + PR + + AL +LH L +++ DLKPENIL+ S +
Sbjct: 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLT 138
Query: 1019 VIDLGSSCFETDHLCS-YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
L E + S + + Y APEV+ YD+ +D W LG +L E+ G
Sbjct: 139 DFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 29/231 (12%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVK---IIKNNKDFFDQSLDEIKLLKYVNKHD 926
+Y + +G +F KAI G +K I K + ++S E+ +L + KH
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHP 59
Query: 927 PGDKYHLLRLYDYFYYREHLLIV---CELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
++++ + F +L IV CE +LY+ K N + G V F ++ +
Sbjct: 60 -----NIVQYQESFEENGNLYIVMDYCE--GGDLYK--KINAQRG--VLFPEDQILDWFV 108
Query: 984 QCLEALQFLHGLGLIHCDLKPENI-LVKSYSRCEVKVIDLG-----SSCFETDHLCSYVQ 1037
Q AL+ +H ++H D+K +NI L K + +K+ D G +S E C +
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGT---IKLGDFGIARVLNSTVELARTC--IG 163
Query: 1038 SRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
+ Y +PE+ Y+ K DIW+LGC+L E+CT F+ + L+ ++I
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 57/223 (25%), Positives = 87/223 (39%), Gaps = 35/223 (15%)
Query: 877 LGSAAFSKAIQAHDLHTG-----MDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHDPGD 929
LG F K ++A V VK++K N + L E LLK VN
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP---- 63
Query: 930 KYHLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESG------------------GE 970
H+++LY LL++ E K +L F + +R+ G E
Sbjct: 64 --HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 971 VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030
TM L S Q +Q+L + L+H DL N+LV + ++ L +E D
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 1031 HLCSYVQSR---SYRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
+ R + A E + Y + D+WS G +L E+ T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDK 930
+ + E +G + K + + G VKI+ D ++ E +LK ++ H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHP---- 75
Query: 931 YHLLRLYDYFYYRE-----HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
++++ Y +Y ++ L +V EL ++ + K + G + P + I +
Sbjct: 76 -NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM--EEPIIAYILHE 132
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD---HLCSYVQSRSY 1041
L LQ LH IH D+K NIL+ + VK++D G S T + V + +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEG--GVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190
Query: 1042 RAPEVI-----LGLSYDKKIDIWSLGCILAELCTGN 1072
APEVI L +YD + D+WSLG EL G+
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-09
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG F K I + +G +KI+K KD +L E ++LK N P
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK--NTRHP----F 56
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
L L F ++ L V E + FH +RE F+ R + + + AL +L
Sbjct: 57 LTSLKYSFQTKDRLCFVMEYVNGGELFFH-LSRER----VFSEDRTRFYGAEIVSALDYL 111
Query: 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRAPEVILG 1049
H +++ DLK EN+++ +K+ D G + + ++ + Y APEV+
Sbjct: 112 HSGKIVYRDLKLENLMLDKDG--HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED 169
Query: 1050 LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
Y + +D W LG ++ E+ G + F N L ++
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 56/213 (26%), Positives = 85/213 (39%), Gaps = 64/213 (30%)
Query: 976 PRLQSITIQCLEALQFL-HGLGLIHCDLKPENILVKSYSRCEVKVIDLG------SSCFE 1028
L+ IT ++ L+FL +IH D+KP N+LV +VK+ D G +S +
Sbjct: 102 DVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG--NGQVKLCDFGVSGNLVASLAK 159
Query: 1029 TDHLCSYVQSRSYRAPEVILG------LSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082
T+ C +SY APE I +Y + D+WSLG + E+ G + ++ A
Sbjct: 160 TNIGC-----QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214
Query: 1083 LLARVIGII-GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPM 1141
+ A++ I+ G P LP
Sbjct: 215 IFAQLSAIVDGD------------------------------------PP------TLPS 232
Query: 1142 GDQGFI-DFVAHLLEINPKKRPSASDALKHPWL 1173
G DFVA L P +RP+ + L+HPWL
Sbjct: 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYVNKHDPGDK 930
LG AF + +D TG ++ VK + + D + S + EI+LLK + +HD
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHD---- 64
Query: 931 YHLLRLYDYF-YYREH----LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
R+ Y+ R+ L I E + K ++ G + + R T Q
Sbjct: 65 ----RIVQYYGCLRDPEEKKLSIFVEYMPGGSI---KDQLKAYGALTENVTR--RYTRQI 115
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS------CFETDHLCSYVQSR 1039
L+ + +LH ++H D+K NIL S VK+ D G+S C + S +
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 1040 SYRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
+ +PEVI G Y +K D+WS+ C + E+ T
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 52/181 (28%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 897 VCVKIIKNNKDFFDQSLD-EIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL-K 954
V +KI+K++ Q E++ LK + +H HL+ L+ E + I+ EL+ K
Sbjct: 33 VAIKILKSDDLLKQQDFQKEVQALKRL-RHK-----HLISLFAVCSVGEPVYIITELMEK 86
Query: 955 ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014
+L F R G+V + L + Q E + +L IH DL NILV
Sbjct: 87 GSL---LAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV 142
Query: 1015 CEVKVIDLGSSCFETDHLCSYVQSRS-----YRAPEVILGLSYDKKIDIWSLGCILAELC 1069
C KV D G + + + Y+ S + APE ++ K D+WS G +L E+
Sbjct: 143 C--KVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF 198
Query: 1070 T 1070
T
Sbjct: 199 T 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 989 LQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC-FETDHLCSYVQSRSYRAPEVI 1047
L+ +H +++ DLKP NIL+ + V++ DLG +C F + V + Y APEV+
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVL 167
Query: 1048 L-GLSYDKKIDIWSLGCILAELCTGNVLFQ 1076
G++YD D +SLGC+L +L G+ F+
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 23/234 (9%)
Query: 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP 927
+ + E +G + K + + G VKI+ D ++ E +L+ + H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHP- 79
Query: 928 GDKYHLLRLYDYFYYREH-----LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSI 981
++++ Y FY + L +V EL ++ E K G + + I
Sbjct: 80 ----NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL--DEAMISYI 133
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD---HLCSYVQS 1038
L LQ LH +IH D+K NIL+ + VK++D G S T + V +
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEG--GVKLVDFGVSAQLTSTRLRRNTSVGT 191
Query: 1039 RSYRAPEVI-----LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
+ APEVI SYD + D+WSLG EL G+ + P L ++
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 877 LGSAAFSKAIQA-HDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLR 935
LG+ F + A ++ HT V VK +K + L E ++K + +HD L++
Sbjct: 14 LGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLAEANVMKTL-QHD-----KLVK 65
Query: 936 LYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG 994
L+ +E + I+ E + K +L +F K + G + +P+L + Q E + F+
Sbjct: 66 LHAVVT-KEPIYIITEFMAKGSLLDFLK--SDEGSKQ--PLPKLIDFSAQIAEGMAFIEQ 120
Query: 995 LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSR------SYRAPEVIL 1048
IH DL+ NILV + C K+ D G + D+ Y + APE I
Sbjct: 121 RNYIHRDLRAANILVSASLVC--KIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAIN 176
Query: 1049 GLSYDKKIDIWSLGCILAELCT 1070
S+ K D+WS G +L E+ T
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-08
Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 43/146 (29%)
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCSY------- 1035
+ + A+ +H LG IH D+KP+N+L+ + + +K+ D G + + H +
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDA--KGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 1036 ---------------------------------VQSRSYRAPEVILGLSYDKKIDIWSLG 1062
V + Y APEV L Y+K+ D WSLG
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 1063 CILAELCTGNVLFQNDSPATLLARVI 1088
I+ E+ G F +D+P ++I
Sbjct: 227 VIMYEMLVGYPPFCSDNPQETYRKII 252
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 41/211 (19%)
Query: 877 LGSAAFSKAIQAHDLHTGM-----DVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDP 927
LGS F +H G DV +K+I+ + DF + E K++ ++ H
Sbjct: 12 LGSGQFGV------VHLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLS-HP- 59
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+L++LY + + IV E + L + + + G L +
Sbjct: 60 ----NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLG-----TEWLLDMCSDVC 110
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR---- 1042
EA+++L G IH DL N LV VKV D G + + D Y S+ +
Sbjct: 111 EAMEYLESNGFIHRDLAARNCLVGE--DNVVKVSDFGLARYVLDD--QYTSSQGTKFPVK 166
Query: 1043 --APEVILGLSYDKKIDIWSLGCILAELCTG 1071
PEV + K D+WS G ++ E+ +
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 50/214 (23%), Positives = 79/214 (36%), Gaps = 60/214 (28%)
Query: 973 FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG--------- 1023
P T Q L+ + +LH ++H D+K N+++ +K+ID G
Sbjct: 99 LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVG 156
Query: 1024 SSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
++ L S + + APEVI Y +K DIWS+GC + E+ TG P
Sbjct: 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK------PPLAS 210
Query: 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD 1143
+ R+ + ++ H R +P
Sbjct: 211 MDRLAAM-----------------FYIGAH----------------------RGLMPRLP 231
Query: 1144 QGF----IDFVAHLLEINPKKRPSASDALKHPWL 1173
F IDFV L + +RPSA L+H +L
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 23/200 (11%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLR 935
+G +F A D+ V +K + + K ++ D IK ++++ K +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ--- 79
Query: 936 LYDYFYYREH----LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
Y Y REH ++ C ++L E HK + + ++T L+ L +
Sbjct: 80 -YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--------VEIAAVTHGALQGLAY 130
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL- 1050
LH +IH D+K NIL+ VK+ D GS+ +V + + APEVIL +
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP-ANXFVGTPYWMAPEVILAMD 187
Query: 1051 --SYDKKIDIWSLGCILAEL 1068
YD K+D+WSLG EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 15/204 (7%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936
LG +F K + A T +KI+K + D ++ + K V PG L +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL-PGKPPFLTQL 66
Query: 937 YDYFYYREHLLIVCELLKAN--LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG 994
+ F + L V E + +Y + + F P + L FLH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-------FKEPHAVFYAAEIAIGLFFLHS 119
Query: 995 LGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRAPEVILGLS 1051
G+I+ DLK +N+++ + +K+ D G + F ++ + Y APE+I
Sbjct: 120 KGIIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP 177
Query: 1052 YDKKIDIWSLGCILAELCTGNVLF 1075
Y K +D W+ G +L E+ G F
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 14/117 (11%)
Query: 967 SGGEVY--------FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018
SGGE++ F+ R + + + AL+ LH +++ DLKPENIL+ + +
Sbjct: 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG--HIA 136
Query: 1019 VIDLGSS---CFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTG 1071
+ D G S + ++ + Y APEV+L Y K +D WSLG ++ E+C G
Sbjct: 137 LCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIK-LLKYVNKHDPGDKYHL 933
E +G +F + + D T V +KII +++ DEI+ + + + D ++
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 934 LRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH 993
+ Y + L I+ E L + G + T ++ +I + L+ L +LH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGG----SALDLLEPGPLDET--QIATILREILKGLDYLH 118
Query: 994 GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCS---YVQSRSYRAPEVILGL 1050
IH D+K N+L+ + EVK+ D G + TD +V + + APEVI
Sbjct: 119 SEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 1051 SYDKKIDIWSLGCILAELCTG 1071
+YD K DIWSLG EL G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 25/183 (13%)
Query: 897 VCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952
V VK +K + KDF L E +++K P L++LY E + IV EL
Sbjct: 33 VAVKTLKPGTMDPKDF----LAEAQIMK--KLRHP----KLIQLYAVCTLEEPIYIVTEL 82
Query: 953 LK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011
+K +L E+ +G + +P+L + Q + +L IH DL N+LV
Sbjct: 83 MKYGSLLEY--LQGGAGRAL--KLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE 138
Query: 1012 YSRCEVKVIDLG-SSCFETDHLCSYVQSR---SYRAPEVILGLSYDKKIDIWSLGCILAE 1067
+ C KV D G + + D + ++ + APE L + K D+WS G +L E
Sbjct: 139 NNIC--KVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTE 196
Query: 1068 LCT 1070
+ T
Sbjct: 197 IVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-08
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 976 PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY 1035
++ ++ Q L A+ ++HG G+IH D+K EN+LV ++ + D G++CF +
Sbjct: 260 AQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLGDFGAACFARGSWSTP 317
Query: 1036 VQ-----SRSYRAPEVILGLSYDKKIDIWSLGCILAE 1067
+ APEV+ G Y +DIWS G ++ E
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 36/206 (17%)
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC----------FETDHLCSY 1035
L AL ++H G IH +K +IL+ + V + L S D S
Sbjct: 111 LNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 1036 VQSRSYRAPEV----ILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT--LLARVIG 1089
V++ + +PEV + G Y++K DI+S+G EL G+V F+ D PAT LL +V G
Sbjct: 169 VKNLPWLSPEVLQQNLQG--YNEKSDIYSVGITACELANGHVPFK-DMPATQMLLEKVRG 225
Query: 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLP--MGDQGFI 1147
+ +L + TY LYE + +R P + F
Sbjct: 226 TV----PCLL--DKSTY-------PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFH 272
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWL 1173
FV L+ +P+ RPSAS L H +
Sbjct: 273 QFVELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 44/135 (32%), Positives = 65/135 (48%), Gaps = 15/135 (11%)
Query: 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL-HGLGLIHCDLKPE 1005
I EL+ +L +F+K+ E + L I + ++AL +L L +IH D+KP
Sbjct: 79 WICMELMDISLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPS 137
Query: 1006 NILVKSYSRCEVKVIDLGSSCFETDHLCSYVQS-----RSYRAPEVILGLS---YDKKID 1057
NIL+ +K+ D G S D S ++ R Y APE I + YD + D
Sbjct: 138 NILLDR--NGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSD 192
Query: 1058 IWSLGCILAELCTGN 1072
+WSLG L E+ TG
Sbjct: 193 VWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 69/321 (21%), Positives = 119/321 (37%), Gaps = 68/321 (21%)
Query: 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP 927
AG + + E +G+ + + + + TG +K++ D ++ EI +LK + H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 64
Query: 928 GDKYHLLRLYDYFYYR------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSI 981
Y Y F + + L +V E A + + G + I
Sbjct: 65 IATY-----YGAFIKKNPPGMDDQLWLVMEFCGAG--SVTDLIKNTKGNT-LKEEWIAYI 116
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC----SYVQ 1037
+ L L LH +IH D+K +N+L+ EVK++D G S + D +++
Sbjct: 117 CREILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVKLVDFGVSA-QLDRTVGRRNTFIG 173
Query: 1038 SRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092
+ + APEVI +YD K D+WSLG E+ G + P L
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------- 225
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
+LIP+ + R + + F F+
Sbjct: 226 ----------------------------------FLIPRNPAPRLKSKKWSKKFQSFIES 251
Query: 1153 LLEINPKKRPSASDALKHPWL 1173
L N +RP+ +KHP++
Sbjct: 252 CLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 32/276 (11%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIK-LLKYVNKHDPGDKYHL 933
E +G +F + + D T V +KII +++ DEI+ + + + D ++
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 934 LRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH 993
+ Y + L I+ E L + G F ++ ++ + L+ L +LH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGG----SALDLLRAGP--FDEFQIATMLKEILKGLDYLH 118
Query: 994 GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---SYVQSRSYRAPEVILGL 1050
IH D+K N+L+ +VK+ D G + TD ++V + + APEVI
Sbjct: 119 SEKKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 1051 SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG-------- 1102
+YD K DIWSLG EL G + P +L + P G +K
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC 236
Query: 1103 -------RDTYKYFTKNHMLYERNQETNRLEYLIPK 1131
R T K K+ + + ++T+ L LI +
Sbjct: 237 LNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDR 272
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936
+G +++K + T +K+IK D+ +D ++ K+V + + L+ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPF-LVGL 61
Query: 937 YDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSI--------TIQCLEA 988
+ F L V E + SGG++ F M R + + + + A
Sbjct: 62 HSCFQTESRLFFVIEFV-------------SGGDLMFHMQRQRKLPEEHARFYSAEISLA 108
Query: 989 LQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET----DHLCSYVQSRSYRAP 1044
L FLH G+I+ DLK +N+L+ + +K+ D G C E D ++ + +Y AP
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIAP 165
Query: 1045 EVILGLSYDKKIDIWSLGCILAELCTGNVLF 1075
E++ G Y +D W+LG ++ E+ G F
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 40/144 (27%), Positives = 71/144 (49%), Gaps = 19/144 (13%)
Query: 950 CELLKANLYEFHKFNR-------ESGGEVY--------FTMPRLQSITIQCLEALQFLHG 994
C + Y FH ++ +GG+++ F+ ++ + + L+ +H
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 995 LGLIHCDLKPENILVKSYSRCEVKVIDLGSSC-FETDHLCSYVQSRSYRAPEVIL-GLSY 1052
+++ DLKP NIL+ + V++ DLG +C F + V + Y APEV+ G +Y
Sbjct: 116 RFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAY 173
Query: 1053 DKKIDIWSLGCILAELCTGNVLFQ 1076
D D +SLGC+L +L G+ F+
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 72/321 (22%), Positives = 120/321 (37%), Gaps = 68/321 (21%)
Query: 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP 927
AG + + E +G+ + + + + TG +K++ +D ++ EI +LK + H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRN 74
Query: 928 GDKYHLLRLYDYFYYR------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSI 981
Y Y F + + L +V E A + + G + I
Sbjct: 75 IATY-----YGAFIKKSPPGHDDQLWLVMEFCGAG--SVTDLVKNTKGNA-LKEDWIAYI 126
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC----SYVQ 1037
+ L L LH +IH D+K +N+L+ EVK++D G S + D +++
Sbjct: 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTE--NAEVKLVDFGVSA-QLDRTVGRRNTFIG 183
Query: 1038 SRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092
+ + APEVI +YD + DIWSLG E+ G + P L
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-------- 235
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
+LIP+ + + + FIDF+
Sbjct: 236 ----------------------------------FLIPRNPPPKLKSKKWSKKFIDFIEG 261
Query: 1153 LLEINPKKRPSASDALKHPWL 1173
L N RPS LKHP++
Sbjct: 262 CLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 62/249 (24%), Positives = 107/249 (42%), Gaps = 30/249 (12%)
Query: 847 RKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK 906
RKN+ +E D NF L + GR + Y AI+ + KIIK +
Sbjct: 23 RKNKMKYE-DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEK-------SKIIKQKQ 74
Query: 907 DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE-LLKANLYEFHKFNR 965
D E K+L Y+N + LY F +L +V E ++ + F + N+
Sbjct: 75 --VDHVFSERKILNYINHP------FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK 126
Query: 966 ESGGEV--YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023
+V ++ Q + ++L L +++ DLKPEN+L+ +K+ D G
Sbjct: 127 RFPNDVGCFYAA--------QIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFG 176
Query: 1024 SSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
+ + + Y APE++L + + K D W+LG + E+ G F + P +
Sbjct: 177 FAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236
Query: 1084 LARVI-GII 1091
+++ GII
Sbjct: 237 YQKILEGII 245
|
Length = 340 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 53/219 (24%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936
+G +++K + +K++K D+ +D ++ K+V + + + L+ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF-LVGL 61
Query: 937 YDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQ---------CLE 987
+ F L +V E + +GG++ F M R + + + C+
Sbjct: 62 HSCFQTTSRLFLVIEYV-------------NGGDLMFHMQRQRKLPEEHARFYAAEICI- 107
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET----DHLCSYVQSRSYRA 1043
AL FLH G+I+ DLK +N+L+ + +K+ D G C E D ++ + +Y A
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDADG--HIKLTDYGM-CKEGLGPGDTTSTFCGTPNYIA 164
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQ--NDSP 1080
PE++ G Y +D W+LG ++ E+ G F D+P
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 18/179 (10%)
Query: 897 VCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL-KA 955
V VK +K + L+E +++K + +HD L++LY E + IV E + K
Sbjct: 33 VAVKTLKPGTMSPESFLEEAQIMKKL-RHD-----KLVQLYAVVS-EEPIYIVTEYMSKG 85
Query: 956 NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC 1015
+L +F K G +P L + Q + ++ + IH DL+ NILV C
Sbjct: 86 SLLDFLK----DGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVC 141
Query: 1016 EVKVIDLGSSCFETDHLCSYVQSRSY----RAPEVILGLSYDKKIDIWSLGCILAELCT 1070
K+ D G + D+ + Q + APE L + K D+WS G +L EL T
Sbjct: 142 --KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-07
Identities = 34/107 (31%), Positives = 56/107 (52%), Gaps = 12/107 (11%)
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD-----HLCSYV 1036
T + + AL +H +GLIH D+KP+N+L+ + +K+ D G +C + D + V
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFG-TCMKMDETGMVRCDTAV 204
Query: 1037 QSRSYRAPEVILGLS----YDKKIDIWSLGCILAELCTGNVLFQNDS 1079
+ Y +PEV+ Y ++ D WS+G L E+ G+ F DS
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936
+G +++K + T +K++K D+ +D ++ K+V + + L+ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF-LVGL 61
Query: 937 YDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG 996
+ F L V E + FH + E + R S I AL +LH G
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH---ARFYSAEISL--ALNYLHERG 116
Query: 997 LIHCDLKPENILVKSYSRCEVKVIDLGSSCFET----DHLCSYVQSRSYRAPEVILGLSY 1052
+I+ DLK +N+L+ S +K+ D G C E D ++ + +Y APE++ G Y
Sbjct: 117 IIYRDLKLDNVLLDSEG--HIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 1053 DKKIDIWSLGCILAELCTG----NVLFQNDSP 1080
+D W+LG ++ E+ G +++ +D+P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 56/213 (26%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVK-------SYSRCEVKVIDLGSSCFETDHLC 1033
I L+AL ++H +G +H +K +IL+ S R + +I+ G
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFP 165
Query: 1034 SY-VQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT--LLARVI 1088
Y V+ + +PEV+ YD K DI+S+G EL G+V F+ D PAT LL ++
Sbjct: 166 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK-DMPATQMLLEKLN 224
Query: 1089 GIIG--------PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLP 1140
G + P E+ + R + +N P +
Sbjct: 225 GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH-- 282
Query: 1141 MGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
F FV L+ NP RPSAS L H +
Sbjct: 283 -----FHHFVEQCLQRNPDARPSASTLLNHSFF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 18/179 (10%)
Query: 897 VCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL-KA 955
V +K +K + L E +++K + +HD L+ LY E + IV E + K
Sbjct: 33 VAIKTLKPGTMMPEAFLQEAQIMKKL-RHD-----KLVPLYAVVS-EEPIYIVTEFMGKG 85
Query: 956 NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC 1015
+L +F K G Y +P+L + Q + + ++ + IH DL+ NILV C
Sbjct: 86 SLLDFLK----EGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVC 141
Query: 1016 EVKVIDLGSSCFETDHLCSYVQSRSY----RAPEVILGLSYDKKIDIWSLGCILAELCT 1070
K+ D G + D+ + Q + APE L + K D+WS G +L EL T
Sbjct: 142 --KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 40/134 (29%), Positives = 69/134 (51%), Gaps = 11/134 (8%)
Query: 960 FHKFNRESGGEVYFTMPRLQSIT--IQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017
+HK +E G++ +P Q + +Q ALQ+LH ++H DLK +N+ + + +
Sbjct: 88 YHKL-KEQKGKL---LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--I 141
Query: 1018 KVIDLG-SSCFET--DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVL 1074
KV DLG + E D + + + Y +PE+ Y+ K D+W+LGC + E+ T
Sbjct: 142 KVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201
Query: 1075 FQNDSPATLLARVI 1088
F +L+ R+I
Sbjct: 202 FNAKDMNSLVYRII 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 25/222 (11%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD-EIKLLKYVNKHDPGDKYHLLR 935
LG +F K + A T +KI+K KD Q D E +++ G L +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILK--KDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65
Query: 936 LYDYFYYREHLLIVCELLKAN--LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH 993
L+ F + L V E + +Y+ + R F P + L FLH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-------FKEPHAVFYAAEIAIGLFFLH 118
Query: 994 GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE-------TDHLCSYVQSRSYRAPEV 1046
G+I+ DLK +N+++ S +K+ D G C E T C + Y APE+
Sbjct: 119 SKGIIYRDLKLDNVMLDSEG--HIKIADFGM-CKENMWDGVTTKTFCG---TPDYIAPEI 172
Query: 1047 ILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
I Y K +D W+ G +L E+ G F+ + L ++
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD-----HLCSYV 1036
T + + AL +H +G IH D+KP+N+L+ +K+ D G +C + D + V
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFG-TCMKMDANGMVRCDTAV 204
Query: 1037 QSRSYRAPEVILGLS----YDKKIDIWSLGCILAELCTGNVLFQNDS 1079
+ Y +PEV+ Y ++ D WS+G L E+ G+ F DS
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET--DHLCSY--VQSRSYR 1042
A+ +H +G +H D+KPEN+L+ +K+ D GS+ T + S V + Y
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYI 170
Query: 1043 APEVILGLS------YDKKIDIWSLGCILAELCTGNVLFQNDSPA 1081
APEV+ ++ Y + D WSLG I E+ G F + A
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 22/209 (10%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG F K I + TG +KI+K KD +L E ++L+ N P
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQ--NTRHP----F 56
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
L L F + L V E FH +RE F+ R + + + AL +L
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRER----VFSEDRARFYGAEIVSALGYL 111
Query: 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET----DHLCSYVQSRSYRAPEVIL 1048
H +++ DLK EN+++ +K+ D G C E + ++ + Y APEV+
Sbjct: 112 HSCDVVYRDLKLENLMLDKDG--HIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLE 168
Query: 1049 GLSYDKKIDIWSLGCILAELCTGNVLFQN 1077
Y + +D W LG ++ E+ G + F N
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 3e-07
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 38/219 (17%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG F K + A TG +K +K +D + + E ++ + N + H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS-----ERH 61
Query: 933 --LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY-------FTMPRLQSITI 983
L+ L+ F +H+ V E +GG++ F+ PR
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYA-------------AGGDLMMHIHTDVFSEPRAVFYAA 108
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE----TDHLCSYVQSR 1039
+ LQ+LH +++ DLK +N+L+ + VK+ D G C E D ++ +
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGL-CKEGMGFGDRTSTFCGTP 165
Query: 1040 SYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078
+ APEV+ SY + +D W LG ++ E+ G F D
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 940 FYYREHLLIVCELLKANLYEFHKFN--RESGGEVYFTMPRLQSITIQCLEALQFLHGLGL 997
F + L +V ++ +H +N E+ G F PR T Q + L+ LH +
Sbjct: 62 FQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG---FPEPRACFYTAQIISGLEHLHQRRI 118
Query: 998 IHCDLKPENILVKSYSRCEVKVIDLGSSCFETD---HLCSYVQSRSYRAPEVILGLSYDK 1054
I+ DLKPEN+L+ + V++ DLG + D Y + + APE++ G YD
Sbjct: 119 IYRDLKPENVLLDNDG--NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 1055 KIDIWSLGCILAEL 1068
+D ++LG L E+
Sbjct: 177 SVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFFDQSLDEIKLLKYVNKHDPGD 929
Y + + +GS + +A +LHTG VKIIK D F EI ++K +
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN--- 67
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQ--CLE 987
++ + + RE L I E S ++Y L + I C E
Sbjct: 68 ---IVAYFGSYLSREKLWICMEYCGGG----------SLQDIYHVTGPLSELQIAYVCRE 114
Query: 988 ALQ---FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---SYVQSRSY 1041
LQ +LH G +H D+K NIL+ +VK+ D G + T + S++ + +
Sbjct: 115 TLQGLAYLHSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYW 172
Query: 1042 RAPEVIL---GLSYDKKIDIWSLGCILAEL 1068
APEV Y++ DIW++G EL
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-07
Identities = 35/117 (29%), Positives = 55/117 (47%), Gaps = 11/117 (9%)
Query: 984 QCLEALQFLHGLGLIHCDLKPENILV-KSYSRCEVKVID-----LGSSCFETDHL----- 1032
Q L+AL H G++H DLKP+NI+V ++ R KV+D L + D
Sbjct: 87 QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146
Query: 1033 CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089
+ + +Y APE + G D+++ G I E TG + Q S A +L + +
Sbjct: 147 TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLS 203
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 877 LGSAAFSKAIQAHDLHTG-MDVCVKI----IKNNKDFFDQSLDEIKLLKYVNKHDPGDKY 931
LG F + TG M C K+ IK K +L+E ++L+ VN
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE-AMALNEKRILEKVNSR------ 60
Query: 932 HLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
++ L + ++ L +V ++ +FH +N + G F R + L+
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLED 117
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLS 1051
L +++ DLKPENIL+ + + L E + + V + Y APEVI
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK 177
Query: 1052 YDKKIDIWSLGCILAELCTGNVLFQ 1076
Y D W LGC++ E+ G F+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-07
Identities = 72/298 (24%), Positives = 113/298 (37%), Gaps = 75/298 (25%)
Query: 893 TGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950
TG +K+I N + Q EI++L+ VN + +++ +D F + + ++
Sbjct: 98 TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPN------VVKCHDMFDHNGEIQVLL 151
Query: 951 ELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVK 1010
E + E E L + Q L + +LH ++H D+KP N+L+
Sbjct: 152 EFMDGGSLEGTHIADE---------QFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN 202
Query: 1011 SYSRCEVKVIDLGSSCF--ETDHLC-SYVQSRSYRAPEVI-LGLS---YDKKI-DIWSLG 1062
S VK+ D G S +T C S V + +Y +PE I L+ YD DIWSLG
Sbjct: 203 SAKN--VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLG 260
Query: 1063 CILAELCTGNVLF----QNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYER 1118
+ E G F Q D + + A I + P E
Sbjct: 261 VSILEFYLGRFPFGVGRQGDWASLMCA--ICMSQPPEA---------------------- 296
Query: 1119 NQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176
P S + F F++ L+ P KR SA L+HP++
Sbjct: 297 -----------PATAS---------REFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334
|
Length = 353 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 34/220 (15%)
Query: 877 LGSAAFSKAIQAHDLHTGMD---------VCVKIIKNN---KDFFDQSLDEIKLLKYVNK 924
LG F + ++A G+D V VK++K+N KD D + E++L+K + K
Sbjct: 20 LGEGCFGQVVRAEAY--GIDKSRPDQTVTVAVKMLKDNATDKDLADL-ISEMELMKLIGK 76
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPR------ 977
H +++ L L ++ E K NL EF + R G + F + +
Sbjct: 77 HK-----NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 978 ----LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC 1033
L S Q +++L IH DL N+LV + ++ L + D+
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 1034 SYVQSR---SYRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
R + APE + Y + D+WS G ++ E+ T
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-06
Identities = 39/147 (26%), Positives = 55/147 (37%), Gaps = 48/147 (32%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCSYVQSRS------ 1040
A++ +H +G IH D+KP+NIL+ +K+ D G + F H Y Q
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 1041 ---------------------------------------YRAPEVILGLSYDKKIDIWSL 1061
Y APEV+L Y + D WS+
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 1062 GCILAELCTGNVLFQNDSPATLLARVI 1088
G IL E+ G F D+PA +VI
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVI 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 38/212 (17%)
Query: 877 LGSAAFSKAIQAHDLHTG----MDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDK 930
LGS AF + + G + V +K+++ + LDE ++ V D
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV------DH 68
Query: 931 YHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQ 990
H++RL + LI + L ++ + ++++ G Y L + +Q + +
Sbjct: 69 PHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY-----LLNWCVQIAKGMS 123
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCSYVQSRSYR------- 1042
+L L+H DL N+LVK+ VK+ D G + + D + Y
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLDVD-------EKEYHAEGGKVP 174
Query: 1043 ----APEVILGLSYDKKIDIWSLGCILAELCT 1070
A E IL Y K D+WS G + EL T
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 30/218 (13%)
Query: 877 LGSAAFSKAIQAHDLHTGMD-------VCVKIIKNN---KDFFDQSLDEIKLLKYVNKHD 926
LG F + + A L D V VK++K++ KD D + E++++K + KH
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK 81
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPR-------- 977
+++ L L ++ E K NL E+ + R G E + + R
Sbjct: 82 -----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 978 --LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY 1035
L S T Q +++L IH DL N+LV + ++ L D+
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 1036 VQSR---SYRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
R + APE + Y + D+WS G ++ E+ T
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQS-LDEIKLLKYVNKHDPGDKYHL 933
E +G F +Q +TG V VK IK D Q+ L+E ++ ++ + L
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKN------L 61
Query: 934 LRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
+RL + L IV EL+ K NL F + + G ++ +L ++ E +++L
Sbjct: 62 VRLLGVILH-NGLYIVMELMSKGNLVNFLR----TRGRALVSVIQLLQFSLDVAEGMEYL 116
Query: 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSY 1052
L+H DL NILV KV D G + + + + + APE + +
Sbjct: 117 ESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKF 174
Query: 1053 DKKIDIWSLGCILAEL 1068
K D+WS G +L E+
Sbjct: 175 SSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 16/179 (8%)
Query: 896 DVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA 955
DV +K+IK D+ ++E K++ + L++LY + + IV E +
Sbjct: 30 DVAIKMIKEGSMSEDEFIEEAKVM--MKLSHE----KLVQLYGVCTKQRPIYIVTEYMSN 83
Query: 956 NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC 1015
+ RE G F +L + E + +L IH DL N LV +
Sbjct: 84 GC--LLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD--QG 137
Query: 1016 EVKVIDLGSSCFE-TDHLCSYVQSR---SYRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
VKV D G S + D S V S+ + PEV+L + K D+W+ G ++ E+ +
Sbjct: 138 CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-06
Identities = 32/111 (28%), Positives = 47/111 (42%), Gaps = 30/111 (27%)
Query: 988 ALQFLHGLGLIHCDLKPENILV---------------KSYSRCEVKVIDLGS-------- 1024
AL++LH LG+++ DLKPENIL+ +S L
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 1025 -------SCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAEL 1068
S + S+V + Y APEVI G + +D W+LG +L E+
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 21/220 (9%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG F K I + TG +KI+K KD +L E ++L+ N P
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ--NSRHP----F 56
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
L L F + L V E FH +RE F+ R + + + AL +L
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRER----VFSEDRARFYGAEIVSALDYL 111
Query: 993 HG-LGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRAPEVIL 1048
H +++ DLK EN+++ +K+ D G + + ++ + Y APEV+
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169
Query: 1049 GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
Y + +D W LG ++ E+ G + F N L ++
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 59/218 (27%), Positives = 88/218 (40%), Gaps = 35/218 (16%)
Query: 877 LGSAAFSKAIQA--HDLHTGMD---VCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKY 931
LG AF K A H+L D V VK +K + Q L V +H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ----- 67
Query: 932 HLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY------------FTMPRLQ 979
H++R Y LL+V E ++ + ++F R G + T+ ++
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHG--DLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCSYVQ 1037
+I Q + +L L +H DL N LV VK+ D G S + TD+ V
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQG--LVVKIGDFGMSRDIYSTDYY--RVG 181
Query: 1038 SRS-----YRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
R+ + PE IL + + DIWS G +L E+ T
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-06
Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 55/161 (34%)
Query: 963 FNRESGGE-VYFTMPRLQSITIQCL-------EAL------------------------Q 990
++ S G+ VY+TMP ++ T++ L E+L +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSY------------ 1035
++H G++H DLKP+NIL+ + EV ++D G++ F E + L
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFG--EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 1036 ------VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
V + Y APE +LG+ + DI++LG IL ++ T
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-06
Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 26/174 (14%)
Query: 929 DKYHLLRLYDYFYYREHLLIVCEL---------LKANLYEFHKFNRESGGEVYFTMPRLQ 979
D + +++ +D F + LL++ E +K L E F G +++
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFY------ 176
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC-----S 1034
Q + AL +H ++H DLK NI + +K+ D G S +D + S
Sbjct: 177 ----QIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSLDVASS 230
Query: 1035 YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
+ + Y APE+ Y KK D+WSLG IL EL T + F+ S ++ +V+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 15/154 (9%)
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL 992
L++LY ++ L IV E ++ + R+ G++ M L S+ E +++L
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGC--LLNYLRQRQGKLSKDM--LLSMCQDVCEGMEYL 116
Query: 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSR------SYRAPEV 1046
IH DL N LV S VKV D G + + D Y S + PEV
Sbjct: 117 ERNSFIHRDLAARNCLVSS--TGVVKVSDFGMTRYVLDD--EYTSSSGAKFPVKWSPPEV 172
Query: 1047 ILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDS 1079
Y K D+WS G ++ E+ T G + F+ S
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-06
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 29/224 (12%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG +F K + A T +KI+K + D + ++ E ++L +K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP-----F 62
Query: 933 LLRLYDYFYYREHLLIVCELLKAN--LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQ 990
L +L+ F + L V E + +Y + + F P+ + L
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-------FKEPQAVFYAAEISVGLF 115
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS------YRAP 1044
FLH G+I+ DLK +N+++ S +K+ D G C E H+ V +R+ Y AP
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEG--HIKIADFGM-CKE--HMVDGVTTRTFCGTPDYIAP 170
Query: 1045 EVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
E+I Y K +D W+ G +L E+ G F + L ++
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-05
Identities = 42/124 (33%), Positives = 57/124 (45%), Gaps = 30/124 (24%)
Query: 981 ITIQCLEALQFLHGLG-------LIHCDLKPENILVKS---------------YSRCEVK 1018
IT Q L AL + H L ++H DLKP+NI + + R K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 1019 VIDLGSS----CFETDHLCSYVQSRSYRAPEVIL--GLSYDKKIDIWSLGCILAELCTGN 1072
+ D G S H C V + Y +PE++L SYD K D+W+LGCI+ ELC+G
Sbjct: 183 IGDFGLSKNIGIESMAHSC--VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
Query: 1073 VLFQ 1076
F
Sbjct: 241 TPFH 244
|
Length = 1021 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 897 VCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL-KA 955
V +K +K + L E +++K + +H+ L++LY E + IV E + K
Sbjct: 33 VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE-----KLVQLYAVVS-EEPIYIVTEYMSKG 85
Query: 956 NLYEFHKFNRESGGEV--YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013
+L +F K GE+ Y +P+L + Q + ++ + +H DL+ NILV
Sbjct: 86 SLLDFLK------GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 139
Query: 1014 RCEVKVIDLGSSCFETDHLCSYVQSRSY----RAPEVILGLSYDKKIDIWSLGCILAELC 1069
C KV D G + D+ + Q + APE L + K D+WS G +L EL
Sbjct: 140 VC--KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 197
Query: 1070 T 1070
T
Sbjct: 198 T 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 44/154 (28%), Positives = 65/154 (42%), Gaps = 15/154 (9%)
Query: 943 REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDL 1002
R LI+ L +L ++ + +R+ + RL + Q + + +L IH DL
Sbjct: 81 RSLRLIMEYLPSGSLRDYLQRHRDQIN-----LKRLLLFSSQICKGMDYLGSQRYIHRDL 135
Query: 1003 KPENILVKSYSRCEVKVIDLGSSCF-ETDHLCSYVQSRS-----YRAPEVILGLSYDKKI 1056
NILV+S VK+ D G + D YV+ + APE + +
Sbjct: 136 AARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSAS 193
Query: 1057 DIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090
D+WS G L EL T Q SP R+IGI
Sbjct: 194 DVWSFGVTLYELFTYGDPSQ--SPPAEFLRMIGI 225
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 29/82 (35%), Positives = 36/82 (43%), Gaps = 12/82 (14%)
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRA 1043
QCL AL+ LH L + L+K GS F+T + A
Sbjct: 25 QCLGALRELHRQAKSGNILLTWDGLLKLD----------GSVAFKTPE--QSRPDPYFMA 72
Query: 1044 PEVILGLSYDKKIDIWSLGCIL 1065
PEVI G SY +K DI+SLG L
Sbjct: 73 PEVIQGQSYTEKADIYSLGITL 94
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-05
Identities = 21/48 (43%), Positives = 31/48 (64%), Gaps = 1/48 (2%)
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025
+Q+I Q L AL LH G++H D+KP+NI+ S K+IDLG++
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG-SFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 36/220 (16%)
Query: 877 LGSAAFSKAIQAH----DLHTG-MDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPG 928
LG AF + ++A D V VK++K++ KD D + E++++K + KH
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK-- 76
Query: 929 DKYHLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPR---------- 977
+++ L L +V E NL +F + R G PR
Sbjct: 77 ---NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQ 1037
L S Q ++FL IH DL N+LV +K+ D G + H Y +
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH--VMKIADFGLA--RDIHHIDYYR 189
Query: 1038 SRS-------YRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
+ + APE + Y + D+WS G +L E+ T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-05
Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 900 KIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYE 959
K +K Q +EI L +N + +LR Y ++ + +LY
Sbjct: 198 KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTY------MITQKYDFDLYS 251
Query: 960 FHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019
F ++ + + + ++I Q L A++++H LIH D+K ENI + C+ K+
Sbjct: 252 F-MYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN----CDGKI 306
Query: 1020 I--DLGSSC-FETDHLC---SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNV 1073
+ D G++ FE + +V + + +PE++ G Y + DIWS G IL ++ + +
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
Query: 1074 LFQND---SPATLLARVI 1088
D P L ++I
Sbjct: 367 CPIGDGGGKPGKQLLKII 384
|
Length = 501 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 18/179 (10%)
Query: 897 VCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL-KA 955
V +K +K + L E L+K + +H L+RLY +E + I+ E +
Sbjct: 33 VAIKSLKQGSMSPEAFLAEANLMKQL-QHP-----RLVRLYAVVT-QEPIYIITEYMENG 85
Query: 956 NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC 1015
+L +F K G ++ T+ +L + Q E + F+ IH DL+ NILV C
Sbjct: 86 SLVDFLK--TPEGIKL--TINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCC 141
Query: 1016 EVKVIDLG-SSCFETDHLCSYVQSR---SYRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
K+ D G + E + + ++ + APE I ++ K D+WS G +L E+ T
Sbjct: 142 --KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 70/314 (22%), Positives = 119/314 (37%), Gaps = 69/314 (21%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFFDQSLDEIKLLKYVNKHDPGD 929
+ + + +GS + +A +++TG +K+IK + F EI ++K KH
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHS--- 66
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI-----Q 984
+++ + + R+ L I E S ++Y L I +
Sbjct: 67 --NIVAYFGSYLRRDKLWICMEFCGGG----------SLQDIYHVTGPLSESQIAYVSRE 114
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---SYVQSRSY 1041
L+ L +LH G +H D+K NIL+ VK+ D G S T + S++ + +
Sbjct: 115 TLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRKSFIGTPYW 172
Query: 1042 RAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098
APEV Y++ DIW++G EL + P L
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------------- 218
Query: 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINP 1158
++ + N + +L+ + S H FV L NP
Sbjct: 219 --------------FLMTKSNFQPPKLKDKMKWSNSFHH-----------FVKMALTKNP 253
Query: 1159 KKRPSASDALKHPW 1172
KKRP+A L+HP+
Sbjct: 254 KKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 33/126 (26%), Positives = 50/126 (39%), Gaps = 13/126 (10%)
Query: 954 KANLYEFHKFNRESGGEVYFTMPRLQ--SITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011
NL F + R + Q + IQ + +LH G+IH D+ N ++
Sbjct: 93 WGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE 152
Query: 1012 YSRCEVKVID--LGSSCFETDHLCSYVQSRSYR-----APEVILGLSYDKKIDIWSLGCI 1064
+ VK+ D L F D+ C + R A E ++ Y D+WS G +
Sbjct: 153 ELQ--VKITDNALSRDLFPMDYHC--LGDNENRPVKWMALESLVNKEYSSASDVWSFGVL 208
Query: 1065 LAELCT 1070
L EL T
Sbjct: 209 LWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 30/89 (33%), Positives = 38/89 (42%), Gaps = 2/89 (2%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVI 1047
AL LH G++ DL P NIL+ R +++ D Y APEV
Sbjct: 97 ALDALHREGIVCRDLNPNNILLDD--RGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVG 154
Query: 1048 LGLSYDKKIDIWSLGCILAELCTGNVLFQ 1076
+ D WSLG IL EL TG L +
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 877 LGSAAFSKAIQ--AHDL-HTG--MDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHDPGD 929
LG+ AF K ++ A+ L + M V VK++K ++ + E+K++ ++ H+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE--- 99
Query: 930 KYHLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988
+++ L +L++ E +L F + RES + T+ L S + Q +
Sbjct: 100 --NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES----FLTLEDLLSFSYQVAKG 153
Query: 989 LQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD--HLCSYVQSRSYR---- 1042
+ FL IH DL N+L+ K++ + D + +YV + R
Sbjct: 154 MAFLASKNCIHRDLAARNVLL-----THGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 1043 --APEVILGLSYDKKIDIWSLGCILAEL 1068
APE I Y + D+WS G +L E+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 855 EDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMD---------VCVKIIKNN 905
ED + V + ++ G+ LG F + + A + G+D V VK++K++
Sbjct: 9 EDPRWEVPRDRLVLGKP-----LGEGCFGQVVMAEAI--GLDKEKPNRVTKVAVKMLKSD 61
Query: 906 ---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL-KANLYEFH 961
KD D + E++++K + KH +++ L L ++ E K NL E+
Sbjct: 62 ATEKDLSDL-ISEMEMMKMIGKHK-----NIINLLGACTQDGPLYVIVEYASKGNLREYL 115
Query: 962 KFNRESGGEVYF----------TMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011
+ R G E + + L S Q +++L IH DL N+LV
Sbjct: 116 RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175
Query: 1012 YSRCEVKVIDLGSSCFETDHLCSYVQSR---SYRAPEVILGLSYDKKIDIWSLGCILAEL 1068
+ ++ L D+ R + APE + Y + D+WS G +L E+
Sbjct: 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
Query: 1069 CT 1070
T
Sbjct: 236 FT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 20/182 (10%)
Query: 897 VCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH-LLIVCELLK- 954
V VK +K++K +D+ LK D +L+RLY H L++V EL
Sbjct: 26 VAVKCLKSDK--LSDIMDD--FLKEAAIMHSLDHENLIRLYGVV--LTHPLMMVTELAPL 79
Query: 955 ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014
+L + + + +F + L +Q +++L IH DL NIL+ S
Sbjct: 80 GSLLDRLRKDALG----HFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL--ASD 133
Query: 1015 CEVKVIDLGSS---CFETDHLCSYVQSR---SYRAPEVILGLSYDKKIDIWSLGCILAEL 1068
+VK+ D G DH + ++ APE + ++ D+W G L E+
Sbjct: 134 DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
Query: 1069 CT 1070
T
Sbjct: 194 FT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 30/218 (13%)
Query: 877 LGSAAFSKAIQAHDLHTGMD-------VCVKIIKNN---KDFFDQSLDEIKLLKYVNKHD 926
LG F + + A + D V VK++K++ KD D + E++++K + KH
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL-VSEMEMMKMIGKHK 78
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYF----------TM 975
+++ L L ++ E K NL E+ + R G + F T
Sbjct: 79 -----NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 976 PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY 1035
L S Q +++L IH DL N+LV + ++ L D+
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 1036 VQSR---SYRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
R + APE + Y + D+WS G +L E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 54/201 (26%)
Query: 954 KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE--------ALQFLHGLGLIHCDLKPE 1005
K NLY +F GG++ + + ++T + + A+ +H LG IH D+KP+
Sbjct: 73 KLNLYLIMEF--LPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPD 130
Query: 1006 NILVKSYSRCEVKVIDLG---------------------SSCFETDHLCSYVQSRSYR-- 1042
N+L+ S + VK+ D G S F ++ S ++ +++
Sbjct: 131 NLLLDS--KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188
Query: 1043 ---------------APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
APEV + Y+K D WSLG I+ E+ G F +++P +V
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248
Query: 1088 IG----IIGPIEQGMLAKGRD 1104
+ +I P E + K +D
Sbjct: 249 MNWKETLIFPPEVPISEKAKD 269
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-04
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 983 IQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-----SSCFETDHLCSYVQ 1037
IQ L A+ +H +IH D+K NIL+ S VK+ D G ++ D ++
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 1038 SRSYRAPEVILGLSYDKKIDIWSLGCILAELCT 1070
+ Y APE+ Y KK D++SLG +L EL T
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 12/146 (8%)
Query: 931 YHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQ 990
++++RL + +I+ E ++ + K+ R+ GE F+ +L + ++
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALD--KYLRDHDGE--FSSYQLVGMLRGIAAGMK 121
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCSYVQSRS-----YRAP 1044
+L + +H DL NILV S C KV D G S E D +Y S + AP
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLEC--KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 1045 EVILGLSYDKKIDIWSLGCILAELCT 1070
E I + D+WS G ++ E+ +
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 12/107 (11%)
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH----LC-SYV 1036
T + + AL +H +G IH D+KP+N+L+ +K+ D G +C + + C + V
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFG-TCMKMNKEGMVRCDTAV 204
Query: 1037 QSRSYRAPEVILGLS----YDKKIDIWSLGCILAELCTGNVLFQNDS 1079
+ Y +PEV+ Y ++ D WS+G L E+ G+ F DS
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 40/139 (28%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---------------------SSC 1026
A+ +H LG IH D+KP+N+L+ + + VK+ D G S
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDA--KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 1027 FETDHL-----------------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELC 1069
F ++ S V + Y APEV + Y+K D WSLG I+ E+
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 1070 TGNVLFQNDSPATLLARVI 1088
G F +++P +V+
Sbjct: 231 IGYPPFCSETPQETYRKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 36/138 (26%), Positives = 53/138 (38%), Gaps = 52/138 (37%)
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCSYVQ----- 1037
+C+ A++ +H LG IH D+KP+NIL+ +K+ D G S+ F H +Y Q
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILID--RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 1038 ---------------------------------SR-----------SYRAPEVILGLSYD 1053
+R Y APE+ L Y
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 1054 KKIDIWSLGCILAELCTG 1071
++ D WSLG I+ E G
Sbjct: 227 QECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 45/200 (22%), Positives = 77/200 (38%), Gaps = 38/200 (19%)
Query: 892 HTGMDVCVKIIKNNKDFFD--QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIV 949
V +K + N + + L+E ++K N H H++RL + L+V
Sbjct: 34 EPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH------HVVRLLGVVSTGQPTLVV 87
Query: 950 CELL-KANLYEFHKFNRESGGEVYFTMP----RLQSITIQCLEALQFLHGLGLIHCDLKP 1004
EL+ K +L + + R P + + + + + +L +H DL
Sbjct: 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAA 147
Query: 1005 ENILVKSYSRCEVKVIDLGSS--CFETDHLCSYVQSRSYR------------APEVILGL 1050
N +V VK+ D G + +ETD+ YR APE +
Sbjct: 148 RNCMVAEDL--TVKIGDFGMTRDIYETDY---------YRKGGKGLLPVRWMAPESLKDG 196
Query: 1051 SYDKKIDIWSLGCILAELCT 1070
+ K D+WS G +L E+ T
Sbjct: 197 VFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 30/94 (31%), Positives = 41/94 (43%), Gaps = 7/94 (7%)
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSR 1039
I IQ +++L +H DL N LV VK+ D G S VQS+
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 1040 S-----YRAPEVILGLSYDKKIDIWSLGCILAEL 1068
S + PE IL + + DIWS G +L E+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 37/218 (16%)
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVK----------SYSRCEVKVIDLGSSCF 1027
+ +I L L +LH G IH ++K +IL+ S+ V+ +
Sbjct: 103 IGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 1028 ETDHLCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT--L 1083
+ + V + +PE++ Y+ K DI+S+G EL TG V FQ D T L
Sbjct: 163 DFPQFSTSVLP--WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ-DMLRTQML 219
Query: 1084 LARVIGI--------IGPIEQGMLAKGRDTYKYFTKNHMLYERNQET---NRLEYLIPKK 1132
L ++ G P E+ + + ++ +T RL K
Sbjct: 220 LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKT 279
Query: 1133 TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170
S F + V L+ +P+KRPSAS L H
Sbjct: 280 FS---------PAFQNLVELCLQQDPEKRPSASSLLSH 308
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 44/198 (22%), Positives = 79/198 (39%), Gaps = 15/198 (7%)
Query: 872 HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKY 931
+ +G F + + G V VK +K++ L E ++ + +H
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHP----- 60
Query: 932 HLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQ 990
+L++L L IV E + K +L ++ + S G T+ + + E ++
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR----SRGRAVITLAQQLGFALDVCEGME 116
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL 1050
+L +H DL N+LV KV D G + + S + APE +
Sbjct: 117 YLEEKNFVHRDLAARNVLVSE--DLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREK 174
Query: 1051 SYDKKIDIWSLGCILAEL 1068
+ K D+WS G +L E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-04
Identities = 39/151 (25%), Positives = 58/151 (38%), Gaps = 52/151 (34%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG------------------------ 1023
A++ +H +G IH D+KP+NIL+ +K+ D G
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 1024 ----------SSCFETDHL-------------C---SYVQSRSYRAPEVILGLSYDKKID 1057
++C D L C S V + +Y APEV+L Y + D
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230
Query: 1058 IWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
WS+G IL E+ G F +P +VI
Sbjct: 231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVI 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 8e-04
Identities = 19/48 (39%), Positives = 32/48 (66%), Gaps = 2/48 (4%)
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025
++ + Q L L+ LH +G++H D+KPEN+LV +VK+ID G++
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG--QVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-04
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMD----VCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDPG 928
E LG AF K + H GMD V +K +K NN + + E L+ + H P
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL--HHP- 67
Query: 929 DKYHLLRLYDYFYYREHLLIVCELL-KANLYEF------HK---FNRESGGEVYFTMPR- 977
+++ L + + ++ E L + +L+EF H + + G V ++
Sbjct: 68 ---NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 978 -LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCS 1034
I IQ +++L +H DL NIL+ + VK+ DLG S + D+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE--QLHVKISDLGLSREIYSADYY-- 180
Query: 1035 YVQSRS-----YRAPEVILGLSYDKKIDIWSLGCILAEL 1068
VQ +S + PE I+ + DIWS G +L E+
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-04
Identities = 37/149 (24%), Positives = 55/149 (36%), Gaps = 48/149 (32%)
Query: 988 ALQFLHGLGLIHCDLKPENILVK------------------------------------- 1010
A++ +H +G IH D+KP+NIL+
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 1011 --------SYSRCEVKVIDLGSSCFETDHLC---SYVQSRSYRAPEVILGLSYDKKIDIW 1059
S RC ++ L + C S V + +Y APEV+L Y + D W
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 1060 SLGCILAELCTGNVLFQNDSPATLLARVI 1088
S+G IL E+ G F +P +VI
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVI 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 34/112 (30%), Positives = 51/112 (45%), Gaps = 10/112 (8%)
Query: 963 FNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022
F R+ G+ FT+ +L + +++L +G +H DL NILV S C KV D
Sbjct: 95 FLRKHDGQ--FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC--KVSDF 150
Query: 1023 G-SSCFETDHLCSYVQSRS-----YRAPEVILGLSYDKKIDIWSLGCILAEL 1068
G S E D +Y + APE I + D+WS G ++ E+
Sbjct: 151 GLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 893 TGMDVCVKIIKNNKDFFDQSLD-EIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951
TG V VK ++++ + + EI++LK + +HD KY + Y R +L +V E
Sbjct: 32 TGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKY---KGVCYSAGRRNLRLVME 87
Query: 952 LLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVK 1010
L +L ++ + +RE +L Q + +++L +H DL NILV+
Sbjct: 88 YLPYGSLRDYLQKHRER-----LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE 142
Query: 1011 SYSRCEVKVIDLG-SSCFETDHLCSYVQSRS-----YRAPEVILGLSYDKKIDIWSLGCI 1064
S +R VK+ D G + D V+ + APE + + D+WS G +
Sbjct: 143 SENR--VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVV 200
Query: 1065 LAELCTGNVLFQNDSPATLLARVIG 1089
L EL T ++ SP R++G
Sbjct: 201 LYELFT--YSDKSCSPPAEFMRMMG 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 41/155 (26%), Positives = 66/155 (42%), Gaps = 17/155 (10%)
Query: 933 LLRLYDYFYYREHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
L++LY R + +V E ++ L ++ + R F+ L + + E + +
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-----FSQETLLGMCLDVCEGMAY 115
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS------YRAPE 1045
L +IH DL N LV VKV D G + F D Y S + +PE
Sbjct: 116 LESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPE 171
Query: 1046 VILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDS 1079
V Y K D+WS G ++ E+ + G ++N S
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 32/107 (29%), Positives = 46/107 (42%), Gaps = 11/107 (10%)
Query: 969 GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCF 1027
+ T+ L S + Q ++FL IH DL NIL+ + VK+ D G +
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDI 223
Query: 1028 ETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILAEL 1068
D YV+ R APE I Y + D+WS G +L E+
Sbjct: 224 YKDP--DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 26/137 (18%), Positives = 48/137 (35%), Gaps = 26/137 (18%)
Query: 896 DVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA 955
D +KI + + D+ E+ +L+ + + + ++ ++ E ++
Sbjct: 23 DYVLKINPSREKGADR-EREVAILQLLARKGL----PVPKVLASGESDGWSYLLMEWIE- 76
Query: 956 NLYEFHKFNRESGGEVYFTMPRLQSITIQCL--EALQFLHGL---GLIHCDLKPENILVK 1010
GE + + I E L LH L L H DL P NILV
Sbjct: 77 -------------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD 123
Query: 1011 SYSRCEVKVIDLGSSCF 1027
+ +ID + +
Sbjct: 124 DGK--ILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.003
Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 15/103 (14%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSR------SY 1041
A+ +H LG +H D+KP+N+L+ +++ D G SC + VQS Y
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLD--KNGHIRLADFG-SCLRLLADGT-VQSNVAVGTPDY 169
Query: 1042 RAPEVILGL-----SYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
+PE++ + Y + D WSLG + E+ G F +S
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.004
Identities = 34/146 (23%), Positives = 64/146 (43%), Gaps = 15/146 (10%)
Query: 932 HLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQ 990
+++RL ++I+ E ++ +L +F + N FT+ +L + ++
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMK 120
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS------YRAP 1044
+L + +H DL NILV S C KV D G S + + ++ + AP
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVC--KVSDFGLS-RRLEDSEATYTTKGGKIPIRWTAP 177
Query: 1045 EVILGLSYDKKIDIWSLGCILAELCT 1070
E I + D+WS G ++ E+ +
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 17/48 (35%), Positives = 28/48 (58%), Gaps = 2/48 (4%)
Query: 976 PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023
+++I L L+++H G+ H D+KPENI+V +R +ID G
Sbjct: 126 KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG--YIIDYG 171
|
Length = 294 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1182 | |||
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.93 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.57 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.57 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.55 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.38 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.06 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.97 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.85 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.82 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.78 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.64 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.21 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.21 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.09 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.05 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.99 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.94 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.92 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.74 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.56 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.56 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.52 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.51 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.4 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.38 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.33 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.32 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.07 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.88 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.87 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.73 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.71 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.68 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.67 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.66 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.41 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.34 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.32 | |
| PLN02236 | 344 | choline kinase | 96.23 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.22 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.03 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.66 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.41 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.34 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.07 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.77 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.34 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.29 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.95 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.78 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.55 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.16 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.62 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 92.28 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 91.67 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 89.31 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 87.99 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 83.65 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 82.36 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-56 Score=523.62 Aligned_cols=320 Identities=48% Similarity=0.797 Sum_probs=291.6
Q ss_pred CcCCCccceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCc
Q 001034 852 GFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKY 931 (1182)
Q Consensus 852 ~fee~~~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HP 931 (1182)
.+++...|.+..++.+..+|+|++.||+|+||+|.+|.+..|++.||||++++.+.+..+...|+++|..|+...+....
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~ 248 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKY 248 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 44567789999999999999999999999999999999999999999999999999999999999999999977777788
Q ss_pred ceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc
Q 001034 932 HLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011 (1182)
Q Consensus 932 nIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs 1011 (1182)
|||+++++|...+|+|||+|++..+|+++++.++..+ |++..++.|+.||+.||.+||+.+|||+||||+||||..
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~G----lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~ 324 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRG----LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD 324 (586)
T ss_pred eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCC----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc
Confidence 9999999999999999999999999999999998765 999999999999999999999999999999999999998
Q ss_pred CCCceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 001034 1012 YSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1012 ~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~il 1091 (1182)
.....|||||||+|++..+..+++++++.|+|||+|+|.+|+.++||||||||++||++|.++|.+.++.++++.|++++
T Consensus 325 ~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 325 PKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred CCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 88889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhhcccccchhhcc-cchhhhhhcch----------------hhhhhccc-cccccccCCC-CCcHHHHHHHHH
Q 001034 1092 GPIEQGMLAKGRDTYKYFTK-NHMLYERNQET----------------NRLEYLIP-KKTSLRHRLP-MGDQGFIDFVAH 1152 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k-~~~~~er~~et----------------s~Le~liP-k~~sL~~~l~-~~SeeL~DLIrk 1152 (1182)
|.+|..|+..++.+.++|++ ...+....... ...+...| ....+..... .....|++||.+
T Consensus 405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 99999999999999999998 44443222221 12344555 5555666665 456789999999
Q ss_pred hcccCCCCCCCHHHHHcCCCCCC
Q 001034 1153 LLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1153 MLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
||.+||.+|+|+.++|+||||+.
T Consensus 485 ~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred HhccCchhcCCHHHHhcCccccc
Confidence 99999999999999999999983
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=488.11 Aligned_cols=338 Identities=23% Similarity=0.345 Sum_probs=262.6
Q ss_pred CCCCCCCCHHHHHhccCCCCccchhHHHhhhHHHHHHhhcccccCCCCCcchHHHHHHHHHHHHHHHHHHHHhhhhhhHh
Q 001034 766 DSSRDENNANAVRSANSSPSTLSNYEREHVKREEAEKISGMREEDPGASLEDEEAAAVQEQVRQIKAQEEEFETFNLKIV 845 (1182)
Q Consensus 766 ~~~~d~~Ssnt~~ra~saK~tIEn~~r~~vk~eeerkir~l~ee~p~a~leeEe~aaiqeq~rqlke~eee~E~~~~kiv 845 (1182)
......+++.|.+++++++++++++|...++...+|++|+...+...+...- ..+...+..+.....+.++-+
T Consensus 60 ~~~~~~~s~~T~~k~~~~k~~ien~Y~~~~~~~~~R~er~~~le~~l~~~~~-s~~~~~~~~~~~~~kEte~lR------ 132 (550)
T KOG0605|consen 60 SEYEFLVSNKTKRKVAAAKQYIENHYSSQIKYLNERKERRKELEEKLASEDV-SEEEQNELLKSLLSKETEYLR------ 132 (550)
T ss_pred cccccccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccc-cHHHHHHHHHHHhhHHHHHHH------
Confidence 4556678899999999999999999999999999999887777666554311 111112222222222333211
Q ss_pred hcccCCCcCCCccceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCC
Q 001034 846 HRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKH 925 (1182)
Q Consensus 846 ~rkn~~~fee~~~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~ 925 (1182)
.++.+ +-.++|+++++||+||||+||+|+.+.||+.||||++++........+.+++..+.+.+.
T Consensus 133 ~~R~r---------------~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~ 197 (550)
T KOG0605|consen 133 LRRTR---------------LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE 197 (550)
T ss_pred hcccc---------------CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh
Confidence 11111 134789999999999999999999999999999999999865544444444444444333
Q ss_pred CCCCCcceEEEEEEEEecCeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCC
Q 001034 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004 (1182)
Q Consensus 926 ~~l~HPnIVkL~dsFqd~e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKP 1004 (1182)
..++|||+||++|++..++||||||++|+ +..++.... .|++..+++|+.+++.||..||+.|||||||||
T Consensus 198 --~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKP 269 (550)
T KOG0605|consen 198 --VDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQLGYIHRDIKP 269 (550)
T ss_pred --cCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHcCcccccCCh
Confidence 25569999999999999999999999975 444444332 299999999999999999999999999999999
Q ss_pred ccEEEccCCCceEEEecCCCccccCC------------------------------C--------------------ccc
Q 001034 1005 ENILVKSYSRCEVKVIDLGSSCFETD------------------------------H--------------------LCS 1034 (1182)
Q Consensus 1005 eNILIDs~~dG~IKLiDFGLA~~~~~------------------------------~--------------------~ss 1034 (1182)
+|+|||. .|+|||+|||||+.... . ..+
T Consensus 270 dNlLiD~--~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~S 347 (550)
T KOG0605|consen 270 DNLLIDA--KGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYS 347 (550)
T ss_pred hheeecC--CCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhc
Confidence 9999994 88999999998742100 0 234
Q ss_pred ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccch
Q 001034 1035 YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHM 1114 (1182)
Q Consensus 1035 ~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~ 1114 (1182)
.+|||.|||||++.+.+|+..||||||||||||||+|++||+++++.+++++|+.+.-.
T Consensus 348 tVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------------- 406 (550)
T KOG0605|consen 348 TVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------------- 406 (550)
T ss_pred ccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------------
Confidence 68999999999999999999999999999999999999999999999999999743211
Q ss_pred hhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCC
Q 001034 1115 LYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS---ASDALKHPWLSHP 1176 (1182)
Q Consensus 1115 ~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT---AeELLqHPWFk~~ 1176 (1182)
+..|.. ...+.+++|||.+||+ ||.+|+- ++||.+||||+..
T Consensus 407 ------------l~fP~~-------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 407 ------------LKFPEE-------VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred ------------ccCCCc-------CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 111221 1235899999999999 9999975 9999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=421.11 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=219.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
-.++|+++++||+|+||+|++|+.+.+++.||||++++.. ....+..+|..+|..+. ||+||+++..||+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~------hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK------HPFIVKLIYSFQT 96 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC------CCcEeeeEEeccc
Confidence 3578999999999999999999999999999999998764 34567888999999865 4599999999999
Q ss_pred cCeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++|+|++|+.|+ |+..+.... .|++..+++|+.+|+.||.|||++|||||||||+||||+ .+|+|+|+|
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd--~~GHi~LtD 168 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD--EQGHIKLTD 168 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec--CCCcEEEec
Confidence 99999999999975 554444332 299999999999999999999999999999999999999 488999999
Q ss_pred CCCccc---cCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1022 LGSSCF---ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1022 FGLA~~---~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
||+|+. ......+.|||+.|||||++.+.+|+.++||||||+++|+||+|.+||.+.+...++.+|.....+.
T Consensus 169 FgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~---- 244 (357)
T KOG0598|consen 169 FGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL---- 244 (357)
T ss_pred cccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC----
Confidence 999974 2345667899999999999999999999999999999999999999999999999998885222110
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC----CHHHHHcCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP----SASDALKHPWLS 1174 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP----TAeELLqHPWFk 1174 (1182)
...-.+.++++||+++|..||++|+ .+.++-+||||.
T Consensus 245 ---------------------------------------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~ 285 (357)
T KOG0598|consen 245 ---------------------------------------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFK 285 (357)
T ss_pred ---------------------------------------CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccc
Confidence 1112478999999999999999995 789999999997
Q ss_pred CC
Q 001034 1175 HP 1176 (1182)
Q Consensus 1175 ~~ 1176 (1182)
..
T Consensus 286 ~i 287 (357)
T KOG0598|consen 286 GI 287 (357)
T ss_pred cC
Confidence 53
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=436.56 Aligned_cols=254 Identities=29% Similarity=0.515 Sum_probs=226.6
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEec----cchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN----NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk----~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.+|...+.||+|||+.||.+++..+|+.||+|++.+ .....+...+|++|.+.|.|+ |||+++.+|++.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~Hp------nIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHP------NIVQFYHFFEDSN 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCC------cEEeeeeEeecCC
Confidence 589999999999999999999999999999999987 445667888999999988765 8999999999999
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++|||+|+|. ++|..+++.++ .+++.+++.|++||+.||.|||+++|||||||..|||++ .+.+|||+|||
T Consensus 92 nVYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~--~~~~VKIgDFG 163 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN--ENMNVKIGDFG 163 (592)
T ss_pred ceEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec--CcCcEEecccc
Confidence 9999999999 56666666433 299999999999999999999999999999999999999 47789999999
Q ss_pred CccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1024 SSCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1024 LA~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+|+... +...+.||||.|+|||++....++..+||||+|||||.||+|+|||...+..+++.+|...
T Consensus 164 LAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~---------- 233 (592)
T KOG0575|consen 164 LATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN---------- 233 (592)
T ss_pred eeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc----------
Confidence 998766 5567899999999999999999999999999999999999999999999999999998411
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
++.+|. ..+.++++||++||+.||.+|||+.+||.|+||+..+.|-
T Consensus 234 -------------------------~Y~~P~---------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 234 -------------------------EYSMPS---------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred -------------------------Cccccc---------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence 222332 3468899999999999999999999999999998887763
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=427.46 Aligned_cols=260 Identities=29% Similarity=0.486 Sum_probs=217.0
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch--------hhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD--------FFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~--------~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
.+.+.|.+.+.||.|+||.|.+|..+.+|+.||||++.+... ......+|+++|+.|+|+ +||+++
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP------~IV~~~ 242 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHP------NIVRIK 242 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCC------CEEEEe
Confidence 356779999999999999999999999999999999986531 223457899999999765 899999
Q ss_pred EEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-CCc
Q 001034 938 DYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-SRC 1015 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-~dG 1015 (1182)
++|....+.||||||++| .|.+++..+.. +.+...+.+++||+.||.|||++||+||||||+|||+... .++
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcce
Confidence 999999999999999995 68888876653 6777889999999999999999999999999999999864 568
Q ss_pred eEEEecCCCccccC--CCcccccCCCcccchhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh
Q 001034 1016 EVKVIDLGSSCFET--DHLCSYVQSRSYRAPEVILGLS---YDKKIDIWSLGCILAELCTGNVLFQNDSPAT-LLARVIG 1089 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~--~~~ss~vGTp~YmAPEVLlg~~---yS~kSDIWSLGVILYELLTGr~PF~g~d~~e-lLakIv~ 1089 (1182)
.+||+|||+|++.. .-..+.||||.|.|||++.+.. +..++|+|||||+||-||+|++||....... +..+|.+
T Consensus 317 llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred EEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 99999999999874 3467899999999999998765 3458899999999999999999998754433 5555532
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
....+- ......+++++++||.+||..||+.|||+.|||+
T Consensus 397 G~y~f~----------------------------------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYAFG----------------------------------------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Cccccc----------------------------------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111110 0112245789999999999999999999999999
Q ss_pred CCCCCCCC
Q 001034 1170 HPWLSHPY 1177 (1182)
Q Consensus 1170 HPWFk~~~ 1177 (1182)
||||+...
T Consensus 437 hpW~~~~~ 444 (475)
T KOG0615|consen 437 HPWFKDAP 444 (475)
T ss_pred Chhhhccc
Confidence 99998543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=406.19 Aligned_cols=251 Identities=25% Similarity=0.464 Sum_probs=225.8
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++++.||.|+||+|.+++++.+|..||+|++.+.. .+.++..+|..+|+.+.| |++++|++.|.+.
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~------PFlv~l~~t~~d~ 116 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH------PFLVKLYGTFKDN 116 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC------ceeEEEEEeeccC
Confidence 468999999999999999999999999999999998764 456788889999998864 4999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++||||||++| -|..+++..+. |++..+++|++||+.||+|||+++|++|||||+|||||. +|+|||+||
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~--~G~iKitDF 188 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQ--NGHIKITDF 188 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeecc--CCcEEEEec
Confidence 999999999996 47777776543 999999999999999999999999999999999999994 889999999
Q ss_pred CCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1023 GSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1023 GLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
|+|+.....+.+.||||.|+|||++...+|+.++|||+|||++|||++|++||.+.++..++.+|+..--.+|
T Consensus 189 GFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP------- 261 (355)
T KOG0616|consen 189 GFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP------- 261 (355)
T ss_pred cceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC-------
Confidence 9999998889999999999999999999999999999999999999999999999999999999963322222
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCC-----CCHHHHHcCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR-----PSASDALKHPWLSHP 1176 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekR-----PTAeELLqHPWFk~~ 1176 (1182)
+-.+..+++||+++|+.|-.+| ...++|..||||+..
T Consensus 262 -------------------------------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 262 -------------------------------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred -------------------------------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 1236889999999999999999 467799999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=428.98 Aligned_cols=283 Identities=30% Similarity=0.525 Sum_probs=244.0
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhH--HHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD--QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~d--q~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.+.+||.++++||.|+||.||+|+.+.++..||||.+++.-...+ .-++|++.|++++. |||||+|++++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~-----hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNP-----HPNIIKLKEVIRDN 81 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCC-----CCcchhhHHHhhcc
Confidence 456899999999999999999999999999999999987532222 35689999999872 45999999999998
Q ss_pred C-eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 E-HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e-~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
. ++|+|||||..+|+++++.+.. .|++..++.|++||++||.|+|++|+.||||||+|||+.. ...|||+||
T Consensus 82 ~~~L~fVfE~Md~NLYqLmK~R~r-----~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~--~~~iKiaDF 154 (538)
T KOG0661|consen 82 DRILYFVFEFMDCNLYQLMKDRNR-----LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG--NDVIKIADF 154 (538)
T ss_pred CceEeeeHHhhhhhHHHHHhhcCC-----cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc--cceeEeccc
Confidence 7 9999999999999999997743 3999999999999999999999999999999999999984 667999999
Q ss_pred CCccccC--CCcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1023 GSSCFET--DHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1023 GLA~~~~--~~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
|+|+-.. .+.+.++.|++|+|||+++.. -|+.++|+|++|||++|+.+-++.|.+.+..+.+.+|..++|.+....+
T Consensus 155 GLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 155 GLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred ccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 9998543 346678999999999999764 6899999999999999999999999999999999999999998876555
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccc--cccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK--TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~--~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
..+. .....+++..|.. ..+...++..+.++.+||.+||.|||.+||||.|+|+||||+..
T Consensus 235 ~eg~----------------~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 235 PEGY----------------NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hhHH----------------HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 4432 2223444444443 35566777889999999999999999999999999999999865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=418.42 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=223.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.+|.+++.||.|+|++|++|.++.+++.|||||+.+.- .....+..|..+|.+|. .||.|++||..|++..
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~-----~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS-----GHPGIVKLYFTFQDEE 147 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh-----CCCCeEEEEEEeeccc
Confidence 57899999999999999999999999999999997642 22345667888899886 4669999999999999
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+|+||++ |.|+++++.... |.+..+++|+.||+.||+|||++|||||||||+||||+ ++++|||+|||
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gs------fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd--~dmhikITDFG 219 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGS------FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD--KDGHIKITDFG 219 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCc------chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc--CCCcEEEeecc
Confidence 9999999999 689999987643 99999999999999999999999999999999999999 58899999999
Q ss_pred CccccCCC----------------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 001034 1024 SSCFETDH----------------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1024 LA~~~~~~----------------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakI 1087 (1182)
.|+.+... ..+++||..|.+||++.....+..+|+|+||||||+|+.|.+||.+.++.-++++|
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI 299 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI 299 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 98754321 14589999999999999999999999999999999999999999999999999999
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
+.+-.++|.. .++.+++||+++|..||.+|+|+.+|
T Consensus 300 ~~l~y~fp~~--------------------------------------------fp~~a~dLv~KLLv~dp~~Rlt~~qI 335 (604)
T KOG0592|consen 300 QALDYEFPEG--------------------------------------------FPEDARDLIKKLLVRDPSDRLTSQQI 335 (604)
T ss_pred HHhcccCCCC--------------------------------------------CCHHHHHHHHHHHccCccccccHHHH
Confidence 8665555442 24788999999999999999999999
Q ss_pred HcCCCCCCC
Q 001034 1168 LKHPWLSHP 1176 (1182)
Q Consensus 1168 LqHPWFk~~ 1176 (1182)
.+||||...
T Consensus 336 k~HpFF~~V 344 (604)
T KOG0592|consen 336 KAHPFFEGV 344 (604)
T ss_pred hhCcccccC
Confidence 999999865
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=402.45 Aligned_cols=280 Identities=26% Similarity=0.456 Sum_probs=245.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|+.+.++|+|+||.|++|+++.||+.||||.+...+ ....-.++|+++|+++.|+ |+|.|+.+|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~------NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHE------NLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccc------hHHHHHHHHHhcce
Confidence 57889999999999999999999999999999997653 3456678999999999766 89999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
++||+||++.++++.+..... | ++...++.|++|++.|+.|||++++|||||||+||||.. +|.+||||||+|
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~--G---~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~--~gvvKLCDFGFA 148 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPN--G---VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ--NGVVKLCDFGFA 148 (396)
T ss_pred eEEEeeecchHHHHHHHhccC--C---CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec--CCcEEeccchhh
Confidence 999999999998888877653 2 889999999999999999999999999999999999994 888999999999
Q ss_pred cccC---CCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1026 CFET---DHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1026 ~~~~---~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+.+. +..+.++.|++|+|||++.+ .+|+..+|||++||++.||++|.+.|.+.+..+++-.|+..+|++...-.
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq-- 226 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ-- 226 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH--
Confidence 8765 33557899999999999998 68999999999999999999999999999999999999999998654221
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccc-cccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKK-TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~-~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
.++..++....+..+.|.. .++...++..+.-+++|+.+||..||.+|++.+++|.||||..
T Consensus 227 ------------~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 227 ------------SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred ------------HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 2233445555666655554 4678888999999999999999999999999999999999943
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=409.12 Aligned_cols=300 Identities=28% Similarity=0.501 Sum_probs=237.1
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-CeE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR-EHL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~-e~L 946 (1182)
.++|+++++||+|+||+||+|.+..+++.||||+++...........|+.+++.+.+.....|++|++++++|... .++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 5789999999999999999999999999999999976555555667899999999888777788899999999865 589
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCC------------
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYS------------ 1013 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~------------ 1013 (1182)
||||+++.++|++++.... .+++..++.|+.||+.||.|||+ .|||||||||+|||++..+
T Consensus 208 ~iv~~~~g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEeccCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 9999999999998876542 28889999999999999999997 6999999999999998532
Q ss_pred --CceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 001034 1014 --RCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1014 --dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~il 1091 (1182)
.+.+||+|||++..........+||+.|+|||++.+..|+.++||||||||||||++|++||.+.+..+.+..|...+
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred CCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 135999999998766655667789999999999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhhccccc--chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1092 GPIEQGMLAKGRDT--YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s--~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
|.+|..+....... ..++........... ...+.... ....+ .....+..+.+||.+||++||.+||||.|||+
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~--~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTD-PKHLARIA-RARPV--REVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCC-HHHHHhhh-cccch--hhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 99988776432110 111111111000000 00000000 00000 00112577999999999999999999999999
Q ss_pred CCCCCCCC
Q 001034 1170 HPWLSHPY 1177 (1182)
Q Consensus 1170 HPWFk~~~ 1177 (1182)
||||...+
T Consensus 438 Hp~~~~~~ 445 (467)
T PTZ00284 438 HPYVLKYY 445 (467)
T ss_pred CccccccC
Confidence 99998754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=402.03 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=216.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEec--cchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN--NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk--~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
...+.+.++.||+|+.|+||+|+++.|++.+|+|++.. +.....++.+|+++++.++++ +||.+|+.|....
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~sp------yIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSP------YIVGFYGAFYSNG 150 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCC------CeeeEeEEEEeCC
Confidence 34567778899999999999999999999999999943 456678899999999998544 9999999999998
Q ss_pred -eEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEec
Q 001034 945 -HLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 945 -~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
.++|+||||+|+ |..+++... .+++..+..++.+|++||.|||. .+||||||||+||||++ +|+|||||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs--kGeVKicD 222 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS--KGEVKICD 222 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc--CCCEEecc
Confidence 499999999965 555544332 28999999999999999999995 99999999999999995 88999999
Q ss_pred CCCccccCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhhcCCcc
Q 001034 1022 LGSSCFETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND-----SPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1022 FGLA~~~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~-----d~~elLakIv~ilGp~P 1095 (1182)
||.+..... ..++++||..|||||.+.+..|+.++||||||+.++||++|++||... +..+++..|+ .+++|
T Consensus 223 FGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv--~~ppP 300 (364)
T KOG0581|consen 223 FGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV--DEPPP 300 (364)
T ss_pred ccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh--cCCCC
Confidence 999976544 457899999999999999999999999999999999999999999764 5555555553 11222
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
. .|. ...+++|++||..||++||.+||++.|||+|||++.
T Consensus 301 ~--------------------------------lP~--------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 301 R--------------------------------LPE--------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred C--------------------------------CCc--------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 1 000 135899999999999999999999999999999987
Q ss_pred CCC
Q 001034 1176 PYE 1178 (1182)
Q Consensus 1176 ~~e 1178 (1182)
...
T Consensus 341 ~~~ 343 (364)
T KOG0581|consen 341 FED 343 (364)
T ss_pred ccc
Confidence 644
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=408.99 Aligned_cols=319 Identities=35% Similarity=0.645 Sum_probs=269.8
Q ss_pred cCCCccceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcc
Q 001034 853 FEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932 (1182)
Q Consensus 853 fee~~~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPn 932 (1182)
-+....+....++.+.++|.|++.||.|.||.|..+.+..++..|||||++.-..+.+..+-|+.+|+++++..+.....
T Consensus 73 dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 73 DDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred CCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceE
Confidence 34556688899999999999999999999999999999999999999999998888899999999999999887766668
Q ss_pred eEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC
Q 001034 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY 1012 (1182)
Q Consensus 933 IVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~ 1012 (1182)
+|++.++|....|.|||+|.++-+++++++.+.. .+|+...++.|++||+.++.|||+.+++|.||||+|||+.+.
T Consensus 153 cv~m~~wFdyrghiCivfellG~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELLGLSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSS 228 (415)
T ss_pred EEeeehhhhccCceEEEEeccChhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEecc
Confidence 9999999999999999999999999999986544 459999999999999999999999999999999999998531
Q ss_pred ------------------CCceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001034 1013 ------------------SRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVL 1074 (1182)
Q Consensus 1013 ------------------~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~P 1074 (1182)
....|+|+|||.|++..+...+.+.|..|+|||++++.+|+.+|||||+||||+||.+|...
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 13469999999999999988999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCC---CCcHHHHHHHH
Q 001034 1075 FQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLP---MGDQGFIDFVA 1151 (1182)
Q Consensus 1075 F~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~---~~SeeL~DLIr 1151 (1182)
|+.++..++++.|-.++||+|..|..... ..++|......+..........+....-..+...+. .....|.|||+
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~-~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTR-KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhh-hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 99999999999999999999999987764 445555443333222222212221111122222222 22357999999
Q ss_pred HhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1152 HLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1152 kMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+||.+||.+|+|+.|||.||||+..
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhcC
Confidence 9999999999999999999999865
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=375.46 Aligned_cols=276 Identities=26% Similarity=0.433 Sum_probs=224.9
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|++.+.||.|+||.||+|.+..+++.||+|+++... .......+|+.+++.+.| |||+++++++.....+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~~ 78 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH------ANIVTLHDIIHTERCL 78 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCC------CCEeeEEEEEcCCCeE
Confidence 57999999999999999999999999999999997542 223456789999988865 4899999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|+||||+.++|..++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 79 ~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~DfG~~~ 151 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE--KGELKLADFGLAR 151 (288)
T ss_pred EEEEeCCCcCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEECcCccee
Confidence 99999999999888765432 2788899999999999999999999999999999999984 6789999999986
Q ss_pred ccCC---CcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1027 FETD---HLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1027 ~~~~---~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 152 AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred eccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 5432 2234567999999999876 56899999999999999999999999999999999999988888776665432
Q ss_pred cccchhhcccchhhhhhcchhhhhhcccc--ccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk--~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.....+. ....|. ........+..+.++++||.+||++||.+|||+.|+|+||||
T Consensus 232 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 232 TSNEEFR----------------SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccchhhh----------------ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 2111110 001111 111112234567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=396.64 Aligned_cols=284 Identities=33% Similarity=0.546 Sum_probs=240.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEec---cchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN---NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk---~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+..+|..++.||.|+||.|+.|.++.+|+.||||.+.. ........++|+++|++++|. ||+.+++++.-+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~He------NIi~l~di~~p~ 93 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHE------NIIGLLDIFRPP 93 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCC------CcceEEeecccc
Confidence 34567778999999999999999999999999999873 345567889999999999765 899999998762
Q ss_pred -----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 944 -----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 944 -----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
+.+|+|+|+|+.+|...++..+. ++...++.+++||++||.|+|+.+|+||||||.|+|++ .++.+|
T Consensus 94 ~~~~f~DvYiV~elMetDL~~iik~~~~------L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n--~~c~lK 165 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELMETDLHQIIKSQQD------LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN--ADCDLK 165 (359)
T ss_pred cccccceeEEehhHHhhHHHHHHHcCcc------ccHHHHHHHHHHHHHhcchhhcccccccccchhheeec--cCCCEE
Confidence 57999999999999998886653 88999999999999999999999999999999999999 488899
Q ss_pred EecCCCccccC-----CCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1019 VIDLGSSCFET-----DHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1019 LiDFGLA~~~~-----~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|+|||+|+... ...+.++.|.+|+|||+++. ..|+.++||||+||||.|||+|++.|.+.+...++..|+..+|
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 99999998773 34467889999999999864 5799999999999999999999999999999999999999999
Q ss_pred Ccchhhhhccccc--chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1093 PIEQGMLAKGRDT--YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1093 p~PeemL~~~k~s--~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.+++..+...... ..+. -+...-........+++.++.+++||.+||.+||.+|+||+|+|+|
T Consensus 246 tP~~e~l~~i~s~~ar~yi---------------~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYI---------------KSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCHHHHHHhccHHHHHHH---------------HhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 9887776543211 0110 0111111234456678889999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 001034 1171 PWLSHPYEP 1179 (1182)
Q Consensus 1171 PWFk~~~eP 1179 (1182)
|||+.-..|
T Consensus 311 PYl~~~hdp 319 (359)
T KOG0660|consen 311 PYLAPYHDP 319 (359)
T ss_pred hhhhhhcCC
Confidence 999876554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=380.73 Aligned_cols=282 Identities=30% Similarity=0.511 Sum_probs=242.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch---hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~---~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.+|..++.||+|.||.||+|++..+|+.||||.++..+. .....++|+++|+.+.|+ ||+.|+++|-....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~------nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHP------NIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCc------chhhhhhhccCCCc
Confidence 578889999999999999999999999999999986542 245678999999999765 89999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+.||+|||+.+|...++... ..++...++.|+.++++||+|||++.|+||||||.|+||++ +|.+||+|||++
T Consensus 76 l~lVfEfm~tdLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~--~g~lKiADFGLA 148 (318)
T KOG0659|consen 76 LSLVFEFMPTDLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS--DGQLKIADFGLA 148 (318)
T ss_pred eEEEEEeccccHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC--CCcEEeecccch
Confidence 99999999999998887543 45999999999999999999999999999999999999995 888999999999
Q ss_pred cccCCCc---ccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1026 CFETDHL---CSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1026 ~~~~~~~---ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+...... ...+-|.+|+|||++.|. .|+..+|+||+|||+.||+-|.+.|.+.+..+++..|...+|.+....|..
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence 9765432 233789999999999886 599999999999999999999999999999999999999999887766665
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
......|. .+. ..| ..++...++..+.+++||+.+||.+||.+|+|+.|+|+||||+...-|
T Consensus 229 ~~~lpdY~--------------~~~-~~P-~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 229 MTSLPDYV--------------KIQ-QFP-KPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred ccccccHH--------------HHh-cCC-CCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 54433321 111 112 223444778889999999999999999999999999999999975444
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.21 Aligned_cols=278 Identities=26% Similarity=0.482 Sum_probs=222.9
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++.+.||.|+||.||+|+++.+++.||||++.... .....+.+|+.+++.++|+ ||++++++|.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE------NIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCc------cccchhhhEecCCE
Confidence 47999999999999999999999999999999997542 2345667888988888654 89999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+|+||||+.++++..+..... .+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~ 147 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMPN-----GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH--NDVLKLCDFGFA 147 (287)
T ss_pred EEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEEeeccCc
Confidence 999999999988877654321 2888899999999999999999999999999999999984 678999999998
Q ss_pred cccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1026 CFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1026 ~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+..+....++++...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 764322 2245789999999999999999999999999999999999999999888888888888888877654432
Q ss_pred ccccchhhcccchhhhhhcchhhhhhcccc--ccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk--~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
......+ ......... ...........+..+.+||.+||++||++|||+.++|+||||
T Consensus 228 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 228 FYSNPRF--------------HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhccchh--------------cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1110000 000000000 000011223467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=413.85 Aligned_cols=256 Identities=26% Similarity=0.430 Sum_probs=222.3
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
+.+-.++|.++++||+|+||+|+++..+.+++.||||++++.. +..+....|.+|+...+ .||+|+.|+..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-----~HPFL~~L~~~ 437 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-----RHPFLVNLFSC 437 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-----cCCeEeecccc
Confidence 3445688999999999999999999999999999999999864 55667778888888776 57899999999
Q ss_pred EEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 940 FYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
||..+|+|+||||+.|+.. ++.... ..|++..+++|+++|+.||.|||++||||||||.+|||+|. .|++||
T Consensus 438 fQT~~~l~fvmey~~Ggdm-~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~--eGh~ki 509 (694)
T KOG0694|consen 438 FQTKEHLFFVMEYVAGGDL-MHHIHT-----DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT--EGHVKI 509 (694)
T ss_pred cccCCeEEEEEEecCCCcE-EEEEec-----ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc--cCcEEe
Confidence 9999999999999998772 222111 13999999999999999999999999999999999999995 889999
Q ss_pred ecCCCccc---cCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1020 IDLGSSCF---ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1020 iDFGLA~~---~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
+|||+++- ....++++||||.|||||++.+..|+.++|||||||+|||||+|..||.+++.++++..|+..-.
T Consensus 510 ADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~---- 585 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV---- 585 (694)
T ss_pred cccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC----
Confidence 99999974 45567899999999999999999999999999999999999999999999999999999851100
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHcCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA-----SDALKHP 1171 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA-----eELLqHP 1171 (1182)
.....++.++.++|++||..+|++|+-+ .+|.+||
T Consensus 586 ----------------------------------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hp 625 (694)
T KOG0694|consen 586 ----------------------------------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHP 625 (694)
T ss_pred ----------------------------------------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCC
Confidence 0112457899999999999999999875 7899999
Q ss_pred CCCCC
Q 001034 1172 WLSHP 1176 (1182)
Q Consensus 1172 WFk~~ 1176 (1182)
||...
T Consensus 626 FFr~i 630 (694)
T KOG0694|consen 626 FFRSI 630 (694)
T ss_pred ccccC
Confidence 99763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=405.10 Aligned_cols=282 Identities=28% Similarity=0.470 Sum_probs=238.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
..+.|+.+++||+|+||.||+|++..+|+.||+|.++.+. ....-..+|+.||++|.|+ ||++|.+.....
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~Hp------NIikL~eivt~~ 188 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHP------NIIKLEEIVTSK 188 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCC------cccceeeEEEec
Confidence 3567899999999999999999999999999999998653 4455677999999999766 899999999887
Q ss_pred --CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 944 --EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 944 --e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..+|||+|||+.+|.-++... .+.|++.+++.|++||+.||+|||.+||+|||||..||||| .+|.+||+|
T Consensus 189 ~~~siYlVFeYMdhDL~GLl~~p-----~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid--n~G~LKiaD 261 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDHDLSGLLSSP-----GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID--NNGVLKIAD 261 (560)
T ss_pred CCceEEEEEecccchhhhhhcCC-----CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc--CCCCEEecc
Confidence 689999999999888776542 34499999999999999999999999999999999999999 588999999
Q ss_pred CCCccccCC----CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1022 LGSSCFETD----HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1022 FGLA~~~~~----~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
||+|++... ..+..+-|.+|+|||+++|. .|+.++|+||+||||.||++|++.|.+.+..+++.+|..++|.+.+
T Consensus 262 FGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e 341 (560)
T KOG0600|consen 262 FGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE 341 (560)
T ss_pred ccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence 999996443 24566789999999999987 5999999999999999999999999999999999999999999888
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
..|.. .+.. ....+....+....+...+...+..+++|+..||..||.+|.||.++|+|+||+..
T Consensus 342 ~~W~~-~kLP--------------~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 342 DYWPV-SKLP--------------HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred hcccc-ccCC--------------cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 76652 1111 11122222333344455567778999999999999999999999999999999443
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=370.47 Aligned_cols=285 Identities=25% Similarity=0.372 Sum_probs=218.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.++|++.+.||.|+||.||+|+++.+++.||||++.... .......+|+.+++.+.| |||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH------ANIVLLHDIIHTKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCC------CCcCeEEEEEecCCe
Confidence 468999999999999999999999999999999997543 223356778899888865 489999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+|+||||+.++|..++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. .+.+||+|||++
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~ 150 (303)
T cd07869 78 LTLVFEYVHTDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD--TGELKLADFGLA 150 (303)
T ss_pred EEEEEECCCcCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECCCCcc
Confidence 999999999999888765432 2788899999999999999999999999999999999984 678999999998
Q ss_pred cccCC---CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETD---HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQND-SPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~---~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~-d~~elLakIv~ilGp~PeemL~ 1100 (1182)
..... .....++++.|+|||++.+. .++.++|||||||++|+|++|.+||.+. +....+..+...++.+....+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred eeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 65332 22345779999999998764 5889999999999999999999999874 4556667776666655443322
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
...... .+... .+....+............+..+.+||.+||++||++|||+.+||+||||+...
T Consensus 231 ~~~~~~-~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 231 GVHSLP-HFKPE-----------RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred chhhcc-ccccc-----------cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 211100 00000 000000100000000112457899999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=395.66 Aligned_cols=321 Identities=34% Similarity=0.591 Sum_probs=274.3
Q ss_pred CCcCCCccceeeeCceec-CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCC--C
Q 001034 851 TGFEEDKNFHVVLNSVIA-GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD--P 927 (1182)
Q Consensus 851 ~~fee~~~f~V~ig~iL~-drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~--~ 927 (1182)
..|....+.+|.+++++. +||.+.++||.|.|++||+|.|..+.++|||||.+....+.+..+.|+++|++++..+ .
T Consensus 59 ~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~ 138 (590)
T KOG1290|consen 59 EDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPND 138 (590)
T ss_pred hhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCC
Confidence 345567788999999999 9999999999999999999999999999999999999999999999999999998766 3
Q ss_pred CCCcceEEEEEEEEec----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCcccccc
Q 001034 928 GDKYHLLRLYDYFYYR----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDL 1002 (1182)
Q Consensus 928 l~HPnIVkL~dsFqd~----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDI 1002 (1182)
....+||+|++.|... .|+|+|+|+++.+|+.++++....+ ++...++.|++||+.||.|||. +||||.||
T Consensus 139 ~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrG----lpl~~VK~I~~qvL~GLdYLH~ecgIIHTDl 214 (590)
T KOG1290|consen 139 PGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRG----LPLSCVKEICRQVLTGLDYLHRECGIIHTDL 214 (590)
T ss_pred CCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCC----CcHHHHHHHHHHHHHHHHHHHHhcCccccCC
Confidence 4456899999999875 7999999999999999999887765 8999999999999999999995 79999999
Q ss_pred CCccEEEcc-----------------------------------------------------------------------
Q 001034 1003 KPENILVKS----------------------------------------------------------------------- 1011 (1182)
Q Consensus 1003 KPeNILIDs----------------------------------------------------------------------- 1011 (1182)
||+|||+..
T Consensus 215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~ 294 (590)
T KOG1290|consen 215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI 294 (590)
T ss_pred CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence 999999720
Q ss_pred -------------------------------------------C------------------------------------
Q 001034 1012 -------------------------------------------Y------------------------------------ 1012 (1182)
Q Consensus 1012 -------------------------------------------~------------------------------------ 1012 (1182)
.
T Consensus 295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~ 374 (590)
T KOG1290|consen 295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI 374 (590)
T ss_pred cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence 0
Q ss_pred --------------CCceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-
Q 001034 1013 --------------SRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN- 1077 (1182)
Q Consensus 1013 --------------~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g- 1077 (1182)
.+..|||.|||-||....+.+.-++|+.|+|||++++.+|+..+||||++||+|||+||..+|..
T Consensus 375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePh 454 (590)
T KOG1290|consen 375 ASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPH 454 (590)
T ss_pred ccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCC
Confidence 00137899999999988888888999999999999999999999999999999999999999954
Q ss_pred -----CCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCC---CCCcHHHHHH
Q 001034 1078 -----DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRL---PMGDQGFIDF 1149 (1182)
Q Consensus 1078 -----~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l---~~~SeeL~DL 1149 (1182)
...+++++.||.++|.+|..+...++.+..+|++.+.+.... ++.++. ....|...+ .....+|.+|
T Consensus 455 sG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~----~LK~Wp-L~~VL~eKY~~s~e~A~~fsdF 529 (590)
T KOG1290|consen 455 SGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIR----RLKPWP-LYEVLIEKYEWSEEDAQQFSDF 529 (590)
T ss_pred CCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceeccc----ccCCCc-HHHHHHHHhCCCHHHHHHHHHH
Confidence 346789999999999999999999999999999887664321 111111 111111111 2234689999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1150 VAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1150 IrkMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
|.-||+++|++||||.++|+||||.....|+
T Consensus 530 L~PmLef~PeKR~tA~~cl~hPwLn~~~~~~ 560 (590)
T KOG1290|consen 530 LSPMLEFDPEKRPTAAQCLKHPWLNPVAGPP 560 (590)
T ss_pred HHHHHhcCccccccHHHHhcCccccCCCCCc
Confidence 9999999999999999999999999877664
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=390.41 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=219.9
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
...++|.+.+.||.|+||+|++|++..+++.||+|++.+.. .....+.+|+.+++.+.+ ||||++++.+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~-----HpnI~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRS-----HPNIIRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhcc-----CCCEeEEEEE
Confidence 45689999999999999999999999999999999887641 123455679999999873 3499999999
Q ss_pred EEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
+....++||||||+.| .|++++.... .+.+..++++++||+.||+|||++||+||||||+|||++... +.+|
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~K 161 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLK 161 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEE
Confidence 9999999999999996 8999888632 288999999999999999999999999999999999999632 8899
Q ss_pred EecCCCcccc---CCCcccccCCCcccchhhhcCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1019 VIDLGSSCFE---TDHLCSYVQSRSYRAPEVILGLS-YD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1019 LiDFGLA~~~---~~~~ss~vGTp~YmAPEVLlg~~-yS-~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
|+|||++... .....+.|||+.|+|||++.+.. |+ .++||||+|||||.|++|+.||...+...++.+|....-.
T Consensus 162 l~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~ 241 (370)
T KOG0583|consen 162 LSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK 241 (370)
T ss_pred EeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc
Confidence 9999999876 34567899999999999999987 86 8999999999999999999999998888888776422111
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCC-cHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMG-DQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~-SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
+|. .. +.++++||++||..||.+|+|+.+++.|||
T Consensus 242 -----------------------------------~p~---------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 242 -----------------------------------IPS---------YLLSPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred -----------------------------------CCC---------CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 121 12 789999999999999999999999999999
Q ss_pred CCC
Q 001034 1173 LSH 1175 (1182)
Q Consensus 1173 Fk~ 1175 (1182)
|+.
T Consensus 278 ~~~ 280 (370)
T KOG0583|consen 278 FQK 280 (370)
T ss_pred hcc
Confidence 997
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=370.47 Aligned_cols=282 Identities=29% Similarity=0.497 Sum_probs=222.6
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec---
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--- 943 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--- 943 (1182)
+|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.++|+ ||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHP------DIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCC------CEeeecceEeccCCC
Confidence 699999999999999999999999999999998743 12234567899998888654 899999988643
Q ss_pred --CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 944 --EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 944 --e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..+|+||||+.++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 75 ~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kL~D 146 (338)
T cd07859 75 EFKDIYVVFELMESDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA--DCKLKICD 146 (338)
T ss_pred CCceEEEEEecCCCCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCcEEEcc
Confidence 3589999999999888876443 2889999999999999999999999999999999999984 77899999
Q ss_pred CCCccccCCC------cccccCCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1022 LGSSCFETDH------LCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1022 FGLA~~~~~~------~ss~vGTp~YmAPEVLlg--~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
||++...... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...++.
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9998753221 134578999999999876 67899999999999999999999999998888888888888887
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
++........... .... ...+.... .......++..+..+.+||.+||+.||.+|||+.+||+||||
T Consensus 227 ~~~~~~~~i~~~~-----~~~~------~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f 293 (338)
T cd07859 227 PSPETISRVRNEK-----ARRY------LSSMRKKQ--PVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293 (338)
T ss_pred CCHHHHHHhhhhh-----HHHH------HHhhcccC--CCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence 7665443321100 0000 00000001 111223345667899999999999999999999999999999
Q ss_pred CCCCC
Q 001034 1174 SHPYE 1178 (1182)
Q Consensus 1174 k~~~e 1178 (1182)
+....
T Consensus 294 ~~~~~ 298 (338)
T cd07859 294 KGLAK 298 (338)
T ss_pred hhcCc
Confidence 76543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=377.80 Aligned_cols=302 Identities=32% Similarity=0.554 Sum_probs=229.4
Q ss_pred cceeeeCc---eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCc
Q 001034 858 NFHVVLNS---VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKY 931 (1182)
Q Consensus 858 ~f~V~ig~---iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HP 931 (1182)
.|++..+. .+.++|++++.||.|+||.||+|.+..+++.||+|++... ........+|+.+++.++| |
T Consensus 7 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~ 80 (359)
T cd07876 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH------K 80 (359)
T ss_pred cceecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCC------C
Confidence 34445544 4678999999999999999999999999999999999653 2334566778888887754 4
Q ss_pred ceEEEEEEEEecC------eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCc
Q 001034 932 HLLRLYDYFYYRE------HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005 (1182)
Q Consensus 932 nIVkL~dsFqd~e------~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPe 1005 (1182)
||++++++|.... .+|+||||+.+++...+.. .+++..+..++.||+.||.|||++||+||||||+
T Consensus 81 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 152 (359)
T cd07876 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 152 (359)
T ss_pred CEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 8999999987543 5799999999998877642 1778889999999999999999999999999999
Q ss_pred cEEEccCCCceEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~el 1083 (1182)
|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 153 NIl~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 230 (359)
T cd07876 153 NIVVKS--DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230 (359)
T ss_pred HEEECC--CCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999984 678999999998754322 3345789999999999999999999999999999999999999999988888
Q ss_pred HHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcccccc--ccccCCCCCcHHHHHHHHHhcccCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT--SLRHRLPMGDQGFIDFVAHLLEINPKKR 1161 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~--sL~~~l~~~SeeL~DLIrkMLq~DPekR 1161 (1182)
+..++..++.++..++.........+......+. ...+....+... .........+..+++||.+||++||++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 306 (359)
T cd07876 231 WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYP----GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306 (359)
T ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCC----CcchhhhccccccccccccccccchhHHHHHHHHhccCcccC
Confidence 8888888887766554332211111100000000 000011111110 0111122346789999999999999999
Q ss_pred CCHHHHHcCCCCCCCCCC
Q 001034 1162 PSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1162 PTAeELLqHPWFk~~~eP 1179 (1182)
||+.|||+||||+.-+.|
T Consensus 307 ~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 307 ISVDEALRHPYITVWYDP 324 (359)
T ss_pred CCHHHHhcCchhhhhcCc
Confidence 999999999999864444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=363.24 Aligned_cols=279 Identities=28% Similarity=0.446 Sum_probs=218.1
Q ss_pred CCEEEEEEeccCCceEEEEEEECC-CCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe--
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLH-TGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY-- 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~-TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd-- 942 (1182)
.+|++++.||+|+||.||+|++.. +++.||+|+++... .......+|+.+++.+... .||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhccc---CCCCcceEEEEEeccc
Confidence 479999999999999999999854 57889999987542 2233556778877777543 57899999999863
Q ss_pred ---cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 943 ---REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 943 ---~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
...+++||||+.++|..++...... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~--~~~~kl 151 (290)
T cd07862 78 TDRETKLTLVFEHVDQDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKL 151 (290)
T ss_pred CCCCCcEEEEEccCCCCHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC--CCCEEE
Confidence 3569999999999998888654322 2788999999999999999999999999999999999984 678999
Q ss_pred ecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1020 IDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1020 iDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..|+...+.+...
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 152 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred ccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 999998754332 334578999999999999999999999999999999999999999999989999998777644332
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.+........ ..+. .-....+....+..+..+.+||.+||++||++|||+.++|+||||
T Consensus 232 ~~~~~~~~~~---------------~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 232 DWPRDVALPR---------------QAFH--SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hchhhhcccc---------------hhcc--CCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 2211100000 0000 000011112234567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.94 Aligned_cols=278 Identities=28% Similarity=0.445 Sum_probs=219.4
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec---
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--- 943 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--- 943 (1182)
+|++++.||+|+||.||+|.++.+++.||+|+++... ........|+.+++.+.+. .||||++++++|...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAF---DHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhc---CCCCeeeeeeeeccccCC
Confidence 5899999999999999999999999999999987532 1223456788888877543 478999999998753
Q ss_pred --CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 944 --EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 944 --e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..+++||||+.++|..++...... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~lv~e~~~~~l~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~kl~d 151 (288)
T cd07863 78 RETKVTLVFEHVDQDLRTYLDKVPPP----GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLAD 151 (288)
T ss_pred CCceEEEEEcccccCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECc
Confidence 468999999999988887654321 2889999999999999999999999999999999999984 67799999
Q ss_pred CCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1022 LGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1022 FGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|++||........+.++....+.+....+
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 152 FGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 9998765432 23456789999999999999999999999999999999999999998888888888877665433222
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
........ . .+............+..+..+.+||.+||++||.+|||+.++|.||||
T Consensus 232 ~~~~~~~~---------------~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 232 PRDVTLPR---------------G--AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccc---------------c--ccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11000000 0 000000111222334567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=379.81 Aligned_cols=287 Identities=25% Similarity=0.399 Sum_probs=240.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR- 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~- 943 (1182)
.+.|+.+..|+.|+||.||+|+++.+++.||+|.++-++ .+.-..++|+.+|..++|+ |||.+..+..-.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~------NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHP------NIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCC------CeeeeEEEEeccc
Confidence 367999999999999999999999999999999997543 2233567899999988755 899999987754
Q ss_pred -CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 -EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 -e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
+.+||||||+..+|..++..... .|...+++.++.|++.||.|||.+.|+||||||+|+|+. ..|.+||+||
T Consensus 149 ~d~iy~VMe~~EhDLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~--~~G~lKiaDF 221 (419)
T KOG0663|consen 149 MDKIYIVMEYVEHDLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS--HKGILKIADF 221 (419)
T ss_pred cceeeeeHHHHHhhHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec--cCCcEEeccc
Confidence 67999999999999998887652 389999999999999999999999999999999999999 4788999999
Q ss_pred CCccccCCC---cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1023 GSSCFETDH---LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1023 GLA~~~~~~---~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
|+|+....+ .+..+-|.+|+|||++++. .|+.++|+||+|||+.||+++++.|.+.+..+++.+|...+|.+.+.+
T Consensus 222 GLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 222 GLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred chhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 999987766 5667889999999999986 599999999999999999999999999999999999999999988877
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCC--cHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMG--DQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~--SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
|..-...... ..+.+.......++..++.. +....+|+..+|.+||.+|.||.++|+|+||.+.
T Consensus 302 wpg~~~lp~~--------------k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 302 WPGYSELPAV--------------KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred CCCccccchh--------------hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 7643222110 01111111122334444443 4899999999999999999999999999999998
Q ss_pred CCCCC
Q 001034 1177 YEPIS 1181 (1182)
Q Consensus 1177 ~eP~~ 1181 (1182)
+.|++
T Consensus 368 P~p~~ 372 (419)
T KOG0663|consen 368 PLPID 372 (419)
T ss_pred CCCCC
Confidence 88765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=366.61 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=212.4
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~~~~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH------PFIIRLFWTEHDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCC------CcHhhhHhhhccCC
Confidence 46999999999999999999999999999999997542 234456778888888865 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~--~~~~kl~Dfg 146 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK--EGHIKLTDFG 146 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEEecC
Confidence 99999999985 6777776443 2788899999999999999999999999999999999984 6789999999
Q ss_pred CccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1024 SSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1024 LA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
++..........+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.....+
T Consensus 147 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------- 216 (291)
T cd05612 147 FAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE---------- 216 (291)
T ss_pred cchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC----------
Confidence 9987666556678999999999999999999999999999999999999999988877766666411100
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSH 1175 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~ 1175 (1182)
+ ....+..+++||++||+.||.+||+ +.++++||||+.
T Consensus 217 -------------------------~---------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 217 -------------------------F---------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred -------------------------C---------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 0 1123678999999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=372.11 Aligned_cols=301 Identities=30% Similarity=0.519 Sum_probs=229.4
Q ss_pred ceeeeCc---eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcc
Q 001034 859 FHVVLNS---VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYH 932 (1182)
Q Consensus 859 f~V~ig~---iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPn 932 (1182)
|++..+. .+.++|++++.||+|+||.||+|.+..+++.||||++... ........+|+.+++.+.|+ |
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------n 77 (355)
T cd07874 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK------N 77 (355)
T ss_pred eeeccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCC------c
Confidence 3444444 3568999999999999999999999999999999999753 23345666788888887654 8
Q ss_pred eEEEEEEEEec------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCcc
Q 001034 933 LLRLYDYFYYR------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPEN 1006 (1182)
Q Consensus 933 IVkL~dsFqd~------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeN 1006 (1182)
|++++++|... ..+|+||||+.+++...+.. .++...++.++.||+.||.|||+.||+||||||+|
T Consensus 78 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 149 (355)
T cd07874 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149 (355)
T ss_pred hhceeeeeeccccccccceeEEEhhhhcccHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHH
Confidence 99999998754 35799999999998877642 17788899999999999999999999999999999
Q ss_pred EEEccCCCceEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001034 1007 ILVKSYSRCEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLL 1084 (1182)
Q Consensus 1007 ILIDs~~dG~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elL 1084 (1182)
||++. ++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 150 ill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 227 (355)
T cd07874 150 IVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_pred EEECC--CCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99984 678999999999765433 23467899999999999999999999999999999999999999999888888
Q ss_pred HHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccc--cccccCCCCCcHHHHHHHHHhcccCCCCCC
Q 001034 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK--TSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162 (1182)
Q Consensus 1085 akIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~--~sL~~~l~~~SeeL~DLIrkMLq~DPekRP 1162 (1182)
..++..++.+...++.........+......+.. ..+....+.. ..........+..+++||.+||++||++||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp 303 (355)
T cd07874 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG----LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_pred HHHHHHhCCCCHHHHHhhcHHHHHHHhcCCcccc----ccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC
Confidence 8888877766554444332221111111000000 0000000000 000111223467899999999999999999
Q ss_pred CHHHHHcCCCCCCCCCC
Q 001034 1163 SASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1163 TAeELLqHPWFk~~~eP 1179 (1182)
|+.|||+||||+..++|
T Consensus 304 s~~ell~hp~~~~~~~~ 320 (355)
T cd07874 304 SVDEALQHPYINVWYDP 320 (355)
T ss_pred CHHHHhcCcchhcccCh
Confidence 99999999999876554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=362.15 Aligned_cols=282 Identities=25% Similarity=0.392 Sum_probs=226.1
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|.+.+.||.|+||.||+|.++.+++.||+|+++... .......+|+.+++.++| +||+++++++....++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH------ANIVTLHDIVHTDKSL 79 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCC------CCcceEEEEEeeCCeE
Confidence 67999999999999999999999999999999987543 223356678888888865 4899999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|+||||+.+++..++..... .+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~ 152 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLAR 152 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECccccce
Confidence 99999999998888765432 2788889999999999999999999999999999999984 6789999999986
Q ss_pred ccCCC---cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..++..++.++...+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 153 AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred ecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 53322 233467899999999875 46899999999999999999999999999998999999888887766554432
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.....+.. ..+.......+....+.++.++++||.+||++||.+|||+.|+|+||||+...
T Consensus 233 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 233 SSNDEFKN--------------YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred cchhhhhh--------------hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 21111100 00000001111223345688999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.52 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=214.0
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++.+.||.|+||.||+|+++.+++.||||++.+.. .....+.+|+.+++.+.| |||++++++|...
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~~~~~~ 90 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH------PFIVNMMCSFQDE 90 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC------CCCCcEEEEEEcC
Confidence 478999999999999999999999999999999997643 234567788888888865 4899999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kl~Df 162 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDN--KGHVKVTDF 162 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECC--CCCEEEeec
Confidence 999999999985 6777665432 2788899999999999999999999999999999999984 678999999
Q ss_pred CCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1023 GSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1023 GLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
|++..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.....+
T Consensus 163 g~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------- 233 (329)
T PTZ00263 163 GFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK--------- 233 (329)
T ss_pred cCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC---------
Confidence 99987766666778999999999999999999999999999999999999999988877766665311000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSH 1175 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~ 1175 (1182)
+| ..++..+.+||.+||+.||.+||+ +.+|+.||||+.
T Consensus 234 --------------------------~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 234 --------------------------FP---------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred --------------------------CC---------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 01 124678999999999999999997 799999999986
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=388.72 Aligned_cols=284 Identities=26% Similarity=0.468 Sum_probs=221.2
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec----
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR---- 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~---- 943 (1182)
..+|++++.||+|+||.||+|.+..+++.||||++..... ...+|+.+++.+.|+ ||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~------niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHI------NIIFLKDYYYTECFKK 135 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCC------CCcceeeeEeeccccc
Confidence 4679999999999999999999999999999999876543 234688898888654 899999887542
Q ss_pred ----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 944 ----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 944 ----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
..+++||||+++++..++....... ..+++..++.++.||+.||.|||+++||||||||+|||++. ..+.+||
T Consensus 136 ~~~~~~l~lvmE~~~~~l~~~~~~~~~~~--~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~-~~~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQTVHKYMKHYARNN--HALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP-NTHTLKL 212 (440)
T ss_pred CCCceEEEEEEecCCccHHHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC-CCCceee
Confidence 2578999999999888876543222 23889999999999999999999999999999999999984 3346999
Q ss_pred ecCCCccccCC--CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1020 IDLGSSCFETD--HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1020 iDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
+|||+++.... .....++|+.|+|||++.+. .|+.++|||||||+||+|++|++||.+.+..+.+.+++..++.++.
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999975432 33456789999999998764 6999999999999999999999999999999999999988887765
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
..+......+..+. +. ......+...+ ....+.++++||.+||++||.+|||+.|+|+||||...
T Consensus 293 ~~~~~~~~~~~~~~-----~~-~~~~~~l~~~~---------p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIK-----FP-DVKPKDLKKVF---------PKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhccc-----CC-ccCchhHHHHh---------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 44432211100000 00 00000011111 12356899999999999999999999999999999765
Q ss_pred CC
Q 001034 1177 YE 1178 (1182)
Q Consensus 1177 ~e 1178 (1182)
..
T Consensus 358 ~~ 359 (440)
T PTZ00036 358 RD 359 (440)
T ss_pred hc
Confidence 43
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=371.43 Aligned_cols=293 Identities=31% Similarity=0.526 Sum_probs=225.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|++.+.||+|+||.||+|.+..+++.||||++... ........+|+.+++.+.| +||++++++|...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~ii~~~~~~~~~ 95 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH------KNIIGLLNVFTPQ 95 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCC------CCccccceeeccc
Confidence 468999999999999999999999999999999999753 2334556778888887755 4899999987643
Q ss_pred ------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 944 ------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 944 ------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
..+|+||||+.+++...+.. .++...+..++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~ 165 (364)
T cd07875 96 KSLEEFQDVYIVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTL 165 (364)
T ss_pred ccccccCeEEEEEeCCCCCHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECC--CCcE
Confidence 35899999999998887642 1678889999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1018 KVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.+++..++.++
T Consensus 166 kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred EEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999999765433 2345789999999999999999999999999999999999999999999999999988888766
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccc--cccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK--TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~--~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
..++.........+......+.. .......+.. ..........+..+++||.+||++||.+|||+.+||+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAG----YSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCC----CChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 55544332221111100000000 0000001100 00111122346789999999999999999999999999999
Q ss_pred CCCCCC
Q 001034 1174 SHPYEP 1179 (1182)
Q Consensus 1174 k~~~eP 1179 (1182)
..-+.|
T Consensus 322 ~~~~~~ 327 (364)
T cd07875 322 NVWYDP 327 (364)
T ss_pred ccccCc
Confidence 865444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=398.60 Aligned_cols=317 Identities=35% Similarity=0.604 Sum_probs=273.2
Q ss_pred CCccceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceE
Q 001034 855 EDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLL 934 (1182)
Q Consensus 855 e~~~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIV 934 (1182)
...+|.+.+++++..+|.+....|+|-|++|.+|.+..-|..||||||++++.....-+.|+.||+.|+...+....|++
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 45689999999999999999999999999999999999999999999999988888899999999999999888889999
Q ss_pred EEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC
Q 001034 935 RLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014 (1182)
Q Consensus 935 kL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d 1014 (1182)
+|+..|...+|+|||+|.+..+|.+.++..... +-|.+..++.|+.||+.||..|-.+||+|.||||+|||++. +.
T Consensus 498 rl~r~F~hknHLClVFE~LslNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE-~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE-SK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhhhchHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc-Cc
Confidence 999999999999999999999999999876543 33888999999999999999999999999999999999996 56
Q ss_pred ceEEEecCCCccccCCC-cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1015 CEVKVIDLGSSCFETDH-LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~~-~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
..+||||||.|.+.... .+.+.-+..|.|||+++|.+|+...|+||+||+||||.||+..|.+.++-.++..+|.+.|+
T Consensus 574 ~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred ceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 68999999999876554 55667788999999999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhcccccchhhcccchhhhhhcc-------hhhhhhccccccc---cc--cCCC----CCcHHHHHHHHHhcccC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQE-------TNRLEYLIPKKTS---LR--HRLP----MGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~e-------ts~Le~liPk~~s---L~--~~l~----~~SeeL~DLIrkMLq~D 1157 (1182)
+|..|+..+...-..|+++...+....- ...+....|.... +. +.++ ..-..|++||.+||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 9999999887766677776554321111 1122233332211 11 1111 22367999999999999
Q ss_pred CCCCCCHHHHHcCCCCCC
Q 001034 1158 PKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1158 PekRPTAeELLqHPWFk~ 1175 (1182)
|++|.|..++|+||||+.
T Consensus 734 P~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 734 PEKRITVNQALKHPFITE 751 (752)
T ss_pred hhhcCCHHHHhcCCcccC
Confidence 999999999999999986
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=381.05 Aligned_cols=285 Identities=21% Similarity=0.328 Sum_probs=220.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
..+|++++.||+|+||.||+|.+..+++.||||.... ....+|+.+++.++| |||++++++|......|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~H------pnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINH------PSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCC------CCCCCEeEEEEECCeeE
Confidence 4679999999999999999999999999999997643 345789999999865 48999999999999999
Q ss_pred EEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 948 LVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
+|||++.++|+.++.... .+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.
T Consensus 160 lv~e~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~--~~~vkL~DFG~a~~ 231 (391)
T PHA03212 160 LILPRYKTDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH--PGDVCLGDFGAACF 231 (391)
T ss_pred EEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcC--CCCEEEEeCCcccc
Confidence 999999999888876542 2788899999999999999999999999999999999984 67899999999865
Q ss_pred cCC----CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhhcCCcch
Q 001034 1028 ETD----HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND-------SPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1028 ~~~----~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~-------d~~elLakIv~ilGp~Pe 1096 (1182)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||... .....+..++..+|..|.
T Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~ 311 (391)
T PHA03212 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311 (391)
T ss_pred cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence 322 233467999999999999999999999999999999999999887542 345667778877887665
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.+......... . .+.. ........+............+.++.+||.+||++||.+||||.|||+||||+..
T Consensus 312 ~~~~~~~~~~~---~---~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 312 EFPIDAQANLD---E---IYIG---LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hcCcchhHHHH---H---HHHH---HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 44321110000 0 0000 0000000011000011112345789999999999999999999999999999987
Q ss_pred CCCC
Q 001034 1177 YEPI 1180 (1182)
Q Consensus 1177 ~eP~ 1180 (1182)
..|.
T Consensus 383 ~~~~ 386 (391)
T PHA03212 383 PDPY 386 (391)
T ss_pred CCCC
Confidence 6654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=379.49 Aligned_cols=281 Identities=29% Similarity=0.509 Sum_probs=233.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--C--
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--E-- 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--e-- 944 (1182)
-.|.-.+++|+|+||.||+|+...+++.||||..-.++... ..|+.+|+.+. |||||+|..+|... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~------HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLD------HPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcC------CcCeeeEEEEEEecCCCch
Confidence 35888999999999999999999999999999987776543 36888888664 55999999999864 2
Q ss_pred -eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 -HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 -~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++.+|||||+.+|+.+++.....+ ..++...++.+++||++||.|||+.||+||||||.|||+|. ..|.+||||||
T Consensus 95 ~~lnlVleymP~tL~~~~r~~~~~~--~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~-~tg~LKicDFG 171 (364)
T KOG0658|consen 95 VYLNLVLEYMPETLYRVIRHYTRAN--QRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP-DTGVLKICDFG 171 (364)
T ss_pred hHHHHHHHhchHHHHHHHHHHhhcC--CCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC-CCCeEEeccCC
Confidence 578999999999999998642222 23788889999999999999999999999999999999996 67899999999
Q ss_pred CccccC--CCcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1024 SSCFET--DHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1024 LA~~~~--~~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+|+.+. ++..++.-|+.|+|||++.+. .|+.++||||.||++.||+-|++.|.+.+..+++..|++++|.+..+-..
T Consensus 172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 998643 445677889999999999886 69999999999999999999999999999999999999999998876655
Q ss_pred cccccchhhcccchhhhhhcchhhhhhcccccc--cc-ccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT--SL-RHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~--sL-~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.....+. +...|... .+ .......++++.+|+.++|+++|.+|.++.|+|.||||...-
T Consensus 252 ~mn~~y~------------------~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 252 SMNPNYT------------------EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred hcCcccc------------------cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 4433221 11111111 11 123456789999999999999999999999999999998766
Q ss_pred CC
Q 001034 1178 EP 1179 (1182)
Q Consensus 1178 eP 1179 (1182)
+|
T Consensus 314 ~~ 315 (364)
T KOG0658|consen 314 DP 315 (364)
T ss_pred Cc
Confidence 55
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=374.05 Aligned_cols=289 Identities=32% Similarity=0.457 Sum_probs=239.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch---hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC-
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE- 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~---~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e- 944 (1182)
..|..+++||.|+||+||+|+.+.+|+.||+|.++.... ......+|+.+|+.++|.+ ||+.|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~-----~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHAN-----HIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCc-----ceEEEEeeeeeccc
Confidence 346667789999999999999999999999999987644 4456789999999999873 3999999999887
Q ss_pred -----eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 945 -----HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 945 -----~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
.+++||||+.-+|..++....... ..++...++.+++||+.||.|||+++|+||||||.||||++ .|.+||
T Consensus 86 ~~~~~~l~lvfe~~d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~--~G~lKl 161 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS--SGVLKL 161 (323)
T ss_pred ccccceEEEEEEeecccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC--CCcEee
Confidence 899999999999999998876431 12666889999999999999999999999999999999995 888999
Q ss_pred ecCCCccccC---CCcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1020 IDLGSSCFET---DHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1020 iDFGLA~~~~---~~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
+|||+|+... ......+.|.+|+|||++.+. .|+...||||+|||++||+++++.|.+.+..+++.+|...+|.+.
T Consensus 162 aDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 162 ADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred eccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 9999997543 224566889999999999987 699999999999999999999999999999999999999999988
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
+..|..-.....+-. .+. ..+....+....+..+....+|+.+||+++|.+|.||..+|.||||.+
T Consensus 242 e~~Wp~v~~~~~~k~----~f~----------~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKA----PFP----------KWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred ccCCCCccccccccc----cCc----------CCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 766654332222110 000 001112333444555678999999999999999999999999999998
Q ss_pred CCCCC
Q 001034 1176 PYEPI 1180 (1182)
Q Consensus 1176 ~~eP~ 1180 (1182)
..++.
T Consensus 308 ~~~~~ 312 (323)
T KOG0594|consen 308 LPEKS 312 (323)
T ss_pred cccch
Confidence 86654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=369.01 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=207.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||+|+||+||+|.++.+++.||||++++.. .....+..|+.++..+. |++|+++++.|....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~------~~~iv~~~~~~~~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD------SLWVVKMFYSFQDKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC------CCCcceEEEEEecCC
Confidence 46999999999999999999999999999999997642 23345667888888775 458999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++||||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~--~~~vkL~DFG 146 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS--KGHVKLSDFG 146 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCCEEEeecc
Confidence 99999999985 6777665432 2889999999999999999999999999999999999984 6789999999
Q ss_pred CccccCCC--------------------------------------cccccCCCcccchhhhcCCCCCchhhHHHHHHHH
Q 001034 1024 SSCFETDH--------------------------------------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065 (1182)
Q Consensus 1024 LA~~~~~~--------------------------------------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVIL 1065 (1182)
+++..... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 98643211 1245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHH
Q 001034 1066 AELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQG 1145 (1182)
Q Consensus 1066 YELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~See 1145 (1182)
|+|++|++||.+.+..+.+.+++.....+ .+|. ....+.+
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------~~p~-------~~~~s~~ 266 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKETL---------------------------------IFPP-------EVPISEK 266 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCcc---------------------------------cCCC-------cCCCCHH
Confidence 99999999999988888777775221110 0111 1124688
Q ss_pred HHHHHHHhcccCCC---CCCCHHHHHcCCCCCCC
Q 001034 1146 FIDFVAHLLEINPK---KRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1146 L~DLIrkMLq~DPe---kRPTAeELLqHPWFk~~ 1176 (1182)
+++||.+||. +|. .||++.+|++||||+..
T Consensus 267 ~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 267 AKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred HHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 9999999876 454 45899999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=367.29 Aligned_cols=283 Identities=30% Similarity=0.531 Sum_probs=225.1
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR- 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~- 943 (1182)
.++|++++.||.|+||.||+|.+..+++.||||++.... .....+.+|+.+|+.+.|+ ||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE------NVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCC------chhhhhhhhcccc
Confidence 478999999999999999999999999999999997542 2234566788888888654 899999888643
Q ss_pred -----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 944 -----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 944 -----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
...|++|+++.++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 88 ~~~~~~~~~~~~~~~~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~--~~~~k 158 (343)
T cd07878 88 SIENFNEVYLVTNLMGADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DCELR 158 (343)
T ss_pred cccccCcEEEEeecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC--CCCEE
Confidence 457999999988887766432 2889999999999999999999999999999999999984 67899
Q ss_pred EecCCCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1019 VIDLGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1019 LiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|+|||++..........++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++....+.++..
T Consensus 159 l~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 159 ILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred EcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999999877666667789999999999987 568999999999999999999999999988888888888877766554
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhcccc--ccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk--~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
++........ .......+. ...+.......++.+.+||.+||++||.+|||+.+||+||||..
T Consensus 239 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 239 VLKKISSEHA---------------RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHHhcchhhH---------------HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 4332211000 000000000 01112223345678999999999999999999999999999987
Q ss_pred CCCCC
Q 001034 1176 PYEPI 1180 (1182)
Q Consensus 1176 ~~eP~ 1180 (1182)
...|.
T Consensus 304 ~~~~~ 308 (343)
T cd07878 304 YHDPE 308 (343)
T ss_pred cCCCc
Confidence 65543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.04 Aligned_cols=258 Identities=25% Similarity=0.342 Sum_probs=215.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||.|+||.||+|++..+++.||||++++.. .....+..|+.++..+.| |||++++++|....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h------~~iv~~~~~~~~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS------EWLVKLLYAFQDDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCC------CCCccEEEEEEcCC
Confidence 46999999999999999999999999999999998643 234456778888887754 49999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++||||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kL~Dfg 146 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA--SGHIKLTDFG 146 (333)
T ss_pred EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCCEEEEeCc
Confidence 99999999985 6777765432 2788999999999999999999999999999999999984 7789999999
Q ss_pred CccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1024 SSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1024 LA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
++..........+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.+..+......+.
T Consensus 147 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-------- 218 (333)
T cd05600 147 LSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ-------- 218 (333)
T ss_pred CCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc--------
Confidence 998766656677899999999999999999999999999999999999999998888777666642111000
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.|... ......+.++.+||.+||..+|.+||++.+|++||||...
T Consensus 219 -------------------------~~~~~---~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 219 -------------------------RPVYD---DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred -------------------------CCCCC---ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 00000 0012457899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=366.40 Aligned_cols=243 Identities=24% Similarity=0.371 Sum_probs=202.9
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||+|+||.||+|+++.+++.||||++++.. ........|+.+++.+.| |||++++++|....++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------p~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH------PFLTALKYSFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC------CCCCCEEEEEEcCCEEEEEE
Confidence 36899999999999999999999999998642 233456678888887754 48999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~--~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 75 EYANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDK--DGHIKITDFGLCKEGI 146 (323)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEeeCCCCcccc
Confidence 99986 5666655432 2889999999999999999999999999999999999984 6789999999987532
Q ss_pred ---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1030 ---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1030 ---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-------------- 212 (323)
T cd05571 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------------- 212 (323)
T ss_pred cCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 223456799999999999999999999999999999999999999988777666555531000
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCC
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSH 1175 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~ 1175 (1182)
.+ ....+..+.+||++||+.||++|| ++.+||+||||+.
T Consensus 213 ---------------------~~---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 213 ---------------------RF---------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred ---------------------CC---------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 00 123478899999999999999999 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=368.15 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=208.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||.|+||+||+|++..+++.||||++.+.. .....+..|+.+++.+. |+||++++++|....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~------h~~iv~~~~~~~~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------NPWVVKLYYSFQDEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCCCcceEEEEEcCC
Confidence 46999999999999999999999999999999997642 23345667888888876 459999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++||||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg 146 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA--KGHIKLSDFG 146 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEeecc
Confidence 99999999985 5666665432 2899999999999999999999999999999999999984 7789999999
Q ss_pred CccccCCC-----------------------------------------cccccCCCcccchhhhcCCCCCchhhHHHHH
Q 001034 1024 SSCFETDH-----------------------------------------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLG 1062 (1182)
Q Consensus 1024 LA~~~~~~-----------------------------------------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLG 1062 (1182)
++...... ....+||+.|+|||++....++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 98643211 1134689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCC
Q 001034 1063 CILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMG 1142 (1182)
Q Consensus 1063 VILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~ 1142 (1182)
|++|+|++|++||.+.+....+..++..... ...|. ....
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~~~-------~~~~ 266 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKET---------------------------------LQFPD-------EVPL 266 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCCc---------------------------------cCCCC-------CCCC
Confidence 9999999999999988877776666421100 00111 1134
Q ss_pred cHHHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCC
Q 001034 1143 DQGFIDFVAHLLEINPKKRPS---ASDALKHPWLSHP 1176 (1182)
Q Consensus 1143 SeeL~DLIrkMLq~DPekRPT---AeELLqHPWFk~~ 1176 (1182)
+..+++||++||. +|.+|++ +.++|+||||+..
T Consensus 267 s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 267 SPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 7889999999997 9999998 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=361.27 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=208.5
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+|++++.||+|+||.||+|++..+++.||||++++.. ........|..++..+.++ ++|++++++|.....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~-----~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP-----PFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCC-----CceeeeEEEEEcCCE
Confidence 4899999999999999999999999999999998642 2345567788888777654 379999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~ 147 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA--EGHIKIADFGM 147 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC--CCCEEEeecCc
Confidence 9999999985 5666654332 2788999999999999999999999999999999999984 67899999999
Q ss_pred cccc---CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1025 SCFE---TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1025 A~~~---~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~------- 220 (324)
T cd05587 148 CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY------- 220 (324)
T ss_pred ceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 8642 222345678999999999999999999999999999999999999999888777776664211110
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA-----SDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA-----eELLqHPWFk~~ 1176 (1182)
....+..+.+||++||..||.+|+++ .++++||||...
T Consensus 221 -------------------------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 221 -------------------------------------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred -------------------------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 11346789999999999999999986 899999999764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=352.67 Aligned_cols=284 Identities=25% Similarity=0.405 Sum_probs=224.9
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|++.+.||.|+||.||+|.+..+++.||+|.++... ........|+.+++.+.| +||++++++|.....+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH------ANIVTLHDIIHTEKSL 79 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCC------CCcceEEEEEecCCeE
Confidence 67999999999999999999999999999999987542 223456678899888865 4899999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|+||||+.++|..++..... .+++..++.++.||+.||.|||+.||+|+||||+|||++. ++.++|+|||++.
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~ 152 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLAR 152 (301)
T ss_pred EEEEeccccCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECC--CCcEEECcCcchh
Confidence 99999999998888765422 2788899999999999999999999999999999999984 6789999999986
Q ss_pred ccCCC---cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||...+....+..+...++.++...+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 153 AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred ccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 53322 2234568899999998764 5889999999999999999999999999988888888888876665444321
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
.....+ ....+.......+....+..+..+.+||.+||++||.+|||+.++|+||||+..-|-
T Consensus 233 ~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 233 LSNEEF--------------KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred hccccc--------------cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 110000 000000000111112234567899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=370.27 Aligned_cols=281 Identities=27% Similarity=0.449 Sum_probs=222.0
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC--
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE-- 944 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e-- 944 (1182)
.|++.+.||.|+||.||++.+..+++.||||++.... .....+.+|+.+++.++|+ ||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHD------NVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCC------CcCCHhheecCCCcc
Confidence 3788999999999999999999999999999986532 2345677888888887654 8999999998876
Q ss_pred ---eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 945 ---HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 945 ---~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
++|+||||+.++|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~--~~~~kL~D 146 (372)
T cd07853 75 PFEEIYVVTELMQSDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS--NCVLKICD 146 (372)
T ss_pred ccceEEEEeeccccCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC--CCCEEecc
Confidence 899999999998888775432 2889999999999999999999999999999999999994 67899999
Q ss_pred CCCccccCCC----cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1022 LGSSCFETDH----LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1022 FGLA~~~~~~----~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
||++...... .....+++.|+|||++.+. .++.++||||||||+|+|++|++||.+.++...+..|...+|.++.
T Consensus 147 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred ccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9998754322 2334678999999999875 4899999999999999999999999999999999999988887665
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
..+......... .... .....+....+.......+.++++||.+||++||.+|||+.++|+||||+..
T Consensus 227 ~~~~~~~~~~~~------~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 227 EAMRSACEGARA------HILR------GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHhhHHHHH------HHHh------CCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 433321110000 0000 0000111111112234457899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=368.16 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=213.6
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCC-cEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTG-MDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TG-r~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
.+..++|++.+.||+|+||.||+|.+..++ ..||+|++.+.. .....+..|+.+++.+.| |||++++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------p~Iv~~~~~ 99 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH------PFCVNLYGS 99 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC------CCCcceEEE
Confidence 344578999999999999999999876654 789999997542 234556778888888754 599999999
Q ss_pred EEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
|.....+|+||||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~--~~~ik 171 (340)
T PTZ00426 100 FKDESYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDK--DGFIK 171 (340)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC--CCCEE
Confidence 9999999999999975 6777776443 2889999999999999999999999999999999999984 77899
Q ss_pred EecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1019 VIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1019 LiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
|+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.++..++..+......
T Consensus 172 L~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~----- 246 (340)
T PTZ00426 172 MTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY----- 246 (340)
T ss_pred EecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-----
Confidence 999999987666566778999999999999999999999999999999999999999988877766666311100
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWL 1173 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWF 1173 (1182)
. ....+..+.+||++||+.||.+|+ ++.++++||||
T Consensus 247 ------------------------------~---------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 247 ------------------------------F---------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred ------------------------------C---------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 0 112367899999999999999995 89999999999
Q ss_pred CCC
Q 001034 1174 SHP 1176 (1182)
Q Consensus 1174 k~~ 1176 (1182)
...
T Consensus 288 ~~~ 290 (340)
T PTZ00426 288 GNI 290 (340)
T ss_pred CCC
Confidence 863
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.62 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=211.6
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||.|+||.||+|++..+++.||||++++.. .....+..|+.++..+. |+||++++++|....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD------SPWIVKLYYSFQDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC------CCCccchhhheecCC
Confidence 47999999999999999999999999999999998642 33455677888888876 459999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~--~~~~kL~Dfg 146 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFG 146 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEeecCC
Confidence 99999999975 6777766442 2889999999999999999999999999999999999984 6789999999
Q ss_pred CccccCCC--------------------------------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhC
Q 001034 1024 SSCFETDH--------------------------------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071 (1182)
Q Consensus 1024 LA~~~~~~--------------------------------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTG 1071 (1182)
++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 98754332 2345789999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHH
Q 001034 1072 NVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVA 1151 (1182)
Q Consensus 1072 r~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIr 1151 (1182)
+.||...+....+.+++.....+ ..|. ...++..+.+||.
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------~~p~-------~~~~~~~~~~li~ 266 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKESL---------------------------------RFPP-------DPPVSPEAIDLIC 266 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCcc---------------------------------cCCC-------CCCCCHHHHHHHH
Confidence 99999888777776664211110 0111 1125789999999
Q ss_pred HhcccCCCCCCC-HHHHHcCCCCCCC
Q 001034 1152 HLLEINPKKRPS-ASDALKHPWLSHP 1176 (1182)
Q Consensus 1152 kMLq~DPekRPT-AeELLqHPWFk~~ 1176 (1182)
+||. ||.+||+ +.+||+||||+..
T Consensus 267 ~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 267 RLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 9998 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=369.03 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=206.5
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+|++++.||+|+||+||+|+++.+++.||||++.+.. .....+.+|+.+++.+.| +||+++++.|....+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h------~~iv~~~~~~~~~~~ 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN------EWVVRLYYSFQDKDN 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCC------CcCCeEEEEEEeCCE
Confidence 6999999999999999999999999999999997643 234566778888888754 489999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+||||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~--~g~~kL~DFGl 147 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFGL 147 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEEeECCC
Confidence 9999999985 5666665432 2788999999999999999999999999999999999984 77899999998
Q ss_pred ccccCC--------------------------------------------------CcccccCCCcccchhhhcCCCCCc
Q 001034 1025 SCFETD--------------------------------------------------HLCSYVQSRSYRAPEVILGLSYDK 1054 (1182)
Q Consensus 1025 A~~~~~--------------------------------------------------~~ss~vGTp~YmAPEVLlg~~yS~ 1054 (1182)
+..... .....+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 742110 012347899999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccc
Q 001034 1055 KIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTS 1134 (1182)
Q Consensus 1055 kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~s 1134 (1182)
++||||||||||+|++|++||.+.++...+.++...... ...|
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~p---- 270 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------------------------LHIP---- 270 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------------------------cCCC----
Confidence 999999999999999999999988877666555321100 0011
Q ss_pred cccCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCC
Q 001034 1135 LRHRLPMGDQGFIDFVAHLLEINPKKRPS---ASDALKHPWLSHP 1176 (1182)
Q Consensus 1135 L~~~l~~~SeeL~DLIrkMLq~DPekRPT---AeELLqHPWFk~~ 1176 (1182)
.....+.++++||.+|+ .+|.+|++ +.++++||||+..
T Consensus 271 ---~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 271 ---PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred ---CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 11235788999999986 59999997 9999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=359.34 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=206.1
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
|++++.||+|+||.||+|.+..+++.||||++++.. .....+..|++++..+.. ..||||++++++|....++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~---l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS---ERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccc---cCCCChhceeeEEEcCCEE
Confidence 788999999999999999999999999999998542 233455666666665543 3588999999999999999
Q ss_pred EEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.++ |...+.. . .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~lv~E~~~~~~L~~~~~~-~------~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~--~~~~kL~Dfg~~ 148 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT-D------VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT--EGFVKIADFGLC 148 (324)
T ss_pred EEEEcCCCCCcHHHHhhc-C------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCcEEeCcccCC
Confidence 9999999975 4444321 1 2899999999999999999999999999999999999995 678999999998
Q ss_pred cccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
.... ......+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--------- 219 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--------- 219 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 6422 2234567899999999999999999999999999999999999999988877766655311000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~~ 1176 (1182)
.....+..+.+||.+||+.||.+|| ++.++++||||+..
T Consensus 220 -----------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 220 -----------------------------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred -----------------------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 0123468899999999999999999 79999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=351.81 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=204.0
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
|++.+.||+|+||.||+|.++.+++.||+|++.+.. .....+.+|+.+++.+.|+ +|++++++|....++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~------~iv~~~~~~~~~~~~ 75 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR------FVVSLAYAYETKDAL 75 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCC------cEEEEEEEEccCCeE
Confidence 788999999999999999999999999999987543 2223466788888888654 899999999999999
Q ss_pred EEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.++ |...+..... ..+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~--~~~~kl~Dfg~~ 149 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDD--RGHIRISDLGLA 149 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC--CCCEEEeeCCCc
Confidence 9999999864 5444432221 23888999999999999999999999999999999999984 678999999998
Q ss_pred cccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1026 CFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1026 ~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~---------- 219 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE---------- 219 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc----------
Confidence 76432 234557899999999999999999999999999999999999999875543222222100000
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSHP 1176 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~~ 1176 (1182)
.........+..+.+||++||+.||.+||+ +.++++||||...
T Consensus 220 ------------------------------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 220 ------------------------------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred ------------------------------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 000112245789999999999999999997 9999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=389.82 Aligned_cols=252 Identities=28% Similarity=0.473 Sum_probs=220.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..+-|++.+.||.|+-|.|.+|++..||+.+|||++.+.. .....+.+|+-||+.+.|+ |+++||+++..
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~Hp------nVl~LydVwe~ 83 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHP------NVLRLYDVWEN 83 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCC------Ceeeeeeeecc
Confidence 3467999999999999999999999999999999998752 3345677899999998766 89999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++|+|.||+.| .|++++..... +++.++..+++||+.|+.|||..+||||||||+|+||+. ++.|||+|
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG~------l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~--~~nIKIAD 155 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKGP------LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV--KNNIKIAD 155 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc--ccCEeeec
Confidence 9999999999995 68888876543 899999999999999999999999999999999999995 55599999
Q ss_pred CCCccccC--CCcccccCCCcccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1022 LGSSCFET--DHLCSYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1022 FGLA~~~~--~~~ss~vGTp~YmAPEVLlg~~yS-~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
||.|.... .-..+.||+|.|+|||++.|.+|. .++||||.|||||.||||++||.+++...++.++......
T Consensus 156 FGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~----- 230 (786)
T KOG0588|consen 156 FGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE----- 230 (786)
T ss_pred cceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc-----
Confidence 99997643 345688999999999999999986 7999999999999999999999999988888877422111
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+| ..++.++.+||++||..||++|+|.+||++|||++.-
T Consensus 231 ------------------------------MP---------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 231 ------------------------------MP---------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ------------------------------CC---------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 22 3457899999999999999999999999999999765
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=374.79 Aligned_cols=261 Identities=29% Similarity=0.461 Sum_probs=227.4
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch----hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD----FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~----~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
...+...|++.+.||+|.||.||+|+++.+|+.+|+|++.+... ......+|+.+|+++.. |||||.++++
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~-----hpniv~l~~~ 104 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSG-----HPNIVQLKDA 104 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccC-----CCCEEEEEEE
Confidence 34566789999999999999999999999999999999987643 34678899999999973 5599999999
Q ss_pred EEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC--ce
Q 001034 940 FYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR--CE 1016 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d--G~ 1016 (1182)
|.+...+++|||++.| .|++.+... .+++..+..++.||+.|+.|||+.||+||||||+|||+..... +.
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCc
Confidence 9999999999999995 677777654 2899999999999999999999999999999999999986543 57
Q ss_pred EEEecCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1017 VKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
+|++|||++..... .....+||+.|+|||++...+|+..+||||+|||+|.||+|.+||.+.+....+.+|...-..+
T Consensus 178 ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f 257 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDF 257 (382)
T ss_pred EEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCC
Confidence 99999999987665 4667899999999999999999999999999999999999999999999888887774221111
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
.....+.++..+++||++||..||.+|+|+.++|+|||++
T Consensus 258 ----------------------------------------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~ 297 (382)
T KOG0032|consen 258 ----------------------------------------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK 297 (382)
T ss_pred ----------------------------------------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence 1123455689999999999999999999999999999998
Q ss_pred CC
Q 001034 1175 HP 1176 (1182)
Q Consensus 1175 ~~ 1176 (1182)
..
T Consensus 298 ~~ 299 (382)
T KOG0032|consen 298 SI 299 (382)
T ss_pred CC
Confidence 75
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=367.68 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=205.9
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||.|+||.||+|.++.+++.||||++.+.. .....+.+|+.+++.+. ||||++++++|....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~------hp~iv~~~~~~~~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD------SPWVVSLYYSFQDAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC------CCCcceEEEEEEcCC
Confidence 46999999999999999999999999999999997643 23345667888887765 459999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++||||||+.| +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~--~~~~kl~DfG 146 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR--GGHIKLSDFG 146 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC--CCCEEEeecc
Confidence 99999999975 6777665432 2888999999999999999999999999999999999984 6789999999
Q ss_pred CccccCCC--------------------------------------------------cccccCCCcccchhhhcCCCCC
Q 001034 1024 SSCFETDH--------------------------------------------------LCSYVQSRSYRAPEVILGLSYD 1053 (1182)
Q Consensus 1024 LA~~~~~~--------------------------------------------------~ss~vGTp~YmAPEVLlg~~yS 1053 (1182)
+++..... ....+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 98521100 0124789999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcccccc
Q 001034 1054 KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT 1133 (1182)
Q Consensus 1054 ~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~ 1133 (1182)
.++|||||||++|+|++|++||.+.+....+..+......+ ..|.
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------~~p~-- 271 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL---------------------------------YFPD-- 271 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc---------------------------------CCCC--
Confidence 99999999999999999999999888777776664211100 0011
Q ss_pred ccccCCCCCcHHHHHHHHHhcccCCCCC---CCHHHHHcCCCCCCC
Q 001034 1134 SLRHRLPMGDQGFIDFVAHLLEINPKKR---PSASDALKHPWLSHP 1176 (1182)
Q Consensus 1134 sL~~~l~~~SeeL~DLIrkMLq~DPekR---PTAeELLqHPWFk~~ 1176 (1182)
....+.++.+||.+||. +|.+| +++.++|+||||+..
T Consensus 272 -----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 272 -----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred -----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 11346889999999998 77765 599999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=353.85 Aligned_cols=286 Identities=26% Similarity=0.392 Sum_probs=208.5
Q ss_pred EEeccCCceEEEEEEEC--CCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe--cCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDL--HTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--REHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk--~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--~e~LyLVm 950 (1182)
.+||+|+||.||+|+++ .+++.||+|++..... .....+|+.+++.+.| |||++++++|.. ..++|+||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKH------PNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCC------CCCcceeeeEecCCCcEEEEEE
Confidence 57999999999999965 4778999999976532 3456789999998865 489999999865 46789999
Q ss_pred EecccChHHHHhhhccc---CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc--CCCceEEEecCCCc
Q 001034 951 ELLKANLYEFHKFNRES---GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS--YSRCEVKVIDLGSS 1025 (1182)
Q Consensus 951 EyL~GsLld~Lk~~~~s---ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs--~~dG~IKLiDFGLA 1025 (1182)
||+.++|..++...... .....+++..++.++.||+.||.|||++||+||||||+|||+.. ...+.+||+|||++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99999998887644321 11234889999999999999999999999999999999999953 13568999999999
Q ss_pred cccCCC------cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHh
Q 001034 1026 CFETDH------LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSP---------ATLLARVIG 1089 (1182)
Q Consensus 1026 ~~~~~~------~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~---------~elLakIv~ 1089 (1182)
...... ....++|+.|+|||++.+. .++.++|||||||++|+|++|++||..... ...+.++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 764322 2345789999999999874 589999999999999999999999975332 355677777
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.+|.++...+............ ...+...... ..+....+.......+..+++||++||++||.+|||++|||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTL-MKDFRRNTYT-----NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred hcCCCChHHhHHHhhccchhhh-hhhhhccccC-----cccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 7776554443322111100000 0000000000 000000111112234678999999999999999999999999
Q ss_pred CCCC
Q 001034 1170 HPWL 1173 (1182)
Q Consensus 1170 HPWF 1173 (1182)
||||
T Consensus 314 hp~f 317 (317)
T cd07868 314 DPYF 317 (317)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=370.47 Aligned_cols=257 Identities=30% Similarity=0.474 Sum_probs=217.2
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+. +...+....|+++|+.++|+ |||.|++.+..+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~------nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHP------NIVRLLDCIEDD 81 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCc------ceeeEEEEEecC
Confidence 357899999999999999999999999999999999765 34456678999999999755 999999999999
Q ss_pred CeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-CC---ceEE
Q 001034 944 EHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-SR---CEVK 1018 (1182)
Q Consensus 944 e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-~d---G~IK 1018 (1182)
+++|||||||. |+|..+++.... +++..++.++.||+.||++||+++||||||||.||||+.. .. -.+|
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~------l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGR------LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEE
Confidence 99999999999 567777776542 8999999999999999999999999999999999999864 22 4699
Q ss_pred EecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1019 VIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1019 LiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
|+|||+|+..... ..+.||+|.|||||++..+.|+.++|+||+|+|+|+|++|++||...++.+++..+-..-.
T Consensus 156 IADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~---- 231 (429)
T KOG0595|consen 156 IADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE---- 231 (429)
T ss_pred ecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc----
Confidence 9999999986643 4678999999999999999999999999999999999999999999999888775521000
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.+|.. ....+..+.+|+...|+.+|..|.+..+-+.|+++...
T Consensus 232 -------------------------------~~~~~------~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 232 -------------------------------IVPVL------PAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred -------------------------------ccCch------hhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 01110 11224556789999999999999999999999988654
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=365.89 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=204.5
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.|++++.||+|+||+||+|+++.+++.||||++.+.. .....+..|+.+++.+.| +||++++++|....+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h------~~iv~l~~~~~~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN------EWVVKLYYSFQDKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCC------CCeeeeEEEEecCCE
Confidence 5899999999999999999999999999999997643 334566788888888754 499999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.| +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+. .+.+||+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~--~~~~kL~DFGl 147 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL--DGHIKLTDFGL 147 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC--CCCEEEeeCcC
Confidence 9999999985 6766665432 2788899999999999999999999999999999999984 67899999998
Q ss_pred ccccCC--------------------------------------------------CcccccCCCcccchhhhcCCCCCc
Q 001034 1025 SCFETD--------------------------------------------------HLCSYVQSRSYRAPEVILGLSYDK 1054 (1182)
Q Consensus 1025 A~~~~~--------------------------------------------------~~ss~vGTp~YmAPEVLlg~~yS~ 1054 (1182)
+..... .....+||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 743210 012357999999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccc
Q 001034 1055 KIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTS 1134 (1182)
Q Consensus 1055 kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~s 1134 (1182)
++||||||||+|+|++|.+||...+......+++.....+ .+|
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------~~~---- 270 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------------------------HIP---- 270 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------------------------CCC----
Confidence 9999999999999999999998877766555553111000 001
Q ss_pred cccCCCCCcHHHHHHHHHhccc--CCCCCCCHHHHHcCCCCCC
Q 001034 1135 LRHRLPMGDQGFIDFVAHLLEI--NPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1135 L~~~l~~~SeeL~DLIrkMLq~--DPekRPTAeELLqHPWFk~ 1175 (1182)
.....+.++++||.+||.. +|..|+++.+|++||||+.
T Consensus 271 ---~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 271 ---PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred ---CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 1123578999999996654 4455999999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=356.34 Aligned_cols=242 Identities=26% Similarity=0.403 Sum_probs=202.0
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 877 LGkGaFGeVyLAkDk~TGr~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
||+|+||.||+|++..+++.||+|++++. ......+..|+.+++.+.| |||++++++|.....+|+||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~~~~lv~e~ 74 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC------PFIVPLKFSFQSPEKLYLVLAF 74 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC------CcEeceeeEEecCCeEEEEEcC
Confidence 69999999999999999999999999753 2334556778888888754 5899999999999999999999
Q ss_pred ccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC-
Q 001034 953 LKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD- 1030 (1182)
Q Consensus 953 L~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~- 1030 (1182)
+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 75 ~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~--~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 75 INGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY--QGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECC--CCcEEEEECcccccCccC
Confidence 985 5667665432 2888999999999999999999999999999999999984 67899999999875322
Q ss_pred --CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchh
Q 001034 1031 --HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKY 1108 (1182)
Q Consensus 1031 --~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~ 1108 (1182)
.....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+..++....
T Consensus 147 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~---------------- 210 (312)
T cd05585 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL---------------- 210 (312)
T ss_pred CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC----------------
Confidence 23346799999999999999999999999999999999999999998877666655531100
Q ss_pred hcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC---CHHHHHcCCCCCCC
Q 001034 1109 FTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP---SASDALKHPWLSHP 1176 (1182)
Q Consensus 1109 F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP---TAeELLqHPWFk~~ 1176 (1182)
......+..+.+||.+||.+||.+|| ++.++|.||||...
T Consensus 211 ----------------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 211 ----------------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ----------------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 00123468899999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=358.91 Aligned_cols=300 Identities=31% Similarity=0.541 Sum_probs=230.5
Q ss_pred ceeeeCc---eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcc
Q 001034 859 FHVVLNS---VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYH 932 (1182)
Q Consensus 859 f~V~ig~---iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPn 932 (1182)
+++..+. .+.++|++++.||.|+||.||+|.+..+++.||||++.+. .........|+.+++.+.| +|
T Consensus 3 ~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~ 76 (353)
T cd07850 3 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNH------KN 76 (353)
T ss_pred eeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCC------CC
Confidence 4555555 4578999999999999999999999999999999998653 2233456678888888765 48
Q ss_pred eEEEEEEEEec------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCcc
Q 001034 933 LLRLYDYFYYR------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPEN 1006 (1182)
Q Consensus 933 IVkL~dsFqd~------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeN 1006 (1182)
|++++++|... .++|+||||+.++|...+... ++...+..++.||+.||.|||++||+||||||+|
T Consensus 77 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~N 148 (353)
T cd07850 77 IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 148 (353)
T ss_pred CcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 99999998654 357999999999988876532 6788899999999999999999999999999999
Q ss_pred EEEccCCCceEEEecCCCccccCCCc--ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001034 1007 ILVKSYSRCEVKVIDLGSSCFETDHL--CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLL 1084 (1182)
Q Consensus 1007 ILIDs~~dG~IKLiDFGLA~~~~~~~--ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elL 1084 (1182)
||++. ++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+....+
T Consensus 149 il~~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~ 226 (353)
T cd07850 149 IVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQW 226 (353)
T ss_pred EEECC--CCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99985 6789999999997654432 3346788999999999999999999999999999999999999999988899
Q ss_pred HHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccc---cccCCCCCcHHHHHHHHHhcccCCCCC
Q 001034 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTS---LRHRLPMGDQGFIDFVAHLLEINPKKR 1161 (1182)
Q Consensus 1085 akIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~s---L~~~l~~~SeeL~DLIrkMLq~DPekR 1161 (1182)
..++..++.++..+..........+....... ....+....+.... ........+..+++||.+||++||.+|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 302 (353)
T cd07850 227 NKIIEQLGTPSDEFMSRLQPTVRNYVENRPKY----AGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302 (353)
T ss_pred HHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCC----CCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhC
Confidence 99998888877766554332222111111000 00001111111100 000122346789999999999999999
Q ss_pred CCHHHHHcCCCCCCCCC
Q 001034 1162 PSASDALKHPWLSHPYE 1178 (1182)
Q Consensus 1162 PTAeELLqHPWFk~~~e 1178 (1182)
||+.|||.||||..-+.
T Consensus 303 ~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 303 ISVDDALQHPYINVWYD 319 (353)
T ss_pred cCHHHHhcChhHhhccC
Confidence 99999999999975443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=354.30 Aligned_cols=296 Identities=24% Similarity=0.312 Sum_probs=214.3
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
..++|++++.||+|+||.||++++..++..||+|++... ......+.+|+.+++.++|+ ||++++++|....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~ 76 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP------YIVGFYGAFYSDG 76 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCC------CCCeEEEEEEECC
Confidence 357899999999999999999999999999999999764 23446788899999988654 8999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-CccccccCCccEEEccCCCceEEEecC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL-GLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~-GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.+++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~--~~~~kl~Df 148 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS--RGEIKLCDF 148 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC--CCcEEEccC
Confidence 99999999986 6766665432 278889999999999999999986 6999999999999984 678999999
Q ss_pred CCccccCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1023 GSSCFETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1023 GLA~~~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
|++..... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+-.............
T Consensus 149 g~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 149 GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred cccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence 99875433 23456789999999999999999999999999999999999999988776554332211000000000000
Q ss_pred ccccc----hhhcccchh-hhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1102 GRDTY----KYFTKNHML-YERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~----k~F~k~~~~-~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
..... ..+...... ................ .........++.++++||.+||++||++|||+.+||+||||+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNE-PPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhC-CCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00000 000000000 0000000000000000 00011122467899999999999999999999999999999865
Q ss_pred C
Q 001034 1177 Y 1177 (1182)
Q Consensus 1177 ~ 1177 (1182)
.
T Consensus 308 ~ 308 (331)
T cd06649 308 E 308 (331)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.43 Aligned_cols=278 Identities=29% Similarity=0.440 Sum_probs=218.0
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+|++++.||.|+||.||+|.+..++..||||+++... .......+|+.+++.+.| |||++++++|.....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH------PNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCC------CCEeeeEEEEeeCCeE
Confidence 4899999999999999999999999999999986532 223556788899888864 5899999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|+||||+.++|..++..... ...+++..++.++.||+.||.|||+.+|+|+||||+|||++. ++.++|+|||++.
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~ 149 (285)
T cd07861 75 YLIFEFLSMDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN--KGVIKLADFGLAR 149 (285)
T ss_pred EEEEecCCCCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC--CCcEEECccccee
Confidence 99999999988888765432 123889999999999999999999999999999999999984 7789999999986
Q ss_pred ccCCC---cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+......+..+...++.+....+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 150 AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred ecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 54322 2234568899999998754 5789999999999999999999999988877777777766666554443322
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.....+ .. . ........+......++.++++||++||+.||.+|||+.+||.||||
T Consensus 230 ~~~~~~-~~------------~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 230 TSLPDY-KN------------T--FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhhHHH-Hh------------h--ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 111100 00 0 00000011112234468999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.66 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=206.6
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+|++++.||+|+||.||+|++..+++.||||++++.. ........|..++..+. .|++|++++++|.....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-----KPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCeEeeEEEEEecCCE
Confidence 4889999999999999999999999999999998643 22234455666666554 34699999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.+ +|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kL~DfG~ 147 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC--CCcEEEccCCC
Confidence 9999999985 6666654332 2888999999999999999999999999999999999994 67899999999
Q ss_pred ccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1025 SCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1025 A~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...++..+......
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-------- 219 (323)
T cd05616 148 CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-------- 219 (323)
T ss_pred ceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 86432 2234567899999999999999999999999999999999999999988887777666421110
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~~ 1176 (1182)
. ....+.++.+||.+||+.||.+|++ ..++++||||...
T Consensus 220 ---------------------------~---------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 220 ---------------------------Y---------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred ---------------------------C---------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 0 1134678999999999999999998 4899999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.62 Aligned_cols=276 Identities=28% Similarity=0.436 Sum_probs=217.3
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+|++.+.||.|+||.||+|.+..+|+.||+|+++... .....+.+|+.+++.++|+ ||+++++++.+...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~------~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK------NIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCC------CeeeHHHHhccCCce
Confidence 5899999999999999999999999999999997532 2234566789999888654 899999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|+|+||+.++|..++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.
T Consensus 75 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~--~~~~~l~dfg~~~ 147 (284)
T cd07839 75 TLVFEYCDQDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK--NGELKLADFGLAR 147 (284)
T ss_pred EEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC--CCcEEECccchhh
Confidence 99999999999888764322 2889999999999999999999999999999999999995 6789999999987
Q ss_pred ccCCC---cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVL-FQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~P-F~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|..| |.+.+....+..+...++.++...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH
Confidence 54322 2234668899999998775 478999999999999999998877 566777778888877777655433221
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
......+ . .....+.........+..+..+++||.+||+.||.+|||+.+||+||||
T Consensus 228 ~~~~~~~-----~----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 228 VSKLPDY-----K----------PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hhhcccc-----c----------ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1110000 0 0000111111223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=364.43 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=206.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||+|+||.||+|++..+++.||||++.+.. .....+.+|+.+|+.+.| +||+++++.|....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h------~~iv~~~~~~~~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN------EWVVKLYYSFQDKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCC------CCcceEEEEEEcCC
Confidence 36999999999999999999999999999999997542 233456778888888865 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++||||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~--~~~ikL~DFG 146 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFG 146 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC--CCCEEEEeCC
Confidence 99999999985 6777765432 2788899999999999999999999999999999999984 6789999999
Q ss_pred CccccCC----------------------------------------------CcccccCCCcccchhhhcCCCCCchhh
Q 001034 1024 SSCFETD----------------------------------------------HLCSYVQSRSYRAPEVILGLSYDKKID 1057 (1182)
Q Consensus 1024 LA~~~~~----------------------------------------------~~ss~vGTp~YmAPEVLlg~~yS~kSD 1057 (1182)
++..... .....+||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 9742110 011347999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcccccccccc
Q 001034 1058 IWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRH 1137 (1182)
Q Consensus 1058 IWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~ 1137 (1182)
|||||||+|+|++|++||...++...+.++...... ..+|
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~~------- 266 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------------------------LHIP------- 266 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------------------------ccCC-------
Confidence 999999999999999999988876665554311000 0011
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCC---CHHHHHcCCCCCC
Q 001034 1138 RLPMGDQGFIDFVAHLLEINPKKRP---SASDALKHPWLSH 1175 (1182)
Q Consensus 1138 ~l~~~SeeL~DLIrkMLq~DPekRP---TAeELLqHPWFk~ 1175 (1182)
.....+..+.+||.+|+ .+|.+|+ |+.++++||||+.
T Consensus 267 ~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 267 SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 11235788999999977 5999999 9999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=372.31 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=215.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.+.|++++.||+|.-|+||+|+...++..+|||++.+.. ....+...|..||+.+. ||+|+.||..|+..
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD------HPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD------HPFLPTLYASFETD 149 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC------CCccchhhheeecc
Confidence 456888899999999999999999999999999998764 33456677888888875 55999999999999
Q ss_pred CeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
...|+|||||+|+ |..+.+.+.. ..|++..+++|+.+|+.||+|||-+|||+|||||+||||. .+|+|.|+||
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~----~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr--edGHIMLsDF 223 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPG----KRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR--EDGHIMLSDF 223 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCC----CccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe--cCCcEEeeec
Confidence 9999999999975 5544444332 3499999999999999999999999999999999999999 5889999999
Q ss_pred CCcccc-----------------------------------C-C-----------------------CcccccCCCcccc
Q 001034 1023 GSSCFE-----------------------------------T-D-----------------------HLCSYVQSRSYRA 1043 (1182)
Q Consensus 1023 GLA~~~-----------------------------------~-~-----------------------~~ss~vGTp~YmA 1043 (1182)
.++... . . ...+++||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 865210 0 0 0234688999999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchh
Q 001034 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETN 1123 (1182)
Q Consensus 1044 PEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets 1123 (1182)
||++.|...+.++|||+||++|||||.|..||.+.+..+++.+|+..-..+|
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp---------------------------- 355 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFP---------------------------- 355 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCC----------------------------
Confidence 9999999999999999999999999999999999999999999862211111
Q ss_pred hhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC----HHHHHcCCCCCCC
Q 001034 1124 RLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS----ASDALKHPWLSHP 1176 (1182)
Q Consensus 1124 ~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT----AeELLqHPWFk~~ 1176 (1182)
..+.++..++|||+++|.+||.+|+. |.||-+||||+..
T Consensus 356 --------------~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 356 --------------EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred --------------CCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence 11245789999999999999999999 9999999999876
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=361.46 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=207.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
+.|++++.||+|+||.||+|.++.+++.||||+++... .....+..|+.++..+.| ++|+++++.|....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~iv~~~~~~~~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG------AWVVKMFYSFQDKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC------CCEeeEEEEEEcCC
Confidence 46999999999999999999999999999999997532 234456678888877654 58999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++||||||++| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~--~~~vkL~DfG 146 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA--KGHVKLSDFG 146 (360)
T ss_pred EEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC--CCCEEEeecc
Confidence 99999999985 6777665432 2889999999999999999999999999999999999984 7789999999
Q ss_pred CccccCCC--------------------------------------cccccCCCcccchhhhcCCCCCchhhHHHHHHHH
Q 001034 1024 SSCFETDH--------------------------------------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065 (1182)
Q Consensus 1024 LA~~~~~~--------------------------------------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVIL 1065 (1182)
++...... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 98643211 1245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHH
Q 001034 1066 AELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQG 1145 (1182)
Q Consensus 1066 YELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~See 1145 (1182)
|+|++|++||.+.++...+.+++..... ..+|. ....+..
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~p~-------~~~~s~~ 266 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKET---------------------------------LVFPP-------EVPISEK 266 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCCc---------------------------------eecCC-------CCCCCHH
Confidence 9999999999998887777666421100 00111 1124788
Q ss_pred HHHHHHHhcccCCCCCC---CHHHHHcCCCCCCC
Q 001034 1146 FIDFVAHLLEINPKKRP---SASDALKHPWLSHP 1176 (1182)
Q Consensus 1146 L~DLIrkMLq~DPekRP---TAeELLqHPWFk~~ 1176 (1182)
+++||.+|+. ||.+|+ ++.++++||||+..
T Consensus 267 ~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 267 AKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred HHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 9999999874 999998 58999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=358.50 Aligned_cols=244 Identities=24% Similarity=0.369 Sum_probs=201.5
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||+|+||.||+|++..+++.||||++.+.. .....+..|+.+++.+.| |||++++++|....++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~~~~~~~~~~lv~ 74 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH------PFLTSLKYSFQTKDRLCFVM 74 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC------CCCcceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999997642 234456678888877754 58999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 75 Ey~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~--~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 75 EYVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDK--DGHIKITDFGLCKEGI 146 (328)
T ss_pred eCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECC--CCcEEEecCcCCccCC
Confidence 99986 5555554322 2889999999999999999999999999999999999984 6789999999987532
Q ss_pred C---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1030 D---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1030 ~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-------------- 212 (328)
T cd05593 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-------------- 212 (328)
T ss_pred CcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc--------------
Confidence 2 23346799999999999999999999999999999999999999988776665554421000
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~~ 1176 (1182)
.+ ....+..+.+||++||+.||.+|+ ++.+|++||||...
T Consensus 213 ---------------------~~---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 213 ---------------------KF---------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred ---------------------cC---------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 123468899999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.86 Aligned_cols=244 Identities=23% Similarity=0.362 Sum_probs=202.1
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||+|+||.||++++..+|+.||+|++++.. ........|+.+++.+.| |||++++++|....++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------p~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH------PFLTALKYAFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC------CCCcceeeEEecCCEEEEEE
Confidence 36899999999999999999999999997642 233455678888887755 48999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 75 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 75 EYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGI 146 (323)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcC--CCCEEecccHHhcccc
Confidence 99986 5555554322 2889999999999999999999999999999999999984 6789999999986432
Q ss_pred C---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1030 D---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1030 ~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~-------------- 212 (323)
T cd05595 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-------------- 212 (323)
T ss_pred CCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 2 22346789999999999999999999999999999999999999988877666655531000
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~~ 1176 (1182)
.+ ....+..+.+||.+||+.||.+|+ ++.++++||||...
T Consensus 213 ---------------------~~---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 213 ---------------------RF---------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred ---------------------CC---------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 00 123468899999999999999998 99999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=355.27 Aligned_cols=244 Identities=24% Similarity=0.406 Sum_probs=202.3
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||+|+||.||+|+++.+++.||||++++.. ........|..++..+. .||||++++++|....++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc-----CCCchhceeeEEEcCCEEEEEE
Confidence 36899999999999999999999999997542 23445566777776653 3569999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc-
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE- 1028 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~- 1028 (1182)
||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~--~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGI 147 (320)
T ss_pred cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeeCCCCeecC
Confidence 99986 5665554432 2889999999999999999999999999999999999984 678999999998642
Q ss_pred --CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1029 --TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1029 --~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...++..+......
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------- 214 (320)
T cd05590 148 FNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV------------- 214 (320)
T ss_pred cCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 22234567899999999999999999999999999999999999999988877776666311000
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHcCCCCCC
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA------SDALKHPWLSH 1175 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA------eELLqHPWFk~ 1175 (1182)
.....+.++.+||++||+.||.+||++ .++++||||+.
T Consensus 215 -------------------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 215 -------------------------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred -------------------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 011246789999999999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.30 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=207.6
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch----hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD----FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~----~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|.+.+.||.|+||+||+|.++.+++.||||++++... ....+..|+.+++.+. |+||++++++|....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~------~~~i~~~~~~~~~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN------SPWIPQLQYAFQDKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCCCcceeeEEecCC
Confidence 469999999999999999999999999999999986532 3344566777777654 459999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++||||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.+|+||||||+|||++. .+.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~--~~~~kL~Dfg 147 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR--TGHIKLADFG 147 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC--CCCEEeccCC
Confidence 99999999975 67777665422 2889999999999999999999999999999999999984 7789999999
Q ss_pred CccccCCC----cccccCCCcccchhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1024 SSCFETDH----LCSYVQSRSYRAPEVIL------GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1024 LA~~~~~~----~ss~vGTp~YmAPEVLl------g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
++...... .....+|+.|+|||++. ...++.++||||||||+|+|++|+.||...+....+.+++.....
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 227 (330)
T cd05601 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF 227 (330)
T ss_pred CCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc
Confidence 98754332 12347899999999997 456889999999999999999999999988877766666421000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
...| ..+..+..+.+||.+||+ +|.+|||+.++++||||
T Consensus 228 ---------------------------------~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 228 ---------------------------------LKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred ---------------------------------cCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 0001 123457889999999998 99999999999999999
Q ss_pred CCC
Q 001034 1174 SHP 1176 (1182)
Q Consensus 1174 k~~ 1176 (1182)
+..
T Consensus 267 ~~~ 269 (330)
T cd05601 267 SKI 269 (330)
T ss_pred CCC
Confidence 863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=331.86 Aligned_cols=252 Identities=34% Similarity=0.575 Sum_probs=206.0
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhH---HHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD---QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~d---q~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
|++.+.||+|+||+||++++..+++.||+|++........ ....|+.+++.+.|+ ||+++++++.....+|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~------~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHP------NIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBT------TBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccc------cccccccccccccccc
Confidence 8999999999999999999999999999999987753322 234588899988544 8999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+|||++.+ +|.+++..... +++..+..++.||+.||.+||+.+|+|+||||+|||++ .++.++|+|||++.
T Consensus 75 ~v~~~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~--~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNKP------LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD--ENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEETTEBHHHHHHHHSS------BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES--TTSEEEESSGTTTE
T ss_pred cccccccccccccccccccc------cccccccccccccccccccccccccccccccccccccc--cccccccccccccc
Confidence 99999998 78888773322 88999999999999999999999999999999999999 47889999999986
Q ss_pred c---cCCCcccccCCCcccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1027 F---ETDHLCSYVQSRSYRAPEVIL-GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1027 ~---~~~~~ss~vGTp~YmAPEVLl-g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
. .........+++.|+|||++. +..++.++||||||+++|+|++|..||...........+...........
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 222 (260)
T PF00069_consen 147 KLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---- 222 (260)
T ss_dssp ESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc----
Confidence 4 233445667899999999998 88899999999999999999999999988744444333322211110000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.. ........+.+||.+||+.||.+||++.++++||||
T Consensus 223 --------------------------~~-------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 --------------------------SQ-------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp --------------------------TT-------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred --------------------------cc-------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00 000112789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=382.53 Aligned_cols=251 Identities=26% Similarity=0.451 Sum_probs=222.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|.+.+.||+|+||.||+++.+.+.+.||||.+.+.. .......+|++|++.++|+ |||.++++|+...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHp------niv~m~esfEt~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHP------NIVEMLESFETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCc------chhhHHHhhcccce
Confidence 57889999999999999999999999999999997653 3456688999999999766 89999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+++|.||+.|+|..++..... +++..++.|+++++.||.|||+.+|+|||+||.|||+. +.|.+||||||+|
T Consensus 76 ~~vVte~a~g~L~~il~~d~~------lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~--~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 76 LWVVTEYAVGDLFTILEQDGK------LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE--KGGTLKLCDFGLA 147 (808)
T ss_pred EEEEehhhhhhHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec--CCCceeechhhhh
Confidence 999999999999999886654 99999999999999999999999999999999999999 5788999999999
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
+..... ..+..|||.|||||++.+.+|+..+|+||||||+|||++|++||+..+..++...|..---+
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--------- 218 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--------- 218 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC---------
Confidence 865543 34668999999999999999999999999999999999999999998887777777411111
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.....+..|++||..+|.+||.+|+|=.++|.|||.+...
T Consensus 219 -----------------------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 219 -----------------------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred -----------------------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 1125578999999999999999999999999999997654
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=344.63 Aligned_cols=286 Identities=25% Similarity=0.400 Sum_probs=225.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR- 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~- 943 (1182)
.++|++.+.||.|+||.||+|.+..+++.||+|+++... .......+|+.+++.+.|+ ||+++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~ 79 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP------NIVELKEVVVGKH 79 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCC------CCcceEEEEecCC
Confidence 467999999999999999999999999999999997542 1223456789999888655 899999999765
Q ss_pred -CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 -EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 -e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
..+|+||||+.++|..++.... ..+++..+..++.||+.||.|||+.|++||||||+|||++. .+.+||+||
T Consensus 80 ~~~~~lv~e~~~~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~kL~df 152 (309)
T cd07845 80 LDSIFLVMEYCEQDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD--KGCLKIADF 152 (309)
T ss_pred CCeEEEEEecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECcc
Confidence 5689999999998888877543 23889999999999999999999999999999999999984 678999999
Q ss_pred CCccccCCC---cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1023 GSSCFETDH---LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1023 GLA~~~~~~---~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
|++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.+...+
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 153 GLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred ceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 998765432 223345788999999876 4688999999999999999999999999999999999988887665544
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYE 1178 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~e 1178 (1182)
+........ .............+.......+..+.+||.+||++||++|||+.+||+||||+....
T Consensus 233 ~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 233 WPGFSDLPL--------------VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred chhhhcccc--------------cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 322111000 000000000011122233445789999999999999999999999999999998776
Q ss_pred CC
Q 001034 1179 PI 1180 (1182)
Q Consensus 1179 P~ 1180 (1182)
|.
T Consensus 299 ~~ 300 (309)
T cd07845 299 PC 300 (309)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.85 Aligned_cols=261 Identities=28% Similarity=0.426 Sum_probs=221.9
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
..+.+.|++.+.||+|+|+.|+++.+..+|+.+|+|++...+ ...+.+.+|++|-+.|+| ||||+|.+.+.
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqH------P~IvrL~~ti~ 80 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH------PNIVRLHDSIQ 80 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCC------CcEeehhhhhc
Confidence 356788999999999999999999999999999999986542 345667778888777754 59999999999
Q ss_pred ecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC-ceEEEe
Q 001034 942 YREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d-G~IKLi 1020 (1182)
.....|||+|+|.|+-+-+-...+ .++++..+..+++||+.||.|+|.+||||||+||.|+|+-+..+ .-+||+
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeec
Confidence 999999999999986444433333 24889999999999999999999999999999999999976443 369999
Q ss_pred cCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1021 DLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1021 DFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
|||++...... ....+|||.|||||++...+|+..+|||+.|||||-||.|++||.+.+...++.+|++.--..|.
T Consensus 156 ~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~-- 233 (355)
T KOG0033|consen 156 DFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS-- 233 (355)
T ss_pred ccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC--
Confidence 99999765532 34678999999999999999999999999999999999999999999999999999743222211
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+..+.+++++++||++||..||.+|+|+.|+|+|||+.+.
T Consensus 234 --------------------------------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 234 --------------------------------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred --------------------------------------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 2345678999999999999999999999999999999764
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=344.23 Aligned_cols=286 Identities=26% Similarity=0.407 Sum_probs=206.5
Q ss_pred EEeccCCceEEEEEEECC--CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe--cCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLH--TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--REHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~--TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--~e~LyLVm 950 (1182)
.+||+|+||.||+|+.+. ++..||+|.+..... .....+|+.+++.+.|+ ||++++++|.. ...+|+||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHP------NVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCC------CeeeEEEEEeccCCCeEEEEE
Confidence 579999999999999654 668899999876532 34567899999988654 89999999864 46789999
Q ss_pred EecccChHHHHhhhccc---CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC--CCceEEEecCCCc
Q 001034 951 ELLKANLYEFHKFNRES---GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY--SRCEVKVIDLGSS 1025 (1182)
Q Consensus 951 EyL~GsLld~Lk~~~~s---ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~--~dG~IKLiDFGLA 1025 (1182)
||+.++|..++...... .....+++..++.++.||+.||.|||+.+|+||||||+|||+... ..+.+||+|||++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 99999998887643221 112348888999999999999999999999999999999999531 3578999999999
Q ss_pred cccCCC------cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHh
Q 001034 1026 CFETDH------LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSP---------ATLLARVIG 1089 (1182)
Q Consensus 1026 ~~~~~~------~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~---------~elLakIv~ 1089 (1182)
+..... .....+|+.|+|||++.+. .++.++|||||||++|+|++|.+||..... ...+.++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 764332 2345678999999999774 589999999999999999999999975332 244566666
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.++.+....+........+................+ ...........+..+++||.+||+.||.+|||+.|||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSL------IKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchh------hhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 666554443332221111100000000000000000 00111112234678999999999999999999999999
Q ss_pred CCCC
Q 001034 1170 HPWL 1173 (1182)
Q Consensus 1170 HPWF 1173 (1182)
||||
T Consensus 314 hp~f 317 (317)
T cd07867 314 DPYF 317 (317)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=351.62 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=200.0
Q ss_pred CEEEEEEeccCCceEEEEEEEC---CCCcEEEEEEEeccc-----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNNK-----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~k-----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
+|++++.||+|+||.||+|++. .+++.||+|++.+.. ........|+.+++.+.+ |++|++++++|.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-----~~~i~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQ-----SPFLVTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccC-----CCCcccEEEEEe
Confidence 4899999999999999999864 578999999997532 223456678888888753 459999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
....+|+||||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~--~~~~kl~ 147 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS--EGHVVLT 147 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECC--CCCEEEe
Confidence 99999999999985 6666665432 2889999999999999999999999999999999999984 6789999
Q ss_pred cCCCccccCC----CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhhc
Q 001034 1021 DLGSSCFETD----HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPA----TLLARVIGII 1091 (1182)
Q Consensus 1021 DFGLA~~~~~----~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~----elLakIv~il 1091 (1182)
|||+++.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...... .....+...
T Consensus 148 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~- 226 (332)
T cd05614 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC- 226 (332)
T ss_pred eCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC-
Confidence 9999875322 22346789999999999875 4889999999999999999999999643221 111111100
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHH
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASD 1166 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeE 1166 (1182)
.+ ......+..+.+||.+||+.||.+|| ++.+
T Consensus 227 -------------------------------------~~------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 263 (332)
T cd05614 227 -------------------------------------DP------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE 263 (332)
T ss_pred -------------------------------------CC------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 00 01123578899999999999999999 8899
Q ss_pred HHcCCCCCCC
Q 001034 1167 ALKHPWLSHP 1176 (1182)
Q Consensus 1167 LLqHPWFk~~ 1176 (1182)
+++||||+..
T Consensus 264 ~l~h~~~~~~ 273 (332)
T cd05614 264 IKEHPFFKGL 273 (332)
T ss_pred HHcCCCcCCC
Confidence 9999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=336.20 Aligned_cols=278 Identities=28% Similarity=0.496 Sum_probs=221.3
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+.| +||++++++|.....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~------~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH------PYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCC------CCCcceeeEEecCCee
Confidence 5899999999999999999999999999999997643 234567788888888864 5899999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|+||||+.++|.+++..... .+++..++.++.||+.||.|||+.+++|+||||+||+++. .+.++|+|||++.
T Consensus 75 ~~v~e~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~--~~~~~l~dfg~~~ 147 (286)
T cd07832 75 VLVMEYMPSDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA--DGVLKIADFGLAR 147 (286)
T ss_pred EEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC--CCcEEEeeeeecc
Confidence 99999997788888765432 3889999999999999999999999999999999999995 6789999999987
Q ss_pred ccCCC----cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETDH----LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~~----~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
..... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+......+.+++..++.+....+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 65432 2345788999999998754 468999999999999999999999999888888888888777654433222
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
......+ ..+.........+....+..+..+.+||.+||.++|.+|||+.++|+||||.
T Consensus 228 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 228 LTSLPDY--------------NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCcchh--------------hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 1111000 0000000011112223345678999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=352.19 Aligned_cols=243 Identities=25% Similarity=0.378 Sum_probs=201.9
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEE
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmE 951 (1182)
.||+|+||.||+|+++.+++.||||++++.. ........|.+++..+. .||+|++++++|....++|+|||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~i~~~~~~~~~~~~~~lv~E 76 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-----KHPFLTALHCCFQTKDRLFFVME 76 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCeEEEEEe
Confidence 6899999999999999999999999998642 23344566777776653 36699999999999999999999
Q ss_pred eccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC-
Q 001034 952 LLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET- 1029 (1182)
Q Consensus 952 yL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~- 1029 (1182)
|+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 77 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~--~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 77 YVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA--EGHCKLADFGMCKEGIL 148 (321)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEeecccceeccc
Confidence 9986 5655554332 2788999999999999999999999999999999999984 6789999999986432
Q ss_pred --CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccch
Q 001034 1030 --DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYK 1107 (1182)
Q Consensus 1030 --~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k 1107 (1182)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||...+....+..+.....
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--------------- 213 (321)
T cd05591 149 NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--------------- 213 (321)
T ss_pred CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 223345789999999999999999999999999999999999999999888777766631100
Q ss_pred hhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-------CHHHHHcCCCCCC
Q 001034 1108 YFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-------SASDALKHPWLSH 1175 (1182)
Q Consensus 1108 ~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-------TAeELLqHPWFk~ 1175 (1182)
.. ....+.++.+||.+||+.||.+|| ++.++++||||..
T Consensus 214 --------------------~~---------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 214 --------------------LY---------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred --------------------CC---------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 00 112467899999999999999999 9999999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.08 Aligned_cols=244 Identities=24% Similarity=0.363 Sum_probs=199.8
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||+|+||.||+|.+..+++.||+|++.+.. ........|+++++.+. ||||++++++|.....+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~------hp~i~~~~~~~~~~~~~~lv~ 74 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR------HPFLTALKYSFQTHDRLCFVM 74 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCCCCceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999998642 22345566777777664 459999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
||+.+ +|..++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++. ++.+||+|||++...
T Consensus 75 E~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~--~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 75 EYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFGLCKEG 146 (325)
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC--CCCEEEecCCCCeec
Confidence 99986 4555544322 28899999999999999999997 79999999999999984 678999999998642
Q ss_pred C---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccccc
Q 001034 1029 T---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105 (1182)
Q Consensus 1029 ~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s 1105 (1182)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~------------- 213 (325)
T cd05594 147 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------- 213 (325)
T ss_pred CCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-------------
Confidence 2 223345799999999999999999999999999999999999999988776665555421000
Q ss_pred chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q 001034 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1106 ~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~~ 1176 (1182)
.. ....+..+.+||.+||++||.+|+ ++.++|+||||...
T Consensus 214 ----------------------~~---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 214 ----------------------RF---------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred ----------------------CC---------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 00 123468899999999999999997 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=351.01 Aligned_cols=245 Identities=26% Similarity=0.405 Sum_probs=199.7
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||+|+||.||+|+++.+++.||||++++.. ........|..++..+. .||+|++++++|....++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW-----ENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc-----CCCCccCeeEEEEeCCEEEEEE
Confidence 36899999999999999999999999998643 22334555666665442 4669999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc-
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE- 1028 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~- 1028 (1182)
||+.+ +|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~--~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR--DGHIKIADFGMCKENV 147 (316)
T ss_pred CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEeCccCCCeecc
Confidence 99986 5666654322 2788999999999999999999999999999999999984 678999999998642
Q ss_pred --CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1029 --TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1029 --~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...++..+.....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~-------------- 213 (316)
T cd05620 148 FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP-------------- 213 (316)
T ss_pred cCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------------
Confidence 2233456789999999999999999999999999999999999999998877666555521000
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH-HHHHcCCCCCCC
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA-SDALKHPWLSHP 1176 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA-eELLqHPWFk~~ 1176 (1182)
......+..+++||.+||+.||.+||++ .++++||||+..
T Consensus 214 ------------------------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 214 ------------------------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred ------------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 0011246789999999999999999998 588899999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=349.81 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=206.5
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+|++.+.||+|+||.||+|+++.+++.||||++++.. ........|..++..+.++ ++|++++++|.....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~-----~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP-----PFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCC-----CchhheeeEEecCCE
Confidence 4788999999999999999999999999999998643 2234456677777766544 489999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.| +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~--~~~ikL~Dfg~ 147 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS--EGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEecccc
Confidence 9999999985 5666554322 2889999999999999999999999999999999999994 67899999999
Q ss_pred ccccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1025 SCFETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1025 A~~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+..... .....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+..++.....
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-------- 219 (323)
T cd05615 148 CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-------- 219 (323)
T ss_pred ccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 865322 233457899999999999999999999999999999999999999988877776666421100
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~~ 1176 (1182)
. ....+..+.+||.+||+.+|.+|++ ..++++||||...
T Consensus 220 ---------------------------~---------p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 220 ---------------------------Y---------PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ---------------------------C---------CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 0 1124678999999999999999997 5799999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=379.77 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=217.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
..|...++||+|+-|.||.|....+++.||||.+.... ...+-+++|+.+|+.+.|. |||.+++.|.....++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~------NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHP------NIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccch------HHHHHHHHhcccceeE
Confidence 56888889999999999999999999999999998654 3346688999999998765 9999999999999999
Q ss_pred EEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+|||||.|+ |.+.+.... +++.+++.|+++++.||+|||.+||||||||.+|||+.. +|.+||+|||+|.
T Consensus 347 VVMEym~ggsLTDvVt~~~-------~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~--~g~vKltDFGFca 417 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR-------MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM--DGSVKLTDFGFCA 417 (550)
T ss_pred EEEeecCCCchhhhhhccc-------ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc--CCcEEEeeeeeee
Confidence 999999964 555554332 899999999999999999999999999999999999995 6779999999997
Q ss_pred ccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1027 FETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1027 ~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
.... ...+.+|||+|||||++....|+.++||||||+++.||+-|.+||.+.++...+..|. .-|.+.
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-~ng~P~-------- 488 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPK-------- 488 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-hcCCCC--------
Confidence 6443 4567899999999999999999999999999999999999999999999888777763 112111
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
......++..|++||.+||+.||.+|++|.|||+||||+-.
T Consensus 489 --------------------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 489 --------------------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred --------------------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 11223568999999999999999999999999999999544
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=360.41 Aligned_cols=284 Identities=24% Similarity=0.362 Sum_probs=216.9
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEEC--CCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDL--HTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk--~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.++..+|++++.||.|+||.||+|... .+++.||+|.+.... ...+|+.+|+.++|+ ||++++++|..
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~------~iv~~~~~~~~ 157 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHR------AIINLIHAYRW 157 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCC------CccceeeeEee
Confidence 345678999999999999999999754 456889999987543 335789999988654 89999999999
Q ss_pred cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 943 REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 943 ~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
...+|+|||++.++|..++.... .+++..++.|+.||+.||.|||++||+||||||+|||++. .+.++|+||
T Consensus 158 ~~~~~lv~e~~~~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~--~~~~~l~Df 229 (392)
T PHA03207 158 KSTVCMVMPKYKCDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE--PENAVLGDF 229 (392)
T ss_pred CCEEEEEehhcCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC--CCCEEEccC
Confidence 99999999999999998884322 2889999999999999999999999999999999999984 678999999
Q ss_pred CCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhhcCCc
Q 001034 1023 GSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS---PATLLARVIGIIGPI 1094 (1182)
Q Consensus 1023 GLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d---~~elLakIv~ilGp~ 1094 (1182)
|+++..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.. ....+..++..++..
T Consensus 230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~ 309 (392)
T PHA03207 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309 (392)
T ss_pred ccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccC
Confidence 998754332 224578999999999999999999999999999999999999997643 455667777766655
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
+..+....... +.+.. ..........+..|.. + .....+.++.+||++||++||.+|||+.+||.||||+
T Consensus 310 ~~~~~~~~~~~---~~~~~---~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~ 379 (392)
T PHA03207 310 PLEFPQNGSTN---LCKHF---KQYAIVLRPPYTIPPV--I--RKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT 379 (392)
T ss_pred ccccCCccchh---HHHHH---HhhcccccCCccccch--h--hccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence 54332211100 00000 0000000000011100 0 1123467899999999999999999999999999998
Q ss_pred CC
Q 001034 1175 HP 1176 (1182)
Q Consensus 1175 ~~ 1176 (1182)
..
T Consensus 380 ~~ 381 (392)
T PHA03207 380 KE 381 (392)
T ss_pred cc
Confidence 64
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=359.27 Aligned_cols=253 Identities=20% Similarity=0.306 Sum_probs=207.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++.+.||.|+||.||+|++..+++.||+|++.+.. .....+..|+.+++.++| |||++++++|...
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h------~~iv~~~~~~~~~ 115 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS------EWIVQLHYAFQDD 115 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC------CCcceEEEEEecC
Confidence 467999999999999999999999999999999997532 222345678888887754 5899999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++|+||||+.| +|..++... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~--~~~~kL~Df 186 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADF 186 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcC--CCCEEEEec
Confidence 999999999985 566665432 2788889999999999999999999999999999999984 778999999
Q ss_pred CCccccCCC----cccccCCCcccchhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1023 GSSCFETDH----LCSYVQSRSYRAPEVILGL----SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1023 GLA~~~~~~----~ss~vGTp~YmAPEVLlg~----~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+.+|+.....
T Consensus 187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~- 265 (370)
T cd05596 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS- 265 (370)
T ss_pred cceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc-
Confidence 998754322 2356799999999999754 4789999999999999999999999988877776666421100
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHcCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK--RPSASDALKHPW 1172 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek--RPTAeELLqHPW 1172 (1182)
...| ....++.++.+||.+||+.+|.+ |+|+.+|++|||
T Consensus 266 --------------------------------~~~~-------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 266 --------------------------------LTFP-------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred --------------------------------CCCC-------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 0011 11235789999999999999987 999999999999
Q ss_pred CCC
Q 001034 1173 LSH 1175 (1182)
Q Consensus 1173 Fk~ 1175 (1182)
|+.
T Consensus 307 ~~~ 309 (370)
T cd05596 307 FKN 309 (370)
T ss_pred cCC
Confidence 986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=349.60 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=202.0
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||.|+||+||+|.+..+++.||||++++.. ........|..+++.+. .||||++++++|....++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCEEEEEE
Confidence 36899999999999999999999999998642 23445566777777664 4669999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc-
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE- 1028 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~- 1028 (1182)
||+.+ +|...+.... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++...
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS--EGHIKIADFGMCKEGI 147 (318)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC--CCcEEecccCCCeecC
Confidence 99986 5555554332 2889999999999999999999999999999999999984 678999999998642
Q ss_pred --CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1029 --TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1029 --~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
.......++++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+....+..+....
T Consensus 148 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--------------- 212 (318)
T cd05570 148 LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--------------- 212 (318)
T ss_pred cCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 222344578999999999999999999999999999999999999998887766655553100
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHcCCCCCCC
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA-----SDALKHPWLSHP 1176 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA-----eELLqHPWFk~~ 1176 (1182)
... ....+..+.+||++||+.||.+||++ .++++||||+..
T Consensus 213 --------------------~~~---------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 213 --------------------VRY---------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred --------------------CCC---------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 11346789999999999999999999 999999999774
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=368.68 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=216.2
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---------------hhhHHHHHHHHHHHHhcCCCCCC
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---------------DFFDQSLDEIKLLKYVNKHDPGD 929 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---------------~~~dq~l~EikILr~L~h~~~l~ 929 (1182)
....++|++++.||+|.||.|.+|++..+++.||||++.+.+ .-.+...+|+.||++|.|+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~---- 168 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP---- 168 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc----
Confidence 345689999999999999999999999999999999997642 2235788999999998764
Q ss_pred CcceEEEEEEEEec--CeEEEEEEecccChHHHHhhhcccCCccc-cCHHHHHHHHHHHHHHHHHHHhcCccccccCCcc
Q 001034 930 KYHLLRLYDYFYYR--EHLLIVCELLKANLYEFHKFNRESGGEVY-FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPEN 1006 (1182)
Q Consensus 930 HPnIVkL~dsFqd~--e~LyLVmEyL~GsLld~Lk~~~~sggel~-Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeN 1006 (1182)
|||+|+.+..+. .++|||+|||..+-..... ...+ +.+.+++.|++.++.||+|||.+|||||||||+|
T Consensus 169 --nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsN 240 (576)
T KOG0585|consen 169 --NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSN 240 (576)
T ss_pred --CeeEEEEeecCcccCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence 999999998876 6899999999865443322 2223 8999999999999999999999999999999999
Q ss_pred EEEccCCCceEEEecCCCccccCC--------CcccccCCCcccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCC
Q 001034 1007 ILVKSYSRCEVKVIDLGSSCFETD--------HLCSYVQSRSYRAPEVILGLS----YDKKIDIWSLGCILAELCTGNVL 1074 (1182)
Q Consensus 1007 ILIDs~~dG~IKLiDFGLA~~~~~--------~~ss~vGTp~YmAPEVLlg~~----yS~kSDIWSLGVILYELLTGr~P 1074 (1182)
+||+. .|+|||+|||.+..... .....+|||.|+|||++.+.. .+.+.|||||||+||.|+.|+.|
T Consensus 241 LLl~~--~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 241 LLLSS--DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred eEEcC--CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 99995 68999999999875421 133479999999999998732 45789999999999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhc
Q 001034 1075 FQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLL 1154 (1182)
Q Consensus 1075 F~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkML 1154 (1182)
|.++...+++.+|+...-. +|. .+...+.+++||.+||
T Consensus 319 F~~~~~~~l~~KIvn~pL~-----------------------------------fP~-------~pe~~e~~kDli~~lL 356 (576)
T KOG0585|consen 319 FFDDFELELFDKIVNDPLE-----------------------------------FPE-------NPEINEDLKDLIKRLL 356 (576)
T ss_pred cccchHHHHHHHHhcCccc-----------------------------------CCC-------cccccHHHHHHHHHHh
Confidence 9999999999998622111 111 2244688999999999
Q ss_pred ccCCCCCCCHHHHHcCCCCCCC-CCCC
Q 001034 1155 EINPKKRPSASDALKHPWLSHP-YEPI 1180 (1182)
Q Consensus 1155 q~DPekRPTAeELLqHPWFk~~-~eP~ 1180 (1182)
++||.+|++..+|..|||.... -.|+
T Consensus 357 ~KdP~~Ri~l~~ik~Hpwvt~~g~~~~ 383 (576)
T KOG0585|consen 357 EKDPEQRITLPDIKLHPWVTRDGDSPQ 383 (576)
T ss_pred hcChhheeehhhheecceeccCCCCCc
Confidence 9999999999999999999887 4444
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=404.65 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=215.8
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|+|+++||+|+||+|.+++.+.+++.||||++.+-. ....-+..|..+|...+.. ||+.|++.|++.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~------Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSE------WIVQLHYAFQDE 147 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcH------HHHHHHHHhcCc
Confidence 478999999999999999999999999999999998732 3345566777887776544 999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++|+|||||+| +|+.++.... .+++.-+++|+.+|+.||..||++|+|||||||+|||||. .|+|||+||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~--~GHikLADF 219 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK--SGHIKLADF 219 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc--cCcEeeccc
Confidence 999999999996 5777766543 2899999999999999999999999999999999999995 888999999
Q ss_pred CCccccCC----CcccccCCCcccchhhhc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1023 GSSCFETD----HLCSYVQSRSYRAPEVIL----G-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1023 GLA~~~~~----~~ss~vGTp~YmAPEVLl----g-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
|.|..... .....+|||+|++||++. + +.|+..||||||||++||||.|..||+.++..+++.+||..
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--- 296 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--- 296 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch---
Confidence 99865442 245679999999999995 2 46999999999999999999999999999999999999722
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHcC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS---ASDALKH 1170 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT---AeELLqH 1170 (1182)
+-.+.+|. ...+|.++++||+++|+ +|+.|+. ++++-.|
T Consensus 297 ------------------------------k~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 297 ------------------------------KESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ------------------------------hhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 00112221 12368999999999888 7999999 9999999
Q ss_pred CCCCCC
Q 001034 1171 PWLSHP 1176 (1182)
Q Consensus 1171 PWFk~~ 1176 (1182)
|||...
T Consensus 339 pFF~g~ 344 (1317)
T KOG0612|consen 339 PFFEGI 344 (1317)
T ss_pred ccccCC
Confidence 999764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=362.38 Aligned_cols=265 Identities=28% Similarity=0.401 Sum_probs=219.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
-.+.|++...||.|.-++||+|+...++..||||++..++ ...+.+..|+..+..+.| |||++++.+|....
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~H------PNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDH------PNIVTYHCSFVVDS 97 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCC------CCcceEEEEEEecc
Confidence 3578999999999999999999999999999999998654 335677888888887755 49999999999999
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+++||.||. |+++++++..-..+ +.+..++.|+++++.||.|||.+|.||||||+.||||+ .+|.|||+|||
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~G----l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~--~dG~VkLadFg 171 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDG----LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID--SDGTVKLADFG 171 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHcccc----ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc--CCCcEEEcCce
Confidence 9999999999 57888888776554 99999999999999999999999999999999999999 48889999999
Q ss_pred CccccCCC-------cccccCCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1024 SSCFETDH-------LCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1024 LA~~~~~~-------~ss~vGTp~YmAPEVLlg--~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
.+...... ..+++||++|||||++.. .+|+.++||||||++..||.+|..||....+..++-.- +-+++
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~p 249 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDP 249 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCC
Confidence 76432211 256799999999999754 47999999999999999999999999998888776443 33443
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
|... ... ........++..|+.||..||++||.+||||.++|+|+||+
T Consensus 250 p~~~-t~~-------------------------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk 297 (516)
T KOG0582|consen 250 PTLL-TSG-------------------------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK 297 (516)
T ss_pred CCcc-ccc-------------------------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence 3211 000 00111233456899999999999999999999999999998
Q ss_pred CCC
Q 001034 1175 HPY 1177 (1182)
Q Consensus 1175 ~~~ 1177 (1182)
+..
T Consensus 298 ~~k 300 (516)
T KOG0582|consen 298 KAK 300 (516)
T ss_pred hcc
Confidence 764
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.29 Aligned_cols=279 Identities=25% Similarity=0.422 Sum_probs=215.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.++|++.+.||.|+||.||++.++.+++.||||.+..... ....+.+|+.+++.++|+ ||+++++++....+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~ 77 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA------NIVTLHDIIHTKKT 77 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCc------ceeeEEEEEecCCe
Confidence 3689999999999999999999999999999999875431 223456799999988654 89999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
.|+||||+.++|..++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~ 150 (291)
T cd07844 78 LTLVFEYLDTDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE--RGELKLADFGLA 150 (291)
T ss_pred EEEEEecCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC--CCCEEECccccc
Confidence 999999999988887764422 3788999999999999999999999999999999999985 678999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDS-PATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d-~~elLakIv~ilGp~PeemL~ 1100 (1182)
...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+.+..+...++.+....+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 151 RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred cccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 653321 222356788999999876 458899999999999999999999997655 566666676666665544433
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCc--HHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD--QGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~S--eeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.......+.... ........+....+..+ ..+.+||.+||+++|.+|||+.++|+||||
T Consensus 231 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 231 GVSSNPEFKPYS--------------FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhcccccccc--------------ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 322111111000 00000111111122233 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.38 Aligned_cols=293 Identities=24% Similarity=0.340 Sum_probs=213.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
..++|++.+.||.|+||.||++.+..++..+|+|++.... .....+.+|+++++.+.| +||++++++|....
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~ 76 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS------PYIVGFYGAFYSDG 76 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC------CcccceeEEEEECC
Confidence 4578999999999999999999999999999999987642 334567889999998865 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-CccccccCCccEEEccCCCceEEEecC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL-GLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~-GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
++|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~--~~~~kL~Df 148 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDF 148 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC--CCCEEEeeC
Confidence 99999999985 7777775432 278888999999999999999974 7999999999999984 677999999
Q ss_pred CCccccCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1023 GSSCFETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1023 GLA~~~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
|++..... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...........+ +.........
T Consensus 149 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~ 224 (333)
T cd06650 149 GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF----GCPVEGDPAE 224 (333)
T ss_pred CcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh----cCcccCCccc
Confidence 99875433 233457899999999999989999999999999999999999999876654433222 1111100000
Q ss_pred ccccc--hhhcccchhhhhhcc-----hhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1102 GRDTY--KYFTKNHMLYERNQE-----TNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1102 ~k~s~--k~F~k~~~~~er~~e-----ts~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
..... .........+..... ......... ...........+.++++||.+||++||.+|||+.+||+||||+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~ 303 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVN-EPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhc-CCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence 00000 000000000000000 000000000 0000011123578899999999999999999999999999998
Q ss_pred CCCC
Q 001034 1175 HPYE 1178 (1182)
Q Consensus 1175 ~~~e 1178 (1182)
....
T Consensus 304 ~~~~ 307 (333)
T cd06650 304 RSEA 307 (333)
T ss_pred cCcc
Confidence 7754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=358.56 Aligned_cols=254 Identities=20% Similarity=0.334 Sum_probs=206.1
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++.+.||+|+||.||+|.++.+++.||+|++.+.. .....+..|+.+++.+.| |||++++++|...
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~h------p~iv~~~~~~~~~ 115 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS------PWVVQLFCAFQDD 115 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC------CCEeeEEEEEEcC
Confidence 467999999999999999999999999999999997532 223345677777777654 5999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++|+||||+.| +|.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++. .+.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~--~~~~kL~DF 186 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK--HGHLKLADF 186 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC--CCCEEEEec
Confidence 999999999985 677766432 2788899999999999999999999999999999999984 778999999
Q ss_pred CCccccCCC----cccccCCCcccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1023 GSSCFETDH----LCSYVQSRSYRAPEVILGLS----YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1023 GLA~~~~~~----~ss~vGTp~YmAPEVLlg~~----yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|++...... ....+||+.|+|||++.+.. ++.++|||||||+||+|++|++||...+....+.+|+.....+
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence 999764322 23567999999999997643 7899999999999999999999999888777776664211100
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHcCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK--RPSASDALKHPW 1172 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek--RPTAeELLqHPW 1172 (1182)
..|. ....+..+++||.+||..+|.+ |+|+.++++|||
T Consensus 267 ---------------------------------~~p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 267 ---------------------------------NFPE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred ---------------------------------CCCC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 0111 1234688999999999865543 899999999999
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
|+..
T Consensus 307 ~~~~ 310 (370)
T cd05621 307 FKND 310 (370)
T ss_pred cCCC
Confidence 9863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=337.94 Aligned_cols=282 Identities=29% Similarity=0.474 Sum_probs=221.1
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch------hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD------FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~------~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+|++.+.||.|+||.||+|.+..+++.||||.++.... ....+..|+.+++.+.| +||+++++++...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h------~~i~~~~~~~~~~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH------PNIIGLLDVFGHK 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCC------CCChhhhheeecC
Confidence 58899999999999999999999999999999976532 23345567888877754 4899999999999
Q ss_pred CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 944 EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 944 e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..+|+||||+.++|..++.... ..+++..+..++.||+.||.|||++||+|+||+|+|||++. ++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~--~~~~~l~dfg 147 (298)
T cd07841 75 SNINLVFEFMETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS--DGVLKLADFG 147 (298)
T ss_pred CEEEEEEcccCCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcC--CCCEEEccce
Confidence 9999999999778888876432 13889999999999999999999999999999999999995 6789999999
Q ss_pred CccccCCC---cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1024 SSCFETDH---LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1024 LA~~~~~~---~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+.++...++.+....+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 148 LARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred eeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence 98765432 223456788999999865 46789999999999999999999999988887778777766655443332
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
........+ ..........+.......+..+++||.+||.++|.+|||+.+||+||||++.+.|
T Consensus 228 ~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 228 PGVTSLPDY----------------VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred hhccccccc----------------ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 211110000 0000011111222334557899999999999999999999999999999998877
Q ss_pred C
Q 001034 1180 I 1180 (1182)
Q Consensus 1180 ~ 1180 (1182)
-
T Consensus 292 ~ 292 (298)
T cd07841 292 T 292 (298)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.55 Aligned_cols=273 Identities=32% Similarity=0.534 Sum_probs=216.6
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--CeE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--EHL 946 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--e~L 946 (1182)
|++++.||.|+||.||++.+..+++.||+|++++... .......|+.+++++. .|+||+++++++.+. ..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS-----PHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC-----CCCCccceEEEEecCCCCcE
Confidence 6789999999999999999999999999999876421 1223346777777664 255999999999988 899
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
++||||+.++++.++..... .+++..++.++.||+.||.|||+.+++||||+|+||+++. +.+||+|||++.
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~ 147 (282)
T cd07831 76 ALVFELMDMNLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCR 147 (282)
T ss_pred EEEEecCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEeccccc
Confidence 99999999999888765331 3889999999999999999999999999999999999994 789999999987
Q ss_pred ccCCC--cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1027 FETDH--LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1027 ~~~~~--~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
..... .....+++.|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++..+.....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 64332 233467889999998754 457889999999999999999999999999988899998888877765532111
Q ss_pred ccchhhcccchhhhhhcchhhhhhcccc--ccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk--~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.. ....+..|. ...+....+..+..+++||.+||.++|.+|||+.++|+||||
T Consensus 228 ~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 228 KS-----------------RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cc-----------------ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00 000011111 111122234568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.91 Aligned_cols=288 Identities=27% Similarity=0.459 Sum_probs=214.6
Q ss_pred CEEEEEEeccCCceEEEEEEECC--CCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLH--TGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~--TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+|++.+.||.|+||.||+|+++. +++.||+|++.... .......+|+.+++.++| |||++++++|...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH------ENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCC------CCccceEEEEeCC
Confidence 58999999999999999999988 89999999998632 334566788888888865 4899999999988
Q ss_pred --CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC--CCceEEE
Q 001034 944 --EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY--SRCEVKV 1019 (1182)
Q Consensus 944 --e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~--~dG~IKL 1019 (1182)
..+|+||||+.+++..++....... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.. ..+.+||
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 75 ADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred CCceEEEEEeCCCcCHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence 8899999999999888776544322 2348899999999999999999999999999999999999831 1678999
Q ss_pred ecCCCccccCCCc------ccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HH
Q 001034 1020 IDLGSSCFETDHL------CSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPA---------TL 1083 (1182)
Q Consensus 1020 iDFGLA~~~~~~~------ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~---------el 1083 (1182)
+|||++....... ...++++.|+|||++.+. .++.++|||||||++|+|++|++||.+.... ..
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 9999987643321 234678899999998764 5889999999999999999999999765432 34
Q ss_pred HHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcccc--ccccccCCCCCcHHHHHHHHHhcccCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk--~~sL~~~l~~~SeeL~DLIrkMLq~DPekR 1161 (1182)
+..++..++.++...+........+. ...... .....+. ...........+..+.+||.+||++||++|
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 304 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYD-TLMKDF--------KTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKR 304 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccch-hhhhhc--------cCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccC
Confidence 55666666654443322111111000 000000 0000000 000001112557899999999999999999
Q ss_pred CCHHHHHcCCCC
Q 001034 1162 PSASDALKHPWL 1173 (1182)
Q Consensus 1162 PTAeELLqHPWF 1173 (1182)
||+.+|++||||
T Consensus 305 ps~~eil~~~~f 316 (316)
T cd07842 305 ITAEEALEHPYF 316 (316)
T ss_pred cCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=330.89 Aligned_cols=278 Identities=27% Similarity=0.456 Sum_probs=214.9
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++.+.||.|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.+.|+ ||++++++|....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~------~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP------NLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCC------CEeeeeeEEeeCCE
Confidence 47999999999999999999999999999999987543 2234567889999888654 89999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+|+||||++++++..+..... .+++..++.++.||+.||.|||+.+++|+||||+||+++. ++.++|+|||++
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~ 147 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK--QGQIKLCDFGFA 147 (286)
T ss_pred EEEEEeccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC--CCcEEECccccc
Confidence 999999999887766543321 2889999999999999999999999999999999999984 678999999998
Q ss_pred cccCCCc---ccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1026 CFETDHL---CSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1026 ~~~~~~~---ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
....... ....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 7654322 24467889999999876 4588999999999999999999999998877777766665555433211110
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccc-cccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIP-KKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liP-k~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.. ...++.. .....+ ....+....+..+..+.+||.+||+.+|++|||+.++|.||||
T Consensus 228 ~~-~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 228 FS-TNQFFKG-------------LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cc-ccccccc-------------ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00 0000000 000000 0011112234567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.91 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=198.8
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||+|+||.||+|.+..+++.||||++++.. ........|..++..+ ..||||++++++|....++|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-----WEHPFLTHLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc-----cCCCCccceeeEEEcCCEEEEEE
Confidence 36899999999999999999999999998643 2223344555555443 24679999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
||+.| +|..++.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK--DGHIKIADFGMCKENM 147 (316)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC--CCCEEEccCcCCeECC
Confidence 99985 5655554332 2889999999999999999999999999999999999984 6789999999987432
Q ss_pred ---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1030 ---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1030 ---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...++..+......
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------- 214 (316)
T cd05592 148 NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPH------------- 214 (316)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 2234567899999999999999999999999999999999999999988877666655311100
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH-HHHHcCCCCCCC
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA-SDALKHPWLSHP 1176 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA-eELLqHPWFk~~ 1176 (1182)
.....+..+.+||.+||+.||.+||++ .++++||||...
T Consensus 215 -------------------------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 215 -------------------------------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred -------------------------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 012246789999999999999999986 588899999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.33 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=200.9
Q ss_pred EEeccCCceEEEEEEEC---CCCcEEEEEEEeccc-----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 875 EYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNNK-----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~k-----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+.||+|+||.||+|++. .+++.||||++++.. ........|+.+++.+.| |||+++++.|.....+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~h------p~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH------PFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCC------CchhceeeEEecCCeE
Confidence 57999999999999864 578999999997542 223455678888888754 5999999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.+ +|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~ 147 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDA--QGHVKLTDFGLC 147 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEeeCcCC
Confidence 999999986 5666665432 2788889999999999999999999999999999999984 678999999998
Q ss_pred cccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||...+....+.++.....
T Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~---------- 217 (323)
T cd05584 148 KESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---------- 217 (323)
T ss_pred eecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 6422 223345789999999999999999999999999999999999999988877666655531100
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~~ 1176 (1182)
...+..+..+.+||++||++||.+|| ++.++++||||...
T Consensus 218 ----------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 218 ----------------------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------------------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 01123467899999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.71 Aligned_cols=245 Identities=26% Similarity=0.420 Sum_probs=199.8
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||+|+||+||+|++..+++.||||+++... ........|..++..+ ..||||++++++|....++|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----cCCCcCcceEEEEEeCCEEEEEE
Confidence 36899999999999999999999999998642 2233445566666543 24679999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc-
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE- 1028 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~- 1028 (1182)
||+.+ +|..++.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++...
T Consensus 76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~--~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT--DGHIKIADFGMCKENM 147 (316)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEccCCcceECC
Confidence 99985 6766665432 2788899999999999999999999999999999999985 678999999998642
Q ss_pred --CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1029 --TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1029 --~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..+....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--------------- 212 (316)
T cd05619 148 LGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--------------- 212 (316)
T ss_pred CCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------
Confidence 223345678999999999999999999999999999999999999998877766655542100
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH-HHHcCCCCCCC
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS-DALKHPWLSHP 1176 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe-ELLqHPWFk~~ 1176 (1182)
+. .....+..+.+||.+||+.||.+||++. ++++||||...
T Consensus 213 -----------------------~~------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 213 -----------------------PC------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred -----------------------CC------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 00 0112467899999999999999999997 89999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=346.43 Aligned_cols=256 Identities=18% Similarity=0.274 Sum_probs=203.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||+|+||.||++++..+++.||||++.+.. .....+..|+.++..+. |+||++++++|....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD------RRWITNLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC------CCCCCceEEEEecCC
Confidence 47999999999999999999999999999999997532 22334566777777664 458999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++|+||||+.| +|..++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg 147 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK--NGHIRLADFG 147 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC--CCCEEEEECC
Confidence 99999999975 67777654321 2888999999999999999999999999999999999984 6789999999
Q ss_pred CccccCCC----cccccCCCcccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1024 SSCFETDH----LCSYVQSRSYRAPEVILG-----LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1024 LA~~~~~~----~ss~vGTp~YmAPEVLlg-----~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
++...... ....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+.+..++.....
T Consensus 148 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~- 226 (331)
T cd05597 148 SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH- 226 (331)
T ss_pred ceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc-
Confidence 98654322 123468999999999973 45788999999999999999999999988777766665311000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHcCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK--RPSASDALKHPW 1172 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek--RPTAeELLqHPW 1172 (1182)
.. +.......+..+++||++||+.++.+ |+++.++|+|||
T Consensus 227 --------------------------------~~------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 227 --------------------------------FQ------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred --------------------------------cc------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 00 01112235789999999999765544 789999999999
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
|...
T Consensus 269 ~~~~ 272 (331)
T cd05597 269 FEGI 272 (331)
T ss_pred CCCC
Confidence 9763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.85 Aligned_cols=244 Identities=22% Similarity=0.337 Sum_probs=195.7
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||+|+||.||+|++..+++.||||++++.. .....+..|..++..+. .||||++++++|.....+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-----NHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCCCceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999998642 23345667778877764 3569999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc-
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE- 1028 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~- 1028 (1182)
||+.| +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~--~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTDYGMCKEGI 147 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEECcCccccccc
Confidence 99986 5655554332 2899999999999999999999999999999999999984 678999999998642
Q ss_pred --CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------H-HHHHHHhhcCCcchh
Q 001034 1029 --TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA--------T-LLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1029 --~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~--------e-lLakIv~ilGp~Pee 1097 (1182)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... . ....+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--------- 218 (329)
T cd05588 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL--------- 218 (329)
T ss_pred cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH---------
Confidence 22334568999999999999999999999999999999999999999532110 0 000000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC------HHHHHcCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS------ASDALKHP 1171 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT------AeELLqHP 1171 (1182)
.... ......+..+.+||++||++||.+|++ +.++++||
T Consensus 219 --------------------------------~~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05588 219 --------------------------------EKQI---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP 263 (329)
T ss_pred --------------------------------cCCC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCC
Confidence 0000 011235788999999999999999987 78999999
Q ss_pred CCCC
Q 001034 1172 WLSH 1175 (1182)
Q Consensus 1172 WFk~ 1175 (1182)
||..
T Consensus 264 ~~~~ 267 (329)
T cd05588 264 FFRN 267 (329)
T ss_pred CCCC
Confidence 9975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=355.07 Aligned_cols=278 Identities=23% Similarity=0.273 Sum_probs=208.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
..|++++.||.|+||.||+|.+..+++.||+|+..... ...|+.+++.++| +||++++++|......|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----~~~E~~~l~~l~h------~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----TLIEAMLLQNVNH------PSVIRMKDTLVSGAITCM 134 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----cHHHHHHHHhCCC------CCCcChhheEEeCCeeEE
Confidence 46999999999999999999999999999999865432 3468888888765 489999999999999999
Q ss_pred EEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 949 VCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 949 VmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
|||++.++|+.++..... .+++..++.|+.||+.||.|||++||+||||||+|||++. .+.+||+|||++...
T Consensus 135 v~e~~~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEccCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEecCcccccc
Confidence 999999999988865432 3889999999999999999999999999999999999984 677999999998753
Q ss_pred CC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCC---------HHHHHHHHHhhcCCcch
Q 001034 1029 TD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGN-VLFQNDS---------PATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1029 ~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr-~PF~g~d---------~~elLakIv~ilGp~Pe 1096 (1182)
.. ......||+.|+|||++.+..++.++|||||||++|+|+++. ++|.... ....+..++..++..|.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 32 233467899999999999999999999999999999999855 4444321 12334455555554444
Q ss_pred hhhhcccc-cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1097 GMLAKGRD-TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1097 emL~~~k~-s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
.+...... ....|. .. ... ...|............+..+.+||.+||++||.+||||.|||+||||+.
T Consensus 288 ~~~~~~~~~~~~~~~-------~~---~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 288 EFPRDPGSRLVRGFI-------EY---ASL-ERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hcCCCCccHHHHHHH-------hh---ccc-CCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 33211000 000000 00 000 0000000000011245678889999999999999999999999999986
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=348.79 Aligned_cols=243 Identities=26% Similarity=0.370 Sum_probs=197.1
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccch----hhHHHHHHHHH-HHHhcCCCCCCCcceEEEEEEEEecCeEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD----FFDQSLDEIKL-LKYVNKHDPGDKYHLLRLYDYFYYREHLLIV 949 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~----~~dq~l~EikI-Lr~L~h~~~l~HPnIVkL~dsFqd~e~LyLV 949 (1182)
+.||+|+||+||+|+++.+++.||||++.+... .......|..+ ++.+ .||||+++++.|.....+|+|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l------~hp~iv~~~~~~~~~~~~~lv 74 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV------KHPFLVGLHYSFQTADKLYFV 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC------CCCCCCCeeEEEEeCCEEEEE
Confidence 368999999999999999999999999975431 12233344333 3333 466999999999999999999
Q ss_pred EEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 950 CELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 950 mEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
|||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~--~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 75 LDYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEG 146 (323)
T ss_pred EcCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeccCCCccc
Confidence 999986 5666554332 2888999999999999999999999999999999999984 678999999998643
Q ss_pred C---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccccc
Q 001034 1029 T---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105 (1182)
Q Consensus 1029 ~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s 1105 (1182)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+++..+....
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------------- 212 (323)
T cd05575 147 IEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-------------- 212 (323)
T ss_pred ccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 2 22334578999999999999999999999999999999999999999888777666653100
Q ss_pred chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH----HHHHcCCCCCC
Q 001034 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA----SDALKHPWLSH 1175 (1182)
Q Consensus 1106 ~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA----eELLqHPWFk~ 1175 (1182)
....+..+..+.+||++||+.||.+||++ .++++||||..
T Consensus 213 ------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 213 ------------------------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred ------------------------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 00112347889999999999999999998 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.82 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=218.7
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
....++|++.+.||+|-||.||+|+.+.++..||+|++.+... ....-+.++.+.+.-...+.||||+++|++|.+..
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi--~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI--LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH--HHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 3445789999999999999999999999999999999987652 22222333333333334456779999999999999
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+||++||.. |.++..+...+.. .|.+..++.|++|++.||.|+|..+||||||||+|+|++. .+.+||+|||
T Consensus 96 riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~--~~~lkiAdfG 169 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS--AGELKIADFG 169 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC--CCCeeccCCC
Confidence 9999999998 6788877743322 3899999999999999999999999999999999999995 7789999999
Q ss_pred Ccccc-CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1024 SSCFE-TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1024 LA~~~-~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
.+... .....+.|||..|.|||.+.+..++..+|+|++|++.||+|+|.+||.+.+..+++++|.+..-.
T Consensus 170 wsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~--------- 240 (281)
T KOG0580|consen 170 WSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK--------- 240 (281)
T ss_pred ceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc---------
Confidence 98765 44566889999999999999999999999999999999999999999999999999998532222
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
+| ..++..+.|||.+||..+|.+|++..|++.|||+..
T Consensus 241 --------------------------~p---------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 --------------------------FP---------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred --------------------------CC---------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 22 245788999999999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=358.61 Aligned_cols=255 Identities=29% Similarity=0.413 Sum_probs=206.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC--e
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE--H 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e--~ 945 (1182)
.+|...+.||+|+||.||++.+..+|..+|||.+..... ..+...+|+.+|.+++|+ +||++++...... .
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p------~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHP------NIVQYYGSSSSRENDE 90 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCC------CEEeeCCccccccCee
Confidence 457888999999999999999999999999999876531 145678899999999744 8999999755554 6
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
++|+|||+. |+|.+++..... .+++..++.+++||+.||.|||++|||||||||+|||++. .++.+||+|||+
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~-~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP-SNGDVKLADFGL 164 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC-CCCeEEeccCcc
Confidence 999999999 578888876542 2999999999999999999999999999999999999994 257899999999
Q ss_pred ccccCC------CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhcCCcch
Q 001034 1025 SCFETD------HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQN-DSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1025 A~~~~~------~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g-~d~~elLakIv~ilGp~Pe 1096 (1182)
+..... ......||+.|||||++... ....++|||||||++.||+||++||.. ....+.+-.|..
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~------- 237 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR------- 237 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc-------
Confidence 875442 23467899999999999963 334599999999999999999999976 333332222210
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
...........+.++++||++||.+||++||||.++|+|||++..
T Consensus 238 -----------------------------------~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 238 -----------------------------------EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -----------------------------------cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 000112223468899999999999999999999999999999765
Q ss_pred C
Q 001034 1177 Y 1177 (1182)
Q Consensus 1177 ~ 1177 (1182)
.
T Consensus 283 ~ 283 (313)
T KOG0198|consen 283 S 283 (313)
T ss_pred c
Confidence 4
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=332.28 Aligned_cols=283 Identities=29% Similarity=0.440 Sum_probs=218.4
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++.+.||.|+||.||+|.+..+++.||+|+++... .....+.+|+.+++.+.+ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE-----SIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccC-----CCCccceeeeEeecCC
Confidence 46999999999999999999999999999999987543 223467789999998864 3589999999987766
Q ss_pred -----EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 946 -----LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 946 -----LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
.|+||||+.++|..++...... ....+++..++.++.||+.||.|||+.+|+||||+|+|||++. .++.+||+
T Consensus 76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~-~~~~~kl~ 153 (295)
T cd07837 76 NGKPSLYLVFEYLDSDLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK-QKGLLKIA 153 (295)
T ss_pred CCCceEEEEeeccCcCHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec-CCCeEEEe
Confidence 8999999999998887654322 1234899999999999999999999999999999999999984 36789999
Q ss_pred cCCCccccCCC---cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1021 DLGSSCFETDH---LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1021 DFGLA~~~~~~---~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+...++.++.
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99998754322 223356888999999875 45789999999999999999999999998888877777766554443
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
..+......... ..+.......+....+..+..+.+||.+||.+||.+||++.++|.||||+
T Consensus 234 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 234 QVWPGVSKLRDW----------------HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhCcchhhccch----------------hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 322211100000 00000000011122345678999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.63 Aligned_cols=277 Identities=29% Similarity=0.465 Sum_probs=217.7
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.|++++.||.|+||.||+|++..+++.||||.+.... .....+..|+.+++.++| |||+++++++.....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH------PNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCC------CCCcchhhhcccCCcE
Confidence 4889999999999999999999999999999987542 223467789999998865 4899999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|+||||+.++|..++..... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++. ++.+||+|||++.
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~--~~~~~l~dfg~~~ 148 (284)
T cd07860 75 YLVFEFLHQDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLAR 148 (284)
T ss_pred EEEeeccccCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEeeccchh
Confidence 99999999888887765432 13788999999999999999999999999999999999994 6789999999986
Q ss_pred ccCCC---cccccCCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg~~-yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
..... .....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||...+....+.++...++.++..++...
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred hcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 54322 22345688899999987654 688999999999999999999999998888888888877776654433211
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.....+ .. .+.......+....+..+..+++||.+||+.||.+|||+.++|+||||
T Consensus 229 ~~~~~~----~~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 229 TSLPDY----KP-----------SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hHHHHH----Hh-----------hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 100000 00 000000011112234467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=333.49 Aligned_cols=282 Identities=25% Similarity=0.407 Sum_probs=222.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++.+.||.|+||.||++.++.+++.||+|.+.... .....+..|+.+++.+.|+ ||+++++++....+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG------NIVRLQDVVHSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCC------CEeeEEEEEecCCe
Confidence 57999999999999999999999999999999986542 2234567888999888654 89999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
.|+||||+++++..++..... ..+++..++.++.||+.||.|||+++++|+||+|+||+++. ..+.+||+|||++
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~-~~~~~kl~dfg~~ 150 (294)
T PLN00009 76 LYLVFEYLDLDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLA 150 (294)
T ss_pred EEEEEecccccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC-CCCEEEEcccccc
Confidence 999999999988887754322 23678888999999999999999999999999999999984 3457999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+....+.++....+.+...++..
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 754322 233466889999999876 4578999999999999999999999999888888888877777665555432
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
......+.. . ........+....+..+..+.+||.+||..+|++||++.++|+||||.+.
T Consensus 231 ~~~~~~~~~-------------~--~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 231 VTSLPDYKS-------------A--FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred cccchhhhh-------------h--cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 221111100 0 00000011112234567889999999999999999999999999999875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.41 Aligned_cols=255 Identities=22% Similarity=0.278 Sum_probs=204.7
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.|++.+.||+|+||+||++.+..+++.||||++.... .....+.+|+.+++.++|+ +|+++++.|....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR------FVVSLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCC------CEeeeeeeecCCCe
Confidence 4889999999999999999999999999999997542 1223456788888888654 89999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.+ +|..++..... ..+++..+..++.||+.||.|||+.+|+||||||+|||++. .+.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~~l~Dfg~ 148 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD--YGHIRISDLGL 148 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC--CCCEEEeeCCC
Confidence 9999999986 55555433211 23889999999999999999999999999999999999984 67899999999
Q ss_pred ccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1025 SCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1025 A~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
+..... .....++++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+...+...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 221 (285)
T cd05605 149 AVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ------- 221 (285)
T ss_pred ceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-------
Confidence 876432 22345789999999999999999999999999999999999999987655433333211100000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~~ 1176 (1182)
......++..+.+||.+||..||.+|| ++.+|++||||...
T Consensus 222 ---------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 222 ---------------------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ---------------------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 001123578899999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=349.66 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=197.6
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 877 LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
||+|+||+||+|+++.+++.||||++.+.. ........|..++..+.. ..||+|+++++.|....++|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~---~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLL---DESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhcc---CCCCcCcceEEEEecCCeEEEEEcC
Confidence 699999999999999999999999997542 122334455556555432 2477999999999999999999999
Q ss_pred ccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC--
Q 001034 953 LKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET-- 1029 (1182)
Q Consensus 953 L~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~-- 1029 (1182)
+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 78 ~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 78 MSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA--TGHIALCDFGLSKANLTD 149 (330)
T ss_pred CCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEecCCcCcCCCCC
Confidence 985 5666654322 2889999999999999999999999999999999999984 6789999999986432
Q ss_pred -CCcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccch
Q 001034 1030 -DHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYK 1107 (1182)
Q Consensus 1030 -~~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k 1107 (1182)
......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------- 214 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--------------- 214 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 223456799999999999765 589999999999999999999999998887766665521000
Q ss_pred hhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC----CHHHHHcCCCCCCC
Q 001034 1108 YFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1108 ~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP----TAeELLqHPWFk~~ 1176 (1182)
.+| ....+..+.+||++||+.||.+|| ++.++++||||...
T Consensus 215 --------------------~~~--------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 215 --------------------RFP--------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred --------------------CCC--------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 001 012468899999999999999998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=332.45 Aligned_cols=281 Identities=24% Similarity=0.408 Sum_probs=216.6
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.++|++.+.||.|+||.||+|.+..+++.||||++.... .......+|+.+++.+.|+ +|+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE------NVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCC------CccceEEEEeccc
Confidence 367999999999999999999999999999999986532 2223456788888888654 8999999887654
Q ss_pred --------eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 945 --------HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 945 --------~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
..|+||||+.+++..++.... ..+++..++.++.||+.||.|||++|++|+||||+|||++. ++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~--~~~ 157 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEHDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITK--DGI 157 (310)
T ss_pred ccccCCCceEEEEEcCCCcCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC--CCc
Confidence 459999999998887775432 13889999999999999999999999999999999999984 678
Q ss_pred EEEecCCCccccCCCc-------ccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 001034 1017 VKVIDLGSSCFETDHL-------CSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~~~-------ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv 1088 (1182)
+||+|||++....... ....++..|+|||++.+. .++.++|+||||+++|+|++|++||.+.+....+..+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~ 237 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999986543221 234567889999998765 47889999999999999999999999998888888888
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
.+.+.++..++..... ...+.... ...... ...+ ..+ .....+..+++||.+||..||.+|||+.++|
T Consensus 238 ~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~-----~~~~--~~l--~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 238 QLCGSITPEVWPGVDK-LELFKKME--LPQGQK-----RKVK--ERL--KPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred HHhCCCChhhcccccc-hhhhhhcc--CCCccc-----hhhH--Hhc--ccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 8888877766543321 11111000 000000 0000 000 1112467889999999999999999999999
Q ss_pred cCCCC
Q 001034 1169 KHPWL 1173 (1182)
Q Consensus 1169 qHPWF 1173 (1182)
+||||
T Consensus 306 ~h~~f 310 (310)
T cd07865 306 NHDFF 310 (310)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=364.89 Aligned_cols=261 Identities=30% Similarity=0.460 Sum_probs=232.4
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
-.+++-|.+.+.||+|.|+.|-+|++..+|..||||++.+.+ ....+++.|++.++.++|+ |||+||.+..
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHp------NiVRLYEViD 87 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHP------NIVRLYEVID 87 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCc------Ceeeeeehhc
Confidence 346788999999999999999999999999999999998765 3456788999999998765 8999999998
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
....+|||+|+-.+ +|++|+-.... + +.+..++.|+.||+.||.|||+..+|||||||+||.+.. +-|.|||+
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe~-G----l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE-KlGlVKLT 161 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHEE-G----LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE-KLGLVKLT 161 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhhc-c----ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee-ecCceEee
Confidence 88999999999885 89999876643 2 899999999999999999999999999999999999875 67899999
Q ss_pred cCCCccc--cCCCcccccCCCcccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1021 DLGSSCF--ETDHLCSYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1021 DFGLA~~--~~~~~ss~vGTp~YmAPEVLlg~~yS-~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|||++-. .+....+.||+..|.|||+++|..|+ +++||||||||||-|+||++||.-.+..+++..||.+...+|.
T Consensus 162 DFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs- 240 (864)
T KOG4717|consen 162 DFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS- 240 (864)
T ss_pred eccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch-
Confidence 9999853 45567889999999999999999998 6889999999999999999999999999999999865544443
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.++.++++||..||..||.+|.+.++|..|+|++..-
T Consensus 241 -------------------------------------------hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 241 -------------------------------------------HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred -------------------------------------------hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 2368899999999999999999999999999999887
Q ss_pred CCCC
Q 001034 1178 EPIS 1181 (1182)
Q Consensus 1178 eP~~ 1181 (1182)
+|++
T Consensus 278 ~~~s 281 (864)
T KOG4717|consen 278 RGLS 281 (864)
T ss_pred CCcc
Confidence 7764
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.43 Aligned_cols=279 Identities=26% Similarity=0.399 Sum_probs=213.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.+|.+.+.||.|+||.||+|.+..++..||+|++.... .......+|+.+++.+.|+ ||+++++++......
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~------ni~~~~~~~~~~~~~ 78 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA------NIVLLHDIIHTKETL 78 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCC------CEeEEEEEEecCCeE
Confidence 67999999999999999999999999999999997543 2223566788888888654 899999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|+||||+.++++.++..... .++...++.++.||+.||.|||+.||+|+||||+|||++. ++.++|+|||++.
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~Dfg~~~ 151 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY--LGELKLADFGLAR 151 (291)
T ss_pred EEEEecccCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC--CCcEEEecccccc
Confidence 99999999998887754321 2677888999999999999999999999999999999984 6789999999986
Q ss_pred ccCC---CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETD---HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDS-PATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~---~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d-~~elLakIv~ilGp~PeemL~~ 1101 (1182)
.... ......+++.|+|||++.+. .++.++|||||||++|+|++|..||...+ ..+.+.++...++.++..+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 152 AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred ccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 5332 22334578899999998764 58899999999999999999999997643 4566667766677555444332
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccc-cccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKK-TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~-~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
......+.. .... ...+.. ....... ..+..+.+||.+||..||.+|||+.++|.||||
T Consensus 232 ~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 232 VSKLPNYKP-EWFL-----------PCKPQQLRVVWKRL-SRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhcccccc-hhcc-----------ccCCcchhhhcccc-CCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 221111100 0000 000000 0000011 125789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=334.99 Aligned_cols=250 Identities=23% Similarity=0.299 Sum_probs=196.4
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 877 LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
||.|+||+||++.++.+++.||+|++.+.. .....+..|+.+++.+.| ++|++++++|....++|+||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~------~~i~~~~~~~~~~~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS------RFIVSLAYAFQTKTDLCLVMTI 74 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCC------CcEeeeeEEEcCCCeEEEEEeC
Confidence 699999999999999999999999997543 223455678888888855 4899999999999999999999
Q ss_pred cccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC
Q 001034 953 LKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH 1031 (1182)
Q Consensus 953 L~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~ 1031 (1182)
+.++ |..++..... ....+++..+..++.||+.||.|||+++|+||||||+|||++. ++.++|+|||++......
T Consensus 75 ~~~g~L~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 75 MNGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEeeCccceecCCC
Confidence 9864 5444432211 1123889999999999999999999999999999999999984 677999999998654322
Q ss_pred ---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchh
Q 001034 1032 ---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKY 1108 (1182)
Q Consensus 1032 ---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~ 1108 (1182)
.....+|+.|+|||++.+..++.++|+|||||++|+|++|+.||...........+....
T Consensus 151 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~----------------- 213 (280)
T cd05608 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI----------------- 213 (280)
T ss_pred CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh-----------------
Confidence 234578999999999999999999999999999999999999997643221111110000
Q ss_pred hcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q 001034 1109 FTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1109 F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~~ 1176 (1182)
... .......++..+.+||.+||+.||.+|| ++.++++||||+..
T Consensus 214 --------------------~~~---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 214 --------------------LND---SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred --------------------ccc---CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 000 0001124578899999999999999999 89999999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=352.47 Aligned_cols=254 Identities=20% Similarity=0.320 Sum_probs=205.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++.+.||.|+||.||+|+++.+++.||+|++.+.. .....+..|+.+++.+. ||||+++++.|...
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~------hp~iv~~~~~~~~~ 115 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN------SPWVVQLFYAFQDD 115 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC------CCCCCeEEEEEEcC
Confidence 478999999999999999999999999999999997532 22234556777777765 45999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++|+||||++| +|..++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~--~~~ikL~Df 186 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADF 186 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC--CCCEEEEeC
Confidence 999999999985 566666432 2788889999999999999999999999999999999984 778999999
Q ss_pred CCccccCCC----cccccCCCcccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1023 GSSCFETDH----LCSYVQSRSYRAPEVILGLS----YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1023 GLA~~~~~~----~ss~vGTp~YmAPEVLlg~~----yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+....+.+|+.....+
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 266 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 998754322 23567999999999997643 7899999999999999999999999988877777764211100
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHcCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK--RPSASDALKHPW 1172 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek--RPTAeELLqHPW 1172 (1182)
.+| ....++..+++||.+||..+|.+ |+++.++++|||
T Consensus 267 ---------------------------------~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 267 ---------------------------------TFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred ---------------------------------cCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 001 11245789999999999844433 789999999999
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
|++.
T Consensus 307 ~~~~ 310 (371)
T cd05622 307 FKND 310 (371)
T ss_pred cCCC
Confidence 9763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=358.42 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=221.5
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
..+..++|..+++||+|.||+|.+|+.+.+++.||||++++. ++...+.+.|-++|+.++|+ ++..|.++
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HP------FLt~LKYs 236 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHP------FLTSLKYS 236 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCc------HHHHhhhh
Confidence 345678899999999999999999999999999999999875 45567788888898887655 99999999
Q ss_pred EEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 940 FYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
|+...++|+||||..|+-+-++..+.. .|++..++++-.+|+.||.|||+.+||+||||.+|+|+| ++|+|||
T Consensus 237 FQt~drlCFVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD--kDGHIKi 309 (516)
T KOG0690|consen 237 FQTQDRLCFVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD--KDGHIKI 309 (516)
T ss_pred hccCceEEEEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec--cCCceEe
Confidence 999999999999999764444333321 399999999999999999999999999999999999999 5889999
Q ss_pred ecCCCccc---cCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1020 IDLGSSCF---ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1020 iDFGLA~~---~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
+|||+++- ......++||||.|+|||++....|+.++|||.+||+||||+||+.||++.+...++..|+-.--
T Consensus 310 tDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~---- 385 (516)
T KOG0690|consen 310 TDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL---- 385 (516)
T ss_pred eecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc----
Confidence 99999973 44567789999999999999999999999999999999999999999999998888888751111
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHP 1171 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHP 1171 (1182)
.+| ...+++++.||..+|..||.+|+ .|.|+.+|+
T Consensus 386 -------------------------------kFP---------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~ 425 (516)
T KOG0690|consen 386 -------------------------------KFP---------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR 425 (516)
T ss_pred -------------------------------cCC---------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh
Confidence 111 24478999999999999999996 489999999
Q ss_pred CCCCC
Q 001034 1172 WLSHP 1176 (1182)
Q Consensus 1172 WFk~~ 1176 (1182)
||...
T Consensus 426 FF~~v 430 (516)
T KOG0690|consen 426 FFASV 430 (516)
T ss_pred hhccC
Confidence 99764
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.09 Aligned_cols=278 Identities=29% Similarity=0.485 Sum_probs=218.0
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
+|++.+.||.|++|.||+|++..++..||||+++... .....+..|+.+++.+.|+ ||++++++|....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE------NIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCC------CEeeeeeeEeeCCcEE
Confidence 4899999999999999999999999999999997643 2235567788999888644 8999999999999999
Q ss_pred EEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 948 LVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
|||||+.++|..++..... ...+++..+..++.||+.||.|||+.|++||||||+||+++. ++.++|+|||++..
T Consensus 75 lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~--~~~~~l~d~g~~~~ 149 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK--RGELKLADFGLARA 149 (284)
T ss_pred EEEecCCccHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCcEEEeecchhhh
Confidence 9999999998888765432 224899999999999999999999999999999999999984 67899999999865
Q ss_pred cCCC---cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1028 ETDH---LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1028 ~~~~---~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
.... .....+++.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+..+.+.++......+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 150 FGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred hcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 4322 2234568899999998764 57899999999999999999999999988888888887666554443332211
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
....+ ... .............+..+..+++||.+||+.||.+||++.++|+||||
T Consensus 230 ~~~~~-~~~--------------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 230 QLPEY-KPT--------------FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCchh-ccc--------------ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11000 000 00000001111223447889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=342.71 Aligned_cols=256 Identities=18% Similarity=0.268 Sum_probs=203.7
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||+|+||.||+++.+.+++.||+|++.+.. .....+..|+.++..+. |++|+++++.|....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD------NQWITTLHYAFQDEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC------CCCEeeEEEEEecCC
Confidence 46999999999999999999999999999999997532 12233455666666553 559999999999999
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++|+||||+. |+|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~--~~~~~kL~DfG 147 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD--MNGHIRLADFG 147 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC--CCCCEEEeecc
Confidence 9999999997 567777764322 288889999999999999999999999999999999998 46789999999
Q ss_pred CccccCCC----cccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1024 SSCFETDH----LCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1024 LA~~~~~~----~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
++...... ....+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+.+.+++.....
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~- 226 (332)
T cd05623 148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER- 226 (332)
T ss_pred hheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc-
Confidence 98643221 22357899999999986 346889999999999999999999999988887777766421100
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHcCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK--RPSASDALKHPW 1172 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek--RPTAeELLqHPW 1172 (1182)
...| .....++..+++||++||+.+|.. |+++.++++|||
T Consensus 227 --------------------------------~~~p------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 227 --------------------------------FQFP------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred --------------------------------ccCC------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 0011 111345789999999999765544 789999999999
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
|+..
T Consensus 269 f~~~ 272 (332)
T cd05623 269 FTGI 272 (332)
T ss_pred cCCC
Confidence 9863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=349.12 Aligned_cols=254 Identities=24% Similarity=0.307 Sum_probs=199.0
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
...|++++.||.|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| +||++++++|.....
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH------PNVVKCHDMFDHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCC------CCcceeeeEeccCCe
Confidence 356788899999999999999999999999999996542 334567789999988865 489999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+|+||||+.++.+... ....+..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 147 ~~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kL~DfG~~ 215 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS--AKNVKIADFGVS 215 (353)
T ss_pred EEEEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEcccccc
Confidence 9999999997543211 12566778889999999999999999999999999999984 678999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILG-----LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg-----~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
...... ....+||..|+|||++.. ...+.++|||||||++|+|++|+.||......+....+....
T Consensus 216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~------ 289 (353)
T PLN00034 216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC------ 289 (353)
T ss_pred eecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh------
Confidence 764432 235678999999999843 234578999999999999999999997432211111110000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.. ........++..+++||.+||..||.+|||+.|||+||||....
T Consensus 290 -----------------------------~~-----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 290 -----------------------------MS-----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred -----------------------------cc-----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 00 00011234578899999999999999999999999999998874
Q ss_pred C
Q 001034 1178 E 1178 (1182)
Q Consensus 1178 e 1178 (1182)
.
T Consensus 336 ~ 336 (353)
T PLN00034 336 P 336 (353)
T ss_pred c
Confidence 3
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.30 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=201.2
Q ss_pred EEeccCCceEEEEEEE---CCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 875 EYLGSAAFSKAIQAHD---LHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkD---k~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
+.||+|+||.||++++ ..+++.||+|++.+.. ........|+.+++.+.| |||++++++|.....+|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH------PFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCC------CCcccEEEEEEcCCEEEE
Confidence 5799999999999986 3678999999998643 123345678888888754 599999999999999999
Q ss_pred EEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||||+. ++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 76 v~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kL~Dfg~~~~ 147 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE--EGHIKLTDFGLSKE 147 (318)
T ss_pred EEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECC--CCcEEEeeccCCcc
Confidence 999998 46776664322 3889999999999999999999999999999999999984 67899999999875
Q ss_pred cCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1028 ETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1028 ~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
.... ....+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 148 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~----------- 216 (318)
T cd05582 148 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG----------- 216 (318)
T ss_pred cCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 4322 34567899999999999999999999999999999999999999988777666655311100
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSHP 1176 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~~ 1176 (1182)
+ ....+..+.+||++||+.||.+||+ +.+++.||||+..
T Consensus 217 ------------------------~---------p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 217 ------------------------M---------PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ------------------------C---------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 0 1124678999999999999999999 7789999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=345.31 Aligned_cols=245 Identities=22% Similarity=0.333 Sum_probs=194.3
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||+|+||.||+|++..+++.||+|++++.. .....+..|+.++..+. .||||++++++|.....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC-----CCCcCCceeeEEEeCCEEEEEE
Confidence 36899999999999999999999999998642 23344566777776653 3569999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc-
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE- 1028 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~- 1028 (1182)
||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~--~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGL 147 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCCEEEeeCCcccccc
Confidence 99996 4555544322 2889999999999999999999999999999999999984 678999999998642
Q ss_pred --CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HH-HHHHHHhhcCCcchh
Q 001034 1029 --TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP--------AT-LLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1029 --~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~--------~e-lLakIv~ilGp~Pee 1097 (1182)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .. ....+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~--------- 218 (329)
T cd05618 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--------- 218 (329)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh---------
Confidence 2223456789999999999999999999999999999999999999953110 00 000000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC------HHHHHcCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS------ASDALKHP 1171 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT------AeELLqHP 1171 (1182)
... .......+..+.+||.+||+.||.+||+ +.++++||
T Consensus 219 --------------------------------~~~---~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 219 --------------------------------EKQ---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred --------------------------------cCC---CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 000 0011245788999999999999999998 57999999
Q ss_pred CCCCC
Q 001034 1172 WLSHP 1176 (1182)
Q Consensus 1172 WFk~~ 1176 (1182)
||+..
T Consensus 264 ~f~~~ 268 (329)
T cd05618 264 FFRNV 268 (329)
T ss_pred CCCCC
Confidence 99763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=342.83 Aligned_cols=246 Identities=23% Similarity=0.332 Sum_probs=196.2
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||+|+||+||+|++..+++.||+|++++.. .....+..|+.++..+.+ |++|++++++|....++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~-----~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-----NPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcC-----CCCEeeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999998643 233456677787777643 459999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc-
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE- 1028 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~- 1028 (1182)
||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA--DGHIKLTDYGMCKEGL 147 (327)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC--CCCEEEeccccceecc
Confidence 99986 5655554332 2899999999999999999999999999999999999984 678999999998642
Q ss_pred --CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhhcCCcchhhhh
Q 001034 1029 --TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP------ATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1029 --~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~------~elLakIv~ilGp~PeemL~ 1100 (1182)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+.+++
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~------------ 215 (327)
T cd05617 148 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI------------ 215 (327)
T ss_pred CCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH------------
Confidence 2233456899999999999999999999999999999999999999953211 11111110
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC------HHHHHcCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS------ASDALKHPWLS 1174 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT------AeELLqHPWFk 1174 (1182)
.. .+ .......+..+.+||.+||..||.+|++ +.++++||||+
T Consensus 216 ------------------------~~--~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~ 264 (327)
T cd05617 216 ------------------------LE--KP-----IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFR 264 (327)
T ss_pred ------------------------Hh--CC-----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCC
Confidence 00 00 0011234688999999999999999998 57999999997
Q ss_pred CC
Q 001034 1175 HP 1176 (1182)
Q Consensus 1175 ~~ 1176 (1182)
..
T Consensus 265 ~~ 266 (327)
T cd05617 265 SI 266 (327)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.48 Aligned_cols=278 Identities=29% Similarity=0.517 Sum_probs=220.6
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++.+.||.|+||.||+|.+..+++.||+|+++.. ......+..|+.+++.+.|. ||++++++|.....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE------NIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCC------CeeehhheEEECCE
Confidence 4799999999999999999999999999999998753 23346778899999988654 89999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+|+||||+.++++..+..... .+++..+..++.||+.||.|||+.+++|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~--~~~~kl~d~g~~ 147 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE--SGVLKLCDFGFA 147 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEEeeecc
Confidence 999999999988776654322 2788999999999999999999999999999999999994 778999999998
Q ss_pred cccCCC----cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDH----LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~----~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
...... .....++..|+|||++.+. .++.++|+||||+++|+|++|++||...+..+.+..+...++..+..+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 764432 2345678899999999888 88999999999999999999999999888877777777777766554332
Q ss_pred cccccchhhcccchhhhhhcchhhhhhcccc-ccccccCCC-CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPK-KTSLRHRLP-MGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk-~~sL~~~l~-~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.......+ .......+. ........+ .++..+++||++||..+|.+|||+.++++||||
T Consensus 228 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 228 LFSSNPRF--------------AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred hcccCccc--------------cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 21110000 000000000 001111122 347899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=341.81 Aligned_cols=285 Identities=31% Similarity=0.551 Sum_probs=219.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR- 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~- 943 (1182)
+.++|++.+.||.|+||.||+|.+..+++.||||++... .........|+.+++.++|+ ||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE------NIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCC------CcCchhheeeccc
Confidence 457899999999999999999999999999999998642 23445677889999988754 899999876654
Q ss_pred ----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 944 ----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 944 ----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
.++|+||||+.+++...+... .+++..++.++.||+.||.|||+.||+||||||+|||++. .+.+||
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~--~~~~kl 147 (336)
T cd07849 77 FESFNDVYIVQELMETDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKI 147 (336)
T ss_pred ccccceEEEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC--CCCEEE
Confidence 468999999999888776532 2888999999999999999999999999999999999984 678999
Q ss_pred ecCCCccccCCC------cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1020 IDLGSSCFETDH------LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1020 iDFGLA~~~~~~------~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
+|||++...... ....++++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...++
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~ 227 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 999998654321 123467899999998765 4689999999999999999999999998888888888877777
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.++...+........ ..+.. . ........+....+..+..+.+||.+||+.+|.+|||+.++|+|||
T Consensus 228 ~~~~~~~~~~~~~~~------~~~~~-----~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~ 294 (336)
T cd07849 228 TPSQEDLNCIISLRA------RNYIK-----S--LPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294 (336)
T ss_pred CCCHHHHHHhhchhh------hhHHh-----h--cCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 654433221110000 00000 0 0000001111123445788999999999999999999999999999
Q ss_pred CCCCCCC
Q 001034 1173 LSHPYEP 1179 (1182)
Q Consensus 1173 Fk~~~eP 1179 (1182)
|+....|
T Consensus 295 ~~~~~~~ 301 (336)
T cd07849 295 LEQYHDP 301 (336)
T ss_pred ccccCCC
Confidence 9877654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=342.79 Aligned_cols=256 Identities=18% Similarity=0.259 Sum_probs=204.4
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||+|+||.||+++++.+++.||+|++.+.. .....+..|+.++..+. |++|++++++|....
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~l~~~~~~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD------CQWITTLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC------CCCEeeEEEEEEcCC
Confidence 47999999999999999999999999999999997532 12233556666666654 459999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++||||||+.| +|..++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~--~~~~kl~DfG 147 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM--NGHIRLADFG 147 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC--CCCEEEEecc
Confidence 99999999985 67777654321 2788999999999999999999999999999999999984 6789999999
Q ss_pred CccccCCC----cccccCCCcccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1024 SSCFETDH----LCSYVQSRSYRAPEVILG-----LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1024 LA~~~~~~----~ss~vGTp~YmAPEVLlg-----~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+.+++.....+
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~ 227 (331)
T cd05624 148 SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 227 (331)
T ss_pred ceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc
Confidence 98654332 123578999999999976 468899999999999999999999999888777666664211000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHcCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK--RPSASDALKHPW 1172 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek--RPTAeELLqHPW 1172 (1182)
..| .....++..+++||.+||+..+.+ |+++.++++|||
T Consensus 228 ---------------------------------~~p------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 228 ---------------------------------QFP------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred ---------------------------------cCC------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 001 112235789999999999976654 579999999999
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
|...
T Consensus 269 f~~~ 272 (331)
T cd05624 269 FEGI 272 (331)
T ss_pred cCCC
Confidence 9763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.14 Aligned_cols=278 Identities=27% Similarity=0.419 Sum_probs=219.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR-- 943 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~-- 943 (1182)
+.|++.+.||.|+||.||+|.+..+++.+|+|.++... .....+.+|+.+++.+.| |||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h------~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH------PNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCC------CCEEEEEEEEEecCC
Confidence 46899999999999999999999999999999997543 222345678888888864 4899999999887
Q ss_pred CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 944 EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 944 e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..+||||||+.++|.+++..... .+++..++.++.||+.||.|||+.+++|+||||+|||++. ++.++|+|||
T Consensus 79 ~~~~lv~e~~~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~--~~~~~l~d~g 151 (293)
T cd07843 79 DKIYMVMEYVEHDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN--RGILKICDFG 151 (293)
T ss_pred CcEEEEehhcCcCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC--CCcEEEeecC
Confidence 89999999999988888765432 3899999999999999999999999999999999999994 6789999999
Q ss_pred CccccCCC---cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1024 SSCFETDH---LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1024 LA~~~~~~---~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
++...... .....+++.|+|||++.+. .++.++|+|||||++|+|++|.+||........+.+++..++.+....+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 152 LAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred ceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 98754432 2334678889999998765 4689999999999999999999999999988889988887776655443
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCC--CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPM--GDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~--~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
........... .....+....+...++. ++..+.+||++||+.+|++|||+.|+|.||||
T Consensus 232 ~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 232 PGFSELPGAKK--------------KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHhhccchhcc--------------cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 32211100000 00000111111222333 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=343.94 Aligned_cols=243 Identities=26% Similarity=0.387 Sum_probs=196.4
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHH-HHHhcCCCCCCCcceEEEEEEEEecCeEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKL-LKYVNKHDPGDKYHLLRLYDYFYYREHLLIV 949 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikI-Lr~L~h~~~l~HPnIVkL~dsFqd~e~LyLV 949 (1182)
+.||+|+||+||+|+++.+|+.||||++.+.. .....+..|..+ ++.+ .||||++++++|.....+|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~------~hp~iv~~~~~~~~~~~~~lv 74 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV------KHPFLVGLHYSFQTTEKLYFV 74 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC------CCCCCccEEEEEecCCEEEEE
Confidence 36899999999999999999999999997642 122233344433 3333 466999999999999999999
Q ss_pred EEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 950 CELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 950 mEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
|||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~--~~~~kL~DfG~~~~~ 146 (325)
T cd05604 75 LDFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS--QGHVVLTDFGLCKEG 146 (325)
T ss_pred EcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEeecCCcccC
Confidence 999986 4555554322 2889999999999999999999999999999999999984 678999999998642
Q ss_pred C---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccccc
Q 001034 1029 T---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105 (1182)
Q Consensus 1029 ~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s 1105 (1182)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+++..++...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-------------- 212 (325)
T cd05604 147 IAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-------------- 212 (325)
T ss_pred CCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 2 22345678999999999999999999999999999999999999999887776665553100
Q ss_pred chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH----HHHHcCCCCCC
Q 001034 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA----SDALKHPWLSH 1175 (1182)
Q Consensus 1106 ~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA----eELLqHPWFk~ 1175 (1182)
....+..+..+.+||++||+.+|.+||++ .++++||||+.
T Consensus 213 ------------------------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 213 ------------------------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred ------------------------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 00112356789999999999999999987 59999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.45 Aligned_cols=250 Identities=25% Similarity=0.452 Sum_probs=212.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++.+.||.|+||.||++.+..+++.||+|++.+.. .....+..|+++++.+.| |||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH------PFLVNLYGSFQDDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC------CCccceeeEEEcCC
Confidence 46999999999999999999999999999999997643 234567778888888864 48999999999999
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|.|||++. ++.+||+|||
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~dfg 146 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS--DGYIKITDFG 146 (290)
T ss_pred eEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC--CCCEEEeeCC
Confidence 9999999995 67877776542 2889999999999999999999999999999999999984 6789999999
Q ss_pred CccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1024 SSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1024 LA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
++..........++++.|+|||.+.+..++.++|+||||+++|+|++|..||...+......++.....+
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 216 (290)
T cd05580 147 FAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR---------- 216 (290)
T ss_pred CccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcc----------
Confidence 9987665555667899999999999888999999999999999999999999887766555555311100
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~~ 1176 (1182)
+ ....+..+.+||.+||..||.+|+ ++.++++||||+..
T Consensus 217 -------------------------~---------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 217 -------------------------F---------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred -------------------------C---------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 0 112367899999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.80 Aligned_cols=254 Identities=23% Similarity=0.312 Sum_probs=202.0
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.|++.+.||+|+||.||++.+..+++.||+|.+.... .....+..|+.+++.++|+ +|+.+++.+....+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~------~i~~~~~~~~~~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR------FVVSLAYAYETKDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCC------CeeeeeEEEecCCE
Confidence 3788899999999999999999999999999987542 2223456788888888654 89999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.| +|..++..... ..+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~--~~~~~l~Dfg~ 148 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD--HGHIRISDLGL 148 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC--CCCEEEeeccc
Confidence 9999999985 56666543321 23888999999999999999999999999999999999984 67799999999
Q ss_pred ccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1025 SCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1025 A~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
+...... .....|++.|+|||++.+..++.++|+|||||++|+|++|++||...........+......
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~--------- 219 (285)
T cd05630 149 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--------- 219 (285)
T ss_pred eeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---------
Confidence 8754322 23457899999999999999999999999999999999999999764321111111000000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSH 1175 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~ 1175 (1182)
. + .......+..+.+||++||+.||.+||| +.|+++||||+.
T Consensus 220 ----------------------~----~-----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 220 ----------------------V----Q-----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred ----------------------h----h-----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 0 0 0011234678999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=365.81 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=202.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhH----HHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD----QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~d----q~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.-|..++.||-|+||+|.++....|...||||.+++..-... +..+|..||... +.+|||+||.+|+++.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA------Dn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA------DNEWVVRLYYSFQDKD 702 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc------CCcceEEEEEEeccCC
Confidence 458889999999999999999999999999999988654444 444555555554 4459999999999999
Q ss_pred eEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+||+|++|+ +..++.... .|.+..+++|+++|..||+++|++|+|||||||+|||||. +|+|||+|||
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr--dGHIKLTDFG 774 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFG 774 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc--CCceeeeecc
Confidence 999999999964 555555433 2999999999999999999999999999999999999995 8899999999
Q ss_pred CccccC-----------CC----------------------------------cccccCCCcccchhhhcCCCCCchhhH
Q 001034 1024 SSCFET-----------DH----------------------------------LCSYVQSRSYRAPEVILGLSYDKKIDI 1058 (1182)
Q Consensus 1024 LA~~~~-----------~~----------------------------------~ss~vGTp~YmAPEVLlg~~yS~kSDI 1058 (1182)
||+-.. ++ ..+.+||+.|+|||++....|+..|||
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 985211 00 124588999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccC
Q 001034 1059 WSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHR 1138 (1182)
Q Consensus 1059 WSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~ 1138 (1182)
||.|||||||+.|++||..+++.++..+|+.+.. ......
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~----------------------------------------~l~~~~ 894 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGETQYKVINWRN----------------------------------------FLHIPY 894 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh----------------------------------------cccccc
Confidence 9999999999999999998887665555431100 001112
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCC---CHHHHHcCCCCCC
Q 001034 1139 LPMGDQGFIDFVAHLLEINPKKRP---SASDALKHPWLSH 1175 (1182)
Q Consensus 1139 l~~~SeeL~DLIrkMLq~DPekRP---TAeELLqHPWFk~ 1175 (1182)
..+.+.++++||.++++ +++.|+ -+.+|-.||||+.
T Consensus 895 ~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 895 QGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred ccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 34568999999998665 688886 4778999999974
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.09 Aligned_cols=249 Identities=26% Similarity=0.339 Sum_probs=202.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
+.|.+.+.||.|+||.||+|.+..+++.||||.+.... .....+.+|+.+++.+.| |||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~ 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH------ERIVQYYGCLRD 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCC------CCeeeeEEEEcc
Confidence 46899999999999999999999999999999987542 123456678888887754 589999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~--~~~~~l~d 147 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS--AGNVKLGD 147 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEee
Confidence 9999999999985 6777665432 2788889999999999999999999999999999999984 67899999
Q ss_pred CCCccccCCCc------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1022 LGSSCFETDHL------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1022 FGLA~~~~~~~------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
||++....... ....++..|+|||++.+..++.++|||||||++|+|++|+.||...+......++.....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--- 224 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--- 224 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC---
Confidence 99986533211 234678899999999999999999999999999999999999987655444333310000
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
........+..+.+||++||..+|.+|||+.++|+||||
T Consensus 225 ---------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 ---------------------------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ---------------------------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 001112356789999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=346.89 Aligned_cols=252 Identities=26% Similarity=0.447 Sum_probs=215.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---------chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---------k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
..|.-.+.||+|..+.|.+|.++.+|+.+|+|++... ....+....|+.||+++. .||+|+++.++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~-----GHP~II~l~D~ 91 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM-----GHPYIIDLQDV 91 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc-----CCCcEEEeeee
Confidence 4577778999999999999999999999999999642 133456778999999986 46799999999
Q ss_pred EEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
|+.+..+++|+|.|+ |.|++++...- .+++...+.|++||+.+++|||..+|+||||||+|||++. +.+||
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd--n~~i~ 163 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD--NMNIK 163 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc--ccceE
Confidence 999999999999998 78999887543 3999999999999999999999999999999999999994 67799
Q ss_pred EecCCCccccC--CCcccccCCCcccchhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 001034 1019 VIDLGSSCFET--DHLCSYVQSRSYRAPEVIL------GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1019 LiDFGLA~~~~--~~~ss~vGTp~YmAPEVLl------g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~i 1090 (1182)
|+|||+++.+. ......||||.|+|||.+. ..+|+..+|+|++|||||.||.|.+||......-+++.|+..
T Consensus 164 isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred EeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 99999998754 4567889999999999985 346999999999999999999999999887777777777632
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
... +..|. ..+.+...++||++||+.||.+|+|+.|+|+|
T Consensus 244 kyq---------------------------------F~spe-------Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 KYQ---------------------------------FRSPE-------WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ccc---------------------------------cCCcc-------hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 221 11222 23447789999999999999999999999999
Q ss_pred CCC
Q 001034 1171 PWL 1173 (1182)
Q Consensus 1171 PWF 1173 (1182)
|||
T Consensus 284 pff 286 (411)
T KOG0599|consen 284 PFF 286 (411)
T ss_pred hHH
Confidence 999
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=342.04 Aligned_cols=243 Identities=25% Similarity=0.368 Sum_probs=196.3
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccch----hhHHHHHHHH-HHHHhcCCCCCCCcceEEEEEEEEecCeEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD----FFDQSLDEIK-LLKYVNKHDPGDKYHLLRLYDYFYYREHLLIV 949 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~----~~dq~l~Eik-ILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLV 949 (1182)
+.||+|+||.||+|++..+++.||+|++.+... ....+..|.. +++.+ .|+||++++++|.....+|+|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~------~h~~Iv~~~~~~~~~~~~~lv 74 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV------KHPFLVGLHFSFQTADKLYFV 74 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC------CCCCCCceeEEEEcCCeEEEE
Confidence 368999999999999999999999999976431 1122333333 23333 466999999999999999999
Q ss_pred EEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 950 CELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 950 mEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
|||+.+ +|..++.... .+.+..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~--~~~~kl~DfG~a~~~ 146 (325)
T cd05602 75 LDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLTDFGLCKEN 146 (325)
T ss_pred EeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEEccCCCCccc
Confidence 999996 5666554322 2788889999999999999999999999999999999984 678999999998643
Q ss_pred C---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccccc
Q 001034 1029 T---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105 (1182)
Q Consensus 1029 ~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s 1105 (1182)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+....
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-------------- 212 (325)
T cd05602 147 IEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------------- 212 (325)
T ss_pred ccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------------
Confidence 2 22345679999999999999999999999999999999999999999888777666653100
Q ss_pred chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH----HHHcCCCCCC
Q 001034 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS----DALKHPWLSH 1175 (1182)
Q Consensus 1106 ~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe----ELLqHPWFk~ 1175 (1182)
....+..+..+.+||.+||+.||.+|+++. ++++|+||..
T Consensus 213 ------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 213 ------------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ------------------------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 001134578899999999999999999876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=337.95 Aligned_cols=285 Identities=28% Similarity=0.445 Sum_probs=223.2
Q ss_pred eecCCEEEE-EEeccCCceEEEEEEECCCCcEEEEEEEeccchhh---------------HHHHHHHHHHHHhcCCCCCC
Q 001034 866 VIAGRYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFF---------------DQSLDEIKLLKYVNKHDPGD 929 (1182)
Q Consensus 866 iL~drYeIl-k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~---------------dq~l~EikILr~L~h~~~l~ 929 (1182)
.+.++|..+ +.||.|+||.||+|.+..+++.||||+++...... ..+.+|+.+++.+.|
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----- 79 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH----- 79 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC-----
Confidence 356788754 77999999999999999999999999987543211 135678888888865
Q ss_pred CcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEE
Q 001034 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV 1009 (1182)
Q Consensus 930 HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILI 1009 (1182)
+||++++++|.....+|+||||+.++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+|||+
T Consensus 80 -~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill 152 (335)
T PTZ00024 80 -ENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152 (335)
T ss_pred -cceeeeeEEEecCCcEEEEEeccccCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE
Confidence 48999999999999999999999999988876432 28889999999999999999999999999999999999
Q ss_pred ccCCCceEEEecCCCccccC-----------------CCcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhC
Q 001034 1010 KSYSRCEVKVIDLGSSCFET-----------------DHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTG 1071 (1182)
Q Consensus 1010 Ds~~dG~IKLiDFGLA~~~~-----------------~~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTG 1071 (1182)
+. .+.++|+|||++.... .......+++.|+|||++.+. .++.++|+|||||++|+|++|
T Consensus 153 ~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 153 NS--KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred CC--CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 84 6789999999886543 111233467889999998764 478999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHH
Q 001034 1072 NVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVA 1151 (1182)
Q Consensus 1072 r~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIr 1151 (1182)
.+||.+.+....+..++..++.++...+........+. ...... ........+..+..+.+||.
T Consensus 231 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~--~~~~~~~~~~~~~~~~~li~ 294 (335)
T PTZ00024 231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYT--------------EFTPRK--PKDLKTIFPNASDDAIDLLQ 294 (335)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhccccc--------------ccCcCC--cccHHHhCcCCChHHHHHHH
Confidence 99999999888888888877766544332221111000 000000 01111223455788999999
Q ss_pred HhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1152 HLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1152 kMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
+||+.+|.+|||+.++|.||||+...-|+
T Consensus 295 ~~l~~~P~~R~s~~~~l~~~~~~~~~~~~ 323 (335)
T PTZ00024 295 SLLKLNPLERISAKEALKHEYFKSDPLPC 323 (335)
T ss_pred HHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence 99999999999999999999999876554
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.11 Aligned_cols=276 Identities=29% Similarity=0.456 Sum_probs=218.2
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
|++.+.||.|++|.||+|.++.+|..||+|++.... .....+.+|+.+++.++| ++|+++++++......|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~------~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH------PNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCC------CCccCHhheeccCCeEE
Confidence 678899999999999999999999999999997543 223456789999988864 48999999999999999
Q ss_pred EEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 948 LVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
+||||+.++|..++..... ..+++..+..++.||+.||.|||+.+++|+||+|+|||++. ++.++|+|||++..
T Consensus 75 iv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~--~~~~~l~df~~~~~ 148 (283)
T cd07835 75 LVFEFLDLDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR--EGALKLADFGLARA 148 (283)
T ss_pred EEEeccCcCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC--CCcEEEeecccccc
Confidence 9999999888888765432 23889999999999999999999999999999999999995 77899999999865
Q ss_pred cCCC---cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1028 ETDH---LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1028 ~~~~---~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
.... .....+++.|+|||++.+. .++.++|+|||||++|+|++|++||...+....+.+++..++.+...++....
T Consensus 149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 149 FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred cCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence 4322 1233568889999988764 57899999999999999999999999888888777887776665544432221
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
....+.. ..............+..+..+.+||.+||+.+|.+|||+.++|+||||
T Consensus 229 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 229 SLPDYKP---------------TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hchhhhh---------------hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1111000 000000111122345567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.84 Aligned_cols=284 Identities=28% Similarity=0.493 Sum_probs=222.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+..+|.+.+.||.|+||.||+|++..+++.||||.+... .........|+.+++.+.|+ ||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------ni~~~~~~~~~~ 76 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE------NVIAIKDIMPPP 76 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCC------CccchHHheecc
Confidence 356899999999999999999999999999999998753 22334566788888887654 899999988654
Q ss_pred -----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 944 -----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 944 -----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
.++|+||||+.++|..++.... .+++..+..++.||+.||.|||+.+++||||||+|||++. ++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~--~~~~k 148 (337)
T cd07858 77 HREAFNDVYIVYELMDTDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--NCDLK 148 (337)
T ss_pred cccccCcEEEEEeCCCCCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEE
Confidence 3589999999999888876432 2889999999999999999999999999999999999985 67899
Q ss_pred EecCCCccccCCC---cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1019 VIDLGSSCFETDH---LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1019 LiDFGLA~~~~~~---~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|+|||++...... .....++..|+|||++.. ..++.++|||||||++|+|++|++||.+.+....+..+...++.+
T Consensus 149 L~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 149 ICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred ECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998754332 234567889999999875 468999999999999999999999999988888888888888766
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhcccc--ccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk--~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
+...+..... ... .......+. ........+..+..+++||++||+++|++|||+.+||+|||
T Consensus 229 ~~~~~~~~~~--------~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 229 SEEDLGFIRN--------EKA-------RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred ChHHhhhcCc--------hhh-------hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 5443311000 000 000000010 01111223456889999999999999999999999999999
Q ss_pred CCCCCCC
Q 001034 1173 LSHPYEP 1179 (1182)
Q Consensus 1173 Fk~~~eP 1179 (1182)
|.....|
T Consensus 294 ~~~~~~~ 300 (337)
T cd07858 294 LASLHDP 300 (337)
T ss_pred hhhhcCc
Confidence 9876544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=340.02 Aligned_cols=243 Identities=25% Similarity=0.367 Sum_probs=194.7
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccch----hhHHHHHHHH-HHHHhcCCCCCCCcceEEEEEEEEecCeEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD----FFDQSLDEIK-LLKYVNKHDPGDKYHLLRLYDYFYYREHLLIV 949 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~----~~dq~l~Eik-ILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLV 949 (1182)
+.||.|+||.||+|++..+++.||+|++.+... ....+..|.. +++.+ .||||++++++|.....+|+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~------~h~~iv~~~~~~~~~~~~~lv 74 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL------KHPFLVGLHYSFQTAEKLYFV 74 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC------CCCCccceeeEEEcCCEEEEE
Confidence 368999999999999999999999999976431 1223334433 34444 456999999999999999999
Q ss_pred EEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 950 CELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 950 mEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
|||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 75 LDYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEG 146 (321)
T ss_pred EcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEccCCCCccC
Confidence 999986 4555444321 2788899999999999999999999999999999999984 678999999998643
Q ss_pred C---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccccc
Q 001034 1029 T---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105 (1182)
Q Consensus 1029 ~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s 1105 (1182)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+...++..+.....
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------------- 213 (321)
T cd05603 147 VEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL------------- 213 (321)
T ss_pred CCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-------------
Confidence 2 223345789999999999999999999999999999999999999998877666555531000
Q ss_pred chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH----HHHHcCCCCCC
Q 001034 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA----SDALKHPWLSH 1175 (1182)
Q Consensus 1106 ~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA----eELLqHPWFk~ 1175 (1182)
...+..+..+.+||.+||+.||.+||++ .++++||||..
T Consensus 214 -------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 214 -------------------------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred -------------------------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 0112346789999999999999999876 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.25 Aligned_cols=283 Identities=34% Similarity=0.501 Sum_probs=227.3
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC--
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE-- 944 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e-- 944 (1182)
+|++.+.||.|+||.||+|++..+++.||||++.... .....+..|+.+++.++| +||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH------ENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCC------cchhhhhhhhcccCcc
Confidence 6899999999999999999999999999999987642 334567788899888864 48999999998875
Q ss_pred ---eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 945 ---HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 945 ---~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
.+|+||+|+.++|..++.... .+++..++.++.||+.||.|||+.||+|+||||.|||++. ++.++|+|
T Consensus 75 ~~~~~~lv~e~~~~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~--~~~~~L~d 146 (330)
T cd07834 75 DFNDVYIVTELMETDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS--NCDLKICD 146 (330)
T ss_pred cccceEEEecchhhhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEcc
Confidence 899999999988887775432 3889999999999999999999999999999999999995 57899999
Q ss_pred CCCccccCCC------cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1022 LGSSCFETDH------LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1022 FGLA~~~~~~------~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
||++...... .....+++.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+..+.+..++..++.+
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9998764433 2345678899999999888 89999999999999999999999999999999999999888877
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
+...+....... ...+... ........+....+..+..+.+||.+||+++|.+|||+.++|+||||+
T Consensus 227 ~~~~~~~~~~~~------~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 293 (330)
T cd07834 227 SEEDLKFITSEK------ARNYLKS-------LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293 (330)
T ss_pred ChhHhhhccccc------hhhHHhh-------cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence 655443211000 0000000 000011122223445688999999999999999999999999999998
Q ss_pred CCCCC
Q 001034 1175 HPYEP 1179 (1182)
Q Consensus 1175 ~~~eP 1179 (1182)
....|
T Consensus 294 ~~~~~ 298 (330)
T cd07834 294 QLHDP 298 (330)
T ss_pred hhccc
Confidence 77655
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.74 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=209.6
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE-EEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD-YFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d-sFq 941 (1182)
.....|+|+++||+|.||+||+|+++.+|..+|.|.+.-. ....+....|+.+|++|+|+ |||++++ .|.
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~Hp------NIVqYy~~~f~ 89 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHP------NIVQYYAHSFI 89 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCc------hHHHHHHHhhh
Confidence 3446799999999999999999999999999999998743 34456788999999999766 8999998 666
Q ss_pred ecCe-EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh--cC--ccccccCCccEEEccCCCc
Q 001034 942 YREH-LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG--LG--LIHCDLKPENILVKSYSRC 1015 (1182)
Q Consensus 942 d~e~-LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS--~G--IIHRDIKPeNILIDs~~dG 1015 (1182)
.... ++||||++. |+|...++..+.. ...+++..++.++.|++.||..+|+ .. |+||||||.||+|+ .+|
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~--~~g 165 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT--ANG 165 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc--CCC
Confidence 6555 999999999 5777777766543 3359999999999999999999998 45 99999999999999 478
Q ss_pred eEEEecCCCccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1016 EVKVIDLGSSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
.+||.|||++++.... ..+++|||.||+||++...+|+.++|||||||++|||+.-.+||.+.+-.+++.+|-+.--
T Consensus 166 vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 166 VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 8999999999987654 3578999999999999999999999999999999999999999999999999888853211
Q ss_pred C-cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 001034 1093 P-IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164 (1182)
Q Consensus 1093 p-~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA 1164 (1182)
+ +|. ..+|..+..||..|+..||+.||+.
T Consensus 246 ~~~p~-------------------------------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 246 PPLPD-------------------------------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCcH-------------------------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 1 111 1347889999999999999999984
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.94 Aligned_cols=284 Identities=26% Similarity=0.499 Sum_probs=224.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe--
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY-- 942 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd-- 942 (1182)
.++|++.+.||.|+||.||+|.++.+++.||+|++.... ........|+.+++.+.| +||++++++|..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~ 77 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH------DNIIAIRDILRPPG 77 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCC------CCccCHHHhccccC
Confidence 478999999999999999999999999999999987542 234556678888888864 489999988864
Q ss_pred --cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 943 --REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 943 --~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
...+|+||||+.++|..++.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~ 149 (334)
T cd07855 78 ADFKDVYVVMDLMESDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE--DCELRIG 149 (334)
T ss_pred CCCceEEEEEehhhhhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEec
Confidence 35789999999988887765432 2889999999999999999999999999999999999994 7789999
Q ss_pred cCCCccccCCC-------cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1021 DLGSSCFETDH-------LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1021 DFGLA~~~~~~-------~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|||++...... ....+++..|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+...+|
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g 229 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence 99998653221 123478899999999866 4688999999999999999999999999988888888888888
Q ss_pred Ccchhhhhcccccchhhcccchhhhhhcchhhhhhcccc--ccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk--~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.++..++....... ........+. ...+....+..+..+.+||.+||+++|.+|||+.++|.|
T Consensus 230 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 230 SPSEEVLNRIGSDR---------------VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CChhHhhhhhchhh---------------HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 77766544321100 0000000010 011112234568899999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 001034 1171 PWLSHPYEPI 1180 (1182)
Q Consensus 1171 PWFk~~~eP~ 1180 (1182)
|||.....|.
T Consensus 295 ~~~~~~~~~~ 304 (334)
T cd07855 295 PFLAQYHDPD 304 (334)
T ss_pred hhhhhccCCc
Confidence 9998766554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=359.05 Aligned_cols=281 Identities=21% Similarity=0.299 Sum_probs=208.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
....|.+.+.||+|+||.||+|.+..+++.||||... .....+|+.+|++++|+ |||++++++......
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~Hp------nIv~l~~~~~~~~~~ 235 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHP------AVLALLDVRVVGGLT 235 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCC------CCCcEEEEEEECCEE
Confidence 3468999999999999999999999999999999643 23456899999998654 899999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|+||+++.++|+.++..... .+++..++.|+.||+.||.|||++|||||||||+||||+. .+.+||+|||+++
T Consensus 236 ~lv~e~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~--~~~vkL~DFGla~ 308 (461)
T PHA03211 236 CLVLPKYRSDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG--PEDICLGDFGAAC 308 (461)
T ss_pred EEEEEccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC--CCCEEEcccCCce
Confidence 99999999999988765422 3889999999999999999999999999999999999984 6779999999987
Q ss_pred ccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhhcCCc
Q 001034 1027 FETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS-------PATLLARVIGIIGPI 1094 (1182)
Q Consensus 1027 ~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d-------~~elLakIv~ilGp~ 1094 (1182)
..... ....+||+.|+|||++.+..++.++||||||||||||++|..|+.... ....+.+++...+..
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 54322 123568999999999999999999999999999999999886553311 123334444332221
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccc-cccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK-TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~-~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
...+..... ..... ..... ......+.. ......+...+..+.+||.+||++||.+|||+.|||+||||
T Consensus 389 ~~~~~~~~~---~~l~~--~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 389 VDEFPQHAG---SRLVS--QYRHR-----AARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred cccCCCCcc---hHHHH--HHHhh-----hhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 111100000 00000 00000 000001110 00111223456789999999999999999999999999999
Q ss_pred CC
Q 001034 1174 SH 1175 (1182)
Q Consensus 1174 k~ 1175 (1182)
+.
T Consensus 459 ~~ 460 (461)
T PHA03211 459 QS 460 (461)
T ss_pred CC
Confidence 75
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=327.69 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=203.0
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
+|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+.| |||++++++|......+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~~~~ 75 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS------PYIIGFYGAFFVENRIS 75 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCC------CCeeeEEEEEEECCEEE
Confidence 5889999999999999999999999999999997642 333457788888888765 48999999999999999
Q ss_pred EEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 948 LVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
+||||++++.+.... .+++..+..++.||+.||.|||+.||+|+||||+|||++. ++.++|+|||++..
T Consensus 76 lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~--~~~~~l~dfg~~~~ 144 (279)
T cd06619 76 ICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT--RGQVKLCDFGVSTQ 144 (279)
T ss_pred EEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC--CCCEEEeeCCccee
Confidence 999999986654331 1678889999999999999999999999999999999985 77899999999875
Q ss_pred cCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1028 ETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1028 ~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
... .....+++..|+|||++.+..++.++|+|||||++|+|++|..||......... ..+..+..
T Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~--------~~~~~~~~------ 210 (279)
T cd06619 145 LVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS--------LMPLQLLQ------ 210 (279)
T ss_pred cccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc--------cchHHHHH------
Confidence 433 234567899999999999999999999999999999999999999652211000 00000000
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
. .... .+ ........+..+++||.+||+.+|.+||++.++|+||||...-.+
T Consensus 211 -~---------------~~~~-~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~ 262 (279)
T cd06619 211 -C---------------IVDE-DP----PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG 262 (279)
T ss_pred -H---------------Hhcc-CC----CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence 0 0000 00 000112356889999999999999999999999999999876443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=322.56 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=202.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec----
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR---- 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~---- 943 (1182)
.++|++.+.||.|+||.||+|.+..+++.||+|++.........+..|+.+++.+. .|+||++++++|...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhc-----CCCCeeeEeeEEeecCCCC
Confidence 46799999999999999999999999999999999876555567788888888874 245999999998763
Q ss_pred --CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 944 --EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 944 --e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
..+|+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+++|+|+||||+||+++. ++.++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~--~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC--CCCEEEc
Confidence 468999999985 67776654321 23788899999999999999999999999999999999994 6779999
Q ss_pred cCCCccccCC---CcccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1021 DLGSSCFETD---HLCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1021 DFGLA~~~~~---~~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|||++..... ......+++.|+|||++. ...++.++|||||||++|+|++|..||...........+..
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~--- 230 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--- 230 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---
Confidence 9999875432 233457889999999986 34688899999999999999999999976544332222110
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.+ .........+..+.+||.+||..+|.+|||+.++++|||
T Consensus 231 ------------------------------------~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 231 ------------------------------------NP---APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred ------------------------------------CC---CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 00 000011234678999999999999999999999999999
Q ss_pred C
Q 001034 1173 L 1173 (1182)
Q Consensus 1173 F 1173 (1182)
|
T Consensus 272 ~ 272 (272)
T cd06637 272 I 272 (272)
T ss_pred C
Confidence 8
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=322.51 Aligned_cols=276 Identities=30% Similarity=0.481 Sum_probs=216.7
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--Ce
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--EH 945 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--e~ 945 (1182)
|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+.| +||+++++++... ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH------PNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccC------CCeeeheeeEecCCCCc
Confidence 688999999999999999999999999999998652 334567788999988864 4899999999988 89
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+|+||||++++|..++.... ..+++..++.++.||+.||.|||+.|++|+||+|+|||++. ++.++|+|||++
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~--~~~~~l~d~g~~ 147 (287)
T cd07840 75 IYMVFEYMDHDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN--DGVLKLADFGLA 147 (287)
T ss_pred EEEEeccccccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC--CCCEEEccccce
Confidence 99999999998888776442 13889999999999999999999999999999999999995 778999999998
Q ss_pred cccCCC----cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDH----LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~----~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+....+.++...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 148 RPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred eeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 765433 223456788999998765 458899999999999999999999999988888888887766655443322
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPM-GDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~-~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
...... .+ .......+....+...... ++..+.+||++||.++|.+||++.++++||||
T Consensus 228 ~~~~~~-~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 228 GVSKLP-WF-------------ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccch-hh-------------hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 211110 00 0000000000111111222 37899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=338.55 Aligned_cols=283 Identities=29% Similarity=0.543 Sum_probs=224.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|++++.||.|+||.||++.+..+++.||||++.... .....+..|+.+++.+.|+ ||++++++|...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~ 86 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE------NVIGLLDVFTPD 86 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCC------CccceeeeecCC
Confidence 4678999999999999999999999999999999986532 2334567889999888654 899999998765
Q ss_pred C------eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 944 E------HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 944 e------~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
. ..|+||+|++++|..++... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~--~~~~ 157 (343)
T cd07880 87 LSLDRFHDFYLVMPFMGTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE--DCEL 157 (343)
T ss_pred ccccccceEEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCE
Confidence 3 46999999977777666421 2889999999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
+|+|||++...........+++.|+|||++.+ ..++.++|+|||||++|+|++|++||...+....+..++...+..+.
T Consensus 158 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 158 KILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred EEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999999876655555678899999999876 45889999999999999999999999998888888888877776665
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhcccc--ccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk--~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
.+......... .......|. ...+....+.++..+.+||.+||+.||.+|||+.+++.||||+
T Consensus 238 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~ 302 (343)
T cd07880 238 EFVQKLQSEDA---------------KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302 (343)
T ss_pred HHHHhhcchhH---------------HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence 55433211100 000000111 0112223356678999999999999999999999999999998
Q ss_pred CCCCC
Q 001034 1175 HPYEP 1179 (1182)
Q Consensus 1175 ~~~eP 1179 (1182)
...++
T Consensus 303 ~~~~~ 307 (343)
T cd07880 303 EFHDP 307 (343)
T ss_pred hhcCc
Confidence 75443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=321.39 Aligned_cols=276 Identities=31% Similarity=0.454 Sum_probs=214.7
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe--
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH-- 945 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~-- 945 (1182)
|++.+.||.|+||.||+|++..+++.||+|+++... .....+..|+.+++.+... .|+||++++++|.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESF---EHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhcc---CCCCcceEEEEEeeccCCC
Confidence 688999999999999999998899999999997532 2233455677777777533 47799999999998876
Q ss_pred ---EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 946 ---LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 946 ---LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
+++||||+.++|.+++...... .+++..++.++.||+.||.|||+.+++|+||+|+|||++. ++.+||+||
T Consensus 78 ~~~~~l~~e~~~~~l~~~l~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~--~~~~~l~df 151 (287)
T cd07838 78 ELKLTLVFEHVDQDLATYLSKCPKP----GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS--DGQVKIADF 151 (287)
T ss_pred CceeEEEehhcccCHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEcc--CCCEEEecc
Confidence 9999999999888877654321 3889999999999999999999999999999999999995 578999999
Q ss_pred CCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1023 GSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1023 GLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
|++...... .....++..|+|||++.+..++.++|+|||||++|+|++|++||...+..+.+.+++...+.....-+.
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 152 GLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred CcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 998764332 234457888999999999999999999999999999999999999999888888887655432211100
Q ss_pred cccc-cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1101 KGRD-TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1101 ~~k~-s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.... ....+ ............+..+..+.+||.+||+.||.+||++.++|.||||
T Consensus 232 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 232 RNVSLPRSSF------------------PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCcccchhhc------------------ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0000 00000 0000001111223446789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.97 Aligned_cols=278 Identities=28% Similarity=0.486 Sum_probs=214.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch---hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~---~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+.| +||++++++|.....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH------ENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCC------cchhhHHHhcccCCe
Confidence 469999999999999999999999999999999865432 23456678888888765 489999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
.|+||||+.++++..+..... .+++..+..++.||+.||.|||+.+|+|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~--~~~~~l~dfg~~ 147 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGFA 147 (286)
T ss_pred EEEEEecCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCcEEEEeeeee
Confidence 999999999876665543321 2788999999999999999999999999999999999984 678999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
...... .....++..|+|||++.+ ..++.++|||||||++|+|++|++||......+.+..+....+.+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 226 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE- 226 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH-
Confidence 754322 223467889999999875 457889999999999999999999999888888888877666654332111
Q ss_pred ccccchhhcccchhhhhhcchhhhhh-ccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEY-LIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~-liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.+.... ....... ..+.........+..+..+.+||.+||..+|.+||++.++|+||||
T Consensus 227 ------~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 227 ------IFQKNP-------LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ------Hhccch-------HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000000 0000000 0011111222345668899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=359.02 Aligned_cols=257 Identities=25% Similarity=0.309 Sum_probs=208.6
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
...++|++.+.||+|+||+||+|++..+++.||||++.... ........|+.++..+. |++|++++..|..
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~------h~~iv~~~~~~~~ 102 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD------FFSIVKCHEDFAK 102 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC------CCcEEEeecceec
Confidence 34579999999999999999999999999999999997542 33345667777777664 4589999888764
Q ss_pred cC--------eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC
Q 001034 943 RE--------HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013 (1182)
Q Consensus 943 ~e--------~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~ 1013 (1182)
.. .+++||||+. |+|.+++...... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~-- 178 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS-- 178 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC--
Confidence 32 4789999998 4787777644322 224889999999999999999999999999999999999984
Q ss_pred CceEEEecCCCccccCC-----CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 001034 1014 RCEVKVIDLGSSCFETD-----HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~-----~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv 1088 (1182)
++.+||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 67899999999875432 2335679999999999999999999999999999999999999998887766655543
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
.... ....+..+..+.+||.+||+.||.+||++.++|
T Consensus 259 ~~~~-------------------------------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell 295 (496)
T PTZ00283 259 AGRY-------------------------------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295 (496)
T ss_pred cCCC-------------------------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 1000 001124568899999999999999999999999
Q ss_pred cCCCCCC
Q 001034 1169 KHPWLSH 1175 (1182)
Q Consensus 1169 qHPWFk~ 1175 (1182)
+|||++.
T Consensus 296 ~~p~~~~ 302 (496)
T PTZ00283 296 NMPICKL 302 (496)
T ss_pred hCHHHHH
Confidence 9999864
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=330.00 Aligned_cols=291 Identities=26% Similarity=0.329 Sum_probs=211.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|++.+.||.|+||.||++.+..++..+|+|.+... ......+.+|+++++.+.|+ ||++++++|....++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSP------YIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCC------CCCeEEEEEeeCCEE
Confidence 3699999999999999999999999999999998754 23345677899998888554 899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCC
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||+ ++++|+||||+|||++. ++.+||+|||+
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~ 146 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGV 146 (308)
T ss_pred EEEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec--CCcEEEccCCC
Confidence 999999985 6777765432 27888999999999999999997 69999999999999984 67799999999
Q ss_pred ccccCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1025 SCFETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1025 A~~~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
+..... .....++++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+ ...+........
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~ 222 (308)
T cd06615 147 SGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF----GRPVSEGEAKES 222 (308)
T ss_pred cccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhh----cCccccccccCC
Confidence 865432 234567899999999998888999999999999999999999999876644433222 111111000000
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
....... ....................... ......++.++.+||.+||..+|.+|||+.+||+||||.....+
T Consensus 223 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 223 HRPVSGH-PPDSPRPMAIFELLDYIVNEPPP-KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred cccccCC-CCCccchhhHHHHHHHHhcCCCc-cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 0000000 00000000000011111110000 01112357889999999999999999999999999999886544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=339.77 Aligned_cols=283 Identities=31% Similarity=0.576 Sum_probs=226.1
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|++.+.||.|+||.||+|++..+++.||||++... .........|+.+++.+.| +||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~ 86 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDH------ENVIGLLDVFTPA 86 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccC------CCHHHHHHHhhcc
Confidence 467899999999999999999999999999999998653 2233456678888888765 4899998887765
Q ss_pred Ce------EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 944 EH------LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 944 e~------LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
.. +|+|+||++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++. .+.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~--~~~~ 157 (343)
T cd07851 87 SSLEDFQDVYLVTHLMGADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCEL 157 (343)
T ss_pred ccccccccEEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCE
Confidence 54 9999999988888877631 2889999999999999999999999999999999999995 6779
Q ss_pred EEecCCCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
+|+|||++...........++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..++..++.++.
T Consensus 158 kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 158 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred EEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 99999999876655556678899999999865 36889999999999999999999999998888888998888887766
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccc--cccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK--TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~--~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
.++....... ...+-...+.. ..........+..+.+||++||..+|.+|||+.+||+||||.
T Consensus 238 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~ 302 (343)
T cd07851 238 ELLQKISSES---------------ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302 (343)
T ss_pred HHHhhccchh---------------HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence 5554322100 00000000000 111112234578999999999999999999999999999998
Q ss_pred CCCCC
Q 001034 1175 HPYEP 1179 (1182)
Q Consensus 1175 ~~~eP 1179 (1182)
....|
T Consensus 303 ~~~~~ 307 (343)
T cd07851 303 EYHDP 307 (343)
T ss_pred ccCCC
Confidence 76554
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.86 Aligned_cols=286 Identities=30% Similarity=0.521 Sum_probs=227.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe-
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY- 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd- 942 (1182)
+.++|++++.||.|+||.||+|.+..+++.||||++.+.. .....+..|+.+++.+.| |||++++++|..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH------ENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCC------CCeeeEeeeEecC
Confidence 5688999999999999999999999999999999886432 234566788899888865 489999999976
Q ss_pred cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 943 REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 943 ~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
...+|+||||++++|..++... .+++..+..++.||+.||.|||+.+|+||||+|.|||++. ++.++|+||
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~--~~~~~l~df 152 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE--NCDLKICDF 152 (328)
T ss_pred CCcEEEEeehhccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC--CCCEEeCcc
Confidence 4679999999988887766422 2677888899999999999999999999999999999984 678999999
Q ss_pred CCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1023 GSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1023 GLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
|++...........+++.|+|||++.+ ..++.++|||||||++|+|++|++||........+..+...++.++..+...
T Consensus 153 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 153 GLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 999866555555677889999999876 5789999999999999999999999999888888888888888887766543
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
.... ....+.. ..............+..+..+.+||++||+.+|.+|||+.++|.||||+..-.|.
T Consensus 233 ~~~~------~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 233 ICSE------NTLRFVQ-------SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred ccch------hhHHHHh-------hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 2110 0000000 0000000111122345678999999999999999999999999999997765553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=335.04 Aligned_cols=289 Identities=21% Similarity=0.257 Sum_probs=201.5
Q ss_pred EEEEeccC--CceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 873 VTEYLGSA--AFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 873 Ilk~LGkG--aFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
++++||+| +|++||++.++.+|+.||||++.... .....+.+|+.+++.++| |||++++++|.....+|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h------pniv~~~~~~~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNH------PNIVPYRATFIADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCC------CCeeeEEEEEEECCEEE
Confidence 56789999 78999999999999999999997542 333456678888887755 48999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+.+ +|.+++...... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.++|+||+...
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~--~~~~~l~~~~~~~ 149 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNL 149 (327)
T ss_pred EEEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEec--CCcEEEcccchhh
Confidence 99999985 677776543221 2788999999999999999999999999999999999984 6779999998643
Q ss_pred ccCC----------CcccccCCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1027 FETD----------HLCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1027 ~~~~----------~~ss~vGTp~YmAPEVLlg--~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........+..... +..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCc
Confidence 2211 1122356778999999976 4689999999999999999999999987555443333321 221
Q ss_pred chhhhhcccccchhh----cccchhhhhhcchhhhhhccccc--cccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1095 EQGMLAKGRDTYKYF----TKNHMLYERNQETNRLEYLIPKK--TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F----~k~~~~~er~~ets~Le~liPk~--~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
+..+ .........+ .+... ..............+.. .........++..+.+||.+||++||++|||+.+||
T Consensus 228 ~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 228 PCLL-DTTTIPAEELTMKPSRSGA-NSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred cccc-cccchhhhhcccCCcccCC-cCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 1100 0000000000 00000 00000000000000000 011112234578999999999999999999999999
Q ss_pred cCCCCCCCC
Q 001034 1169 KHPWLSHPY 1177 (1182)
Q Consensus 1169 qHPWFk~~~ 1177 (1182)
+||||+...
T Consensus 306 ~~p~f~~~~ 314 (327)
T cd08227 306 NHSFFKQIK 314 (327)
T ss_pred cChhhhhcc
Confidence 999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=325.75 Aligned_cols=279 Identities=27% Similarity=0.419 Sum_probs=214.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR- 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~- 943 (1182)
.++|++.+.||.|+||.||+|.++.+++.+|||++.... .......+|+.+++.+.|+ ||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP------NVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCC------Cccchhhheeccc
Confidence 588999999999999999999999999999999986532 1223456788999888654 899999887543
Q ss_pred -------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 944 -------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 944 -------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
..+|+||+|+.+++...+.... ..+++..++.++.||+.||.|||++||+|+||||+|||++. ++.
T Consensus 81 ~~~~~~~~~~~lv~~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~--~~~ 153 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDHDLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN--QGI 153 (311)
T ss_pred ccccccCceEEEEEecCCcCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCC
Confidence 3579999999988877765432 23899999999999999999999999999999999999994 678
Q ss_pred EEEecCCCccccCCCc--------------ccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 001034 1017 VKVIDLGSSCFETDHL--------------CSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPA 1081 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~~~--------------ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~ 1081 (1182)
++|+|||++....... ....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999986533211 223567889999998754 5889999999999999999999999998888
Q ss_pred HHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCC
Q 001034 1082 TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161 (1182)
Q Consensus 1082 elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekR 1161 (1182)
..+..+....+.++...+........... ... .......+...+...+..+.+||.+||+.||.+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 299 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEG------------VHS--FTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccc------------ccc--CCCCCccHHHHcccCChhHHHHHHHHcccCcccC
Confidence 88888877766554433222111110000 000 0000011112233456889999999999999999
Q ss_pred CCHHHHHcCCCC
Q 001034 1162 PSASDALKHPWL 1173 (1182)
Q Consensus 1162 PTAeELLqHPWF 1173 (1182)
||+.++|.||||
T Consensus 300 ~t~~ell~~~~f 311 (311)
T cd07866 300 LTASDALEHPYF 311 (311)
T ss_pred cCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=323.29 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=203.3
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe----
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY---- 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd---- 942 (1182)
..+.|++.+.||.|+||.||+|++..+++.+|+|++.........+..|+.+++.+. .|+||++++++|..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS-----HHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhc-----CCCcEEEEeeehhccccc
Confidence 347899999999999999999999999999999999876655566778888888874 34599999999863
Q ss_pred --cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 943 --REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 943 --~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
..++|+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+.+|+|+||+|+||+++. ++.++|
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~--~~~~~l 162 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE--NAEVKL 162 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEE
Confidence 4678999999986 67777654332 12778888999999999999999999999999999999994 677999
Q ss_pred ecCCCccccCC---CcccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 001034 1020 IDLGSSCFETD---HLCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1020 iDFGLA~~~~~---~~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~il 1091 (1182)
+|||++..... ......+++.|+|||++. ...++.++|+|||||++|+|++|.+||....+...+..+..
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-- 240 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-- 240 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh--
Confidence 99999865432 233457889999999986 34688899999999999999999999976554332222110
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHP 1171 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHP 1171 (1182)
. .+ .......++..+.+||++||+.||.+|||+.+||+||
T Consensus 241 -~-----------------------------------~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~ 280 (282)
T cd06636 241 -N-----------------------------------PP----PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHP 280 (282)
T ss_pred -C-----------------------------------CC----CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCC
Confidence 0 00 0001123568899999999999999999999999999
Q ss_pred CC
Q 001034 1172 WL 1173 (1182)
Q Consensus 1172 WF 1173 (1182)
||
T Consensus 281 ~~ 282 (282)
T cd06636 281 FI 282 (282)
T ss_pred CC
Confidence 98
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.37 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=204.8
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.|++.+.||.|+||+||++.+..+++.||+|++.... ........|+.+++.++|+ +|+.+++.|.....
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~------~i~~~~~~~~~~~~ 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ------FVVNLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCc------CceeEEEEEecCCE
Confidence 3788899999999999999999999999999997543 2223456788999888655 89999999999999
Q ss_pred EEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.++ |..++..... ..+++..+..++.||+.||.|||+.||+||||||+|||++. .+.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~--~~~~kl~Dfg~ 148 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDD--YGHIRISDLGL 148 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECC--CCCEEEecCCc
Confidence 99999999964 5544433221 13899999999999999999999999999999999999984 56799999999
Q ss_pred ccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1025 SCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1025 A~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
+..... ......+++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+........
T Consensus 149 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~------- 221 (285)
T cd05632 149 AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE------- 221 (285)
T ss_pred ceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-------
Confidence 865432 22345789999999999999999999999999999999999999987665444333321000000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSHP 1176 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~~ 1176 (1182)
.......+..+.+||.+||+.||.+||+ +.+++.||||...
T Consensus 222 ---------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 222 ---------------------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ---------------------------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 0011234678999999999999999999 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=313.19 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=206.0
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.|.+.+.||+|+||.||+|.+..+++.|++|.+... ......+..|+.+++.+.| |||+++++++.....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS------SYIIRYYESFLDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCC------CCeehheeeeccCCEE
Confidence 488999999999999999999999999999998753 2345567778888887755 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.+ +|.+++..... ..++...+..++.||+.||.|||+.||+|+||||+||+++. .+.++|+|||++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~--~~~~~l~df~~~ 148 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA--YDNVKIGDLGVA 148 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeC--CCCEEEcccccc
Confidence 999999975 77777765321 13888899999999999999999999999999999999994 678999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+......++.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 218 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF---------- 218 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 754432 2234678899999999999999999999999999999999999988776655554421000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
+ .....++..+.++|++||+.+|++||++.++++|||+
T Consensus 219 ---------------------------~------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 ---------------------------P------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ---------------------------C------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0 0011346789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=337.34 Aligned_cols=281 Identities=29% Similarity=0.538 Sum_probs=219.9
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|.+.+.||.|+||.||+|.++.+++.||||++.+. ......+..|+.+++.+.|+ ||++++++|...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~ 86 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE------NVIGLLDVFTSA 86 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCC------Cccchhheeccc
Confidence 357899999999999999999999999999999998753 22334567888888887654 899999998754
Q ss_pred ------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 944 ------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 944 ------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
..+|+||||+..++..+.. ..+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~--~~~~ 156 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQTDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE--DCEL 156 (342)
T ss_pred ccCCCCceEEEEecccccCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCE
Confidence 3569999999876655431 12788999999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
||+|||++...........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..++...+.++.
T Consensus 157 kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 157 KILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236 (342)
T ss_pred EEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999998766555555677899999999876 46899999999999999999999999998888888888877776554
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.+......... ..+ ...+ .......+....+..+..+++||++||+.||.+||++.+||.||||...
T Consensus 237 ~~~~~~~~~~~------~~~-----~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 237 EFVQKLEDKAA------KSY-----IKSL--PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHhcccch------HHH-----Hhhc--CCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 44332211100 000 0000 0000111222334567889999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.51 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=202.3
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-Ce
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR-EH 945 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~-e~ 945 (1182)
.|++++.||.|+||.||++.++.+++.||+|.+.... .....+..|+.+++.+.|+ +++++++.|... ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHP------NIVAYRESWEGEDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCC------CeeeeeeeecCCCCE
Confidence 4899999999999999999999999999999987542 3344567788888887654 899999988643 46
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+++ +|.+++..... ..+++..+..++.||+.||.|||+.||+|+||||+||+++. .+.++|+|||+
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~--~~~~~l~df~~ 148 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR--TNIIKVGDLGI 148 (257)
T ss_pred EEEEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec--CCcEEEecccc
Confidence 8999999985 67666654321 13789999999999999999999999999999999999984 67899999999
Q ss_pred ccccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1025 SCFETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1025 A~~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+..... ......+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------- 219 (257)
T cd08223 149 ARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--------- 219 (257)
T ss_pred eEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 875432 22345678999999999999999999999999999999999999987665554444321000
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
+ ......+..+.+||.+||+.+|.+|||+.++|+||||
T Consensus 220 ----------------------------~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 ----------------------------P------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ----------------------------C------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=326.13 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=194.1
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 877 LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
||+|+||.||+++++.+|+.||+|.+.... ........|+.+++.+.| |||++++++|....++|+||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~h------p~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS------PFIVNLAYAFESKTHLCLVMSL 74 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCC------CcEEEEEEEEecCCeEEEEEec
Confidence 699999999999999999999999996532 122344568888888755 4899999999999999999999
Q ss_pred ccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC
Q 001034 953 LKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH 1031 (1182)
Q Consensus 953 L~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~ 1031 (1182)
+.| +|..++.... ...+++..+..++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++......
T Consensus 75 ~~g~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 75 MNGGDLKYHIYNVG----ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD--QGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCCHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC--CCCEEEeeceeeeecCCC
Confidence 986 5555554322 123788889999999999999999999999999999999984 677999999998754432
Q ss_pred --cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhh
Q 001034 1032 --LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYF 1109 (1182)
Q Consensus 1032 --~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F 1109 (1182)
.....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+...
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~------------------- 209 (277)
T cd05607 149 KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR------------------- 209 (277)
T ss_pred ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH-------------------
Confidence 23456899999999999989999999999999999999999999754321111111000
Q ss_pred cccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH----HHHHcCCCCCCC
Q 001034 1110 TKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA----SDALKHPWLSHP 1176 (1182)
Q Consensus 1110 ~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA----eELLqHPWFk~~ 1176 (1182)
.+... .......++.++++||.+||++||.+||++ .+++.||||+..
T Consensus 210 --------------~~~~~------~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 210 --------------TLEDE------VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred --------------hhccc------cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 00000 000112457889999999999999999999 678899999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.69 Aligned_cols=281 Identities=26% Similarity=0.460 Sum_probs=217.0
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
...++|++.+.||.|+||.||+|.++.+++.||+|+++... ........|+.+++.++|+ ||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~------~i~~~~~~~~~ 77 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR------NIVNLKEIVTD 77 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCC------CeeeeeheecC
Confidence 45678999999999999999999999999999999997542 2234556788888888654 89999999876
Q ss_pred cC----------eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC
Q 001034 943 RE----------HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY 1012 (1182)
Q Consensus 943 ~e----------~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~ 1012 (1182)
.. ++|+||||+++++..++.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~- 151 (302)
T cd07864 78 KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN- 151 (302)
T ss_pred cchhhhccccCCcEEEEEcccCccHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-
Confidence 55 899999999998887766432 13889999999999999999999999999999999999984
Q ss_pred CCceEEEecCCCccccCCCc----ccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 001034 1013 SRCEVKVIDLGSSCFETDHL----CSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1013 ~dG~IKLiDFGLA~~~~~~~----ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakI 1087 (1182)
++.+||+|||++....... ....++..|+|||++.+. .++.++|||||||++|+|++|++||...+....+..+
T Consensus 152 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~ 230 (302)
T cd07864 152 -KGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230 (302)
T ss_pred -CCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 7789999999987643322 223457789999998654 5788999999999999999999999998888888888
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
....+.++...+....... .+.. ..........+.......+..+.+||.+||+.||.+|||+.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 296 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLP-YFNT-------------MKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA 296 (302)
T ss_pred HHHhCCCChhhcccccccc-cccc-------------cccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 8777655443322211100 0000 0000000001111223457889999999999999999999999
Q ss_pred HcCCCC
Q 001034 1168 LKHPWL 1173 (1182)
Q Consensus 1168 LqHPWF 1173 (1182)
|.||||
T Consensus 297 l~~~~~ 302 (302)
T cd07864 297 LNSPWL 302 (302)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=353.98 Aligned_cols=255 Identities=25% Similarity=0.289 Sum_probs=208.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCC-CcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHT-GMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~T-Gr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... .....+..|+.+|+.+.| ||||+++++|....+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~H------pniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDH------FGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCC------CCEeEEEEEEEECCE
Confidence 34599999999999999999998877 7889999875543 333456678888888755 489999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+||||||+.| +|.+++..... ....+++..+..++.||+.||.|||+.+|+||||||+|||++. .+.+||+|||+
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~~kL~DFgl 215 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP--TGIIKLGDFGF 215 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC--CCcEEEEeCcC
Confidence 9999999985 67666643321 1234889999999999999999999999999999999999994 67899999999
Q ss_pred ccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1025 SCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1025 A~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..++....+
T Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~------ 289 (478)
T PTZ00267 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD------ 289 (478)
T ss_pred ceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------
Confidence 9764432 33457999999999999999999999999999999999999999887776666555310000
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
.....++..+.+||.+||..||.+||++.++|.|||++.
T Consensus 290 -------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 -------------------------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -------------------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 001234678999999999999999999999999999864
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.38 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=205.6
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
++|++.+.||.|+||.||++....+++.||+|.+..... ...+.+|+.+++.++| +||++++++|....++|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~------~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDS------PYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCC------CcEeeeeeeeecCCcEEE
Confidence 579999999999999999999998899999999986654 6678889999988844 489999999999999999
Q ss_pred EEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
|+||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++. .+.++|+|||++..
T Consensus 76 ~~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~--~~~~~l~dfg~~~~ 148 (256)
T cd06612 76 VMEYCGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE--EGQAKLADFGVSGQ 148 (256)
T ss_pred EEecCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC--CCcEEEcccccchh
Confidence 9999996 6666664332 23889999999999999999999999999999999999995 67799999999876
Q ss_pred cCCCc---ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1028 ETDHL---CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1028 ~~~~~---ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
..... ....++..|+|||++.+..++.++||||||||+|+|++|++||....+......+....
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 215 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP------------- 215 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC-------------
Confidence 54332 33457889999999999999999999999999999999999998765543322221000
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.+ ........+..+.+||.+||+.||.+|||+.++|+||||
T Consensus 216 ------------------------~~----~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 216 ------------------------PP----TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ------------------------CC----CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00 000112346789999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.03 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=205.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC---
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE--- 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e--- 944 (1182)
.++|++.+.||.|+||.||+|.+..+++.+++|++.........+..|+.+++.+. .|+||++++++|....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS-----NHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhc-----CCCChheEEEEEEecCCCC
Confidence 47899999999999999999999999999999999877665677888999999874 2459999999997654
Q ss_pred ---eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 945 ---HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 945 ---~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
.+|+||||+.+ +|.+++....... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++. ++.++|+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~--~~~~~l~ 155 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKG--KRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK--NAEVKLV 155 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEcc--CCeEEEC
Confidence 48999999996 6666665433111 23889999999999999999999999999999999999984 6789999
Q ss_pred cCCCccccCC---CcccccCCCcccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1021 DLGSSCFETD---HLCSYVQSRSYRAPEVILG-----LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1021 DFGLA~~~~~---~~ss~vGTp~YmAPEVLlg-----~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|||++..... ......+++.|+|||++.. ..++.++|||||||+||+|++|++||........+.++...
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-- 233 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN-- 233 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc--
Confidence 9999865432 2234568889999999864 34778999999999999999999999876554444433210
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
+. +. .......+..+.+||.+||..||.+|||+.+|++|||
T Consensus 234 ~~-----------------------------------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 234 PP-----------------------------------PT----LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred CC-----------------------------------CC----CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 00 00 0001124678999999999999999999999999999
Q ss_pred C
Q 001034 1173 L 1173 (1182)
Q Consensus 1173 F 1173 (1182)
+
T Consensus 275 ~ 275 (275)
T cd06608 275 I 275 (275)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=321.91 Aligned_cols=276 Identities=30% Similarity=0.512 Sum_probs=218.9
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch---hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~---~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
|++.+.||.|++|.||+|.+..+++.+|+|.+..... .......|+.+++.+.|+ +|+++++++.....+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHP------NIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCC------CcchHHHhhccCCCEE
Confidence 6678899999999999999999999999999875432 345677888899888644 8999999999999999
Q ss_pred EEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 948 LVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
+||||+.+++..++.... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++. ++.++|+|||.+..
T Consensus 75 ~v~e~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~df~~~~~ 147 (283)
T cd05118 75 LVFEFMDTDLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT--EGVLKLADFGLARS 147 (283)
T ss_pred EEEeccCCCHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECC--CCcEEEeeeeeeEe
Confidence 999999998888876543 13889999999999999999999999999999999999994 67899999999865
Q ss_pred cCCCc---ccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1028 ETDHL---CSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1028 ~~~~~---ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
..... ....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+.+.++...++.+...++....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccch
Confidence 54322 234578889999999876 78999999999999999999999999988888888887776665443333221
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
...... ................+..+..+++||.+||.+||.+||++.++|.||||
T Consensus 228 ~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 228 SLARNY--------------KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhh--------------hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 110000 00000000111112234568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=361.76 Aligned_cols=292 Identities=20% Similarity=0.270 Sum_probs=207.2
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCC-CcEEEEE------------------EEeccchhhHHHHHHHHHHHHhcC
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHT-GMDVCVK------------------IIKNNKDFFDQSLDEIKLLKYVNK 924 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~T-Gr~VAVK------------------IIkk~k~~~dq~l~EikILr~L~h 924 (1182)
+..+.++|++++.||+|+||+||+|..+.. +..+++| .+.........+.+|+.+|+.++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 345668899999999999999999875432 2222222 222222334456788999988865
Q ss_pred CCCCCCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCC
Q 001034 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004 (1182)
Q Consensus 925 ~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKP 1004 (1182)
+ ||+++++++......|+||+++.++++.++....... ........++.|+.||+.||.|||++|||||||||
T Consensus 223 p------nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP 295 (501)
T PHA03210 223 E------NILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL 295 (501)
T ss_pred C------CcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 4 8999999999999999999999999888875432211 11234667888999999999999999999999999
Q ss_pred ccEEEccCCCceEEEecCCCccccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCC-CCC--
Q 001034 1005 ENILVKSYSRCEVKVIDLGSSCFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVL-FQN-- 1077 (1182)
Q Consensus 1005 eNILIDs~~dG~IKLiDFGLA~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~P-F~g-- 1077 (1182)
+|||++. ++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||+||||++|..+ |..
T Consensus 296 ~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~ 373 (501)
T PHA03210 296 ENIFLNC--DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG 373 (501)
T ss_pred HHEEECC--CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence 9999984 678999999999764332 2345799999999999999999999999999999999998754 432
Q ss_pred CCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccC
Q 001034 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1078 ~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~D 1157 (1182)
..+...+.+++..++.....+.......+.++... ........++ .+. .....+..+.+||.+||++|
T Consensus 374 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~--------~~~~~~~~~~---~~~-~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 374 GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSA--------EIDHAGHSVP---PLI-RNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred CCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhh--------hcccCccchh---hHH-HhcCCChHHHHHHHHHhccC
Confidence 34556666666555544333322111111111000 0000000000 000 01124678999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCC
Q 001034 1158 PKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1158 PekRPTAeELLqHPWFk~~ 1176 (1182)
|.+|||+.|+|.||||+..
T Consensus 442 P~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 442 WHLRPGAAELLALPLFSAE 460 (501)
T ss_pred cccCcCHHHHhhChhhhcC
Confidence 9999999999999999764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.66 Aligned_cols=286 Identities=30% Similarity=0.527 Sum_probs=223.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|.+.+.||+|+||.||++.+..+++.||+|++.... .......+|+.+++.++| +||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h------~~iv~~~~~~~~~ 88 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH------ENVIGLLDVFTPA 88 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCC------Ccccceeeeeeec
Confidence 4578999999999999999999999999999999997542 223456678888888765 4899999988643
Q ss_pred ------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 944 ------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 944 ------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
...|+|++++.++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCEL 159 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC--CCCE
Confidence 457999999988887766432 2788999999999999999999999999999999999995 6789
Q ss_pred EEecCCCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
||+|||++...........+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..++...+..+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 160 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred EEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999999876655556678999999999876 56889999999999999999999999988888888888877776655
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.+......... .. ....+. ..+. ..........+..+++||.+||++||.+||++.++|.||||+..
T Consensus 240 ~~~~~~~~~~~----------~~-~~~~~~-~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 240 ELLKKISSESA----------RN-YIQSLT-QMPK-MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHhhcccHhH----------HH-HHHHhc-ccCC-cchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 55433211100 00 000000 0000 00111122457889999999999999999999999999999976
Q ss_pred CCCC
Q 001034 1177 YEPI 1180 (1182)
Q Consensus 1177 ~eP~ 1180 (1182)
..|.
T Consensus 307 ~~~~ 310 (345)
T cd07877 307 HDPD 310 (345)
T ss_pred CCCC
Confidence 6554
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.20 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=206.4
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|++.+.||.|+||+||+|....++..+|+|++.... .....+.+|+.+++.+.| ++|+++++.+......
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH------PNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCC------CCEEEEEEEEeeCCEE
Confidence 46999999999999999999998999999999997543 245667788888887754 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+|||++.+ .|.+++..... ...+++..++.++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~--~~~~~l~df~~~ 149 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE--DGSVKIADFGVS 149 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEEcccchH
Confidence 999999986 56666654322 113788999999999999999999999999999999999995 677999999998
Q ss_pred cccCCCc-------ccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1026 CFETDHL-------CSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1026 ~~~~~~~-------ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
....... ...+++..|+|||++... .++.++|+|||||++|+|++|+.||...+....+.++.... +.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~- 225 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---PP- 225 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC---CC-
Confidence 6543321 234688999999999876 78999999999999999999999998776655444442110 00
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
. ..........+..+.+||.+||+.||.+|||+.+|++||||
T Consensus 226 ---------------------------------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 ---------------------------------S-LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ---------------------------------C-cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 00000123457889999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.43 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=201.6
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|++.+.||.|+||.||++.++.+|+.||||+++... ........|+.++.+. ..||||+++++++.....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS-----VDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHH-----cCCCCeeeeeEEEecCCcE
Confidence 46999999999999999999999999999999997643 2223444555543332 2466999999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-CccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL-GLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~-GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||++++|..++...... ...+++..++.++.||+.||.|||++ +++||||||+|||++. ++.+||+|||++
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~--~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR--NGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhcccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC--CCCEEEeecccc
Confidence 999999999988887654322 23489999999999999999999997 9999999999999984 678999999998
Q ss_pred cccCCCc--ccccCCCcccchhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhcCCcchhh
Q 001034 1026 CFETDHL--CSYVQSRSYRAPEVILG----LSYDKKIDIWSLGCILAELCTGNVLFQND-SPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1026 ~~~~~~~--ss~vGTp~YmAPEVLlg----~~yS~kSDIWSLGVILYELLTGr~PF~g~-d~~elLakIv~ilGp~Peem 1098 (1182)
....... ....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||... ...+.+..+.. +..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---- 225 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPS---- 225 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cCC----
Confidence 7543322 23467889999999865 45788999999999999999999999642 22222222210 000
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
...+ ...++.++.+||.+||..+|.+||++.++++||||...-
T Consensus 226 ----------------------------~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 226 ----------------------------PQLP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ----------------------------CCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 0000 112468899999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.81 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=208.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++.+.||.|+||.||+|.+..+++.||+|.+.+.. .....+..|+.+++.+.| ++|+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH------PFLPTLYASFQTET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCC------CCchhheeeeecCC
Confidence 36999999999999999999999999999999998653 234456778888888764 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..|+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+.|++|+||||+|||++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg 148 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE--SGHIMLSDFD 148 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC--CCCEEEeecc
Confidence 99999999985 67776653321 23889999999999999999999999999999999999995 6779999999
Q ss_pred CccccCCC--------------------------------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhC
Q 001034 1024 SSCFETDH--------------------------------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071 (1182)
Q Consensus 1024 LA~~~~~~--------------------------------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTG 1071 (1182)
++...... .....|+..|+|||++.+..++.++|||||||++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 87543211 1134678899999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHH
Q 001034 1072 NVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVA 1151 (1182)
Q Consensus 1072 r~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIr 1151 (1182)
..||.+.+....+..+...... .+ .....+..+.+||.
T Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~-----------------------------------~~-------~~~~~~~~~~~li~ 266 (316)
T cd05574 229 TTPFKGSNRDETFSNILKKEVT-----------------------------------FP-------GSPPVSSSARDLIR 266 (316)
T ss_pred CCCCCCCchHHHHHHHhcCCcc-----------------------------------CC-------CccccCHHHHHHHH
Confidence 9999887766655554310000 00 01124688999999
Q ss_pred HhcccCCCCCCC----HHHHHcCCCCCCC
Q 001034 1152 HLLEINPKKRPS----ASDALKHPWLSHP 1176 (1182)
Q Consensus 1152 kMLq~DPekRPT----AeELLqHPWFk~~ 1176 (1182)
+||+.||.+||| +.+||.||||+..
T Consensus 267 ~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 267 KLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.55 Aligned_cols=258 Identities=29% Similarity=0.455 Sum_probs=205.7
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
..+.|++++.||.|+||.||++++..+++.||+|++.... .....+..|+.+++.+.|+ ||+++++.|.....
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~ 83 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHP------YIVKLLGAFYWDGK 83 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCC------cEeeeEEEEEeCCe
Confidence 3467999999999999999999999999999999997543 3345667788888887654 89999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+|+||||+.++.+..+..... ..+++..+..++.||+.||.|||+.+++||||||+|||++. ++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~dfg~~ 157 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL--DGDIKLADFGVS 157 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC--CCCEEEccCccc
Confidence 999999999765543322211 12788999999999999999999999999999999999984 678999999988
Q ss_pred cccCCC---cccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
...... .....+++.|+|||++. ...++.++|||||||++|+|++|.+||...+....+.++.....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 233 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP---- 233 (292)
T ss_pred eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc----
Confidence 653222 23456788999999985 345788999999999999999999999876665544443211000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
........+..+.+||.+||..+|.+||++.++|+||||+...
T Consensus 234 -------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 234 -------------------------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred -------------------------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0001123467899999999999999999999999999998653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=334.41 Aligned_cols=282 Identities=24% Similarity=0.402 Sum_probs=212.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR-- 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~-- 943 (1182)
+.++|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+|+.+++.++|+ ||+++++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~------~i~~~~~~~~~~~~ 76 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHD------NIVKVYEVLGPSGS 76 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCC------cchhhHhhhccccc
Confidence 3578999999999999999999999999999999986543 3345677899999888654 899998766543
Q ss_pred ------------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc
Q 001034 944 ------------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011 (1182)
Q Consensus 944 ------------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs 1011 (1182)
..+|+||||+.++|..++... .+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~ 149 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYMETDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT 149 (342)
T ss_pred ccccccccccccceEEEEeecccccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC
Confidence 368999999998887776432 2788999999999999999999999999999999999974
Q ss_pred CCCceEEEecCCCccccCCC------cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001034 1012 YSRCEVKVIDLGSSCFETDH------LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLL 1084 (1182)
Q Consensus 1012 ~~dG~IKLiDFGLA~~~~~~------~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elL 1084 (1182)
.++.+||+|||++...... .....++..|+|||++.. ..++.++|||||||++|+|++|+.||...++...+
T Consensus 150 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 150 -EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred -CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 3567999999998754321 122357889999998764 56889999999999999999999999988877777
Q ss_pred HHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 001034 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164 (1182)
Q Consensus 1085 akIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA 1164 (1182)
..+............... ....... ......+.........+..+.++++||++||++||.+|||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~------~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 294 (342)
T cd07854 229 QLILESVPVVREEDRNEL------LNVIPSF--------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294 (342)
T ss_pred HHHHHhcCCCChHHhhhh------hhhhhhh--------hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH
Confidence 666544332221111100 0000000 00000011111222334567899999999999999999999
Q ss_pred HHHHcCCCCCCC
Q 001034 1165 SDALKHPWLSHP 1176 (1182)
Q Consensus 1165 eELLqHPWFk~~ 1176 (1182)
.+||.||||+..
T Consensus 295 ~ell~h~~~~~~ 306 (342)
T cd07854 295 EEALMHPYMSCY 306 (342)
T ss_pred HHHhCCCccccc
Confidence 999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=319.20 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=204.2
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec---
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--- 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--- 943 (1182)
..++|.+.+.||.|+||.||+|.+..+++.+|+|++.........+..|+.+++.+. .|+||++++++|...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~-----~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEEecccc
Confidence 468899999999999999999999999999999999765544556677888888774 256999999998754
Q ss_pred --CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 944 --EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 944 --e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
..+|+||||+.+ +|.+++....... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++. .+.+||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~--~~~~kl~ 170 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICG--QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGVKLV 170 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEe
Confidence 368999999985 6767665432111 23788999999999999999999999999999999999984 6679999
Q ss_pred cCCCccccCCC---cccccCCCcccchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1021 DLGSSCFETDH---LCSYVQSRSYRAPEVILGL-----SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1021 DFGLA~~~~~~---~ss~vGTp~YmAPEVLlg~-----~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|||++...... .....++..|+|||++... .++.++|||||||++|+|++|++||........+..+...
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-- 248 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN-- 248 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC--
Confidence 99998754321 2345678899999998643 3688999999999999999999999876655444443210
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
+.+ .. ......+..+.+||.+||+++|.+||++.+||+|||
T Consensus 249 ~~~-----------------------------------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~ 289 (291)
T cd06639 249 PPP-----------------------------------TL----LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289 (291)
T ss_pred CCC-----------------------------------CC----CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence 000 00 001123567999999999999999999999999999
Q ss_pred CC
Q 001034 1173 LS 1174 (1182)
Q Consensus 1173 Fk 1174 (1182)
|+
T Consensus 290 ~~ 291 (291)
T cd06639 290 IK 291 (291)
T ss_pred cC
Confidence 95
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=319.75 Aligned_cols=275 Identities=31% Similarity=0.458 Sum_probs=221.3
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
|++.+.||.|+||.||+|+...+++.||+|++... .........|+.+++.+.| ++|+++++++.....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~------~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH------PNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCC------CCHHHHHhhhhcCCceE
Confidence 67788999999999999999999999999999864 3334566778888888764 48999999999999999
Q ss_pred EEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 948 LVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
+||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+||||+|+||+++. ++.++|+|||++..
T Consensus 75 ~v~e~~~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~--~~~~~l~d~g~~~~ 147 (282)
T cd07829 75 LVFEYCDMDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR--DGVLKLADFGLARA 147 (282)
T ss_pred EEecCcCcCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC--CCCEEEecCCcccc
Confidence 999999999988887643 12889999999999999999999999999999999999995 67899999999875
Q ss_pred cCCC---cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1028 ETDH---LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1028 ~~~~---~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
.... ......+..|+|||.+.+. .++.++|+|||||++|+|++|++||.+.+....+.++...++.+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhc
Confidence 4332 2234557789999999876 78999999999999999999999999999888899988888766655544332
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
... .+... +............+..+..+.+||++||..||.+||++.+++.||||
T Consensus 228 ~~~-~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 228 KLP-DYKPT--------------FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccc-ccccc--------------ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 211 00000 00000111122234457899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.87 Aligned_cols=252 Identities=29% Similarity=0.412 Sum_probs=208.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|++.+.||.|+||.||++++..+++.||+|++.... .....+.+|+.+++.+.| +||++++++|.....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS------PYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCC------CCeeeeeEEEEECCeE
Confidence 47889999999999999999999999999999997643 334566788888888864 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+|+||+.+ +|.+++... .+++..++.++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~ 145 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE--EGDVKLADFGVS 145 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEcccccc
Confidence 999999986 677666533 3889999999999999999999999999999999999995 778999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|.+||...++......+.....
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---------- 215 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP---------- 215 (274)
T ss_pred eeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC----------
Confidence 765432 3345778899999999998899999999999999999999999987665544433321000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
+. + ....++..+.+||.+||..+|.+|||+.++++||||+..-
T Consensus 216 ---------------------------~~---~--~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 216 ---------------------------PS---L--EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred ---------------------------CC---C--cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 00 0 0011467899999999999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.65 Aligned_cols=255 Identities=30% Similarity=0.469 Sum_probs=206.8
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.++|++++.||.|+||.||++.+..++..+|+|++.... .....+..|+.+++.++|+ ||++++++|.....+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~ 77 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHP------NIVGLYEAYFYENKL 77 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCC------ceeEEEEEEecCCeE
Confidence 367999999999999999999998899999999997543 3345677889998888654 899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+++ +|..++..... .+++..++.++.||+.||.|||+.+|+|+||||+||+++. ++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~--~~~~~l~d~g~~ 150 (280)
T cd06611 78 WILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL--DGDVKLADFGVS 150 (280)
T ss_pred EEEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC--CCCEEEccCccc
Confidence 999999997 55555543221 3889999999999999999999999999999999999984 678999999988
Q ss_pred cccCC---CcccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1026 CFETD---HLCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1026 ~~~~~---~~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
..... ......+++.|+|||++. ...++.++|+|||||++|+|++|++||...+....+.++.... .
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~--- 225 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--P--- 225 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--C---
Confidence 65432 223456889999999985 3457889999999999999999999998876655544442100 0
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+. .......+..+.+||.+||+.+|.+||++.++|+||||...
T Consensus 226 --------------------------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 226 --------------------------------PT----LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred --------------------------------CC----cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00 00112346789999999999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=323.00 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=205.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..+|++.+.||.|+||.||++++..+++.||+|.+.... .....+..|+.+++.+.| +||+++++.|....++
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h------~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN------PNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCC------CCEeeEEEEEEeCCEE
Confidence 368999999999999999999999999999999987643 234566778888887754 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.+ +|.+++... .++...+..++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~--~~~~kl~dfg~~ 163 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 163 (296)
T ss_pred EEeecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC--CCCEEECccccc
Confidence 999999985 566665421 2778899999999999999999999999999999999984 678999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|++||...++...+..+... +.
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~--------- 233 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GT--------- 233 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CC---------
Confidence 654322 23357889999999999988999999999999999999999999877654433222100 00
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+. ......++..+.+||.+||..+|.+|||+.++|+||||...
T Consensus 234 ---------------------------~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 234 ---------------------------PE----LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ---------------------------CC----CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00 00012345789999999999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=328.62 Aligned_cols=284 Identities=31% Similarity=0.509 Sum_probs=220.6
Q ss_pred CEEEEEEeccCCceEEEEEEECCC--CcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHT--GMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR- 943 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~T--Gr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~- 943 (1182)
+|++.+.||.|+||.||++.+..+ +..||||++... .........|+.+++.+. .|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR-----GHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc-----CCCChheeeeeeeecc
Confidence 589999999999999999999888 999999998753 222445678888888874 245999999875432
Q ss_pred ---CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 944 ---EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 944 ---e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
..+|++|+++.++|..++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 76 ~~~~~~~~~~e~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~--~~~~kl~ 147 (332)
T cd07857 76 GNFNELYLYEELMEADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA--DCELKIC 147 (332)
T ss_pred ccCCcEEEEEecccCCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcC--CCCEEeC
Confidence 5689999999999888876432 2889999999999999999999999999999999999985 6789999
Q ss_pred cCCCccccCCC-------cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1021 DLGSSCFETDH-------LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1021 DFGLA~~~~~~-------~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+.+++..+|
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99998754321 223468899999998876 4689999999999999999999999999998999999999988
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.++..++........ ..... .........+....+..+..+.+||.+||++||.+|||+.+||.|||
T Consensus 228 ~~~~~~~~~~~~~~~------~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 228 TPDEETLSRIGSPKA------QNYIR-------SLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred CCCHHHHHhhhhhhH------HHHHH-------hccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 777655433211100 00000 00000011112223445789999999999999999999999999999
Q ss_pred CCCCCCC
Q 001034 1173 LSHPYEP 1179 (1182)
Q Consensus 1173 Fk~~~eP 1179 (1182)
|..-..|
T Consensus 295 ~~~~~~~ 301 (332)
T cd07857 295 LAIWHDP 301 (332)
T ss_pred hhhhcCc
Confidence 9754433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=318.00 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=201.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE-----
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY----- 941 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq----- 941 (1182)
..++|++++.||+|+||.||+|.+..+++.+|+|++.........+.+|+.+++.+. .|+||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh-----cCCCeeeeeeeeeecccC
Confidence 568999999999999999999999999999999998765444456778888888884 2459999999884
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
....+|+||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+.+|+||||||+||+++. .+.++|+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~--~~~~kl~ 166 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT--EGGVKLV 166 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECC--CCCEEEc
Confidence 34579999999985 566665432211 123788899999999999999999999999999999999995 6679999
Q ss_pred cCCCccccCC---CcccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1021 DLGSSCFETD---HLCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1021 DFGLA~~~~~---~~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|||++..... ......+++.|+|||++. +..++.++|||||||++|+|++|+.||....+...+..+...
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-- 244 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-- 244 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--
Confidence 9999875432 223456899999999985 345889999999999999999999999776543332221100
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
. .+. .......+..+.+||.+||+.||.+|||+.+||+|||
T Consensus 245 ~-----------------------------------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 245 P-----------------------------------PPT----LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred C-----------------------------------CCc----ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 0 000 0001123578999999999999999999999999999
Q ss_pred C
Q 001034 1173 L 1173 (1182)
Q Consensus 1173 F 1173 (1182)
|
T Consensus 286 ~ 286 (286)
T cd06638 286 I 286 (286)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.42 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=201.6
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
+|++.+.||+|+||.||++.+..+++.||+|++.... .....+..|+++++.++|+ ||++++++|..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~ 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP------HIIRMLGATCE 74 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCC------ceehhhceecc
Confidence 4788899999999999999999999999999997533 1345677888999888654 89999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++++||||+.+ +|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++. ....++|+|
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~-~~~~~~l~d 147 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS-TGQRLRIAD 147 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEcc
Confidence 9999999999996 5666665332 2788999999999999999999999999999999999974 233699999
Q ss_pred CCCccccCCC-------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1022 LGSSCFETDH-------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1022 FGLA~~~~~~-------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
||++...... .....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+....-
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 225 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-- 225 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc--
Confidence 9998654332 1234678899999999988999999999999999999999999975443222222210000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
...........+..+.+||.+||..+|.+|||+.++|+||||+
T Consensus 226 -------------------------------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 226 -------------------------------------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred -------------------------------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0000011123468899999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=314.43 Aligned_cols=247 Identities=28% Similarity=0.418 Sum_probs=200.6
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
+|.+...||.|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+.| |||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~ 74 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH------ENIVQYLGS 74 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCC------CCeeeEEEE
Confidence 4778899999999999999999999999999886532 122456678888888854 489999999
Q ss_pred EEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
+....++++||||+++ +|..++.... .+++..+..++.||+.||.|||++|++||||+|+|||++. ++.++
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~--~~~~~ 146 (267)
T cd06628 75 SLDADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN--KGGIK 146 (267)
T ss_pred EEeCCccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC--CCCEE
Confidence 9999999999999986 6666665432 2788899999999999999999999999999999999984 67799
Q ss_pred EecCCCccccCCC---------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 001034 1019 VIDLGSSCFETDH---------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089 (1182)
Q Consensus 1019 LiDFGLA~~~~~~---------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ 1089 (1182)
|+|||++...... .....++..|+|||++.+..++.++|+|||||++|+|++|+.||...+....+.++..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence 9999998754321 1134578899999999998899999999999999999999999987654433333211
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ..+ ......+..+.+||++||+.||.+||++.++++
T Consensus 227 ~-------------------------------------~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 N-------------------------------------ASP------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c-------------------------------------CCC------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 000 011234688999999999999999999999999
Q ss_pred CCCC
Q 001034 1170 HPWL 1173 (1182)
Q Consensus 1170 HPWF 1173 (1182)
||||
T Consensus 264 ~~~~ 267 (267)
T cd06628 264 HPFL 267 (267)
T ss_pred CCCC
Confidence 9998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=310.45 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=208.9
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+|++++.||.|+||.||++++..+++.+++|.+... ......+.+|+.+++.++| +||++++++|.....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h------~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH------PNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCC------CCeeEEEeEEecCCeE
Confidence 599999999999999999999999999999998653 2334567789999998854 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~--~~~~kl~d~~~~ 148 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK--AGLIKLGDFGIS 148 (256)
T ss_pred EEEEEecCCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeC--CCCEEECcCcce
Confidence 999999985 7887776542 123788999999999999999999999999999999999984 677999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... .....+++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+.+..+.. +.++
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~------- 219 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYT------- 219 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCC-------
Confidence 754332 2345789999999999988899999999999999999999999988777666665531 0000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
......+..+.+||.+||+.+|.+||++.++|+||||
T Consensus 220 ----------------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 ----------------------------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ----------------------------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0012346789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.79 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=205.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|++++.||.|+||.||+|.+..+++.||+|.++.. ......+.+|+.+++.+.| +||+++++.|.....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~------~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS------PYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCC------CcHHhhhhheecCCeE
Confidence 3689999999999999999999999999999998753 2334567788899888765 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCC
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
|+||||+++ +|..++..... ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++. ++.++|+|||+
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~ 149 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG--NGQVKLCDFGV 149 (286)
T ss_pred EEEEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC--CCCEEEeecCC
Confidence 999999997 45555443211 1238999999999999999999996 69999999999999995 67899999999
Q ss_pred ccccCC-CcccccCCCcccchhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1025 SCFETD-HLCSYVQSRSYRAPEVILGL------SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1025 A~~~~~-~~ss~vGTp~YmAPEVLlg~------~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
+..... ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||........+..+..+....+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 227 (286)
T cd06622 150 SGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP-- 227 (286)
T ss_pred cccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC--
Confidence 865432 23345678899999998654 358899999999999999999999976554443333321111000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
....+.++.++.+||.+||+.+|.+||++.+++.||||....
T Consensus 228 --------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 228 --------------------------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred --------------------------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 001123578899999999999999999999999999997664
Q ss_pred CC
Q 001034 1178 EP 1179 (1182)
Q Consensus 1178 eP 1179 (1182)
.+
T Consensus 270 ~~ 271 (286)
T cd06622 270 NA 271 (286)
T ss_pred CC
Confidence 43
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.60 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=200.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.++|.+.+.||.|+||.||+|++..+++.||+|+++... .....+.+|+.+++.+.| |||+++++++.....+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h------~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH------SNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCC------CCeeeEEEEEEeCCEE
Confidence 357888899999999999999999999999999997653 223456678888887754 5899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+++ +|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++. ++.++|+|||++
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~--~~~~~l~dfg~~ 153 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD--NGHVKLADFGVS 153 (267)
T ss_pred EEEEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECcceee
Confidence 999999985 6777665432 2889999999999999999999999999999999999984 677999999998
Q ss_pred cccCCC---cccccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
...... .....+++.|+|||++. ...++.++|+|||||++|+|++|.+||....+...+..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-------- 225 (267)
T cd06645 154 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN-------- 225 (267)
T ss_pred eEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC--------
Confidence 654332 23457899999999985 4568899999999999999999999997655433222221000
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
...+.. .....++..+.+||.+||..+|++|||+.+||+|||
T Consensus 226 ---------------------------~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 226 ---------------------------FQPPKL----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ---------------------------CCCCcc----cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000000 001134678999999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=319.57 Aligned_cols=254 Identities=28% Similarity=0.454 Sum_probs=203.5
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIV 949 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLV 949 (1182)
|++++.||.|+||.||++.+..++..+++|.+.... .....+..|+.+++.+.| +||++++++|......|+|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h------~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH------PNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCC------CCeeeEEEEEeeCCEEEEE
Confidence 678889999999999999999999999999997543 344567778888888754 4899999999999999999
Q ss_pred EEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 950 CELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 950 mEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
|||+.++.+..+..... ..+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 81 IEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL--DGDIKLADFGVSAKNT 154 (282)
T ss_pred EEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcc--CCCEEEcccccccccc
Confidence 99999765544322211 13888999999999999999999999999999999999984 6779999999986543
Q ss_pred CC---cccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1030 DH---LCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1030 ~~---~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
.. .....+++.|+|||++. +..++.++|||||||++|+|++|.+||...+....+..+.....+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------- 227 (282)
T cd06643 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------- 227 (282)
T ss_pred ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-------
Confidence 22 23456889999999984 4457889999999999999999999998877655554443111100
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
. .....++..+.+||.+||..||.+||++.++|+||||+...
T Consensus 228 ---------------------------~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 228 ---------------------------L-------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred ---------------------------C-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 0 00112467899999999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.19 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=194.6
Q ss_pred cCCEEEEEEeccCCceEEEEEEE-----CCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHD-----LHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkD-----k~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|++.+.||.|+||.||+|.+ ..+++.||||+++... .....+..|+.++..+. .||||++++++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~~~ 80 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG-----NHLNVVNLLGAC 80 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc-----cCcceeeEEeEe
Confidence 46899999999999999999975 3456789999997542 23456788999998884 245999999988
Q ss_pred Eec-CeEEEEEEecc-cChHHHHhhhcccC--------------------------------------------------
Q 001034 941 YYR-EHLLIVCELLK-ANLYEFHKFNRESG-------------------------------------------------- 968 (1182)
Q Consensus 941 qd~-e~LyLVmEyL~-GsLld~Lk~~~~sg-------------------------------------------------- 968 (1182)
... ..+|+||||+. |+|.+++.......
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 765 46899999998 46777776432100
Q ss_pred ------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC-----cccccC
Q 001034 969 ------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQ 1037 (1182)
Q Consensus 969 ------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vG 1037 (1182)
....+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++..... .....+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC--CCcEEEeecccccccccCcchhcccCCCC
Confidence 0123778888999999999999999999999999999999984 678999999998754321 122345
Q ss_pred CCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhh
Q 001034 1038 SRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLY 1116 (1182)
Q Consensus 1038 Tp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~ 1116 (1182)
++.|+|||++.+..++.++|||||||+||+|++ |..||.+......+...+.. +.
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~----------------------- 294 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GT----------------------- 294 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CC-----------------------
Confidence 678999999999999999999999999999997 99999875433222221100 00
Q ss_pred hhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1117 ERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1117 er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
........+..+.+||.+||+.||.+|||+.+|++
T Consensus 295 ------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 295 ------------------RMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00011234678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.85 Aligned_cols=253 Identities=27% Similarity=0.390 Sum_probs=200.1
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
...+|++.+.||+|+||.||+|.++.+++.||+|++.... .....+..|+.+++.+.| +||++++++|.....
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h------~~ii~~~~~~~~~~~ 80 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH------CNIVAYFGSYLSREK 80 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCC------CCeeeeeEEEEeCCE
Confidence 3467999999999999999999999999999999997542 334456678888887754 489999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+++ +|.+++.... .+++..+..++.||+.||.|||+.+|+||||+|+||+++. ++.++|+|||+
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~--~~~~~l~dfg~ 152 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD--NGDVKLADFGV 152 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCCEEECcCcc
Confidence 9999999985 5666665332 2788999999999999999999999999999999999984 67799999999
Q ss_pred ccccCCC---cccccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1025 SCFETDH---LCSYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1025 A~~~~~~---~ss~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
+...... .....+++.|+|||.+. ...++.++|+|||||++|+|++|+.||....+......+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------- 224 (267)
T cd06646 153 AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------- 224 (267)
T ss_pred ceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC--------
Confidence 8754322 23456888999999985 345788999999999999999999999655433222111000
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
....+.. ......+..+.+||++||..+|.+|||+.+||+|+|
T Consensus 225 ---------------------------~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 ---------------------------NFQPPKL----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ---------------------------CCCCCCC----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0000000 011234688999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=314.06 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=199.2
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
+|++.+.||.|+||+||+|.+ .+++.+|+|.+.... .....+.+|+.+++.++|. ||++++++|..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~ 73 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV------NIVQYLGTCLD 73 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCC------CEeeEeeEeec
Confidence 478889999999999999986 588999999987432 2234566788888887654 89999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++. ++.++|+|
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~l~d 145 (265)
T cd06631 74 DNTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP--NGIIKLID 145 (265)
T ss_pred CCeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECC--CCeEEecc
Confidence 9999999999986 6666665432 2788899999999999999999999999999999999984 67899999
Q ss_pred CCCccccCC---------CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1022 LGSSCFETD---------HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1022 FGLA~~~~~---------~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
||++..... ......++..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+....+
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG 225 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC
Confidence 998864321 12245678899999999998999999999999999999999999976554433322211000
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
. .+ .....++..+.+||++||..+|.+||++.++|+|||
T Consensus 226 ~-----------------------------------~~------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 226 L-----------------------------------MP------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred C-----------------------------------CC------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 0 00 011235788999999999999999999999999999
Q ss_pred C
Q 001034 1173 L 1173 (1182)
Q Consensus 1173 F 1173 (1182)
|
T Consensus 265 ~ 265 (265)
T cd06631 265 L 265 (265)
T ss_pred C
Confidence 8
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=309.27 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=206.0
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....+..|+.+++.++| ++|+++++.+.....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~------~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH------PNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCC------CchhheeeeEecCCEE
Confidence 5899999999999999999999999999999987542 334567788888888854 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
++||||+.+ +|.+++..... ..+++..+..++.||+.||.|||++||+|+||+|+||+++. ..+.+||+|||++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~-~~~~~~l~d~~~~ 149 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK-HKMVVKIGDFGIS 149 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEccCCCc
Confidence 999999986 67777754321 23788899999999999999999999999999999999984 3456899999998
Q ss_pred cccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1026 CFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1026 ~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~----------- 218 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF----------- 218 (256)
T ss_pred eecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-----------
Confidence 765433 2235678899999999988899999999999999999999999987766555444421000
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.......+..+.+||.+||..+|.+|||+.+||+||||
T Consensus 219 --------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 --------------------------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred --------------------------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00112346789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=310.72 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=205.9
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+|++.+.||.|+||.||++.+..+++.||+|.+... ......+.+|+.+++.+.| +||++++++|....+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH------PNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCC------CCeeeeEeeecCCCeE
Confidence 589999999999999999999999999999998753 2334567788888888865 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+++++|+||+|+|||++. ++.++|+|||++
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~--~~~~~l~d~~~~ 148 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTIKLGDFGIA 148 (256)
T ss_pred EEEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEEeeccce
Confidence 999999985 67776654321 23788899999999999999999999999999999999984 667999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... .....+++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+.+..++. +..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~------- 219 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSYP------- 219 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCCC-------
Confidence 754332 1234578889999999998999999999999999999999999987776665555421 0000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
......+..+.+||.+||+.+|.+||++.++|+||||
T Consensus 220 ----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 ----------------------------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ----------------------------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.30 Aligned_cols=276 Identities=34% Similarity=0.540 Sum_probs=217.3
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchh--hHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF--FDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~--~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
|++.+.||.|+||+||+|+...+++.||||.+...... .....+|+..++.+. .|++|++++++|......|+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----EHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc-----CCCCchhHHHHhhcCCcEEE
Confidence 67889999999999999999999999999998754321 123345777776664 25589999999999999999
Q ss_pred EEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 949 VCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 949 VmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
||||+.+++++++..... ..+++..+..++.||+.||.|||+++++|+||+|+||+++. .+.++|+|||++...
T Consensus 76 v~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~--~~~~~l~d~~~~~~~ 149 (283)
T cd07830 76 VFEYMEGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG--PEVVKIADFGLAREI 149 (283)
T ss_pred EEecCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC--CCCEEEeecccceec
Confidence 999998899888775431 23789999999999999999999999999999999999994 778999999998765
Q ss_pred CCC--cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccccc
Q 001034 1029 TDH--LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105 (1182)
Q Consensus 1029 ~~~--~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s 1105 (1182)
... .....++..|+|||++.. ..++.++|+||||+++|+|++|++||......+.+.++...++.+....+......
T Consensus 150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 150 RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred cCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 432 234567889999998854 45889999999999999999999999999888888888888887765544332211
Q ss_pred chhhcccchhhhhhcchhhhhhccccc--cccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1106 YKYFTKNHMLYERNQETNRLEYLIPKK--TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1106 ~k~F~k~~~~~er~~ets~Le~liPk~--~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
...+ ....+.. ..+....+..+..+++||++||+.+|.+|||+.|++.||||
T Consensus 230 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 ASKL----------------GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hccc----------------cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 1100 0011111 01112223346889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=308.25 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=204.0
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe--cC
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--RE 944 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--~e 944 (1182)
+|++++.||.|+||.||+|.+..+++.||+|++... ......+..|+.+++.+.|+ ||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHP------NIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCC------ccceeeeeeecCCCC
Confidence 589999999999999999999999999999998753 23345667788888888654 89999998864 35
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHH-----hcCccccccCCccEEEccCCCceEE
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH-----GLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLH-----S~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
.+|+||||+.+ +|..++...... ...+++..++.++.||+.||.||| +.+++|+||+|+||+++. .+.+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~--~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKE--RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA--NNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec--CCCEE
Confidence 68999999985 677777654322 223888999999999999999999 899999999999999994 67899
Q ss_pred EecCCCccccCCCc---ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1019 VIDLGSSCFETDHL---CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1019 LiDFGLA~~~~~~~---ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
|+|||++....... ....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+...+...+....
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---- 226 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK---- 226 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC----
Confidence 99999987654322 34568999999999999889999999999999999999999998876554443331000
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
........+..+.+||.+||+.+|.+|||+.+||+|||+
T Consensus 227 ---------------------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 ---------------------------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ---------------------------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 000112346789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.84 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=204.1
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..+|++++.||.|+||.||++++..+++.||+|.+.... .....+..|+.+++.+.| +||++++++|....++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h------~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN------PNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCC------CCEeeEEEEEecCCEE
Confidence 478999999999999999999999999999999997543 233456678888887654 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+++ +|..++... .+++..+..++.|++.||.|||+.||+||||||+|||++. ++.++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~--~~~~~l~Dfg~~ 162 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 162 (297)
T ss_pred EEeecccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEECcCccc
Confidence 999999986 566655421 2788899999999999999999999999999999999984 678999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|++||...++...+..+.. .+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~--------- 232 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT--------- 232 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCC---------
Confidence 654322 2245678899999999999999999999999999999999999977554322111100 000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
+. .......+..+.+||.+||..+|.+||++.++|+||||....
T Consensus 233 ---------------------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 233 ---------------------------PE----LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred ---------------------------CC----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 00 001123467889999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=309.44 Aligned_cols=253 Identities=30% Similarity=0.431 Sum_probs=204.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.++| |||+++++++.....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h------~~i~~~~~~~~~~~~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRH------PNIVAYFGSYLRRDKL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCC------CChhceEEEEEeCCEE
Confidence 367999999999999999999999999999999998653 234667788888888755 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.+ +|..++..... .+++..+..++.||+.||.|||+.+|+|+||+|+||+++. ++.++|+|||++
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~ 148 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE--DGDVKLADFGVS 148 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC--CCCEEECccccc
Confidence 999999996 56655554321 2889999999999999999999999999999999999994 677999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGL---SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~---~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
...... .....++..|+|||.+.+. .++.++|+|||||++|+|++|.+||...++......+...-.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~----- 223 (262)
T cd06613 149 AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP----- 223 (262)
T ss_pred hhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----
Confidence 754432 2345678899999999877 88999999999999999999999998776555443331100000
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
+. .......+..+.+||++||..+|..|||+.+++.|||
T Consensus 224 ------------------------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 224 ------------------------------PK----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------------------------------cc----ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00 0001123577999999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=321.67 Aligned_cols=252 Identities=29% Similarity=0.444 Sum_probs=205.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.+|++.+.||.|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.+.| +||++++++|.....+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKN------PNIVNFLDSFLVGDELF 92 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCC------CceeeeeeeEecCceEE
Confidence 57999999999999999999999999999999987543 234566778888888754 48999999999999999
Q ss_pred EEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+.++ |..++.. . .+++..+..++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||++.
T Consensus 93 lv~e~~~~~~L~~~~~~-~------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~--~~~~kl~dfg~~~ 163 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE-T------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM--DGSVKLTDFGFCA 163 (296)
T ss_pred EEEEecCCCcHHHHHHh-c------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccCccch
Confidence 999999865 4444432 1 2788999999999999999999999999999999999984 6789999999886
Q ss_pred ccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
..... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+....+..+... +. +
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~-~-------- 233 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT-P-------- 233 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC-c--------
Confidence 54322 23356788999999999988999999999999999999999999887765544333210 00 0
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.......++..+.+||++||..||.+|||+.++++||||+..
T Consensus 234 -------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 234 -------------------------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred -------------------------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 000112346789999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=355.96 Aligned_cols=250 Identities=30% Similarity=0.427 Sum_probs=213.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..|..++.||+|+||.||+|.+..+++.||+|++..+ ......+.+|+.+|..+.+. ||.++|+.|..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~------~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSP------NITEYYGSYLKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcc------hHHhhhhheeecccH
Confidence 4578889999999999999999999999999999865 35567888999999998764 899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+|+|||+.| +++++++.... +.+..+..++++++.||.|||..+.+|||||+.|||+.. .|.+||+|||.+
T Consensus 87 wiiMey~~gGsv~~lL~~~~~------~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~--~g~vkl~DfgVa 158 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNI------LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE--SGDVKLADFGVA 158 (467)
T ss_pred HHHHHHhcCcchhhhhccCCC------CccceeeeehHHHHHHhhhhhhcceecccccccceeEec--cCcEEEEeccee
Confidence 999999995 57777664432 578888899999999999999999999999999999995 588999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... ..+++|||.|||||++.+..|+.++||||||++.+||++|.+||....+...+
T Consensus 159 ~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------------------ 220 (467)
T KOG0201|consen 159 GQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------------------ 220 (467)
T ss_pred eeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------------------
Confidence 765432 36789999999999999989999999999999999999999999776653222
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
+.||+...-. .....+..|++||..||.+||+.||+|.+||+|+|++.
T Consensus 221 ------------------------flIpk~~PP~-L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 221 ------------------------FLIPKSAPPR-LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ------------------------EeccCCCCCc-cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 2233332211 11256788999999999999999999999999999987
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=371.74 Aligned_cols=266 Identities=26% Similarity=0.365 Sum_probs=210.8
Q ss_pred eCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 863 LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 863 ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
.+..+.++|++++.||.|+||+||+|+++.++..||+|++... ......+..|+.+|+.|.|+ |||+++++
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HP------NIVrl~d~ 80 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK------NIVRYIDR 80 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCC------CcCeEEEE
Confidence 4566778999999999999999999999999999999998753 23455678899999998654 89999999
Q ss_pred EEec--CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-------CccccccCCccEEE
Q 001034 940 FYYR--EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL-------GLIHCDLKPENILV 1009 (1182)
Q Consensus 940 Fqd~--e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~-------GIIHRDIKPeNILI 1009 (1182)
|... ..+||||||+.+ +|..++....... ..+++..++.|+.||+.||.|||+. +||||||||+||||
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~--g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMF--GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 8654 579999999985 7777776543221 2389999999999999999999985 49999999999999
Q ss_pred ccC---------------CCceEEEecCCCccccCCC--cccccCCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHh
Q 001034 1010 KSY---------------SRCEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCT 1070 (1182)
Q Consensus 1010 Ds~---------------~dG~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg--~~yS~kSDIWSLGVILYELLT 1070 (1182)
+.. ....+||+|||++...... ....++|+.|+|||++.+ ..++.++||||||||||+|++
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 641 2345899999998764322 234578999999999965 458899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHH
Q 001034 1071 GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFV 1150 (1182)
Q Consensus 1071 Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLI 1150 (1182)
|..||...+....+..++... |. ......+..+.+||
T Consensus 239 Gk~PF~~~~~~~qli~~lk~~--------------------------------------p~-----lpi~~~S~eL~dLI 275 (1021)
T PTZ00266 239 GKTPFHKANNFSQLISELKRG--------------------------------------PD-----LPIKGKSKELNILI 275 (1021)
T ss_pred CCCCCCcCCcHHHHHHHHhcC--------------------------------------CC-----CCcCCCCHHHHHHH
Confidence 999997654433222221000 00 01123467899999
Q ss_pred HHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1151 AHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1151 rkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
..||.++|.+||++.++|.||||+....|
T Consensus 276 ~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 276 KNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred HHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 99999999999999999999999877655
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.79 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=201.9
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+|+..+.||.|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+.|+ +|+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~------~i~~~~~~~~~~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP------NIVQYLGTEREE 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCC------CchheeeeEecC
Confidence 5778899999999999999998899999999987543 2445677888888887654 899999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
..+|+||||+++ +|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.+||+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~--~~~~kl~d~ 146 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT--NGVVKLADF 146 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccC
Confidence 999999999986 6776665432 2788899999999999999999999999999999999984 678999999
Q ss_pred CCccccCCC--cccccCCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1023 GSSCFETDH--LCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1023 GLA~~~~~~--~ss~vGTp~YmAPEVLlg~~-yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
|++...... .....+++.|+|||.+.... ++.++|+|||||++|+|++|.+||..........++...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------- 217 (258)
T cd06632 147 GMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS--------- 217 (258)
T ss_pred ccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc---------
Confidence 998754332 23456889999999998776 899999999999999999999999765543333222100
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.........++..+.+||++||+.+|.+||++.++|.||||
T Consensus 218 ---------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 218 ---------------------------------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ---------------------------------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00001122356889999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.51 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=204.4
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
+.|++++.||.|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.+.| |||+++++.|....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~------~~i~~~~~~~~~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN------PFVVSMFCSFETKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC------CCeeeeEEEEecCC
Confidence 36899999999999999999999999999999987643 223456678888887654 59999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++|+||||+.| +|..++.... .+++..+..++.||+.||.|||+.+++||||||.|||++. .+.++|+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~--~~~~~l~dfg 146 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS--MGHIKLTDFG 146 (305)
T ss_pred EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC--CCCEEEeeCC
Confidence 99999999986 5666664432 2788899999999999999999999999999999999984 6789999999
Q ss_pred CccccCCC------------------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 001034 1024 SSCFETDH------------------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLA 1085 (1182)
Q Consensus 1024 LA~~~~~~------------------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLa 1085 (1182)
++...... .....++..|+|||.+....++.++|+|||||++|+|++|..||.+....+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 87531100 012356788999999999899999999999999999999999998877766655
Q ss_pred HHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC--
Q 001034 1086 RVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-- 1163 (1182)
Q Consensus 1086 kIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-- 1163 (1182)
.+.......| . .....+..+.+||.+||+.||++||+
T Consensus 227 ~~~~~~~~~~-----------------------------------~------~~~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 227 QVISDDIEWP-----------------------------------E------GDEALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred HHHhcccCCC-----------------------------------C------ccccCCHHHHHHHHHHhccChhhccCcc
Confidence 5431111000 0 01135678999999999999999998
Q ss_pred -HHHHHcCCCCCC
Q 001034 1164 -ASDALKHPWLSH 1175 (1182)
Q Consensus 1164 -AeELLqHPWFk~ 1175 (1182)
+.++|+||||..
T Consensus 266 ~~~~ll~~~~~~~ 278 (305)
T cd05609 266 GAFEVKQHRFFLG 278 (305)
T ss_pred CHHHHHhCccccC
Confidence 899999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=313.84 Aligned_cols=252 Identities=30% Similarity=0.424 Sum_probs=203.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|++.+.||.|+||.||+|.++.+++.+|+|.+.... .....+.+|+.+++.+. ||||+++++.+.....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN------SPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC------CCchhhhheeeecCCEE
Confidence 35788899999999999999999999999999987653 33456778888888775 44899999999999999
Q ss_pred EEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCC
Q 001034 947 LIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 947 yLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++. ++.++|+|||.
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~--~~~~~l~d~g~ 147 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS--RGQIKLCDFGV 147 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC--CCCEEEeeccc
Confidence 99999999 57777766542 238889999999999999999999 99999999999999995 67899999999
Q ss_pred ccccCCC-cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhhcCCcchhh
Q 001034 1025 SCFETDH-LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS-----PATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1025 A~~~~~~-~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d-----~~elLakIv~ilGp~Peem 1098 (1182)
+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.... ....+..++. .
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~----- 219 (265)
T cd06605 148 SGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---E----- 219 (265)
T ss_pred chhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---C-----
Confidence 8654322 122678889999999999999999999999999999999999997542 1122222210 0
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
..+.. .....+..+++||.+||..||.+|||+.+++.||||+.
T Consensus 220 -----------------------------~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 220 -----------------------------PPPRL-----PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred -----------------------------CCCCC-----ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 00000 00015788999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.86 Aligned_cols=251 Identities=30% Similarity=0.438 Sum_probs=207.4
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.++..++| +||+++++++.....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES------PYVVKCYGAFYKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCC------CCeeeEEEEEccCCeE
Confidence 36899999999999999999999999999999997654 345677888888888864 4899999999999999
Q ss_pred EEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCC
Q 001034 947 LIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 947 yLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+ .+++|+||+|+||+++. ++.++|+|||+
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~--~~~~~l~df~~ 146 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS--KGEVKIADFGI 146 (264)
T ss_pred EEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC--CCCEEEccCcc
Confidence 99999999 56777766432 28899999999999999999999 99999999999999984 77899999999
Q ss_pred ccccCCCc---ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhhcCCcchhh
Q 001034 1025 SCFETDHL---CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS---PATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1025 A~~~~~~~---ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d---~~elLakIv~ilGp~Peem 1098 (1182)
+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+.. .
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~----- 218 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---G----- 218 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---C-----
Confidence 87543322 24467889999999999899999999999999999999999997753 2222222210 0
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPM-GDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~-~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.. ...... ++..+.+||.+||..+|.+||++.++|+||||+..
T Consensus 219 -----------------------------~~------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 219 -----------------------------PP------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred -----------------------------CC------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 00 001112 57899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=310.84 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=195.3
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccchh----hHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF----FDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~----~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.||.|+||.||+|.+..+++.||||++++.... ......|..++... ..|+||++++++|.....+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQ-----GESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhc-----CCCCCeeeeeeeEEcCCeEEEEE
Confidence 5689999999999999999999999999764321 11222333332221 25679999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
||+.+ +|..++.... .+++..+..++.||+.||.|||+.+++|+||+|+|||++. ++.++|+|||++....
T Consensus 77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGL 148 (260)
T ss_pred eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCcEEEeecccceecc
Confidence 99986 6666665432 2788999999999999999999999999999999999985 6779999999987543
Q ss_pred CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhh
Q 001034 1030 DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYF 1109 (1182)
Q Consensus 1030 ~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F 1109 (1182)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|.+||...+....+..+.......
T Consensus 149 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 212 (260)
T cd05611 149 E-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW--------------- 212 (260)
T ss_pred c-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC---------------
Confidence 3 234568889999999998889999999999999999999999998877666555542110000
Q ss_pred cccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH---HHHHcCCCCCCC
Q 001034 1110 TKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA---SDALKHPWLSHP 1176 (1182)
Q Consensus 1110 ~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA---eELLqHPWFk~~ 1176 (1182)
+. .....++..+.+||.+||+.+|.+||++ .|+|.||||+..
T Consensus 213 --------------------~~-----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 213 --------------------PE-----EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred --------------------CC-----cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 00 0112357889999999999999999955 799999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=313.39 Aligned_cols=248 Identities=24% Similarity=0.422 Sum_probs=205.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|.+.+.||.|+||.||++.+..+++.||+|++.+.. ........|+.+++.+. .|+||++++++|....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~-----~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-----GHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc-----cCCCchhHHHHhcCCc
Confidence 46999999999999999999999999999999997632 22345667788887775 2569999999999999
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+|||++. ++|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~--~~~~~l~df~ 147 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK--DMHIKITDFG 147 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEecCCc
Confidence 9999999995 67877776542 3899999999999999999999999999999999999984 6779999999
Q ss_pred CccccCCCc-----------------------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 001034 1024 SSCFETDHL-----------------------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080 (1182)
Q Consensus 1024 LA~~~~~~~-----------------------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~ 1080 (1182)
++....... ....++..|+|||++....++.++|+|||||++|+|++|+.||...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 986543321 234568899999999988899999999999999999999999988775
Q ss_pred HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1081 ~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
...+..+...... .....+..+.+||.+||+.+|.+
T Consensus 228 ~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~li~~~l~~~p~~ 263 (280)
T cd05581 228 YLTFQKILKLEYS--------------------------------------------FPPNFPPDAKDLIEKLLVLDPQD 263 (280)
T ss_pred HHHHHHHHhcCCC--------------------------------------------CCCccCHHHHHHHHHHhcCCHhh
Confidence 5555444211100 01123678999999999999999
Q ss_pred CCCH----HHHHcCCCC
Q 001034 1161 RPSA----SDALKHPWL 1173 (1182)
Q Consensus 1161 RPTA----eELLqHPWF 1173 (1182)
||++ .+||+||||
T Consensus 264 R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 264 RLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCcccCHHHHhcCCCC
Confidence 9999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.75 Aligned_cols=259 Identities=20% Similarity=0.277 Sum_probs=198.1
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECC----------------CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCC
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLH----------------TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPG 928 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~----------------TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l 928 (1182)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+|+.++..+.|
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h---- 78 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKD---- 78 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCC----
Confidence 35789999999999999999998532 34579999997642 334567789998888755
Q ss_pred CCcceEEEEEEEEecCeEEEEEEeccc-ChHHHHhhhcccC-------------CccccCHHHHHHHHHHHHHHHHHHHh
Q 001034 929 DKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESG-------------GEVYFTMPRLQSITIQCLEALQFLHG 994 (1182)
Q Consensus 929 ~HPnIVkL~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg-------------gel~Lse~eIr~Ia~QILsALeYLHS 994 (1182)
|||++++++|.....+|+||||+.+ +|.+++....... ....+++..+..++.||+.||.|||+
T Consensus 79 --~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 79 --PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred --CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 4899999999999999999999985 6777765432110 11236778889999999999999999
Q ss_pred cCccccccCCccEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHH
Q 001034 995 LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELC 1069 (1182)
Q Consensus 995 ~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELL 1069 (1182)
.||+||||||+|||++. .+.+||+|||++...... .....++..|+|||++....++.++|||||||++|+|+
T Consensus 157 ~~ivH~dlkp~Nill~~--~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 157 LNFVHRDLATRNCLVGE--NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CCccccCcchhheEEcC--CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999994 678999999998754322 12334578899999999989999999999999999998
Q ss_pred h--CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHH
Q 001034 1070 T--GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFI 1147 (1182)
Q Consensus 1070 T--Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~ 1147 (1182)
+ +..||...+..+.+..+...+-.... .......+.++..+.
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~ 278 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFFRDQGR------------------------------------QVYLFRPPPCPQGLY 278 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHhhhccc------------------------------------cccccCCCCCCHHHH
Confidence 6 56788877666555444211100000 000011234568899
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q 001034 1148 DFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1148 DLIrkMLq~DPekRPTAeELLq 1169 (1182)
+||.+||+.||.+|||+.+|.+
T Consensus 279 ~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 279 ELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHHHccCCchhCcCHHHHHH
Confidence 9999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.47 Aligned_cols=244 Identities=26% Similarity=0.407 Sum_probs=200.1
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 877 LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
||.|+||.||+|.+..+++.||+|++.+.. .....+..|+.+++.+.| +||+++++.+.....+|+||||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~lv~e~ 74 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNH------PFIVKLYRTFKDKKYIYMLMEY 74 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCC------CCEeeeeeeEEcCCccEEEEec
Confidence 699999999999999999999999997643 334567778888888754 4899999999999999999999
Q ss_pred ccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC
Q 001034 953 LKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH 1031 (1182)
Q Consensus 953 L~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~ 1031 (1182)
+.+ +|.+++.... .++...+..++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~--~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 75 CLGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS--NGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcC--CCCEEEeeCCcccccCcc
Confidence 974 7777775432 2788899999999999999999999999999999999984 678999999998765443
Q ss_pred --cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhcCCcchhhhhcccccch
Q 001034 1032 --LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS--PATLLARVIGIIGPIEQGMLAKGRDTYK 1107 (1182)
Q Consensus 1032 --~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d--~~elLakIv~ilGp~PeemL~~~k~s~k 1107 (1182)
.....+++.|+|||.+....++.++|+||||+++|+|++|..||.... +...+..++.....
T Consensus 147 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 212 (262)
T cd05572 147 QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK-------------- 212 (262)
T ss_pred cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC--------------
Confidence 334578899999999988889999999999999999999999998765 44444443210000
Q ss_pred hhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q 001034 1108 YFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSHP 1176 (1182)
Q Consensus 1108 ~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~~ 1176 (1182)
. ......+..+.+||.+||+.+|.+||+ +.|+++||||+..
T Consensus 213 -------------------~---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 213 -------------------L---------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred -------------------C---------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 0 001122678999999999999999999 9999999999853
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.17 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=208.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
....+|.+.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+.|+ ||++++++|.
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~------niv~~~~~~~ 85 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP------NTIEYKGCYL 85 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCC------CEEEEEEEEE
Confidence 34567999999999999999999999999999999986432 2334567888888887654 8999999999
Q ss_pred ecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 942 YREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 942 d~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
.....|+||||+.|++.+++..... .+++..+..++.||+.||.|||+.+|+|+||+|+||+++. ++.++|+|
T Consensus 86 ~~~~~~lv~e~~~g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~--~~~~kL~d 158 (307)
T cd06607 86 REHTAWLVMEYCLGSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE--PGTVKLAD 158 (307)
T ss_pred eCCeEEEEHHhhCCCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC--CCCEEEee
Confidence 9999999999999998887764432 2788999999999999999999999999999999999984 67899999
Q ss_pred CCCccccCCCcccccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1022 LGSSCFETDHLCSYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1022 FGLA~~~~~~~ss~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
||++...... ....+++.|+|||++. ...++.++||||||+++|+|++|++||.+.+....+..+... ..
T Consensus 159 fg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~---- 231 (307)
T cd06607 159 FGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS---- 231 (307)
T ss_pred cCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC----
Confidence 9998765432 3456788999999985 356889999999999999999999999877655544333100 00
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
+.. .....+..+.+||.+||..+|.+||++.+++.||||....
T Consensus 232 -------------------------------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 232 -------------------------------PTL-----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred -------------------------------CCC-----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 000 0012357899999999999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.31 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=204.2
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+|.+.+.||.|+||.||++.++.++..+|+|.+.... .....+.+|+.+++.++|+ ||+++++.+.....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~------~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP------NIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCC------ChhhhhheeccCCeE
Confidence 5899999999999999999999999999999997542 2345667888888888654 899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+|+||+.+ +|.+++..... ..+++..+..++.||+.||.|||+.+++|+||||+||+++. ....+||+|||.+
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~~l~d~~~~ 149 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK-NGMVAKLGDFGIA 149 (257)
T ss_pred EEEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC-CCCeEEecccccc
Confidence 999999975 67776654321 23788999999999999999999999999999999999985 2235799999998
Q ss_pred cccCCCc---ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDHL---CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~~---ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
....... ....+++.|+|||++....++.++|+|||||++|+|++|..||...+....+..+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~--------- 218 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG--Y--------- 218 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--c---------
Confidence 7554322 2346788999999998888999999999999999999999999876655544433200 0
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.....+..+..+.++|.+||..+|++|||+.+|++||||
T Consensus 219 --------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 --------------------------------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred --------------------------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 000112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.27 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=202.1
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.. .....+.+|+.+++.+.| |||+++++.|....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH------PFLVNLWYSFQDEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCC------CChHHHHHhhcCCCe
Confidence 4899999999999999999999999999999997643 345677788888888754 489999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.| +|..++... ..+++..+..++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~l~d~~~ 146 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE--QGHVHITDFNI 146 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC--CCCEEEeeccc
Confidence 9999999986 566665543 13888999999999999999999999999999999999984 77899999999
Q ss_pred ccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhcCCcchhhhh
Q 001034 1025 SCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA--TLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1025 A~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~--elLakIv~ilGp~PeemL~ 1100 (1182)
+...... .....++..|+|||++.+..++.++|+|||||++|+|++|..||...+.. ..+..... .
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~------- 216 (258)
T cd05578 147 ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---T------- 216 (258)
T ss_pred ccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---c-------
Confidence 8764432 23456788999999999888999999999999999999999999876531 11111100 0
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH--HHHHcCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA--SDALKHPWL 1173 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA--eELLqHPWF 1173 (1182)
.........+..+.+||.+||+.||.+||++ .++++||||
T Consensus 217 ---------------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ---------------------------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ---------------------------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0000112235889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=327.51 Aligned_cols=282 Identities=30% Similarity=0.521 Sum_probs=219.3
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHh-cCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYV-NKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L-~h~~~l~HPnIVkL~dsFq 941 (1182)
.+.++|++.+.||.|+||.||+|.+..+++.+|||.+... .........|+.+++.+ .| +||++++++|.
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h------~ni~~~~~~~~ 77 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH------PNIVKLLNVIK 77 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCC------CCccceeeeec
Confidence 4568899999999999999999999999999999988542 22334566788888888 54 48999999987
Q ss_pred ec--CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 942 YR--EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 942 d~--e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
.. ..+|+||||+.++|..++... .+.+..++.++.||+.||.|||+.||+||||||+|||++. ++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~--~~~~kl 148 (337)
T cd07852 78 AENDKDIYLVFEYMETDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKL 148 (337)
T ss_pred cCCCceEEEEecccccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEE
Confidence 54 468999999999888777542 2778888999999999999999999999999999999994 778999
Q ss_pred ecCCCccccCCC--------cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 001034 1020 IDLGSSCFETDH--------LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1020 iDFGLA~~~~~~--------~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~i 1090 (1182)
+|||++...... .....+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+......+.++...
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 228 (337)
T cd07852 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228 (337)
T ss_pred eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999998653322 223567889999998865 45789999999999999999999999998888888888877
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhh-hccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLE-YLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le-~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.+.++...+........ ...+. .............+..+..+.+||.+||+.||.+|||+.++|+
T Consensus 229 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 229 IGPPSAEDIESIKSPFA--------------ATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred hCCCCHHHHHHHHhhhH--------------HHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 77655433322110000 00000 0001111122233446889999999999999999999999999
Q ss_pred CCCCCCC
Q 001034 1170 HPWLSHP 1176 (1182)
Q Consensus 1170 HPWFk~~ 1176 (1182)
||||+..
T Consensus 295 ~~~~~~~ 301 (337)
T cd07852 295 HPYVAQF 301 (337)
T ss_pred Chhhhhh
Confidence 9999665
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=297.94 Aligned_cols=249 Identities=32% Similarity=0.512 Sum_probs=205.7
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
.|.+.+.||.|+||.||++.+..+++.+++|++..... ....+.+|+.+++.+.+ ++|++++++|......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH------PNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCC------CCEeEEEEEEecCCeEEE
Confidence 48889999999999999999998999999999977643 45677888888888864 489999999999999999
Q ss_pred EEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
|+||++ ++|.+++.... ..+++..+..++.||+.||.|||..|++|+||+|+||+++. .+.++|+|||.+..
T Consensus 75 ~~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~~~~~~ 147 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS--DGEVKLIDFGLSAQ 147 (253)
T ss_pred EEecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEcc--CCeEEEeecccccc
Confidence 999999 56766665432 13889999999999999999999999999999999999995 67899999999876
Q ss_pred cCCCc--ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccccc
Q 001034 1028 ETDHL--CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105 (1182)
Q Consensus 1028 ~~~~~--ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s 1105 (1182)
..... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+....+..+.. ...
T Consensus 148 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~----------- 214 (253)
T cd05122 148 LSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGP----------- 214 (253)
T ss_pred ccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCC-----------
Confidence 65443 456788999999999988899999999999999999999999987654444333311 000
Q ss_pred chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1106 ~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
+.. .....++..+.+||.+||+.||.+|||+.++|+|||
T Consensus 215 ------------------------~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 215 ------------------------PGL----RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------------------------CCc----CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000 001113678999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.79 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=196.7
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.|++.+.||.|+||.||+|.+..++..||+|++.... .....+.+|+.+++.+.|+ ||+++++++...
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~ 76 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE------RIVQYYGCLRDR 76 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCC------CeeeEEEEEEcC
Confidence 5889999999999999999999999999999986432 2234566788888887654 899999998763
Q ss_pred --CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 944 --EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 944 --e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
..+++||||+.+ +|.+++.... .++...++.++.||+.||.|||+++|+||||+|+||+++. ++.++|+
T Consensus 77 ~~~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~--~~~~~l~ 148 (266)
T cd06651 77 AEKTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS--AGNVKLG 148 (266)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC--CCCEEEc
Confidence 678999999985 6777665432 2788889999999999999999999999999999999984 6779999
Q ss_pred cCCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1021 DLGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1021 DFGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|||++...... .....++..|+|||++.+..++.++|+|||||++|+|++|+.||........+..+.... .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~- 226 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-T- 226 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-C-
Confidence 99998654321 123457889999999999899999999999999999999999997655433332221000 0
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
.| ......+..+.+|| +||..+|.+||++.+|++||||+
T Consensus 227 ----------------------------------~~------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ----------------------------------NP------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----------------------------------CC------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00 00112457788888 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=307.11 Aligned_cols=249 Identities=26% Similarity=0.363 Sum_probs=198.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..|++.+.||.|+||.||++.+..+++.||||.+.... .....+.+|+.+++.+.| +||+++++++..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~ 75 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH------ERIVQYYGCLRD 75 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCC------CCeeeEEeEecc
Confidence 46899999999999999999999999999999986431 223466778888888854 489999999876
Q ss_pred c--CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 943 R--EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 943 ~--e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
. ..+|+||||+++ +|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+|||++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~l 147 (265)
T cd06652 76 PMERTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS--VGNVKL 147 (265)
T ss_pred CCCceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecC--CCCEEE
Confidence 4 568999999985 6777665332 2678889999999999999999999999999999999984 678999
Q ss_pred ecCCCccccCC------CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1020 IDLGSSCFETD------HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1020 iDFGLA~~~~~------~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
+|||++..... ......++..|+|||++.+..++.++|+|||||++|+|++|+.||........+.++.. .
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~ 224 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---Q 224 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---C
Confidence 99999875332 12334678899999999988899999999999999999999999976654443333210 0
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.. .+ ......+..+.++|++||. +|.+||++.++++|||+
T Consensus 225 ~~---------------------------------~~------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 225 PT---------------------------------NP------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred CC---------------------------------CC------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 00 00 0112345788999999995 99999999999999998
Q ss_pred C
Q 001034 1174 S 1174 (1182)
Q Consensus 1174 k 1174 (1182)
.
T Consensus 265 ~ 265 (265)
T cd06652 265 H 265 (265)
T ss_pred C
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=311.54 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=202.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--C
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--E 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--e 944 (1182)
++|++.+.||.|++|.||+|.+..+++.+|+|++.... .....+.+|+.+++.+.| |||++++++|... .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS------PYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCC------CCeeeeeeEEEccCCC
Confidence 46999999999999999999999999999999997643 245667888888888755 4899999998754 4
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+||||+++ +|.+++...... ...+++..+..++.||+.||.|||+.+++|+||+|+||+++. .+.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~--~~~~~l~dfg 150 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKR--GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR--KGQVKLCDFG 150 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec--CCeEEEeecc
Confidence 79999999985 676665533221 223788899999999999999999999999999999999985 6779999999
Q ss_pred CccccCCC-cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhhcCCcchh
Q 001034 1024 SSCFETDH-LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP-----ATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1024 LA~~~~~~-~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~-----~elLakIv~ilGp~Pee 1097 (1182)
++...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||..... .+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 224 (287)
T cd06621 151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP------ 224 (287)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC------
Confidence 98654332 2234578899999999999999999999999999999999999976521 12111111000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.+............+..+.+||.+||.++|.+|||+.|+++||||+..
T Consensus 225 -------------------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 225 -------------------------------NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred -------------------------------chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 000000000001235789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=300.89 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=208.0
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+|.+.+.||.|+||.||++.+..+++.||+|++.... ........|+++++.++|+ |++++++.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHP------NIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCC------ChhheEEEEecCCEE
Confidence 5899999999999999999999999999999997643 3445677888888888644 899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
++|||++++ +|..++...... ...+++..+..++.+|+.||.|||+.|++|+||+|+||+++. .+.++|+|||++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~--~~~~~l~d~~~~ 150 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKE--GKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS--NGLVKLGDFGIS 150 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhcc--CCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC--CCcEEECCccce
Confidence 999999985 677777654321 124899999999999999999999999999999999999994 678999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 220 (258)
T cd08215 151 KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY---------- 220 (258)
T ss_pred eecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC----------
Confidence 764433 2345678899999999998999999999999999999999999987765554444321100
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.......+..+.++|.+||..+|.+|||+.++|+||||
T Consensus 221 ---------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 ---------------------------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ---------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00111346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.13 Aligned_cols=252 Identities=28% Similarity=0.421 Sum_probs=198.7
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-----------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-----------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-----------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
+|.+.+.||.|+||.||+|.+..+++.||+|.++... ...+.+..|+.+++.+. |+||+++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~ 75 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD------HLNIVQYLG 75 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC------CCCcceEEE
Confidence 5889999999999999999999999999999986421 11234566777777775 458999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
++.....+++||||+.+ +|.+++.... .++...++.++.||+.||.|||+.+++|+||+|+||+++. ++.+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~--~~~~ 147 (272)
T cd06629 76 FETTEEYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA--DGIC 147 (272)
T ss_pred EeccCCceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC--CCeE
Confidence 99999999999999985 5666665432 2788899999999999999999999999999999999984 7789
Q ss_pred EEecCCCccccCCC-----cccccCCCcccchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 001034 1018 KVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLS--YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~--yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~i 1090 (1182)
+|+|||++...... .....++..|+|||++.... ++.++|+||||+++|+|++|..||........+..+...
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK 227 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc
Confidence 99999998754322 22346788999999997654 889999999999999999999999765543332222100
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......+. ...+.++..+.+||.+||.++|.+|||+.++|+|
T Consensus 228 ---------------------------------~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 ---------------------------------RSAPPIPP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---------------------------------ccCCcCCc-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000000 1123457899999999999999999999999999
Q ss_pred CCC
Q 001034 1171 PWL 1173 (1182)
Q Consensus 1171 PWF 1173 (1182)
|||
T Consensus 270 ~~~ 272 (272)
T cd06629 270 PFI 272 (272)
T ss_pred CCC
Confidence 997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.74 Aligned_cols=246 Identities=28% Similarity=0.433 Sum_probs=201.8
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
+|++.+.||.|+||.||+++++.+++.||+|.++.. ....+....|+.+++.+.| +||+++++.|....++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH------PNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCC------CCcceEEEEEEECCEEE
Confidence 589999999999999999999999999999998653 2344566778888887754 48999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+++ ++.+++..... ..+++..+..++.||+.||.|||++||+|+||||+|||++. ++.++|+|||++.
T Consensus 75 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~ 148 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ--NGKVKLGDFGSAR 148 (255)
T ss_pred EEEeeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECC--CCcEEEcccCcce
Confidence 99999985 67776654321 13788999999999999999999999999999999999984 6779999999986
Q ss_pred ccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
..... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+....+..+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 217 (255)
T cd08219 149 LLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY----------- 217 (255)
T ss_pred eecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-----------
Confidence 54332 2345688999999999998999999999999999999999999988776555444421000
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.......+..+.+||.+||+.||.+|||+.++|.-
T Consensus 218 --------------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 --------------------------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --------------------------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00011245779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=341.59 Aligned_cols=253 Identities=27% Similarity=0.507 Sum_probs=220.8
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
.+.-||+|.+.||+|.||+|-+|.+...|+.||||.|++++ ...-++.+|++|+..|+|+ ||+.+|.+|.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHP------hII~IyEVFE 123 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHP------HIIQIYEVFE 123 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCC------ceeehhhhhc
Confidence 35678999999999999999999999999999999998764 4455678899999888765 8999999999
Q ss_pred ecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
....+.|||||.. |.|++++..++. +++.+++.|++||+.|+.|||+++++|||||.+|||+|. ++++||.
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer~~------LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~--N~NiKIA 195 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISERGS------LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQ--NNNIKIA 195 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecC--CCCeeee
Confidence 9999999999998 579999987653 999999999999999999999999999999999999995 7789999
Q ss_pred cCCCccccCCC--cccccCCCcccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1021 DLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1021 DFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS-~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|||++....+. ..++||+|-|.+||++.|.+|. +.+|.||||++||.|+.|..||.+.+...++.+|.. |.
T Consensus 196 DFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~--Ga---- 269 (668)
T KOG0611|consen 196 DFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR--GA---- 269 (668)
T ss_pred ccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc--cc----
Confidence 99999765443 5688999999999999999985 789999999999999999999999999888888831 10
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
+. .+..+..+.-||+.||..||.+|.|..++..|=|++=.|
T Consensus 270 -----------------------------Yr----------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy 310 (668)
T KOG0611|consen 270 -----------------------------YR----------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGY 310 (668)
T ss_pred -----------------------------cc----------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeeccc
Confidence 11 122346788999999999999999999999999986443
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.68 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=205.7
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.|++.+.||.|+||.||+|.+..+++.||+|+++.. ......+.+|+.+++.+.+. .|++|++++++|......|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~---~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQS---QPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccC---CCCCeeeEeeeeeeCCEEE
Confidence 478889999999999999999999999999998754 23345677889999988753 5779999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+.+ +|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++. .+.++|+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~--~~~~~l~dfg~~~ 149 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN--TGNVKLCDFGVAA 149 (277)
T ss_pred EEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC--CCCEEEccCCcee
Confidence 99999986 566655422 3788999999999999999999999999999999999995 7789999999987
Q ss_pred ccCCC---cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------ 217 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------ 217 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence 54432 234468889999999865 45789999999999999999999999765543322111000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
..+. + .....+.++.+||++||+.||.+||++.+++.||||+....+
T Consensus 218 -------------------------~~~~---~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~ 264 (277)
T cd06917 218 -------------------------KPPR---L--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT 264 (277)
T ss_pred -------------------------CCCC---C--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence 0000 0 001146789999999999999999999999999999887643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=304.29 Aligned_cols=249 Identities=31% Similarity=0.487 Sum_probs=201.6
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch---hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~---~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+|.+.+.||.|+||.||++.+..+++.||+|+++.... ....+..|+.+++.+.|. ||+++++.+.....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~------~i~~~~~~~~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHP------NLVKYYGVEVHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCC------ChhheeeeEecCCEE
Confidence 68999999999999999999999999999999986543 567788899998888654 899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
++|+||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++. .+.+||+|||++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~kl~d~g~~ 146 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH--NGVIKLGDFGCA 146 (264)
T ss_pred EEEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEcccccc
Confidence 999999985 5666655321 2778889999999999999999999999999999999995 678999999998
Q ss_pred cccCCCc-------ccccCCCcccchhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhcCCc
Q 001034 1026 CFETDHL-------CSYVQSRSYRAPEVILGLS---YDKKIDIWSLGCILAELCTGNVLFQNDS-PATLLARVIGIIGPI 1094 (1182)
Q Consensus 1026 ~~~~~~~-------ss~vGTp~YmAPEVLlg~~---yS~kSDIWSLGVILYELLTGr~PF~g~d-~~elLakIv~ilGp~ 1094 (1182)
....... ....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.... .......+.. +..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~ 224 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHK 224 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CCC
Confidence 7644321 1245688999999998766 8899999999999999999999997643 2222222110 000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
+ ..| .....+..+.+||.+||+.+|.+|||+.+++.||||
T Consensus 225 ~--------------------------------~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 225 P--------------------------------PIP-------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred C--------------------------------CCC-------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 011 112346789999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=334.34 Aligned_cols=261 Identities=27% Similarity=0.430 Sum_probs=208.9
Q ss_pred ecCCEEEE-EEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe---
Q 001034 867 IAGRYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--- 942 (1182)
Q Consensus 867 L~drYeIl-k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--- 942 (1182)
+.++|.|. ++||-|--|.|..|.++.||+.+|+|++.-.. ...+|+++....+ .|+|||.++++|..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s-----~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMAS-----GHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhc-----CCCceEEeehhhhhhcc
Confidence 34667776 67999999999999999999999999996443 4557777665554 56799999998764
Q ss_pred -cCeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-CCceEEE
Q 001034 943 -REHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-SRCEVKV 1019 (1182)
Q Consensus 943 -~e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-~dG~IKL 1019 (1182)
...+.||||.|.|+ |+.-+..+ ++..|++.++..|++||..||.|||+++|.||||||+|+|.... .+..+||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~----g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDR----GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHc----ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence 47899999999964 66655533 45569999999999999999999999999999999999999752 4568999
Q ss_pred ecCCCccccC--CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1020 IDLGSSCFET--DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1020 iDFGLA~~~~--~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
+|||+|+... ....+.|-||.|.|||++-..+|+..||+||||||||-||+|++||++..-.. ++.+
T Consensus 206 tDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----------ispg 274 (400)
T KOG0604|consen 206 TDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------ISPG 274 (400)
T ss_pred cccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----------CChh
Confidence 9999998655 44567899999999999999999999999999999999999999998754211 1111
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
|.. ........+..|.+ ..+|+.++++|+++|..+|.+|+|.++++.|||+++.
T Consensus 275 Mk~------------------rI~~gqy~FP~pEW-------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 275 MKR------------------RIRTGQYEFPEPEW-------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred HHh------------------HhhccCccCCChhH-------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 111 01112222333333 3458899999999999999999999999999999865
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=311.14 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=205.2
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
-|++++.||.|+||.||++.+..++..||||++.... .....+.+|+.+++.+.| +||+++++.|.....+|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS------PYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCC------CCEeEEEEEEEeCCeEE
Confidence 4778889999999999999999999999999986543 334556678888887754 58999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+++ +|..++... .++...+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++.
T Consensus 79 lv~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~--~~~~~l~dfg~~~ 149 (277)
T cd06641 79 IIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAG 149 (277)
T ss_pred EEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC--CCCEEEeecccce
Confidence 99999986 555555321 2788899999999999999999999999999999999984 6789999999986
Q ss_pred ccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~---------- 217 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--N---------- 217 (277)
T ss_pred ecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--C----------
Confidence 54332 22346788999999998888999999999999999999999999776554433332100 0
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
.+ .....++..+.+||.+||+.+|.+||++.++++||||......+
T Consensus 218 -------------------------~~------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~~ 263 (277)
T cd06641 218 -------------------------PP------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKT 263 (277)
T ss_pred -------------------------CC------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhcc
Confidence 00 01123467899999999999999999999999999999887654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.52 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=204.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|++++.||+|+||+||++.+..+++.||+|++... ......+.+|+.+++.+.| +||+++++++.....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS------PYIVSFYGAFLNENNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCC------CCcceEeeeEecCCEE
Confidence 5788999999999999999999999999999998754 2344667788898888754 4899999999999999
Q ss_pred EEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCC
Q 001034 947 LIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 947 yLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
|+||||++++ |..++.... .+++..++.++.+++.||.|||+ .+++||||+|+||+++. ++.++|+|||+
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~--~~~~~l~d~gl 150 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS--RGQIKLCDFGV 150 (284)
T ss_pred EEEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC--CCcEEEccCCc
Confidence 9999999964 555544321 27889999999999999999997 69999999999999984 67899999999
Q ss_pred ccccCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1025 SCFETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1025 A~~~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
+..... .....+++..|+|||++.+..++.++|+|||||++|+|++|+.||............ +..+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~-------~~~~~~--- 220 (284)
T cd06620 151 SGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD-------PMGILD--- 220 (284)
T ss_pred ccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh-------hhHHHH---
Confidence 864322 223457899999999999889999999999999999999999999865432110000 000000
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
.+ ........+. + .....+..+.+||.+||+.||.+|||+.|+++||||.....+
T Consensus 221 ----~~------------~~~~~~~~~~---~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~ 275 (284)
T cd06620 221 ----LL------------QQIVQEPPPR---L--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA 275 (284)
T ss_pred ----HH------------HHHhhccCCC---C--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 00 0000000000 0 001245789999999999999999999999999999776543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.73 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=201.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|++.+.||.|+||.||++.+..+++.||+|.+.... .....+..|+.++.++. .|+||+++++++......
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-----DCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc-----CCCCEeeeeeEEecCCcE
Confidence 34666778999999999999999999999999987543 33445677888887775 245999999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
++||||+.+++..+....... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++. ++.++|+|||++
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~ 155 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR--NGNIKLCDFGIS 155 (288)
T ss_pred EEEEecccCCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc--CCcEEEeecchh
Confidence 999999998776655432111 11238899999999999999999997 59999999999999985 677999999998
Q ss_pred cccCCC--cccccCCCcccchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDH--LCSYVQSRSYRAPEVILGL---SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~--~ss~vGTp~YmAPEVLlg~---~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
...... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||..... ....+.......+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~----- 228 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP----- 228 (288)
T ss_pred HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC-----
Confidence 654322 2334678899999999876 689999999999999999999999975431 1222211110000
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
|... ......++..+.+||.+||+.+|.+|||+.++++||||..
T Consensus 229 -----------------------------~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 229 -----------------------------PILS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred -----------------------------CcCC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 0000 0011235788999999999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.81 Aligned_cols=244 Identities=26% Similarity=0.385 Sum_probs=198.5
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcE-EEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC-
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMD-VCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE- 944 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~-VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e- 944 (1182)
...+.+.||.|+||+||++.. .|.. ||+|++.... .....+.+|+.+|..++|+ |||++++++....
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~Hp------NIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHP------NIVQFYGACTSPPG 113 (362)
T ss_pred HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCC------CeeeEEEEEcCCCC
Confidence 345556699999999999974 5666 9999997643 2256889999999998655 8999999999887
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC-ccccccCCccEEEccCCCc-eEEEec
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG-LIHCDLKPENILVKSYSRC-EVKVID 1021 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G-IIHRDIKPeNILIDs~~dG-~IKLiD 1021 (1182)
.++|||||+++ +|..++..... ..++...+..|+.+|+.||.|||+++ ||||||||+|||++. ++ ++||+|
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~----~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~--~~~~~KI~D 187 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRK----RKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDL--KGKTLKIAD 187 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcC--CCCEEEECC
Confidence 79999999995 66666655311 23999999999999999999999999 999999999999994 65 899999
Q ss_pred CCCccccCC---CcccccCCCcccchhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1022 LGSSCFETD---HLCSYVQSRSYRAPEVIL--GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1022 FGLA~~~~~---~~ss~vGTp~YmAPEVLl--g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
||+++.... ......||+.|||||++. ...|+.++||||||++||||+||..||.+..+.+....++.. +..
T Consensus 188 FGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~-~~R-- 264 (362)
T KOG0192|consen 188 FGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG-GLR-- 264 (362)
T ss_pred CccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-CCC--
Confidence 999986553 344478999999999999 669999999999999999999999999998875555554310 000
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
..+| ...+..+..||.+|+..||.+||+..+++.
T Consensus 265 ------------------------------p~~p---------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 265 ------------------------------PPIP---------KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ------------------------------CCCC---------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 0011 125688999999999999999999998764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=313.41 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=190.2
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEeccch----hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEE
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD----FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~----~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmE 951 (1182)
.||+|+||.||++.+..+++.+|+|++.+... .......+..+++.+... .|++|+.++++|.....+|+|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG---DCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhC---CCCcEeEEEEEEecCCeEEEEEe
Confidence 37999999999999999999999999976431 112234444444444332 57799999999999999999999
Q ss_pred eccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC
Q 001034 952 LLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 952 yL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~ 1030 (1182)
|+.+ +|..++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.++|+|||++.....
T Consensus 78 ~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~--~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 78 LMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSK 149 (279)
T ss_pred cCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC--CCCEEEccCCcceeccc
Confidence 9996 4555554322 2899999999999999999999999999999999999984 67899999999865432
Q ss_pred -CcccccCCCcccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhhcCCcchhhhhcccccc
Q 001034 1031 -HLCSYVQSRSYRAPEVIL-GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT--LLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1031 -~~ss~vGTp~YmAPEVLl-g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~e--lLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
......+++.|+|||.+. +..++.++|+|||||++|+|++|..||....... .+..+.
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------------ 211 (279)
T cd05633 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------------ 211 (279)
T ss_pred cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh------------------
Confidence 223457899999999987 4568999999999999999999999996532211 111110
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCC
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSH 1175 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~ 1175 (1182)
...+ .......+..+.+||.+||..||.+|| |+.++++||||+.
T Consensus 212 --------------------~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 212 --------------------LTVN-----VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred --------------------hcCC-----cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 0000 001123568899999999999999999 6999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=346.81 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=220.2
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.+.|.+++++|+|+||.+++++++...+.|++|.+.... .......+|+.+++++.|+ |||.++++|..+.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP------~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHP------NIVEYKDSFEEDG 76 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCC------CeeeeccchhcCC
Confidence 367999999999999999999999999999999998654 3334678899999987655 8999999999998
Q ss_pred e-EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 945 H-LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 945 ~-LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
. +||||+|++| ++.+.++..+ ...|++..+..|+.||+.||.|||++.|+|||||+.|||+.. ++.|||.||
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk--~~~VkLgDf 150 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTK--DKKVKLGDF 150 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccc--cCceeecch
Confidence 8 9999999996 5666666554 245999999999999999999999999999999999999995 666899999
Q ss_pred CCccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1023 GSSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1023 GLA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
|+|+..... ..+.+|||.|+.||++.+.+|+.++|||||||++|||++-+++|.+.+...++.+|+.....
T Consensus 151 GlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~------ 224 (426)
T KOG0589|consen 151 GLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS------ 224 (426)
T ss_pred hhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC------
Confidence 999876654 45789999999999999999999999999999999999999999999999999888644311
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
+....++.+++.||..||+.+|..||+|.+||.+|.+.
T Consensus 225 -------------------------------------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 225 -------------------------------------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred -------------------------------------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 12235578999999999999999999999999998875
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.68 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=191.8
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEeccchh----hHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEE
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF----FDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~----~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmE 951 (1182)
.||.|+||.||+|.+..+++.||+|++.+.... ......|..+++.+.+ ..||+|++++++|.....+|+|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh---CCCCcEeeeeeeeecCCEEEEEEe
Confidence 379999999999999999999999998764311 1223445555554443 257899999999999999999999
Q ss_pred ecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC
Q 001034 952 LLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 952 yL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~ 1030 (1182)
|+.|+ |..++.... .+++..++.++.|++.||.|||+.+|+||||||+|||++. ++.++|+|||++.....
T Consensus 78 ~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~--~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 78 LMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSK 149 (278)
T ss_pred cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC--CCCEEEccCcCccccCc
Confidence 99865 544443221 3899999999999999999999999999999999999984 67799999999864432
Q ss_pred -CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhcCCcchhhhhccccc
Q 001034 1031 -HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPA---TLLARVIGIIGPIEQGMLAKGRDT 1105 (1182)
Q Consensus 1031 -~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~---elLakIv~ilGp~PeemL~~~k~s 1105 (1182)
.....+++..|+|||++.+. .++.++|+|||||++|+|++|+.||...... .....+.
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 212 (278)
T cd05606 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------------- 212 (278)
T ss_pred cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-----------------
Confidence 23345789999999999754 6899999999999999999999999765321 1111110
Q ss_pred chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q 001034 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1106 ~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~~ 1176 (1182)
... .......+..+.+||.+||..+|.+|| ++.++++||||+..
T Consensus 213 ------------------~~~---------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 213 ------------------TMA---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred ------------------ccC---------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 000 001123478999999999999999999 99999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=320.53 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=205.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
+.|.....||.|+||.||++.+..++..||||.+.... .....+..|+.+++.+.| +||+++++.|....+.|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHH------ENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCC------CcHHHHHHheecCCeEE
Confidence 44555678999999999999999999999999986543 334456778888887754 48999999999999999
Q ss_pred EEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+.++ |..++. .. .+++..+..++.||+.||.|||+++|+||||||+||+++. ++.++|+|||++.
T Consensus 96 lv~e~~~~~~L~~~~~-~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kL~dfg~~~ 166 (292)
T cd06658 96 VVMEFLEGGALTDIVT-HT------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS--DGRIKLSDFGFCA 166 (292)
T ss_pred EEEeCCCCCcHHHHHh-cC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEccCcchh
Confidence 999999875 444432 21 2788899999999999999999999999999999999984 6779999999986
Q ss_pred ccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
..... .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+....+..+...+.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 237 (292)
T cd06658 167 QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR--------- 237 (292)
T ss_pred hcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc---------
Confidence 43222 234568899999999998899999999999999999999999998776655444432111000
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
. ......+..+.+||.+||..||.+|||+.++|+||||.....|.
T Consensus 238 -------------------------~-------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 238 -------------------------V-------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred -------------------------c-------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 0 00123467899999999999999999999999999999887664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=296.83 Aligned_cols=248 Identities=30% Similarity=0.420 Sum_probs=203.9
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--C
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--E 944 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--e 944 (1182)
+|.+.+.||.|+||.||+|.+..+++.|++|++.... .....+.+|+.+++.+.| ++|+++++.+... .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH------PNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCC------CCEeeEEEEEecCCCC
Confidence 4888999999999999999999999999999997665 346677889999998864 4899999999988 8
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++. .+.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~--~~~~~l~d~~ 146 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS--DGVVKLADFG 146 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC--CCCEEEcccc
Confidence 9999999996 56777765433 3889999999999999999999999999999999999995 6789999999
Q ss_pred CccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhcCCcchh
Q 001034 1024 SSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS-PATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1024 LA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d-~~elLakIv~ilGp~Pee 1097 (1182)
.+...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ....+..+. .
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~----- 218 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG---S----- 218 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc---c-----
Confidence 98765443 234567889999999998889999999999999999999999997655 111111110 0
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
...........+..+.+||.+||..+|.+||++.++|+||||
T Consensus 219 ----------------------------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 ----------------------------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ----------------------------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000000112236889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.61 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=218.3
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.+-..+|.++.+||+|+||+|.++..+.+.+.||||+++++. +..+-.+.|.++|..... .|++++|+..|
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~k-----ppFL~qlHScF 419 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-----PPFLVQLHSCF 419 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCC-----CchHHHHHHHh
Confidence 345678999999999999999999999999999999999864 233445566676665544 35999999999
Q ss_pred EecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 941 YYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 941 qd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
+.-..+|+||||+.|+.+.+...+-.. |.++.+.+|+.+|+-||-|||++|||+||||.+|||++. .|+|||+
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~--eGHiKi~ 492 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIA 492 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEecc--CCceEee
Confidence 999999999999998877776655322 899999999999999999999999999999999999994 8889999
Q ss_pred cCCCccc---cCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1021 DLGSSCF---ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1021 DFGLA~~---~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|||+++- ....+.++||||.|+|||++..++|+.++||||+||+|||||.|.+||.+++..++++.|+..--..|
T Consensus 493 DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP-- 570 (683)
T KOG0696|consen 493 DFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP-- 570 (683)
T ss_pred ecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc--
Confidence 9999863 44556789999999999999999999999999999999999999999999999999999963221111
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHcCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA-----SDALKHPW 1172 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA-----eELLqHPW 1172 (1182)
.-.|.++.+++..+|...|.+|+.. +++-.|||
T Consensus 571 ------------------------------------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~F 608 (683)
T KOG0696|consen 571 ------------------------------------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPF 608 (683)
T ss_pred ------------------------------------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcc
Confidence 1236789999999999999999653 57899999
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
|...
T Consensus 609 FR~i 612 (683)
T KOG0696|consen 609 FRRI 612 (683)
T ss_pred hhhc
Confidence 9753
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.31 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=202.6
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEE
Q 001034 873 VTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951 (1182)
Q Consensus 873 Ilk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmE 951 (1182)
....||.|+||.||++.+..+++.||+|++.... .....+.+|+.+++.+.| |||+++++.|......|+|||
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h------p~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH------QNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCC------CchhhhhhheeeCCeEEEEEe
Confidence 3447899999999999999999999999986532 233456677777777654 589999999999999999999
Q ss_pred ecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC-
Q 001034 952 LLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD- 1030 (1182)
Q Consensus 952 yL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~- 1030 (1182)
|+.++.+..+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.....
T Consensus 99 ~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~--~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 99 FLQGGALTDIVSQT------RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL--DGRVKLSDFGFCAQISKD 170 (297)
T ss_pred cCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc--CCcEEEeechhHhhcccc
Confidence 99965443333221 2788999999999999999999999999999999999984 67899999999864332
Q ss_pred --CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchh
Q 001034 1031 --HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKY 1108 (1182)
Q Consensus 1031 --~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~ 1108 (1182)
......+++.|+|||++.+..++.++|+|||||++|+|++|+.||........+..+.... +
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~------------- 234 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---P------------- 234 (297)
T ss_pred cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC---C-------------
Confidence 2234578899999999999899999999999999999999999998777655554432100 0
Q ss_pred hcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1109 FTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1109 F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
.........+..+.+||++||+.+|.+||++.++++||||.....|.
T Consensus 235 -------------------------~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~ 281 (297)
T cd06659 235 -------------------------PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPE 281 (297)
T ss_pred -------------------------CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence 00011123467899999999999999999999999999999887553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=311.14 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=204.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..|++++.||.|+||.||+|.+..++..||+|++.... .....+..|+.+++.+.| ++|+++++++.....+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS------PYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC------CCEeeEEEEEEECCEE
Confidence 45788889999999999999999999999999987543 344567778888887755 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.+ +|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~--~~~~~l~dfg~~ 148 (277)
T cd06640 78 WIIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE--QGDVKLADFGVA 148 (277)
T ss_pred EEEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC--CCCEEEcccccc
Confidence 999999986 666665421 2778889999999999999999999999999999999984 677999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... .....++..|+|||++.+..++.++|+|||||++|+|++|.+||....+......+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~----------- 217 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN----------- 217 (277)
T ss_pred eeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC-----------
Confidence 654322 233467888999999999899999999999999999999999998766544332221000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYE 1178 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~e 1178 (1182)
.+ ......+..+.+||.+||+.+|.+||++.++|+||||.....
T Consensus 218 --------------------------~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 218 --------------------------PP------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred --------------------------CC------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 00 011123567899999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.30 Aligned_cols=248 Identities=25% Similarity=0.321 Sum_probs=193.8
Q ss_pred CCEEEEEEe--ccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYL--GSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~L--GkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+.|.+.+.+ |.|+||.||+++++.++..+|+|++....... .|+.....+. .|+||+++++.|.....+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~-----~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMK-----DNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhh-----cCCCEEEEEEEEecCCee
Confidence 345565555 99999999999999999999999997543211 1222222221 367999999999999999
Q ss_pred EEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCc-eEEEecCCC
Q 001034 947 LIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC-EVKVIDLGS 1024 (1182)
Q Consensus 947 yLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG-~IKLiDFGL 1024 (1182)
|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++. .+ .++|+|||+
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~~l~dfg~ 156 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR--AKDRIYLCDYGL 156 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC--CCCeEEEecCcc
Confidence 99999997 57888776543 3899999999999999999999999999999999999985 44 799999999
Q ss_pred ccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhhcCCcchhhhhccc
Q 001034 1025 SCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL-LARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1025 A~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~el-LakIv~ilGp~PeemL~~~k 1103 (1182)
+...... ....++..|+|||++.+..++.++|||||||++|+|++|+.||........ ...+...
T Consensus 157 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 222 (267)
T PHA03390 157 CKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR------------- 222 (267)
T ss_pred ceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-------------
Confidence 8765433 234688999999999999999999999999999999999999975443221 1111000
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-HHHHHcCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-ASDALKHPWLSH 1175 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-AeELLqHPWFk~ 1175 (1182)
... .....+..+..+.+||.+||+.+|.+||+ +.+||+||||+.
T Consensus 223 -------------------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 223 -------------------------QQK---KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -------------------------hcc---cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 000 00111246789999999999999999996 599999999974
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.74 Aligned_cols=247 Identities=30% Similarity=0.434 Sum_probs=205.3
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+|++.+.||.|+||.||++++..+++.||+|.+.... .....+..|+.+++.+.|+ +++++++++.....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP------NIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCC------CccEEEEEEEeCCEE
Confidence 5899999999999999999999999999999998764 3556778888888888654 899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.+ +|.+++.... .+++..+..++.|++.||.|||+.||+||||+|+||+++. .+.++|+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~~l~d~~~~ 146 (254)
T cd06627 75 YIILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK--DGVVKLADFGVA 146 (254)
T ss_pred EEEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC--CCCEEEeccccc
Confidence 999999986 6766665432 2889999999999999999999999999999999999995 678999999998
Q ss_pred cccCCCc---ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDHL---CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~~---ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||........+.++.. .
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~---------- 214 (254)
T cd06627 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ--D---------- 214 (254)
T ss_pred eecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--c----------
Confidence 7654432 245678899999999888899999999999999999999999987654433333210 0
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.. .......+..+.+||.+||..+|++|||+.++|.||||
T Consensus 215 -------------------------~~------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 -------------------------DH------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------------------------CC------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 00 00112346889999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=308.55 Aligned_cols=250 Identities=20% Similarity=0.241 Sum_probs=200.8
Q ss_pred CCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
++|.+.+.||+|+||.||+|... .+++.||||+++.... ....+.+|+.+++.+.|+ ||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~ 78 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE------NIVKFYGVCT 78 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCC------CchheeeEEe
Confidence 56889999999999999999874 3468899999976432 346778899999988654 8999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcc--------cCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRE--------SGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY 1012 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~--------sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~ 1012 (1182)
....+|+||||+.+ +|.+++..... ......+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~- 157 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY- 157 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC-
Confidence 99999999999985 67777764422 111224788899999999999999999999999999999999984
Q ss_pred CCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 001034 1013 SRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLAR 1086 (1182)
Q Consensus 1013 ~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLak 1086 (1182)
++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+.+..
T Consensus 158 -~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 158 -DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred -CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 688999999998653221 123345678999999999999999999999999999998 9999988776665554
Q ss_pred HHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 001034 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASD 1166 (1182)
Q Consensus 1087 Iv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeE 1166 (1182)
+..... .......+..+.+||++||+.||.+|||+.|
T Consensus 237 ~~~~~~-------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 273 (280)
T cd05049 237 ITQGRL-------------------------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKD 273 (280)
T ss_pred HHcCCc-------------------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 421000 0011234678999999999999999999999
Q ss_pred HHc
Q 001034 1167 ALK 1169 (1182)
Q Consensus 1167 LLq 1169 (1182)
+++
T Consensus 274 il~ 276 (280)
T cd05049 274 IHE 276 (280)
T ss_pred HHH
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=309.61 Aligned_cols=248 Identities=25% Similarity=0.312 Sum_probs=196.0
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 877 LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
||.|+||+||+|.+..+++.||+|++.... .....+..|+.+++.++| |+|++++++|....++|+||||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS------RFIVSLAYAFETKDDLCLVMTL 74 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCC------CCEeeeeeEEecCCeEEEEEec
Confidence 689999999999999999999999997532 223345678888888864 4899999999999999999999
Q ss_pred ccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC
Q 001034 953 LKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH 1031 (1182)
Q Consensus 953 L~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~ 1031 (1182)
+.+ +|.+++..... ..+++..+..++.||+.||.|||+.|++|+||+|+|||++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~--~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 75 MNGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD--HGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEccCcchhhhccC
Confidence 985 66666654332 23889999999999999999999999999999999999984 677999999998754322
Q ss_pred --cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhh
Q 001034 1032 --LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYF 1109 (1182)
Q Consensus 1032 --~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F 1109 (1182)
.....++..|+|||++.+..++.++|+|||||++|+|++|+.||...........+....
T Consensus 149 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 210 (277)
T cd05577 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT------------------ 210 (277)
T ss_pred CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc------------------
Confidence 223467788999999998889999999999999999999999997654321111111000
Q ss_pred cccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q 001034 1110 TKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1110 ~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~~ 1176 (1182)
.. .........+..+.+||++||+.||.+|| ++.+|+.||||+..
T Consensus 211 -------------------~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 211 -------------------LE---MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred -------------------cc---ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence 00 00001123478899999999999999999 99999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.67 Aligned_cols=247 Identities=20% Similarity=0.261 Sum_probs=203.1
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
..|.+.+.||.|+||.||+|.++.+++.||+|++.........+.+|+.+++.+.| +||+++++++.....+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH------PNLVQLLGVCTREPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCC------CChhheEEEEcCCCCcEE
Confidence 46899999999999999999999999999999998766556678889999998865 489999999999999999
Q ss_pred EEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||||+. ++|.+++..... ..+++..++.++.||+.||.|||+.+++||||||+|||++. ++.+||+|||++..
T Consensus 80 v~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~df~~~~~ 153 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRL 153 (263)
T ss_pred EEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC--CCcEEeCCCccccc
Confidence 999997 567777754321 23788889999999999999999999999999999999984 77899999999876
Q ss_pred cCCCcc----cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1028 ETDHLC----SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1028 ~~~~~s----s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... ....+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---------- 223 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------
Confidence 543321 1223567999999999999999999999999999998 9999988776655544421000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
+ ......+..+.+||.+||+.+|.+|||+.++++.
T Consensus 224 ---------------------------~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 224 ---------------------------M------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred ---------------------------C------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 0 0012346889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=330.31 Aligned_cols=296 Identities=28% Similarity=0.438 Sum_probs=231.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCc----EEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGM----DVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr----~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
..|+++..||+|.||.||+|..+.++. .||||.++..+ .......+|+.+++.+.|+ ||+.|..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~------nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHP------NVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCC------cchhHHHHHh
Confidence 358899999999999999997655433 68999998663 2335667899999998766 8999998888
Q ss_pred e-cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC--CCceEE
Q 001034 942 Y-REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY--SRCEVK 1018 (1182)
Q Consensus 942 d-~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~--~dG~IK 1018 (1182)
. ...+++++||.+.+|+..++..+.... ..++...++.|++||+.|+.|||++=|+||||||.|||+... .+|.||
T Consensus 98 ~~d~~v~l~fdYAEhDL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEHDLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhhhHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 788999999999999999998876655 468889999999999999999999999999999999999742 358999
Q ss_pred EecCCCccccCCCcc------cccCCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCC---------CHHH
Q 001034 1019 VIDLGSSCFETDHLC------SYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQND---------SPAT 1082 (1182)
Q Consensus 1019 LiDFGLA~~~~~~~s------s~vGTp~YmAPEVLlg~~-yS~kSDIWSLGVILYELLTGr~PF~g~---------d~~e 1082 (1182)
|.|||+++....... ..+-|.+|+|||+++|.. |+.++|+|++|||+.|||+-.+.|.+. -..+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 999999987665432 346799999999999874 999999999999999999999999653 2346
Q ss_pred HHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcccc-ccccccCCCCCcHHHHHHHHHhcccCCCCC
Q 001034 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK-KTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161 (1182)
Q Consensus 1083 lLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk-~~sL~~~l~~~SeeL~DLIrkMLq~DPekR 1161 (1182)
.+.+|+.++|.+....|...+...++-...... .. ++..+. .....+....-++...+||.+||.+||.+|
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f-~~-------~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kR 328 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDF-RR-------HYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKR 328 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHh-HH-------hhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhh
Confidence 789999999988776666554443321110000 00 000000 000111122235569999999999999999
Q ss_pred CCHHHHHcCCCCCCCCCC
Q 001034 1162 PSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1162 PTAeELLqHPWFk~~~eP 1179 (1182)
+|++++|+|+||..-..|
T Consensus 329 Ita~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 329 ITAEQALEHPYFTEDPLP 346 (438)
T ss_pred ccHHHHhcccccccCCCC
Confidence 999999999999988666
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.12 Aligned_cols=244 Identities=22% Similarity=0.312 Sum_probs=198.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
++|++.+.||+|+||.||++..+ .+..+|+|.+.........+..|+.+++.+.| |||++++++|.....+|+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSH------PKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCC------CCceeEEEEEccCCCEEE
Confidence 46899999999999999999864 45679999987665555678889999999865 489999999999999999
Q ss_pred EEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||||+. |+|.+++..... .+++..+..++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++..
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~kl~d~g~~~~ 149 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS--TGVVKVSDFGMTRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC--CCeEEECCCCCccc
Confidence 999998 467776654321 2788899999999999999999999999999999999984 67899999999875
Q ss_pred cCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1028 ETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1028 ~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
..... ....++..|+|||++.+..++.++|+|||||++|+|++ |++||...+....+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--------- 220 (256)
T cd05114 150 VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL--------- 220 (256)
T ss_pred cCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC---------
Confidence 43221 12234567999999998899999999999999999999 99999888776666665311000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.. ....+..+.+||.+||+.+|.+||++.+|++
T Consensus 221 -------------------------~~---------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 -------------------------YR---------PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -------------------------CC---------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 0113567899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.80 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=200.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.++|+++++||.|+||.||+|.. ..+..||+|.+.........+..|+.+++.++|+ ||+++++.+.....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD------KLVRLYAVVTKEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCCC------CeeeEEEEEcCCCCcE
Confidence 46799999999999999999986 4567799999876655566788899999988654 8999999999999999
Q ss_pred EEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+++||||||+||+++. ++.++|+|||++.
T Consensus 78 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~ 151 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE--SLMCKIADFGLAR 151 (261)
T ss_pred EEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecC--CCcEEECCCccce
Confidence 9999997 578877764321 13788889999999999999999999999999999999994 6789999999997
Q ss_pred ccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
...... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---------- 221 (261)
T cd05072 152 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---------- 221 (261)
T ss_pred ecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC----------
Confidence 654321 12234667999999998889999999999999999998 999998877665554442100
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.. .....++..+.+||.+||..+|++||++.++++
T Consensus 222 --------------------------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 222 --------------------------RM-------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred --------------------------CC-------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 011234678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=302.30 Aligned_cols=244 Identities=30% Similarity=0.437 Sum_probs=200.2
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 877 LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
||.|+||.||++.+..+++.+|+|++.... .....+..|+.+++.+.| +||+++++.+.....+|+||||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h------~~i~~~~~~~~~~~~~~lv~e~ 74 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS------PYVVKLYYSFQGKKNLYLVMEY 74 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCC------cchhHHHHheecCcEEEEEEec
Confidence 689999999999999999999999997653 234566777888887764 4899999999999999999999
Q ss_pred ccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC
Q 001034 953 LKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH 1031 (1182)
Q Consensus 953 L~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~ 1031 (1182)
+.+ +|..++.... .+++..+..++.||+.||.|||+.+++|+||+|+|||++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~--~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 75 LPGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS--NGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcC--CCCEEEEecccchhcccC
Confidence 985 6777765432 2889999999999999999999999999999999999995 678999999988653222
Q ss_pred -----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1032 -----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1032 -----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
.....++..|+|||.+....++.++|+||||+++|+|++|..||........+..+.....+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 219 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE------- 219 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC-------
Confidence 22346788899999999888999999999999999999999999887776665555310000
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH---HHHHcCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA---SDALKHPWLSHP 1176 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA---eELLqHPWFk~~ 1176 (1182)
.|. ....+..+.+||++||+.+|.+|||+ .++|+||||++.
T Consensus 220 ----------------------------~~~-------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 220 ----------------------------WPE-------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ----------------------------CCc-------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 000 01136889999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.29 Aligned_cols=245 Identities=16% Similarity=0.204 Sum_probs=195.2
Q ss_pred CCEEEEEEeccCCceEEEEEEEC---CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.+|++.+.||+|+||.||++..+ ..+..||+|+++... .....+.+|+.+++.+. ||||+++++++...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~ 78 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD------HSNIVRLEGVITRG 78 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC------CCCcCeEEEEEecC
Confidence 56999999999999999999765 456789999998653 23345677888887764 55999999999999
Q ss_pred CeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++|+||||++++ |..++.... ..+++..++.++.||+.||.|||+++++||||||+|||++. ++.++|+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~--~~~~~l~df 151 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS--DLVCKISGF 151 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC--CCcEEECCC
Confidence 9999999999975 555554322 13789999999999999999999999999999999999984 678999999
Q ss_pred CCccccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1023 GSSCFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1023 GLA~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|.+....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+.....
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----- 226 (266)
T cd05064 152 RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR----- 226 (266)
T ss_pred cccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-----
Confidence 9875432211 12234578999999999999999999999999999775 9999988777665555421000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. .....++..+.+||.+||+.+|.+||++.+|++
T Consensus 227 -------------------------------~-------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 227 -------------------------------L-------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -------------------------------C-------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0 011234678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=308.18 Aligned_cols=252 Identities=21% Similarity=0.243 Sum_probs=202.0
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCC-----cEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTG-----MDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TG-----r~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
..+|++++.||.|+||.||+|.....+ ..||+|.+.... .....+.+|+.++..+.| |||+++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h------~~i~~~~~~~ 77 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH------PNIVCLLGVC 77 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCC------cccceEEEEE
Confidence 357899999999999999999876554 679999987543 334557788888888764 4899999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhcccCC----------ccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEE
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRESGG----------EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV 1009 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~sgg----------el~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILI 1009 (1182)
......|++|||+. ++|.+++........ ...+++..+..++.||+.||.|||+.+++|+||||+|||+
T Consensus 78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 99999999999998 578887765422110 1347888999999999999999999999999999999999
Q ss_pred ccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 001034 1010 KSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATL 1083 (1182)
Q Consensus 1010 Ds~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~el 1083 (1182)
+. ++.++|+|||++...... .....+++.|+|||.+....++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 158 ~~--~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 158 GE--GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred cC--CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 84 677999999998653221 223456788999999998899999999999999999998 9999998777666
Q ss_pred HHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT 1163 (1182)
...+.... .......++.++.+||.+||+.||.+||+
T Consensus 236 ~~~i~~~~-------------------------------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~ 272 (283)
T cd05048 236 IEMIRSRQ-------------------------------------------LLPCPEDCPARVYALMIECWNEIPARRPR 272 (283)
T ss_pred HHHHHcCC-------------------------------------------cCCCcccCCHHHHHHHHHHccCChhhCcC
Confidence 55542100 00011245789999999999999999999
Q ss_pred HHHHHcC
Q 001034 1164 ASDALKH 1170 (1182)
Q Consensus 1164 AeELLqH 1170 (1182)
+.++++|
T Consensus 273 ~~~i~~~ 279 (283)
T cd05048 273 FKDIHTR 279 (283)
T ss_pred HHHHHHH
Confidence 9999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=319.92 Aligned_cols=290 Identities=19% Similarity=0.230 Sum_probs=197.3
Q ss_pred EeccC--CceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 876 YLGSA--AFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 876 ~LGkG--aFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
.||+| +||+||+|++..+++.||+|++.... ...+.+.+|+.+++.++ ||||++++++|.....+|+||
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~------h~niv~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR------HPNIMTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCcceEeeeEecCCceEEEE
Confidence 45666 99999999999999999999987543 22345666777776665 458999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
||+.+ ++.+++...... .+++..+..++.||+.||.|||++||+||||||+|||++. .+.++|+||+.+....
T Consensus 79 e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~--~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 79 PFMAYGSANSLLKTYFPE----GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG--DGLVSLSGLSHLYSLV 152 (328)
T ss_pred ecccCCCHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeC--CCcEEEechHHHhhhh
Confidence 99995 677666544221 2788899999999999999999999999999999999984 6789999998543211
Q ss_pred C---C-------cccccCCCcccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1030 D---H-------LCSYVQSRSYRAPEVILGL--SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1030 ~---~-------~ss~vGTp~YmAPEVLlg~--~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
. . .....++..|+|||++.+. .++.++|||||||++|+|++|.+||........+..++......|..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 1 0 1112345679999999764 57899999999999999999999998876655554443322211111
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhh----ccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEY----LIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~----liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.................. ........... ..............++..+++||++||++||.+|||+.++|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 233 ITTFPCEESRMKNSQSGV-DSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred ccccchhhhhhccchhhh-hcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 000000000000000000 00000000000 0000000001122356789999999999999999999999999999
Q ss_pred CCCCC
Q 001034 1174 SHPYE 1178 (1182)
Q Consensus 1174 k~~~e 1178 (1182)
....+
T Consensus 312 ~~~~~ 316 (328)
T cd08226 312 KQVKE 316 (328)
T ss_pred HHHHH
Confidence 76544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.00 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=205.9
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
.|...+.||.|+||.||++.+..+++.+|+|++.... .....+.+|+.+++.+.| +||++++++|....+.|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h------~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH------PNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCC------CChheEEEEEEcCCeEEE
Confidence 3555679999999999999999999999999986543 233456778888888754 489999999999999999
Q ss_pred EEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
|+||+.+ +|.+++.. . .++...+..++.||+.||.|||++||+||||+|+||+++. ++.++|+|||++..
T Consensus 94 v~e~~~~~~L~~~~~~-~------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~d~g~~~~ 164 (285)
T cd06648 94 VMEFLEGGALTDIVTH-T------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS--DGRVKLSDFGFCAQ 164 (285)
T ss_pred EEeccCCCCHHHHHHh-C------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcC--CCcEEEcccccchh
Confidence 9999985 56665543 1 2788899999999999999999999999999999999984 67899999998764
Q ss_pred cCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1028 ETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1028 ~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
.... .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...++...+.++..... +
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~--~--------- 233 (285)
T cd06648 165 VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP--P--------- 233 (285)
T ss_pred hccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC--C---------
Confidence 3322 2234688999999999988899999999999999999999999988776665555431100 0
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
. ......++..+.+||++||.++|.+|||+.++|+||||+..-.|
T Consensus 234 --------------------------~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 234 --------------------------K----LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred --------------------------C----CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence 0 00112346789999999999999999999999999999887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.50 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=192.5
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEec
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL 953 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL 953 (1182)
..||+|+||.||++.+..++..||+|.+.... .....+.+|+.+++.++|+ ||+++++++......++||||+
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR------NIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCC------CeeeeeeeeccCCEEEEEEecC
Confidence 47999999999999999999999999887543 3445677888988887654 8999999999999999999999
Q ss_pred cc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC--
Q 001034 954 KA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD-- 1030 (1182)
Q Consensus 954 ~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~-- 1030 (1182)
.+ +|..++..... ....+...+..++.||+.||.|||+.||+||||||+|||++. ..+.++|+|||++.....
T Consensus 88 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~-~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 88 PGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred CCCCHHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-CCCeEEEecchhheecccCC
Confidence 85 67766654321 111377888999999999999999999999999999999974 346799999999865422
Q ss_pred -CcccccCCCcccchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhhcCCcchhhhhcccccc
Q 001034 1031 -HLCSYVQSRSYRAPEVILGLS--YDKKIDIWSLGCILAELCTGNVLFQNDSPAT-LLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1031 -~~ss~vGTp~YmAPEVLlg~~--yS~kSDIWSLGVILYELLTGr~PF~g~d~~e-lLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
......+++.|+|||++.... ++.++|+||||+++|+|++|++||....... ....+. ..
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~-~~--------------- 227 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG-MF--------------- 227 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-hh---------------
Confidence 122345788999999987643 7899999999999999999999996432211 100000 00
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
...+ ......+..+.+||.+||..+|.+|||+.+++.||||
T Consensus 228 --------------------~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 --------------------KIHP------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred --------------------ccCC------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0000 0112346789999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.62 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=204.4
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.|...+.||.|+||.||+|++..+++.||+|++.... .....+..|+.+++.++| +|++++++++.....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~~ 95 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH------PNTIEYKGCYLKEHT 95 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCC------CCCccEEEEEEeCCE
Confidence 3677788999999999999999999999999987432 233456778888888764 489999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
.|+||||+.+++..++..... .+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.+||+|||++
T Consensus 96 ~~lv~e~~~~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~--~~~~kL~dfg~~ 168 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFGSA 168 (313)
T ss_pred EEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC--CCCEEEeecCCC
Confidence 999999999998888765332 2788899999999999999999999999999999999984 677999999998
Q ss_pred cccCCCcccccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDHLCSYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~~ss~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
.... ......++..|+|||++. ...++.++|||||||++|+|++|.+||...+....+..+... ..
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~-------- 237 (313)
T cd06633 169 SKSS-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS-------- 237 (313)
T ss_pred cccC-CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CC--------
Confidence 6533 233557889999999984 456889999999999999999999999887665554444210 00
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+. ......+..+.+||.+||+++|.+||++.++|.||||...
T Consensus 238 ---------------------------~~-----~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 238 ---------------------------PT-----LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ---------------------------CC-----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 00 0112235679999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=306.91 Aligned_cols=281 Identities=28% Similarity=0.434 Sum_probs=233.6
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.|.-+++||+|.||+||++++..+++.||+|.++.+. ......++|+-+|+.+.|. |||++++.......+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhk------nivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK------NIVRLHDVLHSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhc------ceeehhhhhccCcee
Confidence 4556678999999999999999999999999998653 3345678999999999877 899999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
.+|+||+...|..++..... .+....++.++.|++++|.|+|++++.||||||.|+||+. +|.+||.|||+++
T Consensus 77 tlvfe~cdqdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~--ngelkladfglar 149 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR--NGELKLADFGLAR 149 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc--CCcEEecccchhh
Confidence 99999999999888876542 2888999999999999999999999999999999999994 8889999999998
Q ss_pred ccCCCc---ccccCCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETDHL---CSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~~~---ss~vGTp~YmAPEVLlg~~-yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
-.+-+. ...+-|.+|++|.++.+.+ |+...|+||.|||+.|+.. |++.|.+.+..+++.+|...+|.+.+.-|..
T Consensus 150 afgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 655443 2346699999999998865 8999999999999999986 9999999999999999999999877655544
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYE 1178 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~e 1178 (1182)
......| ..++.... ..++....++.+..-++|+.++|.-+|.+|++|+.+|+||||++.-.
T Consensus 230 ~t~lpdy-----k~yp~ypa----------ttswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s~ 291 (292)
T KOG0662|consen 230 MTKLPDY-----KPYPIYPA----------TTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFSP 291 (292)
T ss_pred cccCCCC-----cccCCccc----------cchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccCC
Confidence 3322221 22222222 22333344555667889999999999999999999999999998643
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=339.14 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=215.5
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
+..+.|+.-++||+|+||+|+-|+.+.||+-||+|.+.+.+ ......++|..||..++.+ +||.|-+.|+
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~------FiVslaYAfe 255 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSP------FIVSLAYAFE 255 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccC------cEEEEeeeec
Confidence 44567888899999999999999999999999999886543 3345678899999999766 9999999999
Q ss_pred ecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 942 YREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 942 d~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
.+..+|+||..|.|+.+.|+.++....+ |++..+++|+++|+.||++||+.+||+|||||+|||+| .+|+|+|+|
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~~g---F~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD--d~GhvRISD 330 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGNPG---FDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD--DHGHVRISD 330 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCCCC---CchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec--cCCCeEeec
Confidence 9999999999999998888887754333 99999999999999999999999999999999999999 589999999
Q ss_pred CCCccccC--CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1022 LGSSCFET--DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1022 FGLA~~~~--~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
+|+|+-.. +.....+||..|||||++....|+...|||||||+||+|+.|+.||.......--..+
T Consensus 331 LGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv------------ 398 (591)
T KOG0986|consen 331 LGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV------------ 398 (591)
T ss_pred cceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH------------
Confidence 99998544 3445569999999999999999999999999999999999999999654322111111
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLS 1174 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk 1174 (1182)
.+.... .-.......++++++|.+.+|+.||.+|+ .+.++-+||||+
T Consensus 399 -----------------drr~~~-----------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk 450 (591)
T KOG0986|consen 399 -----------------DRRTLE-----------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK 450 (591)
T ss_pred -----------------HHHHhc-----------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence 000000 00112245689999999999999999996 467999999998
Q ss_pred CC
Q 001034 1175 HP 1176 (1182)
Q Consensus 1175 ~~ 1176 (1182)
..
T Consensus 451 ~l 452 (591)
T KOG0986|consen 451 DL 452 (591)
T ss_pred cC
Confidence 74
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=350.34 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=216.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc-chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN-KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~-k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
+-|+|+..||.|+||.||+|+.+.++-..|.|+|... ......++-|+.||..+. ||+||+|++.|...+.++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~Cd------HP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECD------HPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCC------ChHHHHHHHHHhccCceE
Confidence 5588999999999999999999999999999998643 455678888999998875 559999999999999999
Q ss_pred EEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 948 LVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
|+.|||+|+..+.+-..... .+++.+++.+++|++.||.|||+++|||||||..|||+.. +|.|+|.|||.+..
T Consensus 106 iliEFC~GGAVDaimlEL~r----~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl--dGdirLADFGVSAK 179 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGR----VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL--DGDIRLADFGVSAK 179 (1187)
T ss_pred EEEeecCCchHhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe--cCcEeeeccccccc
Confidence 99999999877766544322 3999999999999999999999999999999999999995 78899999998754
Q ss_pred cC---CCcccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1028 ET---DHLCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1028 ~~---~~~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
.. ....+++|||+|||||++. ..+|++++||||||++|.||.-+.+|-...++..++-+|...- +|. ++
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--PPT-Ll 256 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPT-LL 256 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--CCc-cc
Confidence 32 3456889999999999974 4689999999999999999999999999999988887774221 111 11
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
. ...-+..|.|||.+||..||..||++.+||+||||+..
T Consensus 257 q--------------------------------------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 257 Q--------------------------------------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred C--------------------------------------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 0 11225689999999999999999999999999999864
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.70 Aligned_cols=245 Identities=22% Similarity=0.327 Sum_probs=199.3
Q ss_pred EEeccCCceEEEEEEECCC---CcEEEEEEEeccchh--hHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHT---GMDVCVKIIKNNKDF--FDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIV 949 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~T---Gr~VAVKIIkk~k~~--~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLV 949 (1182)
+.||+|+||.||+|.+... +..||+|+++..... ...+..|+.+++.+.| ++|+++++++.....+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~------~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH------PNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCC------CChheeeeeecCCCceEEE
Confidence 3689999999999998866 899999999876433 5677788888888864 4899999999999999999
Q ss_pred EEecc-cChHHHHhhhccc---CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 950 CELLK-ANLYEFHKFNRES---GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 950 mEyL~-GsLld~Lk~~~~s---ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|||+. ++|.+++...... .....+++..++.++.||+.||.|||+++|+|+||+|+||+++. ++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~--~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE--DLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECC--CCcEEEcccccc
Confidence 99995 6788877654210 00123899999999999999999999999999999999999995 578999999998
Q ss_pred cccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1026 CFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1026 ~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
...... .....+++.|+|||.+....++.++|+|||||++|+|++ |..||........+..+.. +.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~~------ 224 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--GY------ 224 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CC------
Confidence 765432 334566889999999998899999999999999999999 6999988877666555531 00
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.......++..+.++|.+||+.+|.+|||+.++++|
T Consensus 225 -----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 -----------------------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -----------------------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000112336889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.63 Aligned_cols=249 Identities=17% Similarity=0.245 Sum_probs=194.8
Q ss_pred EEEEEEeccCCceEEEEEEECCC---CcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHT---GMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~T---Gr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
|++.+.||+|+||.||+|....+ +..||+|+++... .....+..|+.+++.+.| +||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH------PNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCC------CCeeeEEeeeccCC
Confidence 56788999999999999987653 4789999997542 334567788888888764 48999999876654
Q ss_pred e------EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 945 H------LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 945 ~------LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
. .++||||+.+ +|..++...........+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE--DMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC--CCeE
Confidence 3 8999999985 66666654432222335889999999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhc
Q 001034 1018 KVIDLGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~il 1091 (1182)
||+|||+++...... .....+..|+|||.+.+..++.++|||||||++|||++ |.+||.+....+.+..+....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987543221 12234678999999988899999999999999999999 999998877665554442100
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. .......+..+.+||.+||+.||.+|||+.+++++
T Consensus 233 ~-------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 R-------------------------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred C-------------------------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00112346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.24 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=198.9
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++.+.||.|+||.||+|+++.+++.||||.++.. ......+..|+.+++.+.| |||++++++|....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH------PNVIKYLDSFIEDN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC------cceeeeeeeEEECC
Confidence 5799999999999999999999999999999988642 2333456778888888865 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..++||||+.+ +|..++...... ...+++..+..++.||+.||.|||+++++|+||||+|||++. ++.++|+|||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~--~~~~~l~d~g 151 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcC--CCCEEECccc
Confidence 99999999995 676666543221 123788889999999999999999999999999999999984 6779999999
Q ss_pred CccccCCCc---ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhcCCcchhh
Q 001034 1024 SSCFETDHL---CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP--ATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1024 LA~~~~~~~---ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~--~elLakIv~ilGp~Peem 1098 (1182)
++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......+. ..+.++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--- 227 (267)
T cd08228 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCDYPP--- 227 (267)
T ss_pred cceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh-cCCCCC---
Confidence 987644322 235678899999999998899999999999999999999999976432 22222221 000000
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......+..+.+||.+||..+|.+||++.++|+.
T Consensus 228 --------------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 228 --------------------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred --------------------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0011345789999999999999999999999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.19 Aligned_cols=237 Identities=19% Similarity=0.228 Sum_probs=194.2
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccch----hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe----cCeE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD----FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY----REHL 946 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~----~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd----~e~L 946 (1182)
..|+.|+++.||++.. +|+.||||+++.... ....+.+|+.+|++++|+ ||++++++|.+ ...+
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~~~g~~~~~~~~~~~~ 97 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN------NILKIYGFIIDIVDDLPRL 97 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCC------CEEEEeeeEEecccCCCce
Confidence 3689999999999986 789999999976432 245667899999998655 89999999987 3578
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCC
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
++||||+.+ +|.+++.... .+++.....++.+++.||.|||+ .+++||||||+|||++. ++.+||+|||+
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~--~~~~kl~dfg~ 169 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE--NYKLKIICHGL 169 (283)
T ss_pred EEEEEeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC--CCcEEEcccch
Confidence 999999996 5777765432 27888899999999999999998 59999999999999994 67899999999
Q ss_pred ccccCCCcccccCCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1025 SCFETDHLCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1025 A~~~~~~~ss~vGTp~YmAPEVLlg--~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
+...........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..++.....+
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------- 241 (283)
T PHA02988 170 EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL-------- 241 (283)
T ss_pred HhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------
Confidence 9866555556678999999999976 689999999999999999999999999877766665553110000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.. ....+..+.+||.+||+.||.+|||+.+||+
T Consensus 242 -------------------------~~---------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 -------------------------KL---------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------------------------CC---------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00 1134678999999999999999999999986
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.66 Aligned_cols=259 Identities=20% Similarity=0.269 Sum_probs=201.2
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECC-----CCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLH-----TGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~-----TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
..++|++.+.||+|+||.||+|..+. .+..||+|.+..... ....+.+|+.+++.+.| +||++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~ 77 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC------HHVVRLLGV 77 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCC------CCeeeEEEE
Confidence 35789999999999999999997542 356899998865432 22345667777777754 489999999
Q ss_pred EEecCeEEEEEEecc-cChHHHHhhhccc----CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC
Q 001034 940 FYYREHLLIVCELLK-ANLYEFHKFNRES----GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~-GsLld~Lk~~~~s----ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d 1014 (1182)
+......|+||||+. |+|.+++...... .+...++...+..++.||+.||.|||+++|+||||||+|||++. +
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~--~ 155 (288)
T cd05061 78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH--D 155 (288)
T ss_pred EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC--C
Confidence 999999999999998 5788777643211 11223567788899999999999999999999999999999994 6
Q ss_pred ceEEEecCCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 001034 1015 CEVKVIDLGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv 1088 (1182)
+.++|+|||+++...... ....++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.+....+.+..+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 789999999987533211 12234677999999999899999999999999999998 789998777665554442
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
.. .. + ......+..+.+||.+||+.||.+|||+.+++
T Consensus 236 ~~--~~-----------------------------------~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 272 (288)
T cd05061 236 DG--GY-----------------------------------L------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272 (288)
T ss_pred cC--CC-----------------------------------C------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 10 00 0 00112357899999999999999999999998
Q ss_pred c------CCCCCCC
Q 001034 1169 K------HPWLSHP 1176 (1182)
Q Consensus 1169 q------HPWFk~~ 1176 (1182)
+ ||||...
T Consensus 273 ~~l~~~~~~~~~~~ 286 (288)
T cd05061 273 NLLKDDLHPSFPEV 286 (288)
T ss_pred HHHHhhcCCCCCCC
Confidence 7 9999764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.74 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=211.2
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..+.|++.+.||.|+||.||++.+..++..||+|++.........+..|+.+++.+.|+ ||+++++.|.....+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHP------NIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCC------CeeEEEEEEEECCEE
Confidence 44668899999999999999999988999999999987654456677888888888654 899999999999999
Q ss_pred EEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+|+||+. ++|.+++.... ..++...+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~--~~~~~l~d~~~~ 163 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK--DGSVKLADFGFA 163 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC--CCCEEECccchh
Confidence 99999999 57888776543 13888999999999999999999999999999999999994 678999999987
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...++......+... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~--~~-------- 233 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK--GI-------- 233 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CC--------
Confidence 654322 22345788999999999889999999999999999999999999877765544443210 00
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+.. .....++..+.+||.+||+.+|.+|||+.++|+||||+..
T Consensus 234 ---------------------------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 234 ---------------------------PPL----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ---------------------------CCC----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 000 0011246789999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=296.95 Aligned_cols=251 Identities=28% Similarity=0.383 Sum_probs=204.4
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+|++.+.||.|+||.||++.+..+++.+|+|.+.... .....+..|+.+++.++| +||++++++|......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH------PNIISYKEAFLDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCC------CCchhhhhhhccCCEE
Confidence 5899999999999999999999999999999997642 233456678888887764 4899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+++ +|..++...... ...+++..+..++.||+.||.|||+.|++|+||+|.||+++. .+.+||+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~--~~~~kl~d~g~~ 150 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA--NDLVKIGDLGIS 150 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec--CCcEEEeeccch
Confidence 999999975 677766553321 123788899999999999999999999999999999999995 677999999998
Q ss_pred cccCCC-cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1026 CFETDH-LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1026 ~~~~~~-~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 217 (256)
T cd08530 151 KVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK------------- 217 (256)
T ss_pred hhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-------------
Confidence 765433 223467889999999999999999999999999999999999998777655443332100
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.+ ......+.+++++|.+||..+|.+|||+.++|+||++
T Consensus 218 ------------------------~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 218 ------------------------YP------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ------------------------CC------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00 0111346789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.90 Aligned_cols=248 Identities=28% Similarity=0.394 Sum_probs=199.5
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+.| +||+++++.|....++|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~ 78 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS------PYITRYYGSYLKGTKLW 78 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCC------CccHhhhcccccCCceE
Confidence 4666778999999999999999999999999987542 334566778888887754 58999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+++ +|..++... .+++..++.++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~--~~~~~l~dfg~~~ 149 (277)
T cd06642 79 IIMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE--QGDVKLADFGVAG 149 (277)
T ss_pred EEEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC--CCCEEEccccccc
Confidence 99999996 555554321 2788899999999999999999999999999999999984 6779999999987
Q ss_pred ccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
..... .....++..|+|||++.+..++.++|+|||||++|+|++|..||....+......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~------------- 216 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN------------- 216 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC-------------
Confidence 54432 22346788999999999989999999999999999999999999765543322221000
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
..+ ......+..+.+||.+||+.+|.+||++.++|+||||..
T Consensus 217 ------------------------~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 217 ------------------------SPP------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred ------------------------CCC------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 000 011134678999999999999999999999999999964
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=303.59 Aligned_cols=254 Identities=20% Similarity=0.243 Sum_probs=200.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECC-----CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLH-----TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~-----TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .....+..|+.+++.+.| +||+++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~ 78 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH------QNIVRLIGVS 78 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC------CCEeeEEEEE
Confidence 4679999999999999999999877 78899999886543 223457778888888765 4899999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhcccC-CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-CceE
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRESG-GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEV 1017 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~sg-gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG~I 1017 (1182)
......|+||||+. ++|.+++....... ....+++..+..++.||+.||.|||+++++||||||+|||++..+ ...+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 99999999999997 57887776543211 112488899999999999999999999999999999999998533 2469
Q ss_pred EEecCCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhc
Q 001034 1018 KVIDLGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~il 1091 (1182)
||+|||+++...... .....+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+....+..+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 238 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987653221 12233567999999999999999999999999999997 999998877665544432100
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. . .....++..+.+||.+||+.+|++||++.+||+|
T Consensus 239 -~-------------------------------~-----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 -R-------------------------------L-----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -c-------------------------------C-----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0 0012346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.10 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=203.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.++|.+.+.||.|+||.||++.+..+++.||+|.+.... .....+..|+.+++.+. ||||++++++|......
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK------HPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcC------CCCeeehhheeeeCCcE
Confidence 478999999999999999999999999999999986432 33456677888877765 44899999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+|+||+.+ +|..++... .+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~--~~~~kL~dfg~~ 162 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 162 (293)
T ss_pred EEEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcC--CCCEEEccCcce
Confidence 999999985 666665432 2678889999999999999999999999999999999984 678999999987
Q ss_pred cccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... .....+++.|+|||++....++.++|+|||||++|+|++|+.||...+....+..+.. +.
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~--------- 231 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NG--------- 231 (293)
T ss_pred ecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--CC---------
Confidence 643322 2234678899999999988899999999999999999999999987654332221100 00
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.+. .......+..+.+||++||..+|.+||++.+++.||||+...
T Consensus 232 --------------------------~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 232 --------------------------TPE----LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred --------------------------CCC----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 000 001112467899999999999999999999999999998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=302.98 Aligned_cols=254 Identities=19% Similarity=0.239 Sum_probs=197.9
Q ss_pred eecCCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
+..++|++.+.||+|+||.||++.+. .++..||+|++.... .....+.+|+.+++.+.| +||+++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~------~~iv~~~~ 76 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC------HHVVRLLG 76 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC------CCeeeEEE
Confidence 34678999999999999999999864 345779999986543 223456778888887754 48999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccC----CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESG----GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg----gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~ 1013 (1182)
++......++||||+.+ +|.+++....... ....++...+..++.||+.||.|||+.+++|+||||+|||++.
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~-- 154 (277)
T cd05062 77 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE-- 154 (277)
T ss_pred EEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC--
Confidence 99999999999999985 6777765432110 1123577788999999999999999999999999999999994
Q ss_pred CceEEEecCCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 001034 1014 RCEVKVIDLGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakI 1087 (1182)
++.++|+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+....+..+
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 6789999999986433221 12344678999999999999999999999999999999 78999887766555444
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
..... .......+..+.+||.+||+.+|.+|||+.++
T Consensus 235 ~~~~~-------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 271 (277)
T cd05062 235 MEGGL-------------------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271 (277)
T ss_pred HcCCc-------------------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 21000 00011235789999999999999999999999
Q ss_pred HcC
Q 001034 1168 LKH 1170 (1182)
Q Consensus 1168 LqH 1170 (1182)
+++
T Consensus 272 l~~ 274 (277)
T cd05062 272 ISS 274 (277)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.18 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=200.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.+.|++.+.||.|+||.||+|.+..+++.||||+++... .....+..|+.++..+. .|+||++++++|.....
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-----DCPYIVKCYGYFITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhcc-----CCCchHhhheeeecCCe
Confidence 467999999999999999999999899999999997643 22334455665554442 36699999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.+.+..++..... .+++..+..++.||+.||.|||+ .+|+||||+|+|||++. ++.+||+|||+
T Consensus 89 ~~~v~e~~~~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~--~~~~kL~dfg~ 161 (296)
T cd06618 89 VFICMELMSTCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA--SGNVKLCDFGI 161 (296)
T ss_pred EEEEeeccCcCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC--CCCEEECcccc
Confidence 999999998877777655322 38888999999999999999997 69999999999999984 67899999999
Q ss_pred ccccCCC--cccccCCCcccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhcCCcchh
Q 001034 1025 SCFETDH--LCSYVQSRSYRAPEVILGLS----YDKKIDIWSLGCILAELCTGNVLFQNDSP-ATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1025 A~~~~~~--~ss~vGTp~YmAPEVLlg~~----yS~kSDIWSLGVILYELLTGr~PF~g~d~-~elLakIv~ilGp~Pee 1097 (1182)
+...... .....++..|+|||++.+.. ++.++|||||||++|+|++|+.||..... .+.+.+++....
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----- 236 (296)
T cd06618 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----- 236 (296)
T ss_pred chhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC-----
Confidence 8754322 22335678899999997654 88899999999999999999999975322 233333221000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
+.. .....++.++.+||.+||..||.+||++.++++||||..
T Consensus 237 --------------------------------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 237 --------------------------------PSL----PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred --------------------------------CCC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 000 001134678999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=338.81 Aligned_cols=263 Identities=26% Similarity=0.381 Sum_probs=210.1
Q ss_pred eCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhh--------HHHHHHHHHHHHhcCCCCCCCcceE
Q 001034 863 LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFF--------DQSLDEIKLLKYVNKHDPGDKYHLL 934 (1182)
Q Consensus 863 ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~--------dq~l~EikILr~L~h~~~l~HPnIV 934 (1182)
...++.+||.++.+||+|+|++||+|+|...+++||||+...++.|. .+..+|.+|.+.| +||.||
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL------DHpRIV 530 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL------DHPRIV 530 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc------Ccceee
Confidence 34678899999999999999999999999999999999998766553 3445566665555 555899
Q ss_pred EEEEEEEec-CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc--CccccccCCccEEEcc
Q 001034 935 RLYDYFYYR-EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL--GLIHCDLKPENILVKS 1011 (1182)
Q Consensus 935 kL~dsFqd~-e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~--GIIHRDIKPeNILIDs 1011 (1182)
++|++|..+ ..+|-|+|||+|+.++|+...... +++.+++.|+.||+.||.||.+. .|||.||||.|||+..
T Consensus 531 KlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~ 605 (775)
T KOG1151|consen 531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVN 605 (775)
T ss_pred eeeeeeeeccccceeeeeecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEec
Confidence 999999865 679999999999988888766543 89999999999999999999976 4999999999999974
Q ss_pred C-CCceEEEecCCCccccCCC----------cccccCCCcccchhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCC
Q 001034 1012 Y-SRCEVKVIDLGSSCFETDH----------LCSYVQSRSYRAPEVILGL----SYDKKIDIWSLGCILAELCTGNVLFQ 1076 (1182)
Q Consensus 1012 ~-~dG~IKLiDFGLA~~~~~~----------~ss~vGTp~YmAPEVLlg~----~yS~kSDIWSLGVILYELLTGr~PF~ 1076 (1182)
. .-|.|||+|||++++.... .....||.+|++||+|.-+ +++.++||||+|||+|.+|.|+.||.
T Consensus 606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 2 3468999999999875543 2346789999999999643 47899999999999999999999997
Q ss_pred CCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhccc
Q 001034 1077 NDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156 (1182)
Q Consensus 1077 g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~ 1156 (1182)
.+-...-+-+--.+ ....+..+| .-|.++.++.+||++||.+
T Consensus 686 hnqsQQdILqeNTI-------------------------------lkAtEVqFP-------~KPvVsseAkaFIRRCLaY 727 (775)
T KOG1151|consen 686 HNQSQQDILQENTI-------------------------------LKATEVQFP-------PKPVVSSEAKAFIRRCLAY 727 (775)
T ss_pred CchhHHHHHhhhch-------------------------------hcceeccCC-------CCCccCHHHHHHHHHHHHh
Confidence 65433211111000 000111222 2356789999999999999
Q ss_pred CCCCCCCHHHHHcCCCCC
Q 001034 1157 NPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1157 DPekRPTAeELLqHPWFk 1174 (1182)
--+.|..+.+|..||+|-
T Consensus 728 RKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 728 RKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hhhhhhhHHHHccCcccc
Confidence 999999999999999994
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.27 Aligned_cols=239 Identities=28% Similarity=0.447 Sum_probs=199.9
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEEeccch----hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD----FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 877 LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~----~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
||.|+||.||++.+..+++.+|+|++.+... ....+..|+.+++.+.| ++|+++++.+.....+|+||||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~~v~e~ 74 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH------PFIVKLHYAFQTEEKLYLVLEY 74 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCC------CcHHHHHHHeecCCeeEEEEec
Confidence 6999999999999998999999999976532 34567788888888864 4899999999999999999999
Q ss_pred cc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC
Q 001034 953 LK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH 1031 (1182)
Q Consensus 953 L~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~ 1031 (1182)
+. ++|.+++.... .+++..+..++.||+.||.|||+.+++|+||+|+||+++. .+.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~--~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 75 APGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA--DGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcC--CCcEEEeecCcceecccC
Confidence 95 67877776543 2788999999999999999999999999999999999985 677999999998765432
Q ss_pred ---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchh
Q 001034 1032 ---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKY 1108 (1182)
Q Consensus 1032 ---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~ 1108 (1182)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.....
T Consensus 147 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 210 (250)
T cd05123 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL---------------- 210 (250)
T ss_pred CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 3445678899999999988899999999999999999999999987776555555431000
Q ss_pred hcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH---HHHHcCCCC
Q 001034 1109 FTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA---SDALKHPWL 1173 (1182)
Q Consensus 1109 F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA---eELLqHPWF 1173 (1182)
......+..+.+||++||..||.+||++ .++++||||
T Consensus 211 ----------------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 ----------------------------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0111226789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.96 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=198.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
.+|++.+.||.|+||.||++.++ ++..+|+|++.........+.+|+.+++.+.| +||+++++++......|+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSH------PNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCC------CCEEEEEEEEcCCCceEE
Confidence 35889999999999999999875 56789999987655445567789999888754 589999999999999999
Q ss_pred EEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||||+++ +|.+++..... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++..
T Consensus 77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~kl~dfg~~~~ 149 (256)
T cd05059 77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE--DNVVKVSDFGLARY 149 (256)
T ss_pred EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC--CCcEEECCccccee
Confidence 9999975 67777764322 3889999999999999999999999999999999999994 67899999999875
Q ss_pred cCCCcc-c---ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1028 ETDHLC-S---YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1028 ~~~~~s-s---~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... . ..++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+..+....+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 219 (256)
T cd05059 150 VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---------- 219 (256)
T ss_pred cccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc----------
Confidence 433221 1 123457999999999999999999999999999999 8999987766655544421000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. ......+..+.+||.+||..+|.+|||+.++++.
T Consensus 220 --------------------------~-------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 --------------------------L-------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred --------------------------C-------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0 0112357889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=310.83 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=205.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
..|.+.+.||.|+||.||++++..++..||+|++.... .....+..|+.+++.+.|+ |++++++++....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~ 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP------NSIEYKGCYLREH 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCC------CEEEEEEEEeeCC
Confidence 44788889999999999999999999999999987532 2334567788888877654 8999999999999
Q ss_pred eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
..|+||||+.|++.+++..... .+++..+..++.||+.||.|||+.+|+||||+|+||+++. ++.++|+|||+
T Consensus 99 ~~~lv~e~~~g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~--~~~~kl~dfg~ 171 (317)
T cd06635 99 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFGS 171 (317)
T ss_pred eEEEEEeCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC--CCCEEEecCCC
Confidence 9999999999988887764432 2788999999999999999999999999999999999984 67899999999
Q ss_pred ccccCCCcccccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1025 SCFETDHLCSYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1025 A~~~~~~~ss~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+..... .....+++.|+|||++. ...++.++|||||||++|+|++|++||...+....+..+.....+
T Consensus 172 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------- 242 (317)
T cd06635 172 ASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-------- 242 (317)
T ss_pred ccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC--------
Confidence 865433 33457888999999984 456889999999999999999999999876655554444211000
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.......+..+++||.+||+.+|.+||++.++++|||+...
T Consensus 243 ----------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 243 ----------------------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ----------------------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 00011345789999999999999999999999999998553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=298.03 Aligned_cols=238 Identities=22% Similarity=0.311 Sum_probs=189.8
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEec
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL 953 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL 953 (1182)
.||.|+||.||+|.++.+++.||+|.+... ......+.+|+.+++.+.| +||++++++|.....+|+||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH------PNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCC------CCcceEEEEEcCCCCeEEEEeec
Confidence 689999999999999999999999988653 2345667889898888754 58999999999999999999999
Q ss_pred cc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCCc
Q 001034 954 KA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL 1032 (1182)
Q Consensus 954 ~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~ 1032 (1182)
.+ +|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++.......
T Consensus 76 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 76 QGGDFLTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTE--KNVLKISDFGMSREEEDGV 148 (252)
T ss_pred cCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcC--CCcEEECccccCccccccc
Confidence 85 6666665322 12788899999999999999999999999999999999984 6779999999987543221
Q ss_pred cc-----ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1033 CS-----YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1033 ss-----~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
.. ...+..|+|||.+.+..++.++|||||||++|+|++ |.+||...........+.... +
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~-~------------- 214 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-R------------- 214 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-C-------------
Confidence 11 122456999999999899999999999999999998 899997665544333331000 0
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......+..+.+||.+||+.+|.+|||+.+|++
T Consensus 215 --------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 --------------------L---------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred --------------------C---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 001133678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=300.01 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=199.2
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCC-----CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHT-----GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~T-----Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
..++|++.+.||.|+||.||++..+.. +..||+|.+.... .....+.+|+.+++.+.|+ ||++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~------~i~~~~~~ 77 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH------HVVRLLGV 77 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCC------ceeEEEEE
Confidence 356899999999999999999987644 4889999987543 2234566788888777544 89999999
Q ss_pred EEecCeEEEEEEecc-cChHHHHhhhcccC----CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC
Q 001034 940 FYYREHLLIVCELLK-ANLYEFHKFNRESG----GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~-GsLld~Lk~~~~sg----gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d 1014 (1182)
+.....+|+||||+. ++|..++....... ....+++..+..++.||+.||.|||+.+|+||||||+|||++. +
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~--~ 155 (277)
T cd05032 78 VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE--D 155 (277)
T ss_pred EcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC--C
Confidence 999999999999997 57777775432211 1123678889999999999999999999999999999999995 6
Q ss_pred ceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 001034 1015 CEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv 1088 (1182)
+.+||+|||+++..... .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+....+..+.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 78999999998653322 223345778999999998889999999999999999998 999998877666554442
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
. +.. .......+..+.+||.+||+.+|.+|||+.+|+
T Consensus 236 ~--~~~-----------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 272 (277)
T cd05032 236 D--GGH-----------------------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272 (277)
T ss_pred c--CCC-----------------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 0 000 000112367899999999999999999999998
Q ss_pred c
Q 001034 1169 K 1169 (1182)
Q Consensus 1169 q 1169 (1182)
+
T Consensus 273 ~ 273 (277)
T cd05032 273 S 273 (277)
T ss_pred H
Confidence 7
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=324.24 Aligned_cols=254 Identities=19% Similarity=0.278 Sum_probs=196.1
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCC-----CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHT-----GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~T-----Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
..++|++.+.||+|+||.||+|++... +..||||+++... .....+..|+.+++.+. .|+||++++++
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----~h~nIv~~~~~ 110 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG-----QHKNIVNLLGA 110 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc-----cCCceeeEeeE
Confidence 356799999999999999999986543 4579999997542 33456778999998873 24599999999
Q ss_pred EEecCeEEEEEEecc-cChHHHHhhhccc---------------------------------------------------
Q 001034 940 FYYREHLLIVCELLK-ANLYEFHKFNRES--------------------------------------------------- 967 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~-GsLld~Lk~~~~s--------------------------------------------------- 967 (1182)
|.....+|+||||+. |+|.+++......
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999998 4677776543210
Q ss_pred -------------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCCc--
Q 001034 968 -------------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL-- 1032 (1182)
Q Consensus 968 -------------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~-- 1032 (1182)
.....+++..++.|+.||+.||.|||++||+||||||+|||++. .+.+||+|||+++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~--~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD--GRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC--CCeEEEeeceeeeeccCCcce
Confidence 00123778889999999999999999999999999999999984 6789999999987543221
Q ss_pred ---ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchh
Q 001034 1033 ---CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKY 1108 (1182)
Q Consensus 1033 ---ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~ 1108 (1182)
....+++.|+|||++....++.++|||||||++|+|++ |+.||........+..++....
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~---------------- 332 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY---------------- 332 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc----------------
Confidence 12234567999999999999999999999999999997 9999976544333323221000
Q ss_pred hcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1109 FTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1109 F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.... ....+.++.+||.+||+.||.+|||+.+|++
T Consensus 333 -----------------~~~~---------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 333 -----------------QMSR---------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -----------------CccC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 1123678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=338.13 Aligned_cols=258 Identities=28% Similarity=0.417 Sum_probs=202.2
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEec---cchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN---NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk---~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
...|+++++||+||-++||+|..-.. +.||+|.+.. +.....-+..|+..|..|.... +||+||+|-....
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~-----~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHD-----KIIQLYDYEVTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCc-----eEEEEeeeeccCc
Confidence 35699999999999999999986444 4555554432 3456778899999999998765 8999999999999
Q ss_pred eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
.+|||||+-..+|...+...... .+..-+++|.+|++.|+.++|..||||.||||.|+|+- .|.+||||||+
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~-----~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGI 505 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSI-----DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGI 505 (677)
T ss_pred eEEEEeecccccHHHHHHhccCC-----CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeech
Confidence 99999999999998888755422 34347899999999999999999999999999999998 68999999999
Q ss_pred ccccCCCc-----ccccCCCcccchhhhcCC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 001034 1025 SCFETDHL-----CSYVQSRSYRAPEVILGL-----------SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1025 A~~~~~~~-----ss~vGTp~YmAPEVLlg~-----------~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv 1088 (1182)
|....... .+.+||+.|||||.+... +.+.++||||||||||+|+.|++||.... ..++++.
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~ 583 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLH 583 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHH
Confidence 97655443 357999999999999633 26689999999999999999999996432 2233332
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
.+..|- . .+ ..|.. + ...+++++++.||.+||.+|||..+||
T Consensus 584 aI~~P~-~---------------------------~I--efp~~-------~-~~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 584 AITDPN-H---------------------------EI--EFPDI-------P-ENDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred hhcCCC-c---------------------------cc--cccCC-------C-CchHHHHHHHHHHhcCcccCCCcHHHh
Confidence 221110 0 00 01110 0 023499999999999999999999999
Q ss_pred cCCCCCCCCCC
Q 001034 1169 KHPWLSHPYEP 1179 (1182)
Q Consensus 1169 qHPWFk~~~eP 1179 (1182)
+|||++-...|
T Consensus 626 qhpFl~~~~i~ 636 (677)
T KOG0596|consen 626 QHPFLQIQPIP 636 (677)
T ss_pred cCccccccccc
Confidence 99999876555
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.45 Aligned_cols=250 Identities=25% Similarity=0.418 Sum_probs=198.1
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+|.+.+.||.|+||.||++.+..++..+++|+++... ........|+.+++.++ ||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD------HPAIVKFHASFLER 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC------CCcHHHHHHHHhcC
Confidence 6899999999999999999998888888888876421 22234556777777765 45899999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
...|+||||+.+ +|..++....... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. +.++|+||
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~---~~~~l~d~ 149 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHTG--KTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN---NLLKIGDF 149 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec---CCEeeccc
Confidence 999999999986 5555554322221 23889999999999999999999999999999999999973 45999999
Q ss_pred CCccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1023 GSSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1023 GLA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
|++...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. ++.+
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~---- 223 (260)
T cd08222 150 GVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPTP---- 223 (260)
T ss_pred CceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCC----
Confidence 998654322 2245678899999999888899999999999999999999999977665444443321 0000
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.....++..+.+||.+||..+|.+||++.++++||||
T Consensus 224 -------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 -------------------------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -------------------------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0112346789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=298.40 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=199.0
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+..++|+++++||.|+||.||+|.. .+++.||+|.+.........+..|+.+++.+.|+ ||+++++++. ...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~-~~~ 74 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHP------RLVRLYAVVT-QEP 74 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCc------CeeeEEEEEc-cCC
Confidence 3457899999999999999999985 4678899999987665566788899999888654 8999999874 567
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+. ++|.+++..... ..++...+..++.||+.||.|||+.|++||||||+||+++. ++.++|+|||+
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l~dfg~ 148 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE--TLCCKIADFGL 148 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcC--CCCEEEccCcc
Confidence 899999997 467777654321 23788899999999999999999999999999999999995 67799999999
Q ss_pred ccccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1025 SCFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1025 A~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
+...... .....++..|+|||++.+..++.++|||||||++|+|++ |++||.+.+..+.+..+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------- 221 (260)
T cd05067 149 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR------- 221 (260)
T ss_pred eeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-------
Confidence 8754421 112345678999999999899999999999999999999 9999987776555544421000
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.+ .....+..+.+||.+||..+|.+|||+.+++.
T Consensus 222 -----------------------------~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 222 -----------------------------MP-------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------------------CC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 01123578999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=299.40 Aligned_cols=248 Identities=20% Similarity=0.275 Sum_probs=192.9
Q ss_pred EEEEEeccCCceEEEEEEECCCCc--EEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec---
Q 001034 872 HVTEYLGSAAFSKAIQAHDLHTGM--DVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--- 943 (1182)
Q Consensus 872 eIlk~LGkGaFGeVyLAkDk~TGr--~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--- 943 (1182)
.+.+.||+|+||.||+|+...++. .+|+|.++.. ......+..|+.+++.++|+ ||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP------NVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCC------CcceEEEEEccCCcc
Confidence 467889999999999999877775 5899998754 33345677788888887654 899999876432
Q ss_pred ---CeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 944 ---EHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 944 ---e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
...++||||+. |+|..++...........+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl 153 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE--NMNVCV 153 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcC--CCCEEE
Confidence 35789999998 567776654432222234888999999999999999999999999999999999984 678999
Q ss_pred ecCCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1020 IDLGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1020 iDFGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp 1093 (1182)
+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.........+... .
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~ 231 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--N 231 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--C
Confidence 9999987643321 12345678999999999999999999999999999999 89999876665544443200 0
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. ....+..+..+.+||.+||+.||.+|||+.+|+++
T Consensus 232 ------------------------------~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 232 ------------------------------R-----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ------------------------------C-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00112346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=298.02 Aligned_cols=246 Identities=24% Similarity=0.336 Sum_probs=200.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.++|++.+.||.|+||.||+|.+. .++.||+|.++........+.+|+.+++.++|+ ||+++++++.....+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP------KLIQLYAVCTLEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCC------CccceeEEEecCCCee
Confidence 467999999999999999999864 457899999987655556778899999988654 8999999999999999
Q ss_pred EEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++.
T Consensus 78 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~dfg~~~ 151 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE--NNICKVADFGLAR 151 (261)
T ss_pred eeeecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC--CCCEEECCcceEE
Confidence 9999995 67888876543 123788999999999999999999999999999999999995 6779999999987
Q ss_pred ccCCCcc-c---ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETDHLC-S---YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~~~s-s---~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
....... . ...+..|+|||++.+..++.++|+|||||++|+|++ |+.||.+......+..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (261)
T cd05068 152 VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR--------- 222 (261)
T ss_pred EccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 6543211 1 122357999999999999999999999999999999 9999988777666555421100
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.+ .....+..+.+||.+||+.+|.+||++.+|++
T Consensus 223 ---------------------------~~-------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 223 ---------------------------MP-------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------------------CC-------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 00 01234578999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=300.38 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=196.6
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.++|++.+.||.|+||.||+|.+..+ ..||+|+++........+..|+.+++.+.| +||+++++.+. ....|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~------~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRH------EKLVQLYAVVS-EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCC------CCcceEEEEEC-CCCcE
Confidence 46799999999999999999988665 459999998755445567889999988765 48999998874 46689
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+.+++||||||+|||++. ++.++|+|||.+.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~--~~~~~L~dfg~~~ 150 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLAR 150 (262)
T ss_pred EEEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC--CCcEEeccCCcee
Confidence 99999985 77777764321 13788899999999999999999999999999999999984 6789999999987
Q ss_pred ccCCCcc----cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETDHLC----SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~~~s----s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
....... ...++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+......+..+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------- 221 (262)
T cd05071 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 221 (262)
T ss_pred eccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC---------
Confidence 5433221 2345677999999999999999999999999999999 8999988776655554421000
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......+..+.+||.+||+.+|.+||++.++++
T Consensus 222 ---------------------------~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 222 ---------------------------M-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ---------------------------C-------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 001234678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=344.39 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=210.7
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+...|++...||.|+|+.|..+.+..+++.+++|++.+.. ....+|+.++.... .|+||+++.+.+.+..+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~-----~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVR-----DHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhc-----CCCcceeecceecCCcee
Confidence 5678999999999999999999999999999999998763 34456777766665 356999999999999999
Q ss_pred EEEEEecccChH-HHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKANLY-EFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~GsLl-d~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+|||++.|..+ +-+...+. +. ..+..|+++|+.|+.|||++|+|||||||+|||++ ...++|+|+|||.+
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~------~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPE------FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFW 463 (612)
T ss_pred eeeehhccccHHHHHHHhcch------hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechh
Confidence 999999998644 33333221 33 67788999999999999999999999999999995 35788999999999
Q ss_pred cccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhcCCcchhhhhcccc
Q 001034 1026 CFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA-TLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1026 ~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~-elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
+.......+.+-|..|.|||++....|+.+|||||||++||+||+|+.||.+.... +++.+| +.++.
T Consensus 464 ~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~-------- 531 (612)
T KOG0603|consen 464 SELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKF-------- 531 (612)
T ss_pred hhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCcc--------
Confidence 88776666678889999999999999999999999999999999999999876555 333333 11110
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC-CCCCCCC
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL-SHPYEPI 1180 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF-k~~~eP~ 1180 (1182)
...+|..+++||++||++||.+||++.+++.|||| +++..|.
T Consensus 532 ----------------------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t~p~ 574 (612)
T KOG0603|consen 532 ----------------------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPTFPP 574 (612)
T ss_pred ----------------------------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCCCCCc
Confidence 03468999999999999999999999999999999 7777665
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=322.80 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=196.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEE-----CCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHD-----LHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkD-----k~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|++.+.||+|+||.||+|.. ..++..||||+++... .....+.+|+.+++.+. .||||++++++|
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~-----~HpnIv~l~~~~ 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHINIVNLLGAC 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc-----CCcceeeeeeee
Confidence 45899999999999999999964 3567789999997542 23456778999999883 255999999999
Q ss_pred EecCeEEEEEEeccc-ChHHHHhhhccc----------------------------------------------------
Q 001034 941 YYREHLLIVCELLKA-NLYEFHKFNRES---------------------------------------------------- 967 (1182)
Q Consensus 941 qd~e~LyLVmEyL~G-sLld~Lk~~~~s---------------------------------------------------- 967 (1182)
......|+||||+.+ +|.+++......
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999984 677777543210
Q ss_pred -----------------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC
Q 001034 968 -----------------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 968 -----------------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~ 1030 (1182)
.....+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~--~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH--GRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC--CCcEEEecCccceeccC
Confidence 01124778889999999999999999999999999999999984 66799999999875433
Q ss_pred Cc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1031 HL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1031 ~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
.. ....++..|+|||++.+..++.++|||||||++|+|++ |..||........+.+++. ..
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~-----------~~-- 333 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK-----------EG-- 333 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH-----------hC--
Confidence 21 12334567999999999999999999999999999998 8999976544332222210 00
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.... .....+.++.+||.+||+.||.+|||+.+|++.
T Consensus 334 --------------------~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 334 --------------------YRML---------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --------------------ccCC---------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0000 011235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=307.96 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=202.0
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
...||.|+||.||++....+++.||||.+.... .....+..|+.+++.+.| +||+++++.|....+.|+||||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH------ENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCC------cchhheeeEEEeCCEEEEEEec
Confidence 357899999999999999999999999986433 234456778888888765 4899999999999999999999
Q ss_pred cccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC
Q 001034 953 LKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH 1031 (1182)
Q Consensus 953 L~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~ 1031 (1182)
+.++ |.+++. .. .+++..++.++.||+.||.|||+.|++|+||+|.||+++. ++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~-~~------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~--~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 99 LEGGALTDIVT-HT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred CCCCcHHHHHh-cC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEcccccceecccc
Confidence 9875 544432 21 2788899999999999999999999999999999999984 677999999987644322
Q ss_pred ---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchh
Q 001034 1032 ---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKY 1108 (1182)
Q Consensus 1032 ---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~ 1108 (1182)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+......+..+...+.
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---------------- 233 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------------- 233 (292)
T ss_pred cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC----------------
Confidence 2335678899999999888899999999999999999999999988766555443321100
Q ss_pred hcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1109 FTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1109 F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
. ........+..+.+||.+||+.+|.+||++.++|+||||.....|
T Consensus 234 ----------------------~---~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 234 ----------------------P---KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred ----------------------c---ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCC
Confidence 0 000112346789999999999999999999999999999998855
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.51 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=198.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc------chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~------k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.+|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+.+++.+.|+ ||+++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~------~i~~~~~~~~~ 75 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD------RIVQYYGCLRD 75 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCC------CcceEEEEEEc
Confidence 3699999999999999999999999999999998542 22345667788888888654 89999999876
Q ss_pred c--CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 943 R--EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 943 ~--e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
. ..+++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.|++|+||||+||+++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l 147 (264)
T cd06653 76 PEEKKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS--AGNVKL 147 (264)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEE
Confidence 4 468999999985 6766665332 2778889999999999999999999999999999999984 677999
Q ss_pred ecCCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1020 IDLGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1020 iDFGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
+|||++...... .....++..|+|||++.+..++.++|+|||||++|+|++|+.||........+.++. ..
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~ 224 (264)
T cd06653 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQ 224 (264)
T ss_pred CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cC
Confidence 999998754321 123467889999999999889999999999999999999999998765444333331 00
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.. . ......++..+.+||.+||+ +|..||++.++|.|||.
T Consensus 225 ~~------------------------------------~---~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 225 PT------------------------------------K---PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CC------------------------------------C---CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 00 0 00122356889999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=301.71 Aligned_cols=251 Identities=21% Similarity=0.257 Sum_probs=198.2
Q ss_pred CCEEEEEEeccCCceEEEEEEEC----CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDL----HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk----~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..|++.+.||+|+||.||+|... ..+..+|+|.+.... .....+.+|+.+++.+.| +||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH------PNIVCLLGVVTQ 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC------CCeeeEEEEEec
Confidence 56899999999999999999853 456789999997532 233566778888888754 489999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhccc-----------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEc
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRES-----------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVK 1010 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~s-----------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILID 1010 (1182)
....|+||||+.+ +|.+++...... .....+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 9999999999985 777776533210 0012377888999999999999999999999999999999999
Q ss_pred cCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 001034 1011 SYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLL 1084 (1182)
Q Consensus 1011 s~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elL 1084 (1182)
. .+.+||+|||+++..... .....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.....+.
T Consensus 159 ~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 E--QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred C--CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5 667999999998754221 223345677999999998899999999999999999998 99999887765555
Q ss_pred HHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 001034 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164 (1182)
Q Consensus 1085 akIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA 1164 (1182)
..+.... .......++..+.+||.+||+.||.+||++
T Consensus 237 ~~~~~~~-------------------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 273 (283)
T cd05090 237 EMVRKRQ-------------------------------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRF 273 (283)
T ss_pred HHHHcCC-------------------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCH
Confidence 4442100 000112346789999999999999999999
Q ss_pred HHHHcC
Q 001034 1165 SDALKH 1170 (1182)
Q Consensus 1165 eELLqH 1170 (1182)
.+|+++
T Consensus 274 ~~i~~~ 279 (283)
T cd05090 274 KDIHTR 279 (283)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=295.43 Aligned_cols=245 Identities=20% Similarity=0.300 Sum_probs=201.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.+.|++.+.||.|+||.||+|.. .++.||+|.+.........+.+|+.+++.+.|+ ||+++++++......|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHP------NLVQLLGVVLQGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCc------ceeeeEEEEcCCCCeE
Confidence 35789999999999999999985 488999999987765567788899999988654 8999999999999999
Q ss_pred EEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+++|+||||+|||++. ++.++|+|||.+.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~--~~~~~l~d~g~~~ 150 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE--DLVAKVSDFGLAK 150 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC--CCCEEEccccccc
Confidence 9999998 578887764431 13889999999999999999999999999999999999984 6789999999988
Q ss_pred ccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhccccc
Q 001034 1027 FETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105 (1182)
Q Consensus 1027 ~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s 1105 (1182)
...........+..|+|||.+....++.++|+|||||++|+|++ |+.||...+.......+....
T Consensus 151 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------- 216 (256)
T cd05039 151 EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-------------- 216 (256)
T ss_pred ccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 66444334445667999999998889999999999999999997 999998776655443331000
Q ss_pred chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1106 ~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.+ ......+..+.+||.+||..+|.+|||+.+|++
T Consensus 217 -----------------------~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 -----------------------RM------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -----------------------CC------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00 001234688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=298.58 Aligned_cols=245 Identities=21% Similarity=0.310 Sum_probs=197.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
.+|++++.||+|+||.||++... .+..+|+|.+.........+.+|+.+++.+.| |||+++++++.....+|+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSH------EKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCC------CCeeeEEEEEccCCCcEE
Confidence 46999999999999999999864 34569999988655445667888888888754 599999999999999999
Q ss_pred EEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||||+.+ +|.+++..... .+++..+..++.||+.||.|||+.|++|+||||.|||++. ++.+||+|||.+..
T Consensus 77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~d~g~~~~ 149 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD--QGCVKVSDFGLSRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCCEEECCCcccee
Confidence 9999985 67777654321 3889999999999999999999999999999999999984 67899999999865
Q ss_pred cCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1028 ETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1028 ~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
..... ....++..|+|||++.+..++.++|+|||||++|+|++ |+.||...+.......+.....+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 220 (256)
T cd05113 150 VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--------- 220 (256)
T ss_pred cCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC---------
Confidence 43221 12234567999999998889999999999999999998 99999877665555544311100
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......+..+++||.+||+.+|.+|||+.+|+.+
T Consensus 221 ----------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ----------------------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ----------------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0011236789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.72 Aligned_cols=245 Identities=22% Similarity=0.321 Sum_probs=201.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.+|++.+.||.|+||.||+|.+.. +..+|+|++..... ....+..|+.+++.++| +||+++++++......|
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRH------KHLISLFAVCSVGEPVY 78 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCC------cchhheeeeEecCCCeE
Confidence 468899999999999999999877 89999999986653 45567788888887754 48999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+.||+|+||+|+|||++. ++.+||+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~--~~~~kl~d~g~~~ 152 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE--DLVCKVADFGLAR 152 (261)
T ss_pred EEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC--CceEEEccccchh
Confidence 99999985 78887764321 23788899999999999999999999999999999999984 6789999999987
Q ss_pred ccCCCc---ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1027 FETDHL---CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1027 ~~~~~~---ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... ....++..|+|||++....++.++|||||||++|+|++ |+.||...+..+.+..+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 222 (261)
T cd05148 153 LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---------- 222 (261)
T ss_pred hcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc----------
Confidence 644322 12344678999999998899999999999999999998 8999988776666655531100
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......+..+.++|.+||+.||.+|||+.+|++
T Consensus 223 --------------------------~-------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 223 --------------------------M-------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred --------------------------C-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 011234678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=309.86 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=203.9
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
..|.+.+.||.|+||.||+++++.++..+|+|.+... ......+..|+.+++.+.|+ |++++++++....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~ 88 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP------NTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCC------CcccEEEEEEcCC
Confidence 4577788999999999999999999999999998642 22344567788888887654 8999999999999
Q ss_pred eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
..++||||+.+++..++..... .+++..+..++.||+.||.|||+.+++||||+|+|||++. .+.++|+|||+
T Consensus 89 ~~~lv~e~~~~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~ 161 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGS 161 (308)
T ss_pred eeEEEEEccCCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC--CCcEEECCccc
Confidence 9999999999988877654332 2788899999999999999999999999999999999984 67899999999
Q ss_pred ccccCCCcccccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1025 SCFETDHLCSYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1025 A~~~~~~~ss~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+..... .....+++.|+|||++. ...++.++|||||||++|+|++|..||...+....+..+....
T Consensus 162 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---------- 230 (308)
T cd06634 162 ASIMAP-ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---------- 230 (308)
T ss_pred ceeecC-cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC----------
Confidence 876443 23456888999999985 3457889999999999999999999997765444333321000
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.+. ......+..+.+||.+||..+|.+||++.++++||||...
T Consensus 231 ---------------------------~~~-----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 231 ---------------------------SPA-----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ---------------------------CCC-----cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 000 0112346789999999999999999999999999999775
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.58 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=201.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..++|++.+.||.|+||.||+|.+. .++.+|||.+.........+.+|+.+++.+.| +||+++++++.....+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRH------DKLVQLYAVCSEEEPI 76 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCC------CCEeeeeeeeecCCce
Confidence 4578999999999999999999975 55789999998766556778889999988865 4899999999988999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
++||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+++++|+||||+||+++. ++.++|+|||++
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~--~~~~~l~d~g~~ 150 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE--NLVCKIADFGLA 150 (261)
T ss_pred EEEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcC--CCCEEECccccc
Confidence 999999985 67777754321 13788999999999999999999999999999999999985 678999999998
Q ss_pred cccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
....... .....+..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+....+..+...+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------- 223 (261)
T cd05034 151 RLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM------- 223 (261)
T ss_pred eeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 7654321 12234567999999999899999999999999999999 99999887776666655311100
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
......+..+.++|.+||+.+|.+||++.++++
T Consensus 224 ------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 ------------------------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ------------------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 001123578999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=308.08 Aligned_cols=278 Identities=22% Similarity=0.255 Sum_probs=195.5
Q ss_pred CceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEeccc-C
Q 001034 881 AFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-N 956 (1182)
Q Consensus 881 aFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~G-s 956 (1182)
+++.||+++...+++.||||++... ......+..|+.+++.++| +||++++++|.....+|++|||+.+ +
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h------~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH------PNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCC------cchhhhhheeecCCeEEEEEeccCCCC
Confidence 5566777777789999999999754 3445677888999888865 4899999999999999999999995 5
Q ss_pred hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC-----
Q 001034 957 LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH----- 1031 (1182)
Q Consensus 957 Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~----- 1031 (1182)
+.+++...... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||.+......
T Consensus 86 l~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~--~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSG--DGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEec--CCceEEecCccceeecccccccc
Confidence 66666543221 2788899999999999999999999999999999999984 678999999987543211
Q ss_pred -----cccccCCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1032 -----LCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1032 -----~ss~vGTp~YmAPEVLlg--~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
.....++..|+|||++.. ..++.++|+|||||++|+|++|..||........+... ..+..+..+... ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~-~~ 236 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCLLDKS-TY 236 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCccccccC-ch
Confidence 123456778999999976 45889999999999999999999999876544333221 122111111000 00
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
.... ...... .....................+..+.+||++||++||.+|||+.+||+||||+...++.
T Consensus 237 --~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~ 305 (314)
T cd08216 237 --PLYE--DSMSQS---RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN 305 (314)
T ss_pred --hhhc--CCcCcc---cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccc
Confidence 0000 000000 00000000000000111223467899999999999999999999999999999877654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=297.57 Aligned_cols=246 Identities=22% Similarity=0.317 Sum_probs=197.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+.........+.+|+.+++.++|+ +|+++++++. ....
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~------~i~~~~~~~~-~~~~ 75 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHD------KLVQLYAVVS-EEPI 75 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCC------ceEEEEeEEC-CCCc
Confidence 4568999999999999999999865 566799999987655556788899999988655 8999999875 4678
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~--~~~~~l~dfg~~ 149 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD--GLVCKIADFGLA 149 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC--CceEEeCCceee
Confidence 999999985 67777654321 13788999999999999999999999999999999999984 678999999998
Q ss_pred cccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
....... ....++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+..+.+..+.... +
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~------- 221 (260)
T cd05070 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-R------- 221 (260)
T ss_pred eeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C-------
Confidence 7543322 12234567999999998899999999999999999999 999998877666555542100 0
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......+..+.+||.+||..+|.+|||+.++++
T Consensus 222 ----------------------------~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 222 ----------------------------M-------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ----------------------------C-------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 011234678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=303.01 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=199.3
Q ss_pred CEEEEEEeccCCceEEEEEEEC---CCCcEEEEEEEeccc-----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNNK-----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~k-----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
.|++.+.||.|+||.||+|.+. .+|+.||+|+++... .....+..|+.+++.+.+ |++|+++++.|.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-----~~~i~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhccc-----CCChhceeeEee
Confidence 4889999999999999999875 488999999997532 223556778888888853 359999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
....+|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.|++||||+|+|||++. ++.+||+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~ 147 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLT 147 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC--CCCEEEe
Confidence 99999999999995 6777765432 2788899999999999999999999999999999999984 6789999
Q ss_pred cCCCccccCCC----cccccCCCcccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1021 DLGSSCFETDH----LCSYVQSRSYRAPEVILGL--SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1021 DFGLA~~~~~~----~ss~vGTp~YmAPEVLlg~--~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|||++...... .....++..|+|||.+... .++.++|||||||++|+|++|..||...........+...+..
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~- 226 (290)
T cd05613 148 DFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK- 226 (290)
T ss_pred eCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-
Confidence 99998654321 2245688999999998753 4778999999999999999999999643322111111100000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHc
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALK 1169 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLq 1169 (1182)
..+ .....++..+.+||++||+.||.+|| ++.+++.
T Consensus 227 ---------------------------------~~~------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 ---------------------------------SEP------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------------------------------cCC------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 000 01123467899999999999999997 8999999
Q ss_pred CCCCCCC
Q 001034 1170 HPWLSHP 1176 (1182)
Q Consensus 1170 HPWFk~~ 1176 (1182)
||||+..
T Consensus 268 ~~~~~~~ 274 (290)
T cd05613 268 HPFFQKI 274 (290)
T ss_pred CcccccC
Confidence 9999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=302.93 Aligned_cols=250 Identities=21% Similarity=0.270 Sum_probs=199.0
Q ss_pred CCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..|.+.+.||.|+||.||++.+. .++..+|+|.+.... .....+..|+.+++.+.|+ +|+++++++..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~ 78 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE------HIVKFYGVCVE 78 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCC------CcceEEEEEec
Confidence 46899999999999999999853 355679999987543 3345678899999888654 89999999999
Q ss_pred cCeEEEEEEecc-cChHHHHhhhccc-------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRES-------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~s-------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d 1014 (1182)
...+++||||+. ++|.+++...... .....+++..+..++.||+.||.|||++|++||||||+|||++. +
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~--~ 156 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE--N 156 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc--C
Confidence 999999999998 4677776543210 11123889999999999999999999999999999999999984 7
Q ss_pred ceEEEecCCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 001034 1015 CEVKVIDLGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv 1088 (1182)
+.+||+|||++....... ....+++.|+|||++.+..++.++|+|||||++|+|++ |.+||........+..+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 789999999987543221 22334678999999999999999999999999999998 999998877766655553
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
.... .......+..+.+||.+||+.||.+|||+.+++
T Consensus 237 ~~~~-------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 237 QGRV-------------------------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred cCCc-------------------------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 1100 000113467899999999999999999999986
Q ss_pred c
Q 001034 1169 K 1169 (1182)
Q Consensus 1169 q 1169 (1182)
.
T Consensus 274 ~ 274 (288)
T cd05093 274 S 274 (288)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.53 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=197.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..++|++.+.||.|+||.||+|.+..+ ..+|+|++.........+.+|+.+++.+.|+ +++++++++. ....
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~-~~~~ 75 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHD------KLVPLYAVVS-EEPI 75 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCC------CeeeEEEEEc-CCCc
Confidence 346799999999999999999987655 4699999876655556778899999988654 8999998875 4678
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+.|++|+||||+|||++. ++.++|+|||++
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~--~~~~~l~dfg~~ 149 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD--NLVCKIADFGLA 149 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC--CCeEEECCCccc
Confidence 999999985 78887764321 23788889999999999999999999999999999999984 678999999998
Q ss_pred cccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |++||.+....+.+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------- 221 (260)
T cd05069 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-------- 221 (260)
T ss_pred eEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 7543322 12345677999999998899999999999999999999 9999988776665554421100
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......+..+.+||++||..||.+||++.++++
T Consensus 222 ----------------------------~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 222 ----------------------------M-------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ----------------------------C-------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 001123578999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=299.32 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=198.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++.+.||.|+||.||++.++.+++.+|||.+... ......+.+|+.+++.+.| +||++++++|....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h------~~i~~~~~~~~~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH------PNVIKYYASFIEDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccC------CchhhhhheeEeCC
Confidence 4688999999999999999999999999999988653 2234567788888888865 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+++||||+.+ +|..++...... ...+++..++.++.||+.||.|||++|++|+||||+||+++. ++.++|+|||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg 151 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEECcch
Confidence 99999999985 677766543221 224888999999999999999999999999999999999984 6789999999
Q ss_pred CccccCCCc---ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhcCCcchhh
Q 001034 1024 SSCFETDHL---CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA--TLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1024 LA~~~~~~~---ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~--elLakIv~ilGp~Peem 1098 (1182)
++....... ....++..|+|||++.+..++.++|+||||+++|+|++|..||.+.... .....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 224 (267)
T cd08229 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD------- 224 (267)
T ss_pred hhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC-------
Confidence 987544322 2456889999999999989999999999999999999999999754321 1111111000
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.+. ......+..+.+||.+||..||.+|||+.+|++
T Consensus 225 ------------------------------~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 225 ------------------------------YPP-----LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ------------------------------CCC-----CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 000 001234678999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=296.06 Aligned_cols=243 Identities=21% Similarity=0.290 Sum_probs=196.6
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE-ecCeEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY-YREHLL 947 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq-d~e~Ly 947 (1182)
.+|++.+.||+|+||.||++.. .+..+|+|.++.... ...+..|+.+++.+.|. +++++++++. ....+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~-~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHS------NLVQLLGVIVEEKGGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCch-HHHHHHHHHHHHhCCCC------CeeeEEEEEEcCCCceE
Confidence 4789999999999999999975 478899999876543 45677899998888654 8999998764 456799
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+++ +|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~ 150 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSE--DNVAKVSDFGLTK 150 (256)
T ss_pred EEEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcC--CCcEEecCCccce
Confidence 99999985 78877764332 23788899999999999999999999999999999999984 6789999999987
Q ss_pred ccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhccccc
Q 001034 1027 FETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105 (1182)
Q Consensus 1027 ~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s 1105 (1182)
...........+..|+|||++.+..++.++|||||||++|+|++ |++||...+.......+.....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------- 217 (256)
T cd05082 151 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------- 217 (256)
T ss_pred eccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-------------
Confidence 65544444455678999999999899999999999999999997 9999987666555444421000
Q ss_pred chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1106 ~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
+ ...+..+..+.+||.+||+.+|.+|||+.++++
T Consensus 218 ------------------------~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 ------------------------M------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------------------------C------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 011234688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=304.54 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=198.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCc--EEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGM--DVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr--~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++.+.||.|+||.||+|....++. .+++|.++.. ......+..|+.++.++.+ ||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~-----hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH-----HPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcC-----CCchhheEEEEccCC
Confidence 579999999999999999999877765 4688888642 2334567788888888742 559999999999999
Q ss_pred eEEEEEEecc-cChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~ 1013 (1182)
.+|+||||++ ++|.+++....... ....+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~-- 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE-- 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC--
Confidence 9999999998 57888876432111 1123788899999999999999999999999999999999984
Q ss_pred CceEEEecCCCccccCCCccc--ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhh
Q 001034 1014 RCEVKVIDLGSSCFETDHLCS--YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~~~ss--~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~i 1090 (1182)
++.+||+|||++......... ...+..|+|||++.+..++.++|||||||++|+|++ |.+||........+.++...
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 678999999998643322222 223457999999999999999999999999999997 99999887766655544210
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.. . .....++..+.+||.+||+.+|.+|||+.++++.
T Consensus 235 ~~----------------------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 YR----------------------------------M---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC----------------------------------C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0 0012356889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=301.70 Aligned_cols=258 Identities=17% Similarity=0.242 Sum_probs=200.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCC----------------cEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTG----------------MDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGD 929 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TG----------------r~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~ 929 (1182)
..+|++++.||+|+||.||+|.+...+ ..||+|++.... .....+.+|+.+++.+.|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~---- 79 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDP---- 79 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCC----
Confidence 367999999999999999999876544 568999987653 3455677899999988654
Q ss_pred CcceEEEEEEEEecCeEEEEEEeccc-ChHHHHhhhccc-----CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccC
Q 001034 930 KYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRES-----GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK 1003 (1182)
Q Consensus 930 HPnIVkL~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~s-----ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIK 1003 (1182)
||++++++|.....+++|||++.+ +|..++...... .....+++..++.++.||+.||.|||+.+|+|||||
T Consensus 80 --~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 80 --NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred --CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 899999999999999999999985 677776544310 011148899999999999999999999999999999
Q ss_pred CccEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 001034 1004 PENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT--GNVLFQ 1076 (1182)
Q Consensus 1004 PeNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT--Gr~PF~ 1076 (1182)
|+|||++. .+.++|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 158 p~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 158 TRNCLVGK--NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hhceeecC--CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999995 578999999998753322 223455778999999998889999999999999999998 778998
Q ss_pred CCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhccc
Q 001034 1077 NDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156 (1182)
Q Consensus 1077 g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~ 1156 (1182)
..+....+..+...+.... ...........+.++.+||.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~l~~li~~cl~~ 279 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDG------------------------------------RQIYLPRPPNCPKDIYELMLECWRR 279 (296)
T ss_pred CcChHHHHHHHHhcccccc------------------------------------ccccCCCccCCCHHHHHHHHHHhcc
Confidence 7666665555532111000 0000011123467899999999999
Q ss_pred CCCCCCCHHHHHc
Q 001034 1157 NPKKRPSASDALK 1169 (1182)
Q Consensus 1157 DPekRPTAeELLq 1169 (1182)
||.+|||+.+|++
T Consensus 280 ~p~~Rpt~~el~~ 292 (296)
T cd05051 280 DEEDRPTFREIHL 292 (296)
T ss_pred ChhcCCCHHHHHH
Confidence 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=307.46 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=197.0
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcE--EEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMD--VCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~--VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++.+.||+|+||.||+|.++.++.. +|+|.++.. ......+.+|+.++.++. .|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~-----~h~~iv~~~~~~~~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc-----CCCCcceEEEEECCC
Confidence 35799999999999999999998887765 477766542 233456677888888883 245999999999999
Q ss_pred CeEEEEEEecc-cChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC
Q 001034 944 EHLLIVCELLK-ANLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY 1012 (1182)
Q Consensus 944 e~LyLVmEyL~-GsLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~ 1012 (1182)
..+|+||||+. ++|.+++....... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~- 159 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE- 159 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC-
Confidence 99999999998 57888776543111 1124788999999999999999999999999999999999984
Q ss_pred CCceEEEecCCCccccCCCccc--ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 001034 1013 SRCEVKVIDLGSSCFETDHLCS--YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIG 1089 (1182)
Q Consensus 1013 ~dG~IKLiDFGLA~~~~~~~ss--~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ 1089 (1182)
++.+||+|||++......... ...+..|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+..
T Consensus 160 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 160 -NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred -CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 677999999998643222111 223567999999988889999999999999999998 9999987666554443310
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.. . . ......+..+.+||.+||+.+|.+||++.++|+
T Consensus 239 ~~----------------------------------~--~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 275 (303)
T cd05088 239 GY----------------------------------R--L-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 275 (303)
T ss_pred CC----------------------------------c--C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0 0 001124678999999999999999999999997
Q ss_pred C
Q 001034 1170 H 1170 (1182)
Q Consensus 1170 H 1170 (1182)
+
T Consensus 276 ~ 276 (303)
T cd05088 276 S 276 (303)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.09 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=199.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECC-------CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLH-------TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~-------TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL 936 (1182)
+..++|.+.+.||+|+||.||+|++.. +...+|+|++.... .....+..|+.+++.+. .|+||+++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~ 89 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINL 89 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc-----CCCCEeeE
Confidence 345789999999999999999998643 33579999997542 33456777888888873 24599999
Q ss_pred EEEEEecCeEEEEEEeccc-ChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCc
Q 001034 937 YDYFYYREHLLIVCELLKA-NLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005 (1182)
Q Consensus 937 ~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPe 1005 (1182)
++++.....+|+||||+.+ +|.+++......+ ....++...+..++.||+.||.|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 9999999999999999984 7888876543211 1123788889999999999999999999999999999
Q ss_pred cEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDS 1079 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d 1079 (1182)
|||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 170 Nill~~--~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 170 NVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred heEEcC--CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999984 678999999998754321 111233568999999999899999999999999999998 899998766
Q ss_pred HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCC
Q 001034 1080 PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159 (1182)
Q Consensus 1080 ~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPe 1159 (1182)
..+....+.... . .......+..+.+||.+||..+|.
T Consensus 248 ~~~~~~~~~~~~-------------------------------------~------~~~~~~~~~~~~~li~~~l~~~p~ 284 (307)
T cd05098 248 VEELFKLLKEGH-------------------------------------R------MDKPSNCTNELYMMMRDCWHAVPS 284 (307)
T ss_pred HHHHHHHHHcCC-------------------------------------C------CCCCCcCCHHHHHHHHHHcccChh
Confidence 655444432000 0 001123467899999999999999
Q ss_pred CCCCHHHHHcC
Q 001034 1160 KRPSASDALKH 1170 (1182)
Q Consensus 1160 kRPTAeELLqH 1170 (1182)
+|||+.+++++
T Consensus 285 ~Rps~~evl~~ 295 (307)
T cd05098 285 QRPTFKQLVED 295 (307)
T ss_pred hCcCHHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=301.32 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=199.2
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCC-----CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHT-----GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~T-----Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|++.+.||+|+||.||++..+.. ...+|+|++.... .....+.+|+.+++.+. .|+||+++++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~~~~~ 85 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINLLGVC 85 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc-----CCCCeeeEEEEE
Confidence 46799999999999999999987643 3789999987542 23345778888888873 245999999999
Q ss_pred EecCeEEEEEEeccc-ChHHHHhhhccc----------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEE
Q 001034 941 YYREHLLIVCELLKA-NLYEFHKFNRES----------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV 1009 (1182)
Q Consensus 941 qd~e~LyLVmEyL~G-sLld~Lk~~~~s----------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILI 1009 (1182)
.....+++||||+.+ +|..++...... .....+++..+..++.||+.||.|||+.+|+||||||.|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 999999999999984 677776543210 112248888999999999999999999999999999999999
Q ss_pred ccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 001034 1010 KSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATL 1083 (1182)
Q Consensus 1010 Ds~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~el 1083 (1182)
+. ++.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.
T Consensus 166 ~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 166 TE--DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred cC--CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 84 778999999998764332 112234567999999999999999999999999999997 9999988776655
Q ss_pred HHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT 1163 (1182)
+..+.... .+ ......+..+.+||.+||..||.+|||
T Consensus 244 ~~~~~~~~-------------------------------------~~------~~~~~~~~~~~~li~~~l~~~p~~Rps 280 (293)
T cd05053 244 FKLLKEGY-------------------------------------RM------EKPQNCTQELYHLMRDCWHEVPSQRPT 280 (293)
T ss_pred HHHHHcCC-------------------------------------cC------CCCCCCCHHHHHHHHHHcccCcccCcC
Confidence 54442000 00 011234678999999999999999999
Q ss_pred HHHHHcC
Q 001034 1164 ASDALKH 1170 (1182)
Q Consensus 1164 AeELLqH 1170 (1182)
+.++|++
T Consensus 281 ~~eil~~ 287 (293)
T cd05053 281 FKQLVED 287 (293)
T ss_pred HHHHHHH
Confidence 9999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.02 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=198.7
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++.+.||.|+||.||+|.+..+++.||+|.++... .....+.+|+++++.+.|. +|++++++|....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~------~i~~~~~~~~~~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHP------NVIKYLASFIENN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC------CeeeeeeeeecCC
Confidence 57999999999999999999999999999999986422 2345677888988888654 8999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..++||||+.+ +|..++...... ...+++..+..++.+|+.||.|||+.||+|+||+|+||+++. ++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~--~~~~~l~d~~ 151 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhccc--CCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC--CCcEEEeccc
Confidence 99999999985 777776543221 224788999999999999999999999999999999999984 6779999999
Q ss_pred CccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhcCCcchhh
Q 001034 1024 SSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP--ATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1024 LA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~--~elLakIv~ilGp~Peem 1098 (1182)
++...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||..... ......+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 223 (267)
T cd08224 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-------- 223 (267)
T ss_pred eeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--------
Confidence 98654332 2345688899999999998999999999999999999999999965431 1111111000
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
..+ . ......+..+.+||.+||.++|.+|||+.+|++
T Consensus 224 -----------------------------~~~---~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 -----------------------------DYP---P--LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -----------------------------CCC---C--CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000 0 001134678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=292.16 Aligned_cols=245 Identities=22% Similarity=0.351 Sum_probs=197.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
.+|++.+.||.|+||.||++.+. .+..+|+|++.........+..|+.+++.+.| |+|+++++++......|+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSH------PKLVQLYGVCTERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCC------CCeeeEEEEEccCCceEE
Confidence 46899999999999999999875 47789999988665445677889999998865 489999999999999999
Q ss_pred EEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||||+.+ +|.+++..... .+++..++.++.|++.||.|||+.+++|+||||+||+++. ++.++|+|||++..
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~~~ 149 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE--NQVVKVSDFGMTRF 149 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC--CCeEEECCCcceee
Confidence 9999986 56555543221 2788889999999999999999999999999999999984 67899999999875
Q ss_pred cCCCcc----cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1028 ETDHLC----SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1028 ~~~~~s----s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
...... ...++..|+|||++.+..++.++|+|||||++|+|++ |+.||........+..+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------- 218 (256)
T cd05112 150 VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF----------- 218 (256)
T ss_pred cccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-----------
Confidence 433211 2234568999999998899999999999999999998 999998777665555442100
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.... ....+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 219 -----------------------~~~~---------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 219 -----------------------RLYK---------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -----------------------CCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0000 01235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=330.80 Aligned_cols=252 Identities=24% Similarity=0.425 Sum_probs=215.7
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIV 949 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLV 949 (1182)
-|.|+.+||.|+||.||+|.++.+|+.+|||.+..+.+ .+.+..|+.|++++..+ ++|++|++|.....++||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-LQEIIKEISIMQQC~S~------yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-LQEIIKEISIMQQCKSK------YVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-HHHHHHHHHHHHHcCCc------hhhhhhhhhccCCceEee
Confidence 46778899999999999999999999999999987664 57788999999998665 999999999999999999
Q ss_pred EEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 950 CELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 950 mEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
||||+ |+..+.++.++.. +++.++..+++..+.+|+|||...-||||||..|||++ .+|+.||.|||.+..+
T Consensus 107 MEYCGAGSiSDI~R~R~K~-----L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN--T~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKP-----LSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN--TDGIAKLADFGVAGQL 179 (502)
T ss_pred hhhcCCCcHHHHHHHhcCC-----ccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc--ccchhhhhhccccchh
Confidence 99999 6788888776653 99999999999999999999999999999999999999 4888999999999765
Q ss_pred CC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccccc
Q 001034 1029 TD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105 (1182)
Q Consensus 1029 ~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s 1105 (1182)
.+ ..++.+|||.|||||++....|+..+||||||++..||.-|++||..-.+...+..|
T Consensus 180 TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------------ 241 (502)
T KOG0574|consen 180 TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------------ 241 (502)
T ss_pred hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------------
Confidence 54 357889999999999999999999999999999999999999999876664433222
Q ss_pred chhhcccchhhhhhcchhhhhhccccccccccCCC-CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLP-MGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1106 ~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~-~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
|...+-..+-+ .-+.+|.|||++||...|++|.||.+|++|||+++..
T Consensus 242 ------------------------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 242 ------------------------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ------------------------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 11111000111 1267899999999999999999999999999998865
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.85 Aligned_cols=246 Identities=20% Similarity=0.279 Sum_probs=197.7
Q ss_pred CCEEEEEEeccCCceEEEEEEECCC---CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHT---GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~T---Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
++|++.+.||+|+||.||+|....+ ...||||+++... .....+..|+.+++.++| +||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH------PNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCC------CCcceEeEEEecC
Confidence 5799999999999999999987644 4579999987543 233456778888888765 4899999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
..+|+||||+.+ +|.+++..... .+++..+..++.||+.||.|||+++|+|+||||+|||++. ++.++|+||
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~--~~~~~l~df 150 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS--NLVCKVSDF 150 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CCCEEECcc
Confidence 999999999985 67777654321 3889999999999999999999999999999999999984 678999999
Q ss_pred CCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1023 GSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1023 GLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
|++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+.....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---- 226 (266)
T cd05033 151 GLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR---- 226 (266)
T ss_pred chhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC----
Confidence 9987654211 12234578999999999999999999999999999998 9999987666555544421000
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.+ .....+..+.+||.+||+.+|.+||++.+++++
T Consensus 227 --------------------------------~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 227 --------------------------------LP-------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred --------------------------------CC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 012346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=307.87 Aligned_cols=246 Identities=20% Similarity=0.289 Sum_probs=193.8
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcE----EEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMD----VCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~----VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
..+|++.+.||+|+||.||+|++..++.. ||||+++... .....+..|+.+++.+.| |||+++++++.
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~g~~~ 79 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN------PHVCRLLGICL 79 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCC------CCCCeEEEEEc
Confidence 45799999999999999999998766664 8999987542 334567778888887754 48999999987
Q ss_pred ecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
.. ..++|++|+. |+|.+++..... .++...+..++.||+.||.|||+.||+||||||+|||++. .+.+||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~--~~~~kl~ 151 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT--PQHVKIT 151 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecC--CCcEEEc
Confidence 64 5779999988 578887765432 2778889999999999999999999999999999999984 6779999
Q ss_pred cCCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1021 DLGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1021 DFGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|||+++...... .....+..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. ....
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~- 229 (316)
T cd05108 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGER- 229 (316)
T ss_pred cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCC-
Confidence 999997654321 12234567999999999999999999999999999997 999998766544322221 0000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. ...+..+..+.++|.+||..+|.+||++.+++.+
T Consensus 230 ----------------------------------~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 230 ----------------------------------L-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ----------------------------------C-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 0112345789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.15 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=198.8
Q ss_pred EEEEEEeccCCceEEEEEEECCCC----cEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTG----MDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TG----r~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
+++.+.||.|+||.||++++...+ ..||+|+++.... ....+..|+.+++.+.| +||+++++++....
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDH------PNIVKLLGVCTEEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCC------CchheEEEEEcCCC
Confidence 356789999999999999998766 8999999976653 45678889999988854 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..|+||||+.+ +|.+++...... .+++..+..++.||+.||.|||+.+++|+||||+||+++. .+.++|+|||
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~--~~~~~l~dfg 148 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFG 148 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEcc--CCeEEEcccC
Confidence 99999999985 677776643321 1788999999999999999999999999999999999994 6689999999
Q ss_pred CccccCCCcc----cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1024 SSCFETDHLC----SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1024 LA~~~~~~~s----s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
++........ ...+++.|+|||.+.+..++.++|+|||||++|+|++ |++||...+....+..+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~------ 222 (258)
T smart00219 149 LSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR------ 222 (258)
T ss_pred CceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC------
Confidence 9875443211 1236788999999988889999999999999999998 8999988776666555421000
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.......+..+.++|.+||..+|.+|||+.++++
T Consensus 223 -------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 -------------------------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -------------------------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0001124688999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=302.06 Aligned_cols=251 Identities=18% Similarity=0.218 Sum_probs=196.4
Q ss_pred CCEEEEEEeccCCceEEEEEEECC-----CCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLH-----TGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~-----TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
.+|++.+.||.|+||.||++.+.. .++.||||+++.... ....+..|+.++..+. ||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~------h~~iv~~~~~~~ 78 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ------HPNIVCLLGVVT 78 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC------CCCcCeEEEEEc
Confidence 357788899999999999998754 357899999975432 2345666777777665 459999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhccc----------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEc
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRES----------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVK 1010 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~s----------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILID 1010 (1182)
....+++++||+.+ +|..++...... .....+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 99999999999985 666666432110 0112377888999999999999999999999999999999998
Q ss_pred cCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 001034 1011 SYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLL 1084 (1182)
Q Consensus 1011 s~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elL 1084 (1182)
. ++.+||+|||+++..... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+
T Consensus 159 ~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 D--KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred C--CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 4 677999999998754322 123345778999999998889999999999999999998 88999887776666
Q ss_pred HHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 001034 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164 (1182)
Q Consensus 1085 akIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA 1164 (1182)
..+..... .......+..+.+||.+||+.+|.+||++
T Consensus 237 ~~i~~~~~-------------------------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~ 273 (283)
T cd05091 237 EMIRNRQV-------------------------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRF 273 (283)
T ss_pred HHHHcCCc-------------------------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence 55531100 00112356789999999999999999999
Q ss_pred HHHHcC
Q 001034 1165 SDALKH 1170 (1182)
Q Consensus 1165 eELLqH 1170 (1182)
.+++..
T Consensus 274 ~~i~~~ 279 (283)
T cd05091 274 KDIHSR 279 (283)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.25 Aligned_cols=246 Identities=21% Similarity=0.280 Sum_probs=192.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCc----EEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGM----DVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr----~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
...+|++++.||.|+||.||+|....+++ .||+|+++... .....+..|+.+++.+. |+||+++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~ 78 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG------SPYVCRLLGIC 78 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC------CCCCceEEEEE
Confidence 35689999999999999999999877776 48999987532 23445667777777664 45899999998
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
.. ...+++|+|+. |+|.+++..... .+++..+..++.||+.||.|||+.+|+||||||+|||++. .+.+||
T Consensus 79 ~~-~~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~--~~~~kL 150 (279)
T cd05109 79 LT-STVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS--PNHVKI 150 (279)
T ss_pred cC-CCcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC--CCcEEE
Confidence 75 45789999998 578777754321 3888999999999999999999999999999999999984 667999
Q ss_pred ecCCCccccCCCcc-----cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1020 IDLGSSCFETDHLC-----SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1020 iDFGLA~~~~~~~s-----s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp 1093 (1182)
+|||+++....... ...+++.|+|||.+.+..++.++|||||||++|||++ |.+||...........+... ..
T Consensus 151 ~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~ 229 (279)
T cd05109 151 TDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ER 229 (279)
T ss_pred CCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-Cc
Confidence 99999875432211 1234567999999999999999999999999999998 99999776654443332100 00
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......+..+.+||.+||..||.+||++.+++.
T Consensus 230 -----------------------------------~-------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 230 -----------------------------------L-------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----------------------------------C-------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 001234678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.46 Aligned_cols=254 Identities=28% Similarity=0.369 Sum_probs=196.9
Q ss_pred CEEEEEEeccCCceEEEEEEEC---CCCcEEEEEEEeccc-----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNNK-----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~k-----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
.|++.+.||.|+||.||++++. .+++.||||++++.. .....+..|+.++..+.+ |++|+++++.|.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~-----~~~i~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR-----CPFLVTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccC-----Ccchhhhheeee
Confidence 4889999999999999999864 467899999997542 223456678888888853 459999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
....+|+||||+.+ +|..++.... .+++..++.++.|++.||.|||+.+++||||+|.||+++. ++.++|+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~--~~~~~l~ 147 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS--EGHVVLT 147 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEE
Confidence 99999999999985 6666654322 2788899999999999999999999999999999999984 6779999
Q ss_pred cCCCccccCCC----cccccCCCcccchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1021 DLGSSCFETDH----LCSYVQSRSYRAPEVILGLS--YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1021 DFGLA~~~~~~----~ss~vGTp~YmAPEVLlg~~--yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|||++...... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+...
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---- 223 (288)
T cd05583 148 DFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR---- 223 (288)
T ss_pred ECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH----
Confidence 99998653322 12346788999999987765 788999999999999999999999653322111111000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHcCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS---ASDALKHP 1171 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT---AeELLqHP 1171 (1182)
+ ... . .......+..+.+||.+||+.||++||| +.++|+||
T Consensus 224 ---~--------------------------~~~-~------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 224 ---I--------------------------LKS-K------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---H--------------------------Hcc-C------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 000 0 0011234678999999999999999998 56789999
Q ss_pred CCCCC
Q 001034 1172 WLSHP 1176 (1182)
Q Consensus 1172 WFk~~ 1176 (1182)
||+..
T Consensus 268 ~~~~~ 272 (288)
T cd05583 268 FFQGI 272 (288)
T ss_pred ccccC
Confidence 99875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.13 Aligned_cols=251 Identities=18% Similarity=0.219 Sum_probs=198.2
Q ss_pred cCCEEEEEEeccCCceEEEEEEECC-----CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLH-----TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~-----TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|++.+.||.|+||.||+|.+.. ++..||+|++.... .....+..|+.+++.+.| |||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h------~~iv~~~~~~ 77 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH------PNIVKLLGVC 77 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCC------CchheEEEEE
Confidence 3679999999999999999998753 67889999987543 234567778888888854 4899999999
Q ss_pred EecCeEEEEEEeccc-ChHHHHhhhccc----------------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccC
Q 001034 941 YYREHLLIVCELLKA-NLYEFHKFNRES----------------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK 1003 (1182)
Q Consensus 941 qd~e~LyLVmEyL~G-sLld~Lk~~~~s----------------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIK 1003 (1182)
....++|+||||+.+ +|.+++...... .....+++..+..++.||+.||.|||+.+++|||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 999999999999985 787777643210 111237788899999999999999999999999999
Q ss_pred CccEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 001034 1004 PENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQN 1077 (1182)
Q Consensus 1004 PeNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g 1077 (1182)
|+|||++. ++.++|+|||++...... ......+..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 158 p~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGE--NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecC--CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999984 778999999998643222 112334667999999999999999999999999999997 8899987
Q ss_pred CCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccC
Q 001034 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1078 ~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~D 1157 (1182)
.+..+.+..+... . ........+..+.+||.+||+.+
T Consensus 236 ~~~~~~~~~~~~~--~-----------------------------------------~~~~~~~~~~~l~~li~~~l~~~ 272 (288)
T cd05050 236 MAHEEVIYYVRDG--N-----------------------------------------VLSCPDNCPLELYNLMRLCWSKL 272 (288)
T ss_pred CCHHHHHHHHhcC--C-----------------------------------------CCCCCCCCCHHHHHHHHHHcccC
Confidence 7666555443200 0 00011234678999999999999
Q ss_pred CCCCCCHHHHHc
Q 001034 1158 PKKRPSASDALK 1169 (1182)
Q Consensus 1158 PekRPTAeELLq 1169 (1182)
|.+|||+.||++
T Consensus 273 p~~Rpt~~el~~ 284 (288)
T cd05050 273 PSDRPSFASINR 284 (288)
T ss_pred cccCCCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.90 Aligned_cols=263 Identities=16% Similarity=0.224 Sum_probs=189.0
Q ss_pred eeCceecCCEEEEEEeccCCceEEEEEEECCC---CcEEEEEEEeccchhhH-H-----HHHHHHHHHHhcCCCCCCCcc
Q 001034 862 VLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHT---GMDVCVKIIKNNKDFFD-Q-----SLDEIKLLKYVNKHDPGDKYH 932 (1182)
Q Consensus 862 ~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~T---Gr~VAVKIIkk~k~~~d-q-----~l~EikILr~L~h~~~l~HPn 932 (1182)
.+.++..++|++.+.||+|+||.||+|.+..+ +..+|+|+......... . ...+...+..+.......|++
T Consensus 5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 34556778999999999999999999998877 67788887543321110 0 001111112222222346889
Q ss_pred eEEEEEEEEecC----eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEE
Q 001034 933 LLRLYDYFYYRE----HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008 (1182)
Q Consensus 933 IVkL~dsFqd~e----~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNIL 1008 (1182)
|+++++.+.... ..+++|+++..++..++..... +++..++.++.||+.||.|||+.+|+||||||+|||
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil 158 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC------KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIM 158 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhcc------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 999998765543 4578899888777776654321 567788999999999999999999999999999999
Q ss_pred EccCCCceEEEecCCCccccCC----------CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 001034 1009 VKSYSRCEVKVIDLGSSCFETD----------HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078 (1182)
Q Consensus 1009 IDs~~dG~IKLiDFGLA~~~~~----------~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~ 1078 (1182)
++. ++.++|+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 159 l~~--~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 159 VDG--NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EcC--CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 984 67799999999865321 122346899999999999999999999999999999999999999875
Q ss_pred CH-HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccC
Q 001034 1079 SP-ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1079 d~-~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~D 1157 (1182)
.. ...+..... .++. .+. .+ ....+..+..+.+|+..|+..+
T Consensus 237 ~~~~~~~~~~~~-------~~~~-----------------------~~~--~~-----~~~~~~~~~~~~~~~~~~~~~~ 279 (294)
T PHA02882 237 GHNGNLIHAAKC-------DFIK-----------------------RLH--EG-----KIKIKNANKFIYDFIECVTKLS 279 (294)
T ss_pred ccchHHHHHhHH-------HHHH-----------------------Hhh--hh-----hhccCCCCHHHHHHHHHHHhCC
Confidence 32 222211100 0000 000 00 0012234688999999999999
Q ss_pred CCCCCCHHHHHc
Q 001034 1158 PKKRPSASDALK 1169 (1182)
Q Consensus 1158 PekRPTAeELLq 1169 (1182)
|.+||++.++++
T Consensus 280 ~~~rp~~~~l~~ 291 (294)
T PHA02882 280 YEEKPDYDALIK 291 (294)
T ss_pred CCCCCCHHHHHH
Confidence 999999999986
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=314.52 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=194.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|++.+.||.|+||.||+|... .+++.||+|+++... .....+..|+.+++.+. .|+||++++++|
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~-----~h~niv~~~~~~ 80 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-----HHLNVVNLLGAC 80 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc-----cCcchhheeeeE
Confidence 468999999999999999999754 346889999987532 23456677888888873 245999999988
Q ss_pred Eec-CeEEEEEEeccc-ChHHHHhhhcccC--------------------------------------------------
Q 001034 941 YYR-EHLLIVCELLKA-NLYEFHKFNRESG-------------------------------------------------- 968 (1182)
Q Consensus 941 qd~-e~LyLVmEyL~G-sLld~Lk~~~~sg-------------------------------------------------- 968 (1182)
... ..+++||||+++ +|.+++.......
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 754 678999999995 6766665432100
Q ss_pred -----CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC-----cccccCC
Q 001034 969 -----GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQS 1038 (1182)
Q Consensus 969 -----gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGT 1038 (1182)
....+++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||++...... .....++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~--~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeC--CCcEEEeccccchhcccCcchhhccCCCCC
Confidence 0114788889999999999999999999999999999999994 678999999999764321 1233456
Q ss_pred CcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhh
Q 001034 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYE 1117 (1182)
Q Consensus 1039 p~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~e 1117 (1182)
..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+...+.. .
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-----------~--------------- 292 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-----------G--------------- 292 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc-----------c---------------
Confidence 78999999999999999999999999999998 99999764433322222100 0
Q ss_pred hhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1118 RNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1118 r~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
... ......+.++.+++.+||+.+|++||++.+|++|
T Consensus 293 -------~~~---------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 293 -------TRM---------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred -------CCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 0012346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=334.32 Aligned_cols=248 Identities=29% Similarity=0.469 Sum_probs=210.4
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmE 951 (1182)
++||.|-||+||-++++++|+.||||+|.+-+ ....+..+|+.||+.+.|+ .||.|...|+..+.+++|||
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HP------GiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHP------GIVNLECMFETPERVFVVME 643 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCC------CeeEEEEeecCCceEEEEeh
Confidence 48999999999999999999999999998643 3446778999999998665 89999999999999999999
Q ss_pred ecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC-ceEEEecCCCccccCC
Q 001034 952 LLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 952 yL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d-G~IKLiDFGLA~~~~~ 1030 (1182)
-+.|++++.+...... .+++...++++.||+.||.|||-++|+|+||||+|||+.+... -++||||||+|++..+
T Consensus 644 Kl~GDMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred hhcchHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 9999999988866432 2899999999999999999999999999999999999986433 3799999999998876
Q ss_pred C--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhcCCcchhhhhcccccch
Q 001034 1031 H--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND-SPATLLARVIGIIGPIEQGMLAKGRDTYK 1107 (1182)
Q Consensus 1031 ~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~-d~~elLakIv~ilGp~PeemL~~~k~s~k 1107 (1182)
. ..+.+|||.|+|||++..+.|+...|+||+|||+|--|.|.+||.-+ +..++++...
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa------------------- 780 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA------------------- 780 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-------------------
Confidence 5 45789999999999999999999999999999999999999999643 2222222211
Q ss_pred hhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1108 YFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1108 ~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
+..|.. ....++.+++|||..+|+..-++|.+....|.|||+++
T Consensus 781 -------------------FMyPp~-----PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 781 -------------------FMYPPN-----PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred -------------------cccCCC-----chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 111111 12245789999999999999999999999999999986
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=292.77 Aligned_cols=246 Identities=19% Similarity=0.266 Sum_probs=195.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCc---EEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGM---DVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr---~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.++|+..+.||+|+||.||+|.++.++. .+|||.++... .....+..|+.+++.+.| +||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH------HNIIRLEGVVTK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCC------CCeeEEEEEEcc
Confidence 4578999999999999999999876655 79999987542 334566778888877754 489999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++|+||||+.+ +|..++.... ..+++..+..++.|++.||.|||+.|++|+||||+|||++. ++.+||+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~--~~~~kl~d 150 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS--NLECKVSD 150 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC--CCcEEECC
Confidence 9999999999996 5656654322 13788899999999999999999999999999999999984 67899999
Q ss_pred CCCccccCCCcc------cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1022 LGSSCFETDHLC------SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1022 FGLA~~~~~~~s------s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
||++........ ....++.|+|||++....++.++|||||||++|+|++ |+.||...+.......+.... .
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~- 228 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-R- 228 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-C-
Confidence 999875432211 1122457999999998889999999999999999997 999998777666555553110 0
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.| .....+..+.+||.+||+.+|.+||++.+|++
T Consensus 229 ----------------------------------~~-------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 229 ----------------------------------LP-------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ----------------------------------CC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00 01123578999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=338.83 Aligned_cols=145 Identities=23% Similarity=0.356 Sum_probs=124.6
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|.+++.||+|+||.||+|.+..+++.||||+++... .....+..|+.+++.+.| +||+++++.+...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~h------p~Iv~~~~~~~~~ 76 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS------PFIVHLYYSLQSA 76 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCC------CCcCeEEEEEEEC
Confidence 368999999999999999999999999999999997643 223556677888877654 5899999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++||||||+.| +|..++.... .+.+..++.|+.||+.||.|||.++||||||||+||||+. .+.+||+||
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~--~g~vkL~DF 148 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN--EGHIKLTDF 148 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC--CCCEEEEeC
Confidence 999999999974 6777765432 2788899999999999999999999999999999999984 678999999
Q ss_pred CCcc
Q 001034 1023 GSSC 1026 (1182)
Q Consensus 1023 GLA~ 1026 (1182)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=299.69 Aligned_cols=258 Identities=19% Similarity=0.278 Sum_probs=196.8
Q ss_pred cCCEEEEEEeccCCceEEEEEEECC----------------CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLH----------------TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGD 929 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~----------------TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~ 929 (1182)
.++|++.+.||.|+||.||+|.+.. +...+|+|+++... .....+..|+.+++.+.|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~---- 79 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDP---- 79 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCC----
Confidence 4679999999999999999986432 34579999997542 3345677899998888654
Q ss_pred CcceEEEEEEEEecCeEEEEEEeccc-ChHHHHhhhcccCC-----ccccCHHHHHHHHHHHHHHHHHHHhcCccccccC
Q 001034 930 KYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGG-----EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK 1003 (1182)
Q Consensus 930 HPnIVkL~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sgg-----el~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIK 1003 (1182)
||+++++++.....+|+||||+.+ +|..++........ ...+++..+..++.||+.||.|||+.||+|+|||
T Consensus 80 --~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 80 --NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred --CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 899999999999999999999984 77777765332111 1237788899999999999999999999999999
Q ss_pred CccEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 001034 1004 PENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT--GNVLFQ 1076 (1182)
Q Consensus 1004 PeNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT--Gr~PF~ 1076 (1182)
|+|||++. ++.++|+|||++...... ......++.|+|||+..+..++.++|+|||||++|+|++ |..||.
T Consensus 158 p~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 158 TRNCLVGK--NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred hheEEEcC--CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999984 678999999998754322 112334678999999988899999999999999999998 778998
Q ss_pred CCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhccc
Q 001034 1077 NDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156 (1182)
Q Consensus 1077 g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~ 1156 (1182)
..+..+.+......+ .... ... .. .....++..+.+||.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~------------------~~~~---------~~~--~~-------~~~~~~~~~~~~li~~cl~~ 279 (296)
T cd05095 236 QLSDEQVIENTGEFF------------------RDQG---------RQV--YL-------PKPALCPDSLYKLMLSCWRR 279 (296)
T ss_pred ccChHHHHHHHHHHH------------------hhcc---------ccc--cC-------CCCCCCCHHHHHHHHHHcCC
Confidence 766655443321100 0000 000 00 11123467899999999999
Q ss_pred CCCCCCCHHHHHc
Q 001034 1157 NPKKRPSASDALK 1169 (1182)
Q Consensus 1157 DPekRPTAeELLq 1169 (1182)
||.+||++.+|++
T Consensus 280 ~p~~Rp~~~~i~~ 292 (296)
T cd05095 280 NAKERPSFQEIHA 292 (296)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=318.84 Aligned_cols=272 Identities=29% Similarity=0.411 Sum_probs=204.9
Q ss_pred CCEEEE-EEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIl-k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+-|++. +.||.|+|+.|--|....++..||||++.+.. .....+++|+.++.+++. |+||++|+++|.+...+
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqg-----h~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQG-----HKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcC-----CccHHHHHHHhcccceE
Confidence 345554 67999999999999999999999999998765 345678899999998874 56999999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-CCceEEEecCCC
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-SRCEVKVIDLGS 1024 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-~dG~IKLiDFGL 1024 (1182)
|||||-|.| .|+.-+..+. .|++.++..+++.|+.||.|||.+||.||||||+|||-... .-.-||||||.+
T Consensus 152 YLVfEKm~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEecccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999996 4666555443 39999999999999999999999999999999999998642 234699999987
Q ss_pred ccccC----------CCcccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 001034 1025 SCFET----------DHLCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089 (1182)
Q Consensus 1025 A~~~~----------~~~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ 1089 (1182)
..... ....+.+|+..|||||++. ...|+.+||.||||||+|-||+|++||.+.--.+- -.
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GW 301 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GW 301 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----Cc
Confidence 64211 1234568888999999974 23699999999999999999999999976321100 00
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
-.|+... .-...+++..++ -.+.+|... ...++.++++||+.+|..||.+|.+|.++|+
T Consensus 302 drGe~Cr-------------~CQ~~LFesIQE---GkYeFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCR-------------VCQNKLFESIQE---GKYEFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccH-------------HHHHHHHHHHhc---cCCcCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0000000 000011111111 012223222 2345889999999999999999999999999
Q ss_pred CCCCCCC
Q 001034 1170 HPWLSHP 1176 (1182)
Q Consensus 1170 HPWFk~~ 1176 (1182)
|||++..
T Consensus 361 hPw~~~~ 367 (463)
T KOG0607|consen 361 HPWVQRC 367 (463)
T ss_pred Ccccccc
Confidence 9999764
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=298.21 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=197.7
Q ss_pred CCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccch-hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNKD-FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k~-~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.+|.+.+.||.|+||.||+|++. .++..+++|.+..... ....+.+|+.+++.+.|+ ||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~ 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE------HIVKFYGVCGD 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCC------CcceEEEEEcc
Confidence 46899999999999999999853 3556799999875542 234567788888887654 89999999999
Q ss_pred cCeEEEEEEecc-cChHHHHhhhccc----------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRES----------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~s----------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs 1011 (1182)
...+++||||+. ++|.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999997 5777777643211 01123788899999999999999999999999999999999994
Q ss_pred CCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 001034 1012 YSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLA 1085 (1182)
Q Consensus 1012 ~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLa 1085 (1182)
++.++|+|||+++..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+.+.
T Consensus 159 --~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 --NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred --CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 678999999998754322 123455788999999999999999999999999999999 999998877665544
Q ss_pred HHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 001034 1086 RVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165 (1182)
Q Consensus 1086 kIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe 1165 (1182)
.+.... . + ......+..+.+||.+||+.+|.+|||+.
T Consensus 237 ~~~~~~--~-----------------------------------~------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 273 (291)
T cd05094 237 CITQGR--V-----------------------------------L------ERPRVCPKEVYDIMLGCWQREPQQRLNIK 273 (291)
T ss_pred HHhCCC--C-----------------------------------C------CCCccCCHHHHHHHHHHcccChhhCcCHH
Confidence 432100 0 0 00112467899999999999999999999
Q ss_pred HHHc
Q 001034 1166 DALK 1169 (1182)
Q Consensus 1166 ELLq 1169 (1182)
++++
T Consensus 274 ~v~~ 277 (291)
T cd05094 274 EIYK 277 (291)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=302.04 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=198.5
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEE-----CCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHD-----LHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkD-----k~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
....++|.+.+.||+|+||.||++.+ ..++..||+|+++... .....+.+|+.+++++. .|+||++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~ 105 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-----NHENIVNLL 105 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc-----CCCCcceEE
Confidence 34567899999999999999999975 3356689999987542 33456778999999883 244999999
Q ss_pred EEEEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 938 DYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
++|.....+|+||||+. ++|..++..... ..+++..+..++.||+.||.|||+.+|+|+||||+|||++ ..+.
T Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~--~~~~ 179 (302)
T cd05055 106 GACTIGGPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT--HGKI 179 (302)
T ss_pred EEEecCCceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc--CCCe
Confidence 99999999999999998 567777654321 1278999999999999999999999999999999999998 4678
Q ss_pred EEEecCCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhh
Q 001034 1017 VKVIDLGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~i 1090 (1182)
++|+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||........+.+++..
T Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~ 259 (302)
T cd05055 180 VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259 (302)
T ss_pred EEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc
Confidence 9999999987543321 12345678999999999999999999999999999998 99999776544433332100
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. .. . ......+..+.+||.+||.++|.+|||+.+|++
T Consensus 260 ~---------------------------------~~--~-------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 260 G---------------------------------YR--M-------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred C---------------------------------Cc--C-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 00 0 001123678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=291.08 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=198.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+..++|++.+.||+|+||.||++... .+..+|+|.+.........+.+|+.+++.+.|. +|+++++.+.. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~-~~ 74 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD------KLVKLHAVVTK-EP 74 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCC------CcceEEEEEcC-CC
Confidence 45678999999999999999999854 556799999987665566788899999888655 89999999887 78
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
.|+||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.|++|+||||+||+++. .+.+||+|||+
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~--~~~~~l~d~~~ 148 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIADFGL 148 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC--CCcEEECCCcc
Confidence 899999997 57887776432 123778889999999999999999999999999999999984 77899999999
Q ss_pred ccccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1025 SCFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1025 A~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
+....... ....++..|+|||++....++.++|+|||||++|+|++ |++||...+.......+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-------- 220 (260)
T cd05073 149 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-------- 220 (260)
T ss_pred eeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--------
Confidence 86543221 12234567999999998889999999999999999999 999998776655544432100
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
..+ .....+..+.+||.+||+.+|.+||++.++++
T Consensus 221 ----------------------------~~~-------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 221 ----------------------------RMP-------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ----------------------------CCC-------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 11234678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=300.13 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=200.8
Q ss_pred eecCCEEEEEEeccCCceEEEEEEEC-------CCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDL-------HTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk-------~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL 936 (1182)
+..++|.+.+.||.|+||.||+|+.. ..+..||+|++... ......+..|+.+++.+. .|+||+++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~ 86 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINL 86 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc-----cCCCchhe
Confidence 44678999999999999999999752 23557999998753 233456778889888873 24599999
Q ss_pred EEEEEecCeEEEEEEeccc-ChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCc
Q 001034 937 YDYFYYREHLLIVCELLKA-NLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005 (1182)
Q Consensus 937 ~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPe 1005 (1182)
++++.....+|+||||+.+ +|..++....... ....++...+..++.||+.||.|||++||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 9999999999999999985 7777776543211 1123778889999999999999999999999999999
Q ss_pred cEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDS 1079 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d 1079 (1182)
|||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 167 Nili~~--~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 167 NVLVTE--NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred eEEEcC--CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999984 678999999998754322 122345678999999999899999999999999999998 889998877
Q ss_pred HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCC
Q 001034 1080 PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159 (1182)
Q Consensus 1080 ~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPe 1159 (1182)
..++...+..... . ......+..+.+||.+||..+|.
T Consensus 245 ~~~~~~~~~~~~~----------------------------------~---------~~~~~~~~~~~~li~~cl~~~p~ 281 (304)
T cd05101 245 VEELFKLLKEGHR----------------------------------M---------DKPANCTNELYMMMRDCWHAIPS 281 (304)
T ss_pred HHHHHHHHHcCCc----------------------------------C---------CCCCCCCHHHHHHHHHHcccChh
Confidence 6665554420000 0 00123468899999999999999
Q ss_pred CCCCHHHHHcC
Q 001034 1160 KRPSASDALKH 1170 (1182)
Q Consensus 1160 kRPTAeELLqH 1170 (1182)
+|||+.++++.
T Consensus 282 ~Rps~~e~l~~ 292 (304)
T cd05101 282 HRPTFKQLVED 292 (304)
T ss_pred hCCCHHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=291.97 Aligned_cols=236 Identities=19% Similarity=0.249 Sum_probs=187.5
Q ss_pred EeccCCceEEEEEEE--CCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 876 YLGSAAFSKAIQAHD--LHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkD--k~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
.||+|+||.||+|.. +.++..+|+|+++... .....+..|+.+++.+.| +||+++++++. ....++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~-~~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN------PYIVRMIGICE-AESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCC------CCcceEEEEEc-CCCcEEEE
Confidence 589999999999964 5678899999987542 334567788888888754 48999999875 45779999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
||+.+ .|.+++.... .+++..+..++.||+.||.|||++||+||||||.|||++. ++.+||+|||++....
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~--~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 75 ELAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT--QHYAKISDFGLSKALG 146 (257)
T ss_pred ecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC--CCeEEECCCccccccC
Confidence 99995 5777765432 2788999999999999999999999999999999999994 6789999999987543
Q ss_pred CCc------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1030 DHL------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1030 ~~~------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
... ....+++.|+|||++....++.++|+|||||++|+|++ |.+||...........+.....
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~---------- 216 (257)
T cd05116 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER---------- 216 (257)
T ss_pred CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC----------
Confidence 321 12233578999999988889999999999999999998 9999988776655544421000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
+ ......+..+.+||.+||+.||.+||++.+|.+
T Consensus 217 ---------------------------~------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 217 ---------------------------M------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ---------------------------C------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0 011235688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=296.64 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=195.1
Q ss_pred CEEEEEEeccCCceEEEEEEECC-----CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLH-----TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~-----TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
+|++.+.||+|+||.||+|++.. ....+|+|.+.... .....+..|+.+++.+. ||||+++++.|..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN------HPHVIKLYGACSQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC------CCCEeeEEEEEec
Confidence 47889999999999999998753 33579999887543 23456778888888875 4589999999999
Q ss_pred cCeEEEEEEecc-cChHHHHhhhccc------------------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccC
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRES------------------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK 1003 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~s------------------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIK 1003 (1182)
....|+||||+. ++|.+++...... .....+++..+..++.||+.||.|||+.+|+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 999999999999 5677766543211 111237888999999999999999999999999999
Q ss_pred CccEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 001034 1004 PENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQN 1077 (1182)
Q Consensus 1004 PeNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g 1077 (1182)
|+|||++. ++.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 155 p~nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAE--GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcC--CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999984 678999999998753221 122345678999999998899999999999999999998 9999987
Q ss_pred CCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccC
Q 001034 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1078 ~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~D 1157 (1182)
..+..+...+.... .. .....++..+++||.+||+.+
T Consensus 233 ~~~~~~~~~~~~~~----------------------------------~~---------~~~~~~~~~~~~~i~~cl~~~ 269 (290)
T cd05045 233 IAPERLFNLLKTGY----------------------------------RM---------ERPENCSEEMYNLMLTCWKQE 269 (290)
T ss_pred CCHHHHHHHHhCCC----------------------------------CC---------CCCCCCCHHHHHHHHHHccCC
Confidence 76655443331000 00 011234678999999999999
Q ss_pred CCCCCCHHHHHc
Q 001034 1158 PKKRPSASDALK 1169 (1182)
Q Consensus 1158 PekRPTAeELLq 1169 (1182)
|.+||++.+|++
T Consensus 270 P~~Rp~~~~i~~ 281 (290)
T cd05045 270 PDKRPTFADISK 281 (290)
T ss_pred cccCCCHHHHHH
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=300.38 Aligned_cols=253 Identities=21% Similarity=0.306 Sum_probs=198.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECC-------CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLH-------TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~-------TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
..++|.+.+.||.|+||.||+|.+.. ....+|+|+++... .....+..|+.+++.+. .||||++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~ 84 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-----KHKNIINLL 84 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc-----CCCCeeeEE
Confidence 34689999999999999999998642 34579999987542 33456778888888774 255999999
Q ss_pred EEEEecCeEEEEEEeccc-ChHHHHhhhccc----------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCcc
Q 001034 938 DYFYYREHLLIVCELLKA-NLYEFHKFNRES----------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPEN 1006 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~s----------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeN 1006 (1182)
+++.....+|+||||+.+ +|.+++...... .....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 999999999999999984 677777654311 011237888899999999999999999999999999999
Q ss_pred EEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 001034 1007 ILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSP 1080 (1182)
Q Consensus 1007 ILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~ 1080 (1182)
||++. ++.+||+|||+++..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 165 ill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 165 VLVTE--DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEEcC--CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99984 678999999999754322 112233467999999999899999999999999999999 8999988776
Q ss_pred HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1081 ~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
...+..+.... . .......+..+.+||.+||..+|.+
T Consensus 243 ~~~~~~~~~~~-------------------------------------~------~~~~~~~~~~l~~li~~cl~~~p~~ 279 (314)
T cd05099 243 EELFKLLREGH-------------------------------------R------MDKPSNCTHELYMLMRECWHAVPTQ 279 (314)
T ss_pred HHHHHHHHcCC-------------------------------------C------CCCCCCCCHHHHHHHHHHcCCCccc
Confidence 66555542100 0 0011234678999999999999999
Q ss_pred CCCHHHHHc
Q 001034 1161 RPSASDALK 1169 (1182)
Q Consensus 1161 RPTAeELLq 1169 (1182)
|||+.++++
T Consensus 280 Rps~~~ll~ 288 (314)
T cd05099 280 RPTFKQLVE 288 (314)
T ss_pred CcCHHHHHH
Confidence 999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=295.94 Aligned_cols=228 Identities=21% Similarity=0.265 Sum_probs=182.8
Q ss_pred CCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEeccc-ChH
Q 001034 880 AAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLY 958 (1182)
Q Consensus 880 GaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~G-sLl 958 (1182)
|.||.||+|+++.+++.||+|+++..... ..+...+... .||||+++++++....+.|+||||+.| +|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~----~~~~~~~~~~------~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY----SRERLTIIPH------CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh----hhHHHHHHhc------CCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 89999999999999999999999765421 2232222222 367999999999999999999999985 677
Q ss_pred HHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCCcccccCC
Q 001034 959 EFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQS 1038 (1182)
Q Consensus 959 d~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~ss~vGT 1038 (1182)
+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||.+...........++
T Consensus 74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~ 145 (237)
T cd05576 74 SHISKFL------NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD--RGHIQLTYFSRWSEVEDSCDGEAVE 145 (237)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEecccchhccccccccCCcC
Confidence 7765432 2889999999999999999999999999999999999994 6779999999887665555555677
Q ss_pred CcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhh
Q 001034 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYER 1118 (1182)
Q Consensus 1039 p~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er 1118 (1182)
..|+|||.+.+..++.++|+|||||++|+|++|+.||...... +..
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------------~~~------------------ 191 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------------INT------------------ 191 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------------ccc------------------
Confidence 8899999998888999999999999999999999887432110 000
Q ss_pred hcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHcCCCC
Q 001034 1119 NQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA-----SDALKHPWL 1173 (1182)
Q Consensus 1119 ~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA-----eELLqHPWF 1173 (1182)
.....+ ....+..+.+||.+||+.||.+||++ .++++||||
T Consensus 192 -----~~~~~~---------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 -----HTTLNI---------PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred -----ccccCC---------cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 000001 12346889999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=290.13 Aligned_cols=237 Identities=22% Similarity=0.278 Sum_probs=189.0
Q ss_pred EEeccCCceEEEEEEECCCC---cEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTG---MDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIV 949 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TG---r~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLV 949 (1182)
+.||+|+||.||+|....++ ..+|+|.+..... ....+..|+.+++.+.| +||+++++++. ...+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH------PCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCC------CCeeeEEEEEc-CCceEEE
Confidence 36899999999999876544 7899999986653 45567788888888754 48999999876 4578999
Q ss_pred EEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 950 CELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 950 mEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
|||+. ++|.+++.... .+++..+..++.||+.||.|||..+++|+||||+|||++. ++.+||+|||+++..
T Consensus 74 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~--~~~~kl~df~~~~~~ 145 (257)
T cd05060 74 MELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN--RHQAKISDFGMSRAL 145 (257)
T ss_pred EEeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcC--CCcEEecccccccee
Confidence 99998 47887776443 2788999999999999999999999999999999999984 678999999998754
Q ss_pred CCCccc------ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1029 TDHLCS------YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1029 ~~~~ss------~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
...... ..++..|+|||.+.+..++.++|||||||++|+|++ |++||...+..+....+.... +
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~-------- 216 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-R-------- 216 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-c--------
Confidence 332211 112457999999999899999999999999999998 999998776655544432100 0
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......+..+.+||.+||..+|.+||++.+|++
T Consensus 217 ---------------------------~-------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 ---------------------------L-------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------------------------C-------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 011234678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=328.01 Aligned_cols=243 Identities=24% Similarity=0.342 Sum_probs=206.4
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+.+++.||+|-||+||++... ....||+|.++......+.+.+|+.+++.|+|. +||++++++.....+||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~------~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHE------KLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCccc------CeEEEEEEEecCCceEEEE
Confidence 444678999999999999853 334799999998777778899999999999876 8999999999988999999
Q ss_pred Eecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 951 ELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 951 EyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
|||. |+|+++++... ...+...+...|+.||+.|++||+++++|||||-..||||+. +..+||+|||+|+...
T Consensus 281 E~m~~GsLl~yLr~~~----~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~--~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTRE----GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE--DLVVKISDFGLARLIG 354 (468)
T ss_pred EecccCcHHHHhhhcC----CCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc--CceEEEcccccccccC
Confidence 9999 78999998622 223888999999999999999999999999999999999994 7789999999999655
Q ss_pred CCccc----ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1030 DHLCS----YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1030 ~~~ss----~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
+..+. ..-+..|.|||.+....++.++|||||||+||||+| |+.||.+.+..+++..+. ++.+
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le------------~GyR 422 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE------------RGYR 422 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh------------ccCc
Confidence 44332 223667999999999999999999999999999999 999999999998888873 1110
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
-.+...++..+-+++..|+..+|++|||++.+..
T Consensus 423 -------------------------------lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 423 -------------------------------LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred -------------------------------CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 1123457899999999999999999999997654
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=304.36 Aligned_cols=254 Identities=20% Similarity=0.311 Sum_probs=199.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECC-------CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLH-------TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~-------TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
...+|++.+.||.|+||.||+|++.. ....||+|+++... .....+..|+.+++.+.. |+||++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~~iv~~~ 84 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK-----HKNIINLL 84 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcC-----CCCeeeee
Confidence 34679999999999999999998643 23468999887532 334567789999888842 44999999
Q ss_pred EEEEecCeEEEEEEeccc-ChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCcc
Q 001034 938 DYFYYREHLLIVCELLKA-NLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPEN 1006 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeN 1006 (1182)
++|.....+|+||||+.+ +|.+++......+ ....++...+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 999999999999999985 7877776543211 12237778889999999999999999999999999999
Q ss_pred EEEccCCCceEEEecCCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 001034 1007 ILVKSYSRCEVKVIDLGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSP 1080 (1182)
Q Consensus 1007 ILIDs~~dG~IKLiDFGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~ 1080 (1182)
||++. ++.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 165 ill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLVTE--DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEEcC--CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99984 6789999999987543321 11233567999999999999999999999999999998 8999988776
Q ss_pred HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1081 ~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
.+.+..+..... .......+..+.+||.+||+.+|.+
T Consensus 243 ~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~ 279 (334)
T cd05100 243 EELFKLLKEGHR-------------------------------------------MDKPANCTHELYMIMRECWHAVPSQ 279 (334)
T ss_pred HHHHHHHHcCCC-------------------------------------------CCCCCCCCHHHHHHHHHHcccChhh
Confidence 665554421000 0011234678999999999999999
Q ss_pred CCCHHHHHcC
Q 001034 1161 RPSASDALKH 1170 (1182)
Q Consensus 1161 RPTAeELLqH 1170 (1182)
|||+.++|++
T Consensus 280 Rps~~ell~~ 289 (334)
T cd05100 280 RPTFKQLVED 289 (334)
T ss_pred CcCHHHHHHH
Confidence 9999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=290.26 Aligned_cols=242 Identities=24% Similarity=0.333 Sum_probs=195.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
++|++.+.||+|+||.||++. .+++.||+|+++... ....+.+|+.+++.+.| +||+++++++.. ..+|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~------~~i~~~~~~~~~-~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-TAQAFLEETAVMTKLHH------KNLVRLLGVILH-NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-hHHHHHHHHHHHHhCCC------CCcCeEEEEEcC-CCcEE
Confidence 569999999999999999986 578899999997643 23567788888888765 489999999865 45799
Q ss_pred EEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+.|++||||||+|||++. ++.+||+|||++..
T Consensus 76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~--~~~~kl~Dfg~~~~ 149 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE--DGVAKVSDFGLARV 149 (254)
T ss_pred EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCcEEECCCcccee
Confidence 9999984 78877764321 23788889999999999999999999999999999999984 67899999999876
Q ss_pred cCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1028 ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1028 ~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
..........+..|+|||.+.+..++.++|+|||||++|+|++ |++||...+..+....+....
T Consensus 150 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------- 214 (254)
T cd05083 150 GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY--------------- 214 (254)
T ss_pred ccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---------------
Confidence 5443334445678999999998899999999999999999998 999998776655443331100
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.. .....++..+.+||.+||+.+|..||++.+++.
T Consensus 215 ---------------------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 ---------------------RM-------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ---------------------CC-------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 001234688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=298.64 Aligned_cols=258 Identities=18% Similarity=0.254 Sum_probs=196.6
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCC--------------cEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCc
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTG--------------MDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKY 931 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TG--------------r~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HP 931 (1182)
.++|++.+.||+|+||.||+|.+..++ ..||+|+++... .....+.+|+++++.+.|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~------ 77 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNP------ 77 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC------
Confidence 368999999999999999999875432 358999987642 3345677899999988654
Q ss_pred ceEEEEEEEEecCeEEEEEEeccc-ChHHHHhhhccc------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCC
Q 001034 932 HLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRES------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004 (1182)
Q Consensus 932 nIVkL~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~s------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKP 1004 (1182)
||+++++++.....+|+||||+.+ +|.+++...... .....+++..+..++.||+.||.|||+.+++||||||
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 899999999999999999999985 676666432110 0111267888899999999999999999999999999
Q ss_pred ccEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 001034 1005 ENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT--GNVLFQN 1077 (1182)
Q Consensus 1005 eNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT--Gr~PF~g 1077 (1182)
+|||++. ++.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 158 ~Nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLVGN--HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEEcC--CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999984 677999999998653221 122344678999999999999999999999999999988 6788887
Q ss_pred CCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccC
Q 001034 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1078 ~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~D 1157 (1182)
.+..+.+..+...+..... .......+..+..+.+||++||++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~l~~li~~~l~~~ 279 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGR------------------------------------QIYLSQTPLCPSPVFKLMMRCWSRD 279 (295)
T ss_pred cChHHHHHHHHHhhhhccc------------------------------------cccCCCCCCCCHHHHHHHHHHcCCC
Confidence 7766655554321100000 0000011234678999999999999
Q ss_pred CCCCCCHHHHHc
Q 001034 1158 PKKRPSASDALK 1169 (1182)
Q Consensus 1158 PekRPTAeELLq 1169 (1182)
|.+||++.++++
T Consensus 280 p~~RPs~~~i~~ 291 (295)
T cd05097 280 IKDRPTFNKIHH 291 (295)
T ss_pred chhCcCHHHHHH
Confidence 999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=291.57 Aligned_cols=245 Identities=19% Similarity=0.271 Sum_probs=195.4
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCc---EEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGM---DVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr---~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.+|++.+.||+|+||.||+|.++.++. .+|+|.++... .....+..|+.+++.+. ||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD------HPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEecC
Confidence 579999999999999999999865543 79999986542 23456677888888775 45899999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
..+|+||||+++ +|.+++.... ..++...+..++.||+.||.|||+.+++||||||+|||++. ++.++|+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~--~~~~~l~df 150 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS--NLVCKVSDF 150 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC--CCeEEeCCC
Confidence 999999999985 6777765432 13788899999999999999999999999999999999984 678999999
Q ss_pred CCccccCCCcc------cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1023 GSSCFETDHLC------SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1023 GLA~~~~~~~s------s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
|++........ ....+..|+|||++.+..++.++|+|||||++|+|++ |..||......+.+..+.....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--- 227 (267)
T cd05066 151 GLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR--- 227 (267)
T ss_pred CcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc---
Confidence 99875433211 1122467999999999899999999999999999886 9999987776655554421100
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.| .....+..+.+||.+||+.+|.+||++.++++
T Consensus 228 ---------------------------------~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 ---------------------------------LP-------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ---------------------------------CC-------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 00 11234678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=294.22 Aligned_cols=259 Identities=22% Similarity=0.234 Sum_probs=190.9
Q ss_pred cCCE-EEEEEeccCCceEEEEEE----ECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRY-HVTEYLGSAAFSKAIQAH----DLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drY-eIlk~LGkGaFGeVyLAk----Dk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.+|| ++++.||.|+||+||++. ...++..||+|+++... .....+.+|+.+++.+.| |||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~ 75 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH------ENIVKYKGCC 75 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCC------CCEeeEEEEE
Confidence 3566 999999999999998865 34578899999997643 234566788899888855 4899999988
Q ss_pred Eec--CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 941 YYR--EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 941 qd~--e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
... ..+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~ 146 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN--DRLV 146 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcC--CCcE
Confidence 764 468999999986 566665432 2889999999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCCCc------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 001034 1018 KVIDLGSSCFETDHL------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~il 1091 (1182)
+|+|||++....... ....++..|+|||++....++.++|||||||++|+|++|+.||...... +..+.
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~--- 221 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMI--- 221 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhh---
Confidence 999999987544321 1223466799999999888999999999999999999999998654321 11111
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
..... .. ... .+........ ........+..+.+||.+||+.+|.+|||+.++++
T Consensus 222 ~~~~~------~~--------~~~--------~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 222 GPKQG------QM--------TVV--------RLIELLERGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ccccc------cc--------chh--------hhhhhhhcCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 00 000 0000000000 00112345689999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=290.99 Aligned_cols=245 Identities=20% Similarity=0.300 Sum_probs=195.4
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCc---EEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGM---DVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr---~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.|++.+.||+|+||.||+|..+.+++ .||||++... ......+..|+.+++.+.| |||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h------~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH------PNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC------cCcceEEEEECCC
Confidence 468999999999999999999877665 5999998753 3334567788888888754 5899999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
..+++||||+.+ +|..++..... .+++..++.++.|++.||.|||++|++|+||||+|||++. ++.+||+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~--~~~~kl~df 150 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS--NLVCKVSDF 150 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC--CCcEEECCC
Confidence 999999999986 56666554321 3788999999999999999999999999999999999984 678999999
Q ss_pred CCccccCCCcc-----ccc---CCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1023 GSSCFETDHLC-----SYV---QSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1023 GLA~~~~~~~s-----s~v---GTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp 1093 (1182)
|++........ ... .+..|+|||.+.+..++.++|||||||++|||++ |..||...+.......+.....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~- 229 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR- 229 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 99865432211 111 1347999999999999999999999999999886 9999988776655554421000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.| .....+..+.++|.+||+.+|.+||++.+|+.
T Consensus 230 -----------------------------------~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 230 -----------------------------------LP-------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -----------------------------------CC-------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 01234578899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=294.64 Aligned_cols=250 Identities=23% Similarity=0.256 Sum_probs=196.5
Q ss_pred CCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.+|++.++||+|+||.||+|... .++..+|+|.+.... .....+.+|+.+++.+.| +||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~ 78 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQH------QHIVRFYGVCTE 78 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCC------CCCceEEEEEec
Confidence 56888999999999999999743 356789999887543 334567788888888765 489999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhccc---------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRES---------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY 1012 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~s---------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~ 1012 (1182)
...+|+||||+.+ +|.+++...... .....+++..+..++.||+.||.|||+.|++||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~- 157 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ- 157 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC-
Confidence 9999999999984 677776643210 00123788899999999999999999999999999999999984
Q ss_pred CCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 001034 1013 SRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLAR 1086 (1182)
Q Consensus 1013 ~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLak 1086 (1182)
++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||......+.+..
T Consensus 158 -~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 158 -GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred -CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 678999999998643221 122334678999999999999999999999999999998 9999987666555444
Q ss_pred HHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 001034 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASD 1166 (1182)
Q Consensus 1087 Iv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeE 1166 (1182)
+..... . .....++..+.+||.+||+.||.+||++.+
T Consensus 237 ~~~~~~----------------------------------~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 273 (280)
T cd05092 237 ITQGRE----------------------------------L---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKD 273 (280)
T ss_pred HHcCcc----------------------------------C---------CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 321000 0 001234678999999999999999999999
Q ss_pred HHc
Q 001034 1167 ALK 1169 (1182)
Q Consensus 1167 LLq 1169 (1182)
|++
T Consensus 274 l~~ 276 (280)
T cd05092 274 IHS 276 (280)
T ss_pred HHH
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=290.80 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=199.1
Q ss_pred CCEEEEEEeccCCceEEEEEEECC-----CCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLH-----TGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~-----TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
.+|++++.||.|+||.||+|+.+. ..+.+|+|.+..... ....+..|+++++.+.|+ ||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK------NVVRLLGLCR 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCc------ceeeeEEEEC
Confidence 578999999999999999999654 456799999875442 356788899999988654 8999999999
Q ss_pred ecCeEEEEEEecc-cChHHHHhhhcccCC---ccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 942 YREHLLIVCELLK-ANLYEFHKFNRESGG---EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 942 d~e~LyLVmEyL~-GsLld~Lk~~~~sgg---el~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
.....|+||||+. ++|.+++........ ...+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~--~~~~ 156 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS--QREV 156 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC--CCcE
Confidence 9899999999998 578777765441110 114889999999999999999999999999999999999985 6789
Q ss_pred EEecCCCccccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcC
Q 001034 1018 KVIDLGSSCFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilG 1092 (1182)
+|+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||........+..+...
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-- 234 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-- 234 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence 99999998643221 123345677999999988889999999999999999999 88999765554444433100
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. +.. ......+..+.+||.+||+.+|.+|||+.+++.+
T Consensus 235 ~-------------------------------~~~---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 K-------------------------------LEL---------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred C-------------------------------cCC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 000 0012346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=291.57 Aligned_cols=244 Identities=21% Similarity=0.272 Sum_probs=190.8
Q ss_pred EeccCCceEEEEEEECCCCc--EEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEE
Q 001034 876 YLGSAAFSKAIQAHDLHTGM--DVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr--~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmE 951 (1182)
.||.|+||.||+|++..++. .+|+|.++.. ......+..|+.++..+.+ ||||++++++|.....+|+|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH-----HPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhcc-----CCCeeeEEEEEecCCCceEEEE
Confidence 68999999999999988876 4688888743 3344567789999888842 4599999999999999999999
Q ss_pred ecc-cChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 952 LLK-ANLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 952 yL~-GsLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
|+. ++|.+++....... ....+++..+..++.||+.||.|||+.|++||||||+|||++. ++.+||+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~--~~~~kl~ 154 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIA 154 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcC--CCeEEEC
Confidence 998 57888776543111 1123788999999999999999999999999999999999984 7789999
Q ss_pred cCCCccccCCCcc--cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1021 DLGSSCFETDHLC--SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1021 DFGLA~~~~~~~s--s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|||++........ ....+..|+|||++....++.++|+|||||++|+|++ |..||...+....+..+....
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------ 228 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY------ 228 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC------
Confidence 9999853322111 1223567999999998899999999999999999997 999998766555444431000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.. ......+..+.+||.+||..+|.+|||+.++++
T Consensus 229 ------------------------------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 ------------------------------RL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------------------------CC-------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00 001124578999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=338.15 Aligned_cols=246 Identities=26% Similarity=0.442 Sum_probs=201.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEe-ccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE-ec--
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY-YR-- 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIk-k~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq-d~-- 943 (1182)
.-+++|.++|.+|||+.||+|++...+..||+|.+- .++...+.+.+|+.+++.|.. |+|||.+++... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~g-----h~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSG-----HKNIVSYIDSSAINRSS 110 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcC-----CCceeeEeccccccccC
Confidence 357899999999999999999998888999999875 455667888999999999974 459999999432 21
Q ss_pred ----CeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccccCCccEEEccCCCce
Q 001034 944 ----EHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 944 ----e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRDIKPeNILIDs~~dG~ 1016 (1182)
-.++|+||||. |+|.+++..+...+ |++.+++.|++++++||.+||.+. |||||||-+||||.. +++
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~----lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~--~g~ 184 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTR----LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA--DGN 184 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhcc----CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC--CCC
Confidence 35889999999 69999998665332 999999999999999999999998 999999999999994 778
Q ss_pred EEEecCCCccccCCCcc------------cccCCCcccchhhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 001034 1017 VKVIDLGSSCFETDHLC------------SYVQSRSYRAPEVI---LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA 1081 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~~~s------------s~vGTp~YmAPEVL---lg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~ 1081 (1182)
+||||||.++....... ...-|+.|+|||++ .+.+++.++|||+|||+||-|+....||......
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 99999999875332221 12458999999997 5788999999999999999999999999764321
Q ss_pred HHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCC
Q 001034 1082 TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161 (1182)
Q Consensus 1082 elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekR 1161 (1182)
. |+ ..++.+|. ++.++..|.+||+.||+.||.+|
T Consensus 265 a----Il-----------------------------------ng~Y~~P~-------~p~ys~~l~~LI~~mL~~nP~~R 298 (738)
T KOG1989|consen 265 A----IL-----------------------------------NGNYSFPP-------FPNYSDRLKDLIRTMLQPNPDER 298 (738)
T ss_pred e----EE-----------------------------------eccccCCC-------CccHHHHHHHHHHHHhccCcccC
Confidence 1 10 11233332 35678999999999999999999
Q ss_pred CCHHHHHcC
Q 001034 1162 PSASDALKH 1170 (1182)
Q Consensus 1162 PTAeELLqH 1170 (1182)
|++.+++.+
T Consensus 299 PnI~Qv~~~ 307 (738)
T KOG1989|consen 299 PNIYQVLEE 307 (738)
T ss_pred CCHHHHHHH
Confidence 999998875
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=294.02 Aligned_cols=245 Identities=20% Similarity=0.281 Sum_probs=188.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcE----EEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMD----VCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~----VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
.++|++++.||.|+||.||+|....+++. +++|.+.... .....+..|+.+++.+ .||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l------~h~~iv~~~~~~~ 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL------DHAYIVRLLGICP 79 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC------CCCCcceEEEEEC
Confidence 35789999999999999999998877774 6777765332 2233445555565554 4569999999875
Q ss_pred ecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
...+++|+||+. |+|.+++..... .+++..+..++.||+.||.|||+.+++||||||+|||++. ++.+||+
T Consensus 80 -~~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~--~~~~kl~ 151 (279)
T cd05111 80 -GASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS--DSIVQIA 151 (279)
T ss_pred -CCccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--CCcEEEc
Confidence 456789999998 678888764332 2888999999999999999999999999999999999984 6789999
Q ss_pred cCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1021 DLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1021 DFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|||+++..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+. . +..
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~-~~~ 229 (279)
T cd05111 152 DFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-K-GER 229 (279)
T ss_pred CCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-C-CCc
Confidence 99998754221 123346678999999999999999999999999999998 999998776544322221 0 000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.+ .....+..+.++|.+||..||.+|||+.++++
T Consensus 230 ----------------------------------~~-------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 230 ----------------------------------LA-------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ----------------------------------CC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00 01123567899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=289.65 Aligned_cols=246 Identities=21% Similarity=0.287 Sum_probs=194.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCC---CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHT---GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~T---Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..+|.+.+.||.|+||.||+|.+... ...||||.+.... ...+.+.+|+.+++.+.| +||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h------~~i~~~~~~~~~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH------PHIVKLIGVITE 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCC------CchhceeEEEcC
Confidence 35699999999999999999987544 4568999887643 344567788888888855 489999998875
Q ss_pred cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...|+||||+. ++|.+++..... .+++..+..++.||+.||.|||+.+++|+||||+|||++. .+.++|+|
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~--~~~~~l~d 150 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS--PDCVKLGD 150 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec--CCCeEEcc
Confidence 56789999998 468777754321 2788999999999999999999999999999999999984 67799999
Q ss_pred CCCccccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1022 LGSSCFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1022 FGLA~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
||++....... ....++..|+|||.+....++.++|+|||||++|+|++ |..||...+..+.+..+....
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----- 225 (270)
T cd05056 151 FGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE----- 225 (270)
T ss_pred CceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----
Confidence 99987543321 12233467999999988899999999999999999996 999998877655544431000
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.. ......+..+.+||.+||.++|.+|||+.+++..
T Consensus 226 -------------------------------~~-------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 226 -------------------------------RL-------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred -------------------------------cC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0112346789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=285.87 Aligned_cols=240 Identities=23% Similarity=0.310 Sum_probs=192.8
Q ss_pred EEeccCCceEEEEEEECC-CCc--EEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLH-TGM--DVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIV 949 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~-TGr--~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLV 949 (1182)
+.||.|+||.||+|.+.. .++ .||||.+..... ....+..|+.+++.+.| +||+++++++.. ..+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH------ENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCC------CCccceeEEEcC-CeEEEE
Confidence 368999999999999765 333 699999987543 45567788888888865 489999999988 899999
Q ss_pred EEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 950 CELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 950 mEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
|||+. ++|.+++..... ..+++..++.++.||+.||.|||+.+++|+||+|+|||++. ++.+||+|||++...
T Consensus 74 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~--~~~~kl~dfg~~~~~ 147 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS--DDKVKIGDFGLMRAL 147 (257)
T ss_pred EEecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEec--CCEEEeccccccccc
Confidence 99997 578777765431 23789999999999999999999999999999999999995 578999999998765
Q ss_pred CCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1029 TDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1029 ~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+.+..+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 219 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-------- 219 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc--------
Confidence 331 112346778999999999999999999999999999998 99999877776665555210000
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......+..+.+||.+||+.+|.+||++.++++
T Consensus 220 -------------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 220 -------------------------L---------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -------------------------C---------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0 001123578999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=289.99 Aligned_cols=245 Identities=21% Similarity=0.321 Sum_probs=191.1
Q ss_pred EeccCCceEEEEEEECCCC------cEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 876 YLGSAAFSKAIQAHDLHTG------MDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TG------r~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.||.|+||.||+++.+... +.+|+|.+.... .....+.+|+.+++.+.| |||++++++|......|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNH------PNIVKLLGVCLLNEPQY 75 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCC------CCeeeEeeeecCCCCeE
Confidence 6899999999999976544 789999886543 334567788888887754 48999999999999999
Q ss_pred EEEEecc-cChHHHHhhhcccC-CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC---CceEEEecC
Q 001034 948 IVCELLK-ANLYEFHKFNRESG-GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS---RCEVKVIDL 1022 (1182)
Q Consensus 948 LVmEyL~-GsLld~Lk~~~~sg-gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~---dG~IKLiDF 1022 (1182)
+||||+. ++|.+++....... ....+++..+..++.||+.||.|||+.+++|+||||+|||++... ...++|+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999998 47777776432211 223478889999999999999999999999999999999998532 127999999
Q ss_pred CCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1023 GSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1023 GLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
|++...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+.+..+... .
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~---- 230 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G---- 230 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C----
Confidence 998643322 122344678999999999999999999999999999998 99999877665554443100 0
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
........+..+.+||.+||..+|.+||++.++++
T Consensus 231 --------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 --------------------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred --------------------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00011234678999999999999999999999876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=333.06 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=202.5
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEecc-chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEecc
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNN-KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLK 954 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~-k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~ 954 (1182)
+||+|.||+||-|+|+.+...+|||-+... ....+-...|+.+.++|+|. |||++++.+....++-|.||-++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHk------NIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHK------NIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhH------hHHHHhhccCCCCeEEEEeecCC
Confidence 689999999999999999999999999754 34556677888888888877 89999999999999999999999
Q ss_pred cC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC---
Q 001034 955 AN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD--- 1030 (1182)
Q Consensus 955 Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~--- 1030 (1182)
|+ |-.+++.... .+.-.+..+.+|.+||+.||.|||++.|||||||-+||||+. -.|.+||+|||-++.+..
T Consensus 656 GGSLSsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP 731 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINP 731 (1226)
T ss_pred CCcHHHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCc
Confidence 75 5555554432 233478899999999999999999999999999999999996 468899999999876432
Q ss_pred CcccccCCCcccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhcCCcchhhhhcccccch
Q 001034 1031 HLCSYVQSRSYRAPEVILGL--SYDKKIDIWSLGCILAELCTGNVLFQN-DSPATLLARVIGIIGPIEQGMLAKGRDTYK 1107 (1182)
Q Consensus 1031 ~~ss~vGTp~YmAPEVLlg~--~yS~kSDIWSLGVILYELLTGr~PF~g-~d~~elLakIv~ilGp~PeemL~~~k~s~k 1107 (1182)
-+.++.||..|||||++-.+ +|+.++|||||||++.||.||++||.- .++...+.++ +.+.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-GmyK--------------- 795 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-GMYK--------------- 795 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-ccee---------------
Confidence 34577899999999999765 599999999999999999999999964 3333333332 0000
Q ss_pred hhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1108 YFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1108 ~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.+-.+| ...+.+++.||.+|+.+||.+||+|.+||+.||+++.
T Consensus 796 -----------------vHP~iP---------eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 796 -----------------VHPPIP---------EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred -----------------cCCCCc---------HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 001111 1236789999999999999999999999999999876
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=284.57 Aligned_cols=237 Identities=21% Similarity=0.314 Sum_probs=189.9
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEec
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL 953 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL 953 (1182)
+||.|+||.||+|.+.. ++.||+|++..... ....+..|+.+++.+.| ++|+++++++....+.|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~~~v~e~~ 74 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH------PNIVKLIGVCVQKQPIYIVMELV 74 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCC------CCeEEEEEEEecCCCeEEEEEcC
Confidence 68999999999999877 99999999876432 34567788888888754 48999999999999999999999
Q ss_pred cc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCCc
Q 001034 954 KA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL 1032 (1182)
Q Consensus 954 ~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~ 1032 (1182)
.+ +|.+++..... .++...+..++.+++.||.|||+++++||||+|+|||++. ++.++|+|||++.......
T Consensus 75 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~--~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 75 PGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE--NNVLKISDFGMSREEEGGI 147 (251)
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcC--CCcEEEeeccccccccCCc
Confidence 75 57666654321 3788889999999999999999999999999999999984 6789999999987544221
Q ss_pred c-----cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccc
Q 001034 1033 C-----SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106 (1182)
Q Consensus 1033 s-----s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~ 1106 (1182)
. ....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+.....
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-------------- 213 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-------------- 213 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC--------------
Confidence 1 1223566999999998899999999999999999999 8999987765544443311000
Q ss_pred hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1107 k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......+..+.+||.+||+.+|.+|||+.++|+
T Consensus 214 ----------------------~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 ----------------------M-------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ----------------------C-------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 001123678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=291.99 Aligned_cols=243 Identities=27% Similarity=0.395 Sum_probs=192.1
Q ss_pred EEEEEeccCCceEEEEEEEC----CCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 872 HVTEYLGSAAFSKAIQAHDL----HTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 872 eIlk~LGkGaFGeVyLAkDk----~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.+.+.||.|+||.||+|... ..+..|+||+++.. ......+.+|+++++.++|+ ||+++++++.....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~------ni~~~~g~~~~~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHP------NIVKLYGFCIENEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBT------TBE-EEEEEESSSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccc------cccccccccccccc
Confidence 56789999999999999876 45678999999653 23467888999999988655 89999999998888
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+++||||+. |+|.+++..... ..+++..+..|+.||+.||.|||+.+++|++|++.|||++. ++.+||+|||+
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~--~~~~Kl~~f~~ 149 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDS--NGQVKLSDFGL 149 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEET--TTEEEEESTTT
T ss_pred cccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccccccc--ccccccccccc
Confidence 999999998 678888876511 23889999999999999999999999999999999999994 77899999999
Q ss_pred ccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1025 SCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1025 A~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
+...... .........|+|||++....++.++||||||+++|||++ |+.||...+......++....-
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~------ 223 (259)
T PF07714_consen 150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR------ 223 (259)
T ss_dssp GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------
Confidence 8765221 123345778999999999889999999999999999999 7899988877776655521000
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.......+..+.+||..||..+|.+|||+.+|++
T Consensus 224 -------------------------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 -------------------------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -------------------------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -------------------------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0011234678999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=306.02 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=193.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEE-----CCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHD-----LHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkD-----k~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|++.+.||.|+||.||+|.+ ..+++.||||+++... .....+..|+.++..+.+ |+||+++++++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~niv~~~~~~ 80 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-----HLNVVNLLGAC 80 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccC-----CccHhhhccee
Confidence 46899999999999999999984 3568899999997542 334567789999988854 45999999987
Q ss_pred Eec-CeEEEEEEeccc-ChHHHHhhhcccC--------------------------------------------------
Q 001034 941 YYR-EHLLIVCELLKA-NLYEFHKFNRESG-------------------------------------------------- 968 (1182)
Q Consensus 941 qd~-e~LyLVmEyL~G-sLld~Lk~~~~sg-------------------------------------------------- 968 (1182)
... ..+++||||+.+ +|.+++.......
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 568999999985 6777765432100
Q ss_pred -----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC-----c
Q 001034 969 -----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH-----L 1032 (1182)
Q Consensus 969 -----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~-----~ 1032 (1182)
....+++..+..++.||+.||.|||+++|+||||||.|||++. ++.+||+|||++...... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC--CCcEEEEecccccccccCcchhhc
Confidence 0013677888999999999999999999999999999999984 678999999998754221 1
Q ss_pred ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcc
Q 001034 1033 CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTK 1111 (1182)
Q Consensus 1033 ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k 1111 (1182)
....+++.|+|||++.+..++.++|||||||++|+|++ |..||........+...+. ..
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----------~~--------- 298 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-----------EG--------- 298 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh-----------cc---------
Confidence 12334677999999999999999999999999999997 9999976433221111110 00
Q ss_pred cchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1112 NHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1112 ~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
..... ....++.+.++|.+||+.||.+|||+.+|++|
T Consensus 299 -------------~~~~~---------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 299 -------------TRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -------------CCCCC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000 11245789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=283.06 Aligned_cols=238 Identities=21% Similarity=0.289 Sum_probs=188.6
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEec
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL 953 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL 953 (1182)
+||.|+||.||++.. .++..+|+|+++... .....+.+|+.+++.+. |+||+++++++......++||||+
T Consensus 2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~ 74 (250)
T cd05085 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD------HPNIVKLIGVCTQRQPIYIVMELV 74 (250)
T ss_pred ccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCC------CCCcCeEEEEEecCCccEEEEECC
Confidence 689999999999985 468899999987543 22345777888888775 458999999999999999999999
Q ss_pred cc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCCc
Q 001034 954 KA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL 1032 (1182)
Q Consensus 954 ~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~ 1032 (1182)
.+ +|..++.... ..+.+..+..++.||+.||.|||+.|++||||||+||+++. ++.+||+|||++.......
T Consensus 75 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~--~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 75 PGGDFLSFLRKKK-----DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE--NNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred CCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcC--CCeEEECCCccceeccccc
Confidence 85 5666654322 12788899999999999999999999999999999999984 6789999999986543322
Q ss_pred c----cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccch
Q 001034 1033 C----SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYK 1107 (1182)
Q Consensus 1033 s----s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k 1107 (1182)
. ...++..|+|||++.+..++.++|||||||++|+|++ |..||...........+....
T Consensus 148 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~---------------- 211 (250)
T cd05085 148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---------------- 211 (250)
T ss_pred cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 1 2233567999999998889999999999999999998 999998766555444331000
Q ss_pred hhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1108 YFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1108 ~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. .......+..+.+||.+||..+|.+||++.++++.
T Consensus 212 ------------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 212 ------------------R---------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred ------------------C---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 0 00012346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=306.65 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=205.7
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
..+++..||.|+.|.||++..+.+|..+|||.+++.. .....++..+.++.... +.|+||++|++|..+..++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~-----dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH-----DCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc-----CCCeeeeeeeEEeeCchHH
Confidence 4566778999999999999999999999999998753 33345555555544433 3579999999999999999
Q ss_pred EEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|.||.|...+-.++++.+.+ +++..+-.+...++.||.||.. ++|||||+||+|||+| ..|.|||||||++-
T Consensus 168 IcMelMs~C~ekLlkrik~p-----iPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD--e~GniKlCDFGIsG 240 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGP-----IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD--ERGNIKLCDFGISG 240 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCC-----chHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc--cCCCEEeecccccc
Confidence 99999987766666655433 8899999999999999999985 6899999999999999 58899999999997
Q ss_pred ccCC--CcccccCCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhcCCcchhhhh
Q 001034 1027 FETD--HLCSYVQSRSYRAPEVILG---LSYDKKIDIWSLGCILAELCTGNVLFQN-DSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1027 ~~~~--~~ss~vGTp~YmAPEVLlg---~~yS~kSDIWSLGVILYELLTGr~PF~g-~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+..+ ......|.+.|||||.+.- ..|+.++||||||+.++||.||..||.+ ....+++.+|+....|
T Consensus 241 rlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP------- 313 (391)
T KOG0983|consen 241 RLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP------- 313 (391)
T ss_pred eeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-------
Confidence 6543 3445689999999999964 4699999999999999999999999987 4566777776531111
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
.+. .....++.|.+|+..||+.|+.+||...+||+|||+.+
T Consensus 314 ---------------------------------~L~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 314 ---------------------------------LLP-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred ---------------------------------CCC-cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 011 11126899999999999999999999999999999865
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=328.15 Aligned_cols=254 Identities=28% Similarity=0.473 Sum_probs=213.3
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
-.+.|.|++.||+|.|++|.++.+..++..||||++.+.. .......+|+++++.++|+ |||+++.+....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HP------nIvkl~~v~~t~ 127 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHP------NIVKLFSVIETE 127 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCc------ceeeeeeeeeec
Confidence 3467999999999999999999999999999999998753 3345578899999988765 899999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
..+|+||||..+ .+++++..... +.+..++.++.|++.|++|||+++|||||||++||||+. +..|||+||
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~--~mnikIaDf 199 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE--NMNIKIADF 199 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc--ccceeeecc
Confidence 999999999985 68888776543 566889999999999999999999999999999999994 667999999
Q ss_pred CCccccCC--CcccccCCCcccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1023 GSSCFETD--HLCSYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1023 GLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS-~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
|++.+... ...++||++.|+|||++.+..|. ..+|+||||++||.|++|.+||.+.+..++-.+.+.
T Consensus 200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~---------- 269 (596)
T KOG0586|consen 200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR---------- 269 (596)
T ss_pred ccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------
Confidence 99987543 45678999999999999998875 789999999999999999999988764433222210
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYE 1178 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~e 1178 (1182)
-.+.+| --++.++.+||++||..+|.+|++..++++|.|....++
T Consensus 270 -------------------------gk~rIp---------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 270 -------------------------GKYRIP---------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred -------------------------eeeccc---------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 011111 123678999999999999999999999999999876543
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=288.50 Aligned_cols=245 Identities=20% Similarity=0.292 Sum_probs=195.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCc----EEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGM----DVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr----~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
..+|++.+.||.|+||.||+|..+.++. .+|+|.+.... .....+.+|+.+++.+.| +||+++++++.
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~ 79 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH------PHVVRLLGICL 79 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC------CCcceEEEEEe
Confidence 4689999999999999999999877665 58999887653 234567778888888754 48999999988
Q ss_pred ecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
. ...++||||+. |+|.+++..... .+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+||+
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~--~~~~kL~ 151 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKT--PQHVKIT 151 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcC--CCeEEEC
Confidence 7 78999999998 467777654322 2889999999999999999999999999999999999984 6779999
Q ss_pred cCCCccccCCCcc-----cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1021 DLGSSCFETDHLC-----SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1021 DFGLA~~~~~~~s-----s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|||++........ ...++..|+|||.+....++.++|+|||||++|+|++ |..||......++...+.... .
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~- 229 (279)
T cd05057 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-R- 229 (279)
T ss_pred CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-C-
Confidence 9999876443221 1123567999999988899999999999999999998 999998877665544442100 0
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.......+..+.++|.+||..+|..||++.++++
T Consensus 230 -----------------------------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 -----------------------------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -----------------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011234578899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=329.94 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=213.8
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
|.-++.||.|+||-||.|++..+.+.||||.+.-. ......++.|+++|+.+.|+ |+|.+.+.|.-....
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HP------ntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHP------NTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCC------CcccccceeeccchH
Confidence 55566899999999999999999999999998632 34457889999999999766 899999999988899
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||||-|+..+++...+++ +.+..+..|+.+.+.||.|||+.+.||||||..|||+. ..|.|||.|||.+.
T Consensus 102 WLVMEYClGSAsDlleVhkKp-----lqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs--e~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS--EPGLVKLADFGSAS 174 (948)
T ss_pred HHHHHHHhccHHHHHHHHhcc-----chHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec--CCCeeeeccccchh
Confidence 999999999888888776653 88999999999999999999999999999999999999 58999999999987
Q ss_pred ccCCCcccccCCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1027 FETDHLCSYVQSRSYRAPEVILG---LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1027 ~~~~~~ss~vGTp~YmAPEVLlg---~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
.. .+.++++|||+|||||+++. +.|+-++||||||+++.||.-.+||+.+.+....+--|.+--.
T Consensus 175 i~-~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes----------- 242 (948)
T KOG0577|consen 175 IM-APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------- 242 (948)
T ss_pred hc-CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-----------
Confidence 54 45678999999999999975 5799999999999999999999999988887766666531110
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
|.. ..+.-+..|+.|+..||++-|..|||++++|+|+|....
T Consensus 243 --------------------------PtL-----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 243 --------------------------PTL-----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred --------------------------CCC-----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 110 012236789999999999999999999999999998754
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=289.33 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=191.3
Q ss_pred CCEEEEEEeccCCceEEEEEE----ECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 869 GRYHVTEYLGSAAFSKAIQAH----DLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAk----Dk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.+|++++.||.|+||.||++. +..+++.||+|.+.... .....+..|+.+++.+.| |||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH------DNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC------CCeeEEEEEEccC
Confidence 478999999999999999997 45678999999987543 334567788999888754 4899999987543
Q ss_pred --CeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 944 --EHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 944 --e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
..+++||||+. ++|.+++..... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~--~~~~~l~ 150 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES--ENRVKIG 150 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECC--CCeEEEC
Confidence 56899999997 578777754321 2788899999999999999999999999999999999984 6789999
Q ss_pred cCCCccccCCCcc------cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1021 DLGSSCFETDHLC------SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1021 DFGLA~~~~~~~s------s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|||++........ ...++..|+|||++.+..++.++|||||||++|+|++|..|+..... .....+ +..
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~----~~~ 225 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMM----GND 225 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhc----ccc
Confidence 9999876433211 11234469999999988999999999999999999999887754331 111111 110
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
... ..... ... ..+.. ..........+..+.+||.+||..+|++|||+.+|++
T Consensus 226 ~~~-----~~~~~------~~~------~~~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 226 KQG-----QMIVY------HLI------ELLKN-----NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ccc-----ccchH------HHH------HHHhc-----CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 00000 000 00000 0000112345688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=287.96 Aligned_cols=251 Identities=20% Similarity=0.258 Sum_probs=196.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECC----CCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLH----TGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~----TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
.++|++.+.||+|+||.||+|.+.. ++..|++|++... ......+..|+.+++.+.| +||+++++++.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h------~ni~~~~~~~~ 78 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH------QNILPILHVCI 78 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCC------CCCCeEEEEEe
Confidence 4689999999999999999999876 3688999998754 2334567778888887754 48999999876
Q ss_pred e-cCeEEEEEEecc-cChHHHHhhhcccC--CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 942 Y-REHLLIVCELLK-ANLYEFHKFNRESG--GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 942 d-~e~LyLVmEyL~-GsLld~Lk~~~~sg--gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
. ....+++++|+. ++|..++....... ....+++..+..++.||+.||.|||+.+++||||||+|||++. ++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~--~~~~ 156 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE--ELQV 156 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC--CCcE
Confidence 5 477899999998 57777765542211 1134889999999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhc
Q 001034 1018 KVIDLGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~il 1091 (1182)
||+|||+++...... ....++..|+|||++.+..++.++|||||||++|+|++ |++||...++.+....+....
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 999999987532211 12345667999999999899999999999999999999 999998877655444332100
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.. .....++..+.++|.+||..||++|||+.++++
T Consensus 237 ------------------------------------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 ------------------------------------RL-------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ------------------------------------CC-------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 001124578999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=312.67 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=195.0
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCC-----CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHT-----GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~T-----Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|++++.||.|+||.||+|.+... +..||||+++... .....+.+|+.+++.+. .||||++++++|
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~-----~HpnIv~l~~~~ 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG-----PHLNIVNLLGAC 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----CCCCeeeEEEEE
Confidence 46789999999999999999986433 3569999997542 33456788999998885 255999999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhccc----------------------------------------------------
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRES---------------------------------------------------- 967 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~s---------------------------------------------------- 967 (1182)
.....+||||||+. |+|.+++..+...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999998 4677776543210
Q ss_pred --------------------------------------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEE
Q 001034 968 --------------------------------------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV 1009 (1182)
Q Consensus 968 --------------------------------------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILI 1009 (1182)
.....+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 001136778889999999999999999999999999999999
Q ss_pred ccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 001034 1010 KSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATL 1083 (1182)
Q Consensus 1010 Ds~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~el 1083 (1182)
+. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 271 ~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 271 AQ--GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred eC--CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 84 677999999998754321 123456778999999999999999999999999999997 9999976443322
Q ss_pred HHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT 1163 (1182)
+...+... . .. ......+..+.+||.+||+.||.+|||
T Consensus 349 ~~~~~~~~---------------------------------~--~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt 386 (400)
T cd05105 349 FYNKIKSG---------------------------------Y--RM-------AKPDHATQEVYDIMVKCWNSEPEKRPS 386 (400)
T ss_pred HHHHHhcC---------------------------------C--CC-------CCCccCCHHHHHHHHHHCccCHhHCcC
Confidence 22211000 0 00 011234678999999999999999999
Q ss_pred HHHHHc
Q 001034 1164 ASDALK 1169 (1182)
Q Consensus 1164 AeELLq 1169 (1182)
+.+|.+
T Consensus 387 ~~~l~~ 392 (400)
T cd05105 387 FLHLSD 392 (400)
T ss_pred HHHHHH
Confidence 999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=286.18 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=195.7
Q ss_pred CEEEEEEeccCCceEEEEEEECC-CCcEEEEEEEeccc-----------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLH-TGMDVCVKIIKNNK-----------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~-TGr~VAVKIIkk~k-----------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
.|++.+.||.|+||.||++.+.. +++.+|+|.+.... ........|+.++... ..|+||++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~h~~i~~~~ 75 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ-----LRHPNIVRYY 75 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc-----CCCCCeeeEE
Confidence 37888999999999999999887 78899999886321 1223445566655542 2456999999
Q ss_pred EEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCc
Q 001034 938 DYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRC 1015 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG 1015 (1182)
++|....++|+||||+.+ +|.+++....... ..+++..++.++.||+.||.|||+ .+++|+||+|.|||++. ++
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~--~~ 151 (269)
T cd08528 76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK--QRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE--DD 151 (269)
T ss_pred eeEccCCeEEEEEecCCCCcHHHHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC--CC
Confidence 999999999999999985 6767664432221 238888999999999999999996 78999999999999984 67
Q ss_pred eEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1016 EVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
.++|+|||.+...... .....++..|+|||++.+..++.++|+||||+++|+|++|++||...........+......
T Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 152 KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 8999999998754433 23456788999999999888999999999999999999999999877665544444210000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
| . .....+..+.+||.+||+.||.+||++.|+..+
T Consensus 232 ------------------------------------~----~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 232 ------------------------------------P----L--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ------------------------------------c----C--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0 0 011346789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=286.65 Aligned_cols=246 Identities=22% Similarity=0.255 Sum_probs=183.4
Q ss_pred EeccCCceEEEEEEEC--CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEE
Q 001034 876 YLGSAAFSKAIQAHDL--HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk--~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmE 951 (1182)
.||+|+||.||+|... .....+|+|.+.... .....+.+|+.+++.+. |+||+++++.|.....+|+|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~------h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN------HPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCC------CCCcceEEEEECCCCceEEEEE
Confidence 5899999999999643 245578888876432 22345667888877765 4599999999999999999999
Q ss_pred eccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC
Q 001034 952 LLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 952 yL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~ 1030 (1182)
|+.+ +|.+++...... ....+.+..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~--~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 76 FCPLGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTA--DLSVKIGDYGLALEQYP 152 (269)
T ss_pred eCCCCcHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecC--CCcEEEecccccccccc
Confidence 9985 677777654321 1122567778899999999999999999999999999999994 67899999999864321
Q ss_pred C-----cccccCCCcccchhhhc-------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1031 H-----LCSYVQSRSYRAPEVIL-------GLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1031 ~-----~ss~vGTp~YmAPEVLl-------g~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
. .....+++.|+|||++. ...++.++|||||||++|+|++ |.+||....+.+.+..++.....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~---- 228 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI---- 228 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc----
Confidence 1 12234567799999974 3457889999999999999999 88999877766655554311110
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
..+. .......+..+.+++..|+ .||.+|||+.+|++
T Consensus 229 ------------------------------~~~~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 229 ------------------------------KLPK----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ------------------------------cCCC----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0000 0112235678889999888 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.91 Aligned_cols=260 Identities=22% Similarity=0.276 Sum_probs=192.9
Q ss_pred CEEEEEEeccCCceEEEEEEE----CCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 870 RYHVTEYLGSAAFSKAIQAHD----LHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkD----k~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
-|++++.||+|+||.||+|.. ..++..||+|.++.. ......+.+|+.+++.+.| +||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~ 78 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH------ENIVKYKGICTED 78 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCC------CCeeeeeeEEecC
Confidence 378899999999999999974 467899999998754 2334567788899888755 4899999998875
Q ss_pred --CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 944 --EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 944 --e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
..+++||||++| +|.+++..... .+++..+..++.||+.||.|||+.|++||||||+|||++. ++.++|+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~--~~~~~l~ 151 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES--EHQVKIG 151 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcC--CCCEEEC
Confidence 678999999975 67766643321 2788899999999999999999999999999999999984 6779999
Q ss_pred cCCCccccCCCc------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1021 DLGSSCFETDHL------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1021 DFGLA~~~~~~~------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|||++....... ....++..|+|||++.+..++.++|||||||++|+|++++.|+.... . .+....++.
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~--~---~~~~~~~~~ 226 (284)
T cd05079 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPM--T---LFLKMIGPT 226 (284)
T ss_pred CCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcccc--c---hhhhhcccc
Confidence 999987543321 23455678999999998899999999999999999999887764421 1 111222222
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
....... .. ...+... . .......++..+.+||.+||+.+|.+|||+.+++++
T Consensus 227 ~~~~~~~------------~~------~~~~~~~--~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 227 HGQMTVT------------RL------VRVLEEG--K---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cccccHH------------HH------HHHHHcC--c---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1110000 00 0000000 0 001123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=286.51 Aligned_cols=237 Identities=18% Similarity=0.251 Sum_probs=186.1
Q ss_pred EeccCCceEEEEEEEC--CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEE
Q 001034 876 YLGSAAFSKAIQAHDL--HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk--~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmE 951 (1182)
.||.|+||.||+|... ..+..||+|++.... .....+.+|+.+++.+.| +||+++++++. ...+++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h------~~ii~~~~~~~-~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN------PYIVRMIGVCE-AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCC------CCeEEEEEEEc-CCCeEEEEE
Confidence 4899999999999764 456679999997653 233557788899988855 48999999875 457899999
Q ss_pred eccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC
Q 001034 952 LLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 952 yL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~ 1030 (1182)
|+++ +|.+++..... .+++..++.++.||+.||.|||++|++||||||+|||++. ++.+||+|||++.....
T Consensus 75 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 75 MASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGA 147 (257)
T ss_pred eCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC--CCcEEeccCCccccccC
Confidence 9985 56666653321 3889999999999999999999999999999999999984 67899999999875432
Q ss_pred Cc------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1031 HL------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1031 ~~------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
.. ....+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------- 216 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR----------- 216 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-----------
Confidence 21 11123568999999998889999999999999999996 9999988776655444321000
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.......+.++.+||.+||.++|++||++.++++
T Consensus 217 --------------------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 --------------------------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011234689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=312.30 Aligned_cols=288 Identities=24% Similarity=0.428 Sum_probs=226.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEec---cchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe--
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN---NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY-- 942 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk---~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd-- 942 (1182)
.+.|+-+.+||+|.||+||+|+.+.+++.||+|++-- ...+-...++|+++|..+.|. |++.++.++..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHe------nv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHE------NVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcch------hHHHHHHHHhhcc
Confidence 4567788899999999999999999999999987532 234456678999999999877 56666554432
Q ss_pred ------cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 943 ------REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 943 ------~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
...+|+||.+|..+|.-++.... ..|+..++..++.+++.||.|||...|+|||+||.|+||+ ++|.
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt--~dgi 162 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT--KDGI 162 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc--CCce
Confidence 24599999999988877765432 2399999999999999999999999999999999999999 5899
Q ss_pred EEEecCCCccccCCC-------cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 001034 1017 VKVIDLGSSCFETDH-------LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~~-------~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv 1088 (1182)
+||+|||+++..... ....+-|.+|++||.++|. .|+++.|||..||||.+|+++.+.|.+++....+..|.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 999999999643221 2334569999999999986 59999999999999999999999999999999999999
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcccccc--ccccC--CCCCcHHHHHHHHHhcccCCCCCCCH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT--SLRHR--LPMGDQGFIDFVAHLLEINPKKRPSA 1164 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~--sL~~~--l~~~SeeL~DLIrkMLq~DPekRPTA 1164 (1182)
.++|.+..++|.......-+ ... + ....|+.. .+..+ .-.-++++.+||.+||.+||.+|+++
T Consensus 243 ~LcGs~tkevWP~~d~lpL~--------~si-e----~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a 309 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLY--------QSI-E----LEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA 309 (376)
T ss_pred HHhccCCcccCCCcccchHH--------Hhc-c----CCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch
Confidence 99999888777654332111 000 0 00011110 00011 11226789999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCC
Q 001034 1165 SDALKHPWLSHPYEPIS 1181 (1182)
Q Consensus 1165 eELLqHPWFk~~~eP~~ 1181 (1182)
.++|.|.||...+.|++
T Consensus 310 d~alnh~~F~kdp~pqa 326 (376)
T KOG0669|consen 310 DQALNHDFFWKDPMPQA 326 (376)
T ss_pred HhhhchhhhhcCCcchh
Confidence 99999999999988864
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=290.87 Aligned_cols=238 Identities=19% Similarity=0.251 Sum_probs=182.4
Q ss_pred EeccCCceEEEEEEECCCCc-------EEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 876 YLGSAAFSKAIQAHDLHTGM-------DVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr-------~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.||.|+||.||+|.+...+. .+|+|.+.... ...+.+..|+.+++.+. ||||+++++++......+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~------h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS------HKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCC------CCChhheeeEEEeCCCcE
Confidence 68999999999999865544 38888886543 33455667778877765 459999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC------ceEEEe
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR------CEVKVI 1020 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d------G~IKLi 1020 (1182)
+||||+.+ +|..++..... .+++..+..++.||+.||.|||++||+||||||+|||++..+. +.++|+
T Consensus 76 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~ 150 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEec
Confidence 99999986 56666654332 3788889999999999999999999999999999999985322 237999
Q ss_pred cCCCccccCCCcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1021 DLGSSCFETDHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGN-VLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1021 DFGLA~~~~~~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr-~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
|||++..... .....+++.|+|||++.+. .++.++|||||||++|+|++|. +||...++........ ..
T Consensus 151 d~g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~~------- 221 (258)
T cd05078 151 DPGISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-DR------- 221 (258)
T ss_pred ccccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-cc-------
Confidence 9999865432 2335678899999999874 5899999999999999999984 6766544433221110 00
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.. .....+..+.+||.+||+.||.+|||+.++++.
T Consensus 222 ----------------------------~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 ----------------------------HQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ----------------------------cc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00 011234678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=283.16 Aligned_cols=237 Identities=22% Similarity=0.277 Sum_probs=183.3
Q ss_pred EEeccCCceEEEEEEECCCC----------cEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 875 EYLGSAAFSKAIQAHDLHTG----------MDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TG----------r~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
+.||+|+||.||++.+..++ ..+++|++.........+.+|+.+++.+.| +||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH------KHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCC------cchhheeeEEec-C
Confidence 36899999999999998776 358888877655435677788888887754 489999999988 7
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC-----ceEE
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-----CEVK 1018 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d-----G~IK 1018 (1182)
..++||||+.+ +|..++..... .++...+..++.||+.||.|||++||+||||||+|||++.... ..+|
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence 78999999986 56666554331 3788889999999999999999999999999999999985321 1699
Q ss_pred EecCCCccccCCCcccccCCCcccchhhhcCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1019 VIDLGSSCFETDHLCSYVQSRSYRAPEVILGL--SYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1019 LiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~--~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
|+|||++..... .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||...+......... .
T Consensus 149 l~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~----- 221 (259)
T cd05037 149 LSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-D----- 221 (259)
T ss_pred eCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-c-----
Confidence 999999876543 2334567789999999876 78999999999999999999 578886654322111110 0
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
....+ ......+.+||.+||..+|.+|||+.++|+
T Consensus 222 ------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 ------------------------------QHRLP---------MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------------------------------CCCCC---------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 001268899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=286.12 Aligned_cols=249 Identities=19% Similarity=0.269 Sum_probs=192.2
Q ss_pred EEEEEEeccCCceEEEEEEEC---CCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 871 YHVTEYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
|.+.+.||+|+||.||+|... .+++.||||++.... ...+.+.+|+.+++.+.| |||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH------PNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCC------CCcceEEEEEccCC
Confidence 667889999999999999864 367899999997642 334567788888888754 48999999887542
Q ss_pred ------eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 945 ------HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 945 ------~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
..+++++|+.+ +|..++...........++...++.++.||+.||.|||+.+|+||||||+|||++. .+.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~--~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE--NMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcC--CCCE
Confidence 24788999884 56655543322222234788889999999999999999999999999999999984 6779
Q ss_pred EEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhc
Q 001034 1018 KVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~il 1091 (1182)
||+|||+++..... .....+++.|++||.+....++.++|||||||++|+|++ |++||...+....+..+....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998754322 122344678999999999899999999999999999999 899998777655544442100
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. + ...+..+..+.+|+.+||..+|..||++.+++++
T Consensus 233 -~-------------------------------~-----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 233 -R-------------------------------L-----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -c-------------------------------C-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0 0012345789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=335.61 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=196.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++.++||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.+.| |||+++++++....
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~H------PNIVkl~~v~~d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH------PGIVPVYSICSDGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCC------cCcCeEEEEEeeCC
Confidence 68999999999999999999999999999999997542 234567788998888865 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccC-----CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESG-----GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sg-----gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
..|+||||+.| +|.+++....... ....++...+..++.||+.||.|||++||+||||||+|||++. .+.++
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~--dg~vK 153 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL--FGEVV 153 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcC--CCCEE
Confidence 99999999985 6766665321110 0112556778899999999999999999999999999999984 67799
Q ss_pred EecCCCccccCC---------------------CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001034 1019 VIDLGSSCFETD---------------------HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN 1077 (1182)
Q Consensus 1019 LiDFGLA~~~~~---------------------~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g 1077 (1182)
|+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999875411 01124689999999999999999999999999999999999999976
Q ss_pred CCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccC
Q 001034 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1078 ~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~D 1157 (1182)
........... .. .|.. .......+..+.+++.+||..|
T Consensus 234 ~~~~ki~~~~~--i~------------------------------------~P~~---~~p~~~iP~~L~~LI~rcL~~D 272 (932)
T PRK13184 234 KKGRKISYRDV--IL------------------------------------SPIE---VAPYREIPPFLSQIAMKALAVD 272 (932)
T ss_pred cchhhhhhhhh--cc------------------------------------Chhh---ccccccCCHHHHHHHHHHccCC
Confidence 44322211100 00 0000 0011245678999999999999
Q ss_pred CCCCCCHHHHHc
Q 001034 1158 PKKRPSASDALK 1169 (1182)
Q Consensus 1158 PekRPTAeELLq 1169 (1182)
|.+|++..+.|.
T Consensus 273 P~kR~ss~eeLl 284 (932)
T PRK13184 273 PAERYSSVQELK 284 (932)
T ss_pred hhhCcCHHHHHH
Confidence 999988766554
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=287.50 Aligned_cols=239 Identities=18% Similarity=0.275 Sum_probs=179.5
Q ss_pred EeccCCceEEEEEEECC------------CCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 876 YLGSAAFSKAIQAHDLH------------TGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~------------TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.||+|+||.||++.... ....+|+|++.... .....+..|+.+++.+.| |||+++++++..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~h------p~iv~~~~~~~~ 75 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSH------KHIVLLYGVCVR 75 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCC------CCEeeEEEEEec
Confidence 68999999999997432 23358889876543 233455667777777754 599999999999
Q ss_pred cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC-----ceE
Q 001034 943 REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-----CEV 1017 (1182)
Q Consensus 943 ~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d-----G~I 1017 (1182)
....++||||+.++.+..+..... ..+++..+..++.||+.||.|||+.+|+||||||+|||++..+. ..+
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCcee
Confidence 999999999999765544433221 13788899999999999999999999999999999999975221 238
Q ss_pred EEecCCCccccCCCcccccCCCcccchhhhc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVIL-GLSYDKKIDIWSLGCILAELC-TGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~vGTp~YmAPEVLl-g~~yS~kSDIWSLGVILYELL-TGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
+|+|||++...... ....++..|+|||++. +..++.++|||||||++|+|+ .|..||......+.. .+.. .
T Consensus 152 ~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~---~-- 224 (262)
T cd05077 152 KLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYE---G-- 224 (262)
T ss_pred EeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHh---c--
Confidence 99999998654322 3346788899999987 567899999999999999998 588888765432221 1100 0
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. . ......+.++.+||.+||+.||.+||++.+||++
T Consensus 225 ----------------------------~----~-------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 ----------------------------Q----C-------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ----------------------------C----c-------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 0 0011124678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.85 Aligned_cols=287 Identities=31% Similarity=0.540 Sum_probs=236.7
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
...||.-++.+|.|+- .|..|.|.-.++.||+|.+... ........+|+.++..++|. ||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~------nii~l~n~ftP~ 87 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHK------NIISLLNVFTPQ 87 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhccc------ceeeeeeccCcc
Confidence 4578999999999999 8899999999999999987643 23345677899998888766 899999999754
Q ss_pred ------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 944 ------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 944 ------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
..+|+|||+|.++|...+... +.-..+..|++|++.|+.|||+.||+||||||+||++.. .+.+
T Consensus 88 ~~l~~~~e~y~v~e~m~~nl~~vi~~e--------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~--~~~l 157 (369)
T KOG0665|consen 88 KTLEEFQEVYLVMELMDANLCQVILME--------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNS--DCTL 157 (369)
T ss_pred ccHHHHHhHHHHHHhhhhHHHHHHHHh--------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecc--hhhe
Confidence 468999999999999988733 566789999999999999999999999999999999984 8899
Q ss_pred EEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1018 KVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
||.|||++...... .+.++.|+.|+|||++.+..|...+||||+|||+.||++|...|.+.+..+.+.+|+..+|.+.
T Consensus 158 Ki~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 158 KILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred eeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence 99999999765443 5677899999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhcccccccc--ccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSL--RHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL--~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
..++.+...+..-|..+.. +... ..+....|...-. ....+.....+++|+.+||..||++|.++++||+||||
T Consensus 238 ~~F~~qL~~~~r~yv~~~~---~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRP---QYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred HHHHHHhhHHHHHHhhcCh---Hhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 8888877666554443221 1111 2333334433211 11113445789999999999999999999999999999
Q ss_pred C
Q 001034 1174 S 1174 (1182)
Q Consensus 1174 k 1174 (1182)
+
T Consensus 314 ~ 314 (369)
T KOG0665|consen 314 K 314 (369)
T ss_pred e
Confidence 7
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=282.12 Aligned_cols=239 Identities=19% Similarity=0.256 Sum_probs=181.2
Q ss_pred EeccCCceEEEEEEECC---CCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE-ecCeEEEE
Q 001034 876 YLGSAAFSKAIQAHDLH---TGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY-YREHLLIV 949 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~---TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq-d~e~LyLV 949 (1182)
.||+|+||.||+|.... ....+|+|.+... ......+..|+.+++.+. ||||+++++++. .....++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS------HPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCC------CCCcceEEEEeecCCCCcEEE
Confidence 68999999999998653 3457999988543 233456667777777665 458999999765 45568999
Q ss_pred EEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 950 CELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 950 mEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
|||+. ++|.+++..... .+....+..++.||+.||.|||+.+++||||||+|||++. .+.+||+|||+++..
T Consensus 76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~--~~~~kl~dfg~~~~~ 148 (262)
T cd05058 76 LPYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE--SFTVKVADFGLARDI 148 (262)
T ss_pred EecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC--CCcEEECCccccccc
Confidence 99998 467777654321 1566778889999999999999999999999999999984 677999999998643
Q ss_pred CCC-------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1029 TDH-------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1029 ~~~-------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
... .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~-------- 220 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR-------- 220 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--------
Confidence 321 112345678999999998899999999999999999999 5677876665544333310000
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
... ....+..+.+||.+||..+|++||++.++++.
T Consensus 221 --------------------------~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 --------------------------LLQ---------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred --------------------------CCC---------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000 01235689999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=283.95 Aligned_cols=246 Identities=22% Similarity=0.245 Sum_probs=184.2
Q ss_pred EeccCCceEEEEEEEC--CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEE
Q 001034 876 YLGSAAFSKAIQAHDL--HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk--~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmE 951 (1182)
.||+|+||.||+|... .++..+|+|.++... .....+.+|+.+++.+.| |||+++++++.....+++|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQH------SNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCC------CCEeeEEEEEcCCCCcEEEEE
Confidence 6899999999999754 456789999987543 223456778888888754 489999999999999999999
Q ss_pred ecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC
Q 001034 952 LLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 952 yL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~ 1030 (1182)
|++ |+|.+++..... .....++...++.++.||+.||.|||+.+++|+||||+|||++. .+.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~--~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRK-AELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA--DLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--CCcEEECCccccccccC
Confidence 998 567777764432 12233667778889999999999999999999999999999985 67899999999864332
Q ss_pred C-----cccccCCCcccchhhhcCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1031 H-----LCSYVQSRSYRAPEVILGL-------SYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1031 ~-----~ss~vGTp~YmAPEVLlg~-------~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
. .....++..|+|||++... .++.++|+|||||++|+|++ |++||......+.+...+...
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------ 226 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ------ 226 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc------
Confidence 2 1224567889999998642 36789999999999999996 999998766554433221000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
......|. .....+..+.++|.+|+ .+|.+|||+.+|+.
T Consensus 227 --------------------------~~~~~~~~------~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 227 --------------------------QLKLPKPR------LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------------------cCCCCCCc------cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00000000 01123567899999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=285.24 Aligned_cols=260 Identities=23% Similarity=0.291 Sum_probs=194.8
Q ss_pred CCEEEEEEeccCCceEEEEEEEC----CCCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDL----HTGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk----~TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..|++.+.||+|+||.||+|... .++..+|+|++..... ....+..|+.+++.+.|+ ||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~------~i~~~~~~~~~ 77 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE------NIVKYKGVCEK 77 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCC------ChheEEeeeec
Confidence 46888899999999999999854 3588999999986654 356788888888887654 89999999887
Q ss_pred --cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 943 --REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 943 --~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
...+++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+.||+|+||||+|||++. ++.++|
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l 150 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVES--EDLVKI 150 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEE
Confidence 5689999999974 78777765432 2888899999999999999999999999999999999985 678999
Q ss_pred ecCCCccccCCCcc------cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1020 IDLGSSCFETDHLC------SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1020 iDFGLA~~~~~~~s------s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
+|||++........ ...++..|+|||.+.+..++.++|+|||||++|+|++|..||....... +...++
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~ 225 (284)
T cd05038 151 SDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGI 225 (284)
T ss_pred cccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccc
Confidence 99999876542211 1234556999999998899999999999999999999999986543211 111111
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.+... ..... ...+.... ........+..+.+||.+||+++|.+|||+.+|++
T Consensus 226 ~~~~~----------------~~~~~--~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 226 AQGQM----------------IVTRL--LELLKEGE-----RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ccccc----------------cHHHH--HHHHHcCC-----cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 10000 00000 00000000 00111234578999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=297.80 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=199.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec---
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--- 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--- 943 (1182)
..||+|.+.||.|+|+-|++++...+++.||+|.+.-.. ...+..++|+...+.++++ ||++++++....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~------~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSP------NVLRLVDHQLREEKD 93 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCc------chHHHHHHHHHhhcc
Confidence 479999999999999999999999999999999886543 5567778888888888664 899998876554
Q ss_pred --CeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccccCCccEEEccCCCceEE
Q 001034 944 --EHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 944 --e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRDIKPeNILIDs~~dG~IK 1018 (1182)
...||+++|.. |+|.+.+......+. ++++.++..|+.+|++||++||+.. ++||||||.|||+.. .+.++
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~--~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~--~~~~v 169 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGN--FVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD--SGLPV 169 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCC--ccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC--CCceE
Confidence 34999999987 779999987765433 5999999999999999999999998 999999999999994 67899
Q ss_pred EecCCCccccCCCcc------------cccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 001034 1019 VIDLGSSCFETDHLC------------SYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083 (1182)
Q Consensus 1019 LiDFGLA~~~~~~~s------------s~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~el 1083 (1182)
|.|||.++....... .-.-|..|+|||++. +...+.++|||||||+||+|+.|..||..
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~------ 243 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER------ 243 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH------
Confidence 999999875432211 123378899999995 44678999999999999999999999932
Q ss_pred HHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT 1163 (1182)
+.+.-|.+... ....+..+|. ...+++.+.+||..||+.||.+||+
T Consensus 244 ---~~~~GgSlaLA------------------------v~n~q~s~P~-------~~~yse~l~~lik~mlqvdP~qRP~ 289 (302)
T KOG2345|consen 244 ---IYQQGGSLALA------------------------VQNAQISIPN-------SSRYSEALHQLIKSMLQVDPNQRPT 289 (302)
T ss_pred ---HhhcCCeEEEe------------------------eeccccccCC-------CCCccHHHHHHHHHHhcCCcccCCC
Confidence 21111111100 0011112222 2337899999999999999999999
Q ss_pred HHHHHcC
Q 001034 1164 ASDALKH 1170 (1182)
Q Consensus 1164 AeELLqH 1170 (1182)
+.++|.+
T Consensus 290 i~~ll~~ 296 (302)
T KOG2345|consen 290 IPELLSK 296 (302)
T ss_pred HHHHHHH
Confidence 9999875
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=325.37 Aligned_cols=247 Identities=27% Similarity=0.466 Sum_probs=209.7
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEEe-----ccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe--
Q 001034 873 VTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-----NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH-- 945 (1182)
Q Consensus 873 Ilk~LGkGaFGeVyLAkDk~TGr~VAVKIIk-----k~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~-- 945 (1182)
...+||+|+|-+||+|.|..+|..||--.++ +.....+.+..|+.+|+.|+|+ |||++|+++.+...
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~------NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHP------NIIRFYDSWVDTDNKT 117 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCC------ceeeeeeheecCCCce
Confidence 4468999999999999999999998854433 2344557889999999998765 89999999998755
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccccCCccEEEccCCCceEEEecC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
+.+|+|++. |+|+.|.+..+. +....++.|++||+.||.|||++. |||||||.+||||+. ..|.|||.|+
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG-~~G~VKIGDL 190 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG-NLGEVKIGDL 190 (632)
T ss_pred eeeeeecccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-CcCceeecch
Confidence 889999998 789999887765 778899999999999999999875 999999999999995 6789999999
Q ss_pred CCccccCCC-cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhcCCcchhhhh
Q 001034 1023 GSSCFETDH-LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN-DSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1023 GLA~~~~~~-~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g-~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
|+|+..... ..+.+|||.|||||++. ..|+..+||||||+.|+||+|+..||.- .++.+++++++....| ..+
T Consensus 191 GLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP--~sl-- 265 (632)
T KOG0584|consen 191 GLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP--AAL-- 265 (632)
T ss_pred hHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH--HHh--
Confidence 999876654 44569999999999998 7899999999999999999999999975 7788889888643322 211
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
....++++++||.+||.. ...|||+.|||+||||...
T Consensus 266 --------------------------------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 266 --------------------------------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred --------------------------------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 011258899999999999 9999999999999999874
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=308.06 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=197.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|.+.+.||.|+||.||+|.+. .+++.||+|+++... .....+..|+.+|..+.. ||||+++++++
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~-----H~niv~~~~~~ 110 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGP-----HLNIVNLLGAC 110 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCC-----CCCeEEEEEEE
Confidence 467889999999999999999853 456789999997542 223467789999988852 45999999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhccc----------------------------------------------------
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRES---------------------------------------------------- 967 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~s---------------------------------------------------- 967 (1182)
....++||||||+. |+|.+++..+...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999 5788877654210
Q ss_pred ----------------------------------------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccE
Q 001034 968 ----------------------------------------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007 (1182)
Q Consensus 968 ----------------------------------------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNI 1007 (1182)
.....+++..+..|+.||+.||.|||+.+|+||||||.||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 0011367778889999999999999999999999999999
Q ss_pred EEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 001034 1008 LVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPA 1081 (1182)
Q Consensus 1008 LIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~ 1081 (1182)
|++. .+.+||+|||+++..... .....+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 271 Ll~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 271 LICE--GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EEeC--CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 9984 678999999998753221 223456788999999999899999999999999999998 89999765544
Q ss_pred HHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCC
Q 001034 1082 TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161 (1182)
Q Consensus 1082 elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekR 1161 (1182)
+.+...+.. + ... .....++..+.+||.+||..+|.+|
T Consensus 349 ~~~~~~~~~-~--------------------------------~~~---------~~p~~~~~~l~~li~~cl~~~P~~R 386 (401)
T cd05107 349 EQFYNAIKR-G--------------------------------YRM---------AKPAHASDEIYEIMQKCWEEKFEIR 386 (401)
T ss_pred HHHHHHHHc-C--------------------------------CCC---------CCCCCCCHHHHHHHHHHcCCChhHC
Confidence 333222100 0 000 0112346889999999999999999
Q ss_pred CCHHHHHcC
Q 001034 1162 PSASDALKH 1170 (1182)
Q Consensus 1162 PTAeELLqH 1170 (1182)
|++.+|++.
T Consensus 387 Ps~~ell~~ 395 (401)
T cd05107 387 PDFSQLVHL 395 (401)
T ss_pred cCHHHHHHH
Confidence 999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=327.04 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=215.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.+++++..||.|+||.|=++.-......+|+|++++. ..+.+++..|..|+..+..+ +||+||..|.+..
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~------fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSD------FIVRLYRTFRDSK 493 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCch------HHHHHHHHhccch
Confidence 3456777899999999999987666556999999864 35567888899999888644 9999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++|++||.|-| .+...++.+. .|....+++|+.+++.|++|||++|||+|||||+|+|++ .+|.+||.|||
T Consensus 494 yvYmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd--~~Gy~KLVDFG 565 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD--NRGYLKLVDFG 565 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec--cCCceEEeehh
Confidence 99999999875 5777666443 289999999999999999999999999999999999999 48899999999
Q ss_pred CccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1024 SSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1024 LA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+|+.... .+.++||||.|.|||+++.+..+.++|+||||+++||||+|.+||.+.++..++..|+..+..+.
T Consensus 566 FAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~------ 639 (732)
T KOG0614|consen 566 FAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE------ 639 (732)
T ss_pred hHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh------
Confidence 9987554 56689999999999999999999999999999999999999999999999999999974332210
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~~ 1176 (1182)
+| ..+...+.+||+++...+|.+|+. ..+|-+|-||...
T Consensus 640 ---------------------------~P---------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 640 ---------------------------FP---------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred ---------------------------cc---------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 11 123456889999999999999987 8899999999765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=323.75 Aligned_cols=275 Identities=20% Similarity=0.185 Sum_probs=178.8
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCC----CcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE----
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHT----GMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY---- 939 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~T----Gr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds---- 939 (1182)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .|..+...+.+.. +.++..++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------~e~~~~e~l~~~~---~~~~~~~~~~~~~~ 201 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------VEIWMNERVRRAC---PNSCADFVYGFLEP 201 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------hHHHHHHHHHhhc---hhhHHHHHHhhhcc
Confidence 46899999999999999999999988 99999998864321 1222222222110 0011111111
Q ss_pred --EEecCeEEEEEEeccc-ChHHHHhhhcccC--------------CccccCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q 001034 940 --FYYREHLLIVCELLKA-NLYEFHKFNRESG--------------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDL 1002 (1182)
Q Consensus 940 --Fqd~e~LyLVmEyL~G-sLld~Lk~~~~sg--------------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDI 1002 (1182)
......++|||||+.+ +|.+++....... .........+..++.||+.||.|||+.+|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2345679999999985 5777765332100 0001223456789999999999999999999999
Q ss_pred CCccEEEccCCCceEEEecCCCccccCC----CcccccCCCcccchhhhcCC----------------------CCCchh
Q 001034 1003 KPENILVKSYSRCEVKVIDLGSSCFETD----HLCSYVQSRSYRAPEVILGL----------------------SYDKKI 1056 (1182)
Q Consensus 1003 KPeNILIDs~~dG~IKLiDFGLA~~~~~----~~ss~vGTp~YmAPEVLlg~----------------------~yS~kS 1056 (1182)
||+|||++. ..+.+||+|||+++.... .....++++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~-~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSE-GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeC-CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999984 356899999999975432 23456789999999976432 234567
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccc
Q 001034 1057 DIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLR 1136 (1182)
Q Consensus 1057 DIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~ 1136 (1182)
||||||||||||+++..|+ .+....+.+++...+.....|.... ... ..+......
T Consensus 361 DVwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~--------------~~~--------~~~~~~~~~ 416 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLV--------------EPR--------ASPDLRRGF 416 (566)
T ss_pred ccHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhh--------------ccc--------cchhhhhhh
Confidence 9999999999999976654 3333334444332222111110000 000 000000001
Q ss_pred cCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1137 HRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1137 ~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.........+.+||.+||++||++|||+.++|+||||+..
T Consensus 417 ~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 417 EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred hhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCC
Confidence 1122334567899999999999999999999999999864
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=289.84 Aligned_cols=246 Identities=20% Similarity=0.268 Sum_probs=190.8
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCc----EEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGM----DVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr----~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
..+|++.+.||.|+||.||++.+..++. .+|+|++.... .....+..|+.+++.+.| +||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h------~niv~~~~~~~ 79 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH------PHLVRLLGVCL 79 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCC------CCcccEEEEEc
Confidence 4578999999999999999999887776 46888886543 222345677777777754 58999999887
Q ss_pred ecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
.. ..++|++|+. |+|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~--~~~~kL~ 151 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS--PNHVKIT 151 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecC--CCceEEc
Confidence 54 5679999998 567777654321 2788889999999999999999999999999999999984 6679999
Q ss_pred cCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1021 DLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1021 DFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|||+++..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+. ....
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~- 229 (303)
T cd05110 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGER- 229 (303)
T ss_pred cccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCC-
Confidence 99999754322 112344678999999999999999999999999999997 999998765444332221 0000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. ...+..+..+.+||.+|+..+|++||++.++++.
T Consensus 230 ----------------------------------~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 230 ----------------------------------L-------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ----------------------------------C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0112345788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=286.11 Aligned_cols=239 Identities=19% Similarity=0.265 Sum_probs=177.8
Q ss_pred EeccCCceEEEEEEECC------------------------CCcEEEEEEEeccch-hhHHHHHHHHHHHHhcCCCCCCC
Q 001034 876 YLGSAAFSKAIQAHDLH------------------------TGMDVCVKIIKNNKD-FFDQSLDEIKLLKYVNKHDPGDK 930 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~------------------------TGr~VAVKIIkk~k~-~~dq~l~EikILr~L~h~~~l~H 930 (1182)
.||+|+||.||++.... ....||+|++..... ....+.+|+.+++.+. |
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~------h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS------H 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC------C
Confidence 58999999999987432 124588898865432 2334556666666664 5
Q ss_pred cceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEc
Q 001034 931 YHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVK 1010 (1182)
Q Consensus 931 PnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILID 1010 (1182)
|||+++++++......|+||||++++.+..+..... ..+++..+..++.||+.||.|||+.+|+||||||+|||++
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 599999999999999999999999765444432211 1378888999999999999999999999999999999997
Q ss_pred cCC-----CceEEEecCCCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHH
Q 001034 1011 SYS-----RCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELC-TGNVLFQNDSPATL 1083 (1182)
Q Consensus 1011 s~~-----dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELL-TGr~PF~g~d~~el 1083 (1182)
..+ ...+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|+|+ +|..||....+.+.
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 522 234899999987543222 23457788999999875 56899999999999999995 69999977654332
Q ss_pred HHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT 1163 (1182)
...+. . ....| ......+.+||.+||+.+|.+|||
T Consensus 231 ~~~~~-~-----------------------------------~~~~~---------~~~~~~~~~li~~cl~~~p~~Rps 265 (274)
T cd05076 231 ERFYE-K-----------------------------------KHRLP---------EPSCKELATLISQCLTYEPTQRPS 265 (274)
T ss_pred HHHHH-h-----------------------------------ccCCC---------CCCChHHHHHHHHHcccChhhCcC
Confidence 21110 0 00000 112357899999999999999999
Q ss_pred HHHHHcC
Q 001034 1164 ASDALKH 1170 (1182)
Q Consensus 1164 AeELLqH 1170 (1182)
+.++|++
T Consensus 266 ~~~il~~ 272 (274)
T cd05076 266 FRTILRD 272 (274)
T ss_pred HHHHHHh
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-31 Score=279.47 Aligned_cols=245 Identities=19% Similarity=0.207 Sum_probs=181.6
Q ss_pred EeccCCceEEEEEEECCC--CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEE
Q 001034 876 YLGSAAFSKAIQAHDLHT--GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~T--Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmE 951 (1182)
.||+|+||.||++..... ...+++|.+.... .....+.+|+.+++.++ ||||+++++.|.....+|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~------h~~iv~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ------HPNILQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccC------CcchhheEEEecCCCccEEEEe
Confidence 589999999999975332 3456677766442 23456777777777665 4599999999999999999999
Q ss_pred eccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC
Q 001034 952 LLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 952 yL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~ 1030 (1182)
|+.+ +|..++...... ...++...++.++.||+.||.|||+.+++||||||+|||++. ++.++|+|||++.....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~--~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS--DLTVKVGDYGIGPSRYK 151 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcC--CccEEecccccccccCc
Confidence 9995 777777643221 112667778899999999999999999999999999999984 77899999999764221
Q ss_pred -----CcccccCCCcccchhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1031 -----HLCSYVQSRSYRAPEVILG-------LSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1031 -----~~ss~vGTp~YmAPEVLlg-------~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
.....+++..|+|||++.. ..++.++|||||||++|+|++ |.+||...+..+.+..++.....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~---- 227 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV---- 227 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc----
Confidence 1224567889999999853 346789999999999999997 57899877766655554311000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
....| ......+..+.++|..|+ .+|.+||++.+|++
T Consensus 228 ----------------------------~~~~~------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 228 ----------------------------KLFKP------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----------------------------ccCCC------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00000 011234678899999999 68999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=266.34 Aligned_cols=238 Identities=35% Similarity=0.522 Sum_probs=194.5
Q ss_pred CceEEEEEEECCCCcEEEEEEEeccchh--hHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEeccc-Ch
Q 001034 881 AFSKAIQAHDLHTGMDVCVKIIKNNKDF--FDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NL 957 (1182)
Q Consensus 881 aFGeVyLAkDk~TGr~VAVKIIkk~k~~--~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~G-sL 957 (1182)
+||.||+|....+++.+|+|++...... ...+..|++.++.+.+ ++|+++++++......++|||++.+ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~------~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKH------PNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCC------CcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 5899999999989999999999765422 4677888898888844 4899999999999999999999997 77
Q ss_pred HHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC--Ccccc
Q 001034 958 YEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD--HLCSY 1035 (1182)
Q Consensus 958 ld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~--~~ss~ 1035 (1182)
..++..... ++...+..++.+++.+|.|||+.+++|+||+|.||+++. .+.++|+|||.+..... .....
T Consensus 75 ~~~~~~~~~------~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 75 FDLLKKRGR------LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE--DGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred HHHHHhccC------CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC--CCcEEEccccceeeeccccccccc
Confidence 777664321 788899999999999999999999999999999999995 57899999999876554 34456
Q ss_pred cCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhcCCcchhhhhcccccchhhcccch
Q 001034 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN-DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHM 1114 (1182)
Q Consensus 1036 vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g-~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~ 1114 (1182)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||.. ......+..+.......
T Consensus 147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 206 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-------------------- 206 (244)
T ss_pred cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC--------------------
Confidence 788899999999988899999999999999999999999977 44433333321000000
Q ss_pred hhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1115 LYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1115 ~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
......++..+.+||.+||..+|.+||++.++++||||
T Consensus 207 ---------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 207 ---------------------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---------------------ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00001146789999999999999999999999999998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=317.68 Aligned_cols=233 Identities=28% Similarity=0.403 Sum_probs=192.9
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEec
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL 953 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL 953 (1182)
++.||.|+.|-||+++ ..++.||||.++.-+ ..+++.|++|.|+ ||+.+.++|...-.+|||||||
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~elk------ETdIKHLRkLkH~------NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRELK------ETDIKHLRKLKHP------NIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhhhh------hhhHHHHHhccCc------ceeeEeeeecCCceeEEeeecc
Confidence 5689999999999997 467899999775322 3567778887655 8999999999999999999999
Q ss_pred c-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC-
Q 001034 954 K-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH- 1031 (1182)
Q Consensus 954 ~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~- 1031 (1182)
. |.|++.++..+. ++......|..+|+.++.|||.+.|||||||.-||||.. +..|||+|||-++-..+.
T Consensus 195 a~GqL~~VLka~~~------itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~--~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRP------ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY--DDVVKISDFGTSKELSDKS 266 (904)
T ss_pred ccccHHHHHhccCc------cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec--cceEEeccccchHhhhhhh
Confidence 8 789998886553 788889999999999999999999999999999999995 556999999998765443
Q ss_pred -cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhc
Q 001034 1032 -LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFT 1110 (1182)
Q Consensus 1032 -~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~ 1110 (1182)
.-+++||..|||||+|...+.+.++|||||||+|||||||..||.+-+... |+...
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGV------------------- 323 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGV------------------- 323 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEec-------------------
Confidence 347899999999999999999999999999999999999999997654322 11111
Q ss_pred ccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1111 KNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1111 k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
....+.++.| ..++..|+=||++||...|..||++.++|.|
T Consensus 324 ----------GsNsL~LpvP---------stcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 324 ----------GSNSLHLPVP---------STCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ----------cCCcccccCc---------ccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 1122223333 2456789999999999999999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-33 Score=294.47 Aligned_cols=281 Identities=22% Similarity=0.396 Sum_probs=218.2
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--C
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--E 944 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--e 944 (1182)
-.++|+|.+++|+|-|++||.+.+..+.+.++||+++.-+ ...+.+|++||+.|.. +|||++|+++..+. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~g-----g~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRG-----GPNIIKLLDIVKDPESK 108 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccC-----CCCeeehhhhhcCcccc
Confidence 3578999999999999999999999999999999998655 4678899999999973 45999999999876 4
Q ss_pred eEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
...||+||+... ...+.. .++...++.+++||+.||.|||++||+|||+||.|++|+. ..-.++|+|+|
T Consensus 109 tpaLiFE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh-~~rkLrlIDWG 178 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH-ELRKLRLIDWG 178 (338)
T ss_pred CchhHhhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech-hhceeeeeecc
Confidence 578999999854 332222 1777889999999999999999999999999999999996 45579999999
Q ss_pred CccccCCC--cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1024 SSCFETDH--LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLF-QNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1024 LA~~~~~~--~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF-~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
+|.+.... .+-.+.+..|.-||++.. ..|+.+.|+|||||+|..|+..+-|| .+.++.+++-+|...+|.-...
T Consensus 179 LAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~-- 256 (338)
T KOG0668|consen 179 LAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY-- 256 (338)
T ss_pred hHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH--
Confidence 99875443 344567889999999875 56899999999999999999988775 6888899999999888853221
Q ss_pred hcccccchhhcccchhh-------hhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1100 AKGRDTYKYFTKNHMLY-------ERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~-------er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.+..+..... ............++. .....++++++|||.++|.+|..+|+||.|++.|||
T Consensus 257 -------~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~-----~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hpy 324 (338)
T KOG0668|consen 257 -------AYLNKYQIDLDPQFEDILGRHSRKPWSRFINS-----ENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPY 324 (338)
T ss_pred -------HHHHHHccCCChhHhhHhhccccccHHHhCCc-----cccccCChHHHHHHHHHHhhccccccchHHHhcCch
Confidence 1111111110 001111111111111 112234799999999999999999999999999999
Q ss_pred CCCCCC
Q 001034 1173 LSHPYE 1178 (1182)
Q Consensus 1173 Fk~~~e 1178 (1182)
|.-..+
T Consensus 325 F~~~~~ 330 (338)
T KOG0668|consen 325 FAPVRE 330 (338)
T ss_pred HHHHHH
Confidence 975433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=300.04 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=203.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|.++.+||+|+|++|.+++.++|.+.||||++++.- ...+-...|..+..... .||++|-|+..|+..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as-----n~pflvglhscfqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NNPFLVGLHSCFQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc-----CCCeEEehhhhhccc
Confidence 468999999999999999999999999999999998642 22333445555555543 467999999999999
Q ss_pred CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 944 EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 944 e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..+++|.||++|+.+.|+-.++.. +++..++++..+|+.||.|||+.|||+||||.+|||++. .|+|||+|+|
T Consensus 324 srlffvieyv~ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rgiiyrdlkldnvllda--eghikltdyg 396 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTDYG 396 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEcc--CCceeecccc
Confidence 999999999998766554433322 999999999999999999999999999999999999995 7889999999
Q ss_pred Cccc---cCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhhcCC
Q 001034 1024 SSCF---ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN-------DSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1024 LA~~---~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g-------~d~~elLakIv~ilGp 1093 (1182)
.++- ..+.+.++||||.|+|||++.+..|+..+|||+|||+||||+.|+.||.- .+.++.+.+++
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi----- 471 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI----- 471 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-----
Confidence 9863 45567789999999999999999999999999999999999999999942 22333333332
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC------CHHHH
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP------SASDA 1167 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP------TAeEL 1167 (1182)
++.++... .-.+..+..+|+..|.+||.+|+ ...++
T Consensus 472 -------------------------------lekqirip-------rslsvkas~vlkgflnkdp~erlgc~~~~g~~di 513 (593)
T KOG0695|consen 472 -------------------------------LEKQIRIP-------RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDI 513 (593)
T ss_pred -------------------------------hhhccccc-------ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhh
Confidence 11111111 12245667889999999999995 47899
Q ss_pred HcCCCCCC
Q 001034 1168 LKHPWLSH 1175 (1182)
Q Consensus 1168 LqHPWFk~ 1175 (1182)
-.||||..
T Consensus 514 k~h~ffr~ 521 (593)
T KOG0695|consen 514 KSHAFFRS 521 (593)
T ss_pred hcchhhhh
Confidence 99999974
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=304.16 Aligned_cols=197 Identities=23% Similarity=0.352 Sum_probs=167.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchh-hHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC-eE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF-FDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE-HL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~-~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e-~L 946 (1182)
+.|.-...||+|+||.||++.- .++..||||.+...... ..++.+|+.+|.+++|+ |||+|+++|.+.. +.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~------Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHP------NLVKLLGYCLEGGEHR 147 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCc------CcccEEEEEecCCceE
Confidence 4566667899999999999985 55589999988776544 56699999999999765 8999999999998 59
Q ss_pred EEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC---ccccccCCccEEEccCCCceEEEecC
Q 001034 947 LIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG---LIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 947 yLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G---IIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
+||+|||. |+|.+.+...... .+++.....|+.+++.||+|||... ||||||||.|||+| .+...||+||
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD--~~~~aKlsDF 221 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD--EDFNAKLSDF 221 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC--CCCCEEccCc
Confidence 99999999 5777766543321 5899999999999999999999843 99999999999999 4788999999
Q ss_pred CCccccCC-Ccc--cc-cCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 001034 1023 GSSCFETD-HLC--SY-VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078 (1182)
Q Consensus 1023 GLA~~~~~-~~s--s~-vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~ 1078 (1182)
|+|+.... ... .. .||..|+|||.+..+..+.++||||||++|+||+||+.+....
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 99976654 222 22 7999999999999999999999999999999999999888653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=314.81 Aligned_cols=249 Identities=22% Similarity=0.345 Sum_probs=201.2
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
++..+...+...||+|.||+||+++.-. .||||++... ....+.+..|+..|+..+|. ||+-+++++.
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~------NIlLFMG~~~ 458 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHE------NILLFMGACM 458 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchh------hheeeehhhc
Confidence 4455667888999999999999998643 4999999754 45678899999999999887 8999999998
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
.+.. .||+.+|.| +|+.++...... |.+...+.|++||++|+.|||.++|||||||..|||+.. ++.|||+
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~etk-----fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~--~~kVkIg 530 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQETK-----FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHE--DLKVKIG 530 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhhh-----hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEcc--CCcEEEe
Confidence 8777 899999998 577777655432 899999999999999999999999999999999999994 5889999
Q ss_pred cCCCccccC-----CCcccccCCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1021 DLGSSCFET-----DHLCSYVQSRSYRAPEVILG---LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1021 DFGLA~~~~-----~~~ss~vGTp~YmAPEVLlg---~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|||++.... ......-|...|||||++.- .+|+..+|||||||++|||+||..||...+.++++.++-
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG---- 606 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG---- 606 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec----
Confidence 999986532 23445567888999999964 479999999999999999999999998666554433321
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.+ +..|. +.....+...++++|+..|+.+++++||.+.+||.
T Consensus 607 --------rG------------------------~l~pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 607 --------RG------------------------YLMPD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred --------cc------------------------ccCcc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 00 00111 11123345679999999999999999999999887
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-33 Score=341.32 Aligned_cols=252 Identities=31% Similarity=0.426 Sum_probs=207.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.-+++-...||.|.||.||.|.+..+|...|||-++.. ...+..+.+|+.+|..++|+ |+|++|++-.+.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHp------NlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHP------NLVRYYGVEVHR 1306 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCc------cccccCceeecH
Confidence 456788888999999999999999999999999988653 34566788999999999876 899999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
+.++|.||||.| +|.+++...+. ..+...+.+..|++.||.|||+.|||||||||.|||++. +|.||+.||
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~gri------~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~--~g~iK~~DF 1378 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRI------EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF--NGLIKYGDF 1378 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHhcch------hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec--CCcEEeecc
Confidence 999999999996 55555554332 678888999999999999999999999999999999994 778999999
Q ss_pred CCccccCCCc-------ccccCCCcccchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH-Hhh
Q 001034 1023 GSSCFETDHL-------CSYVQSRSYRAPEVILGL---SYDKKIDIWSLGCILAELCTGNVLFQNDSP-ATLLARV-IGI 1090 (1182)
Q Consensus 1023 GLA~~~~~~~-------ss~vGTp~YmAPEVLlg~---~yS~kSDIWSLGVILYELLTGr~PF~g~d~-~elLakI-v~i 1090 (1182)
|.|.....+. ....||+.|||||++.+. +...+.|||||||++.||+||+.||...+. -+++-.+ +..
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH 1458 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC
Confidence 9997654432 457899999999999754 577899999999999999999999976332 2222222 111
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.+++ |. .++.+.++||.+||+.||++|+++.|||+|
T Consensus 1459 ~Pq~-----------------------------------P~---------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 KPQI-----------------------------------PE---------RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCC-----------------------------------ch---------hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111 11 247889999999999999999999999999
Q ss_pred CCCCCC
Q 001034 1171 PWLSHP 1176 (1182)
Q Consensus 1171 PWFk~~ 1176 (1182)
-|=+..
T Consensus 1495 ~f~~~~ 1500 (1509)
T KOG4645|consen 1495 AFGKSC 1500 (1509)
T ss_pred hccccc
Confidence 987654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=316.89 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=210.1
Q ss_pred cCCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
..+.++.+.||+|+||+||+|+-. .....||||.++... ....++.+|+.++..++|+ |||+|++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~------nIVrLlGVC 558 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHP------NIVRLLGVC 558 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCC------CeEEEEEEE
Confidence 456778899999999999999853 344679999998654 3567889999999999765 899999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhcccCCcc--------ccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRESGGEV--------YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~sggel--------~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs 1011 (1182)
..++.+|+|+|||. |+|.+|++.+....... .++..+...|+.||+.|++||-++.+|||||-..|+||.
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg- 637 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG- 637 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec-
Confidence 99999999999999 89999998765433221 388889999999999999999999999999999999998
Q ss_pred CCCceEEEecCCCccccCCCcc-----cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 001034 1012 YSRCEVKVIDLGSSCFETDHLC-----SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLA 1085 (1182)
Q Consensus 1012 ~~dG~IKLiDFGLA~~~~~~~s-----s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLa 1085 (1182)
.+..|||+|||+++..-...+ ...-+.+|||||.|...+|+.++||||+||+|||+++ |..||++.++++++.
T Consensus 638 -e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 638 -ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred -cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 477899999999975332222 2234788999999999999999999999999999998 999999999999988
Q ss_pred HHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 001034 1086 RVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165 (1182)
Q Consensus 1086 kIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe 1165 (1182)
.|.+ + .+......++.++.+|+..|++.+|.+||++.
T Consensus 717 ~i~~------------g-------------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~ 753 (774)
T KOG1026|consen 717 CIRA------------G-------------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFK 753 (774)
T ss_pred HHHc------------C-------------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence 8831 0 11123346688999999999999999999999
Q ss_pred HHH
Q 001034 1166 DAL 1168 (1182)
Q Consensus 1166 ELL 1168 (1182)
||-
T Consensus 754 eI~ 756 (774)
T KOG1026|consen 754 EIH 756 (774)
T ss_pred HHH
Confidence 973
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=313.44 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=216.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec---
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--- 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--- 943 (1182)
-.+.|+|.+.||.|.+|.||+++.+++++..|+||+......-+.+..|..||+.+.+ |||++.+|++|...
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~-----hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSH-----HPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccC-----CCCcceEEEEEEEecCC
Confidence 4678999999999999999999999999999999998887777788888999988764 56999999998754
Q ss_pred --CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 944 --EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 944 --e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
+.++||||||.| +..++++... + ..+.+..+..|++.++.||.+||...+||||||-.|||++. ++.|||+
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g--~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~--e~~VKLv 165 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK--G--NRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTE--NAEVKLV 165 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc--c--cchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEec--cCcEEEe
Confidence 679999999995 5666666544 2 24899999999999999999999999999999999999994 7889999
Q ss_pred cCCCccccCC---CcccccCCCcccchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1021 DLGSSCFETD---HLCSYVQSRSYRAPEVILGL-----SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1021 DFGLA~~~~~---~~ss~vGTp~YmAPEVLlg~-----~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|||.+..... ..++.+|||.|||||++... .|+..+|+||||++..||.-|.+|+....+...+.+|. ..
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip--RN 243 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--RN 243 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC--CC
Confidence 9999876554 35678999999999999643 48899999999999999999999999888876655552 22
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
|+|.-+ +..+-+.+|.+||..||..|-++||++.++|+|||
T Consensus 244 PPPkLk---------------------------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 244 PPPKLK---------------------------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred CCcccc---------------------------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 222100 11122578999999999999999999999999999
Q ss_pred CCC
Q 001034 1173 LSH 1175 (1182)
Q Consensus 1173 Fk~ 1175 (1182)
+++
T Consensus 285 i~e 287 (953)
T KOG0587|consen 285 ITE 287 (953)
T ss_pred ccc
Confidence 984
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=323.05 Aligned_cols=253 Identities=27% Similarity=0.394 Sum_probs=192.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR- 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~- 943 (1182)
...+|+.++.||+||||.||+|+++-+|+.||||.|... ......+.+|++.|.+|+|+ |||++|..+...
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHp------NVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHP------NVVRYYSAWVEST 550 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCc------ceeeeehhhhccC
Confidence 456788999999999999999999999999999999876 55667889999999999776 788887653100
Q ss_pred --------------------------------------------------------------------------------
Q 001034 944 -------------------------------------------------------------------------------- 943 (1182)
Q Consensus 944 -------------------------------------------------------------------------------- 943 (1182)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred --------------------------------------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHH
Q 001034 944 --------------------------------------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985 (1182)
Q Consensus 944 --------------------------------------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QI 985 (1182)
..+||=||||.-.++..+....... -....++++++||
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREI 706 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHH
Confidence 1368888888876665555443211 1356789999999
Q ss_pred HHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC---------------------CCcccccCCCcccch
Q 001034 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET---------------------DHLCSYVQSRSYRAP 1044 (1182)
Q Consensus 986 LsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~---------------------~~~ss~vGTp~YmAP 1044 (1182)
+.||.|+|++|||||||||.||+++. ++.|||+|||+|+... ...+..+||..|+||
T Consensus 707 lEGLaYIH~~giIHRDLKP~NIFLd~--~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 707 LEGLAYIHDQGIIHRDLKPRNIFLDS--RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHHhCceeeccCCcceeEEcC--CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 99999999999999999999999994 7789999999997611 023457899999999
Q ss_pred hhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhc
Q 001034 1045 EVILGL---SYDKKIDIWSLGCILAELCTGNVLFQNDS-PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQ 1120 (1182)
Q Consensus 1045 EVLlg~---~yS~kSDIWSLGVILYELLTGr~PF~g~d-~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ 1120 (1182)
|++.+. .|+.++|+||||+|||||+. ||...- ...++..+- -|.+|..
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~----------------------- 836 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEP----------------------- 836 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCC-----------------------
Confidence 999765 49999999999999999996 564321 112222221 1112211
Q ss_pred chhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1121 ETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1121 ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
. ......-+.-..+|+.||+.||.+||||.|||++.||.
T Consensus 837 ------------~---~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 837 ------------A---DFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ------------c---ccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 0 00011123456899999999999999999999999996
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=292.97 Aligned_cols=275 Identities=29% Similarity=0.489 Sum_probs=217.4
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-----CeE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR-----EHL 946 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~-----e~L 946 (1182)
+.||.|+||.||.+.|..+|+.||+|.+.+- -.....+.+|+++|..++|. |++..+++.+-. ..+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHd------NVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHD------NVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccc------cHHHHHHhcCCCCchHHHHH
Confidence 4899999999999999999999999998753 23346778899999998876 788888776643 468
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|+|+|+|..+|...+-.-+ .++...++-+++||+++|.|||+.+|.||||||.|+|+++ ++.+||||||+++
T Consensus 133 YV~TELmQSDLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS--NCvLKICDFGLAR 204 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS--NCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHhhhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc--CceEEeccccccc
Confidence 8999999888777665432 3888899999999999999999999999999999999994 8999999999998
Q ss_pred ccCC----CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETD----HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~----~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
.... +...-+-|..|+|||++.|. .|+.++||||+|||+.|||-.+..|...++.+.+..|+.++|.+..+-+.-
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 6543 23445668899999999987 599999999999999999999999999999999999999999876544332
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCC--CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLP--MGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~--~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
.-.-. +.+.+. -....|....+..... ....+..+++.+||.+||.+|.+..+++.|+++.+
T Consensus 285 ACEGA----k~H~LR--------~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 285 ACEGA----KNHVLR--------AGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred Hhhhh----HHHhhc--------cCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 11000 111110 0112233333333322 23467899999999999999999999999999854
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=300.70 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=203.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCc---E-EEEEEEec----cchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGM---D-VCVKIIKN----NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr---~-VAVKIIkk----~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
...+-.+.++||+|+||+||++.-+..+. . ||+|..+. .+.....++.|.++++.++|+ |||++|+
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~------NVVr~yG 228 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHP------NVVRFYG 228 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCC------CEEEEEE
Confidence 34566677999999999999998665322 3 89999884 246677889999999998765 8999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
+......++||||+|.| +|.++++.... .++..+...++.+.+.||+|||++++|||||-..|+|++. ++.+
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~--~~~v 301 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK--KGVV 301 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC--CCeE
Confidence 99999999999999995 78888887654 2889999999999999999999999999999999999994 5668
Q ss_pred EEecCCCccccCCCc--c-cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1018 KVIDLGSSCFETDHL--C-SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~--s-s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp 1093 (1182)
||+|||+++...... . ...-+..|+|||.+....|+.++|||||||++||+++ |..||.+....++.++|......
T Consensus 302 KISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r 381 (474)
T KOG0194|consen 302 KISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR 381 (474)
T ss_pred EeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc
Confidence 999999987654211 1 1134678999999999999999999999999999998 88999999999888888421111
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ..| ...+..+..++.+|+..+|++|||+.++.+
T Consensus 382 ~---------------------------------~~~---------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 382 M---------------------------------PIP---------SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred C---------------------------------CCC---------CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 0 011 133567888999999999999999999876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=295.07 Aligned_cols=276 Identities=18% Similarity=0.252 Sum_probs=185.7
Q ss_pred ecCCEEEEEEeccCCceEEEEEEEC----------------CCCcEEEEEEEeccchh---------------hHHHHHH
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDL----------------HTGMDVCVKIIKNNKDF---------------FDQSLDE 915 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk----------------~TGr~VAVKIIkk~k~~---------------~dq~l~E 915 (1182)
-.++|.+.++||+|+||.||++... ..++.||||.+...... .+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3578999999999999999999742 34567999998654211 1123346
Q ss_pred HHHHHHhcCCCCCCCcceEEEEEEEEe--------cCeEEEEEEeccc-ChHHHHhhhccc-----------C-------
Q 001034 916 IKLLKYVNKHDPGDKYHLLRLYDYFYY--------REHLLIVCELLKA-NLYEFHKFNRES-----------G------- 968 (1182)
Q Consensus 916 ikILr~L~h~~~l~HPnIVkL~dsFqd--------~e~LyLVmEyL~G-sLld~Lk~~~~s-----------g------- 968 (1182)
+.++.++.+.. ..+.++++++++|.. ....+|||||+.+ +|.+++...... +
T Consensus 223 ~~~l~~l~~~~-l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKIKRNP-IAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHhhccc-chhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 66677776542 344567777777653 3568999999995 676666532110 0
Q ss_pred CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC--cc--cccCCCcccch
Q 001034 969 GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH--LC--SYVQSRSYRAP 1044 (1182)
Q Consensus 969 gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~--~s--s~vGTp~YmAP 1044 (1182)
....+.+..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++...... .. ...+++.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV--DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC--CCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 0112456778899999999999999999999999999999984 678999999998653321 11 22347899999
Q ss_pred hhhcCCC--------------------CC--chhhHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1045 EVILGLS--------------------YD--KKIDIWSLGCILAELCTGNV-LFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1045 EVLlg~~--------------------yS--~kSDIWSLGVILYELLTGr~-PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
|++.... |+ ...||||+|||+|+|++|.. ||.+...... ......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~~--------- 447 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQYD--------- 447 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhcc---------
Confidence 9986432 12 24799999999999999985 7754221110 000000
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCC---CCCCCHHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINP---KKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DP---ekRPTAeELLqHPWFk~~ 1176 (1182)
.....+.. . ....+ ........+..+++||.+||..+| .+|+|+.|+|+||||...
T Consensus 448 ---------~~~~~~r~-~--~~~~~-------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 448 ---------NDLNRWRM-Y--KGQKY-------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred ---------chHHHHHh-h--cccCC-------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 00000000 0 00000 011234567899999999999876 789999999999999754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=294.91 Aligned_cols=294 Identities=26% Similarity=0.380 Sum_probs=217.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECC---CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLH---TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~---TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.+.|.++.+||.|.|+.||++.+.. ..+.||+|.+..... ...+.+|+.+|..+.... ||+++.+.|...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~-----ni~~~~~~~rnn 107 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSD-----NIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccch-----hhhcchhhhccC
Confidence 34568889999999999999999887 789999999976542 467899999999998765 999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
+++++||||++. ...+++.. ++...++.+++.++.||.++|.+|||||||||.|+|.+. ..+.-.|+||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~-~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR-RTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc-ccCCceEEec
Confidence 999999999985 44444332 677889999999999999999999999999999999996 5677899999
Q ss_pred CCcccc-----------------CC----------------C--------------cccccCCCcccchhhhcCC-CCCc
Q 001034 1023 GSSCFE-----------------TD----------------H--------------LCSYVQSRSYRAPEVILGL-SYDK 1054 (1182)
Q Consensus 1023 GLA~~~-----------------~~----------------~--------------~ss~vGTp~YmAPEVLlg~-~yS~ 1054 (1182)
|+|... .. + .....||++|+|||++... ..+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 988510 00 0 0124679999999999764 5788
Q ss_pred hhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccc--hhhhhhcchhhh--hhcc
Q 001034 1055 KIDIWSLGCILAELCTGNVLFQ-NDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNH--MLYERNQETNRL--EYLI 1129 (1182)
Q Consensus 1055 kSDIWSLGVILYELLTGr~PF~-g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~--~~~er~~ets~L--e~li 1129 (1182)
++||||.|||+.-+++++.||. ..+....+..|+.++|.....-.+........+.+.. ...+.......+ ....
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 9999999999999999999985 4667778888888998754322221111100011000 000000000000 0000
Q ss_pred ccc---cccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1130 PKK---TSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1130 Pk~---~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+.. ..........+..+.+|+.+||..||.+|+||+++|+||||.+.
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 000 11222233446799999999999999999999999999999854
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=305.68 Aligned_cols=202 Identities=25% Similarity=0.363 Sum_probs=172.3
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR- 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~- 943 (1182)
...-|...+.||+||||.||+++++.+|+.||||.+++. ....+....|+++|++++|+ |||+++++-...
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~------NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHP------NIVKLFDIEETKF 84 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCch------hhhhhcccCCccc
Confidence 345677888999999999999999999999999999874 33457788999999999855 899999875543
Q ss_pred -----CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCc--
Q 001034 944 -----EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC-- 1015 (1182)
Q Consensus 944 -----e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG-- 1015 (1182)
....+|||||.| +|+..+..-.+..| +++.++..++..|+.||.|||++|||||||||.||++-...+|
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~G---LpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~ 161 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYG---LPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQS 161 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccccC---CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce
Confidence 467899999995 67766665443333 9999999999999999999999999999999999999754434
Q ss_pred eEEEecCCCccccCC--CcccccCCCcccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001034 1016 EVKVIDLGSSCFETD--HLCSYVQSRSYRAPEVIL-GLSYDKKIDIWSLGCILAELCTGNVLFQN 1077 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLl-g~~yS~kSDIWSLGVILYELLTGr~PF~g 1077 (1182)
.-||+|||.|+-..+ ...+.+||+.|++||++. .+.|+..+|.|||||++|++.||..||-.
T Consensus 162 IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 162 IYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred EEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 579999999986554 456889999999999999 58899999999999999999999999954
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-31 Score=286.56 Aligned_cols=262 Identities=26% Similarity=0.345 Sum_probs=202.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.+..+-+..||.|+||+|++..++.+|+.+|||.++.... ...+++.|......-. ..|+||++|+.......
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~-----~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSS-----NCPNIVKFYGALFSEGD 137 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhc-----CCcHHHHHhhhhhcCCc
Confidence 3445556789999999999999999999999999986543 2334555555544433 45699999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
.+|.||+|.-++-.+.++-.... ...+++..+-.|+..++.||.||-. ..||||||||+|||++. .|.|||||||+
T Consensus 138 cWiCMELMd~SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr--~G~vKLCDFGI 214 (361)
T KOG1006|consen 138 CWICMELMDISLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR--HGDVKLCDFGI 214 (361)
T ss_pred eeeeHHHHhhhHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec--CCCEeeecccc
Confidence 99999999988766665433221 2238888888899999999999985 78999999999999994 88899999999
Q ss_pred ccccCCCc--ccccCCCcccchhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhcCCcchhhh
Q 001034 1025 SCFETDHL--CSYVQSRSYRAPEVIL--GLSYDKKIDIWSLGCILAELCTGNVLFQND-SPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1025 A~~~~~~~--ss~vGTp~YmAPEVLl--g~~yS~kSDIWSLGVILYELLTGr~PF~g~-d~~elLakIv~ilGp~PeemL 1099 (1182)
+-.+.... +.-.|...|||||.+. ...|+.++|+||||++|||+.||+.|+..- +..+++.+++ .|.+|. ++
T Consensus 215 cGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~-l~ 291 (361)
T KOG1006|consen 215 CGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPI-LL 291 (361)
T ss_pred hHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCe-ec
Confidence 87654432 3457889999999995 346999999999999999999999999773 3344444443 222221 00
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
.....-.++..++.||.-||.+|-..||...+|+++||+..
T Consensus 292 -----------------------------------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 292 -----------------------------------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred -----------------------------------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 00111235788999999999999999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=306.86 Aligned_cols=251 Identities=20% Similarity=0.317 Sum_probs=204.0
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCC-C----cEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHT-G----MDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~T-G----r~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
....++.+.||+|+||.||.+.-... | ..||||.+++. ......++.|..+++.++|+ |||++++++
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~Hp------Niv~liGv~ 764 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHP------NIVSLIGVC 764 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCc------ceeeEEEee
Confidence 35678889999999999999985532 2 34899999875 45567788888888887655 999999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhcccC-CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRESG-GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~sg-gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
......+||+|||. |+|+.|++..+... ..-.++...+..|+.+|++|+.||+++++|||||-..|+||+. +..+|
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~--~r~VK 842 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDE--RRVVK 842 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecc--cCcEE
Confidence 99999999999999 57999998764322 1234899999999999999999999999999999999999994 67899
Q ss_pred EecCCCccccCC-Cccc----ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcC
Q 001034 1019 VIDLGSSCFETD-HLCS----YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1019 LiDFGLA~~~~~-~~ss----~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilG 1092 (1182)
|.|||+|+..-. ..+. ..-+..|||||.+....++.++|||||||+|||+++ |..||.+.++.+++.-.+..
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-- 920 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-- 920 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC--
Confidence 999999984322 2221 233578999999999999999999999999999999 99999998887776544210
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
+ . ......++..+.++|..|++.+|++||++..|++
T Consensus 921 ---------g-----------------------R---------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 921 ---------G-----------------------R---------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ---------C-----------------------c---------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 0 0 0112345778889999999999999999999987
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=299.20 Aligned_cols=246 Identities=29% Similarity=0.401 Sum_probs=191.7
Q ss_pred EEEeccCCceE-EEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 874 TEYLGSAAFSK-AIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 874 lk~LGkGaFGe-VyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
.+++|.|+-|+ ||++. ..++.||||.+-.. ...-+.+|+..|+... .|||||++|+.-++...+||..|+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e--~~~~A~rEi~lL~eSD-----~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEE--FFDFAQREIQLLQESD-----EHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhhH--hHHHHHHHHHHHHhcc-----CCCceEEEEeeccCCceEEEEehH
Confidence 46789999986 57886 68899999988543 3456678998888764 577999999999999999999999
Q ss_pred cccChHHHHhhhcccCCccc-cCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc---CCCceEEEecCCCcccc
Q 001034 953 LKANLYEFHKFNRESGGEVY-FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS---YSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 953 L~GsLld~Lk~~~~sggel~-Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs---~~dG~IKLiDFGLA~~~ 1028 (1182)
|..+|.+++.... .+.. ..-...+.++.|++.||++||+.+||||||||.||||.. .+...++|+|||+++..
T Consensus 585 C~~sL~dlie~~~---~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 585 CACSLQDLIESSG---LDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hhhhHHHHHhccc---cchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9999999998641 1111 111445788999999999999999999999999999986 35568999999999865
Q ss_pred CCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1029 TDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG-NVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1029 ~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTG-r~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
... .....||-.|+|||++....-..++|||||||++|+.++| ..||...-.. -..|+. |.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~--~~-------- 729 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILT--GN-------- 729 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhc--Cc--------
Confidence 432 3455789999999999998888899999999999999996 8999653321 122210 00
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
..+-...+....++.+||.+||.++|..||+|.++|.||||=
T Consensus 730 -------------------------------~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 730 -------------------------------YTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred -------------------------------cceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 001111111223899999999999999999999999999993
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=301.48 Aligned_cols=185 Identities=22% Similarity=0.311 Sum_probs=150.2
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
|...+.||+|+||.||+|+++.++..||||.+...... ...|+.++++++ |||||+++++|......|+||
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~------HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQ------HPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCC------CCCcceEEEEEEcCCCCEEEE
Confidence 44556899999999999999999999999998754322 224566666664 569999999999999999999
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHH---hcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH---GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLH---S~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
||+++ +|.+++.. +++..+..|+.||+.||.||| +.+|+||||||+||+++. .+..++. ||...
T Consensus 763 Ey~~~g~L~~~l~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~--~~~~~~~-~~~~~ 830 (968)
T PLN00113 763 EYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG--KDEPHLR-LSLPG 830 (968)
T ss_pred eCCCCCcHHHHHhc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC--CCceEEE-ecccc
Confidence 99984 67776641 678889999999999999999 679999999999999985 3444544 55443
Q ss_pred ccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001034 1027 FETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN 1077 (1182)
Q Consensus 1027 ~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g 1077 (1182)
.... .....+++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 831 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 831 LLCT-DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred cccc-CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 2211 1234678999999999999999999999999999999999999953
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=279.68 Aligned_cols=244 Identities=21% Similarity=0.287 Sum_probs=208.9
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
..+..+||-|-||.||.+..+.-.-.||||.++.+.+..+.++.|..+++.+.|+ |+|+|+++|...-.+|||+
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHp------NLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP------NLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCc------cHHHHhhhhccCCCeEEEE
Confidence 4455789999999999999998888999999999999999999999999999765 8999999999999999999
Q ss_pred Eecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 951 ELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 951 EyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
|||. |+|+++++.+.... ++...+..++.||..|++||..+++|||||-..|+|+. .+..||+.|||++++..
T Consensus 343 EfM~yGNLLdYLRecnr~e----v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg--EnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSE----VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHIVKVADFGLSRLMT 416 (1157)
T ss_pred ecccCccHHHHHHHhchhh----cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc--ccceEEeeccchhhhhc
Confidence 9998 89999999876432 77778889999999999999999999999999999998 47789999999999876
Q ss_pred CCccc-cc---CCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1030 DHLCS-YV---QSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1030 ~~~ss-~v---GTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
...++ .. .++-|.|||-+....++.++|||+|||+|||+.| |-.||.+-+...++..+- ++..
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE------------kgyR 484 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE------------KGYR 484 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh------------cccc
Confidence 55443 22 3677999999999999999999999999999998 999999988766665441 1100
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
-.....+++...+|++.|++|.|..||++.|+-+
T Consensus 485 -------------------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 485 -------------------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred -------------------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 0112356788999999999999999999998743
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=226.93 Aligned_cols=208 Identities=40% Similarity=0.643 Sum_probs=180.3
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEecc
Q 001034 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLK 954 (1182)
Q Consensus 877 LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~ 954 (1182)
||.|++|.||++....+++.+++|++..... ....+.+|+..++.+.+. +|+++++++......++|||++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~------~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP------NIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCC------CeeeEeeeeecCCeEEEEEecCC
Confidence 6899999999999988899999999987654 256788899999998763 89999999999999999999999
Q ss_pred -cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC--
Q 001034 955 -ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH-- 1031 (1182)
Q Consensus 955 -GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~-- 1031 (1182)
++|..++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ..+.++|+|||.+......
T Consensus 75 ~~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~-~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 75 GGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS-DNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC-CCCcEEEecCCceEEccCCcc
Confidence 57777766432 12788899999999999999999999999999999999994 1567999999998765544
Q ss_pred -cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhh
Q 001034 1032 -LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYF 1109 (1182)
Q Consensus 1032 -~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F 1109 (1182)
.....+...|++||.+... .++.+.|+|+||+++|+|
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------- 187 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------- 187 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence 3445678899999999887 888999999999999999
Q ss_pred cccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 001034 1110 TKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHP 1171 (1182)
Q Consensus 1110 ~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHP 1171 (1182)
..+.++|.+||..+|.+||++.++++|+
T Consensus 188 ----------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3467899999999999999999999986
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=278.37 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=204.8
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
+....+..+.++||+|-||+|.+|.- ..+..||+|+++... .....+..|+++|.+|+|+ ||++|+++|..
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhP------NIveLvGVC~~ 606 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHP------NIVELLGVCVQ 606 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCC------CeeEEEeeeec
Confidence 33456778889999999999999983 557999999998653 3457889999999999655 89999999999
Q ss_pred cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
++.+|+|||||. |+|.+|+.....+. .......+|+.||+.|++||.+.++|||||.+.|+|++ +++++||+|
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~--~e~~iKiad 680 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD--GEFTIKIAD 680 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHHhhchhhccccccceeec--CcccEEecC
Confidence 999999999999 78888887664321 34445667999999999999999999999999999999 588899999
Q ss_pred CCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1022 LGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT--GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1022 FGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT--Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
||.++-+-... ...+-+..|||||.++-++++.++|+|+||++|||+++ ...||...+.++.....-.++...
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~ 760 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQ 760 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCC
Confidence 99998432222 23355789999999999999999999999999999865 678998877766655543222211
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
+. .....+.+.++..+.+||.+|+.+|-++||+.++|-.
T Consensus 761 ~~------------------------------------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 761 GR------------------------------------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred Cc------------------------------------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 11 1111233456788999999999999999999999855
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=279.26 Aligned_cols=242 Identities=22% Similarity=0.334 Sum_probs=196.3
Q ss_pred EEEEEEeccCCceEEEEEEECC----CCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLH----TGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~----TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
..+.++||.|-||.||.+.-.. ..-.||||..+.+ ....+.++.|..+++.+.| ||||+|++++.. .
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdH------phIikLIGv~~e-~ 463 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDH------PHIIKLIGVCVE-Q 463 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCC------cchhheeeeeec-c
Confidence 3445789999999999997432 2334899999874 3557789999999988855 599999999864 6
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..+||||+++ |.|..+++.+... ++......|++||+.||.|||+.++|||||-..|||+.+ .. -|||.|||
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~s-----L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS-p~-CVKLaDFG 536 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDS-----LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS-PQ-CVKLADFG 536 (974)
T ss_pred ceeEEEecccchhHHHHHHhcccc-----chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC-cc-eeeecccc
Confidence 7999999999 7899999887654 888899999999999999999999999999999999996 33 39999999
Q ss_pred CccccCCCccc----ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1024 SSCFETDHLCS----YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1024 LA~~~~~~~ss----~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
+++...+..+. ..-+.-|||||.+.-..++.++|||.|||.|||+|. |..||.+-.+.+++..|-
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE---------- 606 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE---------- 606 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec----------
Confidence 99987665332 233667999999999999999999999999999987 999998865544432220
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
++ ...+..+++++.|..|+.+|+.++|.+||++.+|..
T Consensus 607 --nG-------------------------------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 607 --NG-------------------------------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred --CC-------------------------------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 11 112345678899999999999999999999988653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=280.69 Aligned_cols=198 Identities=30% Similarity=0.514 Sum_probs=176.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHH---------HHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQ---------SLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq---------~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
..|..++.||.|+||.|++|.++.+...|+||.|.+.+...+. +-.|+.||..++.+ .|+||++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~---sH~NIlKlLdf 637 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH---SHENILKLLDF 637 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc---Cccchhhhhhe
Confidence 4599999999999999999999999999999999887633332 34699999999977 58899999999
Q ss_pred EEecCeEEEEEEeccc--ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 940 FYYREHLLIVCELLKA--NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G--sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
|++..++||+||.-.. +|++++.+... +++.++..|++||+.|+++||++||||||||-+||+++ ++|-+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~------m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd--~~g~~ 709 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPR------MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD--SNGFV 709 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCc------cchHHHHHHHHHHHhccccccccCceecccccccEEEe--cCCeE
Confidence 9999999999998763 68888887654 89999999999999999999999999999999999999 48889
Q ss_pred EEecCCCccccC-CCcccccCCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 001034 1018 KVIDLGSSCFET-DHLCSYVQSRSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQN 1077 (1182)
Q Consensus 1018 KLiDFGLA~~~~-~~~ss~vGTp~YmAPEVLlg~~y-S~kSDIWSLGVILYELLTGr~PF~g 1077 (1182)
||+|||.+.... .+...++||..|.|||++.|.+| +..-|||+||++||.++....||++
T Consensus 710 klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 710 KLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999987544 45667899999999999999886 5788999999999999999999975
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=276.93 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=202.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECC-CC--cEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLH-TG--MDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~-TG--r~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..+..+.++||.|.||.|+++.... +| -.||||.++... .....+++|+.++..|.|+ |+++||++..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~------hliRLyGvVl~ 182 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHP------HLIRLYGVVLD 182 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCc------ceeEEeeeecc
Confidence 3556777899999999999997653 33 358999998654 3567899999999888765 89999999887
Q ss_pred cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..+.+|||++. |+|++-+.... ...|....+..|+.||+.|+.||.++++|||||-..|||+-+ .-.|||+|
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas--prtVKI~D 255 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS--PRTVKICD 255 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc--cceeeeec
Confidence 77889999999 67888777521 223888899999999999999999999999999999999985 55699999
Q ss_pred CCCccccCCCccccc------CCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1022 LGSSCFETDHLCSYV------QSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1022 FGLA~~~~~~~ss~v------GTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
||+.+-+......++ -...|+|||.+....++.++|+|++||+||||++ |..||.+-....++.+|-
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD------ 329 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID------ 329 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc------
Confidence 999987655433322 2567999999999999999999999999999998 889999999888887761
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......+..-+++.+.+++..|+..+|.+|||+..|.+.
T Consensus 330 -------------------------------------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 -------------------------------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred -------------------------------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 001112334568899999999999999999999988643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=249.08 Aligned_cols=214 Identities=27% Similarity=0.417 Sum_probs=177.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++...-+..||+|++|.|=+.++..+|...|+|.++..- ....+.++|+.+..+. ...|++|++|+.+.....
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~-----~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRT-----VDCPFTVHFYGALFREGD 119 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccC-----CCCCeEEEeehhhhcccc
Confidence 455566778999999999999999999999999997542 3334455555554443 356799999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
++|.||.|..+|-.|.+.--..++. +++..+-+|+..++.||.|||+ ..+||||+||+||||+. .|++||||||.
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~--ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~--~GqVKiCDFGI 195 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGT--IPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY--DGQVKICDFGI 195 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCc--CchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc--CCcEEEccccc
Confidence 9999999999888877766555443 8999999999999999999996 58999999999999995 88999999999
Q ss_pred ccccCCCcc--cccCCCcccchhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhh
Q 001034 1025 SCFETDHLC--SYVQSRSYRAPEVILG----LSYDKKIDIWSLGCILAELCTGNVLFQN-DSPATLLARVIGI 1090 (1182)
Q Consensus 1025 A~~~~~~~s--s~vGTp~YmAPEVLlg----~~yS~kSDIWSLGVILYELLTGr~PF~g-~d~~elLakIv~i 1090 (1182)
+-.+.+... ...|...|||||.+.. ..|+.++||||||++++||.+++.||.+ .++.+++.+++..
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 976655432 2567889999999853 4799999999999999999999999976 6788888888744
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=225.59 Aligned_cols=205 Identities=35% Similarity=0.502 Sum_probs=173.0
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
|.+.+.||.|++|.||++....+++.+|+|.+..... ....+..|+..++.+.+ ++++++++++......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~------~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKH------PNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCC------CChhhheeeeecCCceEE
Confidence 5678899999999999999988899999999986543 45677788888888854 489999999998899999
Q ss_pred EEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
|+|++.+ +|.+++...... +++..+..++.+++.+|.+||+++++|+||+|.||+++. .+.++|+|||++..
T Consensus 75 v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~--~~~~~l~d~g~~~~ 147 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM--DGLVKLADFGLARF 147 (225)
T ss_pred EEeccCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeeCceeeE
Confidence 9999997 788777654321 678889999999999999999999999999999999995 57899999999876
Q ss_pred cCCCc----ccccCCCcccchhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHH-HHHHHHH
Q 001034 1028 ETDHL----CSYVQSRSYRAPEVI-LGLSYDKKIDIWSLGCILAELCTGNVLFQN-DSPA-TLLARVI 1088 (1182)
Q Consensus 1028 ~~~~~----ss~vGTp~YmAPEVL-lg~~yS~kSDIWSLGVILYELLTGr~PF~g-~d~~-elLakIv 1088 (1182)
..... ....++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .+.. .+...|.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 55432 456778889999999 667788899999999999999999999977 4444 4555543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=289.94 Aligned_cols=195 Identities=19% Similarity=0.221 Sum_probs=145.2
Q ss_pred ceEEEEEEE-------EecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCC
Q 001034 932 HLLRLYDYF-------YYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004 (1182)
Q Consensus 932 nIVkL~dsF-------qd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKP 1004 (1182)
||+.++++| .....++++||++.++|.+++.... ..+++..++.|++||+.||.|||++|||||||||
T Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 34 YVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred HHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 677777776 2335688899999999999986422 2388999999999999999999999999999999
Q ss_pred ccEEEcc-----------------CCCceEEEecCCCccccCC-------------------CcccccCCCcccchhhhc
Q 001034 1005 ENILVKS-----------------YSRCEVKVIDLGSSCFETD-------------------HLCSYVQSRSYRAPEVIL 1048 (1182)
Q Consensus 1005 eNILIDs-----------------~~dG~IKLiDFGLA~~~~~-------------------~~ss~vGTp~YmAPEVLl 1048 (1182)
+||||+. ...+.+||+|||+++.... .....++|+.|+|||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 9999963 2345677788887753211 001246789999999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhc
Q 001034 1049 GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYL 1128 (1182)
Q Consensus 1049 g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~l 1128 (1182)
+..|+.++||||||||||||++|.+||.... ..+..+....
T Consensus 189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~------------------------------------- 229 (793)
T PLN00181 189 GSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV------------------------------------- 229 (793)
T ss_pred cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-------------------------------------
Confidence 9999999999999999999999998874321 1111110000
Q ss_pred cccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1129 IPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1129 iPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.|. ........+.+++.+||+++|.+||++.|||+||||...
T Consensus 230 ~~~------~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 230 LPP------QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred cCh------hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 000 000112456789999999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=273.85 Aligned_cols=245 Identities=19% Similarity=0.293 Sum_probs=205.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCc---EEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGM---DVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr---~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
....|.++||.|-||+|++++.+..|+ .||||.++.. ......++.|..|+-++. ||||++|.++....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd------HPNIIrLEGVVTks 702 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD------HPNIIRLEGVVTKS 702 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC------CCcEEEEEEEEecC
Confidence 456788999999999999999887764 4999999864 345667888888888775 55999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
..+.||+|||.. .|-.|++.+. + .|+..++..+++.|+.|+.||-++++|||||-..|||+++ +-.+|++||
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~D---G--qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs--nLvCKVsDF 775 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQND---G--QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS--NLVCKVSDF 775 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcC---C--ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc--ceEEEeccc
Confidence 999999999994 5656655443 2 2888999999999999999999999999999999999995 778999999
Q ss_pred CCccccCCCc---ccccC---CCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1023 GSSCFETDHL---CSYVQ---SRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1023 GLA~~~~~~~---ss~vG---Tp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
|+++.+.+.. ++..| +..|.|||.+...+++.++||||+|++|||.++ |..||..-++.+++..|.+.+.=
T Consensus 776 GLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL-- 853 (996)
T KOG0196|consen 776 GLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL-- 853 (996)
T ss_pred cceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC--
Confidence 9999765433 22222 578999999999999999999999999999886 99999999999999988532221
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
+....++..|.+|+..|+++|-..||++.+|+.
T Consensus 854 -----------------------------------------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 854 -----------------------------------------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred -----------------------------------------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 112345788999999999999999999999876
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-27 Score=275.83 Aligned_cols=257 Identities=26% Similarity=0.361 Sum_probs=212.9
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
-.++|+++..+|.|+||.||+++++.+++..|+|+++... +.+.-+..|+-+++.++|+ |||.+++.+.....
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~------nivay~gsylr~dk 86 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHP------NIVAYFGSYLRRDK 86 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCc------ChHHHHhhhhhhcC
Confidence 3578999999999999999999999999999999998764 4455666788887777554 89999999999999
Q ss_pred EEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
++|+|||++|+ |.+... ...++++.++...+++.+.+|.|||++|-+|||||-.|||+.. .|.+||.|||.
T Consensus 87 lwicMEycgggslQdiy~------~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd--~gDvklaDfgv 158 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYH------VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTD--EGDVKLADFGV 158 (829)
T ss_pred cEEEEEecCCCcccceee------ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecc--cCceeecccCc
Confidence 99999999965 444332 2334999999999999999999999999999999999999994 77899999999
Q ss_pred ccccCC---CcccccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1025 SCFETD---HLCSYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1025 A~~~~~---~~ss~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
+..... ...++.||+.|||||+.. ...|...||+|++|+...|+---.+|.....+...+..+.+...++|.
T Consensus 159 saqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~-- 236 (829)
T KOG0576|consen 159 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT-- 236 (829)
T ss_pred hhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc--
Confidence 865443 345789999999999974 567999999999999999999999988777777777666544443332
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
... -..-++-|-+|++.+|..+|++|||++.+|+|||.+..
T Consensus 237 ---------------------------------lkD----k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 237 ---------------------------------LKD----KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ---------------------------------ccC----CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 000 01124678899999999999999999999999998765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=264.26 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=196.8
Q ss_pred CCEEEEEEeccCCceEEEEEEEC----C---CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDL----H---TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk----~---TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
.+..+.+.||.|+||.|+++.-. . ....||||.++... .....+..|+.+++.+. .|+||+.+.+.
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g-----~H~niv~llG~ 370 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG-----KHPNIVNLLGA 370 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc-----CCcchhhheee
Confidence 33456679999999999999743 1 24579999987543 44667888999999886 45699999999
Q ss_pred EEecCeEEEEEEecc-cChHHHHhhhc---ccCCc-------cccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEE
Q 001034 940 FYYREHLLIVCELLK-ANLYEFHKFNR---ESGGE-------VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~-GsLld~Lk~~~---~sgge-------l~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNIL 1008 (1182)
+.....+++|+||+. |+|+.+++.++ ..... ..++......+++||+.|++||++..+|||||-..|||
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 999999999999998 78999998877 11111 23888999999999999999999999999999999999
Q ss_pred EccCCCceEEEecCCCccccCCCccc----cc--CCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-H
Q 001034 1009 VKSYSRCEVKVIDLGSSCFETDHLCS----YV--QSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDS-P 1080 (1182)
Q Consensus 1009 IDs~~dG~IKLiDFGLA~~~~~~~ss----~v--GTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d-~ 1080 (1182)
+.. +..+||+|||+++........ .. -+..|||||.+....|+.++||||+|++||||++ |..||.+-. .
T Consensus 451 i~~--~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 451 ITK--NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred ecC--CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 994 567999999999854332211 11 2456999999999999999999999999999998 889998733 3
Q ss_pred HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1081 ~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
.+++..+. .+.. ......++.++.++++.|++.+|.+
T Consensus 529 ~~l~~~l~------------~G~r-------------------------------~~~P~~c~~eiY~iM~~CW~~~p~~ 565 (609)
T KOG0200|consen 529 EELLEFLK------------EGNR-------------------------------MEQPEHCSDEIYDLMKSCWNADPED 565 (609)
T ss_pred HHHHHHHh------------cCCC-------------------------------CCCCCCCCHHHHHHHHHHhCCCccc
Confidence 33333221 1110 0112234788999999999999999
Q ss_pred CCCHHHHHc
Q 001034 1161 RPSASDALK 1169 (1182)
Q Consensus 1161 RPTAeELLq 1169 (1182)
||+..++.+
T Consensus 566 RP~F~~~~~ 574 (609)
T KOG0200|consen 566 RPTFSECVE 574 (609)
T ss_pred CCCHHHHHH
Confidence 999999865
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=258.38 Aligned_cols=267 Identities=21% Similarity=0.247 Sum_probs=189.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC---
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE--- 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e--- 944 (1182)
....+++++||+|.||.||+|+ -+++.||||++.... .+.+++|..|..... ..|+||+++++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~----m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQE--KQSFQNEKNIYSLPG----MKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecCHHH--HHHHHhHHHHHhccC----ccchhHHHhhchhccCCccc
Confidence 3456788899999999999997 466999999997543 467778888877663 35889999998766554
Q ss_pred -eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh---------cCccccccCCccEEEccCC
Q 001034 945 -HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG---------LGLIHCDLKPENILVKSYS 1013 (1182)
Q Consensus 945 -~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS---------~GIIHRDIKPeNILIDs~~ 1013 (1182)
.++||++|-+ |+|.++++.+. +++....+|+.-+++||+|||+ ..|+|||||..||||..
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~nt-------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~-- 351 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANT-------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN-- 351 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc--
Confidence 7899999988 89999998764 8999999999999999999995 35999999999999994
Q ss_pred CceEEEecCCCccccCC-----CcccccCCCcccchhhhcCCC-CC-----chhhHHHHHHHHHHHHhCCCCCC-CCCHH
Q 001034 1014 RCEVKVIDLGSSCFETD-----HLCSYVQSRSYRAPEVILGLS-YD-----KKIDIWSLGCILAELCTGNVLFQ-NDSPA 1081 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~-----~~ss~vGTp~YmAPEVLlg~~-yS-----~kSDIWSLGVILYELLTGr~PF~-g~d~~ 1081 (1182)
++..-|+|||+|..... .....+||.+|||||++.+.- +. .++||||+|.+||||++...-+. +..+.
T Consensus 352 DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~ 431 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE 431 (534)
T ss_pred CCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc
Confidence 78899999999975432 233479999999999997642 22 57899999999999999765543 21110
Q ss_pred HHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCC
Q 001034 1082 TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161 (1182)
Q Consensus 1082 elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekR 1161 (1182)
...-.-+.+|..|. .+..+....-+...|......... ..-..+++.|..|+..||+.|
T Consensus 432 -Yqlpfe~evG~hPt-------------------~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeAR 490 (534)
T KOG3653|consen 432 -YQLPFEAEVGNHPT-------------------LEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEAR 490 (534)
T ss_pred -ccCchhHHhcCCCC-------------------HHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhh
Confidence 00000011121111 001111111111122221111111 234678999999999999999
Q ss_pred CCHHH------HHcCCC
Q 001034 1162 PSASD------ALKHPW 1172 (1182)
Q Consensus 1162 PTAeE------LLqHPW 1172 (1182)
+||.= .|.|+|
T Consensus 491 LTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 491 LTAGCVEERMAELMMLW 507 (534)
T ss_pred hhhHHHHHHHHHHhccC
Confidence 99863 455665
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-26 Score=248.91 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=197.9
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE-EEEecCe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD-YFYYREH 945 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d-sFqd~e~ 945 (1182)
+.+.|.|.+.||.|.||.+.+|.++.++..+++|.+++.......+.+|...--.|.+ |.||+.-|+ .|+....
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~-----H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSP-----HQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeecc-----chhhhHHHHHHhhcCce
Confidence 5688999999999999999999999999999999999887777888888766555554 448888776 5777788
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
++++|||++ |+|..-+.-. | +-+.....++.|+++||.|+|+.++||||||.+||||-......|||||||+
T Consensus 97 YvF~qE~aP~gdL~snv~~~----G---igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA----G---IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEEeeccCccchhhhhcCcc----c---ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccc
Confidence 999999999 6676554432 1 7788899999999999999999999999999999999765667999999999
Q ss_pred ccccCCCcccccCCCcccchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhcCCcchhh
Q 001034 1025 SCFETDHLCSYVQSRSYRAPEVILGL-----SYDKKIDIWSLGCILAELCTGNVLFQNDSPA-TLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1025 A~~~~~~~ss~vGTp~YmAPEVLlg~-----~yS~kSDIWSLGVILYELLTGr~PF~g~d~~-elLakIv~ilGp~Peem 1098 (1182)
.+..+......--+..|.|||+.... ...+.+|+|.||+|+|.+|||++||+..... ..+.+.++
T Consensus 170 t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~--------- 240 (378)
T KOG1345|consen 170 TRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ--------- 240 (378)
T ss_pred ccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH---------
Confidence 88766555444556779999988643 2567899999999999999999999742211 01111111
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCC---CCHHHHHcCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR---PSASDALKHPW 1172 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekR---PTAeELLqHPW 1172 (1182)
++..+...+...+...++.+..+.++-|..+|++| .++......-|
T Consensus 241 ----------------------------w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 241 ----------------------------WLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred ----------------------------HhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 11112223344556678899999999999999999 45544444333
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=217.90 Aligned_cols=167 Identities=26% Similarity=0.358 Sum_probs=125.8
Q ss_pred cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCCccc
Q 001034 955 ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCS 1034 (1182)
Q Consensus 955 GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~ss 1034 (1182)
|+|.+++..... .+++..++.|+.||+.||.|||+.+ ||+|||++. ++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~--~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTW--DGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcC--ccceee--ccceEeecccc--
Confidence 567777765322 3899999999999999999999998 999999984 677888 99987654432
Q ss_pred ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhcCCcchhhhhcccccchhhcccc
Q 001034 1035 YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA-TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNH 1113 (1182)
Q Consensus 1035 ~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~-elLakIv~ilGp~PeemL~~~k~s~k~F~k~~ 1113 (1182)
..+|+.|+|||++.+..++.++|||||||++|+|++|++||...... ..+..++....+..
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------------ 125 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------------------ 125 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------------------
Confidence 36899999999999999999999999999999999999999764432 22222221100000
Q ss_pred hhhhhhcchhhhhhccccccccccCCCCCc--HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1114 MLYERNQETNRLEYLIPKKTSLRHRLPMGD--QGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1114 ~~~er~~ets~Le~liPk~~sL~~~l~~~S--eeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
+... ......+ ..+.+||.+||..+|.+||++.++++|+|+..
T Consensus 126 ----------------~~~~---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 126 ----------------PRDR---SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ----------------cccc---ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0000 0000111 36899999999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-22 Score=205.03 Aligned_cols=258 Identities=31% Similarity=0.464 Sum_probs=197.8
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch----hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD----FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~----~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
|.+.+.||.|+|+.||++.+. ..+++|.+..... ....+.+|..+++.+.++. +|+++++.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-----~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP-----NIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCc-----ceeeEEEEEecCCEE
Confidence 788999999999999999986 7899999976542 3567788888888887663 799999999877888
Q ss_pred EEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCc-eEEEecCCC
Q 001034 947 LIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC-EVKVIDLGS 1024 (1182)
Q Consensus 947 yLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG-~IKLiDFGL 1024 (1182)
+++++++.+. +..++...... ..+....+..++.|++.+|.|+|+.+++||||||+||+++. .+ .++++|||.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~--~~~~~~l~dfg~ 148 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR--DGRVVKLIDFGL 148 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC--CCCeEEEeccCc
Confidence 9999999965 44344332210 23888899999999999999999999999999999999995 44 699999999
Q ss_pred ccccCC---------CcccccCCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Q 001034 1025 SCFETD---------HLCSYVQSRSYRAPEVILG---LSYDKKIDIWSLGCILAELCTGNVLFQNDSP----ATLLARVI 1088 (1182)
Q Consensus 1025 A~~~~~---------~~ss~vGTp~YmAPEVLlg---~~yS~kSDIWSLGVILYELLTGr~PF~g~d~----~elLakIv 1088 (1182)
+..... .....+++..|+|||.+.+ ..++...|+||+|++++++++|..||..... ......+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 228 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence 864332 2356789999999999988 5789999999999999999999999877653 23333322
Q ss_pred hhcCC-cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1089 GIIGP-IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1089 ~ilGp-~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
....+ ... +...... ......+.+++.+|+..+|..|.++...
T Consensus 229 ~~~~~~~~~---------------------------------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~ 272 (384)
T COG0515 229 ELPTPSLAS---------------------------------PLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSD 272 (384)
T ss_pred hcCCccccc---------------------------------ccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHH
Confidence 11111 000 0000000 1223678899999999999999999999
Q ss_pred HcCCCCCCCC
Q 001034 1168 LKHPWLSHPY 1177 (1182)
Q Consensus 1168 LqHPWFk~~~ 1177 (1182)
..++|+....
T Consensus 273 ~~~~~~~~~~ 282 (384)
T COG0515 273 LSHDLLAHLK 282 (384)
T ss_pred hhchHhhCcc
Confidence 9997776543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=255.88 Aligned_cols=241 Identities=22% Similarity=0.300 Sum_probs=192.8
Q ss_pred EEEEEeccCCceEEEEEEECCCCc----EEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 872 HVTEYLGSAAFSKAIQAHDLHTGM----DVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 872 eIlk~LGkGaFGeVyLAkDk~TGr----~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+..++||.|+||+||++.....|+ +||||++.... .....++.|.-++..+. ||||++|++++....
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld------Hpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD------HPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC------CchHHHHhhhcccch-
Confidence 345789999999999998765554 58889887654 33567778888777775 559999999998766
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+-||++||+ |.|+++++..+.. +-......|.+||++||.|||.++++||||-..|||+.. -.++||+|||+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~-----igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVks--P~hvkitdfgl 844 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDN-----IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKS--PNHVKITDFGL 844 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhcc-----ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecC--CCeEEEEecch
Confidence 889999999 6899999987654 667788999999999999999999999999999999995 55799999999
Q ss_pred ccccCCCcc-----cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1025 SCFETDHLC-----SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1025 A~~~~~~~s-----s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
++....... ...-.+-|||-|.+....|+.++|||||||++|||+| |..|+.+-...++-..+
T Consensus 845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll----------- 913 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL----------- 913 (1177)
T ss_pred hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-----------
Confidence 987554322 1223567999999999999999999999999999998 99999887655432221
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
..+ .. ....+..+.++.-++.+||..|+..||+++++..
T Consensus 914 -e~g------------------------------eR-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 914 -EKG------------------------------ER-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -hcc------------------------------cc-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 000 00 1234566788999999999999999999999764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=238.29 Aligned_cols=196 Identities=24% Similarity=0.343 Sum_probs=158.8
Q ss_pred cceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 858 NFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 858 ~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
-.+.-....++.+.++.+.||+|.||+||++. .-|+.||||++.... .....+|.+|.+.+-. .|+||+.++
T Consensus 200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~srd--E~SWfrEtEIYqTvmL----RHENILgFI 271 (513)
T KOG2052|consen 200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSRD--ERSWFRETEIYQTVML----RHENILGFI 271 (513)
T ss_pred CchhHhHHhhhheeEEEEEecCccccceeecc--ccCCceEEEEecccc--hhhhhhHHHHHHHHHh----ccchhhhhh
Confidence 34556667788999999999999999999996 678999999997543 2345566666665432 355999998
Q ss_pred EEEEec----CeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-----c---CccccccCC
Q 001034 938 DYFYYR----EHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-----L---GLIHCDLKP 1004 (1182)
Q Consensus 938 dsFqd~----e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-----~---GIIHRDIKP 1004 (1182)
+.-..+ ..++||++|-+ |+|++|+..+. ++......++.-++.||++||- + .|.|||||.
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t-------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT-------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhhcc-------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 875544 46999999998 89999998743 7888999999999999999994 2 499999999
Q ss_pred ccEEEccCCCceEEEecCCCccccCC-------CcccccCCCcccchhhhcCCC------CCchhhHHHHHHHHHHHHh
Q 001034 1005 ENILVKSYSRCEVKVIDLGSSCFETD-------HLCSYVQSRSYRAPEVILGLS------YDKKIDIWSLGCILAELCT 1070 (1182)
Q Consensus 1005 eNILIDs~~dG~IKLiDFGLA~~~~~-------~~ss~vGTp~YmAPEVLlg~~------yS~kSDIWSLGVILYELLT 1070 (1182)
.|||+.+ ++..-|.|+|+|..... ..+..+||.+|||||++...- --..+||||||+++||++.
T Consensus 345 KNILVKk--n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 345 KNILVKK--NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred ccEEEcc--CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9999994 78899999999965433 356789999999999995431 1256899999999999976
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-22 Score=219.87 Aligned_cols=205 Identities=27% Similarity=0.315 Sum_probs=169.6
Q ss_pred CEEEEEEeccCCceEEEEEEECCCC-cEEEEEEEeccchh-hHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE-EecCeE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTG-MDVCVKIIKNNKDF-FDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF-YYREHL 946 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TG-r~VAVKIIkk~k~~-~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF-qd~e~L 946 (1182)
+|.+.+.||.|+||.||+|.+..++ ..+|+|+....... ......|+.++..+... ....++..+++.+ ....+-
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~--~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKK--NGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhh--cCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999988775 68999998765322 12567788888888751 1123789999998 477889
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-C--ceEEEecCC
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-R--CEVKVIDLG 1023 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-d--G~IKLiDFG 1023 (1182)
||||+.++.+|.++...... ..|+...+..++.|++.||++||+.|++||||||.|+++.... . ..+.|+|||
T Consensus 97 ~iVM~l~G~sL~dl~~~~~~----~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNPP----GRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEeccCccHHHHHHhCCC----CCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99999999999998766541 2399999999999999999999999999999999999998532 1 469999999
Q ss_pred Ccc--ccC-C---------C-cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 001034 1024 SSC--FET-D---------H-LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080 (1182)
Q Consensus 1024 LA~--~~~-~---------~-~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~ 1080 (1182)
+++ ... . . ...+.||..|+++.+..+...+.+.|+||++.++.+|+.|..||.+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 998 210 0 1 1235699999999999999999999999999999999999999976553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-22 Score=211.98 Aligned_cols=213 Identities=21% Similarity=0.357 Sum_probs=181.0
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+..+.|.++++||.|+||.+|++....+|..||||+-++... ..+...|.++.+.|++.. .|..+..++....+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~-----GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGV-----GIPHIRHYGTEKDY 85 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCC-----CCchhhhhcccccc
Confidence 456899999999999999999999999999999998876543 356778899999988764 67888888888999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCc-eEEEecCCC
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC-EVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG-~IKLiDFGL 1024 (1182)
-.+||++++.+|.+++..+... |+..++.-++-|++.-|+|+|..++|||||||+|+|+.-..++ .+.|||||+
T Consensus 86 nvlVMdLLGPsLEdLfnfC~R~-----ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 86 NVLVMDLLGPSLEDLFNFCSRR-----FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ceeeeeccCccHHHHHHHHhhh-----hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 9999999999999999888653 9999999999999999999999999999999999999754333 689999999
Q ss_pred ccccCCC----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh
Q 001034 1025 SCFETDH----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP---ATLLARVIG 1089 (1182)
Q Consensus 1025 A~~~~~~----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~---~elLakIv~ 1089 (1182)
|+...+. .....||..|.+--...+...+..-|+-|+|.+|.++.-|..||++-.+ .+-+.+|..
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 9753322 2346789999999999999999999999999999999999999998543 344555543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-23 Score=246.31 Aligned_cols=266 Identities=20% Similarity=0.239 Sum_probs=190.6
Q ss_pred CCE-EEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRY-HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drY-eIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
..| ....++|.|++|.|+.+........++.|.++.. ....... ....+...+.....+.||+++..+..++....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~-~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERK-YNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHH-HhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 444 3456899999999999988777777776655421 1101111 11114444444455678888887777666655
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
.+-+|||++++|+.++.... .++...+..++.||+.||.|||.+||.||||||+|+++.. .|.+||+|||.+
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~--~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTE--NGILKIIDFGAA 467 (601)
T ss_pred chhhhhcccHHHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEec--CCceEEeecCcc
Confidence 55559999997777776542 2788889999999999999999999999999999999995 678999999988
Q ss_pred cccCC-------CcccccCCCcccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhhcCCcch
Q 001034 1026 CFETD-------HLCSYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLA-RVIGIIGPIEQ 1096 (1182)
Q Consensus 1026 ~~~~~-------~~ss~vGTp~YmAPEVLlg~~yS-~kSDIWSLGVILYELLTGr~PF~g~d~~elLa-kIv~ilGp~Pe 1096 (1182)
..... .....+|+..|+|||++.+..|. ...||||.|++++.|.+|+.||.-....+... .+
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--------- 538 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--------- 538 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh---------
Confidence 54322 23457889999999999999988 46899999999999999999995433221110 00
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
..... ..............+...+.+|.+||++||.+|.|+.+||+.+||+..
T Consensus 539 --------------~~~~~-------------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 539 --------------NYSDQ-------------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred --------------ccccc-------------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 00000 000011111222335678899999999999999999999999999987
Q ss_pred CCC
Q 001034 1177 YEP 1179 (1182)
Q Consensus 1177 ~eP 1179 (1182)
..|
T Consensus 592 ~~c 594 (601)
T KOG0590|consen 592 ECC 594 (601)
T ss_pred ceE
Confidence 655
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-22 Score=242.32 Aligned_cols=220 Identities=24% Similarity=0.352 Sum_probs=167.6
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
....+|..++.|..|+||-||+++++.+.+.+|+|+ .++.. ||+.+... ...|++|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----------ilRnilt~--a~npfvv----------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----------ILRNILTF--AGNPFVV----------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----------hhhccccc--cCCccee-----------
Confidence 446789999999999999999999999999999954 33221 12211111 0112222
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+-..+++... . ++. +++.|++|||+-||+|||+||+|+||.. -|++|++|||++
T Consensus 136 ---------gDc~tllk~~g----~--lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~--mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIG----P--LPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITS--MGHIKLTDFGLS 190 (1205)
T ss_pred ---------chhhhhcccCC----C--Ccc--------hhhHHhHhhccCCeecCCCCCCcceeee--cccccccchhhh
Confidence 33333333221 1 221 2378999999999999999999999995 788999999987
Q ss_pred cccCCC------------------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 001034 1026 CFETDH------------------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1026 ~~~~~~------------------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakI 1087 (1182)
+..... ....||||.|+|||++..+.|++.+|||+||+|+|+.|.|+.||.++++++++.++
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v 270 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 270 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence 531110 23468999999999999999999999999999999999999999999999999999
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCC---CCH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR---PSA 1164 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekR---PTA 1164 (1182)
+......|++. .....++.++|.++|+.+|..| ..+
T Consensus 271 isd~i~wpE~d-----------------------------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 271 ISDDIEWPEED-----------------------------------------EALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred hhhhccccccC-----------------------------------------cCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 76555544431 1235789999999999999999 567
Q ss_pred HHHHcCCCCCC
Q 001034 1165 SDALKHPWLSH 1175 (1182)
Q Consensus 1165 eELLqHPWFk~ 1175 (1182)
.++.+|+||+.
T Consensus 310 ~evk~h~ff~~ 320 (1205)
T KOG0606|consen 310 LEVKQHGFFQL 320 (1205)
T ss_pred hhhhhccceee
Confidence 88999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=238.97 Aligned_cols=236 Identities=23% Similarity=0.326 Sum_probs=189.1
Q ss_pred eccCCceEEEEEEE---CCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 877 LGSAAFSKAIQAHD---LHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 877 LGkGaFGeVyLAkD---k~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
+|.|+||.|+++.. ...+..||||++++.. ........|..++..++. ||++|++...|+....+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~-----~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHN-----TPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccC-----CCceeeeeeeeccccchhHhh
Confidence 79999999999864 3567889999987642 111255567777777763 459999999999999999999
Q ss_pred EecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 951 ELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 951 EyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
+++.|+ +..-+.. ...+.+...+.+...++.|++++|+.+|+|||+|++||+++ .+|+|++.|||+++..-
T Consensus 77 d~~rgg~lft~l~~------~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld--~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSK------EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL--LEGHIKLTDFGLSKEAV 148 (612)
T ss_pred hhcccchhhhcccc------CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec--ccCccccCCchhhhHhH
Confidence 999974 4333222 22388888999999999999999999999999999999999 48899999999998644
Q ss_pred CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhh
Q 001034 1030 DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYF 1109 (1182)
Q Consensus 1030 ~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F 1109 (1182)
..... |||..|||||++. ....++||||||+++|+|++|..||.. ++..+|+..--..|.
T Consensus 149 ~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~------------- 208 (612)
T KOG0603|consen 149 KEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR------------- 208 (612)
T ss_pred hhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch-------------
Confidence 43333 9999999999998 678899999999999999999999987 556666532222222
Q ss_pred cccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHcCCCCCCC
Q 001034 1110 TKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA-----SDALKHPWLSHP 1176 (1182)
Q Consensus 1110 ~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA-----eELLqHPWFk~~ 1176 (1182)
..+..+.++++.|+..+|..|.-+ .|+++|+||+..
T Consensus 209 -------------------------------~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 209 -------------------------------ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred -------------------------------hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 225678899999999999999765 799999999753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=214.68 Aligned_cols=250 Identities=20% Similarity=0.224 Sum_probs=189.9
Q ss_pred CCEEEEEEeccCCceEEEEEEECCC-----CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHT-----GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~T-----Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
.|+++..++-+|.||+||.+..... .+.|-+|.++... .+...++.|--.|..+ .|||+..+.++..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~------sH~nll~V~~V~i 357 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA------SHPNLLSVLGVSI 357 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC------cCCCccceeEEEe
Confidence 4566677889999999999965432 2335556554432 2334444454444444 4669999988766
Q ss_pred ec-CeEEEEEEecc-cChHHHHhhhccc--CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 942 YR-EHLLIVCELLK-ANLYEFHKFNRES--GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 942 d~-e~LyLVmEyL~-GsLld~Lk~~~~s--ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
.. ...++++.+++ |+|..|+..++.. .+...++..++..++.||+.|+.|||+.|+||.||-..|++|+. .-++
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd--~LqV 435 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD--QLQV 435 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh--heeE
Confidence 54 66788889988 8999999866522 22234777788889999999999999999999999999999994 6789
Q ss_pred EEecCCCccccCCCccccc-----CCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhc
Q 001034 1018 KVIDLGSSCFETDHLCSYV-----QSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~v-----GTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~il 1091 (1182)
||+|=.+++.+-...+... .+..||+||.+....|+.++|+|||||+||||+| |+.|+..-++.++..-+.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk--- 512 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK--- 512 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh---
Confidence 9999999886544333322 3667999999999999999999999999999998 999999888888765552
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.+++ . ...-+++.++..++.-|+..+|++||+.+|+..
T Consensus 513 ---------dGyR----------------------l---------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 513 ---------DGYR----------------------L---------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ---------ccce----------------------e---------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1111 0 112256889999999999999999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=212.67 Aligned_cols=212 Identities=19% Similarity=0.299 Sum_probs=182.9
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++.-.|+|.++||+|+||.++++.+..++++||||.-.... ...+...|.+..+.|.... .|...|++-+...+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~~-----GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGTE-----GIPQVYYFGQEGKY 98 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCCC-----CCCceeeeccccch
Confidence 34557999999999999999999999999999999765433 3456778899999888654 89999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC---CceEEEecC
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS---RCEVKVIDL 1022 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~---dG~IKLiDF 1022 (1182)
-.||||+++.+|.+++..+... |+...+.-++.|++.-|+|+|++.+|+|||||+|+||...+ ...|.|+||
T Consensus 99 NiLVidLLGPSLEDLFD~CgR~-----FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 99 NILVIDLLGPSLEDLFDLCGRR-----FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhhhhCcCHHHHHHHhcCc-----ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 9999999999999999988643 99999999999999999999999999999999999997532 346999999
Q ss_pred CCccccCCC----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHH
Q 001034 1023 GSSCFETDH----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN---DSPATLLARVI 1088 (1182)
Q Consensus 1023 GLA~~~~~~----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g---~d~~elLakIv 1088 (1182)
|+|+...++ ..+..||..||+--..+|...+.+-|+-|||-+++++|-|.+||.+ .+..+-+++|-
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 999864433 2356789999999999999999999999999999999999999987 55566666663
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=211.39 Aligned_cols=163 Identities=20% Similarity=0.176 Sum_probs=125.5
Q ss_pred eCceecCCEEEEEEeccCCceEEEEEEECC-CCcEEEEEEEecc------chhhHHHHHHHHHHHHhcCCCCCCCcceE-
Q 001034 863 LNSVIAGRYHVTEYLGSAAFSKAIQAHDLH-TGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLL- 934 (1182)
Q Consensus 863 ig~iL~drYeIlk~LGkGaFGeVyLAkDk~-TGr~VAVKIIkk~------k~~~dq~l~EikILr~L~h~~~l~HPnIV- 934 (1182)
....+.++|.+.+.||+|+||+||+|+++. +++.||||++... ......+.+|+++|+.+.|+ +++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~------~iv~ 85 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGI------GVVP 85 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCC------CCCc
Confidence 345678999999999999999999998876 7888899987532 12245578999999999766 566
Q ss_pred EEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCcccccc-CCccEEEccCC
Q 001034 935 RLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDL-KPENILVKSYS 1013 (1182)
Q Consensus 935 kL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDI-KPeNILIDs~~ 1013 (1182)
.+++. ...||||||+.|..+.... . .. ...++.|++.||.|||++||+|||| ||+|||++.
T Consensus 86 ~l~~~----~~~~LVmE~~~G~~L~~~~----~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~-- 147 (365)
T PRK09188 86 QLLAT----GKDGLVRGWTEGVPLHLAR----P-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGP-- 147 (365)
T ss_pred EEEEc----CCcEEEEEccCCCCHHHhC----c-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcC--
Confidence 45442 4689999999986554221 1 11 1457889999999999999999999 999999974
Q ss_pred CceEEEecCCCccccCCC-----------cccccCCCcccchhhhcC
Q 001034 1014 RCEVKVIDLGSSCFETDH-----------LCSYVQSRSYRAPEVILG 1049 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~~-----------~ss~vGTp~YmAPEVLlg 1049 (1182)
++.+||+|||+|+..... .....+++.|+|||.+..
T Consensus 148 ~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 148 DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 567999999999754322 134567888999999853
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=197.67 Aligned_cols=241 Identities=21% Similarity=0.277 Sum_probs=151.1
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCC-CC---CCcceEEEEEEEEe
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHD-PG---DKYHLLRLYDYFYY 942 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~-~l---~HPnIVkL~dsFqd 942 (1182)
+.....||.|+|+.||.|.+..|++.+|+|++.... ...+...+|......+.... +. .|-.++..++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 556688999999999999999999999999986543 22333333333332222100 00 01134444443332
Q ss_pred c-----------------CeEEEEEEecccChHHHHhhhcccCCc-cccCHHHHHHHHHHHHHHHHHHHhcCccccccCC
Q 001034 943 R-----------------EHLLIVCELLKANLYEFHKFNRESGGE-VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004 (1182)
Q Consensus 943 ~-----------------e~LyLVmEyL~GsLld~Lk~~~~sgge-l~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKP 1004 (1182)
. -..+++|+.+.++|..++......... ..+.......+..|+++.+++||..|++|+||+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 1 135789999999888876643222111 1133334455668999999999999999999999
Q ss_pred ccEEEccCCCceEEEecCCCccccCCCcccccCCCcccchhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001034 1005 ENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILG--------LSYDKKIDIWSLGCILAELCTGNVLFQ 1076 (1182)
Q Consensus 1005 eNILIDs~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg--------~~yS~kSDIWSLGVILYELLTGr~PF~ 1076 (1182)
+|+|++. +|.++|+||+.....+........+..|.+||.... ..++.+.|.|+||+++|.|+||..||.
T Consensus 174 ~nfll~~--~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 174 ENFLLDQ--DGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp GGEEE-T--TS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred eeEEEcC--CCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 9999995 788999999887665554443445678999998743 257889999999999999999999996
Q ss_pred CCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhccc
Q 001034 1077 NDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156 (1182)
Q Consensus 1077 g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~ 1156 (1182)
...+... . .. ....+. .+++.++.||+.||++
T Consensus 252 ~~~~~~~---------~-----------~~---------------------------~f~~C~-~~Pe~v~~LI~~lL~~ 283 (288)
T PF14531_consen 252 LSSPEAD---------P-----------EW---------------------------DFSRCR-DMPEPVQFLIRGLLQR 283 (288)
T ss_dssp CCGGGST---------S-----------GG---------------------------GGTTSS----HHHHHHHHHHT-S
T ss_pred CCCcccc---------c-----------cc---------------------------cchhcC-CcCHHHHHHHHHHccC
Confidence 5432100 0 00 112233 6678999999999999
Q ss_pred CCCCC
Q 001034 1157 NPKKR 1161 (1182)
Q Consensus 1157 DPekR 1161 (1182)
+|.+|
T Consensus 284 ~~~~R 288 (288)
T PF14531_consen 284 NPEDR 288 (288)
T ss_dssp SGGGS
T ss_pred CcccC
Confidence 99988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-20 Score=226.09 Aligned_cols=244 Identities=26% Similarity=0.390 Sum_probs=173.3
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.|...+.||.+.|=+|.+|++ ..|. |+||++-+.. .....+.+.++-++.. ...+||++.+.-........|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~----l~~~pn~lPfqk~~~t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIKFA----LMKAPNCLPFQKVLVTDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHHHH----hhcCCcccchHHHHHhhHHHH
Confidence 688889999999999999986 4555 9999997653 1122333333333311 124568888777766677889
Q ss_pred EEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 948 LVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||-+|+..+|++-+..+. ++...+.+.|+.||+.||.-+|..||+|||||.+||||++ -.=+.|+||..-+.
T Consensus 98 lvRqyvkhnLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS--WNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 98 LVRQYVKHNLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS--WNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHhhhhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee--echhhhhcccccCC
Confidence 999999999999887654 3888889999999999999999999999999999999995 33488999987542
Q ss_pred --cCC--C--cccccC----CCcccchhhhcCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 001034 1028 --ETD--H--LCSYVQ----SRSYRAPEVILGL----------S-YDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLA 1085 (1182)
Q Consensus 1028 --~~~--~--~ss~vG----Tp~YmAPEVLlg~----------~-yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLa 1085 (1182)
+.. + ...+.. -.+|+|||.|... + ..++.||||+||+++||++ |++||. +.
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------LS 242 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------LS 242 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------HH
Confidence 111 1 111222 3469999998542 2 5688999999999999998 899993 22
Q ss_pred HHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 001034 1086 RVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165 (1182)
Q Consensus 1086 kIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe 1165 (1182)
++.+-. .+ .. .....+-.. ..+..++.||..|++.||.+|.+|+
T Consensus 243 QL~aYr---------~~-----------~~----~~~e~~Le~------------Ied~~~Rnlil~Mi~rdPs~RlSAe 286 (1431)
T KOG1240|consen 243 QLLAYR---------SG-----------NA----DDPEQLLEK------------IEDVSLRNLILSMIQRDPSKRLSAE 286 (1431)
T ss_pred HHHhHh---------cc-----------Cc----cCHHHHHHh------------CcCccHHHHHHHHHccCchhccCHH
Confidence 221000 00 00 000001011 1245789999999999999999999
Q ss_pred HHHcC
Q 001034 1166 DALKH 1170 (1182)
Q Consensus 1166 ELLqH 1170 (1182)
+.|+-
T Consensus 287 dyL~~ 291 (1431)
T KOG1240|consen 287 DYLQK 291 (1431)
T ss_pred HHHHh
Confidence 99974
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-18 Score=179.78 Aligned_cols=139 Identities=15% Similarity=0.218 Sum_probs=103.5
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchh---------------------------hHHHHHHHHHHHHhcCCC
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF---------------------------FDQSLDEIKLLKYVNKHD 926 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~---------------------------~dq~l~EikILr~L~h~~ 926 (1182)
...||.|+||.||+|.+. +|+.||||+++..... ......|++++..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999986 8999999999764210 012234888999987642
Q ss_pred CCCCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHH-HhcCccccccCCc
Q 001034 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL-HGLGLIHCDLKPE 1005 (1182)
Q Consensus 927 ~l~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYL-HS~GIIHRDIKPe 1005 (1182)
. .+|+++. .. ..+|||||++|+.+....... ..++...+..++.||+.+|.+| |+.||+||||||+
T Consensus 81 v-~~p~~~~------~~-~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~ 147 (190)
T cd05147 81 I-PCPEPIL------LK-SHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCRLVHADLSEY 147 (190)
T ss_pred C-CCCcEEE------ec-CCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 1 2334331 12 238999999986433221111 1378889999999999999999 7999999999999
Q ss_pred cEEEccCCCceEEEecCCCccccC
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
|||++ ++.++|+|||+|....
T Consensus 148 NIli~---~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 148 NLLYH---DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HEEEE---CCcEEEEEccccccCC
Confidence 99998 3679999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=185.76 Aligned_cols=177 Identities=15% Similarity=0.223 Sum_probs=130.3
Q ss_pred ceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHH------HHHHHHHHHHhcCCCCC
Q 001034 859 FHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQ------SLDEIKLLKYVNKHDPG 928 (1182)
Q Consensus 859 f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq------~l~EikILr~L~h~~~l 928 (1182)
|.-...+.+.++|+++++||.|+||.||++.+ ++..+|+|+++... ..... ..+|+..+.++.++
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~--- 95 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE--- 95 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC---
Confidence 44555677899999999999999999999765 46789999997542 11112 45777888888766
Q ss_pred CCcceEEEEEEEEec--------CeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccc
Q 001034 929 DKYHLLRLYDYFYYR--------EHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIH 999 (1182)
Q Consensus 929 ~HPnIVkL~dsFqd~--------e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIH 999 (1182)
+|..+.+++... ...+|||||++|. |.++.. +++ ..+.+|+.+|..||..|++|
T Consensus 96 ---GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~gi~H 158 (232)
T PRK10359 96 ---GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQHGMVS 158 (232)
T ss_pred ---CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHcCCcc
Confidence 677777765543 4589999999984 544311 222 24569999999999999999
Q ss_pred cccCCccEEEccCCCceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHH
Q 001034 1000 CDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELC 1069 (1182)
Q Consensus 1000 RDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELL 1069 (1182)
|||||.|||++. .| ++|+|||.......... ..-+++...|+.++|+||||+++..+.
T Consensus 159 ~Dikp~Nili~~--~g-i~liDfg~~~~~~e~~a---------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 159 GDPHKGNFIVSK--NG-LRIIDLSGKRCTAQRKA---------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCChHHEEEeC--CC-EEEEECCCcccccchhh---------HHHHHHHhHhcccccccceeEeehHHH
Confidence 999999999985 45 99999998754322111 111445556778999999999986554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=170.60 Aligned_cols=140 Identities=19% Similarity=0.192 Sum_probs=102.5
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchh---------------------------hHHHHHHHHHHHHhcCCC
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF---------------------------FDQSLDEIKLLKYVNKHD 926 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~---------------------------~dq~l~EikILr~L~h~~ 926 (1182)
.+.||.|+||.||+|.+. +|+.||||+++..... ......|...+.++.+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~- 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA- 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 468999999999999987 8999999999864210 11124677888888765
Q ss_pred CCCCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCc
Q 001034 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPE 1005 (1182)
Q Consensus 927 ~l~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPe 1005 (1182)
++.....+.. ...||||||++|.......... ..++...+..++.|++.+|.+||. .||+||||||+
T Consensus 80 -----~i~~p~~~~~--~~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~ 147 (190)
T cd05145 80 -----GVPVPEPILL--KKNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEY 147 (190)
T ss_pred -----CCCCceEEEe--cCCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChh
Confidence 2322211111 1348999999986322111111 126778889999999999999999 99999999999
Q ss_pred cEEEccCCCceEEEecCCCccccCC
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~~~~ 1030 (1182)
|||++ ++.++|+|||++.....
T Consensus 148 NIll~---~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 148 NILYH---DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hEEEE---CCCEEEEEcccceecCC
Confidence 99998 46799999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-17 Score=207.23 Aligned_cols=196 Identities=17% Similarity=0.284 Sum_probs=157.3
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+-...|.|-+.||.|+||+||+|.+.. |+.||+|+-+....| .+.-..+++.+|+ . ..-+.|+.+...+...+.
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W--EfYI~~q~~~RLk-~--~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW--EFYICLQVMERLK-P--QMLPSIMHISSAHVFQNA 768 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce--eeeehHHHHHhhc-h--hhhcchHHHHHHHccCCc
Confidence 345689999999999999999999866 999999998876644 2333445555555 1 112256677776777778
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-----CCceEEE
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-----SRCEVKV 1019 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-----~dG~IKL 1019 (1182)
-+||++|.+ |+|++++...+ .+++..+.+|+.|++..|+.||.++|||+||||+|+||... ..--++|
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence 889999999 78999987333 38888999999999999999999999999999999999631 2335999
Q ss_pred ecCCCcccc---C--CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 001034 1020 IDLGSSCFE---T--DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNV 1073 (1182)
Q Consensus 1020 iDFGLA~~~---~--~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~ 1073 (1182)
||||.+-.. . ......++|-.+-.+|+..|.+|++.+|.|.|+.+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999988532 1 23445678889999999999999999999999999999999974
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.8e-17 Score=173.26 Aligned_cols=183 Identities=17% Similarity=0.105 Sum_probs=138.7
Q ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhH-----HHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 872 HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFD-----QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 872 eIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~d-----q~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.+...|++|+||+|+++.. .+..++.+.+.....+.. .+.+|+++|++|.+.. ++++++++ ...
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~-----~vP~ll~~----~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLP-----RTPRLLHW----DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCC-----CCCEEEEE----cCE
Confidence 4567899999999998864 778888888877665544 5678999999997643 67777775 457
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCcccccc-CCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDL-KPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDI-KPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|++|+|+.|..+.... .. ....++.|++.+|.+||++||+|||| ||.|||++. ++.++|+|||++
T Consensus 74 ~lvmeyI~G~~L~~~~-----------~~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~--~g~i~LIDFG~A 139 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP-----------PR-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE--DGSPAVIDFQLA 139 (218)
T ss_pred EEEEeeecCccHHhhh-----------hh-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC--CCCEEEEECCCc
Confidence 9999999986542211 00 11347789999999999999999999 799999984 677999999999
Q ss_pred cccCCCcc----------------cccCCCcccchhhhcCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 001034 1026 CFETDHLC----------------SYVQSRSYRAPEVILGL-SYD-KKIDIWSLGCILAELCTGNVLFQNDS 1079 (1182)
Q Consensus 1026 ~~~~~~~s----------------s~vGTp~YmAPEVLlg~-~yS-~kSDIWSLGVILYELLTGr~PF~g~d 1079 (1182)
........ ....++.|++|+...-. ..+ ...+|++.|+.+|.++|+..|+.++.
T Consensus 140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 75432211 11247888999876433 344 67899999999999999999886654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-17 Score=185.66 Aligned_cols=189 Identities=23% Similarity=0.293 Sum_probs=141.5
Q ss_pred CCCcceEEEEEEEEec---------------------------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHH
Q 001034 928 GDKYHLLRLYDYFYYR---------------------------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQS 980 (1182)
Q Consensus 928 l~HPnIVkL~dsFqd~---------------------------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~ 980 (1182)
..|||||+++..|.+. ..+|+||..++.+|..++-.+. .+....+-
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-------~s~r~~~~ 345 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-------RSYRTGRV 345 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-------CchHHHHH
Confidence 4699999999988653 3589999999999999987653 55667788
Q ss_pred HHHHHHHHHHHHHhcCccccccCCccEEEccCCCc--eEEEecCCCccccCC---------CcccccCCCcccchhhhcC
Q 001034 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC--EVKVIDLGSSCFETD---------HLCSYVQSRSYRAPEVILG 1049 (1182)
Q Consensus 981 Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG--~IKLiDFGLA~~~~~---------~~ss~vGTp~YmAPEVLlg 1049 (1182)
++.|++.|+.|||++||.|||+|.+||||.-+.++ .+.|+|||++--... ..-..-|.-.-||||++..
T Consensus 346 ~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999999999999999999999654443 688999998743221 1223456778999999975
Q ss_pred CC------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchh
Q 001034 1050 LS------YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETN 1123 (1182)
Q Consensus 1050 ~~------yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets 1123 (1182)
.+ --.++|.|+.|.+.||++.-..||+......+ . .+.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----------------~----------------~r~---- 469 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----------------D----------------TRT---- 469 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee----------------c----------------hhh----
Confidence 43 12579999999999999999999987322110 0 000
Q ss_pred hhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 001034 1124 RLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165 (1182)
Q Consensus 1124 ~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe 1165 (1182)
++ ...+......+++.+++|+..+|+.||.+|+++.
T Consensus 470 ---Yq---e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 470 ---YQ---ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ---hh---hhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 00 0112223345678999999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.5e-16 Score=164.32 Aligned_cols=138 Identities=20% Similarity=0.226 Sum_probs=106.7
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEecc-chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC---eEE-EE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN-KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE---HLL-IV 949 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~-k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e---~Ly-LV 949 (1182)
+.||+|+|+.||. +..++.. +||++... ......+.+|+.+++.+.+. ...||||+++|+++.... .++ +|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~-~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRR-LIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhcc-CCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 5899999999995 6667665 79998754 22346789999999999764 357899999999999874 434 78
Q ss_pred EEecc---cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHH-HHHHhcCccccccCCccEEEccC--CCceEEEecCC
Q 001034 950 CELLK---ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL-QFLHGLGLIHCDLKPENILVKSY--SRCEVKVIDLG 1023 (1182)
Q Consensus 950 mEyL~---GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsAL-eYLHS~GIIHRDIKPeNILIDs~--~dG~IKLiDFG 1023 (1182)
|||.+ ++|.+++.... +++. ..++.|++.++ .|||+++|+||||||+|||++.. +...++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99954 58888885421 4444 35678888777 99999999999999999999853 23479999954
Q ss_pred Cc
Q 001034 1024 SS 1025 (1182)
Q Consensus 1024 LA 1025 (1182)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.4e-16 Score=167.65 Aligned_cols=144 Identities=18% Similarity=0.145 Sum_probs=107.9
Q ss_pred EEEEEEeccCCceEEEEEE-ECCCCcEEEEEEEeccch-------------------------hhHHHHHHHHHHHHhcC
Q 001034 871 YHVTEYLGSAAFSKAIQAH-DLHTGMDVCVKIIKNNKD-------------------------FFDQSLDEIKLLKYVNK 924 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAk-Dk~TGr~VAVKIIkk~k~-------------------------~~dq~l~EikILr~L~h 924 (1182)
|.|.+.||.|+||.||+|. +..+|+.||||+++.... .......|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7788899999999999999 778999999999975421 01124578899998875
Q ss_pred CCCCCCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC-ccccccC
Q 001034 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG-LIHCDLK 1003 (1182)
Q Consensus 925 ~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G-IIHRDIK 1003 (1182)
. +..+.+++.. ...+|||||++|..+....... ..+....+..++.||+.+|.+||+.| |+|||||
T Consensus 110 ~----~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 110 A----GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred c----CCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 3 1234444442 2358999999985443222111 12555667889999999999999999 9999999
Q ss_pred CccEEEccCCCceEEEecCCCccccCC
Q 001034 1004 PENILVKSYSRCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 1004 PeNILIDs~~dG~IKLiDFGLA~~~~~ 1030 (1182)
|+|||++ .+.++|+|||.+.....
T Consensus 177 p~NIli~---~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILVH---DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEEE---CCCEEEEEChhhhccCC
Confidence 9999998 56799999999875443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=8e-15 Score=150.99 Aligned_cols=132 Identities=20% Similarity=0.265 Sum_probs=102.6
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccch---------hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---------FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~---------~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+.||+|++|.||+|.. .+..+++|+...... .......|+.++..+.+. +|+....++.....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~------~i~~p~~~~~~~~~ 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKA------GVNVPAVYFVDPEN 73 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHC------CCCCCeEEEEeCCC
Confidence 5789999999999986 778899998653211 123456788888888755 45554555566778
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
.++||||++| +|.+++... .. ....++.+|+.+|.+||+.+++|+|++|.|||++ .+.++|+|||+
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~---~~~~~liDf~~ 140 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS---GGKIYLIDFGL 140 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE---CCCEEEEECCc
Confidence 8999999987 555554321 11 6778999999999999999999999999999998 46799999999
Q ss_pred ccc
Q 001034 1025 SCF 1027 (1182)
Q Consensus 1025 A~~ 1027 (1182)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-15 Score=177.70 Aligned_cols=176 Identities=31% Similarity=0.434 Sum_probs=131.6
Q ss_pred CeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++||.|+++. .+|.+++...+. ..+ .+...+..++.|+..|++| ++.+|+|+||.||+... +..+||.||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~--~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~--d~q~kIgDF 400 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEE--RSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSD--DDQLKIGDF 400 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccc--cchhHHHHHHHhhccchhh---ccchhhhcccccccccc--chhhhhhhh
Confidence 46999999998 567777764432 222 6677788999999999999 99999999999999984 567999999
Q ss_pred CCccccCCC---------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhc-
Q 001034 1023 GSSCFETDH---------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGII- 1091 (1182)
Q Consensus 1023 GLA~~~~~~---------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~il- 1091 (1182)
|+.+..... ....+||..||+||.+.+..|+.++||||||+|||||+. -...| +.++.+..+.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~~d~r~ 474 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF------ERIATLTDIRD 474 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH------HHHHhhhhhhc
Confidence 998654332 345689999999999999999999999999999999998 22222 1111111100
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHP 1171 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHP 1171 (1182)
|.+|..++ ...+.-..|+.+||...|.+||++.+..-|+
T Consensus 475 g~ip~~~~-----------------------------------------~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~ 513 (516)
T KOG1033|consen 475 GIIPPEFL-----------------------------------------QDYPEEYTLLQQLLSPSPEERPSAIEVALHE 513 (516)
T ss_pred CCCChHHh-----------------------------------------hcCcHHHHHHHHhcCCCcccCchHHHHhhhh
Confidence 11111110 1124456899999999999999999998898
Q ss_pred CCC
Q 001034 1172 WLS 1174 (1182)
Q Consensus 1172 WFk 1174 (1182)
|++
T Consensus 514 ~~~ 516 (516)
T KOG1033|consen 514 FLQ 516 (516)
T ss_pred hcC
Confidence 864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.6e-15 Score=163.37 Aligned_cols=242 Identities=18% Similarity=0.255 Sum_probs=179.1
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
....++.+|.....|+.|+++. .|..++.|++.... .....+..|.-.|+.+ .||||+.+++.+..+-+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrif------shpnilpvlgacnsppn 261 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIF------SHPNILPVLGACNSPPN 261 (448)
T ss_pred hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeee------cCCchhhhhhhccCCCC
Confidence 3455677889999999999974 56677888886432 2233455555555555 46699999999999999
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccccCCccEEEccCCCceEEEecC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
+.+|..||+ |+|+..+... ........++.+++..|++++.|||+.. |.---|....++||..-...+...|-
T Consensus 262 lv~isq~mp~gslynvlhe~----t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQ----TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred ceEeeeeccchHHHHHHhcC----ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccc
Confidence 999999999 7888887743 3345778889999999999999999874 44456888999999533334444454
Q ss_pred CCccccCCCcccccCCCcccchhhhcCCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1023 GSSCFETDHLCSYVQSRSYRAPEVILGLSYD---KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1023 GLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS---~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
-++..... ..-.|.|++||.+..++-+ .++|+|||++++|||.|...||..-++.+.-.+|.
T Consensus 338 kfsfqe~g----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia----------- 402 (448)
T KOG0195|consen 338 KFSFQEVG----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA----------- 402 (448)
T ss_pred eeeeeccc----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----------
Confidence 43332221 2336889999999877643 68999999999999999999999888776655542
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
...+. .+..+..+..+..|+.-|+.-||.+||....++
T Consensus 403 ----------------------leglr---------v~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 403 ----------------------LEGLR---------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------------------hcccc---------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 00111 123356678899999999999999999987654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=4e-14 Score=146.24 Aligned_cols=137 Identities=19% Similarity=0.171 Sum_probs=102.0
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchh-----------------------hHHHHHHHHHHHHhcCCCC
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF-----------------------FDQSLDEIKLLKYVNKHDP 927 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~-----------------------~dq~l~EikILr~L~h~~~ 927 (1182)
|.+.+.||.|+||.||++.. .+|+.||||+++..... ......|..++..+.+..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~- 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG- 94 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC-
Confidence 77788999999999999986 48999999998753210 112456777777776542
Q ss_pred CCCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccE
Q 001034 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007 (1182)
Q Consensus 928 l~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNI 1007 (1182)
..++.+++ ....++||||+.|..+..+.. ......++.+|+.+|.++|..||+||||||.||
T Consensus 95 ---i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Ni 156 (198)
T cd05144 95 ---FPVPKPID----WNRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNI 156 (198)
T ss_pred ---CCCCceee----cCCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccE
Confidence 13444443 245689999999854433211 124567889999999999999999999999999
Q ss_pred EEccCCCceEEEecCCCccccC
Q 001034 1008 LVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 1008 LIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
+++. ++.++|+|||++....
T Consensus 157 ll~~--~~~~~liDfg~~~~~~ 176 (198)
T cd05144 157 LVDD--DEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEcC--CCcEEEEECCccccCC
Confidence 9984 7789999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.4e-14 Score=143.33 Aligned_cols=129 Identities=19% Similarity=0.205 Sum_probs=96.5
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEeccc---------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.||+|+||.||++. .++..+++|+..... ........|++++..+.+. ++....-++......
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~------~i~~p~~~~~~~~~~ 72 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKA------GVNTPVVYDVDPDNK 72 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHC------CCCCCEEEEEECCCC
Confidence 37999999999998 567899999865421 1124456789999888765 222222233456677
Q ss_pred EEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
++||||++|. |.+++... .. .++.+|+.+|.+||+.|++|+|++|.|||++ .+.++|+|||++
T Consensus 73 ~lv~e~~~g~~l~~~~~~~------------~~-~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~---~~~~~liDfg~a 136 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEEG------------ND-ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR---DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEEECCccHHHHHhhc------------HH-HHHHHHHHHHHHHHHCCeecCCCCcceEEEE---CCcEEEEECCCC
Confidence 9999999864 54443211 00 7889999999999999999999999999998 567999999998
Q ss_pred ccc
Q 001034 1026 CFE 1028 (1182)
Q Consensus 1026 ~~~ 1028 (1182)
...
T Consensus 137 ~~~ 139 (199)
T TIGR03724 137 KYS 139 (199)
T ss_pred cCC
Confidence 753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.1e-14 Score=141.00 Aligned_cols=138 Identities=22% Similarity=0.256 Sum_probs=95.6
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHH-------------------------HHHHHHHHHHhcCCCCC
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQ-------------------------SLDEIKLLKYVNKHDPG 928 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq-------------------------~l~EikILr~L~h~~~l 928 (1182)
.+.||+|+||.||+|.+. +++.||||+++........ ...|...+..+....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-- 78 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG-- 78 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC--
Confidence 467999999999999976 8999999998764311111 123455555554331
Q ss_pred CCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccE
Q 001034 929 DKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENI 1007 (1182)
Q Consensus 929 ~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNI 1007 (1182)
..+.+++.. ...++||||++++........... .. ..++.++.+++.++.++|. .+|+|+||||+||
T Consensus 79 --~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Ni 146 (187)
T cd05119 79 --VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNI 146 (187)
T ss_pred --CCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhE
Confidence 124444443 246899999997321111000000 11 5678899999999999999 9999999999999
Q ss_pred EEccCCCceEEEecCCCccccC
Q 001034 1008 LVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 1008 LIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
+++ ++.++|+|||.+....
T Consensus 147 li~---~~~~~liDfg~a~~~~ 165 (187)
T cd05119 147 LVD---DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEE---CCcEEEEECccccccc
Confidence 998 5679999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=129.46 Aligned_cols=134 Identities=19% Similarity=0.181 Sum_probs=107.3
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 873 VTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 873 Ilk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
+++.||.|.++.||++.... ..+++|++..... ...+..|+.+++.+.+. ..++++++.++......++||||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~----~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARK----GLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHc----CCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999643 7899999876543 45678899999999765 23677888888777889999999
Q ss_pred cccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc---CccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 953 LKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL---GLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 953 L~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~---GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
+.|.....+ +......++.+++.+|.+||.. +++|+||+|.|||++. .+.++|+|||.+..
T Consensus 75 ~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~--~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD--GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC--CcEEEEEecccccC
Confidence 987533211 3345667889999999999985 7999999999999984 67899999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.6e-13 Score=161.20 Aligned_cols=136 Identities=21% Similarity=0.222 Sum_probs=103.1
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
...|...+.||+|+||.||++... +..+++|+..... .....+..|+++++.+.++ +++.++.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~------~i~~p~~ 403 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRA------GVPTPVI 403 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhccc------CCCeeEE
Confidence 445667889999999999999754 3344554432110 1234567899999998765 5666666
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
++......++||||+.| +|.+++. ....++.+|+.+|.+||+.|++||||||+|||++ .+.+
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~---~~~~ 466 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR---DDRL 466 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE---CCcE
Confidence 66677788999999986 4554443 2456889999999999999999999999999995 5679
Q ss_pred EEecCCCcccc
Q 001034 1018 KVIDLGSSCFE 1028 (1182)
Q Consensus 1018 KLiDFGLA~~~ 1028 (1182)
+|+|||+++..
T Consensus 467 ~liDFGla~~~ 477 (535)
T PRK09605 467 YLIDFGLGKYS 477 (535)
T ss_pred EEEeCcccccC
Confidence 99999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.2e-15 Score=179.28 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=189.8
Q ss_pred cCCEEEEEEeccCCceEEEEEEEC-CCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDL-HTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk-~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
...|.+.+.||+|+|+.|-++... .+...+|+|.+.... ....++..|..+.+.+.. |.|++.+++.....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~-----h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSK-----HSNTVHMIEPSSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccc-----cccccccCCccCCC
Confidence 456888999999999999998864 445557777765442 333344445555555542 56999999999999
Q ss_pred CeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHH-hcCccccccCCccEEEccCCCc-eEEEe
Q 001034 944 EHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH-GLGLIHCDLKPENILVKSYSRC-EVKVI 1020 (1182)
Q Consensus 944 e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLH-S~GIIHRDIKPeNILIDs~~dG-~IKLi 1020 (1182)
+..++++++..|+ +...+. .... ...+...+.+++.|+..+|.|+| ..++.|+||||+|.+++. .+ .+++.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~-~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~--s~~~l~~~ 167 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKIS-HPDS---TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE--SGSALKIA 167 (601)
T ss_pred cccccccCcccccccccccc-cCCc---cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc--CCCcccCC
Confidence 9999999997763 443331 1111 12667788999999999999999 999999999999999995 55 79999
Q ss_pred cCCCccccCC-C-----cccccC-CCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1021 DLGSSCFETD-H-----LCSYVQ-SRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1021 DFGLA~~~~~-~-----~ss~vG-Tp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|||+|..... . ....+| ++.|+|||.+.+. -.....|+||+|+++.-|++|..|+........
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------- 238 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------- 238 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---------
Confidence 9999975444 1 234678 9999999999985 456789999999999999999999865432210
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.++. + ... ............+....+++.+||..+|..|.+.+++-.+||
T Consensus 239 --------------~~~~----~---------~~~---~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 239 --------------RYSS----W---------KSN---KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNW 288 (601)
T ss_pred --------------ccee----e---------ccc---ccccccCccccCChhhhhcccccccCCchhcccccccccccc
Confidence 0000 0 000 000011123344678889999999999999999999999999
Q ss_pred CCC
Q 001034 1173 LSH 1175 (1182)
Q Consensus 1173 Fk~ 1175 (1182)
+..
T Consensus 289 ~~~ 291 (601)
T KOG0590|consen 289 LSS 291 (601)
T ss_pred ccc
Confidence 987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.2e-14 Score=173.11 Aligned_cols=259 Identities=21% Similarity=0.273 Sum_probs=194.9
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
-.+.+.+.+-+-+|+|+.++.+....+|...++|+..+...........+..-+.+.+. ..+|.++.....|.-...+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~--p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILIT--PRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCcccc--CCCCceecccCCCCCCCCc
Confidence 34678888999999999999999888998888888776543322212222222222211 1346777777777777899
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+|||+|+.+ +|...+.... .....-++.++..++.+++|||...++|+|++|.|+|+. ..++.++++||..
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~--~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG------CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA--YDGHRPLTDFGTL 951 (1205)
T ss_pred chhhHHhccCCchhhhhcCC------CcccccccchhHHHHhhhhccccchhhcccccccchhhc--ccCCcccCccccc
Confidence 999999975 5555544332 255566788889999999999999999999999999998 4778999999832
Q ss_pred cccC----------------------------------CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhC
Q 001034 1026 CFET----------------------------------DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071 (1182)
Q Consensus 1026 ~~~~----------------------------------~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTG 1071 (1182)
.... ......++|+.|++||...+......+|||++|+++++.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 1100 001234679999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHH
Q 001034 1072 NVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVA 1151 (1182)
Q Consensus 1072 r~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIr 1151 (1182)
.+||....+...+..|.....+.|.. ....+.++.+++.
T Consensus 1032 ~pp~na~tpq~~f~ni~~~~~~~p~g-----------------------------------------~~~~s~~aq~~~~ 1070 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRDIPWPEG-----------------------------------------PEEGSYEAQDLIN 1070 (1205)
T ss_pred CCCCCCcchhhhhhccccCCCCCCCC-----------------------------------------ccccChhhhhhhh
Confidence 99999999988887774322222211 1123577889999
Q ss_pred HhcccCCCCCCCHH---HHHcCCCCCCC
Q 001034 1152 HLLEINPKKRPSAS---DALKHPWLSHP 1176 (1182)
Q Consensus 1152 kMLq~DPekRPTAe---ELLqHPWFk~~ 1176 (1182)
.+|..+|.+|..+. ++-.||||+..
T Consensus 1071 ~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1071 RLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhccCchhccCcccccccccCCccCCC
Confidence 99999999999988 99999999876
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-12 Score=152.97 Aligned_cols=198 Identities=23% Similarity=0.275 Sum_probs=144.0
Q ss_pred CCCcceEEEEEEEEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCc-cccccCCc
Q 001034 928 GDKYHLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGL-IHCDLKPE 1005 (1182)
Q Consensus 928 l~HPnIVkL~dsFqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GI-IHRDIKPe 1005 (1182)
+.|.|+.++++.+.+....++|.+|+. |+|.+.+.... ..+...-...+++.|+.+|.|||.-.| .|+.+++.
T Consensus 4 l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 4 LDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred cchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 456799999999999999999999998 67887776522 225566667788999999999998665 99999999
Q ss_pred cEEEccCCCceEEEecCCCccccCC-----CcccccCCCcccchhhhcCCC-------CCchhhHHHHHHHHHHHHhCCC
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCFETD-----HLCSYVQSRSYRAPEVILGLS-------YDKKIDIWSLGCILAELCTGNV 1073 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~~~~-----~~ss~vGTp~YmAPEVLlg~~-------yS~kSDIWSLGVILYELLTGr~ 1073 (1182)
|++++. ...+||+|||+...... ......-..-|.|||++.... .+.+.|+||+|+|++|+++..-
T Consensus 79 nClvd~--~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 79 NCLVDS--RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cceeee--eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999994 88999999999876542 111122345599999997631 4677999999999999999999
Q ss_pred CCCCC----CHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHH
Q 001034 1074 LFQND----SPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDF 1149 (1182)
Q Consensus 1074 PF~g~----d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DL 1149 (1182)
||... .+.+++.++.. .+. ....|...... ...+.+..+
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-~~~--------------------------------~~~rP~i~~~~----e~~~~l~~l 199 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-GGS--------------------------------NPFRPSIELLN----ELPPELLLL 199 (484)
T ss_pred ccccccccCChHHHHHHHHh-cCC--------------------------------CCcCcchhhhh----hcchHHHHH
Confidence 99752 22233333321 000 00011111110 223478999
Q ss_pred HHHhcccCCCCCCCHHHHHc
Q 001034 1150 VAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1150 IrkMLq~DPekRPTAeELLq 1169 (1182)
++.|+.-+|..||++.++-.
T Consensus 200 ~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 200 VARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HHHhcccChhhCccHHHHHh
Confidence 99999999999999998643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-11 Score=134.01 Aligned_cols=133 Identities=15% Similarity=0.168 Sum_probs=95.6
Q ss_pred Eec-cCCceEEEEEEECCCCcEEEEEEEeccc--------------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 876 YLG-SAAFSKAIQAHDLHTGMDVCVKIIKNNK--------------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 876 ~LG-kGaFGeVyLAkDk~TGr~VAVKIIkk~k--------------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.|| .|+.|+||.+.. .+..++||.+.... .......+|+.++..+.+.. ..++.++++.
T Consensus 38 ~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~g----i~vP~pl~~~ 111 (239)
T PRK01723 38 VVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAG----LPVPRPIAAR 111 (239)
T ss_pred eeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCC----CCCceeEeee
Confidence 566 788888888875 47889999885421 11245677999999998753 1245555554
Q ss_pred EecC----eEEEEEEeccc--ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC
Q 001034 941 YYRE----HLLIVCELLKA--NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014 (1182)
Q Consensus 941 qd~e----~LyLVmEyL~G--sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d 1014 (1182)
.... ..+||||+++| +|.+++... .++.. .+.+|+.+|.+||++||+||||||.|||++. +
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~--~ 178 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDP--D 178 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcC--C
Confidence 3322 23599999996 565554321 13433 3578999999999999999999999999985 5
Q ss_pred ceEEEecCCCccc
Q 001034 1015 CEVKVIDLGSSCF 1027 (1182)
Q Consensus 1015 G~IKLiDFGLA~~ 1027 (1182)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 5799999999865
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.5e-10 Score=120.19 Aligned_cols=139 Identities=17% Similarity=0.183 Sum_probs=98.9
Q ss_pred EEeccCCceEEEEEEECC------CCcEEEEEEEeccc-----------------------hhhHHHH----HHHHHHHH
Q 001034 875 EYLGSAAFSKAIQAHDLH------TGMDVCVKIIKNNK-----------------------DFFDQSL----DEIKLLKY 921 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~------TGr~VAVKIIkk~k-----------------------~~~dq~l----~EikILr~ 921 (1182)
..||.|--+.||.|.... .+..+|||+++... .+...+. .|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 35799999986320 0111222 78889988
Q ss_pred hcCCCCCCCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHH-HhcCcccc
Q 001034 922 VNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFL-HGLGLIHC 1000 (1182)
Q Consensus 922 L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYL-HS~GIIHR 1000 (1182)
+.... -.+.+++++ ..-+|||||++++.+..-... +..++...+..+..+++.+|..| |+.||||+
T Consensus 83 l~~~G----v~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHG 149 (197)
T cd05146 83 MQKAG----IPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHA 149 (197)
T ss_pred HHHcC----CCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 87652 135555553 456799999986422111111 11245556677889999999999 89999999
Q ss_pred ccCCccEEEccCCCceEEEecCCCccccC
Q 001034 1001 DLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 1001 DIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
||++.|||+. ++.+.|+|||.+....
T Consensus 150 DLs~~NIL~~---~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH---DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE---CCcEEEEECCCceeCC
Confidence 9999999997 4679999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-10 Score=112.82 Aligned_cols=129 Identities=19% Similarity=0.175 Sum_probs=93.9
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEec
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL 953 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL 953 (1182)
++.|+.|.++.||++.. .+..|++|+.............|..+++.+.... .+.+++..+ ....++|||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~-----~~P~~~~~~--~~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAG-----IGPKLYYFD--PETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhC-----CCCceEEEe--CCCCeEEEEec
Confidence 45789999999999985 3788999998765432334568889998886542 234455443 33458999999
Q ss_pred ccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCc-----cccccCCccEEEccCCCceEEEecCCCccc
Q 001034 954 KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGL-----IHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 954 ~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GI-----IHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
+|....... . ....++.+++.+|..||..++ +|+|++|.|||++ .+.++|+||+.+..
T Consensus 74 ~G~~l~~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~---~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD---DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCcccccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE---CCeEEEEecccccC
Confidence 985332110 1 113456799999999999885 9999999999998 35699999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.6e-11 Score=140.69 Aligned_cols=254 Identities=20% Similarity=0.187 Sum_probs=184.5
Q ss_pred eecCCEEEEEEecc--CCceEEEEEEE--CCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGS--AAFSKAIQAHD--LHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGk--GaFGeVyLAkD--k~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
.+...|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.. ......-.++....+ ....|++.++.+.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~-----~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHH-----KIDSHENPVRDSP 185 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhccc-----ccCccccccccCc
Confidence 45567888889999 99999999998 889999999973321 111122233333333 3345678999999
Q ss_pred EEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHH----HHHHHHhcCccccccCCccEEEccCCC
Q 001034 939 YFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE----ALQFLHGLGLIHCDLKPENILVKSYSR 1014 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILs----ALeYLHS~GIIHRDIKPeNILIDs~~d 1014 (1182)
.+.....+|+-+|++...+..+...... .++...++.++.++.. ||.++|..+++|-|+||.||++.. +
T Consensus 186 ~~e~~~~lfiqtE~~~~sl~~~~~~~~~-----~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~--~ 258 (524)
T KOG0601|consen 186 AWEGSGILFIQTELCGESLQSYCHTPCN-----FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTS--D 258 (524)
T ss_pred ccccCCcceeeeccccchhHHhhhcccc-----cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccc--c
Confidence 9999999999999999887777654432 2777888888888888 999999999999999999999985 4
Q ss_pred -ceEEEecCCCccccCCCc--------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHH
Q 001034 1015 -CEVKVIDLGSSCFETDHL--------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND-SPATLL 1084 (1182)
Q Consensus 1015 -G~IKLiDFGLA~~~~~~~--------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~-d~~elL 1084 (1182)
...+++|||+........ ....+...|++||+..+ -++...|+|+||.++.+..++-.++... +.
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---- 333 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS---- 333 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC----
Confidence 779999999876544332 12245677999998755 5688999999999999999887655321 10
Q ss_pred HHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 001034 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164 (1182)
Q Consensus 1085 akIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA 1164 (1182)
.|..+++ .. +|. ......+..+...+..||+.+|..|+++
T Consensus 334 --------------------~W~~~r~---------~~------ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~ 373 (524)
T KOG0601|consen 334 --------------------SWSQLRQ---------GY------IPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTA 373 (524)
T ss_pred --------------------Ccccccc---------cc------Cch-----hhhcCcchhhhhHHHHhcCcchhhhhHH
Confidence 0000000 00 000 0111234566669999999999999999
Q ss_pred HHHHcCCCCCCC
Q 001034 1165 SDALKHPWLSHP 1176 (1182)
Q Consensus 1165 eELLqHPWFk~~ 1176 (1182)
+.++.|+++...
T Consensus 374 q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 374 QILTALNVIHSK 385 (524)
T ss_pred HHHhccccccch
Confidence 999999998643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-10 Score=138.67 Aligned_cols=151 Identities=18% Similarity=0.267 Sum_probs=88.5
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-----------------------------------hhhHHHHH
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-----------------------------------DFFDQSLD 914 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-----------------------------------~~~dq~l~ 914 (1182)
.|.. +.||.|++|+||+|+.+.+|+.||||+++... .......+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 68999999999999998889999999997541 01111222
Q ss_pred HHHHHH------HhcCC-CCCCCcceEEEEEEEEecCeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHH
Q 001034 915 EIKLLK------YVNKH-DPGDKYHLLRLYDYFYYREHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCL 986 (1182)
Q Consensus 915 EikILr------~L~h~-~~l~HPnIVkL~dsFqd~e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QIL 986 (1182)
|+.+.+ ++... .....-.|.++|.- .....+|||||+.|. +.++............+....+..++.||
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d--~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWD--YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecc--cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 333322 22211 00011122333321 245678999999984 44332211110000013333344444444
Q ss_pred HHHHHHHhcCccccccCCccEEEccCC--CceEEEecCCCccccCC
Q 001034 987 EALQFLHGLGLIHCDLKPENILVKSYS--RCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 987 sALeYLHS~GIIHRDIKPeNILIDs~~--dG~IKLiDFGLA~~~~~ 1030 (1182)
+..|++|+|+||.||+++.++ .+.++++|||++.....
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 458999999999999998522 23899999998865443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.6e-09 Score=127.03 Aligned_cols=141 Identities=16% Similarity=0.212 Sum_probs=89.8
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccchh-h----------------------------------H------HHH
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF-F----------------------------------D------QSL 913 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~-~----------------------------------d------q~l 913 (1182)
+.||.|++|+||+|+. .+|+.||||+.+..-.. . . .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3699999999999985 58999999998754100 0 0 122
Q ss_pred HHHHHHHHhcCCCCCCCcc--eEEEEEEEEecCeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHH-HH
Q 001034 914 DEIKLLKYVNKHDPGDKYH--LLRLYDYFYYREHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLE-AL 989 (1182)
Q Consensus 914 ~EikILr~L~h~~~l~HPn--IVkL~dsFqd~e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILs-AL 989 (1182)
.|...+.++...- ..+++ +.+++. ......+|||||+.|. +.++...... + + ....++..++. .+
T Consensus 202 ~Ea~n~~~~~~~~-~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~-~----~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 202 REAANASELGENF-KNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEA-G----L---DRKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHhc-CCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhc-C----C---CHHHHHHHHHHHHH
Confidence 2333333333210 01222 333332 2345578999999974 4444332211 1 1 12345556655 47
Q ss_pred HHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 990 eYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
..+|..|++|+|++|.||+++. ++.++|+|||++....
T Consensus 271 ~ql~~~g~~H~D~hPgNilv~~--~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVLRDGFFHADLHPGNIFVLK--DGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHhCCceeCCCCcccEEECC--CCcEEEEeCCCeeECC
Confidence 8899999999999999999984 6789999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.9e-10 Score=132.81 Aligned_cols=254 Identities=19% Similarity=0.169 Sum_probs=180.7
Q ss_pred eecCCEEEEEEeccCCceEEEEEEEC-CCCcEEEEEEEeccchhh---HHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDL-HTGMDVCVKIIKNNKDFF---DQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk-~TGr~VAVKIIkk~k~~~---dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
....+|.++..||.|.|+.|+.+... .++..|++|-+.+..... ...+.|+.++..+.. |.+++..+..+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~-----~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGS-----HLPSVGKNSSWS 336 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhc-----ccccCCCCCCcc
Confidence 34678999999999999999998755 678889999887653211 123456666666653 347888888888
Q ss_pred ecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 942 YREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 942 d~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...+.||=.||+.+....+-... .+++.+...+.+..|++.++.++|++.++|+|+||+||++...+ +..++.|
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~ 410 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGD 410 (524)
T ss_pred ccccccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccc
Confidence 88888899999986544433311 12377888999999999999999999999999999999998532 7789999
Q ss_pred CCCccccCCCcccccC-CCcc-cchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1022 LGSSCFETDHLCSYVQ-SRSY-RAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1022 FGLA~~~~~~~ss~vG-Tp~Y-mAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
||..+...-....... +..| .+|.......+..+.|++|||.-+.+.+++.+.-...... ..
T Consensus 411 ~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~------------- 474 (524)
T KOG0601|consen 411 FGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LT------------- 474 (524)
T ss_pred cccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---ee-------------
Confidence 9988653222222222 3334 3555556667889999999999999999987543221100 00
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.........+.....+..+...|+..++..|+.+.++..|.=|-..-
T Consensus 475 -------------------------------i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 475 -------------------------------IRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred -------------------------------eecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 00011122233346778889999999999999999999998765443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1e-09 Score=123.20 Aligned_cols=195 Identities=18% Similarity=0.261 Sum_probs=134.9
Q ss_pred CcceEEEEEEEEecC-----eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccc
Q 001034 930 KYHLLRLYDYFYYRE-----HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCD 1001 (1182)
Q Consensus 930 HPnIVkL~dsFqd~e-----~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRD 1001 (1182)
|-|||+++.++.+.. ...++.|||. |++..+++.....+. .+......+|+-||+.||.|||++. |+|+.
T Consensus 126 HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~--a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgn 203 (458)
T KOG1266|consen 126 HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQK--ALFQKAWKKWCTQILSALSYLHSCDPPIIHGN 203 (458)
T ss_pred HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhh--hhhHHHHHHHHHHHHhhhhhhhccCCccccCC
Confidence 447899888877653 4788999998 788888887655433 3778888999999999999999875 99999
Q ss_pred cCCccEEEccCCCceEEEecCCCccccCC-------CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001034 1002 LKPENILVKSYSRCEVKVIDLGSSCFETD-------HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVL 1074 (1182)
Q Consensus 1002 IKPeNILIDs~~dG~IKLiDFGLA~~~~~-------~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~P 1074 (1182)
+..+-|++.. +|-|||.---....... ......+-+.|.|||.=..-..+.++|||++|....+|..+..-
T Consensus 204 lTc~tifiq~--ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 204 LTCDTIFIQH--NGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred cchhheeecC--CceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 9999999984 66677643221111100 01112346789999987766778899999999999999887643
Q ss_pred C-CCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHh
Q 001034 1075 F-QNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153 (1182)
Q Consensus 1075 F-~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkM 1153 (1182)
- .+.+....-..|. +. ........-+++|.+|
T Consensus 282 ~tnseS~~~~ee~ia-------------------------------------~~----------i~~len~lqr~~i~kc 314 (458)
T KOG1266|consen 282 STNSESKVEVEENIA-------------------------------------NV----------IIGLENGLQRGSITKC 314 (458)
T ss_pred cCCCcceeehhhhhh-------------------------------------hh----------eeeccCccccCcCccc
Confidence 2 2211111100110 00 0000112234789999
Q ss_pred cccCCCCCCCHHHHHcCCCCCC
Q 001034 1154 LEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1154 Lq~DPekRPTAeELLqHPWFk~ 1175 (1182)
|+..|..||+|..+|.||-+=+
T Consensus 315 l~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 315 LEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ccCCCCCCcchhhhhcCceeee
Confidence 9999999999999999997643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-08 Score=120.69 Aligned_cols=165 Identities=24% Similarity=0.280 Sum_probs=120.5
Q ss_pred EEEECCCCcEEEEEEEeccch-hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhc
Q 001034 887 QAHDLHTGMDVCVKIIKNNKD-FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNR 965 (1182)
Q Consensus 887 LAkDk~TGr~VAVKIIkk~k~-~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~ 965 (1182)
-+..+.++.+|.|.+++.... +.....+-++.|+.++ ||+|+++++.+....++|||+|.+.. |-.+++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlR------HP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~-- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLR------HPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE-- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhcc------CchhhhhhhhhcccCceEEEeecccc-HHHHHHH--
Confidence 355578889999999876553 3344555566666665 45999999999999999999999853 2223322
Q ss_pred ccCCccccCHHHHHHHHHHHHHHHHHHH-hcCccccccCCccEEEccCCCceEEEecCCCccccCCCc---ccccCCCcc
Q 001034 966 ESGGEVYFTMPRLQSITIQCLEALQFLH-GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL---CSYVQSRSY 1041 (1182)
Q Consensus 966 ~sggel~Lse~eIr~Ia~QILsALeYLH-S~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~---ss~vGTp~Y 1041 (1182)
+....+...++||+.||.||| +++++|++|.-+.|+++. .|+.||.+|.++....... .....-..|
T Consensus 101 -------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~--~GeWkLggle~v~~~~~~~~~~~~~~~~~s~ 171 (690)
T KOG1243|consen 101 -------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE--SGEWKLGGLELVSKASGFNAPAKSLYLIESF 171 (690)
T ss_pred -------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC--CCcEEEeeeEEEeccccCCcccccchhhhcc
Confidence 224566778899999999997 789999999999999994 7889999998875433222 112222336
Q ss_pred cchhhhcCCCCCchhhHHHHHHHHHHHHhC
Q 001034 1042 RAPEVILGLSYDKKIDIWSLGCILAELCTG 1071 (1182)
Q Consensus 1042 mAPEVLlg~~yS~kSDIWSLGVILYELLTG 1071 (1182)
..|+.+-... ...|.|-|||++++++.|
T Consensus 172 ~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 172 DDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 6666553322 457999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.5e-08 Score=102.35 Aligned_cols=142 Identities=13% Similarity=0.101 Sum_probs=95.9
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec---CeEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR---EHLLIV 949 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~---e~LyLV 949 (1182)
+.|+.|.++.||++... +|+.+++|+...... .......|..+++.+.... ..+.+++.+.... ...++|
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~----~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTG----VPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCC----CCCCCEEEECCCCCccCCceEE
Confidence 57899999999999863 368899999876543 3557788999999987641 1345555555443 257899
Q ss_pred EEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 001034 950 CELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG----------------------------------- 994 (1182)
Q Consensus 950 mEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS----------------------------------- 994 (1182)
|||+.|..+...... ..++......++.+++.+|..||+
T Consensus 79 ~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (223)
T cd05154 79 MERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD 152 (223)
T ss_pred EEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence 999987422111100 013444455555555555555552
Q ss_pred ---------------------cCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 995 ---------------------LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 995 ---------------------~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
..+||+|++|.|||++....+.+.|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 347999999999999852245689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.2e-07 Score=111.84 Aligned_cols=169 Identities=19% Similarity=0.217 Sum_probs=126.4
Q ss_pred eEEEEEEECCCCcEEEEEEEeccchhh-HHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe----cCeEEEEEEeccc--
Q 001034 883 SKAIQAHDLHTGMDVCVKIIKNNKDFF-DQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY----REHLLIVCELLKA-- 955 (1182)
Q Consensus 883 GeVyLAkDk~TGr~VAVKIIkk~k~~~-dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd----~e~LyLVmEyL~G-- 955 (1182)
.+.|+|....+|..|++|.++..+... .....-+++++++.|. |||++.++|.. ...+++|++|+++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~------NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHT------NVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccC------ceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 578999999999999999996554322 2344557788888766 89999999883 3679999999995
Q ss_pred ChHHHHhhhcccC---------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 956 NLYEFHKFNRESG---------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 956 sLld~Lk~~~~sg---------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+|++++-...... .....++..+|.|+.||..||.+||+.|+..+-|.|.+||++ ++.+|+|+..|...
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~--G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT--GKMRIRISGCGIMD 441 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee--CcceEEEeccccee
Confidence 6777664332211 112377889999999999999999999999999999999999 45578888877765
Q ss_pred ccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 001034 1027 FETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNV 1073 (1182)
Q Consensus 1027 ~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~ 1073 (1182)
....... +.+. --.+-|.=.||.+++.|.||..
T Consensus 442 vl~~d~~-----------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 442 VLQEDPT-----------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred eecCCCC-----------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 4332220 1111 1246799999999999999964
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.9e-08 Score=102.36 Aligned_cols=143 Identities=20% Similarity=0.159 Sum_probs=107.1
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEEecc---------chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 873 VTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 873 Ilk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---------k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.+..|-+|+-+.|+++. ..|+.++||.-... +-......+|.++|.++... .|.-..-+|.+.
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~------GI~~P~l~~~D~ 82 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL------GIPAPRLIFIDT 82 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh------CCCCceEEEEec
Confidence 56688899999999996 67888888753221 12345677899999988765 344444456677
Q ss_pred CeEEEEEEeccc--ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-CceEEEe
Q 001034 944 EHLLIVCELLKA--NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVI 1020 (1182)
Q Consensus 944 e~LyLVmEyL~G--sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG~IKLi 1020 (1182)
..-+|+|||++| ++.+++....... ........++..|-..|.-||..+|||+||..+||++.+.+ ...+.|+
T Consensus 83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~----~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lI 158 (229)
T KOG3087|consen 83 YGGQIYMEFIDGASTVKDFILSTMEDE----SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILI 158 (229)
T ss_pred CCCeEEEEeccchhHHHHHHHHHccCc----ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEE
Confidence 778899999999 7888887654332 22333467888999999999999999999999999998632 2345899
Q ss_pred cCCCccc
Q 001034 1021 DLGSSCF 1027 (1182)
Q Consensus 1021 DFGLA~~ 1027 (1182)
|||++..
T Consensus 159 dfgls~~ 165 (229)
T KOG3087|consen 159 DFGLSSV 165 (229)
T ss_pred eecchhc
Confidence 9999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.4e-08 Score=102.13 Aligned_cols=129 Identities=19% Similarity=0.177 Sum_probs=94.0
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEecc---------chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---------k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.+.+|+-+.++++.. -|..+++|.-.+. +-......+|.+++..+... .|...+-++.+....
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~------GV~~P~v~dvD~~~~ 74 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREA------GVPVPIVYDVDPDNG 74 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHc------CCCCCeEEEEcCCCC
Confidence 578999999999953 4445666653322 12234567788999888765 344444455667788
Q ss_pred EEEEEecccChHH-HHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKANLYE-FHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~GsLld-~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
.|+|||++|.++. ++... ...++..+-..+.-||..||||+||.++||++. .+.+.++|||++
T Consensus 75 ~I~me~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~---~~~i~~IDfGLg 138 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS---GGRIYFIDFGLG 138 (204)
T ss_pred EEEEEEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe---CCcEEEEECCcc
Confidence 8999999996543 54432 134677788888999999999999999999998 344999999998
Q ss_pred ccc
Q 001034 1026 CFE 1028 (1182)
Q Consensus 1026 ~~~ 1028 (1182)
.+.
T Consensus 139 ~~s 141 (204)
T COG3642 139 EFS 141 (204)
T ss_pred ccc
Confidence 753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.4e-07 Score=99.81 Aligned_cols=127 Identities=26% Similarity=0.315 Sum_probs=80.1
Q ss_pred EEEEEEECCCCcEEEEEEEeccc---------------------------hhhHHHHHHHHHHHHhcCCCCCCCcceEEE
Q 001034 884 KAIQAHDLHTGMDVCVKIIKNNK---------------------------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936 (1182)
Q Consensus 884 eVyLAkDk~TGr~VAVKIIkk~k---------------------------~~~dq~l~EikILr~L~h~~~l~HPnIVkL 936 (1182)
.||.|.. ..|..+|||+.+... .......+|.+.|..+.... -++.++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~G----v~vP~p 75 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAG----VPVPKP 75 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-----SS--E
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCC----ccCCcE
Confidence 3888886 667899999987421 01233567889999887652 135566
Q ss_pred EEEEEecCeEEEEEEecc--cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHH-HHhcCccccccCCccEEEccCC
Q 001034 937 YDYFYYREHLLIVCELLK--ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF-LHGLGLIHCDLKPENILVKSYS 1013 (1182)
Q Consensus 937 ~dsFqd~e~LyLVmEyL~--GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeY-LHS~GIIHRDIKPeNILIDs~~ 1013 (1182)
+++- .-+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++.
T Consensus 76 ~~~~----~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~-- 142 (188)
T PF01163_consen 76 YDYN----RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD-- 142 (188)
T ss_dssp EEEE----TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET--
T ss_pred EEEe----CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec--
Confidence 5432 3469999999 64333332211 1123456778888885555 58999999999999999984
Q ss_pred CceEEEecCCCccccC
Q 001034 1014 RCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~ 1029 (1182)
+.+.|||||.+....
T Consensus 143 -~~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 143 -GKVYIIDFGQAVDSS 157 (188)
T ss_dssp -TCEEE--GTTEEETT
T ss_pred -ceEEEEecCcceecC
Confidence 379999999986544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.3e-08 Score=119.48 Aligned_cols=152 Identities=18% Similarity=0.251 Sum_probs=110.6
Q ss_pred HHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEecCCCccccCCCccc------------ccCCCcccchhhhcCC
Q 001034 984 QCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCS------------YVQSRSYRAPEVILGL 1050 (1182)
Q Consensus 984 QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~ss------------~vGTp~YmAPEVLlg~ 1050 (1182)
+++.||.|+|. .++||+.|.|++|.++ ..+..||+.|+++......... ......|.|||++...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n--a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVN--ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeec--cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 45589999995 6899999999999999 4778999999987543331111 1225679999999998
Q ss_pred CCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcc
Q 001034 1051 SYDKKIDIWSLGCILAELC-TGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLI 1129 (1182)
Q Consensus 1051 ~yS~kSDIWSLGVILYELL-TGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~li 1129 (1182)
..+.++|+|||||++|.+. .|+..|........+..-. ..+.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-~~~~------------------------------------ 227 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-NLLN------------------------------------ 227 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-cccc------------------------------------
Confidence 8889999999999999999 5665554433211111110 0000
Q ss_pred ccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1130 PKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1130 Pk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.........+++++++=|.++|..++..||++.+++..|||+++-
T Consensus 228 ---~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 228 ---AGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred ---cccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 000111245678999999999999999999999999999999863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.6e-06 Score=96.26 Aligned_cols=133 Identities=14% Similarity=0.072 Sum_probs=90.1
Q ss_pred EEEEEECCCCcEEEEEEEeccch--hh----------HHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe-----cCeEE
Q 001034 885 AIQAHDLHTGMDVCVKIIKNNKD--FF----------DQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY-----REHLL 947 (1182)
Q Consensus 885 VyLAkDk~TGr~VAVKIIkk~k~--~~----------dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd-----~e~Ly 947 (1182)
|+++. ..|+.|.||....... .. ....+|...+..+.... .. .+.+..++.. ...-+
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~G-Ip---tP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVG-VD---TMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcC-CC---CCCeeEEEEecCCCccceeE
Confidence 44443 3567788886643221 01 13678888888886552 12 2233333332 23578
Q ss_pred EEEEeccc--ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc-----CCCceEEEe
Q 001034 948 IVCELLKA--NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS-----YSRCEVKVI 1020 (1182)
Q Consensus 948 LVmEyL~G--sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs-----~~dG~IKLi 1020 (1182)
||||++++ +|.+++..... ..........++.+|+..+.-||..||+|+|+++.|||++. .+...+.||
T Consensus 112 LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 99999997 46666642211 11455667789999999999999999999999999999984 235689999
Q ss_pred cCCCccc
Q 001034 1021 DLGSSCF 1027 (1182)
Q Consensus 1021 DFGLA~~ 1027 (1182)
||+.+..
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9998753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.6e-05 Score=84.30 Aligned_cols=108 Identities=20% Similarity=0.244 Sum_probs=78.5
Q ss_pred HHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec----CeEEEEEEeccc--ChHHHHhhhcccCCccccCHHHHHHHHH
Q 001034 910 DQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR----EHLLIVCELLKA--NLYEFHKFNRESGGEVYFTMPRLQSITI 983 (1182)
Q Consensus 910 dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~----e~LyLVmEyL~G--sLld~Lk~~~~sggel~Lse~eIr~Ia~ 983 (1182)
....+|...+..+..... .+++++.+.... ...+||+|++++ +|.+++..... ........++.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi----~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~------~~~~~~~~ll~ 125 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGI----PTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ------LDPSQRRELLR 125 (206)
T ss_pred hHHHHHHHHHHHHHHcCC----CCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc------cchhhHHHHHH
Confidence 456778888777765431 233444444432 245899999997 46666654221 34556788999
Q ss_pred HHHHHHHHHHhcCccccccCCccEEEccCC-CceEEEecCCCccc
Q 001034 984 QCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVIDLGSSCF 1027 (1182)
Q Consensus 984 QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG~IKLiDFGLA~~ 1027 (1182)
+++..+.-||..||+|+|+++.|||++... ...+.|+||+.+..
T Consensus 126 ~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 126 ALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999999999999632 34799999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=5.3e-06 Score=92.60 Aligned_cols=137 Identities=19% Similarity=0.158 Sum_probs=97.9
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-------------------h----hhHHHHHHHHHHHHhcCCCC
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-------------------D----FFDQSLDEIKLLKYVNKHDP 927 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-------------------~----~~dq~l~EikILr~L~h~~~ 927 (1182)
+.|...||-|--|.||.|.+ ..|..+|||..+... . ......+|.++|.+|....
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G- 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG- 170 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC-
Confidence 56778999999999999997 479999999876321 1 1223557888888886541
Q ss_pred CCCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccE
Q 001034 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007 (1182)
Q Consensus 928 l~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNI 1007 (1182)
..+.+.++ -+.-++|||++.|-.+--+. +....+..++..|+.-+.-+-..||||+|+++-||
T Consensus 171 ---~~VP~P~~----~nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNI 233 (304)
T COG0478 171 ---VKVPKPIA----WNRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNI 233 (304)
T ss_pred ---CCCCCccc----cccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheE
Confidence 13555544 24567999999984332111 22334555666677666666699999999999999
Q ss_pred EEccCCCceEEEecCCCcccc
Q 001034 1008 LVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 1008 LIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
|++. +|.+.++||-.+...
T Consensus 234 lV~~--dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 234 LVTE--DGDIVVIDWPQAVPI 252 (304)
T ss_pred EEec--CCCEEEEeCcccccC
Confidence 9994 778999999776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.09 E-value=3e-05 Score=84.64 Aligned_cols=146 Identities=15% Similarity=0.216 Sum_probs=94.6
Q ss_pred eeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHH----------HHHHHHHHHHhcCC--CCCC
Q 001034 862 VLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQ----------SLDEIKLLKYVNKH--DPGD 929 (1182)
Q Consensus 862 ~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq----------~l~EikILr~L~h~--~~l~ 929 (1182)
....++.+.|.+++++-......|.+.. -+|..+++|..+......++ ..+.+..+..+... ....
T Consensus 24 l~~~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~ 101 (229)
T PF06176_consen 24 LGEKILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA 101 (229)
T ss_pred HHHHHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence 3445678899999999998888888875 57789999998754211111 12233333333221 1111
Q ss_pred CcceEEEEEEEEecCeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEE
Q 001034 930 KYHLLRLYDYFYYREHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008 (1182)
Q Consensus 930 HPnIVkL~dsFqd~e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNIL 1008 (1182)
-+.++...-.+......+|||||++|- |.++.. +++ .++..|+.+|.-||+.|+.|+|+.|.|++
T Consensus 102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFl 167 (229)
T PF06176_consen 102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFL 167 (229)
T ss_pred cceeeeeeeeccceeEEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEE
Confidence 223443334444445667999999984 332211 222 24456778899999999999999999999
Q ss_pred EccCCCceEEEecCCCcc
Q 001034 1009 VKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 1009 IDs~~dG~IKLiDFGLA~ 1026 (1182)
+. ++.++++||+..+
T Consensus 168 v~---~~~i~iID~~~k~ 182 (229)
T PF06176_consen 168 VS---NNGIRIIDTQGKR 182 (229)
T ss_pred EE---CCcEEEEECcccc
Confidence 98 3449999997643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.3e-05 Score=83.38 Aligned_cols=139 Identities=19% Similarity=0.215 Sum_probs=94.7
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccchhh-------------------------HHHHHHHHHHHHhcCCCCCC
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFF-------------------------DQSLDEIKLLKYVNKHDPGD 929 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~-------------------------dq~l~EikILr~L~h~~~l~ 929 (1182)
-.|..|--+.||+|.. ..+..+|+|+++.....+ .=...|..-|+++....
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAG--- 129 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG--- 129 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcC---
Confidence 3778899999999974 678999999997532111 11234666666665431
Q ss_pred CcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEE
Q 001034 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENIL 1008 (1182)
Q Consensus 930 HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNIL 1008 (1182)
-.+.+.+.++ +-.|||||++.... ..+.-.+..+....+..+..+++..+.-|-. .++||+||+.-|||
T Consensus 130 -VrvP~Pi~~~----~nVLvMEfIg~~g~-----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL 199 (268)
T COG1718 130 -VRVPEPIAFR----NNVLVMEFIGDDGL-----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL 199 (268)
T ss_pred -CCCCCceeec----CCeEEEEeccCCCC-----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence 1344555543 34699999984311 0011112224444677788899998888876 99999999999999
Q ss_pred EccCCCceEEEecCCCccccCC
Q 001034 1009 VKSYSRCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 1009 IDs~~dG~IKLiDFGLA~~~~~ 1030 (1182)
+. .+.+.|||||.|.....
T Consensus 200 ~~---~~~p~iID~~QaV~~~h 218 (268)
T COG1718 200 VH---DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred EE---CCeEEEEECccccccCC
Confidence 98 56799999999976553
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00014 Score=79.09 Aligned_cols=141 Identities=15% Similarity=0.109 Sum_probs=96.8
Q ss_pred ccCCceEEEEEEECCCCcEEEEEEEecc-------chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--CeEEE
Q 001034 878 GSAAFSKAIQAHDLHTGMDVCVKIIKNN-------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--EHLLI 948 (1182)
Q Consensus 878 GkGaFGeVyLAkDk~TGr~VAVKIIkk~-------k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--e~LyL 948 (1182)
|+||.|-|+.... .|+.+-+|.-.+. +.-...+.+|+..|..+...... -|-++ +...-... -..+|
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEEE
Confidence 7799999998763 3446777765421 22346788999999999876421 22233 11111111 24789
Q ss_pred EEEeccc--ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 949 VCELLKA--NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 949 VmEyL~G--sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|+|-++| +|.+++...... ..+......++.+|+.+|.-||..|+.|+|+-+.|||++..+...|+++||.-++
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~----~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVS----PYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcC----CcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 9999985 666665332111 2456666789999999999999999999999999999985444469999998654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00026 Score=72.77 Aligned_cols=76 Identities=11% Similarity=0.102 Sum_probs=54.5
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe---cCeEEEEE
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY---REHLLIVC 950 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd---~e~LyLVm 950 (1182)
++.|+.|..+.||++.... ..+++|+.... ........|..+++.+..... -+.+++..... ....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~----pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGI----PVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTS----BS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCC----CCceEEeecccccccccceEEE
Confidence 4688999999999998644 58999998766 455677788899888876532 24455543322 34579999
Q ss_pred EecccC
Q 001034 951 ELLKAN 956 (1182)
Q Consensus 951 EyL~Gs 956 (1182)
+++.|.
T Consensus 75 ~~i~g~ 80 (239)
T PF01636_consen 75 EYIPGR 80 (239)
T ss_dssp EEESSE
T ss_pred EEeccc
Confidence 999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.3e-05 Score=88.40 Aligned_cols=191 Identities=14% Similarity=0.096 Sum_probs=123.5
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcc----eEE----EEEEEEecCe
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYH----LLR----LYDYFYYREH 945 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPn----IVk----L~dsFqd~e~ 945 (1182)
...||+|+-+.+|-.-. -...+.|++.....-. ...-+..|.... .||- |+- |++-- ....
T Consensus 16 gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~--~aqk~a~la~~p-----~~p~~~~rvaWPqa~L~G~~-~~~~ 84 (637)
T COG4248 16 GRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAA--QAQKVAELAATP-----DAPLLNYRVAWPQATLHGGR-RGKV 84 (637)
T ss_pred CccccCCccceeeecch---hhchhheeecCCCchH--HHHHHHHhccCC-----CCcchhhhhcccHHHhhCCC-ccce
Confidence 35789999999997642 2233558887654221 111222222221 2221 111 11110 1123
Q ss_pred EEEEEEeccc--ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 946 LLIVCELLKA--NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 946 LyLVmEyL~G--sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..++|..++| ...+++.-......--.+.+.-+.+.++.|+.|...||..|.+-+|+.++|+|+.. .+.+.|+|=.
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd--~~~V~LVdsD 162 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSD--DSKVVLVDSD 162 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeec--CceEEEEccc
Confidence 7788998886 44444432211111112667778888999999999999999999999999999984 7778988765
Q ss_pred CccccCC--CcccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Q 001034 1024 SSCFETD--HLCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTG-NVLFQN 1077 (1182)
Q Consensus 1024 LA~~~~~--~~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTG-r~PF~g 1077 (1182)
.-..... ...-.+|...|.+||.-. +..-+...|.|.||+++|++|.| +.||.+
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 4332221 123357889999999864 44566789999999999999996 999976
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00035 Score=75.61 Aligned_cols=73 Identities=11% Similarity=-0.005 Sum_probs=53.5
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEecc
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLK 954 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~ 954 (1182)
..||.|..+.||+. .+..+++|+.+... ......+|.++++.+.... . -+.+.+.+.......++||+++.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~g-l---pvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLG-I---PTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcC-C---CCCceEEEEecCCeeeeeeeecC
Confidence 47899999999984 25567889887543 3345688999999887442 1 24566666667777899999999
Q ss_pred cC
Q 001034 955 AN 956 (1182)
Q Consensus 955 Gs 956 (1182)
|.
T Consensus 78 G~ 79 (226)
T TIGR02172 78 GK 79 (226)
T ss_pred Cc
Confidence 84
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00065 Score=72.76 Aligned_cols=72 Identities=8% Similarity=0.045 Sum_probs=50.4
Q ss_pred EeccCCc-eEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEecc
Q 001034 876 YLGSAAF-SKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLK 954 (1182)
Q Consensus 876 ~LGkGaF-GeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~ 954 (1182)
.|-.|.. +.||++.. .+..+++|+..... ......|+.+++.+... . -+.+++.+.......++||++++
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~--~---~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP--TYELEREAERLRWLAGK--L---PVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc--ccchHHHHHHHHHHHhc--C---CCCeEEEEEecCCccEEEEEeeC
Confidence 3445555 78899864 34678889886543 34566899998888644 1 25667776666667899999998
Q ss_pred cC
Q 001034 955 AN 956 (1182)
Q Consensus 955 Gs 956 (1182)
|.
T Consensus 76 G~ 77 (244)
T cd05150 76 GV 77 (244)
T ss_pred Cc
Confidence 84
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00039 Score=84.04 Aligned_cols=144 Identities=20% Similarity=0.269 Sum_probs=84.5
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc-----------------------------------hhhHHHHH-----
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-----------------------------------DFFDQSLD----- 914 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-----------------------------------~~~dq~l~----- 914 (1182)
+.|+.++-|+||+|+- .+|+.||||+.+..- ........
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 3689999999999995 569999999987431 00011111
Q ss_pred -HHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHH-HHH
Q 001034 915 -EIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEA-LQF 991 (1182)
Q Consensus 915 -EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsA-LeY 991 (1182)
|..-+.++...-. ..++|.-..-+......-.|+|||+.|- +.+...... .+ +... .++..++.+ +.-
T Consensus 210 ~EA~n~~~~~~nf~-~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g----~d~k---~ia~~~~~~f~~q 280 (517)
T COG0661 210 REAANAERFRENFK-DDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AG----IDRK---ELAELLVRAFLRQ 280 (517)
T ss_pred HHHHHHHHHHHHcC-CCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cC----CCHH---HHHHHHHHHHHHH
Confidence 2222222222100 2223333223333456678999999983 333322221 11 3322 233333322 333
Q ss_pred HHhcCccccccCCccEEEccCCCceEEEecCCCccccCC
Q 001034 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030 (1182)
Q Consensus 992 LHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~ 1030 (1182)
+-..|++|.|.+|.||++.. +|.+.+.|||.......
T Consensus 281 ~~~dgffHaDpHpGNi~v~~--~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLRDGFFHADPHPGNILVRS--DGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHhcCccccCCCccceEEec--CCcEEEEcCcceecCCH
Confidence 44589999999999999995 68899999998765443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0014 Score=70.52 Aligned_cols=134 Identities=20% Similarity=0.319 Sum_probs=96.6
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc-----------------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-----------------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-----------------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
..||+|+.-.||.- ......+||++.... ....+..+|+.....+.......+.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 36899999888874 455668999987655 2346677888777777633345667899999
Q ss_pred EEEEecCeEEEEEEecc---c----ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEc
Q 001034 938 DYFYYREHLLIVCELLK---A----NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVK 1010 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~---G----sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILID 1010 (1182)
++.+.+..+.+|+|.+. | +|.+++.... ++. . +...+-.-..||-+.+|+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-------~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-------LTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-------ccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence 99999999999999975 3 4555553221 343 2 333444556788899999999999999998
Q ss_pred cCCCc--eEEEecC
Q 001034 1011 SYSRC--EVKVIDL 1022 (1182)
Q Consensus 1011 s~~dG--~IKLiDF 1022 (1182)
....+ .+.|+|-
T Consensus 153 ~~~~~~~~lvlIDG 166 (199)
T PF10707_consen 153 RRDSGEFRLVLIDG 166 (199)
T ss_pred ecCCCceEEEEEeC
Confidence 65544 4778873
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00074 Score=81.89 Aligned_cols=144 Identities=18% Similarity=0.225 Sum_probs=87.3
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccc--------------------------------hhhHHHHHHHHH----
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--------------------------------DFFDQSLDEIKL---- 918 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--------------------------------~~~dq~l~EikI---- 918 (1182)
+.|+..+.|+|++|+-+ +|+.||||+-+..- ........|+..
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 47899999999999964 49999999976421 001111222222
Q ss_pred ------HHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEeccc---ChHHHHhhhcccCCccccCHHHHHHHHHHHHHH-
Q 001034 919 ------LKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA---NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA- 988 (1182)
Q Consensus 919 ------Lr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~G---sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsA- 988 (1182)
.+.+.+.+...--.|.++|-.+ ...-.|+||||.| +..+.+.... ++...+ +..+..+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-------i~~~~i---~~~l~~~~ 313 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-------ISPHDI---LNKLVEAY 313 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-------CCHHHH---HHHHHHHH
Confidence 2223222200111244444333 3456799999998 4455555443 333333 3333333
Q ss_pred HHHHHhcCccccccCCccEEEccC--CCceEEEecCCCccccCCC
Q 001034 989 LQFLHGLGLIHCDLKPENILVKSY--SRCEVKVIDLGSSCFETDH 1031 (1182)
Q Consensus 989 LeYLHS~GIIHRDIKPeNILIDs~--~dG~IKLiDFGLA~~~~~~ 1031 (1182)
++-|-..|++|+|-+|.||++.+. +.+.+.|.|||+.......
T Consensus 314 ~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 314 LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 223335689999999999999953 4678999999998765544
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0011 Score=71.95 Aligned_cols=129 Identities=19% Similarity=0.280 Sum_probs=93.8
Q ss_pred CCEEEEEEeccCCc-eEEEEEEECCCCcEEEEEEEec----------------cc------hhhHHHHHHHHHHHHhcCC
Q 001034 869 GRYHVTEYLGSAAF-SKAIQAHDLHTGMDVCVKIIKN----------------NK------DFFDQSLDEIKLLKYVNKH 925 (1182)
Q Consensus 869 drYeIlk~LGkGaF-GeVyLAkDk~TGr~VAVKIIkk----------------~k------~~~dq~l~EikILr~L~h~ 925 (1182)
..++.++.||.|.- |.||+++ -.|+.||+|+++. .. .+...+..|.++..+|...
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 9999997 5788999999431 00 2345677899998888765
Q ss_pred CCCCCcceEEEEEEEEec------------------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHH
Q 001034 926 DPGDKYHLLRLYDYFYYR------------------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987 (1182)
Q Consensus 926 ~~l~HPnIVkL~dsFqd~------------------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILs 987 (1182)
.. .+-+-|++++++.-. ....||.||+...- .+... =+.+|++
T Consensus 115 ~~-e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~----~~~~~~~ 175 (207)
T PF13095_consen 115 GR-EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIR----DIPQMLR 175 (207)
T ss_pred cc-cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchh----HHHHHHH
Confidence 31 111249999987433 12367888775322 02222 3457788
Q ss_pred HHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 988 ALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
-|..+|..||+-+|+++.|.. + -||+|||.+
T Consensus 176 dl~~~~k~gI~~~Dv~~~ny~-~------G~lvDfs~~ 206 (207)
T PF13095_consen 176 DLKILHKLGIVPRDVKPRNYR-G------GKLVDFSSS 206 (207)
T ss_pred HHHHHHHCCeeeccCcccccc-C------CEEEecccC
Confidence 889999999999999999987 2 389999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0017 Score=68.85 Aligned_cols=73 Identities=16% Similarity=0.263 Sum_probs=48.0
Q ss_pred EEEeccCCceEEEEEEECC-CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 874 TEYLGSAAFSKAIQAHDLH-TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~-TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
++.|..|-...+|++.... .+..|++|+.............|..+++.+.... ..++++..+. -.+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~g-----l~P~v~~~~~----~~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHG-----LAPKLYATFQ----NGLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCC-----CCCeEEEEeC----CcEEEEe
Confidence 3567888888999997433 3578999987654333233457888888886543 2344444432 2489999
Q ss_pred ccc
Q 001034 953 LKA 955 (1182)
Q Consensus 953 L~G 955 (1182)
+.|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 887
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=3.7e-05 Score=93.16 Aligned_cols=184 Identities=18% Similarity=0.094 Sum_probs=134.7
Q ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEE
Q 001034 872 HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCE 951 (1182)
Q Consensus 872 eIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmE 951 (1182)
.....+++++++++++.+...+...+ .+.+... ....-++++|.++++++ -.+..++.++-..++.|+|+
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~-----~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPN-----PVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCC-----CcccccccCCcccccchhhh
Confidence 33445789999999999876665544 5655433 23445778888888763 16666777777788999999
Q ss_pred ecccC--hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 952 LLKAN--LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 952 yL~Gs--Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
++.++ ...... ..+..+...+...+.+.-+.+|++||+.--+|+| ||+.. .+..++.+|+....+.
T Consensus 315 i~s~~rs~~~~~~-----~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s---~~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 315 ICSTGRSSALEMT-----VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS---EEEVKLLDFAVPPQLT 382 (829)
T ss_pred hhcCCccccccCC-----hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc---ccccccccccCCcccC
Confidence 99854 111110 1112244445555666677889999998778998 88877 4668999999887665
Q ss_pred CC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001034 1030 DH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN 1077 (1182)
Q Consensus 1030 ~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g 1077 (1182)
.. .++..+++.++|||+.....+....|.|++|+--.+|.-|-+|-.+
T Consensus 383 ~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 383 RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 55 6778899999999999999999999999999877778888887655
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0012 Score=70.71 Aligned_cols=72 Identities=15% Similarity=0.036 Sum_probs=44.0
Q ss_pred EEeccCCce-EEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec---CeEEEEE
Q 001034 875 EYLGSAAFS-KAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR---EHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFG-eVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~---e~LyLVm 950 (1182)
+.|+.|+.. .||++. ..+++|+.+... .......|.++|+.+........|. ++...... ...++||
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-~~~~~~~E~~~l~~L~~~~~v~vP~---~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-YAGQVRKEQRWLPRLAPHLPLPVPE---PLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccc-hHHHHHHHHHHHHHHhccCCCCCCc---eeecCCCccCCCcceEEE
Confidence 456767776 488762 357788765432 3457788999999887532223333 33322221 2358899
Q ss_pred Eeccc
Q 001034 951 ELLKA 955 (1182)
Q Consensus 951 EyL~G 955 (1182)
++++|
T Consensus 74 ~~i~G 78 (235)
T cd05155 74 RWLEG 78 (235)
T ss_pred EeecC
Confidence 99887
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0018 Score=82.10 Aligned_cols=80 Identities=11% Similarity=0.098 Sum_probs=54.0
Q ss_pred EEEeccCCceEEEEEEECCCC--cEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec---CeE
Q 001034 874 TEYLGSAAFSKAIQAHDLHTG--MDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR---EHL 946 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TG--r~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~---e~L 946 (1182)
++.|+.|.+..+|++.....+ ..+++|+..... .....+.+|.++++.+...... -+.+++.++.+. ...
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~v---pVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDV---PVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCC---CCCcEEEEecCCCcCCCc
Confidence 467899999999998754332 467777765432 1224577899999998632111 246666666554 467
Q ss_pred EEEEEecccC
Q 001034 947 LIVCELLKAN 956 (1182)
Q Consensus 947 yLVmEyL~Gs 956 (1182)
|+||||+.|.
T Consensus 120 flVME~v~G~ 129 (822)
T PLN02876 120 FYIMEYLEGR 129 (822)
T ss_pred eEEEEecCCc
Confidence 8999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0094 Score=77.03 Aligned_cols=195 Identities=24% Similarity=0.296 Sum_probs=123.9
Q ss_pred HHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE----Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHH
Q 001034 914 DEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC----ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988 (1182)
Q Consensus 914 ~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm----EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsA 988 (1182)
.|+..+..+.|. |++.++.+-.......+++ +++.. .+...+..- ...+....+.+..+++.+
T Consensus 231 ~e~~~l~k~~~~------n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v------~~i~~~~~r~~~~~~~~G 298 (1351)
T KOG1035|consen 231 IELESLSKIAHD------NLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV------GSIPLETLRILHQKLLEG 298 (1351)
T ss_pred HHHHHHHhhccc------cccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc------cccCHHHHHHHHHHHhhh
Confidence 344555555444 7888877765543333333 44443 233222221 127788889999999999
Q ss_pred HHHHHhcCccccccCCc---cEEEccCCCceEEEe--cCCCccccCCCcc--cccCCCcccchhhhcCCCCCc--hhhHH
Q 001034 989 LQFLHGLGLIHCDLKPE---NILVKSYSRCEVKVI--DLGSSCFETDHLC--SYVQSRSYRAPEVILGLSYDK--KIDIW 1059 (1182)
Q Consensus 989 LeYLHS~GIIHRDIKPe---NILIDs~~dG~IKLi--DFGLA~~~~~~~s--s~vGTp~YmAPEVLlg~~yS~--kSDIW 1059 (1182)
|.|+|+....|.-|... +..++ +.+.+.++ ||+.+........ ....+..+.|||......+.. ..|+|
T Consensus 299 L~~~h~~~l~~v~L~~s~~~~~~~~--~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 299 LAYLHSLSLEHVVLSASSSKESTVD--GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHHHHHhccceeEEecccccccccC--ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHH
Confidence 99999986666555444 22223 34555655 9988876554433 334466688888887665554 47999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCC
Q 001034 1060 SLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRL 1139 (1182)
Q Consensus 1060 SLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l 1139 (1182)
++|.++..+..|..+-... . .+..++
T Consensus 377 ~lgll~~~~~~~~~i~~~~---~-----------~~~~~l---------------------------------------- 402 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKS---A-----------VPVSLL---------------------------------------- 402 (1351)
T ss_pred HHHHHHhhhhhcCcccccc---c-----------chhhhh----------------------------------------
Confidence 9999999999876432100 0 000000
Q ss_pred CCCc-HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1140 PMGD-QGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1140 ~~~S-eeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+... ..+.+++.+|+.-++++|+++.++|.|||.+-+
T Consensus 403 ~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 403 DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 0001 156788999999999999999999999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0091 Score=69.85 Aligned_cols=139 Identities=20% Similarity=0.292 Sum_probs=94.0
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---------------------------hhhHHHHHHHHHHHHhcCC
Q 001034 873 VTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---------------------------DFFDQSLDEIKLLKYVNKH 925 (1182)
Q Consensus 873 Ilk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---------------------------~~~dq~l~EikILr~L~h~ 925 (1182)
|-.+|..|--+.||.|.. .+|..+||||++..- +..-=...|++-|.+++..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445789999999999984 778889999986320 0001122456666666644
Q ss_pred C-CCCCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHH-hcCccccccC
Q 001034 926 D-PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH-GLGLIHCDLK 1003 (1182)
Q Consensus 926 ~-~l~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLH-S~GIIHRDIK 1003 (1182)
. ++..|.+++ .-.|||+|++.+-...=+ -....++...+..+-.|++.-+.-|- .+++||.||.
T Consensus 227 GIP~PePIlLk---------~hVLVM~FlGrdgw~aPk-----LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLS 292 (520)
T KOG2270|consen 227 GIPCPEPILLK---------NHVLVMEFLGRDGWAAPK-----LKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLS 292 (520)
T ss_pred CCCCCCceeee---------cceEeeeeccCCCCcCcc-----cccccCChHHHHHHHHHHHHHHHHHHHHhceeccchh
Confidence 2 223334443 235999999853221111 11223677778888888888888774 6899999999
Q ss_pred CccEEEccCCCceEEEecCCCccccC
Q 001034 1004 PENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 1004 PeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
--|+|+. .|.+.|||.+.+.-..
T Consensus 293 EfN~Lyh---dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 293 EFNLLYH---DGKLYIIDVSQSVEHD 315 (520)
T ss_pred hhhheEE---CCEEEEEEccccccCC
Confidence 9999998 6889999999886443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0065 Score=67.29 Aligned_cols=72 Identities=8% Similarity=0.106 Sum_probs=48.1
Q ss_pred EEeccCCceEEEEEEECC------CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 875 EYLGSAAFSKAIQAHDLH------TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~------TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
+.|..|--..||++.... +++.|++|+.............|.+++..+.... -..+++.++.. .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g-----~~P~~~~~~~~----~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERN-----LGPKLYGIFPN----GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCC-----CCCceEEEeCC----Cc
Confidence 456667677888887432 3678999998765444456678999999887653 13445555532 36
Q ss_pred EEEeccc
Q 001034 949 VCELLKA 955 (1182)
Q Consensus 949 VmEyL~G 955 (1182)
|++|+.|
T Consensus 75 v~e~i~G 81 (302)
T cd05156 75 IEEFIPS 81 (302)
T ss_pred hhheeCC
Confidence 8898876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0076 Score=65.44 Aligned_cols=137 Identities=13% Similarity=0.150 Sum_probs=75.1
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEEeccchhh-HHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEeccc
Q 001034 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFF-DQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA 955 (1182)
Q Consensus 877 LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~-dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~G 955 (1182)
+..|-.+.+|++. .++..+++|+........ -....|..+++.+..... .|. ++..+. -++||+|++|
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~--~P~---~i~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGL--APK---PILVNE----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCC--CCc---eEEEeC----CEEEEEeccC
Confidence 4567777889886 456788899865443222 235678899998876431 233 333321 3689999987
Q ss_pred ChHH---------------HHh-hhcccCCccccCH-HHHHHHHHHH---------HHHHHHHHh--------cCccccc
Q 001034 956 NLYE---------------FHK-FNRESGGEVYFTM-PRLQSITIQC---------LEALQFLHG--------LGLIHCD 1001 (1182)
Q Consensus 956 sLld---------------~Lk-~~~~sggel~Lse-~eIr~Ia~QI---------LsALeYLHS--------~GIIHRD 1001 (1182)
.... .+. ..........+.. ..+..+..++ ...+..+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 3221 111 1100000011111 1112221111 111222211 2589999
Q ss_pred cCCccEEEccCCCceEEEecCCCccc
Q 001034 1002 LKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 1002 IKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
+.|.|||++. ++ +.|+||..+..
T Consensus 153 l~~~Nil~~~--~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTP--QG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeC--CC-CEEEeccccCc
Confidence 9999999984 33 78999988754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.028 Score=62.81 Aligned_cols=77 Identities=4% Similarity=-0.064 Sum_probs=45.6
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEE---EEEEecCeEEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY---DYFYYREHLLIVCE 951 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~---dsFqd~e~LyLVmE 951 (1182)
+.|..|....+|++.. ..| .+++|++.. ........+..+++.|.... ...|.++... .+.......++||+
T Consensus 28 ~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~g-lpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTT-TQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARG-VPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEe-CCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCC-CCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 3567788889999874 333 688998862 12234445667777775432 2233333211 11233566899999
Q ss_pred ecccC
Q 001034 952 LLKAN 956 (1182)
Q Consensus 952 yL~Gs 956 (1182)
+++|.
T Consensus 103 ~l~G~ 107 (319)
T PRK05231 103 FLEGK 107 (319)
T ss_pred ecCCC
Confidence 99874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.033 Score=62.79 Aligned_cols=77 Identities=10% Similarity=0.096 Sum_probs=52.9
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe---cCeEEEEE
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY---REHLLIVC 950 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd---~e~LyLVm 950 (1182)
.+.||.|..+.||+... ..+ .+++|..+.. .....+..|...|+.+...... .+.++++++.+ ....+|||
T Consensus 19 ~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~-~~~~~~~~Ea~~L~~L~~~~~v---pVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 19 VECISEQPYAALWALYD-SQG-NPMPLMARSF-STPGVAQQEAWKLSMLARSGTV---RMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eeecCCccceeEEEEEc-CCC-CEEEEEeccc-ccchHHHHHHHHHHHHccCCCC---CcCcEEEEeccCCcCCCeEEEE
Confidence 45789999999999963 223 4777875431 1235778899999988754222 35666666543 36689999
Q ss_pred EecccC
Q 001034 951 ELLKAN 956 (1182)
Q Consensus 951 EyL~Gs 956 (1182)
|++.|.
T Consensus 93 E~i~G~ 98 (297)
T PRK10593 93 ERLRGV 98 (297)
T ss_pred eccCCE
Confidence 999863
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0094 Score=63.95 Aligned_cols=134 Identities=20% Similarity=0.215 Sum_probs=88.7
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
-++.+.|++|.+|.||++. ..|..+|+|+-+.+. ....+..|.++|..++... .-.++|.+- .-++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~-----~~p~vy~yg----~~~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDS-PRRNLEKEAKILEILAGEG-----VTPEVYFYG----EDFIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEee--ccCceEEEEEecCCc-chhhHHHHHHHHHHhhhcC-----CCceEEEec----hhhhhh
Confidence 3456789999999999997 567799999877654 3466778999999887653 233454443 334669
Q ss_pred Eeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccC-CccEEEccCCCceEEEecCCCcccc
Q 001034 951 ELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK-PENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 951 EyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIK-PeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
||+.| .|.....- .. +.-+..++.+---|-.+||-|+.|. |..++|.. +..+.||||..|++.
T Consensus 92 e~i~G~~L~~~~~~---------~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~--~~~~~iIDFd~At~k 156 (201)
T COG2112 92 EYIDGRPLGKLEIG---------GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN--DRDVYIIDFDSATFK 156 (201)
T ss_pred hhhcCcchhhhhhc---------cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec--CCcEEEEEccchhhc
Confidence 99998 44433221 01 2233445555555667899999985 44444442 447999999998854
Q ss_pred CCC
Q 001034 1029 TDH 1031 (1182)
Q Consensus 1029 ~~~ 1031 (1182)
..+
T Consensus 157 ~~p 159 (201)
T COG2112 157 KKP 159 (201)
T ss_pred cCC
Confidence 433
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.024 Score=62.48 Aligned_cols=147 Identities=14% Similarity=0.055 Sum_probs=81.0
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEE-E--EEEecCeEEEEE
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY-D--YFYYREHLLIVC 950 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~-d--sFqd~e~LyLVm 950 (1182)
++.|..|....+|++.. .+..+++|+... ........|+.++..+.... ..-|.++... + +.......++||
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g-~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VSAEELPFFLALLDHLAERG-LPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--CChHhccHHHHHHHHHHHCC-CCCCccccCCCCcEeeeeCCceEEEE
Confidence 44677888889999863 345789998865 22355667888888886542 1112222210 0 123345678999
Q ss_pred EecccChH----------------HHHhhhcccCCc----cccCHHHH----------HHHHHHHHHHHHHHHh------
Q 001034 951 ELLKANLY----------------EFHKFNRESGGE----VYFTMPRL----------QSITIQCLEALQFLHG------ 994 (1182)
Q Consensus 951 EyL~GsLl----------------d~Lk~~~~sgge----l~Lse~eI----------r~Ia~QILsALeYLHS------ 994 (1182)
++++|... .++......... ........ ......+..++.++..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 99987321 111111000000 00000000 0011123334444443
Q ss_pred -cCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 995 -LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 995 -~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
.++||+|+.|.|||++. .+.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~--~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDG--DELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeC--CceEEEeehhhhcC
Confidence 47999999999999984 45568999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.027 Score=62.95 Aligned_cols=148 Identities=14% Similarity=0.107 Sum_probs=79.8
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE---EEEecCeEEEEE
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD---YFYYREHLLIVC 950 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d---sFqd~e~LyLVm 950 (1182)
++.|+.|.-..+|++.. .++ .+++|+..... .......+..++..|.... ...|-++...+ +.......++||
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g-~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAARG-LPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCC-CCCCccccCCCCCeehhcCCeEEEEE
Confidence 45677787789999863 344 57889876532 1344556777887775432 11222222111 112245678999
Q ss_pred EecccChH----------------HHHhhhccc-CC-ccccCHHH-----HH----------HHHHHHHHHHHHHH----
Q 001034 951 ELLKANLY----------------EFHKFNRES-GG-EVYFTMPR-----LQ----------SITIQCLEALQFLH---- 993 (1182)
Q Consensus 951 EyL~GsLl----------------d~Lk~~~~s-gg-el~Lse~e-----Ir----------~Ia~QILsALeYLH---- 993 (1182)
+|++|... .++.....- .. ........ .. .....+..++.+|.
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99987311 111110000 00 00000000 00 01112334455553
Q ss_pred ---hcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 994 ---GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 994 ---S~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
..++||+|+.+.||+++. ++.+.|+||+.+..
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~--~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDG--DSVKGVIDFYFACT 217 (307)
T ss_pred hcCCCccCCCCCCcCcEEEEC--CceEEEeecccccC
Confidence 268999999999999984 45568999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.029 Score=66.34 Aligned_cols=77 Identities=23% Similarity=0.237 Sum_probs=54.2
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEec------c--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN------N--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk------~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.+.||.|.+..||++.....++.++||.-.. . ....+....|...|+.+....+ .++++++.+ +...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p---~~VPkV~~~--D~~~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVP---DLVPKVYHY--DEEL 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCC---CCCCeEEEE--CCCC
Confidence 3578999999999999854446899998531 1 1234567778888888764432 246666665 4566
Q ss_pred EEEEEEeccc
Q 001034 946 LLIVCELLKA 955 (1182)
Q Consensus 946 LyLVmEyL~G 955 (1182)
.++|||++++
T Consensus 106 ~~lVME~L~~ 115 (401)
T PRK09550 106 AVTVMEDLSD 115 (401)
T ss_pred CEEEEecCCC
Confidence 7899999874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.003 Score=72.81 Aligned_cols=135 Identities=20% Similarity=0.247 Sum_probs=92.9
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhh-----------------------HHHHHHHHHHHHhcCCC
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFF-----------------------DQSLDEIKLLKYVNKHD 926 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~-----------------------dq~l~EikILr~L~h~~ 926 (1182)
-|.+...||-|--+.||.+-+ ..|++.|+|+.+..+..+ -....|...++.|..+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367788999999999999986 678999999875322111 12345666666665532
Q ss_pred CCCCcceEEEEEEEEecCeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCc
Q 001034 927 PGDKYHLLRLYDYFYYREHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005 (1182)
Q Consensus 927 ~l~HPnIVkL~dsFqd~e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPe 1005 (1182)
.-+.+.++ .+..|+|||++.|- |...... ..+..+...+..-|.-|-..|+||+|..-=
T Consensus 172 ----fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEF 231 (465)
T KOG2268|consen 172 ----FPVPKPID----HNRHCVVMELVDGYPLRQVRHV------------EDPPTLYDDLMGLIVRLANHGLIHGDFNEF 231 (465)
T ss_pred ----CCCCCccc----ccceeeHHHhhcccceeeeeec------------CChHHHHHHHHHHHHHHHHcCceecccchh
Confidence 12444444 34668999999873 3322211 123345556666677888999999999999
Q ss_pred cEEEccCCCceEEEecCCCccc
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||+|+. .+.+++|||-.+..
T Consensus 232 Nimv~d--d~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 232 NIMVKD--DDKIVVIDFPQMVS 251 (465)
T ss_pred eeEEec--CCCEEEeechHhhc
Confidence 999994 67799999976543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.035 Score=63.96 Aligned_cols=143 Identities=22% Similarity=0.303 Sum_probs=79.1
Q ss_pred EEeccCCceEEEEEEECC----CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLH----TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~----TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
..|-.|-...+|++.... .++.|++|+........-....|..+++.+.... --.++++.|... .|+
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~g-----l~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHG-----QGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcC-----CCCceEEEECCc----eEE
Confidence 355557788899886322 3478999988765433333467888888887653 123445555322 578
Q ss_pred EecccChHHHH---------------h-hh--cccCCccccCHHHHHHHHHHH-----------------HHHHHHH---
Q 001034 951 ELLKANLYEFH---------------K-FN--RESGGEVYFTMPRLQSITIQC-----------------LEALQFL--- 992 (1182)
Q Consensus 951 EyL~GsLld~L---------------k-~~--~~sggel~Lse~eIr~Ia~QI-----------------LsALeYL--- 992 (1182)
+|+.|..+... . .. ...+...+.....+..++.++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 88876321100 0 00 001111011112222322111 1111111
Q ss_pred -----HhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 993 -----HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 993 -----HS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
+...++|+|+++.|||++. .++.+.|+||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~-~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDE-ETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeC-CCCcEEEEeehhccc
Confidence 1236899999999999984 345799999988753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.03 Score=63.94 Aligned_cols=72 Identities=14% Similarity=0.227 Sum_probs=44.2
Q ss_pred EeccCCceEEEEEEECCC---CcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEe
Q 001034 876 YLGSAAFSKAIQAHDLHT---GMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~T---Gr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEy 952 (1182)
.|..|=...+|++..... +..|++|+........-...+|..+++.+..... -.++++++. +. +|.+|
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl-----~P~~l~~~~--~G--~i~~f 91 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGF-----GAKLLGVFG--NG--MIQSF 91 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCC-----CCceeEEeC--Cc--Eeehh
Confidence 444466777888864322 3478999887654434445678888888876531 234555552 22 57888
Q ss_pred cccC
Q 001034 953 LKAN 956 (1182)
Q Consensus 953 L~Gs 956 (1182)
+.|.
T Consensus 92 i~g~ 95 (330)
T PLN02421 92 INAR 95 (330)
T ss_pred hcCC
Confidence 7753
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.017 Score=61.36 Aligned_cols=101 Identities=24% Similarity=0.265 Sum_probs=73.9
Q ss_pred HHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHH
Q 001034 913 LDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991 (1182)
Q Consensus 913 l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeY 991 (1182)
..|.-+++.+.+.. +++++++++ .-++|.||++. .++..... ...-...++.....|+.+++..+.+
T Consensus 7 ~~E~lll~~l~~~~-----~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~---l~~~~~~~w~~R~~iA~~lL~~l~~ 74 (188)
T PF12260_consen 7 NNEPLLLQLLQGSE-----PFPKLLGSC----GRFYVVEYVGAGSLYGIYRP---LSQFLQSPWEQRAKIALQLLELLEE 74 (188)
T ss_pred ccHHHHHHHcCCCC-----CCCCeeeEC----CCEEEEEeecCccccccccc---cccccccCHHHHHHHHHHHHHHHHH
Confidence 35778888887653 799999987 34678899884 34311000 0000116788899999999999999
Q ss_pred HHh---cCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 992 LHG---LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 992 LHS---~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
|+. ..+...|++|+|+-++. ++++|++|......
T Consensus 75 l~~~~~~~~~lcDv~~~nfgv~~--~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 75 LDHGPLGFFYLCDVSPDNFGVND--DGRLKLIDLDDVFV 111 (188)
T ss_pred HhcCCCCcEEEeecchHHeEEeC--CCcEEEEechhcch
Confidence 987 34777999999999994 67899999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.035 Score=58.71 Aligned_cols=53 Identities=17% Similarity=0.136 Sum_probs=33.7
Q ss_pred CcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEeccc
Q 001034 894 GMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA 955 (1182)
Q Consensus 894 Gr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~G 955 (1182)
.+.|++++........-....|..+++.+.... .-.+++++|.. .+|.+|+.|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g-----~~p~~~~~~~~----g~v~e~i~g 54 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAG-----LGPKIIYFFEN----GRVEEFIEG 54 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTT-----SSS-EEEEETT----EEEEE--SS
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcC-----CCCeEEEEcCC----CcEEEEecc
Confidence 467899999877555566778899988887653 23455555522 256688765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.024 Score=68.63 Aligned_cols=91 Identities=22% Similarity=0.250 Sum_probs=62.8
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcccccc
Q 001034 1054 KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT 1133 (1182)
Q Consensus 1054 ~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~ 1133 (1182)
+++||||+|.|+.++..|...|..-...+.+..|.+..- .+.+.. . . ....
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~-~d~~~~----------------~-~----a~e~------- 160 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYT-DDQELL----------------S-T----AMEH------- 160 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhcc-CchhHH----------------H-H----HHHH-------
Confidence 499999999999999999988877666666555542221 111100 0 0 0000
Q ss_pred ccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1134 SLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1134 sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.....++..+++++.+|+...|..||...++++|+-|++.
T Consensus 161 ---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 161 ---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred ---HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 0111345678899999999999999999999999988765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.16 Score=56.92 Aligned_cols=53 Identities=19% Similarity=0.157 Sum_probs=33.7
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCc
Q 001034 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKY 931 (1182)
Q Consensus 877 LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HP 931 (1182)
++.|--..|+.+. ...|+.+++|.-+... ......+|.++|+.+...-+...|
T Consensus 19 ~~~g~~~~v~~i~-~~~g~~~VlR~p~~~~-~~~~l~rE~~vL~~L~~~l~vpvP 71 (276)
T cd05152 19 NESGLDFQVVFAK-DTDGVPWVLRIPRRPD-VSERAAAEKRVLALVRKHLPVQVP 71 (276)
T ss_pred cCCcceeEEEEEE-cCCCCeEEEEecCCHH-HHHHHHHHHHHHHHHHhcCCCCCC
Confidence 3555556667663 2457788888775432 345678899999998754333334
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.48 Score=52.45 Aligned_cols=29 Identities=41% Similarity=0.493 Sum_probs=24.9
Q ss_pred cCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 995 LGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 995 ~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
.++||+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~---~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD---NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC---CcEEEEECcccc
Confidence 57899999999999984 458999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.42 Score=54.68 Aligned_cols=74 Identities=12% Similarity=-0.000 Sum_probs=45.0
Q ss_pred CCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCC-CCcceEEEEE--EEEecCeEEEEEEecccC
Q 001034 880 AAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPG-DKYHLLRLYD--YFYYREHLLIVCELLKAN 956 (1182)
Q Consensus 880 GaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l-~HPnIVkL~d--sFqd~e~LyLVmEyL~Gs 956 (1182)
+.-..||++.. .++..+++|+.+........+..|+.++..|...... .-| +..-+ .+......+.|++++.|.
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p--~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAP--LAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCC--ccCCCCEEEEECCEEEEEEeeeCCC
Confidence 44567888864 5567899999875544456677888888877653210 111 11111 122345678899998763
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.45 Score=54.12 Aligned_cols=75 Identities=17% Similarity=0.197 Sum_probs=49.7
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEec
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL 953 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL 953 (1182)
.+.|+-|....+|++. .+++.+.||+-.. .....+..|..-|+.|...... .+.+++.+.......||||||+
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~~~~---~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE--SGRDMFEGEAEGLKALAEANPI---RVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEG--GGCCHHHHHHHHHHHHCHTTTS---BS--EEEEEE-SSCCEEEEE--
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecCh--hhHHHHHHHHHHHHHHHhcCCC---CCCeEEEEEeecCCceEEEEee
Confidence 4578889999999987 7788899998873 3345677888888888544322 5778888887777789999998
Q ss_pred cc
Q 001034 954 KA 955 (1182)
Q Consensus 954 ~G 955 (1182)
+.
T Consensus 95 ~~ 96 (288)
T PF03881_consen 95 EM 96 (288)
T ss_dssp --
T ss_pred cC
Confidence 74
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.31 Score=57.51 Aligned_cols=73 Identities=12% Similarity=0.144 Sum_probs=44.0
Q ss_pred EEeccCCceEEEEEEECCC-Cc-----EEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHT-GM-----DVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~T-Gr-----~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
+.|..|--..+|++..... +. .|.+++........-....|+.+++.+.... .-.++++.|. -++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~g-----lgP~l~~~f~----~g~ 126 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNN-----FGPKIIGRFG----DFT 126 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCC-----CCCeEEEecC----CEE
Confidence 4555688888998864322 12 2444443232222333457888988887664 3456667663 368
Q ss_pred EEEecccC
Q 001034 949 VCELLKAN 956 (1182)
Q Consensus 949 VmEyL~Gs 956 (1182)
|.||+.|.
T Consensus 127 l~efIeGr 134 (383)
T PTZ00384 127 IQEWVEGN 134 (383)
T ss_pred EEEEeccc
Confidence 99999874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.38 Score=56.70 Aligned_cols=75 Identities=19% Similarity=0.159 Sum_probs=50.3
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEec-----c---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKN-----N---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk-----~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.||-|...-||++.+...++.++||.-.. . +....+...|..+|+......+. +++++|. .+.....
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~---~vP~vy~--~D~e~~~ 76 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPH---LVPRIFH--FDTEMAV 76 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCcc---ccCeEEE--Eccccce
Confidence 47999999999999754446899997531 1 23345666788888777654322 4555543 3456667
Q ss_pred EEEEeccc
Q 001034 948 IVCELLKA 955 (1182)
Q Consensus 948 LVmEyL~G 955 (1182)
+|||+++.
T Consensus 77 ~vMEdL~~ 84 (370)
T TIGR01767 77 TVMEDLSH 84 (370)
T ss_pred ehHhhCcc
Confidence 99999853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.78 E-value=0.76 Score=60.47 Aligned_cols=149 Identities=17% Similarity=0.106 Sum_probs=78.1
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCC-CCCCcceEEEE-----EEEEe-c--CeE
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD-PGDKYHLLRLY-----DYFYY-R--EHL 946 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~-~l~HPnIVkL~-----dsFqd-~--e~L 946 (1182)
.|+ |..-.+|++.. .+|..+++|+++.... ......+..+|..|.... ....|.+++.. ..... . .+.
T Consensus 32 ~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~-~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 32 PLD-GERDLNFRLTT-DDGADYILKIVNPSEP-RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred ecC-CcCCceEEEEe-CCCCeEEEEEcCCccc-hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 453 34577788763 5677899999986532 233344566777665432 12334444422 11111 1 157
Q ss_pred EEEEEecccChHHH-------------------Hh---hhcccCCccccC-----------------HHHHHHHHHHHHH
Q 001034 947 LIVCELLKANLYEF-------------------HK---FNRESGGEVYFT-----------------MPRLQSITIQCLE 987 (1182)
Q Consensus 947 yLVmEyL~GsLld~-------------------Lk---~~~~sggel~Ls-----------------e~eIr~Ia~QILs 987 (1182)
+.+++|++|..+.- .. ....+.....+. ....+.++.+++.
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 78899999853321 00 000000000000 1112222333333
Q ss_pred HHH-----HHH--hcCccccccCCccEEEccCCCceEE-EecCCCccc
Q 001034 988 ALQ-----FLH--GLGLIHCDLKPENILVKSYSRCEVK-VIDLGSSCF 1027 (1182)
Q Consensus 988 ALe-----YLH--S~GIIHRDIKPeNILIDs~~dG~IK-LiDFGLA~~ 1027 (1182)
.+. .|. ..++||+|+.+.|||++....+.+. |+|||.+..
T Consensus 189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 322 122 2579999999999999964333555 999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.58 Score=52.71 Aligned_cols=30 Identities=20% Similarity=0.261 Sum_probs=25.9
Q ss_pred CccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 996 GLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 996 GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
++||+|+.++|||++. ++.+.|+||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~--~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDE--TRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcC--CCCEEEEEhhhccc
Confidence 7999999999999984 55689999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.16 E-value=0.78 Score=53.34 Aligned_cols=142 Identities=20% Similarity=0.199 Sum_probs=80.7
Q ss_pred CceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCC-CCCcceEEEEEEEE--ecC--eEEEEEEeccc
Q 001034 881 AFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP-GDKYHLLRLYDYFY--YRE--HLLIVCELLKA 955 (1182)
Q Consensus 881 aFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~-l~HPnIVkL~dsFq--d~e--~LyLVmEyL~G 955 (1182)
.-..+|++.. .+|+. ++|+.+.. .....+..|+.++..|..... ..-| |..+-+-.. ... +.+.|++|++|
T Consensus 37 ~eN~~f~~~~-~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~P-l~~~dG~~l~~~~~~~r~a~lf~~l~G 112 (331)
T COG2334 37 EENSNFRVQT-EDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAP-LPSLDGELLEALSGGPRPAALFEYLPG 112 (331)
T ss_pred ccCceEEEEe-cCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCC-ccCCCcchhhhccCCceeEEEEEecCC
Confidence 5567888874 44444 99999887 556777888888888876532 1222 333222111 123 77889999987
Q ss_pred ChHHH-----------------HhhhcccC----Ccc-ccCHH----HH---------HHHHHHHHHHHHHHHh------
Q 001034 956 NLYEF-----------------HKFNRESG----GEV-YFTMP----RL---------QSITIQCLEALQFLHG------ 994 (1182)
Q Consensus 956 sLld~-----------------Lk~~~~sg----gel-~Lse~----eI---------r~Ia~QILsALeYLHS------ 994 (1182)
..... +...+.-. ... ...+. .. .....++...+..+.+
T Consensus 113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l 192 (331)
T COG2334 113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL 192 (331)
T ss_pred cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence 54431 00000000 000 01111 00 1122344455555542
Q ss_pred --cC--ccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 995 --LG--LIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 995 --~G--IIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
.+ +||+|+.|+|||++.... .+.++||+.++.
T Consensus 193 p~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~~ 228 (331)
T COG2334 193 PALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAGY 228 (331)
T ss_pred CcccceeeecCCCccceeEcCCCC-eeeEEEcccccc
Confidence 34 999999999999995222 488999998753
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.62 E-value=0.8 Score=55.12 Aligned_cols=74 Identities=15% Similarity=0.080 Sum_probs=46.6
Q ss_pred EEEeccCCceEEEEEEECC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 874 TEYLGSAAFSKAIQAHDLH--------TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~--------TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++.|..|=...+|++.... .++.|.+++.-......-....|..+++.+..... -.++++.|.
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi-----~P~l~~~f~---- 180 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRI-----APQLLNTFS---- 180 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCC-----CCceEEEeC----
Confidence 4456666667788876432 25689999986654433355678888888876531 124555552
Q ss_pred EEEEEEecccC
Q 001034 946 LLIVCELLKAN 956 (1182)
Q Consensus 946 LyLVmEyL~Gs 956 (1182)
-+.|.+|+.|.
T Consensus 181 gg~I~efi~g~ 191 (442)
T PTZ00296 181 GGRIEEWLYGD 191 (442)
T ss_pred CCEEEEeeCCc
Confidence 34678888764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.48 E-value=0.74 Score=54.97 Aligned_cols=76 Identities=18% Similarity=0.168 Sum_probs=53.0
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEe----cc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIk----k~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.+.||-|...-||++.+...++.|+||.-. .. +...++..-|..+|+.+....+. +++++|. .+....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~---~VP~vy~--~D~e~~ 108 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPG---LVPKVYL--FDSVMN 108 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCC---cCCeEEE--ECcHHh
Confidence 568899999999999974445679998743 21 23356677788888887665332 4555544 355667
Q ss_pred EEEEEecc
Q 001034 947 LIVCELLK 954 (1182)
Q Consensus 947 yLVmEyL~ 954 (1182)
.+|||+++
T Consensus 109 ~~vMEdL~ 116 (409)
T PRK12396 109 CCVMEDLS 116 (409)
T ss_pred hHHHHhCc
Confidence 78999985
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=92.28 E-value=0.14 Score=68.43 Aligned_cols=143 Identities=13% Similarity=0.017 Sum_probs=98.7
Q ss_pred CCcceEEEEEEEEe--cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-----Ccccc
Q 001034 929 DKYHLLRLYDYFYY--REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL-----GLIHC 1000 (1182)
Q Consensus 929 ~HPnIVkL~dsFqd--~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~-----GIIHR 1000 (1182)
.|+++...+.-... ....|++++|+. |.+...+....... .++...-+.....+.+.+..-+|+. =.+|+
T Consensus 1287 ~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~--~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~ 1364 (2724)
T KOG1826|consen 1287 KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES--PDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSK 1364 (2724)
T ss_pred hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC--CcchhchHHHHHHHHHhccchhhhcccCCccchhh
Confidence 34455554443322 245688888887 45666665433221 1122222222233337777777753 27899
Q ss_pred ccCCccEEEccCCCceEEEecCCCccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001034 1001 DLKPENILVKSYSRCEVKVIDLGSSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLF 1075 (1182)
Q Consensus 1001 DIKPeNILIDs~~dG~IKLiDFGLA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF 1075 (1182)
+||+-|.+|.. +..+|+.++|+.+..... ....++++.|++|++.....++.++|+|.+++.+|...-|..+|
T Consensus 1365 ~Lkf~lpmIVt--ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1365 SLKFTLPMIVT--NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhhccceec--CCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999999994 667999999999843332 33456788899999999989999999999999999999998887
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=91.67 E-value=1.2 Score=53.50 Aligned_cols=75 Identities=13% Similarity=0.103 Sum_probs=51.2
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEe-----ccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-----NNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIk-----k~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.+.||-|....||++.+ .+..++||.-. ... ........|...|+.+....+ ..+.+++.+.. ..
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p---~~VPkVy~~de--d~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCP---DHVPEVYHFDR--TM 109 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCC---CCCCeEEEECC--CC
Confidence 56889999999999986 34568899865 111 134455666777777654322 25677777664 45
Q ss_pred EEEEEEeccc
Q 001034 946 LLIVCELLKA 955 (1182)
Q Consensus 946 LyLVmEyL~G 955 (1182)
-++|||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 6789999976
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.31 E-value=1.1 Score=53.36 Aligned_cols=104 Identities=19% Similarity=0.231 Sum_probs=68.1
Q ss_pred cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++|++|++-.+.+.- ++. ....++..|+++++..|.-+.. ..+=||++..+||||+ .|.|.|||
T Consensus 298 ~~y~yl~~kdhgt~is~-ik~---------~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId---~GnvtLID 364 (488)
T COG5072 298 TLYLYLHFKDHGTPISI-IKA---------DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID---EGNVTLID 364 (488)
T ss_pred ceEEEEEEecCCceeee-eec---------ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee---cCceEEEE
Confidence 46788888887655431 111 3456778888888887776664 4689999999999999 67899999
Q ss_pred CCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHH
Q 001034 1022 LGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLG 1062 (1182)
Q Consensus 1022 FGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLG 1062 (1182)
|-+++...... .+..-..--|-.|.|.. +..-+||-+-
T Consensus 365 fklsRl~~~q~--~isy~rldhp~lF~G~d-d~QFeIYrlM 402 (488)
T COG5072 365 FKLSRLSYSQG--IISYNRLDHPDLFNGVD-DYQFEIYRLM 402 (488)
T ss_pred eeeeecccCCc--eeeccccCchhhhcCcc-ceeeeHHHHH
Confidence 99987432211 11111233455555443 5566777643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.99 E-value=4.4 Score=47.24 Aligned_cols=30 Identities=23% Similarity=0.451 Sum_probs=25.6
Q ss_pred CccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 996 GLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 996 GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
.++|+|+.+.||+|+. .+-+-++||+++..
T Consensus 199 ~lvHGD~~~gNlii~~--~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDP--GRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeC--CCeeEEEecccccc
Confidence 4899999999999995 33499999999865
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=83.65 E-value=1.7 Score=48.97 Aligned_cols=48 Identities=23% Similarity=0.222 Sum_probs=35.1
Q ss_pred HHHHHHHHHHHHHHHHhc--CccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 978 LQSITIQCLEALQFLHGL--GLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 978 Ir~Ia~QILsALeYLHS~--GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
++..+..+-.++.-+|.. -+||+|+.|+|+|++. .+.++|+||..|..
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~--~~~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTD--KGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcC--CCcEEEEecccCCC
Confidence 333444555555555544 5999999999999993 57899999988764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=82.36 E-value=5.2 Score=45.22 Aligned_cols=84 Identities=15% Similarity=0.198 Sum_probs=55.6
Q ss_pred HHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHH
Q 001034 911 QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQ 990 (1182)
Q Consensus 911 q~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALe 990 (1182)
-+..+.++++++. .|++|..- ..-.+.+|.|+|-. ......- ++..=+.+|.
T Consensus 104 ~y~nky~v~Armh--------GilrL~ND--n~~~yGvIlE~Cy~-----------------~~i~~~N-~i~agi~~L~ 155 (308)
T PF07387_consen 104 LYFNKYRVFARMH--------GILRLKND--NNYKYGVILERCYK-----------------IKINFSN-FITAGIKDLM 155 (308)
T ss_pred hhhhhhhHHHHhh--------heeEeecC--CCceeEEEEeeccC-----------------cccchhH-HHHHhHHHHH
Confidence 3456778888763 58888732 23357788898831 0011111 1222246677
Q ss_pred HHHh--cCccccccCCccEEEccCCCceEEEecCCC
Q 001034 991 FLHG--LGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 991 YLHS--~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
-.|+ .+.+|+|..|+|||-| +.|.+||.|=+.
T Consensus 156 ~fH~~~~~~lHGD~np~NiM~D--~~G~lKlVDP~~ 189 (308)
T PF07387_consen 156 DFHSENQHCLHGDCNPDNIMCD--KFGYLKLVDPVC 189 (308)
T ss_pred HhhccCCCeecCCCChhheeec--CCCCEEecChhh
Confidence 8884 5799999999999999 478899999764
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1182 | ||||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-51 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-51 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-50 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-44 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-43 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-43 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-40 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-40 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-40 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 8e-39 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-38 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-38 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-36 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-36 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-34 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 4e-34 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 6e-32 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-31 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-29 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-29 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-26 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-26 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-26 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-26 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-26 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-26 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-26 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-26 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-26 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-26 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-26 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-25 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-25 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-25 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-25 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-25 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-25 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-25 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-25 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-25 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-25 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-25 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-25 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-25 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-25 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-24 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-24 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-24 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-24 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-24 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-24 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-24 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-24 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-24 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-24 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-24 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-24 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-24 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-24 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-24 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-24 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-24 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-24 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-24 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-24 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-24 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-24 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-24 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-24 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-24 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-24 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-24 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-24 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-24 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-24 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-24 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-24 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-24 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-24 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-24 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-24 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-24 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-24 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-24 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-24 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-24 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-24 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-24 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-24 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-24 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-24 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-24 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-24 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-24 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-24 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-24 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-24 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-24 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-23 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-23 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-23 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-23 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-23 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-23 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-23 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-23 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-23 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-23 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-23 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-23 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-23 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-23 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-23 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-23 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-23 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-23 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-23 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-23 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-23 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-23 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-23 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-23 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-23 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-23 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-23 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-23 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-23 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-23 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-23 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-23 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-23 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-23 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-23 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-23 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-23 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-23 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-23 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-22 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-22 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-22 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-22 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-22 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-22 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-22 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-22 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-21 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-21 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-21 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-20 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-20 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-20 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-20 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-20 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-20 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-20 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-20 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-19 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-19 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-19 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-19 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-18 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-16 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-15 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-14 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 8e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-04 |
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1182 | |||
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-137 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-136 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-134 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-133 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-130 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-119 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-70 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-54 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 4e-54 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-53 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-53 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-53 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-52 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 9e-52 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-51 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-51 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-50 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-50 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-49 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-48 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-47 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-47 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-46 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-45 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-44 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-44 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-43 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-42 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-42 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-41 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-41 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-41 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-41 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-41 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 5e-41 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-41 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-41 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 8e-41 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-40 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 5e-40 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-39 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 5e-39 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 7e-39 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 8e-39 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-38 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-38 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-38 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-38 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-38 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-38 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-38 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-38 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-37 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-37 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-36 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-36 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-36 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-36 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-36 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 6e-36 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 9e-36 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 9e-36 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-35 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-35 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-34 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-34 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-34 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-34 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-34 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 8e-34 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-33 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 5e-33 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-32 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-32 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-32 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-32 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-32 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-07 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-32 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 9e-06 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 6e-32 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 6e-32 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-31 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-31 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-31 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-31 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-06 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-31 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-30 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-06 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-30 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-06 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-29 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-06 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-29 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-06 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-29 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-07 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-29 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 8e-06 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-29 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 9e-06 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-29 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-29 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-06 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-29 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-29 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-29 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-06 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-29 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-29 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-06 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-29 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 5e-29 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-29 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 9e-07 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-28 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-28 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-28 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 8e-08 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-28 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 8e-06 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-27 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-06 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-27 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-06 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-27 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-27 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-06 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-27 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-27 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 8e-06 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-27 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-26 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-26 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-26 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-06 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-26 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 8e-06 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-26 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-26 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-26 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-06 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-26 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-26 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-06 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 8e-26 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-25 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-06 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-25 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-25 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-06 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-25 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-06 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-25 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-25 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-06 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 6e-25 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-06 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-24 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 7e-07 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-22 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-22 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-22 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-22 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-22 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 7e-21 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-20 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 7e-20 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 8e-20 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 5e-19 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 8e-19 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-17 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-17 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 8e-17 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-16 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-16 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-16 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-16 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-16 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 6e-16 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 9e-16 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-15 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-15 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-15 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 6e-15 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-14 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-14 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-14 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 5e-14 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 6e-14 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-13 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-13 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-13 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-13 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-13 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 9e-13 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-12 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-12 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-12 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-12 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 3e-12 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-12 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 6e-12 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-11 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-11 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-11 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-11 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-11 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-11 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-11 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-11 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-11 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 5e-11 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-11 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-11 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 6e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-10 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-10 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-10 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-10 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-10 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-10 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 6e-10 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-09 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-09 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-09 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-09 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-09 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-09 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 7e-09 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-08 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-08 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-08 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-08 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-08 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-08 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-08 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-08 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 6e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-08 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-08 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 8e-08 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-07 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-07 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-07 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-07 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-06 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-06 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-06 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-06 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-06 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 5e-06 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 5e-06 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-06 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 9e-06 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-05 | |
| 3lvg_D | 190 | LCB, clathrin light chain B; SELF assembly, coated | 2e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-05 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-04 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-04 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 6e-04 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-04 |
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 423 bits (1089), Expect = e-137
Identities = 116/343 (33%), Positives = 181/343 (52%), Gaps = 20/343 (5%)
Query: 848 KNRTGF-EEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK 906
N G+ ++ ++ V + +A RY V + +G +F + ++A+D V +K+++N K
Sbjct: 75 PNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK 134
Query: 907 DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRE 966
F Q+ +EI++L+++ K D + +++ + + F +R H+ + ELL NLYE K N+
Sbjct: 135 RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF 194
Query: 967 SGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026
G F++P ++ L+ L LH +IHCDLKPENIL+K R +KVID GSSC
Sbjct: 195 QG----FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250
Query: 1027 FETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLAR 1086
+E + +Y+QSR YRAPEVILG Y ID+WSLGCILAEL TG L + LA
Sbjct: 251 YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
Query: 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHML-YERNQETNRLEYLIPKKTSLRHRL------ 1139
+I ++G Q +L + + + Y + ++ S R +L
Sbjct: 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370
Query: 1140 --------PMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174
D F+DF+ LE +P R + AL+HPWL
Sbjct: 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 419 bits (1078), Expect = e-136
Identities = 112/362 (30%), Positives = 180/362 (49%), Gaps = 31/362 (8%)
Query: 840 FNLKIVHRKNRTGF-----EEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTG 894
F H+K R + +++ ++ V RY + +G +F + ++A+D
Sbjct: 20 FQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQ 79
Query: 895 MDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLK 954
V +KIIKN K F +Q+ E++LL+ +NKHD KY+++ L +F +R HL +V E+L
Sbjct: 80 EWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS 139
Query: 955 ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG--LGLIHCDLKPENILVKSY 1012
NLY+ + G ++ + Q AL FL L +IHCDLKPENIL+ +
Sbjct: 140 YNLYDLLRNTNFRG----VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195
Query: 1013 SRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGN 1072
R +K++D GSSC + Y+QSR YR+PEV+LG+ YD ID+WSLGCIL E+ TG
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
Query: 1073 VLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTK--NHMLYERNQETNRLEYLIP 1130
LF + + +++ ++G +L + K+F K + + + + EY P
Sbjct: 256 PLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315
Query: 1131 KKTSLRHRLPMGDQG------------------FIDFVAHLLEINPKKRPSASDALKHPW 1172
L + L + G F D + +L+ +PK R AL+H +
Sbjct: 316 GTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSF 375
Query: 1173 LS 1174
Sbjct: 376 FK 377
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 412 bits (1060), Expect = e-134
Identities = 103/346 (29%), Positives = 173/346 (50%), Gaps = 30/346 (8%)
Query: 858 NFH--VVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTG-MDVCVKIIKNNKDFFDQSLD 914
+ H V++ RY + + LG AF K ++ D G V VKI+KN + + +
Sbjct: 1 SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS 60
Query: 915 EIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFT 974
EI++L+++N DP + +++ ++F + H+ IV ELL + Y+F K N F
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP----FR 116
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV-----------------KSYSRCEV 1017
+ ++ + Q +++ FLH L H DLKPENIL ++ ++
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN 1077
KV+D GS+ ++ +H + V +R YRAPEVIL L + + D+WS+GCIL E G +F
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRH 1137
LA + I+GP+ + M+ K R KYF + + ++ + R Y+ L+
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKR-KYFHHDRLDWDEHSSAGR--YVSRACKPLKE 293
Query: 1138 RLPMGD---QGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180
+ D + D + +LE +P KR + +ALKHP+ + I
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 409 bits (1054), Expect = e-133
Identities = 98/354 (27%), Positives = 168/354 (47%), Gaps = 32/354 (9%)
Query: 847 RKNRTGFEEDKNFH--VVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN 904
R+N +D+ H ++ + V +G F + + + VK+++N
Sbjct: 11 RENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN 70
Query: 905 NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFN 964
K + + E +LK + D + ++++ + F Y +H+ ++ E L +LYE N
Sbjct: 71 IKKYTRSAKIEADILKKIQNDDI-NNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRN 129
Query: 965 RESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS------------- 1011
+G F + ++ I+ L+AL +L + L H DLKPENIL+
Sbjct: 130 NYNG----FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185
Query: 1012 ----------YSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSL 1061
+K+ID G + F++D+ S + +R YRAPEVIL L +D D+WS
Sbjct: 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSF 245
Query: 1062 GCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG--RDTYKYFTKNHMLYERN 1119
GC+LAEL TG++LF+ LA + II PI + ML + + KY K+ +
Sbjct: 246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWP 305
Query: 1120 QETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
+ + + + K L + + F DF+ +L+I+P RPS ++ LKH +L
Sbjct: 306 ENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 400 bits (1030), Expect = e-130
Identities = 106/349 (30%), Positives = 165/349 (47%), Gaps = 30/349 (8%)
Query: 854 EEDKNFH--VVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTG-MDVCVKIIKNNKDFFD 910
E+DK H + + RY + LG F K ++ D G V +KII+N + +
Sbjct: 2 EDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE 61
Query: 911 QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE 970
+ EI +LK + + D +K+ + + D+F + H+ I ELL N +EF K N
Sbjct: 62 AARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP-- 119
Query: 971 VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV-----------------KSYS 1013
+ +P ++ + Q AL+FLH L H DLKPENIL KS
Sbjct: 120 --YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 1014 RCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNV 1073
++V D GS+ F+ +H + V +R YR PEVIL L + + D+WS+GCIL E G
Sbjct: 178 NTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
Query: 1074 LFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT 1133
LFQ L + I+GPI M+ + R KYF K ++++ N R Y+
Sbjct: 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQ-KYFYKGGLVWDENSSDGR--YVKENCK 294
Query: 1134 SLRHRLPMG---DQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
L+ + D + +LE +P +R + ++AL HP+ +
Sbjct: 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 372 bits (958), Expect = e-119
Identities = 97/330 (29%), Positives = 168/330 (50%), Gaps = 28/330 (8%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD 926
RY + LG FS A D+ V +KI++ +K + + + DEIKLL+ VN D
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 927 PGDK-----YHLLRLYDYFYYR----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPR 977
+ H+L+L D+F ++ H+++V E+L NL K G +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG----IPLIY 132
Query: 978 LQSITIQCLEALQFLH-GLGLIHCDLKPENILVKSYSRCE----VKVIDLGSSCFETDHL 1032
++ I+ Q L L ++H G+IH D+KPEN+L++ E +K+ DLG++C+ +H
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 1033 CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL------LAR 1086
+ +Q+R YR+PEV+LG + DIWS C++ EL TG+ LF+ D + +A+
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 1087 VIGIIGPIEQGMLAKGRDTYKYFTKN-HMLYERNQETNRLEYLIPKKTSLRHRLPMGDQG 1145
+I ++G + +L G+ T +F + + LE ++ +K +
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF---SKDEAKE 309
Query: 1146 FIDFVAHLLEINPKKRPSASDALKHPWLSH 1175
DF++ +L+++P+KR A + HPWL
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-70
Identities = 102/379 (26%), Positives = 181/379 (47%), Gaps = 71/379 (18%)
Query: 859 FHVV-LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIK 917
+H+V + + GRYHV LG FS + D+ V +K++K+ + + + +LDEI+
Sbjct: 26 YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIR 85
Query: 918 LLKYVNKHDPGD--KYHLLRLYDYFYYR----EHLLIVCELLKANLYEFHKFNRESGGEV 971
LLK V DP D + +++L D F H+ +V E+L +L ++ + G
Sbjct: 86 LLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG--- 142
Query: 972 YFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILV--------------------- 1009
+P ++ I Q L+ L +LH +IH D+KPENIL+
Sbjct: 143 -LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201
Query: 1010 --------------------------KSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRA 1043
K+ + +VK+ DLG++C+ H +Q+R YR+
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRS 261
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQ------NDSPATLLARVIGIIGPIEQG 1097
EV++G Y+ DIWS C+ EL TG+ LF+ +A +I ++G + +
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321
Query: 1098 MLAKGRDTYKYFTKN-HMLYERNQETNRLEYLIPKKTSLRHRLPMGD-QGFIDFVAHLLE 1155
++ G+ + ++FTK + + + L ++ +K + + GF DF+ +LE
Sbjct: 322 LIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEK----YEWSQEEAAGFTDFLLPMLE 377
Query: 1156 INPKKRPSASDALKHPWLS 1174
+ P+KR +A++ L+HPWL+
Sbjct: 378 LIPEKRATAAECLRHPWLN 396
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-54
Identities = 77/355 (21%), Positives = 133/355 (37%), Gaps = 60/355 (16%)
Query: 849 NRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVK-IIKNNKD 907
N GF+ + RY + LG A D V +K I+ +
Sbjct: 3 NIHGFD------------LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ 50
Query: 908 FFDQSLDEIKLLKYVNKHD----------PGDKYHLLRLYDYFYYREHLLIVCELLKANL 957
+L EIK+++ ++ HD P + + IV E ++ +L
Sbjct: 51 SVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNS-VYIVQEYMETDL 108
Query: 958 YEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017
+ + Q L L+++H ++H DLKP N+ + + +
Sbjct: 109 ANVLEQGP-------LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT-EDLVL 160
Query: 1018 KVIDLG------SSCFETDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCT 1070
K+ D G HL + ++ YR+P ++L + Y K ID+W+ GCI AE+ T
Sbjct: 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 1071 GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIP 1130
G LF + ++ I + + + + +N M
Sbjct: 221 GKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTE-------------- 266
Query: 1131 KKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY-----EPI 1180
L LP + +DF+ +L +P R +A +AL HP++S Y EPI
Sbjct: 267 PHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS-IYSFPMDEPI 320
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 4e-54
Identities = 97/346 (28%), Positives = 157/346 (45%), Gaps = 43/346 (12%)
Query: 854 EEDKNFH--VVLNSV--IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFF 909
+ D NF+ + +S + RY + +GS A A+D +V +K + F
Sbjct: 6 KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---PF 62
Query: 910 DQSLD------EIKLLKYVNKHDPGDKYHLLRLYDYFY------YREHLLIVCELLKANL 957
E+ L+K VN H +++ L + F + + IV EL+ ANL
Sbjct: 63 QNQTHAKRAYRELVLMKCVN-HK-----NIIGLLNVFTPQKSLEEFQDVYIVMELMDANL 116
Query: 958 YEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017
+ + R+ + Q L ++ LH G+IH DLKP NI+VKS C +
Sbjct: 117 CQVIQME--------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTL 166
Query: 1018 KVIDLG--SSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLF 1075
K++D G + + + YV +R YRAPEVILG+ Y + +DIWS+GCI+ E+ G VLF
Sbjct: 167 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
Query: 1076 QNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK--KT 1133
+VI +G + K + T + + +N Y E L P
Sbjct: 227 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS----FEKLFPDVLFP 282
Query: 1134 SLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
+ + D ++ +L I+ KR S +AL+HP+++ Y+P
Sbjct: 283 ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 328
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-53
Identities = 94/384 (24%), Positives = 161/384 (41%), Gaps = 57/384 (14%)
Query: 812 GASLEDEEAAAVQEQVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRY 871
G + + + + + +F + + + F + RY
Sbjct: 23 GFDKQVDVSYIAKHYNMSKSKVDNQFYSVEV------GDSTFT------------VLKRY 64
Query: 872 HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYVNKH 925
+ +GS A A+D +V +K + F E+ L+K VN H
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---PFQNQTHAKRAYRELVLMKCVN-H 120
Query: 926 DPGDKYHLLRLYDYFYYR------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQ 979
+++ L + F + + + +V EL+ ANL + + R+
Sbjct: 121 K-----NIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQME-----LDHERMS 167
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG--SSCFETDHLCSYVQ 1037
+ Q L ++ LH G+IH DLKP NI+VKS C +K++D G + + + YV
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVV 225
Query: 1038 SRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
+R YRAPEVILG+ Y + +DIWS+GCI+ E+ +LF +VI +G
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285
Query: 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLE 1155
+ K + T + + +N Y L P + + D ++ +L
Sbjct: 286 FMKKLQPTVRNYVENRPKYAGLT----FPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341
Query: 1156 INPKKRPSASDALKHPWLSHPYEP 1179
I+P KR S DAL+HP+++ Y+P
Sbjct: 342 IDPAKRISVDDALQHPYINVWYDP 365
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-53
Identities = 89/371 (23%), Positives = 157/371 (42%), Gaps = 64/371 (17%)
Query: 823 VQEQVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAF 882
+ + F L N+T +E + RY +GS A+
Sbjct: 1 MAHHHHHHSQERPTFYRQEL------NKTIWE------------VPERYQNLSPVGSGAY 42
Query: 883 SKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYVNKHDPGDKYHLLRL 936
A D TG+ V VK + F + E++LLK++ H+ +++ L
Sbjct: 43 GSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLLKHMK-HE-----NVIGL 93
Query: 937 YDYFYYREHLL------IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQ 990
D F L +V L+ A+L K + T +Q + Q L L+
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIYQILRGLK 146
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL 1050
++H +IH DLKP N+ V CE+K++D G + D + YV +R YRAPE++L
Sbjct: 147 YIHSADIIHRDLKPSNLAVNE--DCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNW 204
Query: 1051 S-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGMLAKGRDTYKY 1108
Y++ +DIWS+GCI+AEL TG LF L ++ ++G P + + ++ +
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 1109 FTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168
+ ++ K + + + +D + +L ++ KR +A+ AL
Sbjct: 265 YIQSLTQM--------------PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 1169 KHPWLSHPYEP 1179
H + + ++P
Sbjct: 311 AHAYFAQYHDP 321
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-53
Identities = 81/324 (25%), Positives = 146/324 (45%), Gaps = 41/324 (12%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN---NKDFFDQSLDEIKLLKYVN 923
+ Y ++GS A+ A D +G V +K + ++ F ++ E+ LLK++
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 924 KHDPGDKYHLLRLYDYFYYREHLL------IVCELLKANLYEFHKFNRESGGEVYFTMPR 977
H+ +++ L D F L +V ++ +L + F+ +
Sbjct: 82 -HE-----NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--------FSEEK 127
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQ 1037
+Q + Q L+ L+++H G++H DLKP N+ V CE+K++D G + + YV
Sbjct: 128 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCELKILDFGLARHADAEMTGYVV 185
Query: 1038 SRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIE 1095
+R YRAPEVIL Y++ +DIWS+GCI+AE+ TG LF+ L +++ + G P
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
+ + K + ++ + P D + +LE
Sbjct: 246 EFVQKLNDKAAKSYIQSLPQT--------------PRKDFTQLFPRASPQAADLLEKMLE 291
Query: 1156 INPKKRPSASDALKHPWLSHPYEP 1179
++ KR +A+ AL HP+ +P
Sbjct: 292 LDVDKRLTAAQALTHPFFEPFRDP 315
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 8e-52
Identities = 84/332 (25%), Positives = 138/332 (41%), Gaps = 52/332 (15%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLK 920
+ RY Y+G A+ A+D + V +K I F+ EIK+L
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILL 80
Query: 921 YVNKHDPGDKYHLLRLYDYFYYR-----EHLLIVCELLKANLYEFHKFNRESGGEVYFTM 975
H+ +++ + D + + IV +L++ +LY+ K +
Sbjct: 81 RFR-HE-----NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------LSN 127
Query: 976 PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG------SSCFET 1029
+ Q L L+++H ++H DLKP N+L+ + C++K+ D G T
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDHT 185
Query: 1030 DHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
L YV +R YRAPE++L Y K IDIWS+GCILAE+ + +F L ++
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245
Query: 1089 GIIG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFI 1147
GI+G P ++ + + + + K P D +
Sbjct: 246 GILGSPSQEDLNCIINLKARNYLLSLPHK--------------NKVPWNRLFPNADSKAL 291
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
D + +L NP KR AL HP+L Y+P
Sbjct: 292 DLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 9e-52
Identities = 84/324 (25%), Positives = 147/324 (45%), Gaps = 40/324 (12%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN---NKDFFDQSLDEIKLLKYVN 923
+ Y + +GS A+ A D TG V +K + ++ F ++ E++LLK++
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 924 KHDPGDKYHLLRLYDYFYYREHLL------IVCELLKANLYEFHKFNRESGGEVYFTMPR 977
H+ +++ L D F E L +V + +L + K + R
Sbjct: 83 -HE-----NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-------LGEDR 129
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQ 1037
+Q + Q L+ L+++H G+IH DLKP N+ V CE+K++D G + + YV
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCELKILDFGLARQADSEMTGYVV 187
Query: 1038 SRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIE 1095
+R YRAPEVIL Y + +DIWS+GCI+AE+ TG LF+ L ++ + G P
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
+ + D K + K +K L ++ + +L
Sbjct: 248 EFVQRLQSDEAKNYMKGLPEL--------------EKKDFASILTNASPLAVNLLEKMLV 293
Query: 1156 INPKKRPSASDALKHPWLSHPYEP 1179
++ ++R +A +AL HP+ ++
Sbjct: 294 LDAEQRVTAGEALAHPYFESLHDT 317
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-51
Identities = 79/324 (24%), Positives = 142/324 (43%), Gaps = 37/324 (11%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
R+ V G F + TGM V +K + + F ++ L ++ L ++ H
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH-HP--- 79
Query: 930 KYHLLRLYDYFY------YRE-HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRL--QS 980
++++L YFY R+ +L +V E + L+ + P + +
Sbjct: 80 --NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV----APPPILIKV 133
Query: 981 ITIQCLEALQFLH--GLGLIHCDLKPENILVKSYSRCEVKVIDLGS--SCFETDHLCSYV 1036
Q + ++ LH + + H D+KP N+LV + + +K+ D GS ++ +Y+
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV-NEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 1037 QSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095
SR YRAPE+I G Y +DIWS+GCI AE+ G +F+ D+ A L ++ ++G
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
+ +L K ++ LY IP + D ++ LL+
Sbjct: 253 REVLRKLNPSHTDV----DLYNSKG--------IPWSNVFSDHSLKDAKEAYDLLSALLQ 300
Query: 1156 INPKKRPSASDALKHPWLSHPYEP 1179
P++R +AL HP+ ++P
Sbjct: 301 YLPEERMKPYEALCHPYFDELHDP 324
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 7e-51
Identities = 79/323 (24%), Positives = 137/323 (42%), Gaps = 44/323 (13%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
Y T+ +G+ +F QA +G V +K + +K F E+++++ ++ H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLD-HC--- 107
Query: 930 KYHLLRLYDYFYYRE------HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
+++RL +FY +L +V + + +Y + + + ++
Sbjct: 108 --NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMY 163
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS--SCFETDHLCSYVQSRSY 1041
Q +L ++H G+ H D+KP+N+L+ + +K+ D GS + SY+ SR Y
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLVRGEPNVSYICSRYY 222
Query: 1042 RAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGML 1099
RAPE+I G + Y ID+WS GC+LAEL G +F DS L +I ++G P + +
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI- 281
Query: 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIP--KKTSLRHRL-PMGDQGFIDFVAHLLEI 1156
R N E+ P K P I + LLE
Sbjct: 282 ------------------REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 323
Query: 1157 NPKKRPSASDALKHPWLSHPYEP 1179
P R + +A H + +P
Sbjct: 324 TPTARLTPLEACAHSFFDELRDP 346
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-50
Identities = 75/334 (22%), Positives = 138/334 (41%), Gaps = 48/334 (14%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF------FDQSLD------ 914
+ Y V ++ S ++ D G+ V +K + N S
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 915 EIKLLKYVNKHDPGDKYHLLRLYDYFYYR-----EHLLIVCELLKANLYEFHKFNRESGG 969
EI+LL + + H ++L L D F + L +V EL++ +L + R
Sbjct: 79 EIRLLNHFH-HP-----NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV-- 130
Query: 970 EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG--SSCF 1027
+ +Q L L LH G++H DL P NIL+ ++ + D
Sbjct: 131 ---ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD--NNDITICDFNLAREDT 185
Query: 1028 ETDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLAR 1086
+ YV R YRAPE+++ + K +D+WS GC++AE+ LF+ + L +
Sbjct: 186 ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245
Query: 1087 VIGIIG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQG 1145
++ ++G P + ++ + + + +N + + +P D
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSN-------------VPARAWTAVVPTADPV 292
Query: 1146 FIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
+D +A +LE NP++R S AL+HP+ ++P
Sbjct: 293 ALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-50
Identities = 88/340 (25%), Positives = 144/340 (42%), Gaps = 60/340 (17%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLK 920
I+ + + LG A+ A TG V +K I+ FD+ L EIK+LK
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKILK 64
Query: 921 YVNKHDPGDKYHLLRLYDYFY------YREHLLIVCELLKANLYEFHKFNRESGGEVYFT 974
+ H+ +++ +++ + E + I+ EL++ +L+ +
Sbjct: 65 HFK-HE-----NIITIFNIQRPDSFENFNE-VYIIQELMQTDLHRVISTQM-------LS 110
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG----------- 1023
+Q Q L A++ LHG +IH DLKP N+L+ S C++KV D G
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS--NCDLKVCDFGLARIIDESAAD 168
Query: 1024 --SSCFETDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSP 1080
+ + +V +R YRAPEV+L + Y + +D+WS GCILAEL +F
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 1081 ATLLARVIGIIG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRL 1139
L + GIIG P L + ++ L
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPR---AREYIKSLPMY----------PAAPLEKMF 275
Query: 1140 PMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
P + ID + +L +P KR +A +AL+HP+L ++P
Sbjct: 276 PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-49
Identities = 96/349 (27%), Positives = 158/349 (45%), Gaps = 53/349 (15%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLK 920
+ +Y + + LG A+ ++ D TG V VK I + F S D EI +L
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILT 63
Query: 921 YVNKHDPGDKYHLLRLYDYFYYR--EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRL 978
++ H+ +++ L + + +V + ++ +L+ + N
Sbjct: 64 ELSGHE-----NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI-------LEPVHK 111
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG--------------- 1023
Q + Q ++ +++LH GL+H D+KP NIL+ + C VKV D G
Sbjct: 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA--ECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 1024 ---------SSCFETDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNV 1073
+ + L YV +R YRAPE++LG + Y K ID+WSLGCIL E+ G
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
Query: 1074 LFQNDSPATLLARVIGIIG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK 1132
+F S L R+IG+I P + + + K ++ +++N+ + K
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWK 289
Query: 1133 TSLRHRLPMGDQGF--IDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
L P D +D + LL+ NP KR SA+DALKHP++S + P
Sbjct: 290 NLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP 338
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-48
Identities = 87/369 (23%), Positives = 153/369 (41%), Gaps = 57/369 (15%)
Query: 824 QEQVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFS 883
+ +K + +K++ +TG + + Y + +G+ +F
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREI------------AYTNCKVIGNGSFG 54
Query: 884 KAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943
QA + + V +K + +K F E+++++ V H +++ L +FY
Sbjct: 55 VVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVK-HP-----NVVDLKAFFYSN 104
Query: 944 EH------LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGL 997
L +V E + +Y + + M ++ Q L +L ++H +G+
Sbjct: 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQT--MPMLLIKLYMYQLLRSLAYIHSIGI 162
Query: 998 IHCDLKPENILVKSYSRCEVKVIDLGS--SCFETDHLCSYVQSRSYRAPEVILGLS-YDK 1054
H D+KP+N+L+ S +K+ID GS + SY+ SR YRAPE+I G + Y
Sbjct: 163 CHRDIKPQNLLLDPPS-GVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTT 221
Query: 1055 KIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGMLAKGRDTYKYFTKNH 1113
IDIWS GC++AEL G LF +S L +I ++G P + +
Sbjct: 222 NIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI--------------- 266
Query: 1114 MLYERNQETNRLEYLIP--KKTSLRHRL-PMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170
+ N +E+ P + P ID ++ LLE P R +A +AL H
Sbjct: 267 ----KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322
Query: 1171 PWLSHPYEP 1179
P+
Sbjct: 323 PFFDELRTG 331
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 1e-47
Identities = 74/318 (23%), Positives = 131/318 (41%), Gaps = 35/318 (11%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---FFDQSLDEIKLLKYVNKHD 926
+Y +G ++ + + TG V +K ++D +L EI++LK + KH
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHP 62
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+L+ L + F + L +V E + + ++SIT Q L
Sbjct: 63 -----NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG-----VPEHLVKSITWQTL 112
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---SSCFETDHLCSYVQSRSYRA 1043
+A+ F H IH D+KPENIL+ +K+ D G +D+ V +R YR+
Sbjct: 113 QAVNFCHKHNCIHRDVKPENILITK--HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRS 170
Query: 1044 PEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGMLAK 1101
PE+++G Y +D+W++GC+ AEL +G L+ S L + +G I + +
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ--Q 228
Query: 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161
T +YF + L + P + + L ++P +R
Sbjct: 229 VFSTNQYF----------SGVKIPDP--EDMEPLELKFPNISYPALGLLKGCLHMDPTER 276
Query: 1162 PSASDALKHPWLSHPYEP 1179
+ L HP+ + E
Sbjct: 277 LTCEQLLHHPYFENIREI 294
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-47
Identities = 84/359 (23%), Positives = 143/359 (39%), Gaps = 76/359 (21%)
Query: 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKH 925
+ +Y + + LG+ +F + D+ +G +K + + + E+ ++K ++ H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLD-H 59
Query: 926 DPGDKYHLLRLYDYFYYREH--------------------------------------LL 947
++++L DYFY L
Sbjct: 60 V-----NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007
++ E + L++ K SG M + Q A+ F+H LG+ H D+KP+N+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRS--IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 1008 LVKSYSRCEVKVIDLGS--SCFETDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCI 1064
LV S +K+ D GS ++ +Y+ SR YRAPE++LG + Y ID+WS+GC+
Sbjct: 173 LVNS-KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 1065 LAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETN 1123
EL G LF ++ L R+I I+G P ++ M +
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM-------------------IRMNPH 272
Query: 1124 RLEYLIP--KKTSLRHRLP-MGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
E P K R LP ID + +L P R + +A+ HP+ H
Sbjct: 273 YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNS 331
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-46
Identities = 67/314 (21%), Positives = 129/314 (41%), Gaps = 35/314 (11%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
Y + LG +S+ +A ++ V VKI+K K + EIK+L+ +
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGP--- 91
Query: 930 KYHLLRLYDYFYYREH---LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+++ L D L+ + N +F + + T ++ + L
Sbjct: 92 --NIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQT------LTDYDIRFYMYEIL 140
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG--SSCFETDHLCSYVQSRSYRAP 1044
+AL + H +G++H D+KP N+++ ++++ID G V SR ++ P
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 1045 EVILGLS-YDKKIDIWSLGCILAELCTG-NVLFQNDSPATLLARVIGIIG-PIEQGMLAK 1101
E+++ YD +D+WSLGC+LA + F L R+ ++G + K
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259
Query: 1102 -GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160
+ F + R R E + + + +DF+ LL + +
Sbjct: 260 YNIELDPRFNDILGRHSR----KRWERFVHSENQ-----HLVSPEALDFLDKLLRYDHQS 310
Query: 1161 RPSASDALKHPWLS 1174
R +A +A++HP+
Sbjct: 311 RLTAREAMEHPYFY 324
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-45
Identities = 79/338 (23%), Positives = 137/338 (40%), Gaps = 47/338 (13%)
Query: 846 HRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN 905
H E+ F + +Y +G ++ ++ + TG V +K +
Sbjct: 8 HSSGVDLGTENLYFQSM------EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES 61
Query: 906 KD---FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHK 962
D ++ EIKLLK + +H+ +L+ L + ++ +V E + + + +
Sbjct: 62 DDDKMVKKIAMREIKLLKQL-RHE-----NLVNLLEVCKKKKRWYLVFEFVDHTILDDLE 115
Query: 963 FNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022
+Q Q + + F H +IH D+KPENILV VK+ D
Sbjct: 116 LFPNG-----LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ--SGVVKLCDF 168
Query: 1023 G---SSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQND 1078
G + + V +R YRAPE+++G + Y K +D+W++GC++ E+ G LF D
Sbjct: 169 GFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228
Query: 1079 SPATLLARVIGIIG-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK---KTS 1134
S L ++ +G I + F KN +P+ +
Sbjct: 229 SDIDQLYHIMMCLGNLIP--------RHQELFNKNP---------VFAGVRLPEIKEREP 271
Query: 1135 LRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172
L R P + ID L I+P KRP ++ L H +
Sbjct: 272 LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 3e-44
Identities = 61/317 (19%), Positives = 108/317 (34%), Gaps = 67/317 (21%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
+ + LG A + + DV VK I + F + E++LL+ ++H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRI--LPECFSFADREVQLLRESDEHP--- 78
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
+++R + R+ I EL A L + ++ Q L
Sbjct: 79 --NVIRYFCTEKDRQFQYIAIELCAATL-----QEYVEQKDFAHLGLEPITLLQQTTSGL 131
Query: 990 QFLHGLGLIHCDLKPENILVKS---YSRCEVKVIDLGSSCFETDHLCSYVQ------SRS 1040
LH L ++H DLKP NIL+ + + + + D G S+ + +
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 1041 YRAPEVILGLS---YDKKIDIWSLGCILAE-LCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096
+ APE++ +DI+S GC+ + G+ F
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL---------- 241
Query: 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156
L+ L P+K D + + ++ +
Sbjct: 242 -----------------------LGACSLDCLHPEKHE--------DVIARELIEKMIAM 270
Query: 1157 NPKKRPSASDALKHPWL 1173
+P+KRPSA LKHP+
Sbjct: 271 DPQKRPSAKHVLKHPFF 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-44
Identities = 80/359 (22%), Positives = 132/359 (36%), Gaps = 81/359 (22%)
Query: 846 HRKNRTGFE-EDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN 904
H + +G + +N + SV Y + + +GS SK Q + +K +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV-- 60
Query: 905 NKDFFDQS-----LDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYE 959
N + D +EI L + +H ++RLYDY +++ +V E +L
Sbjct: 61 NLEEADNQTLDSYRNEIAYLNKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNS 116
Query: 960 F-HKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018
+ K +S LEA+ +H G++H DLKP N L+ +K
Sbjct: 117 WLKKKKS-------IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---VDGMLK 166
Query: 1019 VIDLG-SSCFETD----HLCSYVQSRSYRAPEVILGLS-----------YDKKIDIWSLG 1062
+ID G ++ + D S V + +Y PE I +S K D+WSLG
Sbjct: 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226
Query: 1063 CILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQET 1122
CIL + G FQ II I + + A +
Sbjct: 227 CILYYMTYGKTPFQ------------QIINQISK-LHAIIDPNH---------------- 257
Query: 1123 NRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPIS 1181
E P + D + L+ +PK+R S + L HP++ P++
Sbjct: 258 ---EIEFPDIPE---------KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-43
Identities = 95/388 (24%), Positives = 146/388 (37%), Gaps = 93/388 (23%)
Query: 853 FEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQS 912
F+ KN HV Y + +G ++ A+D +T +V +K + F+
Sbjct: 16 FQGIKNVHV------PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDL 66
Query: 913 LD------EIKLLKYVNKHDPGDKYHLLRLYDYFYYR-----EHLLIVCELLKANLYEFH 961
+D EI +L + D +++RLYD + L IV E+ ++L
Sbjct: 67 IDCKRILREITILNRLK-SD-----YIIRLYDLIIPDDLLKFDELYIVLEIADSDL---K 117
Query: 962 KFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021
K + ++ T +++I L F+H G+IH DLKP N L+ C VKV D
Sbjct: 118 KLFKTP---IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN--QDCSVKVCD 172
Query: 1022 LG-------------------------SSCFETDHLCSYVQSRSYRAPEVILGLS-YDKK 1055
G + L S+V +R YRAPE+IL Y K
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232
Query: 1056 IDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHML 1115
IDIWS GCI AEL ND P+ G + K H
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTNR---------FPLFPGSSCFPLSPDRNSKKVHEK 283
Query: 1116 YERNQ--------------------ETNRLEYL----IPKKTSLRHRLPMGDQGFIDFVA 1151
R+Q + ++Y+ K +L+ + P I+ +
Sbjct: 284 SNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343
Query: 1152 HLLEINPKKRPSASDALKHPWLSHPYEP 1179
+L+ NP KR + AL HP+L +
Sbjct: 344 SMLKFNPNKRITIDQALDHPYLKDVRKK 371
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-42
Identities = 50/401 (12%), Positives = 111/401 (27%), Gaps = 68/401 (16%)
Query: 810 DPGASLEDEEAAAVQEQVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVV-LNSVIA 868
+ G S + +E + EE +V T + ++ V L S
Sbjct: 5 EAGDSFMRDLLKREEELIGY---CREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGE 61
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII----KNNKDFFDQSLDEIKLLKYVNK 924
+ + E L S D+ D +K+ +N++ ++ + +
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 925 HDPGDKYHLLRLYDYF--------------------YYREHLLIVCELLKANLYE-FHKF 963
P + RL Y + L++ +L F
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 964 NRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023
+ + L +T Q + L GL+H P+N+ + + + D+
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM--PDGRLMLGDVS 239
Query: 1024 SSCFETDHLCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLFQNDSPA 1081
+ + +Y E + ++ ++ W LG + + + F +P
Sbjct: 240 ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 1082 TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPM 1141
+ + + L + P+
Sbjct: 300 I----------------------------------KGSWKRPSLRVPGTDSLAFGSCTPL 325
Query: 1142 GDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
D + L + ++R +A++ P IS+
Sbjct: 326 PD-FVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISS 365
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 62/313 (19%), Positives = 95/313 (30%), Gaps = 65/313 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKH 925
+ LG ++ + + G VK KD + L E+ + V +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQH 116
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+RL + L + EL +L + + G ++
Sbjct: 117 P-----CCVRLEQAWEEGGILYLQTELCGPSLQQHCE---AWGA--SLPEAQVWGYLRDT 166
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF--ETDHLCSYVQSRSYRA 1043
L AL LH GL+H D+KP NI + R K+ D G Y A
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAGEVQEGDPRYMA 224
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103
PE++ G SY D++SLG + E+ L L + G + P
Sbjct: 225 PELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ--GYLPP---------- 271
Query: 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163
S + +LE +PK R +
Sbjct: 272 ------------------------EFTAGLS---------SELRSVLVMMLEPDPKLRAT 298
Query: 1164 ASDALKHPWLSHP 1176
A L P L P
Sbjct: 299 AEALLALPVLRQP 311
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-41
Identities = 70/336 (20%), Positives = 113/336 (33%), Gaps = 78/336 (23%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD 926
+ + LG + + G V VK + DF D +L EIKLL + H
Sbjct: 13 LKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRM--LIDFCDIALMEIKLLTESDDH- 68
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEF---HKFNRESGGEVYFTMPRLQSITI 983
P +++R Y L I EL NL + + E+ S+
Sbjct: 69 P----NVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLR 122
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKS-----------YSRCEVKVIDLGSSCFETDHL 1032
Q + LH L +IH DLKP+NILV + + + D G
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 1033 CSYVQSRS-------YRAPEVILGLS-------YDKKIDIWSLGCILAE-LCTGNVLFQN 1077
S+ + + +RAPE++ + + IDI+S+GC+ L G F +
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRH 1137
Y R R + + + L
Sbjct: 243 K-------------------------------------YSRESNIIRGIFSLDEMKCLHD 265
Query: 1138 RLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
D ++ +++ +P KRP+A L+HP
Sbjct: 266 --RSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 62/332 (18%), Positives = 110/332 (33%), Gaps = 73/332 (21%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII-KNNKDFFDQSLDEIKLLKYVNKHDPG 928
Y + LG FS LH G +K I + + +++ E + + N H
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN-HP-- 86
Query: 929 DKYHLLRLYDYFYYRE----HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITI 983
++LRL Y ++ K L+ + ++ G + T ++ + +
Sbjct: 87 ---NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLLL 141
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSR---- 1039
L+ +H G H DLKP NIL+ + ++DLGS H+ Q+
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILL--GDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 1040 --------SYRAPEVILGLSY---DKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
SYRAPE+ S+ D++ D+WSLGC+L + G + +
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
Query: 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFID 1148
+ + IP+
Sbjct: 260 -VQN---------------------------------QLSIPQSPRH-------SSALWQ 278
Query: 1149 FVAHLLEINPKKRPSASDALKHPW-LSHPYEP 1179
+ ++ ++P +RP L L P
Sbjct: 279 LLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-41
Identities = 75/334 (22%), Positives = 122/334 (36%), Gaps = 80/334 (23%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQS-----LDEIKLLKYVNK 924
Y + + +GS SK Q + +K + N + D +EI L + +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEF-HKFNRESGGEVYFTMPRLQSITI 983
H ++RLYDY +++ +V E +L + K +S
Sbjct: 67 HSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS-------IDPWERKSYWK 115
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETD----HLCSYVQS 1038
LEA+ +H G++H DLKP N L+ +K+ID G ++ + D S V +
Sbjct: 116 NMLEAVHTIHQHGIVHSDLKPANFLI---VDGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 1039 RSYRAPEVILGLS-----------YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
+Y PE I +S K D+WSLGCIL + G FQ
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ----------- 221
Query: 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFI 1147
II I + + A + E P +
Sbjct: 222 -QIINQISK-LHAIIDPNH-------------------EIEFPDIPE---------KDLQ 251
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSHPYEPIS 1181
D + L+ +PK+R S + L HP++ P++
Sbjct: 252 DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 62/312 (19%), Positives = 119/312 (38%), Gaps = 64/312 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII---KNNKDFFDQSLDEIKLLKYVNKHD 926
+Y + +G +F KAI G +K I + + ++S E+ +L + H
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HP 83
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
++++ + F L IV + + +L++ + F ++ +Q
Sbjct: 84 -----NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV----LFQEDQILDWFVQI 134
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRSYR 1042
AL+ +H ++H D+K +NI + V++ D G + + + + + Y
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPYYL 192
Query: 1043 APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI-GIIGPIEQGMLAK 1101
+PE+ Y+ K DIW+LGC+L ELCT F+ S L+ ++I G P
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-------- 244
Query: 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161
+ S V+ L + NP+ R
Sbjct: 245 ---------------------------VSLHYS---------YDLRSLVSQLFKRNPRDR 268
Query: 1162 PSASDALKHPWL 1173
PS + L+ ++
Sbjct: 269 PSVNSILEKGFI 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 63/333 (18%), Positives = 112/333 (33%), Gaps = 76/333 (22%)
Query: 863 LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLL 919
+ S +H E +GS F + G +K K +L E+
Sbjct: 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 920 KYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRL 978
+ +H H++R + + +H+LI E +L + N YF L
Sbjct: 65 AVLGQHS-----HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS--YFKEAEL 117
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILV-----------------KSYSRCEVKVID 1021
+ + +Q L+++H + L+H D+KP NI + + ++ K+ D
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 1022 LGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080
LG + A EV+ ++ K DI++L + L +N
Sbjct: 178 LGHVT-RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLP 1140
I QG L + IP+ S
Sbjct: 237 ----------WHEIRQGRLPR---------------------------IPQVLS------ 253
Query: 1141 MGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
Q F + + ++ +P++RPSA +KH L
Sbjct: 254 ---QEFTELLKVMIHPDPERRPSAMALVKHSVL 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 71/320 (22%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKH 925
Y V +G+ ++ + + G + K + + + E+ LL+ + H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK-H 64
Query: 926 DPGDKYHLLRLYDYFYYRE--HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSIT 982
+++R YD R L IV E + +L + Y + +
Sbjct: 65 P-----NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVM 117
Query: 983 IQCLEALQFLH-----GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCS 1034
Q AL+ H G ++H DLKP N+ + VK+ D G + +T +
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKT 175
Query: 1035 YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI-GIIGP 1093
+V + Y +PE + +SY++K DIWSLGC+L ELC F S L ++ G
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 235
Query: 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153
IP + S + + +
Sbjct: 236 -----------------------------------IPYRYS---------DELNEIITRM 251
Query: 1154 LEINPKKRPSASDALKHPWL 1173
L + RPS + L++P +
Sbjct: 252 LNLKDYHRPSVEEILENPLI 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-41
Identities = 77/339 (22%), Positives = 124/339 (36%), Gaps = 80/339 (23%)
Query: 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQS-----LDEIKLL 919
SV Y + + +GS SK Q + +K + N + D +EI L
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV--NLEEADNQTLDSYRNEIAYL 108
Query: 920 KYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEF-HKFNRESGGEVYFTMPRL 978
+ +H ++RLYDY +++ +V E +L + K
Sbjct: 109 NKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS-------IDPWER 157
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETD----HLC 1033
+S LEA+ +H G++H DLKP N L+ +K+ID G ++ + D
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 1034 SYVQSRSYRAPEVILGLS-----------YDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082
S V + +Y PE I +S K D+WSLGCIL + G FQ
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------ 268
Query: 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMG 1142
II I + + A + E P
Sbjct: 269 ------QIINQISK-LHAIIDPNH-------------------EIEFPDIPE-------- 294
Query: 1143 DQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPIS 1181
+ D + L+ +PK+R S + L HP++ P++
Sbjct: 295 -KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-41
Identities = 68/320 (21%), Positives = 115/320 (35%), Gaps = 64/320 (20%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNK 924
+ + + +G FS+ +A L G+ V +K ++ + + EI LLK +N
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN- 90
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITI 983
H ++++ Y F L IV EL A +L K ++ + +
Sbjct: 91 HP-----NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR--LIPERTVWKYFV 143
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRS 1040
Q AL+ +H ++H D+KP N+ + + VK+ DLG F +T S V +
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPY 201
Query: 1041 YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND--SPATLLARVI-GIIGPIEQG 1097
Y +PE I Y+ K DIWSLGC+L E+ F D + +L ++ P+
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261
Query: 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157
+ V + +
Sbjct: 262 HY-------------------------------------------SEELRQLVNMCINPD 278
Query: 1158 PKKRPSASDALKHPWLSHPY 1177
P+KRP + H
Sbjct: 279 PEKRPDVTYVYDVAKRMHAC 298
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 68/348 (19%), Positives = 119/348 (34%), Gaps = 87/348 (25%)
Query: 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVN 923
+ A + LG AF + ++A + +K I++ ++ L E+ LL +N
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKAN--LY---EFHKFNRESGGE-------- 970
H +++R Y + R + + +K L+ E+ G
Sbjct: 61 -HQ-----YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYC-----ENGTLYDLIHSE 109
Query: 971 -VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS---- 1025
+ + Q LEAL ++H G+IH DLKP NI + VK+ D G +
Sbjct: 110 NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVH 167
Query: 1026 -------------CFETDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTG 1071
+D+L S + + Y A EV+ G Y++KID++SLG I E+
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
Query: 1072 NVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK 1131
+L ++ + P
Sbjct: 228 --FSTGMERVNILKKLRSV-----------------------------------SIEFPP 250
Query: 1132 KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
+ + L++ +P KRP A L WL ++
Sbjct: 251 DFD-----DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 82/318 (25%), Positives = 141/318 (44%), Gaps = 35/318 (11%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFFD-QSLDEIKLLKYVNKHDP 927
Y + LG ++ + T V +K I+ +++ ++ E+ LLK + KH
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHA- 60
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
+++ L+D + + L +V E L +L ++ + G M ++ Q L
Sbjct: 61 ----NIVTLHDIIHTEKSLTLVFEYLDKDL---KQYLDDCGN--IINMHNVKLFLFQLLR 111
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY---VQSRSYRAP 1044
L + H ++H DLKP+N+L+ R E+K+ D G + ++ +Y V + YR P
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169
Query: 1045 EVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGMLAKG 1102
+++LG Y +ID+W +GCI E+ TG LF + L + I+G P E
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE------- 222
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
+T+ N +E Y + +L P D D + LL+ + R
Sbjct: 223 -ETWPGILSN-------EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI 274
Query: 1163 SASDALKHPWLSHPYEPI 1180
SA DA+KHP+ E I
Sbjct: 275 SAEDAMKHPFFLSLGERI 292
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-39
Identities = 91/440 (20%), Positives = 152/440 (34%), Gaps = 106/440 (24%)
Query: 812 GASLEDEEAAAVQEQVRQ-IKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGR 870
G+S E A + + ++E + + + ++ + R
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI------PDR 54
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYVNK 924
Y + +G+ ++ +A+D V +K I F+ +D EI +L +N
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRLN- 110
Query: 925 HDPGDKYHLLRLYDYFYYR-----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQ 979
HD H++++ D + + L +V E+ ++ K R VY T ++
Sbjct: 111 HD-----HVVKVLDIVIPKDVEKFDELYVVLEIADSDF---KKLFRTP---VYLTELHIK 159
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG---------------- 1023
++ L ++++H G++H DLKP N LV C VKV D G
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ--DCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 1024 --------------SSCFETDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAEL 1068
+ L +V +R YRAPE+IL Y + ID+WS+GCI AEL
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
Query: 1069 CTGNV-----------LFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYE 1117
LF S P+ A + L
Sbjct: 278 LNMIKENVAYHADRGPLFPGSSCF-----------PLSPDQKAGNDFKFHTRGNRDQLNV 326
Query: 1118 ----------------RNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPK 1159
++ R + PK T L R P I + +L NP
Sbjct: 327 IFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPN 386
Query: 1160 KRPSASDALKHPWLSHPYEP 1179
KR + ++ L HP+
Sbjct: 387 KRITINECLAHPFFKEVRIA 406
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 86/317 (27%), Positives = 142/317 (44%), Gaps = 44/317 (13%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFD-QSLDEIKLLKYVNKHD 926
+Y E +G + +A + T V +K ++ ++ + +L EI LLK + KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHK 61
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+++RL+D + + L +V E +L ++ ++S Q L
Sbjct: 62 -----NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD-----LDPEIVKSFLFQLL 111
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY---VQSRSYRA 1043
+ L F H ++H DLKP+N+L+ E+K+ + G + + Y V + YR
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 1044 PEVILG-LSYDKKIDIWSLGCILAELCTGNV-LFQNDSPATLLARVIGIIG-PIEQ---G 1097
P+V+ G Y ID+WS GCI AEL LF + L R+ ++G P E+
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157
M K D YK + P TSL + +P + D + +LL+ N
Sbjct: 230 M-TKLPD-YKPYPM-----------------YPATTSLVNVVPKLNATGRDLLQNLLKCN 270
Query: 1158 PKKRPSASDALKHPWLS 1174
P +R SA +AL+HP+ S
Sbjct: 271 PVQRISAEEALQHPYFS 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-39
Identities = 85/320 (26%), Positives = 146/320 (45%), Gaps = 32/320 (10%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFFD-QSLDEIKLLKYVNKHDP 927
++ E LG+ ++ + + TG+ V +K +K ++++ ++ EI L+K + KH+
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHE- 63
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
+++RLYD + L +V E + +L ++ + ++ Q L+
Sbjct: 64 ----NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY---VQSRSYRAP 1044
L F H ++H DLKP+N+L+ R ++K+ D G + + ++ V + YRAP
Sbjct: 120 GLAFCHENKILHRDLKPQNLLIN--KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177
Query: 1045 EVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQ---GML 1099
+V++G +Y IDIWS GCILAE+ TG LF + L + I+G P E +
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV- 236
Query: 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159
+ N L+ H D +DF+ LL++NP
Sbjct: 237 ----TKLPKYNPNIQQRPPRDLRQVLQ---------PHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 1160 KRPSASDALKHPWLSHPYEP 1179
R SA AL HPW + Y
Sbjct: 284 MRLSAKQALHHPWFAEYYHH 303
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-39
Identities = 69/332 (20%), Positives = 122/332 (36%), Gaps = 85/332 (25%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII-KNNKDFFDQSLDEIKLLKYVNKHDPG 928
R V L F+ +A D+ +G + +K + N ++ + E+ +K ++ H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP-- 86
Query: 929 DKYHLLRLYDYFYYREH--------LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQS 980
++++ + L++ EL K L EF K ES G + +
Sbjct: 87 ---NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRG--PLSCDTVLK 140
Query: 981 ITIQCLEALQFLHGLG--LIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQS 1038
I Q A+Q +H +IH DLK EN+L+ ++ +K+ D GS+ + + +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 1039 R---------------SYRAPEVI---LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080
+ YR PE+I +K DIW+LGCIL LC F++ +
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258
Query: 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLP 1140
L I G +Y IP
Sbjct: 259 ---LR--------IVNG----------------------------KYSIPPH-------D 272
Query: 1141 MGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172
F + +L++NP++R S ++ +
Sbjct: 273 TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 72/331 (21%), Positives = 124/331 (37%), Gaps = 72/331 (21%)
Query: 860 HVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDE 915
V+++ RY +LG F+K + D T KI+ ++ E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 916 IKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKAN-LYEFHKFNRESGGEVYFT 974
I + + + H H++ + +F + + +V EL + L E HK + T
Sbjct: 66 ISIHRSL-AH-Q----HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK------ALT 113
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDH-- 1031
P + Q + Q+LH +IH DLK N+ + EVK+ D G ++ E D
Sbjct: 114 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLATKVEYDGER 171
Query: 1032 ---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
LC + +Y APEV+ + ++D+WS+GCI+ L G F+ R
Sbjct: 172 KKVLCG---TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-- 226
Query: 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFID 1148
I++ EY IPK +
Sbjct: 227 -----IKKN----------------------------EYSIPKHIN---------PVAAS 244
Query: 1149 FVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
+ +L+ +P RP+ ++ L + + Y P
Sbjct: 245 LIQKMLQTDPTARPTINELLNDEFFTSGYIP 275
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-38
Identities = 81/317 (25%), Positives = 136/317 (42%), Gaps = 47/317 (14%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFFDQSLD-----EIKLLKYVN 923
RY ++LG F+ +A D +T V +K IK ++ ++ EIKLL+ +
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL- 69
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
H +++ L D F ++ ++ +V + ++ +L K N + T +++ +
Sbjct: 70 SHP-----NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYML 119
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY---VQSRS 1040
L+ L++LH ++H DLKP N+L+ +K+ D G + +Y V +R
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRAYTHQVVTRW 177
Query: 1041 YRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQ-- 1096
YRAPE++ G Y +D+W++GCILAEL DS L R+ +G P E+
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237
Query: 1097 -GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
M D Y F L H +D + L
Sbjct: 238 PDM-CSLPD-YVTFKSF------------------PGIPLHHIFSAAGDDLLDLIQGLFL 277
Query: 1156 INPKKRPSASDALKHPW 1172
NP R +A+ ALK +
Sbjct: 278 FNPCARITATQALKMKY 294
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 72/330 (21%), Positives = 125/330 (37%), Gaps = 84/330 (25%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNK 924
+ + LG F A + + + +K++ + Q E+++ ++ +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 67
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMP 976
H P ++LRLY YF+ + ++ E G VY F
Sbjct: 68 H-P----NILRLYGYFHDATRVYLILEYAP-------------LGTVYRELQKLSKFDEQ 109
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH----L 1032
R + + AL + H +IH D+KPEN+L+ S E+K+ D G S L
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAPSSRRTDL 167
Query: 1033 CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092
C + Y PE+I G +D+K+D+WSLG + E G F+ ++ R+
Sbjct: 168 CG---TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---- 220
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
R+E+ P + +G D ++
Sbjct: 221 -------------------------------RVEFTFPDFVT---------EGARDLISR 240
Query: 1153 LLEINPKKRPSASDALKHPWLSHPYEPISA 1182
LL+ NP +RP + L+HPW++ S
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSN 270
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 80/319 (25%), Positives = 132/319 (41%), Gaps = 45/319 (14%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQ----SLDEIKLLKYVN 923
RY +G A+ +A D H+G V +K ++ N ++ E+ LL+ +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 924 --KHDPGDKYHLLRLYDYFYYREH-----LLIVCELLKANLYEFHKFNRESGGEVYFTMP 976
+H +++RL D + +V E + +L + +
Sbjct: 70 AFEHP-----NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTY----LDKAPPPGLPAE 120
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDH-LCS 1034
++ + Q L L FLH ++H DLKPENILV S VK+ D G + + L
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGTVKLADFGLARIYSYQMALTP 178
Query: 1035 YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-P 1093
V + YRAPEV+L +Y +D+WS+GCI AE+ LF +S A L ++ +IG P
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238
Query: 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153
E + + ++ +P ++ + +
Sbjct: 239 PEDDW--PRDVSLPRGA----------------FPPRGPRPVQSVVPEMEESGAQLLLEM 280
Query: 1154 LEINPKKRPSASDALKHPW 1172
L NP KR SA AL+H +
Sbjct: 281 LTFNPHKRISAFRALQHSY 299
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 54/338 (15%), Positives = 106/338 (31%), Gaps = 65/338 (19%)
Query: 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD----EIKLLK 920
S + +++ LG A + + TG +K+ N F + +D E ++LK
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLK 62
Query: 921 YVNKHDPGDKYHLLRLYDYFYYR--EHLLIVCELLKANLYEFHKFNRESGGEVY------ 972
+N H ++++L+ H +++ E G +Y
Sbjct: 63 KLN-HK-----NIVKLFAIEEETTTRHKVLIMEFC-------------PCGSLYTVLEEP 103
Query: 973 -----FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS--RCEVKVIDLGSS 1025
+ + + L G++H ++KP NI+ + K+ D G++
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
Query: 1026 CFETD--HLCSYVQSRSYRAPEVILGL--------SYDKKIDIWSLGCILAELCTGNVLF 1075
D S + Y P++ Y +D+WS+G TG++ F
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
Query: 1076 QNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSL 1135
+ V+ I T K + + +P SL
Sbjct: 224 RPFEGPRRNKEVMYKI------------ITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271
Query: 1136 RHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
L +A++LE + +K
Sbjct: 272 SRGL---QVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 78/313 (24%), Positives = 136/313 (43%), Gaps = 37/313 (11%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFD-QSLDEIKLLKYVNKHD 926
+Y E +G + +A D G V +K I+ + ++ EI LLK + H
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHP 79
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+++ L D + L +V E ++ +L + N+ +++ Q L
Sbjct: 80 -----NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG-----LQDSQIKIYLYQLL 129
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY---VQSRSYRA 1043
+ H ++H DLKP+N+L+ S +K+ D G + + SY V + YRA
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINS--DGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 1044 PEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGMLAK 1101
P+V++G Y +DIWS+GCI AE+ TG LF + L ++ I+G P
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP------ 241
Query: 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161
+ + + + + +K +P Q ID ++++L +P KR
Sbjct: 242 --REWPQVQE-------LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292
Query: 1162 PSASDALKHPWLS 1174
SA DA+ HP+
Sbjct: 293 ISARDAMNHPYFK 305
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 56/330 (16%), Positives = 107/330 (32%), Gaps = 82/330 (24%)
Query: 863 LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYV 922
++ + E +GS F + +A G +K +K N + ++ E+K L +
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKL 61
Query: 923 NKHDPGDKYHLLRLYDYFYYREH----------------LLIVCELL-KANLYEFHKFNR 965
+ H +++ + ++ L I E K L ++ + R
Sbjct: 62 D-HV-----NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115
Query: 966 ESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025
+ Q + + ++H LI+ DLKP NI + +VK+ D G
Sbjct: 116 GE----KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL--VDTKQVKIGDFGLV 169
Query: 1026 CF--ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
+ Y +PE I Y K++D+++LG ILAEL A
Sbjct: 170 TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC------DTAFE 223
Query: 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD 1143
++ + + +I
Sbjct: 224 TSKFFTDL---------------------------------RDGIISDIFD--------- 241
Query: 1144 QGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
+ + LL P+ RP+ S+ L+ +
Sbjct: 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 76/316 (24%), Positives = 139/316 (43%), Gaps = 44/316 (13%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQS-LDEIKLLKYVNKHD 926
+YH E +G + +A + + G +K I+ + + + EI +LK + KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHS 60
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
++++LYD + ++ L++V E L +L + +S +Q L
Sbjct: 61 -----NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLL 110
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY---VQSRSYRA 1043
+ + H ++H DLKP+N+L+ E+K+ D G + + Y + + YRA
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 1044 PEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQ---GM 1098
P+V++G Y IDIWS+GCI AE+ G LF S A L R+ I+G P + +
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINP 1158
+ + + + L D+ ID ++ +L+++P
Sbjct: 229 -----TELPKY--------------DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 1159 KKRPSASDALKHPWLS 1174
+R +A AL+H +
Sbjct: 270 NQRITAKQALEHAYFK 285
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 75/322 (23%), Positives = 146/322 (45%), Gaps = 39/322 (12%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQ-SLDEIKLLKYVNKHD 926
RY LG + + +A D T V +K I+ + ++ ++ E+ LLK + +H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHR 93
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+++ L ++ L ++ E + +L ++ + + +M ++S Q +
Sbjct: 94 -----NIIELKSVIHHNHRLHLIFEYAENDLKKY----MDKNPD--VSMRVIKSFLYQLI 142
Query: 987 EALQFLHGLGLIHCDLKPENILV---KSYSRCEVKVIDLGSSCFETDHLCSY---VQSRS 1040
+ F H +H DLKP+N+L+ + +K+ D G + + + + +
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202
Query: 1041 YRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIEQGM 1098
YR PE++LG Y +DIWS+ CI AE+ LF DS L ++ ++G P +
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD--- 259
Query: 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINP 1158
T+ T + + + ++ KT R + D +D + +LE++P
Sbjct: 260 -----TTWPGVTAL-----PDWKQSFPKF--RGKTLKRVLGALLDDEGLDLLTAMLEMDP 307
Query: 1159 KKRPSASDALKHPWL-SHPYEP 1179
KR SA +AL+HP+ + ++P
Sbjct: 308 VKRISAKNALEHPYFSHNDFDP 329
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-37
Identities = 71/324 (21%), Positives = 120/324 (37%), Gaps = 72/324 (22%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNK 924
RY +LG F+K + D T KI+ ++ EI + + +
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-A 99
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITI 983
H H++ + +F + + +V EL + L E HK + T P +
Sbjct: 100 H-Q----HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLR 148
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDH-----LCSYVQ 1037
Q + Q+LH +IH DLK N+ + EVK+ D G ++ E D LC
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLATKVEYDGERKKVLCG--- 203
Query: 1038 SRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
+ +Y APEV+ + ++D+WS+GCI+ L G F+ R I++
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-------IKKN 256
Query: 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157
EY IPK + + +L+ +
Sbjct: 257 ----------------------------EYSIPKHINPVAA---------SLIQKMLQTD 279
Query: 1158 PKKRPSASDALKHPWLSHPYEPIS 1181
P RP+ ++ L + + Y P
Sbjct: 280 PTARPTINELLNDEFFTSGYIPAR 303
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 65/328 (19%), Positives = 121/328 (36%), Gaps = 84/328 (25%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNK 924
+ + LG F A + + +K++ ++ Q EI++ ++
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR- 72
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMP 976
H P ++LR+Y+YF+ R+ + ++ E GE+Y F
Sbjct: 73 H-P----NILRMYNYFHDRKRIYLMLEFAP-------------RGELYKELQKHGRFDEQ 114
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH----L 1032
R + + +AL + H +IH D+KPEN+L+ + E+K+ D G S +
Sbjct: 115 RSATFMEELADALHYCHERKVIHRDIKPENLLMGY--KGELKIADFGWSVHAPSLRRRTM 172
Query: 1033 CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092
C + Y PE+I G ++D+K+D+W G + E G F + S R++
Sbjct: 173 CG---TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV---- 225
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
++ P S G D ++
Sbjct: 226 -------------------------------NVDLKFPPFLS---------DGSKDLISK 245
Query: 1153 LLEINPKKRPSASDALKHPWLSHPYEPI 1180
LL +P +R ++HPW+ +
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKANSRRV 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 67/336 (19%), Positives = 119/336 (35%), Gaps = 64/336 (19%)
Query: 846 HRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII--K 903
H R + LGS AF + +G++ +K I
Sbjct: 7 HSSGRENLYFQGTID--------DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD 58
Query: 904 NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYE-FHK 962
++ +Q EI++LK ++ H +++++++ F ++ IV E + E +
Sbjct: 59 RSQVPMEQIEAEIEVLKSLD-HP-----NIIKIFEVFEDYHNMYIVMETCEGG--ELLER 110
Query: 963 FNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVID 1021
+ + + Q + AL + H ++H DLKPENIL + S +K+ID
Sbjct: 111 IVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 1022 LGSSCF--ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
G + +H + + Y APEV K DIWS G ++ L TG + F S
Sbjct: 171 FGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229
Query: 1080 PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRL 1139
+ + E + +
Sbjct: 230 LEEVQQKAT------------YKE------------PNYAVE--------CRPLT----- 252
Query: 1140 PMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175
+D + +L +P++RPSA+ L H W
Sbjct: 253 ----PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 69/330 (20%), Positives = 121/330 (36%), Gaps = 78/330 (23%)
Query: 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD-------EI 916
+ +Y V LGS F + + V +K ++ ++ L E+
Sbjct: 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 917 KLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKAN--LYEF---HKFNRESGGEV 971
LLK V+ ++RL D+F + +++ E + L++F +E
Sbjct: 98 VLLKKVSSGFS----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 153
Query: 972 YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD- 1030
+F Q LEA++ H G++H D+K ENIL+ +R E+K+ID GS D
Sbjct: 154 FFW---------QVLEAVRHCHNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALLKDT 203
Query: 1031 HLCSYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089
+ +R Y PE I Y + +WSLG +L ++ G++ F++D
Sbjct: 204 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----------- 252
Query: 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDF 1149
+E R + ++ S
Sbjct: 253 ------------------------------EEIIRGQVFFRQRVS---------SECQHL 273
Query: 1150 VAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
+ L + P RP+ + HPW+ P
Sbjct: 274 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 72/332 (21%), Positives = 125/332 (37%), Gaps = 87/332 (26%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNK 924
+ V LG +F+ +A +HTG++V +K+I + +E+K+ + K
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-K 69
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY---------FTM 975
H P +L LY+YF ++ +V E+ GE+ F+
Sbjct: 70 H-P----SILELYNYFEDSNYVYLVLEMCH-------------NGEMNRYLKNRVKPFSE 111
Query: 976 PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDH--- 1031
+ Q + + +LH G++H DL N+L+ +K+ D G ++ + H
Sbjct: 112 NEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADFGLATQLKMPHEKH 169
Query: 1032 --LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089
LC + +Y +PE+ ++ + D+WSLGC+ L G F D+ L +V
Sbjct: 170 YTLCG---TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV-- 224
Query: 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDF 1149
+Y +P S+ + D
Sbjct: 225 ---------------------------------VLADYEMPSFLSIEAK---------DL 242
Query: 1150 VAHLLEINPKKRPSASDALKHPWLSHPYEPIS 1181
+ LL NP R S S L HP++S S
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSRNSSTKS 274
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-36
Identities = 58/321 (18%), Positives = 112/321 (34%), Gaps = 39/321 (12%)
Query: 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQS--LDEIKLLKYV 922
+ G + + E LG+ F ++ TG V +K + ++ EI+++K +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 923 NKHDPGDKYHLLRLYDYFYYREHL------LIVCELLKANLYEFHKFNRESGGEVYFTMP 976
N H +++ + + L L+ E + K+ +
Sbjct: 70 N-HP-----NVVSAREVPDGLQKLAPNDLPLLAMEY--CEGGDLRKYLNQFENCCGLKEG 121
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVIDLG-SSCFETDHLC- 1033
++++ AL++LH +IH DLKPENI+++ R K+IDLG + + LC
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 1034 SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093
+V + Y APE++ Y +D WS G + E TG F + +
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV----- 236
Query: 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153
K + + + + +L R +
Sbjct: 237 -----REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWL----------QCM 281
Query: 1154 LEINPKKRPSASDALKHPWLS 1174
L + ++R +
Sbjct: 282 LMWHQRQRGTDPQNPNVGCFQ 302
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 81/319 (25%), Positives = 137/319 (42%), Gaps = 43/319 (13%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDL-HTGMDVCVKIIK--NNKDFFD-QSLDEIKLLKYVN-- 923
+Y +G A+ K +A DL + G V +K ++ ++ ++ E+ +L+++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 924 KHDPGDKYHLLRLYDYFYYREH-----LLIVCELLKANLYEFHKFNRESGGEVYFTMPRL 978
+H +++RL+D L +V E + +L + + E +
Sbjct: 72 EHP-----NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY----LDKVPEPGVPTETI 122
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDH-LCSYV 1036
+ + Q L L FLH ++H DLKP+NILV S ++K+ D G + + L S V
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT--SSGQIKLADFGLARIYSFQMALTSVV 180
Query: 1037 QSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG-PIE 1095
+ YRAPEV+L SY +D+WS+GCI AE+ LF+ S L +++ +IG P E
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
+ + + + D+ D + L
Sbjct: 241 EDW--PRDVALPRQA----------------FHSKSAQPIEKFVTDIDELGKDLLLKCLT 282
Query: 1156 INPKKRPSASDALKHPWLS 1174
NP KR SA AL HP+
Sbjct: 283 FNPAKRISAYSALSHPYFQ 301
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-36
Identities = 74/333 (22%), Positives = 110/333 (33%), Gaps = 80/333 (24%)
Query: 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD-------EI 916
Y + LG F H L + V +K+I N+ L E+
Sbjct: 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 917 KLLKYVNKHD--PGDKYHLLRLYDYFYYREHLLIVCELLKAN--LYEF---HKFNRESGG 969
LL V P ++RL D+F +E ++V E L+++ E
Sbjct: 86 ALLWKVGAGGGHP----GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS 141
Query: 970 EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029
+F Q + A+Q H G++H D+K ENIL+ R K+ID GS
Sbjct: 142 RCFFG---------QVVAAIQHCHSRGVVHRDIKDENILIDL-RRGCAKLIDFGSGALLH 191
Query: 1030 D-HLCSYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
D + +R Y PE I Y +WSLG +L ++ G++ F+ D
Sbjct: 192 DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--------- 242
Query: 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFI 1147
QE E P S
Sbjct: 243 --------------------------------QEILEAELHFPAHVS---------PDCC 261
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180
+ L P RPS + L PW+ P E +
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-36
Identities = 75/315 (23%), Positives = 129/315 (40%), Gaps = 39/315 (12%)
Query: 884 KAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943
KA + D D +K I+ + EI LL+ + KH +++ L F
Sbjct: 39 KA-KRKDGKDDKDYALKQIEGT-GISMSACREIALLREL-KHP-----NVISLQKVFLSH 90
Query: 944 EH--LLIVCELLKANLY---EFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLI 998
+ ++ + + +L+ +FH+ ++ + V ++S+ Q L+ + +LH ++
Sbjct: 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 150
Query: 999 HCDLKPENILVKSY--SRCEVKVIDLGSSCFETDHLCSYVQSRS------YRAPEVILGL 1050
H DLKP NILV R VK+ D+G + L YRAPE++LG
Sbjct: 151 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 210
Query: 1051 -SYDKKIDIWSLGCILAELCTGNVLFQNDSPATL---------LARVIGIIG-PIEQGML 1099
Y K IDIW++GCI AEL T +F L R+ ++G P ++
Sbjct: 211 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW- 269
Query: 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159
+ + + RN TN + D + LL ++P
Sbjct: 270 -EDIKKMPEHSTLMKDFRRNTYTN-----CSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323
Query: 1160 KRPSASDALKHPWLS 1174
KR ++ A++ P+
Sbjct: 324 KRITSEQAMQDPYFL 338
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 66/342 (19%), Positives = 108/342 (31%), Gaps = 90/342 (26%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDP 927
+ + LG F +A + + +K I+ N + ++ + E+K L + H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HP- 63
Query: 928 GDKYHLLRLYDYF------------YYREHLLIVCELL-KANLYEFHKFNRESGGEVYFT 974
++R ++ + + +L I +L K NL ++
Sbjct: 64 ----GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC---TIEERE 116
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF------- 1027
I +Q EA++FLH GL+H DLKP NI VKV D G
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEE 174
Query: 1028 --------ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
V ++ Y +PE I G SY K+DI+SLG IL EL F
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP---FSTQM 231
Query: 1080 PATLLARVI--GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRH 1137
+ P + +
Sbjct: 232 ERVRTLTDVRNLKFPP-----------------------------------LFTQKY--- 253
Query: 1138 RLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
V +L +P +RP A + +++ P
Sbjct: 254 ------PCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 55/319 (17%), Positives = 96/319 (30%), Gaps = 83/319 (26%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLL 934
+G +F + + D TG VK + ++E+ ++ ++
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLS-SP-----RIV 113
Query: 935 RLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSITIQCL 986
LY + I ELL GG + R Q L
Sbjct: 114 PLYGAVREGPWVNIFMELL-------------EGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHLCSYVQSRS----- 1040
E L++LH ++H D+K +N+L+ S + D G + C + D L + +
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDG-SRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 1041 --YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098
+ APEV++G D K+DIWS C++ + G + L
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-------------- 265
Query: 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMG-DQGFIDFVAHLLEIN 1157
I + +P + L
Sbjct: 266 ----------------------------LKIASEPPPIREIPPSCAPLTAQAIQEGLRKE 297
Query: 1158 PKKRPSASDALKHPWLSHP 1176
P R SA + + +
Sbjct: 298 PVHRASAMELRRKVGKALQ 316
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 78/325 (24%), Positives = 136/325 (41%), Gaps = 79/325 (24%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII---KNNKDFFDQSLDEIKLLKYVNKH 925
G Y + + +G F+K A + TG +V +KII + N + E++++K +N H
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-H 73
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY---FTMPRLQ--- 979
P ++++L++ + L ++ E SGGEV+ R++
Sbjct: 74 -P----NIVKLFEVIETEKTLYLIMEYA-------------SGGEVFDYLVAHGRMKEKE 115
Query: 980 --SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD--HLCSY 1035
S Q + A+Q+ H ++H DLK EN+L+ + +K+ D G S T L ++
Sbjct: 116 ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD--ADMNIKIADFGFSNEFTVGGKLDAF 173
Query: 1036 VQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094
+ Y APE+ G YD ++D+WSLG IL L +G++ F + L RV+
Sbjct: 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL------ 227
Query: 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLL 1154
+G+ Y IP S + + L
Sbjct: 228 ------RGK-----------------------YRIPFYMSTDCE---------NLLKRFL 249
Query: 1155 EINPKKRPSASDALKHPWLSHPYEP 1179
+NP KR + +K W++ +E
Sbjct: 250 VLNPIKRGTLEQIMKDRWINAGHEE 274
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 75/347 (21%), Positives = 119/347 (34%), Gaps = 99/347 (28%)
Query: 870 RYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKII-KNNKDFFDQSLDEIKLLKYVNKHDP 927
Y + + LG A ++ +L T + VKII K + E+++L H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR- 71
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE--------VYFTMPRLQ 979
++L L ++F + +V E + GG +F
Sbjct: 72 ----NVLELIEFFEEEDRFYLVFEKM-------------RGGSILSHIHKRRHFNELEAS 114
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLG-SSCFETDHLCSYVQ 1037
+ AL FLH G+ H DLKPENIL + ++ VK+ D S + + CS +
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 1038 SRS---------YRAPEVILGLS-----YDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
+ Y APEV+ S YDK+ D+WSLG IL L +G F +
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234
Query: 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD 1143
+ + I +
Sbjct: 235 GWDRGEACPACQNMLFES---------------------------IQE------------ 255
Query: 1144 QGFIDF---------------VAHLLEINPKKRPSASDALKHPWLSH 1175
G +F ++ LL + K+R SA+ L+HPW+
Sbjct: 256 -GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 58/413 (14%), Positives = 110/413 (26%), Gaps = 98/413 (23%)
Query: 810 DPGASLEDEEAAAVQEQVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAG 869
PG + + ++ Q + E + + + + F V S +
Sbjct: 18 GPGDVV----IEELFNRIPQANVRTTS-EYMQSAADSLVSTSLWNTGQPFRVE--SELGE 70
Query: 870 R---YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIK--------L 918
R LG ++A D TG V + + ++ ++K L
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 919 LKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKAN---------LYEFHKFNRESGG 969
N+ + +D + ++ L LY + N ++ G
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 970 EVYFTMPRLQ---------SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020
EV + +T+Q + L LH GL+H L+P +I++ R V +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLT 248
Query: 1021 DLGSSCFETDHLCSYVQSRSYRAPEVIL-----------GLSYDKKIDIWSLGCILAELC 1069
SR + PE+ D W+LG ++ +
Sbjct: 249 GFEHLV-RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 1070 TGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLI 1129
++ D+ + R I
Sbjct: 308 CADLPITKDAALGGSEWIF-----------------------------------RSCKNI 332
Query: 1130 PKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
P Q + L + R A++ P +SA
Sbjct: 333 P-------------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSA 372
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 76/386 (19%), Positives = 126/386 (32%), Gaps = 96/386 (24%)
Query: 846 HRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN 905
H + + E+ F + +YH+ +G ++ A + T +KI+ N
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 906 KDFFDQSLD------EIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL------ 953
K D E++L+K + H ++ RLY+ + +++ +V EL
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKL-HHP-----NIARLYEVYEDEQYICLVMELCHGGHLL 116
Query: 954 -----------------------------KANLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
+ + +I Q
Sbjct: 117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF-------ETDHLCSYVQ 1037
AL +LH G+ H D+KPEN L + E+K++D G S E + +
Sbjct: 177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 1038 SRSYRAPEVILGL--SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095
+ + APEV+ SY K D WS G +L L G V F + A I +
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-------DTISQVL 289
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
L Y + D +++LL
Sbjct: 290 NKKLCFENPNYNVLSPLA---------------------------------RDLLSNLLN 316
Query: 1156 INPKKRPSASDALKHPWLSHPYEPIS 1181
N +R A AL+HPW+S + I
Sbjct: 317 RNVDERFDAMRALQHPWISQFSDKIY 342
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-34
Identities = 54/337 (16%), Positives = 106/337 (31%), Gaps = 65/337 (19%)
Query: 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD----EIKLLK 920
S + +++ LG A + + TG +K+ N F + +D E ++LK
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLK 62
Query: 921 YVNKHDPGDKYHLLRLYDYFYYR--EHLLIVCELLKANLYEFHKFNRESGGEVY------ 972
+N H ++++L+ H +++ E G +Y
Sbjct: 63 KLN-HK-----NIVKLFAIEEETTTRHKVLIMEFC-------------PCGSLYTVLEEP 103
Query: 973 -----FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS--RCEVKVIDLGSS 1025
+ + + L G++H ++KP NI+ + K+ D G++
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
Query: 1026 CFETD--HLCSYVQSRSYRAPEVILGL--------SYDKKIDIWSLGCILAELCTGNVLF 1075
D S + Y P++ Y +D+WS+G TG++ F
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
Query: 1076 QNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSL 1135
+ V+ I T K + + +P SL
Sbjct: 224 RPFEGPRRNKEVMYKI------------ITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271
Query: 1136 RHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172
L +A++LE + +K
Sbjct: 272 SRGL---QVLLTPVLANILEADQEKCWGFDQFFAETS 305
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-34
Identities = 79/326 (24%), Positives = 141/326 (43%), Gaps = 48/326 (14%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQ-SLDEIKLLKYVNKHD 926
+Y +G F + +A TG V +K + N K+ F +L EIK+L+ + KH+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHE 76
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLY---EF--HKFNR--ESGGEVYFTMPRLQ 979
+++ L + + C K ++Y +F H + V FT+ ++
Sbjct: 77 -----NVVNLIEICRTKASPYNRC---KGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIK 127
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG----SSCFETDHLCSY 1035
+ L L ++H ++H D+K N+L+ +K+ D G S + Y
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 1036 ---VQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091
V + YR PE++LG Y ID+W GCI+AE+ T + + Q ++ LA + +
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 1092 G-PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLP--MGDQGFID 1148
G + D Y+ + K LE + +K ++ RL + D +D
Sbjct: 246 GSITPEVW--PNVDNYELYEK-------------LELVKGQKRKVKDRLKAYVRDPYALD 290
Query: 1149 FVAHLLEINPKKRPSASDALKHPWLS 1174
+ LL ++P +R + DAL H +
Sbjct: 291 LIDKLLVLDPAQRIDSDDALNHDFFW 316
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-33
Identities = 58/435 (13%), Positives = 112/435 (25%), Gaps = 101/435 (23%)
Query: 789 NYEREHVKREEAEKISGMREEDPGASLEDEEAAAVQEQVRQIKAQEEEFETFNLKIVHRK 848
++ H E G R DPG D + ++ Q + E
Sbjct: 2 HHHHHHSSGRENLYFQGFRGTDPG----DVVIEELFNRIPQANVRTTS-EYMQSAADSLV 56
Query: 849 NRTGFEEDKNFHVVLNSVIAGRY---HVTEYLGSAAFSKAIQAHDLHTGMDVCVKII--- 902
+ + + + F V S + R LG ++A D TG V +
Sbjct: 57 STSLWNTGQPFRVE--SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 114
Query: 903 -KNNKDFFDQSLDEIKLLKYVNKH-DPGDKYHLLRL---------------YDYFYYREH 945
+ + Q +E+ L+ + + LR
Sbjct: 115 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 174
Query: 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQ---------SITIQCLEALQFLHGLG 996
+ ++ LY + N ++ GEV + +T+Q + L LH G
Sbjct: 175 MWVLSRFF---LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231
Query: 997 LIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC----SYVQSRSYRAPEVILG--- 1049
L+H L+P +I++ V + + A ++
Sbjct: 232 LVHTYLRPVDIVLDQRGG--VFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQH 289
Query: 1050 --LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYK 1107
D W+LG + + ++ +D+ +
Sbjct: 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF------------------- 330
Query: 1108 YFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167
+P Q + L + R A
Sbjct: 331 --------------------------RSCKNIP---QPVRALLEGFLRYPKEDRLLPLQA 361
Query: 1168 LKHPWLSHPYEPISA 1182
++ P +SA
Sbjct: 362 METPEYEQLRTELSA 376
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 73/331 (22%), Positives = 117/331 (35%), Gaps = 90/331 (27%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD---------EIKLL 919
+Y LGS AF A D +V VK IK K D ++ EI +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 920 KYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY---FTMP 976
V H +++++ D F + +V E SG +++ P
Sbjct: 84 SRVE-H-A----NIIKVLDIFENQGFFQLVMEKHG------------SGLDLFAFIDRHP 125
Query: 977 RLQ-----SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS-CFETD 1030
RL I Q + A+ +L +IH D+K ENI++ +K+ID GS+ E
Sbjct: 126 RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA--EDFTIKLIDFGSAAYLERG 183
Query: 1031 HLCS-YVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
L + + Y APEV++G Y ++++WSLG L L F
Sbjct: 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL---------- 233
Query: 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFID 1148
+ET P S + +
Sbjct: 234 -------------------------------EETVEAAIHPPYLVS---------KELMS 253
Query: 1149 FVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
V+ LL+ P++R + + PW++ P
Sbjct: 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVNL 284
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 70/338 (20%), Positives = 118/338 (34%), Gaps = 66/338 (19%)
Query: 850 RTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDF 908
R+ E D ++ LG + DL + + +K I + +
Sbjct: 3 RSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY 62
Query: 909 FDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLK----ANLYEFHKFN 964
+EI L K++ H ++++ F + I E + + L K+
Sbjct: 63 SQPLHEEIALHKHLK-HK-----NIVQYLGSFSENGFIKIFMEQVPGGSLSALLR-SKWG 115
Query: 965 RESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024
E + T Q LE L++LH ++H D+K +N+L+ +YS +K+ D G+
Sbjct: 116 PLKDNE-----QTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV-LKISDFGT 169
Query: 1025 S---CFETDHLCSYVQSRSYRAPEVILGLS--YDKKIDIWSLGCILAELCTGNVLFQN-D 1078
S ++ + Y APE+I Y K DIWSLGC + E+ TG F
Sbjct: 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229
Query: 1079 SPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHR 1138
P + +V + + IP+ S
Sbjct: 230 EPQAAMFKV------------GMFKVHPE---------------------IPESMS---- 252
Query: 1139 LPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176
F+ E +P KR A+D L +L
Sbjct: 253 -----AEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-32
Identities = 38/273 (13%), Positives = 98/273 (35%), Gaps = 33/273 (12%)
Query: 828 RQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ 887
+ + + ++ + + F + +V LG AF++ +
Sbjct: 29 KLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSK-----LVYVHHLLGEGAFAQVYE 83
Query: 888 A-----HDLHTGMDVCVKIIKNNKDF-FDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941
A +D +K+ K + F ++ LK +H ++ Y
Sbjct: 84 ATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQH------MFMKFYSAHL 137
Query: 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHC 1000
++ ++V EL L + + +V + S ++ L ++ +H +IH
Sbjct: 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKV-MPQGLVISFAMRMLYMIEQVHDCEIIHG 196
Query: 1001 DLKPENILVKSYSRCE---------VKVIDLGSSCF-----ETDHLCSYVQSRSYRAPEV 1046
D+KP+N ++ + + + +IDLG S + + ++ ++ E+
Sbjct: 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEM 256
Query: 1047 ILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
+ ++ +ID + + + + G + +
Sbjct: 257 LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-32
Identities = 69/318 (21%), Positives = 104/318 (32%), Gaps = 60/318 (18%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPG 928
RY + +GS F A D T V VK I+ + EI + + H P
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR-H-P- 76
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKA-NLYEF---HKFNRESGGEVYFTMPRLQSITIQ 984
+++R + HL I+ E LYE E +F Q
Sbjct: 77 ---NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ---------Q 124
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH--LCSYVQSRSYR 1042
L + + H + + H DLK EN L+ +K+ D G S H S V + +Y
Sbjct: 125 LLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184
Query: 1043 APEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101
APEV+L YD K D+WS G L + G F++ + I I
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI---------- 234
Query: 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161
++Y IP + ++ + +P R
Sbjct: 235 ---------------------LSVKYSIPDDIRI-------SPECCHLISRIFVADPATR 266
Query: 1162 PSASDALKHPWLSHPYEP 1179
S + H W
Sbjct: 267 ISIPEIKTHSWFLKNLPA 284
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 30/233 (12%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSL-DEIKLLKYVNKH 925
I + E LGS AFS+ TG +K IK + F D SL +EI +LK + KH
Sbjct: 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KH 65
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV--------YFTMPR 977
+ +++ L D + H +V +L+ SGGE+ +T
Sbjct: 66 E-----NIVTLEDIYESTTHYYLVMQLV-------------SGGELFDRILERGVYTEKD 107
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLG-SSCFETDHLCSY 1035
+ Q L A+++LH G++H DLKPEN+L + ++ + D G S + + +
Sbjct: 108 ASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA 167
Query: 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
+ Y APEV+ Y K +D WS+G I L G F ++ + L ++
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK 220
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 6e-07
Identities = 13/27 (48%), Positives = 18/27 (66%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
DF+ HLLE +P +R + AL HPW+
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWID 266
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 54/237 (22%), Positives = 91/237 (38%), Gaps = 39/237 (16%)
Query: 846 HRKNRTGFEEDKNFHVVLNSVIAGRYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKIIKN 904
H + +G E + Y ++ + LG K ++ TG +K++ +
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD 64
Query: 905 NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF----YYREHLLIVCELLKANLYEF 960
+ E+ + H++ + D + + + LLI+ E +
Sbjct: 65 SPKARQ----EVDHHWQASGGP-----HIVCILDVYENMHHGKRCLLIIMECM------- 108
Query: 961 HKFNRESGGE----------VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVK 1010
GGE FT I A+QFLH + H D+KPEN+L
Sbjct: 109 ------EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 162
Query: 1011 SYSR-CEVKVIDLG-SSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
S + +K+ D G + + L + + Y APEV+ YDK D+WSLG I+
Sbjct: 163 SKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 7/28 (25%), Positives = 16/28 (57%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSH 1175
+ LL+ +P +R + + + HPW++
Sbjct: 266 QLIRLLLKTDPTERLTITQFMNHPWINQ 293
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-32
Identities = 74/347 (21%), Positives = 123/347 (35%), Gaps = 28/347 (8%)
Query: 835 EEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTG 894
++ E L RK F K L + LG+ + +G
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELK---DDDFEKISELGAGNGGVVFKVSHKPSG 58
Query: 895 MDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952
+ + K+I +Q + E+++L N +++ Y FY + I E
Sbjct: 59 LVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP-----YIVGFYGAFYSDGEISICMEH 112
Query: 953 LKA----NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENI 1007
+ + + E L ++I ++ L +L ++H D+KP NI
Sbjct: 113 MDGGSLDQVLKKAGRIPE---------QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163
Query: 1008 LVKSYSRCEVKVIDLGSSCFETDHLC-SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILA 1066
LV SR E+K+ D G S D + S+V +RSY +PE + G Y + DIWS+G L
Sbjct: 164 LV--NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221
Query: 1067 ELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLE 1126
E+ G L + + R + K M L
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281
Query: 1127 YLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
I + + + F DFV L NP +R + H ++
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 75/330 (22%), Positives = 124/330 (37%), Gaps = 80/330 (24%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD-----EIKLLKYVN 923
G+Y + + LG ++ K + D T VKI+K K + + EI+LL+ +
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 924 KHDPGDKYHLLRLYDYFYY--REHLLIVCELLKANLYE-FHKFNR----ESGGEVYFTMP 976
H ++++L D Y ++ + +V E + E YF
Sbjct: 65 -H-K----NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC-- 116
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS----CFETDHL 1032
Q ++ L++LH G++H D+KP N+L+ + +K+ LG + F D
Sbjct: 117 -------QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAADDT 167
Query: 1033 CSYVQ-SRSYRAPEVILGL-SYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089
C Q S +++ PE+ GL ++ K+DIWS G L + TG F+ D+ L
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN--- 224
Query: 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDF 1149
I +G Y IP D
Sbjct: 225 ----IGKG----------------------------SYAIPGDCG---------PPLSDL 243
Query: 1150 VAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
+ +LE P KR S +H W + P
Sbjct: 244 LKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 78/327 (23%), Positives = 118/327 (36%), Gaps = 82/327 (25%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYV 922
G Y + + LG F K TG V VKI+ N+ EI+ LK
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKIL--NRQKIRSLDVVGKIKREIQNLKLF 68
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELLKAN-LYEF---HKFNRESGGEVYFTMPRL 978
H P H+++LY +V E + L+++ H E F
Sbjct: 69 R-H-P----HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---- 118
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHL----C 1033
Q L A+ + H ++H DLKPEN+L+ + K+ D G S+ C
Sbjct: 119 -----QILSAVDYCHRHMVVHRDLKPENVLLD--AHMNAKIADFGLSNMMSDGEFLRTSC 171
Query: 1034 SYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092
S +Y APEVI G Y ++DIWS G IL L G + F ++ TL +
Sbjct: 172 G---SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK------ 222
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
I G + IP+ + + + H
Sbjct: 223 -IRGG----------------------------VFYIPEYLN---------RSVATLLMH 244
Query: 1153 LLEINPKKRPSASDALKHPWLSHPYEP 1179
+L+++P KR + D +H W
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDLPS 271
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 73/326 (22%), Positives = 122/326 (37%), Gaps = 81/326 (24%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYV 922
G Y + E LG +F K A T V +K I ++ +S EI LK +
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFI--SRQLLKKSDMHMRVEREISYLKLL 66
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEF---HKFNRESGGEVYFTMPRLQ 979
H P H+++LYD +++V E L+++ K E G +F
Sbjct: 67 R-H-P----HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQ----- 115
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHL----CS 1034
Q + A+++ H ++H DLKPEN+L+ VK+ D G S+ + C
Sbjct: 116 ----QIICAIEYCHRHKIVHRDLKPENLLLD--DNLNVKIADFGLSNIMTDGNFLKTSCG 169
Query: 1035 YVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093
S +Y APEVI G Y ++D+WS G +L + G + F ++ L +V
Sbjct: 170 ---SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN----- 221
Query: 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153
Y++P S G + +
Sbjct: 222 -------SC-----------------------VYVMPDFLS---------PGAQSLIRRM 242
Query: 1154 LEINPKKRPSASDALKHPWLSHPYEP 1179
+ +P +R + + + PW +
Sbjct: 243 IVADPMQRITIQEIRRDPWFNVNLPD 268
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 61/318 (19%), Positives = 117/318 (36%), Gaps = 69/318 (21%)
Query: 869 GRYH-VTEYLGSAAFSKAIQAHDLHTGMDVCVKII---KNNKDFFDQSLDEIKLLKYVNK 924
GR+ +G +F + D T ++V + K K + +E ++LK + +
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-Q 83
Query: 925 HDPGDKYHLLRLYDYFYY----REHLLIVCELLKA-NLYEF-HKFNRESGGEVYFTMPRL 978
H +++R YD + ++ +++V EL+ + L + +F + L
Sbjct: 84 HP-----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-------MKIKVL 131
Query: 979 QSITIQCLEALQFLH--GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC-SY 1035
+S Q L+ LQFLH +IH DLK +NI + + VK+ DLG + + +
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT-GSVKIGDLGLATLKRASFAKAV 190
Query: 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095
+ + + APE+ YD+ +D+++ G + E+ T + A
Sbjct: 191 IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------------- 235
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
Y+ T K + + + +
Sbjct: 236 -------AQIYRRVTSGVK-----------PASFDKVAIPEVK---------EIIEGCIR 268
Query: 1156 INPKKRPSASDALKHPWL 1173
N +R S D L H +
Sbjct: 269 QNKDERYSIKDLLNHAFF 286
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 32/239 (13%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDK 930
+ LG +FS + + VKII +K + EI LK H
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHP---- 66
Query: 931 YHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE--------VYFTMPRLQSIT 982
++++L++ F+ + H +V ELL +GGE +F+ I
Sbjct: 67 -NIVKLHEVFHDQLHTFLVMELL-------------NGGELFERIKKKKHFSETEASYIM 112
Query: 983 IQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLGSSCF---ETDHLCSYVQS 1038
+ + A+ +H +G++H DLKPEN+L + E+K+ID G + + L + +
Sbjct: 113 RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172
Query: 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
Y APE++ YD+ D+WSLG IL + +G V FQ+ + + I+ I++G
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 9/28 (32%), Positives = 13/28 (46%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSH 1175
D + LL ++P KR S + WL
Sbjct: 249 DLIQGLLTVDPNKRLKMSGLRYNEWLQD 276
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 69/374 (18%), Positives = 114/374 (30%), Gaps = 119/374 (31%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVN----- 923
+ + +G F +A + + +K I+ N + ++ + E+K L +
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 924 ----------------------------------------------KHDPGDKYHLLRLY 937
+ DP + +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 938 DYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG 996
+ +L I +L K NL ++ I IQ EA++FLH G
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMN---RRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 997 LIHCDLKPENILVKSYSRCEVKVIDLG---------------SSCFETDHLCSYVQSRSY 1041
L+H DLKP NI VKV D G + V ++ Y
Sbjct: 185 LMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 1042 RAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101
+PE I G +Y K+DI+SLG IL EL F S R+I +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS---F---STQMERVRIITDV---------- 286
Query: 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161
RN + + + V +L +P +R
Sbjct: 287 ----------------RNLKFPL----LFTQKY---------PQEHMMVQDMLSPSPTER 317
Query: 1162 PSASDALKHPWLSH 1175
P A+D +++ +
Sbjct: 318 PEATDIIENAIFEN 331
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 42/234 (17%)
Query: 846 HRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII--- 902
H R F RY++ LG +F + ++ D T + VK+I
Sbjct: 7 HSSGRENLYFQGTFA--------ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 903 KNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHK 962
L E++LLK ++ H ++++L++ IV EL
Sbjct: 59 SAKNKDTSTILREVELLKKLD-HP-----NIMKLFEILEDSSSFYIVGELY--------- 103
Query: 963 FNRESGGE--------VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014
+GGE F+ I Q + ++H ++H DLKPENIL++S +
Sbjct: 104 ----TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 1015 -CEVKVIDLGSSCF--ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
C++K+ID G S + + + + Y APEV+ G +YD+K D+WS G IL
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 9/28 (32%), Positives = 16/28 (57%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSH 1175
D + +L +P R +A+ L+HPW+
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-30
Identities = 66/236 (27%), Positives = 113/236 (47%), Gaps = 35/236 (14%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYV 922
+ RY LG +F + I D TG + VK+I K + L E++LLK +
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FT 974
+ H ++++LY++F + + +V E+ +GGE++ F+
Sbjct: 84 D-HP-----NIMKLYEFFEDKGYFYLVGEVY-------------TGGELFDEIISRKRFS 124
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVIDLGSSCF--ETDH 1031
I Q L + ++H ++H DLKPEN+L++S S +++ID G S +
Sbjct: 125 EVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 1032 LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
+ + + Y APEV+ G +YD+K D+WS G IL L +G F + +L +V
Sbjct: 185 MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 11/35 (31%), Positives = 16/35 (45%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
D + +L P R SA DAL H W+ + +
Sbjct: 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS 294
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD 926
Y V E +G ++S + T M+ VKII +K +EI++L +H
Sbjct: 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHP 76
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE--------VYFTMPRL 978
+++ L D + +++ +V EL+K GGE +F+
Sbjct: 77 -----NIITLKDVYDDGKYVYVVTELMK-------------GGELLDKILRQKFFSEREA 118
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR--CEVKVIDLGSSCF---ETDHLC 1033
++ + +++LH G++H DLKP NIL S +++ D G + E L
Sbjct: 119 SAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 1034 SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLF---QNDSPATLLARV 1087
+ + ++ APEV+ YD DIWSLG +L + TG F +D+P +LAR+
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 11/28 (39%), Positives = 20/28 (71%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSH 1175
D V+ +L ++P +R +A+ L+HPW+ H
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIVH 283
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 34/235 (14%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII---KNNKDFFDQSLDEIKLLKYVN 923
++ Y + LGS A+ + + D T ++ +KII + + L+E+ +LK ++
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTM 975
H ++++LYD+F + + +V E GGE++ F
Sbjct: 95 -HP-----NIMKLYDFFEDKRNYYLVMECY-------------KGGELFDEIIHRMKFNE 135
Query: 976 PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVIDLGSSCF--ETDHL 1032
I Q L + +LH ++H DLKPEN+L++S +K++D G S +
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195
Query: 1033 CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
+ + Y APEV+ YD+K D+WS+G IL L G F + +L +V
Sbjct: 196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 10/27 (37%), Positives = 18/27 (66%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
D + +L+ + ++R SA AL+HPW+
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWIK 296
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 45/246 (18%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--------------NNKDFFDQS 912
I Y LGS A+ + + + + + +K+IK N + F ++
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 913 LDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY 972
+EI LLK + H P ++++L+D F +++ +V E GGE++
Sbjct: 94 YNEISLLKSL-DH-P----NIIKLFDVFEDKKYFYLVTEFY-------------EGGELF 134
Query: 973 --------FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVIDLG 1023
F +I Q L + +LH ++H D+KPENIL+++ + +K++D G
Sbjct: 135 EQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 1024 SSCF--ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA 1081
S F + L + + Y APEV+ Y++K D+WS G I+ L G F +
Sbjct: 195 LSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253
Query: 1082 TLLARV 1087
++ +V
Sbjct: 254 DIIKKV 259
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-07
Identities = 8/35 (22%), Positives = 16/35 (45%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
+ + +L + KR +A +AL W+ I+
Sbjct: 280 ELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK 314
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 40/220 (18%)
Query: 864 NSVIAGRYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYV 922
+ I Y VT + LG K +Q + T +K++++ E++L
Sbjct: 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRA 111
Query: 923 NKHDPGDKYHLLRLYDYF----YYREHLLIVCELLKANLYEFHKFNRESGGE-------- 970
++ H++R+ D + R+ LLIV E L GGE
Sbjct: 112 SQCP-----HIVRIVDVYENLYAGRKCLLIVMECL-------------DGGELFSRIQDR 153
Query: 971 --VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLGSSCF 1027
FT I EA+Q+LH + + H D+KPEN+L S +K+ D G +
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213
Query: 1028 ETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
T H L + + Y APEV+ YDK D+WSLG I+
Sbjct: 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 7/28 (25%), Positives = 16/28 (57%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSH 1175
+ +LL+ P +R + ++ + HPW+
Sbjct: 300 MLIRNLLKTEPTQRMTITEFMNHPWIMQ 327
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 46/225 (20%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD----------EI 916
Y E LG S + T + VKII + + E+
Sbjct: 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 917 KLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE------ 970
+L+ V+ H ++++L D + +V +L+K GE
Sbjct: 75 DILRKVSGHP-----NIIQLKDTYETNTFFFLVFDLMK-------------KGELFDYLT 116
Query: 971 --VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF- 1027
V + + I LE + LH L ++H DLKPENIL+ +K+ D G SC
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQL 174
Query: 1028 -ETDHLCSYVQSRSYRAPEVILGLS------YDKKIDIWSLGCIL 1065
+ L + SY APE+I Y K++D+WS G I+
Sbjct: 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 9e-06
Identities = 11/28 (39%), Positives = 17/28 (60%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSH 1175
D V+ L + P+KR +A +AL HP+
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 77/338 (22%), Positives = 136/338 (40%), Gaps = 82/338 (24%)
Query: 856 DKNFHVVLNSVI-----AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFF 909
D+ L S++ +Y E +G A A D+ TG +V ++ + +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 910 DQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGG 969
+ ++EI +++ NK+ +++ D + + L +V E L +GG
Sbjct: 62 ELIINEILVMRE-NKNP-----NIVNYLDSYLVGDELWVVMEYL-------------AGG 102
Query: 970 -------EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022
E ++ ++ +CL+AL+FLH +IH D+K +NIL+ VK+ D
Sbjct: 103 SLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDF 160
Query: 1023 GSSCFETDHLC---SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
G T + V + + APEV+ +Y K+DIWSLG + E+ G + N++
Sbjct: 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
Query: 1080 PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT--SLRH 1137
P R + YLI L++
Sbjct: 221 P----LRAL--------------------------------------YLIATNGTPELQN 238
Query: 1138 RLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175
+ F DF+ LE++ +KR SA + L+H +L
Sbjct: 239 PEKLSAI-FRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII-KNNKDFFDQSLDEIKLLKYVNKH 925
I Y + +G ++ + A T + K I K + D+ EI+++K ++ H
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD-H 65
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV--------YFTMPR 977
+++RLY+ F + +V EL +GGE+ F
Sbjct: 66 P-----NIIRLYETFEDNTDIYLVMELC-------------TGGELFERVVHKRVFRESD 107
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLGSSCF--ETDHLCS 1034
I L A+ + H L + H DLKPEN L + S +K+ID G + + +
Sbjct: 108 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 1035 YVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
V + Y +P+V+ G Y + D WS G ++
Sbjct: 168 KVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 9/27 (33%), Positives = 15/27 (55%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
+ LL +PK+R ++ AL+H W
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFE 266
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 59/340 (17%), Positives = 108/340 (31%), Gaps = 64/340 (18%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK------------------NNKDFFD 910
Y + L F+K I +K + + K +D
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 911 QSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL-----LKANLYEFHKFNR 965
+E++++ + + + L + + I+ E + F ++
Sbjct: 89 DFKNELQIITDIK-N-E----YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 966 ESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLG- 1023
+ + ++ I L + ++H + H D+KP NIL+ VK+ D G
Sbjct: 143 NYTC--FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK--NGRVKLSDFGE 198
Query: 1024 SSCFETDHLCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLFQNDSPA 1081
S + + + PE K+DIWSLG L + V F
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 1082 TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPM 1141
+ + ++ Y ++ K T + L
Sbjct: 259 ---------------------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSN 297
Query: 1142 GDQGFIDFVAHLLEINPKKRPSASDALKHPWLS-HPYEPI 1180
D DF+ L NP +R ++ DALKH WL+ E +
Sbjct: 298 EDI---DFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 63/340 (18%), Positives = 104/340 (30%), Gaps = 60/340 (17%)
Query: 868 AGRYHVTEYLGSAAFSKAI--QAHDLHTGMDVCVKII---KNNKDFFDQSLDEIKLLKYV 922
G Y + +G A TG V V+ I + + E+ + K +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK-L 82
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA----NLYEFHKFNRESGGEVYFTMPRL 978
H +++ F L +V + +L H + +
Sbjct: 83 FNHP-----NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-------MNELAI 130
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQS 1038
I L+AL ++H +G +H +K +IL+ +V + L S+ H
Sbjct: 131 AYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 1039 RSYR----------APEVI--LGLSYDKKIDIWSLGCILAELCTGN----------VLF- 1075
+ +PEV+ YD K DI+S+G EL G+ +L
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 1076 --QNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT 1133
P L I ++ R + + +
Sbjct: 249 KLNGTVPC--LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306
Query: 1134 SLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
S F FV L+ NP RPSAS L H +
Sbjct: 307 S---------PHFHHFVEQCLQRNPDARPSASTLLNHSFF 337
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-29
Identities = 68/257 (26%), Positives = 115/257 (44%), Gaps = 38/257 (14%)
Query: 846 HRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII--- 902
H + + +N + A RY++ LG +F + ++ D T + VK+I
Sbjct: 3 HHHHHSS--GRENLYFQGT--FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 903 KNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHK 962
L E++LLK ++ H ++++L++ IV EL
Sbjct: 59 SAKNKDTSTILREVELLKKLD-HP-----NIMKLFEILEDSSSFYIVGELY--------- 103
Query: 963 FNRESGGEVY--------FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS- 1013
+GGE++ F+ I Q + ++H ++H DLKPENIL++S
Sbjct: 104 ----TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 1014 RCEVKVIDLGSSCF--ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
C++K+ID G S + + + + Y APEV+ G +YD+K D+WS G IL L +G
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG 218
Query: 1072 NVLFQNDSPATLLARVI 1088
F + +L RV
Sbjct: 219 TPPFYGKNEYDILKRVE 235
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 9/27 (33%), Positives = 16/27 (59%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
D + +L +P R +A+ L+HPW+
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-29
Identities = 76/328 (23%), Positives = 117/328 (35%), Gaps = 82/328 (25%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIKLLKYV 922
G Y + + LG F K TG V VKI+ N+ EI+ LK
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKIL--NRQKIRSLDVVGKIRREIQNLKLF 73
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELLKAN-LYEF---HKFNRESGGEVYFTMPRL 978
H P H+++LY + +V E + L+++ + E F
Sbjct: 74 R-H-P----HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ---- 123
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-SSCFETDHL----C 1033
Q L + + H ++H DLKPEN+L+ + K+ D G S+ C
Sbjct: 124 -----QILSGVDYCHRHMVVHRDLKPENVLLD--AHMNAKIADFGLSNMMSDGEFLRTSC 176
Query: 1034 SYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092
S +Y APEVI G Y ++DIWS G IL L G + F +D TL ++
Sbjct: 177 G---SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC---- 229
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
G + P+ + I + H
Sbjct: 230 --------DG-----------------------IFYTPQYLN---------PSVISLLKH 249
Query: 1153 LLEINPKKRPSASDALKHPWLSHPYEPI 1180
+L+++P KR + D +H W
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDLPKY 277
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII---KNNKDFFDQSLDEIKLLKYVN 923
+ Y V E LG AFS + TG++ KII K + F + E ++ + +
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL- 62
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE--------VYFTM 975
+H +++RL+D +V +L+ +GGE +++
Sbjct: 63 QHP-----NIVRLHDSIQEESFHYLVFDLV-------------TGGELFEDIVAREFYSE 104
Query: 976 PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLGSSCF--ETDHL 1032
Q LE++ + H G++H +LKPEN+L+ S ++ VK+ D G + +++
Sbjct: 105 ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164
Query: 1033 CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
+ + Y +PEV+ Y K +DIW+ G IL
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 12/27 (44%), Positives = 17/27 (62%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
+ +L +NPKKR +A ALK PW+
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWIC 266
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 73/332 (21%), Positives = 118/332 (35%), Gaps = 76/332 (22%)
Query: 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKH 925
Y + E +GS A + A+ V +K I + D+ L EI+ + H
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS-QCHH 72
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQ--SIT 982
+++ Y F ++ L +V +LL ++ + K G + +I
Sbjct: 73 P-----NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 983 IQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR 1042
+ LE L++LH G IH D+K NIL+ V++ D G S F R
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLG--EDGSVQIADFGVSAFLATGGDITRNKV--R 183
Query: 1043 ----------APEVIL-GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091
APEV+ YD K DIWS G EL TG +P
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA------AP----------- 226
Query: 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT--SLRHRLPMGDQG---- 1145
Y M ++ L + SL + +
Sbjct: 227 ----------------YHKYPPM---------KVLMLTLQNDPPSLETGVQDKEMLKKYG 261
Query: 1146 --FIDFVAHLLEINPKKRPSASDALKHPWLSH 1175
F ++ L+ +P+KRP+A++ L+H +
Sbjct: 262 KSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 69/336 (20%), Positives = 130/336 (38%), Gaps = 78/336 (23%)
Query: 856 DKNFHVVLNSVI-----AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFF 909
+ F L V+ +G + A + H+G V VK++ +
Sbjct: 27 HEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR 86
Query: 910 DQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGG 969
+ +E+ +++ +H +++ +Y + E L ++ E L GG
Sbjct: 87 ELLFNEVVIMRD-YQHF-----NVVEMYKSYLVGEELWVLMEFL-------------QGG 127
Query: 970 -------EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022
+V ++ ++ L+AL +LH G+IH D+K ++IL+ VK+ D
Sbjct: 128 ALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL--DGRVKLSDF 185
Query: 1023 GSSCFETDHLC---SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
G + + S V + + APEVI Y ++DIWSLG ++ E+ G + +DS
Sbjct: 186 GFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245
Query: 1080 PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRL 1139
P + + + R+ +L+ K S
Sbjct: 246 P----VQAMKRL--------------------------RDSPPPKLKN--SHKVS----- 268
Query: 1140 PMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175
DF+ +L +P++R +A + L HP+L
Sbjct: 269 ----PVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-29
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD 926
++ + V LG A S + T +K++K D EI +L + H
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRL-SHP 108
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV--------YFTMPRL 978
++++L + F + +V EL+ +GGE+ Y++
Sbjct: 109 -----NIIKLKEIFETPTEISLVLELV-------------TGGELFDRIVEKGYYSERDA 150
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLGSSCF--ETDHLCSY 1035
Q LEA+ +LH G++H DLKPEN+L + + +K+ D G S + +
Sbjct: 151 ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210
Query: 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
+ Y APE++ G +Y ++D+WS+G I
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 12/27 (44%), Positives = 19/27 (70%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
D V L+ ++PKKR + AL+HPW++
Sbjct: 284 DLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 73/316 (23%), Positives = 124/316 (39%), Gaps = 69/316 (21%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
+ V E LG ++ +A TG V +K + D + + EI +++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQQ-CDSP--- 84
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKA----NLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
H+++ Y ++ L IV E A ++ T + +I
Sbjct: 85 --HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR--------NKTLTEDEIATILQST 134
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---SYVQSRSYR 1042
L+ L++LH + IH D+K NIL+ + K+ D G + TD + + + + +
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNT--EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWM 192
Query: 1043 APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
APEVI + Y+ DIWSLG I A IE +A+G
Sbjct: 193 APEVIQEIGYNCVADIWSLG-ITA---------------------------IE---MAEG 221
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKT--SLRHRLPMGDQGFIDFVAHLLEINPKK 1160
+ Y + M R ++IP + R D F DFV L +P++
Sbjct: 222 KP--PYADIHPM---------RAIFMIPTNPPPTFRKPELWSDN-FTDFVKQCLVKSPEQ 269
Query: 1161 RPSASDALKHPWLSHP 1176
R +A+ L+HP++
Sbjct: 270 RATATQLLQHPFVRSA 285
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 76/326 (23%), Positives = 121/326 (37%), Gaps = 74/326 (22%)
Query: 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII--KNNKDFFDQSLDEIKLLKYVNKH 925
+ E +G +F + + D T V +KII + +D + EI +L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DS 79
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKA----NLYEFHKFNRESGGEVYFTMPRLQSI 981
++ + Y + L I+ E L +L E + E + +I
Sbjct: 80 P-----YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-----ETQ-----IATI 124
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---SYVQS 1038
+ L+ L +LH IH D+K N+L+ EVK+ D G + TD ++V +
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTDTQIKRNTFVGT 182
Query: 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098
+ APEVI +YD K DIWSLG EL G P P
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGE-------P------------P----- 218
Query: 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT--SLRHRLPMGDQGFIDFVAHLLEI 1156
+ + M ++ +LIPK +L + +FV L
Sbjct: 219 ---------HSELHPM---------KVLFLIPKNNPPTLEGNY---SKPLKEFVEACLNK 257
Query: 1157 NPKKRPSASDALKHPWLSHPYEPISA 1182
P RP+A + LKH ++ + S
Sbjct: 258 EPSFRPTAKELLKHKFILRNAKKTSY 283
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 30/210 (14%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD 926
+ +Y + E LG F + + + K +K EI +L H
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HR 61
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE---------VYFTMPR 977
++L L++ F E L+++ E + SG +
Sbjct: 62 -----NILHLHESFESMEELVMIFEFI-------------SGLDIFERINTSAFELNERE 103
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF--ETDHLCSY 1035
+ S Q EALQFLH + H D++PENI+ ++ +K+I+ G + D+
Sbjct: 104 IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163
Query: 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
+ Y APEV D+WSLG ++
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 8e-08
Identities = 17/35 (48%), Positives = 21/35 (60%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSHPYEPISA 1182
DFV LL K R +AS+AL+HPWL E +S
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERVST 270
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-28
Identities = 63/313 (20%), Positives = 113/313 (36%), Gaps = 47/313 (15%)
Query: 779 SANSSPSTLSNYERE-HVKREEAEKISGMREEDPGASLEDEEAAAVQEQVRQIKAQEEEF 837
+ S + + +E R E + + E A + Q +A++
Sbjct: 4 HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63
Query: 838 ETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDV 897
G E++ +Y + +G S + TG +
Sbjct: 64 AQPKGTENLYFQSMGPEDELPDWAAAKE-FYQKYDPKDVIGRGVSSVVRRCVHRATGHEF 122
Query: 898 CVKIIKNNK---------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948
VKI++ + + + E +L+ V H H++ L D + + +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP-----HIITLIDSYESSSFMFL 177
Query: 949 VCELLKANLYEFHKFNRESGGE--------VYFTMPRLQSITIQCLEALQFLHGLGLIHC 1000
V +L++ GE V + +SI LEA+ FLH ++H
Sbjct: 178 VFDLMR-------------KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHR 224
Query: 1001 DLKPENILVKSYSRCEVKVIDLGSSCF--ETDHLCSYVQSRSYRAPEVILGLS------Y 1052
DLKPENIL+ ++++ D G SC + L + Y APE++ Y
Sbjct: 225 DLKPENILLDDNM--QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 1053 DKKIDIWSLGCIL 1065
K++D+W+ G IL
Sbjct: 283 GKEVDLWACGVIL 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 10/26 (38%), Positives = 19/26 (73%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWL 1173
D ++ LL+++P+ R +A AL+HP+
Sbjct: 338 DLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 19/213 (8%)
Query: 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD------EIK 917
+ + Y + E +G FS + + TG VKI+ K L E
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 918 LLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMP 976
+ + KH H++ L + + L +V E + A+L + + + ++
Sbjct: 79 ICHML-KHP-----HIVELLETYSSDGMLYMVFEFMDGADL--CFEIVKRADAGFVYSEA 130
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLGSSCF---ETDHL 1032
Q LEAL++ H +IH D+KP +L+ S VK+ G +
Sbjct: 131 VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
Query: 1033 CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
V + + APEV+ Y K +D+W G IL
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 11/27 (40%), Positives = 17/27 (62%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
D V +L ++P +R + +AL HPWL
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWLK 291
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII---KNNKDFFDQSLDEIKLLKYVN 923
+ Y V E LG AFS + TG++ KII K + F + E ++ + +
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL- 85
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE--------VYFTM 975
+H +++RL+D +V +L+ +GGE +++
Sbjct: 86 QHP-----NIVRLHDSIQEESFHYLVFDLV-------------TGGELFEDIVAREFYSE 127
Query: 976 PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLGSSCF--ETDHL 1032
Q LE++ + H G++H +LKPEN+L+ S ++ VK+ D G + +++
Sbjct: 128 ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187
Query: 1033 CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
+ + Y +PEV+ Y K +DIW+ G IL
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 12/27 (44%), Positives = 17/27 (62%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
+ +L +NPKKR +A ALK PW+
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWIC 289
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 59/337 (17%), Positives = 111/337 (32%), Gaps = 100/337 (29%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHD 926
+ + + LG A+ + A + T V VKI+ + D + EI + K +N H
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-H- 64
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV--------------- 971
++++ Y + + E SGGE+
Sbjct: 65 E----NVVKFYGHRREGNIQYLFLEYC-------------SGGELFDRIEPDIGMPEPDA 107
Query: 972 --YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029
+F Q + + +LHG+G+ H D+KPEN+L+ +K+ D G +
Sbjct: 108 QRFFH---------QLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFR 156
Query: 1030 DH-----LCSYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLF--QNDSPA 1081
+ L + Y APE++ + + +D+WS G +L + G + + +DS
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216
Query: 1082 TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPM 1141
+ + +
Sbjct: 217 EYSDWKEK------------------------------------KTYLNPWKKI------ 234
Query: 1142 GDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYE 1178
D + + +L NP R + D K W + P +
Sbjct: 235 -DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 34/214 (15%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII-KNNKDFFDQS--LDEIKLLKYVN 923
Y + E LG AFS + + G + II D E ++ + +
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL- 67
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE--------VYFTM 975
KH +++RL+D H ++ +L+ +GGE Y++
Sbjct: 68 KHP-----NIVRLHDSISEEGHHYLIFDLV-------------TGGELFEDIVAREYYSE 109
Query: 976 PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLGSSCF---ETDH 1031
Q LEA+ H +G++H +LKPEN+L+ S + VK+ D G + E
Sbjct: 110 ADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 1032 LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
+ + Y +PEV+ Y K +D+W+ G IL
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 16/28 (57%), Positives = 22/28 (78%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSH 1175
D + +L INP KR +A++ALKHPW+SH
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISH 273
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 72/326 (22%), Positives = 125/326 (38%), Gaps = 74/326 (22%)
Query: 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP 927
AG + + E +G+ + + + + TG +K++ D ++ EI +LK + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHR- 81
Query: 928 GDKYHLLRLYDYFYYR------EHLLIVCELLKA----NLYEFHKFNRESGGEVYFTMPR 977
++ Y F + + L +V E A +L + K N
Sbjct: 82 ----NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-------LKEEW 130
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC---S 1034
+ I + L L LH +IH D+K +N+L+ EVK++D G S + +
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 1035 YVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089
++ + + APEVI +YD K D+WSLG
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLG--------------------------- 221
Query: 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDF 1149
I IE +A+G + M R +LIP+ + R + + F F
Sbjct: 222 -ITAIE---MAEGA--PPLCDMHPM---------RALFLIPRNPAPRLKSKKWSKKFQSF 266
Query: 1150 VAHLLEINPKKRPSASDALKHPWLSH 1175
+ L N +RP+ +KHP++
Sbjct: 267 IESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 43/222 (19%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD---------EIK 917
+ Y +++ LGS A + A + T V ++II K + + EI+
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 918 LLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE------- 970
+LK +N H ++++ + F+ E IV EL+ GGE
Sbjct: 193 ILKKLN-HP-----CIIKIKN-FFDAEDYYIVLELM-------------EGGELFDKVVG 232
Query: 971 -VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVIDLGSSCF- 1027
+ Q L A+Q+LH G+IH DLKPEN+L+ S C +K+ D G S
Sbjct: 233 NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292
Query: 1028 -ETDHLCSYVQSRSYRAPEVILGL---SYDKKIDIWSLGCIL 1065
ET + + + +Y APEV++ + Y++ +D WSLG IL
Sbjct: 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 13/27 (48%), Positives = 18/27 (66%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
D V LL ++PK R + +AL+HPWL
Sbjct: 378 DLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 872 HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKY 931
V E +G AF +A DV +K I++ + + E++ L VN H
Sbjct: 11 EVEEVVGRGAFGVVCKAK--WRAKDVAIKQIES-ESERKAFIVELRQLSRVN-HP----- 61
Query: 932 HLLRLYDYFYYREHLLIVCELLKA-NLYEF-HKFNRESGGEVYFTMPRLQSITIQCLEAL 989
++++LY + +V E + +LY H Y+T S +QC + +
Sbjct: 62 NIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLP----YYTAAHAMSWCLQCSQGV 115
Query: 990 QFLHGL---GLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEV 1046
+LH + LIH DLKP N+L+ + +K+ D G++C H+ + S ++ APEV
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTV-LKICDFGTACDIQTHMTNNKGSAAWMAPEV 174
Query: 1047 ILGLSYDKKIDIWSLGCILAELCTGNVLFQN 1077
G +Y +K D++S G IL E+ T F
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 81/333 (24%), Positives = 131/333 (39%), Gaps = 76/333 (22%)
Query: 860 HVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-NNKDFFDQSLDEIKL 918
HV + + + LG AF K +A + TG K+I+ +++ + + EI++
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69
Query: 919 LKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA----NLYEFHKFNRESGGEVYFT 974
L H ++++L +Y+ L I+ E + T
Sbjct: 70 LAT-CDHP-----YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD--------RGLT 115
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC- 1033
P++Q + Q LEAL FLH +IH DLK N+L+ ++++ D G S L
Sbjct: 116 EPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT--LEGDIRLADFGVSAKNLKTLQK 173
Query: 1034 --SYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLAR 1086
S++ + + APEV++ YD K DIWSLG
Sbjct: 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG------------------------ 209
Query: 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQ-- 1144
I IE +A+ + N M R+ I K L +
Sbjct: 210 ----ITLIE---MAQIEP--PHHELNPM---------RVLLKIAKSDP--PTLLTPSKWS 249
Query: 1145 -GFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176
F DF+ L+ NP+ RPSA+ L+HP++S
Sbjct: 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 68/314 (21%), Positives = 121/314 (38%), Gaps = 63/314 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII----KNNKDFFDQSLDEIKLLKYVNKH 925
+ +G +F A D+ V +K + K + + + + E++ L+ +H
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRH 113
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+ ++ + +V E + + + +++ EV + ++T
Sbjct: 114 P-----NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGA 163
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPE 1045
L+ L +LH +IH D+K NIL+ VK+ D GS+ S+V + + APE
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGSASIMAPAN-SFVGTPYWMAPE 220
Query: 1046 VILGL---SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
VIL + YD K+D+WSLG I IE LA+
Sbjct: 221 VILAMDEGQYDGKVDVWSLG-ITC---------------------------IE---LAER 249
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
+ F N M Y I + S + + F +FV L+ P+ RP
Sbjct: 250 KP--PLFNMNAM---------SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP 298
Query: 1163 SASDALKHPWLSHP 1176
++ LKH ++
Sbjct: 299 TSEVLLKHRFVLRE 312
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 56/293 (19%), Positives = 100/293 (34%), Gaps = 31/293 (10%)
Query: 808 EEDPGASLEDEEAAAVQEQVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVI 867
P DE V + T + + + + + +
Sbjct: 96 PTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHV 155
Query: 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII-KNNKDFFDQSLDEIKLLKYVNKHD 926
Y + E LG+ AF + + TG + K + ++ + EI+ + + H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HP 214
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE---------VYFTMPR 977
L+ L+D F ++++ E + SGGE +
Sbjct: 215 -----TLVNLHDAFEDDNEMVMIYEFM-------------SGGELFEKVADEHNKMSEDE 256
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF--ETDHLCSY 1035
Q + L +H +H DLKPENI+ + E+K+ID G + +
Sbjct: 257 AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 316
Query: 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
+ + APEV G D+WS+G + L +G F ++ L V
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 12/27 (44%), Positives = 17/27 (62%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
DF+ LL +P R + AL+HPWL+
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWLT 415
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 43/222 (19%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---------NNKDFFDQSLDEIK 917
+ Y +++ LGS A + A + T V +KII D EI+
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 918 LLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE------- 970
+LK +N H P ++++ + F+ E IV EL+ GGE
Sbjct: 68 ILKKLN-H-P----CIIKIKN-FFDAEDYYIVLELM-------------EGGELFDKVVG 107
Query: 971 -VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVIDLGSSCF- 1027
+ Q L A+Q+LH G+IH DLKPEN+L+ S C +K+ D G S
Sbjct: 108 NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 1028 -ETDHLCSYVQSRSYRAPEVILGL---SYDKKIDIWSLGCIL 1065
ET + + + +Y APEV++ + Y++ +D WSLG IL
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 8e-06
Identities = 13/27 (48%), Positives = 18/27 (66%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
D V LL ++PK R + +AL+HPWL
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQ 279
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 59/338 (17%), Positives = 111/338 (32%), Gaps = 100/338 (29%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHD 926
+ + + LG A+ + A + T V VKI+ + D + EI + K +N H
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-H- 64
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV--------------- 971
++++ Y + + E SGGE+
Sbjct: 65 E----NVVKFYGHRREGNIQYLFLEYC-------------SGGELFDRIEPDIGMPEPDA 107
Query: 972 --YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029
+F Q + + +LHG+G+ H D+KPEN+L+ +K+ D G +
Sbjct: 108 QRFFH---------QLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFR 156
Query: 1030 DH-----LCSYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLF--QNDSPA 1081
+ L + Y APE++ + + +D+WS G +L + G + + +DS
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216
Query: 1082 TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPM 1141
+ + +
Sbjct: 217 EYSDWKEK------------------------------------KTYLNPWKKI------ 234
Query: 1142 GDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179
D + + +L NP R + D K W + P +
Sbjct: 235 -DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 38/215 (17%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD-------EIKLLKYV 922
Y + E LGS F+ + TG + K IK + + E+ +L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE--------VYFT 974
H +++ L+D F + ++++ EL+ SGGE T
Sbjct: 66 R-HP-----NIITLHDIFENKTDVVLILELV-------------SGGELFDFLAEKESLT 106
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR--CEVKVIDLGSSCF--ETD 1030
Q L+ + +LH + H DLKPENI++ + +K+ID G + +
Sbjct: 107 EDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 1031 HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
+ + + APE++ + D+WS+G I
Sbjct: 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 10/27 (37%), Positives = 18/27 (66%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
DF+ LL +PK+R + + +L+H W+
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIK 270
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 68/314 (21%), Positives = 117/314 (37%), Gaps = 63/314 (20%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDPG 928
LG A+ + + +G + VK I+ N + L ++ +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP-- 66
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988
+ Y + + I EL+ +L +F+K + G L I + ++A
Sbjct: 67 ---FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQT--IPEDILGKIAVSIVKA 121
Query: 989 LQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL--CSYVQSRSYRAPE 1045
L+ LH L +IH D+KP N+L+ + +VK+ D G S + D + + Y APE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179
Query: 1046 VILG----LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101
I Y K DIWSLG + E LA
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIE-------------------------------LAI 208
Query: 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD--QGFIDFVAHLLEINPK 1159
R + Y + + + ++ S +LP F+DF + L+ N K
Sbjct: 209 LR--FPYDSWGTPF--------QQLKQVVEEPSP--QLPADKFSAEFVDFTSQCLKKNSK 256
Query: 1160 KRPSASDALKHPWL 1173
+RP+ + ++HP+
Sbjct: 257 ERPTYPELMQHPFF 270
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 38/215 (17%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD-------EIKLLKYV 922
Y + E LGS F+ + + TG++ K IK + + E+ +L+ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE--------VYFT 974
H +++ L+D + R ++++ EL+ SGGE +
Sbjct: 73 L-HH-----NVITLHDVYENRTDVVLILELV-------------SGGELFDFLAQKESLS 113
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV--KSYSRCEVKVIDLGSSCF--ETD 1030
S Q L+ + +LH + H DLKPENI++ K+ +K+ID G + +
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 1031 HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
+ + + APE++ + D+WS+G I
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 11/27 (40%), Positives = 18/27 (66%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
DF+ LL +KR + +AL+HPW++
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWIT 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 70/343 (20%), Positives = 122/343 (35%), Gaps = 70/343 (20%)
Query: 845 VHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK- 903
+ + ++++ +G A+ + +G + VK I+
Sbjct: 3 IESSGKLKISPEQHWDFTAED-----LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS 57
Query: 904 -NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHK 962
++ Q L ++ ++ + ++++ Y + I EL+ + +F+K
Sbjct: 58 TVDEKEQKQLLMDLDVVMRSSDCP-----YIVQFYGALFREGDCWICMELMSTSFDKFYK 112
Query: 963 FNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVID 1021
+ +V L IT+ ++AL L L +IH D+KP NIL+ +K+ D
Sbjct: 113 YVYSVLDDV-IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR--SGNIKLCD 169
Query: 1022 LGSSCFETDHL--CSYVQSRSYRAPEVI----LGLSYDKKIDIWSLGCILAELCTGNVLF 1075
G S D + R Y APE I YD + D+WSLG
Sbjct: 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG------------- 216
Query: 1076 QNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSL 1135
I E LA GR + Y N + + K
Sbjct: 217 ---------------ITLYE---LATGR--FPYPKWNSVF--------DQLTQVVKGDPP 248
Query: 1136 RHRLPMGDQG-----FIDFVAHLLEINPKKRPSASDALKHPWL 1173
+L ++ FI+FV L + KRP + LKHP++
Sbjct: 249 --QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 51/239 (21%), Positives = 98/239 (41%), Gaps = 37/239 (15%)
Query: 846 HRKNRTGFEEDKNFHVVLNSV--IAGRYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKII 902
H + + + ++ S+ Y +T + LG F+ Q TG + K +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62
Query: 903 ---KNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYE 959
+ +D + L EI +L+ K P ++ L++ + ++++ E
Sbjct: 63 KKRRRGQDCRAEILHEIAVLELA-KSCP----RVINLHEVYENTSEIILILEYA------ 111
Query: 960 FHKFNRESGGEV----------YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV 1009
+GGE+ + + + Q LE + +LH ++H DLKP+NIL+
Sbjct: 112 -------AGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILL 164
Query: 1010 KS-YSRCEVKVIDLGSSCF--ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
S Y ++K++D G S L + + Y APE++ D+W++G I
Sbjct: 165 SSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 14/27 (51%), Positives = 17/27 (62%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
DF+ LL NP+KRP+A L H WL
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSHSWLQ 292
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 66/316 (20%), Positives = 113/316 (35%), Gaps = 68/316 (21%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDPG 928
+GS + + TG + VK ++ NK+ + L ++ ++ +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP-- 84
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988
++++ + F + I EL+ + K + E L +T+ ++A
Sbjct: 85 ---YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI-----LGKMTVAIVKA 136
Query: 989 LQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL--CSYVQSRSYRAPE 1045
L +L G+IH D+KP NIL+ R ++K+ D G S D +Y APE
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDE--RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE 194
Query: 1046 VI-----LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100
I YD + D+WSLG L EL TG ++N E
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------------DFEV---- 238
Query: 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD---QGFIDFVAHLLEIN 1157
L + ++ LP F FV L +
Sbjct: 239 ------------------------LTK-VLQEEP--PLLPGHMGFSGDFQSFVKDCLTKD 271
Query: 1158 PKKRPSASDALKHPWL 1173
+KRP + L+H ++
Sbjct: 272 HRKRPKYNKLLEHSFI 287
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 46/208 (22%), Positives = 86/208 (41%), Gaps = 31/208 (14%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSL-DEIKLLKYVNKHDPG 928
Y + E LGS AF + + TG K I ++ +EI ++ ++ H
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HP-- 108
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE---------VYFTMPRLQ 979
L+ L+D F + ++++ E L SGGE + +
Sbjct: 109 ---KLINLHDAFEDKYEMVLILEFL-------------SGGELFDRIAAEDYKMSEAEVI 152
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF--ETDHLCSYVQ 1037
+ Q E L+ +H ++H D+KPENI+ ++ VK+ID G + + +
Sbjct: 153 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 212
Query: 1038 SRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
+ + APE++ D+W++G +
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 14/28 (50%), Positives = 20/28 (71%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSH 1175
DF+ +LL+ P+KR + DAL+HPWL
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLKG 310
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 47/218 (21%), Positives = 89/218 (40%), Gaps = 38/218 (17%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD-------EIKLL 919
+ Y E LGS F+ + + TG+ K IK + + E+ +L
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 920 KYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE--------V 971
K + +H +++ L++ + + ++++ EL+ +GGE
Sbjct: 69 KEI-QHP-----NVITLHEVYENKTDVILILELV-------------AGGELFDFLAEKE 109
Query: 972 YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR--CEVKVIDLGSSCF-- 1027
T Q L + +LH L + H DLKPENI++ + +K+ID G +
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 1028 ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
+ + + + APE++ + D+WS+G I
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 13/27 (48%), Positives = 19/27 (70%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
DF+ LL +PKKR + D+L+HPW+
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 58/347 (16%), Positives = 118/347 (34%), Gaps = 105/347 (30%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII-------------------------- 902
+Y + + +G ++ A++ + +K++
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 903 -KNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--REHLLIVCELLKANLYE 959
+ +Q EI +LK ++ H P ++++L + +HL +V EL+
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLD-H-P----NVVKLVEVLDDPNEDHLYMVFELVN----- 121
Query: 960 FHKFNRESGGEV--YFTMPRLQSITI-----QCLEALQFLHGLGLIHCDLKPENILVKSY 1012
G V T+ L ++ +++LH +IH D+KP N+LV
Sbjct: 122 --------QGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED 173
Query: 1013 SRCEVKVIDLGSSCFETD---HLCSYVQSRSYRAPEVILGLS--YD-KKIDIWSLGCILA 1066
+K+ D G S L + V + ++ APE + + K +D+W++G L
Sbjct: 174 GH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 1067 ELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLE 1126
G F ++ L ++ I+
Sbjct: 232 CFVFGQCPFMDERIMCLHSK-------IKSQ----------------------------A 256
Query: 1127 YLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173
P + + + D + +L+ NP+ R + HPW+
Sbjct: 257 LEFPDQPDI-------AEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 56/217 (25%)
Query: 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVN 923
N++I ++ LG K +Q + T +K++++ E++L +
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRAS 68
Query: 924 KHDPGDKYHLLRLYDYF----YYREHLLIVCELLKANLYEFHKFNRESGGE--------- 970
+ H++R+ D + R+ LLIV E L GGE
Sbjct: 69 QCP-----HIVRIVDVYENLYAGRKCLLIVMECL-------------DGGELFSRIQDRG 110
Query: 971 -VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLGSSCFE 1028
FT I EA+Q+LH + + H D+KPEN+L S +K+ D G
Sbjct: 111 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----- 165
Query: 1029 TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
A E G YDK D+WSLG I+
Sbjct: 166 -------------FAKET-TGEKYDKSCDMWSLGVIM 188
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 7/28 (25%), Positives = 16/28 (57%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLSH 1175
+ +LL+ P +R + ++ + HPW+
Sbjct: 235 MLIRNLLKTEPTQRMTITEFMNHPWIMQ 262
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 38/215 (17%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK-------NNKDFFDQSLDEIKLLKYV 922
Y + E LGS F+ + + TG++ K IK ++ E+ +L+ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE--------VYFT 974
H +++ L+D + R ++++ EL+ SGGE +
Sbjct: 73 -LHP-----NIITLHDVYENRTDVVLILELV-------------SGGELFDFLAQKESLS 113
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV--KSYSRCEVKVIDLGSSCF--ETD 1030
S Q L+ + +LH + H DLKPENI++ K+ +K+ID G + +
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 1031 HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCIL 1065
+ + + APE++ + D+WS+G I
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 11/27 (40%), Positives = 18/27 (66%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
DF+ LL +KR + +AL+HPW++
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWIT 277
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 42/232 (18%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN-----KDFFDQSLDEIKLLKYVNKHDPGD 929
E LG F +AI+ TG + +K + + F L E+K+++ + +H
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF----LKEVKVMRCL-EHP--- 67
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKA-NLYEF-HKFNRESGGEVYFTMPRLQSITIQCLE 987
++L+ Y + L + E +K L + + + + S
Sbjct: 68 --NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ------YPWSQRVSFAKDIAS 119
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR----- 1042
+ +LH + +IH DL N LV+ V D G + D RS +
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNV--VVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 1043 ------------APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082
APE+I G SYD+K+D++S G +L E+ + P T
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 38/226 (16%), Positives = 75/226 (33%), Gaps = 31/226 (13%)
Query: 873 VTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLD--------EIKLLKYVNK 924
+ +G F + + V +K + + + E+ ++ +N
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN- 81
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEF-HKFNRESGGEVYFTMPRLQSIT 982
H ++++LY +V E + +LY +
Sbjct: 82 HP-----NIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHP------IKWSVKLRLM 128
Query: 983 IQCLEALQFLHGLG--LIHCDLKPENILVKSYSRCE---VKVIDLGSSCFETDHLCSYVQ 1037
+ ++++ ++H DL+ NI ++S KV D G S + +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG 188
Query: 1038 SRSYRAPEVILGLS--YDKKIDIWSLGCILAELCTGNVLFQNDSPA 1081
+ + APE I Y +K D +S IL + TG F S
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 60/304 (19%), Positives = 111/304 (36%), Gaps = 52/304 (17%)
Query: 780 ANSSPSTLSNYEREHVKREEAEKISGMREEDPGASLEDEEAAAVQEQVRQIKAQEEEFET 839
++ N + +K + E + + + ++ A +
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 840 ----FNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHV--TEYLGSAAFSKAIQAHDLHT 893
F+ +IV K + Y V TE LG F + + + T
Sbjct: 69 PPAPFDHRIVTAKQGA---------------VNSFYTVSKTEILGGGRFGQVHKCEETAT 113
Query: 894 GMDVCVKII-KNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952
G+ + KII ++ +EI ++ ++ H +L++LYD F + +++V E
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLD-HA-----NLIQLYDAFESKNDIVLVMEY 167
Query: 953 LKANLYEFHKFNRESGGE---------VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK 1003
+ GGE T Q E ++ +H + ++H DLK
Sbjct: 168 V-------------DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214
Query: 1004 PENILVKSYSRCEVKVIDLGSSCF--ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSL 1061
PENIL + ++K+ID G + + L + + APEV+ D+WS+
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274
Query: 1062 GCIL 1065
G I
Sbjct: 275 GVIA 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 15/27 (55%), Positives = 19/27 (70%)
Query: 1148 DFVAHLLEINPKKRPSASDALKHPWLS 1174
+F++ LL R SAS+ALKHPWLS
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLS 347
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 49/212 (23%), Positives = 79/212 (37%), Gaps = 31/212 (14%)
Query: 894 GMDVCVKIIKNNKD-----FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948
G +V VK +++ D + E KL + H +++ L +L +
Sbjct: 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HP-----NIIALRGVCLKEPNLCL 83
Query: 949 VCELLKA-NLYEF-HKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG---LIHCDLK 1003
V E + L + L + +Q + +LH +IH DLK
Sbjct: 84 VMEFARGGPLNRVLS--GKR------IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLK 135
Query: 1004 PENILV------KSYSRCEVKVIDLGSSCFETDHLC-SYVQSRSYRAPEVILGLSYDKKI 1056
NIL+ S +K+ D G + S + ++ APEVI + K
Sbjct: 136 SSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGS 195
Query: 1057 DIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
D+WS G +L EL TG V F+ + V
Sbjct: 196 DVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA 227
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 894 GMDVCVKIIKN---NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950
G DV VKI+ + + ++ L E+ ++K + +H +++ +L IV
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHP-----NIVLFMGAVTQPPNLSIVT 113
Query: 951 ELL-KANLYEF-HKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPEN 1006
E L + +LY HK SG R S+ + + +LH ++H +LK N
Sbjct: 114 EYLSRGSLYRLLHK----SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPN 169
Query: 1007 ILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSR-SYR--APEVILGLSYDKKIDIWSLGC 1063
+LV VKV D G S + S + + APEV+ ++K D++S G
Sbjct: 170 LLVDKKYT--VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227
Query: 1064 ILAELCTGNVLFQNDSPATLLARV 1087
IL EL T + N +PA ++A V
Sbjct: 228 ILWELATLQQPWGNLNPAQVVAAV 251
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 37/231 (16%)
Query: 875 EYLGSAAFSKAIQAHDLHTGM---DVCVKIIKN---NKDFFDQSLDEIKLLKYVNKHDPG 928
+ +GS +F ++ G DV VK++ +E+ +L+ +H
Sbjct: 30 QRIGSGSFG------TVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHV-- 80
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKA-NLYEF-HKFNRESGGEVYFTMPRLQSITIQCL 986
++L Y L IV + + +LY H E F M +L I Q
Sbjct: 81 ---NILLFMGYST-APQLAIVTQWCEGSSLYHHLHA------SETKFEMKKLIDIARQTA 130
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS-----Y 1041
+ +LH +IH DLK NI + + VK+ D G + ++ S+ + +
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFL--HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 1042 RAPEVILGLS---YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089
APEVI Y + D+++ G +L EL TG + + N + + ++G
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 42/238 (17%), Positives = 88/238 (36%), Gaps = 46/238 (19%)
Query: 875 EYLGSAAFSKAIQAHDLHTGM---DVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHDPG 928
E +G F + ++ G +V +++I +N+D E+ + +H+
Sbjct: 39 ELIGKGRFGQ------VYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHE-- 89
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKA-NLYEF-HKFNRESGGEVYFTMPRLQSITIQCL 986
+++ HL I+ L K LY ++ + + + I + +
Sbjct: 90 ---NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD------AKIVLDVNKTRQIAQEIV 140
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSR------S 1040
+ + +LH G++H DLK +N+ + V + D G + +
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDNGK---VVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 1041 YR--APEVI---------LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
APE+I L + K D+++LG I EL F+ ++ ++
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 7e-21
Identities = 50/229 (21%), Positives = 96/229 (41%), Gaps = 32/229 (13%)
Query: 866 VIAGRYHVTEYLGSAAFSKAIQAHDLH-TGMDVCVKIIKNNKD--FFDQSLDEIKLLKYV 922
++AG+Y V + A D + G V +K + ++ D ++ E + L V
Sbjct: 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV 136
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLL-----IVCELLK-ANLYEFHKFNRESGGEVYFTMP 976
H P +++++++ + + IV E + +L + +
Sbjct: 137 V-H-P----SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR-----SKGQK---LPVA 182
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG--SSCFETDHLCS 1034
+ ++ L AL +LH +GL++ DLKPENI++ + ++K+IDLG S +L
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIML---TEEQLKLIDLGAVSRINSFGYLYG 239
Query: 1035 YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
++APE++ DI+++G LA L L
Sbjct: 240 TPG---FQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL 284
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 73/322 (22%), Positives = 117/322 (36%), Gaps = 94/322 (29%)
Query: 877 LGSAAFSKAIQAHDLHTG----MDVCVK--IIKNNKDFFDQSLDEIKLLKYVNKHDPGDK 930
LG +FS + A +L T + + K IIK NK E ++ ++ H P
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENK--VPYVTRERDVMSRLD-H-PF-- 91
Query: 931 YHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC----- 985
++LY F E L GE+ + ++ S C
Sbjct: 92 --FVKLYFTFQDDEKLYFGLSYA-------------KNGELLKYIRKIGSFDETCTRFYT 136
Query: 986 ---LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS-- 1040
+ AL++LHG G+IH DLKPENIL+ +++ D G+ ++ S
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGT-AKVLSPESKQARANSFV 193
Query: 1041 ----YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096
Y +PE++ S K D+W+LGCI+ +L G F+ + + ++I
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-------- 245
Query: 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156
+LEY P+K + R D V LL +
Sbjct: 246 ---------------------------KLEYDFPEKFFPKAR---------DLVEKLLVL 269
Query: 1157 NPKKRP------SASDALKHPW 1172
+ KR HP+
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPF 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 50/234 (21%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKY 921
+I RY + + LG S A D + V +K I ++ + E+
Sbjct: 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 922 VNKHDPGDKYHLLRLYDYFYYREHLLIVCEL-----LKANLYEFHKFNRESGGEVYFTMP 976
++ H +++ + D + +V E L + ++
Sbjct: 68 LS-H-Q----NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL----------SVD 111
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG-------SSCFET 1029
+ T Q L+ ++ H + ++H D+KP+NIL+ S +K+ D G +S +T
Sbjct: 112 TAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQT 169
Query: 1030 DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
+H+ VQ Y +PE G + D+ DI+S+G +L E+ G F ++ ++
Sbjct: 170 NHVLGTVQ---YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-20
Identities = 55/244 (22%), Positives = 87/244 (35%), Gaps = 55/244 (22%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDF---FDQ------SLDE 915
G Y + +G +A D V +K++ ++ F + L E
Sbjct: 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 916 IKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL-----LKANLYEFHKFNRESGGE 970
P H++ ++D+ L + L L A L R G
Sbjct: 94 -----------P----HVVPIHDFGEIDGQLYVDMRLINGVDLAAML-------RRQGP- 130
Query: 971 VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG------- 1023
PR +I Q AL H G H D+KPENILV + ++D G
Sbjct: 131 --LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTD 186
Query: 1024 SSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
+ + V + Y APE + DI++L C+L E TG+ +Q D + +
Sbjct: 187 EKLTQLG---NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243
Query: 1084 LARV 1087
A +
Sbjct: 244 GAHI 247
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 35/209 (16%), Positives = 70/209 (33%), Gaps = 31/209 (14%)
Query: 894 GMDVCVKIIKNNKDFFDQSLD---EIKLLKYVNKHDPGDKYHLLRLYDYFY--YREHLLI 948
G D+ VK++K +S D E L+ + H ++L + H +
Sbjct: 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HP-----NVLPVLGACQSPPAPHPTL 86
Query: 949 VCELLKA-NLYEF-HKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKP 1004
+ + +LY H+ + + + FLH L + L
Sbjct: 87 ITHWMPYGSLYNVLHEGTNFV-----VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNS 141
Query: 1005 ENILVKSYSRCEVKVIDLGSSCF--ETDHLCSYVQSRSYRAPEVILGLSYD---KKIDIW 1059
++++ ++ + + ++ APE + D + D+W
Sbjct: 142 RSVMIDEDMT--ARISMADVKFSFQSPGRMYAP----AWVAPEALQKKPEDTNRRSADMW 195
Query: 1060 SLGCILAELCTGNVLFQNDSPATLLARVI 1088
S +L EL T V F + S + +V
Sbjct: 196 SFAVLLWELVTREVPFADLSNMEIGMKVA 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 65/243 (26%), Positives = 99/243 (40%), Gaps = 51/243 (20%)
Query: 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKY---- 921
++ RY + E LG S+ A DL DV VK+++ D + D L++
Sbjct: 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA-----DLARDPSFYLRFRREA 63
Query: 922 -----------VNKHDPGDKYHLLRLYDYFYYREHLLIVCEL-----LKANLYEFHKFNR 965
V +D G+ Y IV E L+ ++
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPY--------IVMEYVDGVTLRDIVHTEGPM-- 113
Query: 966 ESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025
T R + +AL F H G+IH D+KP NI++ + + VKV+D G +
Sbjct: 114 --------TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIA 163
Query: 1026 CFETDHLCSYVQSRS------YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
D S Q+ + Y +PE G S D + D++SLGC+L E+ TG F DS
Sbjct: 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
Query: 1080 PAT 1082
P +
Sbjct: 224 PVS 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 33/227 (14%), Positives = 59/227 (25%), Gaps = 45/227 (19%)
Query: 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKY 921
+ GRY + + G + QA D V + + D ++L L
Sbjct: 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR 87
Query: 922 VNKHDPGDKYHLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQS 980
++ P + R+ D + R L+V E ++ +L E ++
Sbjct: 88 ID--KP----GVARVLDVVHTRAGGLVVAEWIRGGSLQEV----ADTSPSP----VGAIR 133
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS 1040
A H G+ P + V V +
Sbjct: 134 AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA----------------- 174
Query: 1041 YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
+ + DI +G L L + LA
Sbjct: 175 TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 5e-17
Identities = 60/298 (20%), Positives = 114/298 (38%), Gaps = 30/298 (10%)
Query: 791 EREHVKREEAEKISGMREEDPGASLEDEEAAAVQEQVRQIKAQE--EEFETFNLKIVHRK 848
+R+ R + D + + +++ Q ++ +E + +
Sbjct: 97 KRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVA 156
Query: 849 NRTGFEEDKNFHVVLNSVIAGRYHVTEY-------LGSAAFSKAIQAHDLHTGMDVCVKI 901
+ + F+ L R VT+ LG F + TG K
Sbjct: 157 PFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKK 216
Query: 902 IK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYH--LLRLYDYFYYREHLLIVCELLKA 955
++ + +L+E ++L+ VN ++ L + ++ L +V L+
Sbjct: 217 LEKKRIKKRKGEAMALNEKQILEKVN--------SRFVVSLAYAYETKDALCLVLTLMNG 268
Query: 956 NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC 1015
+FH ++ G+ F R + L+ LH +++ DLKPENIL+ +
Sbjct: 269 GDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH- 324
Query: 1016 EVKVIDLGSSC--FETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
+++ DLG + E + V + Y APEV+ Y D W+LGC+L E+ G
Sbjct: 325 -IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-17
Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKN----NKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG+ +F + + +G +KI+ + +L+E ++L+ VN
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--------F 100
Query: 933 --LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSIT 982
L++L F +L +V E + +GGE++ F+ P +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYV-------------AGGEMFSHLRRIGRFSEPHARFYA 147
Query: 983 IQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS-- 1040
Q + ++LH L LI+ DLKPEN+L+ ++V D G V+ R+
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFG--------FAKRVKGRTWT 197
Query: 1041 ------YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080
APE+IL Y+K +D W+LG ++ E+ G F D P
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 31/163 (19%), Positives = 67/163 (41%), Gaps = 14/163 (8%)
Query: 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKH 925
++ + V + +G F + +L+T V +K+ Q E + K +
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLGS- 63
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+ ++Y + ++ +V ELL +L + + F++ + I IQ
Sbjct: 64 ----GDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT-----FSLKTVLMIAIQL 114
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVK---VIDLGSS 1025
+ ++++H LI+ D+KPEN L+ + +ID +
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 53/306 (17%), Positives = 87/306 (28%), Gaps = 71/306 (23%)
Query: 894 GMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY----DYFYYREHLLIV 949
G V VK+ ++ EI + +H+ ++L L ++
Sbjct: 60 GEKVAVKVFFTTEEASWFRETEIYQTVLM-RHE-----NILGFIAADIKGTGSWTQLYLI 113
Query: 950 CELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL--------GLIHC 1000
+ +LY++ K + + + L LH + H
Sbjct: 114 TDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166
Query: 1001 DLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS-------YRAPEVILG---- 1049
DLK +NILVK C + DLG + + Y PEV+
Sbjct: 167 DLKSKNILVKKNGTC--CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 1050 --LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYK 1107
D++S G IL E+ V G +E+ L
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARRCVSG----------------GIVEEYQLPYHDLVPS 268
Query: 1108 YFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI----NPKKRPS 1163
+ M + R P + S L + L+ NP R +
Sbjct: 269 DPSYEDMREIVCIKKLRPS--FPNRWSSDECLRQ--------MGKLMTECWAHNPASRLT 318
Query: 1164 ASDALK 1169
A K
Sbjct: 319 ALRVKK 324
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 35/165 (21%), Positives = 65/165 (39%), Gaps = 14/165 (8%)
Query: 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVN 923
N+V+ Y V +G +F + +L V +K D Q DE + K +
Sbjct: 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLA 63
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
+ +Y + H ++V +LL +L + F++ +
Sbjct: 64 G-----CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-----FSVKTVAMAAK 113
Query: 984 QCLEALQFLHGLGLIHCDLKPENILV---KSYSRCEVKVIDLGSS 1025
Q L +Q +H L++ D+KP+N L+ S + + V+D G
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 57/308 (18%), Positives = 98/308 (31%), Gaps = 75/308 (24%)
Query: 894 GMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY----DYFYYREHLL 947
G +V VKI + K +F ++ E+ + +H+ ++L + L
Sbjct: 31 GENVAVKIFSSRDEKSWFRET--ELYNTVML-RHE-----NILGFIASDMTSRHSSTQLW 82
Query: 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL--------GLI 998
++ + +LY++ + I + L LH +
Sbjct: 83 LITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135
Query: 999 HCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS-------YRAPEVILG-- 1049
H DLK +NILVK +C + DLG + + + Y APEV+
Sbjct: 136 HRDLKSKNILVKKNGQC--CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI 193
Query: 1050 ----LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105
K++DIW+ G +L E+ V G +E
Sbjct: 194 QVDCFDSYKRVDIWAFGLVLWEVARRMVSN----------------GIVEDYKPPFYDVV 237
Query: 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE----INPKKR 1161
+ M + R IP + L +A L++ NP R
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPN--IPNRWFSDPTLTS--------LAKLMKECWYQNPSAR 287
Query: 1162 PSASDALK 1169
+A K
Sbjct: 288 LTALRIKK 295
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 5e-16
Identities = 66/345 (19%), Positives = 116/345 (33%), Gaps = 51/345 (14%)
Query: 742 ETDDPLKALMGADDMLATWRQKSTDSSRDENNAN-AVRSANSSPSTLSNYEREHVKREEA 800
T + + + + + A A + S + E V R A
Sbjct: 77 RTHEQHGPALQLWKDIEDYDTADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARA 136
Query: 801 EKISGMREEDPGASLEDEEAAAVQEQVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFH 860
G+ + A L A QE + + L+ + + E+
Sbjct: 137 GAGDGLFQPLLRAVLAHLGQAPFQEF------LDSLYFLRFLQWKWLEAQPMGEDWFLDF 190
Query: 861 VVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEI 916
VL G F + TG K + + + ++ E
Sbjct: 191 RVL--------------GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 917 KLLKYVNKHDPGDKYH--LLRLYDYFYYREHLLIVCEL-----LKANLYEFHKFNRESGG 969
K+L V+ ++ L F + L +V + ++ ++Y + N
Sbjct: 237 KILAKVH--------SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG--- 285
Query: 970 EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC--- 1026
F PR T Q + L+ LH +I+ DLKPEN+L+ V++ DLG +
Sbjct: 286 ---FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELK 340
Query: 1027 FETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
Y + + APE++LG YD +D ++LG L E+
Sbjct: 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 24/218 (11%)
Query: 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKH 925
+ RY + +GS +F D+ G +V +K+ Q E K+ K +
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQG- 63
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+ + ++ ++V ELL +L + F F++ + + Q
Sbjct: 64 ----GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQM 114
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRC-EVKVIDLGSSCFETD-----HLCSYVQSR 1039
+ ++++H IH D+KP+N L+ + V +ID G + D H+ Y +++
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP-YRENK 173
Query: 1040 S------YRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
+ Y + LG+ ++ D+ SLG +L G
Sbjct: 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 2e-15
Identities = 41/218 (18%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKH 925
+ ++ + +GS +F + ++ T +V +K+ Q L E K+ + +
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQG- 61
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+ + + ++ ++V +LL +L + F ++ + + Q
Sbjct: 62 ----GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK-----LSLKTVLMLADQM 112
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRC-EVKVIDLGSSCFETD-----HLCSYVQSR 1039
+ ++F+H +H D+KP+N L+ R +V +ID G + D H+ Y +++
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP-YRENK 171
Query: 1040 S------YRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
+ Y + LG+ ++ D+ SLG +L G
Sbjct: 172 NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 4e-15
Identities = 62/333 (18%), Positives = 123/333 (36%), Gaps = 48/333 (14%)
Query: 755 DMLATWRQKSTDSSRDENNANAVRSANSSPSTLSNYEREHVKREEAEKISGMREEDPGAS 814
+ + + + T+ R + L K + ++
Sbjct: 87 EEIKKYEKLETEEERLVCSREIF--DTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPD 144
Query: 815 LEDEEAAAVQEQVRQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVT 874
L + + +R Q+ + KN + N H+ +N + V
Sbjct: 145 LFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKN-----VELNIHLTMND-----FSVH 194
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDK 930
+G F + TG +K + K +L+E +L V+ D
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---- 250
Query: 931 YH--LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQS 980
++ + F+ + L + +L+ +GG+++ F+ ++
Sbjct: 251 -CPFIVCMSYAFHTPDKLSFILDLM-------------NGGDLHYHLSQHGVFSEADMRF 296
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC-FETDHLCSYVQSR 1039
+ + L+ +H +++ DLKP NIL+ + V++ DLG +C F + V +
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTH 354
Query: 1040 SYRAPEVIL-GLSYDKKIDIWSLGCILAELCTG 1071
Y APEV+ G++YD D +SLGC+L +L G
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 40/213 (18%), Positives = 73/213 (34%), Gaps = 41/213 (19%)
Query: 894 GMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY----DYFYYREHLLIV 949
G +V VKI + ++ EI + +H+ ++L L +V
Sbjct: 65 GEEVAVKIFSSREERSWFREAEIYQTVML-RHE-----NILGFIAADNKDNGTWTQLWLV 118
Query: 950 CELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG--------LGLIHC 1000
+ +L+++ T+ + + + L LH + H
Sbjct: 119 SDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171
Query: 1001 DLKPENILVKSYSRCEVKVIDLGSSCFETDHL-------CSYVQSRSYRAPEVILG---- 1049
DLK +NILVK C + DLG + V ++ Y APEV+
Sbjct: 172 DLKSKNILVKKNGTC--CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 1050 --LSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080
K+ DI+++G + E+ +
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG +F K A T +K +K D + ++ E ++L +H P
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH-P----F 79
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSITIQ 984
L ++ F +E+L V E L +GG++ F + R +
Sbjct: 80 LTHMFCTFQTKENLFFVMEYL-------------NGGDLMYHIQSCHKFDLSRATFYAAE 126
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCE--VKVIDLGSS---CFETDHLCSYVQSR 1039
+ LQFLH G+++ DLK +NIL+ + +K+ D G ++ +
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDK----DGHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 1040 SYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078
Y APE++LG Y+ +D WS G +L E+ G F
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 1e-14
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG +F K + + T VKI+K D + ++ E ++L K P
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP-P----F 403
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSITIQ 984
L +L+ F + L V E + +GG++ F P +
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYV-------------NGGDLMYHIQQVGRFKEPHAVFYAAE 450
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS---- 1040
L FL G+I+ DLK +N+++ S +K+ D G C E ++ V +++
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFGM-CKE--NIWDGVTTKTFCGT 505
Query: 1041 --YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
Y APE+I Y K +D W+ G +L E+ G F+ +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 46/213 (21%), Positives = 86/213 (40%), Gaps = 41/213 (19%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
+G +++K + T +K++K N+ + D E + + + H P
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH-P----F 71
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSITIQ 984
L+ L+ F L V E + +GG++ + + +
Sbjct: 72 LVGLHSCFQTESRLFFVIEYV-------------NGGDLMFHMQRQRKLPEEHARFYSAE 118
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS---- 1040
AL +LH G+I+ DLK +N+L+ S +K+ D G + L + +
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMC---KEGLRPGDTTSTFCGT 173
Query: 1041 --YRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
Y APE++ G Y +D W+LG ++ E+ G
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 53/229 (23%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKN----NKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG+ +F + H G +K++K + + DE +L V H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--------H 65
Query: 933 --LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSIT 982
++R++ F + + ++ + + GGE++ F P +
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYI-------------EGGELFSLLRKSQRFPNPVAKFYA 112
Query: 983 IQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS-- 1040
+ AL++LH +I+ DLKPENIL+ +K+ D G YV +
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFG--------FAKYVPDVTYT 162
Query: 1041 ------YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
Y APEV+ Y+K ID WS G ++ E+ G F + +
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 37/178 (20%), Positives = 69/178 (38%), Gaps = 19/178 (10%)
Query: 861 VVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLK 920
VL+ + ++ + + +GS F A + ++K E+K +
Sbjct: 29 KVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQ 88
Query: 921 YVNKHDPGDKYHLLRLYDY-----FYY--------REHLLIVCELLKANLYEFHKFNRES 967
V K D K+ + DY FY R + +V E L +L + N
Sbjct: 89 RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT- 147
Query: 968 GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025
F + + I+ L+ L+++H +H D+K N+L+ + +V + D G S
Sbjct: 148 -----FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 6e-14
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 41/220 (18%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG +F K + A TG VK++K D + ++ E ++L H P
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH-P----F 85
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSITIQ 984
L +L+ F + L V E + +GG++ F R + +
Sbjct: 86 LTQLFCCFQTPDRLFFVMEFV-------------NGGDLMFHIQKSRRFDEARARFYAAE 132
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS---- 1040
+ AL FLH G+I+ DLK +N+L+ K+ D G C E +C+ V + +
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFG-MCKE--GICNGVTTATFCGT 187
Query: 1041 --YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078
Y APE++ + Y +D W++G +L E+ G+ F+ +
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 41/223 (18%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
+G +++K + T ++++K N+ + D E + + + H P
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH-P----F 114
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSITIQ 984
L+ L+ F L V E + +GG++ + + +
Sbjct: 115 LVGLHSCFQTESRLFFVIEYV-------------NGGDLMFHMQRQRKLPEEHARFYSAE 161
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS---- 1040
AL +LH G+I+ DLK +N+L+ S +K+ D G + L + +
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMC---KEGLRPGDTTSTFCGT 216
Query: 1041 --YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA 1081
Y APE++ G Y +D W+LG ++ E+ G F +
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 259
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 39/220 (17%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG +F K + + T VKI+K D + ++ E ++L K P
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP-P----F 82
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSITIQ 984
L +L+ F + L V E + +GG++ F P +
Sbjct: 83 LTQLHSCFQTMDRLYFVMEYV-------------NGGDLMYHIQQVGRFKEPHAVFYAAE 129
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCE--VKVIDLG---SSCFETDHLCSYVQSR 1039
L FL G+I+ DLK +N+++ S E +K+ D G + ++ ++ +
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDS----EGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 1040 SYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
Y APE+I Y K +D W+ G +L E+ G F+ +
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 59/319 (18%), Positives = 109/319 (34%), Gaps = 84/319 (26%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
+G +F K T +K + ++ E+++++ + H
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE--------H 74
Query: 933 --LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGE--------VYFTMPRLQSIT 982
L+ L+ F E + +V +LL GG+ V+F ++
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLL-------------LGGDLRYHLQQNVHFKEETVKLFI 121
Query: 983 IQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG--SSCFETDHLCSYVQSRS 1040
+ + AL +L +IH D+KP+NIL+ + V + D + + + ++
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPRETQITTMAGTKP 179
Query: 1041 YRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
Y APE+ G Y +D WSLG EL G + S +
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-------------- 225
Query: 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157
++ F + Y P S Q + + LLE N
Sbjct: 226 -----KEIVHTFETTVVTY-------------PSAWS---------QEMVSLLKKLLEPN 258
Query: 1158 PKKRPSASDALK-HPWLSH 1175
P +R S ++ P+++
Sbjct: 259 PDQRFSQLSDVQNFPYMND 277
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 54/228 (23%), Positives = 89/228 (39%), Gaps = 56/228 (24%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKN----NKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG F K I + TG +KI++ KD ++ E ++L+ H
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--------H 64
Query: 933 --LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSIT 982
L L F + L V E +GGE++ FT R +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFTEERARFYG 111
Query: 983 IQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC----SYVQS 1038
+ + AL++LH +++ D+K EN+++ +K+ D G LC S +
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFG--------LCKEGISDGAT 161
Query: 1039 RS-------YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 34/160 (21%)
Query: 954 KANLY---EFHKFNRESGGEVYFTMPRLQSI---------TIQCLEALQFLHGLGLIHCD 1001
+ LY E++ GG++ + + + + A+ +H LG +H D
Sbjct: 133 ENYLYLVMEYY-----VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187
Query: 1002 LKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS------YRAPEVILGLS---- 1051
+KP+NIL+ +++ D G SC + V+S Y +PE++ +
Sbjct: 188 IKPDNILLDRCG--HIRLADFG-SCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 1052 ---YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088
Y + D W+LG E+ G F DS A +++
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 9e-13
Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKN----NKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG F K I + TG +KI+K KD +L E ++L+ H
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--------H 207
Query: 933 --LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSIT 982
L L F + L V E +GGE++ F+ R +
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFSEDRARFYG 254
Query: 983 IQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVIDLGSS---CFETDHLCSYVQS 1038
+ + AL +LH +++ DLK EN+++ +K+ D G + + ++ +
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGT 312
Query: 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078
Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 47/205 (22%), Positives = 80/205 (39%), Gaps = 29/205 (14%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG + + + + V VK +K + ++F L E ++K + H +
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIK-HP-----N 277
Query: 933 LLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
L++L I+ E + NL ++ RE + + L + Q A+++
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQE-VSAVVLLYMATQISSAMEY 333
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APE 1045
L IH +L N LV VKV D G S T +Y + APE
Sbjct: 334 LEKKNFIHRNLAARNCLV--GENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPE 389
Query: 1046 VILGLSYDKKIDIWSLGCILAELCT 1070
+ + K D+W+ G +L E+ T
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 35/153 (22%), Positives = 63/153 (41%), Gaps = 32/153 (20%)
Query: 954 KANLY---EFHKFNRESGGEVYFTMPRLQSI---------TIQCLEALQFLHGLGLIHCD 1001
NLY +++ GG++ + + + + + A+ +H L +H D
Sbjct: 146 DNNLYLVMDYY-----VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 1002 LKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS------YRAPEVILGLS---- 1051
+KP+NIL+ +++ D G SC + VQS Y +PE++ +
Sbjct: 201 IKPDNILMDMNG--HIRLADFG-SCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 1052 -YDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
Y + D WSLG + E+ G F +S
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 9/101 (8%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCE--VKVIDLGSS---CFETDHLCSYVQSRSYR 1042
AL LH G+I+ DLKPENI++ + VK+ D G + ++ + Y
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNH----QGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 1043 APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
APE+++ +++ +D WSLG ++ ++ TG F ++
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCE--VKVIDLGSS---CFETDHLCSYVQSRSYR 1042
AL LH LG+I+ DLKPENIL+ E +K+ D G S S+ + Y
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDE----EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193
Query: 1043 APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078
APEV+ + + D WS G ++ E+ TG + FQ
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 37/148 (25%), Positives = 63/148 (42%), Gaps = 29/148 (19%)
Query: 956 NLY---EFHKFNRESGGEVY-------FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005
LY E+ GG++ + T + + AL +H +G IH D+KP+
Sbjct: 143 YLYMVMEYM-----PGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD 197
Query: 1006 NILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS------YRAPEVILG----LSYDKK 1055
N+L+ +K+ D G +C + + V+ + Y +PEV+ Y ++
Sbjct: 198 NMLLDKSG--HLKLADFG-TCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 1056 IDIWSLGCILAELCTGNVLFQNDSPATL 1083
D WS+G L E+ G+ F DS
Sbjct: 254 CDWWSVGVFLYEMLVGDTPFYADSLVGT 281
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 52/305 (17%), Positives = 97/305 (31%), Gaps = 69/305 (22%)
Query: 894 GMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY----FYYREHLLIV 949
V VKI Q+ E+ L + KH+ ++L+ L ++
Sbjct: 47 NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHE-----NILQFIGAEKRGTSVDVDLWLI 100
Query: 950 CELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG----------LGLI 998
K +L +F K N + L I L +LH +
Sbjct: 101 TAFHEKGSLSDFLKANV-------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS 153
Query: 999 HCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS-----YRAPEVI-----L 1048
H D+K +N+L+K+ + D G + + Y APEV+
Sbjct: 154 HRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF 211
Query: 1049 GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKY 1108
+ID++++G +L EL + R GP+++ ML + ++
Sbjct: 212 QRDAFLRIDMYAMGLVLWELAS---------------RCTAADGPVDEYMLPFEEEIGQH 256
Query: 1109 FTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI----NPKKRPSA 1164
+ M + R + + M + +E + + R SA
Sbjct: 257 PSLEDMQEVVVHKKKRPV--LRDYWQKHAGMAM--------LCETIEECWDHDAEARLSA 306
Query: 1165 SDALK 1169
+
Sbjct: 307 GCVGE 311
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 31/192 (16%)
Query: 893 TGMDVCVKIIKNN-----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD--YFYYREH 945
TG V VK ++++ +DF EI++LK + +HD ++++ Y R +
Sbjct: 38 TGEVVAVKKLQHSTEEHLRDF----EREIEILKSL-QHD-----NIVKYKGVCYSAGRRN 87
Query: 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004
L ++ E L +L ++ + ++E +L T Q + +++L IH DL
Sbjct: 88 LKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 142
Query: 1005 ENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDI 1058
NILV++ +R K+ D G + + APE + + D+
Sbjct: 143 RNILVENENRV--KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDV 200
Query: 1059 WSLGCILAELCT 1070
WS G +L EL T
Sbjct: 201 WSFGVVLYELFT 212
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 55/232 (23%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
+G +F K + A + VK+++ K + E +L KH P
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH-P----F 100
Query: 933 LLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVY--------FTMPRLQSITIQ 984
L+ L+ F + L V + + +GGE++ F PR + +
Sbjct: 101 LVGLHFSFQTADKLYFVLDYI-------------NGGELFYHLQRERCFLEPRARFYAAE 147
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCE--VKVIDLGSSCFETDHLC-----SYVQ 1037
AL +LH L +++ DLKPENIL+ S + + + D G LC
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDS----QGHIVLTDFG--------LCKENIEHNST 195
Query: 1038 SRS------YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL 1083
+ + Y APEV+ YD+ +D W LG +L E+ G F + + A +
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 31/192 (16%)
Query: 893 TGMDVCVKIIKNN-----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD--YFYYREH 945
TG V VK ++++ +DF EI++LK + +HD ++++ Y R +
Sbjct: 69 TGEVVAVKKLQHSTEEHLRDF----EREIEILKSL-QHD-----NIVKYKGVCYSAGRRN 118
Query: 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004
L ++ E L +L ++ + ++E +L T Q + +++L IH DL
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 173
Query: 1005 ENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDI 1058
NILV++ +R K+ D G + Y APE + + D+
Sbjct: 174 RNILVENENRV--KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDV 231
Query: 1059 WSLGCILAELCT 1070
WS G +L EL T
Sbjct: 232 WSFGVVLYELFT 243
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 28/188 (14%)
Query: 895 MDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948
+ V +K +K DF L E ++ + H +++RL + ++I
Sbjct: 74 VPVAIKTLKAGYTEKQRVDF----LGEAGIMGQFS-HH-----NIIRLEGVISKYKPMMI 123
Query: 949 VCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008
+ E ++ KF RE GE F++ +L + +++L + +H DL NIL
Sbjct: 124 ITEYMENG--ALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 179
Query: 1009 VKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWSLG 1062
V S C KV D G S D + + + APE I + D+WS G
Sbjct: 180 VNSNLVC--KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFG 237
Query: 1063 CILAELCT 1070
++ E+ T
Sbjct: 238 IVMWEVMT 245
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 49/205 (23%), Positives = 80/205 (39%), Gaps = 29/205 (14%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG + + + + V VK +K + ++F L E ++K + KH +
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEI-KHP-----N 70
Query: 933 LLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
L++L I+ E + NL + RE + + L + Q A+++
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQE-VSAVVLLYMATQISSAMEY 126
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APE 1045
L IH DL N LV VKV D G S T +Y + APE
Sbjct: 127 LEKKNFIHRDLAARNCLVG--ENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPE 182
Query: 1046 VILGLSYDKKIDIWSLGCILAELCT 1070
+ + K D+W+ G +L E+ T
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-11
Identities = 48/183 (26%), Positives = 80/183 (43%), Gaps = 22/183 (12%)
Query: 895 MDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL- 953
V +K +K + L E +++K + H+ L++LY E + IV E +
Sbjct: 209 TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE-----KLVQLYAVVS-EEPIYIVTEYMS 261
Query: 954 KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013
K +L F + G+ Y +P+L + Q + ++ + +H DL+ NILV +
Sbjct: 262 KGSL---LDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV-GEN 316
Query: 1014 RCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILAE 1067
KV D G + D+ Y + + APE L + K D+WS G +L E
Sbjct: 317 LV-CKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 373
Query: 1068 LCT 1070
L T
Sbjct: 374 LTT 376
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 3e-11
Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 22/183 (12%)
Query: 895 MDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL- 953
V +K +K + L E +++K + H+ L++LY E + IV E +
Sbjct: 292 TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE-----KLVQLYAVVS-EEPIYIVTEYMS 344
Query: 954 KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013
K +L F + G+ Y +P+L + Q + ++ + +H DL+ NILV
Sbjct: 345 KGSL---LDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG--E 398
Query: 1014 RCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILAE 1067
KV D G + D+ Y + + APE L + K D+WS G +L E
Sbjct: 399 NLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 456
Query: 1068 LCT 1070
L T
Sbjct: 457 LTT 459
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 43/188 (22%), Positives = 78/188 (41%), Gaps = 28/188 (14%)
Query: 895 MDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948
+ V +K +K +DF L E ++ + H +++RL + ++I
Sbjct: 74 ISVAIKTLKVGYTEKQRRDF----LGEASIMGQFD-HP-----NIIRLEGVVTKSKPVMI 123
Query: 949 VCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008
V E ++ F R+ + FT+ +L + +++L +G +H DL NIL
Sbjct: 124 VTEYME--NGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNIL 179
Query: 1009 VKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWSLG 1062
+ S C KV D G D + +R + +PE I + D+WS G
Sbjct: 180 INSNLVC--KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 1063 CILAELCT 1070
+L E+ +
Sbjct: 238 IVLWEVMS 245
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 47/194 (24%), Positives = 76/194 (39%), Gaps = 45/194 (23%)
Query: 894 GMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY-------DYFYYR 943
G V VK IKN+ + F L E ++ + +H +L++L Y
Sbjct: 216 GNKVAVKCIKNDATAQAF----LAEASVMTQL-RHS-----NLVQLLGVIVEEKGGLY-- 263
Query: 944 EHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDL 1002
IV E + K +L + R G V L ++ EA+++L G +H DL
Sbjct: 264 ----IVTEYMAKGSL---VDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 1003 KPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKI 1056
N+LV + KV D G + + + APE + + K
Sbjct: 316 AARNVLVSEDNVA--KVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 1057 DIWSLGCILAELCT 1070
D+WS G +L E+ +
Sbjct: 368 DVWSFGILLWEIYS 381
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 31/211 (14%)
Query: 875 EYLGSAAF---SKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKH 925
+ +GS + V +K +K +DF L E ++ + H
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIMGQFD-H 109
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+++RL +IV E ++ F R G+ FT+ +L +
Sbjct: 110 P-----NIIRLEGVVTRGRLAMIVTEYME--NGSLDTFLRTHDGQ--FTIMQLVGMLRGV 160
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR--- 1042
+++L LG +H DL N+LV S C KV D G S D + + +
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVC--KVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 1043 ---APEVILGLSYDKKIDIWSLGCILAELCT 1070
APE I ++ D+WS G ++ E+
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-11
Identities = 46/208 (22%), Positives = 74/208 (35%), Gaps = 33/208 (15%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDK 930
+G F + V VK + F L E ++LK + H
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQYS-HP---- 172
Query: 931 YHLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
+++RL ++ + IV EL+ + F + + L + +
Sbjct: 173 -NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGM 226
Query: 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------- 1042
++L IH DL N LV + +K+ D G S E D Y S R
Sbjct: 227 EYLESKCCIHRDLAARNCLVT--EKNVLKISDFGMSREEADG--VYAASGGLRQVPVKWT 282
Query: 1043 APEVILGLSYDKKIDIWSLGCILAELCT 1070
APE + Y + D+WS G +L E +
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFS 310
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 26/182 (14%), Positives = 74/182 (40%), Gaps = 26/182 (14%)
Query: 862 VLNSVIAGRYHVTEYLGSAAF-----SKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEI 916
++ + A + V +G F + + + + VK+ ++ E+
Sbjct: 28 IITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTEL 84
Query: 917 KLLKYVNKHDPGDKYHLLRLYDY-----FYY--------REHLLIVCELLKANLYEFHKF 963
K + K + K+ R Y ++ + + ++ + ++L + ++
Sbjct: 85 KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA 144
Query: 964 NRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023
N + F+ + ++++ L+ L+++H +H D+K N+L+ + +V ++D G
Sbjct: 145 NAKR-----FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 1024 SS 1025
+
Sbjct: 200 LA 201
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 49/207 (23%), Positives = 76/207 (36%), Gaps = 31/207 (14%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDK 930
+ LGS F DV VK+IK +F E + + ++ H
Sbjct: 14 KELGSGQFGVVKLG-KWKGQYDVAVKMIKEGSMSEDEF----FQEAQTMMKLS-HP---- 63
Query: 931 YHLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
L++ Y + IV E + L + + + + +L + E +
Sbjct: 64 -KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-----LEPSQLLEMCYDVCEGM 117
Query: 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------A 1043
FL IH DL N LV VKV D G + + D YV S + A
Sbjct: 118 AFLESHQFIHRDLAARNCLVD--RDLCVKVSDFGMTRYVLDD--QYVSSVGTKFPVKWSA 173
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCT 1070
PEV Y K D+W+ G ++ E+ +
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 46/205 (22%), Positives = 80/205 (39%), Gaps = 31/205 (15%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
+GS F + V +K I+ +DF ++E +++ + H
Sbjct: 16 IGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDF----IEEAEVMMKL-SHP-----K 64
Query: 933 LLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
L++LY + + +V E + L ++ + R F L + + E + +
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAY 119
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APE 1045
L +IH DL N LV +KV D G + F D Y S + +PE
Sbjct: 120 LEEACVIHRDLAARNCLVG--ENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPE 175
Query: 1046 VILGLSYDKKIDIWSLGCILAELCT 1070
V Y K D+WS G ++ E+ +
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 42/213 (19%), Positives = 71/213 (33%), Gaps = 52/213 (24%)
Query: 894 GMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY-----DYFYYREHL 946
V VK+ N ++F ++ I + + +HD ++ R R
Sbjct: 36 ERPVAVKVFSFANRQNFINEK--NIYRVPLM-EHD-----NIARFIVGDERVTADGRMEY 87
Query: 947 LIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG---------LG 996
L+V E +L ++ + + L +LH
Sbjct: 88 LLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA 140
Query: 997 LIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS-----------YRAPE 1045
+ H DL N+LVK+ C + D G S T + Y APE
Sbjct: 141 ISHRDLNSRNVLVKNDGTC--VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198
Query: 1046 VILGL-------SYDKKIDIWSLGCILAELCTG 1071
V+ G S K++D+++LG I E+
Sbjct: 199 VLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 1e-10
Identities = 106/756 (14%), Positives = 194/756 (25%), Gaps = 265/756 (35%)
Query: 449 DSDEYDDDDDVGYMRQPIEDEAWFLAHEIDYPSDNEKGTGHGSVPDPQGRG-------PT 501
+ D D D + + E EID+ D +
Sbjct: 32 NFDCKDVQD---MPKSILSKE------EIDHII---------MSKDAVSGTLRLFWTLLS 73
Query: 502 KDEDDDQSFAEE---DSY-FSGEQYFQGKNVEPVTTSDDPIGLTVSEMYERTDNDLMDQY 557
K E+ Q F EE +Y F E S + MY + L +
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLMSPI----KTEQRQPSMM------TRMYIEQRDRLYN-- 121
Query: 558 DGQLMDEEELNLMRAEPVWQGFVT------QTNELI----MLGDGKVVSERGRPRL-DDI 606
D Q+ + N+ R +P + + + + + +LG GK + D+
Sbjct: 122 DNQVFAK--YNVSRLQPYLK--LRQALLELRPAKNVLIDGVLGSGKTW-------VALDV 170
Query: 607 CMDDDQH----GSVRSIGVG-INSDAAEMGSEVRDSLLGGSSEGDLEYFHDHDVGIGGSR 661
C+ + + + NS + E+ LL
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVL--EMLQKLL---------------------- 206
Query: 662 FSHHESDKKYIDRKSKDKNKISKQESNKYIVGNDKGKCTQVKNLTDGGFSFPPPLRDGQL 721
++ D + R N + S + +++ L L
Sbjct: 207 ---YQIDPNWTSRSDHSSNIKLRIHSIQ----------AELRRL---------------L 238
Query: 722 VQKGSSKSLWSNNCDPVISDETDDP--LKALMGADDMLATWRQKSTDSSRDENNANAVRS 779
K L ++ + A + +L T +R + + + +
Sbjct: 239 KSKPYENCL-------LVLLNVQNAKAWNAFNLSCKILLT--------TRFKQVTDFLSA 283
Query: 780 ANSSPSTLSNYEREHVKREEAE---KISGMREED-PGASLEDEEA--------AAVQEQV 827
A ++ +L ++ E K R +D P E + + E +
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP------REVLTTNPRRLSIIAESI 337
Query: 828 RQIKAQEEEFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQ 887
R A + ++ N + + VL + + + F
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLN-------VLEPAEYRKM----FDRLSVFPP--- 383
Query: 888 AHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKY--VNKHDPGDKYHLLRLYD-YFYYRE 944
H + + +I + D + KL KY V K K + + Y +
Sbjct: 384 --SAHIPTIL-LSLIWFDVIKSDVMVVVNKLHKYSLVEKQ---PKESTISIPSIYLELKV 437
Query: 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004
L N Y H+ ++
Sbjct: 438 KL--------ENEYALHR---------------------SIVDHYNIPKTFDSDDLIPPY 468
Query: 1005 ENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRA-PEVILGLSY-DKKIDIWSLG 1062
+ S+ +G HL + V L + ++KI S
Sbjct: 469 LDQYFYSH---------IG------HHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDS-- 511
Query: 1063 CILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYK-YFTKNHMLYER--- 1118
A +G++L L ++ YK Y N YER
Sbjct: 512 --TAWNASGSIL-------NTLQQL----------------KFYKPYICDNDPKYERLVN 546
Query: 1119 -------NQETNRLEYLIPKKTSLRHRLPMGDQGFI 1147
E N + K T L M + I
Sbjct: 547 AILDFLPKIEENLICS---KYTDLLRIALMAEDEAI 579
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 2e-10
Identities = 94/620 (15%), Positives = 173/620 (27%), Gaps = 206/620 (33%)
Query: 76 EVSNELIVKEIECGIGRNGSESKWRNTASTGE----RNKPNEASGTSKDRNFTF--SKGS 129
V + V +C + ++ S E + SGT R F SK
Sbjct: 23 SVFEDAFVDNFDC----KDVQDMPKSILSKEEIDHIIMSKDAVSGT--LRLFWTLLSKQE 76
Query: 130 E------DTVLDL-YSWNCNS----NNGPSDPYRN-----DSIHN----FSE-------- 161
E + VL + Y + + PS R D ++N F++
Sbjct: 77 EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136
Query: 162 -------LQTLEQSRYCTTE-IPGVGKVKL-----RPRDSDSSEEILFSGEKKTSWLEST 208
L L ++ + + G GK + + K WL
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL----SYKVQCKMDF--KIFWLNLK 190
Query: 209 SKSNAESKYEKIQASEPKVVDKQLKTGSTCSKETFTDNPWSRNEEPGSSSSELWKDCSVK 268
+ ++ E+ E +Q ++ D S+ + N R + L K
Sbjct: 191 NCNSPETVLEMLQKLLYQI-DPNW-----TSRSDHSSNIKLRIHSIQAELRRLLKS---- 240
Query: 269 TVFPFS---MGDVSTS-----YDIG-----TGSDKKEGKRKTDAADVRASIKQQVDEVGR 315
+ + +V + +++ T K+ TD + +D
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ----VTDFLSAATTTHISLDHHSM 296
Query: 316 ALYLGKSQGNSEQKNISVGFPLVADNPREEFPRLPPVKLKSEDKPLNIN----------- 364
L + + L+ LP L + P ++
Sbjct: 297 TLTPDEVKS------------LLLKYLDCRPQDLPREVLTTN--PRRLSIIAESIRDGLA 342
Query: 365 -WEEKFERDVSGTKLLSS-ENSLLIGSYLDVPVGQEIHSSGGKRTGGGSWLSVSQGIAED 422
W+ + V+ KL + E+SL + L+ +++ LSV
Sbjct: 343 TWD--NWKHVNCDKLTTIIESSL---NVLEPAEYRKMFDR----------LSV------- 380
Query: 423 TSDLVSGFATIGDGLSESVDYPHE----YWDSDEYDDDDDVGYM----------RQPIED 468
S P W D V + +QP ++
Sbjct: 381 --------------FPPSAHIPTILLSLIWFDVIKSDVMVV--VNKLHKYSLVEKQP-KE 423
Query: 469 EAWFLAHEI--DY--PSDNEKGTGHGSVPDPQGRGPTKDEDDDQSFAEEDSYF------- 517
+ I + +NE H S+ D P + DD D YF
Sbjct: 424 STISI-PSIYLELKVKLENEY-ALHRSIVD-HYNIPKTFDSDDLIPPYLDQYFYSHIGHH 480
Query: 518 --SGEQY--------------FQGKNVEPVTTSDDPIG-----LTVSEMYER--TDNDLM 554
+ E F + + +T+ + G L + Y+ DND
Sbjct: 481 LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDND-- 538
Query: 555 DQYDGQLMDEEELNLMRAEP 574
+Y+ +L++ L + E
Sbjct: 539 PKYE-RLVNAILDFLPKIEE 557
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 3e-10
Identities = 68/444 (15%), Positives = 116/444 (26%), Gaps = 150/444 (33%)
Query: 836 EFETFNLKIVHRKNRTGFEED--KNFHVVLNSVIAGRYHVTEYLGSAAFSKA-----IQA 888
+FET + ++ + FE+ NF V + S SK I +
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDC---------KDVQDMPKSI-LSKEEIDHIIMS 57
Query: 889 HDLHTGMDVCVKIIKNN-----KDFFDQSLD-----------------EIKLLKYVNKHD 926
D +G + + + F ++ L + Y+ + D
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD 117
Query: 927 P--GD-----KYHLLRLYDYFYYREHLLIVCEL------------------LKANLYEFH 961
D KY++ RL Y R+ LL EL + ++ +
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQALL---ELRPAKNVLIDGVLGSGKTWVALDVCLSY 174
Query: 962 KFNRESGGEVY-FTMPRLQSITIQCLEALQ-FLHGLGLIHCDL--KPENI---------- 1007
K + +++ + S LE LQ L+ + NI
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPE-TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 1008 -----LVKSYSRC-----------EVKVIDLGSSC---------FETDHLCSYVQSRSYR 1042
K Y C +L C TD L + +
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS--CKILLTTRFKQVTDFLSAATTTH-IS 290
Query: 1043 APEVILGLSYDKKIDIWS--LGCILAEL----CTGNVLFQNDSPATLLARVIGIIGPIEQ 1096
+ L+ D+ + L C +L T N P R + II
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN-------P-----RRLSIIA---- 334
Query: 1097 GMLAKGRDTYKYFTKNHMLYERNQETNR--LEYLIPKKTSLRHRLPMGDQGFIDFVAHLL 1154
+ G T+ + H+ ++ L L P R F
Sbjct: 335 ESIRDGLATWDNW--KHVNCDKLTTIIESSLNVLEP--AEYRKM-------FDRLS---- 379
Query: 1155 EINPKKRPSASDALKHPWLSHPYE 1178
+ P + L W
Sbjct: 380 -VFPPSAHIPTILLSLIWFDVIKS 402
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 42/223 (18%)
Query: 893 TGMDVCVKIIKNN-----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD--YFYYREH 945
TG V VK ++++ +DF EI++LK + D +++ Y R+
Sbjct: 51 TGALVAVKQLQHSGPDQQRDF----QREIQILKAL-HSD-----FIVKYRGVSYGPGRQS 100
Query: 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004
L +V E L + L +F + +R RL + Q + +++L +H DL
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQICKGMEYLGSRRCVHRDLAA 155
Query: 1005 ENILVKSYSRCEVKVIDLG-SSCFETDHLCSYVQSRSYR-------APEVILGLSYDKKI 1056
NILV+S + K+ D G + D Y R APE + + ++
Sbjct: 156 RNILVESEAHV--KIADFGLAKLLPLDK--DYYVVREPGQSPIFWYAPESLSDNIFSRQS 211
Query: 1057 DIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGM 1098
D+WS G +L EL T D + A + ++G
Sbjct: 212 DVWSFGVVLYELFTYC------DKSCSPSAEFLRMMGCERDVP 248
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCE--VKVIDLGSS----CFETDHLCSYVQSRSY 1041
AL+ LH LG+I+ D+K ENIL+ S V + D G S ET+ + + Y
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDS----NGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 1042 RAPEVILGLS--YDKKIDIWSLGCILAELCTG 1071
AP+++ G +DK +D WSLG ++ EL TG
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-10
Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 22/183 (12%)
Query: 895 MDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL- 953
V VK +K + L E ++K + HD L++L+ +E + I+ E +
Sbjct: 213 TKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HD-----KLVKLHAVVT-KEPIYIITEFMA 265
Query: 954 KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013
K +L +F + G +P+L + Q E + F+ IH DL+ NILV +
Sbjct: 266 KGSLLDFL---KSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV--SA 319
Query: 1014 RCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILAE 1067
K+ D G + D+ Y + APE I S+ K D+WS G +L E
Sbjct: 320 SLVCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME 377
Query: 1068 LCT 1070
+ T
Sbjct: 378 IVT 380
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 41/223 (18%), Positives = 80/223 (35%), Gaps = 50/223 (22%)
Query: 875 EYLGSAAFS-------KAIQAHDLHTGMDVCVKIIKN-----NKDFFDQSLDEIKLLKYV 922
E LG F+ + + + +V +K++ ++ F + ++ +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF----FEAASMMSKL 69
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSI 981
+ H HL+ Y + ++V E +K +L + K N+ + +
Sbjct: 70 S-HK-----HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-----INILWKLEV 118
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE------VKVIDLGSSCFETDHLCSY 1035
Q A+ FL LIH ++ +NIL+ + +K+ D G +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG--------ISIT 170
Query: 1036 VQSRSYR-------APEVIL-GLSYDKKIDIWSLGCILAELCT 1070
V + PE I + + D WS G L E+C+
Sbjct: 171 VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-10
Identities = 50/187 (26%), Positives = 76/187 (40%), Gaps = 30/187 (16%)
Query: 895 MDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950
V VK +K F L E L+K + +H L+RLY +E + I+
Sbjct: 38 TKVAVKSLKQGSMSPDAF----LAEANLMKQL-QHQ-----RLVRLYAVVT-QEPIYIIT 86
Query: 951 ELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV 1009
E + +L +F K T+ +L + Q E + F+ IH DL+ NILV
Sbjct: 87 EYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV 142
Query: 1010 KSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGC 1063
K+ D G + D+ Y + APE I ++ K D+WS G
Sbjct: 143 --SDTLSCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 1064 ILAELCT 1070
+L E+ T
Sbjct: 199 LLTEIVT 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 44/195 (22%), Positives = 78/195 (40%), Gaps = 36/195 (18%)
Query: 893 TGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD--YFYYRE 944
TG V VK +K D EI++L+ + H+ ++++
Sbjct: 49 TGEQVAVKSLKPESGGNHIADL----KKEIEILRNL-YHE-----NIVKYKGICTEDGGN 98
Query: 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK 1003
+ ++ E L + +L E+ N+ + + +Q + + +L +H DL
Sbjct: 99 GIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153
Query: 1004 PENILVKSYSRCEVKVIDLG-SSCFETDHLCSYVQSRSYR-------APEVILGLSYDKK 1055
N+LV+S + K+ D G + ETD Y + R APE ++ +
Sbjct: 154 ARNVLVESEHQV--KIGDFGLTKAIETDK--EYYTVKDDRDSPVFWYAPECLMQSKFYIA 209
Query: 1056 IDIWSLGCILAELCT 1070
D+WS G L EL T
Sbjct: 210 SDVWSFGVTLHELLT 224
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 51/222 (22%), Positives = 81/222 (36%), Gaps = 38/222 (17%)
Query: 877 LGSAAF-----SKAIQAHDLHTGMDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHDPGD 929
LG+ AF + A M V VK++K + ++ + E+K+L Y+ H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM--- 87
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKA-NLYEF------------HKFNRESGGEVYFTMP 976
+++ L L++ E +L F E+ +
Sbjct: 88 --NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCS 1034
L S + Q + + FL IH DL NIL+ K+ D G + +
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KICDFGLARDIKNDSN--- 200
Query: 1035 YVQSRSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
YV + R APE I Y + D+WS G L EL +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 48/205 (23%), Positives = 84/205 (40%), Gaps = 31/205 (15%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG+ F DV +K+IK +F ++E K++ ++ H+
Sbjct: 32 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEF----IEEAKVMMNLS-HE-----K 80
Query: 933 LLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
L++LY + + I+ E + L + + R F +L + EA+++
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEY 135
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APE 1045
L +H DL N LV + VKV D G S + D Y S + PE
Sbjct: 136 LESKQFLHRDLAARNCLVN--DQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPE 191
Query: 1046 VILGLSYDKKIDIWSLGCILAELCT 1070
V++ + K DIW+ G ++ E+ +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 35/205 (17%)
Query: 877 LGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHL 933
+G F + + G V VK IKN+ + F L E ++ + +H +L
Sbjct: 29 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAF----LAEASVMTQL-RHS-----NL 76
Query: 934 LRLYDY-FYYREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
++L + L IV E + K +L + R G V L ++ EA+++
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSL---VDYLRSRGRSV-LGGDCLLKFSLDVCEAMEY 132
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APE 1045
L G +H DL N+LV KV D G + + + APE
Sbjct: 133 LEGNNFVHRDLAARNVLVS--EDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPE 184
Query: 1046 VILGLSYDKKIDIWSLGCILAELCT 1070
+ + K D+WS G +L E+ +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYS 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 24/181 (13%), Positives = 55/181 (30%), Gaps = 26/181 (14%)
Query: 861 VVLNSVIAGRYHVTEYLGSAAF--------SKAIQAHDLHTGMDVCVKIIKNNKDFFDQS 912
VL ++ + + + + +K+ + F+
Sbjct: 34 TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFN-- 91
Query: 913 LDEIKLLKYVNKHDPGDKYHLLRLYDY-----FYY-----REHLLIVCELLKANLYEFHK 962
E + K +K+ L ++ +V L +L
Sbjct: 92 --EQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALD 149
Query: 963 FNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022
+ + + + + + L+AL+FLH +H ++ ENI V + +V +
Sbjct: 150 VS----PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGY 205
Query: 1023 G 1023
G
Sbjct: 206 G 206
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 49/226 (21%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 877 LGSAAF-------SKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVN 923
LG AF + + + V VK++K++ D + E++++K +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL----ISEMEMMKMIG 132
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEF----------HKFNRESGGEVY 972
KH +++ L L ++ E NL E+ + +N E
Sbjct: 133 KHK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 973 FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETD 1030
+ L S Q +++L IH DL N+LV +K+ D G + D
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNVMKIADFGLARDIHHID 245
Query: 1031 HLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
+ Y ++ + R APE + Y + D+WS G +L E+ T
Sbjct: 246 Y---YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 877 LGSAAF-------SKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVN 923
LG AF + I + V VK++K++ D + E++++K +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIG 98
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYF--------- 973
KH +++ L L ++ E NL E+ + R G E +
Sbjct: 99 KHK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 974 -TMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETD 1030
T L S T Q +++L IH DL N+LV +K+ D G + D
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT--ENNVMKIADFGLARDINNID 211
Query: 1031 HLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
+ Y ++ + R APE + Y + D+WS G ++ E+ T
Sbjct: 212 Y---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 44/222 (19%), Positives = 88/222 (39%), Gaps = 42/222 (18%)
Query: 877 LGSAAFSKAIQA--HDLHTG---MDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKH 925
LG+ AF K ++A L + V VK++K+ + + E+K++ ++ +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----MSELKIMSHLGQH 109
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNR--------ESGGEVYFTMP 976
+ +++ L + +L++ E +L F + + +
Sbjct: 110 E-----NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCS 1034
L + Q + + FL IH D+ N+L+ + K+ D G + +
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARDIMNDSN--- 219
Query: 1035 YVQSRSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
Y+ + R APE I Y + D+WS G +L E+ +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 51/226 (22%), Positives = 88/226 (38%), Gaps = 46/226 (20%)
Query: 877 LGSAAF-------SKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVN 923
LG F + I + V VK++K++ D + E++++K +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIG 144
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYF--------- 973
KH +++ L L ++ E NL E+ + R G E +
Sbjct: 145 KHK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 974 -TMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETD 1030
T L S T Q +++L IH DL N+LV +K+ D G + D
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE--NNVMKIADFGLARDINNID 257
Query: 1031 HLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
+ Y ++ + R APE + Y + D+WS G ++ E+ T
Sbjct: 258 Y---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 40/194 (20%), Positives = 77/194 (39%), Gaps = 42/194 (21%)
Query: 895 MDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY----DYFYYRE 944
+ VC+K+I++ + D + + ++ H H++RL
Sbjct: 43 IPVCIKVIEDKSGRQSFQAV----TDHMLAIGSLD-HA-----HIVRLLGLCPG-----S 87
Query: 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK 1003
L +V + L +L + + +R + L + +Q + + +L G++H +L
Sbjct: 88 SLQLVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142
Query: 1004 PENILVKSYSRCEVKVIDLG-SSCFETDHLCSYVQSRSYR------APEVILGLSYDKKI 1056
N+L+KS S+ +V D G + D + + A E I Y +
Sbjct: 143 ARNVLLKSPSQV--QVADFGVADLLPPDD--KQLLYSEAKTPIKWMALESIHFGKYTHQS 198
Query: 1057 DIWSLGCILAELCT 1070
D+WS G + EL T
Sbjct: 199 DVWSYGVTVWELMT 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 46/194 (23%), Positives = 73/194 (37%), Gaps = 39/194 (20%)
Query: 895 MDVCVKIIKNN--------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY----DYFYY 942
+ V VK +K + DF + E+ + ++ H +L+RLY
Sbjct: 47 VSVAVKCLKPDVLSQPEAMDDF----IREVNAMHSLD-HR-----NLIRLYGVVLT---- 92
Query: 943 REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDL 1002
+ +V EL A L R+ G F + L +Q E + +L IH DL
Sbjct: 93 -PPMKMVTEL--APLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147
Query: 1003 KPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKI 1056
N+L+ +R VK+ D G + YV + APE + ++
Sbjct: 148 AARNLLLA--TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 205
Query: 1057 DIWSLGCILAELCT 1070
D W G L E+ T
Sbjct: 206 DTWMFGVTLWEMFT 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 43/194 (22%), Positives = 72/194 (37%), Gaps = 36/194 (18%)
Query: 893 TGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD--YFYYRE 944
TG V VK +K + + EI +L+ + H+ H+++
Sbjct: 59 TGEMVAVKALKADAGPQHRSGW----KQEIDILRTL-YHE-----HIIKYKGCCEDAGAA 108
Query: 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK 1003
L +V E + +L ++ + + +L Q E + +LH IH DL
Sbjct: 109 SLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLA 161
Query: 1004 PENILVKSYSRCEVKVIDLG-SSCFETDHLCSYVQSRS------YRAPEVILGLSYDKKI 1056
N+L+ + K+ D G + H V+ Y APE + +
Sbjct: 162 ARNVLLDNDRLV--KIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYAS 218
Query: 1057 DIWSLGCILAELCT 1070
D+WS G L EL T
Sbjct: 219 DVWSFGVTLYELLT 232
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 39/190 (20%), Positives = 77/190 (40%), Gaps = 34/190 (17%)
Query: 895 MDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948
+ V +K ++ K+ LDE ++ V+ + H+ RL + +
Sbjct: 45 IPVAIKELREATSPKANKEI----LDEAYVMASVD-NP-----HVCRLLG-ICLTSTVQL 93
Query: 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007
+ +L+ L ++ + ++++ L + +Q + + +L L+H DL N+
Sbjct: 94 ITQLMPFGCLLDYVREHKDN-----IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 148
Query: 1008 LVKSYSRCEVKVIDLG-SSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWS 1060
LVK + VK+ D G + + + + A E IL Y + D+WS
Sbjct: 149 LVK--TPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 204
Query: 1061 LGCILAELCT 1070
G + EL T
Sbjct: 205 YGVTVWELMT 214
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 43/218 (19%), Positives = 81/218 (37%), Gaps = 39/218 (17%)
Query: 877 LGSAAFS---KAIQAHDLHTGMDVCVKIIKNN-------KDFFDQSLDEIKLLKYVNKHD 926
LG F + + T + V VK +K + ++F L E +K + H
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF----LSEAACMKDFS-HP 96
Query: 927 PGDKYHLLRLY-----DYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQS 980
+++RL +++ +K +L+ + ++R G + + L
Sbjct: 97 -----NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCSYVQS 1038
+ +++L +H DL N ++ V V D G S + D+ Y Q
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCML-RDDMT-VCVADFGLSKKIYSGDY---YRQG 206
Query: 1039 RSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
R + A E + Y K D+W+ G + E+ T
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 42/219 (19%), Positives = 79/219 (36%), Gaps = 40/219 (18%)
Query: 877 LGSAAFS---KAIQAHDLHTGMDVCVKIIKNN-------KDFFDQSLDEIKLLKYVNKHD 926
LG F +A + + + V VK++K + ++F L E +K + H
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF----LREAACMKEFD-HP 85
Query: 927 PGDKYHLLRLY------DYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQ 979
H+ +L +++ +K +L+ F +R + L
Sbjct: 86 -----HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCSYVQ 1037
+ +++L IH DL N ++ + V V D G S + D+ Y Q
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCML-AEDMT-VCVADFGLSRKIYSGDY---YRQ 195
Query: 1038 SRSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
+ + A E + Y D+W+ G + E+ T
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 48/231 (20%), Positives = 82/231 (35%), Gaps = 51/231 (22%)
Query: 877 LGSAAF-----SKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKH 925
LGS AF + A + V VK++K + + E+K++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL----MSELKMMTQLGSH 108
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYF----------- 973
+ +++ L + ++ E +L + + RE E
Sbjct: 109 E-----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 974 ------TMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS-- 1025
T L Q + ++FL +H DL N+LV VK+ D G +
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT--HGKVVKICDFGLARD 221
Query: 1026 CFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
+ YV + R APE + Y K D+WS G +L E+ +
Sbjct: 222 IMSDSN---YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 5e-08
Identities = 38/184 (20%), Positives = 75/184 (40%), Gaps = 21/184 (11%)
Query: 895 MDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCEL 952
+DV +K++K + D + E +++ ++ + +++RL E L++V E+
Sbjct: 364 IDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NP-----YIVRLIG-VCQAEALMLVMEM 416
Query: 953 LKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY 1012
A HKF E + + + Q +++L +H +L N+L+
Sbjct: 417 --AGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-- 470
Query: 1013 SRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILA 1066
+R K+ D G S Y + + APE I + + D+WS G +
Sbjct: 471 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
Query: 1067 ELCT 1070
E +
Sbjct: 531 EALS 534
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 38/189 (20%), Positives = 75/189 (39%), Gaps = 31/189 (16%)
Query: 895 MDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY---DYFYYREHLLI 948
V VKI+KN D+ L E +++ ++ + +++R+ + E ++
Sbjct: 45 KTVAVKILKNEANDPALKDELLAEANVMQQLD-NP-----YIVRMIGICE----AESWML 94
Query: 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007
V E+ + L ++ + NR + + Q +++L +H DL N+
Sbjct: 95 VMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 148
Query: 1008 LVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWSL 1061
L+ ++ K+ D G S Y + APE I + K D+WS
Sbjct: 149 LLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206
Query: 1062 GCILAELCT 1070
G ++ E +
Sbjct: 207 GVLMWEAFS 215
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 6e-08
Identities = 44/211 (20%), Positives = 73/211 (34%), Gaps = 34/211 (16%)
Query: 875 EYLGSAAF---SKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKH 925
+G F + I + M V +K KN + F L E ++ + H
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF----LQEALTMRQFD-H 450
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
H+++L + I+ EL E F + + L Q
Sbjct: 451 P-----HIVKLIGVIT-ENPVWIIMELCTLG--ELRSFLQVRKFS--LDLASLILYAYQL 500
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR--- 1042
AL +L +H D+ N+LV S K+ D G S + D +Y ++ +
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCV--KLGDFGLSRYMEDS--TYYKASKGKLPI 556
Query: 1043 ---APEVILGLSYDKKIDIWSLGCILAELCT 1070
APE I + D+W G + E+
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 45/225 (20%)
Query: 877 LGSAAF-----SKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKH 925
LG AF + A T V VK++K + + E+K+L ++ H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL----MSELKILIHIGHH 90
Query: 926 DPGDKYHLLRLYDY-FYYREHLLIVCELLKA-NLYEF----------HKFNRESGGEVYF 973
+++ L L+++ E K NL + +K E + +
Sbjct: 91 L-----NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 974 TMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDH 1031
T+ L + Q + ++FL IH DL NIL+ + K+ D G + ++
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV--KICDFGLARDIYKDPD 203
Query: 1032 LCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
YV+ R APE I Y + D+WS G +L E+ +
Sbjct: 204 ---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 38/191 (19%), Positives = 75/191 (39%), Gaps = 35/191 (18%)
Query: 895 MDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY---DYFYYREH 945
+DV +K++K ++ + E +++ ++ + +++RL E
Sbjct: 38 IDVAIKVLKQGTEKADTEEM----MREAQIMHQLD-NP-----YIVRLIGVCQ----AEA 83
Query: 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005
L++V E+ A HKF E + + + Q +++L +H DL
Sbjct: 84 LMLVMEM--AGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAAR 139
Query: 1006 NILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIW 1059
N+L+ +R K+ D G S Y + + APE I + + D+W
Sbjct: 140 NVLLV--NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 197
Query: 1060 SLGCILAELCT 1070
S G + E +
Sbjct: 198 SYGVTMWEALS 208
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 43/214 (20%), Positives = 81/214 (37%), Gaps = 40/214 (18%)
Query: 875 EYLGSAAFS---KAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKH 925
LG F + + + ++V VK K + + F + E ++K ++ H
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF----MSEAVIMKNLD-H 72
Query: 926 DPGDKYHLLRLY---DYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSIT 982
H+++L + E I+ EL E + + + L +
Sbjct: 73 P-----HIVKLIGIIE----EEPTWIIMELYP--YGELGHYLERNKNS--LKVLTLVLYS 119
Query: 983 IQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR 1042
+Q +A+ +L + +H D+ NILV S VK+ D G S + D Y ++ R
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVA--SPECVKLGDFGLSRYIEDE--DYYKASVTR 175
Query: 1043 ------APEVILGLSYDKKIDIWSLGCILAELCT 1070
+PE I + D+W + E+ +
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 44/211 (20%), Positives = 74/211 (35%), Gaps = 34/211 (16%)
Query: 875 EYLGSAAFS---KAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKH 925
+G F + I + + V +K KN + F L E ++ + H
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF----LQEALTMRQFD-H 75
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
H+++L + I+ EL E F + + L Q
Sbjct: 76 P-----HIVKLIGVIT-ENPVWIIMELCTLG--ELRSFLQVRKYS--LDLASLILYAYQL 125
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYR--- 1042
AL +L +H D+ N+LV S VK+ D G S + D +Y ++ +
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVS--SNDCVKLGDFGLSRYMEDS--TYYKASKGKLPI 181
Query: 1043 ---APEVILGLSYDKKIDIWSLGCILAELCT 1070
APE I + D+W G + E+
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 46/219 (21%), Positives = 79/219 (36%), Gaps = 40/219 (18%)
Query: 877 LGSAAFSKAIQA--HDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPG 928
+G F + ++A MD +K +K +DF E+++L + H
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF----AGELEVLCKLGHHP-- 86
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNR----------ESGGEVYFTMPR 977
+++ L +R +L + E NL +F + +R + + +
Sbjct: 87 ---NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQ 1037
L + +L IH DL NILV K+ D G S + YV+
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG--ENYVAKIADFGLS-RGQEV---YVK 197
Query: 1038 SRSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
R A E + Y D+WS G +L E+ +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 38/190 (20%), Positives = 76/190 (40%), Gaps = 34/190 (17%)
Query: 895 MDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948
+ V +K ++ K+ LDE ++ V+ + H+ RL + +
Sbjct: 45 IPVAIKELREATSPKANKEI----LDEAYVMASVD-NP-----HVCRLLG-ICLTSTVQL 93
Query: 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007
+ +L+ L ++ + ++++ L + +Q + + +L L+H DL N+
Sbjct: 94 ITQLMPFGCLLDYVREHKDN-----IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 148
Query: 1008 LVKSYSRCEVKVIDLG-SSCFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWS 1060
LVK+ K+ D G + + + + A E IL Y + D+WS
Sbjct: 149 LVKTPQHV--KITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 204
Query: 1061 LGCILAELCT 1070
G + EL T
Sbjct: 205 YGVTVWELMT 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 41/217 (18%), Positives = 76/217 (35%), Gaps = 35/217 (16%)
Query: 872 HVTEYLGSAAFS---KAIQAHDLHTGMDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHD 926
H +G F + +K + + L E L++ +N H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN-HP 82
Query: 927 PGDKYHLLRLYDY-FYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
++L L ++ + +L +F + + + T+ L S +Q
Sbjct: 83 -----NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-----PTVKDLISFGLQ 132
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCSYVQSRSYR 1042
+++L +H DL N ++ S VKV D G + + + Y + +R
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDE-SFT-VKVADFGLARDILDRE----YYSVQQHR 186
Query: 1043 ---------APEVILGLSYDKKIDIWSLGCILAELCT 1070
A E + + K D+WS G +L EL T
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 2e-06
Identities = 42/246 (17%), Positives = 71/246 (28%), Gaps = 51/246 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---------FFDQSLDEIKLLK 920
+ E +G F + Q HT V +KII F++ L EI + K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 921 YVNKHDPGDKYH--------------------LLRLYDYFYYREHLLIVCELLKANLYEF 960
++ LL+ +D++ + + F
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 961 HKFNRESGGE-------VYFTMPRLQSITIQCLEALQFLH-GLGLIHCDLKPENILVKSY 1012
E GG ++ +SI Q +L L H DL N+L+K
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 1013 SRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGN 1072
S ++ G S S + S + + Y + ++
Sbjct: 199 SLKKLHYTLNGKS--------STIPSCGLQVSII----DYTLSRLERDGIVVFCDVSMDE 246
Query: 1073 VLFQND 1078
LF D
Sbjct: 247 DLFTGD 252
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 42/214 (19%), Positives = 84/214 (39%), Gaps = 31/214 (14%)
Query: 877 LGSAAFSK-----AIQAHDLHTGMDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHDPGD 929
LG +F A V +K + ++ L+E ++K N H
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH---- 88
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNR----ESGGEVYFTMPRLQSITIQ 984
H++RL + L++ EL+ +L + + R + ++ ++ + +
Sbjct: 89 --HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCSYVQSRSYR 1042
+ + +L+ +H DL N +V + VK+ D G + +ETD+ Y +
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMV-AEDFT-VKIGDFGMTRDIYETDY---YRKGGKGL 201
Query: 1043 ------APEVILGLSYDKKIDIWSLGCILAELCT 1070
+PE + + D+WS G +L E+ T
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 45/214 (21%), Positives = 77/214 (35%), Gaps = 29/214 (13%)
Query: 872 HVTEYLGSAAFS---KAIQAHDLHTGMDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHD 926
H E +G F + + VK + D + S L E ++K +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP- 150
Query: 927 PGDKYHLLRLYDYFYYREH-LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
++L L E L+V +K +L F + + T+ L +Q
Sbjct: 151 -----NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQ 200
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCSYVQSRSYR 1042
+ ++FL +H DL N ++ VKV D G + ++ + S +
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLDE-KFT-VKVADFGLARDMYDKEF-DSVHNKTGAK 257
Query: 1043 ------APEVILGLSYDKKIDIWSLGCILAELCT 1070
A E + + K D+WS G +L EL T
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 41/218 (18%), Positives = 70/218 (32%), Gaps = 35/218 (16%)
Query: 875 EYLGSAAF-----SKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVN 923
LG AF + + + + V VK + DF L E ++ N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKFN 91
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGE-VYFTMPRLQSI 981
+++R I+ EL+ +L F + R + M L +
Sbjct: 92 HQ------NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSY-SRCEVKVIDLGSS--CFETDHLCSYVQS 1038
Q+L IH D+ N L+ K+ D G + + + Y +
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKG 202
Query: 1039 RSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
PE + + K D WS G +L E+ +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 41/218 (18%), Positives = 69/218 (31%), Gaps = 35/218 (16%)
Query: 875 EYLGSAAFSK-----AIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVN 923
LG AF + + + + V VK + DF L E ++ N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKFN 132
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNR-ESGGEVYFTMPRLQSI 981
+++R I+ EL+ +L F + R M L +
Sbjct: 133 HQ------NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSY-SRCEVKVIDLGSS--CFETDHLCSYVQS 1038
Q+L IH D+ N L+ K+ D G + + + Y +
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKG 243
Query: 1039 RSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
PE + + K D WS G +L E+ +
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 54/229 (23%), Positives = 86/229 (37%), Gaps = 56/229 (24%)
Query: 877 LGSAAF-----SKAIQAHDLHTGMDVCVKIIKNN-----KDFFDQSLDEIKLLKYVNKHD 926
LG AF ++ M V VK +K+ KDF E +LL + H+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF----QREAELLTNLQ-HE 77
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEF----------HKFNRESGGEVYFTM 975
H+++ Y + L++V E +K +L +F + + +
Sbjct: 78 -----HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 976 PRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLC 1033
++ I Q + +L +H DL N LV + VK+ D G S + TD
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG--ANLLVKIGDFGMSRDVYSTD--- 187
Query: 1034 SYVQSRSYR------------APEVILGLSYDKKIDIWSLGCILAELCT 1070
Y YR PE I+ + + D+WS G IL E+ T
Sbjct: 188 -Y-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 44/216 (20%), Positives = 76/216 (35%), Gaps = 33/216 (15%)
Query: 872 HVTEYLGSAAFS---KAIQAHDLHTGMDVCVKIIKNNKDFFDQS--LDEIKLLKYVNKHD 926
H E +G F + + VK + D + S L E ++K +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP- 86
Query: 927 PGDKYHLLRLYDYFYYREH-LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
++L L E L+V +K +L F + + T+ L +Q
Sbjct: 87 -----NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQ 136
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCSYVQSRSYR 1042
+ +++L +H DL N ++ VKV D G + ++ + Y
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDE-KFT-VKVADFGLARDMYDKE---YYSVHNKTG 191
Query: 1043 --------APEVILGLSYDKKIDIWSLGCILAELCT 1070
A E + + K D+WS G +L EL T
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 9e-06
Identities = 63/232 (27%), Positives = 92/232 (39%), Gaps = 53/232 (22%)
Query: 877 LGSAAF-----SKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKH 925
LG F + A V VK++K N +D L E +LK VN H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL----LSEFNVLKQVN-H 85
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNR------------------E 966
H+++LY LL++ E K +L F + +R +
Sbjct: 86 P-----HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 967 SGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS- 1025
E TM L S Q + +Q+L + L+H DL NILV + R +K+ D G S
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-AEGRK-MKISDFGLSR 198
Query: 1026 -CFETDHLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
+E D YV+ R A E + Y + D+WS G +L E+ T
Sbjct: 199 DVYEEDS---YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 55/228 (24%), Positives = 82/228 (35%), Gaps = 55/228 (24%)
Query: 877 LGSAAF-----SKAIQAHDLHTGMDVCVKIIKNN-----KDFFDQSLDEIKLLKYVNKHD 926
LG AF ++ M V VK +K +DF E +LL +
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF----QREAELLTMLQHQ- 103
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEF---------HKFNRESGGEVYFTMP 976
H++R + LL+V E ++ +L F E +
Sbjct: 104 -----HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCS 1034
+L ++ Q + +L GL +H DL N LV VK+ D G S + TD
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG--QGLVVKIGDFGMSRDIYSTD---- 212
Query: 1035 YVQSRSYR------------APEVILGLSYDKKIDIWSLGCILAELCT 1070
Y YR PE IL + + D+WS G +L E+ T
Sbjct: 213 Y-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 17/74 (22%), Positives = 33/74 (44%), Gaps = 10/74 (13%)
Query: 792 REHVKREEAEKISGMREEDPGASLE--DEEAAAVQEQVRQIKAQE-EEF-ETFNLKIVHR 847
+ +E E I REE L+ D + ++++ R+ ++ EE+ + + ++
Sbjct: 76 QADRLTQEPESIRKWREEQ-RKRLQELDAASKVMEQEWREKAKKDLEEWNQRQSEQVEKN 134
Query: 848 K--NRTGFEEDKNF 859
K NR DK F
Sbjct: 135 KINNR---IADKAF 145
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 29/106 (27%), Positives = 46/106 (43%), Gaps = 13/106 (12%)
Query: 973 FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETD 1030
T+ L + Q + ++FL IH DL NIL+ + K+ D G + ++
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV--KICDFGLARDIYKDP 247
Query: 1031 HLCSYVQSRSYR------APEVILGLSYDKKIDIWSLGCILAELCT 1070
YV+ R APE I Y + D+WS G +L E+ +
Sbjct: 248 D---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 45/232 (19%), Positives = 76/232 (32%), Gaps = 57/232 (24%)
Query: 875 EYLGSAAFSK-----AIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVN 923
E LG F K V +K +K+ ++F E L +
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF----RHEAMLRARLQ 70
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVY---------- 972
H +++ L + L ++ +L+EF
Sbjct: 71 -HP-----NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 973 FTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETD 1030
P + Q +++L ++H DL N+LV Y + VK+ DLG + D
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFREVYAAD 182
Query: 1031 HLCSYVQSRSYR------------APEVILGLSYDKKIDIWSLGCILAELCT 1070
+ Y+ APE I+ + DIWS G +L E+ +
Sbjct: 183 Y---------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 48/196 (24%), Positives = 75/196 (38%), Gaps = 30/196 (15%)
Query: 891 LHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944
L G V VK +K F E++++ H +LLRL +
Sbjct: 51 LADGTLVAVKRLKEERTQGGELQF----QTEVEMISMA-VHR-----NLLRLRGFCMTPT 100
Query: 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH---GLGLIHCD 1001
L+V + R + P+ Q I + L +LH +IH D
Sbjct: 101 ERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRD 159
Query: 1002 LKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSR-----SYRAPE-VILGLSYDKK 1055
+K NIL+ E V D G + D+ ++V + + APE + G S +K
Sbjct: 160 VKAANILLDEE--FEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 216
Query: 1056 IDIWSLGCILAELCTG 1071
D++ G +L EL TG
Sbjct: 217 -DVFGYGVMLLELITG 231
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 6e-04
Identities = 36/152 (23%), Positives = 60/152 (39%), Gaps = 24/152 (15%)
Query: 932 HLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMP---RLQSITIQCLEA 988
+L+ L + + L +V + + + R + I A
Sbjct: 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG----TPPLSWHMRCK---I-AQGA 142
Query: 989 ---LQFLHGLGLIHCDLKPENILV-KSYSRCEVKVIDLGSSCFETDHLCSYVQSR----- 1039
+ FLH IH D+K NIL+ +++ K+ D G + + + SR
Sbjct: 143 ANGINFLHENHHIHRDIKSANILLDEAF---TAKISDFGLARASEKFAQTVMTSRIVGTT 199
Query: 1040 SYRAPEVILGLSYDKKIDIWSLGCILAELCTG 1071
+Y APE + G K DI+S G +L E+ TG
Sbjct: 200 AYMAPEALRGEITPKS-DIYSFGVVLLEIITG 230
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 6e-04
Identities = 44/198 (22%), Positives = 83/198 (41%), Gaps = 37/198 (18%)
Query: 891 LHTGMDVCVKIIKNN-----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945
L G V +K ++F EI+ L + P HL+ L + R
Sbjct: 60 LRDGAKVALKRRTPESSQGIEEF----ETEIETLSFC--RHP----HLVSLIGFCDERNE 109
Query: 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMP---RLQSITIQCLEA---LQFLHGLGLIH 999
++++ + ++ + H + + +M RL+ I C+ A L +LH +IH
Sbjct: 110 MILIYKYMENGNLKRHLYGSDLPTM---SMSWEQRLE---I-CIGAARGLHYLHTRAIIH 162
Query: 1000 CDLKPENILV-KSYSRCEVKVIDLGSSCFETDHLCSYVQSR-----SYRAPEVILGLSYD 1053
D+K NIL+ +++ K+ D G S T+ +++ + Y PE +
Sbjct: 163 RDVKSINILLDENF---VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT 219
Query: 1054 KKIDIWSLGCILAELCTG 1071
+K D++S G +L E+
Sbjct: 220 EKSDVYSFGVVLFEVLCA 237
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1182 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.54 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.79 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.31 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.26 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.09 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.84 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.83 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.48 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.42 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.22 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.88 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.58 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.41 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.33 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.02 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.01 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.48 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.09 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.15 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=468.84 Aligned_cols=255 Identities=24% Similarity=0.404 Sum_probs=219.7
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
..|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++| ||||+++++|.+..++|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H------pnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH------ENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCC------TTBCCEEEEEEETTEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCC------CCCCcEEEEEEECCEEE
Confidence 56999999999999999999999999999999997543 334567899999999865 49999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|||||+.| +|.+++... .+++..++.|+.||+.||.|||++|||||||||+||||+. +|.+||+|||+|+
T Consensus 148 ivmEy~~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~DFGla~ 218 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCA 218 (346)
T ss_dssp EEECCCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCE
T ss_pred EEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC--CCCEEEecCcCce
Confidence 99999996 566665432 2899999999999999999999999999999999999984 7889999999998
Q ss_pred ccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1027 FETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1027 ~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
.... ...+.+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+++..|.....+..
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-------- 290 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-------- 290 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC--------
T ss_pred ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC--------
Confidence 6543 34578999999999999999999999999999999999999999999998888877753211100
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
.....++.++++||.+||++||.+|||+.|||+||||+....|
T Consensus 291 ---------------------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 291 ---------------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp ---------------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ---------------------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 0112357899999999999999999999999999999976544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=473.84 Aligned_cols=284 Identities=27% Similarity=0.484 Sum_probs=233.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+|+.++| ||||+++++|...
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~ 125 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH------DNIIAIKDILRPT 125 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCC------TTBCCEEEECCCS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCC------CCcceEeeeeecc
Confidence 4578999999999999999999999999999999997643 334567889999999865 4999999998643
Q ss_pred ------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 944 ------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 944 ------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
.++|||||||.|+|..++.... .+++..++.|++||+.||.|||++|||||||||+|||++. ++.+
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~--~~~~ 197 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE--NCEL 197 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TCCE
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC--CCCE
Confidence 6799999999999998886543 3999999999999999999999999999999999999994 7889
Q ss_pred EEecCCCccccCC-------CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 001034 1018 KVIDLGSSCFETD-------HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089 (1182)
Q Consensus 1018 KLiDFGLA~~~~~-------~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ 1089 (1182)
||+|||+|+.... ...+.+||+.|+|||++.+. .|+.++||||||||+|||++|++||.+.+..+++..|+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999975422 24567999999999999876 569999999999999999999999999999999999999
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcccc--ccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk--~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
..|.++...+........ .......|. ...+....+..+.++++||.+||++||.+||||.||
T Consensus 278 ~~g~p~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 342 (398)
T 4b99_A 278 VLGTPSPAVIQAVGAERV---------------RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 342 (398)
T ss_dssp HHCCCCGGGTC-----CH---------------HHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred hcCCCChHHhhhhhhhhh---------------hhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 999877655433211100 000001111 112233456678999999999999999999999999
Q ss_pred HcCCCCCCCCCC
Q 001034 1168 LKHPWLSHPYEP 1179 (1182)
Q Consensus 1168 LqHPWFk~~~eP 1179 (1182)
|+||||+....|
T Consensus 343 L~Hp~f~~~~~p 354 (398)
T 4b99_A 343 LRHPFLAKYHDP 354 (398)
T ss_dssp TTSGGGTTTCCG
T ss_pred hcCHhhCcCCCC
Confidence 999999986554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=456.23 Aligned_cols=250 Identities=28% Similarity=0.486 Sum_probs=206.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+.+|+.++| ||||+++++|.+..
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH------PHIIKLYDVIKSKD 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCC------TTBCCEEEEEECSS
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCC------CCCCeEEEEEEECC
Confidence 68999999999999999999999999999999997642 334568899999999865 49999999999999
Q ss_pred eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
++||||||++|+|++++.... .+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~--~~~vkl~DFGl 158 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE--HLNVKIADFGL 158 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT--TCCEEECCSSC
T ss_pred EEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC--CCCEEEeecCC
Confidence 999999999999999887543 2899999999999999999999999999999999999984 77899999999
Q ss_pred ccccCC--CcccccCCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1025 SCFETD--HLCSYVQSRSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1025 A~~~~~--~~ss~vGTp~YmAPEVLlg~~y-S~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
|+.... ...+.+||+.|||||++.+..| +.++|||||||++|+|+||++||.+.+...++.+|.....+
T Consensus 159 a~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~-------- 230 (275)
T 3hyh_A 159 SNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT-------- 230 (275)
T ss_dssp C---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------
T ss_pred CeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 986543 3456799999999999999886 58999999999999999999999998888877776421111
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+| ..+++++++||.+||++||.+|||+.|||+||||+..
T Consensus 231 ---------------------------~p---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 231 ---------------------------LP---------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp ---------------------------CC---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred ---------------------------CC---------CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 11 2347899999999999999999999999999999754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=464.63 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=219.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||+|+||+||+|+++.+++.||||++.+.. .....+.+|+++|+.++ |||||+++++|++..
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~ 105 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD------HPFFVKLYFTFQDDE 105 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC------CTTBCCEEEEEECSS
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEEeCC
Confidence 57999999999999999999999999999999998642 33567889999999885 459999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++||||||+.| +|.+++..... +++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~------l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~--~g~vKl~DFG 177 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFG 177 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcC--CCCEEEEEcC
Confidence 99999999985 78888875432 899999999999999999999999999999999999984 7889999999
Q ss_pred CccccCC-----CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1024 SSCFETD-----HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1024 LA~~~~~-----~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
+|+.... ...+.+||+.|||||++.+..|+.++||||||||||+|++|++||.+.+..+++.+|+..-..
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----- 252 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD----- 252 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 9986432 245679999999999999999999999999999999999999999999998888888522111
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHH------HHcCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASD------ALKHPW 1172 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeE------LLqHPW 1172 (1182)
+| ..+++++++||.+||++||.+|||+.| |++|||
T Consensus 253 ------------------------------~p---------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~ 293 (311)
T 4aw0_A 253 ------------------------------FP---------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293 (311)
T ss_dssp ------------------------------CC---------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred ------------------------------CC---------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCC
Confidence 11 134788999999999999999999998 589999
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
|+..
T Consensus 294 F~~i 297 (311)
T 4aw0_A 294 FESV 297 (311)
T ss_dssp GTTC
T ss_pred cCCC
Confidence 9874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=468.72 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=216.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+.+|+.++| ||||+++++|.+...
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H------pnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH------PNIVQYRESFEENGS 97 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCC------TTBCCEEEEEEETTE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCC------CCCCcEEEEEEECCE
Confidence 78999999999999999999999999999999997643 345678899999999865 499999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+||||||+.| +|.+++..... ..+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~DFGl 171 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTVQLGDFGI 171 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECT--TCCEEECSTTE
T ss_pred EEEEEeCCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC--CCCEEEccccc
Confidence 9999999985 78888865432 23789999999999999999999999999999999999984 77899999999
Q ss_pred ccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1025 SCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1025 A~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
|+..... ....+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+++.+|+....+
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-------- 243 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-------- 243 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------
T ss_pred ceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------
Confidence 9876542 34568999999999999999999999999999999999999999999998888887521100
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYE 1178 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~e 1178 (1182)
.....++.++.+||.+||++||.+|||+.|||+||||+...+
T Consensus 244 -----------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 244 -----------------------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp -----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred -----------------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 011245789999999999999999999999999999986543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=470.77 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=220.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
..|++++.||+|+||.||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++| ||||+++++|....++|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H------pnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH------ENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCC------TTBCCEEEEEEETTEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCC------CCCCceEEEEEECCEEE
Confidence 57999999999999999999999999999999997643 334568899999999865 49999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
||||||.| +|.+++... .+++..++.|+.||+.||.|||++|||||||||+||||+. +|.|||+|||+|+
T Consensus 225 iVmEy~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~--~g~vKl~DFGla~ 295 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCA 295 (423)
T ss_dssp EEEECCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT--TCCEEECCCTTCE
T ss_pred EEEeCCCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC--CCCEEEecCccce
Confidence 99999996 566666432 2899999999999999999999999999999999999984 7889999999998
Q ss_pred ccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1027 FETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1027 ~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
.... ...+.+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+++..|.....+.
T Consensus 296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--------- 366 (423)
T 4fie_A 296 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR--------- 366 (423)
T ss_dssp ECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred ECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---------
Confidence 6533 3457799999999999999999999999999999999999999999999888887774221110
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
......++.++++||.+||++||.+|||+.|||+||||+....|
T Consensus 367 --------------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 367 --------------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp --------------------------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred --------------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 01123467899999999999999999999999999999976544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=452.24 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=209.0
Q ss_pred CCEEEEEEeccCCceEEEEEEEC---CCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
++|++++.||+|+||+||+|++. .+++.||||++++.. .....+.+|+.+|+.+ .|||||+++++|++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV------NHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC------CCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC------CCCCCCeEEEEEEE
Confidence 57999999999999999999974 478899999997643 2223456677776665 46699999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++||||||+.| +|.+++.... .+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~D 169 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE--EGHIKLTD 169 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT--TSCEEEES
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcC--CCCEEecc
Confidence 9999999999985 7888887543 2899999999999999999999999999999999999984 77899999
Q ss_pred CCCccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1022 LGSSCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1022 FGLA~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
||+|+... ....+.+||+.|||||++.+..|+.++|||||||+||+|+||++||.+.+..+++.+|.....++
T Consensus 170 FGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---- 245 (304)
T 3ubd_A 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---- 245 (304)
T ss_dssp SEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----
T ss_pred cccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC----
Confidence 99997542 23456799999999999999999999999999999999999999999999988888875221111
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWL 1173 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWF 1173 (1182)
...+++++++||++||++||.+||| ++|||+||||
T Consensus 246 ----------------------------------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 246 ----------------------------------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp ----------------------------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred ----------------------------------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 1235789999999999999999998 5799999999
Q ss_pred CCC
Q 001034 1174 SHP 1176 (1182)
Q Consensus 1174 k~~ 1176 (1182)
+..
T Consensus 286 ~~i 288 (304)
T 3ubd_A 286 STI 288 (304)
T ss_dssp TTC
T ss_pred cCC
Confidence 863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=440.17 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=206.7
Q ss_pred cCCE-EEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe-
Q 001034 868 AGRY-HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY- 942 (1182)
Q Consensus 868 ~drY-eIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd- 942 (1182)
.++| ++.++||+|+||+||+|.++.+++.||+|++.... .....+.+|+.+|+.++| ||||+++++|..
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H------pnIV~~~~~~~~~ 97 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH------PNIVRFYDSWEST 97 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCC------TTBCCEEEEEEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC------CCCCcEEEEEeec
Confidence 4566 77889999999999999999999999999997543 334667899999999865 499999999976
Q ss_pred ---cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccccCCccEEEccCCCce
Q 001034 943 ---REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 943 ---~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRDIKPeNILIDs~~dG~ 1016 (1182)
...+||||||+.| +|.+++.... .+++..++.|+.||+.||.|||+++ ||||||||+||||+. .++.
T Consensus 98 ~~~~~~~~lvmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~-~~g~ 170 (290)
T 3fpq_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGS 170 (290)
T ss_dssp ETTEEEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS-TTSC
T ss_pred cCCCcEEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC-CCCC
Confidence 3568999999985 7888876543 2899999999999999999999998 999999999999973 3578
Q ss_pred EEEecCCCccccCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhcCCc
Q 001034 1017 VKVIDLGSSCFETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP-ATLLARVIGIIGPI 1094 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~-~elLakIv~ilGp~ 1094 (1182)
+||+|||+|+.... ...+.+||+.|||||++.+ +|+.++|||||||+||||+||++||.+.+. ..++..+.... .
T Consensus 171 vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~--~ 247 (290)
T 3fpq_A 171 VKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--K 247 (290)
T ss_dssp EEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--C
T ss_pred EEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC--C
Confidence 99999999986543 3456789999999999875 699999999999999999999999976544 34444432110 0
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
|.. .....++++++||.+||+.||.+|||+.|||+||||+
T Consensus 248 ~~~----------------------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 248 PAS----------------------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp CGG----------------------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCC----------------------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 000 0112467899999999999999999999999999998
Q ss_pred CC
Q 001034 1175 HP 1176 (1182)
Q Consensus 1175 ~~ 1176 (1182)
+.
T Consensus 288 ~~ 289 (290)
T 3fpq_A 288 EE 289 (290)
T ss_dssp --
T ss_pred CC
Confidence 63
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=452.13 Aligned_cols=254 Identities=23% Similarity=0.305 Sum_probs=214.4
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
+.|++.++||+|+||+||+|+++.+|+.||||+++..... .+|+.+++.++ |||||+++++|.+..++||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~------HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLS------SPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCC------CTTBCCEEEEEEETTEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCC------CCCCCcEEEEEEECCEEEE
Confidence 5699999999999999999999999999999999865432 36888877775 5599999999999999999
Q ss_pred EEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCc-eEEEecCCCcc
Q 001034 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC-EVKVIDLGSSC 1026 (1182)
Q Consensus 949 VmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG-~IKLiDFGLA~ 1026 (1182)
||||+.| +|.+++.... .+++..++.|+.||+.||.|||++|||||||||+||||+. +| ++||+|||+|+
T Consensus 128 vmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS--DGSRAALCDFGHAL 199 (336)
T ss_dssp EECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECT--TSCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeC--CCCEEEEeeCCCCe
Confidence 9999995 7888886543 2899999999999999999999999999999999999985 44 69999999997
Q ss_pred ccCCC--------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1027 FETDH--------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1027 ~~~~~--------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
..... ....+||+.|||||++.+.+|+.++||||||||||||+||++||.+.+...++.+|.....+
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~----- 274 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP----- 274 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-----
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-----
Confidence 64321 23458999999999999999999999999999999999999999887766666665421100
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH-----------
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA----------- 1167 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL----------- 1167 (1182)
.....+.+++.+.+||.+||++||.+|||+.||
T Consensus 275 ------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 275 ------------------------------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp ------------------------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------------------------------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 011234568899999999999999999999997
Q ss_pred --HcCCCCCCCCCCCC
Q 001034 1168 --LKHPWLSHPYEPIS 1181 (1182)
Q Consensus 1168 --LqHPWFk~~~eP~~ 1181 (1182)
|+|||++...+|-+
T Consensus 319 ~~l~hPw~~~~~~Pr~ 334 (336)
T 4g3f_A 319 GGLKSPWKGEYKEPRG 334 (336)
T ss_dssp TSSCSCSSSSCCCCCC
T ss_pred hhccCCCcCCCCCCCC
Confidence 57999999988865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=451.60 Aligned_cols=294 Identities=21% Similarity=0.327 Sum_probs=220.3
Q ss_pred ecCCEEEEEEeccCCceEEEEEEEC---CCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|++.+.||+|+||+||+|+++ .+++.||||++.+... ...+.+|+++|+.+. .|||||+++++|...
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~-----~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAG-----GQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTC-----SBTTBCCCSEEEEET
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhc-----CCCCCceEEEEEEEC
Confidence 4578999999999999999999875 4688999999976543 356788999998875 356999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++||||||+.| +|.+++. .+++..++.|++||+.||.|||++|||||||||+|||++. ..+.+||+||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~-~~~~~kl~DF 162 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR-RLKKYALVDF 162 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEEEECCC
T ss_pred CEEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC-CCCeEEECcC
Confidence 999999999985 6777663 1889999999999999999999999999999999999985 3478999999
Q ss_pred CCccccCC-------------------------------CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHh
Q 001034 1023 GSSCFETD-------------------------------HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCT 1070 (1182)
Q Consensus 1023 GLA~~~~~-------------------------------~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLT 1070 (1182)
|+|+.... ...+.+||+.|+|||++.+. .|+.++||||||||+|+|++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 99964322 12345899999999999876 48999999999999999999
Q ss_pred CCCCCC-CCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccc---hhhhhhcchhhhhhccccc-------cccccCC
Q 001034 1071 GNVLFQ-NDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNH---MLYERNQETNRLEYLIPKK-------TSLRHRL 1139 (1182)
Q Consensus 1071 Gr~PF~-g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~---~~~er~~ets~Le~liPk~-------~sL~~~l 1139 (1182)
|++||. +.+..+++.+|+..+|.++.................. ................|.. .......
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 999985 5778899999999998755433222111000000000 0000000000011111111 1112234
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1140 PMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1140 ~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
..++++++|||++||++||.+||||+|||+||||++.
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 5678999999999999999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=461.00 Aligned_cols=263 Identities=23% Similarity=0.348 Sum_probs=227.5
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+.+|+.++| ||||+++++|.+..
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~~ 227 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH------PTLVNLHDAFEDDN 227 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCC------TTBCCEEEEEECSS
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCC------CCCCeEEEEEEECC
Confidence 34579999999999999999999999999999999997654 335667889999999865 49999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++|||||||.| +|++++..... .+++..++.|++||+.||.|||++||+||||||+|||++....+.+||+|||
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEEEEEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeecc
Confidence 99999999985 78777754321 2899999999999999999999999999999999999986556899999999
Q ss_pred CccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1024 SSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1024 LA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+|+.... .....+||+.|||||++.+..|+.++||||||||||+||+|++||.+.+..+++.+|......++..
T Consensus 303 ~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---- 378 (573)
T 3uto_A 303 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS---- 378 (573)
T ss_dssp SCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG----
T ss_pred ceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc----
Confidence 9987543 3456799999999999999999999999999999999999999999999999988886433222211
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
....++.++++||++||++||.+|||+.|||+||||+....|
T Consensus 379 ------------------------------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 379 ------------------------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp ------------------------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred ------------------------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 123457899999999999999999999999999999987665
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=435.38 Aligned_cols=316 Identities=35% Similarity=0.610 Sum_probs=259.8
Q ss_pred cceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 858 NFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 858 ~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
.+....+..+..+|++++.||+|+||.||+|.+..+++.||||+++...........|+.+++.+.+.....|+||++++
T Consensus 86 ~~~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 86 SYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp CBCCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred CccccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 34445567889999999999999999999999999999999999998777777888999999999998888899999999
Q ss_pred EEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 938 DYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
++|....++|+||||+.++|.+++...... .+++..++.|+.||+.||.|||++|||||||||+||||+..+...+
T Consensus 166 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLSMNLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCCCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCE
T ss_pred eecccCCeEEEEEeccCCCHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcce
Confidence 999999999999999999999998865432 2899999999999999999999999999999999999996443449
Q ss_pred EEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
||+|||+++.........++|+.|+|||++.+..++.++||||||||||+|++|++||.+.+..+.+..++..++.++..
T Consensus 242 kL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 242 KVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321 (429)
T ss_dssp EECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred EEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 99999999887777778899999999999999999999999999999999999999999999999999999999999988
Q ss_pred hhhcccccchhhcccchhhhhhcch-------------hhhhh-ccccccccc-cCCCCCcHHHHHHHHHhcccCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQET-------------NRLEY-LIPKKTSLR-HRLPMGDQGFIDFVAHLLEINPKKRP 1162 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~et-------------s~Le~-liPk~~sL~-~~l~~~SeeL~DLIrkMLq~DPekRP 1162 (1182)
++........++............. ..... ..+....+. ......+..+++||++||++||.+||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 8877665555544332211000000 00000 000000110 11123478899999999999999999
Q ss_pred CHHHHHcCCCCCCCC
Q 001034 1163 SASDALKHPWLSHPY 1177 (1182)
Q Consensus 1163 TAeELLqHPWFk~~~ 1177 (1182)
|+.|||+||||+...
T Consensus 402 ta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 402 TPGQALRHPWLRRRL 416 (429)
T ss_dssp CHHHHHTSTTTC---
T ss_pred CHHHHhCChhhccCC
Confidence 999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=409.19 Aligned_cols=315 Identities=30% Similarity=0.535 Sum_probs=254.9
Q ss_pred ceeeeCceecCCEEEEEEeccCCceEEEEEEE-CCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 859 FHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHD-LHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 859 f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkD-k~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
+.+..++.+.++|++++.||+|+||.||+|.+ ..+++.||||+++..........+|+.+++.+.+.....|++|++++
T Consensus 4 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp GTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred eeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 34556788999999999999999999999998 56899999999987776677888999999999988777888999999
Q ss_pred EEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC----
Q 001034 938 DYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS---- 1013 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~---- 1013 (1182)
++|....++||||||+.++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++...
T Consensus 84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 84 EWFEHHGHICIVFELLGLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred cccccCCcEEEEEcCCCCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 99999999999999999999998876532 2388999999999999999999999999999999999998533
Q ss_pred -------------CceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 001034 1014 -------------RCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080 (1182)
Q Consensus 1014 -------------dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~ 1080 (1182)
.+.+||+|||++..........++|+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 5679999999998877767778899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1081 ~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
.+.+..+...++++|..++........+......+.........+.................+..+.+||.+||++||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 99999999999999988776554322111111111000000000111111111111122334678999999999999999
Q ss_pred CCCHHHHHcCCCCCCCC
Q 001034 1161 RPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1161 RPTAeELLqHPWFk~~~ 1177 (1182)
|||+.|||+||||+..-
T Consensus 320 Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 320 RITLREALKHPFFDLLK 336 (339)
T ss_dssp SCCHHHHTTSGGGGGGG
T ss_pred ccCHHHHhcCHHHHHHh
Confidence 99999999999998653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=419.13 Aligned_cols=310 Identities=30% Similarity=0.527 Sum_probs=249.9
Q ss_pred ccceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEE
Q 001034 857 KNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936 (1182)
Q Consensus 857 ~~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL 936 (1182)
..+....+.++.++|++++.||+|+||.||+|++..+++.||||+++...........|+.+++.+.+. ...||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~-~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND-DINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCC-STTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhccc-CCCCCCeecc
Confidence 345666778899999999999999999999999999999999999987766667788899999999854 4578999999
Q ss_pred EEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc-----
Q 001034 937 YDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS----- 1011 (1182)
Q Consensus 937 ~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs----- 1011 (1182)
+++|....++||||||+.++|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCCCCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 9999999999999999988999988765432 2889999999999999999999999999999999999974
Q ss_pred ------------------CCCceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 001034 1012 ------------------YSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNV 1073 (1182)
Q Consensus 1012 ------------------~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~ 1073 (1182)
...+.+||+|||+++.........+||+.|+|||++.+..++.++|||||||++|+|++|++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 23678999999999887777777899999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCcchhhhhcccccch--hhcccchh--hh-hhcchhhhhhccccccccccCCCCCcHHHHH
Q 001034 1074 LFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYK--YFTKNHML--YE-RNQETNRLEYLIPKKTSLRHRLPMGDQGFID 1148 (1182)
Q Consensus 1074 PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k--~F~k~~~~--~e-r~~ets~Le~liPk~~sL~~~l~~~SeeL~D 1148 (1182)
||...+..+.+..+....+++|..++........ ++...... +. ............ ..+.......+..+.+
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK---KCLPLYKIIKHELFCD 334 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHH---TCCCHHHHCCCHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhh---hcccccccchHHHHHH
Confidence 9999999999999999999988877654322111 11000000 00 000000000000 0000011123578999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1149 FVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1149 LIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
||.+||++||.+|||+.|||+||||+
T Consensus 335 li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHhcCChhhCCCHHHHhcCcccC
Confidence 99999999999999999999999996
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=409.79 Aligned_cols=317 Identities=30% Similarity=0.519 Sum_probs=257.5
Q ss_pred CccceeeeCceecCCEEEEEEeccCCceEEEEEEECCCC-cEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceE
Q 001034 856 DKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTG-MDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLL 934 (1182)
Q Consensus 856 ~~~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TG-r~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIV 934 (1182)
...+.+..++.+.++|++++.||+|+||.||+|.+..++ +.||+|+++........+..|+.+++.+.+.....+++++
T Consensus 6 ~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 6 EGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp TSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred CCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 456778889999999999999999999999999998877 7899999987766677888999999999987766777899
Q ss_pred EEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc---
Q 001034 935 RLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS--- 1011 (1182)
Q Consensus 935 kL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs--- 1011 (1182)
.++++|....++||||||+.+++++++..... ..+++..++.++.||+.||.|||++||+||||||+|||+..
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELLGKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp CEEEEEEETTEEEEEEECCCCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred EeeeeeeeCCeEEEEEeccCCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence 99999999999999999999999988876532 13889999999999999999999999999999999999942
Q ss_pred --------------CCCceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001034 1012 --------------YSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN 1077 (1182)
Q Consensus 1012 --------------~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g 1077 (1182)
...+.+||+|||++..........++|+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 146789999999998877777778899999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccC
Q 001034 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1078 ~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~D 1157 (1182)
.+....+..+...++++|..++........++.....+.........+....+............+..+.+||.+||++|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 99999999999999999988877654333222111111110000011111111111111122233568999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCC
Q 001034 1158 PKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1158 PekRPTAeELLqHPWFk~~ 1176 (1182)
|.+|||+.|||+||||+..
T Consensus 322 P~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 322 PAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TTTSCCHHHHTTSGGGGGC
T ss_pred hhhCcCHHHHhcChhhcCC
Confidence 9999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=421.92 Aligned_cols=318 Identities=31% Similarity=0.570 Sum_probs=252.8
Q ss_pred CCCcCCCccceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCC--
Q 001034 850 RTGFEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP-- 927 (1182)
Q Consensus 850 ~~~fee~~~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~-- 927 (1182)
...|.....+++.+++.+.++|++++.||+|+||.||+|++..+++.||||+++........+.+|+.+++.+.+...
T Consensus 18 ~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~ 97 (397)
T 1wak_A 18 PNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97 (397)
T ss_dssp ----CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTC
T ss_pred cccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCC
Confidence 344555667788899999999999999999999999999999999999999998877667788999999999986532
Q ss_pred CCCcceEEEEEEEE----ecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-Ccccccc
Q 001034 928 GDKYHLLRLYDYFY----YREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL-GLIHCDL 1002 (1182)
Q Consensus 928 l~HPnIVkL~dsFq----d~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~-GIIHRDI 1002 (1182)
..|+||++++++|. ...++||||||+.++++..+...... .+++..++.|+.||+.||.|||++ ||+||||
T Consensus 98 ~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~givHrDi 173 (397)
T 1wak_A 98 PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQ----GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDI 173 (397)
T ss_dssp GGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCEECCCC
T ss_pred CCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 24789999999998 45789999999999999888765321 289999999999999999999998 9999999
Q ss_pred CCccEEEccCC-----------------------------------------------CceEEEecCCCccccCCCcccc
Q 001034 1003 KPENILVKSYS-----------------------------------------------RCEVKVIDLGSSCFETDHLCSY 1035 (1182)
Q Consensus 1003 KPeNILIDs~~-----------------------------------------------dG~IKLiDFGLA~~~~~~~ss~ 1035 (1182)
||+||||+..+ ...+||+|||+++.........
T Consensus 174 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 253 (397)
T 1wak_A 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED 253 (397)
T ss_dssp SGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSC
T ss_pred CHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccC
Confidence 99999998532 1379999999998877777778
Q ss_pred cCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhhcCCcchhhhhcccccchhh
Q 001034 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS------PATLLARVIGIIGPIEQGMLAKGRDTYKYF 1109 (1182)
Q Consensus 1036 vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d------~~elLakIv~ilGp~PeemL~~~k~s~k~F 1109 (1182)
++|+.|+|||++.+..++.++||||||||||+|++|++||...+ ....+..+...++.+|..++........+|
T Consensus 254 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 333 (397)
T 1wak_A 254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333 (397)
T ss_dssp CSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred CCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence 89999999999999999999999999999999999999997654 567788899999999988877666555554
Q ss_pred cccchhhhhhcch--hhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1110 TKNHMLYERNQET--NRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1110 ~k~~~~~er~~et--s~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
............. ....... .........+..+++||.+||++||.+|||+.|||+||||+.
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 334 TKKGDLKHITKLKPWGLFEVLV----EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CTTSSBSSCCCCCCCCHHHHHH----HTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CCccccccccccCCcchhHhhh----hhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 4332211100000 0000000 000111223567999999999999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=423.48 Aligned_cols=316 Identities=34% Similarity=0.576 Sum_probs=255.0
Q ss_pred cceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 858 NFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 858 ~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
.+.+..+..+.++|++.+.||+|+||+||+|.+..+++.||||+++...........|+.+++.+.++....+++|++++
T Consensus 43 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred cEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 36677888999999999999999999999999999999999999988776677888899999999877667788899999
Q ss_pred EEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHH--hcCccccccCCccEEEccCCCc
Q 001034 938 DYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH--GLGLIHCDLKPENILVKSYSRC 1015 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLH--S~GIIHRDIKPeNILIDs~~dG 1015 (1182)
++|....++||||||+.++|.+++...... .+++..++.++.||+.||.||| +.||+||||||+|||++....+
T Consensus 123 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSYNLYDLLRNTNFR----GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred eeeccCCceEEEEecCCCCHHHHHhhcCcC----CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 999999999999999999999998765422 2889999999999999999999 5799999999999999755678
Q ss_pred eEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1016 EVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
.+||+|||+++.........++|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.+|+..++.++
T Consensus 199 ~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp CEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred cEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 89999999998877777778999999999999999999999999999999999999999999999999999999999888
Q ss_pred hhhhhcccccchhhcccch--hhhhhcchhhhhhccccccccc------------cCCC------CCcHHHHHHHHHhcc
Q 001034 1096 QGMLAKGRDTYKYFTKNHM--LYERNQETNRLEYLIPKKTSLR------------HRLP------MGDQGFIDFVAHLLE 1155 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~--~~er~~ets~Le~liPk~~sL~------------~~l~------~~SeeL~DLIrkMLq 1155 (1182)
..++........+|..... +...........+..+....+. .... .....+++||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 8777655443333322110 0000000000000000000000 0000 012479999999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCCC
Q 001034 1156 INPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1156 ~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
+||.+|||+.|||+||||+...
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC--
T ss_pred CChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=422.27 Aligned_cols=254 Identities=24% Similarity=0.307 Sum_probs=192.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC--
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE-- 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e-- 944 (1182)
++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|+.++| ||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~H------pnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH------PGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCC------TTBCCEEEEEEEEC--
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCC------CCCCeEEEEEEecCcc
Confidence 45999999999999999999999999999999997543 334567889999988854 59999999998654
Q ss_pred ----------eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC
Q 001034 945 ----------HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013 (1182)
Q Consensus 945 ----------~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~ 1013 (1182)
++||||||+.| +|.+++...... .......++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~-- 153 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM-- 153 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC--
Confidence 47999999985 777777644321 12456678899999999999999999999999999999984
Q ss_pred CceEEEecCCCccccCCC---------------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 001034 1014 RCEVKVIDLGSSCFETDH---------------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND 1078 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~~---------------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~ 1078 (1182)
++.+||+|||+|+..... ....+||+.|||||++.+..|+.++||||||||||||++ ||.+.
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 678999999999764321 234589999999999999999999999999999999996 88643
Q ss_pred CHHHHHHHHHhhc-CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccC
Q 001034 1079 SPATLLARVIGII-GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1079 d~~elLakIv~il-Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~D 1157 (1182)
. +....+.... +.+|. .....++.+.+||.+||+.|
T Consensus 231 ~--~~~~~~~~~~~~~~p~-----------------------------------------~~~~~~~~~~~li~~~L~~d 267 (299)
T 4g31_A 231 M--ERVRTLTDVRNLKFPP-----------------------------------------LFTQKYPCEYVMVQDMLSPS 267 (299)
T ss_dssp H--HHHHHHHHHHTTCCCH-----------------------------------------HHHHHCHHHHHHHHHHTCSS
T ss_pred c--HHHHHHHHHhcCCCCC-----------------------------------------CCcccCHHHHHHHHHHcCCC
Confidence 2 2222221110 01110 00112456789999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCCCC
Q 001034 1158 PKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1158 PekRPTAeELLqHPWFk~~~eP 1179 (1182)
|.+|||+.|||+||||++.--|
T Consensus 268 P~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 268 PMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp GGGSCCHHHHHTSGGGCCC---
T ss_pred hhHCcCHHHHhcCHhhCCCCCC
Confidence 9999999999999999876433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=457.37 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=210.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..++|+++++||+|+||+||+|+++.+|+.||||++.+.. .......+|..++..+... .|||||+++++|++
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~---~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG---DCPFIVCMSYAFHT 263 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS---CCTTBCCEEEEEEC
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC---CCCCEeEEEEEEEE
Confidence 3578999999999999999999999999999999998643 2233455666666665543 58899999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++||||||+.| +|..++.... .|++..+++|++||+.||.|||++|||||||||+||||+. +|+|||+|
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~--~G~vKL~D 335 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISD 335 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeC--CCCEEecc
Confidence 9999999999995 6777776543 2999999999999999999999999999999999999994 78899999
Q ss_pred CCCccccC-CCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhhcCCcch
Q 001034 1022 LGSSCFET-DHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDS---PATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1022 FGLA~~~~-~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d---~~elLakIv~ilGp~Pe 1096 (1182)
||+|+... ....+.+||+.|||||++.. ..|+.++||||||||||||++|++||.+.+ ...++..+....
T Consensus 336 FGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~----- 410 (689)
T 3v5w_A 336 LGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----- 410 (689)
T ss_dssp CTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-----
T ss_pred cceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-----
Confidence 99998654 34567899999999999974 589999999999999999999999997643 223333321100
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHP 1171 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHP 1171 (1182)
. .....++.++++||.+||+.||.+|++ +.||++||
T Consensus 411 ------------------------------~---------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 411 ------------------------------V---------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp ------------------------------C---------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred ------------------------------C---------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 0 011245789999999999999999998 89999999
Q ss_pred CCCCC
Q 001034 1172 WLSHP 1176 (1182)
Q Consensus 1172 WFk~~ 1176 (1182)
||+..
T Consensus 452 fF~~i 456 (689)
T 3v5w_A 452 FFRSL 456 (689)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99763
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=398.60 Aligned_cols=290 Identities=27% Similarity=0.420 Sum_probs=228.0
Q ss_pred eCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc------hhhHHHHHHHHHHHHhcCCCCCCCcceEEE
Q 001034 863 LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936 (1182)
Q Consensus 863 ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k------~~~dq~l~EikILr~L~h~~~l~HPnIVkL 936 (1182)
++..+.++|++++.||+|+||+||+|++..+++.||||++.... .......+|+.+++.+... .||||+++
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~niv~~ 79 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF---EHPNVVRL 79 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHH---CCTTBCCE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhc---CCCCeEEe
Confidence 45677899999999999999999999999999999999997432 2234566788888877632 36699999
Q ss_pred EEEEEecC-----eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc
Q 001034 937 YDYFYYRE-----HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011 (1182)
Q Consensus 937 ~dsFqd~e-----~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs 1011 (1182)
+++|.... .+++||||+.++|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 80 MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS 155 (308)
T ss_dssp EEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT
T ss_pred eeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence 99998765 68999999999999988765432 2899999999999999999999999999999999999984
Q ss_pred CCCceEEEecCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 001034 1012 YSRCEVKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089 (1182)
Q Consensus 1012 ~~dG~IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ 1089 (1182)
++.+||+|||++..... .....++|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+.+++.
T Consensus 156 --~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 156 --GGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp --TSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred --CCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 67899999999976543 23456889999999999999999999999999999999999999999999999999998
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.++.++...+........ ..+.......+....+.++..+.+||.+||++||.+|||+.|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPR-----------------GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCG-----------------GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccc-----------------cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 888776544332211000 000000111222234567899999999999999999999999999
Q ss_pred CCCCCCCCC
Q 001034 1170 HPWLSHPYE 1178 (1182)
Q Consensus 1170 HPWFk~~~e 1178 (1182)
||||+....
T Consensus 297 h~~~~~~~~ 305 (308)
T 3g33_A 297 HSYLHKDEG 305 (308)
T ss_dssp STTC-----
T ss_pred CccccCCCC
Confidence 999997643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=393.25 Aligned_cols=283 Identities=27% Similarity=0.418 Sum_probs=230.1
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++++.||+|+||+||+|++..+++.||||++.... .......+|+.+++.++| |||++++++|....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH------KNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC------TTBCCEEEEEEETTE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCC------CCEeeEEeEEEeCCE
Confidence 58999999999999999999999999999999997543 334567788888888754 599999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+||||||+.++++.++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~--~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 76 LTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLA 148 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTC
T ss_pred EEEEEecCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeecccc
Confidence 999999999999888775432 2899999999999999999999999999999999999984 678999999999
Q ss_pred cccCC---CcccccCCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETD---HLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVL-FQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~---~~ss~vGTp~YmAPEVLlg~~-yS~kSDIWSLGVILYELLTGr~P-F~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
..... .....++|+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+....+.++...++.++...+.
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred eecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 76542 234567899999999998766 89999999999999999987766 67788889999998888877665443
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
.......+. .....+....+....+..+..+++||++||++||.+|||+.|||+||||+....|
T Consensus 229 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~pP 292 (292)
T 3o0g_A 229 SMTKLPDYK---------------PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292 (292)
T ss_dssp TGGGSTTCC---------------CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC---
T ss_pred hhccccccc---------------ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCCC
Confidence 322111100 0001122223334455678999999999999999999999999999999986654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=398.47 Aligned_cols=288 Identities=26% Similarity=0.406 Sum_probs=230.2
Q ss_pred eeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 862 VLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 862 ~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
...+.+.++|++++.||+|+||+||+|++. +++.||+|++.... .....+.+|+.+++.++| |||+++++
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~ 86 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH------PNIVSLID 86 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCC------TTBCCEEE
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCC------CCEeeeee
Confidence 345667899999999999999999999985 58999999997543 234567889999999864 49999999
Q ss_pred EEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 939 YFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
+|....++|+||||+.++|..++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~--~~~~k 159 (311)
T 3niz_A 87 VIHSERCLTLVFEFMEKDLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS--DGALK 159 (311)
T ss_dssp EECCSSCEEEEEECCSEEHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEE
T ss_pred EEccCCEEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECC--CCCEE
Confidence 9999999999999999999988875432 2899999999999999999999999999999999999984 67899
Q ss_pred EecCCCccccCC---CcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1019 VIDLGSSCFETD---HLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1019 LiDFGLA~~~~~---~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|+|||+++.... .....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.+..+...++.+
T Consensus 160 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 239 (311)
T 3niz_A 160 LADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP 239 (311)
T ss_dssp ECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCC
T ss_pred EccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCC
Confidence 999999976542 2344578999999999987 568999999999999999999999999988888899998888866
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
+...+........+... ..............+.++.++++||.+||++||.+|||+.|||+||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 305 (311)
T 3niz_A 240 NPREWPQVQELPLWKQR--------------TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305 (311)
T ss_dssp CTTTSGGGTTSHHHHSC--------------CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred ChHHhhhhhccchhhhc--------------ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 54433322211111000 0001111122233456788999999999999999999999999999999
Q ss_pred CCC
Q 001034 1175 HPY 1177 (1182)
Q Consensus 1175 ~~~ 1177 (1182)
...
T Consensus 306 ~~~ 308 (311)
T 3niz_A 306 DLD 308 (311)
T ss_dssp TSC
T ss_pred cCC
Confidence 754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=412.92 Aligned_cols=297 Identities=29% Similarity=0.473 Sum_probs=221.9
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
+..+.++|++++.||+|+||.||+|.+..+++.||||++... ........+|+.+++.+. .||||++++++|
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~l~~~~ 78 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS-----GHENIVNLLNVL 78 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEE
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc-----CCCCCCeeeeEE
Confidence 345678999999999999999999999999999999998643 334556778999998886 245999999999
Q ss_pred EecC--eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 941 YYRE--HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 941 qd~e--~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
.... .+||||||+.++|..++... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 79 ~~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~k 149 (388)
T 3oz6_A 79 RADNDRDVYLVFDYMETDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA--ECHVK 149 (388)
T ss_dssp ECTTSSCEEEEEECCSEEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEE
T ss_pred ecCCCCEEEEEecccCcCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcC--CCCEE
Confidence 8654 79999999999988888643 2888999999999999999999999999999999999984 77899
Q ss_pred EecCCCccccCC------------------------CcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCC
Q 001034 1019 VIDLGSSCFETD------------------------HLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNV 1073 (1182)
Q Consensus 1019 LiDFGLA~~~~~------------------------~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~ 1073 (1182)
|+|||+++.... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++
T Consensus 150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 229 (388)
T 3oz6_A 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229 (388)
T ss_dssp ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence 999999975321 1234689999999999987 679999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCcchhhhhcccccch-hhcccchhhhhhcc--hhhhhhcccccc---ccccCCCCCcHHHH
Q 001034 1074 LFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYK-YFTKNHMLYERNQE--TNRLEYLIPKKT---SLRHRLPMGDQGFI 1147 (1182)
Q Consensus 1074 PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k-~F~k~~~~~er~~e--ts~Le~liPk~~---sL~~~l~~~SeeL~ 1147 (1182)
||.+.+....+.+|+..++.++...+........ .+.. ....... ........+... .........+..++
T Consensus 230 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (388)
T 3oz6_A 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIE---SLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306 (388)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHH---HHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH---hCcccccccCCCHHHhCcchhhhcccccccccCCHHHH
Confidence 9999999999999999888777655543221110 0000 0000000 000000000000 00011235688999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1148 DFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1148 DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
+||.+||++||.+|||+.|||+||||+...
T Consensus 307 dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 307 DLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred HHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 999999999999999999999999997653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=422.56 Aligned_cols=301 Identities=30% Similarity=0.499 Sum_probs=229.1
Q ss_pred ccceeeeCc---eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCC
Q 001034 857 KNFHVVLNS---VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDK 930 (1182)
Q Consensus 857 ~~f~V~ig~---iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~H 930 (1182)
..+++..+. .+.++|++++.||+|+||.||+|++..+++.||||++.+. ......+.+|+.+|+.++|
T Consensus 47 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------ 120 (464)
T 3ttj_A 47 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH------ 120 (464)
T ss_dssp CEEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCC------
T ss_pred cceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCC------
Confidence 345555555 4579999999999999999999999999999999999763 3445677889999998865
Q ss_pred cceEEEEEEEEec------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCC
Q 001034 931 YHLLRLYDYFYYR------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004 (1182)
Q Consensus 931 PnIVkL~dsFqd~------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKP 1004 (1182)
|||++++++|... .++||||||+.+++...+.. .+++..++.+++||+.||.|||++||+||||||
T Consensus 121 pnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp 192 (464)
T 3ttj_A 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192 (464)
T ss_dssp TTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred CCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh
Confidence 4899999999765 46799999999998887642 178899999999999999999999999999999
Q ss_pred ccEEEccCCCceEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 001034 1005 ENILVKSYSRCEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082 (1182)
Q Consensus 1005 eNILIDs~~dG~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~e 1082 (1182)
+|||++. ++.+||+|||+++..... ....+||+.|+|||++.+..|+.++||||||||||+|++|++||.+.+..+
T Consensus 193 ~NIll~~--~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~ 270 (464)
T 3ttj_A 193 SNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270 (464)
T ss_dssp GGEEECT--TSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HhEEEeC--CCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999994 778999999999865443 345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccc--cccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTS--LRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1083 lLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~s--L~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
++.+|+..+|.++..++.........+......+. ...+....|.... ........+..+++||.+||++||.+
T Consensus 271 ~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA----GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp HHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCC----CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccC----CCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhh
Confidence 99999999998776665543322111111000000 0000001111000 00000011567999999999999999
Q ss_pred CCCHHHHHcCCCCCCCC
Q 001034 1161 RPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1161 RPTAeELLqHPWFk~~~ 1177 (1182)
|||+.|||+||||+..+
T Consensus 347 R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 347 RISVDDALQHPYINVWY 363 (464)
T ss_dssp SCCHHHHHTSTTTGGGC
T ss_pred CCCHHHHhcChhhhhcc
Confidence 99999999999998644
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=400.96 Aligned_cols=316 Identities=30% Similarity=0.534 Sum_probs=245.9
Q ss_pred CCccceeeeCcee-cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCC-----C
Q 001034 855 EDKNFHVVLNSVI-AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP-----G 928 (1182)
Q Consensus 855 e~~~f~V~ig~iL-~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~-----l 928 (1182)
....+++..+..+ .++|++++.||+|+||.||+|++..+++.||||++...........+|+.+++.+.+... .
T Consensus 4 ~~~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~ 83 (373)
T 1q8y_A 4 PGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83 (373)
T ss_dssp ---CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred CCCceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhcc
Confidence 3445566666555 569999999999999999999999999999999998777667788899999999986531 1
Q ss_pred CCcceEEEEEEEEecC----eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-CccccccC
Q 001034 929 DKYHLLRLYDYFYYRE----HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL-GLIHCDLK 1003 (1182)
Q Consensus 929 ~HPnIVkL~dsFqd~e----~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~-GIIHRDIK 1003 (1182)
.|+||++++++|.... ++++|||++.++|.+++...... .+++..++.++.||+.||.|||++ ||+|||||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dik 159 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 159 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCS
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhcc----CCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCC
Confidence 3779999999998764 89999999988999988764322 288999999999999999999998 99999999
Q ss_pred CccEEEccC----CCceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 001034 1004 PENILVKSY----SRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079 (1182)
Q Consensus 1004 PeNILIDs~----~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d 1079 (1182)
|+||||+.. ..+.+||+|||+++.........++|+.|+|||++.+..++.++|||||||++|+|++|++||...+
T Consensus 160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred hHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999632 3458999999999887776677789999999999999999999999999999999999999998654
Q ss_pred ------HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchh-hhhhccccccccccCCCCCcHHHHHHHHH
Q 001034 1080 ------PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETN-RLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152 (1182)
Q Consensus 1080 ------~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets-~Le~liPk~~sL~~~l~~~SeeL~DLIrk 1152 (1182)
....+.+++..++++|..++........+|.............. .+.... ..........+..+.+||.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~ 316 (373)
T 1q8y_A 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL---TEKYKFSKDEAKEISDFLSP 316 (373)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH---HHTTCCCHHHHHHHHHHHGG
T ss_pred ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh---hhcccCCcchHHHHHHHHHH
Confidence 56778889999999998887776655444433322111000000 000000 00001112346789999999
Q ss_pred hcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1153 LLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1153 MLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
||++||.+|||+.|||+||||+...
T Consensus 317 ~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 317 MLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp GGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HhccCccccCCHHHHhhChhhhccc
Confidence 9999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=403.97 Aligned_cols=254 Identities=21% Similarity=0.262 Sum_probs=207.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
.++|.+.+.||+|+||+||+|+.. .++..||||+++... .....+.+|+.+|+.++| ||||+++++|.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H------pnIV~l~g~~~ 85 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH------EHIVKFYGVCV 85 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCC------TTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCC------CCCccEEEEEe
Confidence 467999999999999999999864 468899999997653 345678899999998864 49999999999
Q ss_pred ecCeEEEEEEecc-cChHHHHhhhcc-------cCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC
Q 001034 942 YREHLLIVCELLK-ANLYEFHKFNRE-------SGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013 (1182)
Q Consensus 942 d~e~LyLVmEyL~-GsLld~Lk~~~~-------sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~ 1013 (1182)
+...+||||||++ |+|.+++..... ......+++..+..|+.||+.||.|||+++||||||||+||||+.
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~-- 163 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE-- 163 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC--
Confidence 9999999999998 578888865421 111234899999999999999999999999999999999999994
Q ss_pred CceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 001034 1014 RCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakI 1087 (1182)
++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||+| |++||.+.+..+++..+
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 778999999999754322 223568999999999999999999999999999999998 99999998888877776
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
....- ......++.++.+||.+||+.||.+|||+.+|
T Consensus 244 ~~~~~-------------------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 244 TQGRV-------------------------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp HHTCC-------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HcCCC-------------------------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 42100 00112457899999999999999999999999
Q ss_pred HcCCCCC
Q 001034 1168 LKHPWLS 1174 (1182)
Q Consensus 1168 LqHPWFk 1174 (1182)
+ +||+
T Consensus 281 ~--~~L~ 285 (299)
T 4asz_A 281 H--TLLQ 285 (299)
T ss_dssp H--HHHH
T ss_pred H--HHHH
Confidence 4 3554
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=385.25 Aligned_cols=279 Identities=27% Similarity=0.470 Sum_probs=221.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch---hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~---~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++++.||+|+||.||+|++ .+++.||+|++..... ....+.+|+.+++.+. ||||++++++|....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK------HSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC------CTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC------CCCEeeeeeEEccCCe
Confidence 5899999999999999999998 7899999999975432 2356778888888875 4599999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+|+||||+.++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 75 LVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLA 147 (288)
T ss_dssp EEEEEECCSEEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCTTHH
T ss_pred EEEEEEecCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEEeECccc
Confidence 999999999999988875432 2889999999999999999999999999999999999984 678999999998
Q ss_pred cccCC---CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1026 CFETD---HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1026 ~~~~~---~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
..... .....++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.+++..++.++...+..
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 75432 23345789999999999764 589999999999999999999999999999999999988877665433322
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
......+ .. ................++..+++||.+||++||.+|||+.|+|+||||+..
T Consensus 228 ~~~~~~~-~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 228 VTELPKY-DP--------------NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp GGGSTTC-CT--------------TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred hhccccc-cc--------------ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1110000 00 000000111222345678999999999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=395.36 Aligned_cols=294 Identities=29% Similarity=0.477 Sum_probs=220.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.++|++++.||+|+||.||+|.++.+++.||||+++... .....+.+|+.+++.+.| |||++++++|.....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH------ENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCB------TTBCCEEEEECCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCC------CCcceEEEEEEECCe
Confidence 468999999999999999999999999999999997543 234567789999988854 599999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+||||||+.++|.+++...........+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK--RGQLKLGDFGLA 155 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCSSC
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcC--CCCEEECcCccc
Confidence 999999999999998876543222234889999999999999999999999999999999999984 678999999999
Q ss_pred cccCC---CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1026 CFETD---HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1026 ~~~~~---~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
..... .....++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+...++.++..++..
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence 76543 23456789999999999874 689999999999999999999999999999999999998888877665543
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
......+.. . ..... ...+.... ........+..+++||.+||++||.+|||+.|||+||||+..+.+
T Consensus 236 ~~~~~~~~~-~---~~~~~-~~~~~~~~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 236 VTKLPKYNP-N---IQQRP-PRDLRQVL-----QPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGGCTTCCT-T---CCCCC-CCCSHHHH-----GGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhhccc-c---ccccc-chhHHHhh-----cccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 322111100 0 00000 00000000 011123467899999999999999999999999999999987654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=415.36 Aligned_cols=282 Identities=28% Similarity=0.491 Sum_probs=215.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|++++.||+|+||.||+|+++.+++.||||++.+. ......+.+|+.+|+.++| |||++++++|...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~ 124 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH------DHVVKVLDIVIPK 124 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC------TTBCCEEEECCCS
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCC------CCCCceEEEEecC
Confidence 458999999999999999999999999999999999753 2345677899999999864 4999999999543
Q ss_pred -----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 944 -----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 944 -----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
..+||||||+.++|..++.... .+++..++.|++||+.||.|||++|||||||||+||||+. ++.+|
T Consensus 125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~--~~~~k 196 (458)
T 3rp9_A 125 DVEKFDELYVVLEIADSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ--DCSVK 196 (458)
T ss_dssp CTTTCCCEEEEECCCSEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TCCEE
T ss_pred CcccCceEEEEEeccccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECC--CCCEe
Confidence 5799999999999998886532 3899999999999999999999999999999999999984 77899
Q ss_pred EecCCCccccCC------------------------------CcccccCCCcccchhhhc-CCCCCchhhHHHHHHHHHH
Q 001034 1019 VIDLGSSCFETD------------------------------HLCSYVQSRSYRAPEVIL-GLSYDKKIDIWSLGCILAE 1067 (1182)
Q Consensus 1019 LiDFGLA~~~~~------------------------------~~ss~vGTp~YmAPEVLl-g~~yS~kSDIWSLGVILYE 1067 (1182)
|+|||+++.... .....+||+.|+|||++. +..|+.++|||||||||||
T Consensus 197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 999999976431 234467899999999874 5679999999999999999
Q ss_pred HHh-----------CCCCCCCCC--------------------HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhh
Q 001034 1068 LCT-----------GNVLFQNDS--------------------PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLY 1116 (1182)
Q Consensus 1068 LLT-----------Gr~PF~g~d--------------------~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~ 1116 (1182)
|++ |++||.+.+ ....+..|+.++|.++...+.......
T Consensus 277 lltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~---------- 346 (458)
T 3rp9_A 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED---------- 346 (458)
T ss_dssp HHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHH----------
T ss_pred HHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHH----------
Confidence 999 778887654 357788888889988776655432110
Q ss_pred hhhcchhhhhhccc--cccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1117 ERNQETNRLEYLIP--KKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1117 er~~ets~Le~liP--k~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
........+ ....+...++..+.++++||++||++||.+|||+.|||+||||+...
T Consensus 347 -----~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 347 -----AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp -----HHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred -----HHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 000000111 12234445667789999999999999999999999999999998763
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=405.09 Aligned_cols=252 Identities=22% Similarity=0.266 Sum_probs=203.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
..+|.+.++||+|+||+||+|+.+ .+++.||||+++... ...+.+.+|+.+|+.++| ||||+++++|.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H------pnIV~l~g~~~ 113 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH------QHIVRFFGVCT 113 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCC------TTBCCEEEEEC
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC------CCCCcEEEEEE
Confidence 357899999999999999999864 468899999997643 345678899999998865 49999999999
Q ss_pred ecCeEEEEEEecc-cChHHHHhhhcccC---------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc
Q 001034 942 YREHLLIVCELLK-ANLYEFHKFNRESG---------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011 (1182)
Q Consensus 942 d~e~LyLVmEyL~-GsLld~Lk~~~~sg---------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs 1011 (1182)
....+||||||+. |+|.+++....... ....+++..+..|+.||+.||.|||+++||||||||+||||+
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~- 192 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG- 192 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC-
Confidence 9999999999999 57888876543211 122489999999999999999999999999999999999999
Q ss_pred CCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 001034 1012 YSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLA 1085 (1182)
Q Consensus 1012 ~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLa 1085 (1182)
.++.+||+|||+++..... ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++.
T Consensus 193 -~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 193 -QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp -TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred -CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 4788999999999754322 234679999999999999999999999999999999999 999999988888777
Q ss_pred HHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 001034 1086 RVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165 (1182)
Q Consensus 1086 kIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe 1165 (1182)
.|..... . .....+++++.+||.+||+.||++|||+.
T Consensus 272 ~i~~g~~----------------------------------~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ 308 (329)
T 4aoj_A 272 CITQGRE----------------------------------L---------ERPRACPPEVYAIMRGCWQREPQQRHSIK 308 (329)
T ss_dssp HHHHTCC----------------------------------C---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHH
T ss_pred HHHcCCC----------------------------------C---------CCcccccHHHHHHHHHHcCcChhHCcCHH
Confidence 6642100 0 01124578999999999999999999999
Q ss_pred HHHcC
Q 001034 1166 DALKH 1170 (1182)
Q Consensus 1166 ELLqH 1170 (1182)
||+++
T Consensus 309 ei~~~ 313 (329)
T 4aoj_A 309 DVHAR 313 (329)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=402.42 Aligned_cols=253 Identities=19% Similarity=0.213 Sum_probs=208.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEE-----CCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHD-----LHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkD-----k~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
-...+++++.||+|+||+||+|+. ..+++.||||+++... .....+.+|+.++++++|+ |||+++++
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~Hp------NIV~l~g~ 97 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP------NVVCLLGV 97 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCT------TBCCEEEE
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCC------CCCCcceE
Confidence 346789999999999999999985 3467899999997542 3456788999999998654 99999999
Q ss_pred EEecCeEEEEEEecc-cChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEE
Q 001034 940 FYYREHLLIVCELLK-ANLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~-GsLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNIL 1008 (1182)
|.....+||||||++ |+|.+++....... ....+++..+..|+.||+.||.|||+++||||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 999999999999998 57888886543211 1224899999999999999999999999999999999999
Q ss_pred EccCCCceEEEecCCCccccCC-----CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 001034 1009 VKSYSRCEVKVIDLGSSCFETD-----HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPAT 1082 (1182)
Q Consensus 1009 IDs~~dG~IKLiDFGLA~~~~~-----~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~e 1082 (1182)
|+. ++.+||+|||+++.... .....+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+
T Consensus 178 l~~--~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 178 VYD--KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp ECG--GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred ECC--CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 994 77899999999975432 2345688999999999999999999999999999999998 899999988888
Q ss_pred HHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC
Q 001034 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162 (1182)
Q Consensus 1083 lLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP 1162 (1182)
++..|..... ......++..+.+||.+||+.||.+||
T Consensus 256 ~~~~i~~~~~-------------------------------------------~~~p~~~~~~~~~li~~C~~~dP~~RP 292 (308)
T 4gt4_A 256 VVEMIRNRQV-------------------------------------------LPCPDDCPAWVYALMIECWNEFPSRRP 292 (308)
T ss_dssp HHHHHHTTCC-------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHcCCC-------------------------------------------CCCcccchHHHHHHHHHHcCCChhHCc
Confidence 7776631100 011234578899999999999999999
Q ss_pred CHHHHHcC
Q 001034 1163 SASDALKH 1170 (1182)
Q Consensus 1163 TAeELLqH 1170 (1182)
|+.||+++
T Consensus 293 s~~ei~~~ 300 (308)
T 4gt4_A 293 RFKDIHSR 300 (308)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999885
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=401.75 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=198.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.++|++.+.||+|+||+||+|+.. ..||||+++.. ......+.+|+.+++.++| ||||++++++. ..
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~H------pNIV~l~g~~~-~~ 104 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRH------VNILLFMGYMT-KD 104 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCC------TTBCCEEEEEC-SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCC------CCEeeEEEEEE-CC
Confidence 467889999999999999999853 35999998743 3445678899999998865 49999999875 46
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+||||||+. |+|.+++..... .+++..+..|+.||+.||.|||+++||||||||+||||+ .++.+||+|||
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~--~~~~~Ki~DFG 177 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH--EGLTVKIGDFG 177 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE--TTEEEEECCCS
T ss_pred eEEEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC--CCCcEEEeecc
Confidence 7899999999 578887764432 389999999999999999999999999999999999999 47889999999
Q ss_pred CccccCC-----CcccccCCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1024 SSCFETD-----HLCSYVQSRSYRAPEVILG---LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1024 LA~~~~~-----~~ss~vGTp~YmAPEVLlg---~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
+|+.... .....+||+.|||||++.+ .+|+.++|||||||+||||+||++||.+.+....+..++.....
T Consensus 178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~-- 255 (307)
T 3omv_A 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA-- 255 (307)
T ss_dssp SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC--
T ss_pred CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC--
Confidence 9976432 2345689999999999974 36999999999999999999999999886665554444311000
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH------Hc
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA------LK 1169 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL------Lq 1169 (1182)
.|. +......++..+.+||.+||+.||.+|||+.|| |+
T Consensus 256 ---------------------------------~p~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 256 ---------------------------------SPD---LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp ---------------------------------CCC---STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred ---------------------------------CCC---cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 010 112234567899999999999999999999976 56
Q ss_pred CCCC
Q 001034 1170 HPWL 1173 (1182)
Q Consensus 1170 HPWF 1173 (1182)
||+-
T Consensus 300 ~~lp 303 (307)
T 3omv_A 300 HSLP 303 (307)
T ss_dssp TTCC
T ss_pred ccCC
Confidence 6653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=396.44 Aligned_cols=285 Identities=26% Similarity=0.404 Sum_probs=225.6
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchh--hHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF--FDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~--~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++|++++.||+|+||.||+|++..+++.||||++...... ...+.+|+.+++.+. ||||++++++|.....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK------HANIVTLHDIIHTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCC------CTTBCCEEEEEECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC------CCCCCeeeeEEeeCCEE
Confidence 5899999999999999999999999999999999754321 123446888888775 45999999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
||||||+.++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE--RGELKLADFGLAR 148 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT--TCCEEECSSSEEE
T ss_pred EEEecccccCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC--CCCEEEccCcccc
Confidence 99999999999998876532 3889999999999999999999999999999999999984 6789999999987
Q ss_pred ccCCC---cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1027 FETDH---LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1027 ~~~~~---~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
..... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...+...
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 149 AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp CC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhh
Confidence 54432 334578999999999987 56899999999999999999999999999999999999999887766554332
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
.....+ ....+.......+....+.++..+.+||.+||++||.+|||+.|||+||||+...+.+
T Consensus 229 ~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 229 LSNEEF--------------KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp GGCHHH--------------HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred hcchhh--------------cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 111100 0011111111122233456789999999999999999999999999999998775543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=392.81 Aligned_cols=254 Identities=26% Similarity=0.455 Sum_probs=218.1
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
...++|++++.||+|+||.||+|.+..+|+.||||++.+.. .....+.+|+.+++.++| |||+++++++..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH------PNIVKLFEVIET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC------TTBCCEEEEEEC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCC------CCEeeEEEEEEE
Confidence 34678999999999999999999999999999999997643 345667889999999864 499999999999
Q ss_pred cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...+|+||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~------l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~--~~~~kl~D 157 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHGR------MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA--DMNIKIAD 157 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECS
T ss_pred CCEEEEEEECCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcC--CCCEEEee
Confidence 999999999997 478887765432 899999999999999999999999999999999999984 77899999
Q ss_pred CCCccccCC--CcccccCCCcccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1022 LGSSCFETD--HLCSYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1022 FGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS-~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
||++..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|++||.+.+...+..++......
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----- 232 (328)
T 3fe3_A 158 FGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR----- 232 (328)
T ss_dssp TTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----
T ss_pred ccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----
Confidence 999975432 34567899999999999988875 8999999999999999999999998888777776421111
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
+| ...+..+.+||++||++||.+|||+.|||+||||+...
T Consensus 233 ------------------------------~p---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 233 ------------------------------IP---------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp ------------------------------CC---------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred ------------------------------CC---------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 11 12468899999999999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=400.79 Aligned_cols=285 Identities=28% Similarity=0.496 Sum_probs=230.3
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|++++.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.++| |||++++++|...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~~~~ 96 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH------ENVIGLLDVFTPD 96 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCB------TTBCCCSEEECSC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCC------cCCCCceeeEecC
Confidence 468999999999999999999999999999999999653 2345667889999999865 4899999999876
Q ss_pred C------eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 944 E------HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 944 e------~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
. .+|+||||+.++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~ 167 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCEL 167 (367)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCE
T ss_pred CccccCceEEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcC--CCCE
Confidence 3 46999999988888887642 2889999999999999999999999999999999999984 7789
Q ss_pred EEecCCCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
||+|||+++.........++|+.|+|||++.+ ..++.++||||||||+|+|++|++||.+.+....+..|+..+|.++.
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 168 KILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred EEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999999887766777889999999999987 68999999999999999999999999999999999999999999888
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.++........ ..+. . .........+....+..+..+++||.+||++||.+|||+.+||+||||+..
T Consensus 248 ~~~~~~~~~~~------~~~~-----~--~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 248 EFVQRLQSDEA------KNYM-----K--GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHTCSCHHH------HHHH-----H--HSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHhhhHHH------HHHH-----H--hCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 77654322100 0000 0 000011122334456778999999999999999999999999999999886
Q ss_pred CCC
Q 001034 1177 YEP 1179 (1182)
Q Consensus 1177 ~eP 1179 (1182)
..|
T Consensus 315 ~~~ 317 (367)
T 1cm8_A 315 HDT 317 (367)
T ss_dssp C--
T ss_pred cCC
Confidence 543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=393.98 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=225.3
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+|+.+++.+.| |||++++++|.....+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH------RNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC------TTBCCEEEEEEETTEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCC------CCCCeEeEEEecCCEE
Confidence 5689999999999999999999999999999999998766556677899999998864 5999999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.| +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++....+.+||+|||++
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 999999986 7777775432 2389999999999999999999999999999999999999655788999999999
Q ss_pred cccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1026 CFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1026 ~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
..... .....++|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+..++.....++..
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------ 225 (321)
T 1tki_A 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE------ 225 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH------
T ss_pred eECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh------
Confidence 76543 2345678999999999999989999999999999999999999999998888887775332222111
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
..+.++.++.+||.+||..||.+|||+.|+|+||||+...+++
T Consensus 226 ----------------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~ 268 (321)
T 1tki_A 226 ----------------------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268 (321)
T ss_dssp ----------------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGS
T ss_pred ----------------------------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcccc
Confidence 1123578899999999999999999999999999998775544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=405.93 Aligned_cols=285 Identities=31% Similarity=0.468 Sum_probs=226.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.+.++|++++.||+|+||.||+|+++.+++.||||++... ......+.+|+.+|+.++| +||+++++++..
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~~~~~~ 96 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS------DYIIRLYDLIIP 96 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCC------TTBCCEEEECCC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCC------CCcceEEEEEec
Confidence 3568999999999999999999999999999999999753 2344677899999999865 489999999987
Q ss_pred c-----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 943 R-----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 943 ~-----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
. ..+||||||+.++|..++.... .+++..++.+++||+.||.|||++||+||||||+||||+. ++.+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~--~~~~ 168 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIADSDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ--DCSV 168 (432)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCE
T ss_pred CCCCcCCeEEEEEecCCcCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECC--CCCE
Confidence 6 5799999999999998886532 2899999999999999999999999999999999999984 7889
Q ss_pred EEecCCCccccCCC-------------------------cccccCCCcccchhhh-cCCCCCchhhHHHHHHHHHHHHh-
Q 001034 1018 KVIDLGSSCFETDH-------------------------LCSYVQSRSYRAPEVI-LGLSYDKKIDIWSLGCILAELCT- 1070 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~-------------------------~ss~vGTp~YmAPEVL-lg~~yS~kSDIWSLGVILYELLT- 1070 (1182)
||+|||+++..... ....+||+.|+|||++ ....|+.++||||||||+|+|++
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 99999999764321 3567899999999997 45679999999999999999998
Q ss_pred ----------CCCCCCCCC-----------------HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchh
Q 001034 1071 ----------GNVLFQNDS-----------------PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETN 1123 (1182)
Q Consensus 1071 ----------Gr~PF~g~d-----------------~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets 1123 (1182)
|+++|.+.+ ....+..|+..+|.++...+........ ..+
T Consensus 249 ~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~------~~~------- 315 (432)
T 3n9x_A 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV------IKY------- 315 (432)
T ss_dssp CTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHH------HHH-------
T ss_pred ccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHH------HHH-------
Confidence 555665543 4678888999999888766544321100 000
Q ss_pred hhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1124 RLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1124 ~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
...........+...++..+..+++||++||++||.+|||+.|||+||||+...
T Consensus 316 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 000011111122333456789999999999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=390.81 Aligned_cols=290 Identities=25% Similarity=0.414 Sum_probs=221.7
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.....++|++++.||+|+||+||+|++..+++.||||+++... .....+.+|+.+++.++| |||++++++|
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~ 102 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH------RNIIELKSVI 102 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC------TTBCCEEEEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC------CCcceEEEEE
Confidence 3456689999999999999999999999999999999997543 223456688888888854 5999999999
Q ss_pred EecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC---CCceE
Q 001034 941 YYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY---SRCEV 1017 (1182)
Q Consensus 941 qd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~---~dG~I 1017 (1182)
.....+||||||+.++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+
T Consensus 103 ~~~~~~~lv~e~~~~~L~~~~~~~~~------~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 176 (329)
T 3gbz_A 103 HHNHRLHLIFEYAENDLKKYMDKNPD------VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176 (329)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEE
T ss_pred ecCCEEEEEEecCCCCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceE
Confidence 99999999999999999998876532 8899999999999999999999999999999999999631 34569
Q ss_pred EEecCCCccccCC---CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1018 KVIDLGSSCFETD---HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1018 KLiDFGLA~~~~~---~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
||+|||+++.... .....++|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.+++..++.
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp EECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 9999999975432 23455789999999999875 4899999999999999999999999999999999999888776
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
++...+........+.. .... .....+... ....++..+++||.+||++||.+|||+.|||+||||
T Consensus 257 ~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQ----SFPK-FRGKTLKRV---------LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp CCTTTSTTGGGSTTCCT----TCCC-CCCCCHHHH---------HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred Cchhhhhhhhhhhhhhh----hhhh-hccccHhhh---------cccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 65543322111100000 0000 000000000 011257899999999999999999999999999999
Q ss_pred CCC-CCC
Q 001034 1174 SHP-YEP 1179 (1182)
Q Consensus 1174 k~~-~eP 1179 (1182)
++. ++|
T Consensus 323 ~~~~~~P 329 (329)
T 3gbz_A 323 SHNDFDP 329 (329)
T ss_dssp SSSCSCC
T ss_pred CCCCCCC
Confidence 876 554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=390.33 Aligned_cols=250 Identities=22% Similarity=0.444 Sum_probs=218.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++++.||+|+||.||+|+++.+|+.||||++++.. .......+|+.+++.+. ||||++++++|++.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT------HPFIIRMWGTFQDA 78 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC------BTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC------CCCCceEeEEEEeC
Confidence 468999999999999999999999999999999998642 23456677888888775 55999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
..+|+||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~Df 150 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDF 150 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcC--CCCEEEeec
Confidence 999999999985 7777776533 2899999999999999999999999999999999999984 778999999
Q ss_pred CCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1023 GSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1023 GLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
|+++.........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+.+|+.....
T Consensus 151 g~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------- 221 (318)
T 1fot_A 151 GFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--------- 221 (318)
T ss_dssp SSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC---------
T ss_pred CcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 99988777777889999999999999999999999999999999999999999998888877777421100
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSH 1175 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~ 1175 (1182)
. ....+.++.+||.+||+.||.+|| ++.+|++||||+.
T Consensus 222 --------------------------~---------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 222 --------------------------F---------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp --------------------------C---------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred --------------------------C---------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 0 123478899999999999999999 9999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=396.01 Aligned_cols=260 Identities=25% Similarity=0.425 Sum_probs=220.7
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-------hhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-------FFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-------~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
..+.++|++.+.||+|+||.||+|.++.+|+.||||++++... ....+.+|+.+|+.+. ||||++++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~ 81 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL------HPNIITLH 81 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC------CTTBCCEE
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC------CcCCCcEE
Confidence 3467899999999999999999999999999999999986532 2456788999998885 45999999
Q ss_pred EEEEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC--
Q 001034 938 DYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-- 1014 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d-- 1014 (1182)
++|.....+||||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+.
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~ 155 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCc
Confidence 99999999999999997 57877775432 3899999999999999999999999999999999999985321
Q ss_pred ceEEEecCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1015 CEVKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
..+||+|||++..... .....+||+.|+|||++.+..++.++||||||||+|+|++|.+||.+.+..+.+..|.....
T Consensus 156 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 235 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235 (361)
T ss_dssp CCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred cCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 2799999999976543 24567899999999999999999999999999999999999999999998888888764332
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.++... ...++..+++||.+||.+||.+|||+.|+|+|||
T Consensus 236 ~~~~~~----------------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 236 DFDEEF----------------------------------------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp CCCHHH----------------------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCCchh----------------------------------------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 222111 1234688999999999999999999999999999
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
|+..
T Consensus 276 ~~~~ 279 (361)
T 2yab_A 276 ITPV 279 (361)
T ss_dssp TSCS
T ss_pred cCCC
Confidence 9853
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=399.32 Aligned_cols=254 Identities=22% Similarity=0.381 Sum_probs=212.6
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
+..++|++++.||+|+||+||+|+++.+++.||||++++.. ........|..+++.+. .||||++++++|+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~-----~hp~Iv~l~~~~~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHPFLTQLFCCFQ 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT-----TCTTBCCEEEEEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc-----CCCceeeEEEEEE
Confidence 34578999999999999999999999999999999998642 33456778888888774 3569999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
...++||||||+.| +|..++..... +++..++.|+.||+.||.|||++||+||||||+||||+. ++++||+
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~g~ikL~ 166 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQKSRR------FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLA 166 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECC--CCCEEEc
Confidence 99999999999986 67766655432 899999999999999999999999999999999999984 7789999
Q ss_pred cCCCccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1021 DLGSSCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1021 DFGLA~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|||+++... ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++.+|+.....+
T Consensus 167 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--- 243 (353)
T 3txo_A 167 DFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--- 243 (353)
T ss_dssp CCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---
T ss_pred cccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 999997532 23456789999999999999999999999999999999999999999999988888875211110
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHcCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA------SDALKHP 1171 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA------eELLqHP 1171 (1182)
....+..+.+||++||++||.+||++ .+|++||
T Consensus 244 -----------------------------------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 244 -----------------------------------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp -----------------------------------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred -----------------------------------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 11246889999999999999999999 8999999
Q ss_pred CCCCC
Q 001034 1172 WLSHP 1176 (1182)
Q Consensus 1172 WFk~~ 1176 (1182)
||+..
T Consensus 283 ~f~~~ 287 (353)
T 3txo_A 283 FFKEI 287 (353)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=392.93 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=214.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++++.||+|+||+||+|+++.+++.||||++++.. ........|+.+|+.+. ||||++++++|+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR------HPFLTALKYAFQTH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC------CTTBCCEEEEEECS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC------CCcCcceEEEEEeC
Confidence 468999999999999999999999999999999998642 33456778888888765 55999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++|+||||+.| +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~vkL~DF 149 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDF 149 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECC--CCCEEEeec
Confidence 999999999986 6666665432 2899999999999999999999999999999999999984 778999999
Q ss_pred CCccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1023 GSSCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1023 GLA~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
|+++... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...++..|......
T Consensus 150 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------ 223 (337)
T 1o6l_A 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------ 223 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------
T ss_pred cchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 9997532 2345678999999999999999999999999999999999999999998887777766411000
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLS 1174 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk 1174 (1182)
. ...++.++.+||.+||+.||.+|| ++.+|++||||+
T Consensus 224 -----------------------------~---------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~ 265 (337)
T 1o6l_A 224 -----------------------------F---------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp -----------------------------C---------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred -----------------------------C---------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence 0 123578999999999999999999 999999999997
Q ss_pred C
Q 001034 1175 H 1175 (1182)
Q Consensus 1175 ~ 1175 (1182)
.
T Consensus 266 ~ 266 (337)
T 1o6l_A 266 S 266 (337)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=387.66 Aligned_cols=292 Identities=26% Similarity=0.429 Sum_probs=223.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe--
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH-- 945 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~-- 945 (1182)
.++|++.+.||+|+||.||+|++..+++.||||++............+++.+..+.| |||++++++|.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h------~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH------PNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCC------TTBCCEEEEEEEECSSC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCC------CCcccHHHhhhcccccc
Confidence 478999999999999999999999999999999998776666667778888887754 599999999976543
Q ss_pred -----EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHH--hcCccccccCCccEEEccCCCceEE
Q 001034 946 -----LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH--GLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 946 -----LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLH--S~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
+|+||||+.+++...+...... ...+++..++.++.||+.||.||| ++||+||||||+|||++. .++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRR--QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE-ADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET-TTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC-CCCcEE
Confidence 8999999999987766543222 223888999999999999999999 999999999999999984 367899
Q ss_pred EecCCCccccCCC--cccccCCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1019 VIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1019 LiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~-yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
|+|||++...... ....++|+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+....+..++..++.++
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 9999999765432 34567899999999997654 89999999999999999999999999999999999999999888
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
..++.........+... .. ...+............+..+.+||.+||++||.+|||+.|||+||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~----~~--------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLY----NS--------KGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHHHHHCTTCCCGGGG----CC--------CCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHHHhcccchhhcccc----cc--------ccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 77665433221111000 00 0001111111223346789999999999999999999999999999998
Q ss_pred CCCCC
Q 001034 1176 PYEPI 1180 (1182)
Q Consensus 1176 ~~eP~ 1180 (1182)
...|.
T Consensus 321 ~~~~~ 325 (360)
T 3e3p_A 321 LHDPA 325 (360)
T ss_dssp GGCTT
T ss_pred cCCcc
Confidence 77664
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=392.70 Aligned_cols=284 Identities=30% Similarity=0.526 Sum_probs=232.1
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR-- 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~-- 943 (1182)
.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++| |||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH------ENIIGINDIIRAPTI 99 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCC------TTBCCCCEEECCSST
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCC------CCCccceeEEecCCc
Confidence 47999999999999999999999999999999999753 2344677899999999864 4899999999765
Q ss_pred ---CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 944 ---EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 944 ---e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
..+|+||||+.++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~~iv~e~~~~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~kl~ 170 (364)
T 3qyz_A 100 EQMKDVYIVQDLMETDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKIC 170 (364)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEEC
T ss_pred cccceEEEEEcccCcCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC--CCCEEEE
Confidence 479999999999999888643 2889999999999999999999999999999999999984 7789999
Q ss_pred cCCCccccCCC------cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1021 DLGSSCFETDH------LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1021 DFGLA~~~~~~------~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..++..++.
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999754432 234589999999998765 45899999999999999999999999999999999999999998
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
++...+........ .........+.........+.++..+++||.+||++||.+|||+.|||+||||
T Consensus 251 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 251 PSQEDLNCIINLKA-------------RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp CCHHHHHTCCCHHH-------------HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred CCHHHHHHhhhhhH-------------HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 87765543221100 00000111111122233445678999999999999999999999999999999
Q ss_pred CCCCCC
Q 001034 1174 SHPYEP 1179 (1182)
Q Consensus 1174 k~~~eP 1179 (1182)
+..+.|
T Consensus 318 ~~~~~~ 323 (364)
T 3qyz_A 318 EQYYDP 323 (364)
T ss_dssp TTTCCG
T ss_pred hhccCc
Confidence 987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=387.26 Aligned_cols=286 Identities=24% Similarity=0.422 Sum_probs=228.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR- 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~- 943 (1182)
.++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++| |||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH------ENVVNLIEICRTKA 89 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCC------TTBCCEEEEEEEC-
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccC------CCcccHhheeeccc
Confidence 478999999999999999999999999999999986543 233467789999999865 4899999999873
Q ss_pred -------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 944 -------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 944 -------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
..+||||||+.+++...+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~--~~~ 162 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGV 162 (351)
T ss_dssp -------CEEEEEEECCSEEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSC
T ss_pred cccccCCceEEEEEeccCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC--CCC
Confidence 56899999999999888865432 2899999999999999999999999999999999999984 678
Q ss_pred EEEecCCCccccC-------CCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 001034 1017 VKVIDLGSSCFET-------DHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1017 IKLiDFGLA~~~~-------~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv 1088 (1182)
+||+|||++.... ......++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9999999987543 12344578999999999986 458999999999999999999999999999999999999
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCC--CCCcHHHHHHHHHhcccCCCCCCCHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRL--PMGDQGFIDFVAHLLEINPKKRPSASD 1166 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l--~~~SeeL~DLIrkMLq~DPekRPTAeE 1166 (1182)
...+.++..++....... .+.. +.........+.... ...++.+++||.+||++||.+|||+.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~-~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYE-LYEK-------------LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp HHHCCCCTTTSTTGGGCG-GGTS-------------SCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHhCCCChhhccccccch-hhcc-------------cccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 888887766544322110 0000 000000000000000 012578999999999999999999999
Q ss_pred HHcCCCCCCCCCCC
Q 001034 1167 ALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1167 LLqHPWFk~~~eP~ 1180 (1182)
||+||||+....|.
T Consensus 309 ~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 309 ALNHDFFWSDPMPS 322 (351)
T ss_dssp HHTSGGGGSSSCCC
T ss_pred HhCCCCcCCCCCcc
Confidence 99999999877664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=375.75 Aligned_cols=284 Identities=25% Similarity=0.407 Sum_probs=221.0
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||++++++|....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH------PNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCC------TTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCC------CCccchhheeecCC
Confidence 478999999999999999999999999999999986543 234566789999999864 48999999999999
Q ss_pred eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
.+|+||||+.++++..+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~ 148 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK--HSVIKLCDFGF 148 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTT
T ss_pred eEEEEEEeCCCchHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC--CCCEEEeeCCC
Confidence 9999999999876555443321 2889999999999999999999999999999999999984 67899999999
Q ss_pred ccccCCC---cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1025 SCFETDH---LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1025 A~~~~~~---~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+...... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 149 ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp CEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred chhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 9764432 345678999999999986 678999999999999999999999999999999888888777765443221
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccc-cccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIP-KKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYE 1178 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liP-k~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~e 1178 (1182)
..... .++ .......+ ....+....+.++..+.+||.+||++||.+|||+.+||+||||+...+
T Consensus 229 ~~~~~-~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 229 VFSTN-QYF-------------SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp HHHTC-GGG-------------TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred ccccc-ccc-------------ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 11000 000 00000001 011122234567899999999999999999999999999999998644
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=398.09 Aligned_cols=302 Identities=30% Similarity=0.504 Sum_probs=225.6
Q ss_pred ccceeeeCc---eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCC
Q 001034 857 KNFHVVLNS---VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDK 930 (1182)
Q Consensus 857 ~~f~V~ig~---iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~H 930 (1182)
..+++.++. .+.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+.|
T Consensus 10 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------ 83 (371)
T 2xrw_A 10 NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH------ 83 (371)
T ss_dssp GEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCC------
T ss_pred cceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCC------
Confidence 445666665 3578999999999999999999999999999999999763 2344567789999998864
Q ss_pred cceEEEEEEEEecC------eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCC
Q 001034 931 YHLLRLYDYFYYRE------HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004 (1182)
Q Consensus 931 PnIVkL~dsFqd~e------~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKP 1004 (1182)
|||++++++|.... .+||||||+.++|.+++.. .+++..++.++.||+.||.|||++||+||||||
T Consensus 84 pniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp 155 (371)
T 2xrw_A 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 155 (371)
T ss_dssp TTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred CCccceEEeeccccccccccceEEEEEcCCCCHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCH
Confidence 48999999998764 7899999999998888752 178899999999999999999999999999999
Q ss_pred ccEEEccCCCceEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 001034 1005 ENILVKSYSRCEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082 (1182)
Q Consensus 1005 eNILIDs~~dG~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~e 1082 (1182)
+|||++. ++.+||+|||+++..... ....++|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 156 ~NIl~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 233 (371)
T 2xrw_A 156 SNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 233 (371)
T ss_dssp GGEEECT--TSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHEEEcC--CCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999994 678999999999765433 345688999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccc--cccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTS--LRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1083 lLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~s--L~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
.+.+++..++.++..++.........+......+. ...+....+.... ........+..+++||++||++||.+
T Consensus 234 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 309 (371)
T 2xrw_A 234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYA----GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309 (371)
T ss_dssp HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCC----CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGG
T ss_pred HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCcccc----ccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhh
Confidence 99999988887766555443222111110000000 0000111111000 00000012568999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCC
Q 001034 1161 RPSASDALKHPWLSHPYE 1178 (1182)
Q Consensus 1161 RPTAeELLqHPWFk~~~e 1178 (1182)
|||+.|||+||||+..+.
T Consensus 310 R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 310 RISVDEALQHPYINVWYD 327 (371)
T ss_dssp SCCHHHHHHSHHHHTTCC
T ss_pred CCCHHHHhCCcchhhhcC
Confidence 999999999999986544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=393.02 Aligned_cols=284 Identities=29% Similarity=0.527 Sum_probs=229.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|.+.+.||+|+||.||+|.++.+++.||||++... ......+.+|+.+++.++| |||++++++|...
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~ 113 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH------ENVIGLLDVFTPA 113 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC------TTBCCCSEEECSC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCC------CCchhhhhheecc
Confidence 678999999999999999999999999999999999763 2345677789999999865 4899999999877
Q ss_pred CeE------EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 944 EHL------LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 944 e~L------yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
... |+||||+.++|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 114 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~--~~~~ 183 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQTDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCEL 183 (371)
T ss_dssp SSSTTCCCCEEEEECCCEEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCE
T ss_pred CCcccceeEEEEEccccccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC--CCCE
Confidence 654 99999999988776531 2889999999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
||+|||+++.........++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.+++...+.++.
T Consensus 184 kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 184 KILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp EECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 99999999887777777889999999999987 68999999999999999999999999999999999999999998887
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.++......... .+. ...............+.++..+.+||.+||++||.+|||+.|||+||||+..
T Consensus 264 ~~~~~~~~~~~~------~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 264 EFVQKLNDKAAK------SYI-------QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHTTCSCHHHH------HHH-------HHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhhhhhhh------hhh-------hccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 765543221100 000 0000111112222345678999999999999999999999999999999865
Q ss_pred CCC
Q 001034 1177 YEP 1179 (1182)
Q Consensus 1177 ~eP 1179 (1182)
..|
T Consensus 331 ~~~ 333 (371)
T 4exu_A 331 RDP 333 (371)
T ss_dssp CCG
T ss_pred CCc
Confidence 443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=394.42 Aligned_cols=282 Identities=28% Similarity=0.505 Sum_probs=223.6
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe---
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--- 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--- 942 (1182)
...++|++++.||+|+||.||+|++..+++.||||++....... .+|+.+++.++ ||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~---~~E~~il~~l~------hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NRELDIMKVLD------HVNIIKLVDYFYTTGD 74 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC---CHHHHHHTTCC------CTTBCCEEEEEEEC--
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH---HHHHHHHHHcC------CCCccchhheeeecCc
Confidence 34578999999999999999999999999999999997664332 36888988875 4599999999954
Q ss_pred -----------------------------------cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHH
Q 001034 943 -----------------------------------REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987 (1182)
Q Consensus 943 -----------------------------------~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILs 987 (1182)
..++++||||+.++|.+.+....... ..+++..++.++.||+.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~--~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSG--RSIPMNLISIYIYQLFR 152 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcC--CCCCHHHHHHHHHHHHH
Confidence 34589999999999888776543222 23899999999999999
Q ss_pred HHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC--CCcccccCCCcccchhhhcCC-CCCchhhHHHHHHH
Q 001034 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET--DHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCI 1064 (1182)
Q Consensus 988 ALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~--~~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVI 1064 (1182)
||.|||++||+||||||+|||++. .++.+||+|||+++... ......++|+.|+|||++.+. .++.++|||||||+
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNS-KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEET-TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEcC-CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999999999999999999999974 46789999999997543 334566889999999999875 49999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccc-cCCCCCc
Q 001034 1065 LAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLR-HRLPMGD 1143 (1182)
Q Consensus 1065 LYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~-~~l~~~S 1143 (1182)
+|+|++|++||.+.+..+.+.+++..+|.++...+......... ..+.......+. ......+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~ 295 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE----------------VRFPTLKAKDWRKILPEGTP 295 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC------------------CCCCCCCCCCHHHHSCTTCC
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc----------------ccCCccCcccHHhhCCCCCC
Confidence 99999999999999999999999999998766544332211100 000000000111 1123467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1144 QGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1144 eeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
..+++||.+||++||.+|||+.|||+||||+.
T Consensus 296 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 89999999999999999999999999999964
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=392.52 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=219.3
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..++|++++.||+|+||.||+|+++.+++.||||++.+.. .....+.+|+.+++.+. ||||++++++|..
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN------FPFLVKLEFSFKD 112 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC------CTTBCCEEEEEEC
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEEc
Confidence 4578999999999999999999999999999999997643 23456778888888774 5599999999999
Q ss_pred cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++||||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~D 184 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ--QGYIQVTD 184 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECC--CCCEEEcc
Confidence 999999999997 57877776543 2899999999999999999999999999999999999984 77899999
Q ss_pred CCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1022 LGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1022 FGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
||+++.........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...++.+|......
T Consensus 185 Fg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------- 256 (350)
T 1rdq_E 185 FGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-------- 256 (350)
T ss_dssp CTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred cccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 999988777777789999999999999999999999999999999999999999999888887777421110
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSH 1175 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~ 1175 (1182)
. ...++..+.+||.+||+.||.+||+ +.+|++||||+.
T Consensus 257 ---------------------------~---------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 257 ---------------------------F---------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp ---------------------------C---------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred ---------------------------C---------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 0 1234788999999999999999998 999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=398.77 Aligned_cols=283 Identities=29% Similarity=0.516 Sum_probs=215.7
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|++++.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.++| |||++++++|...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~~~~~~~~ 100 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH------ENVIGLLDVFTPA 100 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCC------TTBCCCSEEECSC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCC------CCCCcEEEEEecC
Confidence 468999999999999999999999999999999999753 2344567789999998865 4899999999754
Q ss_pred ------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 944 ------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 944 ------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
..+|+|||++.++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~ 171 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCEL 171 (367)
T ss_dssp SSGGGCCCCEEEEECCCEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCE
T ss_pred CccccCCeEEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC--CCCE
Confidence 568999999988888777542 2889999999999999999999999999999999999984 7789
Q ss_pred EEecCCCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
||+|||+++.........++|+.|+|||++.+ ..++.++||||||||+|+|++|++||.+.+....+..|+..+|.++.
T Consensus 172 kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 172 KILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp EECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999999877666667789999999999987 67999999999999999999999999999999999999999998877
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhcccc--ccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPK--KTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk--~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
.++........ ..+....+. ...+....+..+..+++||.+||++||.+|||+.+||+||||+
T Consensus 252 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 252 ELLKKISSESA---------------RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp HHHTTCCCHHH---------------HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHhhhHHH---------------HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 66554321100 000000010 1122233456789999999999999999999999999999999
Q ss_pred CCCCC
Q 001034 1175 HPYEP 1179 (1182)
Q Consensus 1175 ~~~eP 1179 (1182)
....|
T Consensus 317 ~~~~~ 321 (367)
T 2fst_X 317 QYHDP 321 (367)
T ss_dssp TTCCG
T ss_pred hccCC
Confidence 76544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=401.69 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=205.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCC-----CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHT-----GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~T-----Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|++.+.||+|+||+||+|....+ ++.||||+++... .....+.+|+.+|..+.|+ ||||+++++|
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hh-----pnIV~l~g~~ 137 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH-----LNVVNLLGAC 137 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCC-----TTBCCEEEEE
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCC-----CcEEEEEEEE
Confidence 47899999999999999999987543 4689999997643 3346788999999999864 4999999998
Q ss_pred Eec-CeEEEEEEecc-cChHHHHhhhccc----------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEE
Q 001034 941 YYR-EHLLIVCELLK-ANLYEFHKFNRES----------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008 (1182)
Q Consensus 941 qd~-e~LyLVmEyL~-GsLld~Lk~~~~s----------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNIL 1008 (1182)
... ..+|||||||. |+|.++++..... .....+++..+..|+.||+.||.|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 764 67999999999 5788888754321 01234899999999999999999999999999999999999
Q ss_pred EccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 001034 1009 VKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPAT 1082 (1182)
Q Consensus 1009 IDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~e 1082 (1182)
++. ++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+..+
T Consensus 218 l~~--~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 218 LSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp ECG--GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eCC--CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 994 778999999999864332 234678999999999999999999999999999999998 999998765433
Q ss_pred HHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC
Q 001034 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162 (1182)
Q Consensus 1083 lLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP 1162 (1182)
.+.+++.. |. .. .....+++++.+||.+||+.||.+||
T Consensus 296 ~~~~~i~~-g~--------------------------------~~---------~~p~~~~~~~~~li~~c~~~dP~~RP 333 (353)
T 4ase_A 296 EFCRRLKE-GT--------------------------------RM---------RAPDYTTPEMYQTMLDCWHGEPSQRP 333 (353)
T ss_dssp HHHHHHHH-TC--------------------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHc-CC--------------------------------CC---------CCCccCCHHHHHHHHHHcCcChhHCc
Confidence 33333210 00 00 01123578999999999999999999
Q ss_pred CHHHHHcC
Q 001034 1163 SASDALKH 1170 (1182)
Q Consensus 1163 TAeELLqH 1170 (1182)
|+.||++|
T Consensus 334 t~~eil~~ 341 (353)
T 4ase_A 334 TFSELVEH 341 (353)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999987
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=381.99 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=219.3
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-------hhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-------FFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-------~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
..+.++|++.+.||+|+||.||+|.++.+++.||+|++..... ....+.+|+.+++.+.| |||++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~ 80 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH------PNVITLH 80 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCC------TTBCCEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCC------CCCCcEE
Confidence 3466789999999999999999999999999999999976432 24567899999999864 4899999
Q ss_pred EEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC--C
Q 001034 938 DYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS--R 1014 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~--d 1014 (1182)
++|.....+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ .
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~ 154 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSS
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCC
Confidence 999999999999999974 7887775432 289999999999999999999999999999999999998532 2
Q ss_pred ceEEEecCCCccccC--CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1015 CEVKVIDLGSSCFET--DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~--~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
..+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 155 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234 (326)
T ss_dssp CCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC
T ss_pred CCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC
Confidence 279999999997653 234456899999999999999999999999999999999999999999888877777643222
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.++.. .....+..+.+||++||+.||.+|||+.++|+|||
T Consensus 235 ~~~~~----------------------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 235 EFEDE----------------------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp CCCHH----------------------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred CcCcc----------------------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 21110 11234688999999999999999999999999999
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
|+..
T Consensus 275 ~~~~ 278 (326)
T 2y0a_A 275 IKPK 278 (326)
T ss_dssp TSCC
T ss_pred ccCC
Confidence 9864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=372.01 Aligned_cols=288 Identities=27% Similarity=0.420 Sum_probs=230.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEEC-CCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE-
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDL-HTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY- 941 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk-~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq- 941 (1182)
..++|++++.||+|+||.||+|.+. .+++.||||+++... .......+|+.+++.+... .||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhcc---CCCCeEeeeeeeee
Confidence 3578999999999999999999995 678999999997542 2234566788888887533 4679999999998
Q ss_pred ----ecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 942 ----YREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 942 ----d~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
....+++||||+.++|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~--~~~~ 159 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVDQDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQI 159 (326)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCE
T ss_pred cccCCCceEEEEEecCCCCHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcC--CCCE
Confidence 45789999999999999988765322 2889999999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1018 KVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+..++..++.++
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 160 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999999765432 3456789999999999999999999999999999999999999999999999999988777654
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
...+........ ..+.......+......++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 240 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 240 EEDWPRDVALPR-----------------QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp GGGSCTTCSSCG-----------------GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccCccccccch-----------------hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 433221110000 000011111223344567899999999999999999999999999999998
Q ss_pred CCCCC
Q 001034 1176 PYEPI 1180 (1182)
Q Consensus 1176 ~~eP~ 1180 (1182)
...+.
T Consensus 303 ~~~~~ 307 (326)
T 1blx_A 303 LERCK 307 (326)
T ss_dssp CCCCC
T ss_pred cchhh
Confidence 76543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=391.84 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=216.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
+..++|++.+.||+|+||.||+|+++.+++.||||++++.. ........|..++..+. .||||++++++|+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~-----~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-----EHPFLTHMFCTFQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-----TCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcC-----CCCCCCcEEEEEE
Confidence 34578999999999999999999999999999999998652 33456778888888763 3569999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
...++|+||||+.| +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++++||+
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~vkL~ 160 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK--DGHIKIA 160 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECC--CCCEEEe
Confidence 99999999999975 7777776543 2899999999999999999999999999999999999984 6789999
Q ss_pred cCCCcccc---CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1021 DLGSSCFE---TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1021 DFGLA~~~---~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|||+++.. .......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+++.+|......
T Consensus 161 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---- 236 (345)
T 1xjd_A 161 DFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF---- 236 (345)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----
T ss_pred EChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC----
Confidence 99999753 22345678999999999999999999999999999999999999999998888877776421100
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH-HHHcCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS-DALKHPWLSHP 1176 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe-ELLqHPWFk~~ 1176 (1182)
. ...++..+.+||.+||+.||.+||++. +|++||||+..
T Consensus 237 -------------------------------~---------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 237 -------------------------------Y---------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp -------------------------------C---------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -------------------------------C---------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 0 123578899999999999999999998 99999999764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=382.77 Aligned_cols=266 Identities=21% Similarity=0.216 Sum_probs=213.0
Q ss_pred cCCCccceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCC
Q 001034 853 FEEDKNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGD 929 (1182)
Q Consensus 853 fee~~~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~ 929 (1182)
+.....++...+..+.++|+++++||+|+||+||+|+++.+++.||||++.... ........|+..+..+. .
T Consensus 41 ~~~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~-----~ 115 (311)
T 3p1a_A 41 LQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG-----Q 115 (311)
T ss_dssp CCCTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHC-----C
T ss_pred cCCCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhc-----C
Confidence 444555677778888999999999999999999999999999999999986542 22334445555555442 4
Q ss_pred CcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEE
Q 001034 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV 1009 (1182)
Q Consensus 930 HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILI 1009 (1182)
|+||++++++|.....+||||||+.++|..++..... .+++..++.++.||+.||.|||+.+|+||||||+|||+
T Consensus 116 h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll 190 (311)
T 3p1a_A 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190 (311)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence 5699999999999999999999999999988876542 28999999999999999999999999999999999999
Q ss_pred ccCCCceEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 001034 1010 KSYSRCEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1010 Ds~~dG~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakI 1087 (1182)
+. ++.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+
T Consensus 191 ~~--~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~ 264 (311)
T 3p1a_A 191 GP--RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQL 264 (311)
T ss_dssp CG--GGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHH
T ss_pred CC--CCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHH
Confidence 84 678999999998765432 334568999999999886 799999999999999999999877654322 1222
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
.. +..+. .....++..+.+||.+||++||.+|||+.+|
T Consensus 265 ~~--~~~~~----------------------------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 302 (311)
T 3p1a_A 265 RQ--GYLPP----------------------------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302 (311)
T ss_dssp TT--TCCCH----------------------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred hc--cCCCc----------------------------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 10 00000 0012357899999999999999999999999
Q ss_pred HcCCCCCCC
Q 001034 1168 LKHPWLSHP 1176 (1182)
Q Consensus 1168 LqHPWFk~~ 1176 (1182)
|+||||+++
T Consensus 303 l~hp~~~~p 311 (311)
T 3p1a_A 303 LALPVLRQP 311 (311)
T ss_dssp HTSGGGSCC
T ss_pred HhCccccCC
Confidence 999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=377.20 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=213.7
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
..++|++++.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||++++++|.....
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN------PNIVNYLDSYLVGDE 91 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC------TTBCCEEEEEEETTE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCC------CCCCeEeEEEEECCE
Confidence 3478999999999999999999999999999999997543 334567789999988754 599999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.| +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~--~~~~kl~Dfg~ 162 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGF 162 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTT
T ss_pred EEEEEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECC--CCCEEEeeCCC
Confidence 9999999974 677766542 2889999999999999999999999999999999999984 67899999999
Q ss_pred ccccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1025 SCFETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1025 A~~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+..... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.....+..
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------ 236 (297)
T 3fxz_A 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL------ 236 (297)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC------
T ss_pred ceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence 875433 23456899999999999999999999999999999999999999998887766655531111000
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.....++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 237 -----------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 237 -----------------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -----------------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----------------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0011346889999999999999999999999999999865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=390.49 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=214.9
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..++|++++.||+|+||+||+|+++.+++.||||++++.. ........|..++..+. .||+|++++++|+.
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~l~~~~~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPPFLTQLHSCFQT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTT-----CCTTBCCEEEEEEC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcC-----CCCEEeeEEEEEEc
Confidence 4578999999999999999999999999999999998643 23455667777776653 35699999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++||||||+.| +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++++||+|
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~vkL~D 164 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIAD 164 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcC--CCcEEEEe
Confidence 9999999999985 7777776443 2899999999999999999999999999999999999984 77899999
Q ss_pred CCCcccc---CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1022 LGSSCFE---TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1022 FGLA~~~---~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
||+++.. .......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+++.+|+.....
T Consensus 165 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~----- 239 (353)
T 2i0e_A 165 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA----- 239 (353)
T ss_dssp CTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----
T ss_pred CCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC-----
Confidence 9999753 23345678999999999999999999999999999999999999999999988888777521111
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWL 1173 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWF 1173 (1182)
. ...++..+.+||.+||+.||.+|| ++.+|++||||
T Consensus 240 ------------------------------~---------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 240 ------------------------------Y---------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp ------------------------------C---------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred ------------------------------C---------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 0 123578999999999999999999 47999999999
Q ss_pred CC
Q 001034 1174 SH 1175 (1182)
Q Consensus 1174 k~ 1175 (1182)
+.
T Consensus 281 ~~ 282 (353)
T 2i0e_A 281 RY 282 (353)
T ss_dssp TT
T ss_pred cC
Confidence 75
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=388.03 Aligned_cols=260 Identities=25% Similarity=0.326 Sum_probs=203.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..++|++++.||+|+||.||+|+++.+++.||||++.........+.+|+.+++.++| |||++++++|....++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH------PNIVRFKEVILTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCC------TTBCCEEEEEECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCC------CCCCcEEEEEeeCCEE
Confidence 4589999999999999999999999999999999998776666778899999999864 4999999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
||||||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++....+.+||+|||++
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred EEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 999999975 7777775443 289999999999999999999999999999999999998655567999999998
Q ss_pred ccc--CCCcccccCCCcccchhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFE--TDHLCSYVQSRSYRAPEVILGLSYDKK-IDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~--~~~~ss~vGTp~YmAPEVLlg~~yS~k-SDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
+.. .......+||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+......+..++.....
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~--------- 236 (361)
T 3uc3_A 166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS--------- 236 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT---------
T ss_pred ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc---------
Confidence 743 233455689999999999998888755 89999999999999999999864432222222100000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.....| ....++..+++||.+||++||.+|||+.|||+||||...
T Consensus 237 ----------------------~~~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 237 ----------------------VKYSIP-------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ----------------------TCCCCC-------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ----------------------CCCCCC-------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 000011 112357899999999999999999999999999999654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=384.42 Aligned_cols=284 Identities=28% Similarity=0.441 Sum_probs=223.7
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
..++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||++++++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~ 81 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH------PNIIGLLDAF 81 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC------TTBCCEEEEE
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCC------CCCCeEEEEE
Confidence 4578999999999999999999999999999999997532 123467789999999864 4999999999
Q ss_pred EecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 941 YYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 941 qd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
.....+|+||||+.++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 82 ~~~~~~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~--~~~~kl~ 154 (346)
T 1ua2_A 82 GHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLA 154 (346)
T ss_dssp CCTTCCEEEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEEC
T ss_pred eeCCceEEEEEcCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC--CCCEEEE
Confidence 9999999999999999888876533 23888899999999999999999999999999999999984 6789999
Q ss_pred cCCCccccCC---CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1021 DLGSSCFETD---HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1021 DFGLA~~~~~---~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
|||++..... .....++|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.+++..++.++.
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 155 DFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 234 (346)
T ss_dssp CCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred ecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 9999976533 23456789999999999764 5899999999999999999999999999999999999887776655
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
..+........++. ........+......++..+++||.+||+.||.+|||+.|||+||||+..
T Consensus 235 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 235 EQWPDMCSLPDYVT----------------FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TTSSSTTSSTTCCC----------------CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhhhccCccccc----------------ccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 43332111110000 00000011222335668999999999999999999999999999999876
Q ss_pred CCC
Q 001034 1177 YEP 1179 (1182)
Q Consensus 1177 ~eP 1179 (1182)
..|
T Consensus 299 ~~~ 301 (346)
T 1ua2_A 299 PGP 301 (346)
T ss_dssp SCC
T ss_pred CCC
Confidence 544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=396.85 Aligned_cols=281 Identities=26% Similarity=0.467 Sum_probs=224.7
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec---
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--- 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--- 943 (1182)
...+|++++.||+|+||.||+|++..+++.||||++...... ..+|+.+|+.+.| +||++++++|...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~il~~l~h------pniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDH------CNIVRLRYFFYSSGEK 122 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHHTCCC------TTBCCEEEEEEEEETT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---HHHHHHHHHHcCC------CCccceeeEEeccCCC
Confidence 345799999999999999999999999999999999765432 2368999988854 5999999998653
Q ss_pred ---CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 944 ---EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 944 ---e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
.++++||||+.+++..++....... ..+++..++.|+.||+.||.|||++||+||||||+||||+. ..+.+||+
T Consensus 123 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~~kl~ 199 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPETVYRVARHYSRAK--QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLC 199 (420)
T ss_dssp TTEEEEEEEEECCCEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET-TTTEEEEC
T ss_pred CcceeEEeehhcccccHHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC-CCCeEEec
Confidence 3478999999998887776433222 23899999999999999999999999999999999999984 34679999
Q ss_pred cCCCccccC--CCcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1021 DLGSSCFET--DHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1021 DFGLA~~~~--~~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|||+++... ......++|+.|+|||++.+. .|+.++||||||||||||++|++||.+.+..+.+.+|+..+|.+...
T Consensus 200 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 200 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp CCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999997543 234457889999999999875 79999999999999999999999999999999999999999877665
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccc--cccc-cCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK--TSLR-HRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~--~sL~-~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
.+......+..+ ..|.. ..+. ...+..+.++++||.+||++||.+|||+.|+|+||||+
T Consensus 280 ~~~~~~~~~~~~------------------~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 280 QIREMNPNYTEF------------------KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHHHHCSCCCCC------------------CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHhhChhhhhh------------------ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 443321111000 01100 0000 11235678999999999999999999999999999997
Q ss_pred CCC
Q 001034 1175 HPY 1177 (1182)
Q Consensus 1175 ~~~ 1177 (1182)
...
T Consensus 342 ~~~ 344 (420)
T 1j1b_A 342 ELR 344 (420)
T ss_dssp GGG
T ss_pred ccc
Confidence 653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=389.16 Aligned_cols=263 Identities=27% Similarity=0.419 Sum_probs=219.9
Q ss_pred eeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 861 VVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 861 V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
......+.++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.+.| |||++++
T Consensus 21 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~~~ 94 (362)
T 2bdw_A 21 MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH------PNIVRLH 94 (362)
T ss_dssp ---CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCC------TTBCCEE
T ss_pred ecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC------CCCCeEE
Confidence 3344556789999999999999999999999999999999997643 334567789999999864 5999999
Q ss_pred EEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-Cc
Q 001034 938 DYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RC 1015 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG 1015 (1182)
++|.....+|+||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++... .+
T Consensus 95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~ 168 (362)
T 2bdw_A 95 DSIQEESFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 168 (362)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTC
T ss_pred EEEEeCCEEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCC
Confidence 999999999999999986 6777765432 389999999999999999999999999999999999998633 35
Q ss_pred eEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1016 EVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
.+||+|||++...... ....+||+.|+|||++.+..|+.++||||||||+|+|++|++||.+.+...++..+......
T Consensus 169 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 248 (362)
T 2bdw_A 169 AVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 248 (362)
T ss_dssp CEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 7999999999765432 34568999999999999999999999999999999999999999998888877777532221
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
++.. ....++..+.+||.+||+.||.+|||+.++|+||||
T Consensus 249 ~~~~----------------------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 249 YPSP----------------------------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp CCTT----------------------------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred CCcc----------------------------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 1110 012346889999999999999999999999999999
Q ss_pred CC
Q 001034 1174 SH 1175 (1182)
Q Consensus 1174 k~ 1175 (1182)
+.
T Consensus 289 ~~ 290 (362)
T 2bdw_A 289 CN 290 (362)
T ss_dssp HT
T ss_pred CC
Confidence 64
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=382.17 Aligned_cols=283 Identities=28% Similarity=0.522 Sum_probs=227.1
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++|.+.+.||.|+||.||+|.++.+|+.||||++... ......+.+|+.+++.++| |||++++++|...
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~ 95 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH------ENVIGLLDVFTPA 95 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCC------TTBCCCSEEECSC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCC------CCcccHhheEecc
Confidence 568999999999999999999999999999999999753 2334567789999998864 4899999999876
Q ss_pred Ce------EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 944 EH------LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 944 e~------LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
.. +|+||||+.++|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~--~~~~ 165 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQTDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCEL 165 (353)
T ss_dssp SSGGGCCCCEEEEECCSEEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT--TCCE
T ss_pred cccccceeEEEEeccccCCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC--CCcE
Confidence 54 499999999887765431 2889999999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
||+|||++..........++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++...|.++.
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 166 KILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245 (353)
T ss_dssp EECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred EEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999999877666667789999999999987 67899999999999999999999999999999999999999888877
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.++......... .+.. .........+....+.++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 246 ~~~~~~~~~~~~------~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 246 EFVQKLNDKAAK------SYIQ-------SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHTTCSCHHHH------HHHH-------TSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhhHHHH------HHHH-------hCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 665543221100 0000 000001112233445678999999999999999999999999999999875
Q ss_pred CC
Q 001034 1177 YE 1178 (1182)
Q Consensus 1177 ~e 1178 (1182)
..
T Consensus 313 ~~ 314 (353)
T 3coi_A 313 RD 314 (353)
T ss_dssp CC
T ss_pred cC
Confidence 44
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=377.93 Aligned_cols=287 Identities=29% Similarity=0.486 Sum_probs=227.3
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
...+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||+++++++.
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~ 79 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH------ENIITIFNIQR 79 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCC------TTBCCEEEECC
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcC------CCcCCeeeeec
Confidence 3456789999999999999999999999999999999997432 334567789999998864 48999999887
Q ss_pred ec-----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 942 YR-----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 942 d~-----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
.. ..+|+||||+.++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 80 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~--~~~ 150 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQTDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS--NCD 150 (353)
T ss_dssp CSCSTTCCCEEEEECCCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCC
T ss_pred ccccCccceEEEEEeccCccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC--CCc
Confidence 64 679999999999988887642 2889999999999999999999999999999999999984 678
Q ss_pred EEEecCCCccccCCC-------------cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 001034 1017 VKVIDLGSSCFETDH-------------LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~~-------------~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~e 1082 (1182)
+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+...
T Consensus 151 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 230 (353)
T 2b9h_A 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230 (353)
T ss_dssp EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 999999999754321 223578999999999865 679999999999999999999999999999999
Q ss_pred HHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccc--cccccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIP--KKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1083 lLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liP--k~~sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
.+..+...++.++............ ........+ ....+....+.++..+.+||.+||++||.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 296 (353)
T 2b9h_A 231 QLLLIFGIIGTPHSDNDLRCIESPR--------------AREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296 (353)
T ss_dssp HHHHHHHHHCCCCSTTTTTTCCCHH--------------HHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGG
T ss_pred HHHHHHHHhCCCchhccccccccch--------------hhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCccc
Confidence 8888888877655321111000000 000000001 111222334567899999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCCC
Q 001034 1161 RPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1161 RPTAeELLqHPWFk~~~eP 1179 (1182)
|||+.+||+||||+....|
T Consensus 297 Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 297 RITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp SCCHHHHHTSGGGTTTCCT
T ss_pred CCCHHHHhcCccccccCCc
Confidence 9999999999999876544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=371.32 Aligned_cols=289 Identities=23% Similarity=0.393 Sum_probs=221.7
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE-
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY- 941 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq- 941 (1182)
+..+.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~ 79 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH------DNIVKVFEILGP 79 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCC------TTBCCEEEEECT
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCC------CCeeEEEEeccc
Confidence 4567899999999999999999999999999999999987653 445677889999998854 58999999874
Q ss_pred -------------ecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEE
Q 001034 942 -------------YREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008 (1182)
Q Consensus 942 -------------d~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNIL 1008 (1182)
....+|+||||+.|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 152 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF 152 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred cccccccccccccccCceeEEeeccCCCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 34689999999999988887532 2889999999999999999999999999999999999
Q ss_pred EccCCCceEEEecCCCccccCC------CcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 001034 1009 VKSYSRCEVKVIDLGSSCFETD------HLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPA 1081 (1182)
Q Consensus 1009 IDs~~dG~IKLiDFGLA~~~~~------~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~ 1081 (1182)
++. .++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 153 ~~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 231 (320)
T 2i6l_A 153 INT-EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231 (320)
T ss_dssp EET-TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EcC-CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 974 356899999999976432 2234567999999999876 67999999999999999999999999999998
Q ss_pred HHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCC
Q 001034 1082 TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161 (1182)
Q Consensus 1082 elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekR 1161 (1182)
..+..++...+................+ .. -.. ......+....+.++..+.+||.+||+.||.+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~------~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVY-------IR------NDM-TEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHH-------HH------HHT-TSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCccc-------cc------ccc-cCCCCChhHhcchhhHHHHHHHHHHcCCCcccc
Confidence 8888887766654433222111000000 00 000 001111222345678999999999999999999
Q ss_pred CCHHHHHcCCCCCCCCCCC
Q 001034 1162 PSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1162 PTAeELLqHPWFk~~~eP~ 1180 (1182)
||+.+||+||||+....|.
T Consensus 298 pt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 298 LTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CCHHHHHTSHHHHTTCC--
T ss_pred CCHHHHhCCcccccccCcc
Confidence 9999999999999876554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=384.75 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=208.7
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..++|++++.||+|+||.||+|+++.+++.||||++++.. .....+..|+.+++.+. .||||++++++|+.
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~l~~~~~~ 81 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQT 81 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEEEC
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcC-----CCCccCeEEEEEEe
Confidence 4578999999999999999999999999999999998643 33455678888888763 35699999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++|+||||+.| +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++++||+|
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~D 153 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTD 153 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC--CCCEEEEe
Confidence 9999999999985 6777766443 2899999999999999999999999999999999999984 77899999
Q ss_pred CCCcccc---CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHh
Q 001034 1022 LGSSCFE---TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS---------PATLLARVIG 1089 (1182)
Q Consensus 1022 FGLA~~~---~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d---------~~elLakIv~ 1089 (1182)
||+++.. .......+||+.|+|||++.+..++.++|||||||++|+|++|++||.... ...++..+..
T Consensus 154 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 154 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp GGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred ccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 9999752 233456789999999999999999999999999999999999999996521 1111111110
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH-----
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA----- 1164 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA----- 1164 (1182)
. .. ......+..+.+||.+||+.||.+||++
T Consensus 234 ~-----------------------------------~~---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~ 269 (345)
T 3a8x_A 234 K-----------------------------------QI---------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTG 269 (345)
T ss_dssp C-----------------------------------CC---------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTH
T ss_pred C-----------------------------------CC---------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCC
Confidence 0 00 0112457899999999999999999995
Q ss_pred -HHHHcCCCCCCC
Q 001034 1165 -SDALKHPWLSHP 1176 (1182)
Q Consensus 1165 -eELLqHPWFk~~ 1176 (1182)
.+|++||||+..
T Consensus 270 ~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 270 FADIQGHPFFRNV 282 (345)
T ss_dssp HHHHHTSGGGTTC
T ss_pred HHHHhcCCccCCC
Confidence 899999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=395.11 Aligned_cols=253 Identities=20% Similarity=0.318 Sum_probs=208.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
-.++|+++++||+|+||+||+|+++.+++.||||++++.. .....+..|..++..+. .||||++++++|+.
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~-----~hp~Iv~l~~~~~~ 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQT 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT-----TCTTBCCEEEEEEC
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC-----CCCCcCeeEEEEEE
Confidence 3468999999999999999999999999999999998643 23445778888888774 35699999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++||||||+.| +|..++.... .+++..++.|+.||+.||.|||++||+||||||+||||+. ++++||+|
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~--~g~ikL~D 196 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTD 196 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECC--CCCEEEee
Confidence 9999999999986 6666665443 2899999999999999999999999999999999999984 77899999
Q ss_pred CCCcccc---CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHh
Q 001034 1022 LGSSCFE---TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP---------ATLLARVIG 1089 (1182)
Q Consensus 1022 FGLA~~~---~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~---------~elLakIv~ 1089 (1182)
||+++.. .......+||+.|+|||++.+..|+.++|||||||++|+|++|++||..... ..++..+..
T Consensus 197 FGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 197 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp CTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred cceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 9999752 2345667899999999999999999999999999999999999999964321 111111110
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH-----
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA----- 1164 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA----- 1164 (1182)
. .. ......+..+++||++||+.||.+||++
T Consensus 277 ~-----------------------------------~~---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~ 312 (396)
T 4dc2_A 277 K-----------------------------------QI---------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTG 312 (396)
T ss_dssp C-----------------------------------CC---------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTH
T ss_pred c-----------------------------------cc---------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCC
Confidence 0 00 1112457899999999999999999995
Q ss_pred -HHHHcCCCCCCC
Q 001034 1165 -SDALKHPWLSHP 1176 (1182)
Q Consensus 1165 -eELLqHPWFk~~ 1176 (1182)
.+|++||||+..
T Consensus 313 ~~ei~~Hpff~~i 325 (396)
T 4dc2_A 313 FADIQGHPFFRNV 325 (396)
T ss_dssp HHHHHHSTTTTTC
T ss_pred HHHHhcCccccCC
Confidence 799999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.54 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=218.9
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++| |||++++++|..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~ 76 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH------PNIVRLHDSIQE 76 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC------TTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC------CCcCeEEEEEEc
Confidence 46789999999999999999999999999999999997643 334567789999999864 489999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-CceEEEe
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVI 1020 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG~IKLi 1020 (1182)
....|+||||+.+ +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++..+ .+.+||+
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 9999999999986 6767766543 289999999999999999999999999999999999998532 3459999
Q ss_pred cCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1021 DLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1021 DFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......+.
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 228 (284)
T 3kk8_A 151 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-- 228 (284)
T ss_dssp CCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred eceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc--
Confidence 99999765433 23467899999999999999999999999999999999999999998887777666422211110
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.....++..+.+||.+||++||.+|||+.++|+||||+...
T Consensus 229 --------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 229 --------------------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp --------------------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred --------------------------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 11234578899999999999999999999999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=391.99 Aligned_cols=284 Identities=28% Similarity=0.489 Sum_probs=225.1
Q ss_pred eCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 863 LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 863 ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.+.....+|++.+.||+|+||.||+|++..+++ +|+|.+....... .+|+.+++.++| |||++++++|..
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~---~~E~~il~~l~h------~niv~l~~~~~~ 103 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK---NRELQIMRIVKH------PNVVDLKAFFYS 103 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSC---CHHHHHHHTCCC------TTBCCEEEEEEE
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchH---HHHHHHHHhCCC------CCcceEEEEEEe
Confidence 345567789999999999999999999987776 8888776554322 368899988864 599999999976
Q ss_pred cCe------EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 943 REH------LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 943 ~e~------LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
... +|+||||+.++++..+........ .+++..++.|+.||+.||.|||++||+||||||+||||+. .++.
T Consensus 104 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~ 180 (394)
T 4e7w_A 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQ--TMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGV 180 (394)
T ss_dssp ESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTE
T ss_pred cCCCCCceEEEEEeeccCccHHHHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC-CCCc
Confidence 543 899999999988777654332222 3889999999999999999999999999999999999983 4678
Q ss_pred EEEecCCCcccc--CCCcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1017 VKVIDLGSSCFE--TDHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1017 IKLiDFGLA~~~--~~~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
+||+|||+++.. .......++|+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..|+..+|.
T Consensus 181 ~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 260 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260 (394)
T ss_dssp EEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999999764 2334567889999999999775 5999999999999999999999999999999999999999998
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccc--ccc-ccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKK--TSL-RHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~--~sL-~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
++...+........ ....|.. ..+ ....+..+.++++||.+||++||.+|||+.|+|+|
T Consensus 261 p~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 261 PSREQIKTMNPNYM------------------EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCHHHHHHHCGGGS------------------SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhChhhh------------------hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 77654433211100 0001110 001 11123468899999999999999999999999999
Q ss_pred CCCCCCC
Q 001034 1171 PWLSHPY 1177 (1182)
Q Consensus 1171 PWFk~~~ 1177 (1182)
|||+...
T Consensus 323 p~f~~~~ 329 (394)
T 4e7w_A 323 PFFDELR 329 (394)
T ss_dssp GGGSTTT
T ss_pred hhhhhhc
Confidence 9998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=373.12 Aligned_cols=253 Identities=21% Similarity=0.369 Sum_probs=204.5
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch---------------------------hhHHHHHHHHH
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---------------------------FFDQSLDEIKL 918 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~---------------------------~~dq~l~EikI 918 (1182)
+..++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 446899999999999999999999999999999999976431 13457789999
Q ss_pred HHHhcCCCCCCCcceEEEEEEEEe--cCeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc
Q 001034 919 LKYVNKHDPGDKYHLLRLYDYFYY--REHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL 995 (1182)
Q Consensus 919 Lr~L~h~~~l~HPnIVkL~dsFqd--~e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~ 995 (1182)
++.++| |||+++++++.. ..++|+||||+.++ |.++.. ...+++..++.++.||+.||.|||++
T Consensus 90 l~~l~h------~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 90 LKKLDH------PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-------LKPLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp HHTCCC------TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-------SSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhCCC------CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 998854 599999999987 57899999999864 443221 11389999999999999999999999
Q ss_pred CccccccCCccEEEccCCCceEEEecCCCccccCCC---cccccCCCcccchhhhcCCC---CCchhhHHHHHHHHHHHH
Q 001034 996 GLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH---LCSYVQSRSYRAPEVILGLS---YDKKIDIWSLGCILAELC 1069 (1182)
Q Consensus 996 GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~---~ss~vGTp~YmAPEVLlg~~---yS~kSDIWSLGVILYELL 1069 (1182)
||+||||||+|||++. ++.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 157 ~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 157 KIIHRDIKPSNLLVGE--DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp TEECCCCCGGGEEECT--TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred CeeccCCCHHHEEECC--CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 9999999999999984 678999999999765432 34568999999999998765 478999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHH
Q 001034 1070 TGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDF 1149 (1182)
Q Consensus 1070 TGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DL 1149 (1182)
+|+.||...........+...... . ...+.++..+.+|
T Consensus 235 ~g~~pf~~~~~~~~~~~~~~~~~~-----------------------------------~-------~~~~~~~~~l~~l 272 (298)
T 2zv2_A 235 FGQCPFMDERIMCLHSKIKSQALE-----------------------------------F-------PDQPDIAEDLKDL 272 (298)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCC-----------------------------------C-------CSSSCCCHHHHHH
T ss_pred HCCCCCCCccHHHHHHHHhcccCC-----------------------------------C-------CCccccCHHHHHH
Confidence 999999887766555444211000 0 0123457899999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1150 VAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1150 IrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
|.+||+.||.+|||+.|||+||||+.
T Consensus 273 i~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 273 ITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHhhcChhhCCCHHHHhcCccccC
Confidence 99999999999999999999999963
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=399.10 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=218.9
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
..+.++|++++.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.+.| |||++++++|.
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l~~~~~ 80 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH------PNIVRLHDSIS 80 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCB------TTBCCEEEEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC------cCCCeEEEEEE
Confidence 345688999999999999999999999999999999998653 234567789999999854 59999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-CCceEEE
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-SRCEVKV 1019 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-~dG~IKL 1019 (1182)
....+|+||||+.| +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEE
Confidence 99999999999986 6777776543 28999999999999999999999999999999999999853 3578999
Q ss_pred ecCCCccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1020 IDLGSSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1020 iDFGLA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
+|||++...... ....+||+.|+|||++.+..|+.++||||||||+|+|++|++||.+.+...++.++......++.
T Consensus 155 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp CCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT
T ss_pred ccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc
Confidence 999999765432 34568999999999999999999999999999999999999999999888888777532222111
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
...+.++..+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 235 ----------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 235 ----------------------------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ----------------------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ----------------------------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 112345789999999999999999999999999999964
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=384.05 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=213.8
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
.+.++|++.+.||+|+||.||+|.++.+++.||||++.... .....+.+|+.+++.++| |||++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~~~~ 94 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH------PHIVELLET 94 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCC------TTBCCEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCC------CCCCcEEEE
Confidence 45678999999999999999999999999999999997532 134667899999999864 599999999
Q ss_pred EEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-CceE
Q 001034 940 FYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEV 1017 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG~I 1017 (1182)
|.....+||||||+.| +|.+++...... ...+++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCE
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcE
Confidence 9999999999999985 676666544322 12388999999999999999999999999999999999998532 3459
Q ss_pred EEecCCCccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1018 KVIDLGSSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
||+|||++...... ....+||+.|+|||++.+..++.++||||||||+|+|++|++||.+.. ...+..+.......
T Consensus 173 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 173 KLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251 (351)
T ss_dssp EECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC
T ss_pred EEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC
Confidence 99999999765432 345689999999999999999999999999999999999999998753 34444443211110
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
+. .....++..+.+||.+||+.||.+|||+.++|+||||+
T Consensus 252 ~~----------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 252 NP----------------------------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp CH----------------------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred Cc----------------------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 00 00123578999999999999999999999999999997
Q ss_pred C
Q 001034 1175 H 1175 (1182)
Q Consensus 1175 ~ 1175 (1182)
.
T Consensus 292 ~ 292 (351)
T 3c0i_A 292 E 292 (351)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=393.29 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=211.7
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
....++|++.+.||+|+||.||+|.+..+++.||||++.+.. .....+.+|+.+++.++| |||++++++|
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~ 78 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH------PHIIKLYDVI 78 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCC------TTBCCEEEEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCC------CCCCeEEEEE
Confidence 345689999999999999999999999999999999997542 223467789999888764 5999999999
Q ss_pred EecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 941 YYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 941 qd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
.....+|+||||+.|+|++++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 79 ~~~~~~~lv~E~~~g~l~~~l~~~~~------l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~ 150 (336)
T 3h4j_B 79 TTPTDIVMVIEYAGGELFDYIVEKKR------MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD--NLNVKIA 150 (336)
T ss_dssp ECSSEEEEEECCCCEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECT--TCCEEEC
T ss_pred EeCCEEEEEEECCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcC--CCCEEEE
Confidence 99999999999999999998876532 899999999999999999999999999999999999994 6789999
Q ss_pred cCCCccccCC--CcccccCCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1021 DLGSSCFETD--HLCSYVQSRSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1021 DFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~y-S~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........+.++
T Consensus 151 DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------- 220 (336)
T 3h4j_B 151 DFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------- 220 (336)
T ss_dssp CSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------
T ss_pred EeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------
Confidence 9999976443 2456789999999999998876 78999999999999999999999754321100000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
...........+..+.+||++||++||.+|||+.|||+||||+..
T Consensus 221 ----------------------------------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 ----------------------------------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ----------------------------------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ----------------------------------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000001123457899999999999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=393.66 Aligned_cols=300 Identities=24% Similarity=0.372 Sum_probs=215.1
Q ss_pred ecCCEEEE-EEeccCCceEEEEEEEC--CCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe-
Q 001034 867 IAGRYHVT-EYLGSAAFSKAIQAHDL--HTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY- 942 (1182)
Q Consensus 867 L~drYeIl-k~LGkGaFGeVyLAkDk--~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd- 942 (1182)
+.+.|++. ++||+|+||.||+|+++ .+++.||||++..... ...+.+|+.+|+.+.| |||++++++|..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h------pniv~~~~~~~~~ 90 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKH------PNVISLQKVFLSH 90 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCC------TTBCCCCEEEEET
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCC------CCeeeEeeEEecC
Confidence 34567774 57999999999999966 5789999999976532 3467889999999964 489999999965
Q ss_pred -cCeEEEEEEecccChHHHHhhhcccC---CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc--CCCce
Q 001034 943 -REHLLIVCELLKANLYEFHKFNRESG---GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS--YSRCE 1016 (1182)
Q Consensus 943 -~e~LyLVmEyL~GsLld~Lk~~~~sg---gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs--~~dG~ 1016 (1182)
...+||||||+.++|+.++....... ....+++..++.|+.||+.||.|||++||+||||||+||||.. ...+.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 67899999999999998887544221 1224899999999999999999999999999999999999942 14678
Q ss_pred EEEecCCCccccCC------CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------
Q 001034 1017 VKVIDLGSSCFETD------HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSP--------- 1080 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~------~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~--------- 1080 (1182)
+||+|||+++.... .....+||+.|+|||++.+. .++.++||||||||||+|++|++||.+...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999976543 23456889999999999875 599999999999999999999999976554
Q ss_pred HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1081 ~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
.+.+.+|+..+|.++...+................ ..... ........+.......+..+++||++||++||.+
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~ 324 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF-----RRNTY-TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHC-----CGGGG-TTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGG
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhc-----cccCC-CcchhhhhHhhcCCCCCHHHHHHHHHHccCCccc
Confidence 47888888888877765554332221111000000 00000 0000000111122344678999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCCC
Q 001034 1161 RPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1161 RPTAeELLqHPWFk~~~eP 1179 (1182)
|||+.|||+||||+....|
T Consensus 325 R~ta~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 325 RITSEQAMQDPYFLEDPLP 343 (405)
T ss_dssp SCCHHHHHTSGGGTSSSCC
T ss_pred CCCHHHHhcChhhccCCCC
Confidence 9999999999999987655
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=389.05 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=219.9
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+.++|++++.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.+. ||||++++++|.....
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH------HPKLINLHDAFEDKYE 122 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC------STTBCCEEEEEECSSE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCC------CcCCCeEEEEEEeCCE
Confidence 4578999999999999999999999999999999997653 23446778889888775 4599999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.| +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++....+.+||+|||+
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999985 6777765432 138999999999999999999999999999999999999865567899999999
Q ss_pred ccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1025 SCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1025 A~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
+...... ....++|+.|+|||++.+..++.++||||||||+|+|++|.+||.+.+....+..+......++
T Consensus 198 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------- 270 (387)
T 1kob_A 198 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD------- 270 (387)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC-------
T ss_pred ceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 9865432 3356799999999999999999999999999999999999999999888777766642111110
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYE 1178 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~e 1178 (1182)
......++..+.+||.+||+.||.+|||+.+||+||||+....
T Consensus 271 ---------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 271 ---------------------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp ---------------------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred ---------------------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 0112345789999999999999999999999999999987644
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=384.79 Aligned_cols=295 Identities=21% Similarity=0.261 Sum_probs=210.2
Q ss_pred cCCEEEEEEeccC--CceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 868 AGRYHVTEYLGSA--AFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 868 ~drYeIlk~LGkG--aFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.++|++++.||+| +||.||+|+++.+++.||||++.... .....+.+|+.+++.++| |||++++++|..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~ 97 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH------PNIVPYRATFIA 97 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC------TTBCCEEEEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCC------CCCCcEeEEEEE
Confidence 4789999999999 99999999999999999999998653 334567779999999865 499999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...+||||||+.+ +|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~--~~~~kl~d 171 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMD----GMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSG 171 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECC
T ss_pred CCEEEEEEEccCCCCHHHHHhhhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEcc
Confidence 9999999999985 677777654221 2899999999999999999999999999999999999984 77899999
Q ss_pred CCCccccC----------CCcccccCCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 001034 1022 LGSSCFET----------DHLCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089 (1182)
Q Consensus 1022 FGLA~~~~----------~~~ss~vGTp~YmAPEVLlg--~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ 1089 (1182)
||++.... ......+||+.|+|||++.+ ..++.++||||||||+|+|++|++||.+.+....+..++.
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 99875321 11233578999999999988 6799999999999999999999999988666555544432
Q ss_pred hcCCcchhhhhcccccchhhcccc-hhhhhhcchhhhhh--ccc--cccccccCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNH-MLYERNQETNRLEY--LIP--KKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~-~~~er~~ets~Le~--liP--k~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA 1164 (1182)
. .++. ++.........+.... ...........+.. ..+ ...........++..+++||++||++||.+|||+
T Consensus 252 ~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 328 (389)
T 3gni_B 252 G--TVPC-LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328 (389)
T ss_dssp ---------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred C--CCCc-cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence 1 1110 0000000000000000 00000000000000 000 0011112334568999999999999999999999
Q ss_pred HHHHcCCCCCCCC
Q 001034 1165 SDALKHPWLSHPY 1177 (1182)
Q Consensus 1165 eELLqHPWFk~~~ 1177 (1182)
.|||+||||+...
T Consensus 329 ~ell~hp~f~~~~ 341 (389)
T 3gni_B 329 STLLNHSFFKQIK 341 (389)
T ss_dssp HHHTTSGGGGGC-
T ss_pred HHHhcCHHHHHHh
Confidence 9999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=381.44 Aligned_cols=288 Identities=27% Similarity=0.488 Sum_probs=221.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc------------hhhHHHHHHHHHHHHhcCCCCCCCcceE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK------------DFFDQSLDEIKLLKYVNKHDPGDKYHLL 934 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k------------~~~dq~l~EikILr~L~h~~~l~HPnIV 934 (1182)
+.++|++.+.||+|+||.||+|.+.. ++.||||++.... .....+.+|+.+++.++| |||+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv 92 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH------PNIL 92 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC------TTBC
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC------cCcc
Confidence 45789999999999999999999854 9999999986432 123678899999999864 4899
Q ss_pred EEEEEEEec-----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEE
Q 001034 935 RLYDYFYYR-----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV 1009 (1182)
Q Consensus 935 kL~dsFqd~-----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILI 1009 (1182)
+++++|... ..+|+||||+.|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI-----VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE
Confidence 999999653 46899999999999998875432 38999999999999999999999999999999999999
Q ss_pred ccCCCceEEEecCCCccccCC--CcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 001034 1010 KSYSRCEVKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLAR 1086 (1182)
Q Consensus 1010 Ds~~dG~IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLak 1086 (1182)
+. ++.+||+|||++..... .....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..
T Consensus 168 ~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 168 AD--NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp CT--TCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cC--CCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 84 67899999999975332 2345678999999999987 6799999999999999999999999999999999999
Q ss_pred HHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 001034 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASD 1166 (1182)
Q Consensus 1087 Iv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeE 1166 (1182)
++...+.++........... ...+.. ..+ ...+ ........+..+..+.+||.+||++||.+|||+.+
T Consensus 246 i~~~~~~~~~~~~~~~~~~~------~~~~~~----~~~-~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPS------ARDYLR----NSL-SNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHH------HHHHTT----TCC-CCCC-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHcCCCChHHhhhccchh------hhHHHH----hhc-ccCC-hhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 99888876544322111000 000000 000 0000 01112233456889999999999999999999999
Q ss_pred HHcCCCCCCCCCCC
Q 001034 1167 ALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1167 LLqHPWFk~~~eP~ 1180 (1182)
||+||||+..+.|.
T Consensus 314 ll~hp~f~~~~~~~ 327 (362)
T 3pg1_A 314 ALRHPYFESLFDPL 327 (362)
T ss_dssp HHTSGGGTTTCCGG
T ss_pred HHcCchhhhccCcc
Confidence 99999999988774
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=397.37 Aligned_cols=255 Identities=20% Similarity=0.313 Sum_probs=215.9
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..++|++++.||+|+||+||+|+++.+++.||||++++.. .....+.+|+.+++.++| |||++++++|++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h------p~Iv~l~~~~~~ 140 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS------PWVVQLFYAFQD 140 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC------TTBCCEEEEEEC
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC------CCCCeEEEEEEE
Confidence 3468999999999999999999999999999999997632 223457789999988754 599999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++||||||+.| +|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+. ++++||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~--~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECC--CCCEEEec
Confidence 9999999999975 677766432 2889999999999999999999999999999999999984 77899999
Q ss_pred CCCccccCCC----cccccCCCcccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1022 LGSSCFETDH----LCSYVQSRSYRAPEVILGLS----YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1022 FGLA~~~~~~----~ss~vGTp~YmAPEVLlg~~----yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
||+++..... ....+||+.|+|||++.+.. |+.++|||||||+||+|++|++||.+.+...++.+|+.....
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc
Confidence 9999765432 34678999999999998766 889999999999999999999999999998888888521100
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHcCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK--RPSASDALKHP 1171 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek--RPTAeELLqHP 1171 (1182)
...| ....++.++++||++||+.+|.+ ||++.||++||
T Consensus 292 ---------------------------------~~~p-------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 292 ---------------------------------LTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp ---------------------------------CCCC-------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ---------------------------------ccCC-------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 0111 11245789999999999999988 99999999999
Q ss_pred CCCCC
Q 001034 1172 WLSHP 1176 (1182)
Q Consensus 1172 WFk~~ 1176 (1182)
||+..
T Consensus 332 ~f~~~ 336 (410)
T 3v8s_A 332 FFKND 336 (410)
T ss_dssp GGCCS
T ss_pred cccCC
Confidence 99874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=376.64 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=207.5
Q ss_pred eecCCEEEEEEeccCCceEEEEEEEC---CCCcEEEEEEEeccc-----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNNK-----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~k-----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
+..++|++++.||+|+||.||+|++. .+++.||||++++.. .....+.+|+.+++.+.| |||++++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~ 87 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH------PFIVDLI 87 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCC------TTBCCEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCC------CCcccee
Confidence 44678999999999999999999985 689999999997642 233456789999998864 5999999
Q ss_pred EEEEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 938 DYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
++|....++||||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~--~~~ 159 (327)
T 3a62_A 88 YAFQTGGKLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH--QGH 159 (327)
T ss_dssp EEEECSSCEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT--TSC
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECC--CCc
Confidence 99999999999999998 47777776543 2889999999999999999999999999999999999984 678
Q ss_pred EEEecCCCccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1017 VKVIDLGSSCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1017 IKLiDFGLA~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+.+++.....
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 239 (327)
T 3a62_A 160 VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239 (327)
T ss_dssp EEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred EEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999999987532 2234568999999999999999999999999999999999999999998888777776421111
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDAL 1168 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELL 1168 (1182)
+ .+..+..+.+||.+||+.||.+|| ++.++|
T Consensus 240 ~--------------------------------------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l 275 (327)
T 3a62_A 240 L--------------------------------------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275 (327)
T ss_dssp C--------------------------------------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHH
T ss_pred C--------------------------------------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHH
Confidence 0 123468899999999999999999 899999
Q ss_pred cCCCCCCC
Q 001034 1169 KHPWLSHP 1176 (1182)
Q Consensus 1169 qHPWFk~~ 1176 (1182)
+||||+..
T Consensus 276 ~hp~f~~~ 283 (327)
T 3a62_A 276 AHPFFRHI 283 (327)
T ss_dssp HSGGGSSC
T ss_pred cCCcccCC
Confidence 99999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=370.69 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=219.2
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-------hhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-------FFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-------~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
..+.++|++.+.||+|+||.||+|.++.+++.||+|++..... ....+.+|+.+++.+.| |||++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~ 81 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH------HNVITLH 81 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCC------TTBCCEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCC------CCcceEE
Confidence 4567889999999999999999999999999999999976431 24567899999999865 4899999
Q ss_pred EEEEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC--
Q 001034 938 DYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-- 1014 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d-- 1014 (1182)
++|.....+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++..+.
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~ 155 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCc
Confidence 99999999999999997 57888776432 2889999999999999999999999999999999999985221
Q ss_pred ceEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1015 CEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
..+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 156 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 235 (321)
T 2a2a_A 156 PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235 (321)
T ss_dssp CCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred CCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 17999999999765432 3456789999999999999999999999999999999999999999888887777753322
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.++.. .....+..+.+||.+||+.||.+|||+.++|+|||
T Consensus 236 ~~~~~----------------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 236 DFDEE----------------------------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp CCCHH----------------------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred ccChh----------------------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 22111 01234688999999999999999999999999999
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
|+..
T Consensus 276 ~~~~ 279 (321)
T 2a2a_A 276 ITPV 279 (321)
T ss_dssp TSCS
T ss_pred ccCC
Confidence 9864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=381.08 Aligned_cols=298 Identities=22% Similarity=0.312 Sum_probs=214.7
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
+.+..++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+. ||||++++++|.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~ 101 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN------SPYIVGFYGAFY 101 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCC------CTTBCCEEEEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCC------CCCEEEEeEEEE
Confidence 456678999999999999999999999999999999999865 333456778888887775 559999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-CccccccCCccEEEccCCCceEEE
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL-GLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~-GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
....+||||||+.+ +|.+++..... +++..+..++.||+.||.|||+. ||+||||||+|||++. ++.+||
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~--~~~~kl 173 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKL 173 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT--TCCEEE
T ss_pred ECCEEEEEEECCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECC--CCCEEE
Confidence 99999999999986 78887765432 88999999999999999999996 9999999999999984 678999
Q ss_pred ecCCCccccC-CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1020 IDLGSSCFET-DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1020 iDFGLA~~~~-~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
+|||++.... ......++|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......+...
T Consensus 174 ~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 174 CDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253 (360)
T ss_dssp CCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred EECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence 9999986432 233456899999999999999999999999999999999999999998877665444321111111000
Q ss_pred hhcccccchhhcccchhh-hhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLY-ERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~-er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
..........+....... ........+...... .........++..+.+||.+||++||.+|||+.+||+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE-PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------------------CCCHHHHHHHHHHS-CCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhcc-CCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000000000000000000 000000000000000 00111123467899999999999999999999999999999753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=394.88 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=206.2
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
+..++|++++.||+|+||.||+|+++.+++.||||++++.. .....+..|+.+++.+ .||||++++++|.
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS------RHPFLTALKYSFQ 218 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC------SCTTSCCEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC------CCCeEeeEEEEEe
Confidence 44578999999999999999999999999999999997542 2223444555555444 4679999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEE
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
...++||||||+.+ +|..++.... .+++..++.++.||+.||.|||+ .|||||||||+||||+. ++.+||
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~--~~~~kl 290 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKI 290 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS--SSCEEE
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC--CCCEEE
Confidence 99999999999986 5666665433 28999999999999999999998 99999999999999984 678999
Q ss_pred ecCCCccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1020 IDLGSSCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1020 iDFGLA~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
+|||+++... ......+||+.|+|||++.+..|+.++||||||||||+|++|++||.+.+...++..+......
T Consensus 291 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--- 367 (446)
T 4ejn_A 291 TDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--- 367 (446)
T ss_dssp CCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---
T ss_pred ccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---
Confidence 9999997532 2345678999999999999999999999999999999999999999998888777776421111
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHP 1171 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHP 1171 (1182)
.....+..+.+||.+||++||.+|| ++.+||+||
T Consensus 368 -----------------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 368 -----------------------------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp -----------------------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred -----------------------------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 0123468899999999999999999 999999999
Q ss_pred CCCCC
Q 001034 1172 WLSHP 1176 (1182)
Q Consensus 1172 WFk~~ 1176 (1182)
||+..
T Consensus 407 ~f~~~ 411 (446)
T 4ejn_A 407 FFAGI 411 (446)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=375.64 Aligned_cols=268 Identities=26% Similarity=0.383 Sum_probs=216.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc------chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~------k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
+.++|++++.||+|+||.||+|.+..+++.||+|++.+. ......+.+|+.+++.++| |||++++++|
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~ 97 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH------PNIARLYEVY 97 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC------TTBCCEEEEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC------CCcceeehhh
Confidence 568899999999999999999999999999999999754 2345678889999999864 5999999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhccc----------------------------------CCccccCHHHHHHHHHHH
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRES----------------------------------GGEVYFTMPRLQSITIQC 985 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~s----------------------------------ggel~Lse~eIr~Ia~QI 985 (1182)
.....+||||||+. |+|.+++...... .....+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 99999999999997 4677776421110 001125677889999999
Q ss_pred HHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCC-------CcccccCCCcccchhhhcC--CCCCchh
Q 001034 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD-------HLCSYVQSRSYRAPEVILG--LSYDKKI 1056 (1182)
Q Consensus 986 LsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~-------~~ss~vGTp~YmAPEVLlg--~~yS~kS 1056 (1182)
+.||.|||++||+||||||+|||++..+.+.+||+|||++..... ......+|+.|+|||++.+ ..++.++
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999999999999999999999865555899999999975322 1345678999999999975 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccc
Q 001034 1057 DIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLR 1136 (1182)
Q Consensus 1057 DIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~ 1136 (1182)
|||||||++|+|++|+.||.+.+..+.+.+++.....++. +
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------------~------ 298 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---------------------------------P------ 298 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---------------------------------G------
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---------------------------------c------
Confidence 9999999999999999999998888777776532111110 0
Q ss_pred cCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1137 HRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1137 ~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
....++..+.+||.+||++||.+|||+.++|+||||+.....+
T Consensus 299 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 299 -NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI 341 (345)
T ss_dssp -GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHhh
Confidence 0112468899999999999999999999999999999876554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=376.42 Aligned_cols=281 Identities=26% Similarity=0.441 Sum_probs=221.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.+.| |||++++++|....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~ 97 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH------ENLVNLLEVCKKKK 97 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCC------TTBCCEEEEEEETT
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCC------CCEeeEEEEeecCC
Confidence 578999999999999999999999999999999986543 234556789999999864 48999999999999
Q ss_pred eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
.+|+||||+.++++..+..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~ 170 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGF 170 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCTT
T ss_pred EEEEEEecCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcC--CCcEEEEeCCC
Confidence 9999999999887766544322 2899999999999999999999999999999999999984 67899999999
Q ss_pred ccccCC---CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1025 SCFETD---HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1025 A~~~~~---~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+..... .....++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..++...+..+.....
T Consensus 171 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 171 ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp C------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence 975433 23456789999999999875 78999999999999999999999999999999999988877765443221
Q ss_pred cccccchhhcccchhhhhhcchhhhhh-ccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEY-LIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~-liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
. +...... ..... ............+.++..+.+||.+||++||.+|||+.|||+||||+.
T Consensus 251 ~-------~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 251 L-------FNKNPVF-------AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp H-------HHHCGGG-------TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred H-------hhhcccc-------ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 1 1100000 00000 001111222334567899999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.38 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=194.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhh--HHHHHHHH-HHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFF--DQSLDEIK-LLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~--dq~l~Eik-ILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
+..++|++++.||+|+||.||+|.+..+++.||||+++...... .....+.. +++. ..||||+++++++..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~------~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT------VDCPFTVTFYGALFR 77 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTT------CCCTTBCCEEEEEEC
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHh------CCCCeEEEEeeeeec
Confidence 45678999999999999999999999999999999997653221 12222222 2222 357799999999999
Q ss_pred cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-CccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL-GLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~-GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++|+||||+.|+|.+++....... ..+++..++.++.||+.||.|||+. ||+||||||+|||++. .+.+||+|
T Consensus 78 ~~~~~lv~e~~~~~l~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~--~~~~kl~D 153 (290)
T 3fme_A 78 EGDVWICMELMDTSLDKFYKQVIDKG--QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA--LGQVKMCD 153 (290)
T ss_dssp SSSEEEEEECCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECT--TCCEEBCC
T ss_pred cCCEEEEEehhccchHHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC--CCCEEEee
Confidence 99999999999999888876543222 2389999999999999999999998 9999999999999984 67899999
Q ss_pred CCCccccCCC--cccccCCCcccchhhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhcCCc
Q 001034 1022 LGSSCFETDH--LCSYVQSRSYRAPEVI----LGLSYDKKIDIWSLGCILAELCTGNVLFQN-DSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1022 FGLA~~~~~~--~ss~vGTp~YmAPEVL----lg~~yS~kSDIWSLGVILYELLTGr~PF~g-~d~~elLakIv~ilGp~ 1094 (1182)
||++...... .....+|+.|+|||++ .+..++.++|||||||++|+|++|+.||.. ......+..++....
T Consensus 154 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-- 231 (290)
T 3fme_A 154 FGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-- 231 (290)
T ss_dssp C---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--
T ss_pred cCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--
Confidence 9999764433 2345789999999997 556789999999999999999999999976 344333333321000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
+ ......++..+.+||.+||+.||.+|||+.+||+||||+
T Consensus 232 -----------------------------------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 232 -----------------------------------P-----QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp -----------------------------------C-----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred -----------------------------------C-----CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 0 001124578899999999999999999999999999997
Q ss_pred C
Q 001034 1175 H 1175 (1182)
Q Consensus 1175 ~ 1175 (1182)
.
T Consensus 272 ~ 272 (290)
T 3fme_A 272 L 272 (290)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=376.60 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=206.3
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
..++|++++.||+|+||.||+|.+ .+++.||||++.... .....+.+|+.+|+.+.|+ |+||+++++++...
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~----~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH----SDKIIRLYDYEITD 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT----CTTBCCEEEEEECS
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhc----CCceEEEeeeEeeC
Confidence 457899999999999999999997 568999999997543 3346678899999999864 35999999999999
Q ss_pred CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 944 EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 944 e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.++|||||+..++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~---~~~~kl~DFG 152 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFG 152 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTEEEECCCS
T ss_pred CEEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE---CCcEEEeecc
Confidence 9999999988889999887643 288999999999999999999999999999999999997 5779999999
Q ss_pred CccccCCC-----cccccCCCcccchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Q 001034 1024 SSCFETDH-----LCSYVQSRSYRAPEVILG-----------LSYDKKIDIWSLGCILAELCTGNVLFQNDSP-ATLLAR 1086 (1182)
Q Consensus 1024 LA~~~~~~-----~ss~vGTp~YmAPEVLlg-----------~~yS~kSDIWSLGVILYELLTGr~PF~g~d~-~elLak 1086 (1182)
+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+..
T Consensus 153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 232 (343)
T 3dbq_A 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232 (343)
T ss_dssp SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH
Confidence 99765432 235679999999999965 6789999999999999999999999976332 222222
Q ss_pred HHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 001034 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASD 1166 (1182)
Q Consensus 1087 Iv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeE 1166 (1182)
++. +. .........+..+.+||.+||+.||.+|||+.+
T Consensus 233 ~~~---~~---------------------------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e 270 (343)
T 3dbq_A 233 IID---PN---------------------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 270 (343)
T ss_dssp HHC---TT---------------------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred Hhc---CC---------------------------------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 210 00 000011233578999999999999999999999
Q ss_pred HHcCCCCCCCCCCC
Q 001034 1167 ALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1167 LLqHPWFk~~~eP~ 1180 (1182)
||+||||+....|.
T Consensus 271 ~l~hp~~~~~~~~~ 284 (343)
T 3dbq_A 271 LLAHPYVQIQTHPV 284 (343)
T ss_dssp HHTSHHHHSCCC--
T ss_pred HHhCccccccCCcc
Confidence 99999998766554
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=386.35 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=208.1
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchh----hHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF----FDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~----~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
...++|++++.||+|+||+||+|+++.+++.||||++++.... ...+..|..++ .....||||++++++|+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~l-----l~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL-----LKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CC-----BCCCCCTTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHH-----HHhCCCCCCCCEEEEEE
Confidence 3457899999999999999999999999999999999865422 12222232221 12346889999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
...++||||||+.| +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++++||+
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~ikL~ 181 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLT 181 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC--CCCEEEe
Confidence 99999999999986 6777665443 2889999999999999999999999999999999999984 7789999
Q ss_pred cCCCccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1021 DLGSSCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1021 DFGLA~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|||+++... ......+||+.|+|||++.+..|+.++||||||||+|+|++|.+||.+.+..+++.+|+....
T Consensus 182 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----- 256 (373)
T 2r5t_A 182 DFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----- 256 (373)
T ss_dssp CCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-----
T ss_pred eCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-----
Confidence 999997532 234567899999999999999999999999999999999999999999988888877742100
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH----HHHHcCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA----SDALKHPWL 1173 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA----eELLqHPWF 1173 (1182)
...+.++..+.+||.+||+.||.+||++ .++++||||
T Consensus 257 ---------------------------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f 297 (373)
T 2r5t_A 257 ---------------------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297 (373)
T ss_dssp ---------------------------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred ---------------------------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence 0112357889999999999999999997 699999999
Q ss_pred CC
Q 001034 1174 SH 1175 (1182)
Q Consensus 1174 k~ 1175 (1182)
+.
T Consensus 298 ~~ 299 (373)
T 2r5t_A 298 SL 299 (373)
T ss_dssp TT
T ss_pred cC
Confidence 75
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=365.24 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=211.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.+.++|.+.+.||+|+||.||+|.+..++..+|+|++.... .....+.+|+.+++.++| |||++++++|...
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~~~~~~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH------PNIIKIFEVFEDY 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCC------TTBCCEEEEEECS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCC------chHHhHHHheecC
Confidence 46689999999999999999999999999999999998654 234677889999998864 4899999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-CCceEEEec
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-SRCEVKVID 1021 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-~dG~IKLiD 1021 (1182)
..+|+||||+.+ +|.+++....... ..+++..++.++.||+.||.|||+.||+||||||+|||++.. ..+.+||+|
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARG--KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 999999999985 7887776543222 238999999999999999999999999999999999999642 357899999
Q ss_pred CCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1022 LGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1022 FGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
||++..... .....++|+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 171 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------ 243 (285)
T 3is5_A 171 FGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN------ 243 (285)
T ss_dssp CCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------
T ss_pred eecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc------
Confidence 999976433 234567899999999986 56899999999999999999999999988776665554211000
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
........+..+.+||.+||++||.+|||+.|||+||||++.
T Consensus 244 -----------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 244 -----------------------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp -----------------------------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred -----------------------------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 000112357889999999999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.64 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=212.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+. ||||++++++|..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR------HPNILRLYGYFHD 80 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC------CTTBCCEEEEEEC
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC------CCCCcchhheEec
Confidence 4578999999999999999999999999999999997543 22345677888888775 4599999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...+|+||||+.+ +|..++..... +++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~------~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~--~~~~~l~D 152 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIAD 152 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECT--TSCEEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcC--CCCEEEEe
Confidence 9999999999985 67777765432 889999999999999999999999999999999999984 67899999
Q ss_pred CCCccccCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1022 LGSSCFETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1022 FGLA~~~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
||++..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+......+
T Consensus 153 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 226 (279)
T 3fdn_A 153 FGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF------ 226 (279)
T ss_dssp CCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC------
T ss_pred ccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC------
Confidence 999865433 2345678999999999999999999999999999999999999999888777776664211111
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
....+..+.+||.+||+.||.+|||+.|||+||||+.....
T Consensus 227 --------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 227 --------------------------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp --------------------------------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred --------------------------------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence 12246789999999999999999999999999999876544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=375.39 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=206.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
+.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||+++++++....
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~~~~~~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH------ENVVKFYGHRREGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCC------TTBCCEEEEEECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCC------CCCCeEEEEEecCC
Confidence 4589999999999999999999999999999999997543 223567789999998864 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~Dfg 150 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFG 150 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeC--CCCEEEEEee
Confidence 99999999985 6766654322 2899999999999999999999999999999999999984 6789999999
Q ss_pred CccccCC-----CcccccCCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhhcCCcch
Q 001034 1024 SSCFETD-----HLCSYVQSRSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPATL-LARVIGIIGPIEQ 1096 (1182)
Q Consensus 1024 LA~~~~~-----~~ss~vGTp~YmAPEVLlg~~y-S~kSDIWSLGVILYELLTGr~PF~g~d~~el-LakIv~ilGp~Pe 1096 (1182)
++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ +..+....
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----- 225 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----- 225 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC-----
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc-----
Confidence 9975321 2345689999999999988775 7899999999999999999999976543211 11111000
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
........++..+.+||.+||++||.+|||+.|||+||||+..
T Consensus 226 -------------------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 226 -------------------------------------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp -------------------------------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -------------------------------------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 0000112347889999999999999999999999999999875
Q ss_pred C
Q 001034 1177 Y 1177 (1182)
Q Consensus 1177 ~ 1177 (1182)
.
T Consensus 269 ~ 269 (323)
T 3tki_A 269 L 269 (323)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=396.60 Aligned_cols=258 Identities=18% Similarity=0.266 Sum_probs=215.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..++|+++++||+|+||+||+|+++.+++.||||++++.. .....+.+|+.++..+. ||||++++++|+.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~------hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD------SKWITTLHYAFQD 145 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC------TTTBCCEEEEEEC
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC------CCCEEEEEEEEee
Confidence 3468999999999999999999999999999999997632 22334778899988875 4599999999999
Q ss_pred cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++||||||+. |+|..++..... .+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~--~g~vkL~D 218 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM--NGHIRLAD 218 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcC--CCCEEEcc
Confidence 999999999997 577777764321 2899999999999999999999999999999999999984 77899999
Q ss_pred CCCccccCCC----cccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1022 LGSSCFETDH----LCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1022 FGLA~~~~~~----~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
||+++..... ....+||+.|+|||++. ...|+.++|||||||++|||++|++||.+.+..+++.+|+....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 9999754332 23468999999999997 56799999999999999999999999999999888888852110
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHcC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK--RPSASDALKH 1170 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek--RPTAeELLqH 1170 (1182)
....| .....++.++++||++||+.+|.+ |+++.||++|
T Consensus 299 ---------------------------------~~~~p------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 ---------------------------------RFQFP------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---------------------------------HCCCC------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---------------------------------cccCC------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00111 112346899999999999998888 9999999999
Q ss_pred CCCCCC
Q 001034 1171 PWLSHP 1176 (1182)
Q Consensus 1171 PWFk~~ 1176 (1182)
|||+..
T Consensus 340 pff~~i 345 (437)
T 4aw2_A 340 PFFSGI 345 (437)
T ss_dssp GGGTTC
T ss_pred CccCCC
Confidence 999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=366.03 Aligned_cols=286 Identities=23% Similarity=0.376 Sum_probs=216.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe--cC
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--RE 944 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--~e 944 (1182)
..++|++++.||+|+||.||+|++..+++.||||+++... ...+.+|+.+++.+.+ ||||+++++++.. ..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~-----~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRG-----GPNIITLADIVKDPVSR 106 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTT-----STTBCCEEEEEECTTTC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCC-----CCCEEEeeeeeccCCCC
Confidence 3578999999999999999999999999999999997544 3567899999999973 4599999999998 67
Q ss_pred eEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..++||||+.++ |..++. .+++..++.++.||+.||.|||++||+||||||+|||++. ....+||+|||
T Consensus 107 ~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~-~~~~~kl~Dfg 176 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWG 176 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCCT
T ss_pred ceEEEEeccCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC-CCCEEEEEeCC
Confidence 899999999964 554442 1788899999999999999999999999999999999984 23389999999
Q ss_pred CccccCC--CcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhhcCCcchh-h
Q 001034 1024 SSCFETD--HLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQ-NDSPATLLARVIGIIGPIEQG-M 1098 (1182)
Q Consensus 1024 LA~~~~~--~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~-g~d~~elLakIv~ilGp~Pee-m 1098 (1182)
++..... .....++++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+....+..+...++..... +
T Consensus 177 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 177 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp TCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 9975432 3445678999999999987 679999999999999999999999984 566777777777666643211 1
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
+...... +................... ........++..+++||.+||++||.+|||+.|||+||||+...
T Consensus 257 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 257 IDKYNIE---LDPRFNDILGRHSRKRWERF-----VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHTTCC---CCTHHHHHHCCCCCCCGGGG-----CCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhccc---cccchhhhhhhccccchhhh-----ccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1110000 00000000000000000000 00011123578999999999999999999999999999999765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=377.69 Aligned_cols=262 Identities=25% Similarity=0.395 Sum_probs=202.9
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
..+.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+|+.+++.+.| |||++++++|....
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSH------PNIIKLKEIFETPT 121 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCC------TTBCCEEEEEECSS
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-HHHHHHHHHHHHhCCC------CCCcceeeeEecCC
Confidence 4567889999999999999999999999999999999986542 3556789999999864 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc-CCCceEEEecC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS-YSRCEVKVIDL 1022 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs-~~dG~IKLiDF 1022 (1182)
.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ..++.+||+||
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccC
Confidence 99999999985 7777775432 2899999999999999999999999999999999999974 23678999999
Q ss_pred CCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhhcCCcchhhh
Q 001034 1023 GSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT-LLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1023 GLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~e-lLakIv~ilGp~PeemL 1099 (1182)
|+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ++..+.......
T Consensus 196 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~----- 270 (349)
T 2w4o_A 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF----- 270 (349)
T ss_dssp C----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-----
T ss_pred ccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-----
Confidence 999765432 345678999999999999999999999999999999999999997755443 444443111100
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
.......++..+.+||++||+.||.+|||+.++|+||||+.....
T Consensus 271 -----------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 271 -----------------------------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp -----------------------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred -----------------------------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 001123457899999999999999999999999999999876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=392.99 Aligned_cols=257 Identities=23% Similarity=0.290 Sum_probs=213.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..++|++++.||+|+||+||+|+++.+++.||||++++.. .....+.+|..++..+. ||||++++++|++
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~------hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD------RRWITQLHFAFQD 132 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC------TTTBCCEEEEEEC
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC------CCCeeeEEEEEee
Confidence 3468999999999999999999999999999999997642 23445778889988875 4599999999999
Q ss_pred cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..++||||||+. |+|..++..... .+++..++.++.||+.||.|||++|||||||||+|||++. ++++||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~--~g~vkL~D 205 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR--CGHIRLAD 205 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecC--CCCEEEee
Confidence 999999999996 578777765421 2899999999999999999999999999999999999994 77899999
Q ss_pred CCCccccCCC----cccccCCCcccchhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 001034 1022 LGSSCFETDH----LCSYVQSRSYRAPEVIL-------GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1022 FGLA~~~~~~----~ss~vGTp~YmAPEVLl-------g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~i 1090 (1182)
||+++..... ....+||+.|+|||++. ...|+.++||||||||+|||++|++||.+.+..+++.+|+..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 9999765432 23468999999999997 457899999999999999999999999999988888887521
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCC---CCHHHH
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR---PSASDA 1167 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekR---PTAeEL 1167 (1182)
.. ....|. ....++.++++||++||+ +|.+| +++.+|
T Consensus 286 ~~---------------------------------~~~~p~------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei 325 (412)
T 2vd5_A 286 KE---------------------------------HLSLPL------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF 325 (412)
T ss_dssp HH---------------------------------HCCCC----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH
T ss_pred cc---------------------------------CcCCCc------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 10 000110 113457899999999999 99998 599999
Q ss_pred HcCCCCCCC
Q 001034 1168 LKHPWLSHP 1176 (1182)
Q Consensus 1168 LqHPWFk~~ 1176 (1182)
++||||+..
T Consensus 326 ~~Hpff~~i 334 (412)
T 2vd5_A 326 RTHPFFFGL 334 (412)
T ss_dssp HTSGGGTTC
T ss_pred hcCCCcCCC
Confidence 999999764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=380.90 Aligned_cols=193 Identities=21% Similarity=0.282 Sum_probs=154.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC---
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE--- 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e--- 944 (1182)
+.+|.+.+.||+|+||+||+|+. +|+.||||++..... .....|.+++. ...+.|||||++++++....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~----~~~l~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQ----TVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHT----STTCCCTTBCCEEEEEEEECSSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHH----HhcCCCCCCCcEEEEEEecCCCc
Confidence 46799999999999999999986 689999999976543 23333333322 11235779999999998764
Q ss_pred -eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc--------CccccccCCccEEEccCCC
Q 001034 945 -HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL--------GLIHCDLKPENILVKSYSR 1014 (1182)
Q Consensus 945 -~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~--------GIIHRDIKPeNILIDs~~d 1014 (1182)
.+||||||++ |+|.+++... .+++..+..++.|++.||.|||+. +||||||||+||||+. +
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~--~ 144 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK--N 144 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT--T
T ss_pred eEEEEEecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC--C
Confidence 6899999998 5788777543 188899999999999999999987 9999999999999994 7
Q ss_pred ceEEEecCCCccccCCC-------cccccCCCcccchhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001034 1015 CEVKVIDLGSSCFETDH-------LCSYVQSRSYRAPEVILGL------SYDKKIDIWSLGCILAELCTGNVLFQN 1077 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~~-------~ss~vGTp~YmAPEVLlg~------~yS~kSDIWSLGVILYELLTGr~PF~g 1077 (1182)
+.+||+|||+|+..... ....+||+.|||||++.+. .|+.++|||||||+||||+||.+||..
T Consensus 145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 88999999999754332 2245899999999999765 367899999999999999999988754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=358.62 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=215.9
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+.++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.+.| |||++++++|.....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH------PNIIRLYETFEDNTD 80 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCC------TTBCCEEEEEECSSE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCC------CCEeeEEEEEecCCe
Confidence 5678999999999999999999999999999999997642 335677889999998854 599999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc-CCCceEEEecCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS-YSRCEVKVIDLG 1023 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs-~~dG~IKLiDFG 1023 (1182)
+|+||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+.. ..++.+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeccCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 9999999985 67777765432 889999999999999999999999999999999999932 146789999999
Q ss_pred CccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1024 SSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1024 LA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
++..... ......+|+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+.+..+......++...
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 230 (277)
T 3f3z_A 155 LAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD--- 230 (277)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH---
T ss_pred cceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh---
Confidence 9975433 33456799999999998765 89999999999999999999999999888877777653322222110
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
...++..+.+||.+||++||.+|||+.++|+||||+..
T Consensus 231 -------------------------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 231 -------------------------------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp -------------------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred -------------------------------------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 12346889999999999999999999999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=365.39 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=203.7
Q ss_pred eecCCEEEE-EEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 866 VIAGRYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 866 iL~drYeIl-k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.+.++|++. +.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++..+. .||||++++++|...
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~-----~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-----GHRNVLELIEFFEEE 83 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEET
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhc-----CCCCeeeEEEEEeeC
Confidence 456889996 78999999999999999999999999997653 33567788999988863 356999999999999
Q ss_pred CeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC-ceEEEec
Q 001034 944 EHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVID 1021 (1182)
Q Consensus 944 e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d-G~IKLiD 1021 (1182)
..+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+. ..+||+|
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEE
Confidence 99999999998 57888876543 2889999999999999999999999999999999999985322 3499999
Q ss_pred CCCccccCC----------CcccccCCCcccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Q 001034 1022 LGSSCFETD----------HLCSYVQSRSYRAPEVILG-----LSYDKKIDIWSLGCILAELCTGNVLFQNDSPA----- 1081 (1182)
Q Consensus 1022 FGLA~~~~~----------~~ss~vGTp~YmAPEVLlg-----~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~----- 1081 (1182)
||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence 999865321 1224568999999999975 45889999999999999999999999765421
Q ss_pred ----------HHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHH
Q 001034 1082 ----------TLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVA 1151 (1182)
Q Consensus 1082 ----------elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIr 1151 (1182)
.++..+.... ...|. .....++..+++||.
T Consensus 238 ~~~~~~~~~~~~~~~i~~~~-----------------------------------~~~~~-----~~~~~~~~~~~~li~ 277 (316)
T 2ac3_A 238 RGEACPACQNMLFESIQEGK-----------------------------------YEFPD-----KDWAHISCAAKDLIS 277 (316)
T ss_dssp ---CCHHHHHHHHHHHHHCC-----------------------------------CCCCH-----HHHTTSCHHHHHHHH
T ss_pred ccccchhHHHHHHHHHhccC-----------------------------------cccCc-----hhcccCCHHHHHHHH
Confidence 1111111000 00000 011245789999999
Q ss_pred HhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1152 HLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1152 kMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+||+.||.+|||+.|||+||||+..
T Consensus 278 ~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 278 KLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHhhCChhhCCCHHHHhcChhhcCC
Confidence 9999999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=373.02 Aligned_cols=269 Identities=23% Similarity=0.337 Sum_probs=220.9
Q ss_pred ceeeeCceecCCEEEE-EEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceE
Q 001034 859 FHVVLNSVIAGRYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLL 934 (1182)
Q Consensus 859 f~V~ig~iL~drYeIl-k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIV 934 (1182)
+.+...+.+.++|.+. +.||+|+||.||+|.++.+++.||||++.... .....+.+|+.+++.+.+ ||||+
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~-----~~~iv 92 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS-----CPRVI 92 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTT-----CTTBC
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccC-----CCCEE
Confidence 3444556788999999 89999999999999999999999999997643 334677889999998864 45999
Q ss_pred EEEEEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-
Q 001034 935 RLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY- 1012 (1182)
Q Consensus 935 kL~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~- 1012 (1182)
+++++|.....+|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp CEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT
T ss_pred EEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC
Confidence 999999999999999999986 6666654321 1238999999999999999999999999999999999999842
Q ss_pred CCceEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 001034 1013 SRCEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1013 ~dG~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~i 1090 (1182)
..+.+||+|||++...... ....++|+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+...
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 248 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248 (327)
T ss_dssp TBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Confidence 2578999999999765433 34567999999999999999999999999999999999999999998888777776533
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
....+. .....++..+.+||.+||++||.+|||+.+||+|
T Consensus 249 ~~~~~~----------------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVDYSE----------------------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCCCT----------------------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccccCc----------------------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 222111 1123457889999999999999999999999999
Q ss_pred CCCCCC
Q 001034 1171 PWLSHP 1176 (1182)
Q Consensus 1171 PWFk~~ 1176 (1182)
|||+..
T Consensus 289 ~~~~~~ 294 (327)
T 3lm5_A 289 SWLQQW 294 (327)
T ss_dssp GGGCCC
T ss_pred Hhhccc
Confidence 999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=355.46 Aligned_cols=259 Identities=22% Similarity=0.292 Sum_probs=206.3
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
..+.++|++++.||+|+||.||+|.+..+++.||||++... ........+|+.++..+. .||||++++++|.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-----~h~~iv~~~~~~~ 81 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG-----QHSHVVRYFSAWA 81 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSC-----SCTTBCCEEEEEE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeee
Confidence 34567899999999999999999999999999999999864 233456777888888773 3559999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC--------
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-------- 1012 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-------- 1012 (1182)
....+|+||||+.+ +|.+++....... ..+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 82 EDDHMLIQNEYCNGGSLADAISENYRIM--SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------
T ss_pred cCCeEEEEEEecCCCcHHHHHHhhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccc
Confidence 99999999999975 8888887653221 138999999999999999999999999999999999999842
Q ss_pred ---------CCceEEEecCCCccccCCCcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 001034 1013 ---------SRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082 (1182)
Q Consensus 1013 ---------~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~e 1082 (1182)
....+||+|||++...... ....+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.....
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-- 236 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSP-QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCS-CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred ccccccccCCceEEEEcccccccccCCc-cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence 2347999999999866543 335689999999999876 567899999999999999999988754432
Q ss_pred HHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC
Q 001034 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162 (1182)
Q Consensus 1083 lLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP 1162 (1182)
...+.. + . .......++..+.+||.+||+.||.+||
T Consensus 237 -~~~~~~--~-----------------------------------~------~~~~~~~~~~~~~~li~~~l~~dp~~Rp 272 (289)
T 1x8b_A 237 -WHEIRQ--G-----------------------------------R------LPRIPQVLSQEFTELLKVMIHPDPERRP 272 (289)
T ss_dssp -HHHHHT--T-----------------------------------C------CCCCSSCCCHHHHHHHHHHTCSSGGGSC
T ss_pred -HHHHHc--C-----------------------------------C------CCCCCcccCHHHHHHHHHHhCCCcccCC
Confidence 112210 0 0 0011234578999999999999999999
Q ss_pred CHHHHHcCCCCCCCC
Q 001034 1163 SASDALKHPWLSHPY 1177 (1182)
Q Consensus 1163 TAeELLqHPWFk~~~ 1177 (1182)
|+.+||+||||+...
T Consensus 273 s~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 273 SAMALVKHSVLLSAS 287 (289)
T ss_dssp CHHHHHTCTTC----
T ss_pred CHHHHhhChHhhhhc
Confidence 999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=391.88 Aligned_cols=267 Identities=24% Similarity=0.409 Sum_probs=220.0
Q ss_pred ceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--------------hhhHHHHHHHHHHHHhcC
Q 001034 859 FHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--------------DFFDQSLDEIKLLKYVNK 924 (1182)
Q Consensus 859 f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--------------~~~dq~l~EikILr~L~h 924 (1182)
+.......+.++|++++.||+|+||+||+|.++.+++.||||++.+.. .....+.+|+.+++.+.|
T Consensus 26 ~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 105 (504)
T 3q5i_A 26 YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105 (504)
T ss_dssp GCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC
T ss_pred eeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC
Confidence 344445567899999999999999999999999999999999997643 234567889999998854
Q ss_pred CCCCCCcceEEEEEEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccC
Q 001034 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLK 1003 (1182)
Q Consensus 925 ~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIK 1003 (1182)
|||++++++|....++||||||+.| +|.+++..... +++..++.++.||+.||.|||++||+|||||
T Consensus 106 ------pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 173 (504)
T 3q5i_A 106 ------PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQILSGICYLHKHNIVHRDIK 173 (504)
T ss_dssp ------TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred ------CCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCc
Confidence 5999999999999999999999985 67777765432 8999999999999999999999999999999
Q ss_pred CccEEEccCCC-ceEEEecCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 001034 1004 PENILVKSYSR-CEVKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP 1080 (1182)
Q Consensus 1004 PeNILIDs~~d-G~IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~ 1080 (1182)
|+|||++..+. ..+||+|||++..... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|++||.+.+.
T Consensus 174 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp GGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999985322 3699999999976543 3446689999999999874 699999999999999999999999999998
Q ss_pred HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1081 ~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
.+++..+......++.. ....++..+++||++||++||.+
T Consensus 253 ~~~~~~i~~~~~~~~~~----------------------------------------~~~~~s~~~~~li~~~L~~dp~~ 292 (504)
T 3q5i_A 253 QDIIKKVEKGKYYFDFN----------------------------------------DWKNISDEAKELIKLMLTYDYNK 292 (504)
T ss_dssp HHHHHHHHHCCCCCCHH----------------------------------------HHTTSCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHcCCCCCCcc----------------------------------------ccCCCCHHHHHHHHHHcCCChhH
Confidence 88888775322111110 01235788999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCC
Q 001034 1161 RPSASDALKHPWLSHPYE 1178 (1182)
Q Consensus 1161 RPTAeELLqHPWFk~~~e 1178 (1182)
|||+.|||+||||+....
T Consensus 293 R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 293 RCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp SCCHHHHHTSHHHHHTCC
T ss_pred CCCHHHHhcCHhhhhchh
Confidence 999999999999976543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=393.94 Aligned_cols=261 Identities=29% Similarity=0.476 Sum_probs=219.1
Q ss_pred eCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 863 LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 863 ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
....+.++|++.+.||+|+||.||+|+++.+++.||||++.+. ......+.+|+.+++.+. ||||+++++
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~ 93 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD------HPNIMKLYE 93 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC------CTTBCCEEE
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC------CCCCCcEEE
Confidence 3456778999999999999999999999999999999999754 234567888999998885 459999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc-CCCce
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS-YSRCE 1016 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs-~~dG~ 1016 (1182)
+|.....+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ...+.
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 94 FFEDKGYFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEeCCEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCc
Confidence 99999999999999985 6777766432 2899999999999999999999999999999999999964 24678
Q ss_pred EEEecCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1017 VKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
+||+|||++..... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|++||.+.+..+++.++......+
T Consensus 168 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 246 (484)
T 3nyv_A 168 IRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF 246 (484)
T ss_dssp EEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999999875433 2345689999999999977 69999999999999999999999999999888887775322111
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
+. | ....++..+++||++||++||.+|||+.+||+||||+
T Consensus 247 ~~---------------------------------~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~ 286 (484)
T 3nyv_A 247 EL---------------------------------P-------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286 (484)
T ss_dssp CS---------------------------------G-------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred CC---------------------------------c-------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence 10 0 1123478899999999999999999999999999997
Q ss_pred CC
Q 001034 1175 HP 1176 (1182)
Q Consensus 1175 ~~ 1176 (1182)
..
T Consensus 287 ~~ 288 (484)
T 3nyv_A 287 TY 288 (484)
T ss_dssp HH
T ss_pred cc
Confidence 54
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=381.63 Aligned_cols=262 Identities=11% Similarity=0.105 Sum_probs=197.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE-------
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY------- 937 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~------- 937 (1182)
..|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.. .||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~----~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG----ESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC--------------CBCCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc----cChhhhhhceeEEeee
Confidence 45999999999999999999999999999999998743 345566778777777764 367888766
Q ss_pred EEEEec-----------------CeEEEEEEecccChHHHHhhhcccCCccccCHHHH------HHHHHHHHHHHHHHHh
Q 001034 938 DYFYYR-----------------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRL------QSITIQCLEALQFLHG 994 (1182)
Q Consensus 938 dsFqd~-----------------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eI------r~Ia~QILsALeYLHS 994 (1182)
+++... .++||||||+.++|.+++...... +..... ..++.||+.||.|||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~-----~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV-----YVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccc-----cchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 444433 348999999999999999875332 334444 5677999999999999
Q ss_pred cCccccccCCccEEEccCCCceEEEecCCCccccCCCcccccCCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHhCC
Q 001034 995 LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGN 1072 (1182)
Q Consensus 995 ~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg--~~yS~kSDIWSLGVILYELLTGr 1072 (1182)
+||+||||||+||||+. ++.+||+|||+++..........+|+.|+|||++.+ ..++.++|||||||+||+|++|+
T Consensus 213 ~~ivHrDikp~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMP--DGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp TTEEETTCSGGGEEECT--TSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCcCCHHHEEECC--CCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999994 678999999999877665546677899999999987 67999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHH
Q 001034 1073 VLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152 (1182)
Q Consensus 1073 ~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrk 1152 (1182)
+||.+..+... . . +.... . .............+.++..+.+||.+
T Consensus 291 ~Pf~~~~~~~~------------~-~----------~~~~~-----~-------~~~~~~~~~~~~~~~~~~~~~~li~~ 335 (371)
T 3q60_A 291 LPFGLVTPGIK------------G-S----------WKRPS-----L-------RVPGTDSLAFGSCTPLPDFVKTLIGR 335 (371)
T ss_dssp CSTTBCCTTCT------------T-C----------CCBCC-----T-------TSCCCCSCCCTTSSCCCHHHHHHHHH
T ss_pred CCCCCcCcccc------------c-c----------hhhhh-----h-------hhccccccchhhccCCCHHHHHHHHH
Confidence 99976542100 0 0 00000 0 00000001111224668999999999
Q ss_pred hcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1153 LLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1153 MLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
||++||.+|||+.++|+||||+..
T Consensus 336 ~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 336 FLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp HTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred HcCCChhhCCCHHHHhcCHHHHHH
Confidence 999999999999999999999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=381.84 Aligned_cols=259 Identities=28% Similarity=0.396 Sum_probs=212.5
Q ss_pred ecCCEEE--EEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 867 IAGRYHV--TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 867 L~drYeI--lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+...|.+ .+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+.+++.+. ||||++++++|...
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~ 158 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD------HANLIQLYDAFESK 158 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEECS
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCC------CCCCCeEEEEEEEC
Confidence 3455666 678999999999999999999999999998654 34566788999988885 45999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
..+||||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||+.....+.+||+||
T Consensus 159 ~~~~lv~E~~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DF 233 (373)
T 2x4f_A 159 NDIVLVMEYVDGGELFDRIIDESY-----NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDF 233 (373)
T ss_dssp SEEEEEEECCTTCEEHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeC
Confidence 999999999985 78777764432 388999999999999999999999999999999999996445788999999
Q ss_pred CCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1023 GSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1023 GLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
|++...... ....+||+.|+|||++.+..++.++||||||||+|+|++|..||.+.+..+.+..++.....++.
T Consensus 234 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~---- 309 (373)
T 2x4f_A 234 GLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED---- 309 (373)
T ss_dssp SSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS----
T ss_pred CCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh----
Confidence 999765432 34557999999999999999999999999999999999999999999888888777533221111
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.....++..+++||.+||++||.+|||+.|||+||||+..
T Consensus 310 ------------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 310 ------------------------------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ------------------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ------------------------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 0123457899999999999999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=381.16 Aligned_cols=256 Identities=28% Similarity=0.454 Sum_probs=210.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.+.++|++++.||+|+||.||+|.++.+++.||||++.+... ...+|+.++.++. .||||++++++|.+..+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~-----~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYG-----QHPNIITLKDVYDDGKY 90 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHT-----TSTTBCCEEEEEECSSE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhc-----CCCCcCeEEEEEEcCCE
Confidence 356789999999999999999999999999999999987643 3346888887774 35699999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC--CceEEEecC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS--RCEVKVIDL 1022 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~--dG~IKLiDF 1022 (1182)
+|+||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+.... .+.+||+||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 9999999985 7777776432 289999999999999999999999999999999999986421 246999999
Q ss_pred CCccccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhhcCCcch
Q 001034 1023 GSSCFETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN---DSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1023 GLA~~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g---~d~~elLakIv~ilGp~Pe 1096 (1182)
|++..... .....++|+.|+|||++.+..|+.++|||||||++|+|++|++||.+ .+..+++..|......++
T Consensus 165 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 243 (342)
T 2qr7_A 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS- 243 (342)
T ss_dssp TTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-
T ss_pred CCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-
Confidence 99975433 23466889999999999988899999999999999999999999975 345555555431110000
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
......++..+++||++||..||.+|||+.++|+||||.+
T Consensus 244 ---------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 244 ---------------------------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp ---------------------------------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ---------------------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 0112346789999999999999999999999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=381.08 Aligned_cols=257 Identities=27% Similarity=0.377 Sum_probs=206.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
..+|++++.||+|+||.||+|.+.. ++.||||++.... .....+.+|+.+|+.+.++ |+||+++++++....
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~----~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH----SDKIIRLYDYEITDQ 129 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT----CTTBCCEEEEEECSS
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccC----CCeEEEEEEEEecCC
Confidence 3569999999999999999999765 8999999997542 3456788999999999863 469999999999999
Q ss_pred eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
.+|||||+..++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~kl~DFG~ 200 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGI 200 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES---SSCEEECCCSS
T ss_pred EEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE---CCeEEEEecCc
Confidence 999999987788998887543 278889999999999999999999999999999999996 46799999999
Q ss_pred ccccCCC-----cccccCCCcccchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q 001034 1025 SCFETDH-----LCSYVQSRSYRAPEVILG-----------LSYDKKIDIWSLGCILAELCTGNVLFQNDS-PATLLARV 1087 (1182)
Q Consensus 1025 A~~~~~~-----~ss~vGTp~YmAPEVLlg-----------~~yS~kSDIWSLGVILYELLTGr~PF~g~d-~~elLakI 1087 (1182)
++..... ....+||+.|+|||++.+ ..++.++||||||||||+|++|++||.... ....+..+
T Consensus 201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 280 (390)
T 2zmd_A 201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280 (390)
T ss_dssp SCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence 9765332 235689999999999975 368999999999999999999999997643 22333333
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
+.... .. ......+..+.+||.+||+.||.+|||+.||
T Consensus 281 ~~~~~---------------------------------~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~el 318 (390)
T 2zmd_A 281 IDPNH---------------------------------EI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318 (390)
T ss_dssp HCTTS---------------------------------CC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hCccc---------------------------------cC---------CCCccchHHHHHHHHHHcccChhhCCCHHHH
Confidence 20000 00 0111236789999999999999999999999
Q ss_pred HcCCCCCCCCCCC
Q 001034 1168 LKHPWLSHPYEPI 1180 (1182)
Q Consensus 1168 LqHPWFk~~~eP~ 1180 (1182)
|+||||+....|.
T Consensus 319 l~hp~~~~~~~~~ 331 (390)
T 2zmd_A 319 LAHPYVQIQTHPV 331 (390)
T ss_dssp HTSHHHHSCC---
T ss_pred hhCcCccccCccc
Confidence 9999998766553
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=364.32 Aligned_cols=253 Identities=24% Similarity=0.300 Sum_probs=199.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
+.++|++++.||+|+||.||+|+++.+++.||||+++... .....+.+|+.+++.++ ||||++++++|....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE------HPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC------CTTBCCEEEEEEECC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC------CCCEeeEEEEEEEec
Confidence 4568999999999999999999999999999999997543 34567888999998885 459999999986643
Q ss_pred ---------------------------------------------------------eEEEEEEeccc-ChHHHHhhhcc
Q 001034 945 ---------------------------------------------------------HLLIVCELLKA-NLYEFHKFNRE 966 (1182)
Q Consensus 945 ---------------------------------------------------------~LyLVmEyL~G-sLld~Lk~~~~ 966 (1182)
++|+||||+.+ +|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 38999999986 77777765432
Q ss_pred cCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC---------------
Q 001034 967 SGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH--------------- 1031 (1182)
Q Consensus 967 sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~--------------- 1031 (1182)
........++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 158 ---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T 3qd2_B 158 ---LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232 (332)
T ss_dssp ---GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTTCEECSCC--------------C
T ss_pred ---ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeC--CCCEEEeecCcccccccchhhcccccccccccc
Confidence 122566678999999999999999999999999999999984 678999999999765432
Q ss_pred cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcc
Q 001034 1032 LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTK 1111 (1182)
Q Consensus 1032 ~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k 1111 (1182)
....+||+.|+|||++.+..++.++|||||||++|+|++|..|+.. ....+..+.. +..+.
T Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~--~~~~~--------------- 293 (332)
T 3qd2_B 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN--LKFPL--------------- 293 (332)
T ss_dssp CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT--TCCCH---------------
T ss_pred ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc--cCCCc---------------
Confidence 2345789999999999999999999999999999999998776521 1111111110 00000
Q ss_pred cchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1112 NHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1112 ~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
.....++.+.+||.+||+.||.+|||+.+||+||||++
T Consensus 294 --------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 294 --------------------------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp --------------------------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred --------------------------ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 00112467889999999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=391.60 Aligned_cols=258 Identities=28% Similarity=0.490 Sum_probs=216.8
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.+.++|++++.||+|+||+||+|.++.+++.||||++.+.. .....+.+|+.+++.+.| |||++++++|..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~~ 92 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH------PNIMKLFEILED 92 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCC------TTBCCEEEEEEC
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCC------CCcCeEEEEEEc
Confidence 46789999999999999999999999999999999997532 334677899999999864 599999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-CCceEEEe
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-SRCEVKVI 1020 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-~dG~IKLi 1020 (1182)
...+|+||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 93 SSSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEE
Confidence 9999999999985 6777776543 28999999999999999999999999999999999999742 35679999
Q ss_pred cCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1021 DLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1021 DFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
|||++..... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|++||.+.+..+++.++......++.
T Consensus 167 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-- 243 (486)
T 3mwu_A 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-- 243 (486)
T ss_dssp SCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS--
T ss_pred ECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--
Confidence 9999975433 2345689999999999976 5999999999999999999999999999988888777532211110
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
| ....++..+++||++||++||.+|||+.+||+||||+..
T Consensus 244 -------------------------------~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 244 -------------------------------P-------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp -------------------------------G-------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred -------------------------------c-------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 0 012347889999999999999999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.76 Aligned_cols=259 Identities=23% Similarity=0.400 Sum_probs=214.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-------hhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-------FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-------~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
++.++|++.+.||+|+||.||+|++..+++.||+|+++.... ....+.+|+.+++.+.| |||+++++
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~ 75 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH------PNIITLHD 75 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC------TTBCCEEE
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCC------CCeeehhh
Confidence 356789999999999999999999999999999999976431 24667889999999864 48999999
Q ss_pred EEEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC--Cc
Q 001034 939 YFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS--RC 1015 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~--dG 1015 (1182)
+|.....+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ ..
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 76 IFENKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSC
T ss_pred eecCCCeEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCC
Confidence 9999999999999997 57888776432 289999999999999999999999999999999999998532 23
Q ss_pred eEEEecCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1016 EVKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
.+||+|||++..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 150 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229 (283)
T ss_dssp CEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred ceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence 799999999976433 234557899999999999999999999999999999999999999998887777666422211
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.+. ......+..+.+||.+||..||.+|||+.++|+||||
T Consensus 230 ~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 230 FDE----------------------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp CCH----------------------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred Ccc----------------------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 111 0112346889999999999999999999999999999
Q ss_pred CCC
Q 001034 1174 SHP 1176 (1182)
Q Consensus 1174 k~~ 1176 (1182)
+..
T Consensus 270 ~~~ 272 (283)
T 3bhy_A 270 KAI 272 (283)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=383.75 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=210.2
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.+..++|++++.||+|+||.||+|++..+++.||||++.+.. .....+.+|+.+|+.+. ||||++++++|
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~------hp~Iv~l~~~~ 84 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE------HPFLVNLWYSF 84 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC------CCCCCcEEEEE
Confidence 445689999999999999999999999999999999997643 33456778999998885 45999999999
Q ss_pred EecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 941 YYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 941 qd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
.....+|+||||+.| +|..++.... .+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~vkL 156 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDE--HGHVHI 156 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEE
T ss_pred EeCCEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECC--CCCEEE
Confidence 999999999999975 5666665432 2899999999999999999999999999999999999984 778999
Q ss_pred ecCCCccccCC--CcccccCCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhhc
Q 001034 1020 IDLGSSCFETD--HLCSYVQSRSYRAPEVILG---LSYDKKIDIWSLGCILAELCTGNVLFQNDS---PATLLARVIGII 1091 (1182)
Q Consensus 1020 iDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg---~~yS~kSDIWSLGVILYELLTGr~PF~g~d---~~elLakIv~il 1091 (1182)
+|||++..... .....+||+.|+|||++.. ..|+.++|||||||++|+|++|++||.... ....+..+....
T Consensus 157 ~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 236 (384)
T 4fr4_A 157 TDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV 236 (384)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC
T ss_pred eccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc
Confidence 99999976433 3456789999999999974 468999999999999999999999997533 222222221100
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-HHHHHcC
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-ASDALKH 1170 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-AeELLqH 1170 (1182)
......++..+.+||.+||+.||.+||+ +.++++|
T Consensus 237 --------------------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 237 --------------------------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp --------------------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred --------------------------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 0111245789999999999999999998 9999999
Q ss_pred CCCCCC
Q 001034 1171 PWLSHP 1176 (1182)
Q Consensus 1171 PWFk~~ 1176 (1182)
|||+..
T Consensus 273 p~f~~~ 278 (384)
T 4fr4_A 273 PYMNDI 278 (384)
T ss_dssp GGGTTC
T ss_pred hhhhcC
Confidence 999763
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=391.33 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=213.6
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
..+.++|++++.||+|+||.||+|+++.++..||||++++.. .....+.+|+.+++.+. ||||++++++|.
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~ 106 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD------HPNIMKLYDFFE 106 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC------CTTBCCEEEEEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC------CCCCCeEEEEEE
Confidence 346678999999999999999999999999999999998643 23456788999998875 459999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-CceEEE
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKV 1019 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG~IKL 1019 (1182)
....+|+||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 180 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKI 180 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEE
Confidence 99999999999985 6777776543 288999999999999999999999999999999999998532 467999
Q ss_pred ecCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1020 IDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1020 iDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
+|||++..... .....+||+.|+|||++. ..|+.++||||||||+|+|++|++||.+.+..+++..+......++.
T Consensus 181 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~- 258 (494)
T 3lij_A 181 VDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS- 258 (494)
T ss_dssp CCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS-
T ss_pred EECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-
Confidence 99999976443 334568999999999986 46999999999999999999999999999988888777532222111
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
.....++..+++||++||++||.+|||+.+||+||||+.
T Consensus 259 ---------------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 259 ---------------------------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp ---------------------------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred ---------------------------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 011245788999999999999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.69 Aligned_cols=259 Identities=23% Similarity=0.354 Sum_probs=217.9
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
.....++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+. |+||++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~ 83 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA------HQHVVGFHGF 83 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC------CCCEeeeeee
Confidence 4456688999999999999999999999999999999997642 34456778888888875 4599999999
Q ss_pred EEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
|.....+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~k 155 (294)
T 2rku_A 84 FEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVK 155 (294)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEE
T ss_pred eccCCEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcC--CCCEE
Confidence 9999999999999985 6777665433 2889999999999999999999999999999999999984 67899
Q ss_pred EecCCCccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1019 VIDLGSSCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1019 LiDFGLA~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
|+|||++.... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+.....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 232 (294)
T 2rku_A 156 IGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--- 232 (294)
T ss_dssp ECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---
T ss_pred EEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---
Confidence 99999987643 223456789999999999999999999999999999999999999988776665555421100
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
......+..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 233 -----------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 233 -----------------------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp -----------------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred -----------------------------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 011234678999999999999999999999999999998
Q ss_pred CCCCC
Q 001034 1176 PYEPI 1180 (1182)
Q Consensus 1176 ~~eP~ 1180 (1182)
.+.|.
T Consensus 272 ~~~~~ 276 (294)
T 2rku_A 272 GYIPA 276 (294)
T ss_dssp SCCCS
T ss_pred CCcCC
Confidence 87764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=366.77 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=212.0
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
.|.+.+.||+|+||.||+|+++.+|+.||||++.... .....+.+|+.+++.++| |||++++++|.....+|+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH------FNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC------TTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC------CCcceEEEEEEECCEEEE
Confidence 4788889999999999999999999999999997543 334567789999888754 589999999999999999
Q ss_pred EEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||||+.+ +|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++..
T Consensus 120 v~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~ 190 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL--DGRVKLSDFGFCAQ 190 (321)
T ss_dssp EECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCcEEEeeeeeeee
Confidence 9999986 565554321 2889999999999999999999999999999999999984 67899999999876
Q ss_pred cCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1028 ETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1028 ~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
.... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+.....+.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 260 (321)
T 2c30_A 191 ISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK---------- 260 (321)
T ss_dssp CCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC----------
T ss_pred cccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----------
Confidence 4432 345689999999999999999999999999999999999999999888777666553211100
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
. ......+..+.+||.+||+.||.+|||+.+||+||||.....|
T Consensus 261 ---------------------------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 304 (321)
T 2c30_A 261 ---------------------------L----KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304 (321)
T ss_dssp ---------------------------C----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred ---------------------------c----CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence 0 0011246789999999999999999999999999999876544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=388.98 Aligned_cols=255 Identities=16% Similarity=0.187 Sum_probs=204.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEE------
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY------ 937 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~------ 937 (1182)
.++|++.+.||+|+||+||+|.++.+++.||||++... ......+.+|+.+++.+... .|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l---~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI---KNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTC---CSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhcccc---CCHHHHHHHhhhhhh
Confidence 47899999999999999999999999999999999743 23456677888777776543 688999998
Q ss_pred -EEEEecC-----------------eEEEEEEecccChHHHHhhhcccCC-ccccCHHHHHHHHHHHHHHHHHHHhcCcc
Q 001034 938 -DYFYYRE-----------------HLLIVCELLKANLYEFHKFNRESGG-EVYFTMPRLQSITIQCLEALQFLHGLGLI 998 (1182)
Q Consensus 938 -dsFqd~e-----------------~LyLVmEyL~GsLld~Lk~~~~sgg-el~Lse~eIr~Ia~QILsALeYLHS~GII 998 (1182)
+++.... ..||||||+.|+|.+++........ ...+++..+..|+.||+.||.|||++||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 7776653 3899999999999999886532111 11244577888999999999999999999
Q ss_pred ccccCCccEEEccCCCceEEEecCCCccccCCCcccccCCCcccchhhhcCC-----------CCCchhhHHHHHHHHHH
Q 001034 999 HCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL-----------SYDKKIDIWSLGCILAE 1067 (1182)
Q Consensus 999 HRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~-----------~yS~kSDIWSLGVILYE 1067 (1182)
||||||+||||+. ++.+||+|||+++.........+| +.|+|||++.+. .++.++|||||||+||+
T Consensus 229 HrDikp~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 229 HTYLRPVDIVLDQ--RGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CSCCCGGGEEECT--TCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcC--CCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999994 678999999999877666667788 999999999887 89999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHH
Q 001034 1068 LCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFI 1147 (1182)
Q Consensus 1068 LLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~ 1147 (1182)
|++|+.||...+....+..+ ......++..+.
T Consensus 306 lltg~~Pf~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~ 337 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWI------------------------------------------------FRSCKNIPQPVR 337 (377)
T ss_dssp HHHSSCCC------CCSGGG------------------------------------------------GSSCCCCCHHHH
T ss_pred HHHCCCCCcccccccchhhh------------------------------------------------hhhccCCCHHHH
Confidence 99999999654321110000 001135578999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1148 DFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1148 DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
+||.+||+.||.+|||+.+||+||||+..
T Consensus 338 ~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 338 ALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 99999999999999999999999999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=357.59 Aligned_cols=253 Identities=24% Similarity=0.421 Sum_probs=215.0
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
...++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||++++++|.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~ 84 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH------PNILRMYNYFH 84 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC------TTBCCEEEEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCC------CCEeeEEEEEE
Confidence 34578999999999999999999999999999999997542 223567788999888854 58999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
....+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~ 156 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGY--KGELKIA 156 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT--TCCEEEC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcC--CCCEEEe
Confidence 99999999999975 7888876543 2889999999999999999999999999999999999984 6789999
Q ss_pred cCCCccccCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1021 DLGSSCFETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1021 DFGLA~~~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
|||++..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....+
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 230 (284)
T 2vgo_A 157 DFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK------ 230 (284)
T ss_dssp CCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC------
T ss_pred cccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC------
Confidence 9999865443 334567899999999999999999999999999999999999999988777666555311100
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.....+..+.+||.+||+.||.+|||+.+||+||||+..
T Consensus 231 --------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 231 --------------------------------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp --------------------------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred --------------------------------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 112357889999999999999999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.39 Aligned_cols=256 Identities=29% Similarity=0.470 Sum_probs=207.4
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
+.+..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+. ||||++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~ 79 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR------HPHIIKLYQV 79 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC------CCCEeEEEEE
Confidence 4566789999999999999999999999999999999997542 23456778888888875 4589999999
Q ss_pred EEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
+.....+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++. ++.+|
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~ 151 (276)
T 2h6d_A 80 ISTPTDFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA--HMNAK 151 (276)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECT--TSCEE
T ss_pred EecCCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECC--CCCEE
Confidence 9999999999999975 7888876543 2889999999999999999999999999999999999984 67899
Q ss_pred EecCCCccccCCC--cccccCCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1019 VIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1019 LiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~y-S~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
|+|||++...... .....+++.|+|||++.+..+ +.++|||||||++|+|++|..||........+..+......
T Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-- 229 (276)
T 2h6d_A 152 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY-- 229 (276)
T ss_dssp ECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--
T ss_pred EeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--
Confidence 9999998765432 235578999999999988776 68999999999999999999999887776666555311100
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
.....+..+.+||.+||+.||.+|||+.+||+||||+.
T Consensus 230 ------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 230 ------------------------------------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp ------------------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred ------------------------------------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 01234678999999999999999999999999999987
Q ss_pred CC
Q 001034 1176 PY 1177 (1182)
Q Consensus 1176 ~~ 1177 (1182)
..
T Consensus 268 ~~ 269 (276)
T 2h6d_A 268 DL 269 (276)
T ss_dssp TC
T ss_pred Cc
Confidence 64
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=361.84 Aligned_cols=259 Identities=28% Similarity=0.420 Sum_probs=215.9
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.+.++|.+.+.||+|+||.||+|++..+++.||+|+++.... ....+.+|+.+++.+.| |||++++++|....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH------ENIVTLEDIYESTT 79 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCC------TTBCCEEEEEECSS
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCC------CCeeehhhhcccCC
Confidence 456789999999999999999999999999999999986542 23456789999998864 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc-CCCceEEEecC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS-YSRCEVKVIDL 1022 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs-~~dG~IKLiDF 1022 (1182)
.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+.. ...+.+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred EEEEEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccC
Confidence 99999999975 7877776543 2889999999999999999999999999999999999932 24678999999
Q ss_pred CCccccCCC-cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1023 GSSCFETDH-LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1023 GLA~~~~~~-~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
|++...... ....++|+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+.....+++.
T Consensus 154 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 228 (304)
T 2jam_A 154 GLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES----- 228 (304)
T ss_dssp STTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT-----
T ss_pred CcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc-----
Confidence 998765433 33457899999999999999999999999999999999999999988887777666422111110
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 229 -----------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 229 -----------------------------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -----------------------------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -----------------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 1123457899999999999999999999999999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=409.21 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=216.6
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++++.||+|+||+||+|+++.+++.||||++++.. ........|..+|..+.+ ||+|++++++|+..
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~-----~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-----PPFLTQLHSCFQTM 414 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTC-----CTTBCCEEEECBCS
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccC-----CCeEEEEEEEEEeC
Confidence 468999999999999999999999999999999998642 334566778888776643 56999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++||||||+.| +|..++.... .+++..++.|+.||+.||.|||++|||||||||+||||+. ++++||+||
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~--~g~ikL~DF 486 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADF 486 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECS--SSCEEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcC--CCcEEEeec
Confidence 999999999985 6766666443 2899999999999999999999999999999999999994 778999999
Q ss_pred CCcccc---CCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1023 GSSCFE---TDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1023 GLA~~~---~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
|+++.. .......+||+.|+|||++.+..|+.++||||||||||||++|++||.+.+..+++.+|+.....+
T Consensus 487 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----- 561 (674)
T 3pfq_A 487 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY----- 561 (674)
T ss_dssp TTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC-----
T ss_pred ceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC-----
Confidence 999752 233456789999999999999999999999999999999999999999999988888885211111
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHcCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA-----SDALKHPWLS 1174 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA-----eELLqHPWFk 1174 (1182)
...++.++.+||++||+.||.+||++ .+|++||||+
T Consensus 562 ---------------------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 562 ---------------------------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp ---------------------------------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred ---------------------------------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 12357899999999999999999997 9999999998
Q ss_pred CC
Q 001034 1175 HP 1176 (1182)
Q Consensus 1175 ~~ 1176 (1182)
..
T Consensus 603 ~i 604 (674)
T 3pfq_A 603 YI 604 (674)
T ss_dssp SC
T ss_pred CC
Confidence 53
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=353.29 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=216.1
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----------hhhHHHHHHHHHHHHhcCCCCCCCcceEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----------DFFDQSLDEIKLLKYVNKHDPGDKYHLLR 935 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----------~~~dq~l~EikILr~L~h~~~l~HPnIVk 935 (1182)
.+.++|++.+.||+|+||.||+|.++.+++.||||++.... .....+.+|+.+++.+. .||||++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~ 88 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-----GHPNIIQ 88 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBCC
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc-----CCCCEee
Confidence 45689999999999999999999999999999999997542 23456778999999985 2459999
Q ss_pred EEEEEEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC
Q 001034 936 LYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014 (1182)
Q Consensus 936 L~dsFqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d 1014 (1182)
++++|.....+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~ 160 (298)
T 1phk_A 89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--D 160 (298)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--T
T ss_pred eeeeeccCCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC--C
Confidence 9999999999999999998 57888876542 2889999999999999999999999999999999999984 6
Q ss_pred ceEEEecCCCccccCC--CcccccCCCcccchhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 001034 1015 CEVKVIDLGSSCFETD--HLCSYVQSRSYRAPEVIL------GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLAR 1086 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLl------g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLak 1086 (1182)
+.+||+|||++..... ......+++.|+|||++. ...++.++|||||||++|+|++|..||...+....+..
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 240 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240 (298)
T ss_dssp CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence 7899999999876433 334567899999999985 45688999999999999999999999998887776666
Q ss_pred HHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 001034 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASD 1166 (1182)
Q Consensus 1087 Iv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeE 1166 (1182)
+......++. .....++..+.+||.+||+.||.+|||+.+
T Consensus 241 ~~~~~~~~~~----------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 280 (298)
T 1phk_A 241 IMSGNYQFGS----------------------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280 (298)
T ss_dssp HHHTCCCCCT----------------------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HhcCCcccCc----------------------------------------ccccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 6422111100 011234688999999999999999999999
Q ss_pred HHcCCCCCCCCC
Q 001034 1167 ALKHPWLSHPYE 1178 (1182)
Q Consensus 1167 LLqHPWFk~~~e 1178 (1182)
+|+||||++...
T Consensus 281 ll~h~~~~~~~~ 292 (298)
T 1phk_A 281 ALAHPFFQQYVV 292 (298)
T ss_dssp HTTSGGGCTTC-
T ss_pred HHhChHhhhccc
Confidence 999999987643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=361.03 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=210.2
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe---
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--- 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--- 942 (1182)
...++|++++.||+|+||.||+|.+..+++.||||++.........+.+|+.+++.+. .||||++++++|..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHC-----CSTTBCCEEEEEEECC-
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhcc-----CCCCeeeeeeEEeeccC
Confidence 4578999999999999999999999999999999999877666678889999999984 24599999999987
Q ss_pred ---cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 943 ---REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 943 ---~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
...+|+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~--~~~~k 169 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVK 169 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TCCEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcC--CCCEE
Confidence 4689999999986 78888775432 23889999999999999999999999999999999999984 67899
Q ss_pred EecCCCccccCCC---cccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 001034 1019 VIDLGSSCFETDH---LCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1019 LiDFGLA~~~~~~---~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~i 1090 (1182)
|+|||++...... .....+|+.|+|||++. +..++.++|||||||++|+|++|..||...+....+..+...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 9999998764432 33557899999999997 567899999999999999999999999887766555444210
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.. + ......++..+.+||.+||..||.+|||+.+||+|
T Consensus 250 ~~-------------------------------------~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 250 PA-------------------------------------P-----RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CC-------------------------------------C-----CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cc-------------------------------------c-----cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0 00123457899999999999999999999999999
Q ss_pred CCCCCCC
Q 001034 1171 PWLSHPY 1177 (1182)
Q Consensus 1171 PWFk~~~ 1177 (1182)
|||+...
T Consensus 288 p~~~~~~ 294 (326)
T 2x7f_A 288 PFIRDQP 294 (326)
T ss_dssp HHHHCCT
T ss_pred hHHhhCc
Confidence 9998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=372.46 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=191.1
Q ss_pred cCCEEEE---EEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 868 AGRYHVT---EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 868 ~drYeIl---k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.++|++. +.||+|+||.||+|.++.+++.||||++.+.. .....+|+.+++.+. .||||++++++|....
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~-----~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCE-----GHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG--HHHHHHHHHHHHHTT-----TCTTBCCEEEEEECSS
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh--hhhHHHHHHHHHHhc-----CCCCeeEEEEEEEcCC
Confidence 4567775 78999999999999999999999999997543 456778999999886 2569999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-CceEEEecC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVIDL 1022 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG~IKLiDF 1022 (1182)
++||||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ ...+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCC
T ss_pred EEEEEEEccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecc
Confidence 99999999986 7777776542 289999999999999999999999999999999999998522 237999999
Q ss_pred CCccccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhhcC
Q 001034 1023 GSSCFETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP-------ATLLARVIGIIG 1092 (1182)
Q Consensus 1023 GLA~~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~-------~elLakIv~ilG 1092 (1182)
|++..... .....++|+.|+|||++.+..++.++|||||||++|+|++|++||...+. .+.+.++.....
T Consensus 154 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 154 GFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp TTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred ccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 99975433 23456789999999999999999999999999999999999999976443 223333211100
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.++. .....++.++++||++||++||.+|||+.+||+|||
T Consensus 234 ~~~~----------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 234 SFEG----------------------------------------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp CCCS----------------------------------------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred CCCc----------------------------------------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 0000 001235789999999999999999999999999999
Q ss_pred CCCCC
Q 001034 1173 LSHPY 1177 (1182)
Q Consensus 1173 Fk~~~ 1177 (1182)
|+...
T Consensus 274 ~~~~~ 278 (325)
T 3kn6_A 274 LQDGS 278 (325)
T ss_dssp GCTTC
T ss_pred hccCc
Confidence 98764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=361.08 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=210.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++ |+||+++++++.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~ 76 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR------HKNVIQLVDVLY 76 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC------CTTBCCEEEEEE
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC------CCCeeEEEEEEE
Confidence 4578999999999999999999999999999999997642 23456778888888875 459999999985
Q ss_pred --ecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 942 --YREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 942 --d~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
....+|+||||+.+++.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~--~~~~kl 150 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCGMQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT--GGTLKI 150 (305)
T ss_dssp CC---CEEEEEECCSEEHHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEE
T ss_pred cCCCCeEEEEehhccCCHHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcC--CCcEEe
Confidence 4468999999999988887765432 23899999999999999999999999999999999999984 678999
Q ss_pred ecCCCccccCC-----CcccccCCCcccchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1020 IDLGSSCFETD-----HLCSYVQSRSYRAPEVILGLS--YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1020 iDFGLA~~~~~-----~~ss~vGTp~YmAPEVLlg~~--yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
+|||++..... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC
Confidence 99999975432 223557899999999998754 47899999999999999999999998877666655531100
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.....++..+.+||.+||..||.+|||+.+||+|||
T Consensus 231 --------------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 231 --------------------------------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp --------------------------------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred --------------------------------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 011235788999999999999999999999999999
Q ss_pred CCCCCCC
Q 001034 1173 LSHPYEP 1179 (1182)
Q Consensus 1173 Fk~~~eP 1179 (1182)
|+....|
T Consensus 267 ~~~~~~~ 273 (305)
T 2wtk_C 267 FRKKHPP 273 (305)
T ss_dssp HHSCCCC
T ss_pred cccCCCC
Confidence 9876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=372.31 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=216.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
..+|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++| |||++++++|...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~~~ 126 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH------PNTIQYRGCYLRE 126 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCC------TTBCCEEEEEEET
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCC------CCEeeEEEEEEEC
Confidence 456999999999999999999999999999999997542 334567889999999864 4899999999999
Q ss_pred CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 944 EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 944 e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..+||||||+.|++.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--~~~~~kL~DfG 199 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--EPGLVKLGDFG 199 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTEEEECCCT
T ss_pred CeEEEEEecCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC--CCCCEEEeecc
Confidence 99999999999999888865432 288999999999999999999999999999999999998 47889999999
Q ss_pred CccccCCCcccccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1024 SSCFETDHLCSYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1024 LA~~~~~~~ss~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
++..... ....+||+.|+|||++. ...++.++|||||||++|+|++|++||.+.+....+..+.....+
T Consensus 200 ~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~------- 271 (348)
T 1u5q_A 200 SASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP------- 271 (348)
T ss_dssp TCBSSSS-BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-------
T ss_pred CceecCC-CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------
Confidence 9976543 34568999999999995 567899999999999999999999999888776665555311000
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
. ......+..+.+||.+||+.||.+|||+.+||+||||.....|
T Consensus 272 ------------------------------~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 272 ------------------------------A-----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp ------------------------------C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred ------------------------------C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 0 0112347889999999999999999999999999999876544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=357.11 Aligned_cols=252 Identities=24% Similarity=0.435 Sum_probs=185.1
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+. ||||++++++|....
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK------HPSILELYNYFEDSN 84 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC------CTTBCCEEEEEECSS
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC------CCCeEeEEEEEccCC
Confidence 57999999999999999999999999999999997543 22356778888888875 459999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~--~~~~kl~dfg 157 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVK-----PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADFG 157 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECT--TCCEEECCCT
T ss_pred eEEEEEecCCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEEEeec
Confidence 99999999975 67777664321 3899999999999999999999999999999999999984 6789999999
Q ss_pred CccccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1024 SSCFETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1024 LA~~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
++..... .....++|+.|+|||++.+..++.++|||||||++|+|++|++||........+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 226 (278)
T 3cok_A 158 LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----------- 226 (278)
T ss_dssp TCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----------
T ss_pred ceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----------
Confidence 9876432 23346789999999999999999999999999999999999999976543222211100
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.. .......+..+.+||.+||+.||.+|||+.+||+||||+...
T Consensus 227 ------------------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 227 ------------------------AD---------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp ------------------------SC---------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred ------------------------cc---------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 00 001123578999999999999999999999999999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=367.30 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=218.0
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
.....++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+. |+||++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~ 109 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA------HQHVVGFHGF 109 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC------CCCCCeEEEE
Confidence 3345678999999999999999999999999999999997642 34556778888888875 4599999999
Q ss_pred EEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
|.....+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~~k 181 (335)
T 2owb_A 110 FEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVK 181 (335)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEE
T ss_pred EecCCeEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcC--CCCEE
Confidence 9999999999999985 6777665443 2889999999999999999999999999999999999984 67899
Q ss_pred EecCCCccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1019 VIDLGSSCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1019 LiDFGLA~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
|+|||++.... ......++|+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+.....
T Consensus 182 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 258 (335)
T 2owb_A 182 IGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--- 258 (335)
T ss_dssp ECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---
T ss_pred EeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC---
Confidence 99999997643 223456789999999999999999999999999999999999999988776665555421100
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
. ....++..+.+||.+||+.||.+|||+.+||+||||+.
T Consensus 259 --------------------------------~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 259 --------------------------------S---------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp --------------------------------C---------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred --------------------------------C---------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0 11234678999999999999999999999999999998
Q ss_pred CCCCC
Q 001034 1176 PYEPI 1180 (1182)
Q Consensus 1176 ~~eP~ 1180 (1182)
.+.|.
T Consensus 298 ~~~~~ 302 (335)
T 2owb_A 298 GYIPA 302 (335)
T ss_dssp SCCCS
T ss_pred CCccc
Confidence 87653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=370.34 Aligned_cols=256 Identities=25% Similarity=0.459 Sum_probs=213.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
+.++|++.+.||.|+||.||+|.++.+|+.||||+++... .....+..|+.+++.+. .||||++++
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~ 166 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA-----GHPHIITLI 166 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBCCEE
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc-----CCCCEeEEE
Confidence 4578999999999999999999999999999999997643 12455678999999884 245999999
Q ss_pred EEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 938 DYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
++|.....+|+||||+.| +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~--~~~ 238 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--NMQ 238 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCC
Confidence 999999999999999986 7777776432 2889999999999999999999999999999999999984 678
Q ss_pred EEEecCCCccccCC--CcccccCCCcccchhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 001034 1017 VKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILG------LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg------~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv 1088 (1182)
+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+.
T Consensus 239 ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 99999999876443 3445789999999999863 368899999999999999999999999888777766664
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
.....++. | .....+..+.+||.+||+.||.+|||+.+||
T Consensus 319 ~~~~~~~~---------------------------------~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 358 (365)
T 2y7j_A 319 EGQYQFSS---------------------------------P-------EWDDRSSTVKDLISRLLQVDPEARLTAEQAL 358 (365)
T ss_dssp HTCCCCCH---------------------------------H-------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hCCCCCCC---------------------------------c-------ccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 22111110 0 0123467899999999999999999999999
Q ss_pred cCCCCCC
Q 001034 1169 KHPWLSH 1175 (1182)
Q Consensus 1169 qHPWFk~ 1175 (1182)
+||||+.
T Consensus 359 ~hp~f~r 365 (365)
T 2y7j_A 359 QHPFFER 365 (365)
T ss_dssp HSGGGCC
T ss_pred cCcccCC
Confidence 9999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=391.69 Aligned_cols=255 Identities=29% Similarity=0.484 Sum_probs=216.7
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
+.+..++|.+.+.||+|+||.||+|++..+|+.||||++.+.. .....+.+|+.+++.+. ||||++++++
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~l~~~ 84 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR------HPHIIKLYQV 84 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC------CTTBCCEEEE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC------CCCCCcEEEE
Confidence 4556789999999999999999999999999999999997643 23456778888888775 4599999999
Q ss_pred EEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
+.....+||||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~--~~~vk 156 (476)
T 2y94_A 85 ISTPSDIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDA--HMNAK 156 (476)
T ss_dssp EECSSEEEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECT--TCCEE
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEec--CCCeE
Confidence 999999999999996 57777775432 2899999999999999999999999999999999999984 67899
Q ss_pred EecCCCccccCC--CcccccCCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1019 VIDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1019 LiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~y-S~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
|+|||++..... .....+||+.|+|||++.+..+ +.++||||||||+|+|++|++||.+.+...++.++......
T Consensus 157 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-- 234 (476)
T 2y94_A 157 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY-- 234 (476)
T ss_dssp ECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC--
T ss_pred EEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC--
Confidence 999999976543 3456789999999999998876 68999999999999999999999988877777666421110
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
.....+..+.+||++||+.||.+|||+.+|++||||+.
T Consensus 235 ------------------------------------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 235 ------------------------------------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ------------------------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ------------------------------------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 01134688999999999999999999999999999986
Q ss_pred C
Q 001034 1176 P 1176 (1182)
Q Consensus 1176 ~ 1176 (1182)
.
T Consensus 273 ~ 273 (476)
T 2y94_A 273 D 273 (476)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=352.46 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=208.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
+.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+. ||||+++++++....
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN------HENVVKFYGHRREGN 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCC------CTTBCCEEEEEEETT
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcC------CCCceeeeeEEEcCC
Confidence 4578999999999999999999999999999999997543 33466778888888875 459999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
..|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~dfg 150 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFG 150 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCCT
T ss_pred EEEEEEEecCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc--CCCEEEeeCC
Confidence 99999999985 677665432 13889999999999999999999999999999999999984 6789999999
Q ss_pred CccccCC-----CcccccCCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhcCCcch
Q 001034 1024 SSCFETD-----HLCSYVQSRSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPA-TLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1024 LA~~~~~-----~~ss~vGTp~YmAPEVLlg~~y-S~kSDIWSLGVILYELLTGr~PF~g~d~~-elLakIv~ilGp~Pe 1096 (1182)
++..... .....++++.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----- 225 (276)
T 2yex_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----- 225 (276)
T ss_dssp TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-----
T ss_pred CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-----
Confidence 9875321 2345678999999999988775 78999999999999999999999765432 1121111000
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.........+..+.+||.+||+.||.+|||+.+||+||||+..
T Consensus 226 -------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 226 -------------------------------------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp -------------------------------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -------------------------------------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 0000112347889999999999999999999999999999987
Q ss_pred CCC
Q 001034 1177 YEP 1179 (1182)
Q Consensus 1177 ~eP 1179 (1182)
...
T Consensus 269 ~~~ 271 (276)
T 2yex_A 269 LKK 271 (276)
T ss_dssp CC-
T ss_pred hhc
Confidence 653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=378.74 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=200.7
Q ss_pred ecCCEEEE-EEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe---
Q 001034 867 IAGRYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--- 942 (1182)
Q Consensus 867 L~drYeIl-k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--- 942 (1182)
+.++|.+. +.||.|+||+||+|.++.+++.||||++.... ...+|+.++.++. .||||++++++|..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~E~~~~~~~~-----~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRAS-----QCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHT-----TSTTBCCEEEEEEEEET
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch----hHHHHHHHHHHhc-----CCCCcceEeEEEeeccc
Confidence 44667777 79999999999999999999999999997543 4567788776553 35699999999876
Q ss_pred -cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-CceEEE
Q 001034 943 -REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKV 1019 (1182)
Q Consensus 943 -~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG~IKL 1019 (1182)
..++||||||+.| +|.+++..... ..+++..++.|+.||+.||.|||++||+||||||+|||++... ++.+||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl 205 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 205 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEE
Confidence 6789999999985 78888765321 2389999999999999999999999999999999999998532 578999
Q ss_pred ecCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhhcCC
Q 001034 1020 IDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT----LLARVIGIIGP 1093 (1182)
Q Consensus 1020 iDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~e----lLakIv~ilGp 1093 (1182)
+|||+++.... .....+||+.|+|||++.+..|+.++||||||||+|+|++|++||.+..... ....+..
T Consensus 206 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~---- 281 (400)
T 1nxk_A 206 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---- 281 (400)
T ss_dssp CCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----
T ss_pred EecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----
Confidence 99999976443 2346788999999999999999999999999999999999999997654311 1111110
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.. +..+ ......++.++.+||++||+.||.+|||+.+||+||||
T Consensus 282 -----------------------------~~--~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 282 -----------------------------GQ--YEFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp -----------------------------TC--CCCC-----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -----------------------------Cc--ccCC-----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 00 0000 01123568899999999999999999999999999999
Q ss_pred CCCC
Q 001034 1174 SHPY 1177 (1182)
Q Consensus 1174 k~~~ 1177 (1182)
....
T Consensus 326 ~~~~ 329 (400)
T 1nxk_A 326 MQST 329 (400)
T ss_dssp HTTT
T ss_pred cCCC
Confidence 7653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=363.70 Aligned_cols=259 Identities=26% Similarity=0.352 Sum_probs=205.8
Q ss_pred eeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 862 VLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 862 ~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
.....+.++|++.+.||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.+ .||||++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~ 78 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL------NHPAIVAVY 78 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC------CCTTBCCEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC------CCCCcceEE
Confidence 345678899999999999999999999999999999999997643 2223444555555444 567999999
Q ss_pred EEEEecCe----EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC
Q 001034 938 DYFYYREH----LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY 1012 (1182)
Q Consensus 938 dsFqd~e~----LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~ 1012 (1182)
+++..... +||||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~- 151 (311)
T 3ork_A 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA- 151 (311)
T ss_dssp EEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-
T ss_pred EeeeccCCCCcccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcC-
Confidence 99987643 499999997 57877776543 2899999999999999999999999999999999999984
Q ss_pred CCceEEEecCCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 001034 1013 SRCEVKVIDLGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLAR 1086 (1182)
Q Consensus 1013 ~dG~IKLiDFGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLak 1086 (1182)
++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......+
T Consensus 152 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~ 230 (311)
T 3ork_A 152 -TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 230 (311)
T ss_dssp -TSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred -CCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 678999999999754332 2345689999999999999999999999999999999999999999887776655
Q ss_pred HHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 001034 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASD 1166 (1182)
Q Consensus 1087 Iv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeE 1166 (1182)
+......++. .....++..+.+||.+||+.||.+||++.+
T Consensus 231 ~~~~~~~~~~----------------------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~ 270 (311)
T 3ork_A 231 HVREDPIPPS----------------------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAA 270 (311)
T ss_dssp HHHCCCCCHH----------------------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred HhcCCCCCcc----------------------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence 5321111110 112345788999999999999999999999
Q ss_pred HHcCCCCC
Q 001034 1167 ALKHPWLS 1174 (1182)
Q Consensus 1167 LLqHPWFk 1174 (1182)
+|.|+|++
T Consensus 271 ~l~~~l~~ 278 (311)
T 3ork_A 271 EMRADLVR 278 (311)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=350.79 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=200.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe----
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY---- 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd---- 942 (1182)
+.++|++++.||+|+||.||+|++..+++.||||++.........+.+|+.+++.+. ||||++++++|..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN------HQYVVRYYAAWLERRNF 77 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEECCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcC------chHHHHHHHHHHhhcch
Confidence 356899999999999999999999999999999999877666677888999998885 4589999998865
Q ss_pred ---------cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC
Q 001034 943 ---------REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY 1012 (1182)
Q Consensus 943 ---------~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~ 1012 (1182)
...+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~- 151 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE- 151 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC-
Confidence 4678999999975 8888876432 23788899999999999999999999999999999999984
Q ss_pred CCceEEEecCCCccccCC-----------------CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Q 001034 1013 SRCEVKVIDLGSSCFETD-----------------HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVL 1074 (1182)
Q Consensus 1013 ~dG~IKLiDFGLA~~~~~-----------------~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~P 1074 (1182)
++.+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |
T Consensus 152 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 152 -SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp -TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred -CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence 67899999999875432 22345789999999999865 68999999999999999998 5
Q ss_pred CCCC-CHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHh
Q 001034 1075 FQND-SPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153 (1182)
Q Consensus 1075 F~g~-d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkM 1153 (1182)
|... +....+..+...... .|. ......+..+.+||++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~-----------------------------------~~~-----~~~~~~~~~~~~li~~~ 267 (303)
T 1zy4_A 228 FSTGMERVNILKKLRSVSIE-----------------------------------FPP-----DFDDNKMKVEKKIIRLL 267 (303)
T ss_dssp CSSHHHHHHHHHHHHSTTCC-----------------------------------CCT-----TCCTTTSHHHHHHHHHH
T ss_pred cCCchhHHHHHHhccccccc-----------------------------------cCc-----cccccchHHHHHHHHHH
Confidence 5432 222223222111000 000 11234467899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1154 LEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1154 Lq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
|+.||.+|||+.+||+||||+...
T Consensus 268 l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 268 IDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp TCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HhcCcccCcCHHHHhCCCCcCCCC
Confidence 999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=354.09 Aligned_cols=261 Identities=28% Similarity=0.408 Sum_probs=208.6
Q ss_pred eCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 863 LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 863 ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
....+.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+.| |||++++++|.
T Consensus 13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~ 86 (302)
T 2j7t_A 13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH------PYIVKLLGAYY 86 (302)
T ss_dssp SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCC------TTBCCEEEEEE
T ss_pred cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCC------CCEeeeeeeee
Confidence 34456789999999999999999999999999999999987543 345677889999988854 59999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
....+|+||||+.+ +|..++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~ 159 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL--EGDIRLA 159 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TSCEEEC
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECC--CCCEEEE
Confidence 99999999999986 55555543321 2899999999999999999999999999999999999984 6789999
Q ss_pred cCCCccccC---CCcccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1021 DLGSSCFET---DHLCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1021 DFGLA~~~~---~~~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|||++.... .......+|+.|+|||++. ...++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (302)
T 2j7t_A 160 DFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239 (302)
T ss_dssp CCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred ECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC
Confidence 999875322 1233457899999999984 66789999999999999999999999998887766655532110
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
+. ......++..+.+||.+||..||.+|||+.+||+|||
T Consensus 240 ~~-----------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 240 PT-----------------------------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp CC-----------------------------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred cc-----------------------------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 00 0001124678999999999999999999999999999
Q ss_pred CCCCC
Q 001034 1173 LSHPY 1177 (1182)
Q Consensus 1173 Fk~~~ 1177 (1182)
|+...
T Consensus 279 ~~~~~ 283 (302)
T 2j7t_A 279 VSSIT 283 (302)
T ss_dssp TTTCC
T ss_pred Hhhhc
Confidence 98753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=369.93 Aligned_cols=247 Identities=26% Similarity=0.432 Sum_probs=206.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch---------hhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD---------FFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~---------~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
+.++|++++.||+|+||.||+|.++.+++.||||++..... ....+..|+.+++.++| |||++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~Iv~~~ 95 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH------ANIIKVL 95 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCC------TTBCCEE
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCC------CCEeeEE
Confidence 45789999999999999999999999999999999986531 23456679999998854 5999999
Q ss_pred EEEEecCeEEEEEEeccc--ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCc
Q 001034 938 DYFYYREHLLIVCELLKA--NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC 1015 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G--sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG 1015 (1182)
++|.....+++||||+.+ +|..++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~ 167 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE--DF 167 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TS
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcC--CC
Confidence 999999999999999864 6777766432 2899999999999999999999999999999999999984 67
Q ss_pred eEEEecCCCccccCCC--cccccCCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1016 EVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~y-S~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
.+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... +
T Consensus 168 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~----- 236 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------T----- 236 (335)
T ss_dssp CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------G-----
T ss_pred cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------H-----
Confidence 8999999999765432 345679999999999998887 8899999999999999999999954110 0
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.. ........++..+.+||.+||++||.+|||+.+||+|||
T Consensus 237 ------~~---------------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 237 ------VE---------------------------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp ------TT---------------------------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred ------Hh---------------------------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00 000011235789999999999999999999999999999
Q ss_pred CCCCC
Q 001034 1173 LSHPY 1177 (1182)
Q Consensus 1173 Fk~~~ 1177 (1182)
|+...
T Consensus 278 ~~~~~ 282 (335)
T 3dls_A 278 VTQPV 282 (335)
T ss_dssp TTCCC
T ss_pred ccCCc
Confidence 98753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.40 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=203.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe---
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--- 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--- 942 (1182)
..|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.++ ||||++++++|..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ------HPNIVRFYDSWESTVK 99 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEEESS
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC------CCCeeeeeeeeccccC
Confidence 45899999999999999999999999999999997543 33456778888888875 4599999999886
Q ss_pred -cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccccCCccEEEccCCCceEE
Q 001034 943 -REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 943 -~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRDIKPeNILIDs~~dG~IK 1018 (1182)
...+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++. ..+.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~-~~~~~k 172 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVK 172 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTSCEE
T ss_pred CCceEEEEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC-CCCCEE
Confidence 3669999999975 7888776543 2889999999999999999999999 999999999999973 467899
Q ss_pred EecCCCccccCCC-cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhcCCcch
Q 001034 1019 VIDLGSSCFETDH-LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA-TLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1019 LiDFGLA~~~~~~-~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~-elLakIv~ilGp~Pe 1096 (1182)
|+|||++...... .....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+..+.....+ .
T Consensus 173 l~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~ 249 (290)
T 1t4h_A 173 IGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--A 249 (290)
T ss_dssp ECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--G
T ss_pred EeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--c
Confidence 9999999765443 345678999999998875 5999999999999999999999999874433 333332110000 0
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
......+..+.+||.+||+.||.+|||+.+||+||||++.
T Consensus 250 ----------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 250 ----------------------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ----------------------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ----------------------------------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 0011235789999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=359.80 Aligned_cols=278 Identities=17% Similarity=0.245 Sum_probs=209.6
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++| |||+++++++..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~ 78 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH------KNIVKLFAIEEE 78 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC------TTBCCEEEEEEC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC------CCcceEEEEeec
Confidence 456689999999999999999999999999999999997643 234567789999999864 499999999987
Q ss_pred cC--eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc--CCCceE
Q 001034 943 RE--HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS--YSRCEV 1017 (1182)
Q Consensus 943 ~e--~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs--~~dG~I 1017 (1182)
.. ++||||||+. ++|.+++...... ..+++..++.++.||+.||.|||++||+||||||+|||+.. ...+.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceE
Confidence 65 8899999997 5788877754332 22899999999999999999999999999999999999821 146789
Q ss_pred EEecCCCccccCC--CcccccCCCcccchhhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHH
Q 001034 1018 KVIDLGSSCFETD--HLCSYVQSRSYRAPEVIL--------GLSYDKKIDIWSLGCILAELCTGNVLFQNDS----PATL 1083 (1182)
Q Consensus 1018 KLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLl--------g~~yS~kSDIWSLGVILYELLTGr~PF~g~d----~~el 1083 (1182)
||+|||+++.... .....++|+.|+|||++. +..++.++|||||||++|+|++|+.||.... ..+.
T Consensus 156 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred EEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 9999999976443 234567999999999986 5789999999999999999999999996422 2344
Q ss_pred HHHHHhhcCCcchhhhhcccccc-hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTY-KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~-k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP 1162 (1182)
+.+++.. .|...+....... ..+. .....+.. .......+..+.+||++||++||++||
T Consensus 236 ~~~~~~~---~p~~~~~~~~~~~~~~~~--------------~~~~~~~~---~~~~~~~~~~l~~ll~~~L~~dP~~R~ 295 (319)
T 4euu_A 236 MYKIITG---KPSGAISGVQKAENGPID--------------WSGDMPVS---CSLSRGLQVLLTPVLANILEADQEKCW 295 (319)
T ss_dssp HHHHHHH---CCTTCCEEEECSTTCCEE--------------EESSCCTT---CSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred HHHHhcC---CCcccchhhhcccCCccc--------------cCccCCcc---cccchhHHHHhHHHHHHhccCChhhhc
Confidence 4444322 2211111110000 0000 00000100 011123357899999999999999999
Q ss_pred CHHHHHcCC
Q 001034 1163 SASDALKHP 1171 (1182)
Q Consensus 1163 TAeELLqHP 1171 (1182)
|+.|+|+||
T Consensus 296 s~~ell~h~ 304 (319)
T 4euu_A 296 GFDQFFAET 304 (319)
T ss_dssp CHHHHHHHH
T ss_pred cHHHhhhcc
Confidence 999999996
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.75 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=207.7
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
...++|++++.||.|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.| |||+++++++.....
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDS------PHVVKYYGSYFKNTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCC------TTBCCEEEEEEETTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCC------CCCccEEEEEEeCCE
Confidence 45678999999999999999999999999999999998654 34667889999998854 589999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+|+||||+|||++. ++.+||+|||+
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~dfg~ 171 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT--EGHAKLADFGV 171 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTT
T ss_pred EEEEeecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECC--CCCEEEeeccc
Confidence 9999999986 77777764322 2889999999999999999999999999999999999984 67899999999
Q ss_pred ccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1025 SCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1025 A~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+.....+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 243 (314)
T 3com_A 172 AGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-------- 243 (314)
T ss_dssp CEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--------
T ss_pred chhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc--------
Confidence 9764432 34567899999999999999999999999999999999999999887765544333211000
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
. .......+..+.+||.+||..||.+|||+.+||+||||+...
T Consensus 244 -----------------------------~----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 -----------------------------T----FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -----------------------------C----CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -----------------------------c----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 0 000112467899999999999999999999999999998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.93 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=214.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe--
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY-- 942 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd-- 942 (1182)
.++|++++.||.|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.++| |||++++++|..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH------PNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC------TTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCC------CCCCeEEEEEecCC
Confidence 478999999999999999999999999999999997542 345667889999999864 499999998865
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC-----ccccccCCccEEEccCCCce
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG-----LIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G-----IIHRDIKPeNILIDs~~dG~ 1016 (1182)
...+|+||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~--~~~ 154 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQN 154 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS--SSC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC--CCC
Confidence 5689999999985 888888755432 223889999999999999999999999 999999999999984 678
Q ss_pred EEEecCCCccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1017 VKVIDLGSSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~- 233 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF- 233 (279)
T ss_dssp EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-
T ss_pred EEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-
Confidence 999999998765432 2245789999999999999999999999999999999999999998877666555531100
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
......++..+.+||.+||+.||.+|||+.+||+|+|+
T Consensus 234 ------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 ------------------------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ------------------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------------------------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 00112457899999999999999999999999999999
Q ss_pred CCCCCCC
Q 001034 1174 SHPYEPI 1180 (1182)
Q Consensus 1174 k~~~eP~ 1180 (1182)
+.+..+.
T Consensus 272 ~~~~~~~ 278 (279)
T 2w5a_A 272 LEHHHHH 278 (279)
T ss_dssp CGGGSCC
T ss_pred hhhcccC
Confidence 9887664
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.80 Aligned_cols=262 Identities=27% Similarity=0.381 Sum_probs=205.9
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
..+..++|++++.||+|+||.||+|.+. +++.||||++... ......+.+|+.+++.+.+. |+||+++++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~----~~~iv~~~~~~ 97 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH----SDKIIRLYDYE 97 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGG----CTTBCCEEEEE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhcccc----CCceEEEEEEe
Confidence 3455678999999999999999999985 5899999999754 23456778999999999863 45999999999
Q ss_pred EecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 941 YYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 941 qd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
.....+|+|||+..++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+
T Consensus 98 ~~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~kL~ 168 (313)
T 3cek_A 98 ITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLI 168 (313)
T ss_dssp ECSSEEEEEECCCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTEEEEC
T ss_pred ecCCEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE---CCeEEEe
Confidence 9999999999988889999887543 288899999999999999999999999999999999997 4789999
Q ss_pred cCCCccccCCC-----cccccCCCcccchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHH
Q 001034 1021 DLGSSCFETDH-----LCSYVQSRSYRAPEVILG-----------LSYDKKIDIWSLGCILAELCTGNVLFQNDSP-ATL 1083 (1182)
Q Consensus 1021 DFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg-----------~~yS~kSDIWSLGVILYELLTGr~PF~g~d~-~el 1083 (1182)
|||++...... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ...
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence 99999764432 234578999999999976 4788999999999999999999999976432 222
Q ss_pred HHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT 1163 (1182)
+..++. + .. ........+..+.+||.+||..||.+|||
T Consensus 249 ~~~~~~---~-------------------------------------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps 286 (313)
T 3cek_A 249 LHAIID---P-------------------------------------NH--EIEFPDIPEKDLQDVLKCCLKRDPKQRIS 286 (313)
T ss_dssp HHHHHC---T-------------------------------------TS--CCCCCCCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHh---c-------------------------------------cc--ccCCcccchHHHHHHHHHHccCCcccCcC
Confidence 222210 0 00 00011233678999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCC
Q 001034 1164 ASDALKHPWLSHPYEPIS 1181 (1182)
Q Consensus 1164 AeELLqHPWFk~~~eP~~ 1181 (1182)
+.+||+||||+....|..
T Consensus 287 ~~ell~h~~~~~~~~~~~ 304 (313)
T 3cek_A 287 IPELLAHPYVQIQTHPVN 304 (313)
T ss_dssp HHHHHTSHHHHCC-----
T ss_pred HHHHhcCccccCCCCchh
Confidence 999999999998877754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=381.18 Aligned_cols=258 Identities=29% Similarity=0.469 Sum_probs=198.6
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---------hhhHHHHHHHHHHHHhcCCCCCCCcceEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---------~~~dq~l~EikILr~L~h~~~l~HPnIVkL 936 (1182)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++.+.. .....+.+|+.+|+.++| |||+++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l 205 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH------PCIIKI 205 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCC------TTBCCC
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCC------CCEeeE
Confidence 34578999999999999999999999999999999997643 112346789999999865 489999
Q ss_pred EEEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-CC
Q 001034 937 YDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-SR 1014 (1182)
Q Consensus 937 ~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-~d 1014 (1182)
+++|. ...+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.. ..
T Consensus 206 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~ 278 (419)
T 3i6u_A 206 KNFFD-AEDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 278 (419)
T ss_dssp CEEEE-SSEEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSS
T ss_pred EEEEe-cCceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCc
Confidence 99975 4568999999985 6666554322 38999999999999999999999999999999999999753 24
Q ss_pred ceEEEecCCCccccCCC--cccccCCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Q 001034 1015 CEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILG---LSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT-LLARVI 1088 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg---~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~e-lLakIv 1088 (1182)
+.+||+|||+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||....... ....+.
T Consensus 279 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~ 358 (419)
T 3i6u_A 279 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358 (419)
T ss_dssp CCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH
T ss_pred ceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh
Confidence 56999999999875443 345689999999999864 578899999999999999999999997643322 122221
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
...... .......++..+.+||.+||++||.+|||+.++|
T Consensus 359 ~~~~~~----------------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 398 (419)
T 3i6u_A 359 SGKYNF----------------------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398 (419)
T ss_dssp TTCCCC----------------------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred cCCCCC----------------------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000000 0011124578999999999999999999999999
Q ss_pred cCCCCCCC
Q 001034 1169 KHPWLSHP 1176 (1182)
Q Consensus 1169 qHPWFk~~ 1176 (1182)
+||||+..
T Consensus 399 ~hp~~~~~ 406 (419)
T 3i6u_A 399 RHPWLQDE 406 (419)
T ss_dssp HSGGGCCH
T ss_pred CCcccCCh
Confidence 99999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=391.24 Aligned_cols=256 Identities=24% Similarity=0.313 Sum_probs=211.9
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
+..++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+..|+.+++.+.| |||++++++|+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h------p~Iv~l~~~~~ 255 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS------RFIVSLAYAFE 255 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC------TTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC------CCEeeEEEEEe
Confidence 34578999999999999999999999999999999997643 234567889999998854 59999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
...++|+||||+.| +|..++...... ...+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~--~g~vkL~ 331 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD--DGNVRIS 331 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeC--CCCEEEe
Confidence 99999999999985 666666543211 223899999999999999999999999999999999999984 7789999
Q ss_pred cCCCccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhhcCC
Q 001034 1021 DLGSSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS----PATLLARVIGIIGP 1093 (1182)
Q Consensus 1021 DFGLA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d----~~elLakIv~ilGp 1093 (1182)
|||+++..... ....+||+.|+|||++.+..|+.++||||||||+|+|++|++||.+.. ...+...+.....
T Consensus 332 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~- 410 (543)
T 3c4z_A 332 DLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV- 410 (543)
T ss_dssp CCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-
T ss_pred ecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc-
Confidence 99999764432 334589999999999999999999999999999999999999998753 3333333321000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDAL 1168 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELL 1168 (1182)
.....++..+.+||.+||+.||.+||+ +.+|+
T Consensus 411 -------------------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 411 -------------------------------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp -------------------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred -------------------------------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 011345789999999999999999996 58999
Q ss_pred cCCCCCC
Q 001034 1169 KHPWLSH 1175 (1182)
Q Consensus 1169 qHPWFk~ 1175 (1182)
+||||+.
T Consensus 448 ~Hpff~~ 454 (543)
T 3c4z_A 448 THPLFRD 454 (543)
T ss_dssp TSGGGTT
T ss_pred cCccccC
Confidence 9999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.45 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=208.3
Q ss_pred eeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 862 VLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 862 ~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
.++.++.++|++++.||+|+||.||+|++..+++.||+|++... ......+.+|+.+++.++ ||||++++
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------hp~iv~~~ 77 (294)
T 4eqm_A 4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS------HQNIVSMI 77 (294)
T ss_dssp CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC------BTTBCCEE
T ss_pred chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC------CCCCceEE
Confidence 45778899999999999999999999999999999999998653 233456778888888775 45999999
Q ss_pred EEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 938 DYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
+++.....+|+||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 78 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~--~~~ 149 (294)
T 4eqm_A 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS--NKT 149 (294)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSC
T ss_pred EeeeeCCeEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCC
Confidence 999999999999999986 7887776543 2899999999999999999999999999999999999984 678
Q ss_pred EEEecCCCccccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1017 VKVIDLGSSCFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......+++....
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 229 (294)
T 4eqm_A 150 LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV 229 (294)
T ss_dssp EEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC
T ss_pred EEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC
Confidence 999999999765432 2345789999999999999999999999999999999999999998887665544431110
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
+.. .....+.++..+.+||.+||..||.+||+..+.|.+.|
T Consensus 230 ~~~---------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 230 PNV---------------------------------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp CCH---------------------------------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred CCc---------------------------------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 000 00112345789999999999999999996666666555
Q ss_pred C
Q 001034 1173 L 1173 (1182)
Q Consensus 1173 F 1173 (1182)
.
T Consensus 271 ~ 271 (294)
T 4eqm_A 271 S 271 (294)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.25 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=203.6
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---------hhhHHHHHHHHHHHHhcCCCCCCCcceEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---------DFFDQSLDEIKLLKYVNKHDPGDKYHLLR 935 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---------~~~dq~l~EikILr~L~h~~~l~HPnIVk 935 (1182)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~ 79 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH------PCIIK 79 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCC------TTBCC
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCC------CCCce
Confidence 346688999999999999999999999999999999997542 123356789999999854 48999
Q ss_pred EEEEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-
Q 001034 936 LYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS- 1013 (1182)
Q Consensus 936 L~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~- 1013 (1182)
+++++.... +|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 80 IKNFFDAED-YYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp EEEEEESSS-EEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSS
T ss_pred EeeEEcCCc-eEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCC
Confidence 999987654 8999999975 7877775432 288999999999999999999999999999999999998532
Q ss_pred CceEEEecCCCccccCCC--cccccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Q 001034 1014 RCEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA-TLLARV 1087 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~-elLakI 1087 (1182)
.+.+||+|||++...... ....++|+.|+|||++. ...++.++|||||||++|+|++|..||...... .....+
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 232 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232 (322)
T ss_dssp SCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH
T ss_pred CCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH
Confidence 346999999999865443 23457899999999984 567899999999999999999999999764322 111122
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
....... .......++..+.+||.+||..||.+|||+.++
T Consensus 233 ~~~~~~~----------------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~ 272 (322)
T 2ycf_A 233 TSGKYNF----------------------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272 (322)
T ss_dssp HHTCCCC----------------------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HhCcccc----------------------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 1000000 000112457899999999999999999999999
Q ss_pred HcCCCCCC
Q 001034 1168 LKHPWLSH 1175 (1182)
Q Consensus 1168 LqHPWFk~ 1175 (1182)
|+||||+.
T Consensus 273 l~h~~~~~ 280 (322)
T 2ycf_A 273 LRHPWLQD 280 (322)
T ss_dssp HTSGGGCC
T ss_pred hhCcCcCC
Confidence 99999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.81 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=212.9
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
...+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||++++++|....
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS------PYVTKYYGSYLKDT 93 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCC------TTBCCEEEEEEETT
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCC------CCEeEEEEEEecCC
Confidence 3467999999999999999999999999999999997643 345678889999988854 48999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+||||+.+ +|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~Dfg 164 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFG 164 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCT
T ss_pred eEEEEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECC--CCCEEEeecc
Confidence 99999999986 677666421 2889999999999999999999999999999999999984 6789999999
Q ss_pred CccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1024 SSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1024 LA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||........+..+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 235 (303)
T 3a7i_A 165 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--------- 235 (303)
T ss_dssp TCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---------
T ss_pred cceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC---------
Confidence 99764432 345678999999999999999999999999999999999999998877665544432100
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
. ......++..+.+||.+||..||.+|||+.+||+||||....
T Consensus 236 ----------------------------~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 236 ----------------------------P------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp ----------------------------C------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred ----------------------------C------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 0 011234578899999999999999999999999999996543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=361.52 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=212.4
Q ss_pred ceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-------hhHHHHHHHHHHHHhcCCCCCCCc
Q 001034 859 FHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-------FFDQSLDEIKLLKYVNKHDPGDKY 931 (1182)
Q Consensus 859 f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-------~~dq~l~EikILr~L~h~~~l~HP 931 (1182)
.+......+.++|++.+.||+|+||.||+|.+..+++.||||++..... ....+..|+.+++.+.+ .|+
T Consensus 33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~----~~~ 108 (320)
T 3a99_A 33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS----GFS 108 (320)
T ss_dssp -------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS----SSC
T ss_pred CcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc----CCC
Confidence 3455667788999999999999999999999999999999999976531 22455679999999976 356
Q ss_pred ceEEEEEEEEecCeEEEEEEecc--cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEE
Q 001034 932 HLLRLYDYFYYREHLLIVCELLK--ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV 1009 (1182)
Q Consensus 932 nIVkL~dsFqd~e~LyLVmEyL~--GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILI 1009 (1182)
||++++++|.....+++|||++. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 109 ~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll 182 (320)
T 3a99_A 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 182 (320)
T ss_dssp SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEE
Confidence 99999999999999999999997 67888876543 28899999999999999999999999999999999999
Q ss_pred ccCCCceEEEecCCCccccCCC-cccccCCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 001034 1010 KSYSRCEVKVIDLGSSCFETDH-LCSYVQSRSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1010 Ds~~dG~IKLiDFGLA~~~~~~-~ss~vGTp~YmAPEVLlg~~y-S~kSDIWSLGVILYELLTGr~PF~g~d~~elLakI 1087 (1182)
+. ..+.+||+|||++...... .....+|+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... +
T Consensus 183 ~~-~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~ 255 (320)
T 3a99_A 183 DL-NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I 255 (320)
T ss_dssp ET-TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H
T ss_pred eC-CCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------h
Confidence 83 3678999999999765443 345678999999999987765 6889999999999999999999965321 1
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
.. +. ......++..+.+||.+||..||.+|||+.+|
T Consensus 256 ~~--~~------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 291 (320)
T 3a99_A 256 IR--GQ------------------------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291 (320)
T ss_dssp HH--CC------------------------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hc--cc------------------------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00 00 00112457899999999999999999999999
Q ss_pred HcCCCCCCCCCC
Q 001034 1168 LKHPWLSHPYEP 1179 (1182)
Q Consensus 1168 LqHPWFk~~~eP 1179 (1182)
|+||||+....|
T Consensus 292 l~hp~~~~~~~~ 303 (320)
T 3a99_A 292 QNHPWMQDVLLP 303 (320)
T ss_dssp HTSGGGSSCCCH
T ss_pred hcCHhhcCccCc
Confidence 999999988765
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.03 Aligned_cols=258 Identities=28% Similarity=0.486 Sum_probs=213.7
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||+++++++..
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~ 92 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH------PNIMKLFEILED 92 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCC------TTBCCEEEEEEC
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccC------CCccEEEEEEeC
Confidence 45678999999999999999999999999999999997543 235677889999998854 589999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-CceEEEe
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVI 1020 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG~IKLi 1020 (1182)
...+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCeEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEe
Confidence 9999999999975 6777766443 288999999999999999999999999999999999998532 4579999
Q ss_pred cCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1021 DLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1021 DFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
|||++...... .....+++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......++
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 242 (287)
T 2wei_A 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD--- 242 (287)
T ss_dssp STTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred ccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 99998754432 234567899999999876 489999999999999999999999999887777666542111100
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
. .....++..+.+||++||.+||.+|||+.+||+||||+..
T Consensus 243 ------------------------------~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 243 ------------------------------L-------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp ------------------------------S-------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred ------------------------------c-------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 0 0112457889999999999999999999999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=393.66 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=211.8
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
+..++|++++.||+|+||.||+|+++.+|+.||||++.+.. .....+.+|+.+|+.++| |||++++++|+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~h------p~Iv~l~~~~~ 254 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS------RFVVSLAYAYE 254 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC------TTBCCEEEEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCC------CCEeeEEEEEe
Confidence 45678999999999999999999999999999999997642 234567789999998864 49999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
...++||||||+.| +|..++.... ...+++..++.|+.||+.||.|||++|||||||||+||||+. ++++||+
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~--~g~vKL~ 328 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMG----QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD--HGHIRIS 328 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeC--CCCeEEE
Confidence 99999999999975 6666665432 123899999999999999999999999999999999999984 7789999
Q ss_pred cCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhhcCCc
Q 001034 1021 DLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS----PATLLARVIGIIGPI 1094 (1182)
Q Consensus 1021 DFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d----~~elLakIv~ilGp~ 1094 (1182)
|||+++.... .....+||+.|+|||++.+..|+.++||||||||+|+|++|++||.+.. ...+...+...
T Consensus 329 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---- 404 (576)
T 2acx_A 329 DLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---- 404 (576)
T ss_dssp CCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----
T ss_pred ecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----
Confidence 9999976543 2345689999999999999999999999999999999999999998753 22222222100
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHc
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALK 1169 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLq 1169 (1182)
+ ......++..+++||.+||+.||.+|| ++.||++
T Consensus 405 -----------------------------------~-----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 -----------------------------------P-----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----------------------------------C-----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----------------------------------c-----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0 001134578999999999999999999 8999999
Q ss_pred CCCCCC
Q 001034 1170 HPWLSH 1175 (1182)
Q Consensus 1170 HPWFk~ 1175 (1182)
||||+.
T Consensus 445 HpfF~~ 450 (576)
T 2acx_A 445 HPLFKK 450 (576)
T ss_dssp SGGGTT
T ss_pred Chhhcc
Confidence 999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=354.03 Aligned_cols=270 Identities=26% Similarity=0.398 Sum_probs=190.9
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ .||||++++++|...
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC------HHPNIVSYYTSFVVK 85 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC------CCTTBCCEEEEEESS
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc------CCCCEeeEEEEEeec
Confidence 44688999999999999999999999999999999986542 2233444555555444 567999999999999
Q ss_pred CeEEEEEEecc-cChHHHHhhhcccC--CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 944 EHLLIVCELLK-ANLYEFHKFNRESG--GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 944 e~LyLVmEyL~-GsLld~Lk~~~~sg--gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
..+|+||||+. ++|.+++....... ....+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~ 163 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE--DGSVQIA 163 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TCCEEEC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC--CCCEEEE
Confidence 99999999997 47877776432111 1224889999999999999999999999999999999999984 6789999
Q ss_pred cCCCccccCCC--------cccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 001034 1021 DLGSSCFETDH--------LCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1021 DFGLA~~~~~~--------~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~il 1091 (1182)
|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........+.......
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 99988653321 234578999999999976 568999999999999999999999998766554443332111
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHP 1171 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHP 1171 (1182)
.+.. +...........++..+.+||.+||+.||.+|||+.+||+||
T Consensus 244 ~~~~----------------------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 244 PPSL----------------------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp CCCT----------------------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred CCcc----------------------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0000 000001122345678999999999999999999999999999
Q ss_pred CCCCCC
Q 001034 1172 WLSHPY 1177 (1182)
Q Consensus 1172 WFk~~~ 1177 (1182)
||+...
T Consensus 290 ~~~~~~ 295 (303)
T 2vwi_A 290 FFQKAK 295 (303)
T ss_dssp TC----
T ss_pred hhhcCC
Confidence 998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.23 Aligned_cols=256 Identities=19% Similarity=0.226 Sum_probs=208.4
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+.++.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.+ |++++++++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~-----~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAG-----CTGIPNVYYFGQEG 78 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTT-----CTTCCCEEEEEEET
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhc-----CCCCCeEEeecCCC
Confidence 4567889999999999999999999999999999999997554 33567789999999854 34899999999999
Q ss_pred CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC---CceEEEe
Q 001034 944 EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS---RCEVKVI 1020 (1182)
Q Consensus 944 e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~---dG~IKLi 1020 (1182)
...|+||||+.++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred ceeEEEEEecCCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 99999999998889998875432 289999999999999999999999999999999999998521 2349999
Q ss_pred cCCCccccCCC----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH
Q 001034 1021 DLGSSCFETDH----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND---SPATLLARV 1087 (1182)
Q Consensus 1021 DFGLA~~~~~~----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~---d~~elLakI 1087 (1182)
|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. .....+..+
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 99999754432 23557899999999999999999999999999999999999999874 333434333
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
.......+ .......++..+.+||.+||..||.+|||+.+|
T Consensus 234 ~~~~~~~~---------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l 274 (298)
T 1csn_A 234 GEKKQSTP---------------------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 274 (298)
T ss_dssp HHHHHHSC---------------------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred HhhccCcc---------------------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHH
Confidence 21110000 001123457899999999999999999999998
Q ss_pred Hc
Q 001034 1168 LK 1169 (1182)
Q Consensus 1168 Lq 1169 (1182)
++
T Consensus 275 ~~ 276 (298)
T 1csn_A 275 QG 276 (298)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=363.77 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=204.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEEC---CCCcEEEEEEEeccc-----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNNK-----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~k-----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
-.++|++++.||+|+||.||+|++. .+++.||||++++.. .....+..|+.+++.+.+ ||||+++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~~iv~~~~ 126 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTLHY 126 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT-----CTTBCCEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccC-----CCceeEEEE
Confidence 3478999999999999999999984 589999999987532 234556779999999863 349999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
+|.....+||||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~ 198 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHV 198 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCE
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCcE
Confidence 99999999999999985 7777776543 2889999999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCC----CcccccCCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Q 001034 1018 KVIDLGSSCFETD----HLCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLFQNDSP----ATLLARV 1087 (1182)
Q Consensus 1018 KLiDFGLA~~~~~----~~ss~vGTp~YmAPEVLlg--~~yS~kSDIWSLGVILYELLTGr~PF~g~d~----~elLakI 1087 (1182)
||+|||+++.... .....+||+.|+|||++.+ ..++.++||||||||||+|++|+.||..... ..+...+
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 278 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence 9999999875322 2335689999999999986 3578999999999999999999999975332 2222221
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP----- 1162 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP----- 1162 (1182)
... .......++..+.+||.+||..||.+||
T Consensus 279 ~~~--------------------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~ 314 (355)
T 1vzo_A 279 LKS--------------------------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 314 (355)
T ss_dssp HHC--------------------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTT
T ss_pred hcc--------------------------------------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCC
Confidence 100 0011234578899999999999999999
Q ss_pred CHHHHHcCCCCCCC
Q 001034 1163 SASDALKHPWLSHP 1176 (1182)
Q Consensus 1163 TAeELLqHPWFk~~ 1176 (1182)
|+.+||+||||+..
T Consensus 315 s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 315 DADEIKEHLFFQKI 328 (355)
T ss_dssp THHHHHTSGGGTTC
T ss_pred CHHHHHcCcchhcC
Confidence 99999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.30 Aligned_cols=280 Identities=22% Similarity=0.316 Sum_probs=216.4
Q ss_pred eeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchh------------------hHHHHHHHHHHHHhc
Q 001034 862 VLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF------------------FDQSLDEIKLLKYVN 923 (1182)
Q Consensus 862 ~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~------------------~dq~l~EikILr~L~ 923 (1182)
.....+.++|++.+.||+|+||.||+|.+ +++.||||++...... ...+.+|+.+++.+.
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 101 (348)
T 2pml_X 24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101 (348)
T ss_dssp SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence 44566779999999999999999999998 9999999999754321 167888999998885
Q ss_pred CCCCCCCcceEEEEEEEEecCeEEEEEEeccc-ChHHHHhhhcc--cCCccccCHHHHHHHHHHHHHHHHHHHh-cCccc
Q 001034 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRE--SGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIH 999 (1182)
Q Consensus 924 h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~--sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIH 999 (1182)
||||+++++++.....+|+||||+.+ +|.+++..... ......+++..++.++.||+.||.|||+ .||+|
T Consensus 102 ------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H 175 (348)
T 2pml_X 102 ------NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175 (348)
T ss_dssp ------CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred ------CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEee
Confidence 45999999999999999999999986 77766221100 1112348999999999999999999999 99999
Q ss_pred cccCCccEEEccCCCceEEEecCCCccccCC-CcccccCCCcccchhhhcCC-CCCc-hhhHHHHHHHHHHHHhCCCCCC
Q 001034 1000 CDLKPENILVKSYSRCEVKVIDLGSSCFETD-HLCSYVQSRSYRAPEVILGL-SYDK-KIDIWSLGCILAELCTGNVLFQ 1076 (1182)
Q Consensus 1000 RDIKPeNILIDs~~dG~IKLiDFGLA~~~~~-~~ss~vGTp~YmAPEVLlg~-~yS~-kSDIWSLGVILYELLTGr~PF~ 1076 (1182)
|||||+|||++. ++.+||+|||++..... ......+++.|+|||++.+. .++. ++|||||||++|+|++|..||.
T Consensus 176 ~dl~p~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 176 RDVKPSNILMDK--NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCCCGGGEEECT--TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCChHhEEEcC--CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999984 67899999999976433 34556889999999999887 6666 9999999999999999999998
Q ss_pred CCCH-HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcc
Q 001034 1077 NDSP-ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155 (1182)
Q Consensus 1077 g~d~-~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq 1155 (1182)
.... ...+..+.....+.|.... .+ .....+. ........++..+.+||.+||+
T Consensus 254 ~~~~~~~~~~~i~~~~~~~~~~~~--------~~---------------~~~~~~~--~~~~~~~~~~~~l~~li~~~L~ 308 (348)
T 2pml_X 254 LKISLVELFNNIRTKNIEYPLDRN--------HF---------------LYPLTNK--KSTCSNNFLSNEDIDFLKLFLR 308 (348)
T ss_dssp CSSCSHHHHHHHTSCCCCCCCSSS--------SS---------------TTTTCC----------CCCHHHHHHHHHHCC
T ss_pred CCCcHHHHHHHHhccCcCCccchh--------hh---------------hcccccc--ccccchhhcCHHHHHHHHHHcc
Confidence 8666 6666666432222221100 00 0000000 0111224568999999999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCC
Q 001034 1156 INPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1156 ~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.||.+|||+.++|+||||+..
T Consensus 309 ~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 309 KNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp SSGGGSCCHHHHHTSGGGTTC
T ss_pred CChhhCCCHHHHhcCccccCC
Confidence 999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.30 Aligned_cols=265 Identities=24% Similarity=0.372 Sum_probs=183.7
Q ss_pred eCceecCCEEEEE-EeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 863 LNSVIAGRYHVTE-YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 863 ig~iL~drYeIlk-~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
....+.++|++++ .||+|+||.||+|.++.+++.||||++...... ..++..+..+. .||||++++++|.
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~-----~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQAS-----GGPHIVCILDVYE 92 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHT-----TSTTBCCEEEEEE
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhc-----CCCChHHHHHHHh
Confidence 3445778999965 699999999999999999999999999765432 23333322221 4569999999998
Q ss_pred e----cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-Cc
Q 001034 942 Y----REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RC 1015 (1182)
Q Consensus 942 d----~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG 1015 (1182)
. ...+||||||+.| +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ .+
T Consensus 93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 93 NMHHGKRCLLIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EEETTEEEEEEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTC
T ss_pred hccCCCceEEEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCc
Confidence 7 4569999999986 78888775432 2389999999999999999999999999999999999998532 46
Q ss_pred eEEEecCCCccccCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1016 EVKVIDLGSSCFETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
.+||+|||++..... .....++|+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....
T Consensus 169 ~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--- 245 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI--- 245 (336)
T ss_dssp CEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred eEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh---
Confidence 799999999975443 2345678999999999998899999999999999999999999997655433211110000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLS 1174 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk 1174 (1182)
.... ...+ ......++..+.+||.+||+.||.+|||+.+||+||||+
T Consensus 246 --------------------------~~~~--~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 292 (336)
T 3fhr_A 246 --------------------------RLGQ--YGFP-----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292 (336)
T ss_dssp ---------------------------------CCC-----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred --------------------------hccc--cccC-----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 0000 0000 011235688999999999999999999999999999997
Q ss_pred CC
Q 001034 1175 HP 1176 (1182)
Q Consensus 1175 ~~ 1176 (1182)
..
T Consensus 293 ~~ 294 (336)
T 3fhr_A 293 QS 294 (336)
T ss_dssp TG
T ss_pred cc
Confidence 64
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=353.64 Aligned_cols=251 Identities=17% Similarity=0.206 Sum_probs=204.7
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++.++|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.+++.+.+ |+||+++++++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~-----h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGS-----GDGIPQVYYFGPCGKY 79 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCS-----CTTSCCEEEEEEETTE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhC-----CCCCCEEEEEEecCCc
Confidence 456889999999999999999999999999999999976542 3567889999999942 4599999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce-----EEEe
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE-----VKVI 1020 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~-----IKLi 1020 (1182)
+|+||||+.++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. .+. +||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~--~~~~~~~~~kl~ 152 (330)
T 2izr_A 80 NAMVLELLGPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR--PGNKTQQVIHII 152 (330)
T ss_dssp EEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECC--GGGTCTTSEEEC
T ss_pred cEEEEEeCCCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecc--CCCCCCceEEEE
Confidence 999999998889998876422 3899999999999999999999999999999999999985 444 9999
Q ss_pred cCCCccccCCC----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH
Q 001034 1021 DLGSSCFETDH----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS---PATLLARV 1087 (1182)
Q Consensus 1021 DFGLA~~~~~~----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d---~~elLakI 1087 (1182)
|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+ ..+.+..+
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence 99999754322 235689999999999999999999999999999999999999998743 33334443
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
.....+.+. .......+ .+.+||..||..||.+||++.+|
T Consensus 233 ~~~~~~~~~---------------------------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l 272 (330)
T 2izr_A 233 GDTKRATPI---------------------------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYL 272 (330)
T ss_dssp HHHHHHSCH---------------------------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHH
T ss_pred HhhhccCCH---------------------------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHH
Confidence 211100000 00011223 89999999999999999999998
Q ss_pred Hc
Q 001034 1168 LK 1169 (1182)
Q Consensus 1168 Lq 1169 (1182)
++
T Consensus 273 ~~ 274 (330)
T 2izr_A 273 RK 274 (330)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=351.46 Aligned_cols=260 Identities=20% Similarity=0.276 Sum_probs=192.3
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCc---EEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGM---DVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr---~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
+..++|++.+.||+|+||.||+|.+..++. .||||+++.. ......+.+|+.+++.++ ||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD------HPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCC------CTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC------CCceehhhce
Confidence 445789999999999999999999887765 8999999764 334567788999988885 4599999999
Q ss_pred EEecCeE------EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC
Q 001034 940 FYYREHL------LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY 1012 (1182)
Q Consensus 940 Fqd~e~L------yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~ 1012 (1182)
+...... ++||||+.+ +|.+++...........+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~- 172 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE- 172 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC-
Confidence 9887655 999999986 78887765543333335899999999999999999999999999999999999984
Q ss_pred CCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 001034 1013 SRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLAR 1086 (1182)
Q Consensus 1013 ~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLak 1086 (1182)
++.+||+|||+++..... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+....+..
T Consensus 173 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 173 -DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp -TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred -CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 678999999999764332 223456788999999999999999999999999999999 9999988776666555
Q ss_pred HHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC---
Q 001034 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS--- 1163 (1182)
Q Consensus 1087 Iv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT--- 1163 (1182)
+..... ....+.++..+.+||.+||+.||.+|||
T Consensus 252 ~~~~~~-------------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 288 (323)
T 3qup_A 252 LIGGNR-------------------------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTC 288 (323)
T ss_dssp HHTTCC-------------------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HhcCCC-------------------------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 531100 0112345788999999999999999999
Q ss_pred ----HHHHHcCCCCCCC
Q 001034 1164 ----ASDALKHPWLSHP 1176 (1182)
Q Consensus 1164 ----AeELLqHPWFk~~ 1176 (1182)
+++++.|||+...
T Consensus 289 l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 289 LRMELENILGHLSVLST 305 (323)
T ss_dssp HHHHHHHHHHC------
T ss_pred HHHHHHHHHHHhhhcCC
Confidence 8889999999765
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=346.54 Aligned_cols=254 Identities=26% Similarity=0.352 Sum_probs=186.0
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchh--hHHHHHHH-HHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF--FDQSLDEI-KLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~--~dq~l~Ei-kILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.++|++++.||.|+||.||+|.++.+++.||||++...... ......+. .+++.+ .||||+++++++....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~------~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH------DCPYIVQCFGTFITNT 97 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT------TCTTBCCEEEEEECSS
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc------CCCceeeEEEEEecCC
Confidence 47899999999999999999999999999999999865321 12223333 333333 4669999999999999
Q ss_pred eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-CccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL-GLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~-GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+||||+.+.+..+...... .+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg 170 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE--RGQIKLCDFG 170 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECT--TSCEEECCCT
T ss_pred cEEEEEeccCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECC--CCCEEEEECC
Confidence 9999999996555444433221 288999999999999999999995 9999999999999984 6789999999
Q ss_pred CccccCC--CcccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhcCCcc
Q 001034 1024 SSCFETD--HLCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQN-DSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1024 LA~~~~~--~~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g-~d~~elLakIv~ilGp~P 1095 (1182)
++..... ......+|+.|+|||++. ...++.++|||||||++|+|++|+.||.. ......+..+.....+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-- 248 (318)
T 2dyl_A 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP-- 248 (318)
T ss_dssp TC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC--
T ss_pred CchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC--
Confidence 9875433 233457899999999994 55788999999999999999999999976 3444444444211000
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
.......++..+.+||.+||..||.+|||+.+||+||||+.
T Consensus 249 ---------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 249 ---------------------------------------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp ---------------------------------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred ---------------------------------------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 00111245789999999999999999999999999999964
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.77 Aligned_cols=246 Identities=21% Similarity=0.338 Sum_probs=207.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.++|++++.||+|+||.||+|.+. +++.||+|++.........+.+|+.+++.++| |||++++++|.....+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH------PKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC------TTBCCEEEEECSSSSEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCC------CCEeeEEEEEecCCceE
Confidence 468999999999999999999986 57789999998776566778899999999864 59999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTR 154 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG--GGCEEECCTTGGG
T ss_pred EEEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcC--CCCEEeccccccc
Confidence 99999986 67777754332 3889999999999999999999999999999999999984 6789999999997
Q ss_pred ccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+....+..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-------- 226 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------- 226 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------
T ss_pred cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC--------
Confidence 65432 233456778999999999999999999999999999999 99999998887776666321100
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......+..+.+||.+||+.||.+|||+.++++|
T Consensus 227 -----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 -----------------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0112346889999999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.69 Aligned_cols=261 Identities=13% Similarity=0.178 Sum_probs=200.8
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCC-----CcEEEEEEEeccchhhHHHHHHHHHHHHhcC---------CCCCCCc
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHT-----GMDVCVKIIKNNKDFFDQSLDEIKLLKYVNK---------HDPGDKY 931 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~T-----Gr~VAVKIIkk~k~~~dq~l~EikILr~L~h---------~~~l~HP 931 (1182)
...++|++.+.||+|+||.||+|.+..+ ++.||||++..... ....|+++++.+.+ .....|+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH---HHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch---hHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 3456999999999999999999998765 58899999986642 44556666666544 2345788
Q ss_pred ceEEEEEEEEec----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccE
Q 001034 932 HLLRLYDYFYYR----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007 (1182)
Q Consensus 932 nIVkL~dsFqd~----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNI 1007 (1182)
||+++++++... .++||||||+.++|.+++..... .+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Ni 183 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL 183 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHE
Confidence 999999999875 56999999997788888875422 289999999999999999999999999999999999
Q ss_pred EEccCCCceEEEecCCCccccCCC----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001034 1008 LVKSYSRCEVKVIDLGSSCFETDH----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN 1077 (1182)
Q Consensus 1008 LIDs~~dG~IKLiDFGLA~~~~~~----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g 1077 (1182)
|++....+.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998545788999999999653321 1344599999999999999999999999999999999999999985
Q ss_pred CCHHHHHHHHHh-hc-CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcc
Q 001034 1078 DSPATLLARVIG-II-GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155 (1182)
Q Consensus 1078 ~d~~elLakIv~-il-Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq 1155 (1182)
......+..... .. ..++. .+.... ....++..+.+||..||.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~--------~~~~~~~~~~~li~~cl~ 308 (364)
T 3op5_A 264 NLKDPKYVRDSKIRYRENIAS---------------------------LMDKCF--------PAANAPGEIAKYMETVKL 308 (364)
T ss_dssp GTTCHHHHHHHHHHHHHCHHH---------------------------HHHHHS--------CTTCCCHHHHHHHHHHHT
T ss_pred cccCHHHHHHHHHHhhhhHHH---------------------------HHHHhc--------ccccCHHHHHHHHHHHhc
Confidence 332222211110 00 00000 000000 113457899999999999
Q ss_pred cCCCCCCCHHHHHc
Q 001034 1156 INPKKRPSASDALK 1169 (1182)
Q Consensus 1156 ~DPekRPTAeELLq 1169 (1182)
.||.+||++.+|++
T Consensus 309 ~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 309 LDYTEKPLYENLRD 322 (364)
T ss_dssp CCTTCCCCHHHHHH
T ss_pred CCCCCCCCHHHHHH
Confidence 99999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.36 Aligned_cols=254 Identities=20% Similarity=0.251 Sum_probs=198.6
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.+++.+.|+. +|..+..++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~-----~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGV-----GIPTIRWCGAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTST-----TCCCEEEEEEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCC-----CCCeeeeecCCCCc
Confidence 456899999999999999999999999999999999765542 346788999999998764 56666667778889
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc-CCCceEEEecCCC
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS-YSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs-~~dG~IKLiDFGL 1024 (1182)
.++||||+.++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ...+.+||+|||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 80 NVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred eEEEEEccCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 999999998899988875432 2899999999999999999999999999999999999921 1467899999999
Q ss_pred ccccCCC----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhc
Q 001034 1025 SCFETDH----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPA---TLLARVIGII 1091 (1182)
Q Consensus 1025 A~~~~~~----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~---elLakIv~il 1091 (1182)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. ..+.++....
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 9754432 23557899999999999999999999999999999999999999764321 1111111000
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
...+ .......++..+.+||.+||+.||.+|||+.++++
T Consensus 235 -----------------------------------~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 -----------------------------------MSTP----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----------------------------------HHSC----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----------------------------------ccch----hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0000 01112345789999999999999999999999886
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.94 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=207.5
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+..++|++++.||+|+||.||+|.+. ++..||+|+++........+.+|+.+++.++| |||+++++++.....
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH------PKLVKFYGVCSKEYP 77 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCC------TTBCCEEEEECSSSS
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCC------CCEeeEEEEEccCCc
Confidence 34578999999999999999999875 67789999998776666778899999999864 489999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~~l~Dfg~ 150 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR--DLCVKVSDFGM 150 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT--TCCEEECCTTC
T ss_pred eEEEEEccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC--CCCEEEccCcc
Confidence 9999999975 68887765432 2889999999999999999999999999999999999984 67899999999
Q ss_pred ccccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1025 SCFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1025 A~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------ 224 (268)
T 3sxs_A 151 TRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL------ 224 (268)
T ss_dssp EEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC------
T ss_pred ceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC------
Confidence 97544322 23345678999999999899999999999999999999 99999888877666555311100
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......+..+.+||.+||+.||.+|||+.++++|
T Consensus 225 -------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 -------------------------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -------------------------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012246789999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=338.01 Aligned_cols=254 Identities=19% Similarity=0.251 Sum_probs=203.6
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.+++.+.|+. ++..+..++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~-----~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGV-----GIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTST-----TCCCEEEEEEETTE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCC-----CCCccccccCCCCc
Confidence 467899999999999999999999999999999999876543 356789999999998764 45556666677889
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc-CCCceEEEecCCC
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS-YSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs-~~dG~IKLiDFGL 1024 (1182)
.|+||||+.++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ...+.+||+|||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 80 NVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred eEEEEEecCCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 999999998899998875432 2899999999999999999999999999999999999941 1367899999999
Q ss_pred ccccCCC----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhhc
Q 001034 1025 SCFETDH----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP---ATLLARVIGII 1091 (1182)
Q Consensus 1025 A~~~~~~----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~---~elLakIv~il 1091 (1182)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 9754432 2356789999999999999999999999999999999999999976332 12222221100
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
+ ..+ .......++..+.+||.+||+.||.+|||+.++++
T Consensus 235 ---------------------------------~--~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 235 ---------------------------------M--STP----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------------------H--HSC----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------------------c--CCc----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0 000 00112345789999999999999999999999876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.27 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=199.8
Q ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEE
Q 001034 872 HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVC 950 (1182)
Q Consensus 872 eIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVm 950 (1182)
.....||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.| |||++++++|.....+++||
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH------KNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCC------TTBCCEEEEEEETTEEEEEE
T ss_pred CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCC------CCEeeEeeEEEeCCcEEEEE
Confidence 33448999999999999999999999999997653 345667789999988854 59999999999999999999
Q ss_pred Eecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccC
Q 001034 951 ELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029 (1182)
Q Consensus 951 EyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~ 1029 (1182)
||+. ++|.+++.... +...+++..++.++.||+.||.|||+.||+||||||+|||++. ..+.+||+|||++....
T Consensus 99 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 99 EQVPGGSLSALLRSKW---GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLA 174 (295)
T ss_dssp ECCSEEEHHHHHHHTT---CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTCCEEECCTTTCEESC
T ss_pred EeCCCCCHHHHHHhhc---cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC-CCCCEEEeecccccccC
Confidence 9997 57777776432 2234778889999999999999999999999999999999984 35789999999997643
Q ss_pred CC---cccccCCCcccchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhhcCCcchhhhhccc
Q 001034 1030 DH---LCSYVQSRSYRAPEVILGLS--YDKKIDIWSLGCILAELCTGNVLFQNDSPAT-LLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1030 ~~---~ss~vGTp~YmAPEVLlg~~--yS~kSDIWSLGVILYELLTGr~PF~g~d~~e-lLakIv~ilGp~PeemL~~~k 1103 (1182)
.. .....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ...... ..
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~------------ 241 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MF------------ 241 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH-HH------------
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc-cc------------
Confidence 32 34567899999999997654 8899999999999999999999996532211 111110 00
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
... ......++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 242 -----------------------~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 242 -----------------------KVH------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp -----------------------CCC------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred -----------------------ccc------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 000 011234578999999999999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.93 Aligned_cols=257 Identities=24% Similarity=0.310 Sum_probs=202.9
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
+..++|++.+.||+|+||.||+|++ +++.||||++.... .....+.+|+.+++.++| |||++++++|..
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~~~~~ 105 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH------PNIVLFMGAVTQ 105 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCC------TTBCCEEEEECS
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC------CCEeeEEEEEEE
Confidence 4467899999999999999999986 68899999997643 334567889999999864 489999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccccCCccEEEccCCCceEEE
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
...+|+||||+.+ +|.+++..... ...+++..++.++.||+.||.|||+.| |+||||||+|||++. ++.+||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~--~~~~kL 180 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK--KYTVKV 180 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT--TCCEEE
T ss_pred CCceEEEEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC--CCcEEE
Confidence 9999999999985 78777764321 123889999999999999999999999 999999999999984 678999
Q ss_pred ecCCCccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1020 IDLGSSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1020 iDFGLA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 181 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~--- 257 (309)
T 3p86_A 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR--- 257 (309)
T ss_dssp CCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC---
T ss_pred CCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---
Confidence 999999754433 34567899999999999999999999999999999999999999988877666554211000
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc--CCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK--HPWLS 1174 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq--HPWFk 1174 (1182)
......++..+.+||.+||+.||.+|||+.+|++ ++|++
T Consensus 258 ---------------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 258 ---------------------------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ---------------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ---------------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0112345788999999999999999999999998 56666
Q ss_pred CCC
Q 001034 1175 HPY 1177 (1182)
Q Consensus 1175 ~~~ 1177 (1182)
...
T Consensus 299 ~~~ 301 (309)
T 3p86_A 299 SAV 301 (309)
T ss_dssp ---
T ss_pred hCC
Confidence 543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=338.49 Aligned_cols=248 Identities=20% Similarity=0.310 Sum_probs=205.8
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+..++|++++.||+|+||.||++.+. ++..||||++.........+.+|+.+++.+.| +||++++++|.....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH------EKLVQLYGVCTKQRP 93 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC------TTBCCEEEEECSSSS
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCC------CCEeeEEEEEecCCC
Confidence 34578999999999999999999875 67789999998776566778899999998864 489999999999999
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~--~~~~kl~Dfg~ 166 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGL 166 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT--TSCEEECSTTG
T ss_pred eEEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcC--CCCEEEccccc
Confidence 999999997 578887765332 2899999999999999999999999999999999999984 67899999999
Q ss_pred ccccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1025 SCFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1025 A~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------ 240 (283)
T 3gen_A 167 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------ 240 (283)
T ss_dssp GGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC------
T ss_pred cccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC------
Confidence 9765432 223456788999999999999999999999999999998 99999988877776666421110
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......+..+.+||.+||+.||.+|||+.+||+|
T Consensus 241 -------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 -------------------------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -------------------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0112346789999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=345.57 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=198.3
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-------hhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-------FFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-------~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
..+.++|++.+.||+|+||.||+|++..+++.||||++..... .......|+.++..+... ..|+||++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~~h~~i~~~~ 104 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG--GGHPGVIRLL 104 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSS--CCCSSBCCEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhccc--CCCCCeeeEE
Confidence 4567899999999999999999999999999999999976431 223445688999888543 2567999999
Q ss_pred EEEEecCeEEEEEEe-cc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCc
Q 001034 938 DYFYYREHLLIVCEL-LK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC 1015 (1182)
Q Consensus 938 dsFqd~e~LyLVmEy-L~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG 1015 (1182)
++|......++|||+ +. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET-TTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC-CCC
Confidence 999999999999998 54 57888877543 2889999999999999999999999999999999999983 367
Q ss_pred eEEEecCCCccccCC-CcccccCCCcccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1016 EVKVIDLGSSCFETD-HLCSYVQSRSYRAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~-~~ss~vGTp~YmAPEVLlg~~yS-~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
.+||+|||++..... ......+++.|+|||++.+..+. .++|||||||++|+|++|+.||.... .+....
T Consensus 178 ~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~-- 249 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAE-- 249 (312)
T ss_dssp EEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTC--
T ss_pred eEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhc--
Confidence 899999999876543 34456789999999999877664 58999999999999999999996421 111000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 250 ------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 250 ------------------------------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp ------------------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred ------------------------------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00112457889999999999999999999999999999
Q ss_pred CCCCCCC
Q 001034 1174 SHPYEPI 1180 (1182)
Q Consensus 1174 k~~~eP~ 1180 (1182)
+...+..
T Consensus 288 ~~~~~~~ 294 (312)
T 2iwi_A 288 QTPAEDV 294 (312)
T ss_dssp CC-----
T ss_pred cCchhcc
Confidence 9876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=349.77 Aligned_cols=250 Identities=21% Similarity=0.273 Sum_probs=205.5
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCc---EEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGM---DVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr---~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
..+..++|++.+.||+|+||.||+|.+..+++ .||||+++.. ......+.+|+.+++.++ ||||+++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 117 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD------HPNIIRLEG 117 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC------CTTBCCEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC------CCCCCcEEE
Confidence 34567899999999999999999999986655 4999999864 334456788999988885 459999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
+|.....+||||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~ 190 (325)
T 3kul_A 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS--NLVC 190 (325)
T ss_dssp EECGGGCCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCE
T ss_pred EEEeCCccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECC--CCCE
Confidence 99999999999999975 77777754321 2899999999999999999999999999999999999984 7789
Q ss_pred EEecCCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhh
Q 001034 1018 KVIDLGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~i 1090 (1182)
||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+......+..+...
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 270 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 99999999765432 122345778999999999999999999999999999999 99999988887776666311
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
... .....++..+.+||.+||..||.+|||+.+|++
T Consensus 271 ~~~-------------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 271 YRL-------------------------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCC-------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-------------------------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 011245788999999999999999999999886
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=342.49 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=201.0
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc-chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN-KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~-k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+++.++ ||||++++++|.....+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE------HPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEETTEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC------CcCcccEEEEEecCCee
Confidence 57899999999999999999999999999999988653 345567888999998885 45999999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
|+||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~ 155 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE--NKNVVVADFGLA 155 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECT--TSCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECC--CCCEEEeecccc
Confidence 999999986 77777765322 2899999999999999999999999999999999999984 778999999999
Q ss_pred cccCCCc-----------------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 001034 1026 CFETDHL-----------------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1026 ~~~~~~~-----------------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv 1088 (1182)
....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~----- 230 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM----- 230 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT-----
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH-----
Confidence 7543221 145799999999999999999999999999999999999999864321000
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
. +.. .....+.. ...+.++..+.+||.+||+.||.+|||+.+|+
T Consensus 231 ----------~---------~~~--------~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~ 274 (310)
T 3s95_A 231 ----------D---------FGL--------NVRGFLDR---------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE 274 (310)
T ss_dssp ----------T---------SSB--------CHHHHHHH---------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ----------H---------Hhh--------hhhccccc---------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 0 000 00000000 01234567899999999999999999999998
Q ss_pred c
Q 001034 1169 K 1169 (1182)
Q Consensus 1169 q 1169 (1182)
+
T Consensus 275 ~ 275 (310)
T 3s95_A 275 H 275 (310)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.33 Aligned_cols=263 Identities=25% Similarity=0.347 Sum_probs=185.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch--hhHHHHHHHH-HHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD--FFDQSLDEIK-LLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~--~~dq~l~Eik-ILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
+..++|++++.||+|+||.||+|.++.+++.||||+++.... .......|+. +++. ..||||+++++++..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~------~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS------SDCPYIVQFYGALFR 92 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSS------CCCTTBCCEEEEEEC
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHc------CCCCcEeeeeeEEEe
Confidence 346899999999999999999999999999999999986532 2233344444 2222 256799999999999
Q ss_pred cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-CccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL-GLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~-GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...+||||||+.++|.+++...... ....+++..+..++.||+.||.|||+. ||+||||||+|||++ .++.+||+|
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~--~~~~~kl~D 169 (327)
T 3aln_A 93 EGDCWICMELMSTSFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD--RSGNIKLCD 169 (327)
T ss_dssp SSEEEEEECCCSEEHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE--TTTEEEECC
T ss_pred CCceEEEEeecCCChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc--CCCCEEEcc
Confidence 9999999999999988887753221 112388999999999999999999998 999999999999998 477899999
Q ss_pred CCCccccCCC--cccccCCCcccchhhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1022 LGSSCFETDH--LCSYVQSRSYRAPEVI----LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1022 FGLA~~~~~~--~ss~vGTp~YmAPEVL----lg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
||++...... .....+|+.|+|||++ .+..++.++|||||||++|+|++|..||....... ..+.....
T Consensus 170 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~--- 244 (327)
T 3aln_A 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVVK--- 244 (327)
T ss_dssp CSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCC---
T ss_pred CCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHHhc---
Confidence 9999765432 2334789999999999 46679999999999999999999999997643210 01100000
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
...+.. .......++..+.+||.+||..||.+|||+.+||+||||..
T Consensus 245 -------------------------------~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 245 -------------------------------GDPPQL--SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp -------------------------------SCCCCC--CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------------------------------CCCCCC--CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 000000 00112356789999999999999999999999999999964
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=338.62 Aligned_cols=250 Identities=20% Similarity=0.264 Sum_probs=211.2
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.+..++|++.+.||+|+||.||+|.+..++..||+|++.........+.+|+.+++.++| |||+++++++....
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH------PNLVQLLGVCTREP 82 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCC------TTBCCEEEEECSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCC------CCEeeEEEEEccCC
Confidence 345678999999999999999999999999999999998877777888899999999964 48999999999999
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~~l~Dfg 156 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFG 156 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECG--GGCEEECCCC
T ss_pred CEEEEEEcCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcC--CCCEEEccCc
Confidence 9999999998 578888765432 23899999999999999999999999999999999999984 6789999999
Q ss_pred CccccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1024 SSCFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1024 LA~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~------ 230 (288)
T 3kfa_A 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ 230 (288)
T ss_dssp GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------
T ss_pred cceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC------
Confidence 997654332 23455788999999999999999999999999999999 9999988766555444421000
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
......++..+.+||.+||..||.+|||+.++++
T Consensus 231 -------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 -------------------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0111345789999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=358.25 Aligned_cols=261 Identities=18% Similarity=0.181 Sum_probs=211.6
Q ss_pred CceecCCEEEEEEeccCCceEEEEEE-----ECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAH-----DLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAk-----Dk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL 936 (1182)
..+..++|++++.||+|+||.||+|+ +..+++.||||+++.. ......+.+|+.+++.++| |||+++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~ 139 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH------QNIVRC 139 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC------TTBCCE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCC------CCCCeE
Confidence 34567899999999999999999999 5567889999999753 3334567789999999854 499999
Q ss_pred EEEEEecCeEEEEEEeccc-ChHHHHhhhcccC-CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-
Q 001034 937 YDYFYYREHLLIVCELLKA-NLYEFHKFNRESG-GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS- 1013 (1182)
Q Consensus 937 ~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg-gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~- 1013 (1182)
+++|......||||||+.+ +|.+++....... ....+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred EEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCC
Confidence 9999999999999999974 8888887654221 112488999999999999999999999999999999999998532
Q ss_pred CceEEEecCCCccccC-----CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 001034 1014 RCEVKVIDLGSSCFET-----DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~-----~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakI 1087 (1182)
...+||+|||+++... .......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+++..+
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i 299 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 3459999999986421 22334567899999999999999999999999999999998 99999998887777666
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
...... .....++..+.+||.+||+.||.+|||+.+|
T Consensus 300 ~~~~~~-------------------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ei 336 (367)
T 3l9p_A 300 TSGGRM-------------------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 336 (367)
T ss_dssp HTTCCC-------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HcCCCC-------------------------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 311100 0112456789999999999999999999999
Q ss_pred HcCCCC
Q 001034 1168 LKHPWL 1173 (1182)
Q Consensus 1168 LqHPWF 1173 (1182)
++|.|+
T Consensus 337 l~~l~~ 342 (367)
T 3l9p_A 337 LERIEY 342 (367)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=343.02 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=185.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe---
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--- 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--- 942 (1182)
...+|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.+. .||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS-----GHPNIVQFCSAASIGKE 100 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT-----TSTTBCCEEEEEEECTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc-----cCCChhhcccccccccc
Confidence 3468999999999999999999999999999999986543 34566788999999986 24599999999953
Q ss_pred -----cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccccCCccEEEccCCCc
Q 001034 943 -----REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPENILVKSYSRC 1015 (1182)
Q Consensus 943 -----~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRDIKPeNILIDs~~dG 1015 (1182)
...+++||||+.|+|.+++......+ .+++..++.++.||+.||.|||+.| |+||||||+|||++. ++
T Consensus 101 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~--~~ 175 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCKGQLVEFLKKMESRG---PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN--QG 175 (337)
T ss_dssp TSTTSSEEEEEEEECCSEEHHHHHHHHHTTC---SCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT--TS
T ss_pred ccccCCceEEEEEEecCCCHHHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC--CC
Confidence 34589999999999999887643222 3899999999999999999999999 999999999999994 67
Q ss_pred eEEEecCCCccccCCCc---------------ccccCCCcccchhhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001034 1016 EVKVIDLGSSCFETDHL---------------CSYVQSRSYRAPEVI---LGLSYDKKIDIWSLGCILAELCTGNVLFQN 1077 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~~~---------------ss~vGTp~YmAPEVL---lg~~yS~kSDIWSLGVILYELLTGr~PF~g 1077 (1182)
.+||+|||+++...... ...++|+.|+|||++ .+..++.++|||||||++|+|++|..||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 89999999997654321 144689999999998 566789999999999999999999999965
Q ss_pred CCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccC
Q 001034 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1078 ~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~D 1157 (1182)
......+.... .. ......+..+.+||.+||+.|
T Consensus 256 ~~~~~~~~~~~---------------------------------------~~-------~~~~~~~~~~~~li~~~l~~~ 289 (337)
T 3ll6_A 256 GAKLRIVNGKY---------------------------------------SI-------PPHDTQYTVFHSLIRAMLQVN 289 (337)
T ss_dssp ----------C---------------------------------------CC-------CTTCCSSGGGHHHHHHHSCSS
T ss_pred hhHHHhhcCcc---------------------------------------cC-------CcccccchHHHHHHHHHccCC
Confidence 44322111100 00 011233466889999999999
Q ss_pred CCCCCCHHHHHcCC
Q 001034 1158 PKKRPSASDALKHP 1171 (1182)
Q Consensus 1158 PekRPTAeELLqHP 1171 (1182)
|.+|||+.++++|-
T Consensus 290 p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 290 PEERLSIAEVVHQL 303 (337)
T ss_dssp GGGSCCHHHHHHHH
T ss_pred hhhCcCHHHHHHHH
Confidence 99999999999873
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=349.03 Aligned_cols=256 Identities=22% Similarity=0.301 Sum_probs=204.7
Q ss_pred eecCCEEEEEEeccCCceEEEEEE-----ECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAH-----DLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAk-----Dk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
+..++|++.+.||+|+||.||+|+ +..+++.||||+++... .....+.+|+.++..+.+ ||||+++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-----hpniv~~~~ 93 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-----HLNVVNLLG 93 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-----CTTBCCEEE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcC-----Ccceeeeee
Confidence 446889999999999999999998 56778999999998643 334568899999999953 459999999
Q ss_pred EEEecC-eEEEEEEeccc-ChHHHHhhhcccC------------------------------------------------
Q 001034 939 YFYYRE-HLLIVCELLKA-NLYEFHKFNRESG------------------------------------------------ 968 (1182)
Q Consensus 939 sFqd~e-~LyLVmEyL~G-sLld~Lk~~~~sg------------------------------------------------ 968 (1182)
+|.... .+|+||||+.+ +|.+++.......
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998764 49999999985 7888876543210
Q ss_pred ------------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccccCCC-----
Q 001034 969 ------------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH----- 1031 (1182)
Q Consensus 969 ------------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~----- 1031 (1182)
....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCGGGSCTTSCTTCEE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC--CCcEEEEeccceeeecccccchh
Confidence 0112889999999999999999999999999999999999984 678999999999754322
Q ss_pred cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhc
Q 001034 1032 LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFT 1110 (1182)
Q Consensus 1032 ~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~ 1110 (1182)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+......+...+.....
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------- 314 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR----------------- 314 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-----------------
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-----------------
Confidence 234567889999999999999999999999999999998 99999876544333333210000
Q ss_pred ccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1111 KNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1111 k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......++..+.+||.+||+.||.+|||+.+|++|
T Consensus 315 -------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 315 -------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 00112357889999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=354.31 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=206.2
Q ss_pred ecCCEEEEEEeccCCceEEEEEEEC-------CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDL-------HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk-------~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
..++|++.+.||+|+||.||+|.+. .++..||||+++... .....+.+|+.+++.+. .||||++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~~ 153 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINLL 153 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC-----CCTTBCCEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc-----CCCCEeeEE
Confidence 3578999999999999999999864 356689999997643 34567889999999983 245999999
Q ss_pred EEEEecCeEEEEEEeccc-ChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCcc
Q 001034 938 DYFYYREHLLIVCELLKA-NLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPEN 1006 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeN 1006 (1182)
++|.....+|+||||+.+ +|.+++......+ ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 999999999999999985 8888887654211 11237889999999999999999999999999999999
Q ss_pred EEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 001034 1007 ILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSP 1080 (1182)
Q Consensus 1007 ILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~ 1080 (1182)
|||+. ++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 234 Ill~~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 234 VLVTE--NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp EEECT--TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEECC--CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99984 778999999999754332 233456789999999999999999999999999999999 9999988766
Q ss_pred HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1081 ~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
.+++..+.... .......++..+.+||.+||+.||.+
T Consensus 312 ~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~ 348 (370)
T 2psq_A 312 EELFKLLKEGH-------------------------------------------RMDKPANCTNELYMMMRDCWHAVPSQ 348 (370)
T ss_dssp GGHHHHHHTTC-------------------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHhcCC-------------------------------------------CCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 55544432100 00112245789999999999999999
Q ss_pred CCCHHHHHcC
Q 001034 1161 RPSASDALKH 1170 (1182)
Q Consensus 1161 RPTAeELLqH 1170 (1182)
|||+.|++++
T Consensus 349 Rpt~~ell~~ 358 (370)
T 2psq_A 349 RPTFKQLVED 358 (370)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=348.30 Aligned_cols=258 Identities=16% Similarity=0.202 Sum_probs=193.8
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECC---CCcEEEEEEEeccchhh------------HHHHHHHHHHHHhcCCCCCC
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLH---TGMDVCVKIIKNNKDFF------------DQSLDEIKLLKYVNKHDPGD 929 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~---TGr~VAVKIIkk~k~~~------------dq~l~EikILr~L~h~~~l~ 929 (1182)
....++|++.+.||+|+||.||+|.+.. ++..+|||++....... ..+..|+.+++.+ .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l------~ 106 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL------D 106 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC------S
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc------c
Confidence 3445799999999999999999999987 88999999998653211 1122333344433 5
Q ss_pred CcceEEEEEEEEe----cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCc
Q 001034 930 KYHLLRLYDYFYY----REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005 (1182)
Q Consensus 930 HPnIVkL~dsFqd----~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPe 1005 (1182)
||||+++++++.. ...+||||||+.++|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 107 h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 180 (345)
T 2v62_A 107 YLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAA 180 (345)
T ss_dssp CCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHH
Confidence 6699999999998 78899999999778888876543 3899999999999999999999999999999999
Q ss_pred cEEEccCCCceEEEecCCCccccCCC----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCFETDH----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLF 1075 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~~~~~----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF 1075 (1182)
|||++..+.+.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999644458999999999654221 24457899999999999999999999999999999999999999
Q ss_pred CC--CCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHh
Q 001034 1076 QN--DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153 (1182)
Q Consensus 1076 ~g--~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkM 1153 (1182)
.. .+..............++..+. . ......++..+.+||.+|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~--------~~~~~~~~~~l~~li~~~ 305 (345)
T 2v62_A 261 EQNLKDPVAVQTAKTNLLDELPQSVL---------------------------K--------WAPSGSSCCEIAQFLVCA 305 (345)
T ss_dssp GGGTTCHHHHHHHHHHHHHTTTHHHH---------------------------H--------HSCTTSCCHHHHHHHHHH
T ss_pred cccccccHHHHHHHHhhcccccHHHH---------------------------h--------hccccccHHHHHHHHHHH
Confidence 65 3333332222222222111110 0 001124678999999999
Q ss_pred cccCCCCCCCHHHHHc
Q 001034 1154 LEINPKKRPSASDALK 1169 (1182)
Q Consensus 1154 Lq~DPekRPTAeELLq 1169 (1182)
|..||.+|||+.+|++
T Consensus 306 l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 306 HSLAYDEKPNYQALKK 321 (345)
T ss_dssp HTCCTTCCCCHHHHHH
T ss_pred hhcCcccCCCHHHHHH
Confidence 9999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=339.06 Aligned_cols=254 Identities=26% Similarity=0.350 Sum_probs=206.2
Q ss_pred eecCCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
+..++|.+.+.||+|+||.||+|.+. .+++.||||+++... .....+.+|+.+++.++ ||||+++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~ 93 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN------HPHVIKLYG 93 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC------CTTBCCEEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC------CCceeeEEE
Confidence 34578999999999999999999973 456899999997643 34466778889888875 459999999
Q ss_pred EEEecCeEEEEEEecc-cChHHHHhhhcccC------------------CccccCHHHHHHHHHHHHHHHHHHHhcCccc
Q 001034 939 YFYYREHLLIVCELLK-ANLYEFHKFNRESG------------------GEVYFTMPRLQSITIQCLEALQFLHGLGLIH 999 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~-GsLld~Lk~~~~sg------------------gel~Lse~eIr~Ia~QILsALeYLHS~GIIH 999 (1182)
+|.....+|+||||+. ++|.+++......+ ....+++..++.++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 9999999999999998 57888887543211 1123889999999999999999999999999
Q ss_pred cccCCccEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCC
Q 001034 1000 CDLKPENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNV 1073 (1182)
Q Consensus 1000 RDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~ 1073 (1182)
|||||+|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 174 ~dikp~NIli~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 174 RDLAARNILVAE--GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCSGGGEEEET--TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccchheEEEcC--CCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999994 678999999999754332 223456788999999999999999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHh
Q 001034 1074 LFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153 (1182)
Q Consensus 1074 PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkM 1153 (1182)
||.+.........+.... .......++..+.+||.+|
T Consensus 252 p~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~~~li~~~ 288 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGH-------------------------------------------RMERPDNCSEEMYRLMLQC 288 (314)
T ss_dssp SSTTCCGGGHHHHHHTTC-------------------------------------------CCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHhhcCC-------------------------------------------cCCCCccCCHHHHHHHHHH
Confidence 998876655544432100 0011234578999999999
Q ss_pred cccCCCCCCCHHHHHcC
Q 001034 1154 LEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1154 Lq~DPekRPTAeELLqH 1170 (1182)
|+.||.+|||+.+|++|
T Consensus 289 l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 289 WKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.16 Aligned_cols=251 Identities=19% Similarity=0.246 Sum_probs=201.0
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchh--------hHHHHHHHHHHHHhcCCCCCCCcceEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF--------FDQSLDEIKLLKYVNKHDPGDKYHLLR 935 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~--------~dq~l~EikILr~L~h~~~l~HPnIVk 935 (1182)
..+..++|++.+.||+|+||.||+|++..+++.||||++...... ...+.+|+.+++.++ ||||++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~ 87 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN------HPNIVK 87 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC------CTTBCC
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC------CCCchh
Confidence 345568999999999999999999999999999999998654311 156778888888885 459999
Q ss_pred EEEEEEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccccCCccEEEccC
Q 001034 936 LYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPENILVKSY 1012 (1182)
Q Consensus 936 L~dsFqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRDIKPeNILIDs~ 1012 (1182)
+++++.... ++||||+. ++|.+++..... .+++..++.++.||+.||.|||+.| |+||||||+|||++..
T Consensus 88 ~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~ 160 (287)
T 4f0f_A 88 LYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL 160 (287)
T ss_dssp EEEEETTTT--EEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC
T ss_pred hheeecCCC--eEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc
Confidence 999986544 79999998 577777754332 3899999999999999999999999 9999999999999852
Q ss_pred C---CceEEEecCCCccccCCCcccccCCCcccchhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH
Q 001034 1013 S---RCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVIL--GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL--LA 1085 (1182)
Q Consensus 1013 ~---dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLl--g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~el--La 1085 (1182)
+ ...+||+|||+++..........+|+.|+|||++. ...++.++|||||||++|+|++|+.||........ ..
T Consensus 161 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 240 (287)
T 4f0f_A 161 DENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240 (287)
T ss_dssp CTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred CCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence 2 12399999999987777667788999999999994 45688999999999999999999999976443222 22
Q ss_pred HHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 001034 1086 RVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165 (1182)
Q Consensus 1086 kIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe 1165 (1182)
.+.. .+ ........++..+.+||.+||+.||.+|||+.
T Consensus 241 ~~~~-~~-----------------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 278 (287)
T 4f0f_A 241 MIRE-EG-----------------------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFS 278 (287)
T ss_dssp HHHH-SC-----------------------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHhc-cC-----------------------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHH
Confidence 2110 00 00011234578999999999999999999999
Q ss_pred HHHc
Q 001034 1166 DALK 1169 (1182)
Q Consensus 1166 ELLq 1169 (1182)
+|++
T Consensus 279 ~ll~ 282 (287)
T 4f0f_A 279 YIVK 282 (287)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.32 Aligned_cols=247 Identities=23% Similarity=0.298 Sum_probs=192.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
-.++|++.+.||+|+||.||+|.+ +++.||||+++... .....+.+|+.+++.++| |||++++++|.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~ 76 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH------PNIIALRGVCL 76 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCC------TTBCCEEEEEC
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCC------CCEeeEEEEEe
Confidence 357899999999999999999996 48899999987542 234567789999998864 48999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC---ccccccCCccEEEccC-----
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG---LIHCDLKPENILVKSY----- 1012 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G---IIHRDIKPeNILIDs~----- 1012 (1182)
....+|+||||+.+ +|.+++. .. .+++..++.++.||+.||.|||+.| |+||||||+|||++..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~-~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLS-GK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHT-SS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred cCCceEEEEEcCCCCCHHHHhh-cC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence 99999999999985 5555543 21 2889999999999999999999999 9999999999999842
Q ss_pred -CCceEEEecCCCccccCCC-cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 001034 1013 -SRCEVKVIDLGSSCFETDH-LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1013 -~dG~IKLiDFGLA~~~~~~-~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~i 1090 (1182)
..+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229 (271)
T ss_dssp CSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred ccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence 2567999999999754432 33567899999999999999999999999999999999999999887766555444210
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
... ......++..+.+||.+||+.||.+|||+.++++|
T Consensus 230 ~~~------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 230 KLA------------------------------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCC------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC------------------------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 000 01123457889999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.31 Aligned_cols=246 Identities=21% Similarity=0.338 Sum_probs=206.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.++|++.+.||+|+||.||+|.+. +++.||+|++.........+.+|+.+++.++ ||||+++++++.....+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------HPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCC------CTTBCCEEEEECSSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCC------CCCEeeEEEEEccCCCeE
Confidence 468999999999999999999985 6788999999877655677889999999885 459999999999999999
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~--~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTR 152 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG--GGCEEECCTTGGG
T ss_pred EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECC--CCCEEEccccccc
Confidence 99999985 78887765432 3889999999999999999999999999999999999984 6789999999987
Q ss_pred ccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
..... .....+++.|+|||++.+..++.++|||||||++|+|++ |++||...+....+..+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~-------- 224 (267)
T 3t9t_A 153 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------- 224 (267)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------
T ss_pred ccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC--------
Confidence 65332 233456788999999999999999999999999999999 89999988877766665311000
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......+..+.+||.+||..||.+|||+.+++++
T Consensus 225 -----------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 -----------------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112346889999999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=343.68 Aligned_cols=254 Identities=19% Similarity=0.198 Sum_probs=206.7
Q ss_pred eecCCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
+..++|++++.||+|+||.||+|.+. .+++.||||+++... .....+.+|+.+++.++| |||+++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~ 117 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN------PNIVKLLG 117 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC------TTBCCEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCC------CCEEEEEE
Confidence 34578999999999999999999987 456899999997643 335667889999998854 59999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccC------------------CccccCHHHHHHHHHHHHHHHHHHHhcCccc
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESG------------------GEVYFTMPRLQSITIQCLEALQFLHGLGLIH 999 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg------------------gel~Lse~eIr~Ia~QILsALeYLHS~GIIH 999 (1182)
+|.....+|+||||+.+ +|.+++....... ....+++..++.++.||+.||.|||++||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 99999999999999985 8888887542110 0134899999999999999999999999999
Q ss_pred cccCCccEEEccCCCceEEEecCCCccccCC-----CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCC
Q 001034 1000 CDLKPENILVKSYSRCEVKVIDLGSSCFETD-----HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNV 1073 (1182)
Q Consensus 1000 RDIKPeNILIDs~~dG~IKLiDFGLA~~~~~-----~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~ 1073 (1182)
|||||+|||++. ++.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 198 ~Dlkp~NIl~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 198 RDLATRNCLVGE--NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp SCCSGGGEEECG--GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCcceEEECC--CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 999999999984 67899999999865332 1234567889999999999999999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHh
Q 001034 1074 LFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153 (1182)
Q Consensus 1074 PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkM 1153 (1182)
||.+.+..+.+..+..... ......++..+.+||.+|
T Consensus 276 p~~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~l~~li~~~ 312 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNI-------------------------------------------LACPENCPLELYNLMRLC 312 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCC-------------------------------------------CCCCTTCCHHHHHHHHHH
T ss_pred cCCCCChHHHHHHHhCCCc-------------------------------------------CCCCCCCCHHHHHHHHHH
Confidence 9998887776655531000 001124578899999999
Q ss_pred cccCCCCCCCHHHHHcC
Q 001034 1154 LEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1154 Lq~DPekRPTAeELLqH 1170 (1182)
|+.||.+|||+.+++++
T Consensus 313 l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 313 WSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cccCcccCCCHHHHHHH
Confidence 99999999999999873
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=337.35 Aligned_cols=249 Identities=19% Similarity=0.278 Sum_probs=199.9
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCC-------cEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTG-------MDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TG-------r~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL 936 (1182)
.+..++|++.+.||+|+||.||+|.+..++ ..||+|++.... .....+.+|+.+++.+.| |||+++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~ 77 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH------KHLVLN 77 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCC------TTBCCE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCC------CCEeEE
Confidence 455689999999999999999999998877 469999997643 445677889999998864 599999
Q ss_pred EEEEEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC-
Q 001034 937 YDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR- 1014 (1182)
Q Consensus 937 ~dsFqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d- 1014 (1182)
+++|......|+||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++....
T Consensus 78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 152 (289)
T 4fvq_A 78 YGVCVCGDENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR 152 (289)
T ss_dssp EEEECCTTCCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBG
T ss_pred EEEEEeCCCCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcc
Confidence 999999999999999998 578888765432 2888999999999999999999999999999999999985322
Q ss_pred -----ceEEEecCCCccccCCCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHH
Q 001034 1015 -----CEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTG-NVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1015 -----G~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTG-r~PF~g~d~~elLakI 1087 (1182)
+.+||+|||++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++| .+||...........+
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 153 KTGNPPFIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp GGTBCCEEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred cccccceeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 12999999998765432 34567899999999988 6799999999999999999995 4555554443332222
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
. .... .....+..+.+||.+||+.||.+|||+.++
T Consensus 232 ~-~~~~--------------------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 266 (289)
T 4fvq_A 232 E-DRHQ--------------------------------------------LPAPKAAELANLINNCMDYEPDHRPSFRAI 266 (289)
T ss_dssp H-TTCC--------------------------------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHH
T ss_pred h-ccCC--------------------------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1 0000 011224668899999999999999999999
Q ss_pred HcC
Q 001034 1168 LKH 1170 (1182)
Q Consensus 1168 LqH 1170 (1182)
++|
T Consensus 267 l~~ 269 (289)
T 4fvq_A 267 IRD 269 (289)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=362.26 Aligned_cols=264 Identities=25% Similarity=0.315 Sum_probs=197.3
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... .+...+|+.+++.+. .||||+++++++....
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~-----~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESD-----DHPNVIRYYCSETTDR 82 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECSS
T ss_pred hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhcc-----CCCCcCeEEEEEecCC
Confidence 4466788889999999999998764 5689999999997643 356678999998763 3569999999999999
Q ss_pred eEEEEEEecccChHHHHhhhcccCCcc-ccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-----------
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEV-YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY----------- 1012 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel-~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~----------- 1012 (1182)
.+||||||+.|+|.+++.......... ..++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 83 ~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred eEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 999999999999999987654321111 12334567899999999999999999999999999999742
Q ss_pred CCceEEEecCCCccccCCC-------cccccCCCcccchhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 001034 1013 SRCEVKVIDLGSSCFETDH-------LCSYVQSRSYRAPEVILG-------LSYDKKIDIWSLGCILAELCT-GNVLFQN 1077 (1182)
Q Consensus 1013 ~dG~IKLiDFGLA~~~~~~-------~ss~vGTp~YmAPEVLlg-------~~yS~kSDIWSLGVILYELLT-Gr~PF~g 1077 (1182)
..+.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 3458999999999765432 234579999999999976 578999999999999999999 9999976
Q ss_pred CCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccC
Q 001034 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1078 ~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~D 1157 (1182)
..... ..++......+ ....+ .....+.++.+||.+||+.|
T Consensus 243 ~~~~~--~~i~~~~~~~~-----------------------------------~~~~~--~~~~~~~~~~~li~~~L~~d 283 (434)
T 2rio_A 243 KYSRE--SNIIRGIFSLD-----------------------------------EMKCL--HDRSLIAEATDLISQMIDHD 283 (434)
T ss_dssp TTTHH--HHHHHTCCCCC-----------------------------------CCTTC--CCHHHHHHHHHHHHHHTCSS
T ss_pred chhhH--HHHhcCCCCcc-----------------------------------ccccc--ccccchHHHHHHHHHHhhCC
Confidence 54332 12211100000 00000 00123578999999999999
Q ss_pred CCCCCCHHHHHcCCCCCC
Q 001034 1158 PKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1158 PekRPTAeELLqHPWFk~ 1175 (1182)
|.+|||+.+||+||||..
T Consensus 284 P~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 284 PLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp GGGSCCHHHHHTSGGGSC
T ss_pred hhhCCCHHHHHhCCccCC
Confidence 999999999999999964
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.31 Aligned_cols=248 Identities=20% Similarity=0.283 Sum_probs=193.3
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCC---CcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHT---GMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~T---Gr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
+..++|++.+.||+|+||.||+|.+..+ +..||+|+++.. ......+.+|+.+++.+. ||||+++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~ 85 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD------HPHIVKLIGVI 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCccceEEEEE
Confidence 4568999999999999999999998654 457999998753 233456778899888875 45999999998
Q ss_pred EecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 941 YYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 941 qd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
....+|+||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 86 -~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl 157 (281)
T 1mp8_A 86 -TENPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVKL 157 (281)
T ss_dssp -CSSSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEE
T ss_pred -ccCccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECC--CCCEEE
Confidence 45678999999985 78887765432 2889999999999999999999999999999999999995 678999
Q ss_pred ecCCCccccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1020 IDLGSSCFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1020 iDFGLA~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+.+..+....
T Consensus 158 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~--- 234 (281)
T 1mp8_A 158 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--- 234 (281)
T ss_dssp CC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---
T ss_pred CccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC---
Confidence 999999765432 223456788999999999999999999999999999997 999998877665555442100
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.....+.++..+.+||.+||..||.+|||+.+++++
T Consensus 235 ----------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 235 ----------------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ----------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001123457899999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.19 Aligned_cols=256 Identities=23% Similarity=0.317 Sum_probs=206.2
Q ss_pred eecCCEEEEEEeccCCceEEEEEEE-----CCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHD-----LHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkD-----k~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
+..++|++.+.||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.+++.+. .||||+++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~~~ 94 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHMNIVNLLG 94 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcc-----cCCCeeeEEE
Confidence 3457899999999999999999984 4678899999998653 33467789999999993 2459999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhccc------------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCc
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRES------------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~s------------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPe 1005 (1182)
+|......|+||||+.+ +|.+++...... .....+++..++.++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 99999999999999985 888888755321 11224899999999999999999999999999999999
Q ss_pred cEEEccCCCceEEEecCCCccccCCCc-----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCFETDHL-----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDS 1079 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~~~~~~-----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d 1079 (1182)
|||++. ++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 175 Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 175 NILLTH--GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GEEEET--TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eEEEcC--CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999984 7789999999997654332 23456788999999999999999999999999999999 999998765
Q ss_pred HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCC
Q 001034 1080 PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159 (1182)
Q Consensus 1080 ~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPe 1159 (1182)
....+..++..... .......+..+.+||.+||..||.
T Consensus 253 ~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~~l~~dp~ 290 (313)
T 1t46_A 253 VDSKFYKMIKEGFR------------------------------------------MLSPEHAPAEMYDIMKTCWDADPL 290 (313)
T ss_dssp SSHHHHHHHHHTCC------------------------------------------CCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred chhHHHHHhccCCC------------------------------------------CCCcccCCHHHHHHHHHHcCCCch
Confidence 44333333210000 001124578999999999999999
Q ss_pred CCCCHHHHHcC
Q 001034 1160 KRPSASDALKH 1170 (1182)
Q Consensus 1160 kRPTAeELLqH 1170 (1182)
+|||+.+++++
T Consensus 291 ~Rps~~ell~~ 301 (313)
T 1t46_A 291 KRPTFKQIVQL 301 (313)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999974
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=348.92 Aligned_cols=256 Identities=20% Similarity=0.297 Sum_probs=210.2
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECC-------CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLH-------TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLR 935 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~-------TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVk 935 (1182)
.+..++|++.+.||+|+||.||+|.+.. .+..||||+++... .....+.+|+.+++.+. .||||++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~ 139 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIIN 139 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCC
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc-----CCchhhh
Confidence 4556899999999999999999999753 34579999997653 33467889999999994 2459999
Q ss_pred EEEEEEecCeEEEEEEeccc-ChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCC
Q 001034 936 LYDYFYYREHLLIVCELLKA-NLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004 (1182)
Q Consensus 936 L~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKP 1004 (1182)
++++|.....+|+||||+.+ +|.+++......+ ....+++..++.|+.||+.||.|||+.||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 99999999999999999985 8888887654211 112489999999999999999999999999999999
Q ss_pred ccEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 001034 1005 ENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQND 1078 (1182)
Q Consensus 1005 eNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~ 1078 (1182)
+||||+. ++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 220 ~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECT--TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcC--CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999984 678999999999765432 234456788999999999999999999999999999999 99999988
Q ss_pred CHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCC
Q 001034 1079 SPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINP 1158 (1182)
Q Consensus 1079 d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DP 1158 (1182)
+..+.+..+..... ......++..+.+||.+||+.||
T Consensus 298 ~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~l~~li~~~l~~dP 334 (382)
T 3tt0_A 298 PVEELFKLLKEGHR-------------------------------------------MDKPSNCTNELYMMMRDCWHAVP 334 (382)
T ss_dssp CHHHHHHHHHTTCC-------------------------------------------CCCCSSCCHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHcCCC-------------------------------------------CCCCccCCHHHHHHHHHHcCCCh
Confidence 87776655531100 00112457899999999999999
Q ss_pred CCCCCHHHHHcC
Q 001034 1159 KKRPSASDALKH 1170 (1182)
Q Consensus 1159 ekRPTAeELLqH 1170 (1182)
.+|||+.+|++|
T Consensus 335 ~~Rps~~ell~~ 346 (382)
T 3tt0_A 335 SQRPTFKQLVED 346 (382)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.63 Aligned_cols=265 Identities=22% Similarity=0.264 Sum_probs=200.3
Q ss_pred ceecCCEEEEEEeccCCceEEEEEE----ECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAH----DLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAk----Dk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
.+..++|++++.||+|+||.||+|+ +..+++.||||++.... .....+.+|+.+++.++| |||++++++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~ 79 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH------DNIVKYKGV 79 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCC------TTBCCEEEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCC------CCEeeEEEE
Confidence 4556899999999999999999998 66789999999997643 344667889999998864 599999999
Q ss_pred EEec--CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 940 FYYR--EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 940 Fqd~--e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
|... .++|+||||+.+ +|.+++..... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~ 152 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN--ENR 152 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTE
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcC--CCe
Confidence 8654 569999999974 88888765432 2889999999999999999999999999999999999995 678
Q ss_pred EEEecCCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 001034 1017 VKVIDLGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~i 1090 (1182)
+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||...... +...
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~--- 227 (295)
T 3ugc_A 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRM--- 227 (295)
T ss_dssp EEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHH---
T ss_pred EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHhh---
Confidence 999999999765432 22345677899999999999999999999999999999999998653221 1111
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.+..+.... .. ......... .........++..+.+||.+||+.||.+|||+.+|++
T Consensus 228 ~~~~~~~~~----------------~~----~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 228 IGNDKQGQM----------------IV----FHLIELLKN--NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HCTTCCTHH----------------HH----HHHHHHHHT--TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcCccccch----------------hH----HHHHHHHhc--cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111110000 00 000000000 0011123456899999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.23 Aligned_cols=259 Identities=19% Similarity=0.229 Sum_probs=209.9
Q ss_pred eeeCceecCCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcce
Q 001034 861 VVLNSVIAGRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHL 933 (1182)
Q Consensus 861 V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnI 933 (1182)
.....+..++|++.+.||+|+||.||+|.+. .+++.||||++.... .....+.+|+.+++.+.| |||
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i 90 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC------HHV 90 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC------TTB
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCC------CCE
Confidence 3344566789999999999999999999876 467889999997543 233457788888888754 489
Q ss_pred EEEEEEEEecCeEEEEEEeccc-ChHHHHhhhccc----CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEE
Q 001034 934 LRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRES----GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008 (1182)
Q Consensus 934 VkL~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~s----ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNIL 1008 (1182)
+++++++.....+|+||||+.+ +|.+++...... .....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 170 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence 9999999999999999999985 888887654321 01123688999999999999999999999999999999999
Q ss_pred EccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 001034 1009 VKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPAT 1082 (1182)
Q Consensus 1009 IDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~e 1082 (1182)
++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus 171 i~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 248 (322)
T 1p4o_A 171 VAE--DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248 (322)
T ss_dssp ECT--TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred EcC--CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence 994 678999999999754332 223456888999999999999999999999999999999 899999888776
Q ss_pred HHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC
Q 001034 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162 (1182)
Q Consensus 1083 lLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP 1162 (1182)
....+.... .......++..+.+||.+||..||.+||
T Consensus 249 ~~~~~~~~~-------------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rp 285 (322)
T 1p4o_A 249 VLRFVMEGG-------------------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRP 285 (322)
T ss_dssp HHHHHHTTC-------------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHcCC-------------------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 665553100 0011234578899999999999999999
Q ss_pred CHHHHHcC
Q 001034 1163 SASDALKH 1170 (1182)
Q Consensus 1163 TAeELLqH 1170 (1182)
|+.++++|
T Consensus 286 s~~e~l~~ 293 (322)
T 1p4o_A 286 SFLEIISS 293 (322)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=364.56 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=194.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
.+|.+.+.||+|+||+|+. ....+++.||||++.... .....+|+.+|+.+. .|||||++++++.....+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~-----~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRESD-----EHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHSC-----CCTTBCCEEEEEEETTEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhcc-----CCCCcCeEEEEEecCCEEEE
Confidence 4699999999999999764 345789999999997543 234568999999874 35699999999999999999
Q ss_pred EEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc---CCCceEEEecCCCc
Q 001034 949 VCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS---YSRCEVKVIDLGSS 1025 (1182)
Q Consensus 949 VmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs---~~dG~IKLiDFGLA 1025 (1182)
||||+.|+|.+++...... +....+..++.||+.||.|||++||+||||||+|||++. .+...+||+|||++
T Consensus 96 v~E~~~g~L~~~l~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDFA-----HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEECCSEEHHHHHHSSSCC-----CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEECCCCCHHHHHHhcCCC-----ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999999988754321 444566789999999999999999999999999999953 23456889999999
Q ss_pred cccCC------CcccccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1026 CFETD------HLCSYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1026 ~~~~~------~~ss~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
+.... .....+||+.|+|||++. ...++.++||||||||+|+|++ |.+||......... .+. +...
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~---~~~~ 246 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILL---GACS 246 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHT---TCCC
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHh---ccCC
Confidence 76542 234467999999999997 4567889999999999999999 99999654433221 111 0000
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
. ... ......+..+.+||.+||+.||.+|||+.+||+||||..
T Consensus 247 ~-----------------------------~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 247 L-----------------------------DCL--------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp C-----------------------------TTS--------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred c-----------------------------ccc--------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 0 000 000112456889999999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.79 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=203.2
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe-
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY- 942 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd- 942 (1182)
+..+..+|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.+.| |||++++++|..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h------~~i~~~~~~~~~~ 76 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDH------VNIVHYNGCWDGF 76 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCC------TTBCCEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCC------CCEEEEeeeEecc
Confidence 4556788999999999999999999999999999999998654 345689999999864 489999998865
Q ss_pred ---------------cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCcc
Q 001034 943 ---------------REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPEN 1006 (1182)
Q Consensus 943 ---------------~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeN 1006 (1182)
...+|+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 152 (284)
T 2a19_B 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSN 152 (284)
T ss_dssp EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHH
Confidence 4568999999996 88888865432 138899999999999999999999999999999999
Q ss_pred EEEccCCCceEEEecCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001034 1007 ILVKSYSRCEVKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLL 1084 (1182)
Q Consensus 1007 ILIDs~~dG~IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elL 1084 (1182)
||++. ++.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||... ....
T Consensus 153 il~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~ 228 (284)
T 2a19_B 153 IFLVD--TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFF 228 (284)
T ss_dssp EEEEE--TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHH
T ss_pred EEEcC--CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHH
Confidence 99984 67899999999876443 234567899999999999999999999999999999999999887321 1111
Q ss_pred HHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 001034 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164 (1182)
Q Consensus 1085 akIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA 1164 (1182)
..+. .. .....++..+.+||.+||..||.+|||+
T Consensus 229 ~~~~-------------------------------------~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~ 262 (284)
T 2a19_B 229 TDLR-------------------------------------DG---------IISDIFDKKEKTLLQKLLSKKPEDRPNT 262 (284)
T ss_dssp HHHH-------------------------------------TT---------CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHhh-------------------------------------cc---------cccccCCHHHHHHHHHHccCChhhCcCH
Confidence 1110 00 0112356889999999999999999999
Q ss_pred HHHHcCCCC
Q 001034 1165 SDALKHPWL 1173 (1182)
Q Consensus 1165 eELLqHPWF 1173 (1182)
.++++|.|.
T Consensus 263 ~e~l~~l~~ 271 (284)
T 2a19_B 263 SEILRTLTV 271 (284)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.26 Aligned_cols=248 Identities=20% Similarity=0.270 Sum_probs=197.1
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcE----EEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMD----VCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~----VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
+..++|++++.||+|+||.||+|.+..+++. ||+|++... ......+.+|+.+++.+. ||||++++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~ 83 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD------HAHIVRLLGL 83 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC------CTTBCCEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC------CCCcCeEEEE
Confidence 3457899999999999999999999888877 666766433 223345667888888875 4599999998
Q ss_pred EEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
+. ...+++||||+. |+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 84 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~k 155 (325)
T 3kex_A 84 CP-GSSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS--PSQVQ 155 (325)
T ss_dssp EC-BSSEEEEEECCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESS--SSCEE
T ss_pred Ec-CCccEEEEEeCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECC--CCeEE
Confidence 85 567999999998 578888765422 3888899999999999999999999999999999999984 67899
Q ss_pred EecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcC
Q 001034 1019 VIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1019 LiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilG 1092 (1182)
|+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.....
T Consensus 156 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 235 (325)
T 3kex_A 156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER 235 (325)
T ss_dssp ECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB
T ss_pred ECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC
Confidence 9999999764332 234567789999999999999999999999999999999 9999988766555444421100
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......++..+.+||.+||..||.+|||+.+|++|
T Consensus 236 -------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 -------------------------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -------------------------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -------------------------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00011234567899999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.46 Aligned_cols=261 Identities=18% Similarity=0.183 Sum_probs=207.9
Q ss_pred CceecCCEEEEEEeccCCceEEEEEE-----ECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAH-----DLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAk-----Dk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL 936 (1182)
..+..++|++++.||+|+||.||+|+ +..+++.||||++... ......+.+|+.+++.+.| |||+++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~ 98 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH------QNIVRC 98 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC------TTBCCE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCC------CCCCeE
Confidence 45667899999999999999999999 5678899999999653 2344567789999998854 599999
Q ss_pred EEEEEecCeEEEEEEecc-cChHHHHhhhcccC-CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-
Q 001034 937 YDYFYYREHLLIVCELLK-ANLYEFHKFNRESG-GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS- 1013 (1182)
Q Consensus 937 ~dsFqd~e~LyLVmEyL~-GsLld~Lk~~~~sg-gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~- 1013 (1182)
++++.....+||||||+. ++|.+++....... ....+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 99 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~ 178 (327)
T 2yfx_A 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 178 (327)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred EEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence 999999999999999996 58888887654221 112388899999999999999999999999999999999998532
Q ss_pred CceEEEecCCCccccCC-----CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 001034 1014 RCEVKVIDLGSSCFETD-----HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~-----~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakI 1087 (1182)
...+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||........+..+
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 44699999999864322 2234567889999999999999999999999999999998 99999988877666555
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
..... ......++..+.+||.+||..||.+|||+.+|
T Consensus 259 ~~~~~-------------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 295 (327)
T 2yfx_A 259 TSGGR-------------------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 295 (327)
T ss_dssp HTTCC-------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCC-------------------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 31100 00112457889999999999999999999999
Q ss_pred HcCCCC
Q 001034 1168 LKHPWL 1173 (1182)
Q Consensus 1168 LqHPWF 1173 (1182)
++|.|+
T Consensus 296 l~~l~~ 301 (327)
T 2yfx_A 296 LERIEY 301 (327)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.50 Aligned_cols=256 Identities=20% Similarity=0.247 Sum_probs=203.5
Q ss_pred eecCCEEEEEEeccCCceEEEEEEE-----CCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHD-----LHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkD-----k~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
+..++|++.+.||+|+||.||+|.+ ..++..||||+++... .....+.+|+.+++.+. .||||+++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~ 116 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-----SHENIVNLLG 116 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhc-----CCCCeeeEEE
Confidence 3457899999999999999999997 3467789999997542 34567889999999993 2459999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccC-----------------CccccCHHHHHHHHHHHHHHHHHHHhcCcccc
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESG-----------------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHC 1000 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg-----------------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHR 1000 (1182)
+|.....+|+||||+.+ +|.+++....... ....+++..++.++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999975 8888887543210 01237889999999999999999999999999
Q ss_pred ccCCccEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 001034 1001 DLKPENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVL 1074 (1182)
Q Consensus 1001 DIKPeNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~P 1074 (1182)
||||+|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 197 Dikp~NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 197 DLAARNVLVTH--GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TCSGGGEEEET--TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCChhhEEEcC--CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999984 778999999999754332 223456788999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhc
Q 001034 1075 FQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLL 1154 (1182)
Q Consensus 1075 F~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkML 1154 (1182)
|.+......+..++.... . .......+..+.+||.+||
T Consensus 275 ~~~~~~~~~~~~~~~~~~---------------------------------~---------~~~~~~~~~~l~~li~~~l 312 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGF---------------------------------K---------MDQPFYATEEIYIIMQSCW 312 (344)
T ss_dssp STTCCCSHHHHHHHHTTC---------------------------------C---------CCCCTTCCHHHHHHHHHHT
T ss_pred cccCCcHHHHHHHHhcCC---------------------------------C---------CCCCCCCCHHHHHHHHHHc
Confidence 987654443333321000 0 0011235789999999999
Q ss_pred ccCCCCCCCHHHHHcC
Q 001034 1155 EINPKKRPSASDALKH 1170 (1182)
Q Consensus 1155 q~DPekRPTAeELLqH 1170 (1182)
..||.+|||+.+|++|
T Consensus 313 ~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 313 AFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCCchhCcCHHHHHHH
Confidence 9999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.10 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=195.0
Q ss_pred eCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 863 LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 863 ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
.+....++|++.+.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.++| |||+++++
T Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~ 99 (310)
T 2wqm_A 26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH------PNVIKYYA 99 (310)
T ss_dssp GTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCC------TTBCCEEE
T ss_pred cccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCC------CCEeeEEE
Confidence 3445567899999999999999999999999999999999752 2345667789999988854 58999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
+|.....+|+||||+.+ +|.+++....... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~--~~~~ 175 (310)
T 2wqm_A 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQK--RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA--TGVV 175 (310)
T ss_dssp EEEETTEEEEEEECCCSCBHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCE
T ss_pred EEEcCCcEEEEEecCCCCCHHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcC--CCCE
Confidence 99999999999999986 7877776543221 23889999999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCCC---cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhcC
Q 001034 1018 KVIDLGSSCFETDH---LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS--PATLLARVIGIIG 1092 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~---~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d--~~elLakIv~ilG 1092 (1182)
||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.. .......+....
T Consensus 176 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 254 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD- 254 (310)
T ss_dssp EECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-
T ss_pred EEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-
Confidence 99999998764432 234578999999999999999999999999999999999999997532 222222221000
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.+. .....++..+.+||.+||..||.+|||+.+|+++
T Consensus 255 ------------------------------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 255 ------------------------------------YPP-----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ------------------------------------SCC-----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------------------CCC-----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000 0113457899999999999999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=346.87 Aligned_cols=263 Identities=20% Similarity=0.165 Sum_probs=191.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC---
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE--- 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e--- 944 (1182)
.++|++++.||+|+||.||+|++. ++.||||++............|+.+++.++ ||||++++++|....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMK------HENILQFIGAEKRGTSVD 94 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCC------CTTBCCEEEEEEEECSSS
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCC------CCCchhhcceeccCCCCC
Confidence 468999999999999999999864 799999999876554445555666666654 569999999998854
Q ss_pred -eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc----------CccccccCCccEEEccC
Q 001034 945 -HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL----------GLIHCDLKPENILVKSY 1012 (1182)
Q Consensus 945 -~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~----------GIIHRDIKPeNILIDs~ 1012 (1182)
++|+||||+.+ +|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~- 166 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN- 166 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT-
T ss_pred ceEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC-
Confidence 47999999985 788887543 188999999999999999999999 9999999999999984
Q ss_pred CCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 001034 1013 SRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGL-----SYDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082 (1182)
Q Consensus 1013 ~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~-----~yS~kSDIWSLGVILYELLTGr~PF~g~d~~e 1082 (1182)
.+.+||+|||+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.....
T Consensus 167 -~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 167 -NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp -TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred -CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 678999999999754322 2346789999999999873 45678899999999999999999997643211
Q ss_pred HHHHHHhhcCCc-chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCC
Q 001034 1083 LLARVIGIIGPI-EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161 (1182)
Q Consensus 1083 lLakIv~ilGp~-PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekR 1161 (1182)
.+.........+ ...+.. ........|..... ......+..+.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~R 303 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQE---------------------VVVHKKKRPVLRDY-WQKHAGMAMLCETIEECWDHDAEAR 303 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHH---------------------HHTTSCCCCCCCGG-GGSSHHHHHHHHHHHHHTCSSGGGS
T ss_pred ccchhhhhccCCchhhhhh---------------------hhhcccCCCCcccc-ccccchHHHHHHHHHHHccCChhhC
Confidence 100000000000 000000 00000000000000 0001124569999999999999999
Q ss_pred CCHHHHHc
Q 001034 1162 PSASDALK 1169 (1182)
Q Consensus 1162 PTAeELLq 1169 (1182)
||+.+|++
T Consensus 304 ps~~ell~ 311 (322)
T 3soc_A 304 LSAGCVGE 311 (322)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=351.51 Aligned_cols=246 Identities=21% Similarity=0.273 Sum_probs=203.9
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.++|++.+.||+|+||.||+|.++.+++.||||+++... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS------HPNIVRLIGVCTQKQP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCC------CTTBCCEEEEECSSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCC------CCCEEEEEEEEecCCC
Confidence 468999999999999999999999999999999997542 33456778999988875 4599999999999999
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+||||||+. |+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~--~~~~kl~DfG~ 259 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE--KNVLKISDFGM 259 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCGGG
T ss_pred cEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcC--CCcEEECcCCC
Confidence 999999997 578888765432 2889999999999999999999999999999999999984 67899999999
Q ss_pred ccccCCCcc-----cccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1025 SCFETDHLC-----SYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1025 A~~~~~~~s-----s~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
++....... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... .
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~----- 333 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-R----- 333 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-C-----
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-----
Confidence 976443321 1234677999999998899999999999999999998 999999877766554442100 0
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. .....++..+.+||.+||+.||.+|||+.+|++
T Consensus 334 ------------------------------~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 334 ------------------------------L-------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ------------------------------C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------C-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 011235688999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.80 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=192.1
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
...+.++|++++.||+|+||.||+|.+ +++.||||++.... ......|..++.... ..||||+++++++...
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~----l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVM----LRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTC----CCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhh----ccCcCeeeEEEeeccc
Confidence 456788999999999999999999986 78999999997653 345566777776643 2467999999987653
Q ss_pred ----CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHH--------hcCccccccCCccEEEc
Q 001034 944 ----EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH--------GLGLIHCDLKPENILVK 1010 (1182)
Q Consensus 944 ----e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLH--------S~GIIHRDIKPeNILID 1010 (1182)
..+|+||||+.+ +|.+++... .+++..+..++.||+.||.||| +.+|+||||||+|||++
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred cCCCceeEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc
Confidence 568999999985 788877432 2889999999999999999999 99999999999999998
Q ss_pred cCCCceEEEecCCCccccCCC-------cccccCCCcccchhhhcCC------CCCchhhHHHHHHHHHHHHhC------
Q 001034 1011 SYSRCEVKVIDLGSSCFETDH-------LCSYVQSRSYRAPEVILGL------SYDKKIDIWSLGCILAELCTG------ 1071 (1182)
Q Consensus 1011 s~~dG~IKLiDFGLA~~~~~~-------~ss~vGTp~YmAPEVLlg~------~yS~kSDIWSLGVILYELLTG------ 1071 (1182)
. ++.+||+|||+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 148 ~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 148 K--NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp T--TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred C--CCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 4 678999999998754332 2234899999999999877 455799999999999999999
Q ss_pred ----CCCCCCCC----HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCc
Q 001034 1072 ----NVLFQNDS----PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGD 1143 (1182)
Q Consensus 1072 ----r~PF~g~d----~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~S 1143 (1182)
..||.... ....+..++...+..+ ..|.. ......+
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~----~~~~~~~ 269 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP--------------------------------NIPNR----WFSDPTL 269 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC--------------------------------CCCGG----GGGSHHH
T ss_pred cccccccccccCCCCcchhhhhHHHhccCCCC--------------------------------CCChh----hccCccH
Confidence 77775421 1112222111000000 00000 0011234
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1144 QGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1144 eeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
..+.+||.+||+.||.+|||+.+|++
T Consensus 270 ~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 270 TSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 78999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=343.11 Aligned_cols=259 Identities=11% Similarity=0.128 Sum_probs=198.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCC---------CCC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLH--------TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDP---------GDK 930 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~--------TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~---------l~H 930 (1182)
.++|++.+.||+|+||.||+|++.. .++.||||++... ..+.+|+.+++.+.|++. ..+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 5799999999999999999999987 4889999999865 356788999998865411 112
Q ss_pred cceEEEEEEEEe-cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEE
Q 001034 931 YHLLRLYDYFYY-REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV 1009 (1182)
Q Consensus 931 PnIVkL~dsFqd-~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILI 1009 (1182)
.+++++++++.. ...+||||||+.++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 344457888876 688999999998899999876521 238999999999999999999999999999999999999
Q ss_pred ccCCCceEEEecCCCccccCCC----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-
Q 001034 1010 KSYSRCEVKVIDLGSSCFETDH----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND- 1078 (1182)
Q Consensus 1010 Ds~~dG~IKLiDFGLA~~~~~~----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~- 1078 (1182)
+..+...+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||+||+|++|+.||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9532238999999999754322 13457899999999999999999999999999999999999999764
Q ss_pred -CHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccC
Q 001034 1079 -SPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157 (1182)
Q Consensus 1079 -d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~D 1157 (1182)
....+...+......++ ...........++..+.+||.+||..|
T Consensus 273 ~~~~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~l~~li~~~l~~d 317 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPG-----------------------------------PFVGPCGHWIRPSETLQKYLKVVMALT 317 (352)
T ss_dssp TCHHHHHHHHHHHHHSCC-----------------------------------CEECTTSCEECCCHHHHHHHHHHHTCC
T ss_pred cCHHHHHHHHHhccCChh-----------------------------------hhhhhccccCCCcHHHHHHHHHHHhCC
Confidence 33332222211111100 000000111245789999999999999
Q ss_pred CCCCCCHHHHHc
Q 001034 1158 PKKRPSASDALK 1169 (1182)
Q Consensus 1158 PekRPTAeELLq 1169 (1182)
|.+|||+.+|++
T Consensus 318 p~~Rps~~~l~~ 329 (352)
T 2jii_A 318 YEEKPPYAMLRN 329 (352)
T ss_dssp TTCCCCHHHHHH
T ss_pred hhhCCCHHHHHH
Confidence 999999999876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=323.01 Aligned_cols=246 Identities=15% Similarity=0.154 Sum_probs=197.8
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
+..++|++.+.||+|+||.||+|++. ++.||||+++... .....+.+|+.+++.+ .||||++++++|..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF------SHPNVLPVLGACQS 78 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC------SCTTEECEEEEECT
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc------CCCchhheEEEEcc
Confidence 34578999999999999999999974 8899999998653 2234456666666655 46699999999988
Q ss_pred c--CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccccCCccEEEccCCCceE
Q 001034 943 R--EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 943 ~--e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRDIKPeNILIDs~~dG~I 1017 (1182)
. .++++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~ 152 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE--DMTA 152 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCS----SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECT--TSCE
T ss_pred CCCCCeEeeecccCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcC--Ccce
Confidence 7 789999999985 8888886533 224899999999999999999999999 999999999999994 6678
Q ss_pred EEecCCCccccCCCcccccCCCcccchhhhcCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1018 KVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDK---KIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~---kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
+|+|||++.... .....+|+.|+|||++.+..++. ++|||||||++|+|++|+.||...+.......+......
T Consensus 153 ~l~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~- 229 (271)
T 3kmu_A 153 RISMADVKFSFQ--SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR- 229 (271)
T ss_dssp EEEGGGSCCTTS--CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-
T ss_pred eEEeccceeeec--ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-
Confidence 888888765432 23457899999999998765544 899999999999999999999988776665554311000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
......++..+.+||.+||+.||.+|||+.++++
T Consensus 230 -----------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 -----------------------------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0111345789999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=329.58 Aligned_cols=268 Identities=21% Similarity=0.266 Sum_probs=203.9
Q ss_pred eeeCceecCCEEEEEEeccCCceEEEEEE----ECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceE
Q 001034 861 VVLNSVIAGRYHVTEYLGSAAFSKAIQAH----DLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLL 934 (1182)
Q Consensus 861 V~ig~iL~drYeIlk~LGkGaFGeVyLAk----Dk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIV 934 (1182)
+........+|++++.||+|+||.||+|+ +..+++.||||++.... .....+.+|+.+++.++| |||+
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~ 86 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH------ENIV 86 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCC------TTBC
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCC------CCee
Confidence 33444556789999999999999999998 67899999999997543 334677889999998864 5999
Q ss_pred EEEEEEEec--CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc
Q 001034 935 RLYDYFYYR--EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011 (1182)
Q Consensus 935 kL~dsFqd~--e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs 1011 (1182)
+++++|... ..+|+||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~ 161 (302)
T 4e5w_A 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 161 (302)
T ss_dssp CEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC
Confidence 999999877 779999999975 78888755432 2889999999999999999999999999999999999985
Q ss_pred CCCceEEEecCCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 001034 1012 YSRCEVKVIDLGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLA 1085 (1182)
Q Consensus 1012 ~~dG~IKLiDFGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLa 1085 (1182)
++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||... ...+.
T Consensus 162 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~ 237 (302)
T 4e5w_A 162 --EHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP--MALFL 237 (302)
T ss_dssp --TTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH--HHHHH
T ss_pred --CCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch--hhHHh
Confidence 678999999999765432 23456788899999999999999999999999999999999997432 22222
Q ss_pred HHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 001034 1086 RVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165 (1182)
Q Consensus 1086 kIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe 1165 (1182)
.. .++........ .....+. . .........++..+.+||.+||+.||.+|||+.
T Consensus 238 ~~---~~~~~~~~~~~------------------~~~~~~~----~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 291 (302)
T 4e5w_A 238 KM---IGPTHGQMTVT------------------RLVNTLK----E-GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQ 291 (302)
T ss_dssp HH---HCSCCGGGHHH------------------HHHHHHH----T-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred hc---cCCcccccCHH------------------HHHHHHh----c-cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHH
Confidence 22 22211110000 0000000 0 001112345689999999999999999999999
Q ss_pred HHHc
Q 001034 1166 DALK 1169 (1182)
Q Consensus 1166 ELLq 1169 (1182)
++++
T Consensus 292 ~ll~ 295 (302)
T 4e5w_A 292 NLIE 295 (302)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.25 Aligned_cols=255 Identities=20% Similarity=0.313 Sum_probs=206.3
Q ss_pred eecCCEEEEEEeccCCceEEEEEEEC-------CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDL-------HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk-------~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL 936 (1182)
+..++|++.+.||+|+||.||+|.+. .++..||||+++... .....+.+|+.+++.+. .||||+++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~ 106 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINL 106 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh-----cCCCEeeE
Confidence 34579999999999999999999976 467889999997643 34567788999999984 24599999
Q ss_pred EEEEEecCeEEEEEEeccc-ChHHHHhhhcccCC----------ccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCc
Q 001034 937 YDYFYYREHLLIVCELLKA-NLYEFHKFNRESGG----------EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005 (1182)
Q Consensus 937 ~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sgg----------el~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPe 1005 (1182)
+++|.....+|+||||+.+ +|.+++......+. ...+++..++.++.||+.||.|||+.||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 9999999999999999985 88888876542111 123788999999999999999999999999999999
Q ss_pred cEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDS 1079 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d 1079 (1182)
|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 187 NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 187 NVLVTE--NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GEEECT--TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEEcC--CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999984 678999999999764432 223456788999999999899999999999999999999 999999887
Q ss_pred HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCC
Q 001034 1080 PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159 (1182)
Q Consensus 1080 ~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPe 1159 (1182)
..+.+..+..... ......++..+.+||.+||..||.
T Consensus 265 ~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~l~~li~~~l~~dp~ 301 (334)
T 2pvf_A 265 VEELFKLLKEGHR-------------------------------------------MDKPANCTNELYMMMRDCWHAVPS 301 (334)
T ss_dssp HHHHHHHHHHTCC-------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHhcCCC-------------------------------------------CCCCccCCHHHHHHHHHHccCChh
Confidence 7666555421100 001124578899999999999999
Q ss_pred CCCCHHHHHcC
Q 001034 1160 KRPSASDALKH 1170 (1182)
Q Consensus 1160 kRPTAeELLqH 1170 (1182)
+|||+.+++++
T Consensus 302 ~Rps~~ell~~ 312 (334)
T 2pvf_A 302 QRPTFKQLVED 312 (334)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.88 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=204.5
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+..++|++++.||+|+||.||+|.+. ++..||||++.........+.+|+.+++.+.| |||+++++++. ...
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~-~~~ 81 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH------QRLVRLYAVVT-QEP 81 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC------TTBCCEEEEEC-SSS
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCC------cCcceEEEEEc-CCC
Confidence 44578999999999999999999974 67789999998766566788899999999864 48999999876 567
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+. ++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~ 155 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD--TLSCKIADFGL 155 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCTT
T ss_pred cEEEEecCCCCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC--CCCEEECCCcc
Confidence 899999997 578887764321 13889999999999999999999999999999999999984 67899999999
Q ss_pred ccccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1025 SCFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1025 A~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
+....... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+.+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------- 228 (279)
T 1qpc_A 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------- 228 (279)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred cccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-------
Confidence 97654322 23456788999999998899999999999999999999 9999998887766655531100
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
......++..+.+||.+||..||.+|||+.+|++
T Consensus 229 ------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 ------------------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0011245789999999999999999999999886
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=352.97 Aligned_cols=276 Identities=17% Similarity=0.253 Sum_probs=206.3
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..+.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++| |||+++++++..
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~~~~~~~ 78 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH------KNIVKLFAIEEE 78 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC------TTBCCEEEEEEC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC------CCCCeEEEeecc
Confidence 456789999999999999999999999999999999997643 234567789999999864 499999999987
Q ss_pred cC--eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc--CCCceE
Q 001034 943 RE--HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS--YSRCEV 1017 (1182)
Q Consensus 943 ~e--~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs--~~dG~I 1017 (1182)
.. ++|+||||+.+ +|.+++...... ..+++..++.++.||+.||.|||++||+||||||+|||+.. ...+.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeE
Confidence 65 78999999974 787777654322 12899999999999999999999999999999999999821 246789
Q ss_pred EEecCCCccccCCC--cccccCCCcccchhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCC----CCHHHH
Q 001034 1018 KVIDLGSSCFETDH--LCSYVQSRSYRAPEVILG--------LSYDKKIDIWSLGCILAELCTGNVLFQN----DSPATL 1083 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg--------~~yS~kSDIWSLGVILYELLTGr~PF~g----~d~~el 1083 (1182)
||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. ....+.
T Consensus 156 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp EECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred EEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 99999999764432 345679999999999875 5678899999999999999999999964 233444
Q ss_pred HHHHHhhcCCcchhhhhcccccc-hhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTY-KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~-k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP 1162 (1182)
+.+++. ..|...+....... ..+. .....|.. .......+..+.+||++||++||++||
T Consensus 236 ~~~~~~---~~p~~~~~~~~~~~~~~~~--------------~~~~~~~~---~~l~~~~~~~l~~ll~~~L~~dP~~R~ 295 (396)
T 4eut_A 236 MYKIIT---GKPSGAISGVQKAENGPID--------------WSGDMPVS---CSLSRGLQVLLTPVLANILEADQEKCW 295 (396)
T ss_dssp HHHHHH---SCCTTCCEEEECSTTCCEE--------------EESSCCTT---CSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred HHHHhc---CCCcccchhheeccCCCcc--------------cCccCCcc---cccchHHHhhchHHHHHhhccChhhhc
Confidence 444432 22221111110000 0000 00000110 011123356889999999999999999
Q ss_pred CHHHHHc
Q 001034 1163 SASDALK 1169 (1182)
Q Consensus 1163 TAeELLq 1169 (1182)
|+.++++
T Consensus 296 s~~e~l~ 302 (396)
T 4eut_A 296 GFDQFFA 302 (396)
T ss_dssp CHHHHHH
T ss_pred cHHHHHH
Confidence 9999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.45 Aligned_cols=248 Identities=24% Similarity=0.289 Sum_probs=193.7
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+. ||||++++++|..
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------hp~iv~~~~~~~~ 105 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ------EPHVVPIHDFGEI 105 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC------CCCeeEEEEEEee
Confidence 3478999999999999999999999999999999997543 23456778888888775 4599999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~--~~~~kl~D 177 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA--DDFAYLVD 177 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECS
T ss_pred CCeEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcC--CCCEEEec
Confidence 9999999999986 7888776543 2889999999999999999999999999999999999984 67899999
Q ss_pred CCCccccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1022 LGSSCFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1022 FGLA~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+. ...+.
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~--- 253 (309)
T 2h34_A 178 FGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPR--- 253 (309)
T ss_dssp CCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCC---
T ss_pred CccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCC---
Confidence 9998754432 234578999999999999999999999999999999999999998766543322221 00000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHc
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-SASDALK 1169 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-TAeELLq 1169 (1182)
.....+.++..+.+||.+||..||.+|| ++.++++
T Consensus 254 -------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 -------------------------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -------------------------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -------------------------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 0112235578899999999999999999 8888875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.12 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=191.7
Q ss_pred eCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 863 LNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 863 ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
.+++..++|++.+.||+|+||.||+|++. ..||+|+++... .....+.+|+.+++.++| |||++++++
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~ 88 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH------VNILLFMGY 88 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCC------TTBCCEEEE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCC------CcEEEEEee
Confidence 45677899999999999999999999853 359999997543 334567788888888764 589999995
Q ss_pred EEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
.....+++||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 89 -~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~--~~~~k 160 (289)
T 3og7_A 89 -STAPQLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE--DNTVK 160 (289)
T ss_dssp -ECSSSCEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TTEEE
T ss_pred -ccCCccEEEEEecCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC--CCCEE
Confidence 456778999999985 67776653322 3889999999999999999999999999999999999994 67899
Q ss_pred EecCCCccccCC-----CcccccCCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 001034 1019 VIDLGSSCFETD-----HLCSYVQSRSYRAPEVIL---GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1019 LiDFGLA~~~~~-----~~ss~vGTp~YmAPEVLl---g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~i 1090 (1182)
|+|||++..... ......+|+.|+|||++. +..++.++|||||||++|+|++|+.||.+......+..++..
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 240 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence 999999875432 223457899999999997 667899999999999999999999999876555444443211
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
... ...+......++..+.+||.+||..||.+|||+.++++
T Consensus 241 ~~~--------------------------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 241 GSL--------------------------------------SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSC--------------------------------------CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccc--------------------------------------CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 00011122355789999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.07 Aligned_cols=247 Identities=18% Similarity=0.234 Sum_probs=201.8
Q ss_pred cCCEEEEE-EeccCCceEEEEEEEC--CCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 868 AGRYHVTE-YLGSAAFSKAIQAHDL--HTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 868 ~drYeIlk-~LGkGaFGeVyLAkDk--~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.++|.+.+ .||+|+||.||+|.+. .++..||||+++.. ......+.+|+.+++.+.| |||+++++++ .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~-~ 80 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN------PYIVRLIGVC-Q 80 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC------TTBCCEEEEE-E
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCC------CCEeEEEEEe-c
Confidence 46788887 9999999999999854 57888999999864 3445678889999999854 4899999999 5
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~D 153 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKISD 153 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE--TTEEEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcC--CCCEEECc
Confidence 5679999999986 6777765332 13899999999999999999999999999999999999984 67899999
Q ss_pred CCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1022 LGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1022 FGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+....
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--- 230 (287)
T 1u59_A 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--- 230 (287)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC---
T ss_pred ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC---
Confidence 9999765322 223356788999999998899999999999999999998 999998877666555542100
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHP 1171 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHP 1171 (1182)
.......++..+.+||.+||..||.+||++.++++|.
T Consensus 231 ----------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 231 ----------------------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp ----------------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ----------------------------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0011234578999999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=332.65 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=203.0
Q ss_pred eecCCEEEEEEeccCCceEEEEEEE-----CCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHD-----LHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkD-----k~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
+..++|++.+.||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.+++.+.+ ||||+++++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-----hp~iv~~~~ 98 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-----HLNVVNLLG 98 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-----CTTBCCEEE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhccc-----CCCeeeEEE
Confidence 3457899999999999999999984 4678999999998653 334567889999999853 459999999
Q ss_pred EEEecC-eEEEEEEeccc-ChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCcc
Q 001034 939 YFYYRE-HLLIVCELLKA-NLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPEN 1006 (1182)
Q Consensus 939 sFqd~e-~LyLVmEyL~G-sLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeN 1006 (1182)
+|.... .+|+||||+.+ +|.+++....... ....+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 988754 59999999985 7888876543210 01127889999999999999999999999999999999
Q ss_pred EEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 001034 1007 ILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSP 1080 (1182)
Q Consensus 1007 ILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~ 1080 (1182)
||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 179 il~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 179 ILLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EEECG--GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EEECC--CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99984 678999999999754332 223467889999999999999999999999999999998 9999977553
Q ss_pred HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1081 ~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
...+...+.... ........+..+.+||.+||+.||.+
T Consensus 257 ~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~ 294 (316)
T 2xir_A 257 DEEFCRRLKEGT------------------------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQ 294 (316)
T ss_dssp SHHHHHHHHHTC------------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred hHHHHHHhccCc------------------------------------------cCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 332222210000 00011235788999999999999999
Q ss_pred CCCHHHHHcC
Q 001034 1161 RPSASDALKH 1170 (1182)
Q Consensus 1161 RPTAeELLqH 1170 (1182)
|||+.+|++|
T Consensus 295 Rps~~ell~~ 304 (316)
T 2xir_A 295 RPTFSELVEH 304 (316)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=339.16 Aligned_cols=247 Identities=20% Similarity=0.281 Sum_probs=193.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEE----EEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDV----CVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~V----AVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
..++|++++.||+|+||.||+|++..+++.+ |+|.++... .....+.+|+.+++.++| |||++++++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~ 86 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN------PHVCRLLGIC 86 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCB------TTBCCEEEEE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC------CCEeEEEEEE
Confidence 4578999999999999999999998888765 666664332 345678889999999865 4999999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
.... .++||+|+. |+|.+++..... .+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~--~~~~kl 158 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKI 158 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEEE
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECC--CCCEEE
Confidence 8754 778888887 578877765432 2889999999999999999999999999999999999984 678999
Q ss_pred ecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1020 IDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1020 iDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp 1093 (1182)
+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+...+...+.....
T Consensus 159 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~- 237 (327)
T 3poz_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER- 237 (327)
T ss_dssp CCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-
T ss_pred ccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-
Confidence 999998754332 223456789999999999999999999999999999999 9999988766554433321000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.......+..+.+||.+||+.||.+|||+.++++|
T Consensus 238 ------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 ------------------------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ------------------------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ------------------------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00122346789999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=327.83 Aligned_cols=246 Identities=20% Similarity=0.284 Sum_probs=194.0
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-C
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR-E 944 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~-e 944 (1182)
+..++|++.+.||+|+||.||++.+ +++.||||+++... ....+.+|+.+++.++ ||||+++++++... .
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLR------HSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTCC------CTTBCCEEEEECCC--
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-HHHHHHHHHHHHHhCC------CCCEeeEEEEEEcCCC
Confidence 3457899999999999999999986 48899999997654 3466788999988885 45899999987654 5
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~Dfg 162 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFG 162 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCCC
T ss_pred ceEEEEecCCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeC--CCcEEEeecc
Confidence 79999999986 88888865432 23788899999999999999999999999999999999984 6789999999
Q ss_pred CccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1024 SSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1024 LA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
++...........+++.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----------- 231 (278)
T 1byg_A 163 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------- 231 (278)
T ss_dssp C------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-----------
T ss_pred ccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 99876655556678899999999999999999999999999999998 999998766554444331000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.......++..+.+||.+||+.||.+|||+.++++
T Consensus 232 --------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 --------------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp --------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 00112345789999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=336.64 Aligned_cols=255 Identities=20% Similarity=0.245 Sum_probs=203.7
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEE--EEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDV--CVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~V--AVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
+-.++|++.+.||+|+||.||+|++..++..+ |+|+++.. ......+.+|+.+++.+. .||||++++++|.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACE 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-----CCTTBCCEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc-----CCCchhhhceeee
Confidence 34578999999999999999999999888866 99998753 234456778999988873 3559999999999
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhccc----------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEc
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRES----------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVK 1010 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~s----------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILID 1010 (1182)
....+|+||||+.+ +|.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 99999999999975 888888654310 1112389999999999999999999999999999999999998
Q ss_pred cCCCceEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 001034 1011 SYSRCEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1011 s~~dG~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakI 1087 (1182)
. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+....+..+
T Consensus 177 ~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 177 E--NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp G--GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred C--CCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 4 678999999998743322 233456889999999999899999999999999999998 99999988876655544
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
..... ......++..+.+||.+||..||.+|||+.++
T Consensus 255 ~~~~~-------------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 291 (327)
T 1fvr_A 255 PQGYR-------------------------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 291 (327)
T ss_dssp GGTCC-------------------------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCC-------------------------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 21000 00112346889999999999999999999999
Q ss_pred HcC
Q 001034 1168 LKH 1170 (1182)
Q Consensus 1168 LqH 1170 (1182)
++|
T Consensus 292 l~~ 294 (327)
T 1fvr_A 292 LVS 294 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.47 Aligned_cols=252 Identities=17% Similarity=0.224 Sum_probs=195.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECC---CCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLH---TGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~---TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
.++|.+.+.||+|+||.||+|.... +++.||+|+++.. ......+.+|+.+++.+. ||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~ 106 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS------HPNVIRLLGVCI 106 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC------CTTBCCCCEEEE
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC------CCCeeeeeEEEe
Confidence 4689999999999999999998765 5668999998754 233456788999998885 459999999998
Q ss_pred ecC-----eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCc
Q 001034 942 YRE-----HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC 1015 (1182)
Q Consensus 942 d~e-----~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG 1015 (1182)
... ..|+||||+.+ +|.+++...........+++..++.++.||+.||.|||++||+||||||+|||++. ++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~--~~ 184 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD--DM 184 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT--TS
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CC
Confidence 764 45999999985 78887765443333345899999999999999999999999999999999999984 67
Q ss_pred eEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 001034 1016 EVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIG 1089 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ 1089 (1182)
.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.........+..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 8999999998754322 223456788999999999999999999999999999999 9999988776555544421
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
... ......++..+.+||.+||..||.+|||+.+|++
T Consensus 265 ~~~-------------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 265 GHR-------------------------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp TCC-------------------------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCC-------------------------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 100 0011245688999999999999999999999987
Q ss_pred C
Q 001034 1170 H 1170 (1182)
Q Consensus 1170 H 1170 (1182)
|
T Consensus 302 ~ 302 (313)
T 3brb_A 302 Q 302 (313)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.19 Aligned_cols=256 Identities=18% Similarity=0.256 Sum_probs=204.8
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCc-----EEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGM-----DVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr-----~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
+..++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+|+.+++.+. .||||+++++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~ 117 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-----QHENIVNLLG 117 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhc-----CCCCeeeEEE
Confidence 446889999999999999999999877665 79999997653 34567789999999993 2459999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccC--------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEE
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESG--------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILV 1009 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg--------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILI 1009 (1182)
+|.....+|+||||+.+ +|.+++....... ....+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 99999999999999985 8888876543210 01237899999999999999999999999999999999999
Q ss_pred ccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 001034 1010 KSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATL 1083 (1182)
Q Consensus 1010 Ds~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~el 1083 (1182)
+. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 198 ~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 198 TN--GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EG--GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CC--CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 84 778999999999754332 123456788999999999999999999999999999998 9999987554443
Q ss_pred HHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT 1163 (1182)
+..++..... .......+..+.+||.+||+.||.+|||
T Consensus 276 ~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps 313 (333)
T 2i1m_A 276 FYKLVKDGYQ------------------------------------------MAQPAFAPKNIYSIMQACWALEPTHRPT 313 (333)
T ss_dssp HHHHHHHTCC------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHhcCCC------------------------------------------CCCCCCCCHHHHHHHHHHhccChhhCcC
Confidence 3333210000 0011234688999999999999999999
Q ss_pred HHHHHcC
Q 001034 1164 ASDALKH 1170 (1182)
Q Consensus 1164 AeELLqH 1170 (1182)
+.+|+++
T Consensus 314 ~~~l~~~ 320 (333)
T 2i1m_A 314 FQQICSF 320 (333)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.24 Aligned_cols=248 Identities=19% Similarity=0.247 Sum_probs=198.9
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECC---CCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLH---TGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~---TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++... ......+.+|+.+++.+.| |||+++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~ 82 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH------PHIVKLIGII 82 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCC------TTBCCEEEEE
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCC------CCcceEEEEE
Confidence 345789999999999999999998653 3456999999864 2345677889999999964 4899999998
Q ss_pred EecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 941 YYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 941 qd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
.. ...|+||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 83 ~~-~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl 154 (281)
T 3cc6_A 83 EE-EPTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS--PECVKL 154 (281)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEE--TTEEEE
T ss_pred cC-CCCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECC--CCcEEe
Confidence 64 567899999984 78777765432 2889999999999999999999999999999999999985 678999
Q ss_pred ecCCCccccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1020 IDLGSSCFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1020 iDFGLA~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||...........+.....
T Consensus 155 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~-- 232 (281)
T 3cc6_A 155 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR-- 232 (281)
T ss_dssp CCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC--
T ss_pred CccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC--
Confidence 999998765432 233456788999999999999999999999999999998 9999987665544443321000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......++..+.+||.+||..||.+|||+.+++++
T Consensus 233 -----------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 233 -----------------------------------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -----------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 00112357889999999999999999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=333.11 Aligned_cols=243 Identities=27% Similarity=0.416 Sum_probs=187.4
Q ss_pred ecCCEEEE-EEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe---
Q 001034 867 IAGRYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--- 942 (1182)
Q Consensus 867 L~drYeIl-k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--- 942 (1182)
+.++|.++ +.||+|+||.||+|.++.+++.||||++.... ...+|+.++.++. .||||++++++|..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~-----~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRAS-----QCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHT-----TSTTBCCEEEEEEEEET
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH----HHHHHHHHHHHhc-----cCCCchhHHhhhhhhcC
Confidence 45677777 88999999999999999999999999997543 4567788775553 35699999999987
Q ss_pred -cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-CceEEE
Q 001034 943 -REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKV 1019 (1182)
Q Consensus 943 -~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-dG~IKL 1019 (1182)
..++||||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred CCceEEEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEE
Confidence 6789999999985 88888875432 2389999999999999999999999999999999999998532 578999
Q ss_pred ecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1020 IDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1020 iDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
+|||++.... +..++.++|||||||++|+|++|++||...........+.
T Consensus 162 ~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~----------- 211 (299)
T 3m2w_A 162 TDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----------- 211 (299)
T ss_dssp CCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC-----------
T ss_pred eccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH-----------
Confidence 9999986432 2457789999999999999999999997755432111100
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.... . .....+ ......++..+.+||.+||+.||.+|||+.+||+||||+...
T Consensus 212 ~~~~------------------~--~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 212 TRIR------------------M--GQYEFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CSSC------------------T--TCCSSC-----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHh------------------h--ccccCC-----chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0000 0 000000 001134578999999999999999999999999999997664
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=326.30 Aligned_cols=244 Identities=19% Similarity=0.233 Sum_probs=198.8
Q ss_pred cCCEEEEE-EeccCCceEEEEEE--ECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 868 AGRYHVTE-YLGSAAFSKAIQAH--DLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 868 ~drYeIlk-~LGkGaFGeVyLAk--Dk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
..+|++.+ .||+|+||.||+|. ...+++.||||+++... .....+.+|+.+++.+.| |||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~- 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN------PYIVRMIGIC- 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC------TTBCCEEEEE-
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCC------CCEEEEEEEE-
Confidence 46899998 99999999999994 45678999999997642 335677889999998854 5899999999
Q ss_pred ecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
....+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~--~~~~kl~ 159 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKIS 159 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC--CCcEEEc
Confidence 5678999999998 57877776532 2889999999999999999999999999999999999995 6789999
Q ss_pred cCCCccccCCCc------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1021 DLGSSCFETDHL------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1021 DFGLA~~~~~~~------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp 1093 (1182)
|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+....
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-- 237 (291)
T 1xbb_A 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-- 237 (291)
T ss_dssp CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--
T ss_pred cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--
Confidence 999997654321 22345688999999999899999999999999999999 999999888766655542100
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.......++..+.+||.+||..||.+|||+.++++
T Consensus 238 -----------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 -----------------------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------------------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00011345789999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=336.22 Aligned_cols=280 Identities=18% Similarity=0.189 Sum_probs=189.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR-- 943 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~-- 943 (1182)
+-.++|++++.||+|+||.||+|+. +++.||||++..... .....|..++.. ....|+||+++++.+...
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~----~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYRV----PLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHTS----TTCCCTTBCCEEEEEEEECT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHHH----HhccCcchhhheeccccccc
Confidence 3457899999999999999999975 789999999976542 233344333321 224577999999866532
Q ss_pred ---CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc---------CccccccCCccEEEc
Q 001034 944 ---EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL---------GLIHCDLKPENILVK 1010 (1182)
Q Consensus 944 ---e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~---------GIIHRDIKPeNILID 1010 (1182)
..+||||||+.+ +|.+++.... +++..++.++.||+.||.|||+. ||+||||||+|||++
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 367999999974 7888875432 57888999999999999999999 999999999999998
Q ss_pred cCCCceEEEecCCCccccCCC-----------cccccCCCcccchhhhcC-------CCCCchhhHHHHHHHHHHHHhCC
Q 001034 1011 SYSRCEVKVIDLGSSCFETDH-----------LCSYVQSRSYRAPEVILG-------LSYDKKIDIWSLGCILAELCTGN 1072 (1182)
Q Consensus 1011 s~~dG~IKLiDFGLA~~~~~~-----------~ss~vGTp~YmAPEVLlg-------~~yS~kSDIWSLGVILYELLTGr 1072 (1182)
. ++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 155 ~--~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 155 N--DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp T--TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred C--CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 4 678999999999754321 224579999999999987 35677899999999999999997
Q ss_pred CCCCCCCH-HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHH
Q 001034 1073 VLFQNDSP-ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVA 1151 (1182)
Q Consensus 1073 ~PF~g~d~-~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIr 1151 (1182)
.||..... ......+....+..+. +. ............+............+..+.+||.
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~------------~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPT------------FE-------DMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCC------------HH-------HHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCch------------HH-------HHHhhhcccccCCCCCcccccccchHHHHHHHHH
Confidence 76643221 1000000000000000 00 0000000000011111111111223568999999
Q ss_pred HhcccCCCCCCCHHHH------HcCCCCCCCCCCCC
Q 001034 1152 HLLEINPKKRPSASDA------LKHPWLSHPYEPIS 1181 (1182)
Q Consensus 1152 kMLq~DPekRPTAeEL------LqHPWFk~~~eP~~ 1181 (1182)
+||+.||.+|||+.|| |-++|-++.-.+.+
T Consensus 294 ~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~~~~ 329 (336)
T 3g2f_A 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329 (336)
T ss_dssp HHSCSSGGGSCCHHHHHHHHHHHHHCCCC-------
T ss_pred HHhcCChhhCcchHHHHHHHHHHHHHHHhcccCCCc
Confidence 9999999999999999 56889887765544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=351.14 Aligned_cols=244 Identities=20% Similarity=0.296 Sum_probs=200.6
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC-eE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE-HL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e-~L 946 (1182)
.++|++++.||+|+||.||++... ++.||||+++... ....+.+|+.+++.++| |||+++++++.... .+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRH------SNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCC------TTBCCEEEEEECTTSCE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccC------CCEEEEEEEEEcCCCce
Confidence 467999999999999999999864 7899999998764 45678899999998864 48999999987765 79
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
||||||+.+ +|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a 336 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFGLT 336 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TSCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC--CCCEEEeeCCCc
Confidence 999999985 88888875432 23788899999999999999999999999999999999984 678999999999
Q ss_pred cccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1026 CFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1026 ~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
+..........+++.|+|||++.+..++.++|||||||+||+|++ |..||...+..+.+..+....
T Consensus 337 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------- 403 (450)
T 1k9a_A 337 KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------- 403 (450)
T ss_dssp EECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-------------
T ss_pred ccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 865554445577889999999999999999999999999999998 999998766555544442100
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......++..+.+||.+||+.||.+|||+.+|++
T Consensus 404 ---------------------~---------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 404 ---------------------K---------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------C---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 0112345789999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=359.99 Aligned_cols=248 Identities=20% Similarity=0.262 Sum_probs=208.7
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
...+|++.+.||+|+||.||+|.++.++..||||+++........+.+|+.+++.++| |||++++++|.....+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH------PNLVQLLGVCTREPPF 291 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC------TTBCCEEEEECSSSSC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCC------CCEeeEEEEEecCCcE
Confidence 3467999999999999999999999999999999998776667788999999999864 4999999999999999
Q ss_pred EEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
||||||+. |+|.+++..... ..+++..+..|+.||+.||.|||++||+||||||+||||+. ++.+||+|||++
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a 365 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE--NHLVKVADFGLS 365 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--GGCEEECCTTCE
T ss_pred EEEEEccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECC--CCcEEEeecccc
Confidence 99999998 588888875432 23889999999999999999999999999999999999984 678999999999
Q ss_pred cccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+...... ....+++.|+|||++.+..++.++|||||||+||+|++ |..||.+.+..+++..+....
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------- 436 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------- 436 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---------
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence 8654322 23345678999999999999999999999999999999 999998876655444432100
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......++..+.+||.+||+.||.+|||+.+|++
T Consensus 437 -------------------------~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 437 -------------------------R---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -------------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------C---------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0 0112345789999999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=351.77 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=207.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..++|++.+.||+|+||.||+|... .+..||||+++........+.+|+.+++.++| |||+++++++. ...+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH------DKLVKLHAVVT-KEPI 257 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCC------TTBCCEEEEEC-SSSC
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCC------CCEeeEEEEEe-CCcc
Confidence 3568999999999999999999975 56789999998776667788999999998864 58999999986 6789
Q ss_pred EEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
||||||+. |+|.+++...... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DFG~a 331 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIADFGLA 331 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHH----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT--TCCEEECSTTGG
T ss_pred EEEEeecCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC--CCcEEEeeCCCc
Confidence 99999997 5888888754321 2788899999999999999999999999999999999984 678999999999
Q ss_pred cccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+..... .....+|+.|+|||++....++.++|||||||+||||++ |+.||.+.+..+++..+.....
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------- 403 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-------- 403 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--------
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 865432 123345778999999999999999999999999999999 9999998887776666531100
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc--CCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK--HPWLS 1174 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq--HPWFk 1174 (1182)
. .....++..+.+||.+||..||.+|||+.+|++ ..+++
T Consensus 404 ----------------------------~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 ----------------------------M-------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ----------------------------C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ----------------------------C-------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0 011245788999999999999999999999976 34443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=336.29 Aligned_cols=262 Identities=24% Similarity=0.275 Sum_probs=201.0
Q ss_pred cCCEEEEEEeccCCceEEEEEE----ECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAH----DLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAk----Dk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.++|++++.||+|+||.||+|. +..+++.||||++.... .....+.+|+.+++.+.| +||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~ 95 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS------DFIVKYRGVSYG 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCC------TTBCCEEEEEEC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCC------CceeEEEEEEec
Confidence 4789999999999999999998 57789999999997653 334567889999998854 489999999874
Q ss_pred --cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 943 --REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 943 --~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
...+|+||||+. ++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~--~~~~kl 168 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES--EAHVKI 168 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEE
T ss_pred CCCceEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECC--CCCEEE
Confidence 467999999996 578888765432 2899999999999999999999999999999999999984 778999
Q ss_pred ecCCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1020 IDLGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1020 iDFGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||........ ........
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~ 246 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL--RMMGCERD 246 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHCC----
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh--hhcccccc
Confidence 999999764332 2234578889999999999999999999999999999999999976433211 11000000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.+. . .......... ........++..+.+||.+||+.||.+|||+.+|++|
T Consensus 247 ~~~------------~------------~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 247 VPA------------L------------SRLLELLEEG--QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CCH------------H------------HHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccc------------H------------HHHHHHhhcc--cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 0 0000000000 0111234568999999999999999999999999653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=335.90 Aligned_cols=260 Identities=19% Similarity=0.257 Sum_probs=194.0
Q ss_pred cceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 858 NFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 858 ~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
.++......+.++|++++.||+|+||.||+|++. ++.||||++..... .....|..++..+. ..||||++++
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~----~~h~~i~~~~ 97 (337)
T 3mdy_A 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVL----MRHENILGFI 97 (337)
T ss_dssp SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTT----CCCTTBCCEE
T ss_pred CCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHh----hcCCCeeeEE
Confidence 3455566677889999999999999999999874 89999999975542 33445555554442 3577999999
Q ss_pred EEEEec----CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc--------CccccccCC
Q 001034 938 DYFYYR----EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL--------GLIHCDLKP 1004 (1182)
Q Consensus 938 dsFqd~----e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~--------GIIHRDIKP 1004 (1182)
+++... ..+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||+. ||+||||||
T Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp 170 (337)
T 3mdy_A 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170 (337)
T ss_dssp EEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCG
T ss_pred EEEccCCCCCCceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccch
Confidence 999987 789999999985 888887543 288999999999999999999998 999999999
Q ss_pred ccEEEccCCCceEEEecCCCccccCCC-------cccccCCCcccchhhhcCCCCCch------hhHHHHHHHHHHHHhC
Q 001034 1005 ENILVKSYSRCEVKVIDLGSSCFETDH-------LCSYVQSRSYRAPEVILGLSYDKK------IDIWSLGCILAELCTG 1071 (1182)
Q Consensus 1005 eNILIDs~~dG~IKLiDFGLA~~~~~~-------~ss~vGTp~YmAPEVLlg~~yS~k------SDIWSLGVILYELLTG 1071 (1182)
+|||++. ++.+||+|||++...... ....+||+.|+|||++.+..+... +|||||||++|+|++|
T Consensus 171 ~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 171 KNILVKK--NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp GGEEECT--TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHEEECC--CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 9999984 678999999999654322 124579999999999988776654 9999999999999999
Q ss_pred CC----------CCCCCC----HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcccccccccc
Q 001034 1072 NV----------LFQNDS----PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRH 1137 (1182)
Q Consensus 1072 r~----------PF~g~d----~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~ 1137 (1182)
.. ||.... ....+..++.. .......|.. .
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~----~ 292 (337)
T 3mdy_A 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCI--------------------------------KKLRPSFPNR----W 292 (337)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT--------------------------------SCCCCCCCGG----G
T ss_pred cCcccccccccccHhhhcCCCCchhhhHHHHhh--------------------------------hccCcccccc----c
Confidence 44 443211 00111111000 0000000000 0
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1138 RLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1138 ~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
....++..+.+||.+||+.||.+|||+.+|++|
T Consensus 293 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 293 SSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 011335779999999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.81 Aligned_cols=247 Identities=20% Similarity=0.279 Sum_probs=194.4
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEE----EEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDV----CVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~V----AVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
+..++|++++.||+|+||.||+|++..+++.+ |+|.+... ......+.+|+.+++.++| |||++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~~ 85 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN------PHVCRLLGI 85 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCB------TTBCCCCEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC------CCeeEEEEE
Confidence 34588999999999999999999999888876 55555432 2345677889999988854 599999999
Q ss_pred EEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
|.... .++||+++. |+|.+++..... .+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 86 ~~~~~-~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~k 157 (327)
T 3lzb_A 86 CLTST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVK 157 (327)
T ss_dssp EESSS-EEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEE
T ss_pred EecCC-ceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcC--CCCEE
Confidence 98765 778888887 578887765432 2889999999999999999999999999999999999984 67899
Q ss_pred EecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcC
Q 001034 1019 VIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1019 LiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilG 1092 (1182)
|+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.........+....
T Consensus 158 L~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~- 236 (327)
T 3lzb_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE- 236 (327)
T ss_dssp ECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-
T ss_pred EccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-
Confidence 9999999764332 223456778999999999999999999999999999999 999998876655444432100
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.......++..+.+||.+||..||.+|||+.+|++
T Consensus 237 ------------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 237 ------------------------------------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------------------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00112235678999999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=332.64 Aligned_cols=250 Identities=18% Similarity=0.251 Sum_probs=198.7
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCC----cEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTG----MDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TG----r~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
.+...+|++.+.||+|+||.||+|.+..++ ..||||+++... .....+.+|+.+++.+. ||||+++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 113 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS------HHNIIRLEG 113 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC------CTTBCCEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC------CCCCCcEEE
Confidence 344678999999999999999999876553 459999997642 33456778999988885 459999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
++.....+||||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~ 186 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS--NLVC 186 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCE
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECC--CCcE
Confidence 99999999999999986 77777764321 2889999999999999999999999999999999999984 6789
Q ss_pred EEecCCCccccCCCc------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhh
Q 001034 1018 KVIDLGSSCFETDHL------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~~------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~i 1090 (1182)
||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+.+..+...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 266 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence 999999997644321 12345778999999999999999999999999999999 99999888777666555311
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.. . .....++..+.+||.+||+.||.+||++.+++++
T Consensus 267 ~~------------------------------------~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 267 FR------------------------------------L-------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CC------------------------------------C-------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred Cc------------------------------------C-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0 0112457889999999999999999999998864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=322.54 Aligned_cols=244 Identities=19% Similarity=0.248 Sum_probs=195.1
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCc---EEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGM---DVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr---~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.|.+.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+|+.+++.++| |||++++++|....
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH------PNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCC------TTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCC------CCeeeEEEEEecCC
Confidence 57888999999999999999765544 79999997543 344667889999998854 59999999998776
Q ss_pred eE-EEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 945 HL-LIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 945 ~L-yLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.. ++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~--~~~~kl~Df 168 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE--SFTVKVADF 168 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECCT
T ss_pred CCcEEEEecccCCCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CCcEEeCcC
Confidence 65 99999996 578877764322 3788999999999999999999999999999999999984 678999999
Q ss_pred CCccccCC-------CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1023 GSSCFETD-------HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1023 GLA~~~~~-------~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
|+++.... ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+.....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-- 246 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-- 246 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC--
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC--
Confidence 99975432 2234567889999999999999999999999999999999 5556665555444443321100
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.......+..+.+||.+||+.||.+|||+.++++
T Consensus 247 -----------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 -----------------------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -----------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0012235688999999999999999999999886
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=359.68 Aligned_cols=255 Identities=17% Similarity=0.256 Sum_probs=206.1
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
..+.++|+++++||+|+||.||+|++..+++.||||++..... ...+..|+.+++.+.++. +|..+..++....
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~-----~i~~i~~~~~~~~ 76 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGT-----GIPNVRWFGVEGD 76 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTST-----TCCCEEEEEEETT
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCC-----CCCeEEEEEeeCC
Confidence 3567899999999999999999999999999999999876543 346788999999998764 6777777778889
Q ss_pred eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc-CCCceEEEecCC
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS-YSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs-~~dG~IKLiDFG 1023 (1182)
..||||||+.++|.+++..... .+++..++.|+.||+.||.|||++|||||||||+||||+. ...+.+||+|||
T Consensus 77 ~~~lvme~~g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEEEECCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence 9999999998899998875432 2899999999999999999999999999999999999941 146789999999
Q ss_pred CccccCCCc----------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhh
Q 001034 1024 SSCFETDHL----------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP---ATLLARVIGI 1090 (1182)
Q Consensus 1024 LA~~~~~~~----------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~---~elLakIv~i 1090 (1182)
+++...... ...+||+.|+|||++.+..++.++||||||||||+|++|+.||.+... ...+.++...
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence 997644322 256799999999999999999999999999999999999999987433 3333333210
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.. . ..+......++.++.+||.+||..||.+||++.+|++
T Consensus 232 ~~---------------------------------~------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 232 KV---------------------------------A------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HH---------------------------------H------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cc---------------------------------c------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0 0000011234689999999999999999999998765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=329.02 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=196.2
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc-chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe---
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN-KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY--- 942 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~-k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd--- 942 (1182)
..++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+. ||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN------HPNILRLVAYCLRERG 100 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCC------CTTBCCCCEEEEEEET
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcC------CCCeeeEEEEEEeccC
Confidence 357899999999999999999999999999999998654 344567788999998885 4589999999873
Q ss_pred -cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 943 -REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 943 -~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
...+|+||||+.+ +|.+++....... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~--~~~~kl~ 176 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKG--NFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD--EGQPVLM 176 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEEC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCCEEEE
Confidence 3579999999986 7888877643222 24899999999999999999999999999999999999984 6789999
Q ss_pred cCCCccccCCC------------cccccCCCcccchhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH
Q 001034 1021 DLGSSCFETDH------------LCSYVQSRSYRAPEVILGLS---YDKKIDIWSLGCILAELCTGNVLFQNDSPA--TL 1083 (1182)
Q Consensus 1021 DFGLA~~~~~~------------~ss~vGTp~YmAPEVLlg~~---yS~kSDIWSLGVILYELLTGr~PF~g~d~~--el 1083 (1182)
|||++...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... ..
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 256 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence 99998654321 12345799999999997654 789999999999999999999999421000 00
Q ss_pred HHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC
Q 001034 1084 LARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163 (1182)
Q Consensus 1084 LakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT 1163 (1182)
...+. . .... ...+.++..+.+||.+||+.||.+|||
T Consensus 257 ~~~~~----------------------------------~--~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps 293 (317)
T 2buj_A 257 ALAVQ----------------------------------N--QLSI-------PQSPRHSSALWQLLNSMMTVDPHQRPH 293 (317)
T ss_dssp HHHHH----------------------------------C--C--C-------CCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hHHhh----------------------------------c--cCCC-------CccccCCHHHHHHHHHHhhcChhhCCC
Confidence 00000 0 0000 112345789999999999999999999
Q ss_pred HHHHHcC
Q 001034 1164 ASDALKH 1170 (1182)
Q Consensus 1164 AeELLqH 1170 (1182)
+.+|++|
T Consensus 294 ~~~ll~~ 300 (317)
T 2buj_A 294 IPLLLSQ 300 (317)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=339.44 Aligned_cols=206 Identities=17% Similarity=0.263 Sum_probs=172.1
Q ss_pred eecCCEEEEEEeccCCceEEEEE-----EECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQA-----HDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLA-----kDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
+..++|.+.+.||+|+||.||+| .+..+++.||||+++... ...+..|+.+++.+.+. .|++|+++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~---~~~~iv~~~~~~ 136 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPS---MQHMFMKFYSAH 136 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGG---GGGGBCCEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhh---hhhhhhhhheee
Confidence 34578999999999999999999 467889999999997654 34677888888888643 578999999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc--------
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS-------- 1011 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs-------- 1011 (1182)
......||||||+. |+|.+++...... ....+++..++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 99999999999998 5788888754321 1234899999999999999999999999999999999999984
Q ss_pred -CCCceEEEecCCCccccC-----CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001034 1012 -YSRCEVKVIDLGSSCFET-----DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQN 1077 (1182)
Q Consensus 1012 -~~dG~IKLiDFGLA~~~~-----~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g 1077 (1182)
...+.+||+|||+++... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||..
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 115789999999996432 223456899999999999999999999999999999999999999954
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=357.53 Aligned_cols=256 Identities=16% Similarity=0.150 Sum_probs=194.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCC----------CC-----
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDP----------GD----- 929 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~----------l~----- 929 (1182)
..|.+.+.||+|+||.||+|.+..+|+.||||+++... .....+.+|+.+++.+.|... ..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35889999999999999999999999999999998332 234667788888888876310 00
Q ss_pred -CcceEEEEEEEEe-----cCeEEEEEEecccChHHHHhhhcc-cCCccccCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q 001034 930 -KYHLLRLYDYFYY-----REHLLIVCELLKANLYEFHKFNRE-SGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDL 1002 (1182)
Q Consensus 930 -HPnIVkL~dsFqd-----~e~LyLVmEyL~GsLld~Lk~~~~-sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDI 1002 (1182)
.++...++.++.. ...++++|+++.++|.+++..... ......+++..+..++.||+.||.|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 0111111122222 235789999999999988863321 111223778888999999999999999999999999
Q ss_pred CCccEEEccCCCceEEEecCCCccccCCCcccccCCCcccchhhh----------cCCCCCchhhHHHHHHHHHHHHhCC
Q 001034 1003 KPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVI----------LGLSYDKKIDIWSLGCILAELCTGN 1072 (1182)
Q Consensus 1003 KPeNILIDs~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVL----------lg~~yS~kSDIWSLGVILYELLTGr 1072 (1182)
||+||||+. ++.+||+|||+++.........+| +.|+|||++ .+..++.++|||||||++|+|++|+
T Consensus 238 Kp~NILl~~--~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 238 RPVDIVLDQ--RGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp CGGGEEECT--TCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred ccceEEEec--CCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 999999995 677999999999877766677788 999999999 5556889999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHH
Q 001034 1073 VLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152 (1182)
Q Consensus 1073 ~PF~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrk 1152 (1182)
.||...+....+. .. ......++..+.+||.+
T Consensus 315 ~Pf~~~~~~~~~~-----------------------------------------~~-------~~~~~~~~~~~~~li~~ 346 (413)
T 3dzo_A 315 LPNTDDAALGGSE-----------------------------------------WI-------FRSCKNIPQPVRALLEG 346 (413)
T ss_dssp CCCCTTGGGSCSG-----------------------------------------GG-------GSSCCCCCHHHHHHHHH
T ss_pred CCCCCcchhhhHH-----------------------------------------HH-------HhhcccCCHHHHHHHHH
Confidence 9997644211000 00 00112457899999999
Q ss_pred hcccCCCCCCCHHHHHcCCCCCC
Q 001034 1153 LLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1153 MLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
||+.||.+|||+.++|+||||+.
T Consensus 347 ~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 347 FLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HccCChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999964
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=323.35 Aligned_cols=247 Identities=21% Similarity=0.281 Sum_probs=193.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEEC-CCCc--EEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDL-HTGM--DVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk-~TGr--~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
..++|++++.||+|+||.||+|.+. .+++ .||||+++.. ......+.+|+.+++.+. ||||++++++
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~ 89 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD------HRNLIRLYGV 89 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC------CCCcccEEEE
Confidence 4578999999999999999999854 3333 6899998753 234567788999999885 4589999999
Q ss_pred EEecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
+.... .++||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~--~~~~k 161 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT--RDLVK 161 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEE
T ss_pred EccCC-ceeeEecccCCCHHHHHHhccC-----CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcC--CCCEE
Confidence 97654 899999998 578888765432 2889999999999999999999999999999999999984 67899
Q ss_pred EecCCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhc
Q 001034 1019 VIDLGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1019 LiDFGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~il 1091 (1182)
|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+....+..+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 9999998765432 123456788999999999899999999999999999999 999999888777666653111
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
..+ .....++..+.+||.+||..||.+|||+.++++
T Consensus 242 ~~~------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 242 ERL------------------------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCC------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC------------------------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 011345789999999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.81 Aligned_cols=266 Identities=21% Similarity=0.275 Sum_probs=200.8
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
...++|++.+.||+|+||.||+|.+ .+++.||||++.... .....+.+|+.+++.+. ||||++++++|....
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCR------HPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCC------CTTBCCEEEECCCTT
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCC------CCCEeeEEEEEcCCC
Confidence 4568899999999999999999996 578999999987543 34456778888887775 559999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+|+||||+.+ +|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE--NFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECT--TCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECC--CCCEEEeecc
Confidence 99999999985 77766643321 1234889999999999999999999999999999999999984 7789999999
Q ss_pred CccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1024 SSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1024 LA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....+......+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-------- 256 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-------- 256 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT--------
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh--------
Confidence 98753321 23346899999999999999999999999999999999999999764432211110000
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhh-ccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEY-LIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~-liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. .. .....+.. ..+. ......+..+..+.+||.+||+.||.+|||+.++++|
T Consensus 257 -~----------------~~-~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 257 -V----------------ES-HNNGQLEQIVDPN--LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp -H----------------HH-HTTTCCCSSSSSS--CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -h----------------hc-cccccHHHhcChh--hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00 00000000 0000 0001112335789999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=328.44 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=193.6
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.++|++.+.||+|+||.||++.. .++.||||++.... ....+.+|+.+++.++| |||+++++++. +..|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h------p~iv~~~~~~~--~~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-ERKAFIVELRQLSRVNH------PNIVKLYGACL--NPVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-HHHHHHHHHHHHHHCCC------TTBCCEEEBCT--TTTE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-HHHHHHHHHHHHhcCCC------CCcCeEEEEEc--CCcE
Confidence 46899999999999999999986 47899999997543 34677889999999864 48999999875 4589
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh---cCccccccCCccEEEccCCCc-eEEEecC
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG---LGLIHCDLKPENILVKSYSRC-EVKVIDL 1022 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS---~GIIHRDIKPeNILIDs~~dG-~IKLiDF 1022 (1182)
+||||+.+ +|.+++..... ...++...+..++.||+.||.|||+ +||+||||||+|||++. ++ .+||+||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~~kl~Df 150 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICDF 150 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET--TTTEEEECCC
T ss_pred EEEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC--CCCEEEEccc
Confidence 99999975 78887764321 1237888999999999999999999 89999999999999984 44 4899999
Q ss_pred CCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhcCCcchhhhh
Q 001034 1023 GSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSP--ATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1023 GLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~--~elLakIv~ilGp~PeemL~ 1100 (1182)
|++...........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.. +
T Consensus 151 g~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~-------- 220 (307)
T 2eva_A 151 GTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--G-------- 220 (307)
T ss_dssp CC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--T--------
T ss_pred ccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--C--------
Confidence 9998766655667899999999999999999999999999999999999999975322 111111100 0
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc-----CCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK-----HPWLSH 1175 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq-----HPWFk~ 1175 (1182)
........++..+.+||.+||+.||.+|||+.++++ .++|..
T Consensus 221 ---------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 221 ---------------------------------TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ---------------------------------CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ---------------------------------CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 000112345788999999999999999999999988 356655
Q ss_pred CCCC
Q 001034 1176 PYEP 1179 (1182)
Q Consensus 1176 ~~eP 1179 (1182)
..+|
T Consensus 268 ~~~~ 271 (307)
T 2eva_A 268 ADEP 271 (307)
T ss_dssp TTSC
T ss_pred CCCc
Confidence 5444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.92 Aligned_cols=272 Identities=21% Similarity=0.248 Sum_probs=201.4
Q ss_pred eeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch--hhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 861 VVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD--FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 861 V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~--~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
........++|++.+.||+|+||.||+|.+ .+++.||||++..... ....+.+|+.+++.+. ||||+++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~ 94 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNLLRLRG 94 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCC------CTTBCCCCE
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhcc------CCCccceEE
Confidence 333445678999999999999999999984 5789999999976432 2235677888877765 559999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc---CccccccCCccEEEccCCC
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGL---GLIHCDLKPENILVKSYSR 1014 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~---GIIHRDIKPeNILIDs~~d 1014 (1182)
+|......++||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+. ||+||||||+|||++. +
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~--~ 170 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE--E 170 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT--T
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC--C
Confidence 99999999999999986 777777654322 23488999999999999999999999 9999999999999984 6
Q ss_pred ceEEEecCCCccccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHH
Q 001034 1015 CEVKVIDLGSSCFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS----PATLLAR 1086 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d----~~elLak 1086 (1182)
+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+..
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 78999999999764322 234568999999999999899999999999999999999999995210 0000000
Q ss_pred HHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 001034 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASD 1166 (1182)
Q Consensus 1087 Iv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeE 1166 (1182)
.+ .... ....+..... ...........+..+.+||.+||+.||.+|||+.+
T Consensus 251 ~~-----------~~~~-----------------~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 301 (326)
T 3uim_A 251 WV-----------KGLL-----------------KEKKLEALVD-VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301 (326)
T ss_dssp HH-----------TTTT-----------------SSCCSTTSSC-TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred HH-----------HHHh-----------------hchhhhhhcC-hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHH
Confidence 00 0000 0000000000 00000111123478999999999999999999999
Q ss_pred HHcCCC
Q 001034 1167 ALKHPW 1172 (1182)
Q Consensus 1167 LLqHPW 1172 (1182)
||+|-+
T Consensus 302 ll~~L~ 307 (326)
T 3uim_A 302 VVRMLE 307 (326)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999743
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=324.30 Aligned_cols=245 Identities=20% Similarity=0.237 Sum_probs=194.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCC---CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE-e
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHT---GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY-Y 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~T---Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq-d 942 (1182)
.+|++.+.||+|+||.||+|.+..+ ...+|+|++.... .....+.+|+.+++.++| |||+++++++. .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~ 98 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH------PNVLSLLGICLRS 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCC------TTBCCCCEEECCS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCC------CCEeeeeeEEEcC
Confidence 5699999999999999999997543 3468999987543 345667889999998864 58999999864 4
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
....|+||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~--~~~~~kl~D 171 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD--EKFTVKVAD 171 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--TTCCEEECS
T ss_pred CCceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC--CCCCEEECc
Confidence 5688999999986 78887764322 378899999999999999999999999999999999998 477899999
Q ss_pred CCCccccCCC-------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1022 LGSSCFETDH-------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1022 FGLA~~~~~~-------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp 1093 (1182)
||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+......
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC
Confidence 9999754332 233456788999999999999999999999999999999 67778766554444443211000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.....++..+.+||.+||..||.+|||+.++++
T Consensus 252 -------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 -------------------------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011234678999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=342.84 Aligned_cols=248 Identities=19% Similarity=0.267 Sum_probs=193.7
Q ss_pred eecCCEEEEEEeccCCceEEEEEEEC---CCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
+...+|.+.+.||+|+||.||+|++. .++..||||+++.. ......+.+|+.+++.+. ||||+++++++
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~ 115 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD------HPNIIRLEGVV 115 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEE
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEE
Confidence 34568999999999999999999876 46778999999754 234456788999988885 45999999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
.....+||||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kl 188 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS--NLVCKV 188 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEE
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC--CCCEEE
Confidence 99999999999997 578887764321 3889999999999999999999999999999999999984 678999
Q ss_pred ecCCCccccCCCc------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcC
Q 001034 1020 IDLGSSCFETDHL------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1020 iDFGLA~~~~~~~------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilG 1092 (1182)
+|||+++...... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+....+..+.....
T Consensus 189 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~ 268 (373)
T 2qol_A 189 SDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR 268 (373)
T ss_dssp CCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE
T ss_pred CcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999997654321 12234678999999999999999999999999999998 9999988887766655521100
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. .....++..+.+||.+||+.||.+||++.+|++
T Consensus 269 ------------------------------------~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 269 ------------------------------------L-------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ------------------------------------C-------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------------C-------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0 011235688999999999999999999999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=347.40 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=204.5
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..++|++.+.||+|+||.||+|.+.. +..||||+++......+.+.+|+.+++.++| |||+++++++.. ..+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH------EKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCC------TTBCCEEEEECS-SSC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCC------CCEeeEEEEEcC-Cce
Confidence 34679999999999999999999864 4679999998766556778999999999865 489999999865 789
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
||||||+.+ +|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a 327 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLA 327 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCCTT
T ss_pred EEEehhhcCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECC--CCCEEECCCccc
Confidence 999999984 88888865322 12889999999999999999999999999999999999984 678999999999
Q ss_pred cccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+...... ....+++.|+|||++.+..++.++|||||||+||+|++ |..||.+....+.+..+.....
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------- 399 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-------- 399 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 7654321 23356788999999999999999999999999999999 9999998887776666531100
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc--CCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK--HPWLSH 1175 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq--HPWFk~ 1175 (1182)
. .....++..+.+||.+||+.||.+|||+.+|++ +.+|+.
T Consensus 400 ----------------------------~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 400 ----------------------------M-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ----------------------------C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----------------------------C-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 0 011245788999999999999999999999988 466654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=330.27 Aligned_cols=262 Identities=22% Similarity=0.252 Sum_probs=198.6
Q ss_pred ceecCCE-EEEEEeccCCceEEEEEE----ECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 865 SVIAGRY-HVTEYLGSAAFSKAIQAH----DLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 865 ~iL~drY-eIlk~LGkGaFGeVyLAk----Dk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
.++.++| ++++.||+|+||.||++. +..+++.||||+++... .....+.+|+.+++.++| |||++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~ 99 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH------EHIIKYK 99 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC------TTBCCEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCC------cchhhEE
Confidence 4566777 999999999999998875 44589999999998653 345667889999999864 4899999
Q ss_pred EEEEec--CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC
Q 001034 938 DYFYYR--EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR 1014 (1182)
Q Consensus 938 dsFqd~--e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d 1014 (1182)
+++... ..+|+||||+.+ +|.+++.... +++..++.++.||+.||.|||+.||+||||||+|||++. +
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~--~ 170 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN--D 170 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGGSC-------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--T
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhhCC-------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcC--C
Confidence 999984 689999999985 7777765432 889999999999999999999999999999999999984 6
Q ss_pred ceEEEecCCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 001034 1015 CEVKVIDLGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv 1088 (1182)
+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...... .....
T Consensus 171 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~ 248 (318)
T 3lxp_A 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK--FLELI 248 (318)
T ss_dssp CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHH
T ss_pred CCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh--hhhhh
Confidence 78999999999765432 23446788899999999999999999999999999999999999653221 11111
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
+...... . . ......+. ..........++..+.+||++||+.||.+|||+.+|+
T Consensus 249 ---~~~~~~~-~---------------~--~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 302 (318)
T 3lxp_A 249 ---GIAQGQM-T---------------V--LRLTELLE-----RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI 302 (318)
T ss_dssp ---CSCCHHH-H---------------H--HHHHHHHH-----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---cccccch-h---------------H--HHHHHHHh-----cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 0000000 0 0 00000000 0001112345678999999999999999999999998
Q ss_pred c
Q 001034 1169 K 1169 (1182)
Q Consensus 1169 q 1169 (1182)
+
T Consensus 303 ~ 303 (318)
T 3lxp_A 303 P 303 (318)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=328.81 Aligned_cols=260 Identities=20% Similarity=0.239 Sum_probs=200.5
Q ss_pred ccceeeeCceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEE
Q 001034 857 KNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL 936 (1182)
Q Consensus 857 ~~f~V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL 936 (1182)
...++..+..+.++|++.+.||+|+||.||+|++ +++.||||++.... ......|..++..+. ..||||+++
T Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~----l~h~ni~~~ 101 (342)
T 1b6c_B 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVM----LRHENILGF 101 (342)
T ss_dssp SSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSC----CCCTTBCCE
T ss_pred CCCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhh----cCCCcEEEE
Confidence 3556666777889999999999999999999987 58999999997543 355677888887743 246799999
Q ss_pred EEEEEecC----eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHH--------hcCccccccC
Q 001034 937 YDYFYYRE----HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH--------GLGLIHCDLK 1003 (1182)
Q Consensus 937 ~dsFqd~e----~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLH--------S~GIIHRDIK 1003 (1182)
++++.... .+|+||||+.+ +|.+++... .+++..++.++.||+.||.||| +.+|+|||||
T Consensus 102 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk 174 (342)
T 1b6c_B 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174 (342)
T ss_dssp EEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCS
T ss_pred EeeecccCCccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCC
Confidence 99998876 89999999986 888887642 2889999999999999999999 8999999999
Q ss_pred CccEEEccCCCceEEEecCCCccccCCC-------cccccCCCcccchhhhcCCC------CCchhhHHHHHHHHHHHHh
Q 001034 1004 PENILVKSYSRCEVKVIDLGSSCFETDH-------LCSYVQSRSYRAPEVILGLS------YDKKIDIWSLGCILAELCT 1070 (1182)
Q Consensus 1004 PeNILIDs~~dG~IKLiDFGLA~~~~~~-------~ss~vGTp~YmAPEVLlg~~------yS~kSDIWSLGVILYELLT 1070 (1182)
|+|||++. ++.+||+|||++...... ....++|+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 175 p~NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t 252 (342)
T 1b6c_B 175 SKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252 (342)
T ss_dssp GGGEEECT--TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHEEECC--CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence 99999984 678999999999754432 24457899999999998763 3478999999999999999
Q ss_pred C----------CCCCCCCC-----HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcccccccc
Q 001034 1071 G----------NVLFQNDS-----PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSL 1135 (1182)
Q Consensus 1071 G----------r~PF~g~d-----~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL 1135 (1182)
| ..||.... .......+... .+...+|..
T Consensus 253 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~--- 296 (342)
T 1b6c_B 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ---------------------------------KLRPNIPNR--- 296 (342)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS---------------------------------CCCCCCCGG---
T ss_pred ccCcCCcccccccCccccCcCcccHHHHHHHHHHH---------------------------------HhCCCCccc---
Confidence 9 67775532 11111111100 000000000
Q ss_pred ccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1136 RHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1136 ~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.........+.+||.+||+.||.+|||+.+|++|
T Consensus 297 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 297 -WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp -GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred -ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 0011224678999999999999999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=346.32 Aligned_cols=254 Identities=20% Similarity=0.187 Sum_probs=188.9
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---------hhhHHHHHHHHHHHHhcCCC---CCCCcceE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---------DFFDQSLDEIKLLKYVNKHD---PGDKYHLL 934 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---------~~~dq~l~EikILr~L~h~~---~l~HPnIV 934 (1182)
..++|++++.||+|+||+||+|++ +++.||||+++... .....+.+|+.+++.+.... ...|+||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999997 78999999998652 22367788999988886321 12355666
Q ss_pred EEEEEEE-----------------e-------------cCeEEEEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHH
Q 001034 935 RLYDYFY-----------------Y-------------REHLLIVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITI 983 (1182)
Q Consensus 935 kL~dsFq-----------------d-------------~e~LyLVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~ 983 (1182)
++.+.+. . ..++||||||+.++ +++.+.. ..+++..++.|+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~ 168 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILH 168 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHH
Confidence 6666543 2 67899999999754 6665532 1279999999999
Q ss_pred HHHHHHHHHH-hcCccccccCCccEEEccCC------------------CceEEEecCCCccccCCCcccccCCCcccch
Q 001034 984 QCLEALQFLH-GLGLIHCDLKPENILVKSYS------------------RCEVKVIDLGSSCFETDHLCSYVQSRSYRAP 1044 (1182)
Q Consensus 984 QILsALeYLH-S~GIIHRDIKPeNILIDs~~------------------dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAP 1044 (1182)
||+.||.||| ++||+||||||+||||+..+ ...+||+|||+++..... ..+||+.|+||
T Consensus 169 qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aP 246 (336)
T 2vuw_A 169 QLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCS
T ss_pred HHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccCh
Confidence 9999999999 99999999999999999632 128999999999876543 45899999999
Q ss_pred hhhcCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcch
Q 001034 1045 EVILGLSYDKKIDIWSLGCI-LAELCTGNVLFQNDSP-ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQET 1122 (1182)
Q Consensus 1045 EVLlg~~yS~kSDIWSLGVI-LYELLTGr~PF~g~d~-~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~et 1122 (1182)
|++.+.. +.++|||||+++ .+++++|..||.+... ......++......
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------- 297 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK---------------------------- 297 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS----------------------------
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC----------------------------
Confidence 9998776 899999998777 7888999999843211 11111221000000
Q ss_pred hhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH-cCCCCC
Q 001034 1123 NRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL-KHPWLS 1174 (1182)
Q Consensus 1123 s~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL-qHPWFk 1174 (1182)
........+.++.++++||++||++| ||.||| +||||+
T Consensus 298 ---------~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 298 ---------TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ---------SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ---------cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 00000001124678999999999987 999999 999996
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=325.73 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=194.8
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc-----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN-----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~-----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
|...+.||+|+||.||+|.. +++.||||++... ......+.+|+.+++.+.| |||+++++++.....
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~~ 104 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH------ENLVELLGFSSDGDD 104 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC------TTBCCEEEEECSSSS
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC------CCeEEEEEEEecCCc
Confidence 33446899999999999985 6889999999753 2345677889999999864 489999999999999
Q ss_pred EEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+|+||||+. ++|.+++...... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~Dfg~ 179 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE--AFTAKISDFGL 179 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTGGGC---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCTT
T ss_pred eEEEEEecCCCcHHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC--CCcEEEeeccc
Confidence 999999997 5788877654321 23889999999999999999999999999999999999984 67899999999
Q ss_pred ccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1025 SCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1025 A~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||........+..+.........
T Consensus 180 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 255 (307)
T 2nru_A 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK--- 255 (307)
T ss_dssp CEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC---
T ss_pred ccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh---
Confidence 8754432 234578999999999875 5889999999999999999999999765433222222111000000
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.+...+.. .+.......+..+.+||.+||+.||.+|||+.+|+++
T Consensus 256 ------------------------~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 256 ------------------------TIEDYIDK--KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ------------------------CHHHHSCS--SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------------------hhhhhccc--cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000000 0011112235679999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=351.15 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=208.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
..++|++.+.||+|+||.||+|.+.. +..||||+++......+.+.+|+.+|+.++|+ ||+++++++.. ..+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE------KLVQLYAVVSE-EPI 336 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCT------TBCCEEEEECS-SSC
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCC------CEeeEEEEEee-ccc
Confidence 45679999999999999999999864 46799999987665567889999999998654 89999999865 789
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
||||||+.+ +|.+++...... .+++..+..|+.||+.||.|||+++||||||||+||||+. ++.+||+|||++
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a 410 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLA 410 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCTTST
T ss_pred eEeeehhcCCcHHHHHhhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcC--CCcEEEcccccc
Confidence 999999985 888888654221 2888999999999999999999999999999999999984 678999999999
Q ss_pred cccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+..... .....++..|+|||++.+..++.++|||||||+||+|++ |+.||.+....+++..+.....
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------- 482 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-------- 482 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC--------
T ss_pred eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 865432 223456788999999999999999999999999999999 9999998887776665531100
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC--CCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH--PWLSH 1175 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH--PWFk~ 1175 (1182)
. .....++..+.+||.+||+.||.+|||+.+|++. .+|..
T Consensus 483 ----------------------------~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 483 ----------------------------M-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ----------------------------C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ----------------------------C-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 0 0112457889999999999999999999999884 66653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.10 Aligned_cols=263 Identities=22% Similarity=0.262 Sum_probs=199.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEE----ECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAH----DLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAk----Dk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
...+|++++.||+|+||.||+|. +..+++.||||++.... .....+.+|+.+++.++| |||+++++++.
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~ 112 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH------DNIVKYKGVCY 112 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCC------TTBCCEEEEEC
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCC------CCeeeEEEEEE
Confidence 45679999999999999999998 46789999999997643 345677889999998854 58999999987
Q ss_pred ecC--eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 942 YRE--HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 942 d~e--~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
... .+++||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~--~~~~k 185 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN--ENRVK 185 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEE
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcC--CCcEE
Confidence 653 78999999985 88888765432 2889999999999999999999999999999999999984 67899
Q ss_pred EecCCCccccCCCc------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1019 VIDLGSSCFETDHL------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1019 LiDFGLA~~~~~~~------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+. .+
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~--~~~~~~---~~ 260 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--AEFMRM---IG 260 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHHHHH---HC
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH--HHHHHh---hc
Confidence 99999997654321 23456778999999999899999999999999999999999986421 111111 11
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
...... ... .......... ........++..+.+||.+||..||.+|||+.+|++
T Consensus 261 ~~~~~~----------------~~~----~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 261 NDKQGQ----------------MIV----FHLIELLKNN--GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp TTCCTH----------------HHH----HHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccchh----------------hhH----HHHHHHhhcC--CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 110000 000 0000000000 001123456789999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.40 Aligned_cols=247 Identities=18% Similarity=0.297 Sum_probs=195.3
Q ss_pred CceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 864 g~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
..+..++|++.+.||+|+||.||+|.+.. .+|+|++.... .....+.+|+.+++.+. |+||+++++++
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~ 98 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTR------HENVVLFMGAC 98 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCC------CTTBCCCCEEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCC------CCCEeEEEEEE
Confidence 34556889999999999999999998754 49999987542 22344556777777664 55999999999
Q ss_pred EecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 941 YYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 941 qd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
.....+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~---~~~~~l 170 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD---NGKVVI 170 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEE
T ss_pred ecCCceEEEeecccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe---CCCEEE
Confidence 999999999999984 6777765432 2388899999999999999999999999999999999998 467999
Q ss_pred ecCCCccccC--------CCcccccCCCcccchhhhcC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 001034 1020 IDLGSSCFET--------DHLCSYVQSRSYRAPEVILG---------LSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082 (1182)
Q Consensus 1020 iDFGLA~~~~--------~~~ss~vGTp~YmAPEVLlg---------~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~e 1082 (1182)
+|||++.... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 250 (319)
T 2y4i_B 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250 (319)
T ss_dssp CCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH
T ss_pred eecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999976532 12234568899999999975 458899999999999999999999999888776
Q ss_pred HHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC
Q 001034 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162 (1182)
Q Consensus 1083 lLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP 1162 (1182)
.+..+.....+ . .....++..+.+||.+||..||.+||
T Consensus 251 ~~~~~~~~~~~-------------------------------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rp 288 (319)
T 2y4i_B 251 IIWQMGTGMKP-------------------------------------N-----LSQIGMGKEISDILLFCWAFEQEERP 288 (319)
T ss_dssp HHHHHHTTCCC-------------------------------------C-----CCCSSCCTTHHHHHHHHHCSSTTTSC
T ss_pred HHHHhccCCCC-------------------------------------C-----CCcCCCCHHHHHHHHHHhcCChhhCc
Confidence 66555311000 0 00113467799999999999999999
Q ss_pred CHHHHHc
Q 001034 1163 SASDALK 1169 (1182)
Q Consensus 1163 TAeELLq 1169 (1182)
|+.+|++
T Consensus 289 t~~~l~~ 295 (319)
T 2y4i_B 289 TFTKLMD 295 (319)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=348.49 Aligned_cols=245 Identities=18% Similarity=0.228 Sum_probs=196.8
Q ss_pred cCCEEEEE-EeccCCceEEEEEEEC--CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 868 AGRYHVTE-YLGSAAFSKAIQAHDL--HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 868 ~drYeIlk-~LGkGaFGeVyLAkDk--~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.++|.+.+ .||+|+||.||+|..+ .++..||||+++... .....+.+|+.+++.++ |||||+++++|..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~------hpniv~l~~~~~~ 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD------NPYIVRLIGVCQA 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC------CTTBCCEEEEEES
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC------CCCEeeEEEEecc
Confidence 45677776 8999999999999865 456779999998642 34567889999998885 4599999999976
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..+||||||+.+ +|.+++.... ..+++..+..|+.||+.||.|||++|||||||||+||||+. ++.+||+|
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~vkL~D 479 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN--RHYAKISD 479 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcC--CCcEEEee
Confidence 679999999986 6777765332 13899999999999999999999999999999999999994 67899999
Q ss_pred CCCccccCCCc------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1022 LGSSCFETDHL------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1022 FGLA~~~~~~~------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
||+++...... ....+++.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+++..+.....
T Consensus 480 FGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-- 557 (613)
T 2ozo_A 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-- 557 (613)
T ss_dssp CSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC--
T ss_pred ccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--
Confidence 99997653221 12344688999999999999999999999999999998 9999998877776655531000
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
......++..+.+||.+||..||.+||++.+|++
T Consensus 558 -----------------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 -----------------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -----------------------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -----------------------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0011245789999999999999999999999854
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=335.11 Aligned_cols=246 Identities=20% Similarity=0.240 Sum_probs=186.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCC---CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe-
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHT---GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY- 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~T---Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd- 942 (1182)
..|++.+.||+|+||.||+|....+ ...||+|+++... .....+.+|+.+++.+. ||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS------HPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCC------CTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEEcC
Confidence 3589999999999999999987543 3468999987532 34456677777777664 5699999998654
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
....|+||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kL~D 235 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVAD 235 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECC
T ss_pred CCCeEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECC--CCCEEEee
Confidence 4688999999985 78888764322 2788899999999999999999999999999999999984 67899999
Q ss_pred CCCccccCCC-------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1022 LGSSCFETDH-------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1022 FGLA~~~~~~-------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp 1093 (1182)
||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~- 314 (373)
T 3c1x_A 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR- 314 (373)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-
T ss_pred ccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-
Confidence 9999754322 123456788999999999999999999999999999999 7888876554443333321000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
......++..+.+||.+||..||.+|||+.+++++
T Consensus 315 ------------------------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 ------------------------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112357889999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=350.02 Aligned_cols=241 Identities=19% Similarity=0.240 Sum_probs=195.4
Q ss_pred EEEE-EEeccCCceEEEEEEE--CCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 871 YHVT-EYLGSAAFSKAIQAHD--LHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 871 YeIl-k~LGkGaFGeVyLAkD--k~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
+.+. +.||+|+||.||+|.. +.+++.||||+++... .....+.+|+.+++.++| ||||++++++. ..
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l~~~~~-~~ 442 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN------PYIVRMIGICE-AE 442 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCC------TTBCCEEEEEE-SS
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC------CCEeeEEEEEe-cC
Confidence 4443 4899999999999954 5677899999998643 335678899999999864 49999999986 45
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.++|||||+.+ +|.+++.... .+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~--~~~~kL~DFG 514 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDFG 514 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECCTT
T ss_pred CEEEEEEccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC--CCCEEEEEcC
Confidence 68999999985 6777775432 2889999999999999999999999999999999999995 6789999999
Q ss_pred CccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1024 SSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1024 LA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
+++..... .....+|+.|+|||++.+..++.++|||||||+||+|++ |+.||.+.+..++...+.....
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---- 590 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---- 590 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence 98754322 223345788999999999999999999999999999998 9999999888777666631100
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
......++..+.+||.+||+.||.+|||+.+|++
T Consensus 591 ---------------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 ---------------------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ---------------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0011245789999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=367.04 Aligned_cols=282 Identities=19% Similarity=0.272 Sum_probs=203.6
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
....++|++.+.||.|+||.||+|.+..+|+.||||+++.. ......+.+|+.+++.++| |||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H------pnIV~l~~v~~~ 83 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH------PNVVSAREVPDG 83 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCB------TTBCCEEECCTT
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCC------CCCCceeeeecc
Confidence 34458999999999999999999999999999999998754 3345667889999999864 589999998765
Q ss_pred ------cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC-C
Q 001034 943 ------REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-R 1014 (1182)
Q Consensus 943 ------~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~-d 1014 (1182)
....|+||||+. ++|.+++...... ..+++..++.++.||+.||.|||+.||+||||||+|||++..+ .
T Consensus 84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~---~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp TCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT---TCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSS
T ss_pred cccccCCCeEEEEEEeCCCCCHHHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCc
Confidence 678899999996 4788877654321 2388889999999999999999999999999999999998532 2
Q ss_pred ceEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1015 CEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
..+||+|||++...... ....++|+.|+|||++.+..++.++|||||||++|+|++|..||........+ ..
T Consensus 161 ~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~------~~ 234 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW------HG 234 (676)
T ss_dssp CEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHS------ST
T ss_pred eeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhh------hh
Confidence 35999999999865432 34568899999999999999999999999999999999999999875433211 11
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
...... ......+ ........+....|. .......++..+.+||.+||.+||.+|||+.++|+|||
T Consensus 235 ~i~~~~----~~~~~~~-------~~l~g~~~~~~~lp~---p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~ 300 (676)
T 3qa8_A 235 KVREKS----NEHIVVY-------DDLTGAVKFSSVLPT---PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300 (676)
T ss_dssp TCC----------CCSC-------CCCSSSCCCCSSSCC---SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred hhhccc----chhhhhh-------hhhccccccccccCC---chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence 100000 0000000 000000000000010 11122345789999999999999999999999999999
Q ss_pred CCC
Q 001034 1173 LSH 1175 (1182)
Q Consensus 1173 Fk~ 1175 (1182)
|+.
T Consensus 301 F~~ 303 (676)
T 3qa8_A 301 FQA 303 (676)
T ss_dssp HHH
T ss_pred HHH
Confidence 964
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=345.70 Aligned_cols=247 Identities=21% Similarity=0.286 Sum_probs=201.1
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCC---CcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHT---GMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~T---Gr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
+..++|++.+.||+|+||.||+|.+..+ +..||||+++... .....+.+|+.+++.+.| |||+++++++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~H------pnIv~l~~~~ 460 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH------PHIVKLIGVI 460 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCC------TTBCCEEEEE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCC------CCCCeEEEEE
Confidence 4467899999999999999999998654 4679999987532 334677889999998854 5999999998
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
. ...+|+||||+. |+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~--~~~vkL 532 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVKL 532 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEE
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeC--CCCEEE
Confidence 4 567999999998 578877764432 2889999999999999999999999999999999999995 678999
Q ss_pred ecCCCccccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCc
Q 001034 1020 IDLGSSCFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPI 1094 (1182)
Q Consensus 1020 iDFGLA~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~ 1094 (1182)
+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+.+..+.....
T Consensus 533 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~-- 610 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-- 610 (656)
T ss_dssp CCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC--
T ss_pred EecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--
Confidence 9999997654332 23456789999999999999999999999999999997 9999998888777666531100
Q ss_pred chhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1095 PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
....+.++..+.+||.+||..||.+|||+.+|++
T Consensus 611 -----------------------------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 611 -----------------------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -----------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0012345789999999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=352.22 Aligned_cols=245 Identities=19% Similarity=0.291 Sum_probs=196.4
Q ss_pred eeeCceecCCEEEEEEeccCCceEEEEEEECC-CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 861 VVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLH-TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 861 V~ig~iL~drYeIlk~LGkGaFGeVyLAkDk~-TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
+..+.++.++|++.+.||+|+||.||+|.+.. +++.||||++.... .....+..|+.+++.++ ||||++++
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~ 145 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV------HPSIVQIF 145 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCC------CTTBCCEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcC------CCCcCeEe
Confidence 34567888999999999999999999999976 79999999986542 33456677888888775 55999999
Q ss_pred EEEEecCe-----EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc
Q 001034 938 DYFYYREH-----LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011 (1182)
Q Consensus 938 dsFqd~e~-----LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs 1011 (1182)
++|..... +||||||+.| +|.+++.. .+++..++.|+.||+.||.|||++|||||||||+|||++.
T Consensus 146 ~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~ 217 (681)
T 2pzi_A 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE 217 (681)
T ss_dssp EEEEEECTTSCEEEEEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS
T ss_pred eeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC
Confidence 99998765 7999999986 55544321 3899999999999999999999999999999999999984
Q ss_pred CCCceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 001034 1012 YSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGII 1091 (1182)
Q Consensus 1012 ~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~il 1091 (1182)
+.+||+|||+++..... ...+||+.|+|||++.+.. +.++||||||||||+|++|.+||.+...
T Consensus 218 ---~~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~----------- 281 (681)
T 2pzi_A 218 ---EQLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV----------- 281 (681)
T ss_dssp ---SCEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-----------
T ss_pred ---CcEEEEecccchhcccC-CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-----------
Confidence 37999999999876544 5568999999999997654 8999999999999999999998864110
Q ss_pred CCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 001034 1092 GPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHP 1171 (1182)
Q Consensus 1092 Gp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHP 1171 (1182)
..++. ..+. ...+..+.+||.+||++||.+||++.++|.|+
T Consensus 282 ~~~~~-------------------------------~~~~--------~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 322 (681)
T 2pzi_A 282 DGLPE-------------------------------DDPV--------LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322 (681)
T ss_dssp SSCCT-------------------------------TCHH--------HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred ccccc-------------------------------cccc--------cccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence 00000 0000 01146789999999999999999999999888
Q ss_pred CCC
Q 001034 1172 WLS 1174 (1182)
Q Consensus 1172 WFk 1174 (1182)
|+.
T Consensus 323 l~~ 325 (681)
T 2pzi_A 323 LTG 325 (681)
T ss_dssp HHH
T ss_pred HHH
Confidence 763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=306.01 Aligned_cols=232 Identities=17% Similarity=0.117 Sum_probs=181.0
Q ss_pred eeeeCc-eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceE
Q 001034 860 HVVLNS-VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLL 934 (1182)
Q Consensus 860 ~V~ig~-iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIV 934 (1182)
.+..+. ++.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.++..+. ||||+
T Consensus 21 ~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------hp~iv 94 (286)
T 3uqc_A 21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID------KPGVA 94 (286)
T ss_dssp CCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC------CTTBC
T ss_pred cCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC------CCCcc
Confidence 345566 77899999999999999999999999999999999998653 33466778888887775 45999
Q ss_pred EEEEEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC
Q 001034 935 RLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013 (1182)
Q Consensus 935 kL~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~ 1013 (1182)
++++++.....+||||||+.| +|.+++... .....+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~-- 164 (286)
T 3uqc_A 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI-- 164 (286)
T ss_dssp CEEEEEEETTEEEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET--
T ss_pred eeeEEEEECCcEEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC--
Confidence 999999999999999999985 677776421 345568889999999999999999999999999999994
Q ss_pred CceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1014 RCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
++.+||++++ |++ +++.++|||||||++|+|++|+.||.+.+....+...
T Consensus 165 ~g~~kl~~~~-----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------ 214 (286)
T 3uqc_A 165 DGDVVLAYPA-----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------ 214 (286)
T ss_dssp TSCEEECSCC-----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------
T ss_pred CCCEEEEecc-----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------
Confidence 6779998543 333 3789999999999999999999999775421100000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. . .+... ........+.++..+.+||.+||+.||.+| |+.++++
T Consensus 215 ---------~---~----------------~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 215 ---------E---R----------------DTAGQ---PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp ---------C---B----------------CTTSC---BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred ---------H---H----------------HhccC---CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 0 0 00000 000111234567899999999999999999 9999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-28 Score=286.27 Aligned_cols=183 Identities=19% Similarity=0.065 Sum_probs=128.7
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEeccc-----------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-----------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-----------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.++.|++|.+..++....|+.||||++.+.. .....+.+|+.+|+++.+ |+||++++++|++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~-----~~~i~~~~~~~ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPA-----GFDAPAVLAHGENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCT-----TCCCCCEEEEEECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCC-----CCCeeEEEEEEEECC
Confidence 3567888888887777889999999997642 234567889999998853 459999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+||||||++| +|.+++..... ++. ..|+.||+.||.|||++|||||||||+||||+. +|.+||+|||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~------l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~--dg~vKL~DFG 384 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEE------IDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDA--RQHARLIDFG 384 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCC------CCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECT--TSCEEECCCT
T ss_pred EEEEEEecCCCCcHHHHHHhCCC------CCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECC--CCCEEEeecc
Confidence 99999999997 67777764432 444 358899999999999999999999999999984 7789999999
Q ss_pred CccccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001034 1024 SSCFETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLF 1075 (1182)
Q Consensus 1024 LA~~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF 1075 (1182)
+|+.... ...+.+||+.|+|||++.+. +..++|+||+|+++|+|+++..+|
T Consensus 385 lAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 385 SIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp TEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred cCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 9976543 24467899999999999764 677899999999999887776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.7e-23 Score=239.51 Aligned_cols=178 Identities=15% Similarity=0.131 Sum_probs=138.6
Q ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 872 HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 872 eIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
...+.||+|+||.||++. ..++.+++|...... .....+.+|+.+++.++|+ ||+++..++..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~------nIv~~~~~~~~ 410 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDF------GIPAPYIFDVD 410 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGG------TCCCCCEEEEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCC------CcCceEEEEEe
Confidence 445789999999999994 567899999875432 1134468999999999654 89965555567
Q ss_pred cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
..+.||||||+. ++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~D 472 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIID 472 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECC
T ss_pred CCccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEE
Confidence 788899999998 577776553 4578999999999999999999999999999994 799999
Q ss_pred CCCccccCCC----------cccccCCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 001034 1022 LGSSCFETDH----------LCSYVQSRSYRAPEVILG--LSYDKKIDIWSLGCILAELCTGNVLF 1075 (1182)
Q Consensus 1022 FGLA~~~~~~----------~ss~vGTp~YmAPEVLlg--~~yS~kSDIWSLGVILYELLTGr~PF 1075 (1182)
||+++..... ....+||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999876542 235689999999999987 56888899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.7e-20 Score=202.47 Aligned_cols=143 Identities=19% Similarity=0.217 Sum_probs=112.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-------------------hhHHHHHHHHHHHHhcCCCCCC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-------------------FFDQSLDEIKLLKYVNKHDPGD 929 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-------------------~~dq~l~EikILr~L~h~~~l~ 929 (1182)
..|.+.+.||.|+||.||+|.+ .+|+.||||+++.... ....+.+|+.+++.+.+
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~----- 163 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG----- 163 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-----
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-----
Confidence 3466779999999999999999 8899999999975321 23467889999999972
Q ss_pred CcceEEEEEEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEE
Q 001034 930 KYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008 (1182)
Q Consensus 930 HPnIVkL~dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNIL 1008 (1182)
++++.+++ ..+.|+||||+.| +|.+ +. . .....++.||+.||.|||++||+||||||+|||
T Consensus 164 -~~v~~~~~----~~~~~lvmE~~~g~~L~~-l~----------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NIL 225 (282)
T 1zar_A 164 -LAVPKVYA----WEGNAVLMELIDAKELYR-VR----------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL 225 (282)
T ss_dssp -SSSCCEEE----EETTEEEEECCCCEEGGG-CC----------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred -CCcCeEEe----ccceEEEEEecCCCcHHH-cc----------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEE
Confidence 24554433 3567999999986 5654 21 1 234579999999999999999999999999999
Q ss_pred EccCCCceEEEecCCCccccCCCcccccCCCcccchhhhc
Q 001034 1009 VKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVIL 1048 (1182)
Q Consensus 1009 IDs~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLl 1048 (1182)
++ ++.+||+|||+++. +..++|||++.
T Consensus 226 l~---~~~vkl~DFG~a~~----------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS---EEGIWIIDFPQSVE----------VGEEGWREILE 252 (282)
T ss_dssp EE---TTEEEECCCTTCEE----------TTSTTHHHHHH
T ss_pred EE---CCcEEEEECCCCeE----------CCCCCHHHHHH
Confidence 98 67899999999863 44578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=4.4e-18 Score=180.48 Aligned_cols=137 Identities=18% Similarity=0.218 Sum_probs=105.6
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcE--EEEEEEeccchh-------------------------hHHHHHHHHHHHHhc
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMD--VCVKIIKNNKDF-------------------------FDQSLDEIKLLKYVN 923 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~--VAVKIIkk~k~~-------------------------~dq~l~EikILr~L~ 923 (1182)
|.+.+.||.|+||.||+|.+..+|+. ||||+++..... ...+..|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998788999 999998654211 125678999999998
Q ss_pred CCCCCCCcceEEEEEEEEecCeEEEEEEeccc------ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHH-hcC
Q 001034 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKA------NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH-GLG 996 (1182)
Q Consensus 924 h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~G------sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLH-S~G 996 (1182)
+.. ..+|.++ .. ...||||||+++ .|.++... +++..+..++.||+.||.||| ++|
T Consensus 129 ~~~-i~~p~~~---~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 129 EAG-VSVPQPY---TY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HTT-CCCCCEE---EE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred hCC-CCCCeEE---Ec----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 763 2233333 22 367899999953 44444221 224467889999999999999 999
Q ss_pred ccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 997 LIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 997 IIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
|+||||||+|||++. .++|+|||+|...
T Consensus 192 ivHrDlkp~NILl~~----~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYID----KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEESS----SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEcC----cEEEEECcccccC
Confidence 999999999999983 7999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.54 E-value=7.9e-15 Score=167.70 Aligned_cols=138 Identities=19% Similarity=0.182 Sum_probs=97.7
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchh-------------------h----HHHHHHHHHHHHhcCCCC
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDF-------------------F----DQSLDEIKLLKYVNKHDP 927 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~-------------------~----dq~l~EikILr~L~h~~~ 927 (1182)
|.|...||.|+||.||+|.+ .+|+.||||+++..... . -....|...|.++.+..
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g- 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG- 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC-
Confidence 99999999999999999997 57999999998642100 0 01234667777775432
Q ss_pred CCCcceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccE
Q 001034 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENI 1007 (1182)
Q Consensus 928 l~HPnIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNI 1007 (1182)
. .+...++. . ..+|||||++|..+..+ .....+..++.||+.+|.+||++|||||||||.||
T Consensus 175 v---~vp~p~~~---~-~~~LVME~i~G~~L~~l-----------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NI 236 (397)
T 4gyi_A 175 F---PVPEPIAQ---S-RHTIVMSLVDALPMRQV-----------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNI 236 (397)
T ss_dssp C---SCCCEEEE---E-TTEEEEECCSCEEGGGC-----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred C---CCCeeeec---c-CceEEEEecCCccHhhh-----------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence 1 12233332 2 34799999987533111 11224567889999999999999999999999999
Q ss_pred EEccCCCc--------eEEEecCCCcccc
Q 001034 1008 LVKSYSRC--------EVKVIDLGSSCFE 1028 (1182)
Q Consensus 1008 LIDs~~dG--------~IKLiDFGLA~~~ 1028 (1182)
|++.++.+ .+.||||+.+...
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEeCCCCcccccccccceEEEEeCCcccC
Confidence 99863321 4899999988653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=4.2e-10 Score=117.48 Aligned_cols=139 Identities=15% Similarity=0.136 Sum_probs=105.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
+.|++...++.|+++.||++.. .+..+++|+..... .....+.+|..+++.+... ..+.++++++......|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~-----~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGK-----LPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTT-----SCCCCEEEEEEETTEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcC-----CCCCeEEEEEecCCceE
Confidence 4588899999999999999974 46889999997531 2234678899999998652 24777888888888999
Q ss_pred EEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh---------------------------------
Q 001034 948 IVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG--------------------------------- 994 (1182)
Q Consensus 948 LVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS--------------------------------- 994 (1182)
+|||+++|..+.... .+......++.+++.+|..||+
T Consensus 87 lv~e~i~G~~l~~~~----------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 87 LLMSEADGVLCSEEY----------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHC----------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEecCCeehhhcc----------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 999999985443221 1112234678899999999998
Q ss_pred --------------------------cCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 995 --------------------------LGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 995 --------------------------~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
..++|+|++|.|||++. ...+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~--~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD--GKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET--TEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC--CcEEEEEEchhcc
Confidence 45899999999999973 3446799998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=3.5e-09 Score=108.61 Aligned_cols=137 Identities=14% Similarity=0.051 Sum_probs=97.5
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
..|.+....+.|..+.||++.. .+|..+++|+.... .......|..+++.+.+.. ..+.+++.++......++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~----~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTG----VPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTT----CCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCC----CCCCeEEEeccCCCCCEE
Confidence 3456654445667799999964 56788999998654 2356778999999987641 125667788877788999
Q ss_pred EEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 001034 949 VCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG-------------------------------- 996 (1182)
Q Consensus 949 VmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G-------------------------------- 996 (1182)
|||+++|..+. .. . .. ...++.+++.+|..||+..
T Consensus 93 v~e~i~G~~l~-~~----~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 93 LLGEVPGQDLL-SS----H-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp EEECCSSEETT-TS----C-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred EEEecCCcccC-cC----c-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 99999985433 11 0 11 2245667777777777643
Q ss_pred --------------------------ccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 997 --------------------------LIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 997 --------------------------IIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
++|+|++|.|||++. .+.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~--~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN--GRFSGFIDCGRLGV 214 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET--TEEEEECCCTTCEE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC--CcEEEEEcchhccc
Confidence 999999999999973 44567999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=5.1e-09 Score=112.63 Aligned_cols=183 Identities=16% Similarity=0.108 Sum_probs=115.3
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC---eEEEEEEe
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE---HLLIVCEL 952 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e---~LyLVmEy 952 (1182)
.|+.|....||++. ..+++|+.... ........|..+|+.+........| +++....... ..|+||++
T Consensus 27 ~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP---~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIP---EVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp EEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCC---CEEEECCCCSSCSCSCEEEEC
T ss_pred ecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCC---ceEeecCCCCCCCcceEEEcc
Confidence 58999999999873 46899987543 3356778899999988654333333 3333332222 35899999
Q ss_pred cccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 001034 953 LKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-------------------------------------- 994 (1182)
Q Consensus 953 L~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-------------------------------------- 994 (1182)
++|..+...... .++......++.+++..|..||+
T Consensus 98 i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 98 IKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp CCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred cCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 998432211110 14555666677777777777774
Q ss_pred --------------------cCccccccCCccEEEccCCCceEEEecCCCccccCCCcccccCCCcc---cchhhhcC--
Q 001034 995 --------------------LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSY---RAPEVILG-- 1049 (1182)
Q Consensus 995 --------------------~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~ss~vGTp~Y---mAPEVLlg-- 1049 (1182)
..++|+|++|.|||++......+.|+||+.+..... .........+ ..|+.+..
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHH
Confidence 247999999999999852245688999998865322 1111111111 23332211
Q ss_pred ---CCC---------CchhhHHHHHHHHHHHHhCCCCC
Q 001034 1050 ---LSY---------DKKIDIWSLGCILAELCTGNVLF 1075 (1182)
Q Consensus 1050 ---~~y---------S~kSDIWSLGVILYELLTGr~PF 1075 (1182)
... ..-.+.|+++.++|.+.+|.++|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12258999999999999999887
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.79 E-value=1.4e-08 Score=111.45 Aligned_cols=141 Identities=10% Similarity=0.117 Sum_probs=100.7
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEe--ccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec---CeE
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR---EHL 946 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIk--k~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~---e~L 946 (1182)
++.|+.|.++.||++.. .+..+++|+.. ... .....+..|..+++.+... +..+++++.++.+. ...
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~----~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGT----DVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTS----SSCCCCEEEEECCTTTTSSC
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcC----CCCCCcEEEECCCCCccCCe
Confidence 46789999999999975 34678889876 332 2234677899999999753 22477788777665 348
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-------------------------------- 994 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-------------------------------- 994 (1182)
|+|||+++|..+... . . ..++......++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~--~---~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ--S---L--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp EEEEECCCCBCCCCT--T---C--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCeecCCC--c---c--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 999999998432100 0 0 015677778889999999999997
Q ss_pred --------------------------cCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 995 --------------------------LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 995 --------------------------~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
..+||+|++|.|||++..+...+.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 369999999999999853333469999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.2e-05 Score=87.48 Aligned_cols=73 Identities=16% Similarity=0.054 Sum_probs=51.8
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE-ecCeEEEEEEec
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY-YREHLLIVCELL 953 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq-d~e~LyLVmEyL 953 (1182)
+.++.|....||++ +..+++|+... .........|..+|+.+.+..... +.+++.+.. .....|+||+++
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~---VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVN---IPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSB---CCCEEEEEECTTSCEEEEEECC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCC---CCCeEeecccCCCceEEEEecc
Confidence 45788999999998 56788998543 334567889999999998653222 444444443 345678999999
Q ss_pred ccC
Q 001034 954 KAN 956 (1182)
Q Consensus 954 ~Gs 956 (1182)
+|.
T Consensus 96 ~G~ 98 (306)
T 3tdw_A 96 QGQ 98 (306)
T ss_dssp CSE
T ss_pred CCe
Confidence 984
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=5.8e-05 Score=78.89 Aligned_cols=72 Identities=8% Similarity=0.085 Sum_probs=54.2
Q ss_pred ccCCce-EEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEecccC
Q 001034 878 GSAAFS-KAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKAN 956 (1182)
Q Consensus 878 GkGaFG-eVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~Gs 956 (1182)
..|..+ .||+......+..+++|+-.... ...+..|..+|+.+...- -+.+++.++.+....|+||++++|.
T Consensus 33 ~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--~~~~~~E~~~l~~l~~~v-----PVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 33 NVGQSGATIYRLYGKPNAPELFLKHGKGSV--ANDVTDEMVRLNWLTAFM-----PLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp ECSSSSCEEEEEECCTTCCCEEEEEEETHH--HHHHHHHHHHHHHHTTTS-----CCCCEEEEEEETTEEEEEEECCCSE
T ss_pred cCCCcCCeEEEEEecCCCeEEEEEECCCCC--HhHHHHHHHHHHHhccCC-----CcCeEEEEEEECCeEEEEEEeeCCc
Confidence 334443 68998877778889999876543 456778999999886432 2667778888889999999999984
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00012 Score=81.69 Aligned_cols=77 Identities=17% Similarity=0.109 Sum_probs=50.9
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccc--------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.+.||.|.++.||++.....++.++||...... ........|..+|+.+....+ ..+.+++.+ +...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~---~~vP~~~~~--d~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVP---HLVPRVFYS--DTEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCG---GGSCCEEEE--ETTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCC---CCcCeEEEE--cCCc
Confidence 457899999999999766667889999865321 123456779999988865321 134455543 4556
Q ss_pred EEEEEEeccc
Q 001034 946 LLIVCELLKA 955 (1182)
Q Consensus 946 LyLVmEyL~G 955 (1182)
.++|||++.|
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 7899999986
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00051 Score=73.44 Aligned_cols=76 Identities=17% Similarity=0.252 Sum_probs=42.1
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEE-E--EEEecCeEEEEEE
Q 001034 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY-D--YFYYREHLLIVCE 951 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~-d--sFqd~e~LyLVmE 951 (1182)
+.|+.|..+.||++.. .+ ..+++|+..... .....|..+++.+.... ...|.++... + +.......++||+
T Consensus 38 ~~l~gG~~n~~~~v~~-~~-~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g-~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT-DS-GAVCLKRIHRPE---KKALFSIFAQDYLAKKG-MNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEE-TT-EEEEEEEECSCH---HHHHHHHHHHHHHHHHT-CSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEe-CC-CCEEEEecCCCH---HHHHHHHHHHHHHHHcC-CCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4566778899999975 33 358999997643 23334566666655321 1223333210 0 1234567899999
Q ss_pred ecccC
Q 001034 952 LLKAN 956 (1182)
Q Consensus 952 yL~Gs 956 (1182)
|++|.
T Consensus 112 ~i~G~ 116 (346)
T 2q83_A 112 WIEGR 116 (346)
T ss_dssp CCCCB
T ss_pred eecCc
Confidence 99873
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00058 Score=74.61 Aligned_cols=81 Identities=7% Similarity=0.030 Sum_probs=54.2
Q ss_pred EEEEEe-ccCCceEEEEEEEC---C---CCcEEEEEEEeccch----hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 872 HVTEYL-GSAAFSKAIQAHDL---H---TGMDVCVKIIKNNKD----FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 872 eIlk~L-GkGaFGeVyLAkDk---~---TGr~VAVKIIkk~k~----~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
...+.| +.|....+|++... . ++..+++|+...... .......|..+++.+..... ..+.+++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~---vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTD---VPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCC---SCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCC---CCCCcEEEEc
Confidence 345678 89999999998642 0 266789998764331 12456788888888865311 1355666666
Q ss_pred Eec---CeEEEEEEeccc
Q 001034 941 YYR---EHLLIVCELLKA 955 (1182)
Q Consensus 941 qd~---e~LyLVmEyL~G 955 (1182)
... ...|+|||+++|
T Consensus 100 ~~~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEG 117 (357)
T ss_dssp CSSTTTSSCEEEEECCCC
T ss_pred cCCCccCCceEEEEecCC
Confidence 544 356899999987
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0012 Score=71.09 Aligned_cols=69 Identities=12% Similarity=0.065 Sum_probs=45.1
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEec
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL 953 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL 953 (1182)
++.|+.|....+|++ ..+++|+.............|..+++.+..... . | +++.. +...-++|++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~-~-P---~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGV-S-P---EVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTS-S-C---CEEEE--CTTTCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCC-C-C---ceEEE--ECCCCEEEEeec
Confidence 467889999999999 568899887543222334578888888776531 1 3 33333 344567899999
Q ss_pred -cc
Q 001034 954 -KA 955 (1182)
Q Consensus 954 -~G 955 (1182)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 65
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0026 Score=71.92 Aligned_cols=76 Identities=20% Similarity=0.134 Sum_probs=46.5
Q ss_pred HhcCccccccCCccEEEccCCCceEEEecCCCccccCCCc--ccccC--CCcccchhhhcCCC---CCchhhHHHHHHHH
Q 001034 993 HGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL--CSYVQ--SRSYRAPEVILGLS---YDKKIDIWSLGCIL 1065 (1182)
Q Consensus 993 HS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~--ss~vG--Tp~YmAPEVLlg~~---yS~kSDIWSLGVIL 1065 (1182)
+...++|+|++|.|||++. ++ ++|+||+.+....... ..... ...|++|+...... -.....+..+...+
T Consensus 230 ~~~~liHGDl~~~Nil~~~--~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQ--DS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECS--SC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeC--CC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 4578999999999999984 33 9999999886533110 01110 23466666553211 11234445777777
Q ss_pred HHHHhC
Q 001034 1066 AELCTG 1071 (1182)
Q Consensus 1066 YELLTG 1071 (1182)
|+++.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.032 Score=59.85 Aligned_cols=149 Identities=10% Similarity=0.041 Sum_probs=78.4
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEE-E--EEEecCeEEEE
Q 001034 873 VTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY-D--YFYYREHLLIV 949 (1182)
Q Consensus 873 Ilk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~-d--sFqd~e~LyLV 949 (1182)
-++.|+.|....+|++... .+ .+++|+..... ....+..|..+++.+.... ...|.++... + +.......++|
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g-~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKG-LSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTT-CCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCC-CCCCcccCCCCCCEEEEECCEEEEE
Confidence 3567888999999999753 33 68899987631 1234556788887776542 1223333210 0 11234567899
Q ss_pred EEecccCh----------------HHHHhhhcccCCcc--ccCHHHHHH---------------HHHHHHHHHHHHHh--
Q 001034 950 CELLKANL----------------YEFHKFNRESGGEV--YFTMPRLQS---------------ITIQCLEALQFLHG-- 994 (1182)
Q Consensus 950 mEyL~GsL----------------ld~Lk~~~~sggel--~Lse~eIr~---------------Ia~QILsALeYLHS-- 994 (1182)
|++++|.. ..++.......... ......... +...+...+..|+.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99998731 11111110000000 001000000 00113344555542
Q ss_pred -----cCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 995 -----LGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 995 -----~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
.++||+|+.+.|||++. ...+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~--~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLG--DELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEET--TEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeC--CceEEEecchhccC
Confidence 46999999999999983 34457999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0073 Score=66.74 Aligned_cols=73 Identities=15% Similarity=0.088 Sum_probs=44.6
Q ss_pred EEEeccCCceEEEEEEECC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 874 TEYLGSAAFSKAIQAHDLH--------TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~--------TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++.|+.|....+|++.... .+..+++|+.............|..+++.+.... .+.+++..+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g-----~~P~~~~~~--~-- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYK-----IAPQLLNTF--N-- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTT-----SSCCEEEEE--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcC-----CCCceEEec--C--
Confidence 3467888889999997542 1368999988654332223467888888887553 133444443 2
Q ss_pred EEEEEEeccc
Q 001034 946 LLIVCELLKA 955 (1182)
Q Consensus 946 LyLVmEyL~G 955 (1182)
-++||+|++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 3689999986
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.51 E-value=0.019 Score=61.72 Aligned_cols=77 Identities=13% Similarity=0.062 Sum_probs=47.1
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE--EEEecCeEEEEEEec
Q 001034 876 YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD--YFYYREHLLIVCELL 953 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d--sFqd~e~LyLVmEyL 953 (1182)
.|+ |....||++.. .+|+.+++|+..........+..|..+++.+.... ...|.++..-+ .+......++||+++
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g-~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE-VPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT-CSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcC-CeecceeecCCcEEEEECCEEEEEEEec
Confidence 456 88889998863 45667999999744323455667888888876542 11122222100 112345678999999
Q ss_pred cc
Q 001034 954 KA 955 (1182)
Q Consensus 954 ~G 955 (1182)
+|
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 87
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.008 Score=68.39 Aligned_cols=143 Identities=12% Similarity=0.069 Sum_probs=78.8
Q ss_pred EeccCCceEEEEEEECC-------CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 876 YLGSAAFSKAIQAHDLH-------TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 876 ~LGkGaFGeVyLAkDk~-------TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
.|..|-...+|++.... .++.|++|+............+|..+++.+..... ..++++.+.. .+
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv-----~P~ll~~~~~----g~ 127 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSL-----GPQLYGVFPE----GR 127 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTS-----SCCEEEEETT----EE
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCC-----CCeEEEEcCC----cc
Confidence 56677778888887532 35789999874432234556689999988876531 2445555533 29
Q ss_pred EEEecccChHH---------------HHh-hhc--ccCCcccc-CHHHHHHHHHHHHH-------------------HHH
Q 001034 949 VCELLKANLYE---------------FHK-FNR--ESGGEVYF-TMPRLQSITIQCLE-------------------ALQ 990 (1182)
Q Consensus 949 VmEyL~GsLld---------------~Lk-~~~--~sggel~L-se~eIr~Ia~QILs-------------------ALe 990 (1182)
||||++|..+. .+. ... ...+..+. ...++..++.++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999862110 010 000 00010011 12445555544321 233
Q ss_pred HHH----h----cCccccccCCccEEEccC--CCceEEEecCCCccc
Q 001034 991 FLH----G----LGLIHCDLKPENILVKSY--SRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 991 YLH----S----~GIIHRDIKPeNILIDs~--~dG~IKLiDFGLA~~ 1027 (1182)
.|. . ..++|+|+.+.|||++.. ..+.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 2 359999999999999853 135799999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.038 Score=58.88 Aligned_cols=78 Identities=9% Similarity=0.040 Sum_probs=54.3
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
...-++.+|.|..+.||++.. .+|+.|++|+..... .....+..|...|+.|........|. ++.+ ..-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~---v~~~----~~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQ---VAGW----DDRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCC---EEEE----ETTEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcce---EEec----cCceE
Confidence 455677899999999999984 678999999876443 22234667999999886543333343 3332 23478
Q ss_pred EEEeccc
Q 001034 949 VCELLKA 955 (1182)
Q Consensus 949 VmEyL~G 955 (1182)
|||++.+
T Consensus 88 v~e~l~~ 94 (288)
T 3f7w_A 88 AMEWVDE 94 (288)
T ss_dssp EEECCCC
T ss_pred EEEeecc
Confidence 9999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.33 E-value=0.014 Score=66.95 Aligned_cols=72 Identities=10% Similarity=0.045 Sum_probs=48.9
Q ss_pred EEEeccCCceEEEEEEECC-------CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 874 TEYLGSAAFSKAIQAHDLH-------TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~-------TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
++.|+.|-...||++.... .++.+++|+..... .......|..+++.+..... ..++++.|. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~li~E~~~l~~L~~~g~-----~P~l~~~~~--~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHL-----GPKLYGIFS--G-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTS-----SSCEEEEET--T--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cHHHHHHHHHHHHHHHhCCC-----CCcEEEEeC--C--
Confidence 4578888899999998542 35789999985421 11455579999988876531 244555543 2
Q ss_pred EEEEEeccc
Q 001034 947 LIVCELLKA 955 (1182)
Q Consensus 947 yLVmEyL~G 955 (1182)
.+||+|++|
T Consensus 148 g~v~e~l~G 156 (429)
T 1nw1_A 148 GRLEEYIPS 156 (429)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEeCC
Confidence 389999986
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.21 E-value=0.097 Score=57.96 Aligned_cols=76 Identities=20% Similarity=0.152 Sum_probs=57.7
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEec
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL 953 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL 953 (1182)
.+.|+.|.+..+|++.. .+..+++|+..... ...+..|...|+.|..... ..+++++.+.......|+|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~--~~~~~~E~~~L~~L~~~~~---v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSY--RSMFRAEADQLALLAKTNS---INVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGG--HHHHHHHHHHHHHHHHTTS---SBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCccc--HHHHHHHHHHHHHHHhhCC---CCcceEEEEeecCCceEEEEEec
Confidence 45789999999999974 56788999887542 4567788888888865421 24667777777778899999999
Q ss_pred ccC
Q 001034 954 KAN 956 (1182)
Q Consensus 954 ~Gs 956 (1182)
+|.
T Consensus 114 ~G~ 116 (312)
T 3jr1_A 114 NKS 116 (312)
T ss_dssp CCC
T ss_pred cCC
Confidence 863
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.049 Score=63.43 Aligned_cols=73 Identities=11% Similarity=0.165 Sum_probs=47.8
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEec
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL 953 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL 953 (1182)
++.|+.|-...+|++.....+..+++|+........-....|..+++.|.... ...++++.| .+ .+||+|+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~g-----l~P~ll~~~--~~--G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKN-----IAKKIYVFF--TN--GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSS-----SBCCEEEEE--TT--EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcC-----CCCCEEEEe--CC--eEEEEee
Confidence 45788898999999986544578999988543322222358899999887653 234566666 22 3599999
Q ss_pred cc
Q 001034 954 KA 955 (1182)
Q Consensus 954 ~G 955 (1182)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 86
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.89 E-value=0.11 Score=56.40 Aligned_cols=34 Identities=24% Similarity=0.355 Sum_probs=27.1
Q ss_pred hcCccccccCCccEEEccCC--CceEEEecCCCccc
Q 001034 994 GLGLIHCDLKPENILVKSYS--RCEVKVIDLGSSCF 1027 (1182)
Q Consensus 994 S~GIIHRDIKPeNILIDs~~--dG~IKLiDFGLA~~ 1027 (1182)
...+||+|+.+.|||++... .+.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 35799999999999998421 15689999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.81 E-value=0.25 Score=53.21 Aligned_cols=97 Identities=15% Similarity=0.042 Sum_probs=61.8
Q ss_pred ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHH-hcCccccccCCccEEEccCCCceEEEecCCCccccCCCccc
Q 001034 956 NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLH-GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCS 1034 (1182)
Q Consensus 956 sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLH-S~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~~~~~ss 1034 (1182)
+|.+.+..... ++++.++|.+++|++.+|.-+- ...-..+=+.|..|++.. +|.|-+.+ ..+.
T Consensus 34 SL~eIL~~~~~-----PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~--dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ-----PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWR--DGAVTLAP-AADD-------- 97 (229)
T ss_dssp EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEET--TSCEEECC-C-----------
T ss_pred cHHHHHHHcCC-----CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEec--CCceeccc-cccc--------
Confidence 57777776543 3999999999999999987762 122224455678999985 66666653 1111
Q ss_pred ccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh
Q 001034 1035 YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT 1070 (1182)
Q Consensus 1035 ~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT 1070 (1182)
.....+.|||... ...+.+.=|||||++||..|-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1233466888763 345678889999999998886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.48 E-value=0.17 Score=55.85 Aligned_cols=71 Identities=11% Similarity=0.166 Sum_probs=42.1
Q ss_pred ccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCC-CcceEEEE-E--EEEecCeEEEEEEec
Q 001034 878 GSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD-KYHLLRLY-D--YFYYREHLLIVCELL 953 (1182)
Q Consensus 878 GkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~-HPnIVkL~-d--sFqd~e~LyLVmEyL 953 (1182)
|.|....||++.. .+| .+++|+...... ..|+.+++.|.... .. .|.++... + +.......++||+|+
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g-~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i 103 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYHD-----EINLSIIRLLHDSG-IKEIIFPIHTLEAKLFQQLKHFKIIAYPFI 103 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSSC-----CHHHHHHHHHHHTT-CCSSCCCCCCTTSCSSEECSSEEEEEEECC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCccc-----hHHHHHHHHHHhcC-CcccccceecCCCCEEEEECCEEEEEEecc
Confidence 4444789999974 345 899998876542 35667777665432 11 12222210 0 123356789999999
Q ss_pred ccC
Q 001034 954 KAN 956 (1182)
Q Consensus 954 ~Gs 956 (1182)
+|.
T Consensus 104 ~G~ 106 (339)
T 3i1a_A 104 HAP 106 (339)
T ss_dssp CCC
T ss_pred CCC
Confidence 874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.09 E-value=0.14 Score=59.22 Aligned_cols=72 Identities=11% Similarity=0.106 Sum_probs=47.6
Q ss_pred EEeccCCceEEEEEEECC-------CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 875 EYLGSAAFSKAIQAHDLH-------TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~-------TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
+.|..|-...+|++.... .++.|++++........-...+|..+++.+.... ...++++.+ . -+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~g-----i~P~l~~~~--~--~~ 146 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNIN-----IAPNIIADF--P--EG 146 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTT-----SSCCEEEEE--T--TE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcC-----CCCCEEEEc--C--CC
Confidence 466778888999988642 1578999987654333334467888888887553 133444433 2 37
Q ss_pred EEEEeccc
Q 001034 948 IVCELLKA 955 (1182)
Q Consensus 948 LVmEyL~G 955 (1182)
+||+|++|
T Consensus 147 ~I~efI~G 154 (424)
T 3mes_A 147 RIEEFIDG 154 (424)
T ss_dssp EEEECCCS
T ss_pred EEEEEeCC
Confidence 89999987
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.15 E-value=0.69 Score=52.25 Aligned_cols=32 Identities=25% Similarity=0.359 Sum_probs=25.8
Q ss_pred CccccccCCccEEEcc----CCCceEEEecCCCccc
Q 001034 996 GLIHCDLKPENILVKS----YSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 996 GIIHRDIKPeNILIDs----~~dG~IKLiDFGLA~~ 1027 (1182)
.++|+|+.+.|||+.. .....+.|+||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 3789999999999953 2356799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1182 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-58 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-54 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-54 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-53 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-53 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-51 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-51 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-50 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-49 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-48 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-45 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-37 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-31 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-28 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-28 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-14 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 1e-58
Identities = 65/308 (21%), Positives = 112/308 (36%), Gaps = 17/308 (5%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDP 927
+ LG+ + +G+ + K+I +Q + E+++L N
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP- 64
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
+++ Y FY + I E + + L ++I ++
Sbjct: 65 ----YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIK 115
Query: 988 ALQFLH-GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC-SYVQSRSYRAPE 1045
L +L ++H D+KP NILV SR E+K+ D G S D + S+V +RSY +PE
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173
Query: 1046 VILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105
+ G Y + DIWS+G L E+ G L + + R
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165
+ + M L I + + + F DFV L NP +R
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 1166 DALKHPWL 1173
+ H ++
Sbjct: 294 QLMVHAFI 301
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 192 bits (487), Expect = 2e-54
Identities = 93/327 (28%), Positives = 162/327 (49%), Gaps = 18/327 (5%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVN----- 923
RY + LG FS A D+ V +KI++ +K + + + DEIKLL+ VN
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
K D H+L+L D+F ++ + ++ L E + + ++ I+
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 984 QCLEALQFLH-GLGLIHCDLKPENILVKS----YSRCEVKVIDLGSSCFETDHLCSYVQS 1038
Q L L ++H G+IH D+KPEN+L++ + ++K+ DLG++C+ +H + +Q+
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 1039 RSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL------LARVIGIIG 1092
R YR+PEV+LG + DIWS C++ EL TG+ LF+ D + +A++I ++G
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
+ +L G+ T +F +L RN + L T + DF++
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLL--RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 1153 LLEINPKKRPSASDALKHPWLSHPYEP 1179
+L+++P+KR A + HPWL
Sbjct: 311 MLQLDPRKRADAGGLVNHPWLKDTLGM 337
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 6e-54
Identities = 79/310 (25%), Positives = 127/310 (40%), Gaps = 27/310 (8%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHT-GMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPG 928
+Y +G A+ K +A DL G V +K ++ L I+ + + +
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 929 DKYHLLRLYDYFY-----YREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
+ +++RL+D L +V E + +L + E G ++ +
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMF 123
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRA 1043
Q L L FLH ++H DLKP+NILV S + ++ L L S V + YRA
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103
PEV+L SY +D+WS+GCI AE+ LF+ S L +++ +IG
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG----------- 232
Query: 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163
+ R+ R + + + D+ D + L NP KR S
Sbjct: 233 ------LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286
Query: 1164 ASDALKHPWL 1173
A AL HP+
Sbjct: 287 AYSALSHPYF 296
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-53
Identities = 81/318 (25%), Positives = 137/318 (43%), Gaps = 34/318 (10%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHD 926
+ E +G + +A + TG V +K I+ + ++ EI LLK +N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP- 61
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
++++L D + L +V E L +L +F + +G +P ++S Q L
Sbjct: 62 -----NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG----IPLPLIKSYLFQLL 112
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRSYRA 1043
+ L F H ++H DLKP+N+L+ + +K+ D G + V + YRA
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 1044 PEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
PE++LG Y +DIWSLGCI AE+ T LF DS L R+ +G ++ +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
Y + + + +P D+ ++ +L +P KR
Sbjct: 231 TSMPDY---------------KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275
Query: 1163 SASDALKHPWLSHPYEPI 1180
SA AL HP+ +P+
Sbjct: 276 SAKAALAHPFFQDVTKPV 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 187 bits (476), Expect = 5e-53
Identities = 60/316 (18%), Positives = 109/316 (34%), Gaps = 53/316 (16%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSL-DEIKLLKYVNKH 925
+ Y + E LG+ AF + + TG + K + + +++ EI+ + + H
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-H 82
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
L+ L+D F ++++ E + + + + Q
Sbjct: 83 P-----TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQV 133
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF--ETDHLCSYVQSRSYRA 1043
+ L +H +H DLKPENI+ + E+K+ID G + + + + A
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103
PEV G D+WS+G + L +G F ++ L V ++
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-------- 245
Query: 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163
+ DF+ LL +P R +
Sbjct: 246 --------------------------------DSAFSGISEDGKDFIRKLLLADPNTRMT 273
Query: 1164 ASDALKHPWLSHPYEP 1179
AL+HPWL+ P
Sbjct: 274 IHQALEHPWLTPGNAP 289
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 6e-53
Identities = 64/310 (20%), Positives = 117/310 (37%), Gaps = 62/310 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKH 925
+ + LG F A + + + +K++ Q E+++ ++
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
++LRLY YF+ + ++ E F R + +
Sbjct: 67 ------NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITEL 115
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF-ETDHLCSYVQSRSYRAP 1044
AL + H +IH D+KPEN+L+ S E+K+ D G S + + + Y P
Sbjct: 116 ANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 173
Query: 1045 EVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104
E+I G +D+K+D+WSLG + E G F+ ++ R+
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---------------- 217
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
R+E+ P + +G D ++ LL+ NP +RP
Sbjct: 218 -------------------RVEFTFPDFVT---------EGARDLISRLLKHNPSQRPML 249
Query: 1165 SDALKHPWLS 1174
+ L+HPW++
Sbjct: 250 REVLEHPWIT 259
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 7e-53
Identities = 85/316 (26%), Positives = 144/316 (45%), Gaps = 13/316 (4%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN---NKDFFDQSLDEIKLLKYVN 923
+ RY + +GS A A+D +V +K + N+ ++ E+ L+K VN
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
+ ++ + + +V EL+ ANL + + R+ +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLY 126
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRA 1043
Q L ++ LH G+IH DLKP NI+VKS ++ L + + + YV +R YRA
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103
PEVILG+ Y + +DIWS+GCI+ E+ +LF +VI +G + K +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163
T + + +N Y + S ++L D ++ +L I+P KR S
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 304
Query: 1164 ASDALKHPWLSHPYEP 1179
DAL+HP+++ Y+P
Sbjct: 305 VDDALQHPYINVWYDP 320
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-52
Identities = 70/324 (21%), Positives = 130/324 (40%), Gaps = 32/324 (9%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKH 925
+Y +G F + +A TG V +K + + F +L EIK+L+ +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 926 DPGDKYHLLRLYDYFYYRE--HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
+ + + R Y R + +V + + +L FT+ ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQ 124
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS-------CFETDHLCSYV 1036
L L ++H ++H D+K N+L+ +K+ D G + + + + V
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 1037 QSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095
+ YR PE++LG Y ID+W GCI+AE+ T + + Q ++ LA + + G I
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
+ + Y E L +K R + + D +D + LL
Sbjct: 243 PEVWPNVDNYELY------------EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 290
Query: 1156 INPKKRPSASDALKHPWLSHPYEP 1179
++P +R + DAL H + P
Sbjct: 291 LDPAQRIDSDDALNHDFFWSDPMP 314
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 2e-51
Identities = 73/314 (23%), Positives = 124/314 (39%), Gaps = 62/314 (19%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII-KNNKDFFDQSLDEIKLLKYVNKHDPG 928
+ + LG AF K +A + T + K+I +++ + + EI +L + H
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD-HP-- 69
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988
++++L D FYY +L I+ E + E T ++Q + Q L+A
Sbjct: 70 ---NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDA 122
Query: 989 LQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD---HLCSYVQSRSYRAPE 1045
L +LH +IH DLK NIL ++K+ D G S T S++ + + APE
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFT--LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 1046 VILGLS-----YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100
V++ + YD K D+WSLG L E+ +P +L ++
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA------------ 228
Query: 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160
++ P + S F DF+ LE N
Sbjct: 229 --------------------KSEPPTLAQPSRWS---------SNFKDFLKKCLEKNVDA 259
Query: 1161 RPSASDALKHPWLS 1174
R + S L+HP+++
Sbjct: 260 RWTTSQLLQHPFVT 273
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-51
Identities = 84/327 (25%), Positives = 139/327 (42%), Gaps = 42/327 (12%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNK 924
+ RY Y+G A+ A+D + V +K I ++ + ++L EIK+L
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 925 HDPGDKYHLLRLYDYFY-----YREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQ 979
+++ + D + + +V L+ A+LY+ K + +
Sbjct: 66 E------NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-------LSNDHIC 112
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF------ETDHLC 1033
Q L L+++H ++H DLKP N+L+ + C++K+ D G + T L
Sbjct: 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDHTGFLT 170
Query: 1034 SYVQSRSYRAPEVIL-GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092
YV +R YRAPE++L Y K IDIWS+GCILAE+ + +F L ++GI+G
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
Q L + + ++ K P D +D +
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHK-------------NKVPWNRLFPNADSKALDLLDK 277
Query: 1153 LLEINPKKRPSASDALKHPWLSHPYEP 1179
+L NP KR AL HP+L Y+P
Sbjct: 278 MLTFNPHKRIEVEQALAHPYLEQYYDP 304
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-51
Identities = 76/319 (23%), Positives = 136/319 (42%), Gaps = 36/319 (11%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
Y T+ +G+ +F QA +G V +K + +K F ++ E+++++ ++ H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLD-HC--- 73
Query: 930 KYHLLRLYDYFY------YREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
+++RL +FY +L +V + + +Y + + + ++
Sbjct: 74 --NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMY 129
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS--CFETDHLCSYVQSRSY 1041
Q +L ++H G+ H D+KP+N+L+ + K+ D GS+ + SY+ SR Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 1042 RAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100
RAPE+I G Y ID+WS GC+LAEL G +F DS L +I ++G + +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160
+ Y F I + P I + LLE P
Sbjct: 249 EMNPNYTEFKFPQ---------------IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 1161 RPSASDALKHPWLSHPYEP 1179
R + +A H + +P
Sbjct: 294 RLTPLEACAHSFFDELRDP 312
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-51
Identities = 75/315 (23%), Positives = 128/315 (40%), Gaps = 39/315 (12%)
Query: 875 EYLGSAAFSKAIQAHDLHTGMDVCVKIIK------NNKDFFDQSLDEIKLLKYVNKHDPG 928
++LG F+ +A D +T V +K IK +L EIKLL+ ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP--- 60
Query: 929 DKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEA 988
+++ L D F ++ ++ +V + ++ +L K N +++ + L+
Sbjct: 61 ---NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP-----SHIKAYMLMTLQG 112
Query: 989 LQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCS---YVQSRSYRAPE 1045
L++LH ++H DLKP N+L+ +K+ D G + + V +R YRAPE
Sbjct: 113 LEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 1046 VILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104
++ G Y +D+W++GCILAEL DS L R+ +G +
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
Y T L H +D + L NP R +A
Sbjct: 231 LPDYVTFKSF----------------PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
Query: 1165 SDALKHPWLSHPYEP 1179
+ ALK + S+ P
Sbjct: 275 TQALKMKYFSNRPGP 289
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-50
Identities = 70/317 (22%), Positives = 118/317 (37%), Gaps = 52/317 (16%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD 926
+ +Y + E LG F + + + K +K EI +L H
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HR 61
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
++L L++ F E L+++ E + + + S E + S Q
Sbjct: 62 -----NILHLHESFESMEELVMIFEFISG--LDIFERINTSAFE--LNEREIVSYVHQVC 112
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF--ETDHLCSYVQSRSYRAP 1044
EALQFLH + H D++PENI+ ++ +K+I+ G + D+ + Y AP
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
Query: 1045 EVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104
EV D+WSLG ++ L +G F ++ ++ ++
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM---------------- 216
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
EY ++ +DFV LL K R +A
Sbjct: 217 -------------------NAEYTFDEE-----AFKEISIEAMDFVDRLLVKERKSRMTA 252
Query: 1165 SDALKHPWLSHPYEPIS 1181
S+AL+HPWL E +S
Sbjct: 253 SEALQHPWLKQKIERVS 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 5e-50
Identities = 68/309 (22%), Positives = 122/309 (39%), Gaps = 59/309 (19%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII-KNNKDFFDQSLDEIKLLKYVNKHDP 927
+Y E +G A A D+ TG +V ++ + + + ++EI +++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NP- 77
Query: 928 GDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
+++ D + + L +V E L ++ ++ +CL+
Sbjct: 78 ----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQ 127
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRSYRAP 1044
AL+FLH +IH D+K +NIL+ VK+ D G E + V + + AP
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 1045 EVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104
EV+ +Y K+DIWSLG + E+ G + N++P L +
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---------------- 229
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
E P+K S F DF+ L+++ +KR SA
Sbjct: 230 ----------------TNGTPELQNPEKLS---------AIFRDFLNRCLDMDVEKRGSA 264
Query: 1165 SDALKHPWL 1173
+ L+H +L
Sbjct: 265 KELLQHQFL 273
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 4e-49
Identities = 77/317 (24%), Positives = 136/317 (42%), Gaps = 26/317 (8%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN---NKDFFDQSLDEIKLLKYVN 923
+ RY +GS A+ A D TG+ V VK + + ++ E++LLK++
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
+ + + +V L+ A+L K + T +Q +
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIY 128
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRA 1043
Q L L+++H +IH DLKP N+ V K++D G + D + YV +R YRA
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCEL--KILDFGLARHTDDEMTGYVATRWYRA 186
Query: 1044 PEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
PE++L + Y++ +DIWS+GCI+AEL TG LF L ++ ++G +L K
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
+ K + + + +D + +L ++ KR
Sbjct: 247 SSESARNYIQSLTQ-------------MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 1163 SASDALKHPWLSHPYEP 1179
+A+ AL H + + ++P
Sbjct: 294 TAAQALAHAYFAQYHDP 310
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 172 bits (437), Expect = 1e-48
Identities = 75/311 (24%), Positives = 135/311 (43%), Gaps = 36/311 (11%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII---KNNKDFFDQSLDEIKLLKYVNKHD 926
+YH E +G + +A + + G +K I K ++ ++ EI +LK +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS- 60
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
++++LYD + ++ L++V E L +L + +S +Q L
Sbjct: 61 -----NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLL 110
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRSYRA 1043
+ + H ++H DLKP+N+L+ E+K+ D G + + + YRA
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 1044 PEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
P+V++G Y IDIWS+GCI AE+ G LF S A L R+ I+G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
+ KY + + + L D+ ID ++ +L+++P +R
Sbjct: 229 TELPKYDPN---------------FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273
Query: 1163 SASDALKHPWL 1173
+A AL+H +
Sbjct: 274 TAKQALEHAYF 284
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (438), Expect = 2e-48
Identities = 62/317 (19%), Positives = 114/317 (35%), Gaps = 63/317 (19%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKH 925
+ +G +F A D+ V +K + + + + + E++ L+ + H
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-H 74
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+ ++ + +V E + + + +++ + ++T
Sbjct: 75 P-----NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGA 124
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPE 1045
L+ L +LH +IH D+K NIL+ VK+ D GS+ S+V + + APE
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGSASI-MAPANSFVGTPYWMAPE 181
Query: 1046 VILGLS---YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
VIL + YD K+D+WSLG EL N + + L +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------------- 227
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
N L S + F +FV L+ P+ RP
Sbjct: 228 -------------------QNESPALQSGHWS---------EYFRNFVDSCLQKIPQDRP 259
Query: 1163 SASDALKHPWLSHPYEP 1179
++ LKH ++ P
Sbjct: 260 TSEVLLKHRFVLRERPP 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (441), Expect = 2e-48
Identities = 63/320 (19%), Positives = 121/320 (37%), Gaps = 55/320 (17%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSL-DEIKLLKYVNKH 925
+ Y + E LGS AF + + TG K I ++ +EI ++ ++ H
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-H 85
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
L+ L+D F + ++++ E L L++ + + + Q
Sbjct: 86 P-----KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQ 135
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF--ETDHLCSYVQSRSYR 1042
E L+ +H ++H D+KPENI+ ++ VK+ID G + + + + +
Sbjct: 136 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA 195
Query: 1043 APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
APE++ D+W++G + L +G F + L V
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-------------- 241
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
R ++ + DF+ +LL+ P+KR
Sbjct: 242 ---------------------RCDWEFDED-----AFSSVSPEAKDFIKNLLQKEPRKRL 275
Query: 1163 SASDALKHPWLSHPYEPISA 1182
+ DAL+HPWL + +++
Sbjct: 276 TVHDALEHPWLKGDHSNLTS 295
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-48
Identities = 77/318 (24%), Positives = 133/318 (41%), Gaps = 36/318 (11%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHD 926
+Y E +G + +A + T V +K ++ +++ +L EI LLK +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK- 61
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+++RL+D + + L +V E +L ++ ++S Q L
Sbjct: 62 -----NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLL 111
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRSYRA 1043
+ L F H ++H DLKP+N+L+ K+ + G + + V + YR
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGEL--KLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 1044 PEVILGLS-YDKKIDIWSLGCILAELCTGNV-LFQNDSPATLLARVIGIIGPIEQGMLAK 1101
P+V+ G Y ID+WS GCI AEL LF + L R+ ++G +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR 1161
Y + + P TSL + +P + D + +LL+ NP +R
Sbjct: 230 MTKLPDY---------------KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274
Query: 1162 PSASDALKHPWLSHPYEP 1179
SA +AL+HP+ S P
Sbjct: 275 ISAEEALQHPYFSDFCPP 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-48
Identities = 72/317 (22%), Positives = 134/317 (42%), Gaps = 26/317 (8%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVN 923
+ Y + +GS A+ A D TG V +K + ++ F ++ E++LLK++
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
+ + + +V + +L + K + R+Q +
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-------LGEDRIQFLVY 128
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRA 1043
Q L+ L+++H G+IH DLKP N+ V K++D G + + YV +R YRA
Sbjct: 129 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL--KILDFGLARQADSEMTGYVVTRWYRA 186
Query: 1044 PEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
PEVIL Y + +DIWS+GCI+AE+ TG LF+ L ++ + G + +
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
+ + +K L ++ + +L ++ ++R
Sbjct: 247 QSDEAKNYMKGLPE-------------LEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 1163 SASDALKHPWLSHPYEP 1179
+A +AL HP+ ++
Sbjct: 294 TAGEALAHPYFESLHDT 310
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-47
Identities = 66/322 (20%), Positives = 116/322 (36%), Gaps = 68/322 (21%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-------DFFDQSLDEIKLL 919
+ +Y V LGS F + + V +K ++ ++ + E+ LL
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 920 KYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQ 979
K V+ ++RL D+F + +++ E + F +
Sbjct: 62 KKVSSGFS----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELAR 113
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD-HLCSYVQS 1038
S Q LEA++ H G++H D+K ENIL+ +R E+K+ID GS D + +
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTVYTDFDGT 172
Query: 1039 RSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
R Y PE I Y + +WSLG +L ++ G++ F++D
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------------------- 213
Query: 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157
+E R + ++ S + L +
Sbjct: 214 ----------------------EEIIRGQVFFRQRVS---------SECQHLIRWCLALR 242
Query: 1158 PKKRPSASDALKHPWLSHPYEP 1179
P RP+ + HPW+ P
Sbjct: 243 PSDRPTFEEIQNHPWMQDVLLP 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 58/318 (18%), Positives = 109/318 (34%), Gaps = 62/318 (19%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKII--KNNKDFFDQSLDEIKLLKYVNKHD 926
+ + + LG A+ + A + T V VKI+ K D + EI + K +N H+
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 63
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
++++ Y + + E P Q Q +
Sbjct: 64 -----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLM 113
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF-----ETDHLCSYVQSRSY 1041
+ +LHG+G+ H D+KPEN+L+ R +K+ D G + L + Y
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 1042 RAPEVILGLSYD-KKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100
APE++ + + +D+WS G +L + G + + S
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS--------------------- 210
Query: 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160
++ + +K + + D + + +L NP
Sbjct: 211 --------------------DSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSA 250
Query: 1161 RPSASDALKHPWLSHPYE 1178
R + D K W + P +
Sbjct: 251 RITIPDIKKDRWYNKPLK 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 168 bits (427), Expect = 3e-47
Identities = 71/323 (21%), Positives = 122/323 (37%), Gaps = 72/323 (22%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----------NNKDFFDQSLDEIKLL 919
Y E LG S + T + VKII ++ + +L E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 920 KYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRL 978
+ V+ H ++++L D + +V +L+K L+++ +
Sbjct: 64 RKVSGHP-----NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKET 112
Query: 979 QSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF--ETDHLCSYV 1036
+ I LE + LH L ++H DLKPENIL+ +K+ D G SC + L
Sbjct: 113 RKIMRALLEVICALHKLNIVHRDLKPENILLD--DDMNIKLTDFGFSCQLDPGEKLREVC 170
Query: 1037 QSRSYRAPEVILG------LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090
+ SY APE+I Y K++D+WS G I+ L G+ F + +L ++
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-- 228
Query: 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFV 1150
+ ++ P+ D V
Sbjct: 229 -------------------------------SGNYQFGSPEWDDY-------SDTVKDLV 250
Query: 1151 AHLLEINPKKRPSASDALKHPWL 1173
+ L + P+KR +A +AL HP+
Sbjct: 251 SRFLVVQPQKRYTAEEALAHPFF 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 5e-47
Identities = 73/323 (22%), Positives = 127/323 (39%), Gaps = 58/323 (17%)
Query: 866 VIAGRYHVT-EYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNK 924
I Y VT + LG K +Q + T +K++++ E++L ++
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQ 63
Query: 925 HDPGDKYHLLRLYDYFYY----REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQ 979
H++R+ D + R+ LLIV E L L+ + G+ FT
Sbjct: 64 CP-----HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREAS 114
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYS-RCEVKVIDLGSSCFETDH--LCSYV 1036
I EA+Q+LH + + H D+KPEN+L S +K+ D G + T H L +
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 1037 QSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096
+ Y APEV+ YDK D+WSLG I+ L G F ++ + + I
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----- 229
Query: 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156
+ E+ P+ + + + + +LL+
Sbjct: 230 ------------------------RMGQYEFPNPEWSEV-------SEEVKMLIRNLLKT 258
Query: 1157 NPKKRPSASDALKHPWLSHPYEP 1179
P +R + ++ + HPW+ +
Sbjct: 259 EPTQRMTITEFMNHPWIMQSTKV 281
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-46
Identities = 68/318 (21%), Positives = 121/318 (38%), Gaps = 67/318 (21%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKH 925
+ + LG +FS + A +L T + +KI++ ++ E ++ ++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
++LY F E L K + S F + T +
Sbjct: 68 P-----FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEI 117
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF-----ETDHLCSYVQSRS 1040
+ AL++LHG G+IH DLKPENIL+ +++ D G++ + S+V +
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 1041 YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100
Y +PE++ S K D+W+LGCI+ +L G F+ + + ++I
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------------ 223
Query: 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160
+LEY P+K D V LL ++ K
Sbjct: 224 -----------------------KLEYDFPEKFF---------PKARDLVEKLLVLDATK 251
Query: 1161 RPSASDALKHPW-LSHPY 1177
R + + +HP+
Sbjct: 252 RLGCEEMEGYGPLKAHPF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 64/317 (20%), Positives = 116/317 (36%), Gaps = 67/317 (21%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHDP 927
Y V +G+ ++ + + G + K + + + E+ LL+ +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP-- 63
Query: 928 GDKYHLLRLYDYFYYRE--HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
+++R YD R L IV E + +L + Y + + Q
Sbjct: 64 ----NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ--YLDEEFVLRVMTQ 117
Query: 985 CLEALQFLH-----GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYV 1036
AL+ H G ++H DLKP N+ + + VK+ D G + +T ++V
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLARILNHDTSFAKAFV 175
Query: 1037 QSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096
+ Y +PE + +SY++K DIWSLGC+L ELC F S L ++
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--------- 226
Query: 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156
R + R+ Y + + + +L +
Sbjct: 227 ---------------------REGKFRRIPYRYSDE-------------LNEIITRMLNL 252
Query: 1157 NPKKRPSASDALKHPWL 1173
RPS + L++P +
Sbjct: 253 KDYHRPSVEEILENPLI 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (412), Expect = 5e-45
Identities = 78/314 (24%), Positives = 130/314 (41%), Gaps = 58/314 (18%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQS--LDEIKLLKYVNK 924
I Y + LG+ AFS+ I A D T V +K I + +EI +L +
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITI 983
H +++ L D + HL ++ +L+ L++ ++T +
Sbjct: 66 HP-----NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIF 114
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSR-CEVKVIDLGSSCFETDH--LCSYVQSRS 1040
Q L+A+++LH LG++H DLKPEN+L S ++ + D G S E L + +
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG 174
Query: 1041 YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100
Y APEV+ Y K +D WS+G I L G F +++ A L +++
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL------------ 222
Query: 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160
E+ P + DF+ HL+E +P+K
Sbjct: 223 ---------------------KAEYEFDSPYWDDI-------SDSAKDFIRHLMEKDPEK 254
Query: 1161 RPSASDALKHPWLS 1174
R + AL+HPW++
Sbjct: 255 RFTCEQALQHPWIA 268
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 160 bits (404), Expect = 1e-43
Identities = 66/307 (21%), Positives = 130/307 (42%), Gaps = 25/307 (8%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
Y + LG +S+ +A ++ V VKI+K K + EIK+L+ +
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGP--- 90
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
+++ L D N +F + + T ++ + L+AL
Sbjct: 91 --NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKAL 142
Query: 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF--ETDHLCSYVQSRSYRAPEVI 1047
+ H +G++H D+KP N+++ ++++ID G + F V SR ++ PE++
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201
Query: 1048 LGLS-YDKKIDIWSLGCILAELCTGNV-LFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105
+ YD +D+WSLGC+LA + F L R+ ++G + +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165
N +L +++ R E + + + +DF+ LL + + R +A
Sbjct: 262 ELDPRFNDILGRHSRK--RWERFVHSENQ-----HLVSPEALDFLDKLLRYDHQSRLTAR 314
Query: 1166 DALKHPW 1172
+A++HP+
Sbjct: 315 EAMEHPY 321
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 4e-43
Identities = 56/319 (17%), Positives = 115/319 (36%), Gaps = 65/319 (20%)
Query: 866 VIAGRY-HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKN---NKDFFDQSLDEIKLLKY 921
GR+ +G +F + D T ++V +++ K + +E ++LK
Sbjct: 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 64
Query: 922 VNKHDPGDKYHLLRLYDYFYY----REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPR 977
+ +++R YD + ++ +++V EL+ + + + + +
Sbjct: 65 LQHP------NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKV 113
Query: 978 LQSITIQCLEALQFLH--GLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLC-S 1034
L+S Q L+ LQFLH +IH DLK +NI + + VK+ DLG + + +
Sbjct: 114 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT-GSVKIGDLGLATLKRASFAKA 172
Query: 1035 YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPI 1094
+ + + APE+ YD+ +D+++ G + E+ T + A + R +
Sbjct: 173 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------ 225
Query: 1095 EQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLL 1154
+ K + + +
Sbjct: 226 --------------------------TSGVKPASFDKVAI---------PEVKEIIEGCI 250
Query: 1155 EINPKKRPSASDALKHPWL 1173
N +R S D L H +
Sbjct: 251 RQNKDERYSIKDLLNHAFF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-43
Identities = 67/318 (21%), Positives = 119/318 (37%), Gaps = 62/318 (19%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQS-------LDEIKLL 919
+ Y E LGS F+ + + TG+ K IK + + E+ +L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 920 KYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQ 979
K + H +++ L++ + + ++++ EL+ +ES T
Sbjct: 68 KEIQ-HP-----NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEAT 116
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILV--KSYSRCEVKVIDLGSSCF--ETDHLCSY 1035
Q L + +LH L + H DLKPENI++ ++ + +K+ID G + + +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095
+ + APE++ + D+WS+G I L +G F D+ LA V + E
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
DF+ LL
Sbjct: 237 ----------------------------------------DEYFSNTSALAKDFIRRLLV 256
Query: 1156 INPKKRPSASDALKHPWL 1173
+PKKR + D+L+HPW+
Sbjct: 257 KDPKKRMTIQDSLQHPWI 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (386), Expect = 2e-41
Identities = 57/313 (18%), Positives = 110/313 (35%), Gaps = 66/313 (21%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKHD 926
+ + LG+ +F + H G +K++K + + DE +L V H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 64
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
++R++ F + + ++ + ++ + F P + +
Sbjct: 65 -----FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVC 114
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEV 1046
AL++LH +I+ DLKPENIL+ +K+ D G + + D + + Y APEV
Sbjct: 115 LALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEV 172
Query: 1047 ILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTY 1106
+ Y+K ID WS G ++ E+ G F + + +++
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL------------------ 214
Query: 1107 KYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKR----- 1161
E P + + D ++ L+ + +R
Sbjct: 215 -----------------NAELRFPPFFN---------EDVKDLLSRLITRDLSQRLGNLQ 248
Query: 1162 PSASDALKHPWLS 1174
D HPW
Sbjct: 249 NGTEDVKNHPWFK 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (380), Expect = 4e-41
Identities = 66/321 (20%), Positives = 112/321 (34%), Gaps = 63/321 (19%)
Query: 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLK 920
S ++ RY + E LG S+ A DL DV VK+++ + F+ + E +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 921 YVNKHDPGDKYHLLRLYDYFYYREH----LLIVCELLKANLYEFHKFNRESGGEVYFTMP 976
+N H ++ +YD IV E + T
Sbjct: 63 ALN-HP-----AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPK 111
Query: 977 RLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID----LGSSCFETDHL 1032
R + +AL F H G+IH D+KP NI++ + + +V + S
Sbjct: 112 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 1033 CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092
+ + + Y +PE G S D + D++SLGC+L E+ TG F DSP ++ + +
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---- 227
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
R + + P R V
Sbjct: 228 -------------------------------REDPIPP-----SARHEGLSADLDAVVLK 251
Query: 1153 LLEINPKKRPSASDALKHPWL 1173
L NP+ R + ++ +
Sbjct: 252 ALAKNPENRYQTAAEMRADLV 272
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (381), Expect = 5e-41
Identities = 51/327 (15%), Positives = 108/327 (33%), Gaps = 61/327 (18%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD 926
+ RY + +GS +F D+ G +V +K+ Q E K+ K +
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGG- 62
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
+ + ++ ++V ELL +L + F F++ + + Q +
Sbjct: 63 ----VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQMI 113
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRC-EVKVIDLGSSCFETD----------HLCSY 1035
++++H IH D+KP+N L+ + V +ID G + D +
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 1036 VQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095
+ Y + LG+ ++ D+ SLG +L G++ +Q AT +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-------- 225
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
+ + + L P + F ++
Sbjct: 226 ---------------ERISEKKMSTPIEVLCKGYPSE-------------FATYLNFCRS 257
Query: 1156 INPKKRPSAS---DALKHPWLSHPYEP 1179
+ +P S ++ + +
Sbjct: 258 LRFDDKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-40
Identities = 62/313 (19%), Positives = 105/313 (33%), Gaps = 64/313 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKH 925
+ + + LG +F K A T +K +K + D + ++ E ++L +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
L ++ F +E+L V E L +H + F + R +
Sbjct: 63 P-----FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEI 112
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF---ETDHLCSYVQSRSYR 1042
+ LQFLH G+++ DLK +NIL+ K+ D G ++ + Y
Sbjct: 113 ILGLQFLHSKGIVYRDLKLDNILLDKDGHI--KIADFGMCKENMLGDAKTNTFCGTPDYI 170
Query: 1043 APEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102
APE++LG Y+ +D WS G +L E+ G F L +
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-------------- 216
Query: 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162
P+ + D + L P+KR
Sbjct: 217 ---------------------MDNPFYPRWLE---------KEAKDLLVKLFVREPEKRL 246
Query: 1163 SA-SDALKHPWLS 1174
D +HP
Sbjct: 247 GVRGDIRQHPLFR 259
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (371), Expect = 1e-39
Identities = 46/238 (19%), Positives = 87/238 (36%), Gaps = 24/238 (10%)
Query: 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKH 925
V+ Y V +G +F + +L V +K D Q DE + K +
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGC 60
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
+ +Y + H ++V +LL +L + F++ + Q
Sbjct: 61 T-----GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQM 110
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCE---VKVIDLGSSCFETD----------HL 1032
L +Q +H L++ D+KP+N L+ + + V+D G F D
Sbjct: 111 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 1033 CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGI 1090
+ + Y + LG ++ D+ +LG + G++ +Q AT + I
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (358), Expect = 3e-37
Identities = 60/316 (18%), Positives = 114/316 (36%), Gaps = 62/316 (19%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKH 925
+ V +G F + TG +K + K +L+E +L V+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST- 63
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQC 985
GD ++ + F+ + L + +L+ +H E ++ +
Sbjct: 64 --GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-----ADMRFYAAEI 116
Query: 986 LEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC-FETDHLCSYVQSRSYRAP 1044
+ L+ +H +++ DLKP NIL+ + V++ DLG +C F + V + Y AP
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKKKPHASVGTHGYMAP 174
Query: 1045 EVIL-GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103
EV+ G++YD D +SLGC+L +L G+ F+
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--------------------- 213
Query: 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163
+E ++ T + +P S + LL+ + +R
Sbjct: 214 -----------KHEIDRMTLTMAVELPDSFS---------PELRSLLEGLLQRDVNRRLG 253
Query: 1164 -----ASDALKHPWLS 1174
A + + P+
Sbjct: 254 CLGRGAQEVKESPFFR 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 61/314 (19%), Positives = 106/314 (33%), Gaps = 67/314 (21%)
Query: 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKH 925
G+ V + +GS +F + DV VK++ +E+ +L+ H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-H 63
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
++L + L IV + + ++LY F M +L I Q
Sbjct: 64 V-----NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQ 112
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF-----ETDHLCSYVQSR 1039
+ + +LH +IH DLK NI + VK+ D G + + S
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 1040 SYRAPEVILGLS---YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096
+ APEVI Y + D+++ G +L EL TG + + N + + ++
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV-------- 222
Query: 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156
YL P + +R P + +A L+
Sbjct: 223 ---------------------------GRGYLSPDLSKVRSNCP---KAMKRLMAECLKK 252
Query: 1157 NPKKRPSASDALKH 1170
+RP L
Sbjct: 253 KRDERPLFPQILAS 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-37
Identities = 61/316 (19%), Positives = 110/316 (34%), Gaps = 69/316 (21%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHD 926
+ + LG F K I + TG +KI++ KD ++ E ++L+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP- 65
Query: 927 PGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCL 986
L L F + L V E FH FT R + + +
Sbjct: 66 -----FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIV 115
Query: 987 EALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS---CFETDHLCSYVQSRSYRA 1043
AL++LH +++ D+K EN+++ +K+ D G + + ++ + Y A
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 1044 PEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103
PEV+ Y + +D W LG ++ E+ G + F N L ++
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--------------- 218
Query: 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS 1163
E P+ S +A LL+ +PK+R
Sbjct: 219 --------------------MEEIRFPRTLS---------PEAKSLLAGLLKKDPKQRLG 249
Query: 1164 -----ASDALKHPWLS 1174
A + ++H +
Sbjct: 250 GGPSDAKEVMEHRFFL 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 7e-37
Identities = 53/303 (17%), Positives = 101/303 (33%), Gaps = 59/303 (19%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
+ + +G F + + G V VK IKN+ L E ++ + H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATA-QAFLAEASVMTQLR-HS--- 60
Query: 930 KYHLLRLYDYFY-YREHLLIVCELL-KANLYEFHKFNRESGGEVYFTMPRLQSITIQCLE 987
+L++L + L IV E + K +L ++ + S G L ++ E
Sbjct: 61 --NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVCE 114
Query: 988 ALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVI 1047
A+++L G +H DL N+LV KV D G + + + + APE +
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEAL 172
Query: 1048 LGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDTYK 1107
+ K D+WS G +L E+ + + P
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------------------------- 205
Query: 1108 YFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167
+ R ++ +++ P + + + ++ RPS
Sbjct: 206 ----LKDVVPRVEKGYKMD--APDGCP---------PAVYEVMKNCWHLDAAMRPSFLQL 250
Query: 1168 LKH 1170
+
Sbjct: 251 REQ 253
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 5e-36
Identities = 57/320 (17%), Positives = 99/320 (30%), Gaps = 66/320 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
+ LG F + T V +K +K + L E +++K +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHE---- 72
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
L++LY ++ + K +L +F K Y +P+L + Q +
Sbjct: 73 --KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGM 126
Query: 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF----ETDHLCSYVQSRSYRAPE 1045
++ + +H DL+ NILV KV D G + E + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 1046 VILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104
L + K D+WS G +L EL T G V + +L +V
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---------------- 228
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
P + + D + P++RP+
Sbjct: 229 ------------------RGYRMPCPPECP---------ESLHDLMCQCWRKEPEERPTF 261
Query: 1165 SDALK--HPWLSH---PYEP 1179
+ + Y+P
Sbjct: 262 EYLQAFLEDYFTSTEPQYQP 281
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (346), Expect = 7e-36
Identities = 64/320 (20%), Positives = 118/320 (36%), Gaps = 66/320 (20%)
Query: 864 NSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLL 919
N+ ++ + LG+ +F + + +G +KI+ K + +L+E ++L
Sbjct: 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 920 KYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQ 979
+ VN L++L F +L +V E + H F+ P +
Sbjct: 96 QAVNFP------FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHAR 144
Query: 980 SITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSR 1039
Q + ++LH L LI+ DLKPEN+L+ + ++V D G + + +
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGRTWTLCGTP 202
Query: 1040 SYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099
APE+IL Y+K +D W+LG ++ E+ G F D P +
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY--------------- 247
Query: 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159
++ + P S D + +LL+++
Sbjct: 248 --------------------EKIVSGKVRFPSHFS---------SDLKDLLRNLLQVDLT 278
Query: 1160 KR-----PSASDALKHPWLS 1174
KR +D H W +
Sbjct: 279 KRFGNLKNGVNDIKNHKWFA 298
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 51/305 (16%), Positives = 98/305 (32%), Gaps = 61/305 (20%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDK 930
+ LG+ F DV +K+IK D+ ++E K++ ++ H+
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HE---- 59
Query: 931 YHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQ 990
L++LY + + I+ E + + F +L + EA++
Sbjct: 60 -KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAME 114
Query: 991 FLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD----HLCSYVQSRSYRAPEV 1046
+L +H DL N LV + VKV D G S + D + PEV
Sbjct: 115 YLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 1047 ILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105
++ + K DIW+ G ++ E+ + G + ++ + + +
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA----------------- 215
Query: 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165
L P S + + +RP+
Sbjct: 216 -----------------QGLRLYRPHLAS---------EKVYTIMYSCWHEKADERPTFK 249
Query: 1166 DALKH 1170
L +
Sbjct: 250 ILLSN 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-33
Identities = 53/305 (17%), Positives = 98/305 (32%), Gaps = 59/305 (19%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
+ +GS F + L V +K I+ + ++E +++ ++ H
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HP--- 60
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
L++LY + + +V E ++ + + F L + + E +
Sbjct: 61 --KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGM 114
Query: 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD----HLCSYVQSRSYRAPE 1045
+L +IH DL N LV +KV D G + F D + +PE
Sbjct: 115 AYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 1046 VILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105
V Y K D+WS G ++ E+ + + +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------------------------- 207
Query: 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165
N + E RL P+ S + H + P+ RP+ S
Sbjct: 208 ------NSEVVEDISTGFRLY--KPRLASTH---------VYQIMNHCWKERPEDRPAFS 250
Query: 1166 DALKH 1170
L+
Sbjct: 251 RLLRQ 255
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-33
Identities = 69/324 (21%), Positives = 121/324 (37%), Gaps = 71/324 (21%)
Query: 870 RYHVTEYLGSAAFS---KAIQAHDLHTGMDVCVKIIK-----NNKDFFDQSLDEIKLLKY 921
+ + + LG+ A+ + TG +K++K + + E ++L++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 922 VNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSI 981
+ + L+ L+ F L ++ + + H RE FT +Q
Sbjct: 85 IRQSP-----FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIY 134
Query: 982 TIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF----ETDHLCSYVQ 1037
+ + AL+ LH LG+I+ D+K ENIL+ S V + D G S ET+ +
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 1038 SRSYRAPEVILGL--SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095
+ Y AP+++ G +DK +D WSLG ++ EL TG F D A +
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS------- 245
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
+ + E P++ S D + LL
Sbjct: 246 ------------------------RRILKSEPPYPQEMS---------ALAKDLIQRLLM 272
Query: 1156 INPKKRPS-----ASDALKHPWLS 1174
+PKKR A + +H +
Sbjct: 273 KDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 9e-33
Identities = 56/312 (17%), Positives = 98/312 (31%), Gaps = 63/312 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
+ E LG+ F + + + V VK +K D L E L+K + H
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQ--- 68
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
L+RLY +E + I+ E ++ T+ +L + Q E +
Sbjct: 69 --RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGM 122
Query: 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF----ETDHLCSYVQSRSYRAPE 1045
F+ IH DL+ NILV C K+ D G + E + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSC--KIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 1046 VILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104
I ++ K D+WS G +L E+ T G + + + ++ +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------------- 223
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
+ P + + + P+ RP+
Sbjct: 224 -----------------ERGYRMVRPDNCP---------EELYQLMRLCWKERPEDRPTF 257
Query: 1165 SDALK--HPWLS 1174
+ +
Sbjct: 258 DYLRSVLEDFFT 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-32
Identities = 56/331 (16%), Positives = 103/331 (31%), Gaps = 78/331 (23%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTG-----MDVCVKIIKNNKD--FFDQSLDEIKLLKYV 922
+ LGS AF K + A + V VK++K D + + E+K++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESGGEV---------- 971
H+ +++ L + ++ E +L + + RE E
Sbjct: 98 GSHE-----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 972 -------YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024
T L Q + ++FL +H DL N+LV VK+ D G
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT--HGKVVKICDFGL 210
Query: 1025 SCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS 1079
+ + + APE + Y K D+WS G +L E
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE------------ 258
Query: 1080 PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRL 1139
+ + G + Y + Y+ Q +++ P +
Sbjct: 259 ------------------IFSLGVNPYPGIPVDANFYKLIQNGFKMD--QPFYAT----- 293
Query: 1140 PMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170
+ + + +KRPS +
Sbjct: 294 ----EEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (309), Expect = 1e-31
Identities = 48/304 (15%), Positives = 91/304 (29%), Gaps = 57/304 (18%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGD 929
+ LG + + + + V VK +K + ++ L E ++K + H
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP--- 73
Query: 930 KYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEAL 989
+L++L I+ E + + + L + Q A+
Sbjct: 74 --NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAM 128
Query: 990 QFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDH----LCSYVQSRSYRAPE 1045
++L IH DL N LV VKV D G S T + APE
Sbjct: 129 EYLEKKNFIHRDLAARNCLVG--ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 1046 VILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRDT 1105
+ + K D+W+ G +L E+ T + + + ++
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----------------- 229
Query: 1106 YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS 1165
P+ + + + + NP RPS +
Sbjct: 230 ----------------EKDYRMERPEGCP---------EKVYELMRACWQWNPSDRPSFA 264
Query: 1166 DALK 1169
+ +
Sbjct: 265 EIHQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 53/315 (16%), Positives = 100/315 (31%), Gaps = 69/315 (21%)
Query: 870 RYHVTEYLGSAAFS---KAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYV 922
+ E LG +F + + V VK +K + + D + E+ + +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSIT 982
+ H +L+RLY ++ +L + + ++ F + L
Sbjct: 69 D-HR-----NLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRYA 117
Query: 983 IQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS-- 1040
+Q E + +L IH DL N+L+ +R VK+ D G + YV
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 1041 ----YRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIE 1095
+ APE + ++ D W G L E+ T G + + + +L ++
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------- 228
Query: 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155
+E RL P+ Q + +
Sbjct: 229 ------------------------KEGERLP--RPEDCP---------QDIYNVMVQCWA 253
Query: 1156 INPKKRPSASDALKH 1170
P+ RP+
Sbjct: 254 HKPEDRPTFVALRDF 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 8e-31
Identities = 55/311 (17%), Positives = 106/311 (34%), Gaps = 66/311 (21%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTG----MDVCVKIIK--NNKDFFDQSLDEIKLLKYVNK 924
+ + LGS AF + + G + V +K ++ + + LDE ++ V+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
H+ RL LI + L ++ + ++++ G L + +Q
Sbjct: 71 P------HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGS-----QYLLNWCVQ 119
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF-----ETDHLCSYVQSR 1039
+ + +L L+H DL N+LVK+ VK+ D G + + H
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 1040 SYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099
+ A E IL Y + D+WS G + EL T + PA+ ++ ++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----------- 226
Query: 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159
++ RL P ++ + I+
Sbjct: 227 --------------------EKGERLP--QPPICTID---------VYMIMVKCWMIDAD 255
Query: 1160 KRPSASDALKH 1170
RP + +
Sbjct: 256 SRPKFRELIIE 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 47/313 (15%), Positives = 99/313 (31%), Gaps = 72/313 (23%)
Query: 877 LGSAAFSKAIQA--HDLHTGMDVCVKIIK---NNKDFFDQSLDEIKLLKYVNKHDPGDKY 931
LGS F + V VKI+K N+ D+ L E +++ ++ +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NP----- 68
Query: 932 HLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
+++R+ E ++V E+ + + + + + Q +++
Sbjct: 69 YIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKY 122
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS------YRAPE 1045
L +H DL N+L+ ++ K+ D G S Y + APE
Sbjct: 123 LEESNFVHRDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 1046 VILGLSYDKKIDIWSLGCILAE-LCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104
I + K D+WS G ++ E G ++ + + A +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML----------------- 223
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
++ R+ P + D + + + RP
Sbjct: 224 ---------------EKGERMG--CPAGCP---------REMYDLMNLCWTYDVENRPGF 257
Query: 1165 SD---ALKHPWLS 1174
+ L++ +
Sbjct: 258 AAVELRLRNYYYD 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 54/318 (16%), Positives = 96/318 (30%), Gaps = 66/318 (20%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIK----NNKDFFDQSLDEIKLLKYVNKH 925
+ +G F + ++A G+ + I + +KD E+++L + H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 926 DPGDKYHLLRLYDYFYYREHLLIVCELLKA-NLYEFHK----------FNRESGGEVYFT 974
+++ L +R +L + E NL +F + F + +
Sbjct: 71 P-----NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 975 MPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCS 1034
+L + +L IH DL NILV K+ D G S + ++
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG--ENYVAKIADFGLSRGQEVYVKK 183
Query: 1035 YVQ--SRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092
+ + A E + Y D+WS G +L E+ +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-------------- 229
Query: 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAH 1152
LYE+ + RLE P D +
Sbjct: 230 -----------------MTCAELYEKLPQGYRLE--KPLNCD---------DEVYDLMRQ 261
Query: 1153 LLEINPKKRPSASDALKH 1170
P +RPS + L
Sbjct: 262 CWREKPYERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-30
Identities = 65/325 (20%), Positives = 112/325 (34%), Gaps = 73/325 (22%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLH-----TGMDVCVKIIKNNKDFFDQS--LDEIKLLKYV 922
R + LG+ AF K ++A M V VK++K + ++ + E+K+L Y+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESG------------G 969
H +++ L L++ E +L F + R+S
Sbjct: 84 GNHM-----NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 970 EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029
E+ + L S + Q + + FL IH DL NIL+ K+ D G +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIK 196
Query: 1030 DHLCSYVQSRS-----YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLL 1084
+ V+ + + APE I Y + D+WS G L EL +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL------------- 243
Query: 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQ 1144
G Y + Y+ +E R+ L P+
Sbjct: 244 -----------------GSSPYPGMPVDSKFYKMIKEGFRM--LSPEHAP---------A 275
Query: 1145 GFIDFVAHLLEINPKKRPSASDALK 1169
D + + +P KRP+ ++
Sbjct: 276 EMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 50/313 (15%), Positives = 103/313 (32%), Gaps = 72/313 (23%)
Query: 877 LGSAAFSKAIQAHDLHT--GMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNKHDPGDKYH 932
LG F Q +DV +K++K K ++ + E +++ ++ + +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NP-----Y 70
Query: 933 LLRLYDYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQF 991
++RL L++V E+ L++F RE + + + Q +++
Sbjct: 71 IVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREE-----IPVSNVAELLHQVSMGMKY 124
Query: 992 LHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS------YRAPE 1045
L +H DL N+L+ +R K+ D G S Y + + APE
Sbjct: 125 LEEKNFVHRDLAARNVLLV--NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 1046 VILGLSYDKKIDIWSLGCILAE-LCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104
I + + D+WS G + E L G ++ ++A +
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI----------------- 225
Query: 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164
++ R+E P + ++ + RP
Sbjct: 226 ---------------EQGKRME--CPPECP---------PELYALMSDCWIYKWEDRPDF 259
Query: 1165 SD---ALKHPWLS 1174
++ + S
Sbjct: 260 LTVEQRMRACYYS 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (295), Expect = 1e-29
Identities = 49/336 (14%), Positives = 102/336 (30%), Gaps = 74/336 (22%)
Query: 857 KNFHVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMD---VCVKIIKNN--KDFFDQ 911
+ F + + + +G+ F + H G V +K +K+ +
Sbjct: 17 REFA---KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD 73
Query: 912 SLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEV 971
L E ++ + H +++ L ++I+ E ++ + +
Sbjct: 74 FLSEASIMGQFD-HP-----NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---- 123
Query: 972 YFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD- 1030
FT+ +L + +++L + +H DL NILV S KV D G S F D
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN--SNLVCKVSDFGLSRFLEDD 181
Query: 1031 -------HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPAT 1082
+ APE I + D+WS G ++ E+ + G + + +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMG 1142
++ + ++ RL P
Sbjct: 242 VINAI--------------------------------EQDYRLP--PPMDCP-------- 259
Query: 1143 DQGFIDFVAHLLEINPKKRPSASDALKH--PWLSHP 1176
+ + + RP + + +P
Sbjct: 260 -SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 57/324 (17%), Positives = 107/324 (33%), Gaps = 70/324 (21%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMD-------VCVKIIKNN--KDFFDQSLDEIKLLK 920
R + + LG AF + + A + D V VK++K++ + + E++++K
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 921 YVNKHDPGDKYHLLRLYDYFYYREHLLIVCELL-KANLYEFHKFNRESG----------G 969
+ KH +++ L L ++ E K NL E+ + R G
Sbjct: 74 MIGKHK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 970 EVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFET 1029
E + L S Q +++L IH DL N+LV + ++ L
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 1030 D---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLAR 1086
D + + APE + Y + D+WS G +L E+ T P
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 242
Query: 1087 VIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGF 1146
L++ +E +R++ P +
Sbjct: 243 -------------------------VEELFKLLKEGHRMD--KPSNCT---------NEL 266
Query: 1147 IDFVAHLLEINPKKRPSASDALKH 1170
+ P +RP+ ++
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-28
Identities = 50/322 (15%), Positives = 100/322 (31%), Gaps = 51/322 (15%)
Query: 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHD 926
IA + E +G F + + G +V VKI + ++ EI + H+
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLR-HE 57
Query: 927 PGDKYHLLRLYDYFYYRE----HLLIVCELLKA-NLYEF-HKFNRESGGEVYFTMPRLQS 980
++L L +V + + +L+++ +++ G + +
Sbjct: 58 -----NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG 112
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSY----- 1035
+ +E + + H DLK +NILVK + DLG + +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVK--KNGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 1036 --VQSRSYRAPEVILG------LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARV 1087
V ++ Y APEV+ K+ DI+++G + E+ +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED------- 223
Query: 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFI 1147
+ Y + E ++ + L P +
Sbjct: 224 --------------YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV-MA 268
Query: 1148 DFVAHLLEINPKKRPSASDALK 1169
+ N R +A K
Sbjct: 269 KIMRECWYANGAARLTALRIKK 290
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-28
Identities = 51/310 (16%), Positives = 91/310 (29%), Gaps = 64/310 (20%)
Query: 870 RYHVTEYLGSAAFS---KAIQAHDLHTGMDVCVKIIKN--NKDFFDQSLDEIKLLKYVNK 924
R + +G F + I + + V +K KN + ++ L E ++ +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD- 66
Query: 925 HDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQ 984
H H+++L +I+ L F + + S + L Q
Sbjct: 67 HP-----HIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQ 116
Query: 985 CLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD----HLCSYVQSRS 1040
AL +L +H D+ N+LV S VK+ D G S + D
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 1041 YRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100
+ APE I + D+W G + E+ V
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------------------- 214
Query: 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160
N+ + R + RL +P + +P +
Sbjct: 215 -----------NNDVIGRIENGERLP--MPPNCP---------PTLYSLMTKCWAYDPSR 252
Query: 1161 RPSASDALKH 1170
RP ++
Sbjct: 253 RPRFTELKAQ 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 52/332 (15%), Positives = 92/332 (27%), Gaps = 73/332 (21%)
Query: 870 RYHVTEYLGSAAFS---KAIQAHDLHTGMDVCVKIIK--NNKDFFDQSLDEIKLLKYVNK 924
H E +G F + + VK + + Q L E ++K +
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 925 HDPGDKYHLLRLYDYFYYRE-HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
++L L E L+V +K N T+ L +
Sbjct: 88 P------NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGL 137
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD-------HLCSYV 1036
Q + ++FL +H DL N ++ + VKV D G + D +
Sbjct: 138 QVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 1037 QSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096
+ A E + + K D+WS G +L EL T D + +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------- 247
Query: 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156
L P+ + +
Sbjct: 248 -------------------------LQGRRLLQPEYCP---------DPLYEVMLKCWHP 273
Query: 1157 NPKKRPSASDALKH------PWLSHPYEPISA 1182
+ RPS S+ + ++ Y ++A
Sbjct: 274 KAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 305
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (277), Expect = 3e-27
Identities = 51/332 (15%), Positives = 92/332 (27%), Gaps = 83/332 (25%)
Query: 870 RYHVTEYLGSAAFSKAIQAH-----DLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYV 922
+G AF + QA V VK++K D E L+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCELL-KANLYEF------------------HKF 963
+ ++++L + + ++ E + +L EF +
Sbjct: 74 DNP------NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 964 NRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023
S G + I Q + +L +H DL N LV VK+ D G
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG--ENMVVKIADFG 185
Query: 1024 SSCF-----ETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVL-FQN 1077
S + + PE I Y + D+W+ G +L E+ + + +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 1078 DSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRH 1137
+ ++ V ++ N L P+ L
Sbjct: 246 MAHEEVIYYV--------------------------------RDGNILA--CPENCPLE- 270
Query: 1138 RLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169
+ + P RPS +
Sbjct: 271 --------LYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 48/321 (14%), Positives = 98/321 (30%), Gaps = 68/321 (21%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTG----MDVCVKIIKN--NKDFFDQSLDEIKLLKYVN 923
+ +G+ F + + + + V +K +K + L E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 924 KHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITI 983
H +++RL + ++I+ E ++ + ++ F++ +L +
Sbjct: 68 HH------NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLR 117
Query: 984 QCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF------ETDHLCSYVQ 1037
+++L + +H DL NILV S KV D G S T
Sbjct: 118 GIAAGMKYLANMNYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 1038 SRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097
+ APE I + D+WS G ++ E+ T +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----------------- 218
Query: 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEIN 1157
NH + + + RL P + +
Sbjct: 219 --------------NHEVMKAINDGFRLPT--PMDCPSA---------IYQLMMQCWQQE 253
Query: 1158 PKKRPSASDALK--HPWLSHP 1176
+RP +D + + P
Sbjct: 254 RARRPKFADIVSILDKLIRAP 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 5e-26
Identities = 61/325 (18%), Positives = 107/325 (32%), Gaps = 72/325 (22%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLH-----TGMDVCVKIIKNN--KDFFDQSLDEIKLLKYV 922
R + + LG AF + I+A T V VK++K + E+K+L ++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 923 NKHDPGDKYHLLRLYDYFYY-REHLLIVCELL-----------KANLYEFHKFNRESGGE 970
H +++ L L+++ E K N + +K E +
Sbjct: 74 GHH-----LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 971 VYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETD 1030
+ T+ L + Q + ++FL IH DL NIL+ + VK+ D G +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS--EKNVVKICDFGLARDIYK 186
Query: 1031 -----HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLA 1085
+ APE I Y + D+WS G +L E+ +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---------- 236
Query: 1086 RVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQG 1145
Y + R +E R+ P T+
Sbjct: 237 --------------------YPGVKIDEEFCRRLKEGTRMR--APDYTT---------PE 265
Query: 1146 FIDFVAHLLEINPKKRPSASDALKH 1170
+ P +RP+ S+ ++H
Sbjct: 266 MYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 8e-26
Identities = 52/329 (15%), Positives = 105/329 (31%), Gaps = 71/329 (21%)
Query: 870 RYHVTEYLGSAAFSKAIQAHDLHTGMD-----VCVKIIKNNKDFFDQS--LDEIKLLKYV 922
+ ++ LG +F + D V +K + ++ L+E ++K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 923 NKHDPGDKYHLLRLYDYFYYREHLLIVCEL-----LKANLYEFHKFNRESGGEVYFTMPR 977
N H H++RL + L++ EL LK+ L + ++ +
Sbjct: 81 NCH------HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 978 LQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHL---CS 1034
+ + + + + +L+ +H DL N +V ++ + +ETD+
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 1035 YVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVL-FQNDSPATLLARVIGIIGP 1093
+ + +PE + + D+WS G +L E+ T +Q S +L V+
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM----- 249
Query: 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHL 1153
E L+ P + +
Sbjct: 250 ---------------------------EGGLLD--KPDNCP---------DMLFELMRMC 271
Query: 1154 LEINPKKRPSASDALK------HPWLSHP 1176
+ NPK RPS + + P
Sbjct: 272 WQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.4 bits (169), Expect = 7e-14
Identities = 32/212 (15%), Positives = 60/212 (28%), Gaps = 37/212 (17%)
Query: 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFF----------DQSLDEIKLLK 920
+ + +G S + + VK K F D + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 921 YVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQS 980
N+ K L + + + + ++ E +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVL---------MELIDAKELY----RVRVENPDE 107
Query: 981 ITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRS 1040
+ LE + + G++H DL N+LV S + +ID S E R
Sbjct: 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLV---SEEGIWIIDFPQSV-EVGE----EGWRE 159
Query: 1041 Y--RAPEVIL---GLSYDKKIDIWSLGCILAE 1067
R I+ +Y + DI S + +
Sbjct: 160 ILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1182 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.06 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.33 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.6 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.9 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=438.45 Aligned_cols=249 Identities=25% Similarity=0.450 Sum_probs=216.6
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||+|+||+||+|+++.+++.||||++.+.. .....+.+|+.+++.++| ||||+++++|.+..
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~~~~~~~~~~ 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH------PNILRLYGYFHDAT 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC------TTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCC------CCCCeEEEEEEECC
Confidence 67999999999999999999999999999999997542 334567789999998865 49999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++||||||+.| +|..++..... +++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~------l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~~kl~DFG 151 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFG 151 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCC
T ss_pred EEEEEEeecCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecC--CCCEeecccc
Confidence 99999999985 67777765432 899999999999999999999999999999999999984 6789999999
Q ss_pred CccccCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1024 SSCFETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1024 LA~~~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
+|..... .....+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.+..+++.++.....+
T Consensus 152 ~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--------- 222 (263)
T d2j4za1 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------- 222 (263)
T ss_dssp SCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---------
T ss_pred eeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 9976543 345678999999999999999999999999999999999999999999888887776421111
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
+| ...++++++||.+||++||.+|||+.|||+||||+.
T Consensus 223 --------------------------~p---------~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 --------------------------FP---------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp --------------------------CC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred --------------------------CC---------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 11 235789999999999999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=449.88 Aligned_cols=292 Identities=24% Similarity=0.347 Sum_probs=211.1
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
+..++|++++.||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.+|+.++ |||||+++++|.+.
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN------SPYIVGFYGAFYSD 76 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC------CTTBCCEEEEEECS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC------CCCCCcEEEEEEEC
Confidence 3467899999999999999999999999999999999764 334567788999988875 45999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccEEEccCCCceEEEec
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
.++||||||+.| +|.+++.... .+++..++.++.||+.||.|||+ +||+||||||+||||+. ++.+||+|
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~--~~~vkl~D 148 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCD 148 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT--TCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC--CCCEEEee
Confidence 999999999996 6777776443 28999999999999999999997 59999999999999984 77899999
Q ss_pred CCCccccCC-CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhhcCCcchhhh
Q 001034 1022 LGSSCFETD-HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATL-LARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1022 FGLA~~~~~-~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~el-LakIv~ilGp~PeemL 1099 (1182)
||+|+.... ...+.+||+.|+|||++.+..|+.++||||||||+|||++|+.||.+.+.... ...+....+.......
T Consensus 149 FGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 149 FGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp CCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred CCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence 999985433 34567999999999999999999999999999999999999999987654332 1112222222111000
Q ss_pred h---cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1100 A---KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1100 ~---~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
. ............. ........+.. +.............+.++++||.+||++||.+||||.|||+||||+.
T Consensus 229 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSR---PPMAIFELLDY-IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------------------CCCCHHHHHHH-HHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccccccc---cchhHHHHHhh-hhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0 0000000000000 00000000000 00000001111245789999999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=437.16 Aligned_cols=279 Identities=27% Similarity=0.436 Sum_probs=225.0
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEEeccch------hhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 873 VTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD------FFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 873 Ilk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~------~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.+++||+|+||+||+|+++.+|+.||||+++.... ....+.+|+.+|+.++|+ |||+++++|....++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~~~~~~~~~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP------NIIGLLDAFGHKSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCT------TBCCEEEEECCTTCC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCC------CEeEEEeeeccCCce
Confidence 46899999999999999999999999999875431 234678899999998654 999999999999999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
||||||+.++++..+.... ..+++..++.+++||+.||.|||++||+||||||+|||++. .+.+||+|||+++
T Consensus 76 ~ivmE~~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~--~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAK 148 (299)
T ss_dssp EEEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECCCGGGS
T ss_pred eehhhhhcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecC--CCccccccCcccc
Confidence 9999999988777665432 23888999999999999999999999999999999999994 7789999999997
Q ss_pred ccCC---CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1027 FETD---HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1027 ~~~~---~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
.... .....+||+.|+|||++... .|+.++|||||||++|+|++|.+||.+.+..+++.+|...++.++...+...
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 149 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence 6543 23456899999999999754 6899999999999999999999999999999999999998887766543322
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPI 1180 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP~ 1180 (1182)
........ ........+....+..+.++++||.+||++||++||||.|||+||||++...|.
T Consensus 229 ~~~~~~~~----------------~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 229 CSLPDYVT----------------FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp TSSTTCCC----------------CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred hccchhhh----------------hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 11110000 000001122233456789999999999999999999999999999999876553
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=437.91 Aligned_cols=256 Identities=22% Similarity=0.337 Sum_probs=208.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
+.++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+|+.+|+.++| ||||+++++|.+..
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~H------pnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH------ENVVKFYGHRREGN 76 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCC------TTBCCEEEEEEETT
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCC------CCEeeEeeeeccCc
Confidence 3468999999999999999999999999999999997653 234567899999998864 59999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+||||||+.| +|.+++.... .+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~--~~~~KL~DFG 148 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFG 148 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCT
T ss_pred eeEEEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECC--CCCEEEccch
Confidence 99999999985 7777765332 3899999999999999999999999999999999999984 6789999999
Q ss_pred CccccCC-----CcccccCCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1024 SSCFETD-----HLCSYVQSRSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1024 LA~~~~~-----~~ss~vGTp~YmAPEVLlg~~y-S~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
+|+.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|++||...+..............
T Consensus 149 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~---- 224 (271)
T d1nvra_ 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---- 224 (271)
T ss_dssp TCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT----
T ss_pred hheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----
Confidence 9976432 2346789999999999998876 57899999999999999999999765432222111100000
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
.......++.++++||.+||+.||.+|||+.|||+||||+++.
T Consensus 225 -------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 225 -------------------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp -------------------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -------------------------------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 0001123478999999999999999999999999999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=430.23 Aligned_cols=285 Identities=27% Similarity=0.432 Sum_probs=230.1
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCC-CcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHT-GMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~T-Gr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++++.||+|+||+||+|++..+ ++.||||+++... .......+|+.+|+.+... .||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~---~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhc---CCCCcceeeeeeccc
Confidence 46899999999999999999999765 6789999997542 2334567888888888643 477999999999643
Q ss_pred -----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 944 -----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 944 -----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
.++|+||||+.++++.+....... .+++..++.++.||+.||.|||++|||||||||+|||++. .+.+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~--~~~~k 156 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIK 156 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEE
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcC--CCCee
Confidence 579999999999887766544322 3899999999999999999999999999999999999984 67899
Q ss_pred EecCCCccccC--CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1019 VIDLGSSCFET--DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1019 LiDFGLA~~~~--~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
|+|||++.... ......+||+.|+|||++.+.+|+.++|||||||++|||++|++||.+.+..+++.+|+..++.++.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 157 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred ecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99999987543 3345678999999999999999999999999999999999999999999999999999998887665
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
..+......... .................++.+++||++||++||.+||||.|||+||||++.
T Consensus 237 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 237 EDWPRDVALPRQ-----------------AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GGSCTTCSSCGG-----------------GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hcccccccchhh-----------------hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 443322111100 000111112233345678999999999999999999999999999999876
Q ss_pred CC
Q 001034 1177 YE 1178 (1182)
Q Consensus 1177 ~e 1178 (1182)
-.
T Consensus 300 ~~ 301 (305)
T d1blxa_ 300 ER 301 (305)
T ss_dssp CC
T ss_pred hh
Confidence 43
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=434.44 Aligned_cols=286 Identities=28% Similarity=0.456 Sum_probs=232.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+++|+.++| ||||+++++|.+..+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H------p~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH------PNIVKLLDVIHTENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCC------TTBCCEEEEEEETTE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC------CcEEEeccccccccc
Confidence 68999999999999999999999999999999997543 235678889999998864 599999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+||||||+.++++.++...... .+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+|
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~----~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~--~~~~kl~DFG~a 149 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLA 149 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECSTTHH
T ss_pred eeEEEeecCCchhhhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc--cCcceeccCCcc
Confidence 9999999999988877654332 2899999999999999999999999999999999999984 678999999999
Q ss_pred cccCC---CcccccCCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1026 CFETD---HLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1026 ~~~~~---~~ss~vGTp~YmAPEVLlg~~-yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
+.... .....+||+.|+|||++.... ++.++|||||||++|+|++|++||.+.+....+.++....+.+....+..
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred eeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccc
Confidence 75433 344568999999999987766 57899999999999999999999999999999999988888766554432
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEPIS 1181 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP~~ 1181 (1182)
........ ...............+..+.++++||++||++||.+|||+.|||+||||++...|+.
T Consensus 230 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 230 VTSMPDYK---------------PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp GGGSTTCC---------------TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred cccccccc---------------cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 21111000 000000111112233467899999999999999999999999999999999988863
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.4e-50 Score=445.68 Aligned_cols=262 Identities=23% Similarity=0.356 Sum_probs=224.8
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+.+|+.++|+ |||+++++|.+..+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~Hp------nIv~~~~~~~~~~~ 97 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP------TLVNLHDAFEDDNE 97 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCT------TBCCEEEEEEETTE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCC------CCCcEEEEEEECCE
Confidence 4579999999999999999999999999999999997654 3345678899999998654 99999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+||||||+.| +|.+++..... .+++..++.|+.||+.||.|||++|||||||||+|||++....+.+||+|||+
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecch
Confidence 9999999985 67777753321 28999999999999999999999999999999999999865678899999999
Q ss_pred ccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1025 SCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1025 A~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
++..... ....+||+.|+|||++.+..|+.++||||||||+|+|++|++||.+.+..+++.+|......++..
T Consensus 173 a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----- 247 (350)
T d1koaa2 173 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS----- 247 (350)
T ss_dssp CEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG-----
T ss_pred heecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-----
Confidence 9865433 345789999999999999999999999999999999999999999999988888886433222211
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
..+.++.++++||.+||++||.+|||+.|||+||||+....|
T Consensus 248 -----------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 248 -----------------------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp -----------------------------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred -----------------------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 112347889999999999999999999999999999876544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=438.67 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=214.2
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++.++| ||||+++++|.+..++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN------PNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC------TTBCCEEEEEEETTEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCC------CCEeeEeEEEEECCEE
Confidence 357999999999999999999999999999999997643 334668899999999865 4999999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
||||||+.| +|..++.. . .+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+|
T Consensus 93 ~ivmEy~~gg~L~~~~~~-~------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~--~~~vkl~DFG~a 163 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTE-T------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 163 (293)
T ss_dssp EEEEECCTTCBHHHHHHH-S------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHhhc-c------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC--CCcEeeccchhh
Confidence 999999996 55554432 2 2899999999999999999999999999999999999984 678999999999
Q ss_pred cccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1026 CFETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1026 ~~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
+.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+....+..+.....+.
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-------- 235 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-------- 235 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC--------
T ss_pred eeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence 76432 3456689999999999999999999999999999999999999999988877766664211100
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
. .....++..+++||.+||++||.+|||+.|||+||||+.
T Consensus 236 ------------------------~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 236 ------------------------L---------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ------------------------C---------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------------------------C---------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0 001234789999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-50 Score=439.76 Aligned_cols=259 Identities=29% Similarity=0.464 Sum_probs=206.8
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.+.++|++.+.||+|+||+||+|+++.+++.||||++.+.. .....+.+|+.+|+.++| ||||+++++|.+.
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~ 79 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH------PNIVALDDIYESG 79 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCC------TTBCCEEEEEECS
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCC------CCCCcEEEEEEEC
Confidence 35688999999999999999999999999999999997653 223456689999998864 5999999999999
Q ss_pred CeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc-CCCceEEEec
Q 001034 944 EHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS-YSRCEVKVID 1021 (1182)
Q Consensus 944 e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs-~~dG~IKLiD 1021 (1182)
.++||||||+. |+|.+++.... .+++..++.|+.||+.||.|||++|||||||||+|||+.. ..++.+||+|
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred CEEEEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEec
Confidence 99999999998 57888876432 2899999999999999999999999999999999999974 2467899999
Q ss_pred CCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1022 LGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1022 FGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
||+|+.... ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++.+|.....+++.
T Consensus 154 FG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~--- 230 (307)
T d1a06a_ 154 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS--- 230 (307)
T ss_dssp C------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT---
T ss_pred cceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC---
Confidence 999986543 345678999999999999999999999999999999999999999999888888777532211110
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
...+.+++++.+||.+||++||.+|||+.|||+||||+..
T Consensus 231 -------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 231 -------------------------------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -------------------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -------------------------------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1123467899999999999999999999999999999853
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.3e-50 Score=443.32 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=224.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
+.++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+|+.++ |||||+++++|.+..+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH------HPKLINLHDAFEDKYE 100 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC------STTBCCEEEEEECSSE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCC------CCCCCcEEEEEEECCE
Confidence 4578999999999999999999999999999999998654 23445678999998885 4599999999999999
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+||||||+.| +|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+....+.+||+|||+
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccc
Confidence 9999999995 6666655432 138999999999999999999999999999999999999865678999999999
Q ss_pred ccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1025 SCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1025 A~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
|+..... ....++|+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+..+++.+|.....+++.
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~------ 249 (352)
T d1koba_ 176 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------ 249 (352)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS------
T ss_pred ceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------
Confidence 9875433 44578999999999999999999999999999999999999999999998888887533222221
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
...+.++.++++||.+||++||.+|||+.|||+||||+..+..
T Consensus 250 ----------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 250 ----------------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp ----------------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred ----------------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence 1123467899999999999999999999999999999876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.5e-50 Score=436.45 Aligned_cols=250 Identities=22% Similarity=0.406 Sum_probs=218.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+++.++| ||||+++++|.+..
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~~~~~~~~~~ 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH------PFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB------TTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccC------cChhheeeeEeeCC
Confidence 57999999999999999999999999999999997542 335677889999988865 59999999999999
Q ss_pred eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
++|+||||+.|+.+..+..... .+++..++.++.||+.||.|||++|||||||||+||||+. ++.+||+|||+
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~--~g~vkL~DFG~ 150 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGF 150 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TSCEEECCCSS
T ss_pred eeeeEeeecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcC--CCCEEEecCcc
Confidence 9999999999765444443322 2788899999999999999999999999999999999984 77899999999
Q ss_pred ccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1025 SCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1025 A~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
|+.......+.+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++.+|...-.+
T Consensus 151 a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~----------- 219 (316)
T d1fota_ 151 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR----------- 219 (316)
T ss_dssp CEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC-----------
T ss_pred ceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-----------
Confidence 998888888889999999999999999999999999999999999999999999988888877521111
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCC
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSH 1175 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~ 1175 (1182)
..+..+.++.+||.+||++||.+|+ |+++||+||||+.
T Consensus 220 ---------------------------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 220 ---------------------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp ---------------------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred ---------------------------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 1123578899999999999999996 9999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=425.91 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=220.9
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+.+|+.++| ||||++++
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~~~~ 80 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH------PNVITLHE 80 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC------TTBCCEEE
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCC------CCCCcEEE
Confidence 35688999999999999999999999999999999997542 234678899999999965 49999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCC--c
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSR--C 1015 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~d--G 1015 (1182)
+|.+..++||||||+.| +|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++..+. .
T Consensus 81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 81 VYENKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSC
T ss_pred EEEECCEEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCccc
Confidence 99999999999999985 7777776543 2899999999999999999999999999999999999985332 3
Q ss_pred eEEEecCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1016 EVKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
.+||+|||++..... .....++|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..|......
T Consensus 155 ~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234 (293)
T ss_dssp CEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred ceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Confidence 699999999976543 345668999999999999999999999999999999999999999999998888887533222
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
++.. ..+..+..+++||++||++||.+|||+.|||+||||
T Consensus 235 ~~~~----------------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 235 FEDE----------------------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp CCHH----------------------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCch----------------------------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1110 112357889999999999999999999999999999
Q ss_pred CC
Q 001034 1174 SH 1175 (1182)
Q Consensus 1174 k~ 1175 (1182)
+.
T Consensus 275 ~~ 276 (293)
T d1jksa_ 275 KP 276 (293)
T ss_dssp CC
T ss_pred CC
Confidence 75
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=439.49 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=217.1
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+|+.++| |||++++++|++.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h------p~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH------PFLTALKYAFQTH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC------TTBCCEEEEEECS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCC------CCEEEEEeeeccc
Confidence 467999999999999999999999999999999998642 345677889999988854 4999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
.++|+||||+.| +|..++..... +++..++.+++||+.||.|||++|||||||||+||||+. +|.+||+||
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~~~------~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~--~g~vkl~DF 149 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDF 149 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCC
T ss_pred cccccceeccCCCchhhhhhcccC------CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecC--CCCEEEeec
Confidence 999999999996 56666655432 899999999999999999999999999999999999984 688999999
Q ss_pred CCccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhh
Q 001034 1023 GSSCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGML 1099 (1182)
Q Consensus 1023 GLA~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL 1099 (1182)
|+|+... ......+||+.|+|||++.+.+|+.++||||||||+|+|++|++||.+.+..+++.++.....++
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~----- 224 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----- 224 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----
T ss_pred ccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC-----
Confidence 9998643 23456789999999999999999999999999999999999999999999888877774211111
Q ss_pred hcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCC
Q 001034 1100 AKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLS 1174 (1182)
Q Consensus 1100 ~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk 1174 (1182)
...+++++++||++||++||.+|+ ++++|++||||+
T Consensus 225 ---------------------------------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 225 ---------------------------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp ---------------------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred ---------------------------------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence 123578999999999999999999 499999999997
Q ss_pred C
Q 001034 1175 H 1175 (1182)
Q Consensus 1175 ~ 1175 (1182)
.
T Consensus 266 ~ 266 (337)
T d1o6la_ 266 S 266 (337)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=433.28 Aligned_cols=250 Identities=25% Similarity=0.422 Sum_probs=214.9
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||+|+||+||+|+++.+++.||||++.+.. .....+.+|+.+++.++| ||||+++++|.+..
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH------PFFVKLYFTFQDDE 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCS------TTBCCEEEEEECSS
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCC------CCeeEEEEEEEECC
Confidence 67999999999999999999999999999999997542 334568899999999865 49999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+||||||+.| +|.+++..... +++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~------l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~--~~~vkl~DFG 153 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFG 153 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCT
T ss_pred EEEEEEEccCCCCHHHhhhccCC------CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCC--CceEEecccc
Confidence 99999999985 67777665432 899999999999999999999999999999999999984 6789999999
Q ss_pred CccccCC-----CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhh
Q 001034 1024 SSCFETD-----HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGM 1098 (1182)
Q Consensus 1024 LA~~~~~-----~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Peem 1098 (1182)
+|+.... .....+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.+..+++.+|......
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~----- 228 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD----- 228 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC-----
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC-----
Confidence 9976532 234568999999999999999999999999999999999999999999988888877521111
Q ss_pred hhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHH------HHcCCC
Q 001034 1099 LAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASD------ALKHPW 1172 (1182)
Q Consensus 1099 L~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeE------LLqHPW 1172 (1182)
+| ..+++++++||.+||++||.+|||+.| +++|||
T Consensus 229 ------------------------------~p---------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpf 269 (288)
T d1uu3a_ 229 ------------------------------FP---------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269 (288)
T ss_dssp ------------------------------CC---------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred ------------------------------CC---------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCc
Confidence 11 235788999999999999999999998 588999
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
|+..
T Consensus 270 f~~i 273 (288)
T d1uu3a_ 270 FESV 273 (288)
T ss_dssp GTTC
T ss_pred cCCC
Confidence 9864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=434.72 Aligned_cols=292 Identities=27% Similarity=0.467 Sum_probs=235.5
Q ss_pred cceeeeCce---ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCc
Q 001034 858 NFHVVLNSV---IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKY 931 (1182)
Q Consensus 858 ~f~V~ig~i---L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HP 931 (1182)
+++..++.. +.++|++++.||+|+||+||+|.++.+|+.||||++++. ......+.+|+.+|+.++|+
T Consensus 4 ~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hp------ 77 (346)
T d1cm8a_ 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE------ 77 (346)
T ss_dssp BCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBT------
T ss_pred cEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCC------
Confidence 345555555 679999999999999999999999999999999999753 23456788999999998654
Q ss_pred ceEEEEEEEEecC------eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCc
Q 001034 932 HLLRLYDYFYYRE------HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005 (1182)
Q Consensus 932 nIVkL~dsFqd~e------~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPe 1005 (1182)
|||+++++|.... ++||||||++.+|..+.+.. .+++..++.++.||+.||.|||++|||||||||+
T Consensus 78 niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~ 150 (346)
T d1cm8a_ 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG 150 (346)
T ss_dssp TBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CeeEEEEEeccCccccccceEEEEEecccccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcc
Confidence 8999999998764 57999999977777665432 2899999999999999999999999999999999
Q ss_pred cEEEccCCCceEEEecCCCccccCCCcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLL 1084 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elL 1084 (1182)
|||++. ++.+||+|||+|+.........++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+
T Consensus 151 NIL~~~--~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~ 228 (346)
T d1cm8a_ 151 NLAVNE--DCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228 (346)
T ss_dssp GEEECT--TCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred hhhccc--ccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH
Confidence 999994 7789999999999888888888999999999999875 5789999999999999999999999999999999
Q ss_pred HHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 001034 1085 ARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSA 1164 (1182)
Q Consensus 1085 akIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTA 1164 (1182)
..+....+.++..++.......... . ...........+.......++.+++||.+||++||.+||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~--~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta 295 (346)
T d1cm8a_ 229 KEIMKVTGTPPAEFVQRLQSDEAKN-----------Y--MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295 (346)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHHH-----------H--HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHhccCCCcHHHHhhhcchhhhh-----------h--hccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH
Confidence 9999999988877665432211100 0 00000111123334456778999999999999999999999
Q ss_pred HHHHcCCCCCCCC
Q 001034 1165 SDALKHPWLSHPY 1177 (1182)
Q Consensus 1165 eELLqHPWFk~~~ 1177 (1182)
.|||+||||+...
T Consensus 296 ~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 296 GEALAHPYFESLH 308 (346)
T ss_dssp HHHHHSGGGTTTC
T ss_pred HHHhcChhhCcCC
Confidence 9999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=430.54 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=214.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc-chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN-KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~-k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
.+.|++++.||+|+||+||+|+++.+++.||||++.+. ......+.+|+.+|+.++| ||||+++++|.+...+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H------pnIv~l~~~~~~~~~~ 84 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH------PNIVKLLDAFYYENNL 84 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCC------TTBCCEEEEEEETTEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC------CCCCeEEEEEeeCCeE
Confidence 35799999999999999999999999999999999764 3455778899999999864 4999999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
||||||+.| +|..++..... .+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~--~~~~Kl~DFG~a 157 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL--DGDIKLADFGVS 157 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC--CCCEEEEechhh
Confidence 999999986 55555543322 2899999999999999999999999999999999999994 678999999999
Q ss_pred cccCC---CcccccCCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1026 CFETD---HLCSYVQSRSYRAPEVIL-----GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1026 ~~~~~---~~ss~vGTp~YmAPEVLl-----g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
+.... .....+||+.|+|||++. ...|+.++|||||||++|+|++|++||.+.+..+++.++.....+.
T Consensus 158 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~--- 234 (288)
T d2jfla1 158 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT--- 234 (288)
T ss_dssp EECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC---
T ss_pred hccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 75433 234678999999999984 4568999999999999999999999999888877777664211100
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
.......+.++++||.+||++||.+|||+.|||+||||+..
T Consensus 235 --------------------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 235 --------------------------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp --------------------------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred --------------------------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 00112347899999999999999999999999999999854
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-50 Score=436.15 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=226.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+.++|++++.||+|+||+||+|+++.+++.||||++++.......+.+|+.+|+.++| ||||+++++|.+..++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~H------pnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH------RNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC------TTBCCEEEEEEETTEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCC------CCCCeEEEEEEECCEE
Confidence 4689999999999999999999999999999999998876655677899999999865 4999999999999999
Q ss_pred EEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
||||||+.| +|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++..+...+||+|||++
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchh
Confidence 999999995 7888776432 1389999999999999999999999999999999999998766678999999999
Q ss_pred cccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhccc
Q 001034 1026 CFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKGR 1103 (1182)
Q Consensus 1026 ~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~k 1103 (1182)
+.... .....++|+.|+|||++.+..|+.++||||||||+|+|++|.+||.+.+..+++.+|+.....++...
T Consensus 152 ~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~----- 226 (321)
T d1tkia_ 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA----- 226 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-----
T ss_pred hccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh-----
Confidence 76543 34566889999999999999999999999999999999999999999999998888864333222211
Q ss_pred ccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 001034 1104 DTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYE 1178 (1182)
Q Consensus 1104 ~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~e 1178 (1182)
.+.++.++++||.+||++||.+|||+.|||+||||+...+
T Consensus 227 -----------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 266 (321)
T d1tkia_ 227 -----------------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp -----------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred -----------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCcc
Confidence 1234788999999999999999999999999999976543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-49 Score=439.03 Aligned_cols=251 Identities=24% Similarity=0.422 Sum_probs=219.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+++|+.++ |||||+++++|...
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN------FPFLVKLEFSFKDN 113 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC------CTTBCCEEEEEECS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC------CCcEeecccccccc
Confidence 378999999999999999999999999999999997542 33456788999998875 45999999999999
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
..+|+||||+.| +|..++.... .+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+||
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~--~g~ikL~DF 185 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ--QGYIQVTDF 185 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCC
T ss_pred cccccccccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCC--CCCEEeeec
Confidence 999999999996 5666655443 2899999999999999999999999999999999999984 678999999
Q ss_pred CCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1023 GSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1023 GLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
|+|+.........+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.+...++.+|......+
T Consensus 186 G~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 257 (350)
T d1rdqe_ 186 GFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-------- 257 (350)
T ss_dssp TTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------
T ss_pred eeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC--------
Confidence 999988777778899999999999999999999999999999999999999999999888888775221111
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDALKHPWLSHP 1176 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeELLqHPWFk~~ 1176 (1182)
...+++++.+||++||++||.+|+ |+++||+||||+..
T Consensus 258 ------------------------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 258 ------------------------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ------------------------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ------------------------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 123578999999999999999995 99999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-49 Score=431.54 Aligned_cols=255 Identities=23% Similarity=0.354 Sum_probs=216.0
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.+|++++.||+|+||+||+|+++.+++.||||+++... .....+.+|+.+|+.++ |||||+++++|.+..
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR------HPNTIQYRGCYLREH 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEETT
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC------CCCEeeEEEEEEECC
Confidence 45999999999999999999999999999999997643 33456778999998885 459999999999999
Q ss_pred eEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 945 HLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 945 ~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
++||||||+.++++..+..... .+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~--~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGS 161 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TTEEEECCCTT
T ss_pred EEEEEEEecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECC--CCCEEEeeccc
Confidence 9999999999877765554432 2899999999999999999999999999999999999994 78899999999
Q ss_pred ccccCCCcccccCCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1025 SCFETDHLCSYVQSRSYRAPEVILG---LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1025 A~~~~~~~ss~vGTp~YmAPEVLlg---~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
|..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.++.....+.
T Consensus 162 a~~~~~-~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~------- 233 (309)
T d1u5ra_ 162 ASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA------- 233 (309)
T ss_dssp CBSSSS-BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------
T ss_pred ccccCC-CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence 986554 346789999999999964 458999999999999999999999999988877776664211100
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
.....+++.+++||.+||++||.+|||+.|||+||||.....|
T Consensus 234 -----------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~ 276 (309)
T d1u5ra_ 234 -----------------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (309)
T ss_dssp -----------------------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred -----------------------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence 0112457899999999999999999999999999999865443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=424.91 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=202.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe--
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY-- 942 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd-- 942 (1182)
.++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+|+.+++.++ |||||+++++|.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK------HPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC------CTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC------CCCEeeEEEEEEeCC
Confidence 367999999999999999999999999999999997643 33455677888877775 5599999999975
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC-----ccccccCCccEEEccCCCce
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG-----LIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G-----IIHRDIKPeNILIDs~~dG~ 1016 (1182)
...+||||||+.| +|.+++....... ..+++..++.++.||+.||.|||+.+ ||||||||+||||+. ++.
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~--~~~ 152 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQN 152 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT--TSC
T ss_pred CCEEEEEEecCCCCcHHHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC--CCc
Confidence 4679999999985 7888776543322 23899999999999999999999876 999999999999994 678
Q ss_pred EEEecCCCccccCC---CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1017 VKVIDLGSSCFETD---HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~---~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp 1093 (1182)
+||+|||+++.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++.+|.....
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~- 231 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF- 231 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-
T ss_pred EEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-
Confidence 99999999976543 23457899999999999999999999999999999999999999999888887777642100
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
......++.++.+||.+||+.||.+|||+.|||+|||+
T Consensus 232 ------------------------------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 ------------------------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ------------------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------------------------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 00112357899999999999999999999999999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=420.44 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=205.9
Q ss_pred ecCCE-EEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 867 IAGRY-HVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 867 L~drY-eIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
..++| ++.++||+|+||+||+|.++.+++.||+|++.... .....+.+|+++|+.++| ||||+++++|..
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~~~~~~~~ 79 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH------PNIVRFYDSWES 79 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCC------TTBCCEEEEEEE
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC------CCeeeEEEEEee
Confidence 44566 67789999999999999999999999999997643 334567789999988864 499999999976
Q ss_pred ----cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--ccccccCCccEEEccCCCc
Q 001034 943 ----REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLG--LIHCDLKPENILVKSYSRC 1015 (1182)
Q Consensus 943 ----~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~G--IIHRDIKPeNILIDs~~dG 1015 (1182)
...+||||||+++ +|.+++.... .+++..++.|+.||+.||.|||+++ ||||||||+||||+. .++
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~-~~~ 152 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTG 152 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTS
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC-CCC
Confidence 3568999999985 6777776543 2899999999999999999999998 999999999999973 367
Q ss_pred eEEEecCCCccccCCC-cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhcCC
Q 001034 1016 EVKVIDLGSSCFETDH-LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS-PATLLARVIGIIGP 1093 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~~-~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d-~~elLakIv~ilGp 1093 (1182)
.+||+|||+|+..... ....+||+.|+|||++.+ +|+.++|||||||++|+|++|++||.... ...++..+....
T Consensus 153 ~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~-- 229 (270)
T d1t4ha_ 153 SVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-- 229 (270)
T ss_dssp CEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--
T ss_pred CEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC--
Confidence 8999999999865443 456789999999999876 59999999999999999999999997654 444444442110
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWL 1173 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWF 1173 (1182)
.|. ......++++.+||.+||++||++|||+.|||+||||
T Consensus 230 ~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~f 269 (270)
T d1t4ha_ 230 KPA----------------------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269 (270)
T ss_dssp CCG----------------------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCc----------------------------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence 000 0011246789999999999999999999999999999
Q ss_pred C
Q 001034 1174 S 1174 (1182)
Q Consensus 1174 k 1174 (1182)
+
T Consensus 270 k 270 (270)
T d1t4ha_ 270 Q 270 (270)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.1e-49 Score=418.21 Aligned_cols=278 Identities=27% Similarity=0.460 Sum_probs=224.8
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++++.||+|+||+||+|+++ +++.||||+++... .....+.+|+.+|+.++| ||||+++++|...++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH------SNIVKLYDVIHTKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC------TTBCCEEEEEECSSC
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC------CcEEeeeeecccCCc
Confidence 68999999999999999999985 78999999997643 234678889999998854 499999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
.|+||+++.++++..+..... .+++..++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||++
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~--~~~~kl~DfG~a 147 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLA 147 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCTTHH
T ss_pred eeEEEEeehhhhHHHHHhhcC-----CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC--CCCEEecccccc
Confidence 999999999988877765432 3999999999999999999999999999999999999984 788999999998
Q ss_pred cccCCC---cccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
...... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+++.++...++.++...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred eecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 764432 3455789999999999765 578999999999999999999999999999999999988888766544432
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
....... ................+..+..+++||++||++||++||||.|||+||||++
T Consensus 228 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 228 VTELPKY---------------DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp GGGSTTC---------------CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhhhhc---------------ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 2111110 0000011111222334567899999999999999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=418.79 Aligned_cols=287 Identities=23% Similarity=0.391 Sum_probs=223.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe--
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY-- 942 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd-- 942 (1182)
.++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+|+.+|+.++|+ ||++++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~------nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE------NVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCT------TBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCC------CccceEeeeeccc
Confidence 479999999999999999999999999999999986542 3446678999999998655 89999998865
Q ss_pred ------cCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 943 ------REHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 943 ------~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
..++|+||||+.++++........ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~--~~~ 155 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGV 155 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSC
T ss_pred ccccccCceEEEEEeccCCCccchhhhccc-----ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecC--CCc
Confidence 357899999999888876654432 3889999999999999999999999999999999999994 778
Q ss_pred EEEecCCCccccCC-------CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 001034 1017 VKVIDLGSSCFETD-------HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~-------~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv 1088 (1182)
+||+|||++..... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+....+..+.
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 99999999965432 23446899999999999865 68999999999999999999999999999999999999
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
..++.++............... ..........+.. .+ .....++.+++||.+||++||++||||.|||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~------~~--~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEK----LELVKGQKRKVKD------RL--KAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp HHHCCCCTTTSTTCCCC-----------CCSSCCBCHHH------HH--HHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HhcCCCChhhccccchhhhhhh----hcccccccccchh------hh--ccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 9888877655443221111000 0000000000000 00 0012367899999999999999999999999
Q ss_pred cCCCCCCCCCC
Q 001034 1169 KHPWLSHPYEP 1179 (1182)
Q Consensus 1169 qHPWFk~~~eP 1179 (1182)
+||||+..+.|
T Consensus 304 ~Hpff~~~p~p 314 (318)
T d3blha1 304 NHDFFWSDPMP 314 (318)
T ss_dssp HSGGGSSSSCC
T ss_pred cChhhccCCCC
Confidence 99999976555
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=427.39 Aligned_cols=283 Identities=27% Similarity=0.474 Sum_probs=227.3
Q ss_pred CEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec------
Q 001034 870 RYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR------ 943 (1182)
Q Consensus 870 rYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~------ 943 (1182)
+|+.+++||+|+||+||+|+++.+|+.||||++.+..... .+|+.+|+.++| +||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~Ei~il~~l~h------~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDH------CNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSC---CHHHHHHHHCCC------TTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHH---HHHHHHHHhcCC------CCCCcEEEEEEecCccCCc
Confidence 6999999999999999999999999999999998765432 369999998865 4899999999653
Q ss_pred CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 944 EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 944 e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.++||||||+++++...+....... ..+++..++.|++||+.||+|||++||+||||||+|||++. ....+||+|||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~-~~~~~kl~DFG 168 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAK--QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFG 168 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-TTCCEEECCCT
T ss_pred eEEEEEEeccCCccHHHHHhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec-CCCceeEeccc
Confidence 4689999999998777665432222 23899999999999999999999999999999999999985 23479999999
Q ss_pred CccccC--CCcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1024 SSCFET--DHLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1024 LA~~~~--~~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+++... ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||...+..+.+.+|+..+|.++...+.
T Consensus 169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 997543 34556789999999999876 468999999999999999999999999999999999999999987776654
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
.......... +. ............+..++++++||.+||++||.+||||.|||+||||+...+|
T Consensus 249 ~~~~~~~~~~--------------~~-~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 249 EMNPNYTEFK--------------FP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHCC---CCC--------------CC-CCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhccchhhcc--------------cc-ccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 3322111000 00 0000011112334568999999999999999999999999999999876554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-48 Score=414.79 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=217.1
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
.++|++++.||+|+||+||+|+++.+++.||||++++.. ...+.+.+|+.+++.+.. |||||+++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----hpnIv~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG-----HPNIIQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTT-----CTTBCCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEEE
Confidence 478999999999999999999999999999999997643 223467789999999963 34999999
Q ss_pred EEEEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCce
Q 001034 938 DYFYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCE 1016 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~ 1016 (1182)
++|.+..++||||||+.| +|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++ .++.
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~--~~~~ 148 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD--DDMN 148 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--TTCC
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc--CCCC
Confidence 999999999999999985 7888886543 289999999999999999999999999999999999998 4778
Q ss_pred EEEecCCCccccCC--CcccccCCCcccchhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 001034 1017 VKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILG------LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVI 1088 (1182)
Q Consensus 1017 IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg------~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv 1088 (1182)
+||+|||+++.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..|+
T Consensus 149 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~ 228 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228 (277)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH
Confidence 99999999986543 3445689999999999863 457889999999999999999999999999888877775
Q ss_pred hhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 001034 1089 GIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDAL 1168 (1182)
Q Consensus 1089 ~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELL 1168 (1182)
.....++ ......+++++++||.+||++||.+|||+.|||
T Consensus 229 ~~~~~~~----------------------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 229 SGNYQFG----------------------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HTCCCCC----------------------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred hCCCCCC----------------------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 2211110 011224578999999999999999999999999
Q ss_pred cCCCCCC
Q 001034 1169 KHPWLSH 1175 (1182)
Q Consensus 1169 qHPWFk~ 1175 (1182)
+||||+.
T Consensus 269 ~h~~~~~ 275 (277)
T d1phka_ 269 AHPFFQQ 275 (277)
T ss_dssp TSGGGCT
T ss_pred cCHHHHH
Confidence 9999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=429.51 Aligned_cols=301 Identities=30% Similarity=0.504 Sum_probs=227.8
Q ss_pred ccceeeeCce---ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCC
Q 001034 857 KNFHVVLNSV---IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDK 930 (1182)
Q Consensus 857 ~~f~V~ig~i---L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~H 930 (1182)
..|++.+++. +.++|+++++||+|+||+||+|+++.+|+.||||++++. ......+.+|+.+|+.++|+
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hp----- 76 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK----- 76 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCT-----
T ss_pred CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCC-----
Confidence 4578888883 458999999999999999999999999999999999864 23445678999999998654
Q ss_pred cceEEEEEEEEec------CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCC
Q 001034 931 YHLLRLYDYFYYR------EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKP 1004 (1182)
Q Consensus 931 PnIVkL~dsFqd~------e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKP 1004 (1182)
|||+++++|... .++|+||||+.++++..+.. .+++..++.++.||+.||.|||++||+||||||
T Consensus 77 -nIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP 147 (355)
T d2b1pa1 77 -NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 147 (355)
T ss_dssp -TBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred -CeeEEEEEEecccccccCceeEEEEeccchHHHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCc
Confidence 899999999643 68999999999998876632 289999999999999999999999999999999
Q ss_pred ccEEEccCCCceEEEecCCCccccCC--CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 001034 1005 ENILVKSYSRCEVKVIDLGSSCFETD--HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPAT 1082 (1182)
Q Consensus 1005 eNILIDs~~dG~IKLiDFGLA~~~~~--~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~e 1082 (1182)
+|||++. ++.+||+|||+++.... .....++|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...
T Consensus 148 ~Nil~~~--~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 148 SNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp GGEEECT--TCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccccccc--ccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH
Confidence 9999994 67799999999875443 3445688999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhcccccc--ccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKT--SLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1083 lLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~--sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
.+.+++..++.++...+.........+......... .......+... .........+.++++||++||++||++
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 301 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG----LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_dssp HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCC----CCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccc----cccccccccccccccccccccCCHHHHHHHHHHCcCChhH
Confidence 999998877776665555443322221111110000 00011111110 000011123678999999999999999
Q ss_pred CCCHHHHHcCCCCCCCC
Q 001034 1161 RPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1161 RPTAeELLqHPWFk~~~ 1177 (1182)
||||+|||+||||+..+
T Consensus 302 R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 302 RISVDDALQHPYINVWY 318 (355)
T ss_dssp SCCHHHHHTSTTTGGGC
T ss_pred CcCHHHHhcCcccCCCC
Confidence 99999999999998743
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-48 Score=430.94 Aligned_cols=257 Identities=20% Similarity=0.296 Sum_probs=208.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
.++|+++++||+|+||.||+|+++.+|+.||||++.+.. .......+|..+++.+.+. .|||||+++++|...
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~---~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG---DCPFIVCMSYAFHTP 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS---CCTTBCCEEEEEECS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC---CCCcEEEEEEEEEEC
Confidence 468999999999999999999999999999999997543 1223455666666666544 578999999999999
Q ss_pred CeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
..+||||||+. |+|..++.... .+++..++.|+.||+.||.|||++|||||||||+||||+. .+.+||+||
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~--~g~iKl~DF 151 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDL 151 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS--SSCEEECCC
T ss_pred CEEEEEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcC--CCcEEEeee
Confidence 99999999999 46777776543 2889999999999999999999999999999999999984 778999999
Q ss_pred CCccccCC-CcccccCCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1023 GSSCFETD-HLCSYVQSRSYRAPEVILG-LSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1023 GLA~~~~~-~~ss~vGTp~YmAPEVLlg-~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
|+|+.... .....+||+.|+|||++.. ..|+.++|||||||+||+|+||++||.+.+.......+......
T Consensus 152 Gla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------- 224 (364)
T d1omwa3 152 GLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------- 224 (364)
T ss_dssp TTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-------
T ss_pred ceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-------
Confidence 99986543 4556789999999999974 57999999999999999999999999875432222111000000
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPS-----ASDALKHPWLSH 1175 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPT-----AeELLqHPWFk~ 1175 (1182)
.......+++++++||.+||++||.+||| |+|||+||||+.
T Consensus 225 ----------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 225 ----------------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp ----------------------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred ----------------------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 00112346789999999999999999999 899999999986
Q ss_pred C
Q 001034 1176 P 1176 (1182)
Q Consensus 1176 ~ 1176 (1182)
.
T Consensus 271 i 271 (364)
T d1omwa3 271 L 271 (364)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=415.58 Aligned_cols=252 Identities=26% Similarity=0.450 Sum_probs=210.0
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-------hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-------DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-------~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
+.++|+|.+.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+.+|+.+++. |||||+++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~----h~nIv~~~~~ 77 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG----FSGVIRLLDW 77 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSS----SCSBCCEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccC----CCCccEEEEE
Confidence 4689999999999999999999999999999999997542 1123456899999999753 6799999999
Q ss_pred EEecCeEEEEEEeccc--ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceE
Q 001034 940 FYYREHLLIVCELLKA--NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEV 1017 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G--sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~I 1017 (1182)
|.+...+|+||||+.+ .+..++.... .+++..++.++.||+.||.|||++|||||||||+|||++. ..+.+
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~-~~~~v 150 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGEL 150 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEE
T ss_pred EeeCCeEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec-CCCeE
Confidence 9999999999999974 5566665443 2899999999999999999999999999999999999984 35789
Q ss_pred EEecCCCccccCCC-cccccCCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1018 KVIDLGSSCFETDH-LCSYVQSRSYRAPEVILGLSY-DKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1018 KLiDFGLA~~~~~~-~ss~vGTp~YmAPEVLlg~~y-S~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
||+|||+|+..... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+ .++.. .
T Consensus 151 kl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~-- 220 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--Q-- 220 (273)
T ss_dssp EECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--C--
T ss_pred EECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--c--
Confidence 99999999865443 456789999999999987765 678999999999999999999996532 12100 0
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSH 1175 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~ 1175 (1182)
. .....+++++++||++||++||.+|||+.|||+||||++
T Consensus 221 -------------------------------~---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 221 -------------------------------V---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp -------------------------------C---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred -------------------------------c---------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 0 011235789999999999999999999999999999998
Q ss_pred CCCC
Q 001034 1176 PYEP 1179 (1182)
Q Consensus 1176 ~~eP 1179 (1182)
...|
T Consensus 261 ~~~p 264 (273)
T d1xwsa_ 261 VLLP 264 (273)
T ss_dssp CCCH
T ss_pred CCCC
Confidence 7655
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=403.82 Aligned_cols=283 Identities=27% Similarity=0.426 Sum_probs=227.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++|++++.||+|+||+||+|+++.+++.||||+++... .....+.+|+.+|+.++| |||++++++|....+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h------~niv~~~~~~~~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH------KNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC------TTBCCEEEEEECSSE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCc------CCEEeeccccccccc
Confidence 68999999999999999999999999999999997543 345677899999988765 499999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
.++||+++.++++..+..... .+++..++.++.|++.||+|||++|||||||||+|||++. .+.+||+|||.+
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~--~~~~kl~DFG~a 148 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLA 148 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTC
T ss_pred eeEEeeecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccccc--CCceeeeecchh
Confidence 999999999877666554332 2889999999999999999999999999999999999995 677999999999
Q ss_pred cccCCC---cccccCCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDH---LCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVL-FQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~---~ss~vGTp~YmAPEVLlg~~-yS~kSDIWSLGVILYELLTGr~P-F~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+..... .....+++.|+|||++.... ++.++|||||||++|+|++|+.| |.+.+..+.+.++....++++...+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred hcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence 865433 23456788999999998765 68999999999999999999987 46678888888888887776654433
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPYEP 1179 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~eP 1179 (1182)
........ ......+............+..+++||++||++||.+||||+|||+||||++...|
T Consensus 229 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~ 292 (292)
T d1unla_ 229 SMTKLPDY---------------KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292 (292)
T ss_dssp TGGGSTTC---------------CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred hhhhcccc---------------cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence 22111100 00001111223334445678999999999999999999999999999999875443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=421.65 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=213.1
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++++.||+|+||+||+|+++.+++.||||++++.. ........|..++.... .|||||+++++|.+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-----~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-----EHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-----TCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-----CCCcEEEEEEEEccCC
Confidence 57999999999999999999999999999999998642 23445667777665421 3569999999999999
Q ss_pred eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
++||||||+.| +|..++..... +++..++.++.||+.||.|||++|||||||||+|||++. .+.+||+|||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~------~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~--~~~~kl~DFG 148 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK--DGHIKIADFG 148 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecC--CCceeccccc
Confidence 99999999985 67777665432 889999999999999999999999999999999999994 7789999999
Q ss_pred CccccC---CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1024 SSCFET---DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1024 LA~~~~---~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+++... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+++.+|......
T Consensus 149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~------- 221 (320)
T d1xjda_ 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF------- 221 (320)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred hhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 997543 2334568999999999999999999999999999999999999999999988888777421110
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH-HHHcCCCCCCC
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS-DALKHPWLSHP 1176 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe-ELLqHPWFk~~ 1176 (1182)
. ...++..+.+||++||++||.+|||+. +|++||||+..
T Consensus 222 ----------------------------~---------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 222 ----------------------------Y---------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp ----------------------------C---------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ----------------------------C---------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 0 123578999999999999999999996 89999999763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=417.61 Aligned_cols=286 Identities=29% Similarity=0.524 Sum_probs=225.4
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR- 943 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~- 943 (1182)
+..+|++++.||+|+||+||+|+++.+|+.||||++++. ......+++|+.+|+.++|+ ||+++++++...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp------~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE------NIIGINDIIRAPT 79 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCT------TBCCCCEEECCSS
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCC------CCCcEEEEEeecc
Confidence 347899999999999999999999999999999999754 34456788999999999655 899999998765
Q ss_pred ----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEE
Q 001034 944 ----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKV 1019 (1182)
Q Consensus 944 ----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKL 1019 (1182)
.++|+||++..|+|.+++... .+++..++.++.||+.||.|||++|||||||||+||||+. .+.+||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~--~~~~kl 150 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKI 150 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEE
T ss_pred ccccceEEEEEeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC--CCCEEE
Confidence 357888887778999888643 2899999999999999999999999999999999999984 678999
Q ss_pred ecCCCccccCC------CcccccCCCcccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1020 IDLGSSCFETD------HLCSYVQSRSYRAPEVIL-GLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1020 iDFGLA~~~~~------~~ss~vGTp~YmAPEVLl-g~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
+|||++..... .....+||+.|+|||++. ...++.++||||+||++|+|++|++||.+.+.......+...++
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc
Confidence 99999875322 234567999999999984 45689999999999999999999999999999888888887777
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPW 1172 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPW 1172 (1182)
.+............ ....................+..+.++++||.+||++||.+||||.|||+|||
T Consensus 231 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 231 SPSQEDLNCIINLK-------------ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp SCCHHHHHTCCCHH-------------HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCChhhhhhhhhhh-------------hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 66554332211100 00000111111112223345567899999999999999999999999999999
Q ss_pred CCCCCCCC
Q 001034 1173 LSHPYEPI 1180 (1182)
Q Consensus 1173 Fk~~~eP~ 1180 (1182)
|+..+.|.
T Consensus 298 ~~~~~~~~ 305 (345)
T d1pmea_ 298 LEQYYDPS 305 (345)
T ss_dssp GTTTCCGG
T ss_pred hccCCCCc
Confidence 99776653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=415.96 Aligned_cols=284 Identities=29% Similarity=0.497 Sum_probs=225.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc---hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK---DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR- 943 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k---~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~- 943 (1182)
.+||++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+|+.++|+ |||+++++|...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~------~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE------NVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCT------TBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCC------CeeeEEEEEeecc
Confidence 589999999999999999999999999999999997643 3345678999999998654 899999999754
Q ss_pred -----CeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 944 -----EHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 944 -----e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
...|+++++..|+|.+++... .+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~--~~~~k 161 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELK 161 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEE
T ss_pred ccccCceEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc--ccccc
Confidence 345666666667888777432 2899999999999999999999999999999999999994 77899
Q ss_pred EecCCCccccCCCcccccCCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcchh
Q 001034 1019 VIDLGSSCFETDHLCSYVQSRSYRAPEVILGLS-YDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQG 1097 (1182)
Q Consensus 1019 LiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~-yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pee 1097 (1182)
|+|||++...........|++.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......|....+.++..
T Consensus 162 l~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 162 ILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp ECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 999999988887778889999999999987764 6899999999999999999999999999999999999888877665
Q ss_pred hhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 001034 1098 MLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1098 mL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~~ 1177 (1182)
+.......... .. ...........+.......+.++++||++||++||.+||||.|||+||||++..
T Consensus 242 ~~~~~~~~~~~----------~~---~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 242 LLKKISSESAR----------NY---IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHTTCCCHHHH----------HH---HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred Hhhhccchhhh----------hh---hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 54332211100 00 000000011122223456789999999999999999999999999999999765
Q ss_pred CC
Q 001034 1178 EP 1179 (1182)
Q Consensus 1178 eP 1179 (1182)
.|
T Consensus 309 ~~ 310 (348)
T d2gfsa1 309 DP 310 (348)
T ss_dssp CT
T ss_pred CC
Confidence 43
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.4e-47 Score=409.40 Aligned_cols=284 Identities=23% Similarity=0.381 Sum_probs=215.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec--Ce
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR--EH 945 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~--e~ 945 (1182)
.++|+++++||+|+||+||+|+++.+++.||||++++.. ...+.+|+.+|+.+.+ ||||++++++|... .+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~-----hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRG-----GPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTT-----STTBCCEEEEEECTTTCS
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccC-----CCCCcEEEEEEEecCCCc
Confidence 368999999999999999999999999999999997654 4567899999999863 45999999999854 57
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
+|+||||+.++.+..+ .+ .+++..++.+++||+.||.|||++||+||||||+||||+. ..+.+||+|||+|
T Consensus 107 ~~~v~e~~~~~~L~~~--~~------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~-~~~~vkl~DFG~a 177 (328)
T d3bqca1 107 PALVFEHVNNTDFKQL--YQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLA 177 (328)
T ss_dssp EEEEEECCCSCBGGGT--TT------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCGGGC
T ss_pred eeEEEeecCCCcHHHH--hc------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC-CCCeeeecccccc
Confidence 9999999997543222 11 2899999999999999999999999999999999999985 3457999999999
Q ss_pred cccCC--CcccccCCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhcCCcchhhh-h
Q 001034 1026 CFETD--HLCSYVQSRSYRAPEVILGL-SYDKKIDIWSLGCILAELCTGNVLFQN-DSPATLLARVIGIIGPIEQGML-A 1100 (1182)
Q Consensus 1026 ~~~~~--~~ss~vGTp~YmAPEVLlg~-~yS~kSDIWSLGVILYELLTGr~PF~g-~d~~elLakIv~ilGp~PeemL-~ 1100 (1182)
+.... .....++|+.|+|||++.+. .++.++|||||||++|+|++|+.||.. .+.......+...+|.+....+ .
T Consensus 178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 76443 45567899999999999875 479999999999999999999999965 4566667777776664332111 1
Q ss_pred ccccc-chhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1101 KGRDT-YKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1101 ~~k~s-~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
..... ...+.. ............. .........+.++++||++||++||.+||||+|||+||||+..
T Consensus 258 ~~~~~~~~~~~~----~~~~~~~~~~~~~-----~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 258 KYNIELDPRFND----ILGRHSRKRWERF-----VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp HTTCCCCGGGGG----TCCCCCCCCGGGG-----CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred hcccccCcccch----hcccccccchhhc-----ccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 10000 000000 0000000000000 0111123457899999999999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=422.73 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=207.4
Q ss_pred eecCCEEEEE-EeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe--
Q 001034 866 VIAGRYHVTE-YLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY-- 942 (1182)
Q Consensus 866 iL~drYeIlk-~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd-- 942 (1182)
.+.++|+|+. +||+|+||+||+|+++.+++.||||++++.. ...+|+.++.++. .|||||+++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~E~~~~~~~~-----~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRAS-----QCPHIVRIVDVYENLY 78 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHT-----TSTTBCCEEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH----HHHHHHHHHHHhc-----CCCCCCeEEEEEeecc
Confidence 3457899885 6999999999999999999999999997643 4567888876663 35699999999986
Q ss_pred --cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-CCceEE
Q 001034 943 --REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-SRCEVK 1018 (1182)
Q Consensus 943 --~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-~dG~IK 1018 (1182)
..++|||||||. |+|.+++..... ..+++..++.|+.||+.||.|||++||+||||||+|||++.. ..+.+|
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~K 154 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 154 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEE
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccc
Confidence 477999999998 588888875322 239999999999999999999999999999999999999853 356899
Q ss_pred EecCCCccccC--CCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1019 VIDLGSSCFET--DHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1019 LiDFGLA~~~~--~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
|+|||+|+... ......+||+.|+|||++.+..|+.++||||||||||+|+||++||.+.+.......+.....
T Consensus 155 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~---- 230 (335)
T d2ozaa1 155 LTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---- 230 (335)
T ss_dssp ECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC----
T ss_pred ccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh----
Confidence 99999997543 334567899999999999999999999999999999999999999987654443333311000
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKHPWLSHP 1176 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqHPWFk~~ 1176 (1182)
... ...|. .....+++++++||++||++||.+|||+.|||+||||++.
T Consensus 231 -------------------------~~~--~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 231 -------------------------MGQ--YEFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -------------------------SCS--SSCCT-----THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred -------------------------cCC--CCCCC-----cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 000 00000 0011357899999999999999999999999999999654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-46 Score=408.57 Aligned_cols=312 Identities=29% Similarity=0.520 Sum_probs=240.1
Q ss_pred ceeeeCceec-CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCC-----CCcc
Q 001034 859 FHVVLNSVIA-GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPG-----DKYH 932 (1182)
Q Consensus 859 f~V~ig~iL~-drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l-----~HPn 932 (1182)
+|+.+|+.+. +||+++++||+|+||+||+|+++.+|+.||||++++.....+...+|+.+++.+.++... .|+|
T Consensus 2 ~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp CCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 6788899887 579999999999999999999999999999999998877677888999999999886533 4689
Q ss_pred eEEEEEEEEec--CeEEEEEEeccc--ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCccccccCCccE
Q 001034 933 LLRLYDYFYYR--EHLLIVCELLKA--NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG-LGLIHCDLKPENI 1007 (1182)
Q Consensus 933 IVkL~dsFqd~--e~LyLVmEyL~G--sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS-~GIIHRDIKPeNI 1007 (1182)
|+++++++... ...++||.++.. +......... ...+++..++.++.||+.||.|||+ .||+||||||+||
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NI 157 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 157 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred eEEEEEEeeeccccceeeeeeeccccccccccccccc----ccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHe
Confidence 99999988754 566667766653 3333333222 1238899999999999999999997 8999999999999
Q ss_pred EEccCCC----ceEEEecCCCccccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----
Q 001034 1008 LVKSYSR----CEVKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND----- 1078 (1182)
Q Consensus 1008 LIDs~~d----G~IKLiDFGLA~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~----- 1078 (1182)
||+..+. ..++|+|||.+..........+||+.|+|||++....|+.++|+|||||++++|++|+.||...
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred eeeccCcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 9985332 3599999999988777778889999999999999999999999999999999999999999653
Q ss_pred -CHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcch-hhhhhccccccccccCCCCCcHHHHHHHHHhccc
Q 001034 1079 -SPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQET-NRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156 (1182)
Q Consensus 1079 -d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~et-s~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~ 1156 (1182)
.....+.+++..+|.++..+.........++............. .......+ .........+..+++||.+||++
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT---EKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH---HTTCCCHHHHHHHHHHHGGGGCS
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc---cccccCcccCHHHHHHHHHHCCC
Confidence 34466788888999988888776655544443322211100000 00000000 00011123467899999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCCC
Q 001034 1157 NPKKRPSASDALKHPWLSHPY 1177 (1182)
Q Consensus 1157 DPekRPTAeELLqHPWFk~~~ 1177 (1182)
||.+||||.|||+||||++..
T Consensus 315 dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 315 DPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp STTTCBCHHHHHTCGGGTTCT
T ss_pred ChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999664
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.2e-46 Score=395.78 Aligned_cols=255 Identities=27% Similarity=0.365 Sum_probs=203.6
Q ss_pred ceecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 865 SVIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 865 ~iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
..+.++|++.+.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+++.++|+ |||++++++
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hp------niv~~~~~~ 76 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP------AIVAVYDTG 76 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCT------TBCCEEEEE
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCC------CCCccccee
Confidence 457899999999999999999999999999999999997542 3345678899999887654 999999999
Q ss_pred EecC----eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCc
Q 001034 941 YYRE----HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRC 1015 (1182)
Q Consensus 941 qd~e----~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG 1015 (1182)
.... .+||||||+.| +|..++.... .+++..++.|+.||+.||.|||++|||||||||+|||++. .+
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~--~~ 148 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA--TN 148 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TS
T ss_pred eeccCCCceEEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc--cc
Confidence 8764 48999999996 5665655443 2899999999999999999999999999999999999984 67
Q ss_pred eEEEecCCCccccCC------CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 001034 1016 EVKVIDLGSSCFETD------HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIG 1089 (1182)
Q Consensus 1016 ~IKLiDFGLA~~~~~------~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ 1089 (1182)
.++|+|||.+..... .....+||+.|+|||++.+..|+.++||||||||+|+|+||++||.+.+..+.+.+++.
T Consensus 149 ~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp CEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence 799999998764322 23456899999999999999999999999999999999999999999988887777653
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.-..++. ...+.++..+.+||.+||++||.+||+..+.|.
T Consensus 229 ~~~~~~~----------------------------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 229 EDPIPPS----------------------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp CCCCCGG----------------------------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred cCCCCCc----------------------------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 2111111 122346789999999999999999995444455
Q ss_pred CCCC
Q 001034 1170 HPWL 1173 (1182)
Q Consensus 1170 HPWF 1173 (1182)
|+|+
T Consensus 269 ~~l~ 272 (277)
T d1o6ya_ 269 ADLV 272 (277)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-45 Score=394.07 Aligned_cols=248 Identities=20% Similarity=0.258 Sum_probs=206.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
-.++|++.+.||+|+||+||+|+++.+++.||||+++.+....+.+.+|+.+|+.++| ||||+++++|.....+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~H------pnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH------PNLVQLLGVCTREPPF 88 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCC------TTBCCEEEEECSSSSC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCC------CCEecCCccEeeCCee
Confidence 3468999999999999999999999999999999998877667788999999999965 4999999999999999
Q ss_pred EEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
||||||+. |+|..++..... ..+++..+..|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+|
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~--~~~~Kl~DFG~a 162 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLS 162 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCCCT
T ss_pred EEEeecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECC--CCcEEEccccce
Confidence 99999999 467777654322 23899999999999999999999999999999999999984 678999999999
Q ss_pred cccCCCc----ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhhcCCcchhhhh
Q 001034 1026 CFETDHL----CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVL-FQNDSPATLLARVIGIIGPIEQGMLA 1100 (1182)
Q Consensus 1026 ~~~~~~~----ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~P-F~g~d~~elLakIv~ilGp~PeemL~ 1100 (1182)
+...... ....+++.|+|||++.+..|+.++|||||||++|||++|..| |.+.+...++..+....
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~--------- 233 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------- 233 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---------
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC---------
Confidence 8754332 234578899999999999999999999999999999996655 55555554443331000
Q ss_pred cccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1101 KGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1101 ~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
. ......++..+.+||.+||+.||.+|||+.+|++
T Consensus 234 -------------------------~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 234 -------------------------R---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -------------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------C---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0 0112345789999999999999999999999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=385.55 Aligned_cols=245 Identities=21% Similarity=0.345 Sum_probs=199.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
++|++++.||+|+||+||+|+++ +++.||||+++......+.+.+|+.+++.++|+ |||+++++|.....+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~Hp------nIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP------KLVQLYGVCLEQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCC------CcccccceeccCCceEE
Confidence 57999999999999999999975 577899999988776677889999999999654 99999999999999999
Q ss_pred EEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||||+.+ +|.+++..... .+++..+..|+.||+.||.|||+++|+||||||+|||++. ++.+||+|||+++.
T Consensus 78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~--~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTRF 150 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG--GGCEEECSCC----
T ss_pred EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecC--CCCeEecccchhee
Confidence 9999985 67777654432 3888999999999999999999999999999999999994 77899999999976
Q ss_pred cCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1028 ETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1028 ~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
.... .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+++..+.....+
T Consensus 151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--------- 221 (263)
T d1sm2a_ 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------- 221 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC---------
T ss_pred ccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC---------
Confidence 4432 224578999999999999999999999999999999999 57778777777776666321000
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. .....+.++.+||.+||+.||.+|||+.+||+|
T Consensus 222 -------------------------~---------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 -------------------------Y---------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -------------------------C---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------C---------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0 012346889999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=389.98 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=208.0
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.++|++++.||+|+||+||+|..+ +++.||||+++......+.+.+|+.+++.++|+ |||++++++. ...+|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~~~g~~~-~~~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ------RLVRLYAVVT-QEPIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCT------TBCCEEEEEC-SSSCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCC------CEeEEEeeec-cCCeE
Confidence 468999999999999999999974 678899999987766677899999999999654 9999999774 56789
Q ss_pred EEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
|||||+.+ +|.+++..... ..+++..+..|+.||+.||.|||+++|+||||||+||||+. ++.+||+|||+|+
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~--~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD--TLSCKIADFGLAR 157 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeec--ccceeeccccceE
Confidence 99999995 56666554332 23899999999999999999999999999999999999994 7789999999998
Q ss_pred ccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
..... .....+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+++..+.....
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~--------- 228 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------- 228 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 65432 234578899999999999999999999999999999999 5666777777666666531100
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc--CCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK--HPWLSH 1175 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq--HPWFk~ 1175 (1182)
. .....++.++.+||.+||+.||.+|||+.+|++ |+||+.
T Consensus 229 -------------------------~---------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 -------------------------M---------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -------------------------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------------C---------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 0 011245788999999999999999999999998 888864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=393.94 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=204.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCc-----EEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGM-----DVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr-----~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|++.++||+|+||+||+|+++.+++ .||+|++... ......+.+|+.++..+. .|||||+++++|
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~l~~~~ 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-----SHENIVNLLGAC 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhc-----CCCcEeEEEEEE
Confidence 4689999999999999999999876554 6999998653 334456788999999884 245999999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhcccC-----------------CccccCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRESG-----------------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDL 1002 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~sg-----------------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDI 1002 (1182)
.....+||||||+. |+|.+++....... ....+++..++.|+.||+.||.|||+++||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 99999999999998 57888886543210 1123889999999999999999999999999999
Q ss_pred CCccEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 001034 1003 KPENILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQ 1076 (1182)
Q Consensus 1003 KPeNILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~ 1076 (1182)
||+|||++. ++.+||+|||+|+..... ....++|+.|+|||++.+..|+.++|||||||+||||+| |++||.
T Consensus 191 Kp~Nill~~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTH--GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEET--TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhcccccc--CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999984 788999999999764432 224567999999999999999999999999999999998 899998
Q ss_pred CCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhccc
Q 001034 1077 NDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEI 1156 (1182)
Q Consensus 1077 g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~ 1156 (1182)
+.+....+.+++..-.. . .....++.++.+||.+||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~---------------------------------~---------~~p~~~~~~l~~li~~cl~~ 306 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFK---------------------------------M---------DQPFYATEEIYIIMQSCWAF 306 (325)
T ss_dssp TCCCSHHHHHHHHTTCC---------------------------------C---------CCCTTCCHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHhcCCC---------------------------------C---------CCCCcCCHHHHHHHHHHcCC
Confidence 87665555555311000 0 01124578999999999999
Q ss_pred CCCCCCCHHHHHcC
Q 001034 1157 NPKKRPSASDALKH 1170 (1182)
Q Consensus 1157 DPekRPTAeELLqH 1170 (1182)
||.+|||+.||++|
T Consensus 307 dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 307 DSRKRPSFPNLTSF 320 (325)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhHCcCHHHHHHH
Confidence 99999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=381.39 Aligned_cols=245 Identities=20% Similarity=0.311 Sum_probs=208.6
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLI 948 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyL 948 (1182)
++|+++++||+|+||+||+|+. .+++.||||++++.....+.+.+|+.+++.++| |||++++++|.....+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~H------pnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH------EKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCC------TTBCCEEEEECCSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCC------CceeeEEEEEeeCCceEE
Confidence 5688899999999999999997 478899999999877667889999999999865 499999999999999999
Q ss_pred EEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCccc
Q 001034 949 VCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCF 1027 (1182)
Q Consensus 949 VmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~ 1027 (1182)
||||+.+ ++..++..... .+++..+..|+.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++.
T Consensus 77 v~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~--~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRY 149 (258)
T ss_dssp EEECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT--TCCEEECCCSSCCB
T ss_pred EEEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC--CCcEEECcchhhee
Confidence 9999984 56666554433 2888999999999999999999999999999999999994 77899999999975
Q ss_pred cCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcc
Q 001034 1028 ETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKG 1102 (1182)
Q Consensus 1028 ~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~ 1102 (1182)
.... .....+|+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..++..++......
T Consensus 150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--------- 220 (258)
T d1k2pa_ 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------- 220 (258)
T ss_dssp CSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred ccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 4332 223568899999999999999999999999999999998 89999999888877776421100
Q ss_pred cccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1103 RDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1103 k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.. ....+..+.+||.+||+.||.+|||+.+||+|
T Consensus 221 -------------------------~~---------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 -------------------------YR---------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -------------------------CC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CC---------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01 12346789999999999999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-44 Score=387.10 Aligned_cols=247 Identities=19% Similarity=0.276 Sum_probs=194.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCc---EEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGM---DVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr---~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.++|++.++||+|+||+||+|+++.+++ .||||.+... ......+.+|+.+|+.++| ||||+++++|..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H------pnIv~l~g~~~~ 98 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH------PNVIHLEGVVTK 98 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC------TTBCCEEEEECS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC------CCCccEEEEEee
Confidence 3679999999999999999999887765 5888888654 3345678899999988864 599999999999
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...+||||||+.+ +|.+++..... .+++..+..|+.||+.||.|||+++||||||||+||||+. ++.+||+|
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~--~~~~Kl~D 171 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS--NLVCKVSD 171 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECC
T ss_pred CCEEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECC--CCcEEECC
Confidence 9999999999996 56665554322 3899999999999999999999999999999999999994 77899999
Q ss_pred CCCccccCCCc--------ccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcC
Q 001034 1022 LGSSCFETDHL--------CSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1022 FGLA~~~~~~~--------ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilG 1092 (1182)
||+++...... ....+|+.|+|||++.+..|+.++|||||||+||||+| |.+||.+.+..+++..+.....
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred cccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99997643321 12457899999999999999999999999999999998 8999999888877766631100
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. .....++..+.+||.+||+.||.+|||+.||+++
T Consensus 252 ------------------------------------~-------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 252 ------------------------------------L-------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ------------------------------------C-------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------------------------------C-------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 0112457889999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=384.28 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=196.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
.++|++.+.||+|+||+||+|+.. ..||||+++.. ......+.+|+.+++.++| ||||++++++. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~H------pnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH------VNILLFMGYST-AP 76 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCC------TTBCCEEEEEC-SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC------CCEeeeeEEEe-cc
Confidence 467899999999999999999743 35999999753 3445677889999988864 49999999764 56
Q ss_pred eEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLG 1023 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFG 1023 (1182)
.+||||||++ |+|.+++..... .+++..+..|+.||+.||.|||+++||||||||+||||+. ++.+||+|||
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~--~~~~Kl~DFG 149 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE--DLTVKIGDFG 149 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TSSEEECCCC
T ss_pred EEEEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcC--CCCEEEcccc
Confidence 7899999999 578887764332 3899999999999999999999999999999999999984 7789999999
Q ss_pred CccccCC-----CcccccCCCcccchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1024 SSCFETD-----HLCSYVQSRSYRAPEVILGL---SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1024 LA~~~~~-----~~ss~vGTp~YmAPEVLlg~---~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
+|+.... ......||+.|+|||++.+. .|+.++|||||||+||||+||+.||.+.+....+..++.....
T Consensus 150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-- 227 (276)
T d1uwha_ 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL-- 227 (276)
T ss_dssp CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC--
T ss_pred ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC--
Confidence 9976433 23456899999999999753 5899999999999999999999999886665544444311000
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.| .+......++..+.+||.+||..||.+|||+.+|++|
T Consensus 228 ---------------------------------~p---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 228 ---------------------------------SP---DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---------------------------------CC---CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------------CC---cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 00 0111233567899999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=392.11 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=207.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEEC---CCCcEEEEEEEeccc-----hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDL---HTGMDVCVKIIKNNK-----DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDY 939 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk---~TGr~VAVKIIkk~k-----~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ds 939 (1182)
.++|++++.||+|+||+||+|++. .+|+.||||++++.. .....+.+|+.++++++|+ |||++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~-----pnIv~~~~~ 97 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS-----PFLVTLHYA 97 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTC-----TTBCCEEEE
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCC-----CeEEEeeee
Confidence 378999999999999999999874 478999999986532 3456678999999999875 389999999
Q ss_pred EEecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEE
Q 001034 940 FYYREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVK 1018 (1182)
Q Consensus 940 Fqd~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IK 1018 (1182)
|.+...+|+||||+.+ +|..++..... +++..++.++.||+.||.|||+++|+||||||+|||++. ++.+|
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~vk 169 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVV 169 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEE
T ss_pred eccCCceeeeeecccccHHHHHHHhccc------ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecC--CCCEE
Confidence 9999999999999995 67777665542 788899999999999999999999999999999999995 67899
Q ss_pred EecCCCccccCC----CcccccCCCcccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcC
Q 001034 1019 VIDLGSSCFETD----HLCSYVQSRSYRAPEVILGL--SYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIG 1092 (1182)
Q Consensus 1019 LiDFGLA~~~~~----~~ss~vGTp~YmAPEVLlg~--~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilG 1092 (1182)
|+|||++..... ......+++.|+|||++.+. .++.++|||||||+||+|++|+.||.+.+.......+.....
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~ 249 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence 999999875432 23456789999999999765 478899999999999999999999987654443333321000
Q ss_pred CcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHH
Q 001034 1093 PIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP-----SASDA 1167 (1182)
Q Consensus 1093 p~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP-----TAeEL 1167 (1182)
.. ........+.++++||.+||++||.+|| |++||
T Consensus 250 ---------------------------------~~-------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~ei 289 (322)
T d1vzoa_ 250 ---------------------------------KS-------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289 (322)
T ss_dssp ---------------------------------HC-------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH
T ss_pred ---------------------------------cC-------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHH
Confidence 00 0011234689999999999999999999 59999
Q ss_pred HcCCCCCC
Q 001034 1168 LKHPWLSH 1175 (1182)
Q Consensus 1168 LqHPWFk~ 1175 (1182)
|+||||+.
T Consensus 290 l~Hpff~~ 297 (322)
T d1vzoa_ 290 KEHLFFQK 297 (322)
T ss_dssp HTSGGGTT
T ss_pred HcCHhhcC
Confidence 99999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-44 Score=382.90 Aligned_cols=249 Identities=19% Similarity=0.257 Sum_probs=203.6
Q ss_pred CCEEEEEE-eccCCceEEEEEEECC--CCcEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec
Q 001034 869 GRYHVTEY-LGSAAFSKAIQAHDLH--TGMDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR 943 (1182)
Q Consensus 869 drYeIlk~-LGkGaFGeVyLAkDk~--TGr~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~ 943 (1182)
++|.+.+. ||+|+||+||+|..+. ++..||||+++.. ......+.+|+.+|+.++|+ |||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~Hp------nIv~l~g~~~~- 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP------YIVRLIGVCQA- 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCT------TBCCEEEEEES-
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCC------CEeeEeeeecc-
Confidence 56888885 9999999999998754 4557999999754 34456788999999998654 99999999864
Q ss_pred CeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecC
Q 001034 944 EHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDL 1022 (1182)
Q Consensus 944 e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDF 1022 (1182)
+.+||||||+++ +|.+++...+. .+++..+..|+.||+.||.|||+++||||||||+|||++. ++.+||+||
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~--~~~~Kl~DF 153 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKISDF 153 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE--TTEEEECCC
T ss_pred CeEEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeecc--CCceeeccc
Confidence 578999999995 67776654322 3899999999999999999999999999999999999995 778999999
Q ss_pred CCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1023 GSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1023 GLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
|+++..... ....+||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..+++..|.....
T Consensus 154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~--- 230 (285)
T d1u59a_ 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--- 230 (285)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---
T ss_pred hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 999764332 234568899999999999999999999999999999998 9999998777776666531000
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH---HcCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA---LKHPW 1172 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL---LqHPW 1172 (1182)
....+.++.++.+||.+||..||++|||+.+| |+|+|
T Consensus 231 ----------------------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 231 ----------------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ----------------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------------------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01123457899999999999999999999888 67888
Q ss_pred CC
Q 001034 1173 LS 1174 (1182)
Q Consensus 1173 Fk 1174 (1182)
++
T Consensus 271 ~~ 272 (285)
T d1u59a_ 271 YS 272 (285)
T ss_dssp HH
T ss_pred HH
Confidence 73
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-43 Score=379.11 Aligned_cols=263 Identities=19% Similarity=0.251 Sum_probs=208.2
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHL 946 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~L 946 (1182)
+.++|++++.||+|+||+||+|+++.+|+.||||++..... ...+..|+++++.+.|+. +|+.+..++......
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~-----~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGV-----GIPTIRWCGAEGDYN 78 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTST-----TCCCEEEEEEETTEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCC-----cccEEEEEEecCCEE
Confidence 45789999999999999999999999999999999876543 356788999999998763 678888888889999
Q ss_pred EEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC-CCceEEEecCCCc
Q 001034 947 LIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY-SRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~-~dG~IKLiDFGLA 1025 (1182)
++||||+++++...+..... .+++..+..++.||+.||+|||++|||||||||+|||++.. ....+||+|||+|
T Consensus 79 ~ivme~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 79 VMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEEEEcCCchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 99999999998887765432 28999999999999999999999999999999999998742 3457999999999
Q ss_pred cccCCC----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1026 CFETDH----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1026 ~~~~~~----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
+..... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||...........+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~--- 230 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--- 230 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH---
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc---
Confidence 764321 2355899999999999999999999999999999999999999987665544333321100
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHH---HHHcCCC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSAS---DALKHPW 1172 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAe---ELLqHPW 1172 (1182)
.....| .....+.++.++.+||.+||..||.+||++. ++|+|+|
T Consensus 231 -----------------------------~~~~~~----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 231 -----------------------------KKMSTP----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -----------------------------HHHHSC----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -----------------------------ccCCCC----hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 000000 1112335678999999999999999999987 5578887
Q ss_pred CCCC
Q 001034 1173 LSHP 1176 (1182)
Q Consensus 1173 Fk~~ 1176 (1182)
.+..
T Consensus 278 ~~~~ 281 (299)
T d1ckia_ 278 HRQG 281 (299)
T ss_dssp HHHT
T ss_pred HHcC
Confidence 6543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=379.83 Aligned_cols=241 Identities=20% Similarity=0.257 Sum_probs=195.4
Q ss_pred EEeccCCceEEEEEEEC--CCCcEEEEEEEecc---chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEE
Q 001034 875 EYLGSAAFSKAIQAHDL--HTGMDVCVKIIKNN---KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIV 949 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk--~TGr~VAVKIIkk~---k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLV 949 (1182)
++||+|+||+||+|... .+++.||||+++.. ....+.+.+|+.+|+.++| ||||+++++|.. ...|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~~~g~~~~-~~~~lv 85 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN------PYIVRMIGICEA-ESWMLV 85 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC------TTBCCEEEEEES-SSEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCC------CCCceEEEEecc-CCEEEE
Confidence 47999999999999754 45688999999753 2345678899999998864 499999999864 567999
Q ss_pred EEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcccc
Q 001034 950 CELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSCFE 1028 (1182)
Q Consensus 950 mEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~~~ 1028 (1182)
|||+.+ +|.+++.... .+++..+..|+.||+.||.|||+++||||||||+|||++. ++.+||+|||+++..
T Consensus 86 mE~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~--~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDFGLSKAL 157 (277)
T ss_dssp EECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccc--cCcccccchhhhhhc
Confidence 999985 6777766433 2899999999999999999999999999999999999994 788999999999754
Q ss_pred CCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1029 TDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1029 ~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
... .....||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..++...+... ..
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~~------- 228 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ER------- 228 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CC-------
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence 322 223568999999999999999999999999999999998 89999988877766655310 00
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH---HcCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA---LKHPWL 1173 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL---LqHPWF 1173 (1182)
......++.++.+||.+||+.||.+|||+.+| |+|+|+
T Consensus 229 ----------------------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 229 ----------------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ----------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----------------------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 00112457899999999999999999999998 567665
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=379.99 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=204.4
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
.++|++.+.||+|+||+||+|++..+ +.||||+++......+.+.+|+.+++.++|+ |||++++++. ...+|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~------nIv~~~g~~~-~~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE------KLVQLYAVVS-EEPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCT------TBCCEEEEEC-SSSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccC------CEeEEEEEEe-cCCeE
Confidence 46899999999999999999998655 5799999987766667899999999998765 8999999985 46689
Q ss_pred EEEEecccC-hHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCcc
Q 001034 948 IVCELLKAN-LYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSSC 1026 (1182)
Q Consensus 948 LVmEyL~Gs-Lld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA~ 1026 (1182)
+||||+.++ |..++...... .+++..+..|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+++
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~----~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~--~~~~kl~DfGla~ 161 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLAR 161 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCCTTC
T ss_pred EEEEecCCCchhhhhhhcccc----cchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECC--CCcEEEcccchhh
Confidence 999999964 56565544322 2899999999999999999999999999999999999984 6789999999997
Q ss_pred ccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhhcCCcchhhhhc
Q 001034 1027 FETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG-NVLFQNDSPATLLARVIGIIGPIEQGMLAK 1101 (1182)
Q Consensus 1027 ~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTG-r~PF~g~d~~elLakIv~ilGp~PeemL~~ 1101 (1182)
..... .....+|+.|+|||++....++.++|||||||++|||++| .+||.+....+++..+.....
T Consensus 162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--------- 232 (285)
T d1fmka3 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 232 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred hccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 64322 2345789999999999999999999999999999999995 566666777666666531100
Q ss_pred ccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc--CCCCCCC
Q 001034 1102 GRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK--HPWLSHP 1176 (1182)
Q Consensus 1102 ~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq--HPWFk~~ 1176 (1182)
......++.++.+||.+||+.||++|||+.+|++ |+||+..
T Consensus 233 ----------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 233 ----------------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ----------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----------------------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 0112345789999999999999999999999998 9999775
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=375.23 Aligned_cols=246 Identities=20% Similarity=0.284 Sum_probs=193.3
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCC---cEEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTG---MDVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TG---r~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.++|++.+.||+|+||+||+|.+..++ ..||||+++.. ......+.+|+.+++.++| ||||+++++|.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~H------pnIv~l~~~~~- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH------PHIVKLIGVIT- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC------TTBCCEEEEEC-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC------CCEeeEEEEEe-
Confidence 468999999999999999999986543 56888888643 3345678899999998864 59999999985
Q ss_pred cCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
...+||||||+.+ ++..++..... .+++..++.++.||+.||.|||+++||||||||+|||++. .+.+||+|
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~--~~~~Kl~D 151 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVKLGD 151 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECC
T ss_pred cCeEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecC--CCcEEEcc
Confidence 5789999999995 56555544322 2899999999999999999999999999999999999995 67899999
Q ss_pred CCCccccCCC----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcch
Q 001034 1022 LGSSCFETDH----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1022 FGLA~~~~~~----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~Pe 1096 (1182)
||+++..... .....+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+++.++.....
T Consensus 152 fG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~---- 227 (273)
T d1mp8a_ 152 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---- 227 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred chhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----
Confidence 9999764432 234567999999999999999999999999999999998 8999998888777766631100
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
....+.++..+.+||.+||..||.+|||+.||++|
T Consensus 228 ---------------------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 ---------------------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ---------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01123457899999999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-43 Score=374.14 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=193.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECC-----CCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLH-----TGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~-----TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|++++.||+|+||+||+|.+.. +++.||||+++... .....+..|..++.++.++ +||+.+++++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h-----~~iv~~~~~~ 86 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH-----LNVVNLLGAC 86 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCC-----TTBCCEEEEE
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCC-----CeEEEeeeee
Confidence 4689999999999999999999754 45789999997542 3345677888888888654 4899999988
Q ss_pred Eec-CeEEEEEEecc-cChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEE
Q 001034 941 YYR-EHLLIVCELLK-ANLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENIL 1008 (1182)
Q Consensus 941 qd~-e~LyLVmEyL~-GsLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNIL 1008 (1182)
... ..+++||||+. |+|.+++....... ....+++..+..|+.||+.||.|||+++||||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 765 56999999998 57888876543210 1124889999999999999999999999999999999999
Q ss_pred EccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHH
Q 001034 1009 VKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG-NVLFQNDSPAT 1082 (1182)
Q Consensus 1009 IDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTG-r~PF~g~d~~e 1082 (1182)
|+. ++.+||+|||+|+..... ....+||+.|+|||++.+..++.++|||||||++|||++| .+||.+.....
T Consensus 167 l~~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 167 LSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp ECG--GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECC--CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 984 778999999999754322 2346789999999999999999999999999999999986 56887755444
Q ss_pred HHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCC
Q 001034 1083 LLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRP 1162 (1182)
Q Consensus 1083 lLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRP 1162 (1182)
.+.+++.... .+ ......++++.+||.+||+.||.+||
T Consensus 245 ~~~~~~~~~~------------------------------------~~------~~~~~~~~~l~~li~~cl~~dP~~Rp 282 (299)
T d1ywna1 245 EFCRRLKEGT------------------------------------RM------RAPDYTTPEMYQTMLDCWHGEPSQRP 282 (299)
T ss_dssp HHHHHHHHTC------------------------------------CC------CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHhcCC------------------------------------CC------CCCccCCHHHHHHHHHHcCCChhHCc
Confidence 4433321000 00 11123578999999999999999999
Q ss_pred CHHHHHcC
Q 001034 1163 SASDALKH 1170 (1182)
Q Consensus 1163 TAeELLqH 1170 (1182)
|+.||++|
T Consensus 283 t~~eil~~ 290 (299)
T d1ywna1 283 TFSELVEH 290 (299)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=369.05 Aligned_cols=246 Identities=17% Similarity=0.231 Sum_probs=192.7
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCC----cEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTG----MDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TG----r~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
...|++.++||+|+||+||+|..+.++ ..||||+++... .....+.+|+.+++.++| ||||++++++.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H------~nIv~~~g~~~ 79 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH------HNIIRLEGVIS 79 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC------TTBCCEEEEEC
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCC------CCEeeeeEEEe
Confidence 357999999999999999999876554 469999997543 334567889999999865 49999999999
Q ss_pred ecCeEEEEEEecccCh-HHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKANL-YEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~GsL-ld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
....+++||||+.+++ .+++..... .+++..+..++.||+.||.|||+++||||||||+||||+. ++.+||+
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~--~~~~Kl~ 152 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS--NLVCKVS 152 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEEC
T ss_pred cCCceEEEEEecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECC--CCeEEEc
Confidence 9999999999999754 444433321 3899999999999999999999999999999999999994 7789999
Q ss_pred cCCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhhcCC
Q 001034 1021 DLGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG-NVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1021 DFGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTG-r~PF~g~d~~elLakIv~ilGp 1093 (1182)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++| .+||...+..+++..+....-
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~- 231 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR- 231 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-
Confidence 99999764322 2234678999999999999999999999999999999995 555666666666555421000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
.......+..+.+||.+||+.||.+|||+.+|++
T Consensus 232 ------------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 ------------------------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 0011235688999999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-43 Score=378.18 Aligned_cols=245 Identities=20% Similarity=0.286 Sum_probs=194.9
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCc----EEEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGM----DVCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY 942 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr----~VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd 942 (1182)
.+|+++++||+|+||+||+|.+..+|+ .||+|.++.. ......+.+|+.+++.++|+ |||+++++|..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~l~g~~~~ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP------HVCRLLGICLT 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCT------TBCCEEEEEES
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCC------CEeeEEEEEec
Confidence 469999999999999999999988877 4788877643 23456788999999998654 99999999987
Q ss_pred cCeEEEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEec
Q 001034 943 REHLLIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVID 1021 (1182)
Q Consensus 943 ~e~LyLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiD 1021 (1182)
.. .++||+++. |+|.+++..... .+++..++.|+.||+.||.|||+++||||||||+||||+. ++.+||+|
T Consensus 83 ~~-~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~--~~~~kl~D 154 (317)
T d1xkka_ 83 ST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITD 154 (317)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEEECC
T ss_pred CC-eeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC--CCCeEeec
Confidence 54 566667666 678877765432 3899999999999999999999999999999999999995 77899999
Q ss_pred CCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcc
Q 001034 1022 LGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIE 1095 (1182)
Q Consensus 1022 FGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~P 1095 (1182)
||+++..... .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..++...+.....
T Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~--- 231 (317)
T d1xkka_ 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--- 231 (317)
T ss_dssp CSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC---
T ss_pred cccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 9999764332 223468999999999999999999999999999999998 8999988776665544421000
Q ss_pred hhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1096 QGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1096 eemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
....+.++..+.+||.+||+.||.+|||+.||++|
T Consensus 232 ----------------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 232 ----------------------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ----------------------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------------------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 00113457889999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-41 Score=366.05 Aligned_cols=254 Identities=19% Similarity=0.235 Sum_probs=206.3
Q ss_pred eecCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
++.++|+|++.||+|+||+||+|+++.+|+.||||++..... ...+.+|+++++.+.++ +|++.+++++....+
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~-----~~i~~~~~~~~~~~~ 75 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGC-----TGIPNVYYFGQEGLH 75 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTC-----TTCCCEEEEEEETTE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcCC-----CCCCEEEEEeecCCc
Confidence 567899999999999999999999999999999999876542 34567889999998764 389999999999999
Q ss_pred EEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccC---CCceEEEecC
Q 001034 946 LLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSY---SRCEVKVIDL 1022 (1182)
Q Consensus 946 LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~---~dG~IKLiDF 1022 (1182)
.|+||||+.++|.+++..... .++...+..++.|++.||.|||++|||||||||+|||++.. ..+.+||+||
T Consensus 76 ~~~vme~~~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 76 NVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp EEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred cEEEEEecCCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccc
Confidence 999999999999988765432 28999999999999999999999999999999999999742 3567999999
Q ss_pred CCccccCCC----------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh
Q 001034 1023 GSSCFETDH----------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQNDS---PATLLARVIG 1089 (1182)
Q Consensus 1023 GLA~~~~~~----------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~d---~~elLakIv~ 1089 (1182)
|+|+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+.++..
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence 999764321 234679999999999999999999999999999999999999997643 3333333321
Q ss_pred hcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1090 IIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1090 ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
..-. . ......+.+++++.+||..|+..+|.+||+.+.+.+
T Consensus 231 ~~~~-----------------------------------~----~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 231 KKQS-----------------------------------T----PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHH-----------------------------------S----CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCC-----------------------------------C----ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0000 0 001112345688999999999999999999776644
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=367.32 Aligned_cols=245 Identities=21% Similarity=0.297 Sum_probs=195.0
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEe-cCeE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYY-REHL 946 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd-~e~L 946 (1182)
.++|++++.||+|+||.||+|.. +|..||||++++.. ..+.+.+|++++++++| |||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~H------pnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRH------SNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTCCC------TTBCCEEEEECCC--CC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCC------CCEeeEEEEEEecCCcE
Confidence 46799999999999999999987 47899999997654 34678899999988864 499999999865 4678
Q ss_pred EEEEEecc-cChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCCc
Q 001034 947 LIVCELLK-ANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGSS 1025 (1182)
Q Consensus 947 yLVmEyL~-GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGLA 1025 (1182)
||||||+. |+|.+++...... .+++..++.|+.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~----~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~--~~~~kl~dfg~s 150 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFGLT 150 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHH----HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCCCC-
T ss_pred EEEEeccCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHhhccccccCceeccccchHhheecC--CCCEeecccccc
Confidence 99999998 4788777644321 3889999999999999999999999999999999999994 778999999999
Q ss_pred cccCCCcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCCcchhhhhcccc
Q 001034 1026 CFETDHLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGPIEQGMLAKGRD 1104 (1182)
Q Consensus 1026 ~~~~~~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp~PeemL~~~k~ 1104 (1182)
+..........+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..+++..|....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~------------- 217 (262)
T d1byga_ 151 KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------- 217 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-------------
T ss_pred eecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 887766667788999999999999999999999999999999998 799998877766665552100
Q ss_pred cchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1105 TYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1105 s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
. .......++.+.+||.+||+.||.+|||+.+|+++
T Consensus 218 ------------------------~------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 ------------------------K------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ------------------------C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------C------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0 01123456899999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-42 Score=368.13 Aligned_cols=251 Identities=19% Similarity=0.216 Sum_probs=204.5
Q ss_pred cCCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEE
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYF 940 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsF 940 (1182)
.++|++++.||+|+||+||+|+.+ .+++.||||+++... .....+.+|+.+|+.++|+ ||++++++|
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~------niv~~~~~~ 85 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP------NIVKLLGVC 85 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCT------TBCCEEEEE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCC------Ccccceeee
Confidence 467999999999999999999864 466889999997543 3356788999999988654 899999999
Q ss_pred EecCeEEEEEEecc-cChHHHHhhhccc------------------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccc
Q 001034 941 YYREHLLIVCELLK-ANLYEFHKFNRES------------------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCD 1001 (1182)
Q Consensus 941 qd~e~LyLVmEyL~-GsLld~Lk~~~~s------------------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRD 1001 (1182)
.....+++||||+. |+|.+++...... .....+++..+..|+.||+.||.|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999998 5788877643211 1122378889999999999999999999999999
Q ss_pred cCCccEEEccCCCceEEEecCCCccccCC-----CcccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 001034 1002 LKPENILVKSYSRCEVKVIDLGSSCFETD-----HLCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGN-VLF 1075 (1182)
Q Consensus 1002 IKPeNILIDs~~dG~IKLiDFGLA~~~~~-----~~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr-~PF 1075 (1182)
|||+||||+. ++.+||+|||+|+.... ......+|+.|+|||++.+..|+.++|||||||++|||++|. +||
T Consensus 166 lKp~NILld~--~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGE--NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECG--GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECC--CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999994 77899999999864322 223457889999999999999999999999999999999985 789
Q ss_pred CCCCHHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcc
Q 001034 1076 QNDSPATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLE 1155 (1182)
Q Consensus 1076 ~g~d~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq 1155 (1182)
.+.+..+++..+.... . ......++.++.+||.+||+
T Consensus 244 ~~~~~~e~~~~v~~~~--~-----------------------------------------~~~p~~~~~~~~~li~~cl~ 280 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGN--I-----------------------------------------LACPENCPLELYNLMRLCWS 280 (301)
T ss_dssp TTSCHHHHHHHHHTTC--C-----------------------------------------CCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHcCC--C-----------------------------------------CCCCccchHHHHHHHHHHcC
Confidence 9888888777663110 0 01122456889999999999
Q ss_pred cCCCCCCCHHHHHc
Q 001034 1156 INPKKRPSASDALK 1169 (1182)
Q Consensus 1156 ~DPekRPTAeELLq 1169 (1182)
.||.+|||+.||++
T Consensus 281 ~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 281 KLPADRPSFCSIHR 294 (301)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHH
Confidence 99999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-42 Score=364.25 Aligned_cols=245 Identities=21% Similarity=0.288 Sum_probs=193.4
Q ss_pred CCEEEEEEeccCCceEEEEEEEC-CCC--cEEEEEEEecc----chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDL-HTG--MDVCVKIIKNN----KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFY 941 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk-~TG--r~VAVKIIkk~----k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFq 941 (1182)
.+|++++.||+|+||+||+|+.. .++ ..||||++.+. ....+.+.+|+.+|+.++|+ |||+++++|.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~------nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR------NLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCT------TBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCC------CEEEEEEEEe
Confidence 57999999999999999999854 333 36899998753 34456788999999998654 9999999996
Q ss_pred ecCeEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEe
Q 001034 942 YREHLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVI 1020 (1182)
Q Consensus 942 d~e~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLi 1020 (1182)
+ ..+++||||+.+ ++.+.+..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~--~~~vkl~ 153 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT--RDLVKIG 153 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEEEC
T ss_pred e-cchheeeeeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc--ccceeec
Confidence 5 578999999984 66666665432 2899999999999999999999999999999999999995 6789999
Q ss_pred cCCCccccCCC------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcCC
Q 001034 1021 DLGSSCFETDH------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSPATLLARVIGIIGP 1093 (1182)
Q Consensus 1021 DFGLA~~~~~~------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~~elLakIv~ilGp 1093 (1182)
|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+.+.+|......
T Consensus 154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233 (273)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred cchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC
Confidence 99999865332 223457889999999999999999999999999999998 89999999988888777421000
Q ss_pred cchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 001034 1094 IEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALK 1169 (1182)
Q Consensus 1094 ~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLq 1169 (1182)
......++..+.+||.+||..||.+|||+.+|++
T Consensus 234 ------------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 234 ------------------------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112345789999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=364.09 Aligned_cols=253 Identities=20% Similarity=0.300 Sum_probs=201.6
Q ss_pred ecCCEEEEEEeccCCceEEEEEEECCCC-------cEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEE
Q 001034 867 IAGRYHVTEYLGSAAFSKAIQAHDLHTG-------MDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLY 937 (1182)
Q Consensus 867 L~drYeIlk~LGkGaFGeVyLAkDk~TG-------r~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~ 937 (1182)
-.++|++++.||+|+||.||+|+...++ ..||||++++.. .....+.+|..++.++. .|||||+++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~-----~HpnIv~~~ 85 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINLL 85 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc-----CCCeEEecc
Confidence 3578999999999999999999976554 479999997654 34467788888888884 356999999
Q ss_pred EEEEecCeEEEEEEeccc-ChHHHHhhhcccC----------CccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCcc
Q 001034 938 DYFYYREHLLIVCELLKA-NLYEFHKFNRESG----------GEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPEN 1006 (1182)
Q Consensus 938 dsFqd~e~LyLVmEyL~G-sLld~Lk~~~~sg----------gel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeN 1006 (1182)
++|.+...+|+||||+.+ +|.+++....... ....+++..+..++.||+.||.|||+.+||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 999999999999999984 6777776543211 12248999999999999999999999999999999999
Q ss_pred EEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 001034 1007 ILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDSP 1080 (1182)
Q Consensus 1007 ILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d~ 1080 (1182)
||++. ++.+||+|||+++..... ....++|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+.
T Consensus 166 iLl~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 166 VLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp EEECT--TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eeecC--CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99994 678999999999754332 334678999999999999999999999999999999998 7999998887
Q ss_pred HHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCC
Q 001034 1081 ATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKK 1160 (1182)
Q Consensus 1081 ~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPek 1160 (1182)
.+++..+..... + .....++..+.+||.+||++||.+
T Consensus 244 ~~~~~~i~~~~~-------------------------------------~------~~p~~~~~~l~~li~~cl~~dP~~ 280 (299)
T d1fgka_ 244 EELFKLLKEGHR-------------------------------------M------DKPSNCTNELYMMMRDCWHAVPSQ 280 (299)
T ss_dssp HHHHHHHHTTCC-------------------------------------C------CCCSSCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHcCCC-------------------------------------C------CCCccchHHHHHHHHHHccCCHhH
Confidence 776655421000 0 011245788999999999999999
Q ss_pred CCCHHHHHc
Q 001034 1161 RPSASDALK 1169 (1182)
Q Consensus 1161 RPTAeELLq 1169 (1182)
|||+.|||+
T Consensus 281 Rps~~eil~ 289 (299)
T d1fgka_ 281 RPTFKQLVE 289 (299)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=365.55 Aligned_cols=252 Identities=20% Similarity=0.244 Sum_probs=202.3
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcE--EEEEEEecc--chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMD--VCVKIIKNN--KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE 944 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~--VAVKIIkk~--k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e 944 (1182)
++|++.++||+|+||+||+|+++.++.. ||||.++.. ......+.+|+++|.++. .|||||+++++|....
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-----CCTTBCCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhcc-----CCCCEeeEEEEEecCC
Confidence 6899999999999999999999888875 667776543 234557889999999874 2559999999999999
Q ss_pred eEEEEEEecc-cChHHHHhhhcc----------cCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC
Q 001034 945 HLLIVCELLK-ANLYEFHKFNRE----------SGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013 (1182)
Q Consensus 945 ~LyLVmEyL~-GsLld~Lk~~~~----------sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~ 1013 (1182)
.+||||||+. |+|.+++..... ......+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~-- 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-- 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC--
Confidence 9999999999 578887754311 011224899999999999999999999999999999999999995
Q ss_pred CceEEEecCCCccccCCC--cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhh
Q 001034 1014 RCEVKVIDLGSSCFETDH--LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGN-VLFQNDSPATLLARVIGI 1090 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~~--~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr-~PF~g~d~~elLakIv~i 1090 (1182)
++.+||+|||+++..... .....+|+.|+|||.+.+..|+.++|||||||++|||++|. +||.+.+..+++..+...
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 678999999999754432 23456899999999999999999999999999999999965 688888877776665310
Q ss_pred cCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 001034 1091 IGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH 1170 (1182)
Q Consensus 1091 lGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH 1170 (1182)
.. ......+++++.+||.+||+.||++|||+.|||+|
T Consensus 243 ~~-------------------------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YR-------------------------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CC-------------------------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-------------------------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 00 00112357899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=360.45 Aligned_cols=255 Identities=23% Similarity=0.320 Sum_probs=205.5
Q ss_pred eecCCEEEEEEeccCCceEEEEEEE-----CCCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHD-----LHTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkD-----k~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
+-.++|++.++||+|+||.||+|+. ..+++.||||+++... .....+.+|+.+++.+. .|||||++++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~-----~HpnIv~~~g 94 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHMNIVNLLG 94 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc-----CCCCEEEEEE
Confidence 3457999999999999999999985 3577899999997643 34456788999999884 3569999999
Q ss_pred EEEecCeEEEEEEeccc-ChHHHHhhhccc------------CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCc
Q 001034 939 YFYYREHLLIVCELLKA-NLYEFHKFNRES------------GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPE 1005 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~G-sLld~Lk~~~~s------------ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPe 1005 (1182)
++.....+||||||+.+ +|.+++...... .....+++..+..|+.||+.||.|||+++||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 99999999999999985 677776544311 12234889999999999999999999999999999999
Q ss_pred cEEEccCCCceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 001034 1006 NILVKSYSRCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCT-GNVLFQNDS 1079 (1182)
Q Consensus 1006 NILIDs~~dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLT-Gr~PF~g~d 1079 (1182)
|||++. .+.+||+|||+++..... ....++|+.|+|||++....++.++|||||||++|||+| |.+||.+.+
T Consensus 175 NIl~~~--~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 175 NILLTH--GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GEEEET--TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccc--cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999984 778999999999865432 234578999999999999999999999999999999998 677777766
Q ss_pred HHHHHHHHHhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCC
Q 001034 1080 PATLLARVIGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPK 1159 (1182)
Q Consensus 1080 ~~elLakIv~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPe 1159 (1182)
....+.+++..-.. + ......+..+.+||.+||++||.
T Consensus 253 ~~~~~~~~i~~~~~------------------------------------~------~~~~~~~~~l~~Li~~cl~~dP~ 290 (311)
T d1t46a_ 253 VDSKFYKMIKEGFR------------------------------------M------LSPEHAPAEMYDIMKTCWDADPL 290 (311)
T ss_dssp SSHHHHHHHHHTCC------------------------------------C------CCCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHhcCCC------------------------------------C------CCcccccHHHHHHHHHHcCCChh
Confidence 65555555311000 0 01123468899999999999999
Q ss_pred CCCCHHHHHc
Q 001034 1160 KRPSASDALK 1169 (1182)
Q Consensus 1160 kRPTAeELLq 1169 (1182)
+|||+.+||+
T Consensus 291 ~RPs~~~il~ 300 (311)
T d1t46a_ 291 KRPTFKQIVQ 300 (311)
T ss_dssp GSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=364.28 Aligned_cols=259 Identities=19% Similarity=0.246 Sum_probs=210.3
Q ss_pred eecCCEEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEEeccc--hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEE
Q 001034 866 VIAGRYHVTEYLGSAAFSKAIQAHDL-----HTGMDVCVKIIKNNK--DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYD 938 (1182)
Q Consensus 866 iL~drYeIlk~LGkGaFGeVyLAkDk-----~TGr~VAVKIIkk~k--~~~dq~l~EikILr~L~h~~~l~HPnIVkL~d 938 (1182)
+..++|++.+.||+|+||+||+|.+. .++..||||+++... .....+.+|+.++++++|+ |||++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~------nIv~~~~ 90 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH------HVVRLLG 90 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCT------TBCCEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCC------CEeeeee
Confidence 34589999999999999999999875 246789999997643 3334577899998888654 8999999
Q ss_pred EEEecCeEEEEEEecc-cChHHHHhhhccc----CCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCC
Q 001034 939 YFYYREHLLIVCELLK-ANLYEFHKFNRES----GGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYS 1013 (1182)
Q Consensus 939 sFqd~e~LyLVmEyL~-GsLld~Lk~~~~s----ggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~ 1013 (1182)
++.....+++||||+. |+|.+++...... .....+++..+..++.||+.||.|||+++|+||||||+||||+ .
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld--~ 168 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA--E 168 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC--T
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec--C
Confidence 9999999999999998 5677776543211 1122368889999999999999999999999999999999999 4
Q ss_pred CceEEEecCCCccccCCC-----cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHH
Q 001034 1014 RCEVKVIDLGSSCFETDH-----LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTG-NVLFQNDSPATLLARV 1087 (1182)
Q Consensus 1014 dG~IKLiDFGLA~~~~~~-----~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTG-r~PF~g~d~~elLakI 1087 (1182)
++.+||+|||+++..... ....++|+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+.+..+
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 778999999999764432 2334689999999999999999999999999999999998 5889888888877776
Q ss_pred HhhcCCcchhhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 001034 1088 IGIIGPIEQGMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDA 1167 (1182)
Q Consensus 1088 v~ilGp~PeemL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeEL 1167 (1182)
+.... ....+.++..+.+||.+||+.||.+|||+.+|
T Consensus 249 ~~~~~-------------------------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~i 285 (308)
T d1p4oa_ 249 MEGGL-------------------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285 (308)
T ss_dssp HTTCC-------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhCCC-------------------------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 42100 01122456889999999999999999999999
Q ss_pred Hc------CCCCCC
Q 001034 1168 LK------HPWLSH 1175 (1182)
Q Consensus 1168 Lq------HPWFk~ 1175 (1182)
++ +|+|++
T Consensus 286 l~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 286 ISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHGGGSCTTHHH
T ss_pred HHHHHHhcCCCCcC
Confidence 98 777754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=351.76 Aligned_cols=253 Identities=20% Similarity=0.253 Sum_probs=195.3
Q ss_pred EEEEEeccCCceEEEEEEECCCC---cEEEEEEEec--cchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEec-Ce
Q 001034 872 HVTEYLGSAAFSKAIQAHDLHTG---MDVCVKIIKN--NKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYR-EH 945 (1182)
Q Consensus 872 eIlk~LGkGaFGeVyLAkDk~TG---r~VAVKIIkk--~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~-e~ 945 (1182)
.+.++||+|+||+||+|....++ ..||||++++ .......+.+|+++|++++| ||||++++++... ..
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~H------pnIv~~~g~~~~~~~~ 103 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH------PNVLSLLGICLRSEGS 103 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCC------TTBCCCCEEEEETTTE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC------CCEeEEeEEEEecCCc
Confidence 34678999999999999986643 3689999974 33445678999999999865 4999999998764 68
Q ss_pred EEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEccCCCceEEEecCCC
Q 001034 946 LLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKSYSRCEVKVIDLGS 1024 (1182)
Q Consensus 946 LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs~~dG~IKLiDFGL 1024 (1182)
+++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+.+|+||||||+||||+. ++.+||+|||+
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~--~~~~kL~DFG~ 176 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVADFGL 176 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECSSGG
T ss_pred eEEEEEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC--CCCEEEecccc
Confidence 9999999996 55555553322 2677888999999999999999999999999999999984 67899999999
Q ss_pred ccccCCC-------cccccCCCcccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhcCCcch
Q 001034 1025 SCFETDH-------LCSYVQSRSYRAPEVILGLSYDKKIDIWSLGCILAELCTGNVLFQND-SPATLLARVIGIIGPIEQ 1096 (1182)
Q Consensus 1025 A~~~~~~-------~ss~vGTp~YmAPEVLlg~~yS~kSDIWSLGVILYELLTGr~PF~g~-d~~elLakIv~ilGp~Pe 1096 (1182)
++..... .....||+.|+|||++....++.++|||||||++|||+||..||... +..+....+... .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~--- 251 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R--- 251 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--C---
T ss_pred hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--C---
Confidence 9754322 22356899999999999999999999999999999999977776543 332323222100 0
Q ss_pred hhhhcccccchhhcccchhhhhhcchhhhhhccccccccccCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC------
Q 001034 1097 GMLAKGRDTYKYFTKNHMLYERNQETNRLEYLIPKKTSLRHRLPMGDQGFIDFVAHLLEINPKKRPSASDALKH------ 1170 (1182)
Q Consensus 1097 emL~~~k~s~k~F~k~~~~~er~~ets~Le~liPk~~sL~~~l~~~SeeL~DLIrkMLq~DPekRPTAeELLqH------ 1170 (1182)
.+ .....++..+.+||.+||+.||.+|||+.||++|
T Consensus 252 --------------------------------~~------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 --------------------------------RL------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --------------------------------CC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------------------------CC------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00 0112456889999999999999999999999998
Q ss_pred CCCCCCCCCC
Q 001034 1171 PWLSHPYEPI 1180 (1182)
Q Consensus 1171 PWFk~~~eP~ 1180 (1182)
.|..+.+..+
T Consensus 294 ~~~~~~~~~~ 303 (311)
T d1r0pa_ 294 TFIGEHYVHV 303 (311)
T ss_dssp TCCSCCBCCC
T ss_pred hhhhhhchhc
Confidence 7777665443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=352.32 Aligned_cols=193 Identities=21% Similarity=0.277 Sum_probs=155.6
Q ss_pred cCCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecC---
Q 001034 868 AGRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYRE--- 944 (1182)
Q Consensus 868 ~drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e--- 944 (1182)
+.+|.+.+.||+|+||+||+|+. +|+.||||+++.... .....|..++.. ....|||||++++++....
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~----~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQT----VMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTS----TTCCCTTBCCEEEEEEEECSSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHH----hhCCCCcCcceEEEEEeCCCcc
Confidence 46799999999999999999985 789999999975543 334444433322 1235779999999998764
Q ss_pred -eEEEEEEeccc-ChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh--------cCccccccCCccEEEccCCC
Q 001034 945 -HLLIVCELLKA-NLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHG--------LGLIHCDLKPENILVKSYSR 1014 (1182)
Q Consensus 945 -~LyLVmEyL~G-sLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS--------~GIIHRDIKPeNILIDs~~d 1014 (1182)
.+||||||+.+ +|..++.... +++..+..++.|++.||.|||+ +|||||||||+||||+ .+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~~-------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~--~~ 144 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK--KN 144 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC--TT
T ss_pred eEEEEEEecccCCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc--CC
Confidence 68999999985 7777776431 8889999999999999999996 5999999999999998 47
Q ss_pred ceEEEecCCCccccCCC-------cccccCCCcccchhhhcCCC------CCchhhHHHHHHHHHHHHhCCCCCCC
Q 001034 1015 CEVKVIDLGSSCFETDH-------LCSYVQSRSYRAPEVILGLS------YDKKIDIWSLGCILAELCTGNVLFQN 1077 (1182)
Q Consensus 1015 G~IKLiDFGLA~~~~~~-------~ss~vGTp~YmAPEVLlg~~------yS~kSDIWSLGVILYELLTGr~PF~g 1077 (1182)
+.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||+||||+||.+||..
T Consensus 145 ~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 88999999998754321 23467999999999987653 67789999999999999999988854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=5e-22 Score=199.12 Aligned_cols=164 Identities=16% Similarity=0.152 Sum_probs=115.9
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccch-------------------hhHHHHHHHHHHHHhcCCCCCCCc
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKD-------------------FFDQSLDEIKLLKYVNKHDPGDKY 931 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~-------------------~~dq~l~EikILr~L~h~~~l~HP 931 (1182)
|.|.++||+|+||+||+|.+ .+|+.||||+++.... .......|...+.++.+.
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~------ 74 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL------ 74 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTS------
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCC------
Confidence 46789999999999999998 4789999999763210 112233466677766544
Q ss_pred ceEEEEEEEEecCeEEEEEEecccChHHHHhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCccccccCCccEEEcc
Q 001034 932 HLLRLYDYFYYREHLLIVCELLKANLYEFHKFNRESGGEVYFTMPRLQSITIQCLEALQFLHGLGLIHCDLKPENILVKS 1011 (1182)
Q Consensus 932 nIVkL~dsFqd~e~LyLVmEyL~GsLld~Lk~~~~sggel~Lse~eIr~Ia~QILsALeYLHS~GIIHRDIKPeNILIDs 1011 (1182)
+++..+++. ..++||||+++.... .++...+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 ~v~~~~~~~----~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~ 138 (191)
T d1zara2 75 AVPKVYAWE----GNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE 138 (191)
T ss_dssp SSCCEEEEE----TTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET
T ss_pred CcceEEEec----CCEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC
Confidence 677766543 237999999874321 1444557789999999999999999999999999999983
Q ss_pred CCCceEEEecCCCccccCCCcccccCCCcccch--h---hhcCCCCCchhhHHHHHHHH
Q 001034 1012 YSRCEVKVIDLGSSCFETDHLCSYVQSRSYRAP--E---VILGLSYDKKIDIWSLGCIL 1065 (1182)
Q Consensus 1012 ~~dG~IKLiDFGLA~~~~~~~ss~vGTp~YmAP--E---VLlg~~yS~kSDIWSLGVIL 1065 (1182)
..++|+|||+|......... .|... + .+....|+.++|+||+.--+
T Consensus 139 ---~~~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 139 ---EGIWIIDFPQSVEVGEEGWR-----EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ---TEEEECCCTTCEETTSTTHH-----HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ---CCEEEEECCCcccCCCCCcH-----HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 44999999999765433211 12211 1 12245688899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.06 E-value=2e-05 Score=79.60 Aligned_cols=82 Identities=6% Similarity=0.028 Sum_probs=57.2
Q ss_pred CCEEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 869 GRYHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNK-DFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 869 drYeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k-~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
..|++.+..+-++.+.||++. ..+..+++|+..... .......+|..+++.+...- -+.+++.++......|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~v-----pvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKL-----PVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTS-----CCCCEEEEEEETTEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccC-----CCCcEEEEEecCCceE
Confidence 356666665555567899886 456677888876542 23445678888888885432 2556677777888999
Q ss_pred EEEEecccCh
Q 001034 948 IVCELLKANL 957 (1182)
Q Consensus 948 LVmEyL~GsL 957 (1182)
+||++++|..
T Consensus 87 lv~~~l~G~~ 96 (263)
T d1j7la_ 87 LLMSEADGVL 96 (263)
T ss_dssp EEEECCSSEE
T ss_pred EEEEeccccc
Confidence 9999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.42 E-value=0.00038 Score=76.05 Aligned_cols=77 Identities=17% Similarity=0.111 Sum_probs=50.8
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEEecc--------chhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCe
Q 001034 874 TEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNN--------KDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREH 945 (1182)
Q Consensus 874 lk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~--------k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~ 945 (1182)
.+.||.|....||++.+..+++.+++|.-... .....+...|..+|+.+....+. .+++++.+ +...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~---~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPH---LVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGG---GSCCEEEE--ETTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCC---CcceEEEE--cCCC
Confidence 34689999999999998778889999975421 11234556788888887654322 35555543 4566
Q ss_pred EEEEEEeccc
Q 001034 946 LLIVCELLKA 955 (1182)
Q Consensus 946 LyLVmEyL~G 955 (1182)
.++|||++.+
T Consensus 106 ~~lvmE~L~~ 115 (392)
T d2pula1 106 AVTVMEDLSH 115 (392)
T ss_dssp TEEEECCCTT
T ss_pred CEEEEeccCC
Confidence 7899999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.33 E-value=0.00079 Score=67.18 Aligned_cols=72 Identities=8% Similarity=-0.021 Sum_probs=51.3
Q ss_pred eccCC-ceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEEEEEEeccc
Q 001034 877 LGSAA-FSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLLIVCELLKA 955 (1182)
Q Consensus 877 LGkGa-FGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~LyLVmEyL~G 955 (1182)
+..|. -+.||++.. ..+..+++|+..... ...+..|...|+.+.... . -+.+++.+..+....++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~g-v---pvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTG-V---PCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTT-C---CBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcC-C---CCCceeeecccccceEEEEEeeec
Confidence 34444 367898874 567778999876543 345677888888887542 1 256677777788889999999976
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.60 E-value=0.005 Score=64.93 Aligned_cols=74 Identities=12% Similarity=0.063 Sum_probs=48.8
Q ss_pred CCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEE--EEEEEecCeEEEEEEeccc
Q 001034 880 AAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRL--YDYFYYREHLLIVCELLKA 955 (1182)
Q Consensus 880 GaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL--~dsFqd~e~LyLVmEyL~G 955 (1182)
+.-..||++.. .+|..|++|+.+.......++..|...+..|..... ..+..+.. -..+......+.|++++.|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gi-pv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEV-PVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTC-SBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCC-CCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 33468999974 678899999998776556778889988888875421 11111111 0122345678889999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.57 E-value=0.0043 Score=67.14 Aligned_cols=71 Identities=10% Similarity=0.045 Sum_probs=49.7
Q ss_pred EEeccCCceEEEEEEECC-------CCcEEEEEEEeccchhhHHHHHHHHHHHHhcCCCCCCCcceEEEEEEEEecCeEE
Q 001034 875 EYLGSAAFSKAIQAHDLH-------TGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKHDPGDKYHLLRLYDYFYYREHLL 947 (1182)
Q Consensus 875 k~LGkGaFGeVyLAkDk~-------TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~~~l~HPnIVkL~dsFqd~e~Ly 947 (1182)
+.|+-|---.+|++.... ..+.|.+++.-.... .....+|..+++.+.... -..+++++|.. .
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~idr~~E~~i~~~ls~~g-----l~Pkll~~~~~----g 117 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-ESHLVAESVIFTLLSERH-----LGPKLYGIFSG----G 117 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-HHHHHHHHHHHHHHHHTT-----SSSCEEEEETT----E
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-hhHHHHHHHHHHHHHhCC-----CCCeEEEEcCC----c
Confidence 578889999999998643 346688888764333 345568888888887653 23466676632 6
Q ss_pred EEEEeccc
Q 001034 948 IVCELLKA 955 (1182)
Q Consensus 948 LVmEyL~G 955 (1182)
+||+|+.|
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 89999886
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.90 E-value=0.062 Score=55.25 Aligned_cols=52 Identities=4% Similarity=-0.022 Sum_probs=30.9
Q ss_pred EEEEEEeccCCceEEEEEEECCCCcEEEEEEEeccchhhHHHHHHHHHHHHhcCC
Q 001034 871 YHVTEYLGSAAFSKAIQAHDLHTGMDVCVKIIKNNKDFFDQSLDEIKLLKYVNKH 925 (1182)
Q Consensus 871 YeIlk~LGkGaFGeVyLAkDk~TGr~VAVKIIkk~k~~~dq~l~EikILr~L~h~ 925 (1182)
..-.+.|..|---+.|++.. ..| .|++|++.... ....+..++.++..+...
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~ 71 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAK 71 (316)
T ss_dssp EEEEEEECC---EEEEEEEE-SSC-CEEEEEECC----CCHHHHHHHHHHHHHHT
T ss_pred ceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhc
Confidence 33445677888899999975 334 48999986542 234455577777776654
|